{"meta":{"query_hash":"e25a5b74ee49","filters":{"venue":"Gynecologic Oncology"},"cohort_total":915,"direct_labels_cover":0,"predictions_cover":915,"exported":915,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e25a5b74ee49","api":"https://metacan.xera.ac/api/v1/cohort?venue=Gynecologic+Oncology"},"results":[{"id":"W1718276241","doi":"10.1016/j.ygyno.2015.06.019","title":"Why have ovarian cancer mortality rates declined? Part III. Prospects for the future","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Debulking; Case fatality rate; Oncology; Mortality rate; Disease; Cancer; Incidence (geometry); Population; Stage (stratigraphy); Gynecology; Internal medicine; Epidemiology; Environmental health; Biology","score_opus":0.13828505688273204,"score_gpt":0.44958799449292913,"score_spread":0.3113029376101971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1718276241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012030353,0.9685408,0.000019969824,0.01413084,0.005626836,0.008497651,0.00041084705,0.00010163483,0.0026593902],"genre_scores_gemma":[0.00002596602,0.96873623,0.00047228325,0.005551174,0.005474976,0.01742315,0.00048064947,0.00008037314,0.0017552064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996583,0.00031921064,0.0010027136,0.0010215347,0.00028987505,0.0007836772],"domain_scores_gemma":[0.9954321,0.0019924804,0.00087632705,0.00096926535,0.000407463,0.0003224093],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011267199,0.0007546171,0.0037474348,0.000103517836,0.00026581818,0.000045094628,0.00040951147,0.0012825843,0.0016408007],"category_scores_gemma":[0.00033018825,0.00039273532,0.0008897413,0.00027992667,0.000245525,0.000046830333,0.00015537327,0.0007127163,0.000064745334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069693764,0.0006573341,0.00089720055,0.0024632625,0.0019654061,0.00019123561,0.000050623647,0.0000015282093,1.6785242e-8,0.0006910486,0.27324286,0.7197698],"study_design_scores_gemma":[0.0032914332,0.0020149176,0.000994964,0.00095399265,0.010861804,0.00009670576,0.00009710576,0.000009415248,7.4272447e-7,0.00040629358,0.98089755,0.00037508807],"about_ca_topic_score_codex":0.00030401844,"about_ca_topic_score_gemma":0.0057641217,"teacher_disagreement_score":0.7193947,"about_ca_system_score_codex":0.0026600074,"about_ca_system_score_gemma":0.004892289,"threshold_uncertainty_score":0.9998525},"labels":[],"label_agreement":null},{"id":"W1760498947","doi":"10.1016/j.ygyno.2015.05.039","title":"Sentinel lymph node procedure in endometrial cancer: A systematic review and proposal for standardization of future research","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université Laval; Centre Hospitalier de l’Université de Montréal; McGill University; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Cervical cancer; Lymph node; Radiology; Cancer; Gynecology; Internal medicine; Breast cancer","score_opus":0.12072088748386403,"score_gpt":0.4742379119905011,"score_spread":0.353517024506637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1760498947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000116246865,0.9815268,0.0000070602055,0.0010214119,0.00045747805,0.016148174,0.00026665596,0.000025793135,0.0005350014],"genre_scores_gemma":[0.00002122213,0.98952657,0.0005321616,0.00019424745,0.00051757076,0.008604766,0.00025360967,0.000042188836,0.00030766963],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954095,0.0012849844,0.0015912425,0.000636872,0.0005494683,0.0005279446],"domain_scores_gemma":[0.99528575,0.0022967216,0.0009158133,0.00034364898,0.00095468416,0.00020340539],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043888334,0.0004009306,0.007314716,0.00084182114,0.000061454244,0.000011562256,0.00022172635,0.00086362375,0.000113707945],"category_scores_gemma":[0.008563401,0.00024260148,0.00035923356,0.0022701186,0.00016505629,0.000041709598,0.00014293917,0.00049238454,0.000006873263],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028120892,0.00040087878,0.00010981553,0.8950087,0.0004437499,0.000040685896,0.000028538003,2.0470061e-7,2.7785038e-7,0.00015986236,0.00075741805,0.10276869],"study_design_scores_gemma":[0.016914913,0.0034429154,0.00007022355,0.38532147,0.021242013,0.00025597776,0.00015616392,0.000004910621,0.0000011760266,0.0005234258,0.57160413,0.0004626617],"about_ca_topic_score_codex":0.00003095068,"about_ca_topic_score_gemma":0.000046410718,"teacher_disagreement_score":0.57084674,"about_ca_system_score_codex":0.0024947908,"about_ca_system_score_gemma":0.007348923,"threshold_uncertainty_score":0.99978787},"labels":[],"label_agreement":null},{"id":"W1771236415","doi":"10.1016/j.ygyno.2015.10.010","title":"Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Genetic testing; Referral; Medicine; Genetic counseling; Ovarian cancer; Family medicine; Family history; Lynch syndrome; Gynecology; Cancer; Internal medicine; Colorectal cancer; Genetics","score_opus":0.1946764230486563,"score_gpt":0.40535181774937484,"score_spread":0.21067539470071855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1771236415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615388,0.016163066,0.0021862895,0.011452998,0.0026118264,0.0010208633,0.000118646036,0.000039701295,0.004867827],"genre_scores_gemma":[0.95279855,0.0077990573,0.029427975,0.0018025724,0.0013110779,0.0013474259,0.00017058443,0.000052011597,0.005290757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887985,0.00013536931,0.0002747158,0.0003662474,0.000060592738,0.00028324462],"domain_scores_gemma":[0.998863,0.00030028506,0.0003332134,0.00015997732,0.00019949867,0.00014406636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054522714,0.00013718815,0.00020273427,0.00008362759,0.000081576996,0.000022437654,0.00012447902,0.00013688536,0.00003072437],"category_scores_gemma":[0.0021631583,0.00013458892,0.00002675715,0.000112318965,0.00010966867,0.000011326612,0.000115814786,0.00012895638,0.00000308546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001573948,0.00021970498,0.023486378,0.000035849127,0.00006868731,0.0000152001685,0.00039078319,0.0010822911,0.007438154,0.00012751707,0.03204651,0.9349315],"study_design_scores_gemma":[0.0019456577,0.0011321201,0.01941297,0.000011422765,0.00004851844,0.000041583844,0.00046316732,0.00043919322,0.0015838526,0.0021879114,0.97249055,0.00024307029],"about_ca_topic_score_codex":0.00025889312,"about_ca_topic_score_gemma":0.004535091,"teacher_disagreement_score":0.940444,"about_ca_system_score_codex":0.00028285992,"about_ca_system_score_gemma":0.002488527,"threshold_uncertainty_score":0.54883766},"labels":[],"label_agreement":null},{"id":"W1843076150","doi":"10.1016/j.ygyno.2015.06.017","title":"Why have ovarian cancer mortality rates declined? Part I. Incidence","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Incidence (geometry); Demography; Epidemiology; Mortality rate; Cancer; Case fatality rate; Gynecology; Parity (physics); Obstetrics; Internal medicine","score_opus":0.19984933680186442,"score_gpt":0.47631370600326356,"score_spread":0.27646436920139916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1843076150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008144698,0.98140585,0.000008044466,0.0037671153,0.0028868667,0.002841333,0.00026163578,0.00014591233,0.00860179],"genre_scores_gemma":[0.000053699274,0.9861762,0.0006177146,0.0052173925,0.0013654474,0.0041384767,0.0004884946,0.000080192534,0.0018624044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953424,0.0007197662,0.0013619836,0.0012866895,0.00042241113,0.0008667607],"domain_scores_gemma":[0.99572504,0.0012059492,0.0010265944,0.0010474825,0.00039937516,0.0005955904],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011876072,0.0008644338,0.005044525,0.00022341055,0.00013886673,0.000039237824,0.00041588783,0.0015449256,0.0050199884],"category_scores_gemma":[0.00076025847,0.0005977543,0.000744747,0.0004085478,0.00031913648,0.000083850595,0.00028584752,0.000910723,0.0004622172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002969625,0.00091119396,0.006140729,0.0028190725,0.0012871163,0.0016997451,0.000041173935,0.0000016699421,4.1091226e-8,0.00012293567,0.16092774,0.82601887],"study_design_scores_gemma":[0.0017387209,0.0018261602,0.0022162423,0.0026556514,0.007270748,0.00024952999,0.000032456315,0.000005032481,9.3011613e-7,0.0002809704,0.98321855,0.0005049894],"about_ca_topic_score_codex":0.0012218201,"about_ca_topic_score_gemma":0.0044283797,"teacher_disagreement_score":0.8255139,"about_ca_system_score_codex":0.0041779056,"about_ca_system_score_gemma":0.005711339,"threshold_uncertainty_score":0.9999254},"labels":[],"label_agreement":null},{"id":"W1852968667","doi":"10.1016/j.ygyno.2015.06.005","title":"Long-term mortality among women with epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Cause of death; Cancer; Stage (stratigraphy); Epidemiology; Disease; Internal medicine; Epithelial ovarian cancer; Gynecology; Oncology","score_opus":0.05131269534732253,"score_gpt":0.3451073308555909,"score_spread":0.2937946355082684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1852968667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799484,0.00023371703,0.000038084152,0.0032792275,0.0007921603,0.0008181309,0.000031131927,0.00011810485,0.014741041],"genre_scores_gemma":[0.9946777,0.00015206811,0.00049731456,0.0018836983,0.00042891764,0.0012879317,0.000026309912,0.000026453537,0.001019581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981636,0.00013510788,0.00030604567,0.00051552727,0.00025948402,0.000620244],"domain_scores_gemma":[0.9985074,0.00014743822,0.00018654922,0.00042203383,0.00017654971,0.0005600228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042949454,0.0002551504,0.0006955713,0.00007996057,0.000077381424,0.000018704215,0.00013053833,0.0002808586,0.0023456025],"category_scores_gemma":[0.00010270283,0.00017078241,0.000060861905,0.0002057936,0.00028688402,0.00008449798,0.00007382986,0.00025007804,0.00012149041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058481836,0.0011312308,0.96035117,0.000028686152,0.0005343894,0.0018121083,0.0006336427,0.0000274959,0.00003010808,0.00014950804,0.0014408942,0.03327592],"study_design_scores_gemma":[0.00794266,0.0063996986,0.9760516,0.000027965069,0.0003468671,0.00008100075,0.00020341433,0.000010322019,0.00016161434,0.000207734,0.008369474,0.00019763986],"about_ca_topic_score_codex":0.00064630277,"about_ca_topic_score_gemma":0.0029700254,"teacher_disagreement_score":0.033078283,"about_ca_system_score_codex":0.0025237997,"about_ca_system_score_gemma":0.0014066129,"threshold_uncertainty_score":0.9985664},"labels":[],"label_agreement":null},{"id":"W1901056508","doi":"10.1016/j.ygyno.2015.04.034","title":"No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University Health Network; Women's College Hospital; Alberta Health Services; BC Cancer Agency; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute","funders":"Niilo Helanderin Säätiö; Medical Research and Materiel Command; National Cancer Institute; European Regional Development Fund; Seventh Framework Programme; Instituto de Salud Carlos III; Cancer Council Western Australia; Cancer Council NSW; Cancer Council Victoria; Cancer Center, University of Kansas; National Institutes of Health; Centre Léon Bérard; Institut Català de la Salut; Liepaja City Council; Gesellschaft der Freunde der Medizinischen Hochschule Hannover; Universität Ulm; Institut Gustave-Roussy; Ministero dello Sviluppo Economico; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Federal Agency for Science and Innovation; Uppsala Universitet; Clalit Health Services; Institute of Cancer Research; Hospices Civils de Lyon; Legal Services Corporation; Syöpäjärjestöt; Radboud Universitair Medisch Centrum; National Health and Medical Research Council; Deutsche Krebshilfe; Royal Marsden NHS Foundation Trust; Sahlgrenska Universitetssjukhuset; Oulun Yliopisto; National Institute for Health and Care Research; Jewish General Hospital; Canadian Institutes of Health Research; European Commission; Lietuvos Mokslo Taryba; Kuopion Yliopistollinen Sairaala; Istituto Toscano Tumori; Roswell Park Cancer Institute; Israel Cancer Association; Linköpings Universitet; Sigrid Juséliuksen Säätiö; Unicancer; General Secretariat for Research and Technology; Norges Forskningsråd; Lunds Universitet; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; California Breast Cancer Research Program; McGill University; Generalitat de Catalunya; Cancer Council South Australia; Istituto Oncologico Veneto; Memorial Sloan-Kettering Cancer Center; Institut National Du Cancer; Cancer Council Queensland; Oak Foundation; Leids Universitair Medisch Centrum; Fundacja na rzecz Nauki Polskiej; Breakthrough Breast Cancer; Fundación Científica Asociación Española Contra el Cáncer; Vrije Universiteit Amsterdam; Ohio State University; Canadian Breast Cancer Research Alliance; Universiteit Leiden; Celma Mastry Ovarian Cancer Foundation; Ministero della Salute; Institut National de la Santé et de la Recherche Médicale; Cancerfonden; Wellcome; Friedrich-Alexander-Universität Erlangen-Nürnberg; Robert Bosch Stiftung; Hungarian Scientific Research Fund; Cancer Association of South Africa; Cancer Institute NSW; Wellcome Trust; Agence Nationale de la Recherche; American Cancer Society; Radboud Universiteit; Cancer Australia; State Education Development Agency Republic of Latvia; Helsingin ja Uudenmaan Sairaanhoitopiiri; Department of Defence, Australian Government; Academy of Finland; King's College London; Cancer Research UK; Vlaamse regering; Fundación Mutua Madrileña; Hamburger Krebsgesellschaft; Center for Molecular Medicine Cologne, University of Cologne; Lon V. Smith Foundation; Rutgers Cancer Institute of New Jersey; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Bundesministerium für Bildung und Forschung; Francis Crick Institute; Génome Québec; Cancer Care Ontario; Deutsches Krebsforschungszentrum; Fred C. and Katherine B. Andersen Foundation; Umeå Universitet; Helsingin Yliopisto; Ljósmæðrafélag Íslands; Ligue Contre le Cancer; Kansas Bioscience Authority; Cancer Council Tasmania; Itä-Suomen Yliopisto; Fox Chase Cancer Center; KWF Kankerbestrijding; Agency for Science, Technology and Research; University of Chicago; U.S. Department of Health and Human Services; Creighton University; Ministerstwo Edukacji i Nauki; Nordic Cancer Union; Breast Cancer Research Foundation; National Breast Cancer Foundation; European Social Fund; Medical Research Council; Mayo Foundation for Medical Education and Research; University of Melbourne; California Department of Public Health; Kræftens Bekæmpelse; National Institute on Handicapped Research; Susan G. Komen for the Cure; Associazione Italiana per la Ricerca sul Cancro; Roswell Park Alliance Foundation, Roswell Park Cancer Institute; Fondation de France; Universitair Medisch Centrum Groningen; Minnesota Ovarian Cancer Alliance; Susan G. Komen; Ministerio de Economía y Competitividad; Erasmus Medisch Centrum; Beth Israel Deaconess Medical Center; Fonds Wetenschappelijk Onderzoek; U.S. Army; Landspítali Háskólasjúkrahús; Ovarian Cancer Research Fund","keywords":"Medicine; Ovarian cancer; Oncology; KRAS; Internal medicine; Breast cancer; Gynecology; Cancer; Colorectal cancer","score_opus":0.11346958900638453,"score_gpt":0.44502414792307615,"score_spread":0.3315545589166916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1901056508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001515834,0.98805547,0.00045152765,0.000102554164,0.002859542,0.003061539,0.00276523,0.00003318733,0.0025193554],"genre_scores_gemma":[0.00022901119,0.9915667,0.0026245518,0.00018920466,0.0016452516,0.00090735656,0.0013618823,0.00007001879,0.0014060057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957311,0.0010049683,0.0015652324,0.0010218138,0.00015345366,0.0005234064],"domain_scores_gemma":[0.9962161,0.0005584977,0.001368574,0.0008771064,0.000715375,0.0002643209],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020931298,0.0005073251,0.0025252514,0.000086131404,0.000068724425,0.000011462478,0.00066143874,0.002401586,0.0011031625],"category_scores_gemma":[0.001706765,0.00036775213,0.00086461566,0.00017084056,0.0003849794,0.000004293948,0.00038782676,0.00031528747,0.00005285111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064028474,0.00084567326,0.00009851314,0.004052473,0.0007400451,0.000026316015,0.0000038122582,0.0000014822305,0.00004061392,0.00006478772,0.054307576,0.9391784],"study_design_scores_gemma":[0.0011653046,0.0014374634,0.00058953086,0.00030740182,0.0012488534,0.00014817929,0.000004911339,0.000025684636,0.0000054917246,0.00009267731,0.99458295,0.0003915226],"about_ca_topic_score_codex":0.000029538805,"about_ca_topic_score_gemma":0.00015862432,"teacher_disagreement_score":0.94027543,"about_ca_system_score_codex":0.00023533663,"about_ca_system_score_gemma":0.0061471923,"threshold_uncertainty_score":0.99987745},"labels":[],"label_agreement":null},{"id":"W1916168367","doi":"10.1016/j.ygyno.2015.06.014","title":"Cancer precursor lesions in the BRCA population at the time of prophylactic salpingo-oophorectomy: Accuracy of assessment and potential surrogate marker for prevention","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecology; Surrogate endpoint; Cancer; Oncology; Population; Oophorectomy; Internal medicine; Surgery; Hysterectomy; Environmental health","score_opus":0.05103400292627381,"score_gpt":0.3894994561347671,"score_spread":0.3384654532084933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1916168367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872393,0.0006640554,0.00002366991,0.0074795657,0.00023885226,0.0023231395,0.000028170458,0.0000075141643,0.000511083],"genre_scores_gemma":[0.9976856,0.00022190761,0.0006705981,0.00019164206,0.000052506017,0.0008417535,0.00005266022,0.000008492818,0.0002748452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987707,0.0003489721,0.00034072442,0.00021055438,0.00015622687,0.0001727901],"domain_scores_gemma":[0.99830276,0.00097161136,0.00035872817,0.00019663737,0.00012795828,0.000042334927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082288444,0.00010919248,0.0003605933,0.000057705092,0.00006275143,0.00000583682,0.00007831576,0.0001209369,0.00018121957],"category_scores_gemma":[0.0003461239,0.000058391925,0.00007878935,0.0001344343,0.000099973564,0.000046210265,0.000056781475,0.000099203695,0.0000023793923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027335468,0.00408927,0.70095855,0.00038566373,0.00047800608,0.000038604594,0.0019828682,0.00047677773,0.0025316896,0.00069235417,0.005135989,0.28049666],"study_design_scores_gemma":[0.003999949,0.0034569239,0.98780626,0.000044050856,0.0004032548,0.00002025215,0.00023987523,0.00051144353,0.00026974143,0.0010009713,0.002186648,0.000060605485],"about_ca_topic_score_codex":0.00029354874,"about_ca_topic_score_gemma":0.00076417625,"teacher_disagreement_score":0.2868477,"about_ca_system_score_codex":0.0006109297,"about_ca_system_score_gemma":0.00042641157,"threshold_uncertainty_score":0.23811536},"labels":[],"label_agreement":null},{"id":"W1925407809","doi":"10.1016/j.ygyno.2015.05.011","title":"Stage I granulosa cell tumours: A management conundrum? Results of long-term follow up","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Chemotherapy; Surgery; Histopathology; Disease; Internal medicine; Pathology","score_opus":0.05518377647312948,"score_gpt":0.3300759917503429,"score_spread":0.2748922152772134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1925407809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8565885,0.0006939062,0.0000530621,0.003829989,0.0015225478,0.0014371818,0.00009321276,0.00009016288,0.13569143],"genre_scores_gemma":[0.9840315,0.00041952936,0.0018240835,0.00087140047,0.00010499845,0.00022160048,0.00012236065,0.000021757953,0.012382746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979547,0.00016308205,0.00059399125,0.0005221315,0.00029005972,0.00047598244],"domain_scores_gemma":[0.9982735,0.0003297217,0.00035635766,0.000541703,0.00017803129,0.00032066746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005920685,0.0002518663,0.00078136905,0.0001290649,0.000047269335,0.000010452383,0.00018086862,0.00023619592,0.0004045122],"category_scores_gemma":[0.00014382954,0.00019868961,0.00017699585,0.00021677522,0.00016823657,0.00004965444,0.00014488013,0.00018327736,0.00020988983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006258858,0.010299929,0.77105,0.00070212723,0.0008566701,0.014051599,0.001757653,0.000066403416,0.0002137842,0.0021358381,0.08350678,0.1091004],"study_design_scores_gemma":[0.061749164,0.018661879,0.82886875,0.00011691191,0.0012248328,0.00011793602,0.0012350532,0.000023418956,0.004119177,0.00041726447,0.0830575,0.00040810314],"about_ca_topic_score_codex":0.000088948844,"about_ca_topic_score_gemma":0.00027863326,"teacher_disagreement_score":0.12744302,"about_ca_system_score_codex":0.00082210754,"about_ca_system_score_gemma":0.0004085847,"threshold_uncertainty_score":0.8102327},"labels":[],"label_agreement":null},{"id":"W1933854096","doi":"10.1016/j.ygyno.2015.11.005","title":"A comparison of the toxicity and tolerability of two intraperitoneal chemotherapy regimens for advanced-stage epithelial ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Carboplatin; Medicine; Tolerability; Cisplatin; Internal medicine; Oncology; Ovarian cancer; Chemotherapy; Toxicity; Neutropenia; Nausea; Cancer; Adverse effect","score_opus":0.07092967197632274,"score_gpt":0.4184938203996043,"score_spread":0.34756414842328154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1933854096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864279,0.0006156419,0.00009804549,0.009752036,0.00055556477,0.0013771931,0.00013704886,0.00001658758,0.0010199763],"genre_scores_gemma":[0.9937612,0.00011601134,0.0047449474,0.0008083445,0.000103580765,0.00031921975,0.0000060602147,0.000011082426,0.00012958501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987619,0.00011994787,0.0004508094,0.00029941052,0.00013394588,0.00023401731],"domain_scores_gemma":[0.99855715,0.00045587154,0.00035791687,0.00031539967,0.0001978675,0.000115821706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040563426,0.00015048511,0.00084303704,0.000031350588,0.00005282924,0.0000030137946,0.000108299806,0.0001597328,0.000134338],"category_scores_gemma":[0.00023036498,0.000096444564,0.00011504933,0.00011671991,0.0003646688,0.000029261646,0.000056437886,0.00013175269,5.218632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029115784,0.005312419,0.8003262,0.00023895976,0.00040547512,0.000007343434,0.0029767323,0.00028467516,0.015459954,0.0035481127,0.0018013634,0.16672717],"study_design_scores_gemma":[0.046510875,0.018484931,0.67019856,0.000105462124,0.00061963906,0.000023556053,0.001575595,0.0011066411,0.16994782,0.0031397971,0.08795447,0.0003326752],"about_ca_topic_score_codex":0.00031661757,"about_ca_topic_score_gemma":0.0010199704,"teacher_disagreement_score":0.1663945,"about_ca_system_score_codex":0.00044587307,"about_ca_system_score_gemma":0.00063156046,"threshold_uncertainty_score":0.3932895},"labels":[],"label_agreement":null},{"id":"W1951006848","doi":"10.1016/j.ygyno.2015.09.077","title":"Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel node; Vulvar Carcinoma; Stage (stratigraphy); Surgery; Vulva; Lymphadenectomy; Vulvar Diseases; Survival rate; Groin; Cancer; Internal medicine; Breast cancer","score_opus":0.07534060042711892,"score_gpt":0.38159567339906647,"score_spread":0.30625507297194754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951006848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856515,0.00066990475,0.000002195648,0.0032703925,0.0024817928,0.0011115246,0.000030534455,0.000036104124,0.006746041],"genre_scores_gemma":[0.99592656,0.00027451932,0.000036833582,0.0014511178,0.00031915176,0.00055081374,0.000023912096,0.000025861487,0.0013912335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973107,0.00036789456,0.0007296663,0.0005631329,0.0005166088,0.0005120223],"domain_scores_gemma":[0.9983823,0.0005337449,0.0003602994,0.00035476097,0.00021548879,0.0001534637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006654981,0.00030599255,0.00088935334,0.00034056715,0.000053672367,0.000012528586,0.0004351288,0.0002589351,0.0007201596],"category_scores_gemma":[0.0008463798,0.0002031024,0.00015133768,0.000782781,0.00015983074,0.00007886108,0.0002979722,0.0004645837,0.00003068702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001548982,0.0032706873,0.9866931,0.000037328737,0.00028408674,0.0002812787,0.0009476308,0.0001445775,0.00064092857,0.00005321854,0.00038987922,0.005708323],"study_design_scores_gemma":[0.023388168,0.0011858778,0.9733375,0.000107291584,0.00019357617,0.000017658676,0.00064812246,0.00007352274,0.00040894435,0.00010516949,0.00035828594,0.0001758831],"about_ca_topic_score_codex":0.0032539787,"about_ca_topic_score_gemma":0.011767345,"teacher_disagreement_score":0.021839185,"about_ca_system_score_codex":0.0015908385,"about_ca_system_score_gemma":0.0007123388,"threshold_uncertainty_score":0.8282275},"labels":[],"label_agreement":null},{"id":"W1956465683","doi":"10.1016/j.ygyno.2015.06.016","title":"Why have ovarian cancer mortality rates declined? Part II. Case-fatality","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine; Case fatality rate; Ovarian cancer; Mortality rate; Epidemiology; Cancer; Incidence (geometry); Demography; Chemotherapy; Internal medicine; Oncology","score_opus":0.2341247714256782,"score_gpt":0.48056356958166,"score_spread":0.24643879815598183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1956465683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044915458,0.9781248,0.0000038957132,0.003185332,0.0032667755,0.003555771,0.0010177899,0.00018855654,0.010207933],"genre_scores_gemma":[0.00016728546,0.9870529,0.0004934084,0.003953593,0.0015722775,0.0040528453,0.0010715015,0.00009649541,0.0015396611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944888,0.00095561065,0.0016304762,0.0015226841,0.0003961323,0.0010063244],"domain_scores_gemma":[0.99530965,0.0010748677,0.0011247896,0.0013418439,0.0004220975,0.0007267686],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015332857,0.0010367779,0.005748255,0.00021871319,0.00032160297,0.00003978216,0.00033823392,0.0018454189,0.0056397915],"category_scores_gemma":[0.00062387856,0.0007255373,0.0009714685,0.0004175118,0.0003804088,0.00008828107,0.0004329608,0.0010316398,0.00022782931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039141523,0.0018190377,0.002651368,0.0030734898,0.0023159515,0.020394942,0.00006778612,0.0000013187924,2.1597295e-8,0.0002666111,0.1483137,0.82105666],"study_design_scores_gemma":[0.0024130405,0.0023829257,0.00058009825,0.0014959291,0.010431832,0.0036156934,0.000063399755,0.0000049737505,8.9780207e-7,0.00020934646,0.9781924,0.0006094508],"about_ca_topic_score_codex":0.0031530678,"about_ca_topic_score_gemma":0.009700207,"teacher_disagreement_score":0.8298787,"about_ca_system_score_codex":0.0045506004,"about_ca_system_score_gemma":0.0054833377,"threshold_uncertainty_score":0.9995196},"labels":[],"label_agreement":null},{"id":"W1963718242","doi":"10.1016/j.ygyno.2012.12.009","title":"Low-grade and high-grade serous Mullerian carcinoma: Review and analysis of publicly available gene expression profiles","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous carcinoma; Serous fluid; Gene; Oncology; Cancer research; Internal medicine; Bioinformatics; Cancer; Biology; Genetics; Ovarian cancer","score_opus":0.0727199607080715,"score_gpt":0.3424772886158243,"score_spread":0.2697573279077528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963718242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018309986,0.9934144,0.0000026451783,0.000853673,0.0002860866,0.0027817818,0.0002705551,0.000046272125,0.0005135668],"genre_scores_gemma":[0.002155109,0.9921187,0.0023853448,0.0005048235,0.00014719668,0.0012708565,0.00089218485,0.00004890996,0.0004768696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644536,0.00058578816,0.0011405642,0.0010043936,0.00021714739,0.0006067583],"domain_scores_gemma":[0.9967752,0.00082500966,0.0010769181,0.0007984386,0.0001249502,0.00039948066],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007121547,0.0006418695,0.0062846965,0.0005584471,0.00010920195,0.000019504485,0.00018875115,0.0008658951,0.0023644473],"category_scores_gemma":[0.0001920084,0.0004254443,0.0005128818,0.00090567966,0.00025711377,0.00008652593,0.00029012456,0.00041956358,0.000042638836],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021473517,0.0022431493,0.0138955945,0.061180737,0.0046650046,0.00025933504,0.0000582677,1.7683386e-7,0.00001502128,0.000082766324,0.007800764,0.9097777],"study_design_scores_gemma":[0.0013845833,0.0014144147,0.010383367,0.003751592,0.076725945,0.00020317986,0.000018632356,0.0000019541292,0.000047568923,0.000008428687,0.90567625,0.00038407455],"about_ca_topic_score_codex":0.00023402869,"about_ca_topic_score_gemma":0.00013384757,"teacher_disagreement_score":0.9093936,"about_ca_system_score_codex":0.0005552815,"about_ca_system_score_gemma":0.0006424077,"threshold_uncertainty_score":0.99981976},"labels":[],"label_agreement":null},{"id":"W1963760152","doi":"10.1016/j.ygyno.2013.03.007","title":"Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer—a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; Internal medicine; Prospective cohort study; Cancer; Chemotherapy; Beta blocker; Oncology; Surgery; Cisplatin","score_opus":0.015416894869214616,"score_gpt":0.3236800283140034,"score_spread":0.3082631334447888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963760152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949185,0.0002277914,0.000008944006,0.00058856857,0.0001111664,0.0039732167,0.00007224828,0.000011364331,0.00008818056],"genre_scores_gemma":[0.9991449,0.0001236591,0.000047465444,0.00009098168,0.000030063706,0.00041844576,0.000103587474,0.00001175159,0.000029149242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706936,0.0011452468,0.0008536624,0.0003698825,0.00028370705,0.00027814874],"domain_scores_gemma":[0.99643534,0.0018466708,0.0009409896,0.00030233894,0.00038832822,0.000086321284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011801342,0.00022620396,0.0015601553,0.000296908,0.00005781865,0.000007646866,0.00010658979,0.00016988975,0.0003108588],"category_scores_gemma":[0.00085703103,0.00012448523,0.00016704362,0.00058911595,0.00035122276,0.00006872138,0.000054453507,0.00024026858,0.0000013596473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008986013,0.0038117792,0.9642263,0.000018321236,0.0029032333,0.00000624826,0.0038943174,0.000017835084,0.00033825234,0.0000040658488,0.000433403,0.015360206],"study_design_scores_gemma":[0.0145728085,0.014927885,0.96543163,0.000036522597,0.0023776926,0.0000018814161,0.001966522,0.00041347407,0.00010947641,0.000007169225,0.000040806608,0.00011412766],"about_ca_topic_score_codex":0.004641351,"about_ca_topic_score_gemma":0.0029561243,"teacher_disagreement_score":0.015246078,"about_ca_system_score_codex":0.0005558134,"about_ca_system_score_gemma":0.000280052,"threshold_uncertainty_score":0.7016365},"labels":[],"label_agreement":null},{"id":"W1964260407","doi":"10.1016/j.ygyno.2005.01.007","title":"Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Medicine; Endometrial cancer; Quality of life (healthcare); Population; Oncology; Sample (material); Demography; Internal medicine; Cancer; Gerontology; Environmental health","score_opus":0.05159512880813364,"score_gpt":0.3617442662273092,"score_spread":0.31014913741917555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964260407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655753,0.0007628326,0.000021148575,0.00071167055,0.0002553735,0.0006214225,0.00021867141,0.000019181969,0.0008321564],"genre_scores_gemma":[0.997713,0.00029191774,0.0013558688,0.00023368598,0.00011661581,0.000119956436,0.00011214842,0.000008056132,0.000048747675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818295,0.0002728092,0.0008410051,0.00023860471,0.00023056871,0.00023407856],"domain_scores_gemma":[0.99439347,0.0046829,0.0005172514,0.00014491047,0.00013386799,0.0001276074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075377594,0.00012812746,0.0010691346,0.00036660337,0.00003612816,0.0000024821632,0.000069900925,0.00025619482,0.0009045052],"category_scores_gemma":[0.0054493416,0.000103839826,0.00011447641,0.0007749018,0.0001017013,0.00004998366,0.00003374253,0.0001443508,0.0000017484945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007817236,0.0009380083,0.9866415,0.000055125267,0.00008126429,0.0000015958511,0.00006670739,0.00006718497,0.00018001259,0.00020042207,0.000023073642,0.01096337],"study_design_scores_gemma":[0.010665914,0.0008203603,0.98735213,0.000020946773,0.0001326443,1.22285e-7,0.00003332703,0.00010396468,0.00023968512,0.00024980074,0.0002975072,0.00008357627],"about_ca_topic_score_codex":0.050919127,"about_ca_topic_score_gemma":0.06406398,"teacher_disagreement_score":0.013144854,"about_ca_system_score_codex":0.0005724759,"about_ca_system_score_gemma":0.0003601418,"threshold_uncertainty_score":0.99036974},"labels":[],"label_agreement":null},{"id":"W1964641392","doi":"10.1016/j.ygyno.2005.07.006","title":"Uterine papillary serous carcinoma: What have we learned over the past quarter century?","year":2005,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Papillary carcinoma; Gynecology; General surgery; Carcinoma; Internal medicine; Archaeology","score_opus":0.02307098474534337,"score_gpt":0.32801671401141796,"score_spread":0.3049457292660746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964641392","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015876284,0.02267347,0.00000340041,0.021501364,0.92937106,0.001975289,0.00017901475,0.0002090144,0.008211132],"genre_scores_gemma":[0.027407326,0.04887248,0.00016657708,0.00391043,0.9077032,0.0005531238,0.0010898471,0.0001117985,0.010185172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955209,0.0005643506,0.0008585142,0.0010934579,0.0008822813,0.0010805003],"domain_scores_gemma":[0.99383587,0.0040045693,0.000552508,0.0009447462,0.00029975534,0.00036253995],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053674926,0.0007942577,0.0018742561,0.00023980468,0.00025366727,0.00011029732,0.0005615617,0.002643215,0.004860101],"category_scores_gemma":[0.00080010964,0.0004695572,0.00055426924,0.00034967292,0.0003340974,0.00017749393,0.0003859804,0.002119726,0.00058455503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013835834,0.00087484607,0.001340569,0.00019439406,0.00047098473,0.0013383413,0.00026187443,0.0000022297904,0.000016522772,0.000008829048,0.87249297,0.12161486],"study_design_scores_gemma":[0.009802122,0.00785417,0.011502166,0.00007431172,0.0008409285,0.00008236539,0.0006418125,0.0000057472107,0.0000070453825,0.00012844415,0.96863467,0.00042622737],"about_ca_topic_score_codex":0.00020469897,"about_ca_topic_score_gemma":0.0005811822,"teacher_disagreement_score":0.121188626,"about_ca_system_score_codex":0.0022173803,"about_ca_system_score_gemma":0.00092304166,"threshold_uncertainty_score":0.9997756},"labels":[],"label_agreement":null},{"id":"W1964740590","doi":"10.1016/j.ygyno.2011.04.005","title":"Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Concordance; Response Evaluation Criteria in Solid Tumors; Radiological weapon; Internal medicine; Ovarian cancer; Predictive value; Oncology; Nuclear medicine; Cancer; Phases of clinical research; Chemotherapy; Radiology","score_opus":0.10797616294569438,"score_gpt":0.3847583790814949,"score_spread":0.2767822161358005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964740590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991023,0.0007013325,0.00005450791,0.0033213806,0.0007603183,0.0018479051,0.0001881623,0.00004025326,0.0020631189],"genre_scores_gemma":[0.9969087,0.0003040638,0.00041025566,0.00051699363,0.00007288588,0.00074526167,0.000049520906,0.000018161492,0.0009741217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782485,0.00052710745,0.0005419172,0.00056943647,0.00014631498,0.0003903645],"domain_scores_gemma":[0.99851614,0.0007171019,0.00021842324,0.00027900055,0.000072146155,0.00019721105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009963433,0.00023664997,0.00073172513,0.00018276343,0.00010253131,0.000009475877,0.000075316384,0.00028289173,0.0015163895],"category_scores_gemma":[0.0002820932,0.00019532732,0.000050262886,0.00028613408,0.00010851456,0.000068331945,0.00008032687,0.00032803343,0.000034206576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004985165,0.0059475,0.73636985,0.000011207753,0.00020370743,0.00060188264,0.0038649782,0.000001037286,0.000041655952,0.000027047176,0.005517482,0.2424285],"study_design_scores_gemma":[0.027672634,0.015621642,0.9302407,0.000036920737,0.00035583606,0.000024733912,0.0008872998,0.00004902365,0.000057288857,0.00011994287,0.024751997,0.0001820049],"about_ca_topic_score_codex":0.002316236,"about_ca_topic_score_gemma":0.0045194854,"teacher_disagreement_score":0.2422465,"about_ca_system_score_codex":0.0013917935,"about_ca_system_score_gemma":0.0004704295,"threshold_uncertainty_score":0.9993964},"labels":[],"label_agreement":null},{"id":"W1966258320","doi":"10.1016/j.ygyno.2014.05.020","title":"Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hysterectomy; Endometrial cancer; Gynecology; Tamoxifen; Complement (music); Oophorectomy; Oncology; Obstetrics; Cancer; Internal medicine; Surgery; Breast cancer; Gene; Genetics","score_opus":0.04107096430846765,"score_gpt":0.3344632035953647,"score_spread":0.29339223928689706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966258320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800266,0.0003675823,0.000071726514,0.007053586,0.00047269496,0.0012964804,0.0000060421494,0.000068527326,0.010636781],"genre_scores_gemma":[0.99504286,0.00007310077,0.0018091137,0.0023512067,0.0001283912,0.00045206829,0.000034682827,0.00001939269,0.00008916398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825454,0.0002581999,0.00039877603,0.00051456224,0.00016110473,0.0004127981],"domain_scores_gemma":[0.9987192,0.0006354001,0.00015981545,0.00024818158,0.00006941274,0.00016796139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048946147,0.00021862637,0.0006241193,0.00018279237,0.00008267264,0.000020842379,0.000071141105,0.00021174748,0.00047808717],"category_scores_gemma":[0.00031185988,0.00017553837,0.000060149458,0.00020537635,0.00012519334,0.000056048357,0.00006491427,0.0002479344,0.000047960526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004967881,0.0018780372,0.5681954,0.0003368112,0.00027366512,0.0008708883,0.0018245141,0.000046900066,0.0009439518,0.0027830277,0.0015358938,0.42081413],"study_design_scores_gemma":[0.010345551,0.0073641413,0.91195965,0.000049213693,0.00021000144,0.00021300116,0.0004566791,0.00055359723,0.00061832124,0.0010328039,0.066952154,0.0002449133],"about_ca_topic_score_codex":0.00026405175,"about_ca_topic_score_gemma":0.0010497359,"teacher_disagreement_score":0.4205692,"about_ca_system_score_codex":0.001004188,"about_ca_system_score_gemma":0.00022705852,"threshold_uncertainty_score":0.71582466},"labels":[],"label_agreement":null},{"id":"W1967608555","doi":"10.1016/j.ygyno.2005.04.014","title":"Vaginal radical trachelectomy: A valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Obstetrics; Miscarriage; Pregnancy; Gynecology; Cervical cancer; Cervix; Fertility preservation; Trachelectomy; Cervical cerclage; Fertility; Gestation; Cancer; Population","score_opus":0.06127238718980464,"score_gpt":0.3834615602306494,"score_spread":0.32218917304084477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967608555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004233291,0.99026215,0.000001365394,0.0011386607,0.00013191722,0.0028532357,0.00008619902,0.000008857688,0.0012843045],"genre_scores_gemma":[0.0034997044,0.99470174,0.0005043656,0.0002785752,0.000055586865,0.0005669383,0.000033249,0.000014364791,0.00034549684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669015,0.0010625368,0.0011190599,0.000395972,0.0004099883,0.00032227027],"domain_scores_gemma":[0.9977803,0.0007371162,0.000749349,0.00053654663,0.00013440027,0.00006227765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011265251,0.00033051902,0.0025517242,0.00013685039,0.000047915877,0.000007592839,0.0005089876,0.00044595322,0.00039723158],"category_scores_gemma":[0.00030303764,0.0001585826,0.0004344266,0.0011981525,0.00036314366,0.00006993182,0.0002806081,0.0006581941,8.997402e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032527806,0.0008183436,0.0011832453,0.2531114,0.0005176855,0.000059125345,0.00032541505,8.549901e-7,0.0000019623114,0.00039886273,0.00007183211,0.743186],"study_design_scores_gemma":[0.0028353576,0.0032172762,0.055763803,0.16251764,0.0052858735,0.00010166771,0.00014292038,0.000002350148,0.000011431074,0.00028796846,0.7696099,0.00022378341],"about_ca_topic_score_codex":0.0001509129,"about_ca_topic_score_gemma":0.00018665851,"teacher_disagreement_score":0.7695381,"about_ca_system_score_codex":0.00043126682,"about_ca_system_score_gemma":0.0005291135,"threshold_uncertainty_score":0.6466811},"labels":[],"label_agreement":null},{"id":"W1967675502","doi":"10.1016/j.ygyno.2006.12.037","title":"Anemia correction in malignancy management: Threat or opportunity?","year":2007,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Anemia; Medicine; Hemoglobin; Hypoxia (environmental); Erythropoietin; Malignancy; Intensive care medicine; Oncology; Internal medicine; Oxygen","score_opus":0.15168168780031152,"score_gpt":0.43970616718196887,"score_spread":0.2880244793816573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967675502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032619817,0.7840662,0.000008716732,0.0002482396,0.002243244,0.0024417862,0.000009295531,0.00016169935,0.21078822],"genre_scores_gemma":[0.000022684015,0.94603944,0.0015195868,0.00074268255,0.00024522716,0.0005137346,0.00043056285,0.000063758074,0.050422315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664557,0.0003297878,0.0011452525,0.0008467748,0.0002295029,0.00080311904],"domain_scores_gemma":[0.9975519,0.0009870292,0.00050488184,0.00057685986,0.000057133137,0.0003222066],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007432015,0.00066739443,0.0030323241,0.00073565054,0.00009994802,0.000012090688,0.0002327846,0.0016065873,0.005026183],"category_scores_gemma":[0.00026768952,0.0004395977,0.00044796432,0.00078276364,0.0001927415,0.000042793126,0.00017762475,0.0010032138,0.00072639855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010115126,0.001151425,0.00019818373,0.008444845,0.00016771164,0.02097206,0.000031337448,1.6602768e-7,5.6718594e-8,0.00017771368,0.01450814,0.95424724],"study_design_scores_gemma":[0.001979955,0.0028591424,0.00030170978,0.005601231,0.0017768829,0.0029325827,0.00025490762,0.0000012078996,5.5000163e-7,0.000056482797,0.9838527,0.00038265562],"about_ca_topic_score_codex":0.000040908526,"about_ca_topic_score_gemma":0.00033494667,"teacher_disagreement_score":0.96934456,"about_ca_system_score_codex":0.002879124,"about_ca_system_score_gemma":0.0011103137,"threshold_uncertainty_score":0.99980557},"labels":[],"label_agreement":null},{"id":"W1967756579","doi":"10.1006/gyno.2001.6409","title":"A Phase II Trial of JM-216 in Cervical Cancer: An NCIC CTG Study","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Nausea; Internal medicine; Vomiting; Anorexia; Gastroenterology; Toxicity; Cervix; Phases of clinical research; Cervical cancer; Surgery; Chemotherapy; Radiation therapy; Cancer","score_opus":0.0876744533324464,"score_gpt":0.40841148670002286,"score_spread":0.3207370333675765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967756579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576725,0.0005415538,0.0000016484395,0.0015363144,0.00088045443,0.002193976,0.000020883508,0.00005747293,0.009000444],"genre_scores_gemma":[0.9971196,0.00024897605,0.00014619318,0.00079606177,0.00037182556,0.0006564968,0.000014407853,0.000016198348,0.00063026237],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99761397,0.00040356,0.0007230708,0.0004952251,0.00029548112,0.00046867592],"domain_scores_gemma":[0.99855256,0.00053589256,0.00021217299,0.00036032172,0.00009134695,0.0002477286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004667871,0.00022577558,0.0011388642,0.0002876282,0.00007758113,0.000004231181,0.00020144045,0.00031591151,0.008847629],"category_scores_gemma":[0.0005333705,0.00016692244,0.00013941336,0.00077210605,0.00012777589,0.0000676731,0.00011479727,0.00034383463,0.000049026534],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0859912,0.22685193,0.05672135,0.00007073226,0.00037461845,0.0014166156,0.002544377,0.000016335911,0.0006843293,0.00009570424,0.0007400372,0.62449276],"study_design_scores_gemma":[0.58804184,0.34402615,0.05455697,0.000019120202,0.00046469466,0.0000247083,0.00087170297,0.0002412112,0.00019012547,0.00029529375,0.011026239,0.00024197271],"about_ca_topic_score_codex":0.00081403134,"about_ca_topic_score_gemma":0.0029187794,"teacher_disagreement_score":0.6242508,"about_ca_system_score_codex":0.00071889826,"about_ca_system_score_gemma":0.0001807684,"threshold_uncertainty_score":0.9920584},"labels":[],"label_agreement":null},{"id":"W1967890742","doi":"10.1016/j.ygyno.2009.03.027","title":"Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Western University; University of British Columbia; Victoria Hospital; London Health Sciences Centre","funders":"Health Research Board","keywords":"Medicine; Carboplatin; Endometrial cancer; Radiation therapy; Chemotherapy; Paclitaxel; Surgery; Internal medicine; Cancer; Oncology; Urology; Cisplatin","score_opus":0.022313531311913114,"score_gpt":0.3405159914096408,"score_spread":0.3182024600977277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967890742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983707,0.0020785043,0.00040210146,0.009289662,0.00049142406,0.0019040197,0.000022591645,0.000078573685,0.002026132],"genre_scores_gemma":[0.98670053,0.0010253675,0.0032697257,0.008064078,0.00030728665,0.0003568545,0.000038089063,0.0000125530205,0.00022553609],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988609,0.000056543606,0.0002862986,0.00035690912,0.000120416815,0.00031891168],"domain_scores_gemma":[0.9981141,0.0013344536,0.00016766967,0.00014223011,0.000092272625,0.00014928202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018052825,0.00019062505,0.0006459184,0.0001636947,0.00007151844,0.0000098490955,0.000062670755,0.00022807876,0.00029158787],"category_scores_gemma":[0.0007014846,0.00012788616,0.00008290403,0.000319108,0.000052783813,0.000058789476,0.00001264102,0.00015571123,0.0000023822802],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012253135,0.0004495281,0.011255784,0.00003101813,0.00016666859,0.000031375374,0.00023958285,0.000006123387,0.0067518386,0.00012726887,0.0004047372,0.96828294],"study_design_scores_gemma":[0.2149402,0.17991804,0.50228596,0.00014893016,0.0010122686,0.0000568783,0.0009810267,0.0004379915,0.03770567,0.0042035677,0.057458416,0.00085105083],"about_ca_topic_score_codex":0.00006269889,"about_ca_topic_score_gemma":0.00022692105,"teacher_disagreement_score":0.9674319,"about_ca_system_score_codex":0.00040933627,"about_ca_system_score_gemma":0.0001999547,"threshold_uncertainty_score":0.52150464},"labels":[],"label_agreement":null},{"id":"W1968086967","doi":"10.1016/j.ygyno.2010.05.016","title":"Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (αE/β7 Integrin) in high-grade serous ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"BC Cancer Agency; Canadian Institutes of Health Research; U.S. Department of Defense","keywords":"Medicine; Ovarian cancer; Serous fluid; CD8; Integrin; Serous ovarian cancer; Cancer research; Lymphocyte; Cancer; Immunology; Pathology; Antigen; Internal medicine; Receptor","score_opus":0.018536711274206336,"score_gpt":0.30159073171386325,"score_spread":0.2830540204396569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968086967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988822,0.0003032912,0.000066255896,0.0049028997,0.0030507355,0.0010246444,0.000017082633,0.000048926264,0.0017641942],"genre_scores_gemma":[0.9943868,0.0003579144,0.0018918372,0.0019268307,0.00038324192,0.00026141468,0.000017060196,0.00002609984,0.00074883475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99796885,0.00028253742,0.0006653556,0.0003917106,0.0002164907,0.00047504582],"domain_scores_gemma":[0.99837184,0.0006058024,0.00040060375,0.0004209907,0.00012842196,0.0000723368],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011229619,0.00024302382,0.0005707457,0.00016772181,0.00011189123,0.00002015573,0.00028550794,0.0005388025,0.001639216],"category_scores_gemma":[0.00023571264,0.00015843908,0.00012313528,0.00038005473,0.00047956448,0.0000999856,0.000081588354,0.0006975883,0.000016226297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033289485,0.0005154728,0.019407177,0.00007720466,0.0001591876,0.00007518905,0.0010728287,0.00002492247,0.7851408,0.00046506332,0.0011036466,0.18862954],"study_design_scores_gemma":[0.0147628,0.0021409828,0.733754,0.00014141275,0.00021870217,0.00013497227,0.00084342575,0.0004332741,0.13828199,0.001386075,0.10745956,0.00044284787],"about_ca_topic_score_codex":0.0022507901,"about_ca_topic_score_gemma":0.0056904145,"teacher_disagreement_score":0.71434677,"about_ca_system_score_codex":0.0008439195,"about_ca_system_score_gemma":0.0010861522,"threshold_uncertainty_score":0.9992734},"labels":[],"label_agreement":null},{"id":"W1970078959","doi":"10.1016/j.ygyno.2006.02.034","title":"Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: A report of 3 cases with radiological evidence of response","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Radiological weapon; Ovary; Radiation therapy; Granulosa cell; Oncology; General surgery; Gynecology; Internal medicine; Radiology","score_opus":0.0448117563078234,"score_gpt":0.34726503545006393,"score_spread":0.3024532791422405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970078959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906638,0.0037104257,0.00012426793,0.0032494478,0.00020092691,0.0017352505,0.00006768665,0.000013258309,0.00023492011],"genre_scores_gemma":[0.9924768,0.0003135673,0.0064608487,0.00023703875,0.000051583047,0.0003375995,0.000011372744,0.000009127393,0.00010202992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816704,0.00039709764,0.0006720014,0.00034221268,0.00018718526,0.00023446989],"domain_scores_gemma":[0.99302423,0.0052630017,0.0009794313,0.00041345748,0.00027243438,0.000047473724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008136271,0.00017749173,0.00090575375,0.00006999616,0.00004404952,0.0000015377598,0.00014055132,0.00013873675,0.00011650453],"category_scores_gemma":[0.0009886066,0.000092361435,0.00022980722,0.00023343327,0.0005077244,0.000022820572,0.00003120668,0.00011851738,4.6106874e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08118844,0.010863157,0.85268456,0.000828134,0.00072900177,0.0041015674,0.00072392356,0.0002817965,0.026553018,0.0010923707,0.014300281,0.0066537326],"study_design_scores_gemma":[0.006835843,0.05790594,0.89183867,0.00030795153,0.0005343519,0.0008785228,0.00015454953,0.000025073794,0.034688286,0.0003788544,0.0063091884,0.0001427904],"about_ca_topic_score_codex":0.00016528403,"about_ca_topic_score_gemma":0.00019756233,"teacher_disagreement_score":0.07435259,"about_ca_system_score_codex":0.00037288747,"about_ca_system_score_gemma":0.0008253096,"threshold_uncertainty_score":0.37663898},"labels":[],"label_agreement":null},{"id":"W1970575758","doi":"10.1016/j.ygyno.2011.10.027","title":"BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"American Cancer Society","keywords":"Ovarian cancer; Medicine; BRCA mutation; Cancer; Family history; Breast cancer; Founder effect; Oncology; Mutation; Prostate cancer; Genetic counseling; Internal medicine; Uterine cancer; Gynecology; Genetics; Biology; Genotype; Gene; Haplotype","score_opus":0.02047130598310197,"score_gpt":0.2748368053377789,"score_spread":0.2543654993546769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970575758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98854005,0.0003910433,0.00016938505,0.00019601439,0.0009356646,0.00038327856,0.00014135231,0.000031425498,0.009211788],"genre_scores_gemma":[0.9936755,0.00019299744,0.0039985953,0.0009426572,0.00015784055,0.00035499735,0.00027710554,0.00002433574,0.00037601206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986067,0.0001531863,0.00028532496,0.00054840924,0.000085028936,0.0003213821],"domain_scores_gemma":[0.9991697,0.00008406131,0.00018097396,0.00028333173,0.0001617226,0.00012020193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001361494,0.00018522266,0.00023030599,0.000056045563,0.00016763207,0.000015322583,0.00022785907,0.00043493818,0.0010333436],"category_scores_gemma":[0.00023578152,0.00018409871,0.00005415234,0.00011137186,0.00037979006,0.000008981277,0.00019541616,0.00014508869,0.000032864034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013567426,0.0005865935,0.9354008,0.000008610672,0.000309278,0.0000185297,0.0013290847,0.00003380835,0.011563059,0.00022616076,0.011876903,0.038511526],"study_design_scores_gemma":[0.0014881493,0.00093829544,0.95569897,0.0000035912533,0.00008263192,0.00000301626,0.00023420023,0.0000316963,0.007968654,0.0014991404,0.031800654,0.00025099426],"about_ca_topic_score_codex":0.0007698305,"about_ca_topic_score_gemma":0.0047042524,"teacher_disagreement_score":0.038260534,"about_ca_system_score_codex":0.00021636541,"about_ca_system_score_gemma":0.00034888758,"threshold_uncertainty_score":0.99987984},"labels":[],"label_agreement":null},{"id":"W1970748307","doi":"10.1016/j.ygyno.2012.04.002","title":"Second primary malignancies among women with uterine sarcoma","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Manitoba; BC Cancer Agency","funders":"","keywords":"Medicine; Uterine sarcoma; Etiology; Incidence (geometry); Cancer; Internal medicine; Breast cancer; Sarcoma; Uterine cancer; Gynecology; Relative risk; Oncology; Gastroenterology; Pathology; Confidence interval","score_opus":0.018174972133007727,"score_gpt":0.27725286256773074,"score_spread":0.259077890434723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970748307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86020184,0.00036229426,0.000032167005,0.0004996906,0.0004942464,0.0004877431,0.000016447244,0.00012821685,0.13777734],"genre_scores_gemma":[0.9771379,0.00008245397,0.0028590322,0.009627732,0.00035484444,0.00028146326,0.00004902259,0.00003099278,0.009576536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803257,0.0001170508,0.0003431815,0.00033562205,0.00017929022,0.0009922684],"domain_scores_gemma":[0.99865097,0.00029870006,0.00016977362,0.0003762084,0.00007295997,0.00043141312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004801746,0.00026304406,0.0007345983,0.00012918033,0.0001133623,0.000010823885,0.00015310834,0.00027714708,0.018129148],"category_scores_gemma":[0.000069740585,0.00019074601,0.00006498493,0.00017674579,0.00037638945,0.00027701864,0.00012477559,0.00036256912,0.00016497912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002254578,0.0012528157,0.8657868,0.00046123832,0.00042300072,0.0008324301,0.0031199462,0.000005026009,0.01676909,0.00028860074,0.018291315,0.09051516],"study_design_scores_gemma":[0.0023169578,0.0030717978,0.62322694,0.000007976546,0.00003448482,0.00032038058,0.00039442405,0.000003967145,0.00042784834,0.000026106323,0.3699972,0.00017188865],"about_ca_topic_score_codex":0.000011894259,"about_ca_topic_score_gemma":0.0000854985,"teacher_disagreement_score":0.3517059,"about_ca_system_score_codex":0.0014131553,"about_ca_system_score_gemma":0.00052845455,"threshold_uncertainty_score":0.9827684},"labels":[],"label_agreement":null},{"id":"W1971745143","doi":"10.1016/j.ygyno.2011.10.031","title":"Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; University of Alberta; University of Manitoba; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Medicine; Colposcopy; Cervical intraepithelial neoplasia; Cytology; Cervical cancer; Gynecology; Obstetrics; Confidence interval; Internal medicine; Cancer; Pathology","score_opus":0.18215748079306304,"score_gpt":0.4549237508913938,"score_spread":0.27276627009833077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971745143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98563933,0.0015359825,0.000016476648,0.0032106163,0.00005970598,0.001376631,0.000010211028,0.000010322685,0.008140699],"genre_scores_gemma":[0.99539757,0.000025893138,0.001918426,0.0023401727,0.000036313777,0.0002574091,0.00000526735,0.000008976545,0.000009964762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978599,0.00060969964,0.00068798225,0.00026402329,0.00016094769,0.00041746654],"domain_scores_gemma":[0.99602884,0.0031862578,0.00031380545,0.00022763094,0.00018294477,0.00006053887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014082636,0.00011373932,0.00076192943,0.00012347831,0.00012585567,0.0000032214123,0.00023862915,0.00018926398,0.00016060102],"category_scores_gemma":[0.0014837667,0.000068329624,0.000058740665,0.00037355127,0.00037772712,0.000025459718,0.00018128366,0.00049336033,1.4801675e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018420129,0.00027081923,0.8988301,0.0005670639,0.000016667664,0.000006801324,0.0060983603,0.0000041603157,0.0003103273,0.00025395432,0.000184187,0.093273364],"study_design_scores_gemma":[0.0018381772,0.0034156444,0.9895594,0.00005692563,0.000029981287,0.000016112635,0.00404018,0.0002116275,0.00010750653,0.00051248685,0.00015330582,0.000058654234],"about_ca_topic_score_codex":0.0022488425,"about_ca_topic_score_gemma":0.014323141,"teacher_disagreement_score":0.093214706,"about_ca_system_score_codex":0.00029463018,"about_ca_system_score_gemma":0.00071516377,"threshold_uncertainty_score":0.7992649},"labels":[],"label_agreement":null},{"id":"W1971951180","doi":"10.1016/j.ygyno.2011.12.121","title":"Management of cervical cancer in low-resource settings","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cervical cancer; Cancer; Oncology; Gynecology; Intensive care medicine; General surgery; Internal medicine","score_opus":0.030313722275398847,"score_gpt":0.3770142155208409,"score_spread":0.34670049324544205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971951180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67772615,0.0016113344,0.000013496881,0.006013716,0.00025570564,0.0006265685,0.000008411999,0.000037297363,0.31370732],"genre_scores_gemma":[0.99599093,0.000292988,0.00040956656,0.0016850947,0.00016775915,0.00015900975,0.000007754165,0.000011521395,0.0012753685],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985092,0.00010897106,0.00032703942,0.00021096837,0.00023357641,0.0006101902],"domain_scores_gemma":[0.9991764,0.00028383892,0.00007055869,0.00019999933,0.00006295236,0.00020628175],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000639569,0.00011118027,0.00043802147,0.00012506546,0.000027600398,0.0000023195666,0.0001408546,0.0002147441,0.017027307],"category_scores_gemma":[0.00007874029,0.00008841043,0.00007589769,0.00033324768,0.00014229897,0.000036121924,0.0001996174,0.00034209163,0.00008421177],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007509819,0.0018694936,0.327855,0.000909637,0.00012160037,0.00024502564,0.0005187878,0.000032832155,0.00026342605,0.0025006328,0.0038200293,0.66111255],"study_design_scores_gemma":[0.0021604877,0.00057337066,0.87946033,0.000032218642,0.000053095744,0.0000120326,0.0005321955,0.00006724985,0.00041038633,0.00010537801,0.11650509,0.00008816891],"about_ca_topic_score_codex":0.0000769387,"about_ca_topic_score_gemma":0.00012669513,"teacher_disagreement_score":0.6610244,"about_ca_system_score_codex":0.0005638197,"about_ca_system_score_gemma":0.00011660455,"threshold_uncertainty_score":0.9838713},"labels":[],"label_agreement":null},{"id":"W1971995565","doi":"10.1016/j.ygyno.2004.04.030","title":"Quantitative histopathology and chromosome 9 polysomy in a clinical trial of 4-HPR","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Polysomy; Medicine; Histopathology; Pathology; Interim analysis; Feulgen stain; Gastroenterology; Internal medicine; Fluorescence in situ hybridization; Chromosome; Staining; Clinical trial; Biology; Genetics","score_opus":0.13638169096658076,"score_gpt":0.4862032815777931,"score_spread":0.3498215906112123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971995565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689275,0.00062835356,0.00003255511,0.004367193,0.00042696713,0.00078537484,0.000004863284,0.000020313499,0.02480685],"genre_scores_gemma":[0.99619263,0.00053928857,0.0019675703,0.00094450027,0.0001306821,0.00008224465,0.0000067266838,0.000008758248,0.00012759428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980811,0.00033992255,0.0007133396,0.0003688748,0.00014887819,0.0003479107],"domain_scores_gemma":[0.9980909,0.0012910157,0.00014687468,0.00019841125,0.0001138874,0.00015891032],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001312498,0.00011610901,0.0008977354,0.00019940801,0.0000299058,0.0000024636533,0.000104415274,0.00041206423,0.0010469385],"category_scores_gemma":[0.0026419545,0.00009292638,0.00010996025,0.00024484113,0.0007844708,0.00003248539,0.00012178793,0.0005488296,0.00003521658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2977687,0.016112912,0.17504688,0.00047928872,0.00017937344,0.0054066237,0.0022425274,0.000023270311,0.005374355,0.059329934,0.00063582754,0.4374003],"study_design_scores_gemma":[0.14044403,0.05701485,0.7884054,0.000010369856,0.000059658072,0.00012614175,0.00031150025,0.000016979893,0.000110059955,0.0077118864,0.0056690825,0.0001200184],"about_ca_topic_score_codex":0.00015454664,"about_ca_topic_score_gemma":0.0008458462,"teacher_disagreement_score":0.61335856,"about_ca_system_score_codex":0.00041184993,"about_ca_system_score_gemma":0.00089324976,"threshold_uncertainty_score":0.99986625},"labels":[],"label_agreement":null},{"id":"W1972758180","doi":"10.1016/j.ygyno.2004.10.021","title":"Lymph node metastases in low-grade endometrial stromal sarcoma","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial stromal sarcoma; Lymph node; Lymph; Sarcoma; Dissection (medical); Stromal cell; Lymphatic system; Radiology; Oncology; Pathology","score_opus":0.031968723576482824,"score_gpt":0.32315893928546324,"score_spread":0.2911902157089804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972758180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891331,0.00026928022,0.000045120098,0.0028837684,0.00065947126,0.00057324034,0.000030380957,0.000095669704,0.006309962],"genre_scores_gemma":[0.99034363,0.00008137195,0.007849685,0.0010993035,0.00019562764,0.00012714257,0.000080207305,0.000019855426,0.00020314932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820787,0.00014074508,0.00044889483,0.00042761312,0.00018433151,0.00059053657],"domain_scores_gemma":[0.9989077,0.00045590405,0.00012764898,0.00028844114,0.000037326685,0.00018299765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026692913,0.00024557518,0.0007806977,0.00037535516,0.000062276864,0.0000111223,0.0001400429,0.00025244625,0.00074067415],"category_scores_gemma":[0.00056242093,0.0001903223,0.00016197369,0.00043968696,0.00013725272,0.000067972775,0.00011983228,0.00021258107,0.00024237597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033077816,0.021976098,0.84774375,0.00017004476,0.0010262525,0.039576948,0.00038373354,0.0005526365,0.010503905,0.0071535963,0.0006369937,0.06696824],"study_design_scores_gemma":[0.056630917,0.0075531416,0.91378456,0.00004617713,0.0002970411,0.0010501499,0.00016682211,0.000026547274,0.0028741367,0.0019058591,0.015349564,0.00031509457],"about_ca_topic_score_codex":0.00029504395,"about_ca_topic_score_gemma":0.00021640485,"teacher_disagreement_score":0.06665315,"about_ca_system_score_codex":0.001086625,"about_ca_system_score_gemma":0.0004523639,"threshold_uncertainty_score":0.8109863},"labels":[],"label_agreement":null},{"id":"W1972943130","doi":"10.1016/j.ygyno.2009.12.024","title":"Pure dysgerminoma of the ovary 35 years on: A single institutional experience","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"American Physicians Fellowship for Medicine in Israel","keywords":"Medicine; Ovary; Dysgerminoma; Gynecology; Internal medicine","score_opus":0.02949583117848758,"score_gpt":0.30659673162726364,"score_spread":0.27710090044877606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972943130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729921,0.000058142337,0.0000024523906,0.0033417463,0.0015691315,0.00035374513,0.000009495669,0.000023252314,0.021649897],"genre_scores_gemma":[0.99689215,0.000014622426,0.0005779791,0.0019744644,0.00016221816,0.00013937168,0.000004962502,0.000006152209,0.00022806569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991718,0.00004241366,0.00020196658,0.00023662715,0.0001544132,0.00019278577],"domain_scores_gemma":[0.9992362,0.0002008803,0.00009548006,0.0003466917,0.00004704687,0.00007367967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009664481,0.00010457093,0.00026105967,0.000045135992,0.00007891775,0.0000040981304,0.00014965411,0.00020637897,0.0012421913],"category_scores_gemma":[0.0002523497,0.00006573975,0.000103826,0.00014544181,0.0003548556,0.0000271102,0.00007388189,0.00026785696,0.000050221715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007983736,0.017055761,0.49992004,0.00009769748,0.0004242371,0.0035472794,0.004150676,0.00014342488,0.056139693,0.064507045,0.011066926,0.34214884],"study_design_scores_gemma":[0.0023140553,0.0031650425,0.88763463,0.000030012865,0.000075293734,0.0003850091,0.00019187061,0.000032946915,0.004732673,0.0005838765,0.100742884,0.00011169245],"about_ca_topic_score_codex":0.000022060749,"about_ca_topic_score_gemma":0.00013860237,"teacher_disagreement_score":0.3877146,"about_ca_system_score_codex":0.00020923813,"about_ca_system_score_gemma":0.00045744763,"threshold_uncertainty_score":0.9996708},"labels":[],"label_agreement":null},{"id":"W1973547363","doi":"10.1016/j.ygyno.2007.10.033","title":"Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/− mice","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"PTEN; Medicine; Progestin; Medroxyprogesterone acetate; Endometrial cancer; PI3K/AKT/mTOR pathway; Endometrial hyperplasia; Internal medicine; Protein kinase B; Endometrium; Hormone; Endocrinology; Cancer; Cancer research; Phosphorylation; Signal transduction; Biology","score_opus":0.03978647153300216,"score_gpt":0.35277429407194005,"score_spread":0.31298782253893787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973547363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95407397,0.0005051568,0.000061892686,0.0009123869,0.0010684858,0.002204495,0.00001796946,0.00011670596,0.041038923],"genre_scores_gemma":[0.9918028,0.00013351433,0.0032896204,0.0009700117,0.0005104587,0.00035115244,0.000050527957,0.000030501253,0.0028613938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735755,0.00020530346,0.00070367014,0.0006046125,0.00027119127,0.00085769495],"domain_scores_gemma":[0.99692833,0.0021643727,0.00022066371,0.00028723828,0.000074523094,0.0003248422],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007774909,0.0003462628,0.000988744,0.0005498885,0.000074342446,0.000011631711,0.00015513026,0.00047602967,0.0017389761],"category_scores_gemma":[0.0012137543,0.0002453774,0.00021304724,0.0012491826,0.00012482615,0.00006272458,0.00007287426,0.00030288406,0.00030949982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008498856,0.006749675,0.4963201,0.000041125346,0.00035150256,0.0029849217,0.00029250846,0.0000065738004,0.002711478,0.00019764777,0.0002708054,0.4815748],"study_design_scores_gemma":[0.060390595,0.022926947,0.776479,0.00003689563,0.00042723928,0.0003476994,0.00024432104,0.00001882719,0.0063778185,0.00053071,0.13184352,0.00037638855],"about_ca_topic_score_codex":0.0005346561,"about_ca_topic_score_gemma":0.0015179577,"teacher_disagreement_score":0.4811984,"about_ca_system_score_codex":0.0024523854,"about_ca_system_score_gemma":0.00048629622,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W1975755750","doi":"10.1016/j.ygyno.2007.11.046","title":"Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto","funders":"National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research; Genome Canada","keywords":"MLH1; Ovarian cancer; Medicine; Endometrial cancer; Penetrance; Colorectal cancer; Lynch syndrome; Oncology; Cancer; Internal medicine; DNA mismatch repair; Gene; Cancer research; Genetics; Biology; Phenotype","score_opus":0.04460794096129212,"score_gpt":0.30696716439226635,"score_spread":0.26235922343097423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975755750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883867,0.00021159356,0.000008161885,0.0059425677,0.00039451403,0.0014738629,0.00006570722,0.000052972886,0.0034639288],"genre_scores_gemma":[0.99330384,0.00021084007,0.0011495997,0.0044795293,0.00005802266,0.00037032945,0.000007867646,0.00001999816,0.0003999851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973866,0.00088383374,0.00048042758,0.00040942107,0.00038271907,0.00045704993],"domain_scores_gemma":[0.99772424,0.0009316378,0.00044970884,0.0006589087,0.00017169041,0.00006380563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009659611,0.00022707232,0.0006403584,0.00006449971,0.00017785883,0.000004051718,0.00042784505,0.00039444046,0.0005867543],"category_scores_gemma":[0.0008073999,0.00011281717,0.00013925848,0.00063495274,0.00061631907,0.000027038315,0.000118586744,0.00072115223,0.0000075294565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005125301,0.0010706522,0.9756736,0.000038091337,0.00031858287,0.0014385724,0.007869821,0.00017958997,0.0037226474,0.00003298075,0.006767385,0.0023755527],"study_design_scores_gemma":[0.0025502858,0.0032781651,0.9862063,0.000060728085,0.00024643185,0.0009453795,0.00024472416,0.00045148988,0.0020437501,0.00043332716,0.0033712916,0.00016812337],"about_ca_topic_score_codex":0.0014872269,"about_ca_topic_score_gemma":0.00648884,"teacher_disagreement_score":0.01053271,"about_ca_system_score_codex":0.00089543086,"about_ca_system_score_gemma":0.0012495448,"threshold_uncertainty_score":0.6424548},"labels":[],"label_agreement":null},{"id":"W1976055328","doi":"10.1016/j.ygyno.2007.12.026","title":"Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Weight loss; Endometrial cancer; Randomized controlled trial; Calorie; Obesity; Physical therapy; Vitamin D and neurology; Body mass index; Clinical endpoint; Weight change; Internal medicine; Cancer","score_opus":0.039978317377286805,"score_gpt":0.3740961290381756,"score_spread":0.3341178116608888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976055328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909414,0.0011579654,0.000007956526,0.000067757865,0.0008030403,0.008052952,0.000015303482,0.000042824176,0.00075806165],"genre_scores_gemma":[0.9957078,0.00086671213,0.0002912096,0.00005174434,0.0001052367,0.0029024782,0.00003437587,0.000009510036,0.000030919753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966119,0.0017696971,0.00073749793,0.00039230654,0.00020782868,0.0002807745],"domain_scores_gemma":[0.9940641,0.005191808,0.00029850582,0.00014817688,0.00017471949,0.00012267644],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001815962,0.00018235394,0.0016654051,0.00032419205,0.00004214017,0.000003508753,0.0000714251,0.0002702012,0.00026363428],"category_scores_gemma":[0.009064791,0.00012578156,0.00030720865,0.00067414704,0.00041947863,0.00006159557,0.00008045906,0.0002182828,0.0000036391066],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67537993,0.008649837,0.2785996,0.00018036696,0.00014616783,0.00004297397,0.000071077244,8.8084033e-7,0.00003405465,0.000028500059,0.0000063947796,0.036860216],"study_design_scores_gemma":[0.6284708,0.01346229,0.35719237,0.000058202993,0.00015814252,0.0000054660977,0.000012684494,0.000009156206,0.00015786689,0.00030742493,0.00009938187,0.000066261004],"about_ca_topic_score_codex":0.0009952146,"about_ca_topic_score_gemma":0.00031295387,"teacher_disagreement_score":0.078592785,"about_ca_system_score_codex":0.0007536709,"about_ca_system_score_gemma":0.00023645654,"threshold_uncertainty_score":0.9992823},"labels":[],"label_agreement":null},{"id":"W1976446230","doi":"10.1016/j.ygyno.2004.12.059","title":"Development of ovarian cancer surgery quality indicators using a modified Delphi approach","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Cancer Care Ontario","funders":"","keywords":"Medicine; Delphi method; Multidisciplinary approach; Delphi; Radiation oncologist; Psychological intervention; Ovarian cancer; Quality (philosophy); Medical physics; Family medicine; Surgery; Cancer; Radiation therapy; Nursing; Internal medicine","score_opus":0.1513645134398713,"score_gpt":0.3984230757904187,"score_spread":0.24705856235054738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976446230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98845243,0.00056457956,0.0007741831,0.0015963307,0.0003011644,0.00060550513,0.000014608488,0.000057004112,0.0076341997],"genre_scores_gemma":[0.9220343,0.00012917032,0.076379575,0.00087407115,0.0001664472,0.00029935784,0.000033258126,0.000017982833,0.00006579242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99781466,0.00017430395,0.0008736388,0.00045033885,0.00024692543,0.00044015134],"domain_scores_gemma":[0.99843055,0.0004990145,0.00048465913,0.0003010795,0.00009166856,0.00019302184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095781917,0.0002231353,0.0009619549,0.00028443566,0.000118650714,0.0000058816786,0.00010765083,0.0003375055,0.0007606207],"category_scores_gemma":[0.00017410822,0.0001788769,0.00016371738,0.00038696744,0.00014150733,0.000052995638,0.00007974347,0.00019184973,0.000013648319],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050809816,0.0063369256,0.26318198,0.0002738685,0.0010786561,0.000073744624,0.0034150868,0.00084253476,0.001229936,0.0019881641,0.0014915343,0.71957946],"study_design_scores_gemma":[0.0051720873,0.00035509685,0.9187515,0.00007460366,0.0005358454,0.00006327915,0.0010163953,0.0008733316,0.0039096307,0.000087756525,0.06868061,0.00047990863],"about_ca_topic_score_codex":0.00019683168,"about_ca_topic_score_gemma":0.00027185507,"teacher_disagreement_score":0.7190996,"about_ca_system_score_codex":0.0014737478,"about_ca_system_score_gemma":0.0025216313,"threshold_uncertainty_score":0.8328263},"labels":[],"label_agreement":null},{"id":"W1977022270","doi":"10.1016/j.ygyno.2010.12.326","title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; BC Cancer Agency; Women's College Hospital; McMaster University; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prophylactic Surgery; Sexual function; Surgical Menopause; Oophorectomy; Vasomotor; Menopause; Hormone replacement therapy (female-to-male); BRCA mutation; Gynecology; Breast cancer; Obstetrics; Hysterectomy; Surgery; Cancer; Internal medicine; Testosterone (patch)","score_opus":0.03688042884613047,"score_gpt":0.33538283628509813,"score_spread":0.29850240743896767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977022270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263656,0.00027387124,0.000002554472,0.00021690426,0.00023760003,0.0011427687,0.000006083507,0.000032238826,0.005451388],"genre_scores_gemma":[0.99906194,0.00007511084,0.000049630402,0.00032040104,0.000045442397,0.000231796,0.000008112253,0.000017634804,0.00018990735],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828273,0.00028670914,0.00042693524,0.0003073925,0.0001499878,0.00054622453],"domain_scores_gemma":[0.99856865,0.0006025087,0.0002856225,0.00023450419,0.00008415377,0.00022457824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006614072,0.00020512097,0.00051330606,0.00018177101,0.00012974793,0.000008521835,0.00006437217,0.00023068208,0.0003065193],"category_scores_gemma":[0.00045227358,0.00011645059,0.000010968691,0.00023012217,0.00016965895,0.0000688414,0.00003494759,0.00027983886,0.000023432221],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04407304,0.0063095912,0.3213383,0.00060979044,0.0014757275,0.0012790703,0.017750347,0.000045952744,0.022453329,0.0008900137,0.0009014464,0.5828734],"study_design_scores_gemma":[0.0054237195,0.14567146,0.8470484,0.000019198562,0.00008759439,0.00010395843,0.00052677747,0.000053995434,0.00009481,0.00065844244,0.00021826656,0.00009340457],"about_ca_topic_score_codex":0.0009923711,"about_ca_topic_score_gemma":0.00022918302,"teacher_disagreement_score":0.58278,"about_ca_system_score_codex":0.0015109334,"about_ca_system_score_gemma":0.00060885795,"threshold_uncertainty_score":0.47487172},"labels":[],"label_agreement":null},{"id":"W1979264572","doi":"10.1016/j.ygyno.2014.12.023","title":"Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital; Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Endometrial cancer; Family history; Lynch syndrome; Genetic testing; Gynecology; Internal medicine; Cancer; Cohort; Oncology; Medical history; Prospective cohort study; Microsatellite instability; Obstetrics; DNA mismatch repair; Genetics","score_opus":0.022468944143599203,"score_gpt":0.27833726350466165,"score_spread":0.25586831936106247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979264572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946,0.00022284323,0.0003442098,0.00063108595,0.0012643099,0.001756312,0.00003249041,0.000048410086,0.0011003138],"genre_scores_gemma":[0.99110097,0.00013961171,0.0038291493,0.0024652258,0.00019457667,0.0019530146,0.000012281794,0.000033734057,0.00027141775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801505,0.00013942625,0.00055778836,0.00046082106,0.00024064118,0.00058628764],"domain_scores_gemma":[0.9979204,0.0009935107,0.00028860054,0.00031156867,0.0002617589,0.0002241776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075531873,0.00024163468,0.0010141724,0.0003775576,0.00003865807,0.0000037051475,0.00021675453,0.0003170159,0.0002920393],"category_scores_gemma":[0.0020873947,0.00020304763,0.000055502762,0.00037120393,0.00022057864,0.000044523855,0.00007204271,0.00024978098,0.000011158205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015296393,0.0010618613,0.52983266,0.0005958339,0.00018239021,0.00014122881,0.0017085876,0.00041579548,0.0081132185,0.00009779607,0.004242134,0.4383121],"study_design_scores_gemma":[0.008223719,0.026543813,0.91244954,0.0001506062,0.000068842426,0.00003626371,0.00006745775,0.00029726364,0.00013758292,0.000020356945,0.051783957,0.00022057138],"about_ca_topic_score_codex":0.00033435118,"about_ca_topic_score_gemma":0.00056797464,"teacher_disagreement_score":0.43809155,"about_ca_system_score_codex":0.004066654,"about_ca_system_score_gemma":0.001272587,"threshold_uncertainty_score":0.9997566},"labels":[],"label_agreement":null},{"id":"W1979360671","doi":"10.1016/j.ygyno.2013.04.325","title":"How oncologists communicate information to women with recurrent ovarian cancer in the context of treatment decision making in the medical encounter","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Context (archaeology); Medical information; Ovarian cancer; Clinical decision making; Gynecology; Cancer; Family medicine; Intensive care medicine; Internal medicine","score_opus":0.020401555483398046,"score_gpt":0.3270587137001763,"score_spread":0.30665715821677825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979360671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165643,0.00019748228,0.0003332026,0.015027613,0.00020168163,0.0011308797,0.000015386426,0.000004324376,0.0014329908],"genre_scores_gemma":[0.9897205,0.00038469964,0.0008805549,0.0063000503,0.000045330497,0.002628457,0.000019823008,0.0000053958574,0.0000151887125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984539,0.0005007474,0.0003517372,0.00019069565,0.00019788487,0.00030503157],"domain_scores_gemma":[0.9986601,0.0005371483,0.00019016207,0.00046381657,0.000110267436,0.000038523263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088844064,0.00014656442,0.00024288382,0.00009033048,0.00006308268,0.00003772688,0.00071523216,0.00025486495,0.00016778031],"category_scores_gemma":[0.000450926,0.00007490761,0.000031194384,0.00024658235,0.00019323987,0.000017681006,0.00014213005,0.00019419282,0.000010960426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005336441,0.0004312705,0.009618418,0.000011463159,0.000054470067,0.000014223621,0.013502462,0.0005179118,0.0006078982,0.00015362704,0.003512765,0.97104186],"study_design_scores_gemma":[0.005997453,0.018735204,0.3758322,0.000106773085,0.00003873886,0.00012049517,0.054424036,0.0005360444,0.000564364,0.0008794517,0.54231805,0.0004472202],"about_ca_topic_score_codex":0.00032310098,"about_ca_topic_score_gemma":0.019834217,"teacher_disagreement_score":0.97059464,"about_ca_system_score_codex":0.0011270614,"about_ca_system_score_gemma":0.00070263306,"threshold_uncertainty_score":0.9980512},"labels":[],"label_agreement":null},{"id":"W1980260368","doi":"10.1016/j.ygyno.2005.01.051","title":"In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Ovarian cancer; Cancer research; Apoptosis; Epithelium; Population; Cancer; Biology; Medicine; Internal medicine; Endocrinology; Pathology; Genetics","score_opus":0.0144896183685381,"score_gpt":0.2953865474280773,"score_spread":0.28089692905953917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980260368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275684,0.0012360382,0.0035191118,0.0005652017,0.00030643048,0.00057553145,0.00020036453,0.000007480449,0.0008330099],"genre_scores_gemma":[0.9805669,0.0016892224,0.016066639,0.00030447493,0.00017759591,0.00018370483,0.00006546552,0.000022598964,0.0009234045],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843186,0.00010984034,0.00055862655,0.00043905393,0.000097497075,0.00036312768],"domain_scores_gemma":[0.9990733,0.00007369202,0.0003924135,0.00023712961,0.00015582253,0.00006762669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049838476,0.00020969524,0.00050701003,0.00005774358,0.000051944626,0.0000061035084,0.00023342499,0.0005290241,0.00014916349],"category_scores_gemma":[0.00009965909,0.00019929858,0.00011955892,0.000110155204,0.00020073143,0.000014329781,0.00011563453,0.00012870319,8.446372e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008325391,0.00025154688,0.00068165263,0.00014576854,0.00007811198,0.0000019184288,0.00012580273,0.008253023,0.98241496,0.00016458998,0.0003200327,0.00673006],"study_design_scores_gemma":[0.003635135,0.00048811597,0.0005422396,0.000013841313,0.00008471237,0.0000047835224,0.0000570542,0.006561996,0.98045844,0.0005105624,0.0074257837,0.00021732289],"about_ca_topic_score_codex":0.0003119372,"about_ca_topic_score_gemma":0.0005758411,"teacher_disagreement_score":0.012547527,"about_ca_system_score_codex":0.000112708534,"about_ca_system_score_gemma":0.0006391079,"threshold_uncertainty_score":0.812716},"labels":[],"label_agreement":null},{"id":"W1980713899","doi":"10.1016/j.ygyno.2013.05.003","title":"Keeping it simple: Genetics referrals for all invasive serous ovarian cancers","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Serous fluid; Serous ovarian cancer; Oncology; Ovarian cancer; Simple (philosophy); Gynecology; Internal medicine; Cancer","score_opus":0.04727251582513783,"score_gpt":0.34301306708539137,"score_spread":0.29574055126025356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980713899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966302,0.0011067147,0.003987579,0.008439024,0.0018203364,0.002565758,0.000108083535,0.00007048549,0.015600023],"genre_scores_gemma":[0.9561158,0.00067875005,0.019987883,0.01894744,0.00059915544,0.0019194311,0.00039997217,0.00005182221,0.0012997843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980123,0.00015681676,0.00043110733,0.0006475404,0.000100060366,0.00065217394],"domain_scores_gemma":[0.99850565,0.0002778914,0.00024437395,0.0004963535,0.00033026515,0.00014543501],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029983983,0.00025374358,0.00033871146,0.000067529356,0.00016858529,0.000034896617,0.00043696744,0.0006036975,0.000653085],"category_scores_gemma":[0.00071502064,0.00025431262,0.00012470013,0.000116740564,0.0001829854,0.000008044497,0.00021709251,0.00017098138,0.000100911464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015282817,0.00019713874,0.0033567564,0.00008414644,0.0006103446,0.000018242812,0.0005559908,0.006037321,0.40012842,0.0004635458,0.52101123,0.06738406],"study_design_scores_gemma":[0.001845244,0.0027258638,0.005855447,0.0000058040246,0.00009800793,0.000047529375,0.000762538,0.00036462306,0.043862943,0.004053342,0.939854,0.000524643],"about_ca_topic_score_codex":0.00018547894,"about_ca_topic_score_gemma":0.0028745988,"teacher_disagreement_score":0.4188428,"about_ca_system_score_codex":0.0007737728,"about_ca_system_score_gemma":0.0014820342,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W1980752656","doi":"10.1016/j.ygyno.2009.09.029","title":"Tumor type and substage predict survival in stage I and II ovarian carcinoma: Insights and implications","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"BC Cancer Agency; Eli Lilly Canada; Michael Smith Health Research BC; National Cancer Institute; Sanofi","keywords":"Medicine; Serous fluid; Serous carcinoma; Ovarian carcinoma; Ovarian cancer; Stage (stratigraphy); Oncology; Clear cell carcinoma; Internal medicine; Clear cell; Carcinoma; Univariate analysis; Population; Cohort; Cancer; Multivariate analysis; Biology","score_opus":0.026131896738301286,"score_gpt":0.3016891471119304,"score_spread":0.2755572503736291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980752656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98136264,0.0022520998,0.0000035784724,0.009203194,0.00013480989,0.00060119526,0.000017312566,0.000034782992,0.0063904044],"genre_scores_gemma":[0.9967656,0.001110267,0.00052458665,0.0012029167,0.00005602668,0.000056565746,0.000023106682,0.000007945303,0.00025297108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989508,0.00008344462,0.00023747578,0.0004083652,0.00006221871,0.00025772367],"domain_scores_gemma":[0.9992159,0.00028576862,0.000076174816,0.00019349271,0.000054926797,0.00017375215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017374012,0.00015760036,0.00043596287,0.00012013476,0.00013021119,0.000013027468,0.000041014053,0.00015093769,0.00009276444],"category_scores_gemma":[0.00013783113,0.0001247815,0.000016809385,0.00020071185,0.00013550499,0.000056362376,0.00006530463,0.00016455876,0.0000027171975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019919554,0.0010095611,0.9516688,0.000034325563,0.000048071317,0.00061948504,0.0008282356,0.0000012659907,0.0005246766,0.015114783,0.00045649955,0.029495103],"study_design_scores_gemma":[0.0037487233,0.0050605224,0.9714731,0.000009756741,0.00008362941,0.00010025714,0.00019012328,0.000036999616,0.00004374207,0.001002422,0.018144453,0.00010627786],"about_ca_topic_score_codex":0.00011344241,"about_ca_topic_score_gemma":0.0008222452,"teacher_disagreement_score":0.029388826,"about_ca_system_score_codex":0.0002051738,"about_ca_system_score_gemma":0.00021593439,"threshold_uncertainty_score":0.5088442},"labels":[],"label_agreement":null},{"id":"W1980961237","doi":"10.1016/j.ygyno.2004.05.032","title":"Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Trachelectomy; Surgery; Dissection (medical); Stage (stratigraphy); Complication; Cervical cancer; Lymph node; Cancer; Internal medicine","score_opus":0.039687459219328,"score_gpt":0.33449433241528415,"score_spread":0.29480687319595617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980961237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768456,0.014282022,0.000003157076,0.0066112457,0.00020695257,0.00076051045,0.000047478374,0.000042240954,0.0012007469],"genre_scores_gemma":[0.99001104,0.005262802,0.001224487,0.0031477155,0.00007442374,0.000056335855,0.00013604687,0.000011759069,0.000075415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747205,0.0007337202,0.00071692956,0.0004239868,0.00026923663,0.0003840706],"domain_scores_gemma":[0.99756414,0.001060018,0.00034543718,0.00046862432,0.0003159385,0.0002458518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009495092,0.00023726786,0.0012552786,0.000102967104,0.00011347308,0.000009859256,0.00026087358,0.00037902532,0.0012107545],"category_scores_gemma":[0.0034333551,0.00013306673,0.00019156325,0.0008114481,0.0005427131,0.0001946362,0.00015337425,0.00040609002,0.0000019009383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023581693,0.027374921,0.5624808,0.01752928,0.0015903763,0.00571431,0.002161467,0.000026099675,0.031124132,0.003909758,0.0034683456,0.32103884],"study_design_scores_gemma":[0.0052537164,0.018426195,0.9538892,0.0015599595,0.00070704153,0.0011691658,0.00015117077,0.0000029431483,0.005041762,0.0032716703,0.010273985,0.0002531931],"about_ca_topic_score_codex":0.00013231704,"about_ca_topic_score_gemma":0.00039347046,"teacher_disagreement_score":0.3914084,"about_ca_system_score_codex":0.00031514044,"about_ca_system_score_gemma":0.0008167927,"threshold_uncertainty_score":0.9997023},"labels":[],"label_agreement":null},{"id":"W1981104387","doi":"10.1016/j.ygyno.2013.01.023","title":"Accuracy of intraoperative pathological examination of SLN in cervical cancer","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Radical Hysterectomy; Frozen section procedure; Micrometastasis; Lymphadenectomy; Sentinel lymph node; Surgery; Dissection (medical); Cervical cancer; Lymph node; Hysterectomy; Radiology; Stage (stratigraphy); Cancer; Metastasis; Internal medicine; Breast cancer","score_opus":0.04088289770714564,"score_gpt":0.35410124969759965,"score_spread":0.313218351990454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981104387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381615,0.00048781378,0.000013992104,0.0016291088,0.0001878771,0.0007886568,0.000010512635,0.000016583412,0.013049315],"genre_scores_gemma":[0.99750376,0.000458833,0.0008625719,0.00059633923,0.00005557336,0.00037182533,0.000016137425,0.0000060747543,0.00012889123],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854255,0.00028496957,0.0005275158,0.0002466184,0.00015792354,0.00024040777],"domain_scores_gemma":[0.997977,0.0013394997,0.0002257535,0.00014314121,0.00022866338,0.000085914624],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029309574,0.00012873394,0.000702964,0.00016662215,0.000016939624,0.0000022814584,0.00010343408,0.00030333758,0.0068343664],"category_scores_gemma":[0.0013578361,0.00008488515,0.00007997641,0.0004599605,0.00020195535,0.00007240932,0.00007151491,0.00021583827,0.000037706963],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004589067,0.0031632532,0.2531797,0.00014662872,0.000098396675,0.00012063263,0.0008254524,0.00002618324,0.026731595,0.0011522097,0.00018964337,0.7139074],"study_design_scores_gemma":[0.004126625,0.0044825,0.9825989,0.000026456335,0.00005605834,0.000011863204,0.00036005367,0.00007407966,0.0069820145,0.000795076,0.00040975775,0.00007661589],"about_ca_topic_score_codex":0.0005411297,"about_ca_topic_score_gemma":0.00025936254,"teacher_disagreement_score":0.7294192,"about_ca_system_score_codex":0.00035969392,"about_ca_system_score_gemma":0.00019946462,"threshold_uncertainty_score":0.9940735},"labels":[],"label_agreement":null},{"id":"W1981365876","doi":"10.1016/j.ygyno.2009.06.018","title":"Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Carcinosarcoma; Medicine; Gynecology; General surgery; Pathology; Carcinoma","score_opus":0.03734688619934872,"score_gpt":0.3397716553639621,"score_spread":0.30242476916461336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981365876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9088637,0.00007966841,0.0012799457,0.0070077297,0.00041250433,0.0018240229,0.000038078688,0.00024791298,0.080246426],"genre_scores_gemma":[0.93996567,0.000030422165,0.03786635,0.011516171,0.00031819887,0.0002539951,0.00006929452,0.000031571388,0.00994836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975535,0.000058300157,0.0005065095,0.00075373106,0.00024575304,0.0008821748],"domain_scores_gemma":[0.99841744,0.00016705392,0.00013682537,0.0006351691,0.00009591348,0.0005475926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020551083,0.00041397623,0.0010086993,0.00027180827,0.00014372119,0.000023492526,0.00027789333,0.0003557146,0.0005260081],"category_scores_gemma":[0.00019666395,0.0002903004,0.00017566336,0.000468403,0.000089206536,0.00007012411,0.00017693789,0.00032381061,0.0002972118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015447999,0.06709651,0.09826785,0.00046895174,0.0017647382,0.020364251,0.0036856215,0.0000982946,0.21142459,0.0045288927,0.0675901,0.5092622],"study_design_scores_gemma":[0.011846217,0.032352056,0.7182757,0.00002305737,0.0002653137,0.003996275,0.00017179726,0.00043312303,0.0019256592,0.00015183339,0.23001981,0.00053912774],"about_ca_topic_score_codex":0.000121967816,"about_ca_topic_score_gemma":0.000061640414,"teacher_disagreement_score":0.6200079,"about_ca_system_score_codex":0.0005455128,"about_ca_system_score_gemma":0.00035530806,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W1981507269","doi":"10.1016/j.ygyno.2014.05.006","title":"POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of British Columbia; University of Calgary; University of Alberta","funders":"University of Alberta; Calgary Laboratory Services","keywords":"Medicine; Endometrium; Carcinoma; Exonuclease; Mutation; Internal medicine; Oncology; Gynecology; Cancer research; Gene; Genetics; Biology; Polymerase","score_opus":0.02481637444424226,"score_gpt":0.3072530966771687,"score_spread":0.28243672223292643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981507269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97833335,0.00059312145,0.00007669875,0.0026899863,0.0012929213,0.0013568953,0.000027870523,0.00005178417,0.015577396],"genre_scores_gemma":[0.99760485,0.000041764324,0.0011278818,0.00057041174,0.00022594281,0.00018680147,0.000028582448,0.000022045968,0.00019173547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969891,0.0007749553,0.00067522493,0.00044443065,0.000581914,0.0005344151],"domain_scores_gemma":[0.9953079,0.003341898,0.00038784387,0.00061660615,0.00013189304,0.00021385323],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0012095999,0.00024413504,0.00084924797,0.0006179259,0.00009740327,0.000008850011,0.00041696412,0.0003353297,0.00041260876],"category_scores_gemma":[0.008807494,0.00015181821,0.0002238397,0.0021800455,0.00030784123,0.00006729362,0.00028850642,0.00039060912,0.000022884591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013919774,0.003016829,0.88287765,0.00017055719,0.000110930705,0.00037403972,0.00026968445,0.0000215021,0.0015979647,0.001210607,0.00028739203,0.10867085],"study_design_scores_gemma":[0.022927947,0.0058889748,0.96031225,0.00004662431,0.0001403649,0.000072536866,0.000208778,0.000049264734,0.003354085,0.0030382879,0.0038142796,0.00014661587],"about_ca_topic_score_codex":0.00020608782,"about_ca_topic_score_gemma":0.00044333827,"teacher_disagreement_score":0.10852423,"about_ca_system_score_codex":0.00064846774,"about_ca_system_score_gemma":0.00032197102,"threshold_uncertainty_score":0.99954176},"labels":[],"label_agreement":null},{"id":"W1982375456","doi":"10.1016/j.ygyno.2003.10.001","title":"An analysis of 84,244 patients from the British Columbia cytology–colposcopy program","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Colposcopy; Medicine; Cytology; Referral; Gynecology; Obstetrics; Cancer; Pathology; Internal medicine; Cervical cancer; Family medicine","score_opus":0.030156709535977138,"score_gpt":0.3660990861473565,"score_spread":0.3359423766113793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982375456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96647525,0.00024581264,0.000020115334,0.00030171135,0.00025556586,0.0011451202,0.00009768159,0.00006176815,0.031396955],"genre_scores_gemma":[0.99562097,0.00012209025,0.0015335503,0.0016408708,0.00005944446,0.00028030158,0.00031297596,0.00001373061,0.00041606356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756706,0.0006308045,0.00047523345,0.00048362877,0.00032669044,0.000516596],"domain_scores_gemma":[0.997496,0.0011105199,0.00016491547,0.00052619603,0.00047092277,0.0002314291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005771592,0.0001213302,0.0008731768,0.00006984334,0.00028776118,0.00009681046,0.0003132829,0.0003861741,0.027738314],"category_scores_gemma":[0.0013091974,0.00011639375,0.00023418487,0.00096958707,0.000507268,0.000048743448,0.00006983493,0.00040823032,0.00003315177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012049876,0.0024486769,0.83843577,0.000011531466,0.0006055191,0.000055306817,0.00008182012,0.000006688776,0.00004546076,0.000033187713,0.0053429087,0.15281263],"study_design_scores_gemma":[0.0023473678,0.0077570206,0.9494666,0.0000028519719,0.0011916747,0.0000055203186,0.00028402839,0.00019532251,0.00002615528,0.00043252422,0.03818234,0.000108581036],"about_ca_topic_score_codex":0.01784157,"about_ca_topic_score_gemma":0.26311406,"teacher_disagreement_score":0.2452725,"about_ca_system_score_codex":0.0003168572,"about_ca_system_score_gemma":0.00045512107,"threshold_uncertainty_score":0.9886987},"labels":[],"label_agreement":null},{"id":"W1983150990","doi":"10.1016/j.ygyno.2013.04.011","title":"A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Onyx Pharmaceuticals; Bayer HealthCare","keywords":"Medicine; Sorafenib; Front line; Oncology; Ovarian carcinoma; Internal medicine; Randomized controlled trial; Ovarian cancer; Gynecology; Hepatocellular carcinoma; Cancer","score_opus":0.03282044406175986,"score_gpt":0.32112195465424237,"score_spread":0.2883015105924825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983150990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97364473,0.00054919557,0.00010834358,0.011528989,0.0003977241,0.005732759,0.000010007849,0.000036405134,0.007991865],"genre_scores_gemma":[0.9909604,0.0005442535,0.0032451907,0.001343538,0.00015311074,0.0028557056,0.000028513772,0.000020873444,0.00084839406],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99784917,0.00038330955,0.00071144354,0.00043457784,0.00017080702,0.00045071472],"domain_scores_gemma":[0.99801904,0.00091979635,0.00037210982,0.00038237675,0.00016809544,0.00013859251],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071003917,0.0002608952,0.001770517,0.00017159045,0.000055447326,0.0000071590575,0.00012689536,0.0002603004,0.0031270103],"category_scores_gemma":[0.00033469519,0.00015261282,0.00019882816,0.00015783886,0.00033059096,0.00006618576,0.000045440924,0.00023467474,0.000043148804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8917067,0.016375769,0.004319241,0.000025516547,0.00042614152,0.0004798183,0.0007814815,0.000013947837,0.0002833534,0.00071979687,0.0019284,0.082939796],"study_design_scores_gemma":[0.93679494,0.046047665,0.010058678,0.00003445189,0.00017331899,0.00003806407,0.00014473025,0.00023341537,0.00043773532,0.00084418955,0.005043533,0.00014925464],"about_ca_topic_score_codex":0.0010955295,"about_ca_topic_score_gemma":0.0005298915,"teacher_disagreement_score":0.082790546,"about_ca_system_score_codex":0.00041395883,"about_ca_system_score_gemma":0.00062727946,"threshold_uncertainty_score":0.99778426},"labels":[],"label_agreement":null},{"id":"W1983692373","doi":"10.1016/j.ygyno.2008.05.019","title":"Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Topotecan; Ovarian cancer; Paclitaxel; Cisplatin; Gemcitabine; Oncology; Chemotherapy; Internal medicine; In vivo; Primary tumor; Cancer; Tumor heterogeneity; Drug resistance; Pathology; Cancer research; Metastasis; Biology","score_opus":0.027707289952550503,"score_gpt":0.3197382537485896,"score_spread":0.2920309637960391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983692373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98059696,0.0017134459,0.0000065320914,0.0061889007,0.00036984877,0.00077286066,0.000037423866,0.00005002863,0.0102640055],"genre_scores_gemma":[0.9931348,0.0009712141,0.000923443,0.0036957283,0.00006501972,0.00079154497,0.000053997057,0.000021336886,0.00034289737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789965,0.00019141764,0.0005084382,0.0006089696,0.00017292252,0.0006185809],"domain_scores_gemma":[0.9989855,0.00032134276,0.00016407047,0.00028533893,0.000058898968,0.000184798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002902682,0.00026374104,0.0008166462,0.00015317074,0.000076254866,0.0000061569,0.00013500167,0.00029985476,0.0008321137],"category_scores_gemma":[0.00020660018,0.00022991568,0.00009309771,0.00046866635,0.00020214648,0.000059667294,0.000048040274,0.0003850523,0.000082076156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014898304,0.004363234,0.92957294,0.000048735063,0.00014373088,0.011502885,0.00020608392,0.00004035273,0.028919887,0.00012663174,0.010065726,0.013519969],"study_design_scores_gemma":[0.009619946,0.0012047848,0.9257618,0.000039082846,0.00006478786,0.00036841142,0.00007382999,0.00007845976,0.046817414,0.0001772884,0.015524962,0.00026923564],"about_ca_topic_score_codex":0.0016244537,"about_ca_topic_score_gemma":0.004733167,"teacher_disagreement_score":0.017897528,"about_ca_system_score_codex":0.0022241736,"about_ca_system_score_gemma":0.0010679136,"threshold_uncertainty_score":0.93756896},"labels":[],"label_agreement":null},{"id":"W1984382819","doi":"10.1016/j.ygyno.2005.08.028","title":"Bcl-XL is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Bcl-xL; Propidium iodide; Apoptosis; Cisplatin; Ovarian cancer; Cell culture; Cancer research; Paclitaxel; Cell growth; Ovarian carcinoma; Cell biology; Biology; Chemistry; Programmed cell death; Medicine; Cancer; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.016650276762788466,"score_gpt":0.28526961175848076,"score_spread":0.2686193349956923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984382819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734665,0.0006698634,0.005804298,0.0031541537,0.0006595806,0.00077843154,0.000030613235,0.000007341132,0.0015490529],"genre_scores_gemma":[0.99656093,0.00056477543,0.0011442975,0.00037331536,0.0002963675,0.00010591529,0.000046845333,0.000009508979,0.0008980631],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991898,0.000053817443,0.00024758658,0.0002594746,0.00007224015,0.00017710148],"domain_scores_gemma":[0.99950725,0.00010007447,0.00014412515,0.00013950256,0.00007956278,0.000029459266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003516706,0.00010518092,0.00017197353,0.00004292061,0.000102702215,0.0000059596364,0.00009687014,0.0002555869,0.00015301493],"category_scores_gemma":[0.000031002775,0.0000780542,0.000059996753,0.00005777962,0.00008614257,0.0000044198205,0.000066186105,0.000059976515,9.5143304e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011220366,0.00012315974,0.0020116463,0.00002410349,0.000041697214,3.352854e-7,0.00008651371,0.0010863489,0.9732141,0.0020973913,0.0010492362,0.020153295],"study_design_scores_gemma":[0.004472596,0.0025046673,0.52027154,0.000013582055,0.00012566289,0.000007407886,0.00021712767,0.0043892222,0.35751942,0.0035658309,0.106554516,0.00035841423],"about_ca_topic_score_codex":0.00007135759,"about_ca_topic_score_gemma":0.00087303657,"teacher_disagreement_score":0.61569464,"about_ca_system_score_codex":0.00004868495,"about_ca_system_score_gemma":0.00008677103,"threshold_uncertainty_score":0.3182958},"labels":[],"label_agreement":null},{"id":"W1984407491","doi":"10.1016/j.ygyno.2005.11.004","title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Endometrial cancer; Brachytherapy; Radiation therapy; Surgery; Genitourinary system; Salvage therapy; External beam radiotherapy; Vagina; Cancer; Internal medicine; Chemotherapy","score_opus":0.04261769501367985,"score_gpt":0.3535464760497805,"score_spread":0.31092878103610067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984407491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97471136,0.0033905667,0.00062456424,0.012330157,0.0015979331,0.0036214993,0.00019663067,0.0002355736,0.0032917184],"genre_scores_gemma":[0.98226917,0.0024954516,0.0064369594,0.0027831227,0.0014287293,0.0021150173,0.000138222,0.000040183466,0.00229317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99781483,0.0001814886,0.00045604023,0.00065596984,0.00018728914,0.00070437096],"domain_scores_gemma":[0.9973441,0.0016180377,0.00026251204,0.0002950373,0.0001988001,0.00028155575],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030268868,0.00038325696,0.0010282813,0.00026354226,0.00016937478,0.000019678153,0.00014366672,0.0003122129,0.002366758],"category_scores_gemma":[0.00021569463,0.0002387241,0.00018554676,0.0007185515,0.00015612583,0.000102663595,0.000026066806,0.00021430495,0.00009346581],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029033834,0.003443247,0.015262462,0.00004360203,0.001146486,0.00024572804,0.0001736839,0.000095204115,0.0027735387,0.00037775395,0.0012173117,0.94618714],"study_design_scores_gemma":[0.15718989,0.17884926,0.07376316,0.00007167592,0.001782492,0.00023745358,0.000098419296,0.00039604172,0.006641786,0.0007319806,0.5794234,0.00081440865],"about_ca_topic_score_codex":0.00042482742,"about_ca_topic_score_gemma":0.001321962,"teacher_disagreement_score":0.94537276,"about_ca_system_score_codex":0.002054468,"about_ca_system_score_gemma":0.0007190062,"threshold_uncertainty_score":0.9985452},"labels":[],"label_agreement":null},{"id":"W1984849300","doi":"10.1016/j.ygyno.2008.07.007","title":"Twenty-year review of radiotherapy for vaginal cancer: An institutional experience","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Radiation therapy; Brachytherapy; Stage (stratigraphy); External beam radiotherapy; Vaginal cancer; Cancer; Odds ratio; Surgery; Retrospective cohort study; Internal medicine; Cervical cancer","score_opus":0.07510804854386592,"score_gpt":0.403380985405483,"score_spread":0.32827293686161707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984849300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93149495,0.05313255,0.00048330578,0.004226532,0.0012022506,0.0019475224,0.00008055134,0.000073707364,0.007358646],"genre_scores_gemma":[0.8484571,0.124327235,0.013404573,0.011333658,0.0005103871,0.0012896804,0.00009680439,0.000015545917,0.00056501426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998937,0.000069211244,0.00032646628,0.0002633572,0.00016860651,0.00023536393],"domain_scores_gemma":[0.99912995,0.0002411675,0.00014445005,0.0001751031,0.00017046575,0.00013885752],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017372883,0.00012194534,0.00059268816,0.00006752361,0.00010344869,0.0000011197344,0.000121387275,0.00011912274,0.002599156],"category_scores_gemma":[0.00029437593,0.00008862658,0.00012449957,0.00024724443,0.00028976245,0.00006341911,0.000018196526,0.00009438862,0.0000073353876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066318563,0.008176323,0.4543672,0.005645057,0.0008961387,0.00061132485,0.0015025797,0.00003428528,0.0057412973,0.007867449,0.015432221,0.49309427],"study_design_scores_gemma":[0.018624082,0.020104995,0.255151,0.0006739214,0.00030632463,0.00042203526,0.00012602595,0.00004527229,0.001673852,0.00035949744,0.7021987,0.00031428985],"about_ca_topic_score_codex":0.0000840745,"about_ca_topic_score_gemma":0.000019308343,"teacher_disagreement_score":0.6867665,"about_ca_system_score_codex":0.00047898534,"about_ca_system_score_gemma":0.0006885428,"threshold_uncertainty_score":0.9983126},"labels":[],"label_agreement":null},{"id":"W1984877106","doi":"10.1016/j.ygyno.2007.02.018","title":"UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Topotecan; Medicine; Neutropenia; Ovarian cancer; Internal medicine; Oncology; Phases of clinical research; Chemotherapy; Carboplatin; Progressive disease; Cancer; Febrile neutropenia; Surgery; Cisplatin","score_opus":0.010832574774115058,"score_gpt":0.305409538293352,"score_spread":0.29457696351923696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984877106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931786,0.00007081545,0.000007479495,0.0018057767,0.00040426943,0.0037226414,0.000012926776,0.000016878696,0.00078063086],"genre_scores_gemma":[0.9990037,0.000031043917,0.00022903051,0.00018175178,0.000016229385,0.0004854146,0.00001701099,0.000013502683,0.000022330916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835926,0.00013570125,0.00047070996,0.0004037978,0.00027136586,0.00035917357],"domain_scores_gemma":[0.99891126,0.00019181304,0.0003702032,0.0003004374,0.00014863383,0.000077632314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034997147,0.00019396808,0.00056172995,0.00015529511,0.000072489616,0.000004007577,0.00013776627,0.00012176606,0.00010792502],"category_scores_gemma":[0.00008475454,0.00011547933,0.000030649033,0.0005397014,0.00013727313,0.00006017626,0.00008029637,0.00027490914,6.470994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027704174,0.035637762,0.8642124,0.000021291866,0.00008445628,0.00012423321,0.0014148562,0.000052438496,0.0000031194133,0.0001240997,0.000024719553,0.09553019],"study_design_scores_gemma":[0.05441102,0.074736975,0.8687559,0.00010179586,0.00010732827,0.000002086678,0.0010079304,0.000009430344,0.000089915964,0.0000338788,0.0006223877,0.000121357276],"about_ca_topic_score_codex":0.00050653337,"about_ca_topic_score_gemma":0.025452003,"teacher_disagreement_score":0.095408835,"about_ca_system_score_codex":0.0013326599,"about_ca_system_score_gemma":0.00043071306,"threshold_uncertainty_score":0.99233097},"labels":[],"label_agreement":null},{"id":"W1985196525","doi":"10.1006/gyno.2002.6632","title":"Caspase 3-Mediated Focal Adhesion Kinase Processing in Human Ovarian Cancer Cells: Possible Regulation by X-Linked Inhibitor of Apoptosis Protein","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Ottawa Hospital Foundation; Ministry of Education, Culture, Sports, Science and Technology; Japan-North America Medical Exchange Foundation","keywords":"XIAP; Focal adhesion; Cell biology; Apoptosis; Signal transduction; Inhibitor of apoptosis; Caspase 8; Programmed cell death; Cisplatin; Caspase; Integrin; Cell adhesion; PTK2; Cancer cell; Caspase 3; Cancer research; Cell; Biology; Biochemistry; Protein kinase C; Cancer; Mitogen-activated protein kinase kinase","score_opus":0.03620174166077832,"score_gpt":0.32528546633334465,"score_spread":0.2890837246725663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985196525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928739,0.0005452782,0.00005176545,0.0021467078,0.000112360496,0.0018097241,0.000018067303,0.00008055541,0.0023616117],"genre_scores_gemma":[0.99536616,0.000085521155,0.0015198863,0.00027001827,0.00009563098,0.00045316562,0.00008593094,0.00003816538,0.0020855549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970829,0.00043104522,0.00080130436,0.0005949481,0.0004572733,0.0006325659],"domain_scores_gemma":[0.9985678,0.00022785635,0.0003541344,0.0003253983,0.00027110463,0.0002536972],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059897336,0.0002585793,0.0006971704,0.00046043855,0.00013817703,0.000015990496,0.00018729395,0.0006605881,0.0033390727],"category_scores_gemma":[0.00064245914,0.00022859924,0.00009661808,0.0008496492,0.00027630024,0.00010581655,0.00013098173,0.0005990558,0.00006450253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029876875,0.0017008482,0.0030673055,0.00026751362,0.0000134307675,0.00014646567,0.0002696923,0.00003957908,0.95885926,0.00001325932,0.0043798103,0.030944085],"study_design_scores_gemma":[0.009148278,0.006003679,0.022990016,0.00032394018,0.00008598949,0.000017156344,0.00034986204,0.012322947,0.94305253,0.00017236148,0.005113835,0.0004194187],"about_ca_topic_score_codex":0.00045629247,"about_ca_topic_score_gemma":0.00032996005,"teacher_disagreement_score":0.030524667,"about_ca_system_score_codex":0.0010605705,"about_ca_system_score_gemma":0.00035117826,"threshold_uncertainty_score":0.997572},"labels":[],"label_agreement":null},{"id":"W1986010151","doi":"10.1016/j.ygyno.2011.05.021","title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Stathmin; Pathology; Cancer research; Biology; Serous fluid; Serous carcinoma; Ovarian carcinoma; PI3K/AKT/mTOR pathway; Medicine; Ovarian cancer; Cancer; Signal transduction; Internal medicine; Cell biology; Microtubule","score_opus":0.013891941137505533,"score_gpt":0.2274982541230577,"score_spread":0.2136063129855522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986010151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973422,0.00021183964,0.00028347867,0.000055068464,0.00009067636,0.00039009005,0.000090605674,0.0000066456037,0.0015293887],"genre_scores_gemma":[0.9971144,0.00017901436,0.0021168212,0.00014702606,0.00001984136,0.00004191115,0.000064867585,0.000018981453,0.0002971284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986394,0.00015904299,0.00044938,0.00039988165,0.0000690766,0.00028322736],"domain_scores_gemma":[0.9991101,0.0000621044,0.00031329333,0.00033896117,0.000117357,0.0000581553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002779022,0.00018165944,0.00039139125,0.000113638445,0.000027429855,0.000003311282,0.00018879733,0.0004567308,0.00006227418],"category_scores_gemma":[0.000108710905,0.00017676008,0.000071770155,0.00009023318,0.00021558427,0.00000843749,0.00018036428,0.00012290111,0.0000018749676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003968006,0.00040978316,0.14450383,0.00007868586,0.000055733122,0.000009819935,0.0010374314,0.0000027436984,0.84787357,0.00020869361,0.00020152103,0.005221403],"study_design_scores_gemma":[0.0017560839,0.0020844731,0.425904,0.000018591103,0.000023621244,0.000012850684,0.0004624169,0.00014269372,0.5673471,0.00037120556,0.0016636348,0.00021333827],"about_ca_topic_score_codex":0.00036831517,"about_ca_topic_score_gemma":0.0010647677,"teacher_disagreement_score":0.28140014,"about_ca_system_score_codex":0.00007392559,"about_ca_system_score_gemma":0.00018334188,"threshold_uncertainty_score":0.7208067},"labels":[],"label_agreement":null},{"id":"W1986172756","doi":"10.1016/j.ygyno.2007.08.083","title":"Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Consejo Nacional de Ciencia y Tecnología; Terry Fox Foundation","keywords":"HeLa; Cancer research; Cancer; Cervical cancer; Medicine; Immunohistochemistry; Trypsin; Cell growth; Flow cytometry; Protease-activated receptor 2; Molecular biology; Pathology; Receptor; Cell; Internal medicine; Biology; Immunology; Enzyme; Biochemistry","score_opus":0.04360928714472513,"score_gpt":0.34413016888437076,"score_spread":0.30052088173964564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986172756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799894,0.000054868502,0.0004313136,0.0060335803,0.0006253588,0.0014213957,0.0000026264645,0.00014965342,0.0112918],"genre_scores_gemma":[0.99226224,0.00002568854,0.0034031058,0.0033998513,0.00020272759,0.00027485585,0.00003595626,0.000016812704,0.0003787622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998476,0.00014446759,0.0004433399,0.00034030684,0.00017203871,0.00042383585],"domain_scores_gemma":[0.9992067,0.00019312663,0.00013887216,0.00017448196,0.00012209748,0.0001646955],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077743223,0.00015593201,0.00043462712,0.00019120866,0.000072400246,0.0000075667294,0.00007577968,0.00047621148,0.0031046036],"category_scores_gemma":[0.00031612458,0.00013174972,0.00005612288,0.0004037734,0.00006787198,0.0000688546,0.000039431707,0.00038124973,0.00014309294],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015417774,0.0031703217,0.33447155,0.00010041293,0.00011642865,0.00025680152,0.0006157827,0.00004923712,0.54761076,0.0050956435,0.0021621657,0.10480909],"study_design_scores_gemma":[0.005027891,0.00276103,0.7921272,0.000042716467,0.00006295014,0.00005080277,0.00024005046,0.0002742422,0.16609816,0.0009904793,0.03206646,0.00025800825],"about_ca_topic_score_codex":0.000077443976,"about_ca_topic_score_gemma":0.00092121685,"teacher_disagreement_score":0.45765564,"about_ca_system_score_codex":0.0006253949,"about_ca_system_score_gemma":0.00036533526,"threshold_uncertainty_score":0.99780667},"labels":[],"label_agreement":null},{"id":"W1986351114","doi":"10.1016/j.ygyno.2007.01.018","title":"Ovarian cancer specific kallikrein profile in effusions","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Institutes of Health; National Cancer Institute; Ovarian Cancer Research Fund","keywords":"Kallikrein; Ovarian cancer; Cancer; Medicine; Effusion; Internal medicine; Biology; Enzyme; Biochemistry","score_opus":0.03424404904935804,"score_gpt":0.3452895406792709,"score_spread":0.3110454916299129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986351114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91172796,0.0018817442,0.00021339259,0.0050248364,0.0014392093,0.0009673917,0.000010505499,0.00015956283,0.07857537],"genre_scores_gemma":[0.98825175,0.00045164902,0.003103397,0.0020895908,0.0005350061,0.00010803592,0.000052390405,0.00002496437,0.0053831963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980416,0.000086890075,0.0005635757,0.00044436194,0.00018036012,0.00068316085],"domain_scores_gemma":[0.9985666,0.00068082346,0.00015389614,0.00028966376,0.00009320821,0.00021578535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084943394,0.00020792644,0.00055033,0.0002765657,0.000121447134,0.0000092559485,0.00014193874,0.00042727313,0.007938077],"category_scores_gemma":[0.00025943332,0.0001778835,0.00011447515,0.0005071746,0.00016440799,0.000059993366,0.00008018199,0.0003481747,0.00030103207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068280444,0.0015676115,0.6328939,0.000056239525,0.00007613148,0.0016453854,0.0013221762,0.00004508882,0.008486139,0.008976419,0.019972222,0.32427585],"study_design_scores_gemma":[0.002478889,0.0006896041,0.7667518,0.00002947805,0.00003323142,0.000061846185,0.00025626505,0.00010180377,0.00096301053,0.0007078536,0.22775704,0.00016915404],"about_ca_topic_score_codex":0.00036916934,"about_ca_topic_score_gemma":0.0036625953,"teacher_disagreement_score":0.3241067,"about_ca_system_score_codex":0.0006591449,"about_ca_system_score_gemma":0.00043322812,"threshold_uncertainty_score":0.9929688},"labels":[],"label_agreement":null},{"id":"W1986692536","doi":"10.1016/j.ygyno.2014.08.029","title":"The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Minority Health and Health Disparities; National Cancer Institute","keywords":"Medicine; Debulking; Socioeconomic status; Odds ratio; Population; Demography; Confidence interval; Cancer; Chemotherapy; Logistic regression; Ovarian cancer; Internal medicine; Gerontology; Gynecology; Surgery; Environmental health","score_opus":0.044914969750298524,"score_gpt":0.3583490059976394,"score_spread":0.3134340362473409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986692536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646115,0.0001313637,0.000016156679,0.0015087682,0.00015185091,0.00055771496,0.000013641967,0.000008133653,0.0011512146],"genre_scores_gemma":[0.99905896,0.00006982838,0.0000643048,0.00039607473,0.00004691518,0.0003076173,0.000026432783,0.0000053724866,0.00002451975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980594,0.00061142707,0.0004965048,0.00031071898,0.000114922004,0.00040701858],"domain_scores_gemma":[0.9967893,0.0027147494,0.0002170404,0.0001958491,0.000019080368,0.00006399362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007771357,0.00016970166,0.00088811177,0.00034171526,0.000052960713,0.0000071424565,0.000113075235,0.0002195967,0.00022239299],"category_scores_gemma":[0.0005172872,0.00010460436,0.00013229332,0.00040846158,0.000082018974,0.00002669527,0.00001870509,0.00021613906,0.0000063633174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010225943,0.00013774807,0.947453,0.0000085395695,0.00008299497,0.00001697187,0.00020688935,0.0029639523,0.00002520109,0.00017005601,0.0000053090816,0.04790673],"study_design_scores_gemma":[0.0047159023,0.0050539942,0.9828814,0.000022448641,0.00015585395,3.9033677e-7,0.00008789211,0.0065640938,0.0000571464,0.00024248437,0.00012988341,0.0000884843],"about_ca_topic_score_codex":0.016821954,"about_ca_topic_score_gemma":0.24408351,"teacher_disagreement_score":0.22726156,"about_ca_system_score_codex":0.0021088815,"about_ca_system_score_gemma":0.00036472082,"threshold_uncertainty_score":0.9897251},"labels":[],"label_agreement":null},{"id":"W1986871969","doi":"10.1016/j.ygyno.2005.03.037","title":"Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Cervical cancer; Carcinoma; Cervical carcinoma; Cancer; Agency (philosophy); Internal medicine; Gynecology; General surgery; Chemotherapy; Cisplatin","score_opus":0.032519757417349054,"score_gpt":0.33772626583861165,"score_spread":0.3052065084212626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986871969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812276,0.011607717,0.000010142969,0.0035333037,0.000426021,0.0011991821,0.000049528808,0.000036078403,0.0019104216],"genre_scores_gemma":[0.99195874,0.0019107909,0.001272877,0.0021270532,0.00028477158,0.001329348,0.000012602537,0.000012351484,0.0010914413],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99870247,0.0000799892,0.00029265243,0.0004264174,0.00011921552,0.00037926945],"domain_scores_gemma":[0.99869555,0.0007763235,0.00010105277,0.00015126377,0.00008500102,0.00019081333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017495186,0.00012900599,0.00044607697,0.000020146319,0.00038719855,0.000066938475,0.00008494481,0.00017659704,0.00064669235],"category_scores_gemma":[0.00044358044,0.00011385768,0.00006578065,0.00015840541,0.0002625611,0.000056564753,0.000091028356,0.00017799824,0.0000029712382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003124079,0.00030936315,0.13261232,0.000060771472,0.000047156565,0.000045716082,0.00057567126,0.0000011477862,0.000372931,0.000036326077,0.0013370201,0.86428916],"study_design_scores_gemma":[0.0072829286,0.0033958482,0.90762025,0.000023328199,0.00016610386,0.00012590674,0.00046605433,0.00010173774,0.00005576082,0.0005141835,0.08008974,0.00015816267],"about_ca_topic_score_codex":0.0042235577,"about_ca_topic_score_gemma":0.0559372,"teacher_disagreement_score":0.86413103,"about_ca_system_score_codex":0.0003162612,"about_ca_system_score_gemma":0.00015669191,"threshold_uncertainty_score":0.96128947},"labels":[],"label_agreement":null},{"id":"W1986958762","doi":"10.1016/j.ygyno.2013.06.029","title":"Risks and benefits of screening asymptomatic women for ovarian cancer: A systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Arthritis Research Centre of Canada; Simon Fraser University; McMaster University; University of Toronto","funders":"Canadian Institutes of Health Research; NCMIC Foundation","keywords":"Medicine; Asymptomatic; Relative risk; Meta-analysis; Ovarian cancer; Odds ratio; Confidence interval; Randomized controlled trial; Gynecology; MEDLINE; Obstetrics; Internal medicine; Cancer","score_opus":0.22172006333392388,"score_gpt":0.4224848015814642,"score_spread":0.2007647382475403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986958762","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020241367,0.985991,0.000034723605,0.0009962836,0.00005238948,0.012337959,0.00039427096,0.00002973794,0.00014338027],"genre_scores_gemma":[0.00007552459,0.9591488,0.003406575,0.00090497546,0.000031675303,0.035940576,0.00008569443,0.000040466246,0.00036566166],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9962619,0.0005751305,0.0017367891,0.0007642846,0.00018432157,0.0004775595],"domain_scores_gemma":[0.99379,0.0030991652,0.002000578,0.0006309214,0.00021258558,0.0002667524],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013334773,0.0006278622,0.01921248,0.00039450865,0.00008899486,0.000022622786,0.00017236969,0.00054870354,0.001182555],"category_scores_gemma":[0.0006452626,0.00036280352,0.001629269,0.0005688975,0.00012769755,0.0000460782,0.00013387787,0.0002299332,0.000007639233],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037410878,0.0001573517,0.000027824108,0.6571058,0.22646755,0.000008399723,0.000046533307,0.0000010276933,5.1460725e-9,0.00011692562,0.0001728516,0.11589199],"study_design_scores_gemma":[0.0007717673,0.0013600859,0.00014161548,0.020288598,0.9348375,0.000075471195,0.00003322719,0.0000080646805,8.497898e-8,0.000039521343,0.04217852,0.00026550976],"about_ca_topic_score_codex":0.0001501248,"about_ca_topic_score_gemma":0.00008816143,"teacher_disagreement_score":0.70837,"about_ca_system_score_codex":0.00056036015,"about_ca_system_score_gemma":0.00040630414,"threshold_uncertainty_score":0.9998824},"labels":[],"label_agreement":null},{"id":"W1987603436","doi":"10.1006/gyno.2001.6426","title":"Intratumoral Sickling in a Patient with Cervix Cancer and Sickle Trait: Effect on Blood Flow and Oxygenation","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sickle cell trait; Hypoxia (environmental); Oxygen tension; Population; Cancer; Cervix; Pathology; Internal medicine; Gastroenterology; Physiology; Oxygen; Disease","score_opus":0.007258297986455976,"score_gpt":0.2544869365330275,"score_spread":0.24722863854657154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987603436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071115,0.00082986645,0.000004675565,0.0028292898,0.00013946054,0.0006693419,0.0000033373474,0.000042460666,0.0047703898],"genre_scores_gemma":[0.99733394,0.0007421528,0.00029586043,0.001384826,0.000038105765,0.00010773457,0.000010747978,0.000013075307,0.00007356791],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998954,0.00010458508,0.00020634533,0.00031922266,0.00010120427,0.0003146523],"domain_scores_gemma":[0.99942684,0.0002637555,0.00007378045,0.00009039856,0.00003299881,0.00011219896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020359094,0.00016785595,0.0003940425,0.00012503978,0.000071968934,0.000008993343,0.00003044312,0.00026077518,0.00011290767],"category_scores_gemma":[0.00012221785,0.000110863315,0.000022828463,0.0002047399,0.00012784795,0.00003811597,0.000026268332,0.00035192646,0.0000037555712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002284068,0.0013333758,0.13948382,0.00016208811,0.00016064299,0.004337468,0.002518903,0.0009845794,0.0026109107,0.00019392806,0.00023680432,0.8456934],"study_design_scores_gemma":[0.04365143,0.13691425,0.7777075,0.00055258506,0.0010019677,0.004312228,0.003248285,0.011419631,0.0016783589,0.0006512122,0.017844545,0.0010180019],"about_ca_topic_score_codex":0.000138083,"about_ca_topic_score_gemma":0.0009780106,"teacher_disagreement_score":0.8446754,"about_ca_system_score_codex":0.00014149875,"about_ca_system_score_gemma":0.00011724881,"threshold_uncertainty_score":0.45208746},"labels":[],"label_agreement":null},{"id":"W1988124776","doi":"10.1016/j.ygyno.2012.12.019","title":"PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"GlaxoSmithKline","keywords":"Medicine; Cervical cancer; Chemoradiotherapy; Oncology; Internal medicine; Exon; Stage (stratigraphy); Cervix; Cancer; Retrospective cohort study; Cancer research; Gene; Biology; Genetics","score_opus":0.010160337556801452,"score_gpt":0.2722536660273477,"score_spread":0.2620933284705462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988124776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977627,0.0006801198,0.000063641644,0.0002391129,0.00018393203,0.00032518597,0.000045097768,0.000017525428,0.00068273314],"genre_scores_gemma":[0.9971459,0.00011879591,0.0012025093,0.0008621268,0.00020957332,0.00013745153,0.00020213994,0.000028879085,0.00009265844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998444,0.00017372407,0.00020819399,0.00039529402,0.00017800838,0.0006007691],"domain_scores_gemma":[0.9993256,0.00011140763,0.00011659269,0.00016457663,0.00008740819,0.00019446542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018863502,0.0002243164,0.00034894008,0.000054461903,0.000057770685,0.000011065472,0.00011374385,0.00033009594,0.0003509055],"category_scores_gemma":[0.000052518844,0.00016407762,0.000027281452,0.00011233439,0.0002955771,0.000011725876,0.000047715122,0.00018831891,0.000003384964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015073583,0.0005157419,0.9913311,0.000010812433,0.00010165449,0.000009855442,0.00007964468,0.00014138749,0.0023969905,0.00006760475,0.00026181593,0.003576024],"study_design_scores_gemma":[0.0066991323,0.003399251,0.9701834,0.0000074322966,0.000030603165,0.000009454826,0.00002579792,0.000021953716,0.0013195435,0.000021078251,0.018007968,0.00027439816],"about_ca_topic_score_codex":0.00014027394,"about_ca_topic_score_gemma":0.00054613594,"teacher_disagreement_score":0.021147722,"about_ca_system_score_codex":0.0002903642,"about_ca_system_score_gemma":0.0003267791,"threshold_uncertainty_score":0.6690891},"labels":[],"label_agreement":null},{"id":"W1988262237","doi":"10.1016/j.ygyno.2010.01.013","title":"A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Sorafenib; Internal medicine; Carcinosarcoma; Carcinoma; Gastroenterology; Oncology; Surgery; Hepatocellular carcinoma","score_opus":0.030291938665822533,"score_gpt":0.36538613515111007,"score_spread":0.33509419648528754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988262237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425334,0.00016026787,0.0000010608546,0.0008576972,0.0007589277,0.003005612,0.00010334634,0.00002118429,0.0008385525],"genre_scores_gemma":[0.99900454,0.000028565284,0.00017802256,0.00023248993,0.000102131526,0.00029870874,0.000014458323,0.000013605112,0.00012745014],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978774,0.00026160368,0.0008413323,0.0004228246,0.00023816242,0.0003586324],"domain_scores_gemma":[0.99824363,0.0006013302,0.00041924164,0.00046695612,0.00011290784,0.0001559591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004722146,0.00023992005,0.0011605632,0.00020106375,0.0001352904,0.0000026120745,0.00021215576,0.00025338892,0.00059031905],"category_scores_gemma":[0.0011170564,0.00014848952,0.00013313929,0.00053885684,0.00037542894,0.00003781672,0.00036648908,0.00050920475,0.0000022301026],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23543313,0.21844521,0.1632247,0.00023059898,0.0004717509,0.00065587764,0.0030675922,0.000004344705,0.1342541,0.00020576594,0.00015547538,0.24385147],"study_design_scores_gemma":[0.67307895,0.22600767,0.09026938,0.000014671947,0.00040778704,0.000061469946,0.00062404585,0.000043420307,0.0048151356,0.00027528236,0.0042350134,0.00016719096],"about_ca_topic_score_codex":0.00029635226,"about_ca_topic_score_gemma":0.0018539714,"teacher_disagreement_score":0.4376458,"about_ca_system_score_codex":0.00011596854,"about_ca_system_score_gemma":0.0003405357,"threshold_uncertainty_score":0.64635795},"labels":[],"label_agreement":null},{"id":"W1988536568","doi":"10.1016/j.ygyno.2004.01.047","title":"Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; Michael Smith Health Research BC","keywords":"Serous fluid; Pathology; Serous Cystadenoma; Immunohistochemistry; Oviduct; Ovary; Epithelium; Serous carcinoma; Medicine; Biology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.013756043613473289,"score_gpt":0.28388539161525517,"score_spread":0.2701293480017819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988536568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97210515,0.00027752394,0.00029934014,0.02506424,0.0003483877,0.00132394,0.0000147195615,0.000062475236,0.0005042497],"genre_scores_gemma":[0.99460983,0.000052607655,0.0034143634,0.0013033631,0.00026547472,0.0002390937,0.000041822215,0.000019300242,0.000054127555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817854,0.00014776294,0.0004364816,0.000535249,0.00025913672,0.00044281592],"domain_scores_gemma":[0.99884295,0.00035008322,0.00015487074,0.0002514679,0.00003666901,0.00036395574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021981083,0.00023746032,0.0005660824,0.00021215476,0.00018292638,0.000020437596,0.000105943735,0.00039225593,0.00047721685],"category_scores_gemma":[0.00027640763,0.0001879605,0.00008158152,0.0002056602,0.00014920908,0.00005765328,0.0002528838,0.00036880386,0.00006374997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034078243,0.007997865,0.8789409,0.00012842349,0.0003013542,0.0038484053,0.0036629122,0.000201873,0.004453939,0.00473383,0.00057108246,0.09175162],"study_design_scores_gemma":[0.018143848,0.0064862473,0.96753395,0.00005762687,0.00015614905,0.00007859712,0.000045580175,0.000105714345,0.0013243227,0.0028769637,0.0030114013,0.00017959361],"about_ca_topic_score_codex":0.0010616079,"about_ca_topic_score_gemma":0.0010730365,"teacher_disagreement_score":0.091572024,"about_ca_system_score_codex":0.0011232038,"about_ca_system_score_gemma":0.0014334902,"threshold_uncertainty_score":0.7664807},"labels":[],"label_agreement":null},{"id":"W1988811947","doi":"10.1016/j.ygyno.2010.08.007","title":"MTHFR polymorphisms in relation to ovarian cancer risk","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Methylenetetrahydrofolate reductase; Ovarian cancer; Medicine; Single-nucleotide polymorphism; Oncology; Internal medicine; Case-control study; Serous fluid; SNP; Gynecology; Carcinogenesis; Cancer; Genotype; Bioinformatics; Genetics; Gene; Biology","score_opus":0.025123171281930045,"score_gpt":0.3568696513187206,"score_spread":0.3317464800367906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988811947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96334785,0.00005984749,0.00002322194,0.013481289,0.00083349063,0.0006075878,0.000008455815,0.00005264365,0.021585602],"genre_scores_gemma":[0.9916417,0.00011354198,0.0027617963,0.0017913952,0.00023457441,0.00017618733,0.000013054216,0.000014371071,0.0032533815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986265,0.00013503335,0.00027556714,0.00033792428,0.00016495536,0.00046007682],"domain_scores_gemma":[0.9989699,0.00037708975,0.00007067219,0.00028288955,0.000084652595,0.0002147641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007303141,0.00012066658,0.0003320055,0.00032101184,0.00007759473,0.0000084398125,0.00013426771,0.00047242153,0.0041681062],"category_scores_gemma":[0.0012451235,0.00009649403,0.000053076303,0.00046569048,0.0000888033,0.000055345372,0.00008924402,0.0009746174,0.0006781066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036066162,0.00052998395,0.7485866,0.000008962458,0.000039738545,0.00039978692,0.0004762919,0.000031693926,0.06770525,0.0008382589,0.005519027,0.17550376],"study_design_scores_gemma":[0.0016077585,0.0014814934,0.8994073,0.000006511704,0.000028138416,0.00003955846,0.000047487552,0.00024164665,0.00066122337,0.00046466093,0.0959127,0.00010147402],"about_ca_topic_score_codex":0.0016499961,"about_ca_topic_score_gemma":0.010977315,"teacher_disagreement_score":0.17540228,"about_ca_system_score_codex":0.0003446385,"about_ca_system_score_gemma":0.00046969368,"threshold_uncertainty_score":0.99674225},"labels":[],"label_agreement":null},{"id":"W1989100170","doi":"10.1016/j.ygyno.2006.01.039","title":"Clinical value of image-guided fine needle aspiration of retroperitoneal masses and lymph nodes in gynecologic oncology","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ureteral procedures and complications","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Lymph; Radiology; Gynecologic oncology; Fine-needle aspiration; Predictive value; Biopsy; Perforation; Surgery; Pathology; Internal medicine","score_opus":0.04549767925804076,"score_gpt":0.3776753939366054,"score_spread":0.3321777146785646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989100170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735549,0.00047653663,0.00016203367,0.0035862431,0.00024506552,0.000614893,0.000014060181,0.000046863253,0.021299392],"genre_scores_gemma":[0.97937644,0.00015799975,0.01906869,0.00077405904,0.00015192831,0.00009548947,0.000069736234,0.000015804208,0.0002898592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717396,0.00040937666,0.0014252479,0.00047143977,0.00014980447,0.00037016347],"domain_scores_gemma":[0.99721056,0.0014842371,0.0005947217,0.00032466347,0.00028917583,0.000096620824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091391476,0.00021290951,0.0011435859,0.00022519371,0.000065473076,0.0000067286205,0.00018365619,0.00063593034,0.00030553245],"category_scores_gemma":[0.0014835944,0.00017396297,0.00014568992,0.00035591255,0.0006795381,0.00008465632,0.00015598667,0.00033133163,0.000011456213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005482616,0.003996784,0.89463454,0.00025824396,0.00009024159,0.0001411899,0.000114244445,0.00021129273,0.051057503,0.009520966,0.00348666,0.035940044],"study_design_scores_gemma":[0.003997093,0.0071126902,0.9752147,0.000027137485,0.00014515602,0.00017395943,0.00017721135,0.001431339,0.0010176289,0.004520158,0.00601305,0.00016983775],"about_ca_topic_score_codex":0.00041522272,"about_ca_topic_score_gemma":0.00043530588,"teacher_disagreement_score":0.08058017,"about_ca_system_score_codex":0.00031165878,"about_ca_system_score_gemma":0.00065648294,"threshold_uncertainty_score":0.70940036},"labels":[],"label_agreement":null},{"id":"W1989554864","doi":"10.1016/j.ygyno.2014.05.012","title":"Is venous thromboprophylaxis necessary in patients undergoing minimally invasive surgery for a gynecologic malignancy?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Malignancy; Gynecologic cancer; Surgery; Venous thromboembolism; General surgery; Internal medicine; Cancer; Thrombosis; Ovarian cancer","score_opus":0.026481425470029685,"score_gpt":0.28509904816342085,"score_spread":0.25861762269339117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989554864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820277,0.00019080997,0.00007579081,0.003677537,0.0012890238,0.0026295932,0.000018932658,0.00012817793,0.009962434],"genre_scores_gemma":[0.9824631,0.00051016937,0.0022285236,0.013299816,0.00018598197,0.00090099307,0.00011611226,0.000055165518,0.00024010935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964732,0.00031079492,0.0009292367,0.00092373695,0.00028609246,0.0010769235],"domain_scores_gemma":[0.9926038,0.005942921,0.00047064712,0.00052496296,0.00024755442,0.00021012868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011562257,0.00042498013,0.0018561265,0.00046024966,0.0002125567,0.0000294108,0.00028922322,0.0005753552,0.0006991735],"category_scores_gemma":[0.0042327223,0.0003746777,0.0003490322,0.0004170274,0.00018944174,0.00013115504,0.00024335812,0.0003047877,0.00018144916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061423617,0.014243678,0.8319421,0.0013109391,0.00047954498,0.000264988,0.0009967693,0.00006384164,0.00029159934,0.0014735201,0.056743264,0.091575526],"study_design_scores_gemma":[0.005059384,0.019300487,0.95059055,0.00013808394,0.00023322011,0.00000865311,0.00036574726,0.000075988726,0.00030390482,0.0040919343,0.019386882,0.00044515435],"about_ca_topic_score_codex":0.000067899935,"about_ca_topic_score_gemma":0.00096742273,"teacher_disagreement_score":0.11864847,"about_ca_system_score_codex":0.00091292436,"about_ca_system_score_gemma":0.0007639258,"threshold_uncertainty_score":0.99987054},"labels":[],"label_agreement":null},{"id":"W1990144562","doi":"10.1016/j.ygyno.2008.10.005","title":"Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McGill University Health Centre","funders":"National Cancer Institute","keywords":"Medicine; Parametrial; Radiology; Cervical cancer; Lymph node; Parametrium; Univariate analysis; Multivariate analysis; Radical Hysterectomy; Biopsy; Retrospective cohort study; Cancer; Internal medicine","score_opus":0.04107077187045733,"score_gpt":0.3291608306282419,"score_spread":0.2880900587577846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990144562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99391735,0.0016376674,0.0000024959083,0.0009754017,0.00041739247,0.0013634712,0.000027705306,0.000026270909,0.0016322717],"genre_scores_gemma":[0.9967658,0.001269548,0.00011070884,0.0011345234,0.00013426905,0.00047568258,0.000011703529,0.000011856535,0.00008593311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978151,0.0006276899,0.0005285572,0.00034133822,0.00029104887,0.00039627816],"domain_scores_gemma":[0.9969238,0.0024286227,0.00018412323,0.00025556708,0.00006511029,0.00014279442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005089284,0.00021893375,0.0008653189,0.00020537015,0.00008202329,0.0000054718707,0.00021022208,0.00010039336,0.00039282598],"category_scores_gemma":[0.00084843626,0.00012779381,0.0001022228,0.00058324233,0.00031555927,0.00007929393,0.00014779255,0.00021753192,0.000012119162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060014916,0.0035297035,0.98406935,0.000056710625,0.00034682133,0.0010163249,0.0038430276,0.0000043233367,0.000064198764,0.000046112058,0.0003480298,0.00607523],"study_design_scores_gemma":[0.0088482695,0.012034625,0.97348034,0.000024868737,0.0004115,0.00021805482,0.0034057535,0.0000031795748,0.00018443211,0.00011879812,0.0011619398,0.000108207925],"about_ca_topic_score_codex":0.002163082,"about_ca_topic_score_gemma":0.00240002,"teacher_disagreement_score":0.010588997,"about_ca_system_score_codex":0.00039936864,"about_ca_system_score_gemma":0.00028092848,"threshold_uncertainty_score":0.52112806},"labels":[],"label_agreement":null},{"id":"W1991700067","doi":"10.1016/j.ygyno.2007.03.029","title":"Histopathologic assessment of chemotherapy effects in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Internal medicine; Ovarian cancer; Oncology; Proportional hazards model; Stage (stratigraphy); Prognostic variable; Hazard ratio; Cancer; Pathology; Surgery; Confidence interval","score_opus":0.008749230358979529,"score_gpt":0.3023285964595628,"score_spread":0.29357936610058327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991700067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288344,0.0005676841,0.00009277942,0.0011846484,0.00018947056,0.0014682342,0.0000135291275,0.000048697908,0.0035515418],"genre_scores_gemma":[0.9919939,0.0010156188,0.0049471264,0.0015921441,0.00007602037,0.00023132419,0.0000421597,0.000031289426,0.0000704411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979671,0.00015683025,0.0005422791,0.00057777565,0.0002316068,0.0005243773],"domain_scores_gemma":[0.9983248,0.00083759264,0.0003234366,0.00023674307,0.00011446145,0.00016296016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061204005,0.00031642633,0.0010577458,0.00021030779,0.00006112041,0.000006660197,0.000088954286,0.000357228,0.00019140248],"category_scores_gemma":[0.000038588867,0.00021483772,0.00008365068,0.0002944394,0.00022395588,0.00004645418,0.000037534388,0.00027962038,0.0000014409121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020139269,0.0029588223,0.7956388,0.00007189174,0.00015388722,0.0014664548,0.00021152086,0.0000077525665,0.0009938609,0.00012612353,0.00003761841,0.19631937],"study_design_scores_gemma":[0.02856482,0.012369427,0.9542988,0.000095096046,0.00016196878,0.0000893498,0.000027797038,0.000045641667,0.0012821953,0.000053990676,0.0028068242,0.0002040666],"about_ca_topic_score_codex":0.00037077753,"about_ca_topic_score_gemma":0.00046478517,"teacher_disagreement_score":0.1961153,"about_ca_system_score_codex":0.0017618889,"about_ca_system_score_gemma":0.00039664222,"threshold_uncertainty_score":0.87608284},"labels":[],"label_agreement":null},{"id":"W1991785732","doi":"10.1006/gyno.2001.6387","title":"Strategies for the Implementation of Cervical and Breast Cancer Screening of Women by Primary Care Physicians","year":2001,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Notice; Cervical cancer screening; Breast cancer screening; Cervical screening; Breast cancer; MEDLINE; Family medicine; Primary care physician; Randomized controlled trial; Cochrane Library; Intervention (counseling); Cancer screening; Cervical cancer; Primary care; Mammography; Gynecology; Obstetrics; Cancer; Nursing; Internal medicine","score_opus":0.08203902468118533,"score_gpt":0.4330542276641006,"score_spread":0.3510152029829153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991785732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024133374,0.9938689,0.00024912908,0.0002887371,0.0001336915,0.0016289656,0.00075805775,0.000015625057,0.0006435408],"genre_scores_gemma":[0.0073933066,0.9904118,0.00040108446,0.00047017875,0.0001640234,0.00085517974,0.00025131454,0.000020271998,0.000032803728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983934,0.00011813276,0.00060040207,0.00030083137,0.0001743221,0.0004128958],"domain_scores_gemma":[0.9980971,0.0007581332,0.00067843666,0.00018710743,0.00021499029,0.00006418871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033652812,0.00024139513,0.0017501382,0.000065151835,0.00008142038,0.000008588064,0.0001844597,0.00031890106,0.00021638464],"category_scores_gemma":[0.0000198857,0.0001553978,0.00022057621,0.00022110008,0.00023366864,0.0000624303,0.0000904961,0.00023686254,4.5229206e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008479516,0.000036020876,0.0007876607,0.008269978,0.00029774575,0.000005621239,0.0006979042,0.0000025126978,0.000005475558,0.00007948628,0.0012727288,0.98846006],"study_design_scores_gemma":[0.0012766818,0.0021784625,0.006737118,0.0018970206,0.00196691,0.000095307834,0.037731618,0.0000052414184,0.000002071366,0.000059564525,0.9478589,0.00019104926],"about_ca_topic_score_codex":0.0008035216,"about_ca_topic_score_gemma":0.00054632605,"teacher_disagreement_score":0.98826903,"about_ca_system_score_codex":0.0009880951,"about_ca_system_score_gemma":0.0014126998,"threshold_uncertainty_score":0.6336939},"labels":[],"label_agreement":null},{"id":"W1992803488","doi":"10.1016/j.ygyno.2005.04.030","title":"Stage II endometrial carcinoma: Limiting post-operative radiotherapy to the vaginal vault in node-negative tumors","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Dalhousie University","funders":"","keywords":"Medicine; Brachytherapy; Vaginal vault; Endometrial cancer; External beam radiotherapy; Stage (stratigraphy); Radiation therapy; Lymphadenectomy; Surgery; Lymph node; Carcinoma; Cancer; Radiology; Hysterectomy; Internal medicine","score_opus":0.03169996522878703,"score_gpt":0.3412405436170546,"score_spread":0.30954057838826754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992803488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498658,0.0006258744,0.000058004793,0.033749696,0.0005796599,0.001849878,0.000053303203,0.00006306267,0.01315473],"genre_scores_gemma":[0.9766878,0.00008666808,0.0048249755,0.014939753,0.0010853524,0.00042837017,0.00002340938,0.000024943884,0.0018987416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99733007,0.00048473696,0.000591703,0.0005698792,0.0003148556,0.0007087511],"domain_scores_gemma":[0.9963951,0.002676864,0.00017896314,0.0002983514,0.00019934509,0.00025135264],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007933107,0.00031730018,0.0009019679,0.0003603134,0.00028289348,0.00002066444,0.00027468774,0.00023572675,0.002474516],"category_scores_gemma":[0.002994901,0.0001949934,0.00016550985,0.0012628456,0.00015854929,0.000103181155,0.00015712561,0.00059298537,0.00014458786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023327518,0.008404714,0.26794344,0.00008320264,0.0010127958,0.0030606217,0.024839768,0.002831356,0.014133889,0.0022264526,0.0043259724,0.6478103],"study_design_scores_gemma":[0.063455336,0.046243977,0.6929093,0.000054279477,0.0002478169,0.000216274,0.0050219246,0.0005379337,0.0068139764,0.000148396,0.1836265,0.0007243068],"about_ca_topic_score_codex":0.00060014706,"about_ca_topic_score_gemma":0.0019934399,"teacher_disagreement_score":0.64708596,"about_ca_system_score_codex":0.0022052983,"about_ca_system_score_gemma":0.00056933827,"threshold_uncertainty_score":0.99843735},"labels":[],"label_agreement":null},{"id":"W1992984772","doi":"10.1016/j.ygyno.2008.06.021","title":"SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Terry Fox Foundation; Michael Smith Health Research BC","keywords":"Serous fluid; Motility; Vimentin; Cancer research; Antigen; Cadherin; Biology; Pathology; Cell; Medicine; Molecular biology; Immunohistochemistry; Immunology; Cell biology","score_opus":0.043517144906768154,"score_gpt":0.2747318047830496,"score_spread":0.23121465987628143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992984772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891758,0.0011284963,0.0000119727965,0.0033950494,0.00085242523,0.0009548721,0.000010827166,0.00010646667,0.0043640975],"genre_scores_gemma":[0.99352705,0.0005768786,0.0019217853,0.002119678,0.00023788631,0.0004352477,0.000015176227,0.00003088241,0.0011353978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980085,0.00016385275,0.00049974245,0.0005440223,0.00018500969,0.00059891155],"domain_scores_gemma":[0.9988703,0.00034540743,0.00015431544,0.0003330248,0.000106447835,0.00019047935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019654808,0.00029012287,0.0007851835,0.00019726697,0.00013624111,0.000011026341,0.0001429893,0.00028067167,0.00072901807],"category_scores_gemma":[0.00019184378,0.0002169669,0.00009786243,0.00032820847,0.00021231273,0.00007614191,0.000087271466,0.00035322466,0.00031296242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012459559,0.009975414,0.8748016,0.00018654275,0.0004039656,0.023861816,0.0027027617,0.00045418605,0.010204809,0.00034872277,0.005429533,0.07038474],"study_design_scores_gemma":[0.0072605107,0.007759921,0.92783266,0.000057775425,0.0001593849,0.0009399195,0.00021490302,0.00014538535,0.005372857,0.00010171602,0.049827486,0.0003274856],"about_ca_topic_score_codex":0.00062413135,"about_ca_topic_score_gemma":0.0009361573,"teacher_disagreement_score":0.07005725,"about_ca_system_score_codex":0.00070472376,"about_ca_system_score_gemma":0.0009299416,"threshold_uncertainty_score":0.8847653},"labels":[],"label_agreement":null},{"id":"W1993552719","doi":"10.1006/gyno.2000.6105","title":"Evaluation of Chemoresistance Markers in Women with Epithelial Ovarian Carcinoma","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Stromal cell; Medicine; Chemotherapy; Paclitaxel; Carcinoma; Epithelial ovarian cancer; Ovarian carcinoma; Internal medicine; Epithelial ovarian carcinoma; Immunocytochemistry; Oncology; Pathology; Ovarian cancer; Andrology; Cancer research; Cancer","score_opus":0.022572181796536903,"score_gpt":0.28371559848238875,"score_spread":0.26114341668585184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993552719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582525,0.00015487197,0.0000950483,0.0008583841,0.00018549137,0.0006849205,0.0000044617072,0.000026675576,0.039737627],"genre_scores_gemma":[0.99712735,0.000064922584,0.0017542412,0.0003137443,0.00005066207,0.00019636491,0.000009788847,0.000014001315,0.0004689014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998292,0.00018136458,0.00035537453,0.00030264092,0.00046259575,0.0004059865],"domain_scores_gemma":[0.9991194,0.00011333159,0.00015970913,0.00024271177,0.000263792,0.00010104863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002141065,0.00014811262,0.00051856437,0.00015712096,0.000034202498,0.0000023797022,0.00010547323,0.00021797496,0.0013498862],"category_scores_gemma":[0.00015218815,0.00010940167,0.000040493553,0.0003666052,0.00015776725,0.000041430736,0.00001240941,0.00018389455,0.000011141886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035007745,0.0039687543,0.4815553,0.00036076122,0.00043831393,0.003612674,0.003921436,0.00047643587,0.050706048,0.0016438465,0.0004585128,0.41785017],"study_design_scores_gemma":[0.009445925,0.002698969,0.9789163,0.000039646497,0.00020553556,0.00006608283,0.0013905955,0.00026027902,0.0013643429,0.0014688127,0.003998823,0.00014471808],"about_ca_topic_score_codex":0.000040327002,"about_ca_topic_score_gemma":0.0011274257,"teacher_disagreement_score":0.49736094,"about_ca_system_score_codex":0.0009804171,"about_ca_system_score_gemma":0.00096394453,"threshold_uncertainty_score":0.99956304},"labels":[],"label_agreement":null},{"id":"W1994504180","doi":"10.1016/j.ygyno.2008.04.008","title":"In vitro metformin anti-neoplastic activity in epithelial ovarian cancer","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Génome Québec","keywords":"Metformin; AMPK; Cisplatin; Medicine; Ovarian cancer; Growth inhibition; Cancer research; Pharmacology; Cancer; Cell growth; P70-S6 Kinase 1; Endocrinology; Internal medicine; Apoptosis; Phosphorylation; Diabetes mellitus; Chemotherapy; Biology; Protein kinase B; Biochemistry; Protein kinase A","score_opus":0.018113377087514575,"score_gpt":0.2874900083661614,"score_spread":0.2693766312786468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994504180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98237133,0.014322569,0.00005939825,0.00015681528,0.0012609133,0.0003085776,0.000046724654,0.000013362176,0.0014603342],"genre_scores_gemma":[0.9726873,0.024624895,0.00042671803,0.0012486347,0.00039597903,0.0002697157,0.000024181358,0.000019553576,0.00030302047],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980972,0.00028875188,0.00032665537,0.0005436959,0.000111608264,0.00063212233],"domain_scores_gemma":[0.99930865,0.00012890396,0.0001415372,0.0002756082,0.000046416902,0.00009887394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040987387,0.00023336678,0.0005476344,0.00014577246,0.00007309158,0.0000056492136,0.00026235878,0.00051891344,0.0003867262],"category_scores_gemma":[0.00033643734,0.00021513655,0.00009451555,0.0002458849,0.0001957387,0.000012434844,0.00013521344,0.0002924972,0.00003597582],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007318222,0.000864115,0.01824318,0.000029662186,0.00006662831,0.0004031624,0.00023624871,0.00041893608,0.7588147,0.000068835245,0.0022051993,0.2179175],"study_design_scores_gemma":[0.0043179975,0.0006964619,0.11868995,0.0000066545285,0.000029917985,0.00006681931,0.00006028773,0.00014609024,0.39953938,0.00028131524,0.47567493,0.0004901963],"about_ca_topic_score_codex":0.00044416447,"about_ca_topic_score_gemma":0.0026531636,"teacher_disagreement_score":0.4734697,"about_ca_system_score_codex":0.0002120709,"about_ca_system_score_gemma":0.0006598334,"threshold_uncertainty_score":0.8773014},"labels":[],"label_agreement":null},{"id":"W1994689333","doi":"10.1016/j.ygyno.2003.11.034","title":"Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Topotecan; Chemotherapy; Etoposide; Internal medicine; Ovarian cancer; Oncology; Cancer; Quality of life (healthcare); Surgery","score_opus":0.040131013655083536,"score_gpt":0.3713003744710657,"score_spread":0.33116936081598214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994689333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913316,0.00017026332,0.000010387482,0.0055947015,0.00012525587,0.0011173629,0.000025717643,0.000024145571,0.0016005652],"genre_scores_gemma":[0.9970332,0.0002507832,0.0014061901,0.00060726656,0.00004414011,0.00055053056,0.000027491526,0.000013196947,0.00006720704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987721,0.00009443497,0.00040144633,0.00030335426,0.00017572202,0.00025297026],"domain_scores_gemma":[0.99916816,0.00014274329,0.0002128873,0.00024735334,0.000119080185,0.000109784916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016189595,0.00016085581,0.0006123347,0.00010597447,0.000047183326,0.0000030688907,0.000050445153,0.00013927513,0.0008042035],"category_scores_gemma":[0.00008655795,0.00010872662,0.00007115395,0.0002140608,0.00008393299,0.00003630669,0.000013753526,0.00008152304,0.000010394562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010931714,0.0057871123,0.9707723,0.000028288016,0.00027318194,0.00001641088,0.00043746934,0.00061807816,0.000071571885,0.00030296922,0.000012661415,0.020586748],"study_design_scores_gemma":[0.040925656,0.0052704886,0.9524407,0.0000312449,0.00009201651,0.000001044515,0.00006643003,0.0000018284702,0.0004862773,0.00017970306,0.0004080372,0.000096579526],"about_ca_topic_score_codex":0.0013241731,"about_ca_topic_score_gemma":0.0033386888,"teacher_disagreement_score":0.039832484,"about_ca_system_score_codex":0.0027390055,"about_ca_system_score_gemma":0.0011773906,"threshold_uncertainty_score":0.88054645},"labels":[],"label_agreement":null},{"id":"W1995336112","doi":"10.1016/j.ygyno.2012.08.018","title":"Accuracy of sentinel lymph node detection following intra-operative cervical injection for endometrial cancer: A prospective study","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Sentinel lymph node; Endometrial cancer; Cervical cancer; Lymphadenectomy; Prospective cohort study; Lymph node; Frozen section procedure; Sentinel node; Biopsy; Radiology; Lymph; Breast cancer; Cancer; Surgery; Internal medicine; Pathology","score_opus":0.04044528078991322,"score_gpt":0.37756040552764875,"score_spread":0.3371151247377355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995336112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903981,0.0006065053,0.00056292274,0.00025354174,0.0028854138,0.003230067,0.000021716998,0.00008485932,0.0019568934],"genre_scores_gemma":[0.99626917,0.000050773284,0.0005420371,0.00030910273,0.0010948326,0.0015875238,0.000017481781,0.00002388635,0.000105190935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978992,0.0002890355,0.0005918556,0.00041155363,0.00026765105,0.000540723],"domain_scores_gemma":[0.996741,0.0022789964,0.0003426209,0.00019146538,0.00025513535,0.0001908079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072965433,0.00025305984,0.00095902814,0.00033082368,0.00017868896,0.000010169848,0.000097469274,0.0002971704,0.0003162147],"category_scores_gemma":[0.0036122052,0.0001901412,0.00031657875,0.0009482402,0.0000728743,0.00018444184,0.000079339785,0.0002267077,0.000015528982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005563843,0.005405462,0.8451043,0.000066270215,0.0010650752,0.000016161503,0.0014071888,0.000018087441,0.005726928,0.00004458344,0.000016709755,0.13556544],"study_design_scores_gemma":[0.040426064,0.010897834,0.9329614,0.000022609684,0.0015252099,0.00003818394,0.0027260291,0.00008741454,0.010068377,0.00021400716,0.00078350445,0.00024938578],"about_ca_topic_score_codex":0.0004684131,"about_ca_topic_score_gemma":0.00012434456,"teacher_disagreement_score":0.13531606,"about_ca_system_score_codex":0.0016412113,"about_ca_system_score_gemma":0.00028725923,"threshold_uncertainty_score":0.77537334},"labels":[],"label_agreement":null},{"id":"W1995368821","doi":"10.1016/j.ygyno.2011.07.022","title":"The case of a viable pregnancy post vaginal radical trachelectomy followed by combined chemo-radiation therapy","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Trachelectomy; Multidisciplinary team; Radiation therapy; Pregnancy; Obstetrics; Multidisciplinary approach; Gynecology; Surgery; Cancer; Internal medicine; Nursing; Cervical cancer","score_opus":0.02661301818674714,"score_gpt":0.30202960002161044,"score_spread":0.2754165818348633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995368821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883566,0.0028276958,0.00003892808,0.0014330676,0.00041710807,0.00086369563,0.000018259703,0.000057029596,0.005987629],"genre_scores_gemma":[0.9975449,0.0009745328,0.00022451988,0.00058906263,0.000046484867,0.00014463106,0.000030218875,0.000017052014,0.00042858365],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869984,0.00015175849,0.0003867786,0.0002666492,0.00010633049,0.000388634],"domain_scores_gemma":[0.998706,0.00050322467,0.00024003739,0.00028530325,0.00012828506,0.00013719243],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031528735,0.0001707482,0.0004689691,0.00005687111,0.0001655254,0.000007258722,0.00014713053,0.00028628603,0.0010073683],"category_scores_gemma":[0.0002620272,0.00010806073,0.00013496622,0.00019825579,0.00031028863,0.00005660309,0.000026767084,0.00030074373,0.000016345723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055306978,0.0053032683,0.12697586,0.00008170469,0.0006540065,0.003389109,0.0034811993,7.197753e-7,0.037659973,0.0018333677,0.03154289,0.7835472],"study_design_scores_gemma":[0.05222858,0.080313675,0.42590907,0.000092423375,0.00084198953,0.0046517197,0.0021339953,0.0005075022,0.07514458,0.0026580195,0.35446855,0.0010498744],"about_ca_topic_score_codex":0.000943378,"about_ca_topic_score_gemma":0.0003999813,"teacher_disagreement_score":0.78249735,"about_ca_system_score_codex":0.00025832665,"about_ca_system_score_gemma":0.00043025063,"threshold_uncertainty_score":0.9999058},"labels":[],"label_agreement":null},{"id":"W1995795701","doi":"10.1016/j.ygyno.2015.01.541","title":"Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Microsatellite instability; MSH2; Lynch syndrome; PMS2; Concordance; MSH6; Medicine; MLH1; DNA mismatch repair; Internal medicine; Oncology; Pathology; Cancer; Microsatellite; Biology; Genetics; Gene","score_opus":0.026770363076104718,"score_gpt":0.2935181497350529,"score_spread":0.2667477866589482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995795701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901619,0.0034464009,0.000015057227,0.00032346597,0.0010890409,0.0013755297,0.00003805652,0.000081367885,0.0034691875],"genre_scores_gemma":[0.99889815,0.000078310695,0.00031250165,0.00017579415,0.00007765984,0.0003173771,0.00001738508,0.000019422698,0.00010339488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974443,0.0005622481,0.0006598288,0.00053844927,0.00030023343,0.00049498037],"domain_scores_gemma":[0.9961081,0.0025821384,0.00032119907,0.00053793716,0.00030295103,0.00014767841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017902749,0.0002706877,0.00076192414,0.00014025357,0.00008688787,0.0000076483775,0.00027336652,0.00048050244,0.000096142256],"category_scores_gemma":[0.0078182705,0.00019761245,0.00018034385,0.00073712936,0.00078571937,0.00003271891,0.00017429028,0.00054481946,0.00000926862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016354407,0.0008990736,0.15537682,0.00010586423,0.00006138236,0.000040763407,0.0020821746,0.000042135267,0.8269477,0.0000057633283,0.000861179,0.011941714],"study_design_scores_gemma":[0.0068205385,0.0073357983,0.40663677,0.000022968645,0.0001412959,0.00009004653,0.002174294,0.000070779424,0.5677857,0.00041845243,0.008189815,0.00031354977],"about_ca_topic_score_codex":0.0017938385,"about_ca_topic_score_gemma":0.00087292906,"teacher_disagreement_score":0.25916198,"about_ca_system_score_codex":0.0030814991,"about_ca_system_score_gemma":0.0010991546,"threshold_uncertainty_score":0.9359765},"labels":[],"label_agreement":null},{"id":"W1996069915","doi":"10.1016/j.ygyno.2012.03.042","title":"Survivors of uterine cancer empowered by exercise and healthy diet (SUCCEED): A randomized controlled trial","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Medicine; Overweight; Randomized controlled trial; Weight loss; Body mass index; Calorie; Internal medicine; Clinical endpoint; Obesity; Endometrial cancer; Physical therapy; Cancer","score_opus":0.020560140196346385,"score_gpt":0.3604443415133525,"score_spread":0.3398842013170061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996069915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97679204,0.010177664,0.000022899481,0.0018955126,0.0026935507,0.005899117,0.000057363006,0.000051153136,0.002410677],"genre_scores_gemma":[0.98480946,0.010957176,0.00016129173,0.0008772519,0.00028889716,0.0017139813,0.000022410222,0.00002037514,0.0011491509],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99766177,0.00041723694,0.0009101369,0.00028432545,0.00018311795,0.0005434323],"domain_scores_gemma":[0.99709374,0.0017001673,0.0005588599,0.00021368405,0.000102990634,0.00033058465],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016795447,0.0002540374,0.0034896187,0.00012376785,0.00006622457,0.00000590892,0.00008506502,0.00034697156,0.0020647214],"category_scores_gemma":[0.000755529,0.00016610388,0.00032530975,0.00013449929,0.00039833458,0.00006803665,0.00007281398,0.0002442431,0.0000067049587],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9741344,0.0010098658,0.012910512,0.00009206304,0.00028207066,0.000007071174,0.00046656982,5.148513e-7,0.00034962897,0.000059192185,0.002971845,0.0077162883],"study_design_scores_gemma":[0.94301665,0.0052001425,0.0050923955,0.000022847438,0.0005196947,0.0000057910793,0.000163698,0.000031888627,0.000082069106,0.00004568278,0.04566015,0.00015897777],"about_ca_topic_score_codex":0.0021672351,"about_ca_topic_score_gemma":0.0005165542,"teacher_disagreement_score":0.042688303,"about_ca_system_score_codex":0.00023148497,"about_ca_system_score_gemma":0.00033199406,"threshold_uncertainty_score":0.99884754},"labels":[],"label_agreement":null},{"id":"W1996221416","doi":"10.1016/j.ygyno.2008.09.017","title":"Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Thailand Research Fund","keywords":"Medicine; Parametrial; Immunohistochemistry; Oncology; Stage (stratigraphy); Lymphovascular invasion; Proportional hazards model; Pathology; Lymph node; Metastasis; Internal medicine; Cancer; Cervical cancer; Biology; Cervical carcinoma","score_opus":0.018758467519007456,"score_gpt":0.2596452291082322,"score_spread":0.24088676158922473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996221416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941222,0.00022173312,0.000008921341,0.00048771265,0.00034715192,0.0006279768,0.000024088982,0.00003844864,0.0041217706],"genre_scores_gemma":[0.99750286,0.000034253837,0.00035874356,0.0013168006,0.000061650666,0.00009507335,0.00001528573,0.000025696756,0.00058963994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979948,0.00043682812,0.00045780273,0.00034717962,0.00029028178,0.00047314732],"domain_scores_gemma":[0.9982549,0.0006959493,0.00035562445,0.0004480666,0.00011771693,0.00012774195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044852836,0.00024506517,0.00078149815,0.00014127525,0.00012019094,0.0000021453895,0.00021566042,0.00035838835,0.0005743945],"category_scores_gemma":[0.00048509176,0.00014307881,0.00014120319,0.00039240488,0.00025859743,0.000044650693,0.0001368359,0.0003080383,0.00002338445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060728344,0.0015172174,0.9562248,0.00018740958,0.000039941602,0.002456758,0.0014250975,0.00008456401,0.033288576,0.00000644814,0.0031791888,0.0009827072],"study_design_scores_gemma":[0.0064405114,0.0015272043,0.89049673,0.000034877998,0.000093426825,0.00018717941,0.00014314501,0.00011987122,0.098553665,0.000014999582,0.0022253804,0.00016301658],"about_ca_topic_score_codex":0.00009864196,"about_ca_topic_score_gemma":0.00012673627,"teacher_disagreement_score":0.06572808,"about_ca_system_score_codex":0.00046063727,"about_ca_system_score_gemma":0.0005389556,"threshold_uncertainty_score":0.6289217},"labels":[],"label_agreement":null},{"id":"W1996485715","doi":"10.1016/j.ygyno.2008.11.012","title":"The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Hysterectomy; Stage (stratigraphy); Carcinoma; Adjuvant therapy; Disease; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.025400298664320982,"score_gpt":0.320065108939362,"score_spread":0.29466481027504104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996485715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408578,0.0027798295,0.0000029000264,0.0022722138,0.00019731474,0.0011567301,0.0000054768097,0.000009691513,0.052718025],"genre_scores_gemma":[0.99840057,0.00051907514,0.00032603956,0.00042282385,0.00007365371,0.00011994476,0.000006048808,0.0000037411448,0.00012810041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985516,0.00030690548,0.0004346602,0.00019095915,0.0002480081,0.00026788772],"domain_scores_gemma":[0.9979393,0.0015202262,0.00017596298,0.00026141686,0.00006134063,0.000041736774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006055238,0.00012372284,0.00047097236,0.00012957268,0.000064800406,0.000004451667,0.00026561308,0.000114447445,0.000107407],"category_scores_gemma":[0.00022680985,0.00005845536,0.00012665192,0.00079431885,0.00014893709,0.000023688357,0.000046715395,0.0001286235,0.000006400099],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005899313,0.006102045,0.22758916,0.00009415295,0.0007429998,0.00055357406,0.0021667483,0.000028565382,0.0027316613,0.04278525,0.00031450862,0.71099204],"study_design_scores_gemma":[0.013080453,0.010108661,0.9520918,0.0000167572,0.0002689797,0.000029493456,0.002688789,0.000014130327,0.0049847118,0.0072115413,0.00942829,0.00007636575],"about_ca_topic_score_codex":0.00007588266,"about_ca_topic_score_gemma":0.000048259622,"teacher_disagreement_score":0.7245027,"about_ca_system_score_codex":0.00024216696,"about_ca_system_score_gemma":0.00010746354,"threshold_uncertainty_score":0.23837404},"labels":[],"label_agreement":null},{"id":"W1996889220","doi":"10.1006/gyno.2000.5877","title":"Hepatocyte Growth Factor Promotes in Vitro Scattering and Morphogenesis of Human Cervical Carcinoma Cells","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Liver physiology and pathology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; University of British Columbia","funders":"University of British Columbia","keywords":"Hepatocyte growth factor; Cell culture; Morphogenesis; C-Met; Biology; Cell biology; Motility; Cell growth; Molecular biology; Kinase; Cancer research; Receptor; Biochemistry","score_opus":0.02481291027551569,"score_gpt":0.27863733420198056,"score_spread":0.25382442392646487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996889220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966907,0.00015965376,0.0000012303332,0.0004593277,0.000107019776,0.00043757475,0.000019865387,0.000034598233,0.0020900606],"genre_scores_gemma":[0.9982698,0.00007728823,0.00060808193,0.00073156104,0.00006486502,0.000052037285,0.000022081396,0.000013714848,0.00016059342],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984659,0.00028525986,0.00039018563,0.00040416486,0.0000680993,0.0003863675],"domain_scores_gemma":[0.9991914,0.00035020043,0.000099021825,0.00020565184,0.00004531663,0.00010838452],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001839011,0.0001871523,0.00075534714,0.00014807594,0.00006510989,0.0000023141658,0.0001219781,0.00044836826,0.001299675],"category_scores_gemma":[0.000044685396,0.00015770835,0.000074804215,0.00014178584,0.00042548947,0.000042131054,0.00008485024,0.00027878597,0.00004919167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047110606,0.0010018849,0.21033064,0.000120008764,0.00003056462,0.0004746494,0.00046409224,5.4034257e-7,0.78046846,0.000037097707,0.000027191456,0.0065737776],"study_design_scores_gemma":[0.003496613,0.0026109607,0.80715096,0.00000963063,0.000055294167,0.00017163804,0.000050665454,0.000038304745,0.1856741,0.00044694144,0.00015989655,0.00013498249],"about_ca_topic_score_codex":0.00017291264,"about_ca_topic_score_gemma":0.000053812044,"teacher_disagreement_score":0.59682035,"about_ca_system_score_codex":0.00010574625,"about_ca_system_score_gemma":0.00009874073,"threshold_uncertainty_score":0.9996133},"labels":[],"label_agreement":null},{"id":"W1997180190","doi":"10.1016/j.ygyno.2013.07.107","title":"ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research and Materiel Command; Cancer Council Western Australia; Cancer Council Queensland; Cancer Council Victoria; Cancer Council South Australia; Canadian Institutes of Health Research; University of New South Wales; Cancer Council Tasmania; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Council NSW; National Health and Medical Research Council; Cancer Research UK; Kræftens Bekæmpelse; Génome Québec; McGill University; Breast Cancer Research Foundation; U.S. Department of Defense; National Cancer Institute; Entertainment Industry Foundation","keywords":"Ovarian cancer; Medicine; Oncology; Genome-wide association study; Internal medicine; Cancer; Single-nucleotide polymorphism; Genetics; Genotype; Gene; Biology","score_opus":0.017767989030938736,"score_gpt":0.2954621825006342,"score_spread":0.2776941934696955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997180190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9243795,0.01616196,0.000089879904,0.056245644,0.0007102595,0.0016187622,0.00014330284,0.000057911213,0.00059276016],"genre_scores_gemma":[0.9813405,0.011705356,0.0004212619,0.003968836,0.00032165085,0.0010940192,0.00006279724,0.000023699795,0.0010618579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976889,0.00044305675,0.0004579915,0.00061727664,0.00029178042,0.0005009807],"domain_scores_gemma":[0.9973861,0.0013869816,0.00046813156,0.00030330205,0.0002638715,0.00019158676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000601924,0.00030152773,0.0010176258,0.00009332662,0.00045004248,0.00007181544,0.00016336786,0.00042470594,0.001677625],"category_scores_gemma":[0.00010855864,0.00015561227,0.000120637626,0.0004005305,0.00061061286,0.00008615177,0.00011093552,0.00043481382,0.0000059424715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008287635,0.00016256,0.95402455,0.000051746236,0.003732293,0.000060790015,0.002983843,0.000039816296,0.008139673,0.0010471939,0.000812938,0.028115815],"study_design_scores_gemma":[0.0050518387,0.0001877465,0.9723297,0.00003409909,0.003134143,0.0000055625765,0.00091002026,0.00053087017,0.00009482833,0.0009244012,0.016587643,0.0002091739],"about_ca_topic_score_codex":0.017990708,"about_ca_topic_score_gemma":0.028466454,"teacher_disagreement_score":0.056961,"about_ca_system_score_codex":0.00038922054,"about_ca_system_score_gemma":0.0003282366,"threshold_uncertainty_score":0.999235},"labels":[],"label_agreement":null},{"id":"W1997326814","doi":"10.1016/j.ygyno.2007.02.008","title":"Sentinel lymph nodes in early stage cervical cancer","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Sentinel lymph node; Lymphadenectomy; Lymph; Cervical cancer; Stage (stratigraphy); Lymph node; Surgery; Biopsy; Sentinel node; Radiology; Cancer; Breast cancer; Internal medicine; Pathology","score_opus":0.0400317143669549,"score_gpt":0.36199256147718384,"score_spread":0.32196084711022893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997326814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455137,0.0005050277,0.000036138685,0.0020031459,0.00058239454,0.00033660274,0.000009766188,0.00008117459,0.050931998],"genre_scores_gemma":[0.9916805,0.00022137162,0.0005048847,0.003957285,0.0003007064,0.000095780524,0.000015165545,0.00001731797,0.003206968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981691,0.00008717212,0.00045970525,0.00039897862,0.00021738534,0.0006676506],"domain_scores_gemma":[0.9986041,0.0007567883,0.00011284412,0.00020184251,0.000078945915,0.00024544378],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055662997,0.00019413215,0.0006065897,0.00025525998,0.0000531573,0.000007849292,0.00012686153,0.00037545082,0.0034242913],"category_scores_gemma":[0.00033425516,0.00014634551,0.00011756365,0.0006429075,0.00012065787,0.000049106886,0.00009113978,0.00028533587,0.00020162617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009182161,0.0009312641,0.9489726,0.00004075625,0.00006644146,0.001288729,0.00010883779,0.000005926648,0.0006775873,0.00037166104,0.00008054368,0.04653744],"study_design_scores_gemma":[0.008419931,0.00051935576,0.9776115,0.000015712516,0.00007052221,0.000022995058,0.00013900334,0.000018042983,0.00046889213,0.00026014517,0.012314263,0.00013966294],"about_ca_topic_score_codex":0.0016326384,"about_ca_topic_score_gemma":0.0010704529,"teacher_disagreement_score":0.04772503,"about_ca_system_score_codex":0.0012031136,"about_ca_system_score_gemma":0.0002918234,"threshold_uncertainty_score":0.9974867},"labels":[],"label_agreement":null},{"id":"W1997527462","doi":"10.1016/j.ygyno.2003.10.004","title":"Presence of multiple human papillomavirus types in cervical samples from HIV-infected women","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Dysplasia; HPV infection; Polymerase chain reaction; Population; Biopsy; Concomitant; Human papillomavirus; Viral load; Cervical cancer; Virology; Human immunodeficiency virus (HIV); Immunology; Internal medicine; Gene; Cancer; Biology; Genetics","score_opus":0.055133183321796904,"score_gpt":0.3579206270763462,"score_spread":0.3027874437545493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997527462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531781,0.00031517123,0.00002057857,0.00034520339,0.00012956174,0.0004623228,0.000032255208,0.00004571977,0.04547107],"genre_scores_gemma":[0.99809337,0.00010222221,0.00076943834,0.00041036907,0.00006441617,0.00014465101,0.000042829623,0.000013913361,0.0003588176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979886,0.0003975482,0.00043456568,0.00038489926,0.00023197323,0.00056242006],"domain_scores_gemma":[0.9971082,0.0021270816,0.0000917498,0.00031706857,0.0001465257,0.00020933026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004827952,0.00015192838,0.0007023944,0.00015258814,0.000056685207,0.0000061057967,0.00017991317,0.00033303874,0.025972536],"category_scores_gemma":[0.0029409758,0.00012323733,0.000072633986,0.00035355968,0.00027323427,0.000038693175,0.00010928586,0.00043244063,0.00011050902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064413087,0.0014551741,0.95950073,0.00009215307,0.00007301151,0.00019237006,0.0007707029,0.00001984098,0.013864371,0.001603075,0.0007593535,0.0210251],"study_design_scores_gemma":[0.004291505,0.0019168899,0.9559714,0.000008154101,0.000021602407,0.000006955791,0.00038854187,0.000058852485,0.0025005513,0.0042189653,0.030491082,0.00012547305],"about_ca_topic_score_codex":0.00081042753,"about_ca_topic_score_gemma":0.0030055486,"teacher_disagreement_score":0.045112252,"about_ca_system_score_codex":0.0005566862,"about_ca_system_score_gemma":0.000378617,"threshold_uncertainty_score":0.9749178},"labels":[],"label_agreement":null},{"id":"W1997743035","doi":"10.1016/j.ygyno.2004.12.055","title":"Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"XIAP; Cisplatin; Ovarian cancer; Inhibitor of apoptosis; Cancer research; Apoptosis; Cancer cell; Downregulation and upregulation; Medicine; Cancer; Oncology; Chemistry; Programmed cell death; Caspase; Internal medicine; Chemotherapy; Biochemistry; Gene","score_opus":0.008664188205546737,"score_gpt":0.26324503352163514,"score_spread":0.2545808453160884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997743035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977126,0.00032614238,0.00014071254,0.00032872934,0.000104341496,0.0005514334,0.000015406209,0.0000057003485,0.00081494],"genre_scores_gemma":[0.99681383,0.0001224522,0.0020567449,0.000061570834,0.000089944166,0.00011999136,0.000080833066,0.000012496734,0.0006421046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986801,0.00012480805,0.0005440298,0.00032377432,0.00009487501,0.00023236955],"domain_scores_gemma":[0.9993425,0.000024092908,0.00032487477,0.00020569998,0.00006802771,0.00003480628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601805,0.00013791578,0.00033397405,0.00009992142,0.000026119318,0.0000026752875,0.00013868665,0.0004734361,0.00013880448],"category_scores_gemma":[0.000043434993,0.00013357167,0.00006155932,0.00016757891,0.00010218174,0.000006491423,0.000055727778,0.000104742605,0.0000010993898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012580783,0.00036185066,0.0010833717,0.000039884624,0.000011078079,6.060045e-7,0.00006549177,0.00076204323,0.9880467,0.00033468765,0.00043130157,0.008737173],"study_design_scores_gemma":[0.0016163796,0.0005476045,0.026081081,0.00002516734,0.000009477767,4.6086652e-7,0.00004252579,0.00020081067,0.9655754,0.00038012885,0.0053838547,0.00013712449],"about_ca_topic_score_codex":0.00014916815,"about_ca_topic_score_gemma":0.0021858767,"teacher_disagreement_score":0.02499771,"about_ca_system_score_codex":0.00015176518,"about_ca_system_score_gemma":0.00011434575,"threshold_uncertainty_score":0.5446894},"labels":[],"label_agreement":null},{"id":"W1998198982","doi":"10.1016/j.ygyno.2006.10.006","title":"Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel—ANZGOG 02-01","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada; Pfizer Canada; Pfizer","keywords":"Medicine; Docetaxel; Paclitaxel; Neutropenia; Internal medicine; Chemotherapy; Ovarian cancer; Oncology; Toxicity; Cancer; Surgery","score_opus":0.022469635385142107,"score_gpt":0.3245821224454167,"score_spread":0.30211248706027455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998198982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722339,0.00047892774,0.000088488785,0.007811774,0.0009520365,0.0069400063,0.00032888286,0.00007939315,0.011086599],"genre_scores_gemma":[0.98821443,0.00031109483,0.0037407896,0.00078931364,0.0005238092,0.0032469688,0.0003554209,0.00005249082,0.002765652],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971815,0.00018754324,0.0008826225,0.0007316927,0.00030967387,0.00070702226],"domain_scores_gemma":[0.99729776,0.00081004295,0.0007501473,0.0005137111,0.00042918918,0.0001991442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043435622,0.00039695864,0.001406,0.00016204441,0.00021925921,0.000013069196,0.00017079488,0.0004615452,0.0010539208],"category_scores_gemma":[0.00037287382,0.00028183742,0.00027337283,0.00022168575,0.00024521534,0.00009088618,0.00006510998,0.00024155006,0.000009303396],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26309028,0.1218746,0.20128068,0.0005096028,0.0025127765,0.00029166986,0.0010474522,0.00011544091,0.00024009062,0.002257216,0.1286844,0.2780958],"study_design_scores_gemma":[0.5480865,0.17373274,0.13731442,0.00016009662,0.00173371,0.000008599528,0.00010206789,0.000066233966,0.00043785555,0.0008358319,0.13711199,0.00040991823],"about_ca_topic_score_codex":0.00061610225,"about_ca_topic_score_gemma":0.0012733288,"teacher_disagreement_score":0.28499624,"about_ca_system_score_codex":0.0010465388,"about_ca_system_score_gemma":0.0009583784,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W1998617484","doi":"10.1006/gyno.2001.6199","title":"Quality of Life in Ovarian Cancer Patients Receiving Chemotherapy","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Carboplatin; Quality of life (healthcare); Chemotherapy; Nausea; Ovarian cancer; Cancer; Disease; Internal medicine; Cisplatin","score_opus":0.0471843192948267,"score_gpt":0.365827130510649,"score_spread":0.31864281121582233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998617484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717479,0.00036127042,0.000010479591,0.007865778,0.0004234286,0.0005652395,0.000008703889,0.000022605085,0.018994626],"genre_scores_gemma":[0.9935768,0.0017092032,0.0006702055,0.0034984362,0.000089744026,0.00020484836,0.000014473112,0.000012836562,0.00022343053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985073,0.00016810106,0.0005599401,0.0003125766,0.00014557508,0.0003064683],"domain_scores_gemma":[0.99884146,0.00044239956,0.0002653591,0.00022347913,0.000106579246,0.00012069863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041101477,0.00014184025,0.000715758,0.0001086036,0.000029276525,0.000003083415,0.00008478023,0.00022820459,0.0024854562],"category_scores_gemma":[0.00044753178,0.00011425308,0.00009060708,0.00027856408,0.000076920514,0.00003786478,0.000032381402,0.00015732617,0.00001946812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041591184,0.0025356545,0.9027545,0.000029937557,0.00008760708,0.000029063774,0.0002174632,0.000011017386,0.00015394948,0.00017185831,0.00089486927,0.09269819],"study_design_scores_gemma":[0.00958213,0.0014788976,0.97405565,0.00002932458,0.000027679424,0.000002101657,0.00006785454,0.000009060841,0.00012700404,0.00022942471,0.014292663,0.00009820552],"about_ca_topic_score_codex":0.0012576923,"about_ca_topic_score_gemma":0.0029720843,"teacher_disagreement_score":0.09259999,"about_ca_system_score_codex":0.0008161104,"about_ca_system_score_gemma":0.00045308654,"threshold_uncertainty_score":0.9984264},"labels":[],"label_agreement":null},{"id":"W1999117615","doi":"10.1016/j.ygyno.2009.10.049","title":"Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: Is it time to change the gold standard?","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sentinel lymph node; Lymphadenectomy; Cervical cancer; Lymph node; Biopsy; Stage (stratigraphy); Lymph; Radiology; Cohort; Surgery; Cancer; Breast cancer; Internal medicine; Pathology","score_opus":0.039959790693316344,"score_gpt":0.33819668448639134,"score_spread":0.298236893793075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999117615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8479547,0.0009482898,0.000005055115,0.12756488,0.00038040424,0.0012320211,0.000121095676,0.00010460318,0.021688962],"genre_scores_gemma":[0.910874,0.00045372033,0.00025114955,0.07898616,0.0005645356,0.00052185345,0.000028486116,0.000027960103,0.008292133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971426,0.00023395954,0.00056544546,0.0006933577,0.00044782824,0.0009168073],"domain_scores_gemma":[0.99828213,0.0005586267,0.00016894414,0.00047325372,0.0001419397,0.00037509808],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00048010415,0.00037259408,0.0010260157,0.0003030275,0.00010894021,0.000032170417,0.00037748067,0.00042423667,0.010166605],"category_scores_gemma":[0.00029018102,0.00024233127,0.00020237494,0.0012672887,0.00011504545,0.000087927976,0.00015262848,0.00029169238,0.0014198781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077090235,0.0028970456,0.7117911,0.00013061392,0.000396634,0.0026890857,0.002767997,0.000025898695,0.001328515,0.00021340165,0.018924939,0.25112572],"study_design_scores_gemma":[0.009767464,0.002008703,0.88648885,0.000046592897,0.00016275918,0.000051769664,0.00011909645,0.000063141124,0.00019575196,0.00013277306,0.10070045,0.0002626165],"about_ca_topic_score_codex":0.0011622781,"about_ca_topic_score_gemma":0.00016292301,"teacher_disagreement_score":0.2508631,"about_ca_system_score_codex":0.0020248098,"about_ca_system_score_gemma":0.00045070733,"threshold_uncertainty_score":0.99935764},"labels":[],"label_agreement":null},{"id":"W1999792213","doi":"10.1016/j.ygyno.2011.10.036","title":"Combined methotrexate–dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Regimen; Methotrexate; Gestational trophoblastic neoplasia; Chemotherapy; Mucositis; Surgery; Adverse effect; Internal medicine","score_opus":0.03811469695914364,"score_gpt":0.3230082693379978,"score_spread":0.28489357237885415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999792213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98599195,0.00012313944,0.0028806764,0.00028878148,0.0007946508,0.0028474429,0.00012022401,0.0001843495,0.006768752],"genre_scores_gemma":[0.9572399,0.00011312814,0.039231975,0.0009021567,0.0001797215,0.0018461432,0.00015468049,0.00004584183,0.00028642613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975873,0.00049244444,0.00047344354,0.00064907357,0.00023899645,0.0005587386],"domain_scores_gemma":[0.99391377,0.004567098,0.0003520637,0.00028780932,0.00056882354,0.00031045737],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000497629,0.00035571997,0.00077167875,0.00020085114,0.00028578786,0.000011199784,0.00016563114,0.00024947472,0.0012323413],"category_scores_gemma":[0.0027479292,0.00028377297,0.00025691302,0.00021974655,0.0003545385,0.00011526081,0.00004975195,0.00030323083,0.00015319066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10007904,0.035649143,0.48388952,0.00079951313,0.00789394,0.0021016425,0.016406663,0.0012021333,0.010551811,0.02886665,0.01203181,0.30052814],"study_design_scores_gemma":[0.010975874,0.027643956,0.94749194,0.000016099732,0.00048965117,0.000051884133,0.00088365615,0.0010406157,0.00067737943,0.008590156,0.0018453731,0.00029343308],"about_ca_topic_score_codex":0.00003518554,"about_ca_topic_score_gemma":0.000036511476,"teacher_disagreement_score":0.4636024,"about_ca_system_score_codex":0.00037165263,"about_ca_system_score_gemma":0.0005136099,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W2000418523","doi":"10.1016/j.ygyno.2012.06.027","title":"FDG-PET-based prognostic nomograms for locally advanced cervical cancer","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Nomogram; Cervical cancer; Concordance; Stage (stratigraphy); Lymph node; Radiation therapy; Nuclear medicine; Radiology; Cervix; Oncology; Cancer; Internal medicine","score_opus":0.04061050754307717,"score_gpt":0.36085581924177723,"score_spread":0.3202453116987001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000418523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576908,0.004265197,0.0024625899,0.011570182,0.0042246883,0.0054251235,0.0001122094,0.00043131897,0.013817909],"genre_scores_gemma":[0.97770405,0.00008217059,0.01068735,0.007029819,0.0006833535,0.0030764453,0.00011835617,0.00003495012,0.00058349414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99789506,0.00010571614,0.00041893276,0.00040579247,0.00021297662,0.00096154393],"domain_scores_gemma":[0.997128,0.001757844,0.00016379668,0.000254154,0.00019977952,0.0004963971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033636167,0.00027681683,0.0007542298,0.00012178218,0.00012389982,0.000008806654,0.00015106515,0.00027511668,0.0022079484],"category_scores_gemma":[0.0010640994,0.00019992438,0.00024771164,0.00040953077,0.00015625346,0.00007697138,0.000055100038,0.0002504779,0.00014744553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045123175,0.005811654,0.37729156,0.00035015625,0.00036077198,0.00016473114,0.000079952486,0.00008431856,0.0011678821,0.00081198144,0.0019270842,0.6074376],"study_design_scores_gemma":[0.039334938,0.022784378,0.5441186,0.000106651816,0.0014100119,0.000120782635,0.0001867727,0.0005824122,0.0022639919,0.00081422395,0.3875872,0.00069006305],"about_ca_topic_score_codex":0.000061669496,"about_ca_topic_score_gemma":0.0001904974,"teacher_disagreement_score":0.6067475,"about_ca_system_score_codex":0.00087347196,"about_ca_system_score_gemma":0.00057036534,"threshold_uncertainty_score":0.9987042},"labels":[],"label_agreement":null},{"id":"W2000820980","doi":"10.1006/gyno.2000.6095","title":"A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Fallopian tube; Medicine; Ovarian cancer; Fallopian tube cancer; Family history; Breast cancer; Lynch syndrome; Gynecology; Cancer; Epidemiology; Population; Obstetrics; Relative risk; Cancer registry; Internal medicine; Oncology; Confidence interval; Colorectal cancer; DNA mismatch repair","score_opus":0.04815611408765114,"score_gpt":0.3317254101505687,"score_spread":0.2835692960629176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000820980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872985,0.00034720186,0.000005245105,0.0028290309,0.00041436302,0.0011856668,0.0000034693842,0.000015823063,0.007900687],"genre_scores_gemma":[0.9980431,0.00013662619,0.00046313545,0.0008087594,0.00007004679,0.00016479044,0.000001424078,0.000007953176,0.00030415723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982738,0.00042569585,0.00056308636,0.0003091067,0.00015418207,0.00027414365],"domain_scores_gemma":[0.9982062,0.00084082555,0.00027573516,0.0004948843,0.00009832333,0.00008404585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003487166,0.00015701336,0.000834991,0.000055867,0.000052875985,0.0000013006838,0.00019441043,0.0002011155,0.00088209123],"category_scores_gemma":[0.00055008265,0.0000831303,0.00017533333,0.0002534069,0.0002061434,0.0000110402825,0.0001296896,0.00017325224,0.000012958401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014031307,0.0046434957,0.98078996,0.000016762275,0.00014554839,0.000238744,0.00028843983,0.000058523987,0.00009764438,0.00032445675,0.0006845193,0.012571579],"study_design_scores_gemma":[0.0036650081,0.013587782,0.97468376,0.000010929444,0.00029605068,0.00012233213,0.00062404934,0.000032758002,0.0000901757,0.00030964744,0.00651273,0.00006475926],"about_ca_topic_score_codex":0.0002959139,"about_ca_topic_score_gemma":0.00062001264,"teacher_disagreement_score":0.012506819,"about_ca_system_score_codex":0.00023763628,"about_ca_system_score_gemma":0.00023459776,"threshold_uncertainty_score":0.96582806},"labels":[],"label_agreement":null},{"id":"W2000845191","doi":"10.1016/j.ygyno.2010.12.362","title":"A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Integrin; Antibody; Epithelial ovarian cancer; Oncology; Internal medicine; Cancer research; Cancer; Immunology; Receptor","score_opus":0.03588117731937461,"score_gpt":0.34868758023954577,"score_spread":0.31280640292017114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000845191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299914,0.000054519453,0.000012542756,0.00028651155,0.00028293295,0.0034371393,0.000033324988,0.000042515003,0.0028513854],"genre_scores_gemma":[0.99713784,0.00004105123,0.0013739916,0.00054515625,0.000040005587,0.0002670778,0.00002195278,0.000045817716,0.0005271153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691445,0.0005197137,0.0007267921,0.0006466428,0.00056508236,0.0006272996],"domain_scores_gemma":[0.9981557,0.00034741408,0.00040433198,0.0006240478,0.00031627095,0.00015221199],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004265526,0.00033667884,0.0010118058,0.0002610217,0.00016683053,0.0000077356935,0.00045817596,0.00029051682,0.0020062733],"category_scores_gemma":[0.00042655406,0.00018799909,0.00008625646,0.00065769075,0.00041496046,0.000077230434,0.00031977022,0.0006959327,0.000009559491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08260725,0.14312029,0.43184796,0.00011249567,0.00038761715,0.0010265365,0.010031404,0.000028657727,0.2158188,0.00003130733,0.000096427335,0.11489125],"study_design_scores_gemma":[0.057037372,0.16845706,0.764923,0.000076141376,0.00010051231,0.000014351035,0.0018333171,0.000044819415,0.0059995926,0.0000329209,0.0012352762,0.00024567827],"about_ca_topic_score_codex":0.00091859885,"about_ca_topic_score_gemma":0.00266629,"teacher_disagreement_score":0.333075,"about_ca_system_score_codex":0.0008842988,"about_ca_system_score_gemma":0.0011921752,"threshold_uncertainty_score":0.998906},"labels":[],"label_agreement":null},{"id":"W2001150727","doi":"10.1016/j.ygyno.2011.07.098","title":"Temporal trends in the relative survival among patients diagnosed with ovarian cancer in Canada 1992–2005: A population-based study","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Relative survival; Medicine; Serous fluid; Ovarian cancer; Population; Relative risk; Cancer; Internal medicine; Survival analysis; Survival rate; Oncology; Demography; Cancer registry; Confidence interval","score_opus":0.03347564626544584,"score_gpt":0.2909303209861102,"score_spread":0.25745467472066436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001150727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296474,0.000035526013,0.0000017059331,0.0013885656,0.00030271552,0.0014145226,0.00004169606,0.00001579826,0.0038347382],"genre_scores_gemma":[0.9975013,0.000006188789,0.00015778052,0.0007767895,0.000034352794,0.0013583452,0.00010456465,0.00001743867,0.000043235937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977757,0.00056002825,0.00044928718,0.0004533221,0.00029948226,0.00046219653],"domain_scores_gemma":[0.99859166,0.00071186194,0.00023232718,0.00030576278,0.000051816183,0.00010659523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040268787,0.00024395804,0.0006012522,0.00022145605,0.00007432033,0.0000064840783,0.00015091005,0.00013020451,0.0012537388],"category_scores_gemma":[0.00009550193,0.00014747582,0.000047534006,0.00058095413,0.00005273047,0.00007101955,0.000025114465,0.00033858287,0.0000026037847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041941024,0.004035097,0.9827827,0.000005153646,0.000104982995,0.0015576635,0.001958426,0.00009994863,4.6286694e-8,0.000046146804,0.00020194732,0.008788483],"study_design_scores_gemma":[0.011956415,0.0038175927,0.98186904,0.00002744715,0.000154194,0.0000011798483,0.0015796976,0.000058138754,9.006951e-7,0.00003335795,0.00034097402,0.00016106277],"about_ca_topic_score_codex":0.9734242,"about_ca_topic_score_gemma":0.99941057,"teacher_disagreement_score":0.025986338,"about_ca_system_score_codex":0.003980164,"about_ca_system_score_gemma":0.001597143,"threshold_uncertainty_score":0.99984336},"labels":[],"label_agreement":null},{"id":"W2001459594","doi":"10.1016/j.ygyno.2010.01.037","title":"What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?","year":2010,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Virology; Population; Demography; Typing; Family medicine; Environmental health; Genetics","score_opus":0.06829239825551464,"score_gpt":0.41527921457756534,"score_spread":0.3469868163220507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001459594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04079961,0.9505492,1.0106808e-7,0.004167732,0.00014533827,0.0023624306,0.000011535718,0.0000073954816,0.0019566633],"genre_scores_gemma":[0.036461107,0.9611307,0.000010371564,0.0018302685,0.000052366817,0.0003033331,0.0001472284,0.000012786531,0.000051876803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730366,0.0013142352,0.00055709324,0.00028711572,0.000187488,0.00035042272],"domain_scores_gemma":[0.99455047,0.0047701346,0.0001976368,0.00037158534,0.000075402575,0.00003474764],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021157062,0.00018953682,0.0010178034,0.00040451152,0.000046864614,0.000041187497,0.00047201375,0.000536225,0.0011417802],"category_scores_gemma":[0.00059519906,0.00008622172,0.000101712314,0.001274526,0.00014629333,0.0000622416,0.00014821297,0.0017625466,0.000014663793],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000630307,0.00017162968,0.002574614,0.00057700864,0.000020520498,0.000058060145,0.0022622496,0.0000031311845,1.7220094e-7,0.00009269833,0.00014078233,0.9940361],"study_design_scores_gemma":[0.00078210654,0.00045638264,0.248237,0.00022953672,0.000105059946,0.000042596334,0.0056579006,0.00016744471,1.0931335e-7,0.0014806943,0.7427515,0.00008968283],"about_ca_topic_score_codex":0.0013745988,"about_ca_topic_score_gemma":0.019902652,"teacher_disagreement_score":0.99394643,"about_ca_system_score_codex":0.00025595218,"about_ca_system_score_gemma":0.00031682185,"threshold_uncertainty_score":0.9997713},"labels":[],"label_agreement":null},{"id":"W2002419036","doi":"10.1016/j.ygyno.2011.01.020","title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":419,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Ovarian cancer; Medicine; Multiplex ligation-dependent probe amplification; Serous fluid; Germline mutation; Oncology; Breast cancer; Cancer; Mutation; Population; Internal medicine; BRCA mutation; Ovarian carcinoma; Gynecology; Genetics; Gene; Biology; Exon","score_opus":0.016518364304312114,"score_gpt":0.2504430953058411,"score_spread":0.23392473100152897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002419036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425316,0.00027369187,0.0001972183,0.00008352459,0.0001947683,0.0004026485,0.00006795465,0.000017330567,0.0045097233],"genre_scores_gemma":[0.9941654,0.00013288774,0.0048592384,0.00028061858,0.000040631938,0.00022307479,0.00014320348,0.000018754552,0.00013614469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889195,0.00012278938,0.00025829716,0.00037937,0.00008923668,0.0002583285],"domain_scores_gemma":[0.9989645,0.000091469774,0.0002507671,0.00023929382,0.0003809965,0.000072956434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010872545,0.00016271239,0.00023797076,0.000080209524,0.00009965198,0.0000060251227,0.00017549813,0.00027825087,0.00031294813],"category_scores_gemma":[0.00027250292,0.00013820374,0.00003451744,0.00019101803,0.00059634517,0.000009425237,0.00008244749,0.000109903456,0.0000032094206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020702436,0.00039825734,0.9629151,0.000033654425,0.00037777246,0.000011647535,0.001794716,0.00010353802,0.02482971,0.0004016154,0.0009866811,0.007940254],"study_design_scores_gemma":[0.0014738649,0.002074282,0.95622325,0.000008799892,0.0000932123,0.000006514712,0.0003699381,0.000007162964,0.037416086,0.00054102385,0.0015811342,0.00020475972],"about_ca_topic_score_codex":0.0003467965,"about_ca_topic_score_gemma":0.0055629625,"teacher_disagreement_score":0.012586375,"about_ca_system_score_codex":0.00014153193,"about_ca_system_score_gemma":0.0007404669,"threshold_uncertainty_score":0.56357855},"labels":[],"label_agreement":null},{"id":"W2002957504","doi":"10.1016/j.ygyno.2005.02.018","title":"Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Banting Research Foundation","keywords":"Medicine; Apoptosis; Ovarian carcinoma; Cancer research; Cell growth; Andrology; Internal medicine; Oncology; Cell biology; Ovarian cancer; Biology; Cancer; Genetics","score_opus":0.02578391586890911,"score_gpt":0.31722333449296997,"score_spread":0.29143941862406086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002957504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983097,0.00014968852,0.00036517894,0.00011248249,0.00006850677,0.0007257044,0.000004333395,0.00000448724,0.00025995565],"genre_scores_gemma":[0.9982198,0.000065144006,0.0014433376,0.00005140488,0.000061298124,0.000039538438,0.00004261791,0.0000095583355,0.00006729784],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876916,0.0003355066,0.00040442453,0.0002609386,0.000052804633,0.00017716007],"domain_scores_gemma":[0.99935156,0.00010383843,0.0002989232,0.00015937949,0.000056142537,0.000030136613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007043189,0.00012599271,0.00025598065,0.00010038548,0.000057905163,0.0000073438446,0.00008824652,0.00025317917,0.000015519856],"category_scores_gemma":[0.000074694384,0.00009621477,0.000035755427,0.00011635592,0.00007994289,0.000009392672,0.00006355891,0.00008826866,4.9905054e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010924292,0.0010591095,0.00876944,0.000041502004,0.0000067352444,9.616723e-7,0.00033398336,0.00067727343,0.9786476,0.000057752597,0.000012819148,0.010283571],"study_design_scores_gemma":[0.00446114,0.0015657977,0.014189632,0.000010289816,0.000024001116,0.0000023471716,0.00020651866,0.004508211,0.97453725,0.00017295805,0.00021642301,0.000105417974],"about_ca_topic_score_codex":0.00009703571,"about_ca_topic_score_gemma":0.0008784372,"teacher_disagreement_score":0.010178153,"about_ca_system_score_codex":0.000042908734,"about_ca_system_score_gemma":0.00007741625,"threshold_uncertainty_score":0.39235246},"labels":[],"label_agreement":null},{"id":"W2003225436","doi":"10.1016/j.ygyno.2014.06.014","title":"Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Medicine; Endometrial cancer; Internal medicine; Biopsy; Immunohistochemistry; Insulin; Insulin-like growth factor; Cancer; Endocrinology; Urology; Growth factor; Gastroenterology; Receptor","score_opus":0.007453078255269397,"score_gpt":0.2514458795834945,"score_spread":0.24399280132822512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003225436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934304,0.005154465,0.000045672798,0.00001189658,0.0002786492,0.00048648228,0.000039143768,0.0000049598116,0.0005483699],"genre_scores_gemma":[0.99686706,0.0019514455,0.00060364086,0.00020477,0.00009850913,0.00015467258,0.00008723573,0.000013124738,0.000019540757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854314,0.0002877863,0.00043466102,0.00030084865,0.00014421994,0.00028933582],"domain_scores_gemma":[0.998987,0.00016378997,0.00036399617,0.0002203264,0.0001794752,0.00008540691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052992447,0.00015813143,0.00054373866,0.0001561786,0.000024712393,0.00000357584,0.00017108691,0.00021555419,0.00018321924],"category_scores_gemma":[0.0012638019,0.00012266282,0.00006650945,0.00023795236,0.00018537206,0.000007166763,0.00005824504,0.00008387102,0.0000012757414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015057275,0.0011260448,0.74883825,0.000119236516,0.0001292154,0.0000022804702,0.000067347166,0.00035926097,0.014784489,0.00013905443,0.00038376593,0.23254535],"study_design_scores_gemma":[0.016451279,0.008299883,0.7098852,0.000045110733,0.00017796899,0.0000014844845,0.000112418216,0.00010475487,0.21171696,0.00024307196,0.05249875,0.00046311456],"about_ca_topic_score_codex":0.00006262778,"about_ca_topic_score_gemma":0.00040967384,"teacher_disagreement_score":0.23208223,"about_ca_system_score_codex":0.00005297563,"about_ca_system_score_gemma":0.00038242983,"threshold_uncertainty_score":0.5002045},"labels":[],"label_agreement":null},{"id":"W2003305754","doi":"10.1016/j.ygyno.2008.02.009","title":"Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: A trial of the Chicago, PMH, and California Phase II consortia","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Fallopian tube cancer; Gastrointestinal perforation; Ovarian cancer; Internal medicine; Tolerability; Clinical endpoint; Nausea; Erlotinib; Perforation; Surgery; Vomiting; Gastroenterology; Phases of clinical research; Cancer; Chemotherapy; Adverse effect; Clinical trial; Peritonitis; Epidermal growth factor receptor","score_opus":0.02357263650907375,"score_gpt":0.30406097685637823,"score_spread":0.28048834034730447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003305754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138325,0.0010436401,0.000005961576,0.0023278384,0.00029223226,0.0041742916,0.00049234426,0.0000135682485,0.00026684313],"genre_scores_gemma":[0.9960609,0.0021445765,0.00084809173,0.00030029292,0.00006937243,0.00046141175,0.00005934304,0.000015399553,0.000040599472],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9985469,0.000115673196,0.00051157596,0.00040309076,0.00016073238,0.00026200846],"domain_scores_gemma":[0.9984857,0.0006376466,0.00036227616,0.00022895748,0.00014530543,0.00014013759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018216838,0.0002148505,0.0008857982,0.00005606836,0.0002455541,0.000003661951,0.000069920025,0.00018912848,0.00006413279],"category_scores_gemma":[0.00023258265,0.00012890135,0.000065671265,0.00010756612,0.0006834026,0.000029107781,0.00011702078,0.00015542253,1.9395306e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35422257,0.018742444,0.32869053,0.0007765744,0.0015287577,0.00006436816,0.0029792495,0.000012957415,0.00020061145,0.0005876461,0.0018692404,0.29032505],"study_design_scores_gemma":[0.3227789,0.04948718,0.60387766,0.000109613924,0.00076648814,0.00005526563,0.000053066244,0.0000408717,0.000094964234,0.000030471792,0.02254887,0.00015661785],"about_ca_topic_score_codex":0.00008965943,"about_ca_topic_score_gemma":0.00020726956,"teacher_disagreement_score":0.29016843,"about_ca_system_score_codex":0.00027770712,"about_ca_system_score_gemma":0.00082427595,"threshold_uncertainty_score":0.5256444},"labels":[],"label_agreement":null},{"id":"W2003321853","doi":"10.1016/j.ygyno.2011.07.006","title":"Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Ontario Ministry of Health and Long-Term Care","keywords":"Lymphangiogenesis; Vascular endothelial growth factor C; Medicine; Cancer research; Hypoxia (environmental); Gene knockdown; Vascular endothelial growth factor; Lymphatic system; Tumor hypoxia; Vascular endothelial growth factor A; Metastasis; Internal medicine; Endocrinology; Pathology; Biology; Cancer; Chemistry; Cell culture; VEGF receptors","score_opus":0.04278681507716873,"score_gpt":0.28790663441565206,"score_spread":0.24511981933848334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003321853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924092,0.0017317062,0.00003161406,0.00019908635,0.0013006252,0.0014850295,0.00078278425,0.00012785291,0.0019320961],"genre_scores_gemma":[0.99617255,0.0012869353,0.0009718821,0.00061330025,0.00031594414,0.00040476926,0.000064300184,0.00006967623,0.00010063829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954801,0.00090930704,0.0011606495,0.0009667189,0.00059331354,0.0008899082],"domain_scores_gemma":[0.9966003,0.0014118848,0.00055581995,0.0005604812,0.00035761035,0.0005139197],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004986891,0.0006196929,0.0018427497,0.00048030977,0.00012598446,0.00001798938,0.00035174025,0.0006832371,0.0040580537],"category_scores_gemma":[0.003064846,0.00046615233,0.00042872972,0.0003827746,0.00031858744,0.00024837803,0.00027408774,0.00014935769,0.00006602656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014413001,0.0034191124,0.6712575,0.0013235529,0.0009437518,0.00029243022,0.0033525033,0.0000016212718,0.3076667,0.00044179425,0.00049371604,0.009366065],"study_design_scores_gemma":[0.018476743,0.0022031204,0.760141,0.00034448708,0.00078051747,0.00006169098,0.0010388347,0.000030448846,0.21409953,0.00042473592,0.0016809345,0.0007179632],"about_ca_topic_score_codex":0.0026737102,"about_ca_topic_score_gemma":0.00023817332,"teacher_disagreement_score":0.093567155,"about_ca_system_score_codex":0.0006548408,"about_ca_system_score_gemma":0.001128435,"threshold_uncertainty_score":0.99977905},"labels":[],"label_agreement":null},{"id":"W2003391982","doi":"10.1016/j.ygyno.2012.10.013","title":"Quantification of ER/PR expression in ovarian low-grade serous carcinoma","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Serous fluid; Immunohistochemistry; Oncology; Internal medicine; Tissue microarray; Serous carcinoma; Ovarian cancer; Cancer; Gynecology","score_opus":0.04633466633727685,"score_gpt":0.331653398810315,"score_spread":0.2853187324730382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003391982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897758,0.00090356555,0.00009667756,0.0025373616,0.000722015,0.00065794884,0.000008474727,0.000028211358,0.005269957],"genre_scores_gemma":[0.9964232,0.00013671322,0.0024810103,0.00039827242,0.0001475675,0.00021399265,0.000042782238,0.000013850463,0.0001426528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985987,0.0001760831,0.00042342494,0.00027138833,0.00013176928,0.00039866203],"domain_scores_gemma":[0.99887127,0.00037790393,0.00021107154,0.00034275054,0.000055298453,0.00014172657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041544653,0.00014979955,0.0005050583,0.00015572426,0.000039272993,0.0000031928653,0.00008799256,0.00029781865,0.000607802],"category_scores_gemma":[0.00017250946,0.000117177224,0.00008036187,0.0002204932,0.00008345024,0.00007851657,0.00004960681,0.00017576983,0.000076242504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018235983,0.0040979446,0.95063424,0.000085477914,0.000035794692,0.00009004309,0.0006671814,0.000017303733,0.027399046,0.0012834049,0.0014010143,0.014106163],"study_design_scores_gemma":[0.003053871,0.0011747567,0.9536824,0.000040454524,0.00008041049,0.00004297865,0.0002544583,0.000027826583,0.034382805,0.00013707645,0.0070220944,0.000100862664],"about_ca_topic_score_codex":0.00013570664,"about_ca_topic_score_gemma":0.00011039504,"teacher_disagreement_score":0.0140053,"about_ca_system_score_codex":0.0005619271,"about_ca_system_score_gemma":0.00020411145,"threshold_uncertainty_score":0.6655006},"labels":[],"label_agreement":null},{"id":"W2003626142","doi":"10.1016/j.ygyno.2011.03.011","title":"Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian carcinoma; Palliative treatment; Oncology; Clear cell carcinoma; Gynecology; General surgery; Carcinoma; Internal medicine; Ovarian cancer; Cancer","score_opus":0.1629775661451262,"score_gpt":0.32336680301499643,"score_spread":0.16038923686987022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003626142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835087,0.00014028016,0.0000057032253,0.0010301303,0.00041223475,0.0012763636,0.000012949868,0.00006791961,0.013545715],"genre_scores_gemma":[0.9889545,0.0009123926,0.005415633,0.0005545726,0.000044999575,0.0036143945,0.000008524492,0.00003070551,0.00046428616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980691,0.00013494636,0.00039398175,0.00059119595,0.00013777749,0.0006730008],"domain_scores_gemma":[0.99877584,0.00036997546,0.00018416552,0.00036503133,0.000058888843,0.00024607035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015076014,0.0003422425,0.0009222545,0.00017358991,0.000071443086,0.000006647355,0.00010496506,0.00014400046,0.001561779],"category_scores_gemma":[0.000059904465,0.00019847296,0.00007361101,0.0002510104,0.00009131129,0.00011096149,0.00005187145,0.00019317289,0.00009743468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010861488,0.0090812445,0.7312729,0.000052103165,0.00027295033,0.0038801932,0.013002955,0.00001062182,0.000027879278,0.00021494566,0.00004530227,0.23127745],"study_design_scores_gemma":[0.014259546,0.060138103,0.91317385,0.000029776184,0.00013434024,0.000017709368,0.0038000331,0.000005586623,0.0006793554,0.00007337841,0.007469392,0.00021893262],"about_ca_topic_score_codex":0.000256725,"about_ca_topic_score_gemma":0.0009940793,"teacher_disagreement_score":0.23105851,"about_ca_system_score_codex":0.0038625128,"about_ca_system_score_gemma":0.00055034953,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W2004042055","doi":"10.1016/j.ygyno.2013.08.003","title":"MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Calgary Laboratory Services; University of Calgary","funders":"Health Research Board; Calgary Laboratory Services; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; PTEN; MSH2; MLH1; Subtyping; Endometrial cancer; Oncology; Univariate analysis; Internal medicine; ARID1A; Cancer; DNA mismatch repair; Multivariate analysis; Mutation; Biology; Apoptosis; Gene; Colorectal cancer","score_opus":0.02213431047915189,"score_gpt":0.2848414856488556,"score_spread":0.2627071751697037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004042055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623686,0.00071345695,0.00003742913,0.0007107197,0.00012259523,0.00035980472,0.000021771206,0.000027113876,0.0017702329],"genre_scores_gemma":[0.99586266,0.00016641936,0.00082724594,0.0023924324,0.000038108046,0.00009459657,0.00007177817,0.000019929179,0.0005268005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998345,0.00018826067,0.00035130326,0.00052409596,0.000119581455,0.00047172228],"domain_scores_gemma":[0.9991565,0.00013995542,0.00017028608,0.0003251685,0.00008700404,0.00012109081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034744502,0.00021547536,0.00043310504,0.00010859379,0.00010674762,0.000029200395,0.00022007589,0.00043224366,0.0002527793],"category_scores_gemma":[0.00020391734,0.00017334073,0.000044176235,0.00025084883,0.00016765433,0.000011252934,0.000112838105,0.00021264103,0.000018937848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010039353,0.0010252157,0.9361063,0.00003732159,0.000080161895,0.00005325807,0.00048003747,0.00027556153,0.043594148,0.0001057147,0.003493158,0.014648734],"study_design_scores_gemma":[0.009755253,0.014590552,0.94073504,0.000027397355,0.00012035952,0.00012823517,0.0012288955,0.002842998,0.018316848,0.0025922302,0.008506157,0.0011560512],"about_ca_topic_score_codex":0.0011499632,"about_ca_topic_score_gemma":0.0021406221,"teacher_disagreement_score":0.0252773,"about_ca_system_score_codex":0.00016566436,"about_ca_system_score_gemma":0.00015991543,"threshold_uncertainty_score":0.706863},"labels":[],"label_agreement":null},{"id":"W2004073507","doi":"10.1016/s0090-8258(03)00473-6","title":"Workshop: options for therapy in ovarian cancer","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Topotecan; Medicine; Carboplatin; Tolerability; Ovarian cancer; Oncology; Internal medicine; Paclitaxel; Chemotherapy; Gemcitabine; Surgery; Cisplatin; Cancer; Adverse effect","score_opus":0.17746734570266418,"score_gpt":0.4648333417566929,"score_spread":0.2873659960540287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004073507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008684552,0.98547,0.000027046639,0.0022837745,0.001641353,0.0053188154,0.00010900765,0.000041237803,0.005100087],"genre_scores_gemma":[0.000012433774,0.974946,0.0027086386,0.0014479326,0.0003576421,0.017671177,0.00021182105,0.00006561531,0.0025787007],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974304,0.00030843233,0.0007733834,0.0007601418,0.0001066133,0.0006210218],"domain_scores_gemma":[0.99723774,0.0016707721,0.00037829578,0.00046606173,0.00008579273,0.0001613393],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046544152,0.0004961836,0.003006347,0.00032388416,0.00008615047,0.000015596244,0.0001756304,0.0011944982,0.0024401515],"category_scores_gemma":[0.00018622445,0.00034908712,0.00066488865,0.00048057604,0.00009437955,0.000028857145,0.000035968627,0.00052196794,0.000078596466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004198313,0.0013203587,0.00017174202,0.0013391206,0.0005189806,0.00016969927,0.000029570187,0.0000030486578,8.5041435e-8,0.0015022837,0.008745816,0.9861573],"study_design_scores_gemma":[0.003921851,0.0017542762,0.00035164415,0.0016834058,0.0011748015,0.00007542936,0.000022068962,0.0000013096471,3.2169092e-7,0.00028439236,0.9904409,0.00028956556],"about_ca_topic_score_codex":0.000050336832,"about_ca_topic_score_gemma":0.0005536749,"teacher_disagreement_score":0.98586774,"about_ca_system_score_codex":0.002839977,"about_ca_system_score_gemma":0.0027826363,"threshold_uncertainty_score":0.9998961},"labels":[],"label_agreement":null},{"id":"W2004207618","doi":"10.1006/gyno.2002.6834","title":"Outcomes in Surgery for Ovarian Cancer","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Gynecologic oncology; Ovarian cancer; Specialty; Comorbidity; Surgery; Population; Cohort; Relative survival; Retrospective cohort study; Relative risk; Cancer; Internal medicine; Confidence interval; Cancer registry","score_opus":0.08444831637244556,"score_gpt":0.35628955968532955,"score_spread":0.271841243312884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004207618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8582387,0.0021435393,0.000053592714,0.1153608,0.002501143,0.0021416633,0.00006259541,0.0001281901,0.01936976],"genre_scores_gemma":[0.9877807,0.00094908575,0.0014313525,0.005510841,0.00015047459,0.0019326562,0.000013965581,0.000017063065,0.002213847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877965,0.000057544978,0.00033735106,0.00033189784,0.00008104787,0.00041249135],"domain_scores_gemma":[0.99770856,0.0018366837,0.00010029032,0.00020176327,0.000048800764,0.00010391352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024751647,0.00015347327,0.0007309619,0.00015510978,0.00004891099,0.0000061876694,0.000057552166,0.0002262269,0.004415664],"category_scores_gemma":[0.00041241638,0.00011509932,0.00017200297,0.00015968145,0.00005520018,0.00003510401,0.000023364877,0.00012019838,0.00008738543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006342419,0.0015034236,0.8253088,0.00003143717,0.00012333003,0.00024447875,0.00009607657,0.000008464025,0.000012702605,0.0005131479,0.028679976,0.14341472],"study_design_scores_gemma":[0.0036472771,0.00083893334,0.8176483,0.000018090763,0.000108816945,0.00001885364,0.00004128898,0.0001481143,0.000052416595,0.00039609402,0.17696148,0.00012036113],"about_ca_topic_score_codex":0.00016850574,"about_ca_topic_score_gemma":0.0010508588,"teacher_disagreement_score":0.1482815,"about_ca_system_score_codex":0.00081348786,"about_ca_system_score_gemma":0.0001683918,"threshold_uncertainty_score":0.9964944},"labels":[],"label_agreement":null},{"id":"W2005698735","doi":"10.1006/gyno.2002.6602","title":"Infrared Spectral Features of Exfoliated Cervical Cells, Cervical Adenocarcinoma Tissue, and an Adenocarcinoma Cell Line (SiSo)","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Medical Research Council","keywords":"Adenocarcinoma; Cell culture; Cell; Pathology; Glycogen; Medicine; Biology; Biochemistry; Internal medicine; Cancer","score_opus":0.01854245881757028,"score_gpt":0.31178469931695296,"score_spread":0.2932422404993827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005698735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637832,0.0054964945,0.00018286082,0.0008366637,0.00020991502,0.00046128177,0.00005351901,0.0000868576,0.02888923],"genre_scores_gemma":[0.9870241,0.001584775,0.0060638743,0.0007732955,0.00040026865,0.00006188399,0.00013488923,0.00003411993,0.0039227484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973349,0.0002681988,0.00051079056,0.00080949295,0.0003085724,0.0007680238],"domain_scores_gemma":[0.99851763,0.00016781011,0.00015968314,0.000554103,0.00013176184,0.00046902834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028682186,0.000332102,0.00055606273,0.00011604434,0.00010260641,0.000021293708,0.0006617427,0.0011495622,0.0022395265],"category_scores_gemma":[0.00024480757,0.00028180867,0.00011286494,0.0002638303,0.00079323864,0.000009526312,0.0005277233,0.0005728238,0.000025605375],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036381028,0.0016361391,0.012061285,0.000117571704,0.000058749465,0.0001509468,0.000107457774,0.0000015327618,0.94878083,0.0003039519,0.030282041,0.0061356667],"study_design_scores_gemma":[0.0014962328,0.011541346,0.03898323,0.000008204994,0.000055611188,0.00008975702,0.00011225765,0.00014269973,0.90802026,0.0018201806,0.037321404,0.00040881202],"about_ca_topic_score_codex":0.0000371922,"about_ca_topic_score_gemma":0.000041548712,"teacher_disagreement_score":0.04076058,"about_ca_system_score_codex":0.000092596,"about_ca_system_score_gemma":0.0000824881,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W2005785330","doi":"10.1006/gyno.2001.6271","title":"Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Folinic acid; Medicine; Methotrexate; Gestational trophoblastic neoplasia; Chemotherapy; Regimen; Internal medicine; Chorioepithelioma; Antimetabolite; Gastroenterology; Antifolate; Urology; Gynecology; Surgery; Oncology; Fluorouracil; Choriocarcinoma","score_opus":0.0307657814903215,"score_gpt":0.3230407527095711,"score_spread":0.2922749712192496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005785330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9248581,0.0003781458,0.053668257,0.007443908,0.0007137574,0.0025417386,0.00015140032,0.0002284731,0.010016227],"genre_scores_gemma":[0.86202526,0.00014306177,0.13281858,0.001801316,0.00020940743,0.00091356004,0.00017831611,0.00005216774,0.0018583165],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99756926,0.00017415598,0.0005728198,0.00061226194,0.00035652338,0.00071498833],"domain_scores_gemma":[0.995275,0.0033744439,0.00029873886,0.00025683056,0.0004888297,0.00030611965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035701194,0.00035942064,0.00086535455,0.00022982662,0.00023517283,0.000018385657,0.0001502453,0.00016977482,0.0009911353],"category_scores_gemma":[0.0022369598,0.00027145,0.00016271281,0.00036172618,0.00040559337,0.00007801205,0.000053202883,0.00026339153,0.00027561103],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10356295,0.03621684,0.18040743,0.0040157544,0.017747816,0.034731336,0.008405893,0.017695293,0.03317084,0.07373789,0.07610716,0.41420078],"study_design_scores_gemma":[0.022834241,0.04778941,0.84144104,0.00011266872,0.0031267775,0.0030145172,0.0025918093,0.0031846787,0.00024450745,0.014349731,0.060399972,0.0009106823],"about_ca_topic_score_codex":0.000009717228,"about_ca_topic_score_gemma":0.00011073342,"teacher_disagreement_score":0.6610336,"about_ca_system_score_codex":0.0004335209,"about_ca_system_score_gemma":0.0011328162,"threshold_uncertainty_score":0.9999738},"labels":[],"label_agreement":null},{"id":"W2005967639","doi":"10.1016/j.ygyno.2005.07.086","title":"Evolving a strategic approach to cervical cancer control in Africa","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Cervical cancer; Control (management); Cancer; Gynecology; Oncology; Internal medicine; Management","score_opus":0.124235012861165,"score_gpt":0.37081789725420944,"score_spread":0.24658288439304443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005967639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54423684,0.0016437932,0.0005279746,0.013238619,0.0002445738,0.0010276634,0.0000090893745,0.00011191827,0.43895954],"genre_scores_gemma":[0.98126185,0.000029198989,0.0062571093,0.011224981,0.000350139,0.0004018955,0.0000042381284,0.000012029446,0.00045853632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809784,0.00013298346,0.0003897828,0.0004491131,0.00021848296,0.000711816],"domain_scores_gemma":[0.999076,0.00024782663,0.00007978655,0.0002119101,0.0001110571,0.00027338162],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055153,0.00018122887,0.0006000139,0.00016093306,0.00006126502,0.00001547691,0.00019547303,0.0003132388,0.0011941426],"category_scores_gemma":[0.0002384323,0.00014895639,0.000082347564,0.00042933068,0.000067717025,0.00008239553,0.000063715706,0.00042372113,0.00017401713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004316984,0.006382415,0.6026619,0.00029661937,0.00044308451,0.0020364579,0.0072866185,0.032544512,0.012195463,0.021036066,0.0689528,0.24184704],"study_design_scores_gemma":[0.016989376,0.008363123,0.66192055,0.00016055585,0.000357829,0.0004834289,0.0059581,0.05192275,0.0001089409,0.0029128098,0.24977252,0.0010500138],"about_ca_topic_score_codex":0.0003159745,"about_ca_topic_score_gemma":0.0020337168,"teacher_disagreement_score":0.438501,"about_ca_system_score_codex":0.0014230055,"about_ca_system_score_gemma":0.00058591645,"threshold_uncertainty_score":0.9997189},"labels":[],"label_agreement":null},{"id":"W2006326796","doi":"10.1006/gyno.2000.5746","title":"Management of Aggressive Histologic Variants of Endometrial Carcinoma at the Tom Baker Cancer Centre between 1984 and 1994","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Proportional hazards model; Carcinoma; Univariate analysis; Serous carcinoma; Cancer registry; Internal medicine; Cancer; Gynecology; Oncology; Surgery; Multivariate analysis; Ovarian cancer","score_opus":0.02944682865586397,"score_gpt":0.3132943424556445,"score_spread":0.28384751379978057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006326796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674702,0.0055549685,0.0000018854184,0.0015232203,0.0003820692,0.0009099157,0.00012246199,0.000018924344,0.024016326],"genre_scores_gemma":[0.99272037,0.0028166524,0.0003027269,0.00032537055,0.00015439428,0.00008623832,0.000036730333,0.000011510362,0.0035459932],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99821615,0.00022961874,0.00053440186,0.00038468814,0.00025694753,0.00037819927],"domain_scores_gemma":[0.99762505,0.0012041505,0.00068168994,0.0002954808,0.000059510025,0.00013414468],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028199863,0.00020910721,0.0009124702,0.00013036722,0.000096804935,0.0000029814994,0.00017346581,0.00024278736,0.011001302],"category_scores_gemma":[0.00020966829,0.00012325909,0.00014999315,0.0005027704,0.0003989202,0.00002643144,0.00016491258,0.00016826268,0.000027456363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026706823,0.0006079985,0.42222568,0.00018148306,0.00091717514,0.0006619125,0.00025176414,0.00000800278,0.0002573314,0.00022076492,0.001263825,0.57073337],"study_design_scores_gemma":[0.014014771,0.0032027601,0.9517735,0.000057511603,0.0012973578,0.000042685195,0.00022212659,0.0000035427174,0.0011689325,0.00036935334,0.027702596,0.00014482264],"about_ca_topic_score_codex":0.0005159079,"about_ca_topic_score_gemma":0.00016492282,"teacher_disagreement_score":0.5705885,"about_ca_system_score_codex":0.00056670746,"about_ca_system_score_gemma":0.00010974857,"threshold_uncertainty_score":0.9899028},"labels":[],"label_agreement":null},{"id":"W2007230092","doi":"10.1006/gyno.2001.6158","title":"Changes in the Demographics and Perioperative Care of Stage IA2/IB1 Cervical Cancer over the Past 16 Years","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Demographics; Perioperative; Cervical cancer; Stage (stratigraphy); Oncology; General surgery; Intensive care medicine; Family medicine; Internal medicine; Demography; Cancer; Surgery","score_opus":0.033539104151063995,"score_gpt":0.3417300302210778,"score_spread":0.3081909260700138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007230092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812127,0.00338674,0.0000015124643,0.008275632,0.0001836919,0.0006251495,0.000029709781,0.000011315799,0.006273556],"genre_scores_gemma":[0.99146515,0.003285584,0.00003490081,0.004566098,0.0001633036,0.00023333458,0.000011690672,0.000007509872,0.00023240081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890417,0.00025999118,0.00018715083,0.00022006422,0.0001707536,0.00025787303],"domain_scores_gemma":[0.9988259,0.0007869541,0.00008354365,0.00017842042,0.0000683438,0.000056838267],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002470612,0.00012775869,0.00037785323,0.00009376829,0.0000750087,0.000007937289,0.000140475,0.00018411611,0.0011505289],"category_scores_gemma":[0.00013191208,0.000062101106,0.0000608874,0.00052284286,0.0003090333,0.000021609827,0.000072046474,0.00028294677,0.0000033064282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039905656,0.00027704082,0.93060607,0.000043015054,0.00008227439,0.00019087036,0.00400985,0.0000038297894,0.00008609862,0.00054608256,0.00016001512,0.063595794],"study_design_scores_gemma":[0.0030551672,0.002265759,0.9298051,0.000012499651,0.00010876074,0.000022260263,0.007881969,0.0000054533216,0.000020372305,0.00006210215,0.056694474,0.00006607696],"about_ca_topic_score_codex":0.0008929104,"about_ca_topic_score_gemma":0.026043175,"teacher_disagreement_score":0.063529715,"about_ca_system_score_codex":0.0002376273,"about_ca_system_score_gemma":0.00011773601,"threshold_uncertainty_score":0.99976254},"labels":[],"label_agreement":null},{"id":"W2007398903","doi":"10.1016/j.ygyno.2010.10.022","title":"Successful management of medulloblastoma arising in an immature ovarian teratoma in pregnancy","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Medulloblastoma; Regimen; Malignancy; Ovarian Teratoma; Surgery; Oncology; Teratoma; Internal medicine; Pathology","score_opus":0.014081955150006141,"score_gpt":0.323446040364004,"score_spread":0.30936408521399783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007398903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984067,0.00026843493,0.0000075378534,0.0022762155,0.0006676633,0.00094708824,0.0000066294806,0.00003697956,0.011722421],"genre_scores_gemma":[0.9920501,0.00014957805,0.0070555075,0.0002677347,0.000052764604,0.00029630476,0.000023342991,0.000017666158,0.00008699442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830574,0.00011962917,0.0005247297,0.00047698987,0.00015175986,0.00042117503],"domain_scores_gemma":[0.99903744,0.00016934355,0.00017934806,0.00043639634,0.000055118704,0.00012236518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030776506,0.00020659823,0.0006306189,0.0002867333,0.000032228243,0.000011768757,0.00017773705,0.00041975445,0.00072711695],"category_scores_gemma":[0.000043458775,0.00017020565,0.00006988156,0.00040963024,0.000107823114,0.000108275206,0.00008871402,0.0005001525,0.000016932301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043108378,0.004142294,0.8262298,0.00018665337,0.00010014745,0.0046670437,0.0005201431,0.000019437768,0.0015069449,0.004633357,0.000088858156,0.15747423],"study_design_scores_gemma":[0.005856577,0.002248517,0.98676085,0.00028630573,0.00008618694,0.000075935335,0.00044021072,0.0000824775,0.0010359744,0.00095861935,0.0020203604,0.00014800076],"about_ca_topic_score_codex":0.0001299779,"about_ca_topic_score_gemma":0.006251607,"teacher_disagreement_score":0.16053103,"about_ca_system_score_codex":0.000350471,"about_ca_system_score_gemma":0.00019581248,"threshold_uncertainty_score":0.79614204},"labels":[],"label_agreement":null},{"id":"W2007576032","doi":"10.1016/j.ygyno.2005.08.026","title":"Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Memorial University of Newfoundland; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"","keywords":"Amplicon; Biology; Comparative genomic hybridization; Gene duplication; Ovarian cancer; Cancer research; Locus (genetics); Breast cancer; Oncogene; Cancer; Gene; Pathology; Chromosome; Polymerase chain reaction; Genetics; Medicine; Cell cycle","score_opus":0.02681821881384079,"score_gpt":0.30131742475444667,"score_spread":0.2744992059406059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007576032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992589,0.00023963474,0.0011678968,0.0026438567,0.000491555,0.00040540923,0.00008616667,0.000017038843,0.0023594464],"genre_scores_gemma":[0.9812565,0.00010402881,0.016986677,0.0007980117,0.00030509598,0.00008165068,0.00014432613,0.000022636861,0.0003010928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983609,0.00016508714,0.00047074194,0.00052622356,0.00012939659,0.00034770506],"domain_scores_gemma":[0.9989619,0.00014400455,0.00025352198,0.0004682005,0.00010641634,0.00006593098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044873595,0.00019397565,0.00032132072,0.00010180038,0.000056283992,0.000006337198,0.00031930118,0.00047151223,0.00012191873],"category_scores_gemma":[0.00024903382,0.00019278323,0.000080734404,0.0002159756,0.00017505299,0.0000049511314,0.00010534486,0.00018178465,0.00004172338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021266259,0.0009738457,0.0067501473,0.00001127396,0.00006345008,0.0000060964376,0.00017642751,0.016561123,0.960674,0.0017901299,0.0011845526,0.01159633],"study_design_scores_gemma":[0.0054108286,0.0035556694,0.19455585,0.000011523462,0.00005737843,0.000046307083,0.00025728781,0.00050640927,0.6199379,0.0006396205,0.17449649,0.00052478147],"about_ca_topic_score_codex":0.00015175743,"about_ca_topic_score_gemma":0.0014457578,"teacher_disagreement_score":0.3407361,"about_ca_system_score_codex":0.00053000054,"about_ca_system_score_gemma":0.0005550101,"threshold_uncertainty_score":0.7861472},"labels":[],"label_agreement":null},{"id":"W2008305848","doi":"10.1016/j.ygyno.2005.04.028","title":"Granulocytic sarcoma presenting as tumors of the cervix","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Cervix; Sarcoma; Pathology; Cancer; Internal medicine","score_opus":0.07411037779845352,"score_gpt":0.4128194413785617,"score_spread":0.33870906358010816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008305848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010313609,0.935522,0.0000016459882,0.0011500381,0.0005735509,0.0034004524,0.000024476285,0.00009139628,0.05820504],"genre_scores_gemma":[0.0006554452,0.98691374,0.00057382,0.0006125401,0.0006217754,0.00039225823,0.00005898768,0.00009160108,0.010079855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481446,0.0013503557,0.0014576608,0.0007648485,0.00058860093,0.0010241044],"domain_scores_gemma":[0.9938267,0.0032499,0.001107095,0.0013401702,0.0002264351,0.00024972938],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012494869,0.0005954195,0.0039365254,0.0003935483,0.00018153425,0.000014039917,0.0013433964,0.0013660211,0.002244388],"category_scores_gemma":[0.0038652292,0.00034225872,0.0012353358,0.0009836416,0.00078425603,0.000046426663,0.0012026188,0.002315964,0.0008563632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029300001,0.00035316433,0.00017731958,0.007920881,0.00034269094,0.00062684,0.000072601186,0.0000011945851,0.0000033169254,0.0003900093,0.0073951953,0.9826875],"study_design_scores_gemma":[0.0010736347,0.00092411763,0.0004619218,0.0019308031,0.0015055581,0.002330473,0.00006177654,0.000019566962,0.0000071473355,0.00020881672,0.9912103,0.00026591326],"about_ca_topic_score_codex":0.000095362135,"about_ca_topic_score_gemma":0.00007306644,"teacher_disagreement_score":0.9838151,"about_ca_system_score_codex":0.003306318,"about_ca_system_score_gemma":0.0077043404,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W2009136967","doi":"10.1016/j.ygyno.2015.01.103","title":"The acceptability and perception of the morbidity and mortality of complex surgical procedures in primary debulking of ovarian cancer: A survey of American and Canadian gynecologic oncologists","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Debulking; Gynecologic cancer; Ovarian cancer; Gynecologic surgical procedures; Gynecology; General surgery; Surgery; Cancer; Internal medicine; Laparoscopy","score_opus":0.0781444801695139,"score_gpt":0.3662620790847306,"score_spread":0.28811759891521665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009136967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953167,0.0007331133,5.488784e-7,0.0017190583,0.000113001464,0.00092541013,0.00012324216,0.0000053627773,0.0010635842],"genre_scores_gemma":[0.99799293,0.0014754257,0.00026610444,0.00013684748,0.000014297525,0.00009084165,0.000011524079,0.0000063150733,0.000005704633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773914,0.00080566504,0.00065277895,0.00033703158,0.00018115368,0.0002842337],"domain_scores_gemma":[0.996703,0.0019410437,0.0006046817,0.0002943588,0.0002828262,0.00017406481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059966,0.00016533825,0.0009948781,0.0000805218,0.00007418565,0.0000046034816,0.00014354466,0.00018832642,0.00006860079],"category_scores_gemma":[0.0016816349,0.00009646234,0.000054912623,0.000330485,0.0019603102,0.00003435657,0.00016882432,0.00018762727,7.431573e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029461965,0.0005047486,0.9541409,0.00015428137,0.0000888635,0.000012486188,0.00047668893,0.0000132636505,0.00009608646,0.00008868992,0.000080130805,0.04404922],"study_design_scores_gemma":[0.002272171,0.0021629906,0.99391055,0.000020769083,0.0001305686,0.000024971234,0.00081273273,0.00007932662,0.000051413488,0.00019168289,0.00026534425,0.000077502955],"about_ca_topic_score_codex":0.3729168,"about_ca_topic_score_gemma":0.79573286,"teacher_disagreement_score":0.42281607,"about_ca_system_score_codex":0.00081132574,"about_ca_system_score_gemma":0.0023549318,"threshold_uncertainty_score":0.72228444},"labels":[],"label_agreement":null},{"id":"W2010521246","doi":"10.1016/j.ygyno.2015.03.005","title":"A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Juravinski Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Notch signaling pathway; Medicine; Epithelial ovarian cancer; Gamma secretase; Platinum; Internal medicine; Cancer research; Oncology; Ovarian cancer; Cancer; Cell biology; Receptor; Biochemistry; Biology","score_opus":0.020853909006809432,"score_gpt":0.2876598021350212,"score_spread":0.26680589312821174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010521246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973843,0.0001530832,0.000008039247,0.00005214402,0.00022805204,0.0019030124,0.0002323762,0.0000050190806,0.00003398125],"genre_scores_gemma":[0.9995234,0.000008616107,0.00014025274,0.000032497042,0.000027162805,0.00014082299,0.000100774574,0.00001111871,0.000015332347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778396,0.0005219743,0.00076764496,0.00045843763,0.00021505842,0.00025290847],"domain_scores_gemma":[0.99858403,0.00005622084,0.0007527813,0.0002839428,0.00023101426,0.0000919819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054834486,0.0002328172,0.0005506606,0.00008622465,0.00011748552,0.0000031568334,0.00022078575,0.00023395155,0.000022378332],"category_scores_gemma":[0.00020994239,0.00015724308,0.000038848437,0.0002075969,0.0002853133,0.0000061941655,0.00040290074,0.0001401523,2.1363674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01747501,0.06816113,0.587759,0.00006165236,0.00047810384,0.000017703032,0.0055116867,0.000236101,0.2981475,0.000006585084,0.00008453641,0.022060975],"study_design_scores_gemma":[0.11061107,0.37556994,0.37566453,0.000098380864,0.00042637734,0.0000074124846,0.0052940655,0.00006880778,0.12969294,0.00005847843,0.0019138642,0.00059411366],"about_ca_topic_score_codex":0.00014936386,"about_ca_topic_score_gemma":0.0044348394,"teacher_disagreement_score":0.3074088,"about_ca_system_score_codex":0.00010516481,"about_ca_system_score_gemma":0.00040814147,"threshold_uncertainty_score":0.64121866},"labels":[],"label_agreement":null},{"id":"W2011709130","doi":"10.1016/j.ygyno.2011.10.034","title":"Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: A systematic review","year":2011,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Oncology; Internal medicine; Pharmacogenomics; MEDLINE; Ovarian cancer; Observational study; Meta-analysis; Population; Bioinformatics; Gynecology; Cancer","score_opus":0.02608697795006214,"score_gpt":0.3092861275621015,"score_spread":0.28319914961203935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011709130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005987695,0.99034804,0.000028169752,0.000071589224,0.000492783,0.006890235,0.00011114804,0.000047161528,0.0014120737],"genre_scores_gemma":[0.00088725454,0.9924583,0.00040412595,0.0011664816,0.00011647377,0.0044641513,0.0002208518,0.00008389531,0.00019847209],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940422,0.0017453468,0.0016912881,0.0014184801,0.00017880832,0.000923858],"domain_scores_gemma":[0.9973889,0.0007024411,0.00074045965,0.00075253216,0.000088967914,0.00032671884],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00089223153,0.00096656405,0.004085728,0.00027070643,0.00011530375,0.000024547364,0.0007175281,0.0017638907,0.00038595241],"category_scores_gemma":[0.0016522758,0.00072156946,0.0006028586,0.00041682125,0.0004910056,0.000007658429,0.00034064558,0.00062525657,0.00013759645],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018897816,0.0008541366,0.00036373103,0.82906514,0.0027836272,0.0012608786,0.00012217346,0.0000022191816,0.000037667116,0.00018862284,0.002041275,0.16309156],"study_design_scores_gemma":[0.0021196431,0.019274333,0.0007362883,0.23731555,0.013341403,0.0046192044,0.00011656409,0.000012862211,0.0000053532463,0.00029067413,0.71947306,0.0026950764],"about_ca_topic_score_codex":0.00014553967,"about_ca_topic_score_gemma":0.00039892676,"teacher_disagreement_score":0.7174318,"about_ca_system_score_codex":0.00045138824,"about_ca_system_score_gemma":0.0016730946,"threshold_uncertainty_score":0.99953204},"labels":[],"label_agreement":null},{"id":"W2011841619","doi":"10.1016/j.ygyno.2008.11.021","title":"Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Chemotherapy; Nausea; Surgery; Chemotherapy regimen; Vomiting; Gynecologic oncology; Internal medicine","score_opus":0.02041710507123097,"score_gpt":0.342952700631732,"score_spread":0.32253559556050104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011841619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546535,0.000054617652,0.000015344716,0.00719511,0.00024096161,0.0062554334,0.00007433313,0.000041038977,0.0006578289],"genre_scores_gemma":[0.9935451,0.000016255286,0.0036884507,0.0007546933,0.00013933524,0.0014735251,0.00034935586,0.000015190278,0.000018097195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983435,0.00019353886,0.00032623665,0.00037644044,0.0004168618,0.00034341888],"domain_scores_gemma":[0.9985552,0.00016579386,0.00026507094,0.00032828815,0.0005899681,0.000095710355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075250777,0.00018871996,0.00040910416,0.00004755436,0.00013530115,0.000010719946,0.00012613375,0.0001510852,0.00051224447],"category_scores_gemma":[0.000096425756,0.00010821844,0.00008445611,0.00013070101,0.00013731839,0.000056367557,0.000022629016,0.00008942396,0.000002342927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013774752,0.0071504246,0.20184836,0.00001380018,0.00023747119,0.000008497214,0.0003981007,0.0000086335185,0.00006291743,0.00017772874,0.00036619822,0.7883504],"study_design_scores_gemma":[0.01903615,0.062247895,0.9074124,0.000008519662,0.00063930266,0.0000065789945,0.00010756686,0.0003186696,0.00094620587,0.0003062993,0.008851507,0.000118916396],"about_ca_topic_score_codex":0.000043687083,"about_ca_topic_score_gemma":0.00032975196,"teacher_disagreement_score":0.7882315,"about_ca_system_score_codex":0.000928714,"about_ca_system_score_gemma":0.0005281832,"threshold_uncertainty_score":0.5608717},"labels":[],"label_agreement":null},{"id":"W2012287359","doi":"10.1006/gyno.2000.6068","title":"Activation of Androgen Receptor-Associated Protein 70 (ARA70) mRNA Expression in Ovarian Cancer","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Androgen receptor; Biology; Cancer research; Endocrinology; Ovarian cancer; Internal medicine; Androgen; Prostate cancer; Cancer; Medicine","score_opus":0.011490764637064556,"score_gpt":0.27600565601031307,"score_spread":0.2645148913732485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012287359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952143,0.0005020457,0.000047321726,0.00040878257,0.00018294623,0.00055655645,0.000007265411,0.000016546024,0.003064256],"genre_scores_gemma":[0.99783504,0.00059869373,0.00040497797,0.00013976372,0.0000761715,0.00019080185,0.00011021455,0.000016347725,0.00062797737],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985995,0.0003339254,0.00031431753,0.00033224293,0.000093102615,0.00032686192],"domain_scores_gemma":[0.9993572,0.00005728636,0.00025372853,0.00018951444,0.000077205965,0.00006501546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035268697,0.00015895965,0.00028983786,0.00008367015,0.000057725483,0.0000043904943,0.00016818057,0.00077679375,0.0001731722],"category_scores_gemma":[0.00033635163,0.00013625801,0.000072895564,0.00022865283,0.00008538552,0.0000069454377,0.000093068615,0.00022084171,0.000010983958],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035857302,0.00042016373,0.019317891,0.00000917524,0.000048707356,0.000015736914,0.00006041481,0.00015187623,0.971154,0.000022846227,0.0010149226,0.007425705],"study_design_scores_gemma":[0.0022222404,0.0018286927,0.014151417,0.000049102808,0.000015671769,0.000007779342,0.00007356218,0.000041537936,0.9636599,0.00015662727,0.017593265,0.0002002073],"about_ca_topic_score_codex":0.00008908403,"about_ca_topic_score_gemma":0.00009138525,"teacher_disagreement_score":0.016578343,"about_ca_system_score_codex":0.00015969819,"about_ca_system_score_gemma":0.00025542994,"threshold_uncertainty_score":0.59913445},"labels":[],"label_agreement":null},{"id":"W2012503255","doi":"10.1016/j.ygyno.2015.01.114","title":"Racial differences in reasons for failure to receive ovarian cancer treatment","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ovarian cancer; Epithelial ovarian cancer; Chemotherapy; Cancer; Oncology; Racial differences; Gynecology; Internal medicine; Gerontology; Demography; Ethnic group","score_opus":0.050951930711884134,"score_gpt":0.3505610152483048,"score_spread":0.29960908453642066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012503255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98396397,0.0004043183,0.0008156903,0.009700261,0.0011850945,0.0010936977,0.00012250307,0.000020504995,0.0026939448],"genre_scores_gemma":[0.9842517,0.000107707674,0.010064325,0.0010925698,0.00046702582,0.0025416217,0.00008781988,0.000016427026,0.0013708093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987499,0.00013759152,0.0002186928,0.00046589327,0.00006726467,0.00036066494],"domain_scores_gemma":[0.9992915,0.000105196574,0.0000857295,0.0002297912,0.00014019376,0.00014762006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023898632,0.00017073232,0.00028832193,0.00007846604,0.000062341176,0.000012403169,0.0002031057,0.0002924674,0.0000875637],"category_scores_gemma":[0.00055557507,0.00014503574,0.00006377648,0.00015007744,0.00007476298,0.0000032517037,0.00007684182,0.00006586677,0.00002048765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034331416,0.0022182446,0.22365333,0.000035766538,0.0006575362,0.000097636446,0.00796427,0.0041841483,0.060619686,0.0017683613,0.2355486,0.4598193],"study_design_scores_gemma":[0.00392921,0.008874441,0.037500955,0.0000070384726,0.000054728087,0.000014931083,0.0013591958,0.00006379649,0.008123714,0.0011393412,0.93856794,0.00036472728],"about_ca_topic_score_codex":0.00019451969,"about_ca_topic_score_gemma":0.025215931,"teacher_disagreement_score":0.7030193,"about_ca_system_score_codex":0.001004675,"about_ca_system_score_gemma":0.0013545738,"threshold_uncertainty_score":0.99257135},"labels":[],"label_agreement":null},{"id":"W2013375884","doi":"10.1016/j.ygyno.2009.06.012","title":"Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Tamoxifen; Breast cancer; Ovarian cancer; Oncology; BRCA mutation; Internal medicine; Odds ratio; Cancer; Gynecology","score_opus":0.008226696362282597,"score_gpt":0.2882687742476421,"score_spread":0.2800420778853595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013375884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968333,0.0018715791,0.00024087568,0.0030144886,0.00027039426,0.0003597257,0.000026922748,0.0000066877087,0.0045259777],"genre_scores_gemma":[0.9967593,0.0011842547,0.0008542324,0.0009019796,0.00008162382,0.00008836275,0.0000137223815,0.0000057325556,0.0001107692],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989552,0.00031035556,0.00024556828,0.00024864863,0.000060820177,0.00017943338],"domain_scores_gemma":[0.99937534,0.00014305895,0.00018747571,0.00019755041,0.000065015585,0.00003156945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005705933,0.00009937591,0.00020848845,0.000048615842,0.00006213194,0.0000055565415,0.00014629457,0.00022744744,0.000064696294],"category_scores_gemma":[0.0004978875,0.000072437455,0.000046174213,0.00013366592,0.00031956882,0.0000031023164,0.0000454456,0.00013069606,0.0000013525674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022526376,0.00041784285,0.09409839,0.000035723842,0.00048094674,0.000050994426,0.0051017143,0.021248154,0.11259816,0.0047092657,0.0058096927,0.7531965],"study_design_scores_gemma":[0.013014738,0.0025345795,0.8939201,0.000012293979,0.00021694461,0.00006279146,0.0011424855,0.0013729559,0.039866604,0.021048259,0.026388317,0.00041988993],"about_ca_topic_score_codex":0.00020492495,"about_ca_topic_score_gemma":0.0012116833,"teacher_disagreement_score":0.79982173,"about_ca_system_score_codex":0.000125691,"about_ca_system_score_gemma":0.00032350098,"threshold_uncertainty_score":0.29539138},"labels":[],"label_agreement":null},{"id":"W2013707540","doi":"10.1016/j.ygyno.2014.03.292","title":"FBxW7 duality in ovarian cancer: Novel insight into ovarian cancer pathogenesis","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ovarian cancer; Medicine; Proteolysis; Ubiquitin; Pathogenesis; Cancer research; Cancer; Suppressor; Oncology; Gene; Internal medicine; Biology; Genetics; Enzyme; Biochemistry","score_opus":0.02499203228825388,"score_gpt":0.3012281312269789,"score_spread":0.276236098938725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013707540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257054,0.0014572559,0.0018785928,0.0033986953,0.0014847631,0.0007247235,0.00010362084,0.00005254303,0.018329255],"genre_scores_gemma":[0.98968714,0.0006411297,0.00327924,0.0042102793,0.0006813462,0.000829485,0.00010851746,0.000036113033,0.0005267264],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972991,0.00054208236,0.00051600387,0.0008341203,0.00014632221,0.00066239643],"domain_scores_gemma":[0.9987615,0.00015063795,0.00024531764,0.0005251325,0.00012752149,0.00018993598],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001032718,0.00033147397,0.0005367671,0.00011284027,0.00016953875,0.00002258893,0.00045649364,0.0008393204,0.0006411914],"category_scores_gemma":[0.000569013,0.00030623487,0.00012820534,0.00026323964,0.00019593426,0.00000828506,0.00033249584,0.00029408574,0.000038053007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023634266,0.000557561,0.049181346,0.00006826077,0.00008768193,0.000027934535,0.00052017195,0.00023457823,0.8349861,0.0021886027,0.00084854686,0.11106288],"study_design_scores_gemma":[0.0037179512,0.0018251315,0.16852325,0.000025590898,0.000060171515,0.000026403364,0.000113405644,0.00022586994,0.12119159,0.001290181,0.7022599,0.000740541],"about_ca_topic_score_codex":0.001860764,"about_ca_topic_score_gemma":0.014673446,"teacher_disagreement_score":0.7137945,"about_ca_system_score_codex":0.00027691454,"about_ca_system_score_gemma":0.00063897064,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W2013709491","doi":"10.1016/j.ygyno.2011.02.037","title":"The significance of surgical staging in intermediate-risk endometrial cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Hysterectomy; Lymph node; Gynecology; Oncology; Cancer; Surgery; Internal medicine; Obstetrics","score_opus":0.05121737087895852,"score_gpt":0.3380364644973451,"score_spread":0.2868190936183866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013709491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741692,0.001457957,0.000008491204,0.0004896992,0.0014072728,0.0007844134,0.000028026661,0.000031646723,0.021623325],"genre_scores_gemma":[0.9943664,0.0043924814,0.00021184898,0.00013028781,0.0002045659,0.0003416223,0.000004780537,0.000010752392,0.000337229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817234,0.00034296446,0.0005671812,0.00029211846,0.00019359477,0.00043178568],"domain_scores_gemma":[0.99609786,0.0031653098,0.0002997911,0.00022583123,0.00008857927,0.0001226275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008453402,0.00015340923,0.00063608686,0.00019956831,0.00007080988,0.000003902218,0.00020627145,0.00019382889,0.0013184812],"category_scores_gemma":[0.0011625495,0.00008848886,0.00014310202,0.00072325737,0.00034688687,0.000035466124,0.00009338163,0.00037676498,0.000025082605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00556908,0.0009778977,0.69807625,0.00003063344,0.00018469052,0.00050569914,0.0004956855,0.0000042445185,0.00019170239,0.0005582154,0.00029593584,0.29310995],"study_design_scores_gemma":[0.022926094,0.007724725,0.9200502,0.000034403496,0.00024830914,0.000022070837,0.0006813555,0.000030560645,0.0033726776,0.0022257697,0.04248565,0.00019815045],"about_ca_topic_score_codex":0.0016525795,"about_ca_topic_score_gemma":0.0012047857,"teacher_disagreement_score":0.2929118,"about_ca_system_score_codex":0.00048370086,"about_ca_system_score_gemma":0.0003768022,"threshold_uncertainty_score":0.99959445},"labels":[],"label_agreement":null},{"id":"W2014677389","doi":"10.1016/j.ygyno.2005.03.039","title":"Invasive vulvar cancer in a woman with human immunodeficiency virus: Case report and review of the literature","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Medicine; Vulvar cancer; Disease; Anal cancer; Cancer; Vulva; Vulvar neoplasm; Vaginal cancer; Radiation therapy; Human immunodeficiency virus (HIV); Dysplasia; Cervical cancer; Dermatology; Surgery; Immunology; Internal medicine","score_opus":0.06167212021489128,"score_gpt":0.43855292349521746,"score_spread":0.3768808032803262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014677389","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006549043,0.98443335,1.0758061e-7,0.0006390675,0.000112162656,0.0028097485,0.00007017276,0.000015272724,0.011265189],"genre_scores_gemma":[0.00052434375,0.9962853,0.000040253268,0.0013275963,0.00012791339,0.00085483113,0.000054552896,0.000030893385,0.0007543126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692684,0.0005717797,0.0010802478,0.00064007094,0.00031368484,0.00046734998],"domain_scores_gemma":[0.99743205,0.0006597603,0.00070606044,0.00075515604,0.00032239238,0.00012455694],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010585865,0.00039386417,0.0028980598,0.00022127856,0.00011691552,0.000012503538,0.00029973942,0.00062690175,0.0030226225],"category_scores_gemma":[0.00094263017,0.00019756536,0.00028650818,0.001118144,0.00047411982,0.00004201161,0.00031706548,0.0015583494,0.000005306705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003433879,0.00031040746,0.00021537177,0.10403541,0.00011880546,0.055464692,0.00016333385,1.3623895e-7,0.0000013303501,0.00004701767,0.0007214646,0.8388877],"study_design_scores_gemma":[0.00082905206,0.0013890248,0.001550158,0.05127281,0.0010128631,0.079866074,0.000046146793,1.7473661e-7,9.899456e-7,0.000019686204,0.8637828,0.00023020623],"about_ca_topic_score_codex":0.00040893094,"about_ca_topic_score_gemma":0.008858817,"teacher_disagreement_score":0.86306137,"about_ca_system_score_codex":0.0011569565,"about_ca_system_score_gemma":0.0033114858,"threshold_uncertainty_score":0.99788874},"labels":[],"label_agreement":null},{"id":"W2015505443","doi":"10.1006/gyno.2002.6760","title":"Malignant Ascites Fluid (MAF), Including Ovarian-Cancer-Associated MAF, Contains Angiostatin and Other Factor(s) Which Inhibit Angiogenesis","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Cancer Care Ontario","funders":"McMaster University; Cancer Research Society","keywords":"Angiostatin; Western blot; Angiogenesis; Ovarian cancer; Cancer; Lysine; Medicine; Vascular endothelial growth factor; Molecular biology; Biology; Internal medicine; Biochemistry; Amino acid; VEGF receptors","score_opus":0.04676558247920607,"score_gpt":0.30304432376847856,"score_spread":0.25627874128927247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015505443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840251,0.009400839,0.00015788877,0.001380967,0.00046258033,0.00044041072,0.00034748288,0.00006275937,0.0037219329],"genre_scores_gemma":[0.99137795,0.0025139367,0.00056006113,0.0036324428,0.00031208704,0.00019633303,0.000054879998,0.000058111862,0.0012941732],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974806,0.00032854758,0.0004803571,0.00079850573,0.00017155167,0.00074046914],"domain_scores_gemma":[0.99875057,0.00021541034,0.00030808302,0.00033454862,0.00020401971,0.00018735226],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041411797,0.00039421293,0.0005550938,0.000116810086,0.00031215395,0.00004435043,0.0002837579,0.00073423446,0.0021295613],"category_scores_gemma":[0.0004588594,0.00034900598,0.00019360987,0.00032337743,0.00020417344,0.000011883672,0.0003188799,0.00013043384,0.00004629324],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016626649,0.000741408,0.33764112,0.00004645646,0.0008688443,0.00007051331,0.00064121187,0.00009881128,0.5823268,0.00044727876,0.024535388,0.052415833],"study_design_scores_gemma":[0.006399292,0.005591547,0.25363818,0.00008829615,0.0004248704,0.00012247544,0.0009205756,0.0010635656,0.1443797,0.00036404212,0.58489954,0.0021078845],"about_ca_topic_score_codex":0.00018777692,"about_ca_topic_score_gemma":0.0014404493,"teacher_disagreement_score":0.5603642,"about_ca_system_score_codex":0.0002311939,"about_ca_system_score_gemma":0.0001390498,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2015919139","doi":"10.1016/j.ygyno.2009.08.012","title":"A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Queen's University; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Sunitinib; Internal medicine; Sunitinib malate; Discontinuation; Clinical endpoint; Oncology; Cervical cancer; Vascular endothelial growth factor; Phases of clinical research; Gastroenterology; Urology; Surgery; Renal cell carcinoma; Cancer; Chemotherapy; Clinical trial; VEGF receptors","score_opus":0.043134646892845095,"score_gpt":0.36050230684209733,"score_spread":0.31736765994925226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015919139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930229,0.00006491238,0.0000086457785,0.00037129427,0.00025919318,0.004510706,0.000020847803,0.00004189036,0.0016995842],"genre_scores_gemma":[0.9977766,0.000008905354,0.0006754265,0.00095018744,0.00006469904,0.00030711558,0.00006300881,0.000016217578,0.00013780415],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972948,0.0003994438,0.0008543446,0.00050061435,0.0004303741,0.00052043237],"domain_scores_gemma":[0.99806887,0.00080676476,0.0003363104,0.0003307401,0.00022651991,0.0002307698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034875996,0.0003052246,0.001420791,0.0003549015,0.00008276875,0.000004866953,0.00018859179,0.00018684263,0.0009973998],"category_scores_gemma":[0.0008501269,0.00018479848,0.00009409136,0.0010709802,0.00011024877,0.00008026737,0.0000778901,0.00037290034,0.000015429632],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5639332,0.16055037,0.053345982,0.000055944805,0.0002715282,0.0013504549,0.0009768909,0.000020803875,0.000045613917,0.00004499235,0.000054177024,0.21935007],"study_design_scores_gemma":[0.40043768,0.34154338,0.25661838,0.000014706319,0.00032132075,0.000006897759,0.00058960036,0.000006152307,0.00002983583,0.00009365317,0.00021571993,0.00012265079],"about_ca_topic_score_codex":0.00009671902,"about_ca_topic_score_gemma":0.00082805316,"teacher_disagreement_score":0.21922742,"about_ca_system_score_codex":0.0005454228,"about_ca_system_score_gemma":0.0006120809,"threshold_uncertainty_score":0.99991584},"labels":[],"label_agreement":null},{"id":"W2016382281","doi":"10.1016/j.ygyno.2010.01.006","title":"Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Canadian Institutes of Health Research; Ovarian Cancer Canada; Ovarian Cancer Research Fund; Cancer Research Institute","keywords":"Microarray; Microarray analysis techniques; Carcinogenesis; Gene; Gene expression; Immunohistochemistry; Medicine; Cancer research; Biology; Pathology; Genetics","score_opus":0.006596686740544914,"score_gpt":0.22996740595466045,"score_spread":0.22337071921411553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016382281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887422,0.00020335082,0.000056532135,0.008088026,0.0006849724,0.0009709328,0.000037717356,0.000052361618,0.0011639192],"genre_scores_gemma":[0.9917367,0.000007840528,0.0023479653,0.0051291115,0.00019240024,0.0000699131,0.000014916013,0.000040225874,0.00046090517],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798435,0.00020014562,0.00038325516,0.0005294736,0.00031834966,0.0005844507],"domain_scores_gemma":[0.99827266,0.00012198052,0.0002688232,0.0008157089,0.00024190385,0.00027893425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026750212,0.00031951818,0.0007147893,0.00014561422,0.00018250616,0.00001367306,0.00042663462,0.00045910434,0.00024307333],"category_scores_gemma":[0.00016480272,0.000185339,0.00022343057,0.0003931892,0.00038449554,0.00003652812,0.0002740598,0.0008107325,0.000026588941],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087125937,0.0014105559,0.12953846,0.00017230885,0.00013394318,0.0061735874,0.0003333092,0.00008079005,0.85240453,0.0002160385,0.0045222323,0.0041429927],"study_design_scores_gemma":[0.0017984122,0.002522984,0.9340279,0.00007184729,0.00019944216,0.004033936,0.0005304291,0.000020118163,0.054951034,0.000063332154,0.0015519393,0.0002286293],"about_ca_topic_score_codex":0.000093522554,"about_ca_topic_score_gemma":0.00038677227,"teacher_disagreement_score":0.80448943,"about_ca_system_score_codex":0.00012886633,"about_ca_system_score_gemma":0.0006609731,"threshold_uncertainty_score":0.7557905},"labels":[],"label_agreement":null},{"id":"W2016917919","doi":"10.1016/j.ygyno.2012.03.048","title":"Preoperative identification of a suspicious adnexal mass: A systematic review and meta-analysis","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Meta-analysis; Adnexal mass; Confidence interval; MEDLINE; Bivariate analysis; Systematic review; Radiology; Receiver operating characteristic; Medical physics; Pathology; Internal medicine; Machine learning; Computer science","score_opus":0.1443210536215035,"score_gpt":0.4172580017863185,"score_spread":0.272936948164815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016917919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011988335,0.99061036,0.000028691655,0.00060845725,0.000087013395,0.0078482665,0.00016830594,0.000027087879,0.000620642],"genre_scores_gemma":[0.00062594883,0.98978066,0.00039594935,0.00052671693,0.000031392876,0.0071435473,0.00020936917,0.000026809557,0.0012595943],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954224,0.0013325312,0.0020818526,0.0006210516,0.00022286589,0.00031927874],"domain_scores_gemma":[0.9952296,0.0013752128,0.0021675217,0.0008171835,0.00024271122,0.00016775251],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015018537,0.0005172508,0.015506159,0.00035195053,0.00005454219,0.00001322058,0.00017547431,0.0005256869,0.0015716644],"category_scores_gemma":[0.0005665013,0.0002886528,0.0024566886,0.0007448791,0.00014042298,0.00005184688,0.00007785775,0.00028933265,0.00009605279],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028643165,0.0005070051,0.000018533165,0.7445482,0.2484868,0.00004417173,0.00005481636,1.3510996e-7,8.494835e-8,0.00023276605,0.0001245347,0.0059800725],"study_design_scores_gemma":[0.00023697797,0.00072515756,0.00004537817,0.0047860737,0.95130235,0.000104500345,0.000022548002,6.717916e-7,5.942141e-7,0.00001640988,0.042570237,0.00018910873],"about_ca_topic_score_codex":0.000016729035,"about_ca_topic_score_gemma":0.000042086973,"teacher_disagreement_score":0.7397621,"about_ca_system_score_codex":0.00063857343,"about_ca_system_score_gemma":0.00048773896,"threshold_uncertainty_score":0.99995655},"labels":[],"label_agreement":null},{"id":"W2017010308","doi":"10.1016/j.ygyno.2009.03.014","title":"A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Anesthesia; Patient-controlled analgesia; Gynecological surgery; Laparotomy; Randomized controlled trial; Surgery; Perioperative; Analgesic; Visual analogue scale; Clinical endpoint; Morphine","score_opus":0.015586088635263728,"score_gpt":0.284745169921226,"score_spread":0.2691590812859623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017010308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93818873,0.00081921386,0.00026197315,0.020787885,0.0005343434,0.035059113,0.000010772013,0.00013597068,0.00420202],"genre_scores_gemma":[0.91540647,0.00017100477,0.0006691585,0.070875734,0.00020965717,0.012134021,0.00003663175,0.000039332852,0.00045800093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9888223,0.0062556076,0.0019667994,0.0013113227,0.00045708573,0.0011869022],"domain_scores_gemma":[0.9847291,0.01287699,0.0010024718,0.0005208444,0.00035894205,0.00051165174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063022813,0.00084327895,0.006915646,0.0006515183,0.0003910512,0.00016988521,0.00033921027,0.0005474838,0.0008799463],"category_scores_gemma":[0.007162927,0.00057417207,0.00082076766,0.0004706215,0.00028393915,0.00018925047,0.00013055035,0.00063433184,0.000055291668],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9186764,0.0023296445,0.01519999,0.000023070457,0.0014723075,0.0013614156,0.00089536567,0.00023417057,0.00005206247,0.00037126924,0.0035414866,0.055842817],"study_design_scores_gemma":[0.8442313,0.0392539,0.1097303,0.000112013106,0.0014600325,0.00004296859,0.0006197581,0.0013479925,0.000014547375,0.00105047,0.0014695001,0.0006672295],"about_ca_topic_score_codex":0.00021757514,"about_ca_topic_score_gemma":0.00046455886,"teacher_disagreement_score":0.094530314,"about_ca_system_score_codex":0.001251548,"about_ca_system_score_gemma":0.0006047832,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W2017043551","doi":"10.1016/j.ygyno.2005.01.041","title":"Systemic therapy for advanced uterine sarcoma: A systematic review of the literature","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"Cancer Care Ontario","keywords":"Ifosfamide; Medicine; Doxorubicin; Sarcoma; Oncology; Uterine sarcoma; Leiomyosarcoma; Randomized controlled trial; Chemotherapy; Internal medicine; Cochrane Library; Dacarbazine; Surgery; Cisplatin; Pathology","score_opus":0.03914729491489344,"score_gpt":0.3964874626598424,"score_spread":0.357340167744949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017043551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023893785,0.9797251,0.0000040579794,0.0004914716,0.00072546705,0.018221851,0.00018753759,0.00005485075,0.0005657701],"genre_scores_gemma":[0.000051446117,0.9882232,0.00082469214,0.001312794,0.00019384341,0.006360903,0.00022659136,0.00006267268,0.0027438467],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.996499,0.0006430498,0.0017042991,0.0005316025,0.00020724886,0.00041478215],"domain_scores_gemma":[0.995672,0.0010462225,0.0017767419,0.0011442213,0.00026441243,0.00009640576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005945766,0.00062815804,0.0070574805,0.00013163165,0.000075613076,0.00000971535,0.0005057901,0.00065316237,0.00012883989],"category_scores_gemma":[0.000730932,0.00028587683,0.0016321953,0.00045143493,0.00008825802,0.000035687062,0.0001529211,0.0004035026,0.000029676514],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024128745,0.00033104158,0.0000018377334,0.7088336,0.000624001,0.00006196719,0.000018693643,2.7753698e-8,9.759669e-7,0.00005959265,0.00046852286,0.28957567],"study_design_scores_gemma":[0.0011703281,0.0014518842,0.0000035601463,0.45842215,0.002779628,0.0017755461,0.0000040119953,3.5155438e-7,4.7299264e-7,0.000007803552,0.5342571,0.00012718505],"about_ca_topic_score_codex":8.788894e-7,"about_ca_topic_score_gemma":0.0000024389658,"teacher_disagreement_score":0.53378856,"about_ca_system_score_codex":0.0007004728,"about_ca_system_score_gemma":0.00067741115,"threshold_uncertainty_score":0.99995935},"labels":[],"label_agreement":null},{"id":"W2017055023","doi":"10.1016/j.ygyno.2005.03.040","title":"Quality of life assessment during adjuvant and salvage chemotherapy for advance stage epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Chemotherapy; Ovarian cancer; Oncology; Internal medicine; Disease; Adjuvant; Cancer; Stage (stratigraphy); Adjuvant therapy","score_opus":0.035496408626650953,"score_gpt":0.3949745626083521,"score_spread":0.3594781539817012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017055023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97736394,0.0014527517,0.00033824152,0.017297192,0.00035362135,0.0013317167,0.00020382158,0.00004761447,0.0016110963],"genre_scores_gemma":[0.9722878,0.0023570284,0.02094032,0.0026189166,0.00039121494,0.00071900885,0.000017123735,0.00002280092,0.000645787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984099,0.000104565304,0.00054365245,0.00043417644,0.00014585706,0.00036184798],"domain_scores_gemma":[0.9985199,0.0005728867,0.00035205044,0.00026837192,0.00010822313,0.00017857601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004661599,0.00020199579,0.0008627943,0.000065585315,0.00009363895,0.0000067331634,0.00007954241,0.00019467401,0.0009588389],"category_scores_gemma":[0.00016994012,0.00016063561,0.00012250834,0.000082046034,0.00013335908,0.000064898326,0.000045315675,0.00014716413,0.000003417123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027769117,0.0038235425,0.5125955,0.00073710945,0.0008864574,0.000047780664,0.0006624109,0.0002491906,0.035113793,0.0058434196,0.00091022806,0.4363537],"study_design_scores_gemma":[0.015920164,0.0019780812,0.912913,0.00002769402,0.00010027087,0.000005442928,0.00014647347,0.000108307,0.0046666465,0.00013754141,0.063829936,0.00016640578],"about_ca_topic_score_codex":0.0001375426,"about_ca_topic_score_gemma":0.00066448876,"teacher_disagreement_score":0.4361873,"about_ca_system_score_codex":0.0007639039,"about_ca_system_score_gemma":0.00060014334,"threshold_uncertainty_score":0.9999544},"labels":[],"label_agreement":null},{"id":"W2017548690","doi":"10.1016/s0090-8258(03)00323-8","title":"Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy☆","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecologic cancer; General surgery; Medical physics; Gynecology; Surgery; Cancer; Internal medicine","score_opus":0.11287293862956714,"score_gpt":0.4442305866477307,"score_spread":0.33135764801816353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017548690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80730134,0.047275033,0.000031938238,0.0072683594,0.00057812384,0.0028121928,0.0000118140015,0.000082736944,0.13463844],"genre_scores_gemma":[0.9584403,0.034681726,0.0012495338,0.0050449427,0.00005665124,0.00035848265,0.000022264636,0.000020662246,0.0001254039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950874,0.0010687921,0.002115084,0.0006460514,0.00030192817,0.00078073627],"domain_scores_gemma":[0.9802108,0.017216528,0.0013523784,0.000477116,0.00044190913,0.0003013128],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004466085,0.00027489662,0.0020435408,0.00024376849,0.000096386604,0.0000073457813,0.00019764408,0.0004925681,0.0058688005],"category_scores_gemma":[0.1224963,0.00021595642,0.00015991546,0.00059932366,0.00050019874,0.00006105391,0.00020398136,0.0007949654,0.000035117137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033276126,0.0018103087,0.6384701,0.0044798804,0.00011752849,0.0038269144,0.00020336811,0.000014870283,0.0010391608,0.0027001747,0.004262744,0.3427422],"study_design_scores_gemma":[0.0032561175,0.0049859923,0.8433779,0.00023855758,0.00017907696,0.00078032486,0.00028312154,0.000023404964,0.00037376035,0.0019195972,0.14434129,0.00024087077],"about_ca_topic_score_codex":0.00016394447,"about_ca_topic_score_gemma":0.0020023135,"teacher_disagreement_score":0.3425013,"about_ca_system_score_codex":0.00071927643,"about_ca_system_score_gemma":0.001289629,"threshold_uncertainty_score":0.99504},"labels":[],"label_agreement":null},{"id":"W2017800162","doi":"10.1016/j.ygyno.2015.01.010","title":"A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal; McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Conjugate; Internal medicine; Paclitaxel; Cancer; Oncology; Nuclear medicine","score_opus":0.14478755348117509,"score_gpt":0.3979734417184835,"score_spread":0.25318588823730837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017800162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553,0.00065000553,0.00001372028,0.0027552748,0.0009108184,0.005734799,0.000010212319,0.000081144404,0.0043140296],"genre_scores_gemma":[0.9956946,0.00020170571,0.00041157386,0.0002725449,0.00016836087,0.0030404134,0.000076302385,0.00003779309,0.00009672102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996276,0.00041402073,0.0012226095,0.00081988715,0.00038208737,0.0008853735],"domain_scores_gemma":[0.99734104,0.0011722617,0.0005435684,0.00029156718,0.0002061398,0.00044543087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017131397,0.0004656064,0.0022996608,0.00046510628,0.000102191705,0.00005405387,0.00014697568,0.00044756584,0.00027046198],"category_scores_gemma":[0.00048800005,0.00035073666,0.00009662794,0.00063308567,0.00031968873,0.00018283806,0.000108616056,0.00053560425,0.000017105054],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.966589,0.005278917,0.019738639,0.00004591147,0.00052802835,0.0009704265,0.0020785988,0.0002682349,0.00016101699,0.001002317,0.00013328905,0.0032056745],"study_design_scores_gemma":[0.9636626,0.016183805,0.013755918,0.00016164436,0.00085698284,0.000029233657,0.00088708644,0.0028782631,0.0004525918,0.00026321484,0.0005110064,0.0003576098],"about_ca_topic_score_codex":0.0041378993,"about_ca_topic_score_gemma":0.028201854,"teacher_disagreement_score":0.024063954,"about_ca_system_score_codex":0.00203759,"about_ca_system_score_gemma":0.00145141,"threshold_uncertainty_score":0.99989444},"labels":[],"label_agreement":null},{"id":"W2017824120","doi":"10.1016/j.ygyno.2014.05.014","title":"Trends in incidence and survival of women with invasive vulvar cancer in the United States and Canada: A population-based study","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vulvar cancer; Incidence (geometry); Population; Demography; Gynecology; Cancer; Oncology; Internal medicine; Environmental health","score_opus":0.022425208741786967,"score_gpt":0.309022368204181,"score_spread":0.28659715946239406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017824120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819386,0.000058917165,8.472185e-7,0.0012011171,0.00004202005,0.00034634906,0.000009613737,0.000004294535,0.00014299601],"genre_scores_gemma":[0.9986404,0.000042423828,0.0000245124,0.0010510407,0.000012785761,0.00018984897,0.000022203008,0.000004128155,0.00001261692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988588,0.00037434924,0.00021430854,0.00018698353,0.00014863652,0.00021692144],"domain_scores_gemma":[0.9975612,0.0021312456,0.000097842436,0.00009816474,0.000045290675,0.00006624432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005228308,0.000099780234,0.00042319845,0.00023430602,0.00002824781,0.0000032204332,0.000058138434,0.000056005145,0.000101971396],"category_scores_gemma":[0.00040725377,0.000055975273,0.000006399679,0.00063849083,0.000059067497,0.00001789685,0.000023042141,0.00012344313,8.342954e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006902242,0.00034275535,0.98926604,0.000021039563,0.000029694707,0.0000821825,0.0011494104,0.00023042112,0.0000068267955,0.000020260926,0.0000054522297,0.00815572],"study_design_scores_gemma":[0.00666097,0.005844752,0.98394614,0.000015090949,0.000040826857,0.0000028692657,0.003148201,0.00008923774,0.0000045511592,0.000074023,0.00011607379,0.00005728582],"about_ca_topic_score_codex":0.793618,"about_ca_topic_score_gemma":0.9878109,"teacher_disagreement_score":0.19419289,"about_ca_system_score_codex":0.00082991476,"about_ca_system_score_gemma":0.0003712865,"threshold_uncertainty_score":0.22826053},"labels":[],"label_agreement":null},{"id":"W2017926574","doi":"10.1016/j.ygyno.2004.05.049","title":"Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Coagulative necrosis; Medicine; Leiomyosarcoma; Smooth Muscle Tumor; Leiomyoma; Necrosis; Lesion; Pathology; Uterus; Myometrium; Uterine sarcoma; Internal medicine","score_opus":0.026521964538667304,"score_gpt":0.32218101965755674,"score_spread":0.29565905511888946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017926574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733311,0.00025211283,0.0003115006,0.023017852,0.000668523,0.0010299936,0.000042595788,0.00007975816,0.0012665478],"genre_scores_gemma":[0.98442996,0.00004188551,0.011466949,0.0032883936,0.00016754429,0.00019460132,0.00003406026,0.000028562808,0.00034806828],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980108,0.00015431609,0.00052091276,0.00046400222,0.0002659581,0.0005840242],"domain_scores_gemma":[0.9987878,0.000160574,0.00022553453,0.0005120728,0.00009861401,0.00021538847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035626773,0.0002854607,0.0007594444,0.00016065563,0.00015927372,0.000014334883,0.00028539955,0.0001354457,0.00075015525],"category_scores_gemma":[0.00019560225,0.0001758574,0.00019641391,0.0003395973,0.00017275008,0.000049354596,0.00028414457,0.00021929681,0.00021874101],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040145894,0.018988425,0.012887675,0.0005806085,0.0050776578,0.06494689,0.0032561473,0.004776488,0.44429243,0.04123589,0.004698536,0.39524466],"study_design_scores_gemma":[0.020178445,0.034234278,0.4461454,0.00011806627,0.0015138973,0.0029521212,0.0009967803,0.0000607532,0.030006332,0.007230926,0.45584795,0.0007150837],"about_ca_topic_score_codex":0.0016742131,"about_ca_topic_score_gemma":0.00043467354,"teacher_disagreement_score":0.4511494,"about_ca_system_score_codex":0.00043208708,"about_ca_system_score_gemma":0.00039793292,"threshold_uncertainty_score":0.8213674},"labels":[],"label_agreement":null},{"id":"W2018100760","doi":"10.1016/j.ygyno.2014.04.003","title":"Dynamic modeling in ovarian cancer: An original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help decisions in early drug development","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Oncology; Receiver operating characteristic; Ovarian cancer; Predictive value; Internal medicine; Parametric statistics; Predictive marker; Cancer; Statistics; Mathematics","score_opus":0.05433801386473591,"score_gpt":0.3277328218629944,"score_spread":0.2733948079982585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018100760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922432,0.00027228595,0.003297016,0.0022492714,0.0003085703,0.0010215568,0.000007536565,0.000029161061,0.00057140394],"genre_scores_gemma":[0.96469826,0.00040071452,0.033606935,0.00032830262,0.00007584956,0.0007768839,0.00003641344,0.000029181327,0.000047471814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728614,0.00028160284,0.0005964564,0.0008561917,0.00025116443,0.00072845974],"domain_scores_gemma":[0.9988076,0.0004381878,0.000106643,0.00029205135,0.00008368325,0.00027182358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010339959,0.00032510434,0.00090961496,0.0006437193,0.00007995985,0.000033981578,0.00018394135,0.000310767,0.000038861945],"category_scores_gemma":[0.00014526531,0.00028991018,0.000035275054,0.0005752949,0.000054114575,0.00008466977,0.00015002837,0.00045577914,0.0000095336945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041543486,0.0018296749,0.85208005,0.000039235223,0.00004795987,0.0002789007,0.0038715098,0.033324372,0.00013099256,0.00038461684,0.0000056016365,0.10759163],"study_design_scores_gemma":[0.0055731665,0.0018846593,0.8483159,0.0001899178,0.000052763095,0.000019259845,0.00033213655,0.14238971,0.000028021212,0.0004285067,0.00047908467,0.00030685504],"about_ca_topic_score_codex":0.004543412,"about_ca_topic_score_gemma":0.18193439,"teacher_disagreement_score":0.17739098,"about_ca_system_score_codex":0.0021519626,"about_ca_system_score_gemma":0.00049733976,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2019067804","doi":"10.1016/j.ygyno.2010.05.012","title":"Risk factors for non-invasive lesions of the fallopian tube in BRCA mutation carriers","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Fallopian tube; BRCA mutation; Mutation; Gynecology; Oncology; Internal medicine; Genetics; Ovarian cancer; Cancer; Gene; Biology","score_opus":0.018958541067977567,"score_gpt":0.3053359126236823,"score_spread":0.28637737155570475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019067804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216473,0.000020018984,0.000020766438,0.0027977014,0.0011381842,0.001314214,0.000074157106,0.000013650007,0.0024565596],"genre_scores_gemma":[0.99794775,0.00006396002,0.001058723,0.00035874933,0.000061184626,0.0003164135,0.000025302475,0.0000106317575,0.00015725788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907416,0.00007449572,0.00028190453,0.00024318989,0.00008715206,0.00023911885],"domain_scores_gemma":[0.9976947,0.0016704162,0.00020421458,0.00025837068,0.00009232593,0.00007999715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021436904,0.0001253983,0.00037475143,0.00008183025,0.000099273144,0.0000033975123,0.0001097537,0.00027452793,0.00025240774],"category_scores_gemma":[0.0016456898,0.00007642542,0.00015102242,0.00016593139,0.0001623294,0.00002683035,0.000036734382,0.00027513778,0.000005506107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008427117,0.0006792202,0.9783043,0.000034530887,0.00012544026,0.000033158114,0.0014639051,0.000091798545,0.0019429906,0.00086954783,0.0010702034,0.01530059],"study_design_scores_gemma":[0.0033237126,0.0018782015,0.9794786,0.000015365624,0.00020617503,0.000009840709,0.001032007,0.00007399313,0.006146595,0.0007789308,0.006980279,0.00007627859],"about_ca_topic_score_codex":0.00051173836,"about_ca_topic_score_gemma":0.013321254,"teacher_disagreement_score":0.0152243115,"about_ca_system_score_codex":0.00030210722,"about_ca_system_score_gemma":0.0006929545,"threshold_uncertainty_score":0.74335724},"labels":[],"label_agreement":null},{"id":"W2020076805","doi":"10.1016/j.ygyno.2005.07.037","title":"Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Biopsy; Pathology; Colposcopy; Histopathology; Interim analysis; Gold standard (test); Papanicolaou stain; Cervical cancer; Cancer; Clinical trial; Internal medicine","score_opus":0.016687666887099013,"score_gpt":0.3267149558925493,"score_spread":0.3100272890054503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020076805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518575,0.0012938734,0.00017149313,0.022365948,0.000057934052,0.0007739165,0.00003425309,0.00010752519,0.023337549],"genre_scores_gemma":[0.99554676,0.00030045366,0.00083264604,0.0022157894,0.00012258963,0.00010813342,0.000097933254,0.000018429493,0.0007572788],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980168,0.0002639023,0.0003033994,0.00050512364,0.0003251893,0.00058561534],"domain_scores_gemma":[0.9987054,0.0004981756,0.0000909631,0.00023866585,0.00017977488,0.00028705687],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061333075,0.0002187088,0.00085291575,0.00035945766,0.00007664796,0.000019703897,0.00013253847,0.00046023264,0.014024676],"category_scores_gemma":[0.00031461095,0.00015187943,0.000071305105,0.0011007298,0.00033067065,0.000055862718,0.00009635739,0.0006739522,0.00007185057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035768938,0.0024822408,0.36015135,0.00020824221,0.0011258487,0.0008398465,0.0012527093,0.00003092367,0.014204827,0.0000785933,0.008432487,0.607616],"study_design_scores_gemma":[0.0051143304,0.0040395116,0.96971095,0.000005433638,0.0005393548,0.00008232708,0.00031596236,0.00275135,0.0011622283,0.00003468911,0.016028408,0.0002154513],"about_ca_topic_score_codex":0.0002364275,"about_ca_topic_score_gemma":0.02215499,"teacher_disagreement_score":0.6095596,"about_ca_system_score_codex":0.0005154847,"about_ca_system_score_gemma":0.00022629021,"threshold_uncertainty_score":0.99568814},"labels":[],"label_agreement":null},{"id":"W2021021306","doi":"10.1016/j.ygyno.2014.02.020","title":"Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Medicine; Progestin; Fertility; Endometrial cancer; Live birth; Obstetrics; Hysterectomy; Gynecology; Population; Fertility preservation; Pregnancy; Cancer; Internal medicine; Surgery; Estrogen","score_opus":0.13221457772885506,"score_gpt":0.3887110697350655,"score_spread":0.2564964920062104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021021306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996617,0.0004627721,0.00006248847,0.0005101322,0.0004199716,0.00081317377,0.000017530128,0.00004937657,0.0010475435],"genre_scores_gemma":[0.9947141,0.000120190874,0.004578431,0.00020165124,0.00018727247,0.000104506835,0.000019394633,0.00001380453,0.0000606398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829745,0.000257506,0.0004471762,0.00041916437,0.00017662835,0.00040205562],"domain_scores_gemma":[0.99818826,0.0011140376,0.0001839378,0.00020065157,0.000079862744,0.0002332257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025159883,0.00022931302,0.0010771722,0.00016077884,0.000090925205,0.000007434438,0.0000713684,0.00024722973,0.0005508801],"category_scores_gemma":[0.0007692264,0.00015867002,0.00013310183,0.00036556786,0.000275674,0.000033341927,0.00006652067,0.00012038586,0.0000075606454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032876597,0.0023091035,0.77317363,0.00008791938,0.000245502,0.000051407074,0.0000771675,0.00002821813,0.011492264,0.00012748758,0.000017525905,0.20910212],"study_design_scores_gemma":[0.020032946,0.012532455,0.9554951,0.000025817042,0.00056571385,0.00009103602,0.00003692737,0.001621275,0.0037009679,0.0003558736,0.005377734,0.00016414023],"about_ca_topic_score_codex":0.00063745264,"about_ca_topic_score_gemma":0.00032598706,"teacher_disagreement_score":0.20893797,"about_ca_system_score_codex":0.000822023,"about_ca_system_score_gemma":0.00021911341,"threshold_uncertainty_score":0.64703757},"labels":[],"label_agreement":null},{"id":"W2021822156","doi":"10.1016/j.ygyno.2014.03.221","title":"The usefulness of ovarian cancer risk scoring in the discrimination of an isolated pelvic mass","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Hamilton Health Sciences; Mount Sinai Hospital; Juravinski Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Body mass index; Cohort; Malignancy; Referral; Prospective cohort study; Oncology; Gynecology; Cancer; Population; Disease; Internal medicine","score_opus":0.03214734786407029,"score_gpt":0.31793091596228823,"score_spread":0.2857835680982179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021822156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105746,0.00024660354,0.00020613572,0.0046414556,0.00043214086,0.0005701524,0.000010538053,0.000012454333,0.0028230746],"genre_scores_gemma":[0.9985525,0.00047096834,0.00033081582,0.00023754034,0.00007928066,0.0002741585,0.000009348145,0.000008646082,0.00003672032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984553,0.0005775559,0.00037578325,0.0002151854,0.00014882616,0.00022733818],"domain_scores_gemma":[0.9977547,0.0014080169,0.0003367977,0.00036293126,0.00009879234,0.00003875891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011896557,0.000114075716,0.00037048088,0.00006945537,0.00010407495,0.0000073894557,0.00019114817,0.00013952258,0.0001064079],"category_scores_gemma":[0.00040149374,0.000058301885,0.00006373472,0.00023460088,0.00015979016,0.000047297443,0.000028509377,0.00019883936,0.0000031309103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005495012,0.0017607245,0.508795,0.00011292968,0.00020784533,0.000046015044,0.0032801514,0.0005392519,0.0007559109,0.010424947,0.0001904262,0.4733373],"study_design_scores_gemma":[0.0026266892,0.0030235061,0.98469335,0.00004456848,0.0002683139,0.000008916414,0.0012907314,0.0019240531,0.00094630907,0.002308987,0.0027958911,0.00006869803],"about_ca_topic_score_codex":0.001117577,"about_ca_topic_score_gemma":0.005525746,"teacher_disagreement_score":0.47589836,"about_ca_system_score_codex":0.00025122808,"about_ca_system_score_gemma":0.00018087367,"threshold_uncertainty_score":0.30834958},"labels":[],"label_agreement":null},{"id":"W2021853462","doi":"10.1016/j.ygyno.2014.03.043","title":"External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Nomogram; Medicine; Family history; Ovarian cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Disease; Gynecology; Cohort","score_opus":0.04117889233257345,"score_gpt":0.336828700878626,"score_spread":0.29564980854605255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021853462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208934,0.0008988095,0.00051537296,0.0023906443,0.0013182398,0.0008731832,0.00015984569,0.00009324713,0.01166129],"genre_scores_gemma":[0.99008685,0.0005553756,0.0034299304,0.004046608,0.0003063867,0.00041822088,0.00012512246,0.000030972667,0.0010005359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792105,0.00024582277,0.0004641419,0.0005771207,0.00028366304,0.00050819706],"domain_scores_gemma":[0.9983161,0.00028470697,0.0004114911,0.00047334377,0.0002072346,0.00030708683],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036531838,0.00026174262,0.00070036435,0.00015027211,0.00005778578,0.000008395145,0.00015524957,0.00033901416,0.0028315885],"category_scores_gemma":[0.00012536296,0.00021663663,0.00014659802,0.00011555643,0.00023160435,0.00012076799,0.00006288986,0.00024070538,0.000031176558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019894538,0.007002879,0.6793507,0.00023676717,0.0014188752,0.00042296376,0.007546414,0.00053476286,0.0083754165,0.0021712305,0.016193137,0.27475742],"study_design_scores_gemma":[0.005156912,0.008771637,0.7558344,0.000040278315,0.0005588724,0.000015706411,0.00035398564,0.00087925734,0.002438228,0.00024759411,0.2255056,0.00019752541],"about_ca_topic_score_codex":0.0023362797,"about_ca_topic_score_gemma":0.00039960872,"teacher_disagreement_score":0.2745599,"about_ca_system_score_codex":0.0026376417,"about_ca_system_score_gemma":0.00083678914,"threshold_uncertainty_score":0.99807996},"labels":[],"label_agreement":null},{"id":"W2021888893","doi":"10.1016/j.ygyno.2003.09.025","title":"Optimal management for surgically Stage 1 serous cancer of the uterus","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Stage (stratigraphy); Surgery; Serous fluid; Regimen; Radiation therapy; Endometrial cancer; Cancer; Retrospective cohort study; Chemotherapy; Adjuvant therapy; Uterine cancer; Internal medicine","score_opus":0.041029493816013625,"score_gpt":0.35011575434099274,"score_spread":0.3090862605249791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021888893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231308,0.0006944969,0.00024620816,0.0022088322,0.0013649843,0.0020587908,0.00006416837,0.000039159742,0.07019253],"genre_scores_gemma":[0.9788928,0.00036215564,0.0058175703,0.0018074326,0.000065877626,0.00065593916,0.00000706672,0.000013248735,0.0123779345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988972,0.00011208802,0.00029045792,0.0002439553,0.00014587514,0.00031044282],"domain_scores_gemma":[0.9989999,0.00045100448,0.00014724673,0.0002325822,0.000086916734,0.00008236791],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027422747,0.00012798402,0.00043282058,0.000051062645,0.000070973874,0.0000032805515,0.00013218002,0.00014699342,0.001904253],"category_scores_gemma":[0.00019665623,0.00007267061,0.00018554639,0.00025571935,0.00010379212,0.00001649477,0.000059055714,0.000105684565,0.000010084818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010595546,0.012330775,0.2793667,0.0022312913,0.0050911005,0.0012173051,0.0007462555,0.0026280275,0.0032229777,0.096496046,0.015999949,0.570074],"study_design_scores_gemma":[0.018019525,0.0055679763,0.14402783,0.000031298117,0.00068084337,0.00003710069,0.0002883901,0.000031909833,0.0041706427,0.0008695296,0.8260787,0.00019625844],"about_ca_topic_score_codex":0.00003808467,"about_ca_topic_score_gemma":0.00007899946,"teacher_disagreement_score":0.81007874,"about_ca_system_score_codex":0.00036540613,"about_ca_system_score_gemma":0.0001833904,"threshold_uncertainty_score":0.9990081},"labels":[],"label_agreement":null},{"id":"W2022157561","doi":"10.1016/j.ygyno.2012.03.027","title":"Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Regimen; Ovarian cancer; Gynecologic oncology; Fallopian tube; Cisplatin; Neutropenia; Paclitaxel; Chemotherapy; Surgery; Fallopian tube cancer; Ovarian carcinoma; Internal medicine; Ovary; Gastroenterology; Oncology; Gynecology; Cancer","score_opus":0.02659873446706569,"score_gpt":0.30471148131131137,"score_spread":0.2781127468442457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022157561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98623127,0.0064976146,0.000009335621,0.0026271895,0.000434855,0.001398218,0.0000986575,0.00002297756,0.0026798674],"genre_scores_gemma":[0.9898476,0.0035716665,0.00542422,0.00049012614,0.00017324022,0.00037644428,0.000047457223,0.000029742294,0.000039503244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742794,0.00027904424,0.00080795045,0.00054119295,0.00031520752,0.00062864064],"domain_scores_gemma":[0.9981574,0.0006836879,0.00036404075,0.000360499,0.000103499646,0.00033087848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069388153,0.00035411894,0.0014058272,0.0001944481,0.000077935285,0.000012266988,0.00011837961,0.00048529598,0.000087865235],"category_scores_gemma":[0.00016583636,0.0002877644,0.00007018062,0.00016188277,0.00065021584,0.00014898219,0.00030680795,0.0003826364,4.130529e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023724306,0.0039758035,0.8468976,0.0010058304,0.0003606601,0.0001386509,0.004689325,0.000006097302,0.007230513,0.0027526505,0.00020606839,0.13036437],"study_design_scores_gemma":[0.009251432,0.0057813963,0.9817447,0.00019589943,0.00025346037,0.0001288995,0.00040340188,0.000069914204,0.00065655087,0.0002818225,0.0009742982,0.00025820266],"about_ca_topic_score_codex":0.0007270814,"about_ca_topic_score_gemma":0.00046690868,"teacher_disagreement_score":0.13484713,"about_ca_system_score_codex":0.0005613736,"about_ca_system_score_gemma":0.00050639256,"threshold_uncertainty_score":0.99995744},"labels":[],"label_agreement":null},{"id":"W2023139738","doi":"10.1016/j.ygyno.2007.12.015","title":"Treating vulvar cancer in the new millennium: Are patients receiving optimal care?","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Vulvar cancer; Vulvar Carcinoma; Cohort; Dissection (medical); Radiation therapy; Cancer; Carcinoma; Vulvar neoplasm; Groin; Cancer registry; General surgery; Surgery; Internal medicine","score_opus":0.03562914100552237,"score_gpt":0.3249115658520411,"score_spread":0.2892824248465187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023139738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973921,0.002981787,0.000005217217,0.0023709899,0.000556922,0.00071689725,0.00001213806,0.000046686215,0.019388366],"genre_scores_gemma":[0.9938129,0.0016559493,0.00077876507,0.002568489,0.0003470063,0.00020404105,0.000026652504,0.000015207638,0.0005909791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836767,0.00021274536,0.00035585056,0.0003619213,0.00024013949,0.0004616825],"domain_scores_gemma":[0.9985483,0.00081644097,0.00017557241,0.0002226608,0.00009953186,0.00013747718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014934436,0.00020155386,0.00055118004,0.00013092594,0.00017390416,0.000006184704,0.00018240426,0.00024473856,0.0009476617],"category_scores_gemma":[0.00063903205,0.0001226922,0.000111978836,0.0005308023,0.000093886854,0.00005089706,0.00006341432,0.00034240223,0.00005659691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003768136,0.00061200187,0.8775307,0.000027232165,0.000056555746,0.0004811659,0.0032969061,0.000081479935,0.000031243882,0.0000078418525,0.0044397833,0.11305827],"study_design_scores_gemma":[0.008253542,0.002738209,0.96603966,0.00003641431,0.000103719634,0.000044360015,0.0016551652,0.00000943783,0.00007261621,0.000018752766,0.02089474,0.00013337262],"about_ca_topic_score_codex":0.0009098391,"about_ca_topic_score_gemma":0.0019194273,"teacher_disagreement_score":0.112924896,"about_ca_system_score_codex":0.0010418218,"about_ca_system_score_gemma":0.00041463968,"threshold_uncertainty_score":0.9999656},"labels":[],"label_agreement":null},{"id":"W2023398941","doi":"10.1016/j.ygyno.2007.08.084","title":"Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Ifosfamide; Paclitaxel; Urology; Chemotherapy; Endometrial cancer; Uterine cancer; Oncology; Internal medicine; Cancer; Gynecology; Cisplatin","score_opus":0.04979267677869392,"score_gpt":0.3714260174683374,"score_spread":0.3216333406896435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023398941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880831,0.0017971992,0.00020898313,0.0011702878,0.002957703,0.0027678143,0.0001355522,0.00010644384,0.0027728972],"genre_scores_gemma":[0.9834353,0.00088807143,0.0026869385,0.0020123604,0.00048605603,0.0024981848,0.000054167143,0.000032410488,0.007906525],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974499,0.00011614667,0.0007078247,0.0006216894,0.00025074612,0.0008537108],"domain_scores_gemma":[0.9975555,0.0013171604,0.00029695526,0.00034588805,0.00019218893,0.00029229332],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005856781,0.00023241632,0.00081554824,0.00004640968,0.00051742885,0.000078625046,0.00026590814,0.00024448903,0.003882212],"category_scores_gemma":[0.0012783416,0.00018530403,0.00019724718,0.00047540752,0.0002552306,0.000061237064,0.00013103358,0.00024357787,0.00001557729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004600382,0.0009710409,0.012737169,0.00016896517,0.00018800123,0.0015543564,0.00095078006,0.000009482982,0.002333804,0.000034709898,0.005350242,0.97110105],"study_design_scores_gemma":[0.025217108,0.017936016,0.5680376,0.0002032028,0.0002993277,0.00048176385,0.0025180213,0.000093608156,0.0011812395,0.00056003686,0.38287976,0.00059227267],"about_ca_topic_score_codex":0.0092038475,"about_ca_topic_score_gemma":0.19100219,"teacher_disagreement_score":0.9705088,"about_ca_system_score_codex":0.0012267976,"about_ca_system_score_gemma":0.0006166892,"threshold_uncertainty_score":0.99739397},"labels":[],"label_agreement":null},{"id":"W2023440667","doi":"10.1006/gyno.2000.5799","title":"Information Needs and Decisional Preferences among Women with Ovarian Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Disease; Ovarian cancer; Coping (psychology); Breast cancer; Health care; Cancer; Family medicine; Gynecology; Gerontology; Internal medicine; Psychiatry","score_opus":0.10685282295810439,"score_gpt":0.39832434832682573,"score_spread":0.29147152536872134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023440667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95496136,0.00024189982,0.000016288534,0.00392633,0.00033965812,0.0010029709,0.000029474088,0.00011420849,0.03936781],"genre_scores_gemma":[0.98999614,0.0005132763,0.0012091505,0.004927799,0.00006268011,0.002452446,0.00003485985,0.000008611263,0.00079501205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997634,0.00086748315,0.00060880306,0.00013484307,0.00019053424,0.0005643691],"domain_scores_gemma":[0.9968081,0.0020311123,0.0003402833,0.00036032943,0.0002429626,0.00021720672],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038501105,0.00015271739,0.00032236532,0.00016759403,0.00081481267,0.000012294064,0.00030835328,0.0004129236,0.011382133],"category_scores_gemma":[0.00030688161,0.00011113744,0.000013279183,0.00032150908,0.00023769656,0.00048101664,0.00014458528,0.00064145855,0.0003005657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004821795,0.00006954219,0.59176916,0.00007981432,0.000033066193,0.0000015312834,0.055465918,0.00009203394,0.0000021434983,0.00091922696,0.003177103,0.3479083],"study_design_scores_gemma":[0.0014146081,0.00094604614,0.7532455,0.000049652575,0.0000103786015,0.0000028612749,0.034112982,0.00013893655,6.128262e-7,0.0022624831,0.20767629,0.00013966692],"about_ca_topic_score_codex":0.00095913024,"about_ca_topic_score_gemma":0.0021993965,"teacher_disagreement_score":0.34776863,"about_ca_system_score_codex":0.00076806627,"about_ca_system_score_gemma":0.0011132687,"threshold_uncertainty_score":0.9895216},"labels":[],"label_agreement":null},{"id":"W2024576843","doi":"10.1016/j.ygyno.2015.01.216","title":"The impact of time between histologic diagnosis of endometrial cancer and surgical treatment on stage and survival","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Stage (stratigraphy); Endometrial cancer; Cancer; Overall survival; Gynecology; General surgery; Oncology; Internal medicine","score_opus":0.09111593916006493,"score_gpt":0.3979023869759154,"score_spread":0.30678644781585046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024576843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98860085,0.004106224,3.2529942e-7,0.0008234329,0.00023866138,0.00059312733,0.00014395837,0.000016278436,0.00547713],"genre_scores_gemma":[0.99454564,0.0045007174,0.000038384627,0.000025485151,0.00017074993,0.00014064291,0.00001685233,0.000008629119,0.0005528793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985535,0.00029206485,0.0003981467,0.00027366876,0.00019836337,0.00028424998],"domain_scores_gemma":[0.9921512,0.007048985,0.00025929173,0.00018116862,0.00010536175,0.0002539755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055847416,0.00019516601,0.0010501557,0.00014048624,0.000059248734,0.000004870465,0.00007898951,0.00028210884,0.00032576223],"category_scores_gemma":[0.0012266426,0.000094409304,0.00015616362,0.00029205575,0.00041176032,0.000021574386,0.000071305025,0.00015077107,0.0000065465847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00390819,0.0008178155,0.8534272,0.000013898569,0.00060019613,0.0001006745,0.00007633642,0.00000900844,0.000043309028,0.0001351174,0.00023919436,0.1406291],"study_design_scores_gemma":[0.036470212,0.09149299,0.8463767,0.000019574001,0.00067841023,0.000026028874,0.0001379316,0.000015412565,0.0012197413,0.0005450115,0.022836743,0.00018121589],"about_ca_topic_score_codex":0.0015346198,"about_ca_topic_score_gemma":0.00011642592,"teacher_disagreement_score":0.14044788,"about_ca_system_score_codex":0.0009258089,"about_ca_system_score_gemma":0.00037929942,"threshold_uncertainty_score":0.38498998},"labels":[],"label_agreement":null},{"id":"W2024595809","doi":"10.1016/j.ygyno.2004.01.011","title":"Primary extranodal marginal zone B-cell lymphoma of MALT type of the endometrium","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pathology; MALT lymphoma; Endometrium; Lymphoma; Medicine; Mucosa-associated lymphoid tissue; Marginal zone; Lymphatic system; B cell; Internal medicine; Immunology; Antibody","score_opus":0.022911765660753956,"score_gpt":0.2820026087674815,"score_spread":0.25909084310672753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024595809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579987,0.0012836029,0.000020000523,0.0016104843,0.00061292265,0.0005674638,0.000015540223,0.000022515052,0.037868805],"genre_scores_gemma":[0.99498284,0.00031372963,0.002992489,0.00084014586,0.00005982851,0.00004001104,0.000014519163,0.000012196414,0.00074424926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866307,0.00009875992,0.00044313387,0.0002507471,0.00023976168,0.00030453902],"domain_scores_gemma":[0.99854356,0.00052515784,0.00030162543,0.00038022536,0.00015991999,0.0000895081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024315236,0.00016795611,0.00065659895,0.00012782484,0.00004950445,0.0000022091663,0.00019046203,0.0002427843,0.000425003],"category_scores_gemma":[0.00022494237,0.0001029128,0.00020540859,0.00046662102,0.00030333668,0.000027346156,0.0001126249,0.00008500073,0.00005129528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037294147,0.047976114,0.6876317,0.0008721123,0.0008334544,0.0015511939,0.00072480075,0.0002045361,0.098974586,0.0074654017,0.0040430175,0.14599366],"study_design_scores_gemma":[0.02093524,0.007272938,0.9019608,0.000035839912,0.0003485481,0.00028085086,0.00010009532,0.000002279255,0.05061842,0.00032252874,0.01801197,0.000110519875],"about_ca_topic_score_codex":0.00011571074,"about_ca_topic_score_gemma":0.00003365413,"teacher_disagreement_score":0.21432906,"about_ca_system_score_codex":0.0008578138,"about_ca_system_score_gemma":0.001190128,"threshold_uncertainty_score":0.46534848},"labels":[],"label_agreement":null},{"id":"W2024881537","doi":"10.1016/j.ygyno.2014.01.009","title":"Oncolytic vaccinia virotherapy for endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health; Mayo Clinic","keywords":"Oncolytic virus; Vaccinia; Medicine; Infectivity; Cancer research; Cell culture; Virotherapy; Sodium-iodide symporter; Survivin; Cancer; Virology; Virus; Biology; Internal medicine; Recombinant DNA; Gene; Symporter; Biochemistry","score_opus":0.032270561366004265,"score_gpt":0.3719238207138113,"score_spread":0.33965325934780705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024881537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882106,0.0008608728,0.0018374055,0.0019164087,0.0011003136,0.0014114238,0.00004345274,0.00004969897,0.004569824],"genre_scores_gemma":[0.98817366,0.000831979,0.0013629878,0.0037085095,0.001945033,0.0014977638,0.00008211142,0.0000601159,0.0023378462],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978042,0.0004174544,0.00034197207,0.00061362726,0.00015244573,0.00067024876],"domain_scores_gemma":[0.9984451,0.00060808094,0.00015845647,0.0004699317,0.00015779157,0.00016063383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012171424,0.00024162202,0.00043026154,0.00013854951,0.00017319516,0.000021691985,0.000491587,0.0004971091,0.00084447657],"category_scores_gemma":[0.0010245073,0.00021348872,0.00020063345,0.00019661506,0.00013237452,0.000003739867,0.000109432505,0.00017425405,0.00006570347],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009037903,0.00034955336,0.0013236597,0.00001768305,0.00019221687,0.0000032617165,0.000030610336,0.00017592033,0.7397259,0.00023148712,0.012946148,0.23596565],"study_design_scores_gemma":[0.008176864,0.0463701,0.0013068048,0.0000032366809,0.00003569909,0.0000082386405,0.000025608293,0.00032237836,0.21178444,0.00083576405,0.73077434,0.00035654282],"about_ca_topic_score_codex":0.000019636027,"about_ca_topic_score_gemma":0.0009081738,"teacher_disagreement_score":0.71782815,"about_ca_system_score_codex":0.00018809586,"about_ca_system_score_gemma":0.00049632834,"threshold_uncertainty_score":0.9246426},"labels":[],"label_agreement":null},{"id":"W2025402387","doi":"10.1016/j.ygyno.2008.10.007","title":"Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"National Cancer Institute","keywords":"Genetic testing; Medicine; Ovarian cancer; Genetic counseling; Cancer; Gynecology; Population; Oncology; Cancer registry; Internal medicine; Genetics; Environmental health; Biology","score_opus":0.09499535920524509,"score_gpt":0.3907492195215358,"score_spread":0.2957538603162907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025402387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971975,0.00011041196,0.00038547587,0.000113024784,0.0006849008,0.0010049237,0.000020973821,0.000010996114,0.00047180403],"genre_scores_gemma":[0.96974957,0.000006700903,0.028876685,0.00032793634,0.0001412572,0.0006404237,0.00004033562,0.000017327076,0.00019975209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811167,0.00019460465,0.00084880035,0.00047995424,0.000091291964,0.00027366696],"domain_scores_gemma":[0.9986941,0.0004235949,0.00033001753,0.0003045481,0.00019343247,0.000054291006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005927159,0.0001452568,0.00042143645,0.00007789314,0.00008627727,0.0000028853628,0.00021503986,0.0003302736,0.000151463],"category_scores_gemma":[0.0013443189,0.00014337832,0.00010127986,0.00016082793,0.00008695192,0.0000023415573,0.00006291157,0.00016443135,0.000001849747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001634433,0.000720276,0.97125065,0.000007207679,0.000049299062,0.000015231033,0.0001236132,0.009159888,0.001412206,0.0000039432416,0.00018423948,0.016909998],"study_design_scores_gemma":[0.003003687,0.0035598567,0.9870998,0.000004228198,0.000037405887,0.0000063208386,0.000083731145,0.0004604677,0.00021056157,0.00008249028,0.0053079063,0.00014352043],"about_ca_topic_score_codex":0.011946606,"about_ca_topic_score_gemma":0.38815802,"teacher_disagreement_score":0.37621143,"about_ca_system_score_codex":0.00037524925,"about_ca_system_score_gemma":0.002714434,"threshold_uncertainty_score":0.9946329},"labels":[],"label_agreement":null},{"id":"W2025879427","doi":"10.1016/j.ygyno.2007.10.011","title":"Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Erythropoietin; Cervical cancer; Gastroenterology; Anemia; Cisplatin; Internal medicine; Nuclear medicine; Hemoglobin; Cancer; Chemotherapy","score_opus":0.03635468900190772,"score_gpt":0.3814412109771353,"score_spread":0.3450865219752276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025879427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854742,0.00029157905,0.000639606,0.005441116,0.0008116321,0.006169975,0.000068758665,0.000059146303,0.0010439481],"genre_scores_gemma":[0.99442655,0.00015392965,0.0029061993,0.0011113349,0.0003622212,0.0005650802,0.00012094985,0.00005370909,0.0003000079],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9959503,0.00041246472,0.0013022717,0.0008653243,0.00049985514,0.00096980477],"domain_scores_gemma":[0.994936,0.003391662,0.0006109129,0.0003866416,0.0003464866,0.0003282975],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002564102,0.00050798256,0.0013547101,0.00025337184,0.00024022936,0.000025424222,0.0002101189,0.00044540642,0.0009637776],"category_scores_gemma":[0.0016702175,0.00033887388,0.00015745891,0.0003974218,0.00053834677,0.00008165549,0.00013881279,0.000509985,0.000016011669],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24620752,0.01278073,0.15612541,0.00038166973,0.00062483945,0.00018611482,0.01193333,0.0004343303,0.0027687466,0.0003602627,0.0060038064,0.5621932],"study_design_scores_gemma":[0.57400817,0.07356479,0.32976812,0.00059331453,0.00096402405,0.00007961739,0.003793105,0.0010027624,0.003269561,0.00012497832,0.012010895,0.000820664],"about_ca_topic_score_codex":0.00027851452,"about_ca_topic_score_gemma":0.0016729884,"teacher_disagreement_score":0.5613726,"about_ca_system_score_codex":0.0014632726,"about_ca_system_score_gemma":0.0007136502,"threshold_uncertainty_score":0.99994946},"labels":[],"label_agreement":null},{"id":"W2025931554","doi":"10.1016/j.ygyno.2010.09.014","title":"CA 125 normalization with chemotherapy is independently predictive of survival in advanced endometrial cancer","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Carboplatin; Oncology; Internal medicine; Chemotherapy; Ovarian cancer; Multivariate analysis; Stage (stratigraphy); Paclitaxel; Serous fluid; Cervical cancer; Gynecology; Epithelial ovarian cancer; Cancer; Cisplatin","score_opus":0.01637145835826378,"score_gpt":0.32490997448567865,"score_spread":0.3085385161274149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025931554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98486555,0.0001534663,0.0000873463,0.0010620626,0.0011452424,0.00098351,0.000059906426,0.000032829805,0.011610117],"genre_scores_gemma":[0.99710476,0.00041791936,0.0008314914,0.0007776659,0.00020919948,0.00024675488,0.000036529145,0.000017664772,0.00035801667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985028,0.000094080315,0.0004053983,0.00035744908,0.0003076626,0.000332629],"domain_scores_gemma":[0.99860805,0.0005945252,0.0002597832,0.00020670115,0.00020881018,0.00012211096],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030769594,0.00018837415,0.00075217267,0.0003295828,0.000035955025,0.0000040188015,0.00012496643,0.00035004184,0.0038445909],"category_scores_gemma":[0.0004467073,0.00013204389,0.00007858296,0.0010467545,0.00015348173,0.000083160936,0.00003779811,0.00039621379,0.000011343145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013676735,0.0017463921,0.881032,0.000058932594,0.00029538455,0.000107833126,0.0005462085,0.000081636266,0.010054202,0.00018030628,0.00011298238,0.09210741],"study_design_scores_gemma":[0.050526444,0.013065517,0.9081219,0.00003290261,0.00019704916,0.000027120204,0.00028873034,0.000092652335,0.01678448,0.00031325672,0.01033025,0.0002196999],"about_ca_topic_score_codex":0.0006384814,"about_ca_topic_score_gemma":0.0043000183,"teacher_disagreement_score":0.091887705,"about_ca_system_score_codex":0.00038408136,"about_ca_system_score_gemma":0.00055239175,"threshold_uncertainty_score":0.997066},"labels":[],"label_agreement":null},{"id":"W2026106407","doi":"10.1016/j.ygyno.2011.02.016","title":"Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Internal medicine; Ovarian cancer; Oncology; Proportional hazards model; Serous fluid; Paclitaxel; Surgery; Cancer","score_opus":0.015773558917520792,"score_gpt":0.2746366058048993,"score_spread":0.2588630468873785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026106407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98057246,0.00033582738,0.000025065277,0.008231757,0.002178071,0.0014781533,0.00010465792,0.00016334651,0.0069106757],"genre_scores_gemma":[0.97385454,0.0018780316,0.008546265,0.012714256,0.0005513258,0.0014753623,0.00004691653,0.0000729087,0.00086041365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975079,0.000080033366,0.00058286195,0.0007947549,0.00025397306,0.00078042794],"domain_scores_gemma":[0.99857765,0.00014590203,0.0002557984,0.00047314924,0.00022190883,0.00032556432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019213262,0.00046422635,0.00092942733,0.00013506225,0.00012467717,0.00002081449,0.00022986768,0.00053476036,0.017458899],"category_scores_gemma":[0.000041654173,0.00027595335,0.0002530394,0.0001932337,0.00024478187,0.00010445729,0.000075235395,0.00032058894,0.00014974848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043698964,0.0065840203,0.54587436,0.000053927546,0.0008614989,0.00048505113,0.0024135069,0.0000031227116,0.00048090308,0.0002887479,0.0010315344,0.4375534],"study_design_scores_gemma":[0.012865129,0.0060257954,0.91750425,0.000048694874,0.00028271897,0.000014922422,0.000076547745,0.000026647514,0.0042227786,0.00059305126,0.057958916,0.0003805235],"about_ca_topic_score_codex":0.00058721955,"about_ca_topic_score_gemma":0.0007470699,"teacher_disagreement_score":0.4371729,"about_ca_system_score_codex":0.0009523523,"about_ca_system_score_gemma":0.0004308146,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W2026192352","doi":"10.1016/j.ygyno.2014.03.572","title":"Impact of robotics on the outcome of elderly patients with endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Outcome (game theory); Robotics; Cancer; Gynecology; Artificial intelligence; Internal medicine; Robot","score_opus":0.042577427353845725,"score_gpt":0.3560151532664086,"score_spread":0.31343772591256286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026192352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913307,0.00004569093,0.000033709617,0.0007144161,0.0003797539,0.0006802463,0.00003499649,0.000014856207,0.006765651],"genre_scores_gemma":[0.99897236,0.000026988828,0.00032467773,0.0003726206,0.00010967805,0.00005558025,0.000012868178,0.000011565476,0.00011367755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986447,0.00018714009,0.00042573328,0.00019867443,0.00028240375,0.00026134404],"domain_scores_gemma":[0.99613065,0.0028867866,0.00037840533,0.0002808065,0.00022702152,0.00009633749],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003078149,0.00016446004,0.0007895199,0.00016092137,0.0000382748,0.0000023373527,0.00014398346,0.00016124858,0.001153895],"category_scores_gemma":[0.0018144514,0.00007232977,0.00020485249,0.0005115688,0.00018293288,0.000018899558,0.000038199494,0.00019114325,0.00001384656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030286442,0.0015546655,0.9502627,0.000025375017,0.0003849792,0.0000038762037,0.000030274594,0.00028035126,0.000068460184,0.00055956264,0.00017601893,0.043625087],"study_design_scores_gemma":[0.01321603,0.05317304,0.93224835,0.000017759798,0.00028660626,0.0000012749844,0.000012968637,0.000012605753,0.0001961089,0.00020191834,0.00055798684,0.00007534693],"about_ca_topic_score_codex":0.0003132924,"about_ca_topic_score_gemma":0.00009498991,"teacher_disagreement_score":0.05161837,"about_ca_system_score_codex":0.00038251813,"about_ca_system_score_gemma":0.00018180058,"threshold_uncertainty_score":0.9997592},"labels":[],"label_agreement":null},{"id":"W2026361533","doi":"10.1016/j.ygyno.2009.04.037","title":"Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; Hôpital Notre-Dame; University of British Columbia; Jewish General Hospital; Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Internal medicine; Neutropenia; Chemotherapy; Taxane; Paclitaxel; Oncology; Phases of clinical research; Gastroenterology; Surgery; Cancer; Cisplatin; Breast cancer","score_opus":0.02413970923359803,"score_gpt":0.3525937397668985,"score_spread":0.32845403053330047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026361533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873741,0.00025853,0.0000028282068,0.0041661886,0.0006402008,0.0047271787,0.0000489041,0.000058169047,0.0027238978],"genre_scores_gemma":[0.99667984,0.000045234076,0.0005715648,0.0017144937,0.00013184949,0.000561255,0.000045477715,0.000027393473,0.00022289588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968002,0.000317855,0.0010784623,0.00082447473,0.00034428973,0.00063475675],"domain_scores_gemma":[0.9980827,0.00044327948,0.0004342796,0.00049752434,0.00022449356,0.0003177405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004470183,0.00040574174,0.001447785,0.000378846,0.000113961796,0.000010608869,0.00021621773,0.00036738455,0.0005155823],"category_scores_gemma":[0.00066235854,0.00032903074,0.0001361973,0.000804332,0.00007129239,0.00006831617,0.000121956306,0.0004116299,0.000021362905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018499035,0.11965813,0.5741322,0.000072522766,0.0012645765,0.0025844304,0.037658654,0.0030549068,0.0022837794,0.00028124577,0.003790636,0.23671988],"study_design_scores_gemma":[0.060075514,0.09784867,0.838048,0.00014324092,0.00049664994,0.000007685272,0.000600357,0.00020735475,0.0011180034,0.000056029505,0.001106308,0.00029219597],"about_ca_topic_score_codex":0.002281464,"about_ca_topic_score_gemma":0.0067234016,"teacher_disagreement_score":0.26391578,"about_ca_system_score_codex":0.0019364958,"about_ca_system_score_gemma":0.00078122655,"threshold_uncertainty_score":0.9999162},"labels":[],"label_agreement":null},{"id":"W2027587613","doi":"10.1016/j.ygyno.2009.12.017","title":"The accuracy of magnetic resonance imaging in staging of vulvar cancer: A retrospective multi-centre study","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"NIHR Cambridge Biomedical Research Centre","keywords":"Medicine; Groin; Magnetic resonance imaging; Radiology; Vulvar cancer; Stage (stratigraphy); Metastasis; Lymph node; Retrospective cohort study; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.021385093592571305,"score_gpt":0.3467167037108642,"score_spread":0.3253316101182929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027587613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235535,0.0031578806,0.0000020121267,0.0012641784,0.000607839,0.0011689306,0.000018359042,0.000019723566,0.0014057396],"genre_scores_gemma":[0.99845695,0.00045930906,0.0004830928,0.00015249953,0.0000589234,0.00013185633,0.0000018929617,0.000011125453,0.0002443628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984155,0.0001912027,0.00051672023,0.00031596833,0.00020634892,0.00035420572],"domain_scores_gemma":[0.99743366,0.0016688692,0.00029672927,0.00031941885,0.00020956644,0.00007176196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000607483,0.00015010283,0.0005995788,0.00011739616,0.00007203277,0.0000046176747,0.00020600039,0.00009739593,0.0005175907],"category_scores_gemma":[0.0027054434,0.00009519047,0.00007639065,0.0004954932,0.000259934,0.0000413627,0.0001183559,0.0004279459,0.0000055140067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004561799,0.0017361273,0.8240549,0.000014943393,0.000021236132,0.000092131566,0.00078200555,0.0000015023955,0.002806609,0.000082147584,0.00003142044,0.1699208],"study_design_scores_gemma":[0.010083022,0.001809306,0.9827503,0.000023899123,0.000092029084,0.0000057168295,0.001832213,0.0000700683,0.0006339585,0.00016203237,0.0024590474,0.00007839635],"about_ca_topic_score_codex":0.0016331067,"about_ca_topic_score_gemma":0.009000069,"teacher_disagreement_score":0.1698424,"about_ca_system_score_codex":0.0003726943,"about_ca_system_score_gemma":0.0003033679,"threshold_uncertainty_score":0.56672555},"labels":[],"label_agreement":null},{"id":"W2027787548","doi":"10.1016/j.ygyno.2013.03.019","title":"Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Developmental Biology and Gene Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Cancer Society Research Institute; University of Alberta; Johns Hopkins University","keywords":"Medicine; Carboplatin; Epithelial–mesenchymal transition; Apoptosis; Cancer research; Ovarian cancer; Epithelial ovarian cancer; Mesenchymal stem cell; Oncology; Internal medicine; Cancer; Pathology; Chemotherapy; Metastasis; Cisplatin; Biology","score_opus":0.011905743461789072,"score_gpt":0.2563263044879779,"score_spread":0.2444205610261888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027787548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995852,0.00018410174,0.000027104521,0.0021039757,0.00045593968,0.00045378262,0.000012153152,0.000013173542,0.0008977676],"genre_scores_gemma":[0.99745107,0.00027743465,0.0007020937,0.0009396931,0.00012267404,0.00025636982,0.00009169522,0.000011096993,0.00014787148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986847,0.00019869382,0.00028325705,0.00043832083,0.00005702961,0.0003379931],"domain_scores_gemma":[0.9995684,0.00006865003,0.00010573543,0.00012674679,0.000054948334,0.00007554507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023468456,0.00018710805,0.00025656703,0.00008205515,0.00009366764,0.000013320401,0.00011039378,0.000594662,0.0002103581],"category_scores_gemma":[0.000047845286,0.00016561693,0.000041263098,0.00011133005,0.00012322432,0.000011834078,0.000074561045,0.00014747024,0.00003544655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041914154,0.00007758871,0.006111792,0.00000844674,0.00003404586,0.00000257958,0.00021454188,0.000040701194,0.95875,0.000015035513,0.00023893786,0.034464423],"study_design_scores_gemma":[0.0009734822,0.0006291535,0.21452452,0.0000068396625,0.000016913513,0.000010953047,0.00027924313,0.000062252366,0.7815751,0.00033695123,0.001339846,0.0002447805],"about_ca_topic_score_codex":0.0004028141,"about_ca_topic_score_gemma":0.0007334673,"teacher_disagreement_score":0.20841272,"about_ca_system_score_codex":0.00007022262,"about_ca_system_score_gemma":0.00013782656,"threshold_uncertainty_score":0.6753662},"labels":[],"label_agreement":null},{"id":"W2028217493","doi":"10.1016/j.ygyno.2004.06.019","title":"FIGO Stage IB2 cervix cancer and putting all your eggs in one basket","year":2004,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Radical surgery; Cervix; Stage (stratigraphy); Cervical cancer; Randomized controlled trial; Surgery; Primary treatment; Cancer; Internal medicine","score_opus":0.09548352078355235,"score_gpt":0.3769090176010327,"score_spread":0.2814254968174803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028217493","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10615584,0.005131926,0.0000056588747,0.86791193,0.0017586338,0.0020036707,0.00029925266,0.00016398692,0.01656908],"genre_scores_gemma":[0.033029124,0.003822833,0.0022214928,0.9411438,0.0042195558,0.0010056809,0.0008150454,0.0001152268,0.01362725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964777,0.00025469463,0.00076535414,0.0010243771,0.0003968083,0.001081068],"domain_scores_gemma":[0.9977147,0.0011432301,0.00041890057,0.00040099878,0.00010472594,0.00021747389],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004288508,0.00056620565,0.001828799,0.0004816838,0.000079638165,0.000025361704,0.00025275702,0.0022714806,0.0058353627],"category_scores_gemma":[0.00060517486,0.0004640192,0.00019489163,0.0004685835,0.0001968252,0.00006681319,0.00024995024,0.0025578,0.000117864925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017065757,0.0036111865,0.0929734,0.004612786,0.0028080659,0.046516284,0.0011838264,0.00007112897,0.00040386379,0.00021223177,0.5645478,0.28135285],"study_design_scores_gemma":[0.011539099,0.0034620247,0.049597632,0.00023711659,0.00059834577,0.00008171799,0.00005907427,0.000006809207,0.000059701066,0.001180473,0.93274647,0.00043152636],"about_ca_topic_score_codex":0.0031135462,"about_ca_topic_score_gemma":0.0019802907,"teacher_disagreement_score":0.36819866,"about_ca_system_score_codex":0.0032900681,"about_ca_system_score_gemma":0.0010190596,"threshold_uncertainty_score":0.99978113},"labels":[],"label_agreement":null},{"id":"W2029010282","doi":"10.1016/j.ygyno.2011.10.037","title":"Experiences of care delivery: Endometrial cancer survivors at end of treatment","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Survivorship curve; Medicine; Endometrial cancer; Preparedness; Focus group; Feeling; Cancer survivor; Cancer; Distress; Family medicine; Health care; Gynecology; Clinical psychology; Psychology; Internal medicine","score_opus":0.05130119295557233,"score_gpt":0.3203977673780555,"score_spread":0.26909657442248314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029010282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96573967,0.003462732,0.0000023117498,0.000041010408,0.0021190352,0.00046367274,0.000050951545,0.000028035212,0.028092554],"genre_scores_gemma":[0.9976798,0.0011258047,0.00018177697,0.000091611386,0.00011220363,0.00032581913,0.000020093146,0.000011437742,0.00045139392],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99867153,0.00015433686,0.00041468214,0.00030254747,0.00016568464,0.00029124191],"domain_scores_gemma":[0.99864304,0.00046732067,0.00028203387,0.0002707442,0.00022140214,0.00011547285],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001460617,0.00017799054,0.00082518,0.00018227131,0.000047879916,0.0000010914459,0.0001385086,0.0002519426,0.008380239],"category_scores_gemma":[0.0001358836,0.00013067546,0.00021868496,0.0002968743,0.0004090644,0.000030285966,0.00008300225,0.00007641327,0.000010389369],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059624403,0.0012000737,0.4473097,0.0002815755,0.0005407974,0.00019432727,0.35482088,0.0000067414644,0.00587828,0.00032105288,0.000331653,0.18315248],"study_design_scores_gemma":[0.014612438,0.079549536,0.14645433,0.000088792716,0.0012457368,0.00007377691,0.36658725,0.000011707876,0.27370945,0.000103401704,0.1169134,0.00065019424],"about_ca_topic_score_codex":0.016178917,"about_ca_topic_score_gemma":0.07827444,"teacher_disagreement_score":0.30085537,"about_ca_system_score_codex":0.0011618509,"about_ca_system_score_gemma":0.00068226777,"threshold_uncertainty_score":0.99252623},"labels":[],"label_agreement":null},{"id":"W2029046676","doi":"10.1016/j.ygyno.2012.05.038","title":"Height, weight, BMI and ovarian cancer survival","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Body mass index; Hazard ratio; Overweight; Obesity; Proportional hazards model; Oncology; Cancer; Internal medicine; Population; Confidence interval; Cancer registry; Gynecology; Environmental health","score_opus":0.05848969438925701,"score_gpt":0.3565522598982975,"score_spread":0.2980625655090405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029046676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8476968,0.008867645,0.000043940727,0.026786188,0.0041546794,0.000896369,0.00003294375,0.00015232948,0.11136915],"genre_scores_gemma":[0.9901518,0.002489703,0.0017283316,0.0028083816,0.0009811519,0.0003502062,0.000018682122,0.000021522157,0.0014501843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855775,0.0001267353,0.00025522776,0.0003302479,0.00013538286,0.00059467327],"domain_scores_gemma":[0.99880356,0.00042291757,0.00010528778,0.00024466027,0.00005746015,0.00036613224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034692598,0.00020980225,0.0005645213,0.00007754923,0.000118836324,0.000010056185,0.000065879496,0.00028468046,0.0044534747],"category_scores_gemma":[0.00008959186,0.00015127088,0.00007930057,0.00013542388,0.0001439234,0.00008955003,0.000084604726,0.0002091987,0.00014950256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014132337,0.0014302232,0.85353,0.00003838556,0.0003289126,0.00015634704,0.0002773519,7.3785344e-7,0.000153784,0.010024292,0.010621124,0.12329752],"study_design_scores_gemma":[0.0026906126,0.0008187635,0.5931282,0.000010357167,0.0002497484,0.000084205945,0.00006146561,0.000007263047,0.00018030856,0.00022762845,0.40242216,0.00011928637],"about_ca_topic_score_codex":0.00018041332,"about_ca_topic_score_gemma":0.0002607541,"teacher_disagreement_score":0.39180103,"about_ca_system_score_codex":0.00055659283,"about_ca_system_score_gemma":0.00026272432,"threshold_uncertainty_score":0.99645656},"labels":[],"label_agreement":null},{"id":"W2029681616","doi":"10.1016/j.ygyno.2006.04.022","title":"Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Sentinel lymph node; Lymph; Cervix; Carcinoma; Population; Cervical cancer; Pathology; Cancer; Internal medicine; Breast cancer","score_opus":0.04160080119872953,"score_gpt":0.33390591510198564,"score_spread":0.2923051139032561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029681616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94978386,0.0005150642,0.000019672578,0.0008813072,0.00044289022,0.00068237964,0.00012204919,0.00007862395,0.04747413],"genre_scores_gemma":[0.9958241,0.00026194155,0.0014370384,0.00084595167,0.00024060321,0.0002074971,0.00012300437,0.000029878604,0.0010300132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969092,0.00032021894,0.000885771,0.000608068,0.0003245316,0.0009522166],"domain_scores_gemma":[0.9969669,0.001733278,0.00044751022,0.00033613024,0.0002706746,0.00024549314],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024407994,0.00038105555,0.001227736,0.0003996892,0.000071665934,0.000011117529,0.00019496566,0.00038910843,0.0014103638],"category_scores_gemma":[0.0010978956,0.00029761708,0.00018822156,0.0010181224,0.00034100265,0.00012243136,0.00019498522,0.00023795415,0.0000745748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002067554,0.0021104454,0.97900146,0.00020013166,0.00014804385,0.000812526,0.00031602883,0.00012565897,0.0021592898,0.0002864998,0.00017697763,0.0125953695],"study_design_scores_gemma":[0.022383722,0.0009913609,0.96872205,0.00004175686,0.0001681538,0.00005517634,0.00044947214,0.00026210689,0.0037280107,0.0021166475,0.000855217,0.00022631658],"about_ca_topic_score_codex":0.0060773627,"about_ca_topic_score_gemma":0.00039080682,"teacher_disagreement_score":0.046444118,"about_ca_system_score_codex":0.0016709302,"about_ca_system_score_gemma":0.000826019,"threshold_uncertainty_score":0.9999476},"labels":[],"label_agreement":null},{"id":"W2030060789","doi":"10.1006/gyno.2002.6815","title":"Is There a Role for Pelvic Lymph Node Debulking in Advanced Cervical Cancer?","year":2002,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; University of Toronto","funders":"","keywords":"Debulking; Medicine; Cervical cancer; Randomized controlled trial; Surgery; Lymph node; Tumor Debulking; Stage (stratigraphy); Population; Cancer; Ovarian cancer; Internal medicine; Chemotherapy","score_opus":0.0813169442767317,"score_gpt":0.40093590925052625,"score_spread":0.31961896497379455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030060789","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044543264,0.98201746,0.0000071303803,0.0008816694,0.0009112094,0.0031148763,0.00016542207,0.0000999115,0.012356862],"genre_scores_gemma":[0.0007357609,0.9883464,0.0010597721,0.0020921768,0.0005158041,0.0052564917,0.00014292492,0.000091010676,0.0017596554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964113,0.0002658659,0.001079527,0.0010242155,0.00024757013,0.0009714711],"domain_scores_gemma":[0.9963134,0.0022967174,0.0005361993,0.0004693839,0.00011113222,0.0002731922],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029135944,0.0006834883,0.0042406237,0.00041643012,0.00010137064,0.000014939354,0.00037909506,0.0012725359,0.004020752],"category_scores_gemma":[0.00052520685,0.00047814904,0.00092658674,0.0009014317,0.000098877725,0.000047888487,0.00015548819,0.0006286844,0.0002470682],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021419252,0.000794592,0.0011292216,0.006598029,0.0003511083,0.0002482478,0.00006133837,0.0000020263333,6.6334013e-7,0.000037887978,0.00027600714,0.9902867],"study_design_scores_gemma":[0.007566676,0.0016270704,0.0022803273,0.0029079139,0.0018499764,0.00009157279,0.000049325667,0.00003518837,0.0000015752586,0.0003420166,0.98281795,0.00043040153],"about_ca_topic_score_codex":0.00020087685,"about_ca_topic_score_gemma":0.00036334686,"teacher_disagreement_score":0.9898563,"about_ca_system_score_codex":0.003942246,"about_ca_system_score_gemma":0.0010711411,"threshold_uncertainty_score":0.99988145},"labels":[],"label_agreement":null},{"id":"W2031563833","doi":"10.1016/j.ygyno.2015.01.476","title":"Racial disparities and the effect of time on ovarian cancer survival among cases identified through the National Cancer Database","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Cancer survival; Demography; Overall survival; Health equity; Oncology; Gerontology; Gynecology; Internal medicine; Pathology; Public health","score_opus":0.0794478521415445,"score_gpt":0.3959322483107213,"score_spread":0.31648439616917684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031563833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842073,0.001057763,0.0000081129465,0.0055727973,0.0016396963,0.0008157614,0.00022511368,0.000024033614,0.006449438],"genre_scores_gemma":[0.9963041,0.00031851075,0.000010678953,0.0011336185,0.0005221892,0.00041535182,0.00003389595,0.000011140161,0.0012505372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984492,0.00048043934,0.00026150377,0.00024821138,0.00032509907,0.0002355315],"domain_scores_gemma":[0.99597156,0.0034445086,0.00019418694,0.00017776072,0.00013730794,0.00007467626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010664696,0.00016138081,0.00053151813,0.000037482434,0.00015159814,0.00001675416,0.00013579067,0.00013875593,0.00076185795],"category_scores_gemma":[0.0013749275,0.00007627394,0.00008164757,0.0001278396,0.0010437676,0.00007967197,0.00010895444,0.0002720749,0.000012229986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025556121,0.00060536235,0.7674794,0.00023902602,0.0016184307,0.00036286886,0.008024515,0.0007031222,0.0005038298,0.013889085,0.14921515,0.031803086],"study_design_scores_gemma":[0.024972202,0.006478928,0.90960425,0.000103844424,0.0011771591,0.00008935216,0.0010638422,0.0005328384,0.0010852984,0.0012630314,0.053252175,0.0003770816],"about_ca_topic_score_codex":0.018186912,"about_ca_topic_score_gemma":0.010237396,"teacher_disagreement_score":0.14212483,"about_ca_system_score_codex":0.00032954948,"about_ca_system_score_gemma":0.00041500843,"threshold_uncertainty_score":0.98835105},"labels":[],"label_agreement":null},{"id":"W2032172756","doi":"10.1016/j.ygyno.2007.07.064","title":"p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: Methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Grading (engineering); Biopsy; Pathology; Atypia; Intraepithelial neoplasia; Internal medicine; Cancer; Biology","score_opus":0.2530757024059997,"score_gpt":0.41026272798023233,"score_spread":0.15718702557423264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032172756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897448,0.0006949196,0.00008757241,0.008145832,0.00021566507,0.0008867084,0.000029768265,0.000009700377,0.00018505674],"genre_scores_gemma":[0.9882707,0.0004308253,0.011064599,0.00013725561,0.000033089047,0.000046627938,4.106354e-7,0.0000045080437,0.000011999354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994445,0.00266244,0.001319163,0.0006085104,0.0006453602,0.00031948663],"domain_scores_gemma":[0.92030483,0.077573836,0.0011415745,0.00048758698,0.00042170187,0.00007048513],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.020931672,0.00020691156,0.00095014315,0.00013602416,0.00017490849,0.000021619579,0.00026321848,0.000252551,0.000035788038],"category_scores_gemma":[0.06493196,0.00009431463,0.000067517525,0.00058784697,0.003017702,0.00005047506,0.00042255464,0.00030807932,2.8033298e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020922697,0.00056508835,0.90502226,0.00003631684,0.000025909192,0.00013934993,0.0007301818,0.00006189223,0.0062473887,0.00045320767,0.00010329541,0.08640588],"study_design_scores_gemma":[0.00068886945,0.0019424815,0.9548075,0.000034121098,0.00006085212,0.00017946567,0.0038089838,0.000069061134,0.027455427,0.010349041,0.00048627597,0.00011790951],"about_ca_topic_score_codex":0.0014289409,"about_ca_topic_score_gemma":0.004308373,"teacher_disagreement_score":0.08628797,"about_ca_system_score_codex":0.00006426038,"about_ca_system_score_gemma":0.00010851438,"threshold_uncertainty_score":0.99969554},"labels":[],"label_agreement":null},{"id":"W2032700567","doi":"10.1016/j.ygyno.2012.11.009","title":"Old versus new FIGO staging systems in predicting overall survival in patients with uterine leiomyosarcoma: A study of 86 cases","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Leiomyosarcoma; Overall survival; Surgery; Gynecology; Internal medicine; Gastroenterology","score_opus":0.04335196817897216,"score_gpt":0.32399233435944064,"score_spread":0.2806403661804685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032700567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661875,0.00009820856,0.0000018991013,0.00007570369,0.0009135079,0.0013955261,0.000012369521,0.000036877263,0.0008471782],"genre_scores_gemma":[0.9992796,0.00000702343,0.00023943644,0.00003251227,0.0000991166,0.00008987053,0.000031971922,0.00001980063,0.00020062874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982032,0.00021560986,0.00051267224,0.00029526086,0.00023501433,0.0005382503],"domain_scores_gemma":[0.99871296,0.000585427,0.00023153619,0.0002611769,0.000054747077,0.00015418304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003107696,0.00022204513,0.0007846635,0.0002378846,0.00003153055,0.000006667437,0.0000943051,0.00012741901,0.0000901937],"category_scores_gemma":[0.00021743607,0.00016487838,0.000033491084,0.00024444764,0.000035809164,0.00013417045,0.00014370444,0.0002124866,0.0000059022946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022900805,0.0069736727,0.9861482,0.00006475653,0.00015595563,0.0007020653,0.0010279053,0.0000626991,0.000013070486,0.00003217497,0.00003341687,0.0024959964],"study_design_scores_gemma":[0.035081834,0.017683677,0.9449542,0.000049557326,0.000093405215,0.000021655294,0.0012428472,0.00004415921,0.000004808966,0.0000018268211,0.00069881853,0.00012318548],"about_ca_topic_score_codex":0.004989975,"about_ca_topic_score_gemma":0.0024577733,"teacher_disagreement_score":0.04119398,"about_ca_system_score_codex":0.00058963016,"about_ca_system_score_gemma":0.00014059608,"threshold_uncertainty_score":0.7543383},"labels":[],"label_agreement":null},{"id":"W2032719786","doi":"10.1016/j.ygyno.2004.04.003","title":"A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cervical cancer; Radical Hysterectomy; Stage (stratigraphy); Laparotomy; Surgery; Cervix; Lymph node; Hysterectomy; Statistical significance; Radical surgery; Cancer; Urology; Internal medicine","score_opus":0.0646902882734208,"score_gpt":0.40054046521770126,"score_spread":0.33585017694428043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032719786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902392,0.0029235724,0.00002433525,0.003573064,0.00024010413,0.0009719568,0.000018584711,0.00001853923,0.0019906498],"genre_scores_gemma":[0.99744046,0.0004143449,0.0012621823,0.0004062318,0.00011637311,0.00029706807,0.00001702938,0.000010539823,0.000035777834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784106,0.0003439132,0.00074388407,0.0003767802,0.00030720825,0.00038718322],"domain_scores_gemma":[0.99815375,0.0011288909,0.00025552115,0.00024403668,0.00006131265,0.00015650502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024922861,0.00024720017,0.0014095942,0.00018521518,0.0000505709,0.0000060134985,0.00016159195,0.00030565853,0.0003943504],"category_scores_gemma":[0.00012156263,0.00014284023,0.00016318687,0.00047522565,0.0005928126,0.000032117852,0.0000333004,0.00024149557,0.0000071457653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053195367,0.01665214,0.7568112,0.00031965686,0.00046584918,0.000525506,0.0029332694,0.00002163431,0.002925759,0.00069012743,0.00008677468,0.21324857],"study_design_scores_gemma":[0.03589741,0.025931813,0.9247065,0.00011412278,0.0005797718,0.000197526,0.0006292891,0.00003394066,0.0035688488,0.00041242733,0.0077727917,0.00015555973],"about_ca_topic_score_codex":0.0010368443,"about_ca_topic_score_gemma":0.0015933332,"teacher_disagreement_score":0.213093,"about_ca_system_score_codex":0.00082189613,"about_ca_system_score_gemma":0.0004361202,"threshold_uncertainty_score":0.58248556},"labels":[],"label_agreement":null},{"id":"W2033768644","doi":"10.1016/j.ygyno.2004.02.006","title":"Brain metastases from endometrial carcinoma: a retrospective study","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Endometrial cancer; Brain metastasis; Stage (stratigraphy); Carcinoma; Medical record; Cancer; Radiation therapy; Retrospective cohort study; Disease; Oncology; Primary tumor; Brain tumor; Internal medicine; Metastasis; Radiology; Pathology","score_opus":0.035639558646720436,"score_gpt":0.33084526945896703,"score_spread":0.2952057108122466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033768644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871652,0.00049465767,0.00017373961,0.005149205,0.0008691681,0.0021200199,0.00017041399,0.00014584303,0.0037117435],"genre_scores_gemma":[0.9901408,0.000015661564,0.0066774734,0.0020814864,0.00041481195,0.0002954225,0.00014047118,0.00002659193,0.00020729785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739355,0.0005184359,0.00049074314,0.00074476044,0.00032779205,0.0005247486],"domain_scores_gemma":[0.9976808,0.001212741,0.00020846007,0.00052226154,0.00012198446,0.00025374262],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084276847,0.00032291326,0.0011496341,0.00026221096,0.00016466997,0.000019521744,0.00015802371,0.00021655334,0.0019379735],"category_scores_gemma":[0.002483384,0.00023871982,0.00026532548,0.00052588515,0.00017353868,0.00006484637,0.00014427464,0.00038013523,0.0002971442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041190544,0.038870793,0.8694152,0.000024261835,0.0041110176,0.026394082,0.0032595512,0.000071275994,0.0020336888,0.0042320765,0.006416173,0.041052826],"study_design_scores_gemma":[0.04947934,0.04117013,0.8831835,0.0000073920687,0.0014306683,0.00019160369,0.0025694997,0.0000035249661,0.0005903735,0.0055921413,0.015492947,0.00028889359],"about_ca_topic_score_codex":0.0016265233,"about_ca_topic_score_gemma":0.0011031625,"teacher_disagreement_score":0.045360286,"about_ca_system_score_codex":0.0016274806,"about_ca_system_score_gemma":0.0004957819,"threshold_uncertainty_score":0.9989744},"labels":[],"label_agreement":null},{"id":"W2034182297","doi":"10.1006/gyno.2002.6762","title":"A Phase II Study of the MDR Inhibitor Biricodar (INCEL, VX-710) and Paclitaxel in Women with Advanced Ovarian Cancer Refractory to Paclitaxel Therapy","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Paclitaxel; Tolerability; Neutropenia; Internal medicine; Gastroenterology; Toxicity; Pharmacokinetics; Febrile neutropenia; Chemotherapy; Ovarian cancer; Refractory (planetary science); Oncology; Urology; Surgery; Pharmacology; Cancer; Adverse effect","score_opus":0.02473335631819492,"score_gpt":0.3059333738720892,"score_spread":0.2812000175538943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034182297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919178,0.0010637785,0.000007888258,0.003087165,0.00039155502,0.0023641752,0.000023331779,0.00004683488,0.0010974574],"genre_scores_gemma":[0.9951416,0.00064542016,0.00044524387,0.0019471799,0.0000782435,0.00067037146,0.0000013996101,0.000030035395,0.0010404707],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786806,0.0002011369,0.00052625424,0.00053948455,0.00029026,0.000574807],"domain_scores_gemma":[0.99877954,0.00019821603,0.0002397477,0.0004631129,0.00010644486,0.00021295073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046199604,0.00028961798,0.0008458791,0.00018825059,0.00016656972,0.000006419734,0.00020451819,0.00023515159,0.0005708046],"category_scores_gemma":[0.000091236994,0.00016635825,0.00004911182,0.0006063401,0.00021002178,0.00007635904,0.000070414375,0.00040962923,0.000004910604],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021889016,0.06934165,0.07124058,0.00023801888,0.00061031204,0.0011643765,0.079767995,0.00008535458,0.12452292,0.00020915031,0.0017795449,0.62915105],"study_design_scores_gemma":[0.103893034,0.23311977,0.48771116,0.00030380776,0.00021764805,0.000046444446,0.034858264,0.000044520213,0.0026136846,0.00044649132,0.13590322,0.00084195187],"about_ca_topic_score_codex":0.00009845993,"about_ca_topic_score_gemma":0.0020233751,"teacher_disagreement_score":0.62830913,"about_ca_system_score_codex":0.00049903546,"about_ca_system_score_gemma":0.00021310161,"threshold_uncertainty_score":0.67838925},"labels":[],"label_agreement":null},{"id":"W2034477259","doi":"10.1016/j.ygyno.2015.04.008","title":"Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Sentinel lymph node; Endometrial cancer; Metastasis; Lymph node metastasis; Oncology; Lymph; Internal medicine; Cancer; Pathology; Breast cancer","score_opus":0.03165664269739838,"score_gpt":0.30972340049364155,"score_spread":0.2780667577962432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034477259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896471,0.0005809063,0.00003724375,0.0007095214,0.001454281,0.0014081025,0.00019767402,0.00006115942,0.0059040003],"genre_scores_gemma":[0.9957228,0.00026978998,0.0014792646,0.0010154278,0.00030762886,0.0006310569,0.00023004648,0.00006529292,0.00027874493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490047,0.0004973269,0.0014971183,0.001000738,0.0009505896,0.0011537423],"domain_scores_gemma":[0.9963836,0.0011829472,0.00077119947,0.00060247583,0.0005112091,0.00054857053],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012310583,0.00064008264,0.0025030838,0.0014988931,0.000063887936,0.00001835992,0.00041308024,0.00053402403,0.0008060761],"category_scores_gemma":[0.0018987426,0.00046347518,0.00031865283,0.0032377176,0.0003209393,0.00021218808,0.0003034762,0.00041005213,0.00006371404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074116,0.0047455537,0.9727006,0.00014457393,0.0009317169,0.00026219853,0.00023241242,0.00031313841,0.00013232803,0.000009303398,0.00034332724,0.012773253],"study_design_scores_gemma":[0.08637374,0.0013781998,0.90878546,0.000100924335,0.0010296948,0.00000993707,0.00027823207,0.00010987367,0.0005397649,0.00004587117,0.00097251276,0.00037580603],"about_ca_topic_score_codex":0.0028988551,"about_ca_topic_score_gemma":0.0003101429,"teacher_disagreement_score":0.07896214,"about_ca_system_score_codex":0.002572496,"about_ca_system_score_gemma":0.0016017219,"threshold_uncertainty_score":0.99978167},"labels":[],"label_agreement":null},{"id":"W2034564420","doi":"10.1006/gyno.2001.6273","title":"Spontaneous Regression of Stage IV Clear Cell Carcinoma of the Endometrium in a Patient with Essential Thrombocytosis","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Thrombocytosis; Medicine; Hysterectomy; Carcinoma; Clear cell carcinoma; Stage (stratigraphy); Curettage; Biopsy; Adenocarcinoma; Endometrium; Gynecology; Internal medicine; Oncology; Platelet; Gastroenterology; Pathology; Cancer","score_opus":0.010621307090903443,"score_gpt":0.2709452297473509,"score_spread":0.2603239226564475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034564420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943274,0.0004335228,0.0000074051904,0.00007959919,0.000089922534,0.00040505326,0.00003052233,0.0000026662137,0.0046239104],"genre_scores_gemma":[0.99910676,0.00034329403,0.00014354633,0.000050930514,0.00001956236,0.00003936405,0.000018009414,0.000009775041,0.0002687592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988476,0.00020529865,0.00023952205,0.00026185843,0.0001627153,0.000283021],"domain_scores_gemma":[0.99926144,0.00008720135,0.00020770944,0.00031762567,0.00007408211,0.000051934287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001162818,0.0001258359,0.00027979855,0.000080845544,0.000039398663,0.000002707748,0.00020897631,0.00016568082,0.00014837095],"category_scores_gemma":[0.00011045704,0.000072992516,0.00008202513,0.00025508908,0.00019566748,0.0000025448142,0.00019499977,0.00011399102,0.000002195557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00779916,0.0033759214,0.29681158,0.00009746009,0.00012936516,0.0036994545,0.00038101748,0.00032887285,0.6681026,0.00003432136,0.00054797076,0.018692264],"study_design_scores_gemma":[0.0066013103,0.021214446,0.18627112,0.000026392054,0.000049732647,0.0006064424,0.0007009275,0.000024902287,0.7716931,0.00003455862,0.012562073,0.0002149993],"about_ca_topic_score_codex":0.00054811675,"about_ca_topic_score_gemma":0.0032237535,"teacher_disagreement_score":0.110540465,"about_ca_system_score_codex":0.00011377111,"about_ca_system_score_gemma":0.0002856297,"threshold_uncertainty_score":0.29765484},"labels":[],"label_agreement":null},{"id":"W2034917523","doi":"10.1006/gyno.2000.5779","title":"Telomerase Activity in Papanicolaou Smear-Negative Exfoliated Cervical Cells and Its Association with Lesions and Oncogenic Human Papillomaviruses","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Telomerase; Medicine; Colposcopy; Papanicolaou stain; Cervical intraepithelial neoplasia; Cytology; Biopsy; Population; Squamous intraepithelial lesion; Cervical cancer; Pathology; Koilocyte; Ascus (bryozoa); Cytopathology; Gynecology; Internal medicine; Cancer; Biology","score_opus":0.02589460674521784,"score_gpt":0.29984867624843103,"score_spread":0.2739540695032132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034917523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482423,0.0002562012,9.0686495e-7,0.0011941632,0.0000797198,0.00087344623,0.000030118277,0.00011100487,0.0026302012],"genre_scores_gemma":[0.99562806,0.0013667707,0.00026795032,0.001163232,0.000068972964,0.00009476925,0.000012779438,0.000025691234,0.0013717657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760664,0.0004814276,0.0003970987,0.00064657594,0.0002557428,0.0006124978],"domain_scores_gemma":[0.9978398,0.0013301161,0.0002134821,0.00020675789,0.0001127754,0.00029705267],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049251097,0.00031102417,0.0008269354,0.00018828403,0.0002579088,0.000024944236,0.00010078341,0.0005584337,0.0014047358],"category_scores_gemma":[0.00039844995,0.00024888082,0.00005408478,0.000449145,0.0001930082,0.00017175532,0.00006794537,0.0006371311,0.00007571167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002115096,0.003299065,0.62654245,0.00017326488,0.00030124362,0.0013992195,0.0022362045,0.000017903272,0.24830097,0.00018449256,0.0007235433,0.114706516],"study_design_scores_gemma":[0.0052795457,0.0036045425,0.9683226,0.000052401476,0.00016900082,0.00008516845,0.00035606642,0.0001176111,0.016959902,0.00015918922,0.0045558927,0.00033809405],"about_ca_topic_score_codex":0.0004024542,"about_ca_topic_score_gemma":0.0031355477,"teacher_disagreement_score":0.3417801,"about_ca_system_score_codex":0.0007091497,"about_ca_system_score_gemma":0.00028704596,"threshold_uncertainty_score":0.99999636},"labels":[],"label_agreement":null},{"id":"W2034943935","doi":"10.1016/j.ygyno.2004.11.007","title":"Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical–pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Radical Hysterectomy; Gynecologic oncology; Parametrial; Cervical cancer; Univariate analysis; Radiation therapy; Hysterectomy; Chemotherapy; Internal medicine; Lymphadenectomy; Oncology; Radiology; Urology; Multivariate analysis; Cancer","score_opus":0.09656403057321561,"score_gpt":0.378504527825341,"score_spread":0.2819404972521254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034943935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817488,0.0023934077,0.00052393595,0.0073070554,0.002199966,0.0045573413,0.00009421668,0.00016328017,0.001011953],"genre_scores_gemma":[0.9679883,0.011507163,0.006432575,0.011610467,0.0007071737,0.0012791666,0.00036569196,0.000063360196,0.00004610518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9884766,0.004791302,0.003390309,0.0015635387,0.0006434904,0.0011347657],"domain_scores_gemma":[0.9789478,0.01636654,0.0028981634,0.000987921,0.00032913245,0.00047042515],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005281261,0.0008077566,0.004765289,0.001208268,0.00029536907,0.000038048336,0.0005862865,0.003060781,0.001218443],"category_scores_gemma":[0.004173847,0.00053473364,0.001296983,0.002711479,0.0022446888,0.00027487718,0.00027821035,0.0015645585,0.000024091432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09570455,0.01399047,0.10381617,0.00008196215,0.005095167,0.0009427046,0.0034586932,0.00011821245,0.0011604634,0.001162127,0.00019654594,0.7742729],"study_design_scores_gemma":[0.16082829,0.13124272,0.6135758,0.000035499852,0.005110641,0.00020132642,0.0005191587,0.00018863865,0.0001300106,0.0037111144,0.083878174,0.00057859713],"about_ca_topic_score_codex":0.00081509317,"about_ca_topic_score_gemma":0.003186411,"teacher_disagreement_score":0.77369434,"about_ca_system_score_codex":0.0030591614,"about_ca_system_score_gemma":0.0013653019,"threshold_uncertainty_score":0.99971044},"labels":[],"label_agreement":null},{"id":"W2034950086","doi":"10.1016/j.ygyno.2013.09.011","title":"Uterine adenosarcomas: A dual-institution update on staging, prognosis and survival","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia; Royal Alexandra Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hysterectomy; Lymph node; Stage (stratigraphy); Dissection (medical); Surgery; Radiation therapy; Endometrial cancer; Adjuvant therapy; Adjuvant radiotherapy; Adjuvant chemotherapy; Cancer; Chemotherapy; Internal medicine; Breast cancer","score_opus":0.02438719299005079,"score_gpt":0.3134292307995361,"score_spread":0.28904203780948534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034950086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97151726,0.000092441296,0.000024147954,0.009973116,0.00047911532,0.0009322267,0.000010552023,0.00014880327,0.01682232],"genre_scores_gemma":[0.99438214,0.00024028882,0.0021693206,0.0017842063,0.00011611281,0.00035047162,0.00004761139,0.00001536625,0.00089449045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872994,0.00009551837,0.0002598468,0.00039668212,0.00013303266,0.00038498628],"domain_scores_gemma":[0.99929065,0.00013411524,0.00010102276,0.00021493403,0.00007309905,0.000186186],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013949155,0.00021387731,0.0004517701,0.00011656827,0.0001130635,0.000025359408,0.000056965957,0.0001783387,0.0012301042],"category_scores_gemma":[0.000107335414,0.00015485215,0.000056001354,0.000109768895,0.00016215259,0.00010065924,0.00012607625,0.00018338731,0.0005225183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003811682,0.0034486707,0.7475473,0.00016984092,0.00048465273,0.0024042064,0.00022748313,0.000003963446,0.00270443,0.0077455873,0.010006477,0.22487617],"study_design_scores_gemma":[0.0038758572,0.005788873,0.85781276,0.000022213497,0.00009619252,0.0002030357,0.0000769977,0.00008575903,0.00027944523,0.0007141422,0.13086578,0.00017891661],"about_ca_topic_score_codex":0.000118824486,"about_ca_topic_score_gemma":0.000047529797,"teacher_disagreement_score":0.22469725,"about_ca_system_score_codex":0.00021651012,"about_ca_system_score_gemma":0.00009519424,"threshold_uncertainty_score":0.9996829},"labels":[],"label_agreement":null},{"id":"W2035361263","doi":"10.1016/j.ygyno.2013.07.078","title":"Surgery for early stage cervical cancer: How radical should it be?","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trachelectomy; Radical surgery; Cervical cancer; Adenosquamous carcinoma; Radical Hysterectomy; Stage (stratigraphy); Pelvic exenteration; Lymph node; Surgery; Cancer; Adenocarcinoma; Internal medicine","score_opus":0.25575922399193196,"score_gpt":0.43758588702465123,"score_spread":0.18182666303271927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035361263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014756626,0.97346264,0.000033240012,0.013807082,0.0029891669,0.0055870987,0.00060233293,0.00018387518,0.0031870094],"genre_scores_gemma":[0.000085904154,0.969014,0.00076571316,0.004460612,0.0017493633,0.008901377,0.0007005008,0.00011938505,0.014203137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533385,0.0005576155,0.0011763171,0.0011853086,0.0004772627,0.0012696557],"domain_scores_gemma":[0.98745424,0.010172982,0.0007739393,0.000622074,0.00022791479,0.0007488508],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007564271,0.0008958693,0.0067207767,0.00049016654,0.00017150385,0.000055823726,0.00043526475,0.0026113957,0.009961547],"category_scores_gemma":[0.0022084336,0.00058319105,0.002033436,0.0007414686,0.00036211798,0.00008840835,0.00021875989,0.0011710408,0.00027952608],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018663783,0.0007000087,0.0004183639,0.009822149,0.0010171947,0.00033385673,0.000015965135,8.5547214e-8,3.1686068e-7,0.00011592378,0.070001714,0.9173878],"study_design_scores_gemma":[0.002662298,0.0030806088,0.00037831947,0.0010345808,0.0037719295,0.00008292555,0.000024441146,0.000002426479,0.0000015839152,0.00007289771,0.9883673,0.00052068755],"about_ca_topic_score_codex":0.00035748395,"about_ca_topic_score_gemma":0.0002814745,"teacher_disagreement_score":0.9183656,"about_ca_system_score_codex":0.002501693,"about_ca_system_score_gemma":0.003148045,"threshold_uncertainty_score":0.9996619},"labels":[],"label_agreement":null},{"id":"W2035386963","doi":"10.1016/j.ygyno.2005.08.005","title":"Polyradiculopathy post-concomitant chemoradiation for carcinoma of the uterine cervix treated with pelvic and para-aortic fields","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Concomitant; Cisplatin; Cervix; Paresis; Lymph node; Radiation therapy; Carcinoma; Urology; Surgery; Internal medicine; Chemotherapy; Cancer","score_opus":0.018320449746914887,"score_gpt":0.28746267995324293,"score_spread":0.26914223020632805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035386963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811474,0.00019491775,0.00013867012,0.015346203,0.0000762448,0.0013500114,0.000026151067,0.000029709498,0.0016906821],"genre_scores_gemma":[0.99302286,0.000024136309,0.0026450723,0.003249091,0.00006159736,0.00015591834,0.000031440708,0.00001369939,0.00079619064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892104,0.00008817249,0.0003384222,0.00026140042,0.0001340757,0.00025689136],"domain_scores_gemma":[0.9989117,0.00032326716,0.00023909635,0.00030617483,0.000113108166,0.00010667765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024797782,0.000159398,0.00045159637,0.00007799558,0.000064266016,0.0000060970033,0.000108352804,0.0001146849,0.0002861007],"category_scores_gemma":[0.00031650785,0.00009640895,0.0000831289,0.00013552271,0.00015295828,0.000047821683,0.000058001002,0.00010665555,0.000005004842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051694093,0.0029445172,0.69632566,0.0013362751,0.000677146,0.0002516242,0.0015744711,0.00007436066,0.006923933,0.0015026722,0.0037263494,0.2794936],"study_design_scores_gemma":[0.00710821,0.0051985215,0.9761483,0.000016322345,0.00065230054,0.00007135166,0.00036801925,0.0021423688,0.0014103674,0.00010895902,0.0066401507,0.00013510614],"about_ca_topic_score_codex":0.000042725358,"about_ca_topic_score_gemma":0.00014142672,"teacher_disagreement_score":0.27982268,"about_ca_system_score_codex":0.0001422541,"about_ca_system_score_gemma":0.00017387574,"threshold_uncertainty_score":0.3931443},"labels":[],"label_agreement":null},{"id":"W2035930598","doi":"10.1016/j.ygyno.2011.01.022","title":"Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Medicine; Univariate analysis; Mitotic index; Malignancy; Immunostaining; Stage (stratigraphy); Pathology; Immunohistochemistry; Internal medicine; Oncology; Multivariate analysis; Biology; Mitosis","score_opus":0.02738040605663311,"score_gpt":0.29961385922946693,"score_spread":0.2722334531728338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035930598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945671,0.00035834615,0.00003336065,0.0009760101,0.000259415,0.0010533324,0.000010616627,0.00011796328,0.0026238568],"genre_scores_gemma":[0.9953606,0.00017314973,0.0031124116,0.0005800632,0.00006352603,0.00030414498,0.000015162218,0.000032865308,0.00035809173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821746,0.00013321298,0.00036397492,0.0006125032,0.000155592,0.0005172731],"domain_scores_gemma":[0.99883956,0.00032198767,0.0001885505,0.00027681587,0.00006177909,0.00031132088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015615558,0.0003688927,0.0007945852,0.00015330841,0.00012689529,0.000025485446,0.00010532483,0.00015340431,0.0005072632],"category_scores_gemma":[0.000093675706,0.00023632159,0.00006511838,0.00016091162,0.00042584978,0.00009927755,0.0002517279,0.00019848849,0.000014382807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009492466,0.0014993369,0.9748757,0.00018449813,0.00065183983,0.002977055,0.00026151157,3.369225e-8,0.0009296242,0.0001521397,0.00014372537,0.017375307],"study_design_scores_gemma":[0.009148017,0.008736838,0.97651786,0.000049318598,0.00043058637,0.0018039495,0.0002142079,0.000040761504,0.00045669114,0.0004160354,0.0019359903,0.000249724],"about_ca_topic_score_codex":0.00016760058,"about_ca_topic_score_gemma":0.00050169753,"teacher_disagreement_score":0.017125582,"about_ca_system_score_codex":0.00015833559,"about_ca_system_score_gemma":0.000073225456,"threshold_uncertainty_score":0.9636915},"labels":[],"label_agreement":null},{"id":"W2036033065","doi":"10.1016/j.ygyno.2003.08.024","title":"Laparoscopic sentinel node mapping in early-stage cervical cancer","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Sentinel node; Dissection (medical); Stage (stratigraphy); Cervical cancer; Lymph node; Surgery; Laparoscopic surgery; Laparoscopy; Parametrial; Nuclear medicine; Cancer; Radical Hysterectomy; Internal medicine; Breast cancer","score_opus":0.049683055606922176,"score_gpt":0.34449814722302663,"score_spread":0.2948150916161045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036033065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9318258,0.0006207104,0.000017382345,0.0025110682,0.00071343075,0.00047394453,0.0000075463563,0.000069412345,0.063760705],"genre_scores_gemma":[0.99019754,0.0003232387,0.0008064345,0.0049916436,0.0001260365,0.00028203125,0.000011261964,0.00001807011,0.003243724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981411,0.00021983452,0.00042026557,0.00043817965,0.00018026569,0.00060034625],"domain_scores_gemma":[0.9989648,0.00043640935,0.00011082154,0.00022768711,0.000057940815,0.00020236376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003034616,0.00020709154,0.0007100819,0.00021513268,0.00006422289,0.000009681496,0.00010605175,0.00034018804,0.005019477],"category_scores_gemma":[0.00053356827,0.00016299557,0.00011115625,0.00067134184,0.00009440943,0.000046750687,0.00005589398,0.0003839131,0.00022577748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013481837,0.0007978751,0.9927206,0.00007132547,0.00007499185,0.0005489411,0.00015704875,0.000020312598,0.0007362747,0.00076190213,0.00036987304,0.0036060428],"study_design_scores_gemma":[0.010526768,0.0006242305,0.87943923,0.000032069842,0.00006931453,0.000021919222,0.00016225076,0.00002793415,0.0007212504,0.0004338461,0.107764475,0.00017673276],"about_ca_topic_score_codex":0.00054833683,"about_ca_topic_score_gemma":0.0005194611,"teacher_disagreement_score":0.113281384,"about_ca_system_score_codex":0.00084991765,"about_ca_system_score_gemma":0.00035502732,"threshold_uncertainty_score":0.9958901},"labels":[],"label_agreement":null},{"id":"W2036287069","doi":"10.1016/j.ygyno.2013.05.008","title":"Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Temsirolimus; Cervix; Oncology; Internal medicine; Clinical trial; Gynecology; Phases of clinical research; Cancer; Discovery and development of mTOR inhibitors","score_opus":0.12960475357555556,"score_gpt":0.4369952286122137,"score_spread":0.3073904750366581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036287069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98712784,0.00027280577,0.000004925329,0.000456504,0.0011083463,0.0103298435,0.00003771583,0.000014261647,0.0006477761],"genre_scores_gemma":[0.9971949,0.00010665574,0.00020463712,0.00036125304,0.000125232,0.0017658286,0.000005846799,0.000023689365,0.00021194636],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99087614,0.0045309924,0.0028289743,0.0005612733,0.0006138083,0.00058880774],"domain_scores_gemma":[0.98880726,0.007765585,0.0020900348,0.0008417701,0.00029522416,0.00020011843],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045376713,0.0003532659,0.0031247356,0.00024573418,0.000094824085,0.0000055104533,0.0006091898,0.00027668077,0.0011320063],"category_scores_gemma":[0.009688561,0.00015006178,0.00032537134,0.0017483317,0.0005044166,0.00008338073,0.0003783792,0.000618099,0.0000049560194],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49718633,0.08090696,0.05076823,0.00034055713,0.0013943813,0.00009147649,0.0019592869,0.000039708837,0.0010499049,0.000047374055,0.00018238142,0.36603343],"study_design_scores_gemma":[0.43236658,0.31605202,0.2458522,0.00010469678,0.0009297326,0.000016170048,0.0032142731,0.00003552243,0.0002466434,0.0004666988,0.00055093144,0.00016454463],"about_ca_topic_score_codex":0.0009004959,"about_ca_topic_score_gemma":0.0027817637,"teacher_disagreement_score":0.36586887,"about_ca_system_score_codex":0.00055182056,"about_ca_system_score_gemma":0.0012229709,"threshold_uncertainty_score":0.9997811},"labels":[],"label_agreement":null},{"id":"W2036927649","doi":"10.1006/gyno.2001.6552","title":"Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer","year":2002,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University; Cancer Care Ontario; Western University; University of Toronto","funders":"National Cancer Institute; Cancer Care Ontario","keywords":"Carboplatin; Medicine; Paclitaxel; Regimen; Cisplatin; Oncology; Chemotherapy; Internal medicine; Adverse effect; Randomized controlled trial; Ovarian cancer; Surgery; Cancer","score_opus":0.043612416413509325,"score_gpt":0.3548521566997152,"score_spread":0.3112397402862059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036927649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006324307,0.96887606,0.000034884742,0.0021165125,0.00060001336,0.02625754,0.001497051,0.000058324236,0.00049636356],"genre_scores_gemma":[0.000030878633,0.97190785,0.0012466549,0.003676719,0.00021501492,0.018353742,0.00062001107,0.00011413317,0.0038349624],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954574,0.00038836626,0.0021316002,0.00097577926,0.0003898143,0.0006570212],"domain_scores_gemma":[0.99299973,0.0028020141,0.0023835746,0.0008798967,0.0006868058,0.0002479564],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005609981,0.00096637994,0.009170757,0.00021333044,0.00020929307,0.000013669547,0.00036744808,0.00076605525,0.0057752444],"category_scores_gemma":[0.0009918694,0.0005039924,0.00085923076,0.00051706325,0.00018709146,0.000064014144,0.00009330367,0.0004077631,0.00002327495],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044773126,0.0038997175,0.00012891673,0.746469,0.003639201,0.00019797558,0.0001881098,0.0000013855556,2.7941084e-8,0.000038776365,0.005523592,0.23946552],"study_design_scores_gemma":[0.012401639,0.01471052,0.00006713849,0.34604117,0.010659298,0.00002281478,0.0000168535,0.000004613739,8.384478e-7,0.000002868802,0.615673,0.00039923575],"about_ca_topic_score_codex":0.000110542416,"about_ca_topic_score_gemma":0.0005857379,"teacher_disagreement_score":0.61014944,"about_ca_system_score_codex":0.0021572255,"about_ca_system_score_gemma":0.0017444103,"threshold_uncertainty_score":0.9997412},"labels":[],"label_agreement":null},{"id":"W2037218944","doi":"10.1016/j.ygyno.2008.08.029","title":"Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer—the British Columbia Cancer Agency experience","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Carboplatin; Medicine; Regimen; Paclitaxel; Internal medicine; Endometrial cancer; Oncology; Chemotherapy; Serous fluid; Cancer; Gynecology; Cisplatin","score_opus":0.027012153984536404,"score_gpt":0.2940908233379035,"score_spread":0.2670786693533671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037218944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480206,0.0018979571,7.68285e-7,0.00030479024,0.00045847282,0.001115068,0.00006020947,0.000022574199,0.0013381189],"genre_scores_gemma":[0.9957694,0.0021565147,0.00028186198,0.00046262832,0.000087935114,0.00059806637,0.000013246621,0.000014455739,0.000615931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982932,0.00017205426,0.00047373187,0.0003954193,0.00029331414,0.0003722701],"domain_scores_gemma":[0.9983633,0.0007901554,0.00025478174,0.00030036437,0.00015509165,0.00013631533],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018592284,0.00014171492,0.0007159776,0.00008473513,0.00021692638,0.00001821287,0.00018128745,0.00020423149,0.0010660732],"category_scores_gemma":[0.0014289748,0.00011956861,0.00006061978,0.0008911674,0.0004951935,0.00006439146,0.000113510185,0.00025677268,0.0000018507657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011436251,0.00069748313,0.959195,0.00002671924,0.000079989186,0.00019896548,0.00074682024,0.000003836858,0.000081480866,0.00000205769,0.00068642054,0.03713756],"study_design_scores_gemma":[0.020409014,0.004751808,0.9724733,0.000055101576,0.00009728383,0.000024713485,0.00012879973,0.0000032638948,0.0000487118,0.00006537506,0.0018180229,0.00012460523],"about_ca_topic_score_codex":0.07331543,"about_ca_topic_score_gemma":0.09020983,"teacher_disagreement_score":0.037012957,"about_ca_system_score_codex":0.00050357543,"about_ca_system_score_gemma":0.00046430112,"threshold_uncertainty_score":0.9998471},"labels":[],"label_agreement":null},{"id":"W2038042951","doi":"10.1006/gyno.2001.6466","title":"Vulvar Squamous Cell Carcinoma in Young Women: A Clinicopathologic Study of 21 Cases","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Lichen sclerosus; Vulvar intraepithelial neoplasia; Vulva; Vulvar cancer; Vulvar neoplasm; Population; Pathology; Pathological; Immunohistochemistry; Dermatology","score_opus":0.07524758547581693,"score_gpt":0.365522267449702,"score_spread":0.29027468197388506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038042951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9182219,0.0006220463,8.076352e-7,0.0002838532,0.0003153446,0.0011454906,0.0000066085904,0.000042879437,0.07936106],"genre_scores_gemma":[0.99770015,0.00009280331,0.000067306064,0.00054385036,0.000121840145,0.00037348265,0.0000040996647,0.000018082499,0.0010783691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970928,0.0005488357,0.00073748414,0.00054464705,0.00031309255,0.00076313777],"domain_scores_gemma":[0.9973519,0.0016117041,0.00017165355,0.00045782654,0.00017568187,0.00023126598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095414376,0.00021232732,0.0009971965,0.0003168766,0.00006884179,0.0000067333126,0.00025044123,0.00035286543,0.017674005],"category_scores_gemma":[0.001480384,0.00016923626,0.00009375345,0.0005730943,0.00021920017,0.00004045115,0.00021506817,0.0006754136,0.00016828011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364014,0.013355702,0.95240563,0.00015213212,0.000011411131,0.007300315,0.004528806,0.000022062914,0.00025355988,0.000014568941,0.0009007138,0.020218667],"study_design_scores_gemma":[0.010322132,0.05246748,0.92570937,0.000001811006,0.000049212318,0.0002921266,0.009655018,0.00019121912,0.00008515059,0.000082351755,0.0009814908,0.00016263007],"about_ca_topic_score_codex":0.000438605,"about_ca_topic_score_gemma":0.002818485,"teacher_disagreement_score":0.07947826,"about_ca_system_score_codex":0.00087462727,"about_ca_system_score_gemma":0.00019032301,"threshold_uncertainty_score":0.983224},"labels":[],"label_agreement":null},{"id":"W2040313171","doi":"10.1016/j.ygyno.2004.11.039","title":"Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation; BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"School of Medicine, Stanford University; American Cancer Society","keywords":"Clusterin; Serous fluid; Biology; Tissue microarray; Immunohistochemistry; DNA microarray; Gene expression; Complementary DNA; Gene expression profiling; Ovarian carcinoma; Gene; Cancer research; Ovarian cancer; Molecular biology; Pathology; Cancer; Medicine; Genetics; Immunology; Apoptosis","score_opus":0.01893596768135654,"score_gpt":0.2960822631584894,"score_spread":0.2771462954771329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040313171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941716,0.000075482014,0.0016713068,0.0008670254,0.00052509765,0.00090597593,0.00008668468,0.0001161985,0.0015806021],"genre_scores_gemma":[0.99406356,0.00000666851,0.005007099,0.00047704438,0.00020539491,0.00007887933,0.000114896204,0.000021173491,0.000025277179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788123,0.00024394706,0.00055238383,0.0006029948,0.00024532975,0.00047408624],"domain_scores_gemma":[0.9986828,0.00025268167,0.00031837163,0.00037884506,0.00012124574,0.00024603936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034238462,0.000272427,0.0007515956,0.00012264341,0.00012010758,0.000007280798,0.00013467831,0.00042993604,0.00012071974],"category_scores_gemma":[0.0004977622,0.00022708307,0.00011592271,0.00018757817,0.00033630448,0.0000425466,0.00017362775,0.0002726537,0.000024075855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031574937,0.00203416,0.916113,0.000761113,0.00007339973,0.0046335743,0.00015541643,0.0055851154,0.05118284,0.00021656025,0.00011583419,0.015971502],"study_design_scores_gemma":[0.00731481,0.007884155,0.9650929,0.00019300936,0.00026256312,0.00057058723,0.00023903113,0.00059343607,0.016545054,0.0009812131,0.00006126772,0.00026198165],"about_ca_topic_score_codex":0.000057677076,"about_ca_topic_score_gemma":0.000027951874,"teacher_disagreement_score":0.0489799,"about_ca_system_score_codex":0.00077668077,"about_ca_system_score_gemma":0.00047650852,"threshold_uncertainty_score":0.9260179},"labels":[],"label_agreement":null},{"id":"W2040380803","doi":"10.1016/j.ygyno.2012.11.036","title":"Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre hospitalier universitaire de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; Cancer Research Society; California HIV/AIDS Research Program","keywords":"DNA methylation; Medicine; Serous fluid; Ovarian cancer; Serous ovarian cancer; Methylation; Disease; Cancer research; Tumor progression; Oncology; Pathology; Cancer; DNA; Internal medicine; Biology; Gene; Genetics; Gene expression","score_opus":0.019703812064061646,"score_gpt":0.3352417699123821,"score_spread":0.31553795784832045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040380803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885924,0.005748,0.0032380566,0.000393286,0.00022326682,0.0012118765,0.00015570523,0.000018886169,0.00015165962],"genre_scores_gemma":[0.99612427,0.00012983693,0.002181462,0.00019802195,0.00013864577,0.00067757117,0.0005081192,0.00001908187,0.000022965964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829924,0.00037615842,0.00030360481,0.000451707,0.00014163989,0.0004276391],"domain_scores_gemma":[0.99868506,0.0002174597,0.00058260415,0.00015369272,0.00016783825,0.00019331442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007466471,0.00022385476,0.00029584588,0.00006615269,0.0001561665,0.000018655286,0.000104684616,0.00033115788,0.000014609923],"category_scores_gemma":[0.0014385501,0.00017625412,0.00004868469,0.0002097002,0.00012632993,0.000018951052,0.00007960097,0.00011486225,5.0212384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010960822,0.0005180866,0.8858189,0.00006070969,0.00012783366,0.0000091492175,0.00028738216,0.00053847884,0.05986691,0.00024284743,0.000046367557,0.051387258],"study_design_scores_gemma":[0.0021492743,0.0010161458,0.9475603,0.000052595522,0.00012855318,0.0000013377123,0.000087382614,0.0007539694,0.04514027,0.0017529291,0.0010473048,0.00030993664],"about_ca_topic_score_codex":0.000023133289,"about_ca_topic_score_gemma":0.0003818325,"teacher_disagreement_score":0.061741404,"about_ca_system_score_codex":0.00022825076,"about_ca_system_score_gemma":0.00032764263,"threshold_uncertainty_score":0.71874344},"labels":[],"label_agreement":null},{"id":"W2040937491","doi":"10.1016/j.ygyno.2015.02.028","title":"Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation","keywords":"Medicine; Gynecology; Population; Cohort; Endometrial cancer; Retrospective cohort study; Menarche; Obstetrics; Lynch syndrome; Cancer; Atypical hyperplasia; Malignancy; Ovarian cancer; Internal medicine","score_opus":0.0578503503750598,"score_gpt":0.37840719588336125,"score_spread":0.32055684550830144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040937491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974974,0.000095810065,0.00006291658,0.00018169939,0.00087151,0.0007641687,0.00008796318,0.000021491198,0.00041707014],"genre_scores_gemma":[0.99835145,0.001000643,0.00013946339,0.000047488153,0.00013847344,0.00016979518,0.000047652837,0.000008636514,0.0000963652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741465,0.0005967795,0.0011041895,0.0003767186,0.00025338822,0.00025425383],"domain_scores_gemma":[0.9979285,0.0008233846,0.00066749414,0.00017429305,0.00018901506,0.00021731906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001773818,0.00014995271,0.0011020247,0.00026241317,0.000021523518,0.00000432511,0.000086131855,0.00042613715,0.00017340375],"category_scores_gemma":[0.0049207294,0.000104064435,0.00009213818,0.00056075526,0.00041411232,0.000061910214,0.000074992065,0.0002921941,0.0000035925436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020669212,0.0011663621,0.9711779,0.000023369328,0.0001199992,0.00001772984,0.00031956495,0.0000026345901,0.005759946,0.000047378122,0.0000057870006,0.019292431],"study_design_scores_gemma":[0.009643036,0.0050358726,0.98342294,0.000010855187,0.00019821852,0.000008777201,0.00022947832,0.00008119671,0.000813371,0.00028564187,0.00018681635,0.00008380312],"about_ca_topic_score_codex":0.00014608825,"about_ca_topic_score_gemma":0.00009154543,"teacher_disagreement_score":0.019208627,"about_ca_system_score_codex":0.0004227817,"about_ca_system_score_gemma":0.00030535652,"threshold_uncertainty_score":0.5890928},"labels":[],"label_agreement":null},{"id":"W2041009410","doi":"10.1016/j.ygyno.2012.10.006","title":"Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Cohort; Cervical cancer; Demography; Cohort study; Cervical cancer screening; Population; Gynecology; Cancer; Oncology; Environmental health; Internal medicine","score_opus":0.05015270162177006,"score_gpt":0.3397202730439451,"score_spread":0.28956757142217504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041009410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965068,0.00028970322,0.00002987093,0.0012088309,0.00016384831,0.0006311027,0.000087965345,0.00004086573,0.0010410141],"genre_scores_gemma":[0.99877244,0.00007287474,0.00011497293,0.00049890054,0.000067300774,0.000097887976,0.00029354126,0.000017595723,0.00006448652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793655,0.00028654237,0.00045457273,0.00031210695,0.00037627644,0.0006339683],"domain_scores_gemma":[0.997601,0.0016260743,0.00020022343,0.00016268616,0.00015071582,0.00025932753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008640163,0.00018866843,0.00075022905,0.0002491867,0.000093167604,0.0000069011217,0.000091578695,0.00042310092,0.0008839036],"category_scores_gemma":[0.00079649716,0.00013865173,0.00008379007,0.0005340226,0.00020389407,0.00008797635,0.000059056823,0.0005290603,9.874603e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013819473,0.00046093002,0.9923174,0.000050590865,0.00013283681,0.000019366036,0.00020836956,0.000083343904,0.000025478752,0.00007858148,0.00008245686,0.005158729],"study_design_scores_gemma":[0.010644504,0.0014791186,0.9868784,0.000026456524,0.0001444508,0.000002578245,0.00009175344,0.0002646671,0.00006267015,0.00008347992,0.00017359921,0.00014832386],"about_ca_topic_score_codex":0.0050133634,"about_ca_topic_score_gemma":0.011586702,"teacher_disagreement_score":0.009262556,"about_ca_system_score_codex":0.00051328813,"about_ca_system_score_gemma":0.00030987608,"threshold_uncertainty_score":0.9678125},"labels":[],"label_agreement":null},{"id":"W2041065068","doi":"10.1016/j.ygyno.2012.04.018","title":"Surgical management of a suspicious adnexal mass: A systematic review","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Context (archaeology); Laparotomy; Systematic review; Adnexal mass; Laparoscopy; MEDLINE; Malignancy; Stage (stratigraphy); Lymphadenectomy; Meta-analysis; Surgery; General surgery; Cancer; Pathology; Internal medicine","score_opus":0.08333958322107564,"score_gpt":0.408514775181626,"score_spread":0.32517519196055034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041065068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010415579,0.9681077,0.0000032026978,0.00033423965,0.0006367023,0.009080489,0.00003872265,0.00006547886,0.021732394],"genre_scores_gemma":[0.000046613124,0.9914888,0.00091560587,0.00034531776,0.00015868085,0.0052568135,0.00016072024,0.000054856366,0.001572573],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955536,0.0008139804,0.0020042183,0.000616537,0.00036114725,0.0006505106],"domain_scores_gemma":[0.9960304,0.0011640865,0.0014357519,0.000979655,0.00010794981,0.00028219324],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012044131,0.0006426136,0.009129649,0.00019274512,0.00004506726,0.0000059948507,0.0003246763,0.0007451989,0.0018989058],"category_scores_gemma":[0.00010643713,0.0003934154,0.0013434482,0.00044031718,0.00013357121,0.000027885128,0.00017475495,0.00045074653,0.00067849737],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009616139,0.0009804318,0.000013364712,0.76669794,0.0019978883,0.002664357,0.000006885122,1.816475e-8,2.8697442e-9,0.0010204667,0.0008672676,0.22574176],"study_design_scores_gemma":[0.00085059326,0.0011531231,0.000010294205,0.3441618,0.047523014,0.000928406,0.00001398611,1.1391924e-7,4.605577e-8,0.000016396407,0.6051467,0.00019551578],"about_ca_topic_score_codex":0.000005928709,"about_ca_topic_score_gemma":0.0000037048408,"teacher_disagreement_score":0.60427946,"about_ca_system_score_codex":0.0016327881,"about_ca_system_score_gemma":0.0005626443,"threshold_uncertainty_score":0.99985176},"labels":[],"label_agreement":null},{"id":"W2041081892","doi":"10.1016/j.ygyno.2008.02.016","title":"The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Delirium; Incidence (geometry); Narcotic; Logistic regression; Comorbidity; Univariate analysis; Surgery; Internal medicine; Multivariate analysis; Anesthesia; Intensive care medicine","score_opus":0.024942777900174067,"score_gpt":0.2657181949401978,"score_spread":0.24077541704002375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041081892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995229,0.00026816168,0.00006021516,0.0015389684,0.00038739401,0.0017910678,0.000043926382,0.00007927182,0.0006019865],"genre_scores_gemma":[0.9936512,0.0011866391,0.00012302904,0.004419856,0.000020139016,0.00025556455,0.00014768147,0.000028805138,0.00016705025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974149,0.00063332845,0.00051345915,0.0005070056,0.00020233903,0.0007289664],"domain_scores_gemma":[0.95884526,0.03375352,0.00048451868,0.00018830792,0.0066068154,0.00012158822],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006367496,0.00032667388,0.0007849117,0.00028530293,0.00069493585,0.000017434428,0.000120103745,0.0003713009,0.000041030547],"category_scores_gemma":[0.1513307,0.00020368832,0.00011541985,0.00058466906,0.0007493286,0.0001099628,0.000092369715,0.00044287296,0.000004711221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004963626,0.0003200127,0.9944509,0.000012920282,0.00016048337,0.00015811119,0.0007548018,0.000015066731,0.00005392764,0.000048852526,0.0027818866,0.0007466711],"study_design_scores_gemma":[0.0034376213,0.0051801214,0.9833996,0.000041209267,0.00014780309,0.000027916025,0.0068002655,0.00006665756,0.000129232,0.00019387741,0.0003139564,0.00026170223],"about_ca_topic_score_codex":0.000108710454,"about_ca_topic_score_gemma":0.009207238,"teacher_disagreement_score":0.15069394,"about_ca_system_score_codex":0.0009569474,"about_ca_system_score_gemma":0.0012494633,"threshold_uncertainty_score":0.85581803},"labels":[],"label_agreement":null},{"id":"W2041145728","doi":"10.1016/j.ygyno.2004.02.013","title":"Systematic review of management options for women with a hereditary predisposition to ovarian cancer","year":2004,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network; Cancer Care Ontario; Western University; University of Ottawa; Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Oophorectomy; Ovarian cancer; Prophylactic Surgery; Cohort study; Cohort; Cancer; Gynecology; Incidence (geometry); Obstetrics; Surgery; Internal medicine; Hysterectomy","score_opus":0.01905950891766023,"score_gpt":0.34427671627143813,"score_spread":0.3252172073537779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041145728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007886107,0.987276,0.0015487955,0.00022762724,0.0004756322,0.009103263,0.00048935175,0.000018788058,0.00085262296],"genre_scores_gemma":[0.000014660605,0.9499105,0.008907502,0.0006843551,0.00017184665,0.038893633,0.0005661166,0.000051452906,0.0007999057],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976479,0.00026962135,0.00090874225,0.00063222897,0.0001447015,0.00039684036],"domain_scores_gemma":[0.9981856,0.000114703515,0.0007146457,0.0006432915,0.00023071186,0.00011105613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000606486,0.000376551,0.0019035363,0.00014468191,0.00007540873,0.000008063202,0.00046151318,0.0004578602,0.00010990075],"category_scores_gemma":[0.00016562197,0.00028377073,0.00025653117,0.00032729228,0.00008608335,0.0000034639315,0.0001663293,0.00012709273,0.000014103398],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039524683,0.00015602377,1.7352451e-7,0.9390978,0.001331388,0.000013891001,0.000031546002,0.00008538963,0.0000035525436,0.0001947754,0.00259639,0.056449536],"study_design_scores_gemma":[0.0005632678,0.0028681147,0.0000049177497,0.31499258,0.003504121,0.000098443146,0.000088837034,5.626955e-7,0.000007037023,0.000104692575,0.67737734,0.00039005905],"about_ca_topic_score_codex":0.00000542844,"about_ca_topic_score_gemma":0.00005608495,"teacher_disagreement_score":0.67478096,"about_ca_system_score_codex":0.0019311492,"about_ca_system_score_gemma":0.0016411447,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W2041589257","doi":"10.1006/gyno.2000.5894","title":"Alterations in SPARC and VEGF Immunoreactivity in Epithelial Ovarian Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Bone and Dental Protein Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Institutes of Health; Scheme for Promotion of Academic and Research Collaboration; University of Washington; Bristol-Myers Squibb","keywords":"Stroma; Matricellular protein; Pathology; Angiogenesis; Osteonectin; Ovary; Vascular endothelial growth factor; Malignant transformation; Ovarian cancer; Ovarian carcinoma; Biology; Medicine; Neoplastic transformation; Cancer research; Cancer; Endocrinology; Immunohistochemistry; Internal medicine; Extracellular matrix; VEGF receptors; Cell biology","score_opus":0.02374096067254824,"score_gpt":0.32609848139532727,"score_spread":0.30235752072277905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041589257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957915,0.00073456136,0.0000018311246,0.0039782375,0.00011595991,0.00044106107,0.000006770932,0.00002085887,0.03678573],"genre_scores_gemma":[0.99612486,0.0010767592,0.00030647445,0.001208041,0.000071629045,0.00023116003,0.0000052121377,0.000005824035,0.00097001495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991216,0.00010836802,0.00022773426,0.00023164325,0.00005930323,0.00025135922],"domain_scores_gemma":[0.9995895,0.00020323625,0.00003664299,0.0001089443,0.000016007652,0.000045695022],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024205886,0.00010381668,0.0003782675,0.000092023394,0.000059217895,0.0000057869474,0.000036643698,0.0001616247,0.0011492729],"category_scores_gemma":[0.000096970136,0.000086448876,0.000026559328,0.00015798397,0.00014131247,0.00006339533,0.00004256502,0.0002771769,0.00005252302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010974881,0.0014329812,0.47400168,0.000038589656,0.000060414168,0.00094173616,0.0016722705,0.000041877916,0.0066174553,0.0005595296,0.000546054,0.51298994],"study_design_scores_gemma":[0.0029981283,0.00074464147,0.9791418,0.000021961714,0.000020403404,0.000061710496,0.00020153243,0.00009495697,0.00024498938,0.001400287,0.014973365,0.00009625168],"about_ca_topic_score_codex":0.0030312503,"about_ca_topic_score_gemma":0.01623232,"teacher_disagreement_score":0.5128937,"about_ca_system_score_codex":0.0002728186,"about_ca_system_score_gemma":0.00013337584,"threshold_uncertainty_score":0.9997638},"labels":[],"label_agreement":null},{"id":"W2041997687","doi":"10.1016/j.ygyno.2014.05.011","title":"Younger age distribution of cervical cancer incidence among survivors of pediatric and young adult cancers","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"American Lebanese Syrian Associated Charities","keywords":"Medicine; Cervical cancer; Population; Cancer; Incidence (geometry); Malignancy; Epidemiology; Young adult; Internal medicine","score_opus":0.020941340102711856,"score_gpt":0.3318990516716566,"score_spread":0.31095771156894475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041997687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990984,0.00053800124,0.00012146002,0.000565424,0.00039586367,0.0003751651,0.000047356294,0.000024756182,0.006947955],"genre_scores_gemma":[0.9974716,0.0016295897,0.00008484367,0.00023980439,0.00025495168,0.000089156914,0.00004085329,0.000011024135,0.00017821461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982626,0.00020880472,0.00046127985,0.0003400575,0.00033302172,0.0003942618],"domain_scores_gemma":[0.99822265,0.000609257,0.00021900219,0.00022596399,0.0005112905,0.0002118324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006048572,0.00014995098,0.00067510677,0.00010229638,0.000057725552,0.000004771172,0.00015093533,0.00032185306,0.0014109631],"category_scores_gemma":[0.0012263939,0.00012054847,0.000087664615,0.0003953265,0.0005459107,0.00007071947,0.00014643146,0.00034627784,0.000004636575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037757633,0.00014779966,0.97367424,0.0003860562,0.0000421465,0.000027006663,0.0002399424,0.000019097874,0.00031597883,0.0006340415,0.00068761845,0.023448512],"study_design_scores_gemma":[0.001478371,0.0017517862,0.9943487,0.000010306379,0.00017033717,0.000009159741,0.00013285887,0.00050548196,0.00030726113,0.0002677189,0.0009068095,0.0001112304],"about_ca_topic_score_codex":0.016417561,"about_ca_topic_score_gemma":0.026750969,"teacher_disagreement_score":0.02333728,"about_ca_system_score_codex":0.000567408,"about_ca_system_score_gemma":0.00048278764,"threshold_uncertainty_score":0.9995019},"labels":[],"label_agreement":null},{"id":"W2042093910","doi":"10.1016/j.ygyno.2005.09.032","title":"A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Regimen; Tirapazamine; Ovarian cancer; Cisplatin; Gynecologic oncology; Internal medicine; Chemotherapy; Oncology; Progressive disease; Chemotherapy regimen; Surgery; Adverse effect; Phases of clinical research; Ovarian carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cancer","score_opus":0.09526104529368758,"score_gpt":0.4222465381856592,"score_spread":0.32698549289197165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042093910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98096937,0.0013268107,0.000008601806,0.004706752,0.0006037942,0.007165845,0.000117951495,0.00003435918,0.0050665424],"genre_scores_gemma":[0.99167365,0.0013241788,0.0015464389,0.0006894227,0.00032171913,0.0041579017,0.00015834412,0.00002460925,0.00010373757],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99480563,0.00176733,0.0013866306,0.00078131165,0.00066495675,0.0005941388],"domain_scores_gemma":[0.99519163,0.0027748605,0.00092453405,0.0005769736,0.00040115774,0.00013086108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002260264,0.00046578672,0.001893609,0.0003451976,0.00017376563,0.0000075274183,0.00022377109,0.00044230075,0.0014886984],"category_scores_gemma":[0.00045002397,0.00027974957,0.0002408871,0.00063802116,0.0003337129,0.00008263558,0.00009107762,0.00032004408,0.0000109491075],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006877163,0.11036751,0.011970546,0.000055257042,0.0007460172,0.00062667456,0.02182391,0.00042781286,0.00052506244,0.00012249398,0.0004220777,0.8460355],"study_design_scores_gemma":[0.11923405,0.43978584,0.39609808,0.00009163832,0.003677349,0.00021115351,0.009933181,0.004651232,0.0005412772,0.00009489368,0.025283579,0.0003977547],"about_ca_topic_score_codex":0.000654157,"about_ca_topic_score_gemma":0.017434372,"teacher_disagreement_score":0.84563774,"about_ca_system_score_codex":0.00846713,"about_ca_system_score_gemma":0.0025257028,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W2042177108","doi":"10.1016/j.ygyno.2005.06.065","title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Occult; Prophylactic Surgery; Oophorectomy; Ovarian cancer; Fallopian tube; Malignancy; Histopathology; Gynecology; Cancer; Carcinoma; Surgery; Internal medicine; Pathology; Hysterectomy","score_opus":0.02890545074826593,"score_gpt":0.35181832090032567,"score_spread":0.3229128701520597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042177108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889309,0.0020914597,0.0000019903985,0.0056302478,0.00021366858,0.000617229,0.000006765451,0.000028165068,0.002479566],"genre_scores_gemma":[0.9933294,0.0021713646,0.0029098657,0.0013038495,0.00009487473,0.000077811186,0.000004355503,0.000011665163,0.00009680918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983473,0.00019734321,0.00056142785,0.0004793356,0.00009591106,0.00031869573],"domain_scores_gemma":[0.99854285,0.00090271054,0.0001579297,0.00019278967,0.000051025032,0.00015271227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071270234,0.00018125819,0.0008319471,0.00015262254,0.000044529996,0.000008118302,0.0000626671,0.00037098327,0.00019439623],"category_scores_gemma":[0.0007819991,0.00013644775,0.000071750655,0.00015883482,0.00059504417,0.00005278241,0.00009472843,0.00030818002,0.000012290165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024472745,0.00068454345,0.8753826,0.00007009181,0.000062020954,0.0003848839,0.00041557883,0.0000027647252,0.00020522592,0.0003137367,0.00026497897,0.121968836],"study_design_scores_gemma":[0.0053207385,0.0055006174,0.9793933,0.000031065887,0.00015225053,0.00022081217,0.000266982,0.00004320137,0.00030551403,0.0004111199,0.008227538,0.00012684513],"about_ca_topic_score_codex":0.000053684,"about_ca_topic_score_gemma":0.00029301838,"teacher_disagreement_score":0.12184199,"about_ca_system_score_codex":0.0002803852,"about_ca_system_score_gemma":0.00025149834,"threshold_uncertainty_score":0.5564178},"labels":[],"label_agreement":null},{"id":"W2042668744","doi":"10.1016/j.ygyno.2012.06.033","title":"Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; CancerCare Manitoba; BC Cancer Agency; University of Toronto","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Benchmarking; Ovarian cancer; General partnership; Oncology; Stage (stratigraphy); Cancer; Gynecology; Internal medicine; Management","score_opus":0.17369846699064362,"score_gpt":0.40524954504904376,"score_spread":0.23155107805840014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042668744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131137,0.019692989,0.0000080667005,0.059540298,0.003352711,0.0006232027,0.00010504186,0.000049020106,0.0035149374],"genre_scores_gemma":[0.963492,0.025499271,0.0004106708,0.0061388537,0.00170557,0.001841155,0.000035156198,0.000018941959,0.00085837726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.00021141561,0.0002857886,0.0004241572,0.00026120682,0.00048811708],"domain_scores_gemma":[0.9954562,0.0037426942,0.00020095572,0.00029369333,0.00008087899,0.0002255373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063983636,0.00021562993,0.00041940802,0.00003184808,0.00020431737,0.000029928768,0.00019463283,0.00020653609,0.014201326],"category_scores_gemma":[0.00044356272,0.00013761064,0.00008763986,0.00011806319,0.00017721833,0.00014677602,0.00026973567,0.00023183496,0.000045958353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013830385,0.00028297008,0.91729736,0.000012730259,0.00036381028,0.00004508983,0.00085228076,0.000011317681,0.00008333481,0.00031467728,0.017377803,0.06322033],"study_design_scores_gemma":[0.0010677362,0.00025011075,0.7109824,0.00008615556,0.00028844297,0.000005909358,0.00016579675,0.00003617489,0.00027604387,0.000036656184,0.28669384,0.00011073141],"about_ca_topic_score_codex":0.0053270254,"about_ca_topic_score_gemma":0.013486943,"teacher_disagreement_score":0.26931605,"about_ca_system_score_codex":0.0017232543,"about_ca_system_score_gemma":0.00029610726,"threshold_uncertainty_score":0.9866998},"labels":[],"label_agreement":null},{"id":"W2042714386","doi":"10.1016/j.ygyno.2007.07.051","title":"Opportunities to improve health systems in Africa. A comparative overview of healthcare challenges for stakeholders and strategic planners","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Excellence; Quarter (Canadian coin); Oil reserves; Work (physics); Population; Health care; Economic growth; Quality (philosophy); Geography; Political science; Medicine; Petroleum; Engineering; Environmental health; Economics","score_opus":0.5176851726791677,"score_gpt":0.43727634224811096,"score_spread":0.08040883043105673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042714386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204347,0.031654652,0.000016651444,0.035712276,0.00048445404,0.0028885484,0.00013419407,0.00003885676,0.008635649],"genre_scores_gemma":[0.99168104,0.004600342,0.0004232227,0.003001093,0.000062181025,0.00009559533,0.00001612223,0.000008084123,0.000112313704],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.99818254,0.00016192373,0.0006273368,0.0003014079,0.00012432387,0.00060247205],"domain_scores_gemma":[0.99861515,0.00048499307,0.00026700844,0.00013215133,0.0001228758,0.000377829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001341389,0.00016521267,0.00097042206,0.00018183875,0.000054744065,0.000004132942,0.000075898824,0.00017790243,0.0000079775],"category_scores_gemma":[0.000042940806,0.00013040144,0.000041081104,0.0000883423,0.00009558653,0.000025653684,0.000036246718,0.00017596324,0.0000020460266],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010231492,0.004264768,0.027218306,0.039560534,0.0005239342,0.0010435781,0.062179267,0.00016283656,0.0007524958,0.6867525,0.006190177,0.16112012],"study_design_scores_gemma":[0.01184933,0.09010314,0.32637584,0.0013643969,0.000096037424,0.00031945333,0.38962322,0.00021729998,0.00006350565,0.009084643,0.17023872,0.000664388],"about_ca_topic_score_codex":0.001311903,"about_ca_topic_score_gemma":0.005320246,"teacher_disagreement_score":0.67766786,"about_ca_system_score_codex":0.00055443676,"about_ca_system_score_gemma":0.0007161496,"threshold_uncertainty_score":0.53176165},"labels":[],"label_agreement":null},{"id":"W2042921510","doi":"10.1016/j.ygyno.2004.09.039","title":"The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University; Université de Montréal; BC Cancer Agency; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Ovarian cancer; Oophorectomy; Oncology; Tamoxifen; Cancer; Internal medicine; Stage (stratigraphy); Gynecology; Disease; Surgery; Hysterectomy","score_opus":0.00640917073123009,"score_gpt":0.2781251309802703,"score_spread":0.2717159602490402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042921510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882479,0.0063320133,0.00005396356,0.0035713424,0.0006334533,0.00029491424,0.00022962123,0.0000074136487,0.0006294355],"genre_scores_gemma":[0.9914214,0.006861517,0.0003635498,0.0005517568,0.00015036219,0.00050305104,0.000006223666,0.000015651112,0.00012647365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876994,0.00015881831,0.00028565087,0.0003711328,0.00008176179,0.000332722],"domain_scores_gemma":[0.99927855,0.00009084428,0.00017822724,0.0002864568,0.00010068405,0.00006527015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036310672,0.00015228438,0.00022031444,0.000047163496,0.00011216607,0.000010738719,0.00020783182,0.0003081286,0.00014708575],"category_scores_gemma":[0.00014102027,0.000113353846,0.00005841686,0.00015470096,0.0004686943,0.000004455778,0.00014325672,0.00018843578,0.0000023520586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010915181,0.00026758848,0.72102034,0.00004547705,0.0005790393,0.00004920946,0.001389397,0.013743038,0.036977254,0.0005380194,0.0015874002,0.22271174],"study_design_scores_gemma":[0.0021513787,0.0003987859,0.9552156,0.000013288766,0.00007583049,0.00004012575,0.00048351887,0.000025444111,0.005941926,0.0014279991,0.034008995,0.00021716348],"about_ca_topic_score_codex":0.0013585372,"about_ca_topic_score_gemma":0.032157194,"teacher_disagreement_score":0.23419523,"about_ca_system_score_codex":0.00047182082,"about_ca_system_score_gemma":0.0010196159,"threshold_uncertainty_score":0.98550344},"labels":[],"label_agreement":null},{"id":"W2043178214","doi":"10.1016/j.ygyno.2005.03.022","title":"Identifying patients unlikely to benefit from further chemotherapy: A descriptive study of outcome at each relapse in ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Ovarian cancer; Retrospective cohort study; Internal medicine; Cancer; Surgery; Oncology","score_opus":0.053480507698290915,"score_gpt":0.3516750492072854,"score_spread":0.29819454150899444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043178214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095005,0.00026795975,0.000008099228,0.0049320976,0.00056812,0.0020231076,0.000052132433,0.000031350046,0.0011671045],"genre_scores_gemma":[0.9937236,0.00008592556,0.00185854,0.002771369,0.00012537513,0.0007589549,0.00002399573,0.00003386075,0.0006183977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978357,0.00013131883,0.0007234332,0.00062683335,0.00025295038,0.0004297921],"domain_scores_gemma":[0.9987523,0.00027831245,0.0002748083,0.00039389677,0.00012894702,0.00017176059],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024678188,0.00026755026,0.000919932,0.00022401988,0.00006063693,0.000008399761,0.00016637689,0.00024779324,0.0025920898],"category_scores_gemma":[0.000110013214,0.00021863916,0.000103069855,0.0003277135,0.000038373273,0.000070667935,0.00015054297,0.00022422282,0.00011658578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007960033,0.007749892,0.9347854,0.000010767906,0.00031702084,0.000087414846,0.014010201,0.0000976529,0.00022478419,0.00002795657,0.00050319894,0.0413897],"study_design_scores_gemma":[0.015873697,0.0048996788,0.97159904,0.00004231383,0.00022959632,0.000001772656,0.001970451,0.000014280757,0.00033177037,0.000093710776,0.0047632465,0.00018041204],"about_ca_topic_score_codex":0.0043494795,"about_ca_topic_score_gemma":0.054828133,"teacher_disagreement_score":0.050478656,"about_ca_system_score_codex":0.0039562616,"about_ca_system_score_gemma":0.0001327805,"threshold_uncertainty_score":0.9998674},"labels":[],"label_agreement":null},{"id":"W2043559279","doi":"10.1006/gyno.2001.6280","title":"Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kinexus Bioinformatics Corporation (Canada); University of British Columbia","funders":"","keywords":"Neoplastic transformation; Biology; Cancer research; Kinase; P70-S6 Kinase 1; Protein kinase A; Carcinogenesis; Cyclin-dependent kinase 4; Protein kinase B; Cyclin-dependent kinase 2; Cell biology; Signal transduction; Cancer; Genetics","score_opus":0.03587211772932169,"score_gpt":0.32660949037437703,"score_spread":0.29073737264505534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043559279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984838,0.00016225645,0.00006695496,0.0034999133,0.000079485995,0.001409696,0.000010112469,0.000014471342,0.009919103],"genre_scores_gemma":[0.99849355,0.00007677575,0.0009922374,0.00017704356,0.000029409919,0.00015755303,0.00002493552,0.0000066426755,0.000041862593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988221,0.00020189043,0.00046499295,0.00016099062,0.00014072571,0.00020929571],"domain_scores_gemma":[0.9990632,0.0004388084,0.00020127665,0.00019394892,0.00007094143,0.000031851356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256748,0.0001131346,0.00042819526,0.00008425412,0.00004261041,0.0000029235423,0.000102533704,0.00014202249,0.00024320121],"category_scores_gemma":[0.00013751141,0.00007163396,0.00007412571,0.00026617572,0.000110334,0.000043421984,0.000012772075,0.00014400147,0.00000699039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016473455,0.013683716,0.7559923,0.0010974979,0.00038442222,0.0009782346,0.008622413,0.0013370613,0.107781634,0.04621117,0.00026585223,0.06199838],"study_design_scores_gemma":[0.009413534,0.016240263,0.9176108,0.00022034907,0.00033508375,0.00015294563,0.0032033615,0.0002535911,0.04685999,0.002310603,0.0031988018,0.00020067536],"about_ca_topic_score_codex":0.00022380626,"about_ca_topic_score_gemma":0.0005063724,"teacher_disagreement_score":0.16161852,"about_ca_system_score_codex":0.00017085926,"about_ca_system_score_gemma":0.00020038987,"threshold_uncertainty_score":0.2921148},"labels":[],"label_agreement":null},{"id":"W2044048655","doi":"10.1016/j.ygyno.2015.03.057","title":"The sooner the better: Genetic testing following ovarian cancer diagnosis","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Genetic testing; Ovarian cancer; Serous ovarian cancer; Family history; Serous fluid; Gynecology; Cancer; Breast cancer; Disease; Oncology; Cohort; Genetic counseling; Internal medicine; Obstetrics; Genetics","score_opus":0.047746599063478945,"score_gpt":0.32452003618025965,"score_spread":0.2767734371167807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044048655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96348065,0.006654404,0.00042031036,0.017916495,0.003390531,0.0005541768,0.000015054415,0.000043550564,0.007524843],"genre_scores_gemma":[0.98575056,0.00034241346,0.004856434,0.005051075,0.0009548226,0.0023296492,0.000013911192,0.000031326123,0.0006698002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998266,0.0003599117,0.00030404993,0.0004131451,0.0001645742,0.0004923236],"domain_scores_gemma":[0.99836373,0.00065810484,0.00016995284,0.0005393386,0.00016776434,0.000101114674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008124351,0.00018859001,0.00018387446,0.000024213601,0.0005333256,0.00005585187,0.000618848,0.00026737538,0.00005259932],"category_scores_gemma":[0.0017722811,0.00011236648,0.000111006746,0.00021958584,0.00027118938,0.000004118527,0.00032343174,0.00021394808,0.00004401599],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065808556,0.00014779459,0.25967312,0.0000064580877,0.00043512686,0.0000648913,0.00046423747,0.0032411364,0.009240999,0.00014281808,0.18990701,0.5366106],"study_design_scores_gemma":[0.00094857864,0.0007160943,0.05819052,0.0000046631917,0.000113289665,0.000039301198,0.000537215,0.0002415166,0.0033109614,0.0014912686,0.9341362,0.00027040415],"about_ca_topic_score_codex":0.00014147616,"about_ca_topic_score_gemma":0.0013128074,"teacher_disagreement_score":0.7442292,"about_ca_system_score_codex":0.00034985386,"about_ca_system_score_gemma":0.0009937064,"threshold_uncertainty_score":0.4582172},"labels":[],"label_agreement":null},{"id":"W2044769523","doi":"10.1016/j.ygyno.2013.08.019","title":"A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval; Hôtel-Dieu de Québec; McGill University; University Health Network; Toronto General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Stage (stratigraphy); Debulking; Interquartile range; Serous fluid; Ovarian cancer; Clinical trial; Clinical endpoint; Taxane; Surgery; Maintenance therapy; Internal medicine; Phases of clinical research; Cancer; Chemotherapy; Breast cancer","score_opus":0.025372295877553023,"score_gpt":0.3351996523039732,"score_spread":0.3098273564264202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044769523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98846155,0.00021194485,0.000018686327,0.0017805939,0.00022509163,0.0040557613,0.000011394645,0.00010942689,0.0051255506],"genre_scores_gemma":[0.9905259,0.00010316869,0.0009601188,0.0023498929,0.000075077885,0.002560886,0.0000059804156,0.000046205078,0.0033727644],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99716103,0.00035022956,0.0006013061,0.00065705035,0.00027088824,0.0009595059],"domain_scores_gemma":[0.9980996,0.0004385071,0.00043844088,0.00055455277,0.0002020461,0.00026685753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050704775,0.0003841223,0.0012094043,0.00023648825,0.00010921914,0.000012163171,0.00027249762,0.0002374754,0.0031315237],"category_scores_gemma":[0.00024949777,0.0002628826,0.00005597793,0.000570355,0.00021873503,0.00015462222,0.00014642505,0.0005013288,0.000031688887],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01764304,0.060883924,0.057469796,0.00018407787,0.0007555438,0.0021461658,0.027226647,0.00037435783,0.13279139,0.0004640458,0.0005127316,0.6995483],"study_design_scores_gemma":[0.14292131,0.45557445,0.35390317,0.00011896201,0.00011471296,0.000067451045,0.028242243,0.00028729983,0.0009511843,0.0005771005,0.01645363,0.0007884737],"about_ca_topic_score_codex":0.006293652,"about_ca_topic_score_gemma":0.005044211,"teacher_disagreement_score":0.6987598,"about_ca_system_score_codex":0.001001512,"about_ca_system_score_gemma":0.00052733236,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2045014139","doi":"10.1016/j.ygyno.2010.05.002","title":"Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Medicine; Colposcopy; Pap test; Cervical cancer; Test (biology); Cervical intraepithelial neoplasia; Gynecology; Cervical screening; Obstetrics; Family medicine; Cancer; Cervical cancer screening; Internal medicine","score_opus":0.06789700888056824,"score_gpt":0.38916876193384337,"score_spread":0.32127175305327516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045014139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722997,0.00014597274,0.0018262763,0.0064949878,0.0011198613,0.006049794,0.0005582795,0.00020336318,0.01130175],"genre_scores_gemma":[0.9796246,0.00009013023,0.005557694,0.00072505884,0.00069854624,0.010929712,0.00023870508,0.000031995507,0.0021035154],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978074,0.00008473153,0.0004064009,0.00058274117,0.00016188221,0.00095683173],"domain_scores_gemma":[0.9940651,0.0046468903,0.00012458104,0.0003048461,0.00055501243,0.0003035647],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007792397,0.0002347384,0.0008030817,0.000107579166,0.00026194696,0.000040287923,0.00028518672,0.0005710395,0.002070392],"category_scores_gemma":[0.0013793227,0.00017345547,0.0001641585,0.00017984149,0.00028878776,0.00006986215,0.00006334822,0.00037399514,0.000010709855],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02024297,0.0037882854,0.033723447,0.0024696798,0.0006587109,0.000017964765,0.0011433995,0.000063017214,0.017269757,0.04407226,0.03923727,0.83731323],"study_design_scores_gemma":[0.01710817,0.027828515,0.5102905,0.0000071414092,0.00011583075,0.000020676762,0.001225649,0.00083710084,0.0014025773,0.10308202,0.33763364,0.00044816206],"about_ca_topic_score_codex":0.00013552475,"about_ca_topic_score_gemma":0.008698584,"teacher_disagreement_score":0.83686507,"about_ca_system_score_codex":0.0004133967,"about_ca_system_score_gemma":0.0013331883,"threshold_uncertainty_score":0.9988418},"labels":[],"label_agreement":null},{"id":"W2047097744","doi":"10.1016/j.ygyno.2014.08.018","title":"Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in Gynecologic Oncology Group trials of cisplatin-based chemoradiation","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Adenosquamous carcinoma; Medicine; Cervix; Oncology; Cervical cancer; Adenocarcinoma; Cisplatin; Internal medicine; Radiation therapy; Stage (stratigraphy); Squamous carcinoma; Carcinoma; Chemotherapy; Cancer; Biology","score_opus":0.0351859626018769,"score_gpt":0.3053002848717595,"score_spread":0.2701143222698826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047097744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872801,0.0014181011,0.00006805179,0.0026382413,0.00092626637,0.0035423131,0.00008235185,0.000030978797,0.0040136115],"genre_scores_gemma":[0.99645096,0.000033595134,0.0013349786,0.0015876549,0.000108773005,0.0003166239,0.00003263727,0.00003479393,0.00010000755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99333763,0.0024281042,0.0022890607,0.0007422049,0.0005241841,0.00067883177],"domain_scores_gemma":[0.9872869,0.009242816,0.001965146,0.0008962667,0.00035462432,0.00025419364],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025044463,0.000473824,0.002991622,0.00040379234,0.00012471755,0.0000061375495,0.00069294113,0.0007210021,0.00037235804],"category_scores_gemma":[0.006465692,0.0002874988,0.0004963457,0.0013864859,0.0006040145,0.000052651776,0.00038278894,0.0005204238,0.000007279651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061080186,0.0036875173,0.9161192,0.00089707435,0.00011939933,0.000047439502,0.0010894015,0.0027421613,0.03461379,0.000473543,0.00026633573,0.033836097],"study_design_scores_gemma":[0.024670018,0.013877974,0.9334073,0.000059288006,0.0006043608,0.000021159572,0.00051194226,0.0007258511,0.024197701,0.00050016446,0.0011714278,0.00025278635],"about_ca_topic_score_codex":0.0010336655,"about_ca_topic_score_gemma":0.0029389816,"teacher_disagreement_score":0.033583313,"about_ca_system_score_codex":0.0011330333,"about_ca_system_score_gemma":0.0009771865,"threshold_uncertainty_score":0.99995774},"labels":[],"label_agreement":null},{"id":"W2047343684","doi":"10.1016/j.ygyno.2005.01.039","title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"National Cancer Institute; National Institutes of Health; Nebraska Department of Health and Human Services; Creighton University","keywords":"Medicine; Ovarian cancer; Prophylactic Surgery; Oophorectomy; Lynch syndrome; Disease; Cancer; Genetic testing; Gynecology; Cancer syndrome; Breast cancer; Oncology; Hysterectomy; Internal medicine; Surgery; Colorectal cancer; Germline mutation; Mutation; DNA mismatch repair","score_opus":0.006936096163197354,"score_gpt":0.24657845890233895,"score_spread":0.2396423627391416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047343684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965618,0.00082563976,0.000029661958,0.0014050829,0.00017416867,0.0004613146,0.00012268439,0.00001457505,0.000405057],"genre_scores_gemma":[0.9967019,0.00006246462,0.0014658624,0.00045955053,0.00011809182,0.001012683,0.00005103837,0.000027672235,0.00010073633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832296,0.00022274315,0.0003886828,0.00048930844,0.00012791059,0.0004484027],"domain_scores_gemma":[0.99915516,0.00011958167,0.00022572503,0.00024258823,0.00015152592,0.000105391184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031064462,0.0002230347,0.00041000082,0.00015841682,0.00006297968,0.000011991643,0.00017152083,0.00038544598,0.00033543172],"category_scores_gemma":[0.00013030214,0.00020168554,0.000037942456,0.00031964327,0.0003788628,0.000015114166,0.00010023661,0.00021114809,0.000004149928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048521534,0.002627758,0.6779057,0.0002808583,0.0017533903,0.0011476778,0.0067155743,0.0047988524,0.073407724,0.000055739005,0.0012842839,0.22517031],"study_design_scores_gemma":[0.00348606,0.0024310758,0.9868596,0.000029709434,0.00011204922,0.0008219809,0.00070571643,0.00016960144,0.003143349,0.0001247012,0.0017537229,0.00036243384],"about_ca_topic_score_codex":0.00016815374,"about_ca_topic_score_gemma":0.0033153372,"teacher_disagreement_score":0.30895394,"about_ca_system_score_codex":0.0010063215,"about_ca_system_score_gemma":0.0009573662,"threshold_uncertainty_score":0.82244974},"labels":[],"label_agreement":null},{"id":"W2047531410","doi":"10.1016/j.ygyno.2004.08.039","title":"The use of transrectal ultrasound to biopsy pelvic masses in women","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; University of Saskatchewan; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biopsy; Malignancy; Radiology; Pathological; Ultrasound; Lesion; Surgery; Pathology","score_opus":0.050013531596475265,"score_gpt":0.3249703964566134,"score_spread":0.27495686486013815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047531410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261326,0.00017641574,0.000029568318,0.0037374662,0.00033829373,0.0005727708,0.000011524993,0.000026612941,0.0024940684],"genre_scores_gemma":[0.99613947,0.00024176868,0.0016570811,0.0014553352,0.000051777526,0.0001946168,0.0000047127855,0.000008876431,0.00024634803],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987984,0.0000936562,0.00033278015,0.00022280925,0.00013911596,0.00041325283],"domain_scores_gemma":[0.9975642,0.0019814754,0.000069682275,0.00018278831,0.000052605945,0.00014923887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024962577,0.00012521632,0.00043210384,0.00013241153,0.000055711957,0.0000085418,0.000113238544,0.00015359602,0.00042666387],"category_scores_gemma":[0.0012531817,0.00007431288,0.000074621676,0.00062092714,0.00013358031,0.00004013885,0.000027495273,0.0001601807,0.000053246084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020264091,0.010951458,0.26842755,0.00024241071,0.0009945298,0.0024798363,0.00855443,0.0017661174,0.06798316,0.0037499235,0.0011787963,0.61340773],"study_design_scores_gemma":[0.012993628,0.013211749,0.8909514,0.00003324697,0.00008646631,0.00018474512,0.0010837581,0.000001508583,0.0026257543,0.0028961892,0.07574173,0.00018980786],"about_ca_topic_score_codex":0.0002549529,"about_ca_topic_score_gemma":0.0006975623,"teacher_disagreement_score":0.6225239,"about_ca_system_score_codex":0.0010136106,"about_ca_system_score_gemma":0.0002863518,"threshold_uncertainty_score":0.46716702},"labels":[],"label_agreement":null},{"id":"W2048466556","doi":"10.1016/j.ygyno.2006.05.040","title":"CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health","funders":"","keywords":"Ovarian cancer; Missense mutation; CHEK2; Medicine; Oncology; Internal medicine; Allele; Cancer; Gene; Biology; Mutation; Genetics; Germline mutation","score_opus":0.009186754337910465,"score_gpt":0.2708690529376283,"score_spread":0.26168229859971787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048466556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868575,0.0004321931,0.00089139823,0.003689774,0.0006038081,0.00064630655,0.00006849813,0.000042020318,0.0067685256],"genre_scores_gemma":[0.98603,0.00008346554,0.008139421,0.003355946,0.00061426946,0.0002396049,0.000221293,0.00003078345,0.0012852073],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820423,0.00015717115,0.00037026632,0.0006864042,0.00010802374,0.0004738785],"domain_scores_gemma":[0.99902606,0.00013088163,0.00014105819,0.0003907271,0.0001669279,0.00014432867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030301424,0.00024305338,0.00031114838,0.0000985938,0.00015098686,0.000026197335,0.00027584026,0.00042190362,0.00015811296],"category_scores_gemma":[0.00063187245,0.00023772073,0.000060369955,0.00020719343,0.00018229998,0.0000062626364,0.00028510467,0.00015538039,0.000042751963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038193064,0.0011594169,0.021325888,0.00007146861,0.00021192094,0.00027007973,0.0003584252,0.0030788372,0.8582779,0.0023771026,0.09232915,0.020157892],"study_design_scores_gemma":[0.0051680477,0.0063960054,0.51793504,0.000029465768,0.00014605085,0.00038427408,0.00060892064,0.00024293605,0.13015673,0.006064362,0.33162078,0.0012474027],"about_ca_topic_score_codex":0.00010555852,"about_ca_topic_score_gemma":0.0020469553,"teacher_disagreement_score":0.72812116,"about_ca_system_score_codex":0.00020417344,"about_ca_system_score_gemma":0.0006564867,"threshold_uncertainty_score":0.969397},"labels":[],"label_agreement":null},{"id":"W2048669662","doi":"10.1016/j.ygyno.2015.03.004","title":"Sentinel node mapping with indocyanine green and endoscopic near-infrared fluorescence imaging in endometrial cancer. A pilot study and review of the literature","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Indocyanine green; Endometrial cancer; Micrometastasis; Sentinel lymph node; Lymphadenectomy; Radiology; Nuclear medicine; Lymph node; Sentinel node; Metastasis; Surgery; Cancer; Pathology; Internal medicine; Breast cancer","score_opus":0.06554720588226444,"score_gpt":0.36602167429100096,"score_spread":0.30047446840873654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048669662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003866694,0.9894907,2.9146608e-7,0.00055009464,0.0003297047,0.0050248434,0.000059528862,0.000023316166,0.00065486814],"genre_scores_gemma":[0.0018096054,0.99601877,0.00026887897,0.0006705312,0.00018516347,0.00079697993,0.000040379287,0.000032146876,0.00017753076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965793,0.00088682625,0.0010256864,0.00070053,0.00037564393,0.00043202273],"domain_scores_gemma":[0.9972183,0.0011307006,0.00081006496,0.00044289685,0.00021533223,0.00018268736],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000983619,0.00051871384,0.0037327108,0.00036544589,0.0000819017,0.000026799382,0.00027134232,0.00019261986,0.00009513681],"category_scores_gemma":[0.0013888833,0.00026832355,0.00013283461,0.0023234617,0.00029921922,0.000065458655,0.0004121288,0.00082609605,0.0000020114749],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039830923,0.001055147,0.057754163,0.054193154,0.00038437257,0.0006169331,0.00025131437,5.70863e-8,0.0000027226135,0.0000035258333,0.00022802339,0.8851123],"study_design_scores_gemma":[0.041122213,0.014548613,0.05241599,0.21465315,0.007082366,0.00083370606,0.00022493527,0.0000064542787,0.0000014415875,0.00006974837,0.6682908,0.00075056864],"about_ca_topic_score_codex":0.00046493244,"about_ca_topic_score_gemma":0.00018514668,"teacher_disagreement_score":0.8843617,"about_ca_system_score_codex":0.0006822149,"about_ca_system_score_gemma":0.0014530176,"threshold_uncertainty_score":0.9999769},"labels":[],"label_agreement":null},{"id":"W2049077879","doi":"10.1016/j.ygyno.2005.07.110","title":"Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre; University of Toronto; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Oncology; Hormone replacement therapy (female-to-male); Gynecology; Internal medicine; BRCA mutation; Cancer","score_opus":0.029140622054095768,"score_gpt":0.34429619208357126,"score_spread":0.3151555700294755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049077879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780445,0.008653684,0.000005190357,0.010459561,0.00008884507,0.0010811756,0.00001433098,0.000011416699,0.00164131],"genre_scores_gemma":[0.98168373,0.015618947,0.00049691874,0.00185787,0.000041650095,0.00014293911,0.0000050907247,0.000007102373,0.00014575865],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887216,0.00026929422,0.00032018393,0.00020925172,0.00009235585,0.00023673281],"domain_scores_gemma":[0.9989624,0.0005124615,0.00022132973,0.00015143405,0.000040191688,0.000112160626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084884174,0.00011221315,0.00040696462,0.00007245372,0.000081990125,0.0000045861384,0.000033488064,0.00013577809,0.0003058072],"category_scores_gemma":[0.00027560088,0.000062843465,0.000008777312,0.00009674252,0.00022456655,0.000036755016,0.000023166569,0.00016454082,0.0000023271687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013521129,0.0007586699,0.2466174,0.00007290251,0.0006402436,0.00010878417,0.00740847,0.00009117532,0.0015286307,0.0009877085,0.0010278134,0.72723705],"study_design_scores_gemma":[0.04477898,0.00887103,0.9351485,0.000011657326,0.00016378665,0.00005769351,0.0004259242,0.000356241,0.00011202225,0.00044364747,0.009561025,0.000069539405],"about_ca_topic_score_codex":0.0018709959,"about_ca_topic_score_gemma":0.0021081502,"teacher_disagreement_score":0.72716755,"about_ca_system_score_codex":0.0003592893,"about_ca_system_score_gemma":0.00023390385,"threshold_uncertainty_score":0.33483744},"labels":[],"label_agreement":null},{"id":"W2049476028","doi":"10.1016/j.ygyno.2010.03.009","title":"Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; American Physicians Fellowship for Medicine in Israel","keywords":"Medicine; Germline; Germline mutation; Gynecology; BRCA mutation; Fallopian tube; Carcinoma; Oncology; Mutation; Internal medicine; Obstetrics; Genetics; Cancer; Gene; Ovarian cancer; Biology","score_opus":0.013273603694827519,"score_gpt":0.28273718075381127,"score_spread":0.26946357705898377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049476028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963767,0.000035742858,0.000011591006,0.0017247016,0.00020165039,0.0010322353,0.000026740732,0.000010702084,0.0005799462],"genre_scores_gemma":[0.9979423,0.000025835732,0.0012167112,0.00029791275,0.000038145616,0.00036920077,0.0000066155258,0.000010056911,0.00009321449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992306,0.000056708,0.00020188757,0.00022247739,0.00007002243,0.00021829535],"domain_scores_gemma":[0.9990798,0.00044585735,0.0001629096,0.00018134239,0.00006156073,0.000068477355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021446662,0.00011488548,0.00036474498,0.000059863985,0.000052846965,0.000003900674,0.00005638155,0.00015471605,0.00010722693],"category_scores_gemma":[0.00028102423,0.00006131028,0.00003247734,0.00010851363,0.00015807826,0.000024727546,0.000026538968,0.0001904621,7.8600436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000385773,0.00040146708,0.9810436,0.000027793641,0.00006395602,0.000011888259,0.0012696907,0.000009200572,0.00029335692,0.0001974322,0.000041412306,0.016254423],"study_design_scores_gemma":[0.0056320033,0.00457892,0.9848791,0.000009956943,0.0001133982,0.000029911922,0.00054930086,0.0000796079,0.00065863837,0.00031961134,0.0030843073,0.00006525166],"about_ca_topic_score_codex":0.00027344792,"about_ca_topic_score_gemma":0.004042418,"teacher_disagreement_score":0.016189171,"about_ca_system_score_codex":0.00021241889,"about_ca_system_score_gemma":0.00026492728,"threshold_uncertainty_score":0.25001606},"labels":[],"label_agreement":null},{"id":"W2049897958","doi":"10.1006/gyno.2002.6638","title":"Peritoneal Lavage Cytology: An Assessment of Its Value during Prophylactic Oophorectomy","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coalition for Research in Women's Health; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Occult; Cytology; Malignancy; Carcinoma; BRCA mutation; Ovarian carcinoma; Gynecology; Pathology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.04060428712800371,"score_gpt":0.3742508951052551,"score_spread":0.33364660797725143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049897958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96495014,0.0007139733,0.0000071916734,0.0029682198,0.00056574185,0.0009419607,0.000013781772,0.00009063796,0.029748358],"genre_scores_gemma":[0.9936945,0.0005466585,0.004113138,0.0004731269,0.00018988397,0.00033789064,0.000015249078,0.000025248655,0.0006043385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980352,0.0002793,0.00046419993,0.00052928214,0.00021291093,0.00047910627],"domain_scores_gemma":[0.99869823,0.0002844003,0.00025549572,0.00041318074,0.0001298522,0.00021886261],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023570163,0.00024278698,0.0008279214,0.0001578218,0.00012414019,0.000009352003,0.00014552203,0.00033785473,0.0037473415],"category_scores_gemma":[0.00014903418,0.00019302688,0.00013471067,0.00022205997,0.00016887537,0.000089727706,0.000078595476,0.00033132365,0.00008869742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007645828,0.03085715,0.7909337,0.0014189058,0.0013730406,0.009459135,0.002040844,0.00029868956,0.06017657,0.008662798,0.0019255666,0.09208901],"study_design_scores_gemma":[0.0062250057,0.013949473,0.963334,0.000030222298,0.00042100344,0.0005292877,0.00020036697,0.0011408547,0.006657211,0.00009637736,0.0071734567,0.00024271567],"about_ca_topic_score_codex":0.000031183205,"about_ca_topic_score_gemma":0.000048639453,"teacher_disagreement_score":0.17240033,"about_ca_system_score_codex":0.00089833327,"about_ca_system_score_gemma":0.00026831048,"threshold_uncertainty_score":0.99716336},"labels":[],"label_agreement":null},{"id":"W2049987718","doi":"10.1006/gyno.2002.6644","title":"Identification of Tissue- and Cancer-Selective Promoters for the Introduction of Genes into Human Ovarian Cancer Cells","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; University of California, San Francisco","keywords":"Promoter; Telomerase reverse transcriptase; Genetic enhancement; Cancer research; Transfection; Gene; Suicide gene; Luciferase; Biology; Cell culture; Gene expression; Ovarian cancer; Molecular biology; Cancer; Telomerase; Genetics","score_opus":0.02486515823424492,"score_gpt":0.3474491258718819,"score_spread":0.322583967637637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049987718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916589,0.0043057776,0.00040138807,0.0023789322,0.00028015432,0.0008979946,0.000029461466,0.0000057018538,0.00004164204],"genre_scores_gemma":[0.99569994,0.0027486605,0.00019124184,0.00006945835,0.00031716467,0.00048867037,0.00001655443,0.000012201677,0.00045609736],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990148,0.00015076305,0.00026905732,0.00030572788,0.00007601906,0.00018365159],"domain_scores_gemma":[0.9991928,0.000076235156,0.00023960903,0.00023491927,0.00022718751,0.000029253393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000428289,0.000099035795,0.00019045145,0.0000511733,0.00012967846,0.000005726219,0.00018775502,0.00017472726,0.00014880724],"category_scores_gemma":[0.00008944751,0.00007708676,0.000041015745,0.000110291054,0.00030603792,0.0000039881797,0.000057218687,0.00007267411,0.0000010267282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002553663,0.000103471335,0.00031232936,0.000040297167,0.00010277664,1.9901375e-7,0.00021976641,0.00022471885,0.8762483,0.00003055611,0.0017969691,0.120665245],"study_design_scores_gemma":[0.0005864551,0.004680347,0.0013913774,0.0000013662295,0.000049481223,0.0000015705285,0.00010035755,0.00022836764,0.9776764,0.00021754425,0.014987415,0.000079347905],"about_ca_topic_score_codex":0.00016484351,"about_ca_topic_score_gemma":0.0018789773,"teacher_disagreement_score":0.120585896,"about_ca_system_score_codex":0.00007864603,"about_ca_system_score_gemma":0.00008123437,"threshold_uncertainty_score":0.3143507},"labels":[],"label_agreement":null},{"id":"W2050421776","doi":"10.1016/j.ygyno.2014.03.508","title":"Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: Results from a population-based analysis","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Groin; Vulvar Carcinoma; Dissection (medical); Vulvar cancer; Population; Carcinoma; Cohort; Surgery; General surgery; Vulva; Internal medicine; Environmental health","score_opus":0.030321411879401922,"score_gpt":0.3196414121338802,"score_spread":0.2893200002544783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050421776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976963,0.00015322842,0.00008708577,0.0006030683,0.00031582292,0.0005356044,0.000050578205,0.00007730725,0.00048104973],"genre_scores_gemma":[0.99835694,0.0000040059654,0.00048706535,0.00047060984,0.000073866184,0.000040788538,0.0005480601,0.0000105282525,0.000008155555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794906,0.0005271336,0.00057210895,0.0004907697,0.00014292613,0.00031800257],"domain_scores_gemma":[0.9970698,0.002155738,0.00036228637,0.00019544839,0.000044154753,0.00017259365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005349432,0.00018659231,0.0008761074,0.00041529743,0.0001295102,0.0000119926235,0.00004273114,0.00014998323,0.000044813998],"category_scores_gemma":[0.00095213874,0.00013723582,0.000105719184,0.0009029835,0.000027792052,0.000038495436,0.000028914063,0.00018896784,0.0000050228127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045081988,0.00026547923,0.9945795,0.00005410152,0.00010444209,0.00003872985,0.0002769521,0.00023012476,0.000043337852,0.000017403583,0.000013825818,0.0039252974],"study_design_scores_gemma":[0.006038639,0.002722875,0.9877003,0.000031715983,0.00028983253,0.000005826861,0.00075991516,0.002134887,0.00013452301,0.000039493767,0.000032829765,0.0001091858],"about_ca_topic_score_codex":0.028306497,"about_ca_topic_score_gemma":0.015015695,"teacher_disagreement_score":0.013290803,"about_ca_system_score_codex":0.0014601352,"about_ca_system_score_gemma":0.000112867696,"threshold_uncertainty_score":0.9781641},"labels":[],"label_agreement":null},{"id":"W2050573111","doi":"10.1016/j.ygyno.2012.08.038","title":"Five-year trends in mortality indices among gynecological cancer patients in Canada","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Mortality rate; Cervical cancer; Cancer; Cause of death; Ovarian cancer; Demography; Population; Epithelial ovarian cancer; Gynecology; Obstetrics; Internal medicine; Disease; Environmental health","score_opus":0.028050574929171665,"score_gpt":0.32555667076780054,"score_spread":0.29750609583862886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050573111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841957,0.0003132032,1.0332548e-7,0.0012014967,0.0010796849,0.00047737075,0.000044450033,0.00002173925,0.012666265],"genre_scores_gemma":[0.9972171,0.00026200814,0.000081001046,0.0014308045,0.00012059442,0.00059931853,0.00007857891,0.00001367695,0.00019689891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772274,0.00022836705,0.0005306493,0.00041795304,0.0002458929,0.0008544138],"domain_scores_gemma":[0.9987604,0.0004851296,0.00019950025,0.00022185135,0.000046711157,0.00028640698],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036004122,0.0002424297,0.00075768324,0.00023508834,0.000045733083,0.0000057026837,0.0001328924,0.00031333556,0.005051165],"category_scores_gemma":[0.00021757363,0.00018793948,0.00007449463,0.0005023671,0.00010645786,0.00011666634,0.00009546119,0.00040312318,0.000023129152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006701524,0.0022260244,0.964284,0.000014524609,0.000069607435,0.00024214757,0.00021006624,0.000031285344,0.0000012769136,0.0000718986,0.0029053062,0.029876847],"study_design_scores_gemma":[0.004590433,0.0008759559,0.9883362,0.000019074692,0.00008592144,0.0000024302865,0.00029333358,0.00002014005,0.000027330012,0.000029110328,0.0055387057,0.0001813866],"about_ca_topic_score_codex":0.79043514,"about_ca_topic_score_gemma":0.9887664,"teacher_disagreement_score":0.19833122,"about_ca_system_score_codex":0.0074314517,"about_ca_system_score_gemma":0.0012571434,"threshold_uncertainty_score":0.99637884},"labels":[],"label_agreement":null},{"id":"W2051122617","doi":"10.1016/j.ygyno.2011.01.021","title":"How are women with high grade Pap smear abnormalities managed? A population based study","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Colposcopy; Dysplasia; Bethesda system; Malignancy; Referral; Obstetrics; Gynecology; Population; Cervical cancer; Carcinoma; Cancer; Cytology; Internal medicine; Pathology; Family medicine","score_opus":0.06737319320820012,"score_gpt":0.316020389705893,"score_spread":0.2486471964976929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051122617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824645,0.000041493484,0.00003528866,0.0022596146,0.00015304584,0.001160094,0.000007782886,0.00013326766,0.013744895],"genre_scores_gemma":[0.9953745,0.000009927889,0.00065549236,0.0013493765,0.00012712817,0.0005627845,0.000023119752,0.00002233562,0.0018753227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810034,0.00031857163,0.00021977123,0.0004018876,0.0003500297,0.00060938456],"domain_scores_gemma":[0.99884474,0.00026464896,0.00012645185,0.00036098226,0.00016551811,0.00023764942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053313765,0.00019241495,0.0005732833,0.00018751404,0.0001468115,0.000024956815,0.00016934556,0.00019561089,0.0070508895],"category_scores_gemma":[0.00021285734,0.00013276572,0.000045905395,0.00028112615,0.00011150582,0.000094723786,0.00008272356,0.00040257294,0.000037892467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025967055,0.0025071816,0.9684879,0.00016112014,0.0001662386,0.001235732,0.0019412328,0.000005875582,0.0000126935,0.0004200582,0.00032579008,0.022139467],"study_design_scores_gemma":[0.0045494535,0.015100033,0.96681374,0.0000048445586,0.0000867811,0.0000169362,0.009202051,0.000018650997,0.000031264066,0.0007083872,0.003310322,0.00015753554],"about_ca_topic_score_codex":0.0007435566,"about_ca_topic_score_gemma":0.0027648003,"teacher_disagreement_score":0.021981932,"about_ca_system_score_codex":0.000826772,"about_ca_system_score_gemma":0.00017889235,"threshold_uncertainty_score":0.9938568},"labels":[],"label_agreement":null},{"id":"W2051950694","doi":"10.1016/j.ygyno.2014.03.121","title":"Evaluation of CA-125 response in the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Paclitaxel; Placebo; Clinical endpoint; Ovarian cancer; Oncology; Internal medicine; Post-hoc analysis; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Phases of clinical research; Pathology","score_opus":0.06933795730224084,"score_gpt":0.38087967814575274,"score_spread":0.3115417208435119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051950694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999155,0.00023089435,0.000003409023,0.004561266,0.00019736114,0.0032739362,0.0000140305965,0.000008587581,0.0017189777],"genre_scores_gemma":[0.9961496,0.00009902606,0.000111310874,0.00038042734,0.000039311686,0.003126467,0.0000044481044,0.00001177851,0.00007765327],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99512166,0.002969072,0.00065070513,0.00039507385,0.0005054676,0.00035801597],"domain_scores_gemma":[0.9964445,0.0024245642,0.0003761371,0.00044156576,0.0002491621,0.00006405326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077939657,0.00019409164,0.00084881467,0.00028758988,0.000034684774,0.000004639285,0.00016941996,0.00016263762,0.0007699132],"category_scores_gemma":[0.0013255869,0.000106120315,0.00003631609,0.0006711092,0.00010850836,0.00003640993,0.0000388931,0.00023699108,0.0000042758456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17274785,0.02817477,0.26344076,0.0001648505,0.00081962126,0.00043003235,0.04728324,0.002924675,0.00018690091,0.000323019,0.0015627039,0.48194158],"study_design_scores_gemma":[0.04547073,0.053008612,0.8863174,0.00008242586,0.00044635354,0.00001447321,0.012153435,0.00046315667,0.000026434409,0.00014093984,0.0017697491,0.00010631218],"about_ca_topic_score_codex":0.0016509102,"about_ca_topic_score_gemma":0.03439103,"teacher_disagreement_score":0.6228766,"about_ca_system_score_codex":0.0031085203,"about_ca_system_score_gemma":0.0022325863,"threshold_uncertainty_score":0.9832288},"labels":[],"label_agreement":null},{"id":"W2051960191","doi":"10.1016/j.ygyno.2014.02.038","title":"“Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?","year":2014,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":442,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ovarian cancer; Clinical trial; Chemotherapy; Intensive care medicine; Oncology; Disease; Cancer; Internal medicine","score_opus":0.07161383321883226,"score_gpt":0.37289602804582245,"score_spread":0.3012821948269902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051960191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010965733,0.90457207,0.000013199302,0.08237842,0.001136512,0.004116209,0.00021025754,0.000080957485,0.007382733],"genre_scores_gemma":[0.00016838245,0.97146326,0.0012987686,0.013838617,0.000847946,0.0034346636,0.00009615073,0.00010704655,0.008745185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588746,0.0003663499,0.0007561747,0.0016528371,0.00038431433,0.00095285394],"domain_scores_gemma":[0.99593496,0.0013660371,0.00049289776,0.0010197321,0.00024535775,0.0009410213],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067556155,0.0009779888,0.005245146,0.00044657107,0.00022548965,0.00022268116,0.00033970678,0.0013668485,0.0014754841],"category_scores_gemma":[0.00040502026,0.00070271495,0.0004460518,0.00061160786,0.000106543026,0.00013841307,0.0002871439,0.00056357053,0.00031214554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012229249,0.00023179875,0.000098123644,0.00356903,0.0005256387,0.00033623134,0.0002584666,7.314334e-7,0.0000011061069,0.00024476208,0.10629075,0.8883211],"study_design_scores_gemma":[0.0018796637,0.0066387453,0.00071733486,0.009802141,0.004251507,0.00013853582,0.00017397957,0.000001103815,0.0000037473471,0.000047149708,0.9757359,0.0006101601],"about_ca_topic_score_codex":0.00018440072,"about_ca_topic_score_gemma":0.0018338518,"teacher_disagreement_score":0.8877109,"about_ca_system_score_codex":0.0028712628,"about_ca_system_score_gemma":0.0012640991,"threshold_uncertainty_score":0.9999296},"labels":[],"label_agreement":null},{"id":"W2051968371","doi":"10.1016/j.ygyno.2006.06.008","title":"Reply to Dr. Bader et al's Letter to the Editor","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Gynecology; General surgery; Stage (stratigraphy); Oncology; Internal medicine; Cancer","score_opus":0.032740609964991105,"score_gpt":0.3780248511781239,"score_spread":0.3452842412131328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051968371","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015222793,0.00009863327,0.00021344557,0.84638464,0.0031301382,0.0009374647,0.0000084399435,0.000080005106,0.13392441],"genre_scores_gemma":[0.18577272,0.000014658825,0.0006395511,0.7924434,0.00908146,0.00037145783,0.00001765343,0.00001944874,0.011639671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817175,0.0002052896,0.0002732325,0.00042934954,0.00033838837,0.0005820219],"domain_scores_gemma":[0.9982238,0.00085474574,0.000036720037,0.00045753224,0.00019091585,0.00023629435],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009056552,0.00014377908,0.0003497913,0.00010565843,0.00012040409,0.000023597817,0.00025988734,0.00016389378,0.008176307],"category_scores_gemma":[0.00087713235,0.00008680653,0.00009360466,0.00033751142,0.00009266037,0.000028638418,0.00023804579,0.0005428716,0.0023221036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002327915,0.00019294598,0.0017459318,0.0000075359944,0.000015286489,0.00009943217,0.00008511805,0.000028023123,0.0007828274,0.0002652275,0.97951436,0.017030546],"study_design_scores_gemma":[0.0007065004,0.001957216,0.17402019,0.0000019112258,0.000017666687,0.00001757564,0.00004491073,0.000009286262,0.00017485346,0.00017983702,0.82278,0.00009001605],"about_ca_topic_score_codex":0.00045381667,"about_ca_topic_score_gemma":0.0011618211,"teacher_disagreement_score":0.17227425,"about_ca_system_score_codex":0.00043019635,"about_ca_system_score_gemma":0.00028966946,"threshold_uncertainty_score":0.9984547},"labels":[],"label_agreement":null},{"id":"W2052266277","doi":"10.1016/j.ygyno.2009.01.012","title":"A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"AstraZeneca","keywords":"Fulvestrant; Medicine; Ovarian cancer; Clinical endpoint; Internal medicine; Response Evaluation Criteria in Solid Tumors; Cancer; Oncology; Progressive disease; Phases of clinical research; Gastroenterology; Breast cancer; Toxicity; Disease; Estrogen receptor; Clinical trial","score_opus":0.05204197889891651,"score_gpt":0.39162367403128223,"score_spread":0.3395816951323657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052266277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906016,0.00092089776,0.000002441509,0.0047730412,0.00034442035,0.0023776272,0.000051988336,0.000013930742,0.0009140526],"genre_scores_gemma":[0.9975826,0.0011050011,0.00023293516,0.00033877714,0.00010974088,0.0005751,0.000012152267,0.0000065400004,0.000037166734],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835503,0.00023876177,0.00058543595,0.0003316335,0.00019218975,0.0002969186],"domain_scores_gemma":[0.99887127,0.00037046257,0.0002584562,0.00035968376,0.000069797214,0.000070340626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025390415,0.0002109502,0.0008324403,0.00013406617,0.00006186442,0.0000028044979,0.00013139549,0.00013396515,0.0003085511],"category_scores_gemma":[0.00004821309,0.000118571166,0.00014137174,0.00026283436,0.00008724794,0.000022596618,0.000013885821,0.000114286304,0.0000031913303],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018930165,0.22766937,0.027398292,0.000017987863,0.0003032371,0.0005327417,0.014647461,0.000052812902,0.0010862005,0.00022436981,0.0001564828,0.726018],"study_design_scores_gemma":[0.06429524,0.4039449,0.51422524,0.00003806773,0.0007407916,0.000025184141,0.003043641,0.00008076678,0.0012806106,0.00016596058,0.012027694,0.00013189531],"about_ca_topic_score_codex":0.0007873612,"about_ca_topic_score_gemma":0.0024705497,"teacher_disagreement_score":0.7258861,"about_ca_system_score_codex":0.0005709423,"about_ca_system_score_gemma":0.00034094186,"threshold_uncertainty_score":0.4835192},"labels":[],"label_agreement":null},{"id":"W2052313990","doi":"10.1006/gyno.2000.6003","title":"Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Coalition for Research in Women's Health; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Medicine; Serous fluid; Ovarian cancer; Gynecology; Oncology; Internal medicine; Cancer","score_opus":0.013018467392510313,"score_gpt":0.2853771380241138,"score_spread":0.27235867063160346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052313990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904582,0.0011817178,0.000019347191,0.0034997386,0.0007057443,0.00035629995,0.00019739343,0.000017180968,0.0035643724],"genre_scores_gemma":[0.99310684,0.0004928201,0.00080093835,0.0022518255,0.0002076395,0.0001602399,0.000047813774,0.000022795002,0.0029090964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869794,0.00014364024,0.00032467462,0.00040793215,0.00013148332,0.00029432293],"domain_scores_gemma":[0.99920416,0.00003801827,0.0001651068,0.00042245415,0.00011418863,0.000056057626],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016474057,0.00017828213,0.00023507744,0.000035360343,0.00011519292,0.000007646424,0.00039051505,0.00033984229,0.0037830288],"category_scores_gemma":[0.000027655396,0.00014148914,0.0000978983,0.00018778123,0.00021324956,0.000006628221,0.00014133114,0.00014469423,0.00003541983],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012106948,0.00147061,0.30395716,0.00037018128,0.0015130439,0.0006418371,0.001788633,0.0044326736,0.13282074,0.0004077511,0.14015646,0.4112302],"study_design_scores_gemma":[0.0011863051,0.0012119245,0.9002338,0.000013534833,0.0000877963,0.0025049828,0.00016724665,0.00010561776,0.0068816184,0.00045255976,0.08689573,0.00025889243],"about_ca_topic_score_codex":0.00020159833,"about_ca_topic_score_gemma":0.00042510775,"teacher_disagreement_score":0.59627664,"about_ca_system_score_codex":0.00021659858,"about_ca_system_score_gemma":0.0004996649,"threshold_uncertainty_score":0.99712765},"labels":[],"label_agreement":null},{"id":"W2052354486","doi":"10.1016/j.ygyno.2010.01.039","title":"Fertility-sparing options for early stage cervical cancer","year":2010,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Stage (stratigraphy); Fertility preservation; Cervix; Population; Fertility; Cancer; Gynecology; Surgery; Obstetrics; Internal medicine","score_opus":0.13304280458169315,"score_gpt":0.4402728210549271,"score_spread":0.30723001647323395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052354486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065633893,0.9846061,0.000043525983,0.00044242825,0.002521243,0.003973761,0.000430213,0.00016356773,0.0071628266],"genre_scores_gemma":[0.00022182129,0.9840614,0.001927078,0.0005197988,0.00071332883,0.005920626,0.00032614512,0.000072181465,0.006237616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700594,0.00022123112,0.0009131337,0.00085944176,0.00021645705,0.00078380696],"domain_scores_gemma":[0.99609524,0.002308923,0.00044589362,0.00055002223,0.00018596866,0.00041393063],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004580842,0.00055731856,0.0034657586,0.0002914907,0.00019683772,0.000026042688,0.00033926996,0.0018756078,0.003996647],"category_scores_gemma":[0.0009041593,0.00038148896,0.0010448514,0.00051194074,0.00018283285,0.00004805019,0.00018924866,0.0013035449,0.0002373546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015374948,0.00066675834,0.0005675825,0.005620306,0.0004381725,0.00007400036,0.000016949734,3.385006e-7,0.0000012242101,0.0003228316,0.00021106265,0.991927],"study_design_scores_gemma":[0.002648555,0.0025184988,0.004486698,0.0006319406,0.0033179906,0.000020498524,0.000009028048,0.000002970001,0.0000016836591,0.00020206097,0.9858422,0.0003178545],"about_ca_topic_score_codex":0.00027551287,"about_ca_topic_score_gemma":0.0010122875,"teacher_disagreement_score":0.99160916,"about_ca_system_score_codex":0.0015210869,"about_ca_system_score_gemma":0.0016508903,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W2052404691","doi":"10.1006/gyno.2001.6461","title":"Psychological Adjustment to Familial-Genetic Risk Assessment for Ovarian Cancer: Predictors of Nonadherence to Surveillance Recommendations","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Toronto General Hospital; Cancer Care Ontario; York University; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Logistic regression; Genetic counseling; Ovarian cancer; Anxiety; Distress; Genetic testing; Depression (economics); Risk assessment; Risk perception; Family medicine; Cancer; Psychiatry; Clinical psychology; Internal medicine; Perception","score_opus":0.03243805008653927,"score_gpt":0.36355022163859513,"score_spread":0.33111217155205586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052404691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493514,0.0006634205,0.028824454,0.007955849,0.0040637,0.0028889398,0.001152727,0.000047905763,0.005051628],"genre_scores_gemma":[0.90450925,0.0012256183,0.08794375,0.0022631553,0.0004051863,0.0028070211,0.0000849675,0.000023125123,0.0007379156],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99788564,0.0002768655,0.0005347292,0.0007261983,0.00013401856,0.00044256714],"domain_scores_gemma":[0.9984999,0.00024705468,0.00025741683,0.00050876645,0.00029214472,0.00019474445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039792465,0.00022131541,0.00036560697,0.000095127674,0.0001381014,0.000009706281,0.0004375629,0.00032061824,0.00093692227],"category_scores_gemma":[0.0005484689,0.0002091663,0.00011304016,0.00027781722,0.000102007696,0.0000036969993,0.00017771944,0.00013504119,0.000042100863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003072602,0.0015927891,0.09211329,0.000037394195,0.0003702245,0.00000474083,0.00035277777,0.012917033,0.07515367,0.00018253856,0.390449,0.42651927],"study_design_scores_gemma":[0.0016632924,0.008815778,0.53931874,0.000009576636,0.00006639966,0.000008759182,0.00015388885,0.00037494954,0.0030046767,0.00023588553,0.44596153,0.00038650588],"about_ca_topic_score_codex":0.00006690595,"about_ca_topic_score_gemma":0.0010076709,"teacher_disagreement_score":0.44720545,"about_ca_system_score_codex":0.00045186412,"about_ca_system_score_gemma":0.0002066026,"threshold_uncertainty_score":0.99997634},"labels":[],"label_agreement":null},{"id":"W2052902650","doi":"10.1016/j.ygyno.2011.02.021","title":"Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Metformin; Apoptosis; Cisplatin; Flow cytometry; Cancer research; Cell cycle; Ovarian cancer; Medicine; Cell culture; Cancer; Internal medicine; Biology; Chemotherapy; Immunology; Insulin; Genetics","score_opus":0.029302263233933503,"score_gpt":0.26319444611640835,"score_spread":0.23389218288247485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052902650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832956,0.0136047,0.000054367072,0.000049035305,0.00077241316,0.0005807243,0.000069872825,0.0000046478467,0.0015686118],"genre_scores_gemma":[0.9859953,0.0124193095,0.000644827,0.00041912214,0.000091782276,0.00028428642,0.000018124743,0.000011292832,0.00011598532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986831,0.00023375264,0.00042504416,0.00027970938,0.00011224923,0.0002661701],"domain_scores_gemma":[0.9991859,0.000020210577,0.0003516639,0.0003097883,0.0000921887,0.00004020232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004752389,0.00014141126,0.0003441903,0.000051459232,0.000036665744,0.0000017169,0.00032732412,0.0003424909,0.00016862221],"category_scores_gemma":[0.000114358736,0.00010126658,0.000101346275,0.0001739648,0.0002156579,0.0000053282665,0.00014540966,0.00013177215,0.0000017172189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015213226,0.00057733635,0.008774384,0.0000390486,0.00009603714,4.260541e-7,0.0004606281,0.000010272041,0.7390863,0.00036586676,0.0018219927,0.24861564],"study_design_scores_gemma":[0.0012119822,0.0009982461,0.017273761,0.000010995387,0.000047522095,6.4790044e-7,0.00045214192,0.0000036974893,0.8504116,0.00044086808,0.12901588,0.00013264168],"about_ca_topic_score_codex":0.0012796243,"about_ca_topic_score_gemma":0.0012696504,"teacher_disagreement_score":0.24848299,"about_ca_system_score_codex":0.00008458407,"about_ca_system_score_gemma":0.00034522277,"threshold_uncertainty_score":0.41295314},"labels":[],"label_agreement":null},{"id":"W2052919443","doi":"10.1016/j.ygyno.2013.11.002","title":"Population-based treatment and outcomes of Stage I uterine serous carcinoma","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Endometrial cancer; Serous fluid; Population; Carboplatin; Surgery; Internal medicine; Adjuvant therapy; Cancer; Oncology; Chemotherapy; Cisplatin","score_opus":0.03457843787755351,"score_gpt":0.33825404062911363,"score_spread":0.30367560275156014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052919443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943353,0.00018024363,0.0000092211585,0.0019021654,0.00017360428,0.0007250051,0.000023008717,0.00003709698,0.0026143787],"genre_scores_gemma":[0.9955051,0.000036122467,0.0013606356,0.00086823816,0.000032985583,0.0001877039,0.000049057777,0.000008860255,0.0019513051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991396,0.000066800574,0.00028340062,0.00021789507,0.00008207765,0.00021020134],"domain_scores_gemma":[0.99895203,0.0005544076,0.00012067788,0.00017908517,0.000062515464,0.00013128696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006110815,0.00014928686,0.0006383189,0.00010557529,0.000037900278,0.0000044411486,0.000041142273,0.0001353137,0.002721717],"category_scores_gemma":[0.00014083619,0.00009295743,0.00008298264,0.00012546632,0.000057671816,0.00003192309,0.000027697966,0.000053989927,0.000035608107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012137402,0.00064315205,0.93876964,0.0000396913,0.000091305716,0.00004026598,0.000030394312,0.000006364031,0.00033925005,0.00007802144,0.00002894101,0.0598116],"study_design_scores_gemma":[0.00679435,0.0076602357,0.98227483,0.0000027411868,0.00010525119,0.000008620951,0.000049744503,0.00006189946,0.0004541411,0.00016037464,0.0023540547,0.00007376202],"about_ca_topic_score_codex":0.0032719083,"about_ca_topic_score_gemma":0.000283968,"teacher_disagreement_score":0.05973784,"about_ca_system_score_codex":0.0004040474,"about_ca_system_score_gemma":0.00010586519,"threshold_uncertainty_score":0.9981899},"labels":[],"label_agreement":null},{"id":"W2053246551","doi":"10.1016/s0090-8258(03)00149-5","title":"Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Danazol; Discontinuation; Internal medicine; Endometrial cancer; Oncology; Carcinoma; Chemotherapy; Gynecologic oncology; Toxicity; Gastroenterology; Cancer; Urology; Gynecology; Endometriosis","score_opus":0.08039759057430494,"score_gpt":0.410656185916944,"score_spread":0.33025859534263907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053246551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97042984,0.0019551578,0.0000068541462,0.00065849203,0.005246339,0.0076216315,0.00006547204,0.00009125991,0.013924954],"genre_scores_gemma":[0.992272,0.0017826603,0.0010439993,0.0006069678,0.00033778622,0.003151506,0.000047904916,0.00003784881,0.00071932643],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936787,0.0016632905,0.0018188073,0.0011586255,0.0005576172,0.0011229682],"domain_scores_gemma":[0.9934613,0.00437368,0.00089776225,0.0005966748,0.00023828683,0.00043229168],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002025545,0.00057977904,0.0029007904,0.0010076913,0.0002172471,0.000009676707,0.00039905251,0.0007416741,0.005722671],"category_scores_gemma":[0.009154705,0.00040956822,0.00058312376,0.0024714656,0.0003253399,0.00012021079,0.00023662357,0.0008334349,0.00003529868],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3334271,0.15198463,0.011136379,0.0001036139,0.0010135184,0.0018511495,0.0010184856,0.000038223363,0.00085646956,0.00026367372,0.0004127808,0.497894],"study_design_scores_gemma":[0.4925033,0.42820507,0.0025235885,0.000027766975,0.0008457639,0.000066731576,0.0026968133,0.000014955172,0.00017118738,0.00016759838,0.07245849,0.000318727],"about_ca_topic_score_codex":0.00031515313,"about_ca_topic_score_gemma":0.0043571168,"teacher_disagreement_score":0.49757525,"about_ca_system_score_codex":0.0039510196,"about_ca_system_score_gemma":0.0017010702,"threshold_uncertainty_score":0.9998726},"labels":[],"label_agreement":null},{"id":"W2053728593","doi":"10.1016/j.ygyno.2014.04.010","title":"Safety and Tolerance of Radical Hysterectomy for Cervical Cancer in the Elderly","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Agency for Healthcare Research and Quality","keywords":"Medicine; Cervical cancer; Hysterectomy; Radical Hysterectomy; Perioperative; Population; Gynecology; Cancer; Obstetrics; Surgery; Internal medicine","score_opus":0.026495168533720203,"score_gpt":0.33494727050895734,"score_spread":0.30845210197523715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053728593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747272,0.0010158941,0.00031286397,0.01223788,0.00037159337,0.001120363,0.000024872232,0.000018768738,0.010170571],"genre_scores_gemma":[0.99612784,0.0002257966,0.00070706615,0.0024090842,0.00016656188,0.00024507786,0.000007131309,0.0000061277688,0.00010531225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998912,0.00019642459,0.00031600185,0.00022340649,0.00011016771,0.00024201437],"domain_scores_gemma":[0.99733925,0.0023173748,0.00009071936,0.00014026549,0.000045274992,0.00006709339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000517713,0.000105789324,0.00053991575,0.00005803849,0.000041992054,0.0000032707549,0.00010645975,0.00018291199,0.00029487387],"category_scores_gemma":[0.00048005802,0.00005996972,0.00007038645,0.00019761533,0.00016594486,0.000019382313,0.000027346112,0.00015707297,0.0000031834313],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036306868,0.00089763454,0.098364785,0.00024480192,0.00008791888,0.000025743651,0.00039187315,0.000016179023,0.0005082057,0.0039409776,0.00040400214,0.8914872],"study_design_scores_gemma":[0.019012965,0.014290905,0.7915938,0.000044800283,0.00018717743,0.000044192027,0.00015614461,0.00034977475,0.00023656116,0.0025723132,0.17138277,0.00012859017],"about_ca_topic_score_codex":0.00012276173,"about_ca_topic_score_gemma":0.00061067863,"teacher_disagreement_score":0.8913586,"about_ca_system_score_codex":0.0001346229,"about_ca_system_score_gemma":0.00010093219,"threshold_uncertainty_score":0.3228662},"labels":[],"label_agreement":null},{"id":"W2053974737","doi":"10.1006/gyno.2000.5926","title":"A Critique of Surgical Cytoreduction in Advanced Ovarian Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Debulking; Medicine; Ovarian cancer; Perioperative; Disease; Quality of life (healthcare); Randomized controlled trial; Surgery; General surgery; Retrospective cohort study; Intensive care medicine; Cancer; Internal medicine","score_opus":0.016943024848871165,"score_gpt":0.35198174616733596,"score_spread":0.3350387213184648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053974737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95192873,0.00082654867,0.0000018439499,0.013052528,0.00032483827,0.0005092297,0.000012732942,0.00003383937,0.033309694],"genre_scores_gemma":[0.9928387,0.0039694654,0.0010871931,0.00054313295,0.000133615,0.0004432784,0.000014367768,0.000010645091,0.0009596249],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988567,0.000111573376,0.0003518848,0.00030686124,0.00009690481,0.00027605536],"domain_scores_gemma":[0.99938333,0.00021714934,0.00007449645,0.00017895938,0.000055910074,0.00009015921],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001791536,0.00012678133,0.0005247113,0.000097626886,0.000026313819,0.0000023971218,0.00005631083,0.00023421929,0.011103647],"category_scores_gemma":[0.000040245814,0.000103678045,0.00008576247,0.00023796984,0.000106200314,0.000047372396,0.00001356883,0.00017812608,0.000037367096],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013747548,0.0031671168,0.12315182,0.000065016335,0.00011234943,0.0014730812,0.00031377288,0.00035377132,0.0005682072,0.002031701,0.0017606975,0.8656277],"study_design_scores_gemma":[0.012293712,0.0042389478,0.68462795,0.000091878195,0.00013171669,0.00027460977,0.00016902834,0.00006209817,0.001763803,0.0008734325,0.29529804,0.000174768],"about_ca_topic_score_codex":0.00048263802,"about_ca_topic_score_gemma":0.00061537436,"teacher_disagreement_score":0.86545295,"about_ca_system_score_codex":0.0006855001,"about_ca_system_score_gemma":0.00040175227,"threshold_uncertainty_score":0.98980033},"labels":[],"label_agreement":null},{"id":"W2054009413","doi":"10.1016/j.ygyno.2014.06.011","title":"Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Intraperitoneal chemotherapy; Ovarian cancer; Oncology; Chemotherapy; Gynecology; Cancer; Internal medicine","score_opus":0.01047705733791128,"score_gpt":0.2887194723815612,"score_spread":0.27824241504364994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054009413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96998626,0.00006673002,0.00002280194,0.023709908,0.00029962944,0.0006983431,0.0000062267754,0.000040029896,0.0051700626],"genre_scores_gemma":[0.99073035,0.00016874414,0.00041677116,0.006939335,0.00043241476,0.0011695913,0.000029385394,0.000016361557,0.000097064505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984865,0.0002617404,0.000252586,0.00032806146,0.0002072553,0.00046385967],"domain_scores_gemma":[0.99903715,0.00041048904,0.00012291917,0.0002671069,0.00004161636,0.00012074291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000712311,0.00017087368,0.0004670215,0.000079173675,0.0000845975,0.000013821258,0.00013315736,0.0002232261,0.0012372498],"category_scores_gemma":[0.000102242564,0.000093492745,0.000045463552,0.00022635006,0.0001522082,0.000044848643,0.000017068642,0.0002601953,0.000012338352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033289773,0.000611704,0.79746073,0.000019689862,0.00010313077,0.00012114526,0.0026348054,0.00003203076,0.00003452099,0.00056300126,0.00050093967,0.19758542],"study_design_scores_gemma":[0.005544676,0.0032748186,0.9591412,0.000026775491,0.00006338065,0.000034713776,0.000668599,0.00011420924,0.000034526987,0.0004391008,0.030549262,0.00010875469],"about_ca_topic_score_codex":0.001271246,"about_ca_topic_score_gemma":0.0043469435,"teacher_disagreement_score":0.19747667,"about_ca_system_score_codex":0.001041286,"about_ca_system_score_gemma":0.00022466495,"threshold_uncertainty_score":0.99967575},"labels":[],"label_agreement":null},{"id":"W2054069333","doi":"10.1016/j.ygyno.2013.03.027","title":"The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: An international prospective cohort study","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Incidence (geometry); Prospective cohort study; Gynecology; Oncology; Cohort; Cohort study; Cancer incidence; Obstetrics; Cancer; Internal medicine; Demography","score_opus":0.017855148765805764,"score_gpt":0.33831976896455057,"score_spread":0.32046462019874483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054069333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941254,0.00017359733,0.0000027412093,0.00068656646,0.0002770213,0.00252656,0.0000071119384,0.00001587259,0.0021851002],"genre_scores_gemma":[0.9961104,0.00029768277,0.00015660332,0.00019049105,0.000084859435,0.003027176,0.0000032363428,0.0000065796376,0.00012297688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998787,0.0001623227,0.00030918024,0.0002883507,0.00022913379,0.00022405216],"domain_scores_gemma":[0.99818796,0.0011809673,0.0001620354,0.00015038278,0.00022578803,0.00009283999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004977808,0.000109773275,0.00039338475,0.00016422836,0.00006852596,0.000016438542,0.00013183021,0.00007670637,0.0008406161],"category_scores_gemma":[0.000976095,0.000060343544,0.00001658236,0.00047742357,0.00022549501,0.0001401176,0.000063350126,0.00016216132,0.0000072264056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016179427,0.0010276538,0.9334205,0.000004383042,0.00025197119,0.000035184912,0.0010175048,0.0000111949785,0.00009507579,0.000056529894,0.0000069633725,0.062455103],"study_design_scores_gemma":[0.009716579,0.0107954005,0.9755741,0.000007882737,0.00006122863,0.000014306198,0.0026769042,0.000023828616,0.00004721551,0.0008351962,0.0001857659,0.00006158807],"about_ca_topic_score_codex":0.0017498205,"about_ca_topic_score_gemma":0.0027929058,"teacher_disagreement_score":0.062393516,"about_ca_system_score_codex":0.00093426177,"about_ca_system_score_gemma":0.00023399101,"threshold_uncertainty_score":0.9204157},"labels":[],"label_agreement":null},{"id":"W2055183928","doi":"10.1016/j.ygyno.2011.11.042","title":"A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Aflibercept; Leiomyosarcoma; Carcinosarcoma; Sarcoma; Internal medicine; Uterine sarcoma; Surgery; Oncology; Cancer; Chemotherapy; Bevacizumab; Gynecology; Pathology; Carcinoma","score_opus":0.05281627150246025,"score_gpt":0.3383873733957119,"score_spread":0.28557110189325163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055183928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933601,0.00019397792,0.0000029574383,0.0003239669,0.00034338504,0.005346528,0.00026235607,0.000023039096,0.0001437138],"genre_scores_gemma":[0.9983338,0.00009490068,0.0007066791,0.00010561754,0.000017389642,0.00061600923,0.000030731717,0.000023594483,0.00007126742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997376,0.00040005278,0.0009052944,0.0005874476,0.00027812092,0.00045308928],"domain_scores_gemma":[0.9983391,0.00023874978,0.00068613124,0.0004152282,0.00014331118,0.00017748597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033640504,0.00038963192,0.0013343886,0.00018859304,0.00015338355,0.000005996963,0.00019934787,0.00014097856,0.00055001857],"category_scores_gemma":[0.00018684665,0.00021142689,0.00008947327,0.00034141866,0.00059664133,0.00007115258,0.00044589944,0.00025356375,6.4026113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06223392,0.16576332,0.6945362,0.0002110925,0.00091683096,0.00047183817,0.005496481,5.7059617e-7,0.00020805947,0.00001654706,0.000055377463,0.07008975],"study_design_scores_gemma":[0.19693689,0.2852857,0.5153033,0.00004659478,0.0007656606,0.000018939349,0.00046788133,0.000016474192,0.0001876442,0.000029877612,0.00076733046,0.00017370116],"about_ca_topic_score_codex":0.0002880384,"about_ca_topic_score_gemma":0.0022855934,"teacher_disagreement_score":0.17923294,"about_ca_system_score_codex":0.00023782492,"about_ca_system_score_gemma":0.00032382587,"threshold_uncertainty_score":0.8621738},"labels":[],"label_agreement":null},{"id":"W2056137961","doi":"10.1016/j.ygyno.2013.04.290","title":"Referral patterns and association with excessive imaging and delays to surgical treatment among patients with gynecologic malignancies","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Referral; Intervention (counseling); Association (psychology); Ultrasound; General surgery; Gynecology; Radiology; Family medicine; Nursing","score_opus":0.013102398661229149,"score_gpt":0.2650923889357506,"score_spread":0.25198999027452146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056137961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932686,0.00012733585,0.0000130278395,0.0022447994,0.000120939185,0.0014976006,0.000022570151,0.000064627406,0.0026404618],"genre_scores_gemma":[0.9967633,0.00013738297,0.0006243071,0.0010120166,0.00006878839,0.00067015167,0.000058590398,0.00001770255,0.0006477509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983411,0.00013936717,0.00026588707,0.00050663424,0.00023304214,0.00051400985],"domain_scores_gemma":[0.99827236,0.0008105505,0.00020734465,0.0001456716,0.00023101103,0.00033307396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013120359,0.0002825846,0.0006573939,0.00013327021,0.00014678414,0.000039899445,0.000054514538,0.00019655493,0.00061350415],"category_scores_gemma":[0.00018100577,0.00015577645,0.000038677543,0.00021500712,0.000114052615,0.0001482967,0.00007737757,0.00014988685,0.000031224863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004694694,0.00044592397,0.9616581,0.000017375827,0.00016793347,0.0002431657,0.00018906975,0.0000024351875,0.000015140761,0.000016122669,0.00013934745,0.03663587],"study_design_scores_gemma":[0.011100497,0.015358807,0.9708546,0.000027036935,0.0002715505,0.000041742296,0.00034837375,0.000012774142,0.00006224987,0.00006823391,0.001659474,0.00019468878],"about_ca_topic_score_codex":0.0007489532,"about_ca_topic_score_gemma":0.0009569863,"teacher_disagreement_score":0.03644118,"about_ca_system_score_codex":0.0012568337,"about_ca_system_score_gemma":0.000097826865,"threshold_uncertainty_score":0.671744},"labels":[],"label_agreement":null},{"id":"W2056963295","doi":"10.1016/j.ygyno.2012.04.048","title":"Green tea for ovarian cancer prevention and treatment: A systematic review of the in vitro, in vivo and epidemiological studies","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Hôtel-Dieu de Québec; McGill University; University Health Network; Toronto General Hospital; Université Laval","funders":"","keywords":"Medicine; Ovarian cancer; Green tea; Oncology; Cancer; In vivo; Cancer research; Epidemiology; Apoptosis; Angiogenesis; Cisplatin; Internal medicine; Traditional medicine; Chemotherapy; Biotechnology; Biology","score_opus":0.14955964856871318,"score_gpt":0.4450840650327389,"score_spread":0.2955244164640257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056963295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006700054,0.98782384,0.0000010147018,0.00080072746,0.00020878088,0.010354252,0.000036757614,0.000010304419,0.000094342824],"genre_scores_gemma":[0.0006652164,0.99184895,0.00020322065,0.00037342598,0.00007559489,0.0065093464,0.000010840076,0.000015066574,0.00029834537],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996275,0.0017820565,0.0011557143,0.0003652443,0.00006736491,0.0003546003],"domain_scores_gemma":[0.9944591,0.00432873,0.00084163336,0.00026584105,0.000038355156,0.00006631961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021929538,0.0003513551,0.00602961,0.00011223905,0.0000378728,0.0000018091338,0.00010066808,0.0005189822,0.000026048698],"category_scores_gemma":[0.0026677218,0.00015825656,0.0003162089,0.00020254277,0.00018583612,0.00002458047,0.00011913545,0.0002357986,0.0000010451629],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028033504,0.0002068464,0.00031764855,0.698313,0.00028724287,0.000010367979,0.00009110551,2.022485e-8,0.0000021673634,0.000095594434,0.000045057375,0.3006029],"study_design_scores_gemma":[0.0031479895,0.0038842831,0.0020146463,0.79043454,0.015658198,0.00029726877,0.00013347209,0.000009342334,0.0000020593905,0.00047250686,0.18359011,0.00035558298],"about_ca_topic_score_codex":0.000122051475,"about_ca_topic_score_gemma":0.0006169678,"teacher_disagreement_score":0.30024734,"about_ca_system_score_codex":0.00077720504,"about_ca_system_score_gemma":0.0002800435,"threshold_uncertainty_score":0.6453515},"labels":[],"label_agreement":null},{"id":"W2057428905","doi":"10.1016/j.ygyno.2014.03.490","title":"Ovarian high grade serous cancer xenografts as pre-clinical models of response to chemotherapy","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Debulking; Ovarian cancer; Chemotherapy; Clinical trial; Oncology; Serous fluid; Disease; In vivo; Cancer; Internal medicine; Serous ovarian cancer; Bioinformatics; Biology","score_opus":0.03270078617377512,"score_gpt":0.39462862560062356,"score_spread":0.3619278394268484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057428905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302,0.00019204534,0.0008192851,0.0035449653,0.00036793534,0.00058637443,0.000042408505,0.000021688573,0.0014053088],"genre_scores_gemma":[0.9927078,0.00046726177,0.0019493371,0.0026903094,0.00029147137,0.0002812284,0.000040229996,0.000025201933,0.0015471592],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977335,0.00067935017,0.0003900345,0.0005509533,0.00016334606,0.00048281555],"domain_scores_gemma":[0.9986787,0.0002791928,0.00015104165,0.00049332326,0.00012695378,0.00027078897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008702796,0.00019501556,0.00043419335,0.00007463062,0.00007080968,0.0000100164125,0.00035696913,0.00041470813,0.00027248025],"category_scores_gemma":[0.00053515297,0.0001662713,0.00014003424,0.00014326199,0.00018530693,0.0000046655973,0.00018405102,0.00015757028,0.000040167877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06067985,0.0071630874,0.06091139,0.00009977074,0.0021784052,0.0001832487,0.0008648859,0.006367202,0.4470844,0.0021452885,0.054283086,0.3580394],"study_design_scores_gemma":[0.015439141,0.050159987,0.2575925,0.000031727122,0.00010629779,0.000056621353,0.00007375843,0.00037663575,0.09014236,0.007288738,0.57797635,0.0007558789],"about_ca_topic_score_codex":0.0013126673,"about_ca_topic_score_gemma":0.0020382553,"teacher_disagreement_score":0.52369326,"about_ca_system_score_codex":0.00012116662,"about_ca_system_score_gemma":0.00052562973,"threshold_uncertainty_score":0.6780347},"labels":[],"label_agreement":null},{"id":"W2057770147","doi":"10.1016/j.ygyno.2006.01.027","title":"Early cervical cancer and parametrial involvement: Is it significant?","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Parametrial; Medicine; Cervical cancer; Lymph node; Stage (stratigraphy); Radical Hysterectomy; Proportional hazards model; Hysterectomy; Radiology; Internal medicine; Cancer","score_opus":0.04966554518678177,"score_gpt":0.33983009113338875,"score_spread":0.29016454594660696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057770147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95725155,0.0010192817,0.000013212416,0.016421514,0.00072902016,0.00074706355,0.000044388005,0.00007339908,0.023700569],"genre_scores_gemma":[0.9862781,0.00046119516,0.0007258102,0.008123368,0.0007435641,0.00025711008,0.000031736203,0.000017433551,0.0033616512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982012,0.00009856954,0.00044124396,0.00050678785,0.00025551856,0.0004966843],"domain_scores_gemma":[0.99861425,0.0007234605,0.00014248073,0.00020232864,0.00009484677,0.00022262441],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024617385,0.00022873633,0.0006796002,0.00017461053,0.00011063959,0.000022194961,0.00010355857,0.00037881488,0.0045060227],"category_scores_gemma":[0.00018710688,0.0001688219,0.000126442,0.00048684957,0.00021615985,0.000053932137,0.0000934321,0.00026935246,0.00015423904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032020719,0.0030235313,0.80010253,0.00015568445,0.0005302626,0.00071981037,0.0003531773,0.0000074717905,0.0023306874,0.0025092983,0.04313066,0.14393483],"study_design_scores_gemma":[0.017042125,0.007079835,0.7188397,0.000022724,0.0005350977,0.000025101668,0.0001552309,0.000034283934,0.0014242739,0.0043139285,0.2502183,0.0003093638],"about_ca_topic_score_codex":0.0027398504,"about_ca_topic_score_gemma":0.00052494445,"teacher_disagreement_score":0.20708765,"about_ca_system_score_codex":0.0005016727,"about_ca_system_score_gemma":0.00024271615,"threshold_uncertainty_score":0.996404},"labels":[],"label_agreement":null},{"id":"W2058293866","doi":"10.1006/gyno.2001.6493","title":"How Important Is Removal of the Parametrium at Surgery for Carcinoma of the Cervix?","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Parametrial; Medicine; Parametrium; Cervical cancer; Radical surgery; Cervix; Lymph node; Radical Hysterectomy; Population; Lymphovascular invasion; Incidence (geometry); Surgery; Radiology; Cancer; Urology; Internal medicine; Metastasis","score_opus":0.06814782421359568,"score_gpt":0.29201224154777616,"score_spread":0.2238644173341805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058293866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737913,0.001954397,0.0000026821583,0.018210841,0.0012050429,0.00096438796,0.00007500671,0.0000120593395,0.0037842668],"genre_scores_gemma":[0.99205273,0.00019067893,0.00020569211,0.0019154865,0.00011429254,0.00008485723,0.000004432879,0.0000118596345,0.0054199584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985501,0.00014840695,0.00048078742,0.00025378822,0.0002446663,0.00032224917],"domain_scores_gemma":[0.9962359,0.0025130734,0.00052763446,0.0004954832,0.00015307967,0.00007481365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035301683,0.00015137477,0.0007337109,0.00008247012,0.000096801086,0.0000030354402,0.00022557043,0.0002493193,0.0009297647],"category_scores_gemma":[0.0023075743,0.0000716157,0.0005699204,0.00063159096,0.00027773628,0.000020247871,0.00016154532,0.00013650813,0.0000035969958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006466022,0.0010965719,0.93962854,0.0002167772,0.00028195238,0.00008619296,0.00020861169,7.150372e-7,0.00249382,0.0001986071,0.020542415,0.03459917],"study_design_scores_gemma":[0.0053049843,0.0027685573,0.81529784,0.000027590713,0.0006229165,0.00030240638,0.00016935224,0.000095386946,0.034690578,0.0009787425,0.13959062,0.00015098907],"about_ca_topic_score_codex":0.00006088462,"about_ca_topic_score_gemma":0.00009125949,"teacher_disagreement_score":0.12433069,"about_ca_system_score_codex":0.0003870244,"about_ca_system_score_gemma":0.00015611366,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W2058346860","doi":"10.1016/j.ygyno.2005.10.024","title":"Small cell of the ovary, hypercalcemic type—Analysis of combined experience and recommendation for management. A GCIG study","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Stage (stratigraphy); Abdomen; Surgery; Chemotherapy; Malignancy; Pelvis; Radiology; Internal medicine","score_opus":0.029604905283734155,"score_gpt":0.30689177300466053,"score_spread":0.27728686772092637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058346860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972852,0.00009607489,0.0005234931,0.00016815985,0.00011143817,0.00043425415,0.000009150033,0.0000043314026,0.0013679197],"genre_scores_gemma":[0.9968798,0.000119764336,0.0023273195,0.0002229595,0.000019858971,0.00006792045,0.000030218147,0.0000051440807,0.00032700048],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99929404,0.00008367724,0.00025167526,0.00021678563,0.000039734383,0.00011409069],"domain_scores_gemma":[0.99946,0.000062423765,0.00017067108,0.00021376181,0.00007409067,0.000019079624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022914955,0.0000791386,0.00022157535,0.000047302372,0.000047225265,0.000002479448,0.00015617056,0.000099312856,0.00004923197],"category_scores_gemma":[0.000057380563,0.00005909417,0.00007794321,0.00016997936,0.000070553055,0.0000016827856,0.00012854802,0.000037207003,4.0642396e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016720636,0.005287852,0.16553438,0.0002448432,0.0030961186,0.0000020897,0.004261821,0.007343932,0.5833822,0.00023675608,0.0033531135,0.22558485],"study_design_scores_gemma":[0.022682235,0.028153587,0.47397664,0.0000354871,0.008644725,0.000015140507,0.018061964,0.04630829,0.25569138,0.00065105525,0.14439297,0.001386547],"about_ca_topic_score_codex":0.000015605663,"about_ca_topic_score_gemma":0.00018478707,"teacher_disagreement_score":0.3276908,"about_ca_system_score_codex":0.000029331522,"about_ca_system_score_gemma":0.00003264835,"threshold_uncertainty_score":0.24097903},"labels":[],"label_agreement":null},{"id":"W2058421409","doi":"10.1016/j.ygyno.2005.12.033","title":"Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"PTEN; Cisplatin; Apoptosis; Cancer research; PI3K/AKT/mTOR pathway; Protein kinase B; Tumor suppressor gene; Ovarian cancer; Western blot; Transfection; Biology; Cell culture; Cancer; Medicine; Carcinogenesis; Chemotherapy; Internal medicine; Gene; Biochemistry","score_opus":0.015517050242244335,"score_gpt":0.3051042285990079,"score_spread":0.28958717835676356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058421409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933563,0.00012622138,0.00010025939,0.00033404378,0.0007137832,0.0004828007,0.000050270508,0.00002468393,0.0048116273],"genre_scores_gemma":[0.99683475,0.000026742286,0.0011036347,0.000728473,0.00036602464,0.00019605845,0.00005598574,0.000033416414,0.0006549279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99776304,0.00025389678,0.00057109876,0.00067653775,0.00019784489,0.00053757115],"domain_scores_gemma":[0.99893826,0.00010939873,0.00029157437,0.00043791512,0.0001216607,0.00010120514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004171202,0.00027769507,0.00050137535,0.00015796533,0.00008683736,0.000012448444,0.00033081754,0.00063525373,0.00037989378],"category_scores_gemma":[0.00009051118,0.0002605772,0.000116100055,0.00018704403,0.00008548029,0.0000058410997,0.00028731683,0.00021791847,0.000016557075],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016300906,0.00027738095,0.0060007423,0.000021844406,0.00002756477,0.000025343285,0.000063849926,0.0021311135,0.9843475,0.00007314237,0.005188482,0.0016799868],"study_design_scores_gemma":[0.0015521969,0.0012420088,0.02184127,0.000031006493,0.000031173447,0.0000045573306,0.00006515236,0.00003160262,0.96858984,0.00022243342,0.006073411,0.0003153613],"about_ca_topic_score_codex":0.0013791262,"about_ca_topic_score_gemma":0.003356959,"teacher_disagreement_score":0.015840529,"about_ca_system_score_codex":0.0002918283,"about_ca_system_score_gemma":0.0002177177,"threshold_uncertainty_score":0.9999846},"labels":[],"label_agreement":null},{"id":"W2058832943","doi":"10.1016/j.ygyno.2014.05.023","title":"Mutations in oncogenes: Context matters","year":2014,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Neural crest; Medicine; Cervix; Context (archaeology); Vulva; Melanoma; Vagina; Population; Dermatology; Cancer; Pathology; Anatomy; Internal medicine; Cancer research; Biology; Genetics; Embryo","score_opus":0.03127688191893395,"score_gpt":0.2988884994544179,"score_spread":0.26761161753548396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058832943","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004527986,0.00009518306,0.000102911006,0.9432903,0.002149305,0.0012826427,0.000009855508,0.00018403286,0.04835781],"genre_scores_gemma":[0.02642195,0.00006250599,0.00040971962,0.9506786,0.0013597113,0.0003722401,0.00035355755,0.000049881804,0.020291865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767905,0.0003309526,0.0006030003,0.00059975113,0.00021918176,0.00056803296],"domain_scores_gemma":[0.9982297,0.0008757842,0.00028297852,0.00044350035,0.00007884908,0.00008921802],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031371714,0.0003404892,0.00100552,0.000580821,0.00006881288,0.000017598555,0.00019230272,0.0014485342,0.0035028954],"category_scores_gemma":[0.0002501797,0.000307212,0.0002040973,0.00021966278,0.0001843796,0.000020801253,0.00008748584,0.0015973705,0.0018827665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005025689,0.00014363306,0.00030235943,0.0001537524,0.00010455773,0.010754628,0.00009946205,0.0000067234546,0.000048677157,0.000048708083,0.95814097,0.030146295],"study_design_scores_gemma":[0.0017256455,0.0017041942,0.00074696715,0.000042255215,0.00021655258,0.0015896923,0.00025705047,0.000044374414,0.000015194494,0.00031259033,0.9930705,0.00027502154],"about_ca_topic_score_codex":0.0001303944,"about_ca_topic_score_gemma":0.00070169976,"teacher_disagreement_score":0.034929514,"about_ca_system_score_codex":0.0013025439,"about_ca_system_score_gemma":0.00030045066,"threshold_uncertainty_score":0.999938},"labels":[],"label_agreement":null},{"id":"W2059162955","doi":"10.1016/j.ygyno.2005.11.043","title":"Remission of a negative Her2/Neu overexpressive metastatic ovarian cancer patient by the single agent of trastuzumab as salvage therapy","year":2006,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Trastuzumab; Medicine; Cetuximab; Bevacizumab; Oncology; HER2/neu; Internal medicine; Ovarian cancer; Fluorescence in situ hybridization; Targeted therapy; Cancer; Chemotherapy; Colorectal cancer; Breast cancer","score_opus":0.06132552669997006,"score_gpt":0.3740022859081994,"score_spread":0.31267675920822935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059162955","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32415769,0.011343348,0.00009219736,0.5976336,0.0024795665,0.011184641,0.0025573543,0.00014432735,0.050407298],"genre_scores_gemma":[0.43864188,0.0034218496,0.0025391723,0.5324685,0.0018976439,0.0039946353,0.0014630405,0.0003995606,0.01517375],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99384356,0.0018196866,0.0013098979,0.0008732157,0.0012162891,0.00093733903],"domain_scores_gemma":[0.9929181,0.003796897,0.0016065491,0.0009399632,0.00059019844,0.00014832927],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006648202,0.0006118477,0.001973168,0.00025269328,0.00013587983,0.000016243108,0.0006530108,0.0012324437,0.0056617847],"category_scores_gemma":[0.0009854462,0.00038083087,0.00042868947,0.00047957082,0.0010051051,0.000048159134,0.00023111653,0.0025828443,0.000027146956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057155604,0.0013174337,0.0002499102,0.00041805994,0.00067134877,0.0009394716,0.001312961,0.000029327686,0.019352384,0.000008875909,0.9173337,0.05779492],"study_design_scores_gemma":[0.0038779594,0.016405936,0.001608643,0.00045001222,0.00039588564,0.00008817304,0.00053858344,0.000021362837,0.037423424,0.000934858,0.9378696,0.0003855822],"about_ca_topic_score_codex":0.003499416,"about_ca_topic_score_gemma":0.00018179721,"teacher_disagreement_score":0.1144842,"about_ca_system_score_codex":0.0025417511,"about_ca_system_score_gemma":0.0027499322,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W2060142689","doi":"10.1006/gyno.2002.6636","title":"The Benefits of Comprehensive Surgical Staging in the Management of Early-Stage Epithelial Ovarian Carcinoma","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Serous fluid; Laparotomy; Serous carcinoma; Population; Ovarian cancer; Logistic regression; Cancer; Surgery; Internal medicine","score_opus":0.05198782285814984,"score_gpt":0.3053745793490813,"score_spread":0.25338675649093145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060142689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971428,0.0014656036,0.0000021242527,0.0056943432,0.00025030872,0.0008343837,0.000029793333,0.000010424764,0.020285042],"genre_scores_gemma":[0.9970076,0.0017333587,0.0003617662,0.00029725442,0.0000562897,0.00014326235,0.0000054780658,0.000008777211,0.00038617887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998474,0.00025141082,0.0004624587,0.00024909934,0.00022953551,0.00033352253],"domain_scores_gemma":[0.99802667,0.001225336,0.00021780455,0.00040342772,0.00007797653,0.000048788068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003984896,0.00014881407,0.0004742376,0.000069008594,0.000092685674,0.0000070699666,0.00022748776,0.00012065364,0.000371639],"category_scores_gemma":[0.000016434125,0.00008003771,0.000121731566,0.00024651378,0.000237956,0.000021852387,0.00009647854,0.00019764295,0.000018122186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000962961,0.004892315,0.5844033,0.00034141535,0.0009766531,0.004435438,0.0041766306,0.00040447435,0.00005813552,0.097767375,0.0017061777,0.2998751],"study_design_scores_gemma":[0.004935917,0.0025638475,0.94454014,0.00003765161,0.00017806709,0.000038538412,0.0018240398,0.00008561669,0.00013385489,0.00014223847,0.045442894,0.000077166995],"about_ca_topic_score_codex":0.00023877378,"about_ca_topic_score_gemma":0.00010983391,"teacher_disagreement_score":0.36013687,"about_ca_system_score_codex":0.00019540667,"about_ca_system_score_gemma":0.000043649394,"threshold_uncertainty_score":0.40691864},"labels":[],"label_agreement":null},{"id":"W2060408001","doi":"10.1016/j.ygyno.2013.04.127","title":"A population-based study to evaluate SGO criteria for the identification of Lynch syndrome among endometrial cancer patients","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Endometrial cancer; Lynch syndrome; Gynecologic oncology; Gynecology; Population; Oncology; Risk assessment; Internal medicine; Cancer; Environmental health","score_opus":0.04544331694104563,"score_gpt":0.38236021285681826,"score_spread":0.3369168959157726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060408001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867288,0.000044969802,0.00021460341,0.0009321804,0.0026872104,0.009256586,0.000041515686,0.000033547913,0.000060577775],"genre_scores_gemma":[0.99280936,0.0000029979133,0.0006044417,0.00046250958,0.00010254756,0.0057880986,0.00004075697,0.00002199561,0.00016728342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978358,0.0002882643,0.0007944851,0.00040206974,0.0003534559,0.00032593356],"domain_scores_gemma":[0.99608374,0.002274316,0.00041658772,0.0003877567,0.00073035096,0.000107253174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010111742,0.00017756213,0.0005613827,0.00023326071,0.00012296552,0.000019435272,0.00025002606,0.00015079511,0.002132424],"category_scores_gemma":[0.0044699884,0.00012063389,0.00011519503,0.00045221185,0.000073861374,0.000047988524,0.00007462612,0.0001266835,0.000041043106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049912196,0.0015234066,0.97956795,0.000047412486,0.00015041187,0.0000020757514,0.00039688853,0.00063056964,0.0031944884,0.0000035610212,0.0016629645,0.012321155],"study_design_scores_gemma":[0.0046076905,0.009920709,0.9820646,0.000011125401,0.0003184834,0.0000010861497,0.00022253583,0.0016577606,0.0007433375,0.00011696227,0.0002185878,0.00011712653],"about_ca_topic_score_codex":0.0011956227,"about_ca_topic_score_gemma":0.0008769575,"teacher_disagreement_score":0.012204028,"about_ca_system_score_codex":0.00082129706,"about_ca_system_score_gemma":0.00029977495,"threshold_uncertainty_score":0.9987798},"labels":[],"label_agreement":null},{"id":"W2061153684","doi":"10.1016/j.ygyno.2011.04.006","title":"Surgical staging of early stage epithelial ovarian cancer","year":2011,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Ovarian cancer; Ovarian carcinoma; Lymph node; Chemotherapy; Oncology; Cancer; Carcinoma; Disease; Gynecology; Internal medicine; General surgery","score_opus":0.052228813079906886,"score_gpt":0.33312647866378425,"score_spread":0.28089766558387735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061153684","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12402844,0.0020744822,0.000020043231,0.76595974,0.006019486,0.0028653983,0.0014581828,0.0002465588,0.097327664],"genre_scores_gemma":[0.20442681,0.0069686086,0.0039426223,0.70579636,0.014333701,0.0026332294,0.0009606335,0.00035612888,0.060581874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967315,0.00033604482,0.0008228202,0.00086857984,0.00038325152,0.0008577977],"domain_scores_gemma":[0.99734944,0.00083592825,0.0007144889,0.00069840706,0.00022705915,0.00017468003],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003726426,0.0005389171,0.0019284564,0.00028903398,0.0000809972,0.0000129186665,0.0003068476,0.0021016481,0.014400586],"category_scores_gemma":[0.00008700977,0.00041593154,0.0004470936,0.00021132805,0.00036715137,0.00004902229,0.00016707547,0.0018597491,0.00017429217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076340046,0.0014765761,0.0945827,0.00068379403,0.00209899,0.0361778,0.0005869852,0.0000037029833,0.000040594405,0.00073148514,0.80864555,0.0542084],"study_design_scores_gemma":[0.0046728584,0.004510388,0.05442986,0.00012254265,0.0009499005,0.00008890207,0.000025024074,0.0000024598571,0.00022515633,0.0001931562,0.9344392,0.00034055283],"about_ca_topic_score_codex":0.0028291377,"about_ca_topic_score_gemma":0.00015585235,"teacher_disagreement_score":0.12579364,"about_ca_system_score_codex":0.0012069135,"about_ca_system_score_gemma":0.0018007229,"threshold_uncertainty_score":0.99982923},"labels":[],"label_agreement":null},{"id":"W2061278190","doi":"10.1016/j.ygyno.2013.08.012","title":"Primary squamous cell carcinoma of the vagina: Prognostic factors, treatment patterns, and outcomes","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Stage (stratigraphy); Vagina; Radiation therapy; Vaginal cancer; Malignancy; Carcinoma; Retrospective cohort study; Urology; Internal medicine; Surgery; Gastroenterology; Oncology; Cancer; Cervical cancer","score_opus":0.023301955066476917,"score_gpt":0.27516686974673915,"score_spread":0.25186491468026223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061278190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990709,0.0005051782,0.0000019875993,0.0017529118,0.00036291874,0.0014246731,0.000022643038,0.000028307259,0.005192401],"genre_scores_gemma":[0.99750596,0.00006589649,0.00012221946,0.00082116865,0.00003972481,0.00022730601,0.000022498958,0.000012081108,0.001183116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988713,0.00012726813,0.00029196308,0.00027113355,0.00014211118,0.00029618866],"domain_scores_gemma":[0.99820536,0.0011793812,0.00015845211,0.00026192665,0.00006423712,0.0001306637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060607363,0.00020782472,0.0006348915,0.00006342053,0.000069031565,0.0000065200775,0.00010339241,0.00017356555,0.0006903609],"category_scores_gemma":[0.00019864422,0.00009817494,0.00013707728,0.00013327623,0.00013048212,0.000035439367,0.000105140316,0.000117087715,0.000025674753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004009108,0.0011317914,0.9808394,0.00008437937,0.00004642222,0.000027218513,0.0001501584,3.0622567e-7,0.0002654097,0.000014939604,0.00014877031,0.017251154],"study_design_scores_gemma":[0.004979558,0.006430946,0.9853219,0.000004608524,0.00029105716,0.000015287007,0.00017727581,0.000002131129,0.001451807,0.00013404498,0.0011042824,0.00008712589],"about_ca_topic_score_codex":0.0012064665,"about_ca_topic_score_gemma":0.00015610947,"teacher_disagreement_score":0.01716403,"about_ca_system_score_codex":0.0004914719,"about_ca_system_score_gemma":0.00018001343,"threshold_uncertainty_score":0.7558968},"labels":[],"label_agreement":null},{"id":"W2061399161","doi":"10.1016/j.ygyno.2005.12.020","title":"A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Bayer (Canada); University of Manitoba; Nova Scotia Cancer Centre; Health Sciences Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Chemotherapy; Ovarian cancer; Interim analysis; Carboplatin; Oncology; Surgery; Placebo; Gemcitabine; Cancer; Paclitaxel; Randomized controlled trial; Pathology; Cisplatin","score_opus":0.027617687288752135,"score_gpt":0.3488508885259267,"score_spread":0.3212332012371746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061399161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934667,0.00023695524,0.000117823874,0.00029050413,0.00080686965,0.0046724956,0.00013075216,0.0000054796005,0.00027242897],"genre_scores_gemma":[0.9963995,0.0002117397,0.0005356108,0.001186027,0.00019388288,0.0012998752,0.00008466865,0.000017255315,0.00007144535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957335,0.0016681392,0.0014837559,0.00050806545,0.0002784884,0.00032806955],"domain_scores_gemma":[0.9968399,0.0014614271,0.0010714087,0.00018430597,0.00035013806,0.00009285365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050138324,0.00024062318,0.0017340301,0.00011027718,0.00005655667,0.0000060139632,0.00012913161,0.00022955019,0.000051615938],"category_scores_gemma":[0.0029570318,0.00017785947,0.00013760958,0.00014991881,0.0001951051,0.000015068391,0.00006255534,0.00014786415,9.270765e-8],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9544449,0.0028584348,0.009399827,0.000010940056,0.00033425682,0.000022737555,0.000107881715,0.000059156922,0.0129831,0.00009671634,0.00065500615,0.019027079],"study_design_scores_gemma":[0.9489583,0.022677189,0.018978814,0.00004916053,0.000056082965,0.0000014033097,0.0001499645,0.000009905823,0.004404079,0.00028145337,0.004153153,0.00028053363],"about_ca_topic_score_codex":0.018313173,"about_ca_topic_score_gemma":0.1423877,"teacher_disagreement_score":0.12407453,"about_ca_system_score_codex":0.00026664353,"about_ca_system_score_gemma":0.0034404167,"threshold_uncertainty_score":0.98822397},"labels":[],"label_agreement":null},{"id":"W2061842004","doi":"10.1016/j.ygyno.2007.11.019","title":"The prognostic significance of elongation factor eEF1A2 in ovarian cancer","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Ottawa","funders":"","keywords":"Cancer research; Ovarian cancer; Ovarian carcinoma; Serous fluid; Cell culture; Ectopic expression; Tissue microarray; Medicine; Immunohistochemistry; Biology; Oncology; Pathology; Cancer; Internal medicine","score_opus":0.022871932623252166,"score_gpt":0.29823084926024696,"score_spread":0.2753589166369948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061842004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955608,0.0011211662,0.00033038016,0.00077564723,0.00027936918,0.0004491116,0.000028625785,0.0000070868023,0.0014478137],"genre_scores_gemma":[0.9967866,0.0013481333,0.0003816216,0.0001839193,0.00010695824,0.00046506943,0.000026544922,0.0000070304923,0.00069410674],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991143,0.00012734422,0.0002514069,0.00021918071,0.00006239977,0.00022538487],"domain_scores_gemma":[0.9993363,0.00018743564,0.0001482314,0.00022542258,0.000066070555,0.000036545833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015570945,0.000092297494,0.00015980814,0.00002790127,0.00012081342,0.000002853594,0.00022264967,0.00015916853,0.00003484594],"category_scores_gemma":[0.00039155735,0.00006669938,0.00004098449,0.00014569245,0.00024308244,0.0000025880238,0.000059172315,0.00009290681,0.000007321417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007753573,0.00033365615,0.20970827,0.0000105941335,0.000035670204,0.000008405633,0.00016093053,0.0001352813,0.7569253,0.0012784732,0.0019046956,0.029421227],"study_design_scores_gemma":[0.00055169384,0.00030133815,0.8377334,0.0000020347481,0.000010079644,0.000009178026,0.000056831406,0.000028172515,0.06129998,0.00038015938,0.09951764,0.0001095047],"about_ca_topic_score_codex":0.000090777205,"about_ca_topic_score_gemma":0.0008008784,"teacher_disagreement_score":0.6956253,"about_ca_system_score_codex":0.000033117045,"about_ca_system_score_gemma":0.0003149497,"threshold_uncertainty_score":0.27199218},"labels":[],"label_agreement":null},{"id":"W2061987716","doi":"10.1016/j.ygyno.2012.12.008","title":"Assessment of the performance of algorithms for cervical cancer screening: Evidence from the Ludwig–McGill cohort study","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Colposcopy; Cytology; Cohort; Cervical cancer; Ascus (bryozoa); Population; Gynecology; Algorithm; Obstetrics; Oncology; Cervical screening; Cancer; Internal medicine; Pathology","score_opus":0.13788153090699426,"score_gpt":0.45415048543999104,"score_spread":0.31626895453299675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061987716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033225,0.00073595793,0.000099562545,0.003065935,0.000583043,0.0027438605,0.00007523274,0.0000146179955,0.0023495518],"genre_scores_gemma":[0.9963014,0.00029718163,0.001180647,0.00085025834,0.000327853,0.00083185674,0.000005911009,0.000012727218,0.0001921387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997924,0.00034160944,0.00047187728,0.00027664343,0.0005281926,0.00045773044],"domain_scores_gemma":[0.99531853,0.003393013,0.00023702049,0.00052064325,0.00040917486,0.0001216322],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001874174,0.00014615557,0.0006163707,0.000033501325,0.00018574251,0.0000035480762,0.00047170045,0.0001719666,0.002726463],"category_scores_gemma":[0.00074161193,0.000072796334,0.00016324308,0.00027209928,0.00032401524,0.000071616036,0.00034653637,0.0004287578,0.0000031919012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002562036,0.00083831925,0.9517013,0.00006675124,0.00019777445,0.000001000814,0.00019898238,0.00003429019,0.00032962428,0.000046934027,0.00052589626,0.045802925],"study_design_scores_gemma":[0.0015885981,0.003322242,0.98643607,0.000027124932,0.00036458974,0.0000030581773,0.0004460253,0.001896854,0.0007003183,0.00002036157,0.0051173246,0.00007743041],"about_ca_topic_score_codex":0.0012864519,"about_ca_topic_score_gemma":0.0007883383,"teacher_disagreement_score":0.045725495,"about_ca_system_score_codex":0.00038192212,"about_ca_system_score_gemma":0.00039862152,"threshold_uncertainty_score":0.99818516},"labels":[],"label_agreement":null},{"id":"W2062295650","doi":"10.1016/j.ygyno.2004.06.023","title":"AKT involvement in cisplatin chemoresistance of human uterine cancer cells","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"","keywords":"AKT2; PTEN; Protein kinase B; AKT3; AKT1; Cisplatin; Tensin; Cancer research; Western blot; PI3K/AKT/mTOR pathway; HeLa; Molecular biology; Phosphorylation; Cell growth; Biology; Apoptosis; Cell culture; Medicine; Internal medicine; Cell biology; Biochemistry; Gene","score_opus":0.021012627785878958,"score_gpt":0.33479773404643287,"score_spread":0.3137851062605539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062295650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951612,0.0008440139,0.00014049772,0.0003690488,0.00052196573,0.00032056108,0.000035736764,0.000015759038,0.002591256],"genre_scores_gemma":[0.9962652,0.00025069114,0.0017658989,0.00082594255,0.00017870852,0.00020056161,0.000042761814,0.000021875047,0.00044841168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838895,0.000085237334,0.00048758197,0.0004889921,0.00013159215,0.00041763036],"domain_scores_gemma":[0.9991473,0.000043075834,0.00027717437,0.00037004205,0.00009061398,0.00007182021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033597744,0.00021197977,0.000402328,0.000076881726,0.00005157795,0.0000056383933,0.00036175363,0.0003624067,0.0003862619],"category_scores_gemma":[0.000068864596,0.0002079523,0.00008770057,0.00015928807,0.00022390895,0.000004145645,0.00018947024,0.00017196588,0.000010006106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102336584,0.0003389452,0.0063112704,0.000060392376,0.000041875057,0.000036594218,0.00010540554,0.0019963325,0.98778707,0.00023557463,0.0010760883,0.001908132],"study_design_scores_gemma":[0.0025219414,0.0021710868,0.0103554465,0.000031853277,0.000018258812,0.0000037798668,0.00008276672,0.000006377059,0.95977014,0.0009019143,0.023870762,0.00026566285],"about_ca_topic_score_codex":0.00030987395,"about_ca_topic_score_gemma":0.0048931027,"teacher_disagreement_score":0.028016904,"about_ca_system_score_codex":0.0004315767,"about_ca_system_score_gemma":0.00039606285,"threshold_uncertainty_score":0.8480049},"labels":[],"label_agreement":null},{"id":"W2062794120","doi":"10.1006/gyno.2001.6484","title":"Peritoneal Implantation of Squamous Cell Carcinoma Following Rupture of a Dermoid Cyst during Laparoscopic Removal","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Laparotomy; Dermoid cyst; Laparoscopy; Malignancy; Stage (stratigraphy); Cyst; Surgery; General surgery; Pathology","score_opus":0.01921274295539734,"score_gpt":0.2748010690353021,"score_spread":0.2555883260799048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062794120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986692,0.001706974,0.0000027714777,0.0005539033,0.00048353532,0.00047097955,0.000024627316,0.000029548231,0.010035646],"genre_scores_gemma":[0.99797666,0.000090324625,0.0012557361,0.000161627,0.00009466403,0.000063296626,0.000025032383,0.000015864594,0.00031679528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986932,0.0000911019,0.00044439555,0.00029822314,0.00016586336,0.00030719617],"domain_scores_gemma":[0.9990486,0.00028935575,0.0002595963,0.0002442751,0.000064016494,0.00009419369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010052846,0.00016939895,0.00068244437,0.00011708429,0.00006854161,0.0000035407406,0.00008570407,0.00025886198,0.000583017],"category_scores_gemma":[0.00008313477,0.00014275477,0.0001871848,0.0001617618,0.00007721374,0.000040208877,0.00004312324,0.00015744193,0.00001949481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005722354,0.0052479235,0.8470626,0.0015231343,0.00021102061,0.009533425,0.0035063026,0.0000721779,0.118714035,0.00019547385,0.0012569559,0.012104709],"study_design_scores_gemma":[0.015773194,0.006131898,0.9106902,0.00004680207,0.00063994183,0.00086249935,0.00064734876,0.00007277535,0.06357456,0.00004456861,0.0013208825,0.00019532531],"about_ca_topic_score_codex":0.00009895507,"about_ca_topic_score_gemma":0.00007743646,"teacher_disagreement_score":0.0636276,"about_ca_system_score_codex":0.00037256983,"about_ca_system_score_gemma":0.00012016668,"threshold_uncertainty_score":0.63836277},"labels":[],"label_agreement":null},{"id":"W2064330422","doi":"10.1016/j.ygyno.2011.01.005","title":"Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010","year":2011,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Calgary Laboratory Services; University of British Columbia","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Ovarian cancer; Clear cell carcinoma; Medicine; Serous fluid; Serous carcinoma; Clear cell; Ovarian carcinoma; Endometriosis; Disease; Ovary; Stage (stratigraphy); Pathological; Oncology; Clinical trial; Internal medicine; Carcinoma; Cancer; Bioinformatics; Biology","score_opus":0.04655003216528951,"score_gpt":0.29563951158551477,"score_spread":0.24908947942022525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064330422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008100509,0.9255724,0.0000019555594,0.0061398027,0.006295759,0.004319821,0.00026335844,0.00007553601,0.05652133],"genre_scores_gemma":[0.006306994,0.98294824,0.00054877705,0.0015946418,0.0008615208,0.00083820027,0.00023602489,0.00013818119,0.006527418],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515885,0.0007469494,0.001705327,0.0012475312,0.00036612962,0.0007752323],"domain_scores_gemma":[0.99249315,0.0021763213,0.0022272638,0.0026838165,0.00018489626,0.00023455548],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008714602,0.0008570031,0.0036075437,0.0001263994,0.0003336237,0.00002511257,0.001106715,0.0016131937,0.0030705966],"category_scores_gemma":[0.00021816227,0.00043523248,0.0014868795,0.00050710514,0.0005508899,0.00004493346,0.000681147,0.001441526,0.00053843553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764097,0.011055939,0.020669036,0.01135742,0.0029466115,0.009299426,0.0018513061,0.000003466744,0.000007839692,0.0007158546,0.58310986,0.35821918],"study_design_scores_gemma":[0.001990207,0.0024890874,0.015201172,0.00092472386,0.006990093,0.0005385586,0.00007936618,0.0000012526531,0.00002602047,0.00009941662,0.9712829,0.0003771936],"about_ca_topic_score_codex":0.0020354844,"about_ca_topic_score_gemma":0.0010133847,"teacher_disagreement_score":0.38817307,"about_ca_system_score_codex":0.0011465378,"about_ca_system_score_gemma":0.0026300135,"threshold_uncertainty_score":0.9998099},"labels":[],"label_agreement":null},{"id":"W2064354484","doi":"10.1016/j.ygyno.2010.05.011","title":"Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; Fallopian tube; Ovarian cancer; Gynecology; Fallopian tube cancer; Breast cancer; Family history; Cancer; Obstetrics; Lynch syndrome; Internal medicine; Oncology; Colorectal cancer; DNA mismatch repair","score_opus":0.010903220087383403,"score_gpt":0.2638797722191378,"score_spread":0.25297655213175435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064354484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930917,0.000104125924,0.000003705034,0.0019447901,0.00019508753,0.00058753823,0.000024362895,0.000012088031,0.004036623],"genre_scores_gemma":[0.99819857,0.000064604465,0.00079506706,0.00022403504,0.000042363292,0.00017388198,0.0000025815737,0.000008661993,0.00049024716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991326,0.00005971506,0.00025501312,0.00023191409,0.00011414562,0.00020666118],"domain_scores_gemma":[0.99886847,0.00037779656,0.00021782782,0.0003204405,0.00012221906,0.00009327768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018780852,0.000114661314,0.0003595733,0.000050173785,0.0000563323,0.0000029791522,0.0001070256,0.00015043972,0.0006417037],"category_scores_gemma":[0.00017713248,0.00006526561,0.000038695027,0.00014113488,0.0005917905,0.00003165681,0.000063056235,0.00020534021,0.0000021373808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089387715,0.0005829088,0.9868081,0.00015071053,0.00010320708,0.000043826778,0.0010112739,0.000009355823,0.0014097326,0.00063880853,0.000056181594,0.00909648],"study_design_scores_gemma":[0.002173905,0.0039411397,0.99008656,0.00002582928,0.00020048753,0.00007921602,0.00024411512,0.000036524343,0.0021537854,0.00017578818,0.00082076236,0.0000618662],"about_ca_topic_score_codex":0.00010665576,"about_ca_topic_score_gemma":0.0006423785,"teacher_disagreement_score":0.009034613,"about_ca_system_score_codex":0.00013020719,"about_ca_system_score_gemma":0.0003820881,"threshold_uncertainty_score":0.70262057},"labels":[],"label_agreement":null},{"id":"W2065071195","doi":"10.1016/s0090-8258(03)00472-4","title":"First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Topotecan; Taxane; Oncology; Ovarian cancer; Chemotherapy; Clinical trial; Radiation therapy; Salvage therapy; Regimen; Internal medicine; Intensive care medicine; Cancer; Breast cancer","score_opus":0.05232850364174327,"score_gpt":0.3771091044721546,"score_spread":0.3247806008304114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065071195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005587456,0.9889609,0.0000012741003,0.0016902062,0.00029689024,0.0038332385,0.000049137823,0.000016443464,0.004593124],"genre_scores_gemma":[0.002201866,0.9926592,0.0003148944,0.00030836434,0.000075839176,0.0040197247,0.000065082626,0.000029103785,0.00032591174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787337,0.0004781215,0.0007286042,0.000502258,0.000104682265,0.0003129893],"domain_scores_gemma":[0.99723685,0.0015774674,0.0006246017,0.0004153785,0.00006594997,0.00007974731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035592992,0.00040659963,0.0027782454,0.00015790986,0.00006697762,0.0000069374173,0.000093381575,0.0004814055,0.00051939784],"category_scores_gemma":[0.00009876044,0.00021066073,0.0002836375,0.0002662419,0.00028675844,0.000024105088,0.000031586846,0.00022956789,0.000009573044],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026602438,0.0009554391,0.0007338026,0.00046376226,0.000603758,0.00005845531,0.00016591727,0.000008617343,2.498246e-7,0.0018726734,0.00004795134,0.99482334],"study_design_scores_gemma":[0.013857985,0.0038113678,0.0006660141,0.0009781256,0.0012987201,0.00007145272,0.000059662594,0.000008039165,0.000007101297,0.0006123281,0.97847074,0.00015843414],"about_ca_topic_score_codex":0.00036503634,"about_ca_topic_score_gemma":0.0010666291,"teacher_disagreement_score":0.9946649,"about_ca_system_score_codex":0.001473409,"about_ca_system_score_gemma":0.0011026345,"threshold_uncertainty_score":0.8590495},"labels":[],"label_agreement":null},{"id":"W2066948744","doi":"10.1016/j.ygyno.2007.09.012","title":"Sarcoma post-embolization for presumed uterine fibroids","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Uterine artery embolization; Embolization; Uterine sarcoma; Uterine fibroids; Malignancy; Radiology; Uterine artery; Endometrial stromal sarcoma; Surgery; Sarcoma; Leiomyosarcoma; Pathology; Pregnancy","score_opus":0.02612254065119067,"score_gpt":0.36304634268130287,"score_spread":0.3369238020301122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066948744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97368175,0.000111109825,0.004062258,0.0032785125,0.0007159301,0.0014620526,0.00003269938,0.00017289398,0.016482785],"genre_scores_gemma":[0.9750421,0.00003333082,0.017593462,0.0021108966,0.0002714141,0.00014081379,0.00028055324,0.0000239438,0.0045034797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99876076,0.00003332713,0.0003384682,0.00030793497,0.00009845266,0.00046105476],"domain_scores_gemma":[0.9988941,0.0004240668,0.00011557525,0.00023580364,0.00017089964,0.00015957974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003065842,0.0001696901,0.0004101004,0.0001269486,0.00009154512,0.000007723979,0.000086750755,0.00024905714,0.0005840647],"category_scores_gemma":[0.00034859963,0.00013289784,0.00011132882,0.0001245992,0.00006837823,0.000053049804,0.00007052884,0.000093956536,0.000070701666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067279343,0.005325781,0.18801284,0.00044746822,0.00080183655,0.0021814075,0.0005523842,0.00001263338,0.05663168,0.00816106,0.014849738,0.71629524],"study_design_scores_gemma":[0.006569683,0.010884618,0.5353983,0.000008588602,0.00013632193,0.00029453094,0.000064271735,0.00011870361,0.0031577083,0.00061310246,0.44260275,0.00015139629],"about_ca_topic_score_codex":0.000021547115,"about_ca_topic_score_gemma":0.0001163954,"teacher_disagreement_score":0.71614385,"about_ca_system_score_codex":0.00028725853,"about_ca_system_score_gemma":0.00012554199,"threshold_uncertainty_score":0.6395099},"labels":[],"label_agreement":null},{"id":"W2066973044","doi":"10.1016/j.ygyno.2007.03.035","title":"B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Medicine; Cancer; Biomarker; Internal medicine; Oncology; Ovarian carcinoma; Gastroenterology; Pathology; Biology","score_opus":0.02423244268222373,"score_gpt":0.3356432818737014,"score_spread":0.31141083919147766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066973044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992251,0.0011020466,0.000037073132,0.0014471106,0.00040518332,0.00053916284,0.000044490567,0.000026004165,0.0041479543],"genre_scores_gemma":[0.99359304,0.0011864124,0.00042167777,0.0032373543,0.000070848386,0.000046994435,0.0000060013813,0.000015187387,0.0014224745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838054,0.00007263503,0.00052690925,0.00039246533,0.00021102683,0.0004163992],"domain_scores_gemma":[0.9989663,0.00032845125,0.0002551055,0.00027397444,0.000062046725,0.00011414398],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007463052,0.00018396233,0.00053626846,0.0002303327,0.00005205163,0.000006656745,0.00012365582,0.0004972012,0.0028422833],"category_scores_gemma":[0.00007295607,0.00014904686,0.0000887969,0.00024795096,0.00020481442,0.00006587212,0.00009413206,0.00030550561,0.000004549105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046277866,0.0005447495,0.64415336,0.000105105064,0.00010874404,0.0002037005,0.0031111378,0.0000013032494,0.2989966,0.000040939885,0.0029901424,0.04511642],"study_design_scores_gemma":[0.007022414,0.0014003053,0.85426724,0.00007185265,0.000036204652,0.00001017878,0.00047569594,0.000014492442,0.07904619,0.00009427553,0.05741442,0.00014674183],"about_ca_topic_score_codex":0.0036744347,"about_ca_topic_score_gemma":0.0025922544,"teacher_disagreement_score":0.21995042,"about_ca_system_score_codex":0.0004143164,"about_ca_system_score_gemma":0.0002512453,"threshold_uncertainty_score":0.9980692},"labels":[],"label_agreement":null},{"id":"W2067353867","doi":"10.1016/j.ygyno.2014.03.559","title":"Impact of socioeconomic status and ethnic enclave on cervical cancer incidence among Hispanics and Asians in California","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Center for Chronic Disease Prevention and Health Promotion; National Cancer Institute","keywords":"Medicine; Socioeconomic status; Ethnic group; Incidence (geometry); Cervical cancer; Demography; Asian americans; Cancer incidence; Gerontology; Environmental health; Cancer; Population; Internal medicine","score_opus":0.031519651808458206,"score_gpt":0.39735789553410056,"score_spread":0.36583824372564233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067353867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914004,0.0006136461,0.000008254039,0.0010227287,0.00006237542,0.0003666456,0.000027452923,0.000014941873,0.006483557],"genre_scores_gemma":[0.9969866,0.002037105,0.000055264594,0.0007158311,0.00006590005,0.000061144376,0.000006413939,0.000012310719,0.000059385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849045,0.00020775234,0.00032757857,0.0003565299,0.00012273321,0.00049494975],"domain_scores_gemma":[0.9982672,0.0010905019,0.00010554691,0.00017519336,0.000073804214,0.00028780862],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055433763,0.00015238808,0.0006522294,0.00015080199,0.000041001298,0.000006061554,0.00008494166,0.00035398456,0.0030758725],"category_scores_gemma":[0.00052031176,0.00011597934,0.000067691166,0.00011242602,0.0004415086,0.000037897684,0.0001298902,0.0005592844,0.00001888991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039311315,0.0001500291,0.85334367,0.000078422476,0.000033068136,0.0000179303,0.00037065076,0.000035235214,0.00013959465,0.00021981637,0.0001536401,0.14506482],"study_design_scores_gemma":[0.0022822921,0.0047824048,0.98904693,0.000014127502,0.000033363598,0.000009388124,0.00011473545,0.0019753757,0.00003377309,0.0009408289,0.00066095096,0.00010583395],"about_ca_topic_score_codex":0.0031754074,"about_ca_topic_score_gemma":0.018080901,"teacher_disagreement_score":0.14495897,"about_ca_system_score_codex":0.0011421609,"about_ca_system_score_gemma":0.00055287493,"threshold_uncertainty_score":0.99983656},"labels":[],"label_agreement":null},{"id":"W2067363820","doi":"10.1016/j.ygyno.2005.11.047","title":"Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Nausea; Radiation therapy; Vomiting; Palliative care; Internal medicine; Ovarian cancer; Cancer; Surgery; Gastroenterology","score_opus":0.030211697689914843,"score_gpt":0.37092783493773945,"score_spread":0.3407161372478246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067363820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87127775,0.011320655,0.0033138015,0.072276354,0.0055245645,0.020080274,0.00046011168,0.00057586865,0.01517065],"genre_scores_gemma":[0.9539643,0.0015397511,0.020476649,0.0039873286,0.0019430222,0.015026251,0.00015645604,0.00007006344,0.002836163],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982087,0.00018722186,0.00040819758,0.00053417595,0.00015168235,0.0005100409],"domain_scores_gemma":[0.99710906,0.0021310097,0.00024355961,0.00025006995,0.00014958264,0.00011673467],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030286633,0.00028178527,0.0008087061,0.00011280174,0.0001495271,0.000016432698,0.00010023607,0.000296567,0.0014703713],"category_scores_gemma":[0.00021258403,0.00018642623,0.00016491661,0.00020646417,0.00012623052,0.00004178708,0.000026291415,0.0001694763,0.000027398464],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007089575,0.007328655,0.14501311,0.0005001824,0.0024736163,0.000818749,0.000977976,0.00022665669,0.00069192273,0.011096016,0.12753467,0.6962489],"study_design_scores_gemma":[0.019948063,0.02090175,0.7315135,0.00014368,0.0008245994,0.000055200544,0.00012087736,0.00045547448,0.0011092162,0.0027133906,0.22185683,0.0003574165],"about_ca_topic_score_codex":0.00027002863,"about_ca_topic_score_gemma":0.0012905769,"teacher_disagreement_score":0.69589144,"about_ca_system_score_codex":0.0024849502,"about_ca_system_score_gemma":0.00068164984,"threshold_uncertainty_score":0.9994424},"labels":[],"label_agreement":null},{"id":"W2067540771","doi":"10.1016/j.ygyno.2014.06.020","title":"The role of palliative colorectal stents in gynaecologic malignancy","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Malignancy; Stent; Retrospective cohort study; Medical record; Surgery; Cohort; Radiology; Internal medicine","score_opus":0.01490141538520249,"score_gpt":0.2944197453496168,"score_spread":0.2795183299644143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067540771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085207,0.00020117905,0.0000063240514,0.0014124005,0.00037864604,0.0004971688,0.000004711191,0.000033704455,0.08894515],"genre_scores_gemma":[0.9976394,0.00009531319,0.0008117799,0.00050673424,0.00006905449,0.00015099185,0.000008125785,0.000009031026,0.0007095291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983802,0.0003315793,0.000459099,0.00025466166,0.00014355878,0.0004309368],"domain_scores_gemma":[0.9961813,0.0031732915,0.00021297025,0.00018369229,0.00015647692,0.00009224934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061756757,0.00015381609,0.00049918704,0.00008165933,0.00013914624,0.0000047481285,0.00020612475,0.00025750202,0.00045415998],"category_scores_gemma":[0.0025638149,0.000090640184,0.000109757835,0.0002422076,0.0003578324,0.000023490042,0.00011235952,0.00034754156,0.00012344214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006156044,0.0011267938,0.8631228,0.00003349853,0.0000506145,0.00013303942,0.0005002794,0.000020393845,0.010055959,0.014906373,0.00043546036,0.108999155],"study_design_scores_gemma":[0.0012808171,0.0077634593,0.9431023,0.00002244621,0.000038218695,0.000036700752,0.0007695357,0.0005957956,0.0021546716,0.011164163,0.032961838,0.00011006369],"about_ca_topic_score_codex":0.00008722298,"about_ca_topic_score_gemma":0.00069783017,"teacher_disagreement_score":0.10888909,"about_ca_system_score_codex":0.00024979212,"about_ca_system_score_gemma":0.00021023212,"threshold_uncertainty_score":0.49727336},"labels":[],"label_agreement":null},{"id":"W2069079549","doi":"10.1006/gyno.2002.6683","title":"Specific Keynote: Experimental Models of Epithelial Ovarian Carcinogenesis","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Carcinogenesis; Cancer research; Oncology; Internal medicine; Cancer","score_opus":0.12722476769499189,"score_gpt":0.3793157282476406,"score_spread":0.2520909605526487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069079549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013608679,0.9652896,0.00003709271,0.00011742108,0.0016110585,0.002261379,0.00017737923,0.000054347285,0.03031563],"genre_scores_gemma":[0.0019511988,0.9927108,0.002886035,0.00023244867,0.00036348004,0.0010134197,0.0001804863,0.00009205227,0.00057002215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963281,0.00052129047,0.0012574227,0.0009611738,0.00030240437,0.00062958396],"domain_scores_gemma":[0.99733776,0.0006476323,0.0007735534,0.0008523543,0.00011433402,0.0002743663],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038726258,0.00071656733,0.0045944382,0.0003342783,0.000090067995,0.0000113588985,0.00028027306,0.001239736,0.0032051266],"category_scores_gemma":[0.000047186113,0.00053131126,0.0011316412,0.00038598938,0.00025885817,0.000046886038,0.0001300407,0.00043774498,0.000228965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008188161,0.0028022393,0.000039647002,0.0025125158,0.000869293,0.0008434961,0.00009038489,0.0000044514336,0.000011386089,0.0031096828,0.0027415934,0.9868934],"study_design_scores_gemma":[0.0025576008,0.0034965104,0.000084501895,0.00095874845,0.0024165027,0.00045634987,0.00005256599,0.000002612259,0.0001284384,0.00022132107,0.9892295,0.00039532303],"about_ca_topic_score_codex":0.00004323175,"about_ca_topic_score_gemma":0.000007379432,"teacher_disagreement_score":0.9864981,"about_ca_system_score_codex":0.002200693,"about_ca_system_score_gemma":0.0018927935,"threshold_uncertainty_score":0.99971384},"labels":[],"label_agreement":null},{"id":"W2069439270","doi":"10.1016/j.ygyno.2012.11.016","title":"Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières","funders":"Canadian Institutes of Health Research","keywords":"AKT2; Protein kinase B; AKT1; Cancer research; Transfection; Downregulation and upregulation; AKT3; Cisplatin; Gene isoform; Cell growth; PI3K/AKT/mTOR pathway; Cancer cell; Endometrial cancer; Apoptosis; Medicine; Biology; Cell culture; Cancer; Internal medicine; Cell biology; Signal transduction; Biochemistry; Gene","score_opus":0.02244616178491498,"score_gpt":0.2865266658858682,"score_spread":0.26408050410095324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069439270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929136,0.0019719827,0.000114958384,0.000052666095,0.0010703232,0.00033593093,0.000030663658,0.0000064342257,0.0035034453],"genre_scores_gemma":[0.99727637,0.00014428352,0.0018084238,0.00020283423,0.0002706394,0.00007299429,0.000031576885,0.00001543911,0.0001774289],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99834317,0.00014286768,0.00057712465,0.00029013428,0.0001540243,0.00049270515],"domain_scores_gemma":[0.99884623,0.00020642253,0.0004004842,0.0003593233,0.00010166778,0.00008589573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083654985,0.0001766092,0.00048574546,0.0001388218,0.000023519064,0.0000020989405,0.00033312247,0.00040093553,0.00015340942],"category_scores_gemma":[0.0004166857,0.0001578496,0.00012616224,0.00025129897,0.0002406605,0.000006323234,0.00018974936,0.00012046923,0.000006757247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043231333,0.0014278971,0.11703232,0.00007743049,0.00005321149,0.0000052064634,0.00016447507,0.000043965105,0.8755157,0.0001745431,0.0020608152,0.0030121387],"study_design_scores_gemma":[0.004796166,0.002273094,0.02628194,0.000008844432,0.000027136004,0.0000035196508,0.00017994503,0.0000070394135,0.9431955,0.00012184344,0.022918046,0.0001868759],"about_ca_topic_score_codex":0.000059283873,"about_ca_topic_score_gemma":0.0002011599,"teacher_disagreement_score":0.090750374,"about_ca_system_score_codex":0.00019378023,"about_ca_system_score_gemma":0.00026301414,"threshold_uncertainty_score":0.643692},"labels":[],"label_agreement":null},{"id":"W2069743849","doi":"10.1016/j.ygyno.2007.07.016","title":"Methodology of a real-time quality control for the multispectral digital colposcope (MDC)","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Multispectral image; Image quality; Computer vision; Artifact (error); Software; Computer science; Artificial intelligence; Image processing; Medicine; Quality (philosophy); Digital image processing; Medical physics; Image (mathematics)","score_opus":0.06291309608711848,"score_gpt":0.3967326545580914,"score_spread":0.33381955847097294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069743849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85945207,0.00034078257,0.045052744,0.0053147525,0.0010061694,0.0030978832,0.00022800006,0.00022296066,0.08528462],"genre_scores_gemma":[0.9851378,0.000025697324,0.012809556,0.0010746715,0.00017623116,0.00008183363,0.000029074658,0.000017879045,0.00064723106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99792653,0.00020023032,0.00071993325,0.00034842308,0.00016157227,0.00064329256],"domain_scores_gemma":[0.9801385,0.01880215,0.00035213333,0.0003280028,0.00022584335,0.00015341677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032566404,0.00020431857,0.00091505796,0.00015907093,0.00010716952,0.00001736572,0.00023542214,0.0002682248,0.0001648284],"category_scores_gemma":[0.0034382667,0.00013235268,0.00040053995,0.0002976609,0.00070344284,0.00011622808,0.000051321193,0.0002255623,0.000022955235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011986969,0.0029345031,0.08669823,0.00020600075,0.0014896311,0.00027741032,0.00069779344,0.000033070977,0.059814464,0.021117242,0.0041133068,0.8106314],"study_design_scores_gemma":[0.016959956,0.013699075,0.9153932,0.000034788558,0.00079944066,0.0008482672,0.0016246194,0.00054028194,0.0036649336,0.0077806185,0.038185798,0.00046904248],"about_ca_topic_score_codex":0.000075540425,"about_ca_topic_score_gemma":0.0000701668,"teacher_disagreement_score":0.82869494,"about_ca_system_score_codex":0.00015400194,"about_ca_system_score_gemma":0.0002429773,"threshold_uncertainty_score":0.53971857},"labels":[],"label_agreement":null},{"id":"W2070417569","doi":"10.1006/gyno.2000.5750","title":"Urolithiasis Following Formation of a Continent Urostomy: Case Report and Review of the Literature","year":2000,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Surgery; Complication; Laparotomy; Urinary diversion; Pouch; Lithotripsy; Urinary system; General surgery; Cystectomy; Cancer; Internal medicine","score_opus":0.03167669363182417,"score_gpt":0.36110412429427236,"score_spread":0.3294274306624482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070417569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014928539,0.99193984,6.220093e-7,0.0007451641,0.00039910822,0.0025238884,0.00011337241,0.000020840194,0.0027642797],"genre_scores_gemma":[0.0006151626,0.9970317,0.00024488597,0.0010092744,0.000051803785,0.0002072338,0.00015031232,0.000026140795,0.0006634933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696594,0.00051160314,0.0016133856,0.00040588187,0.00022692002,0.00027625044],"domain_scores_gemma":[0.9968685,0.000488557,0.0016508431,0.00070501165,0.00015385162,0.00013321724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006219109,0.00040049877,0.0034470565,0.00015297916,0.000080121994,0.000006027484,0.0001439749,0.00066426815,0.00011797484],"category_scores_gemma":[0.0013211744,0.00021498083,0.0011012577,0.0004943057,0.00013164057,0.000058730933,0.00012900305,0.00047016854,0.0000045372017],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002443619,0.00037383483,0.0002731602,0.11058505,0.00046929644,0.02825145,0.00015991401,1.9400737e-8,4.3166543e-7,0.000019372825,0.0011701735,0.85867286],"study_design_scores_gemma":[0.0006676768,0.00062961155,0.00024332054,0.050986186,0.0051481547,0.15188375,0.000014268682,5.4297647e-7,0.0000014469167,0.000012708039,0.7902882,0.00012415057],"about_ca_topic_score_codex":0.000014375423,"about_ca_topic_score_gemma":0.0000040782697,"teacher_disagreement_score":0.8585487,"about_ca_system_score_codex":0.00026998096,"about_ca_system_score_gemma":0.00081283855,"threshold_uncertainty_score":0.87666637},"labels":[],"label_agreement":null},{"id":"W2070821176","doi":"10.1016/j.ygyno.2015.01.551","title":"Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Genotyping; Genotype; Cervical cancer; Cervical intraepithelial neoplasia; Gynecology; Population; Cytology; Cancer; Internal medicine; Obstetrics; Pathology; Genetics; Biology","score_opus":0.12341755769710044,"score_gpt":0.3937065127747227,"score_spread":0.27028895507762224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070821176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498004,0.0018296425,0.00005445366,0.0004010114,0.00015032817,0.0009130886,0.0010699525,0.000022652514,0.0005788614],"genre_scores_gemma":[0.9977521,0.0010649706,0.00053155166,0.0001180619,0.00019069832,0.000047060035,0.00023434794,0.000011693415,0.000049529892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720293,0.0010857609,0.0005871365,0.00042145816,0.0003682952,0.00033443296],"domain_scores_gemma":[0.99631,0.0023427375,0.0004124701,0.00059542723,0.0001947064,0.00014467596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023181972,0.00013558002,0.0006666817,0.00007060611,0.00012229245,0.0000070408028,0.0004197778,0.0003177507,0.0014173487],"category_scores_gemma":[0.0052241078,0.00009016595,0.000054733868,0.00026415708,0.00023111106,0.00006748931,0.00060880714,0.0005671393,0.000004738393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008440136,0.0008407332,0.9318746,0.000048334772,0.00015097395,0.00001762718,0.00054609013,0.000026781512,0.000059169564,0.0001308226,0.00044262773,0.057422157],"study_design_scores_gemma":[0.0272559,0.003630699,0.96495813,0.000021728578,0.00031499335,0.0000014723886,0.00018877143,0.0007380713,0.000026356553,0.0022209457,0.00055963587,0.0000832663],"about_ca_topic_score_codex":0.027841639,"about_ca_topic_score_gemma":0.050360285,"teacher_disagreement_score":0.057338893,"about_ca_system_score_codex":0.00023499213,"about_ca_system_score_gemma":0.00031249216,"threshold_uncertainty_score":0.9994955},"labels":[],"label_agreement":null},{"id":"W2072389101","doi":"10.1016/j.ygyno.2005.12.031","title":"Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Neutropenia; Toxicity; Internal medicine; Febrile neutropenia; Gastroenterology; Ovarian cancer; Population; Chemotherapy; Phases of clinical research; Surgery; Cancer; Oncology","score_opus":0.016617943977690612,"score_gpt":0.2809942957040493,"score_spread":0.2643763517263587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072389101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956849,0.0003835128,0.00016316815,0.0009372631,0.000561494,0.00046552118,0.000026075866,0.0000105922,0.0017674448],"genre_scores_gemma":[0.9978016,0.00013073972,0.0007922886,0.0007498252,0.00012813899,0.0000726661,0.000009901765,0.000013118293,0.00030170183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988067,0.00014297635,0.00030472648,0.00036312483,0.00009101069,0.0002914426],"domain_scores_gemma":[0.9993932,0.00006755446,0.00017732922,0.0002845437,0.000040425835,0.00003693808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031273064,0.00015714823,0.00025839763,0.00003680707,0.00005006233,0.0000053228578,0.00024226129,0.00031364945,0.00007972603],"category_scores_gemma":[0.00011645689,0.00011602624,0.00007299369,0.00011446141,0.00017717938,0.000002149181,0.00020816478,0.00013935486,0.0000022835718],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014364216,0.0006084838,0.0031752153,0.000013507424,0.000027989445,0.0000024407416,0.000041169158,0.00012244175,0.9802178,0.00043957625,0.00021402395,0.0149936825],"study_design_scores_gemma":[0.0038929088,0.0014054328,0.19392209,0.000016741205,0.000047248173,0.000022014061,0.000032180382,0.00017269145,0.7604342,0.000817233,0.038992893,0.00024435887],"about_ca_topic_score_codex":0.000119535485,"about_ca_topic_score_gemma":0.0016062101,"teacher_disagreement_score":0.21978362,"about_ca_system_score_codex":0.00011280912,"about_ca_system_score_gemma":0.00018600938,"threshold_uncertainty_score":0.47314125},"labels":[],"label_agreement":null},{"id":"W2072468007","doi":"10.1016/j.ygyno.2010.12.333","title":"Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Autofluorescence; Fallopian tube; Occult; Epithelium; Pathology; Narrow-band imaging; Radiology; Gynecology; Endoscopy; Optics","score_opus":0.07394357259399684,"score_gpt":0.34897690703052553,"score_spread":0.27503333443652866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072468007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923782,0.00024477908,0.00089312054,0.002153696,0.00038877316,0.0013397095,0.000010166041,0.00011391179,0.0024776643],"genre_scores_gemma":[0.9798908,0.00037271736,0.018299328,0.0008659607,0.00008778211,0.00030483832,0.0000052047585,0.000024481877,0.00014886167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766314,0.00027212437,0.0006779719,0.0006836959,0.0001690857,0.00053401134],"domain_scores_gemma":[0.99859357,0.00047509684,0.00025772443,0.00028952345,0.00013761906,0.00024644888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066800683,0.0002581256,0.0006537531,0.0002204734,0.00016988392,0.000031820153,0.00013499938,0.00028037187,0.00022701915],"category_scores_gemma":[0.0009883511,0.00019374656,0.00010499309,0.0002759625,0.000236649,0.00012986804,0.00015496057,0.00044442865,0.000012860377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056591176,0.00055020995,0.5174568,0.00004270247,0.000086586515,0.0014338421,0.001608578,0.0000017641366,0.0005575351,0.000046292756,0.00003901822,0.4776107],"study_design_scores_gemma":[0.004446241,0.0040826327,0.98754877,0.00019852062,0.00022485564,0.00025211758,0.0007309757,0.00028001936,0.0010933641,0.00019258662,0.00074135355,0.00020858513],"about_ca_topic_score_codex":0.0023662727,"about_ca_topic_score_gemma":0.0060806405,"teacher_disagreement_score":0.47740212,"about_ca_system_score_codex":0.0005687894,"about_ca_system_score_gemma":0.00063550787,"threshold_uncertainty_score":0.79007554},"labels":[],"label_agreement":null},{"id":"W2072622889","doi":"10.1016/j.ygyno.2008.05.010","title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; BC Cancer Agency; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Fallopian tube; Serous carcinoma; Serous fluid; Salpingectomy; Pathology; Medicine; Mucinous carcinoma; Cystadenocarcinoma; Ovarian carcinoma; Carcinoma; Ovarian cancer; Gynecology; Adenocarcinoma; Biology; Internal medicine; Cancer; Pregnancy","score_opus":0.03237494038853245,"score_gpt":0.28247338832374574,"score_spread":0.2500984479352133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072622889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203587,0.0017202953,0.000010361036,0.001974595,0.00025893006,0.0016134206,0.00014277997,0.000041706127,0.0022020214],"genre_scores_gemma":[0.99628997,0.0005565907,0.0024445204,0.00028033665,0.00007148902,0.00023007921,0.000049760503,0.000027698552,0.00004954108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682796,0.0004250164,0.0010075194,0.0008655863,0.00025942407,0.00061452313],"domain_scores_gemma":[0.99786705,0.00068045367,0.00033747507,0.0005822513,0.00018822747,0.00034452617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045878196,0.00041398473,0.0015060626,0.0002118492,0.00014413007,0.000006948814,0.00017217548,0.0005395484,0.00020701886],"category_scores_gemma":[0.00030223656,0.00035708724,0.00014729067,0.00030700944,0.0009027988,0.00010651521,0.00023044465,0.00040489517,0.0000032109103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044829163,0.0027869523,0.9805564,0.0003650211,0.00015178163,0.0011749945,0.0017148944,0.000018284156,0.0006195079,0.0008908091,0.000058436086,0.01121461],"study_design_scores_gemma":[0.007374398,0.007266237,0.9812845,0.000054678305,0.00023654188,0.00086790713,0.00036297366,0.0002018222,0.0011477362,0.00031389948,0.0006284433,0.00026088383],"about_ca_topic_score_codex":0.0053548245,"about_ca_topic_score_gemma":0.0073793577,"teacher_disagreement_score":0.010953726,"about_ca_system_score_codex":0.001032501,"about_ca_system_score_gemma":0.0013169689,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W2073364823","doi":"10.1016/j.ygyno.2006.10.052","title":"AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation","funders":"National Cancer Institute; Terry Fox Foundation","keywords":"Imatinib mesylate; Wortmannin; Imatinib; Medicine; Ovarian cancer; Cancer research; Protein kinase B; Cell growth; Pharmacology; Apoptosis; Cancer; Internal medicine; Biology","score_opus":0.01654087820117539,"score_gpt":0.3226925712631955,"score_spread":0.3061516930620201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073364823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949018,0.00014781013,0.00002255382,0.0028423956,0.000099930316,0.0012331234,0.000020500724,0.00000875255,0.0007231868],"genre_scores_gemma":[0.99770045,0.00003385594,0.0017931552,0.00017272582,0.00003402525,0.00015533996,0.0000029103119,0.000008086102,0.00009946367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861234,0.00030737463,0.00031110752,0.00023572403,0.00017025258,0.0003631878],"domain_scores_gemma":[0.99745876,0.0020217283,0.00014743359,0.00017064667,0.00010015526,0.0001012604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059678266,0.00013928214,0.0005736046,0.00010083802,0.000031893826,0.0000032347587,0.00006040397,0.00007202469,0.000052683707],"category_scores_gemma":[0.00063377153,0.00008199985,0.000053867567,0.00018517699,0.000217754,0.000017699209,0.000105651416,0.00016572939,0.000006692021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009769589,0.0018100748,0.53541034,0.0006874984,0.00009960788,0.0037623304,0.0007704644,0.000034636436,0.4242495,0.00018164325,0.00045119892,0.03156575],"study_design_scores_gemma":[0.002381556,0.0053876564,0.7780115,0.00010485942,0.00008016761,0.00011704797,0.00009288584,0.00017928977,0.21307953,0.00034073135,0.00015844576,0.000066338864],"about_ca_topic_score_codex":0.0023323626,"about_ca_topic_score_gemma":0.0032422745,"teacher_disagreement_score":0.24260116,"about_ca_system_score_codex":0.00015079536,"about_ca_system_score_gemma":0.0002287263,"threshold_uncertainty_score":0.35258502},"labels":[],"label_agreement":null},{"id":"W2073770980","doi":"10.1016/j.ygyno.2004.01.028","title":"Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"","keywords":"Medicine; Acis; Colposcopy; Hysterectomy; Endocervical curettage; Surgery; Cervix; Dysplasia; Retrospective cohort study; Cervical cancer; Internal medicine; Cancer","score_opus":0.06529013233571804,"score_gpt":0.3954296871087526,"score_spread":0.3301395547730346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073770980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93485785,0.00026766234,0.0022778045,0.024573276,0.00019730053,0.0026704005,0.000044109922,0.000118111064,0.0349935],"genre_scores_gemma":[0.9910375,0.0002543416,0.0030670422,0.003197614,0.00023898183,0.00063861464,0.000049943923,0.000026259153,0.001489708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977992,0.000082719096,0.0003258938,0.00062555826,0.0003439803,0.0008226079],"domain_scores_gemma":[0.99795765,0.00094619626,0.00008062635,0.0003073302,0.00032709906,0.00038107776],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027667536,0.00026046636,0.00072445505,0.00013328045,0.0001900327,0.000019075147,0.00014485372,0.00035545175,0.005840258],"category_scores_gemma":[0.00024398834,0.00015805764,0.00020793274,0.00035492756,0.00028641883,0.000038768452,0.00006970275,0.00032108554,0.00016674836],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.091189615,0.040171362,0.041388914,0.0006266273,0.0018368226,0.00484603,0.0069295126,0.0009319702,0.005155067,0.02721776,0.011705619,0.7680007],"study_design_scores_gemma":[0.06416309,0.19872525,0.45218605,0.000029920702,0.0005201386,0.00059557095,0.0012155111,0.000722627,0.014371275,0.006775157,0.26001003,0.0006853564],"about_ca_topic_score_codex":0.00009425581,"about_ca_topic_score_gemma":0.00054220343,"teacher_disagreement_score":0.7673153,"about_ca_system_score_codex":0.002734211,"about_ca_system_score_gemma":0.0012543877,"threshold_uncertainty_score":0.99506855},"labels":[],"label_agreement":null},{"id":"W2074141001","doi":"10.1016/s0090-8258(02)00144-0","title":"Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hamilton Regional Laboratory Medicine Program; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Toxicity; Internal medicine; Cancer; Phases of clinical research; Oncology; Gastroenterology; Ovary","score_opus":0.14226297164992605,"score_gpt":0.46476003455572107,"score_spread":0.32249706290579505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074141001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992545,0.00044141692,0.00006132667,0.00007375734,0.002757684,0.0029385923,0.00008717308,0.000027545615,0.0010674794],"genre_scores_gemma":[0.9977227,0.00028801974,0.00031103592,0.00026155447,0.00047318407,0.00071115355,0.00008400307,0.000032889126,0.00011549464],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9873453,0.008283091,0.0022348699,0.0011972211,0.0002633047,0.00067623064],"domain_scores_gemma":[0.99704796,0.0007277425,0.0009113695,0.00087352697,0.00016155576,0.0002778376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010042926,0.00042761312,0.0017181807,0.00020720108,0.00018763104,0.000015444699,0.00058737205,0.00080535916,0.00046412548],"category_scores_gemma":[0.0052855313,0.00036077475,0.00026708408,0.000329828,0.00018135166,0.000012148512,0.00030159496,0.0005136599,0.000013764506],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070199673,0.21362042,0.28724322,0.00005535824,0.0010924246,0.0005036649,0.0043967725,0.00008145636,0.09355678,0.0005696456,0.0022132962,0.38964698],"study_design_scores_gemma":[0.10219235,0.64521605,0.14502421,0.000027059988,0.00094014016,0.0000530792,0.018761134,0.00007505985,0.009066974,0.0008235805,0.0763303,0.0014900782],"about_ca_topic_score_codex":0.0003128722,"about_ca_topic_score_gemma":0.010540318,"teacher_disagreement_score":0.4315956,"about_ca_system_score_codex":0.00015659088,"about_ca_system_score_gemma":0.0007462316,"threshold_uncertainty_score":0.9998844},"labels":[],"label_agreement":null},{"id":"W2075021378","doi":"10.1006/gyno.2000.6097","title":"Recurrent Metastatic Fallopian Tube Carcinoma in Pregnancy","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Fallopian tube; Fallopian tube cancer; Carboplatin; Pregnancy; Laparotomy; Chemotherapy; Surgery; Carcinoma; Asymptomatic; Gynecology; Ovarian cancer; Cancer; Cisplatin; Internal medicine","score_opus":0.05266140451056141,"score_gpt":0.34107674936985305,"score_spread":0.28841534485929166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075021378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9274632,0.003763771,0.000020846897,0.009985072,0.00082827045,0.0012299359,0.000007979258,0.00007027838,0.056630675],"genre_scores_gemma":[0.994311,0.0015115415,0.0014275453,0.0012356214,0.000073892086,0.0005826697,0.000031508014,0.000016535432,0.0008097061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983325,0.0001629883,0.00040991325,0.00045250868,0.00013866351,0.00050342386],"domain_scores_gemma":[0.99901587,0.00034255785,0.00010495924,0.00031230348,0.000054372955,0.00016993014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019185831,0.00020708071,0.00062766095,0.00017770137,0.00004948764,0.000008288195,0.00010590677,0.00015234547,0.0019518111],"category_scores_gemma":[0.00018809234,0.00016124816,0.00011259747,0.00032685837,0.000080530444,0.00004990503,0.000058052472,0.0002497332,0.00019906483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016766634,0.0025746033,0.6749032,0.000048632435,0.00008937295,0.0059849643,0.00026249868,0.000016187121,0.000020476115,0.0013957672,0.0014290704,0.31310752],"study_design_scores_gemma":[0.0063438867,0.0056590885,0.87495404,0.00010276467,0.00019051098,0.0003609569,0.00019326882,0.000115646304,0.000071386225,0.0008488384,0.11098809,0.0001715343],"about_ca_topic_score_codex":0.0001325801,"about_ca_topic_score_gemma":0.0015378809,"teacher_disagreement_score":0.31293598,"about_ca_system_score_codex":0.0010864593,"about_ca_system_score_gemma":0.00040575152,"threshold_uncertainty_score":0.99896055},"labels":[],"label_agreement":null},{"id":"W2075405774","doi":"10.1016/j.ygyno.2012.01.035","title":"A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Sexual arousal; Medicine; Mindfulness; Distress; Clinical psychology; Sexual dysfunction; Mood; Generalizability theory; Intervention (counseling); Cognition; Arousal; Psychiatry; Psychology; Developmental psychology; Sexual behavior","score_opus":0.04637354204009562,"score_gpt":0.3660696457848054,"score_spread":0.31969610374470975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075405774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143296,0.00047489253,0.0008304685,0.00057460455,0.0036220523,0.0019184509,0.0001707445,0.00013279864,0.00084303966],"genre_scores_gemma":[0.9885796,0.0000034385878,0.000048020494,0.0018052327,0.00039970718,0.008239241,0.00023556528,0.00003528524,0.0006539599],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973801,0.00032183138,0.000549301,0.0005215277,0.00016588005,0.0010613694],"domain_scores_gemma":[0.99720263,0.0017615595,0.0003096454,0.00018334627,0.0002775561,0.00026524637],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000868417,0.0003314871,0.000845215,0.0002571837,0.00015804016,0.000022415987,0.00011375513,0.00058195,0.0021549105],"category_scores_gemma":[0.00069834036,0.0002969306,0.00019380773,0.0003426461,0.00022899742,0.0001691716,0.00004531859,0.0004080994,0.00001840056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037511494,0.005766265,0.31202182,0.0002761432,0.00039107454,0.00012520912,0.0020177194,0.000028050197,0.0017375462,0.00009497412,0.0009784027,0.6390513],"study_design_scores_gemma":[0.13235146,0.070009,0.7176399,0.00018782323,0.0022721116,0.00004455532,0.033824448,0.0014890213,0.004729987,0.00014386952,0.03598004,0.0013277484],"about_ca_topic_score_codex":0.0023154144,"about_ca_topic_score_gemma":0.020860484,"teacher_disagreement_score":0.63772357,"about_ca_system_score_codex":0.0028712754,"about_ca_system_score_gemma":0.00044563695,"threshold_uncertainty_score":0.99994826},"labels":[],"label_agreement":null},{"id":"W2075560868","doi":"10.1016/j.ygyno.2007.01.036","title":"Retrieval of immature oocytes followed by in vitro maturation and vitrification: A case report on a new strategy of fertility preservation in women with borderline ovarian malignancy","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Fertility preservation; Medicine; In vitro maturation; Ovary; Laparotomy; Andrology; Cryopreservation; Menstrual cycle; Fertility; Gynecology; Urology; Surgery; Oocyte; Biology; Internal medicine; Embryo; Population; Hormone","score_opus":0.020760754014153993,"score_gpt":0.3072636550460342,"score_spread":0.2865029010318802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075560868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669266,0.00032481083,0.00016128247,0.0013017866,0.00007513667,0.0009836437,0.000008873675,0.000015891253,0.0004359267],"genre_scores_gemma":[0.9985186,0.000019659645,0.0010847944,0.000102800754,0.000026108688,0.00002541759,0.00007786196,0.0000060231414,0.00013877117],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981791,0.00021581822,0.0007583056,0.0004808802,0.00011438934,0.0002515578],"domain_scores_gemma":[0.9985419,0.00040230344,0.00043267946,0.00036144367,0.00018630062,0.00007538086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020604283,0.00014516496,0.0005775082,0.00015406328,0.000026444075,0.0000023488142,0.000055229,0.0004635319,0.00003847156],"category_scores_gemma":[0.0016816651,0.00010939967,0.000024164425,0.00046203824,0.00018643179,0.00009802365,0.000021015006,0.00031909737,3.2513748e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41200662,0.0022195496,0.08477226,0.00019537138,0.000077922356,0.005923597,0.00113417,0.000014028771,0.47388658,0.000061101025,0.00011267669,0.019596124],"study_design_scores_gemma":[0.003239424,0.0035589454,0.9380522,0.00002150031,0.00002343385,0.0009362652,0.00046900607,0.000030838153,0.052827243,0.000578627,0.00018049194,0.000082018865],"about_ca_topic_score_codex":0.00026550144,"about_ca_topic_score_gemma":0.00042980633,"teacher_disagreement_score":0.85327995,"about_ca_system_score_codex":0.0003025851,"about_ca_system_score_gemma":0.00039433214,"threshold_uncertainty_score":0.4461189},"labels":[],"label_agreement":null},{"id":"W2075788740","doi":"10.1016/j.ygyno.2005.09.048","title":"Insulin-like growth factor receptor I targeting in epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Insulin-like growth factor; Epithelial ovarian cancer; Cancer research; Ovarian cancer; Oncology; Growth factor; Receptor; Cancer; Internal medicine","score_opus":0.023151451142766725,"score_gpt":0.2971058502792706,"score_spread":0.2739543991365039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075788740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97343415,0.001372666,0.000046850084,0.011633678,0.0020944965,0.00092750974,0.000066828165,0.0002401586,0.010183633],"genre_scores_gemma":[0.98326355,0.0015214995,0.005365445,0.0072487644,0.0012791769,0.00023820305,0.00008343682,0.00005846726,0.00094146223],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.996428,0.0003142766,0.0010274616,0.00078817114,0.00032813576,0.0011139548],"domain_scores_gemma":[0.9981186,0.0005957789,0.00031764325,0.00033549085,0.00023378996,0.00039874428],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006346743,0.00045572803,0.00106593,0.00043802997,0.00016108649,0.000021266731,0.00032389906,0.0008773346,0.004617761],"category_scores_gemma":[0.0013030122,0.00038415633,0.00021080118,0.000651695,0.0002106183,0.00025964025,0.00016785577,0.0010617966,0.0008461685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022730043,0.004090144,0.5907634,0.00020655156,0.0003801783,0.0006557263,0.0046903403,0.00007083298,0.09805329,0.0015966296,0.07818719,0.21903275],"study_design_scores_gemma":[0.008852401,0.0027456544,0.46842143,0.000046825306,0.00010580765,0.00004853516,0.00047123412,0.00028381182,0.0072499,0.00032380203,0.51075524,0.0006953738],"about_ca_topic_score_codex":0.00046674366,"about_ca_topic_score_gemma":0.00041243684,"teacher_disagreement_score":0.43256804,"about_ca_system_score_codex":0.0016121254,"about_ca_system_score_gemma":0.0008487463,"threshold_uncertainty_score":0.9999318},"labels":[],"label_agreement":null},{"id":"W2075850662","doi":"10.1016/j.ygyno.2014.02.037","title":"The association between cervical cancer screening and mortality from cervical cancer: A population based case–control study","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cervical cancer; Odds ratio; Conditional logistic regression; Cancer; Logistic regression; Gynecology; Obstetrics; Mortality rate; Population; Internal medicine","score_opus":0.05209445940606961,"score_gpt":0.39523486349074266,"score_spread":0.34314040408467306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075850662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861125,0.00042474503,0.00041232182,0.009922024,0.0003273015,0.0012631299,0.00015567282,0.00008478388,0.0012975456],"genre_scores_gemma":[0.99614114,0.000057711088,0.00012242317,0.0019416341,0.0011047539,0.0004870602,0.000045193192,0.000020149175,0.000079944664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965347,0.0012445906,0.00052387157,0.00055259553,0.0005437072,0.0006005464],"domain_scores_gemma":[0.99269265,0.006151281,0.0002388526,0.0003274749,0.00028489745,0.00030486856],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021798112,0.00021478321,0.00075977994,0.000069590445,0.000527508,0.000058619557,0.00016046909,0.00043188003,0.002539802],"category_scores_gemma":[0.0014620231,0.00014684768,0.00011191317,0.00023940152,0.00009012066,0.000060001643,0.00011688437,0.000714846,0.000011168077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002688682,0.00016202177,0.7653115,0.000018232002,0.00031105656,0.00007577411,0.00007960752,0.000039849132,0.0000071451627,0.000024534549,0.000103271275,0.23359817],"study_design_scores_gemma":[0.0059881364,0.0015157234,0.9797231,0.0000060508924,0.0008940392,0.0000062050012,0.00019705549,0.007207204,0.000005958842,0.0003923496,0.0039108586,0.00015333774],"about_ca_topic_score_codex":0.03094011,"about_ca_topic_score_gemma":0.10688083,"teacher_disagreement_score":0.23344482,"about_ca_system_score_codex":0.0013396806,"about_ca_system_score_gemma":0.00026809474,"threshold_uncertainty_score":0.998372},"labels":[],"label_agreement":null},{"id":"W2076119228","doi":"10.1016/j.ygyno.2014.12.003","title":"Mucinous metaplasia of the endometrium: Current concepts","year":2014,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Mucinous carcinoma; Pathology; Metaplasia; Biopsy; Malignancy; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.09314412137678901,"score_gpt":0.4398528241334739,"score_spread":0.34670870275668486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076119228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005944202,0.9769771,0.000008585126,0.00014631452,0.0040610563,0.0023376062,0.00006880051,0.000051350726,0.016289705],"genre_scores_gemma":[0.0010831624,0.99657184,0.00016171698,0.0002808947,0.00049277325,0.0004603988,0.00007970443,0.000040135747,0.00082937843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614877,0.0010028565,0.0012720183,0.0006193016,0.00041421162,0.0005428764],"domain_scores_gemma":[0.9931126,0.004417834,0.0012751404,0.0008041646,0.00017189786,0.00021832442],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066066225,0.0005475594,0.0052674096,0.0003914848,0.00008900045,0.0000067064584,0.00058257615,0.0008088685,0.0015957903],"category_scores_gemma":[0.003127694,0.00026935508,0.0016927584,0.0015161922,0.00040469796,0.000019942234,0.0003294747,0.00094586355,0.0002900459],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044967797,0.0006833021,0.00011212157,0.007150248,0.00057412416,0.00003379101,0.000014942739,1.5489378e-7,5.638086e-7,0.00031556768,0.0013028958,0.9897673],"study_design_scores_gemma":[0.0028829107,0.002861046,0.00033064035,0.0014463095,0.0059306533,0.00018808858,0.000008394637,3.8610244e-7,0.0000068532213,0.00013171618,0.9860053,0.00020769618],"about_ca_topic_score_codex":0.000021586115,"about_ca_topic_score_gemma":0.000021704724,"teacher_disagreement_score":0.98955965,"about_ca_system_score_codex":0.001039832,"about_ca_system_score_gemma":0.001465709,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W2076910309","doi":"10.1016/j.ygyno.2010.10.015","title":"Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Fulvestrant; Response Evaluation Criteria in Solid Tumors; Internal medicine; Oncology; Carcinoma; Gynecologic oncology; Progressive disease; Estrogen receptor; Endometrial cancer; Phases of clinical research; Gastroenterology; Chemotherapy; Cancer; Breast cancer","score_opus":0.022097255103753596,"score_gpt":0.33752202426478634,"score_spread":0.31542476916103274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076910309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911047,0.00043363645,0.000010899347,0.00009645075,0.0027427343,0.0039702994,0.000024770476,0.00004228233,0.0015742346],"genre_scores_gemma":[0.99802047,0.00008149137,0.0006630157,0.00009914189,0.00023679137,0.0006828395,0.000095617725,0.000040366882,0.00008029335],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99450856,0.0018279325,0.0013057187,0.0011470843,0.00028999776,0.00092072476],"domain_scores_gemma":[0.99719167,0.00095591554,0.0006682302,0.0007725192,0.00015637647,0.0002553175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023367242,0.00053770863,0.0013555083,0.00055268296,0.00023822697,0.000015067413,0.00076101266,0.00093268993,0.00022751435],"category_scores_gemma":[0.0021007368,0.0004486099,0.00023774887,0.00078298314,0.0003839974,0.0000141703895,0.0006056453,0.001319031,0.000024589943],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007007735,0.2711017,0.07351098,0.000055716962,0.0008111999,0.002754814,0.0033715228,0.00007348083,0.5126617,0.0001342967,0.0006749401,0.12784192],"study_design_scores_gemma":[0.09710591,0.8192121,0.054131977,0.0000072767216,0.0006380073,0.0002934138,0.009210636,0.00012986867,0.006838348,0.00022598034,0.011267204,0.0009392864],"about_ca_topic_score_codex":0.0001769424,"about_ca_topic_score_gemma":0.00446791,"teacher_disagreement_score":0.54811037,"about_ca_system_score_codex":0.00018241916,"about_ca_system_score_gemma":0.00053607294,"threshold_uncertainty_score":0.99979657},"labels":[],"label_agreement":null},{"id":"W2077169940","doi":"10.1016/s0090-8258(02)00090-2","title":"Women’s perceptions about treatment decision making for ovarian cancer","year":2003,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Foundation for Healthcare Improvement; McMaster University; Western University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Gynecology; Ovarian cancer; Oncology; Cancer; Family medicine; Internal medicine","score_opus":0.25944130977841606,"score_gpt":0.49057560869558786,"score_spread":0.2311342989171718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077169940","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010547549,0.004017128,0.00088290474,0.93062234,0.020368077,0.014363937,0.0017826778,0.0005787211,0.016836641],"genre_scores_gemma":[0.008643556,0.0021630272,0.019524166,0.87312204,0.003386065,0.08136045,0.00084004685,0.000176773,0.010783857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907102,0.003737117,0.0018272618,0.0011604392,0.00032870303,0.002236266],"domain_scores_gemma":[0.97964907,0.015999412,0.0015750288,0.0018005606,0.00075778604,0.00021816739],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00065041217,0.0007116616,0.0015823098,0.00046420612,0.00272422,0.000020567471,0.000992756,0.0050380295,0.014936795],"category_scores_gemma":[0.0020182,0.0006072913,0.00032874136,0.00030635175,0.0002295119,0.000099761295,0.00032634617,0.003678652,0.0009129861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012931922,0.00018554105,0.005652768,0.00042073714,0.000138926,0.000041320618,0.009206293,0.000019754023,0.0000029547602,0.00018347013,0.91501844,0.0690005],"study_design_scores_gemma":[0.0025678521,0.0018850677,0.0051928484,0.00028409457,0.00014015574,0.000007705991,0.008022866,0.00006135173,2.0527159e-7,0.0047774976,0.97654265,0.00051768863],"about_ca_topic_score_codex":0.0005169321,"about_ca_topic_score_gemma":0.003451021,"teacher_disagreement_score":0.06848281,"about_ca_system_score_codex":0.025772564,"about_ca_system_score_gemma":0.00557506,"threshold_uncertainty_score":0.99986494},"labels":[],"label_agreement":null},{"id":"W2077422669","doi":"10.1016/j.ygyno.2010.05.005","title":"A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Carboplatin; Erlotinib; Medicine; Ovarian cancer; Internal medicine; Oncology; Progressive disease; Chemotherapy; Epidermal growth factor receptor; Cancer; Cisplatin","score_opus":0.016665746575817732,"score_gpt":0.31674435591680217,"score_spread":0.30007860934098446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077422669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410504,0.00003199049,0.0000022741037,0.0011065617,0.0005274997,0.003370464,0.000043862263,0.000024843024,0.00078749243],"genre_scores_gemma":[0.9980149,0.000016095779,0.00047256763,0.00016553474,0.000051325922,0.0011604716,0.00005792142,0.00002384634,0.00003729752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797016,0.00019655796,0.0005628195,0.00053340854,0.0003060012,0.00043104507],"domain_scores_gemma":[0.9987141,0.00024766283,0.00039475426,0.0003244029,0.00019840186,0.00012066054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040063908,0.00027013774,0.000830949,0.00032743218,0.000072993294,0.000006120288,0.00012833964,0.00024360215,0.00035836425],"category_scores_gemma":[0.0001310237,0.0001871617,0.000036919086,0.00050345855,0.00012480121,0.00007293828,0.000076419834,0.00056380045,0.000003738873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045101075,0.06184781,0.8382408,0.00003188193,0.00015218346,0.0001809321,0.0028414573,0.000040500006,0.000100512465,0.00010237228,0.00007549646,0.09187596],"study_design_scores_gemma":[0.087224275,0.09968347,0.81147885,0.00007591653,0.00018911387,0.000004103481,0.00040929765,0.000051307663,0.000113303635,0.000057962923,0.0005495017,0.00016291327],"about_ca_topic_score_codex":0.001822634,"about_ca_topic_score_gemma":0.050836593,"teacher_disagreement_score":0.09171305,"about_ca_system_score_codex":0.00074650516,"about_ca_system_score_gemma":0.000672931,"threshold_uncertainty_score":0.9664832},"labels":[],"label_agreement":null},{"id":"W2077515066","doi":"10.1016/j.ygyno.2010.11.015","title":"Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institutes of Health","keywords":"Medicine; Oncology; Ovarian cancer; Prostate; Internal medicine; Colorectal cancer; Prostate cancer; Gynecology; Cancer","score_opus":0.02926786420893145,"score_gpt":0.35645225734779407,"score_spread":0.3271843931388626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077515066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759673,0.0007814209,0.00023222563,0.013920544,0.0017558604,0.0059204735,0.00018426795,0.00008862862,0.0011492993],"genre_scores_gemma":[0.9796243,0.00020802717,0.009485418,0.0026775529,0.0005738297,0.00718241,0.000072483344,0.00004438355,0.00013164904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970319,0.000304251,0.0006049229,0.00089642976,0.00026205598,0.0009004008],"domain_scores_gemma":[0.99649054,0.0026136066,0.0002753574,0.00030003808,0.00013393952,0.00018651082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017159521,0.00042909884,0.00096585124,0.00021829175,0.00046374748,0.00008602827,0.00024353083,0.0006199912,0.0002727724],"category_scores_gemma":[0.0009790636,0.00029337424,0.00024935298,0.0004260148,0.00024228063,0.00015158876,0.000121899815,0.00086413376,0.000002865272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016972756,0.0017000381,0.75954086,0.00009286393,0.0008031338,0.0022077793,0.0053163692,0.00006293448,0.0041785063,0.0014800703,0.0021465898,0.20549808],"study_design_scores_gemma":[0.07421592,0.0063690017,0.90869576,0.00016062625,0.00087612594,0.00018532047,0.00094292325,0.0005684269,0.000414515,0.00047659222,0.006651004,0.0004437624],"about_ca_topic_score_codex":0.0011101022,"about_ca_topic_score_gemma":0.0066213575,"teacher_disagreement_score":0.20505433,"about_ca_system_score_codex":0.000434459,"about_ca_system_score_gemma":0.0005949494,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W2077520295","doi":"10.1016/j.ygyno.2013.03.021","title":"Ovarian surface epithelium as a source of ovarian cancers: Unwarranted speculation or evidence-based hypothesis?","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Serous fluid; Ovary; Pathology; Metaplasia; Stroma; Epithelium; Biology; Serous carcinoma; Ovarian carcinoma; Mesothelium; Malignant transformation; Ovarian cancer; Medicine; Mesothelial Cell; Immunohistochemistry; Cancer; Endocrinology; Genetics","score_opus":0.1768499433057926,"score_gpt":0.39191442066935583,"score_spread":0.21506447736356324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077520295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000592982,0.9855461,0.00020356184,0.0029680901,0.0011381388,0.006225643,0.00006420242,0.00017369373,0.003087602],"genre_scores_gemma":[0.0020854706,0.98260194,0.00966524,0.0010431269,0.0004289363,0.0012021562,0.00013196935,0.00013252441,0.0027086285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945246,0.0011677815,0.00173957,0.0012404864,0.00049679633,0.0008307718],"domain_scores_gemma":[0.9895286,0.0066188895,0.0018953406,0.0011881599,0.00038428043,0.00038473532],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009234627,0.000950079,0.005077654,0.00040745246,0.00014340231,0.000038748578,0.00046826617,0.0015995223,0.011388246],"category_scores_gemma":[0.0022079276,0.00062246056,0.0010018009,0.00093647966,0.0003469358,0.00013142539,0.0001241633,0.00069849263,0.0009082021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004597388,0.0010912912,0.00033779835,0.008405955,0.0014712268,0.0005592113,0.00009785861,0.000101205595,0.0000103245775,0.00015613074,0.002476026,0.98483324],"study_design_scores_gemma":[0.0034605379,0.0064591644,0.0012426447,0.014170381,0.00656882,0.00028003694,0.00008064482,0.00008555811,0.000045084384,0.00011030579,0.9668891,0.00060776155],"about_ca_topic_score_codex":0.002190663,"about_ca_topic_score_gemma":0.00039778292,"teacher_disagreement_score":0.98422545,"about_ca_system_score_codex":0.0046210173,"about_ca_system_score_gemma":0.0105763255,"threshold_uncertainty_score":0.9998697},"labels":[],"label_agreement":null},{"id":"W2077708976","doi":"10.1016/j.ygyno.2010.12.113","title":"Cooperative regulation of hPygo2 biomarker expression in cervical dysplasia and cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Biomarker; Cervical cancer; Dysplasia; Cancer; Oncology; Internal medicine; Genetics; Biology","score_opus":0.05196578949977551,"score_gpt":0.33931768805103285,"score_spread":0.2873518985512573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077708976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944993,0.00055610767,0.00012757163,0.000120899655,0.00009835901,0.00031043493,0.0000110685,0.0000059868526,0.004270236],"genre_scores_gemma":[0.9988009,0.00022524386,0.0005872964,0.00005880045,0.00002477329,0.000096460775,0.000018775003,0.000008951764,0.0001788385],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988625,0.00029559716,0.00021414594,0.00033079647,0.00007253858,0.00022441005],"domain_scores_gemma":[0.9994805,0.00010257151,0.00008484524,0.00015868634,0.000111844514,0.00006159247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002771125,0.00011029317,0.0002138661,0.00008593796,0.000034778648,0.0000028507652,0.00012023137,0.00029916115,0.000806626],"category_scores_gemma":[0.0003336972,0.00009378384,0.000025799049,0.00011937917,0.0002234865,0.0000055595965,0.00020061557,0.00010786717,0.000004790478],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003821192,0.0001616174,0.15398367,0.000015832446,0.000020861673,0.000009959438,0.0002686387,0.000003544803,0.82896984,0.00014021005,0.00023906401,0.015804654],"study_design_scores_gemma":[0.0007776315,0.0009691309,0.7371419,0.000007941689,0.000005873795,0.0000068717377,0.00012737898,0.000051588617,0.25681987,0.00021283167,0.0037850398,0.000093902854],"about_ca_topic_score_codex":0.00011448669,"about_ca_topic_score_gemma":0.00086513214,"teacher_disagreement_score":0.58315825,"about_ca_system_score_codex":0.00006315592,"about_ca_system_score_gemma":0.00013572493,"threshold_uncertainty_score":0.8831989},"labels":[],"label_agreement":null},{"id":"W2078793238","doi":"10.1016/j.ygyno.2005.03.034","title":"Immunosuppressive activity of proteases in cervical carcinoma","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Consejo Nacional de Ciencia y Tecnología; Terry Fox Foundation","keywords":"Proteases; Collagenase; Medicine; Carcinoma; Cathepsin; Cervix; Cathepsin L; Cancer research; Lymphocyte; Cervical carcinoma; Cervical cancer; Immune system; Squamous carcinoma; Pathology; Cancer; Immunology; Enzyme; Biology; Internal medicine; Biochemistry","score_opus":0.0124541819800379,"score_gpt":0.2729224684098157,"score_spread":0.2604682864297778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078793238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936876,0.00046784713,0.0001041426,0.00045925716,0.00014007585,0.0004759972,0.000014698663,0.000010789357,0.004639565],"genre_scores_gemma":[0.9979175,0.000046203288,0.0011582025,0.00032164095,0.00018896305,0.0001749702,0.000019950001,0.000010501172,0.000162098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880993,0.00022194267,0.0002540118,0.00032586887,0.00008240675,0.00030581947],"domain_scores_gemma":[0.9993919,0.00005309108,0.00015223162,0.0002828523,0.000059204962,0.000060721122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022641887,0.0001433768,0.00028310253,0.00006206269,0.000035651716,0.000003517998,0.00022249995,0.00038888602,0.00020185974],"category_scores_gemma":[0.0002643907,0.0001288495,0.00008882628,0.00008362579,0.00011045306,0.0000067566953,0.00019972758,0.00016214688,0.00002062236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002733632,0.0006111701,0.0043314467,0.000015059453,0.000016467919,0.00002136256,0.000038772738,0.000036803136,0.97815764,0.00017842933,0.0005106967,0.015808802],"study_design_scores_gemma":[0.0011641232,0.002163844,0.025929987,0.000005779932,0.000010344852,0.000021846707,0.00004259959,0.000066627625,0.9528662,0.00029023658,0.01728607,0.0001523588],"about_ca_topic_score_codex":0.000049530045,"about_ca_topic_score_gemma":0.00019660652,"teacher_disagreement_score":0.025291445,"about_ca_system_score_codex":0.00008085562,"about_ca_system_score_gemma":0.00023572784,"threshold_uncertainty_score":0.525433},"labels":[],"label_agreement":null},{"id":"W2078873145","doi":"10.1016/j.ygyno.2011.06.037","title":"Ovarian immature teratoma: Treatment and outcome in a single institutional cohort","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Oophorectomy; Immature teratoma; Surgery; Cystectomy; Teratoma; Hysterectomy; Chemotherapy; Cohort; Adjuvant therapy; Cancer; Internal medicine; Germ cell tumors","score_opus":0.07308704056774572,"score_gpt":0.31479253301895777,"score_spread":0.24170549245121203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078873145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94868916,0.00049062946,0.000010818978,0.0022746958,0.0004012032,0.0008037851,0.000013745473,0.000052456868,0.047263525],"genre_scores_gemma":[0.99427384,0.00016341334,0.0037262198,0.0009995475,0.000072674295,0.0003784158,0.000029239975,0.00000966069,0.00034698614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885994,0.00006867657,0.00031912437,0.0003863323,0.000070487156,0.0002954503],"domain_scores_gemma":[0.9994249,0.00013184379,0.000079165045,0.00019376623,0.000033567132,0.00013677588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015262676,0.0001910995,0.0005290513,0.00013044926,0.00006926171,0.000008154448,0.000046444577,0.00027363363,0.0008467072],"category_scores_gemma":[0.00007369482,0.00013454567,0.00006703762,0.00013162551,0.00014937908,0.000052812,0.00004072945,0.00013983285,0.000053146563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029492367,0.0032736224,0.9662601,0.000014235964,0.00015118926,0.0017854782,0.00043348115,9.3302725e-7,0.00009310496,0.0032184266,0.00014892622,0.0243256],"study_design_scores_gemma":[0.0053232363,0.0046442165,0.962751,0.000014189305,0.00016790025,0.0003899222,0.000074478616,0.000009087042,0.00020827181,0.00047063056,0.025830304,0.00011679237],"about_ca_topic_score_codex":0.00029182914,"about_ca_topic_score_gemma":0.00074876717,"teacher_disagreement_score":0.046916537,"about_ca_system_score_codex":0.0013500538,"about_ca_system_score_gemma":0.00028868072,"threshold_uncertainty_score":0.92708504},"labels":[],"label_agreement":null},{"id":"W2079036144","doi":"10.1016/j.ygyno.2010.06.002","title":"Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytology; Histology; Chemotherapy; Biopsy; Radiology; Debulking; Medical diagnosis; Surgical pathology; Ovarian cancer; Cancer; Pathology; Internal medicine","score_opus":0.01719130201086838,"score_gpt":0.30666990075511763,"score_spread":0.28947859874424925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079036144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96193326,0.00009455724,0.000021222244,0.027781306,0.001423467,0.0011609835,0.000041283765,0.000059807495,0.0074840914],"genre_scores_gemma":[0.9822178,0.00014022722,0.011300711,0.004923473,0.00039832527,0.0006442786,0.000013643918,0.000027942628,0.00033362364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839914,0.00006678189,0.0004436787,0.0004720905,0.00017979837,0.00043851664],"domain_scores_gemma":[0.9982812,0.0005567553,0.00017719003,0.0005247708,0.00015010199,0.00031000908],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032342685,0.0002309236,0.0007775743,0.00015998862,0.00007561639,0.000008092554,0.000183828,0.00036550543,0.004530845],"category_scores_gemma":[0.00036642005,0.00017694673,0.00018277459,0.00024503504,0.00014341995,0.000032674223,0.000077185505,0.00031353376,0.00019780132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004768066,0.0026016145,0.48465768,0.0000383808,0.00017314049,0.00034292022,0.00057256425,0.0000031272925,0.01136924,0.0014979569,0.005943953,0.49232262],"study_design_scores_gemma":[0.0050721033,0.004808101,0.76961863,0.0000140373895,0.0001512205,0.00007129369,0.00006269125,0.0000088447105,0.024683243,0.000266349,0.19509456,0.00014893158],"about_ca_topic_score_codex":0.0002544202,"about_ca_topic_score_gemma":0.000550061,"teacher_disagreement_score":0.49217367,"about_ca_system_score_codex":0.0002703273,"about_ca_system_score_gemma":0.0005246666,"threshold_uncertainty_score":0.99637914},"labels":[],"label_agreement":null},{"id":"W2079406970","doi":"10.1016/j.ygyno.2005.12.004","title":"Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Radioimmunotherapy; Paclitaxel; Medicine; Ovarian cancer; Monoclonal antibody; In vivo; Chemotherapy; Cancer research; Combination therapy; Antibody; Oncology; Pharmacology; Cancer; Internal medicine; Immunology; Biology","score_opus":0.026282496526653234,"score_gpt":0.3162870287131962,"score_spread":0.290004532186543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079406970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918683,0.00043485203,0.00011800683,0.00076002814,0.00012929301,0.0006025301,0.000011733045,0.000034460252,0.0060407575],"genre_scores_gemma":[0.99820566,0.00006497684,0.0010244602,0.0004020308,0.00012248842,0.000056169745,0.00002132017,0.0000144714695,0.000088448294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987697,0.00011502833,0.00040908056,0.0002975345,0.00013120467,0.0002774728],"domain_scores_gemma":[0.9978587,0.0014479974,0.00021669404,0.00024755622,0.00010994781,0.0001190803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018915998,0.00018296775,0.0006242316,0.00007749014,0.00007239781,0.000003516325,0.00010223717,0.00025274252,0.00007441704],"category_scores_gemma":[0.00030711282,0.00014886717,0.00009283832,0.00023446776,0.00043482883,0.000021020222,0.000035488905,0.00021680795,0.0000028739753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007537877,0.0025422347,0.0548446,0.00060246966,0.0001190161,0.00017807823,0.00006883449,0.000024633026,0.9252955,0.012538889,0.0005236862,0.0025083192],"study_design_scores_gemma":[0.009468046,0.0064574825,0.43435335,0.000072820396,0.0003658202,0.00006841048,0.000051574247,0.00074086187,0.54158807,0.005150133,0.0014221375,0.00026127562],"about_ca_topic_score_codex":0.00009033926,"about_ca_topic_score_gemma":0.0000028776642,"teacher_disagreement_score":0.38370737,"about_ca_system_score_codex":0.00011694412,"about_ca_system_score_gemma":0.00012740942,"threshold_uncertainty_score":0.6070627},"labels":[],"label_agreement":null},{"id":"W2079755758","doi":"10.1016/j.ygyno.2011.10.030","title":"Informational needs of gynecologic cancer survivors","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Cancer Care Ontario; Princess Margaret Cancer Centre","funders":"","keywords":"Gynecologic oncology; Medicine; Information needs; Gynecologic cancer; Needs assessment; Modalities; Survivorship curve; Family medicine; Population; Disease; Oncology; Internal medicine; Gynecology; Cancer; Gerontology; Ovarian cancer","score_opus":0.05317504729659887,"score_gpt":0.3100903791691051,"score_spread":0.2569153318725062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079755758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.798502,0.00037380325,0.00007151484,0.00057086465,0.0017467575,0.00041178675,0.000029151568,0.00009773323,0.19819637],"genre_scores_gemma":[0.99496585,0.0003041875,0.0005061097,0.0023818181,0.00011700951,0.00021071814,0.000036349713,0.000014652669,0.0014632763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984945,0.00011696379,0.00056862383,0.00017987494,0.00021342866,0.00042661015],"domain_scores_gemma":[0.9984787,0.00043072164,0.00031382075,0.00029571028,0.00031245215,0.00016858897],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046196388,0.00020357099,0.0006424905,0.0003023858,0.00007060966,0.0000036070862,0.00021627398,0.00043081137,0.013160367],"category_scores_gemma":[0.0003175839,0.00016358364,0.00018134453,0.0005247638,0.00030014585,0.000111549045,0.00011435527,0.00030026774,0.00012393123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825394,0.0014294606,0.81786287,0.0003375939,0.00039447707,0.00012139065,0.017343808,0.000032439875,0.00094783306,0.013728418,0.006012057,0.14070714],"study_design_scores_gemma":[0.0026927248,0.005348606,0.81361157,0.000031986816,0.00029227833,0.00010902047,0.009065933,0.000083457075,0.0026262745,0.0019901106,0.1637458,0.00040220018],"about_ca_topic_score_codex":0.0023591053,"about_ca_topic_score_gemma":0.0101134395,"teacher_disagreement_score":0.19673309,"about_ca_system_score_codex":0.00038034705,"about_ca_system_score_gemma":0.0007465898,"threshold_uncertainty_score":0.9877417},"labels":[],"label_agreement":null},{"id":"W2079856228","doi":"10.1016/s0090-8258(03)00085-4","title":"High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Brachytherapy; Stage (stratigraphy); Endometrial cancer; Vaginal vault; Lymphadenectomy; Radiation therapy; Surgery; Survival rate; Hysterectomy; Retrospective cohort study; Pelvis; Adenocarcinoma; Cancer; Internal medicine","score_opus":0.027834836814452965,"score_gpt":0.3333146071514754,"score_spread":0.3054797703370224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079856228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814397,0.0015934712,0.000057905956,0.0019343125,0.0015962104,0.0011805904,0.000106588246,0.00017668432,0.011914537],"genre_scores_gemma":[0.98619354,0.0027163671,0.003191861,0.0016240729,0.00036408988,0.0004697112,0.00004677035,0.000040914485,0.005352678],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997002,0.0005654991,0.00056972477,0.0006607623,0.00044447996,0.000757523],"domain_scores_gemma":[0.9958639,0.002827939,0.00035521996,0.00040281346,0.00015964638,0.00039049593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00062412844,0.00040001096,0.001589631,0.00029333786,0.00018940931,0.000018691006,0.00015791903,0.00043764856,0.010675102],"category_scores_gemma":[0.0011330007,0.00023957863,0.00024928842,0.001005434,0.00023875223,0.00007633929,0.000039392486,0.00056242745,0.0001557137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006818262,0.00242669,0.8929895,0.000033228313,0.0012498007,0.0021297124,0.000069368245,0.00008272089,0.000086248285,0.0021917806,0.0005838511,0.0913388],"study_design_scores_gemma":[0.1253227,0.027680503,0.36311287,0.000017813696,0.00087778445,0.00025666493,0.0001791809,0.0000058269484,0.0015560734,0.00089962094,0.47948167,0.0006093132],"about_ca_topic_score_codex":0.0013189819,"about_ca_topic_score_gemma":0.0012411192,"teacher_disagreement_score":0.52987665,"about_ca_system_score_codex":0.0009090495,"about_ca_system_score_gemma":0.0006592162,"threshold_uncertainty_score":0.99022925},"labels":[],"label_agreement":null},{"id":"W2080407657","doi":"10.1016/j.ygyno.2014.12.017","title":"Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; Simon Fraser University; University of Calgary; Alberta Health Services","funders":"National Institutes of Health; Cancer Research UK; National Cancer Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; Francis Crick Institute","keywords":"Genome-wide association study; Ovarian cancer; Oncology; Single-nucleotide polymorphism; Medicine; Genetic association; Breast cancer; Biology; Gene; Genetics; Cancer; Internal medicine; Bioinformatics; Genotype","score_opus":0.09765061622820562,"score_gpt":0.4051553375416975,"score_spread":0.30750472131349194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080407657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705351,0.00053738564,0.000037411315,0.020255,0.0008691449,0.001814746,0.000011855604,0.00008499803,0.005854338],"genre_scores_gemma":[0.98853165,0.00020201268,0.0021974682,0.005714056,0.0005398942,0.0020334541,0.000006975291,0.000026340836,0.0007481379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99763846,0.0006782514,0.0003966622,0.0005341072,0.00026417262,0.00048831746],"domain_scores_gemma":[0.997685,0.0012561686,0.00021366139,0.0005836726,0.000115899406,0.00014556212],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011016086,0.00023977688,0.00060914096,0.00007178777,0.00029371298,0.000024842526,0.00020777254,0.00015533797,0.0017358289],"category_scores_gemma":[0.0006889077,0.00013905285,0.00011473571,0.00021610661,0.00011618367,0.00003098054,0.000105090214,0.0002642968,0.00016192398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045909703,0.0032678582,0.2404521,0.000026685579,0.0009287532,0.0002236623,0.0013121364,0.00026606416,0.00091950595,0.0005347509,0.0027363985,0.748873],"study_design_scores_gemma":[0.007633153,0.014981761,0.9320883,0.000020447376,0.0010615208,0.00006721578,0.00044269155,0.00078381953,0.00024055231,0.0006579075,0.041821674,0.0002009618],"about_ca_topic_score_codex":0.0011370167,"about_ca_topic_score_gemma":0.0021455972,"teacher_disagreement_score":0.748672,"about_ca_system_score_codex":0.00086124014,"about_ca_system_score_gemma":0.00054684025,"threshold_uncertainty_score":0.99917674},"labels":[],"label_agreement":null},{"id":"W2080522735","doi":"10.1006/gyno.2001.6546","title":"A Comparison of Two Prophylactic Regimens for Hypersensitivity Reactions to Paclitaxel","year":2002,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Regimen; Paclitaxel; Dexamethasone; Corticosteroid; Hypersensitivity reaction; Ovarian cancer; Internal medicine; Surgery; Chemotherapy; Anesthesia; Cancer","score_opus":0.13963297052741352,"score_gpt":0.42908927168922445,"score_spread":0.2894563011618109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080522735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7813352,0.000054989836,0.00090214977,0.012307256,0.0011220749,0.0026799247,0.000045312783,0.0002098012,0.2013433],"genre_scores_gemma":[0.9814133,0.000008962403,0.013485203,0.00068446243,0.00015976986,0.0002630912,0.000013750939,0.00002383743,0.0039476207],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833596,0.00014687795,0.0004969989,0.00040994596,0.00016106236,0.0004491776],"domain_scores_gemma":[0.9971446,0.0015898313,0.00029197737,0.00043350994,0.0002900243,0.00025009416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035103303,0.0001889968,0.00080044096,0.00025326718,0.000153347,0.000005193556,0.00008059849,0.00024208588,0.00010536742],"category_scores_gemma":[0.002334372,0.00016971068,0.00019337624,0.0003779359,0.00015401146,0.00007390152,0.00005135303,0.00034670715,0.00029590554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031519087,0.014635769,0.009870987,0.0004275491,0.0005726055,0.00027110716,0.003752467,0.00054259517,0.483428,0.008057524,0.011652865,0.46647334],"study_design_scores_gemma":[0.006907278,0.0067118607,0.049907207,0.000057005695,0.00094676804,0.0007025136,0.004180024,0.003611899,0.0110061,0.00075649854,0.9147078,0.00050508796],"about_ca_topic_score_codex":0.00007622469,"about_ca_topic_score_gemma":0.00017095282,"teacher_disagreement_score":0.9030549,"about_ca_system_score_codex":0.0007427404,"about_ca_system_score_gemma":0.00016864859,"threshold_uncertainty_score":0.69206005},"labels":[],"label_agreement":null},{"id":"W2080894104","doi":"10.1016/j.ygyno.2006.03.052","title":"Outcomes for systemic therapy in women with ovarian cancer","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; York University; McMaster University; Institute for Clinical Evaluative Sciences; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Systemic therapy; Internal medicine; Cancer; Population; Ovarian cancer; Comorbidity; Cohort; Multivariate analysis; Surgery; Oncology; Breast cancer","score_opus":0.02278868901704574,"score_gpt":0.31802419259884995,"score_spread":0.2952355035818042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080894104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920334,0.00071948685,0.000041279778,0.015009009,0.00024539017,0.0017585517,0.000014756276,0.000059622227,0.0029485857],"genre_scores_gemma":[0.9880998,0.00034912903,0.0011662635,0.003452759,0.00013845744,0.0058970745,0.000013180025,0.000021353379,0.00086194975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873984,0.00005692805,0.00029190982,0.00034798568,0.00009438594,0.0004689539],"domain_scores_gemma":[0.9990977,0.0004298737,0.0001243305,0.00020334267,0.00007305496,0.00007171142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022722152,0.00018335738,0.0006574936,0.00010871084,0.000050662842,0.000008642598,0.00007330322,0.00018996245,0.00047629757],"category_scores_gemma":[0.000025804344,0.00011330873,0.00005420943,0.0001579966,0.000061463805,0.000031334384,0.000011525254,0.00010523893,0.000013766703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014432672,0.0015441014,0.92125106,0.00005327944,0.00022998994,0.0003760829,0.00023805219,0.00012971972,0.00016181776,0.0012633904,0.0027135548,0.07059569],"study_design_scores_gemma":[0.015146629,0.00577059,0.93157685,0.000036956397,0.000052404153,0.00007640213,0.00020160493,0.000015178647,0.0000852913,0.00061231613,0.046288915,0.00013685161],"about_ca_topic_score_codex":0.00067369145,"about_ca_topic_score_gemma":0.0013597298,"teacher_disagreement_score":0.07045884,"about_ca_system_score_codex":0.0018725022,"about_ca_system_score_gemma":0.00050076697,"threshold_uncertainty_score":0.52151245},"labels":[],"label_agreement":null},{"id":"W2081367905","doi":"10.1016/j.ygyno.2007.07.077","title":"Antitumor activity of 4-(N-hydroxyphenyl)retinamide conjugated with poly(l-glutamic acid) against ovarian cancer xenografts","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; University of British Columbia; John S. Dunn Foundation","keywords":"Medicine; Ovarian cancer; Cancer research; Conjugated system; Pharmacology; Cancer; Oncology; Internal medicine; Chemistry","score_opus":0.009008589325472506,"score_gpt":0.272575378572526,"score_spread":0.2635667892470535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081367905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820758,0.0015983745,0.0037758125,0.00022752714,0.00046959275,0.00038088637,0.000022266735,0.000049785467,0.011399929],"genre_scores_gemma":[0.99628645,0.000583439,0.0017845212,0.00048033477,0.00025101524,0.00005241586,0.000076802666,0.00003816131,0.00044683117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978588,0.00018657956,0.0004281271,0.0006360309,0.00019456148,0.0006958651],"domain_scores_gemma":[0.998593,0.00011024641,0.00045394522,0.00045395023,0.00023312289,0.00015578303],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071999285,0.0003334336,0.0005326796,0.000106336134,0.00014549485,0.000013242373,0.00041851684,0.0005917253,0.0001248487],"category_scores_gemma":[0.00023748184,0.00027373497,0.00011720145,0.0003120351,0.00062419486,0.000010538766,0.00017620306,0.0003057394,0.000010989875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077506807,0.0003387506,0.020540327,0.00007303139,0.0001552821,0.00017894358,0.00007164732,0.00006891544,0.954894,0.000099590055,0.00024178067,0.022562645],"study_design_scores_gemma":[0.002028602,0.0027184675,0.035911262,0.000026290612,0.000081444814,0.000079147394,0.00016233583,0.000058121113,0.9384565,0.000055951597,0.020003185,0.000418734],"about_ca_topic_score_codex":0.000113877475,"about_ca_topic_score_gemma":0.00057336723,"teacher_disagreement_score":0.022143912,"about_ca_system_score_codex":0.00016552303,"about_ca_system_score_gemma":0.0007488323,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W2081434843","doi":"10.1016/j.ygyno.2012.08.033","title":"Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"Sanofi Pasteur; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Medicine; HPV infection; Chlamydia trachomatis; Cervical cancer; Gynecology; Chlamydia; Risk factor; Sexual intercourse; Obstetrics; Logistic regression; Gonorrhea; Young adult; Internal medicine; Cancer; Immunology; Population; Human immunodeficiency virus (HIV)","score_opus":0.03426336585836616,"score_gpt":0.3514734990344717,"score_spread":0.3172101331761056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081434843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952764,0.00026441907,0.000007903269,0.00046626793,0.00021983731,0.0014353617,0.000021497006,0.000010921307,0.0022974217],"genre_scores_gemma":[0.99723583,0.0012739274,0.00005441013,0.00024253207,0.00020014393,0.0008604167,0.0000141544215,0.0000050894664,0.00011349109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985546,0.0003636975,0.00026842812,0.00019717852,0.00018011889,0.0004359617],"domain_scores_gemma":[0.9970501,0.002620233,0.00007262734,0.000081154256,0.000073166295,0.00010272804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015136413,0.00010520196,0.00026512414,0.00012571417,0.00010753382,0.000010128947,0.000053401178,0.00019964643,0.0008604546],"category_scores_gemma":[0.0017334219,0.00006742882,0.000032347445,0.00012590818,0.00013130663,0.00008217691,0.0000931403,0.00028745536,0.0000027026085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004959793,0.00047810166,0.9737213,0.00012757731,0.000013067338,0.0000026168834,0.004399679,0.0000020936034,0.0000035722064,0.0002493066,0.00005017042,0.015992718],"study_design_scores_gemma":[0.01957114,0.0031029854,0.97453415,0.0000021869896,0.000027530206,0.000015125839,0.0010684406,0.00019334725,0.000009270846,0.00033568134,0.0010696115,0.000070517366],"about_ca_topic_score_codex":0.0008323642,"about_ca_topic_score_gemma":0.0039512273,"teacher_disagreement_score":0.0159222,"about_ca_system_score_codex":0.0008365021,"about_ca_system_score_gemma":0.00008198535,"threshold_uncertainty_score":0.9421374},"labels":[],"label_agreement":null},{"id":"W2082216559","doi":"10.1016/j.ygyno.2007.05.037","title":"Incidental MRI detection of BRCA1-related solitary peritoneal carcinoma during breast screening—A case report","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Radiology; Carcinoma; Breast carcinoma; Breast MRI; General surgery; Mammography; Gynecology; Oncology; Pathology; Breast cancer; Internal medicine; Cancer","score_opus":0.013712456771947606,"score_gpt":0.2933257482801208,"score_spread":0.2796132915081732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082216559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299186,0.00038583725,0.00011560444,0.00075612165,0.0007540823,0.0006074908,0.000018845327,0.00009255474,0.004277581],"genre_scores_gemma":[0.99818313,0.000028643657,0.0010514933,0.00013141423,0.00021951222,0.00005197314,0.000034859462,0.000024017936,0.000274963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979449,0.00008779158,0.0007889731,0.0004893627,0.0001997629,0.0004892321],"domain_scores_gemma":[0.9986081,0.00028059699,0.0003713588,0.0003529197,0.00015489152,0.0002321135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670898,0.0002216837,0.0006157136,0.00022501011,0.00017711557,0.000005215915,0.00006833571,0.00041059512,0.000523193],"category_scores_gemma":[0.000102667094,0.00019591842,0.00019715,0.00026206777,0.00020343265,0.000074176736,0.00010014742,0.00032454196,0.000022510096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078031386,0.0012707025,0.47561866,0.00007347543,0.00034127757,0.46716434,0.000424948,0.000021778495,0.0066561145,0.000039357918,0.000085905725,0.047523122],"study_design_scores_gemma":[0.003164807,0.0017712611,0.65594774,0.000016384407,0.00024088795,0.32955468,0.00074175326,0.000047523725,0.008031631,0.000021356835,0.00034661387,0.00011536412],"about_ca_topic_score_codex":0.0018473935,"about_ca_topic_score_gemma":0.002215651,"teacher_disagreement_score":0.18032907,"about_ca_system_score_codex":0.0011454177,"about_ca_system_score_gemma":0.00023437849,"threshold_uncertainty_score":0.79893214},"labels":[],"label_agreement":null},{"id":"W2082752599","doi":"10.1016/j.ygyno.2014.04.052","title":"Prospective Quality of Life Outcomes Following Robotic Surgery in Gynecologic Oncology","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Quality of life (healthcare); Robotic surgery; Wilcoxon signed-rank test; Statistical significance; Gynecologic oncology; Surgery; Clinical significance; Prospective cohort study; Physical therapy; General surgery; Mann–Whitney U test; Internal medicine","score_opus":0.07375046026200607,"score_gpt":0.3818602299609808,"score_spread":0.30810976969897474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082752599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636278,0.00038314788,0.00008941348,0.0035807462,0.001888992,0.0011637529,0.000005309026,0.000116169394,0.029144637],"genre_scores_gemma":[0.99404377,0.000079143894,0.0014224697,0.0035256622,0.00011269613,0.00035677786,0.000027579594,0.000025033565,0.00040684658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952255,0.0013615541,0.0015315629,0.00071522663,0.0003622621,0.0008039126],"domain_scores_gemma":[0.9818717,0.016502371,0.0006746751,0.00045931147,0.00016013876,0.000331801],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029448613,0.0003742597,0.0032570448,0.0005036514,0.00008848057,0.000007009278,0.00023012683,0.0007569731,0.0009902277],"category_scores_gemma":[0.02189702,0.000274962,0.0006569039,0.0009126518,0.00027090873,0.000090182795,0.00017548437,0.0005417159,0.00011877839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006799502,0.0027964353,0.96570885,0.00010856254,0.00034258893,0.00016674119,0.00013466434,0.000063740365,0.00028133992,0.0011015892,0.00020099251,0.028414555],"study_design_scores_gemma":[0.0090855155,0.0052349316,0.9792403,0.000021755439,0.00021138323,0.000009137655,0.000284226,0.000027697948,0.000119718745,0.003632008,0.0018817999,0.00025151725],"about_ca_topic_score_codex":0.00046755842,"about_ca_topic_score_gemma":0.001552651,"teacher_disagreement_score":0.030415958,"about_ca_system_score_codex":0.0018548131,"about_ca_system_score_gemma":0.0011089125,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W2082991733","doi":"10.1006/gyno.2002.6682","title":"General Keynote: Expression of Epidermal Growth Factor Receptor Family in Transgenic Mouse Models of Human Breast Cancer","year":2003,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Genetically modified mouse; Human Epidermal Growth Factor Receptor 2; Cancer research; Transgene; Epidermal growth factor receptor; Expression (computer science); Cancer; Oncology; Internal medicine; Genetics; Gene; Biology","score_opus":0.16879511054871607,"score_gpt":0.4461844866397767,"score_spread":0.2773893760910606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082991733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033674274,0.9580452,0.000048259193,0.00017910516,0.00066358637,0.0034685615,0.0011971213,0.000054688593,0.0026692294],"genre_scores_gemma":[0.0056830603,0.990448,0.0010668309,0.00017582692,0.0002210541,0.0010272497,0.00016364691,0.00012251904,0.0010918351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933016,0.0018185674,0.0022335255,0.0009785801,0.0006349647,0.001032818],"domain_scores_gemma":[0.99670845,0.00084264384,0.000991267,0.00074176874,0.00038845217,0.00032741812],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010130003,0.00070158415,0.005376391,0.0007798657,0.00006313673,0.0000059685763,0.0006831283,0.0020094046,0.0035245582],"category_scores_gemma":[0.00022739224,0.0005399789,0.0008056764,0.00073516625,0.0005186943,0.000096859425,0.00017363626,0.0016690153,0.000024897472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005149423,0.003309236,0.0013816884,0.056305394,0.00056102604,0.00019802658,0.00058986386,0.00008420986,0.01930648,0.0005862684,0.010177192,0.9069857],"study_design_scores_gemma":[0.012406585,0.009892713,0.0030309716,0.020529624,0.0020754356,0.00025840604,0.00024416723,0.00007694055,0.005745939,0.00082238036,0.9425201,0.0023967489],"about_ca_topic_score_codex":0.000831008,"about_ca_topic_score_gemma":0.00026069404,"teacher_disagreement_score":0.9323429,"about_ca_system_score_codex":0.0024621645,"about_ca_system_score_gemma":0.0043922327,"threshold_uncertainty_score":0.9997052},"labels":[],"label_agreement":null},{"id":"W2083016284","doi":"10.1016/s0090-8258(03)00331-7","title":"Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; London Health Sciences Centre","funders":"","keywords":"Medicine; Serous fluid; Surgery; Omentectomy; Laparotomy; Dissection (medical); Stage (stratigraphy); Carboplatin; Radiation therapy; Chemotherapy; Lymph node; Debulking; Radiology; Ovarian cancer; Cancer; Internal medicine; Cisplatin","score_opus":0.03745914480063468,"score_gpt":0.3143284644674656,"score_spread":0.2768693196668309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083016284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842794,0.000520384,0.00003117014,0.0035744496,0.00047415844,0.0018547156,0.000063157895,0.000033803353,0.009168767],"genre_scores_gemma":[0.99472964,0.00027169092,0.001630283,0.0013692058,0.000062120285,0.00078902516,0.000036525023,0.000022672179,0.0010888644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986666,0.00013170608,0.0003428696,0.00034313466,0.00012289679,0.00039281882],"domain_scores_gemma":[0.99749196,0.0016436664,0.00027010535,0.0003578441,0.00013010998,0.000106322084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021945432,0.00022242489,0.00077264855,0.00006516487,0.00011627131,0.0000044101544,0.00007137635,0.0001618242,0.00028680675],"category_scores_gemma":[0.00028219537,0.0001160515,0.00021193974,0.0001722595,0.00014601942,0.000023299748,0.000019386976,0.00008411323,0.000014965324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553598,0.010782385,0.8856345,0.00022183996,0.0022994983,0.002172789,0.00076085795,0.00016672625,0.00055897987,0.004492618,0.016934717,0.0734215],"study_design_scores_gemma":[0.027330387,0.05647932,0.51892346,0.00026724962,0.002458346,0.004905386,0.0013912108,0.000027540074,0.072328776,0.0020778785,0.313156,0.00065442215],"about_ca_topic_score_codex":0.00013461465,"about_ca_topic_score_gemma":0.0006040534,"teacher_disagreement_score":0.36671102,"about_ca_system_score_codex":0.00061368773,"about_ca_system_score_gemma":0.0018497602,"threshold_uncertainty_score":0.47324428},"labels":[],"label_agreement":null},{"id":"W2083461538","doi":"10.1016/j.ygyno.2014.06.033","title":"Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre; Fraser Health; Interior Health; Princess Margaret Cancer Centre; University of the Fraser Valley; Hamilton Health Sciences; University Health Network; University of Toronto; McGill University","funders":"","keywords":"Medicine; Tolerability; Endometrial cancer; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Angiogenesis; Protein kinase B; Cancer research; Cancer; Adverse effect; Signal transduction; Biology","score_opus":0.038709145644150435,"score_gpt":0.3676299882226336,"score_spread":0.32892084257848314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083461538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974999,0.00025121006,0.0001110462,0.000104057704,0.000705629,0.0008554977,0.000030745545,0.000015423877,0.0004265166],"genre_scores_gemma":[0.9976383,0.000099671335,0.0007011634,0.00034457864,0.0001562066,0.0008818995,0.0000149757,0.000023795148,0.00013942919],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976616,0.0005398513,0.0005199877,0.0005429604,0.00019055097,0.00054505485],"domain_scores_gemma":[0.9987579,0.00028401118,0.00035113847,0.00037188618,0.00012037764,0.000114709066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010108302,0.00024954407,0.00069102814,0.00018374232,0.000073152274,0.000007189043,0.00035483256,0.00018536056,0.00044288218],"category_scores_gemma":[0.0008257456,0.00017700654,0.000045399924,0.00039479454,0.000165801,0.000005624712,0.00020016053,0.00020433047,0.0000037651694],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05588828,0.034092084,0.011857852,0.00013059766,0.0013343457,0.00021287218,0.0034652962,0.0035346234,0.15235825,0.00005533393,0.0033256437,0.73374486],"study_design_scores_gemma":[0.11167327,0.6856549,0.0065594595,0.00004255067,0.00034345544,0.000050016264,0.0028054302,0.00034466793,0.020636557,0.00024045329,0.17066462,0.0009846538],"about_ca_topic_score_codex":0.00015894185,"about_ca_topic_score_gemma":0.0039902134,"teacher_disagreement_score":0.7327602,"about_ca_system_score_codex":0.00031144914,"about_ca_system_score_gemma":0.0005184126,"threshold_uncertainty_score":0.7218117},"labels":[],"label_agreement":null},{"id":"W2083938280","doi":"10.1016/j.ygyno.2008.08.002","title":"Synchronous occult cancers of the endometrium and fallopian tube in an MSH2 mutation carrier at time of prophylactic surgery","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Fallopian tube; Lynch syndrome; Prophylactic Surgery; Endometrial cancer; Occult; Fallopian tube cancer; Gynecology; Endometrium; Ovarian cancer; Carcinoma; Cancer; Obstetrics; Internal medicine; Pathology; DNA mismatch repair","score_opus":0.02554251331803289,"score_gpt":0.2792722187936372,"score_spread":0.2537297054756043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083938280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968441,0.00039507396,0.0000018423373,0.00025528003,0.000474078,0.00074919476,0.000018043618,0.000015130813,0.0012472261],"genre_scores_gemma":[0.99905246,0.00008637696,0.00024691573,0.00024626518,0.000036513444,0.000073498704,0.000009624881,0.000013497881,0.00023484745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844223,0.0002803286,0.0004752924,0.00029843644,0.00021717715,0.00028650355],"domain_scores_gemma":[0.99801654,0.0011554,0.00029900868,0.00027399836,0.00016225297,0.000092814706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034687115,0.00015052885,0.00065425475,0.00021700718,0.00006245714,0.0000014818302,0.00011243511,0.0002692676,0.00044005841],"category_scores_gemma":[0.0015114252,0.000106913176,0.00008331288,0.00048692524,0.0006331797,0.00004275213,0.00009140934,0.00020308667,0.000004038689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068210653,0.0002898807,0.94978184,0.00018145892,0.000054878314,0.00017584972,0.0019155832,0.000364466,0.039771736,0.0000052197215,0.00033087342,0.0064461194],"study_design_scores_gemma":[0.0014994892,0.00341143,0.9751222,0.000020694953,0.00007411225,0.00034500955,0.00023074368,0.00021445073,0.018344,0.00003182799,0.0005840227,0.00012198895],"about_ca_topic_score_codex":0.00036983093,"about_ca_topic_score_gemma":0.001567511,"teacher_disagreement_score":0.025340402,"about_ca_system_score_codex":0.001416189,"about_ca_system_score_gemma":0.0014087036,"threshold_uncertainty_score":0.4818331},"labels":[],"label_agreement":null},{"id":"W2084103484","doi":"10.1016/j.ygyno.2012.03.026","title":"A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"DNA methylation; Epigenetics; Ovarian cancer; Biology; Cancer research; Methylation; Gene; Bisulfite sequencing; Molecular biology; Serous fluid; Cancer; Gene expression; Genetics","score_opus":0.023341207626056633,"score_gpt":0.2825349384834104,"score_spread":0.25919373085735375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084103484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96388125,0.0015404967,0.028114475,0.000148829,0.00020424086,0.00047755547,0.000018801038,0.000017079494,0.0055972473],"genre_scores_gemma":[0.9858144,0.00012435864,0.012856099,0.00028198774,0.00023110723,0.00023294748,0.00027137998,0.000026262358,0.00016146831],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848855,0.0001837797,0.00029448062,0.00040199596,0.00013144214,0.000499781],"domain_scores_gemma":[0.9991868,0.00011433824,0.00021464251,0.00027736378,0.000079443285,0.0001273836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005596959,0.00021501484,0.00026606768,0.0001252871,0.000088941415,0.000012726408,0.00015960056,0.00053111685,0.000100962636],"category_scores_gemma":[0.00016978453,0.00017390479,0.000053731655,0.00022449551,0.0000973526,0.000011106308,0.000081159036,0.00019381379,0.000008157593],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020609447,0.00064144627,0.12469977,0.000017802546,0.00002457895,0.0000012967527,0.00009865824,0.009481418,0.86204946,0.000099125224,0.000028221139,0.0026521282],"study_design_scores_gemma":[0.005365954,0.002221966,0.75239635,0.000030801388,0.000058448804,0.0000105481,0.00016539125,0.0019017664,0.21019547,0.00017450262,0.026788792,0.0006900368],"about_ca_topic_score_codex":0.00008093495,"about_ca_topic_score_gemma":0.00013010533,"teacher_disagreement_score":0.651854,"about_ca_system_score_codex":0.00016846287,"about_ca_system_score_gemma":0.00023789835,"threshold_uncertainty_score":0.7091631},"labels":[],"label_agreement":null},{"id":"W2084265116","doi":"10.1016/j.ygyno.2006.06.024","title":"Evaluation of predictive formulae for glomerular filtration rate for carboplatin dosing in gynecological malignancies","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Renal function; Carboplatin; Dosing; Urology; Creatinine; Kidney disease; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.047906941268246774,"score_gpt":0.3428660800700276,"score_spread":0.2949591388017808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084265116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98504573,0.00013415531,0.0066014226,0.0013441006,0.00026721242,0.0049129045,0.000052300755,0.00006142259,0.0015807436],"genre_scores_gemma":[0.98744035,0.000011413762,0.010504251,0.000314709,0.00018847444,0.0011602328,0.0002918013,0.000023480423,0.00006527394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978138,0.0003217405,0.00073957286,0.00041796474,0.0003082886,0.00039863735],"domain_scores_gemma":[0.99649584,0.0019993535,0.00043776346,0.00018629959,0.00083187164,0.000048840328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035714186,0.00020233619,0.00062614394,0.00022078656,0.00008833788,0.000008708868,0.0000865646,0.00053956284,0.00013027195],"category_scores_gemma":[0.0041170274,0.00018426948,0.00014961073,0.0002816156,0.00013546435,0.000121535966,0.000019865665,0.00015006292,0.0000022333784],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010345186,0.0012696735,0.01588351,0.00019721709,0.000102346974,0.0000056490276,0.0005215173,0.004014876,0.94562507,0.001820321,0.00072788406,0.028797392],"study_design_scores_gemma":[0.015635017,0.00717283,0.47602293,0.000058637022,0.0005953659,0.000019312987,0.0005325016,0.06388922,0.40362197,0.03132621,0.00085457944,0.00027141577],"about_ca_topic_score_codex":0.00004624369,"about_ca_topic_score_gemma":0.0007467882,"teacher_disagreement_score":0.5420031,"about_ca_system_score_codex":0.0015826825,"about_ca_system_score_gemma":0.00075094274,"threshold_uncertainty_score":0.75142914},"labels":[],"label_agreement":null},{"id":"W2084323036","doi":"10.1006/gyno.2000.5727","title":"Results of Radical Radiotherapy for Recurrent Endometrial Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Univariate analysis; Carcinoma; Endometrial cancer; Pathological; Stage (stratigraphy); External beam radiotherapy; Urology; Cancer; Radiology; Surgery; Internal medicine; Multivariate analysis; Brachytherapy","score_opus":0.05099323955660762,"score_gpt":0.38250404997196297,"score_spread":0.33151081041535535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084323036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9261065,0.010966146,0.00012817203,0.013212416,0.0035507914,0.004182959,0.00074187794,0.0001548907,0.040956262],"genre_scores_gemma":[0.9636739,0.012220806,0.011462335,0.0030693978,0.002193026,0.001225415,0.00022291526,0.000041592757,0.005890632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830896,0.000130651,0.000602402,0.00037393376,0.00019896423,0.00038507622],"domain_scores_gemma":[0.99728125,0.0020439238,0.00017575843,0.00021519914,0.000098928555,0.00018495329],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044588384,0.00017134601,0.0008616725,0.00017577388,0.000054854347,0.0000035871426,0.0001301296,0.00029860888,0.0074804192],"category_scores_gemma":[0.0010303828,0.00012089141,0.00027106632,0.0004987141,0.00018837112,0.000027148819,0.00001452433,0.00016713214,0.000023021428],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03897454,0.0015356829,0.0010426478,0.00004625032,0.00033223338,0.000032085736,0.00008485679,0.000014159281,0.0011526598,0.00012855689,0.008377576,0.9482787],"study_design_scores_gemma":[0.061706204,0.029644106,0.010491048,0.000025124076,0.00029025658,0.00002541048,0.000018806639,0.00006374858,0.0018465692,0.00045757912,0.895282,0.00014919708],"about_ca_topic_score_codex":0.00010896653,"about_ca_topic_score_gemma":0.00007421422,"teacher_disagreement_score":0.94812953,"about_ca_system_score_codex":0.000625448,"about_ca_system_score_gemma":0.00038796713,"threshold_uncertainty_score":0.99342686},"labels":[],"label_agreement":null},{"id":"W2085768767","doi":"10.1016/j.ygyno.2006.03.008","title":"Adjuvant radiotherapy in women with stage I endometrial cancer: A systematic review","year":2006,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; London Health Sciences Centre; McMaster University; Juravinski Cancer Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Endometrial cancer; Adjuvant radiotherapy; Radiation therapy; Stage (stratigraphy); Adjuvant; Oncology; Gynecology; Systematic review; Cancer; General surgery; Internal medicine; MEDLINE","score_opus":0.05123929374735893,"score_gpt":0.39025953350276177,"score_spread":0.33902023975540285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085768767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032013882,0.9839101,0.0000044836956,0.00023458787,0.0005949385,0.012461063,0.00014560779,0.0000978292,0.0025193724],"genre_scores_gemma":[0.000009256906,0.97887075,0.0002382105,0.0019786526,0.00038660967,0.01591251,0.00012735932,0.00008753231,0.0023891302],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941788,0.001307731,0.0020829958,0.00092971895,0.0004959456,0.0010048656],"domain_scores_gemma":[0.9945474,0.002894115,0.0014356544,0.0007098403,0.00010666851,0.0003063092],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001374075,0.00086522946,0.013728954,0.00088511186,0.000057134323,0.000017382867,0.00040706276,0.0008202362,0.0021678589],"category_scores_gemma":[0.0010685239,0.00047345183,0.0005683323,0.0026659775,0.00014942861,0.000048970196,0.000077448014,0.00088376476,0.00010874785],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003852383,0.00065182266,0.00002363879,0.6065685,0.0008894546,0.0012567771,0.00001706261,5.401895e-7,8.84053e-8,0.000008860709,0.00041548756,0.38978252],"study_design_scores_gemma":[0.007849592,0.006445146,0.00003352557,0.26678082,0.004778245,0.00019338683,0.000016319585,3.9306397e-7,8.208633e-8,0.0000070816372,0.71351635,0.0003790426],"about_ca_topic_score_codex":0.0002874697,"about_ca_topic_score_gemma":0.00033752486,"teacher_disagreement_score":0.7131009,"about_ca_system_score_codex":0.009728993,"about_ca_system_score_gemma":0.0025925718,"threshold_uncertainty_score":0.9997717},"labels":[],"label_agreement":null},{"id":"W2085841804","doi":"10.1016/j.ygyno.2004.04.014","title":"Job satisfaction, stress, and burnout among Canadian gynecologic oncologists","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Healthcare professionals’ stress and burnout","field":"Health Professions","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Cancer Care Nova Scotia; McMaster University","funders":"","keywords":"Medicine; Gynecologic cancer; Burnout; Family medicine; Depersonalization; Job satisfaction; Gynecologic oncology; Emotional exhaustion; Health care; Nursing; Cancer; Clinical psychology; Oncology; Internal medicine; Psychology","score_opus":0.04179773365716025,"score_gpt":0.3973657114178175,"score_spread":0.35556797776065724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085841804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272679,0.0014017313,0.000050300827,0.019975895,0.0047250697,0.0022187228,0.0001622309,0.000345374,0.043852765],"genre_scores_gemma":[0.9830921,0.001797019,0.001588214,0.010075042,0.0006108346,0.00096103054,0.000076553566,0.000049598806,0.0017495882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993297,0.0017078767,0.0013378533,0.0010262169,0.0003408235,0.0022902305],"domain_scores_gemma":[0.9938046,0.0030813331,0.0006811397,0.0005632458,0.0004836033,0.0013861194],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0018348006,0.000536551,0.0011210091,0.00044519134,0.0030906335,0.00002786887,0.0004506767,0.002326153,0.004626431],"category_scores_gemma":[0.0028555316,0.00043108928,0.0001278444,0.0004507284,0.0007518395,0.0002814524,0.00038493628,0.0024787367,0.00090064853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000046491594,0.000116236704,0.95253795,0.00018462377,0.00005337311,0.00043166592,0.0012693395,0.00005831542,0.000032753658,0.0060130744,0.0035312946,0.035724882],"study_design_scores_gemma":[0.0023962427,0.0011598357,0.9427074,0.00034354386,0.000048751936,0.000022839264,0.00470312,0.000015546319,0.000010013719,0.010245857,0.037882697,0.00046413133],"about_ca_topic_score_codex":0.2864717,"about_ca_topic_score_gemma":0.91993666,"teacher_disagreement_score":0.63346493,"about_ca_system_score_codex":0.004796684,"about_ca_system_score_gemma":0.008133814,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W2086139141","doi":"10.1016/j.ygyno.2015.01.258","title":"The effect of time on racial differences in ovarian cancer stage at diagnosis among cases identified through the National Cancer Database","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Cancer; Epithelial ovarian cancer; Gynecology; Cancer stage; Oncology; Demography; Internal medicine","score_opus":0.08072550410260793,"score_gpt":0.3842631669295571,"score_spread":0.30353766282694916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086139141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831696,0.0019195987,0.0000010461039,0.008186291,0.001204622,0.0012905515,0.00029887754,0.000019183948,0.0039102254],"genre_scores_gemma":[0.99157786,0.0012364313,0.000016346652,0.0008126872,0.00028418592,0.00402888,0.000041390773,0.000013863378,0.0019883781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978077,0.00059406046,0.00039909175,0.0003973092,0.00043229767,0.00036954653],"domain_scores_gemma":[0.9925543,0.006640362,0.00029815178,0.00027729856,0.00013057547,0.000099301],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086736726,0.00022728926,0.00057935546,0.00006191806,0.00021580243,0.000019580031,0.00022354978,0.00017033011,0.0019504855],"category_scores_gemma":[0.0013243752,0.00010984719,0.000106302396,0.00024807893,0.00043971674,0.000078855555,0.00014890864,0.0002396567,0.000057725934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014036761,0.0005776066,0.9612066,0.000029761752,0.00035264497,0.00032139028,0.00088666065,0.0001392257,0.00005132888,0.00047218704,0.026550824,0.008008065],"study_design_scores_gemma":[0.00610631,0.004623423,0.95956117,0.00009791292,0.00032473484,0.0000123364425,0.00022780843,0.00006913536,0.0026597197,0.00012639546,0.026030662,0.00016041784],"about_ca_topic_score_codex":0.0063548516,"about_ca_topic_score_gemma":0.027388686,"teacher_disagreement_score":0.021033835,"about_ca_system_score_codex":0.0017898559,"about_ca_system_score_gemma":0.0005560376,"threshold_uncertainty_score":0.99896187},"labels":[],"label_agreement":null},{"id":"W2086758043","doi":"10.1016/j.ygyno.2003.11.052","title":"Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Ludwig Institute for Cancer Research","keywords":"Vulvar Carcinoma; Medicine; Lymph node; Polymerase chain reaction; Vulvar cancer; Lymph; Oncology; Pathology; Proportional hazards model; Vulva; Pathological; Internal medicine; Gene; Biology","score_opus":0.031751831281429034,"score_gpt":0.30278334149911046,"score_spread":0.2710315102176814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086758043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906356,0.00065595243,0.000012005698,0.00056968257,0.00014980111,0.0008001543,0.000015902157,0.00003189841,0.008701026],"genre_scores_gemma":[0.99747443,0.00014389204,0.001229364,0.0007449582,0.00006588823,0.00021624358,0.000021395015,0.000013133405,0.00009071241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985462,0.00012289334,0.00043739763,0.00038557284,0.00014353216,0.00036444954],"domain_scores_gemma":[0.9984574,0.00095417874,0.00017585234,0.0001915524,0.00007882633,0.00014220495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002410216,0.0001862604,0.00072966324,0.00018473908,0.000059904643,0.000004646426,0.00010500548,0.00026065743,0.0002522473],"category_scores_gemma":[0.0009165981,0.00014578446,0.000058447855,0.00041871623,0.00026490344,0.00004496983,0.000081132144,0.00015651056,0.00001669552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040893676,0.0015102074,0.9563793,0.00021127664,0.00008146288,0.0009085048,0.00024884313,0.000034573313,0.03331979,0.0026460972,0.000016938611,0.0042341044],"study_design_scores_gemma":[0.012288836,0.0040634777,0.96764946,0.000063474115,0.00016031096,0.00006178806,0.00019559088,0.0000011008375,0.008119095,0.0070206732,0.00023661368,0.00013958245],"about_ca_topic_score_codex":0.0013524964,"about_ca_topic_score_gemma":0.0007079915,"teacher_disagreement_score":0.025200695,"about_ca_system_score_codex":0.00066036277,"about_ca_system_score_gemma":0.00055159064,"threshold_uncertainty_score":0.5944918},"labels":[],"label_agreement":null},{"id":"W2086770058","doi":"10.1016/j.ygyno.2007.10.035","title":"Epithelial–stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Institute for Cancer Research","keywords":"Stromal cell; Epithelial ovarian cancer; Medicine; Ovarian cancer; Cancer research; Cell growth; Epithelium; Cancer; Oncology; Internal medicine; Pathology; Biology; Genetics","score_opus":0.026005048930182757,"score_gpt":0.33677595470002913,"score_spread":0.3107709057698464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086770058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976668,0.00011602592,0.00025078462,0.0000684328,0.00010224836,0.00038146073,0.00013937721,0.000009034269,0.0012658597],"genre_scores_gemma":[0.998613,0.00021822196,0.000434522,0.00007192503,0.00013487111,0.000092999006,0.00007968689,0.000012221067,0.00034257822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987289,0.00015121904,0.00032493353,0.00034153927,0.0001088303,0.000344583],"domain_scores_gemma":[0.99942183,0.000066168956,0.00014729366,0.0001590887,0.00009826138,0.00010732366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050153304,0.00014608835,0.0002629134,0.000105832245,0.000080698555,0.000009285973,0.00011607093,0.00020747106,0.000054339554],"category_scores_gemma":[0.00012701066,0.00013298784,0.000051385567,0.00007438673,0.00013501893,0.000009501815,0.000117501804,0.00014686436,0.0000020268956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087521673,0.00075254525,0.108272456,0.00002150363,0.000043070155,0.000017786082,0.0000852146,0.00027684253,0.88633555,0.00010565539,0.000042967313,0.0031712172],"study_design_scores_gemma":[0.004547656,0.0033719484,0.07747176,0.000006682678,0.00003149683,0.000010653424,0.00022752333,0.000477769,0.9126651,0.0004439654,0.00052144594,0.00022395591],"about_ca_topic_score_codex":0.0042555663,"about_ca_topic_score_gemma":0.042896755,"teacher_disagreement_score":0.03864119,"about_ca_system_score_codex":0.00018563747,"about_ca_system_score_gemma":0.0003264498,"threshold_uncertainty_score":0.9745679},"labels":[],"label_agreement":null},{"id":"W2086879010","doi":"10.1016/j.ygyno.2014.09.017","title":"Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stornoway Diamond (Canada)","funders":"","keywords":"Medicine; Hazard ratio; Chemotherapy; Ovarian cancer; Cytoreductive surgery; Internal medicine; Multivariate analysis; Oncology; Observational study; Surgery; Cancer; Confidence interval","score_opus":0.020351057303024167,"score_gpt":0.31312800113464356,"score_spread":0.2927769438316194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086879010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571264,0.000017942659,0.000004170048,0.00039954123,0.0007339267,0.00095009577,0.00026893744,0.000008021629,0.001904712],"genre_scores_gemma":[0.9995363,0.0000138920805,0.00004702694,0.000069953836,0.000089826375,0.00010302289,0.000111824025,0.000011365443,0.000016828735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979405,0.0005939097,0.0005452067,0.00037220822,0.00026447495,0.00028371453],"domain_scores_gemma":[0.9966472,0.0020848056,0.0006235164,0.00034332418,0.00022949916,0.000071651535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005052734,0.00021173034,0.0014064834,0.0003447172,0.00003923922,0.0000028869924,0.00007598394,0.00018879157,0.00026751426],"category_scores_gemma":[0.00037364123,0.00011647664,0.0004269211,0.0008506665,0.00020578338,0.000027296543,0.000041078576,0.0002492818,0.0000011874603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022671444,0.0034171154,0.9397632,0.0000146948705,0.0026086615,0.000013414138,0.00021010285,0.0008529589,0.000008172711,0.0000895312,0.00031499943,0.030035743],"study_design_scores_gemma":[0.026060339,0.010758222,0.9611229,0.000045792018,0.0015694561,6.5071345e-7,0.00005080737,0.00007938645,0.0001042231,0.000026230371,0.0000790849,0.00010293257],"about_ca_topic_score_codex":0.002247707,"about_ca_topic_score_gemma":0.003476664,"teacher_disagreement_score":0.02993281,"about_ca_system_score_codex":0.0013084343,"about_ca_system_score_gemma":0.0010470416,"threshold_uncertainty_score":0.47497797},"labels":[],"label_agreement":null},{"id":"W2088050133","doi":"10.1016/j.ygyno.2013.05.013","title":"The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study)","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Carboplatin; Medicine; Ovarian cancer; Proportional hazards model; Internal medicine; Oncology; Progression-free survival; Population; Confidence interval; Multivariate analysis; Chemotherapy; Paclitaxel; Urology; Cancer; Cisplatin","score_opus":0.07237740890737773,"score_gpt":0.3571437969437789,"score_spread":0.2847663880364012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088050133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526466,0.00079833966,0.000444936,0.0059962124,0.0009911124,0.005193913,0.0006834781,0.00003540646,0.00059195136],"genre_scores_gemma":[0.990804,0.0001137788,0.0050307,0.00055429933,0.00031188672,0.0024827966,0.00059771526,0.000032743286,0.00007204735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967795,0.00049458677,0.00096432195,0.0008534899,0.00032601028,0.0005821066],"domain_scores_gemma":[0.99249774,0.0053951824,0.00041653417,0.0013871936,0.00014453146,0.00015881864],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044248987,0.0003472606,0.0010722737,0.00010747036,0.00009352697,0.00003955767,0.0006095396,0.00034277295,0.0010355895],"category_scores_gemma":[0.0010142379,0.0002273639,0.00011503675,0.00025749853,0.00022721541,0.00008032097,0.00028081934,0.00039617007,0.00004780712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010872934,0.024956204,0.860756,0.00004880044,0.0017335253,0.0004887689,0.0005669776,0.015491509,0.00047638582,0.0001942034,0.016360313,0.068054415],"study_design_scores_gemma":[0.07732876,0.009690967,0.7701076,0.00006451548,0.0014013139,0.0000012320072,0.00032328843,0.13620867,0.0001255938,0.0014293488,0.0030218328,0.00029684408],"about_ca_topic_score_codex":0.035723526,"about_ca_topic_score_gemma":0.028115617,"teacher_disagreement_score":0.12071715,"about_ca_system_score_codex":0.00076790137,"about_ca_system_score_gemma":0.0010284104,"threshold_uncertainty_score":0.9998776},"labels":[],"label_agreement":null},{"id":"W2088467998","doi":"10.1006/gyno.2000.5912","title":"Combined Laparoscopic and Vaginal Radical Surgery in Cervical Cancer","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Surgery; Laparotomy; Cervical cancer; Radical Hysterectomy; Stage (stratigraphy); Parametrial; Laparoscopy; Dissection (medical); Cancer","score_opus":0.03186502192448284,"score_gpt":0.32950552172543396,"score_spread":0.29764049980095114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088467998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97715235,0.0011851678,6.752148e-7,0.008766572,0.00033726197,0.00034641876,0.000006919102,0.00005378543,0.0121508315],"genre_scores_gemma":[0.99173886,0.0019355491,0.00017851822,0.0045453226,0.00015798902,0.00018869687,0.000020136817,0.000011070153,0.0012238795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853945,0.00016705859,0.00035099647,0.00036166297,0.00014806601,0.0004327963],"domain_scores_gemma":[0.99847436,0.0010768567,0.000047266432,0.00013667323,0.000024365601,0.00024050337],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025151568,0.00016440025,0.0008123334,0.00014641289,0.00005146362,0.0000074476147,0.000064790634,0.0002908923,0.015959011],"category_scores_gemma":[0.00019610036,0.00012394531,0.000072853996,0.0003921205,0.00022138465,0.00004015129,0.000034235713,0.0003026918,0.00011194618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016639702,0.0010530102,0.7303495,0.00005507671,0.00006474199,0.00074746006,0.000058018006,0.0000030763413,0.00008494098,0.0001360502,0.0015030708,0.26428112],"study_design_scores_gemma":[0.008992115,0.0019804977,0.9458021,0.00003094317,0.00009212924,0.000060825972,0.000022325798,0.00003580344,0.00009826291,0.00075534824,0.041997492,0.0001321491],"about_ca_topic_score_codex":0.00045540664,"about_ca_topic_score_gemma":0.0004899461,"teacher_disagreement_score":0.26414898,"about_ca_system_score_codex":0.00042955196,"about_ca_system_score_gemma":0.00032413166,"threshold_uncertainty_score":0.9849405},"labels":[],"label_agreement":null},{"id":"W2088902275","doi":"10.1016/j.ygyno.2005.04.009","title":"Papillary serous carcinoma—A less radio-sensitive subtype of endometrial cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Hysterectomy; Radioresistance; Carcinoma; Radiation therapy; Clear cell carcinoma; Biopsy; Stage (stratigraphy); Oncology; Serous fluid; Cancer; Internal medicine; Pathology; Biology","score_opus":0.04604910088207736,"score_gpt":0.3309521435185285,"score_spread":0.2849030426364511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088902275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97315603,0.0030161948,0.000016607977,0.0028385848,0.0011496983,0.000741571,0.00005487494,0.000067224755,0.018959217],"genre_scores_gemma":[0.99396235,0.0011019539,0.0009986896,0.00172639,0.0010727204,0.00010725599,0.000037768066,0.000021955073,0.0009709052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805737,0.00022332722,0.0005311715,0.00042050763,0.00027752243,0.0004901171],"domain_scores_gemma":[0.9976767,0.0012975872,0.0002825276,0.000272346,0.00024219396,0.00022869017],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033744142,0.00024266222,0.0010770945,0.00029757147,0.00007363813,0.000004520351,0.00013535089,0.00038306855,0.001756081],"category_scores_gemma":[0.00074666506,0.00018322891,0.0002296251,0.0007523353,0.00021942165,0.00005890072,0.000091846414,0.00029328678,0.000093356575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008597766,0.0026013535,0.26945108,0.00015563284,0.0009245899,0.0010921203,0.0005380893,0.00009583733,0.012014633,0.0005867076,0.003708373,0.7002338],"study_design_scores_gemma":[0.039907526,0.014572711,0.82191753,0.000045017834,0.0011879728,0.00033796293,0.00062120735,0.00007887059,0.0386043,0.0002539837,0.081977345,0.0004955915],"about_ca_topic_score_codex":0.0006266017,"about_ca_topic_score_gemma":0.0005797384,"teacher_disagreement_score":0.6997382,"about_ca_system_score_codex":0.0011063521,"about_ca_system_score_gemma":0.0006291221,"threshold_uncertainty_score":0.9991565},"labels":[],"label_agreement":null},{"id":"W2088947243","doi":"10.1016/j.ygyno.2014.05.016","title":"A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Adverse effect; Clinical endpoint; Oncology; Phases of clinical research; Endometrial cancer; Toxicity; Progressive disease; Progression-free survival; Tyrosine-kinase inhibitor; Cancer; Surgery; Chemotherapy; Clinical trial","score_opus":0.04853611210948144,"score_gpt":0.34689161806409785,"score_spread":0.2983555059546164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088947243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953291,0.00008348872,0.0000043323826,0.00030196962,0.0003155612,0.0032192357,0.0000463728,0.000011375622,0.00068860984],"genre_scores_gemma":[0.99898636,0.000031950753,0.00014703504,0.00015164095,0.00006698753,0.00055879855,0.000005429949,0.000010573876,0.00004120059],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974512,0.00084359944,0.0007403138,0.00033149924,0.0002974499,0.00033594048],"domain_scores_gemma":[0.9966353,0.002345403,0.0004893812,0.0002884657,0.00010447653,0.00013694272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010422292,0.00019748008,0.0012450747,0.00026920822,0.000069966656,0.0000036283716,0.00016354476,0.00010377769,0.00035179977],"category_scores_gemma":[0.0029163223,0.00009597638,0.00005648513,0.00093328743,0.00029905693,0.000023848026,0.00016811198,0.000258762,0.0000010484733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7030228,0.06232155,0.076217785,0.00027413873,0.00070987403,0.00020432677,0.0032589058,0.000004825762,0.00026806482,0.0001131928,0.000037831844,0.15356676],"study_design_scores_gemma":[0.59107345,0.31871438,0.08513407,0.000035646448,0.0005761108,0.00003609617,0.001998796,0.00001889875,0.00021817959,0.00014671024,0.0019236766,0.00012401347],"about_ca_topic_score_codex":0.0002203555,"about_ca_topic_score_gemma":0.0014301797,"teacher_disagreement_score":0.2563928,"about_ca_system_score_codex":0.0002684512,"about_ca_system_score_gemma":0.00045429665,"threshold_uncertainty_score":0.3913803},"labels":[],"label_agreement":null},{"id":"W2089343115","doi":"10.1016/j.ygyno.2014.03.492","title":"Treatment of low-risk GTN with biweekly actinomycin-D","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital; University of Toronto","funders":"","keywords":"Medicine; Methotrexate; Gestational trophoblastic neoplasia; Randomized controlled trial; Internal medicine; Oncology","score_opus":0.012906075073960712,"score_gpt":0.2833809676421334,"score_spread":0.2704748925681727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089343115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473079,0.00008870725,0.00026962723,0.0011833719,0.00018354566,0.0004603601,0.0000164169,0.000057204496,0.05043291],"genre_scores_gemma":[0.99199045,0.00012797772,0.006512096,0.0002101686,0.00010551881,0.000113806746,0.000018128847,0.000013654501,0.00090818474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889225,0.00013186802,0.00026138313,0.00028355385,0.00016029185,0.00027065276],"domain_scores_gemma":[0.99798924,0.0012276752,0.00023263413,0.00023521179,0.00018309223,0.0001321301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009862602,0.00017713073,0.0005888673,0.000095214215,0.000073452495,0.000002600997,0.000056983656,0.00010269718,0.00039756479],"category_scores_gemma":[0.0006854525,0.00011059134,0.000084291794,0.00013778014,0.0002778035,0.00002195984,0.000025644316,0.00007919876,0.00011666776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037124453,0.008094768,0.8479122,0.00025620137,0.0013334202,0.00059902837,0.0011319199,0.00042366024,0.0019354272,0.005477902,0.0020919158,0.12703112],"study_design_scores_gemma":[0.0067287437,0.034348354,0.9272267,0.000020001178,0.0005847602,0.00009823574,0.0005690708,0.00019437943,0.0005449552,0.000666573,0.028869262,0.0001489401],"about_ca_topic_score_codex":0.000037149242,"about_ca_topic_score_gemma":0.00006629894,"teacher_disagreement_score":0.12688218,"about_ca_system_score_codex":0.00028881637,"about_ca_system_score_gemma":0.0003269697,"threshold_uncertainty_score":0.4509784},"labels":[],"label_agreement":null},{"id":"W2090453433","doi":"10.1016/j.ygyno.2010.10.011","title":"An open-label, single-arm Phase II study of intravenous weekly (Days 1 and 8) topotecan in combination with carboplatin (Day 1) every 21days as second-line therapy in patients with platinum-sensitive relapsed ovarian cancer","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"GlaxoSmithKline","keywords":"Topotecan; Medicine; Carboplatin; Platinum; Phases of clinical research; Oncology; Internal medicine; Surgery; Chemotherapy; Cisplatin","score_opus":0.025037199839799518,"score_gpt":0.3150109359607031,"score_spread":0.2899737361209036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090453433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937188,0.000032061667,0.0000037344155,0.00081432605,0.0002387677,0.0039672493,0.000046822377,0.000025821642,0.0011523959],"genre_scores_gemma":[0.9980492,0.000028388018,0.00071740075,0.00051517354,0.0000375266,0.000477671,0.000094778545,0.000035444144,0.000044447188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997814,0.00033421948,0.00056006317,0.0006699911,0.00023778035,0.00038394402],"domain_scores_gemma":[0.99836195,0.00043564045,0.00041858814,0.00037637373,0.000254807,0.00015266557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369947,0.0003194062,0.00095908146,0.00027529543,0.00011944288,0.000023263518,0.00015685907,0.00030187174,0.0003992792],"category_scores_gemma":[0.000096893804,0.00023430435,0.000013626153,0.0004118038,0.00018872923,0.0001879503,0.00008318643,0.00055974425,0.0000011024531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015369957,0.20289819,0.5029514,0.000031440046,0.00045015727,0.00091051846,0.014161635,0.000073298615,0.005154169,0.0002775929,0.00003788089,0.25768375],"study_design_scores_gemma":[0.10038648,0.29991537,0.59677696,0.000053579937,0.000101984035,0.000015684429,0.0012134583,0.00010430866,0.0010128979,0.00011373912,0.000099517325,0.00020603863],"about_ca_topic_score_codex":0.002505771,"about_ca_topic_score_gemma":0.050321467,"teacher_disagreement_score":0.25747773,"about_ca_system_score_codex":0.0005882377,"about_ca_system_score_gemma":0.0006224126,"threshold_uncertainty_score":0.9670077},"labels":[],"label_agreement":null},{"id":"W2090869756","doi":"10.1016/j.ygyno.2010.09.011","title":"Physician and patient factors associated with follow up of high grade dysplasias of the cervix: A population-based study","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Medicine; Referral; Colposcopy; Population; Comorbidity; Logistic regression; Obstetrics; Multivariate analysis; Abnormality; Health care; Dysplasia; Cervix; Gynecology; Cervical cancer; Family medicine; Internal medicine; Cancer","score_opus":0.03456258150745868,"score_gpt":0.3186498661701245,"score_spread":0.2840872846626658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090869756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708736,0.0000119782235,0.0000012361272,0.0006691874,0.00027452462,0.0009178609,0.000022481305,0.000016628192,0.0009987714],"genre_scores_gemma":[0.9995506,8.605005e-7,0.000030252497,0.00028929446,0.000018015146,0.00004326033,0.000020951547,0.000010352471,0.000036441965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878156,0.00018894266,0.0002736408,0.00021272825,0.00032152655,0.00022161608],"domain_scores_gemma":[0.99830836,0.0009054083,0.00023227707,0.00025540046,0.00021656246,0.00008198059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018845545,0.000122119,0.00050767424,0.00007178185,0.00008022263,0.0000034856948,0.00011800366,0.00016436339,0.0005071951],"category_scores_gemma":[0.0006793386,0.00006678691,0.00006775886,0.00029979905,0.00016787834,0.000019300389,0.00006952997,0.00036392704,6.445783e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027555908,0.001703407,0.9863163,0.00002796298,0.00011641798,0.0000060983725,0.00064156647,0.000013635719,0.00064297626,0.000099717116,0.000041514955,0.010114793],"study_design_scores_gemma":[0.0042946306,0.007259217,0.9859021,0.000006484543,0.00014370673,6.183087e-7,0.0007559901,0.000044889617,0.0011978036,0.00022493981,0.00010372586,0.0000659298],"about_ca_topic_score_codex":0.00083172764,"about_ca_topic_score_gemma":0.011432903,"teacher_disagreement_score":0.010601176,"about_ca_system_score_codex":0.00013239229,"about_ca_system_score_gemma":0.00025504615,"threshold_uncertainty_score":0.63798285},"labels":[],"label_agreement":null},{"id":"W2091617338","doi":"10.1016/j.ygyno.2009.04.018","title":"The role of PET/CT in the management of patients with cervical cancer: Practice patterns of the members of the Society of Gynecologic Oncologists","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cervical cancer; Modalities; Disease; Cancer; Radiology; Medical physics; Internal medicine","score_opus":0.014120606194902212,"score_gpt":0.30570280785253007,"score_spread":0.2915822016576279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091617338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98167515,0.0006316789,0.0000017281576,0.006226183,0.00025839038,0.0018757259,0.00006110878,0.000006806604,0.00926324],"genre_scores_gemma":[0.9971453,0.0009933291,0.0003468194,0.0012763486,0.000020123773,0.00012739719,0.0000058436167,0.000008165798,0.000076691394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970524,0.000741941,0.00090536097,0.00028047344,0.0006604846,0.00035936266],"domain_scores_gemma":[0.99417686,0.00326046,0.0015093484,0.0006685687,0.00034179757,0.000042950407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010841478,0.0002185105,0.0008273491,0.000044099703,0.000098794415,0.000002753915,0.0008263168,0.00009149701,0.00019682775],"category_scores_gemma":[0.0004745895,0.00008222604,0.00039691615,0.0008234391,0.00065146707,0.000044339686,0.00024181827,0.00037887224,5.7439524e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025373453,0.0070912326,0.924636,0.00038227608,0.0011147024,0.000035581612,0.0009031064,0.00028407414,0.00015984374,0.0019587534,0.00026896974,0.060628112],"study_design_scores_gemma":[0.005648305,0.0061857784,0.9755816,0.000093365445,0.0008565892,0.0000127309395,0.0045773406,0.000018654275,0.001319054,0.0007151554,0.004909971,0.00008146706],"about_ca_topic_score_codex":0.0007972472,"about_ca_topic_score_gemma":0.001130635,"teacher_disagreement_score":0.060546644,"about_ca_system_score_codex":0.00043553373,"about_ca_system_score_gemma":0.00033891128,"threshold_uncertainty_score":0.33530807},"labels":[],"label_agreement":null},{"id":"W2091938246","doi":"10.1016/j.ygyno.2004.03.020","title":"A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian cancer","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Temozolomide; Medicine; Toxicity; Ovarian cancer; Chemotherapy; Internal medicine; Ovarian carcinoma; Oncology; Phases of clinical research; Gastroenterology; Cancer; Surgery; Urology","score_opus":0.036127711828768824,"score_gpt":0.36129383086308176,"score_spread":0.3251661190343129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091938246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252725,0.0002690295,0.000009246202,0.0032825824,0.00043333234,0.001616834,0.00005006692,0.000018401135,0.0017932337],"genre_scores_gemma":[0.9976773,0.00008996881,0.0010386811,0.00038234063,0.00006537596,0.0006557645,0.00006113868,0.000011804747,0.00001761943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985262,0.00013660405,0.00038049152,0.00033844096,0.00034127888,0.00027698342],"domain_scores_gemma":[0.99905807,0.00009592821,0.00023532564,0.00021748945,0.0003024132,0.00009080509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051791605,0.00015951296,0.00051089196,0.0001472072,0.000052372343,0.0000025811648,0.00006611563,0.00016603731,0.00080544164],"category_scores_gemma":[0.00019368956,0.00011191419,0.0000567051,0.00024950336,0.000097148375,0.000047305875,0.000037975286,0.00015499553,0.000011220656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00352757,0.03353081,0.29550347,0.00004321125,0.00028993833,0.00006758306,0.00081005995,0.0008294267,0.00017199505,0.0005561228,0.0002230089,0.66444683],"study_design_scores_gemma":[0.10270404,0.040415723,0.85229623,0.00011565376,0.0005949196,0.000004316362,0.00005788274,0.00005565095,0.0006793319,0.0007240327,0.0022185403,0.00013366208],"about_ca_topic_score_codex":0.00033447237,"about_ca_topic_score_gemma":0.0016991467,"teacher_disagreement_score":0.66431314,"about_ca_system_score_codex":0.0023973593,"about_ca_system_score_gemma":0.0014873791,"threshold_uncertainty_score":0.88190216},"labels":[],"label_agreement":null},{"id":"W2091998086","doi":"10.1016/j.ygyno.2011.02.020","title":"MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Institutes of Health","keywords":"Gene knockdown; Carcinogenesis; Cell growth; Cancer research; Biology; Cell; Cytoplasm; Cell culture; Cell biology; Cancer","score_opus":0.031028473054384206,"score_gpt":0.2849403432867452,"score_spread":0.253911870232361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091998086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97357833,0.0013984011,0.0001675707,0.00046173524,0.00035897177,0.00044973195,0.000055059863,0.000034435867,0.02349577],"genre_scores_gemma":[0.990887,0.002017353,0.00385464,0.0005549764,0.00017937517,0.00021345778,0.00004027396,0.000025195495,0.0022277385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982725,0.0002788947,0.00028077015,0.0005516788,0.00012822867,0.00048794597],"domain_scores_gemma":[0.99913347,0.00005969425,0.00012678349,0.00030422918,0.0001846676,0.00019113961],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044261527,0.00021686354,0.0002975789,0.00006955355,0.00017576231,0.000017036575,0.00026928305,0.00037545827,0.002388043],"category_scores_gemma":[0.000217374,0.00018413065,0.00009044836,0.00012361878,0.00023980958,0.000009328492,0.0002573475,0.00013610232,0.0000556808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008144143,0.00084857474,0.020882506,0.00008936387,0.00027830328,0.00014687522,0.0005006198,0.000008046277,0.8744088,0.0017925805,0.005592644,0.09463728],"study_design_scores_gemma":[0.0019903968,0.0025566064,0.07075486,0.0000040720874,0.00008138073,0.00005414033,0.00032481283,0.000039699094,0.80790234,0.0013079694,0.11454147,0.00044226594],"about_ca_topic_score_codex":0.0010319067,"about_ca_topic_score_gemma":0.001652607,"teacher_disagreement_score":0.10894883,"about_ca_system_score_codex":0.00007962554,"about_ca_system_score_gemma":0.000247199,"threshold_uncertainty_score":0.9985239},"labels":[],"label_agreement":null},{"id":"W2092092230","doi":"10.1016/j.ygyno.2011.12.062","title":"Classifying endocervical adenocarcinoma (EADC) by pattern correlates better with the presence or absence of lymph node (LN) metastasis than using tumor depth of invasion","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Lymph node metastasis; Adenocarcinoma; Metastasis; Lymph node; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.06731152495171942,"score_gpt":0.3208683018893459,"score_spread":0.25355677693762646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092092230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466413,0.001808366,0.0005974771,0.0012206767,0.00028867705,0.0005765227,0.00003693096,0.000026975591,0.0007802225],"genre_scores_gemma":[0.99590576,0.00007306664,0.0019984222,0.0017208188,0.000109766035,0.00007295631,0.000017848375,0.000022485445,0.00007886294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978785,0.00033544868,0.00050279463,0.0003344981,0.00037597472,0.0005727934],"domain_scores_gemma":[0.996459,0.0023871148,0.00047621483,0.00035325735,0.00013153521,0.00019284434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042274393,0.00025874277,0.0008380903,0.00010898785,0.00010262283,0.0000057811108,0.00025202936,0.00018535313,0.0007968987],"category_scores_gemma":[0.00043753147,0.00012748965,0.00013180771,0.0004904874,0.00042630432,0.00012710434,0.00018180869,0.0002721535,0.000016514297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010890481,0.0008493757,0.968696,0.0001629539,0.00026804185,0.00010291744,0.0003267617,0.00001250101,0.006093166,0.000018845629,0.00025216208,0.02212824],"study_design_scores_gemma":[0.0059515457,0.0036333005,0.9689144,0.00012581775,0.00090596266,0.0004504002,0.0010678001,0.00027343666,0.017509859,0.000036333207,0.000907311,0.000223865],"about_ca_topic_score_codex":0.00044736214,"about_ca_topic_score_gemma":0.00015821595,"teacher_disagreement_score":0.021904374,"about_ca_system_score_codex":0.00029863347,"about_ca_system_score_gemma":0.00025569898,"threshold_uncertainty_score":0.87254816},"labels":[],"label_agreement":null},{"id":"W2092148144","doi":"10.1016/j.ygyno.2005.11.025","title":"Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Regimen; Internal medicine; Paclitaxel; Ovarian cancer; Prospective cohort study; Gastroenterology; Chemotherapy; Surgery; Toxicity; Oncology; Cancer","score_opus":0.030082444865835615,"score_gpt":0.35884730214217925,"score_spread":0.32876485727634364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092148144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93736666,0.0021254744,0.00002439332,0.02878192,0.00071672496,0.002685967,0.00018757585,0.00006350531,0.028047768],"genre_scores_gemma":[0.99353707,0.0004718664,0.0029902987,0.0005457822,0.00024670706,0.0012681854,0.000028204837,0.00001899466,0.0008929045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979351,0.00022404226,0.00067314715,0.00049267244,0.00024843944,0.00042659263],"domain_scores_gemma":[0.998392,0.0005705032,0.00035708892,0.00032157855,0.00023060401,0.00012822347],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000594841,0.00022376506,0.0008334153,0.00018518564,0.00006701121,0.0000070827477,0.00011253173,0.00026155246,0.0041043707],"category_scores_gemma":[0.0004603206,0.00017935569,0.00011299621,0.00030683284,0.00016841893,0.000062150284,0.00005672327,0.0002812656,0.000082425904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038333,0.012071829,0.40096235,0.0001359468,0.0009537994,0.00042752124,0.0043423595,0.00038895372,0.0066603264,0.013212653,0.011722353,0.5452886],"study_design_scores_gemma":[0.012002812,0.007998617,0.9357345,0.00012205156,0.00038136973,0.00002107097,0.0004961739,0.00013901034,0.0015871306,0.0014703934,0.03983817,0.00020868587],"about_ca_topic_score_codex":0.0004897238,"about_ca_topic_score_gemma":0.005275372,"teacher_disagreement_score":0.54507995,"about_ca_system_score_codex":0.0023942462,"about_ca_system_score_gemma":0.0010994409,"threshold_uncertainty_score":0.996806},"labels":[],"label_agreement":null},{"id":"W2092422456","doi":"10.1016/j.ygyno.2014.07.088","title":"Incidence of ano-genital and head and neck malignancies in women with a previous diagnosis of cervical intraepithelial neoplasia","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Centre for Advancing Health Outcomes; Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Cervix; Gynecology; Vulva; Incidence (geometry); Vagina; Cervical intraepithelial neoplasia; Cervical cancer; Intraepithelial neoplasia; Anal cancer; Obstetrics; Vaginal cancer; Cancer; Sex organ; Cancer registry; Internal medicine; Dermatology; Surgery; Prostate cancer","score_opus":0.015281128827745767,"score_gpt":0.30270853839557643,"score_spread":0.28742740956783064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092422456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952653,0.00052746217,0.000009822375,0.0009869653,0.000032918288,0.00044151038,0.000008203581,0.000011741649,0.002716052],"genre_scores_gemma":[0.99792576,0.0007251121,0.00065852585,0.00044033566,0.000041221916,0.0001740353,0.0000017848926,0.0000085253005,0.000024699051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986909,0.00015643254,0.00033676723,0.0002780413,0.00018366006,0.0003542006],"domain_scores_gemma":[0.99841744,0.0010301153,0.000098841774,0.00015416191,0.00012942715,0.00017003092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048172232,0.00012639965,0.0006891727,0.00012896677,0.00002668468,0.0000048684738,0.000091144415,0.00019493068,0.0006244925],"category_scores_gemma":[0.00073610793,0.000089932895,0.000021938442,0.00022401208,0.00057547726,0.000045135686,0.00014951632,0.00023375555,0.000002310958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022726494,0.00042136403,0.8297763,0.00043252553,0.000030313284,0.000070970425,0.0012175663,0.0000025172965,0.0005473097,0.00024626814,0.000042302036,0.16493993],"study_design_scores_gemma":[0.0036779714,0.01609452,0.97709167,0.00004304171,0.000032069787,0.000101526195,0.0003620097,0.00007119908,0.00068116654,0.0005768886,0.0011800787,0.00008784969],"about_ca_topic_score_codex":0.00023991431,"about_ca_topic_score_gemma":0.0020948472,"teacher_disagreement_score":0.16485208,"about_ca_system_score_codex":0.0001471468,"about_ca_system_score_gemma":0.00024970926,"threshold_uncertainty_score":0.6837755},"labels":[],"label_agreement":null},{"id":"W2092697205","doi":"10.1016/j.ygyno.2005.11.019","title":"Systematic review of systemic therapy for advanced or recurrent endometrial cancer","year":2006,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McMaster University; London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Doxorubicin; Oncology; Internal medicine; Regimen; Cisplatin; Chemotherapy; Randomized controlled trial; Paclitaxel; Endometrial cancer; Medroxyprogesterone acetate; Cochrane Library; Cancer; Estrogen","score_opus":0.10444626157791387,"score_gpt":0.4476941645453757,"score_spread":0.3432479029674618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092697205","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000052186106,0.96945745,0.000016217906,0.0000967188,0.0027151154,0.026371324,0.00048635295,0.00007352809,0.00077807583],"genre_scores_gemma":[0.0000075126322,0.9726872,0.00040013963,0.0005276012,0.00056721113,0.023903025,0.00047024837,0.0000723195,0.0013647838],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99419105,0.0008980367,0.0031328183,0.000766156,0.0004135656,0.00059835904],"domain_scores_gemma":[0.98758,0.008104679,0.0030127726,0.0006621019,0.00045916365,0.00018129885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012698611,0.0007421864,0.012920139,0.00051906955,0.00006590146,0.000007053952,0.00042361367,0.0008409264,0.00085986784],"category_scores_gemma":[0.0057632555,0.0003835298,0.0019778423,0.001459883,0.00010615053,0.000033676268,0.000076441705,0.00040138882,0.00003851253],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005152562,0.00045473935,9.160441e-7,0.5626064,0.00093595247,0.00003338366,0.0000033915373,7.276632e-8,5.0612186e-7,0.00001731738,0.0008968567,0.4345352],"study_design_scores_gemma":[0.0065163965,0.007829421,8.1362947e-7,0.5273617,0.010057405,0.00015234301,0.0000079152605,2.1111717e-7,0.0000017714855,0.000013398185,0.44781786,0.00024079169],"about_ca_topic_score_codex":0.000030012825,"about_ca_topic_score_gemma":0.000027870146,"teacher_disagreement_score":0.446921,"about_ca_system_score_codex":0.0024224517,"about_ca_system_score_gemma":0.0027019486,"threshold_uncertainty_score":0.99986166},"labels":[],"label_agreement":null},{"id":"W2092859040","doi":"10.1016/j.ygyno.2010.05.022","title":"Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; National Cancer Institute; Ludwig Institute for Cancer Research","keywords":"Medicine; Cervical intraepithelial neoplasia; Antioxidant; Nutrient; Consumption (sociology); Internal medicine; Cervical cancer; Biochemistry; Cancer; Biology","score_opus":0.025415584601915463,"score_gpt":0.34218632743783484,"score_spread":0.3167707428359194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092859040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952468,0.00019984461,0.000017267253,0.00041317227,0.00038503544,0.00041005205,0.000036200276,0.000018586177,0.0032730033],"genre_scores_gemma":[0.9968048,0.001977136,0.0009057595,0.00012338134,0.000110409055,0.000021718606,0.000010788281,0.000007642316,0.000038386795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986925,0.00014692839,0.00041888215,0.00024651378,0.00023581482,0.00025932945],"domain_scores_gemma":[0.99844885,0.00073667173,0.0001975352,0.00021437946,0.00022307008,0.0001795079],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000592311,0.000110845154,0.00054415,0.00012506981,0.00004777045,0.000003046742,0.0001055832,0.0003242781,0.003648785],"category_scores_gemma":[0.0009454662,0.00008397944,0.00008276864,0.000121429344,0.00061107887,0.000032910102,0.0001535955,0.00060047006,0.0000235083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011552438,0.0007168333,0.81792575,0.00021567874,0.00008355496,0.00004129545,0.0001584418,7.773023e-7,0.028138706,0.00028460592,0.00015326552,0.15112583],"study_design_scores_gemma":[0.0029682291,0.0033613523,0.9847415,0.0000064006163,0.00015683053,0.000072190924,0.00007278309,0.00012633254,0.0052881963,0.0008184381,0.0023183373,0.000069385715],"about_ca_topic_score_codex":0.00024346792,"about_ca_topic_score_gemma":0.0010489053,"teacher_disagreement_score":0.16681576,"about_ca_system_score_codex":0.000065775945,"about_ca_system_score_gemma":0.00022931998,"threshold_uncertainty_score":0.997262},"labels":[],"label_agreement":null},{"id":"W2092869153","doi":"10.1006/gyno.2001.6437","title":"“What Doesn't Kill You Makes You Stronger”: An Ovarian Cancer Survivor Survey","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ovarian cancer; Disease; Quality of life (healthcare); Population; Cancer survivor; Human sexuality; Cancer; Fertility; Gerontology; Reproductive health; Sexual function; Gynecology; Internal medicine","score_opus":0.05322735751817815,"score_gpt":0.3555524050434101,"score_spread":0.302325047525232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092869153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96138996,0.0021041692,0.00007391913,0.0070606596,0.01127111,0.00084565254,0.00013003303,0.0003094416,0.016815033],"genre_scores_gemma":[0.9747202,0.0036595047,0.00019425497,0.0066863517,0.0010638734,0.00033031084,0.00042677094,0.00006841046,0.012850345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960291,0.0009193832,0.0006132869,0.0009676047,0.00038868142,0.0010819553],"domain_scores_gemma":[0.99715203,0.0007333433,0.00026081686,0.00085472845,0.0004555928,0.000543481],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015813151,0.0004557201,0.0010814331,0.00021884171,0.00021238484,0.00009445437,0.0004147891,0.0007674401,0.00926087],"category_scores_gemma":[0.0004899067,0.00037479226,0.00020221162,0.0005987053,0.00033258865,0.00043236793,0.00014812665,0.00064601755,0.00022159833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014415791,0.0011398083,0.80961293,0.00005577432,0.00024748116,0.0009602324,0.001562917,0.000042381682,0.00045929645,0.0003411595,0.0047340426,0.17940243],"study_design_scores_gemma":[0.0024778366,0.0026768118,0.7093564,0.000028985818,0.00017195678,0.00015042843,0.0029049828,0.000056423956,0.00008855324,0.00024655974,0.28142726,0.0004137679],"about_ca_topic_score_codex":0.01676802,"about_ca_topic_score_gemma":0.36776346,"teacher_disagreement_score":0.35099545,"about_ca_system_score_codex":0.0010059865,"about_ca_system_score_gemma":0.00090334844,"threshold_uncertainty_score":0.9998704},"labels":[],"label_agreement":null},{"id":"W2092966547","doi":"10.1016/j.ygyno.2006.07.028","title":"Response to Maneo et al.","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Trachelectomy; Cervical cancer; Gynecology; General surgery; Cancer; Internal medicine","score_opus":0.025653195627968684,"score_gpt":0.34629861764751857,"score_spread":0.3206454220195499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092966547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81849563,0.00011625338,0.00011595975,0.13962744,0.00048519287,0.0005028351,0.00000479075,0.00011843865,0.040533476],"genre_scores_gemma":[0.92615265,0.0000100654825,0.0028573885,0.06403012,0.00008554798,0.0000932982,0.000020560463,0.000009301616,0.006741046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9981109,0.0006322816,0.00027470058,0.00054058724,0.00008676207,0.00035476426],"domain_scores_gemma":[0.99845433,0.0008198626,0.00006549294,0.00043782758,0.00011314008,0.00010936451],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018629787,0.00014690512,0.00040997125,0.00010754125,0.00007679165,0.000003805347,0.000107430176,0.00025692247,0.00086432137],"category_scores_gemma":[0.002171416,0.00010780667,0.00008196312,0.00017721388,0.00019296746,0.000028064624,0.00009018043,0.0002741251,0.00084467744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051431455,0.002125998,0.12802799,0.000012041646,0.00006573578,0.0012618202,0.00016911558,0.0000335524,0.20393656,0.0017364207,0.588553,0.022646293],"study_design_scores_gemma":[0.00053209485,0.0022054089,0.5112725,0.0000014979222,0.000012537421,0.00011278197,0.000023801542,0.0000019440072,0.0009199643,0.00076762936,0.48409003,0.000059820602],"about_ca_topic_score_codex":0.000040959963,"about_ca_topic_score_gemma":0.00007615726,"teacher_disagreement_score":0.3832445,"about_ca_system_score_codex":0.00028625614,"about_ca_system_score_gemma":0.0002550024,"threshold_uncertainty_score":0.9999333},"labels":[],"label_agreement":null},{"id":"W2093339404","doi":"10.1016/j.ygyno.2008.01.043","title":"P16 expression in relation to human papillomavirus in liquid-based cervical smears","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Ascus (bryozoa); Medicine; Cervical cancer; HPV infection; Immunocytochemistry; Cervical intraepithelial neoplasia; Human papillomavirus; Oncology; Cancer; Pathology; Internal medicine; Biology","score_opus":0.07713024717275593,"score_gpt":0.39378019263385317,"score_spread":0.31664994546109726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093339404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95024806,0.000110089866,0.00004185655,0.0038094555,0.00012617667,0.00074483355,0.0000021561973,0.00005601057,0.04486136],"genre_scores_gemma":[0.9947937,0.000048332986,0.001021357,0.0034538377,0.00010422734,0.00023007975,0.000027005137,0.000016238004,0.0003051957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794877,0.0003084777,0.00046215334,0.0004434168,0.00029666038,0.00054054364],"domain_scores_gemma":[0.9988075,0.00052303536,0.000053223703,0.00027094272,0.00008742075,0.00025788156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005574846,0.00014916093,0.0005188832,0.00044188395,0.00009782021,0.0000040455916,0.00015524826,0.00045841478,0.006507967],"category_scores_gemma":[0.0006573228,0.0001263582,0.000071512026,0.00059336587,0.00013197392,0.000048286023,0.00011842562,0.0006630029,0.00032548295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009420779,0.0043163286,0.8441099,0.00018579025,0.000017814149,0.0057579563,0.0017743866,0.0008973486,0.076123334,0.0006238098,0.00539396,0.051378604],"study_design_scores_gemma":[0.004604131,0.0053229937,0.97244096,0.000021582575,0.0000060431094,0.00002173725,0.00007225171,0.00014996206,0.002310879,0.00027438515,0.014639231,0.0001358488],"about_ca_topic_score_codex":0.00024607804,"about_ca_topic_score_gemma":0.002221526,"teacher_disagreement_score":0.12833107,"about_ca_system_score_codex":0.0012130347,"about_ca_system_score_gemma":0.00046363164,"threshold_uncertainty_score":0.9944002},"labels":[],"label_agreement":null},{"id":"W2093993158","doi":"10.1016/j.ygyno.2004.04.008","title":"Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Radiation therapy; Cervical cancer; Hemoglobin; Proportional hazards model; Oncology; Retrospective cohort study; Stage (stratigraphy); Multivariate analysis; Cancer; Surgery","score_opus":0.021639258769043414,"score_gpt":0.28378020792501063,"score_spread":0.2621409491559672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093993158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432373,0.00013668563,0.000033723678,0.0007845725,0.00024299807,0.0033415842,0.00004427757,0.000081301274,0.0010111141],"genre_scores_gemma":[0.9969839,0.00003832674,0.0018690778,0.00038364498,0.000044202112,0.00051615934,0.00008179438,0.00003803444,0.00004489173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641794,0.00075442565,0.00086560106,0.0007716936,0.00048290667,0.0007074286],"domain_scores_gemma":[0.9970359,0.001310799,0.0007394093,0.0003109404,0.00035498454,0.00024792503],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010983661,0.00044245023,0.0014797051,0.00033911422,0.00010705226,0.000012872408,0.00019493514,0.00065081526,0.00021385639],"category_scores_gemma":[0.0005565357,0.0003194964,0.00008486514,0.0005955662,0.0003892097,0.000098642995,0.000117088224,0.00049541343,0.000006473542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040340857,0.009692026,0.9724882,0.00010106535,0.0005261707,0.0008690891,0.00093218026,0.000023870229,0.00025720207,0.0000729702,0.00005498628,0.0109481085],"study_design_scores_gemma":[0.04182339,0.04391888,0.9117841,0.00004041846,0.00048712225,0.000042769687,0.0010452697,0.000047396294,0.000118548356,0.000040201547,0.00034400597,0.00030791148],"about_ca_topic_score_codex":0.00024673826,"about_ca_topic_score_gemma":0.004626561,"teacher_disagreement_score":0.06070416,"about_ca_system_score_codex":0.0045234268,"about_ca_system_score_gemma":0.0007527592,"threshold_uncertainty_score":0.99992573},"labels":[],"label_agreement":null},{"id":"W2094305394","doi":"10.1016/j.ygyno.2007.02.022","title":"The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Debulking; Medicine; Chemotherapy; Ovarian cancer; Oncology; Stage (stratigraphy); Internal medicine; Proportional hazards model; Neoadjuvant therapy; Hazard ratio; Surgery; Cancer; Confidence interval; Breast cancer","score_opus":0.019977366058998372,"score_gpt":0.3154018376649635,"score_spread":0.29542447160596513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094305394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953352,0.0005958528,0.000009028014,0.002049825,0.000092872266,0.0009119558,0.00002762461,0.00001341346,0.00096420443],"genre_scores_gemma":[0.9979152,0.00097048585,0.00047298003,0.00038387606,0.000033974124,0.0001062267,0.000009830487,0.000015458696,0.000091972775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842334,0.00021852358,0.0005191697,0.0003116183,0.0001762489,0.00035109423],"domain_scores_gemma":[0.9967622,0.00246617,0.0003209757,0.00021074146,0.00014770594,0.000092215654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009877702,0.00017233889,0.0006308541,0.000098579156,0.00005968887,0.000003832194,0.00008501434,0.00019520396,0.000070927366],"category_scores_gemma":[0.00012837393,0.00009928052,0.000052485622,0.00026561716,0.00035059144,0.000025418709,0.000030217383,0.00016414857,8.452091e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043960806,0.001669713,0.8216502,0.000035544275,0.00023044471,0.00043705167,0.0005020405,0.000017753175,0.0017848006,0.00011379842,0.00006442502,0.12953341],"study_design_scores_gemma":[0.014400454,0.009951739,0.9654609,0.00005879119,0.00010185829,0.000022445201,0.00010623007,0.000016502727,0.004260497,0.00003179866,0.005489718,0.00009906872],"about_ca_topic_score_codex":0.0007717605,"about_ca_topic_score_gemma":0.0015589749,"teacher_disagreement_score":0.14381069,"about_ca_system_score_codex":0.0006133543,"about_ca_system_score_gemma":0.00050144317,"threshold_uncertainty_score":0.4048542},"labels":[],"label_agreement":null},{"id":"W2094755056","doi":"10.1016/j.ygyno.2005.08.034","title":"The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: A patient care evaluation study from the American College of Surgeons National Cancer Data Base","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Cancer; Surgery; Stage (stratigraphy); Adjuvant therapy; Uterine cancer; Disease; Internal medicine; Oncology","score_opus":0.06272661811327947,"score_gpt":0.360860993670702,"score_spread":0.29813437555742256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094755056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912315,0.0019165121,8.2221067e-7,0.00085273123,0.00021720378,0.0020636623,0.0037036755,0.0000069374582,0.0000069434354],"genre_scores_gemma":[0.99454266,0.0041632797,0.0000802822,0.0003814653,0.000049580143,0.00045127358,0.00031635596,0.000008890086,0.0000061866062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980657,0.00056922145,0.0004267128,0.000301962,0.00046686074,0.0001695449],"domain_scores_gemma":[0.9965552,0.0020169416,0.0006195411,0.00030880384,0.00044899623,0.000050535436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003966693,0.00014080854,0.00045926578,0.00008372701,0.00011743339,0.000004692678,0.00014834823,0.000045817713,0.0001260436],"category_scores_gemma":[0.00070869725,0.00007002789,0.000027138834,0.00036978337,0.00022945095,0.00008632789,0.00013995742,0.00013700694,2.7023182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021388805,0.00071129954,0.59950846,0.0000031386344,0.00016104637,0.00000208354,0.0006901814,0.0001474994,0.000007610476,9.493559e-7,0.00015822351,0.39647064],"study_design_scores_gemma":[0.01180222,0.012947361,0.9693667,0.000016575228,0.00019661238,2.8829905e-7,0.0009217325,0.00041978122,0.00004449442,0.000008696696,0.0042072274,0.00006830101],"about_ca_topic_score_codex":0.009851762,"about_ca_topic_score_gemma":0.059002753,"teacher_disagreement_score":0.39640233,"about_ca_system_score_codex":0.0007149799,"about_ca_system_score_gemma":0.00061690976,"threshold_uncertainty_score":0.9967417},"labels":[],"label_agreement":null},{"id":"W2095088551","doi":"10.1016/j.ygyno.2009.09.040","title":"Adenocarcinoma: A unique cervical cancer","year":2009,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Cervix; Medicine; Adenocarcinoma; Basal cell; Oncology; Cervical cancer; Cancer; Squamous carcinoma; Carcinoma; Internal medicine; Gynecology","score_opus":0.10246285469462146,"score_gpt":0.4238178381886665,"score_spread":0.321354983494045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095088551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019884077,0.96489984,0.000004157187,0.0011350762,0.0009895093,0.002082134,0.0000657029,0.00019365187,0.030610066],"genre_scores_gemma":[0.00008481178,0.9905096,0.00051912764,0.0028453055,0.0010552438,0.0012438418,0.00024213627,0.000059791106,0.0034401305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648803,0.00051633705,0.0009793041,0.0009199706,0.00028962636,0.00080673135],"domain_scores_gemma":[0.9971431,0.0012046159,0.00048471417,0.0005578685,0.00012566039,0.00048403352],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003071263,0.0007100341,0.0049117054,0.0004033212,0.000102221355,0.000015582917,0.0003696604,0.0019339757,0.0058446135],"category_scores_gemma":[0.0004005132,0.00046014614,0.0010586864,0.0009922993,0.00015865472,0.000035535766,0.00016640217,0.0012290446,0.0007272401],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009803209,0.0008020133,0.00017121535,0.0039281575,0.0004951314,0.0014259578,0.000012359959,1.0946056e-7,1.2880848e-7,0.00023796462,0.003320149,0.9895088],"study_design_scores_gemma":[0.002334596,0.0044739754,0.0014506149,0.0016462223,0.004941041,0.00053155905,0.00000812574,5.9866073e-7,5.5286046e-7,0.0003387488,0.9838878,0.00038619636],"about_ca_topic_score_codex":0.00013814657,"about_ca_topic_score_gemma":0.00016120881,"teacher_disagreement_score":0.98912257,"about_ca_system_score_codex":0.0031890194,"about_ca_system_score_gemma":0.002846597,"threshold_uncertainty_score":0.999785},"labels":[],"label_agreement":null},{"id":"W2095194845","doi":"10.1016/j.ygyno.2009.07.025","title":"Utilization of preoperative imaging in uterine cancer patients","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Malignancy; Radiology; Cancer registry; Cancer; Ultrasound; Magnetic resonance imaging; Internal medicine","score_opus":0.03868936131343118,"score_gpt":0.37887945239607357,"score_spread":0.34019009108264237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095194845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843689,0.00036082254,0.000022889308,0.0014233979,0.00023701167,0.00047695643,0.000010780965,0.00002037077,0.013078836],"genre_scores_gemma":[0.99752885,0.00027348936,0.00029885577,0.0015681736,0.00004095462,0.00005084852,0.000029712448,0.000003968332,0.0002051614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918956,0.000068118956,0.00027897532,0.00018368008,0.000097592725,0.00018210355],"domain_scores_gemma":[0.999535,0.000113171634,0.00009968907,0.00008359901,0.00011491885,0.000053613596],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008909616,0.00009384021,0.0003511579,0.00012990471,0.000018488912,0.0000019352628,0.0000495912,0.000077945,0.00095421216],"category_scores_gemma":[0.00024151248,0.00006895538,0.00004078538,0.00032488463,0.000041993047,0.000049761293,0.00002173369,0.0000855056,0.000007636594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004023692,0.0014170374,0.71309197,0.000016313817,0.000014309093,0.000032608103,0.00018100523,0.000014513701,0.0005016744,0.00012167146,0.00013095957,0.28407556],"study_design_scores_gemma":[0.00563446,0.003364037,0.9863801,0.000020001424,0.000033446137,0.0000023306663,0.00004344474,0.00006551461,0.0020465334,0.0003875708,0.0019641442,0.000058445727],"about_ca_topic_score_codex":0.00010048496,"about_ca_topic_score_gemma":0.00013167513,"teacher_disagreement_score":0.28401712,"about_ca_system_score_codex":0.000421691,"about_ca_system_score_gemma":0.0001230623,"threshold_uncertainty_score":0.99995905},"labels":[],"label_agreement":null},{"id":"W2095234732","doi":"10.1016/j.ygyno.2009.04.034","title":"Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: Results of a multicenter phase II study","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Johnson and Johnson; PharmaMar","keywords":"Medicine; Trabectedin; Nausea; Endometrial cancer; Clinical endpoint; Adverse effect; Internal medicine; Vomiting; Surgery; Population; Phases of clinical research; Chemotherapy; Cancer; Clinical trial","score_opus":0.11446827957044008,"score_gpt":0.40396383889791815,"score_spread":0.28949555932747806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095234732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890453,0.0024296397,0.0000020865266,0.0015926021,0.0013229776,0.0026983807,0.00018385188,0.00004676731,0.0026783668],"genre_scores_gemma":[0.9964046,0.0013045471,0.00026019936,0.0007167663,0.00030935917,0.00015448713,0.00005542969,0.000013894054,0.00078075274],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9970208,0.00034486255,0.0012119217,0.00055067305,0.00042381827,0.00044791878],"domain_scores_gemma":[0.99731165,0.0011004634,0.0006682787,0.0003548821,0.00032706713,0.00023763986],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005954594,0.00031064235,0.0014095413,0.00041706147,0.000082929626,0.0000047640306,0.00021328725,0.0002446923,0.0038995002],"category_scores_gemma":[0.0017916773,0.00019632223,0.00048250004,0.00091622624,0.00013264813,0.00004542237,0.0000669443,0.00027799568,0.000008591327],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1862054,0.07668749,0.0010156808,0.000039083436,0.0012003081,0.0002740845,0.0020239493,0.000008380446,0.018000865,0.000005823047,0.0004990495,0.71403986],"study_design_scores_gemma":[0.2199959,0.71803594,0.010876462,0.0000639991,0.0007874169,0.000029870147,0.0013731853,0.0000355739,0.02020587,0.000037688027,0.028325126,0.00023296612],"about_ca_topic_score_codex":0.00018177633,"about_ca_topic_score_gemma":0.0003715685,"teacher_disagreement_score":0.7138069,"about_ca_system_score_codex":0.00079045445,"about_ca_system_score_gemma":0.00040781454,"threshold_uncertainty_score":0.99701107},"labels":[],"label_agreement":null},{"id":"W2095459904","doi":"10.1016/j.ygyno.2005.07.008","title":"Who should operate on patients with ovarian cancer? An evidence-based review","year":2005,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cochrane Library; Specialty; MEDLINE; Ovarian cancer; Gynecologic oncology; Disease; Stage (stratigraphy); Evidence-based medicine; Internal medicine; Confounding; Oncology; Intensive care medicine; Surgery; Gynecology; General surgery; Cancer; Family medicine; Meta-analysis; Alternative medicine; Pathology","score_opus":0.19397694325257508,"score_gpt":0.4469568336005771,"score_spread":0.252979890348002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095459904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047774327,0.98227215,0.000002167009,0.0069621494,0.00064717967,0.0066317027,0.00016978089,0.00012375436,0.0031433587],"genre_scores_gemma":[0.00006546402,0.9696793,0.0007491298,0.022582639,0.0005850439,0.005125523,0.00059651735,0.000115396826,0.0005009883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517155,0.00093346246,0.0011089526,0.0014710343,0.0005220435,0.0007929637],"domain_scores_gemma":[0.99574,0.0012839667,0.00088013906,0.0012365029,0.00035115224,0.0005082609],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006613354,0.001014519,0.0052039535,0.0002672394,0.00016998751,0.00003604431,0.00044206594,0.00097009016,0.0051736],"category_scores_gemma":[0.00040199843,0.00059134094,0.0005375711,0.0006045997,0.00017465922,0.00014674819,0.00007757716,0.0009888975,0.00037805492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015254878,0.00244891,0.0011296393,0.014176826,0.0005296893,0.0003646694,0.000009065223,0.000008846921,6.534968e-9,0.00010182977,0.00954004,0.97153795],"study_design_scores_gemma":[0.002762713,0.014092507,0.003505145,0.11010232,0.00689556,0.000021704473,0.0000025370134,0.000003014801,2.416633e-7,0.000001942852,0.8620944,0.0005178883],"about_ca_topic_score_codex":0.00009727593,"about_ca_topic_score_gemma":0.00034310494,"teacher_disagreement_score":0.97102004,"about_ca_system_score_codex":0.004347961,"about_ca_system_score_gemma":0.0051409677,"threshold_uncertainty_score":0.9996538},"labels":[],"label_agreement":null},{"id":"W2096896517","doi":"10.1016/j.ygyno.2007.03.025","title":"Use of systemic therapy in women with recurrent ovarian cancer—Development of a national clinical practice guideline","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University; Ottawa Hospital; Ottawa Regional Cancer Foundation; Jewish General Hospital; Canadian Partnership Against Cancer; Alberta Cancer Foundation; Juravinski Cancer Centre","funders":"","keywords":"Guideline; Medicine; Data extraction; Systematic review; MEDLINE; Family medicine; Randomized controlled trial; Context (archaeology); Health care; Surgery; Pathology","score_opus":0.33098511556192667,"score_gpt":0.5530215186382309,"score_spread":0.22203640307630423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096896517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989717,0.00018764034,0.0023798407,0.005265946,0.00050867884,0.0011558757,0.000011049494,0.000022919472,0.0007510647],"genre_scores_gemma":[0.8533819,0.0006482909,0.14001547,0.005623063,0.00014702538,0.00011239407,0.000032116906,0.00001451851,0.000025220255],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9943075,0.0005010714,0.003914335,0.0003704985,0.0005445475,0.00036201772],"domain_scores_gemma":[0.9844983,0.011395538,0.0019761792,0.00022099455,0.0017678153,0.00014114271],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013104371,0.0001636222,0.0008101295,0.00023510902,0.000030799758,0.000003909688,0.00012251528,0.00028492959,0.00038442176],"category_scores_gemma":[0.021793256,0.00012382185,0.00005477957,0.00044306362,0.00013325576,0.00018720701,0.00006892971,0.00042659036,0.000006759425],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020741582,0.004267163,0.08837882,0.000078425175,0.0004115549,0.00012477378,0.00175608,0.00014658425,0.0027671494,0.00020133166,0.0030771152,0.87804943],"study_design_scores_gemma":[0.015401935,0.013947598,0.6529,0.00021852923,0.00011435386,0.00022134083,0.005960124,0.00021593901,0.00038562412,0.00012645262,0.3102489,0.0002592097],"about_ca_topic_score_codex":0.00023480825,"about_ca_topic_score_gemma":0.0011229328,"teacher_disagreement_score":0.8777902,"about_ca_system_score_codex":0.0013558727,"about_ca_system_score_gemma":0.0042693755,"threshold_uncertainty_score":0.9864466},"labels":[],"label_agreement":null},{"id":"W2097402549","doi":"10.1016/j.ygyno.2006.02.001","title":"Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: Case report","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McGill University; Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Fertility preservation; Stage (stratigraphy); Chemotherapy; Fertility; Radical surgery; Dissection (medical); Surgery; Cancer; Gynecology; Internal medicine; Population","score_opus":0.018280329835925875,"score_gpt":0.33134634426294535,"score_spread":0.3130660144270195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097402549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766115,0.0022263543,0.0000665687,0.010308899,0.0005757475,0.0009994748,0.00005393163,0.00014220488,0.009015324],"genre_scores_gemma":[0.99055874,0.00023655484,0.00092215504,0.0031098449,0.00042902323,0.00045832622,0.00017079001,0.000037690625,0.0040768483],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970228,0.00015622942,0.000861464,0.0007677055,0.0003414185,0.00085038226],"domain_scores_gemma":[0.9983801,0.0006157378,0.00025681217,0.0003448846,0.000092180824,0.00031027506],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005251425,0.0003632545,0.0011431271,0.00021276824,0.00010537138,0.000017266795,0.00015727166,0.000594526,0.0050789197],"category_scores_gemma":[0.0002542624,0.00028275617,0.00021611771,0.00073372474,0.0002339268,0.00006994937,0.00005176427,0.00064383587,0.000048264654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003317124,0.007326974,0.36193785,0.00011426298,0.00027970746,0.5167768,0.000119175646,0.000030787116,0.010328442,0.00020494865,0.025633173,0.07393074],"study_design_scores_gemma":[0.074761234,0.0120144775,0.34251446,0.000057151912,0.0005794634,0.05410232,0.0002349239,0.00022254612,0.012056277,0.0009384363,0.5014639,0.0010548295],"about_ca_topic_score_codex":0.0066262283,"about_ca_topic_score_gemma":0.0050820056,"teacher_disagreement_score":0.4758307,"about_ca_system_score_codex":0.0018375943,"about_ca_system_score_gemma":0.00066849956,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W2097672752","doi":"10.1016/j.ygyno.2009.03.035","title":"Sentinel lymph node biopsy in patients with gynecologic cancers","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Sentinel lymph node; Sentinel node; Biopsy; Gynecologic oncology; General surgery; Radiology; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.012429742027722025,"score_gpt":0.27515708508095515,"score_spread":0.26272734305323314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097672752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654345,0.00016085691,0.000008242,0.0070916796,0.000357209,0.0007782007,0.000011322273,0.00010461982,0.02605338],"genre_scores_gemma":[0.9895945,0.00010210958,0.0018626384,0.007776203,0.000085717795,0.0001832213,0.00007419812,0.000017838813,0.00030357204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790424,0.00010957686,0.00042639257,0.0006334636,0.0002256155,0.00070070295],"domain_scores_gemma":[0.998797,0.00028606062,0.00020613894,0.00038043613,0.00012677757,0.00020360072],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020939062,0.0003144534,0.00077828806,0.00021875519,0.00008713099,0.000013643644,0.00014216897,0.00034243183,0.0010438006],"category_scores_gemma":[0.00016853536,0.00022009642,0.000097041324,0.0004567851,0.00013297642,0.00007175072,0.000040626222,0.0002455418,0.00013189255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005273481,0.0027014455,0.96089363,0.000014645489,0.00008686454,0.00068142277,0.0000611287,0.00010386649,0.000019396093,0.00023580312,0.00084406964,0.0338304],"study_design_scores_gemma":[0.014212601,0.0029444324,0.9784349,0.000034637324,0.00015098874,0.00003155593,0.00006385048,0.000040190273,0.000025910653,0.00021712892,0.003606542,0.00023721371],"about_ca_topic_score_codex":0.000115095696,"about_ca_topic_score_gemma":0.00007515498,"teacher_disagreement_score":0.03359319,"about_ca_system_score_codex":0.003082355,"about_ca_system_score_gemma":0.000755684,"threshold_uncertainty_score":0.9998694},"labels":[],"label_agreement":null},{"id":"W2098808445","doi":"10.1016/j.ygyno.2014.01.023","title":"Meeting Report: American College of Surgeons Clinical Congress 2013","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; General surgery; Family medicine","score_opus":0.029990317316657432,"score_gpt":0.3621743525589428,"score_spread":0.3321840352422854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098808445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8641381,0.00008131417,0.000043885753,0.010764383,0.001341347,0.00043024638,0.000011235423,0.00009682968,0.12309265],"genre_scores_gemma":[0.9892553,0.00020733569,0.0023642979,0.002262671,0.00021554729,0.000034093937,0.000021086184,0.000018756235,0.005620925],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99673426,0.0009782186,0.0011683905,0.00043234185,0.00024574465,0.00044105522],"domain_scores_gemma":[0.9860726,0.0122467475,0.00067912403,0.00048582794,0.00022719415,0.00028849102],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035513719,0.00018998006,0.0022687246,0.00010940245,0.00006903129,0.0000029926987,0.00013591065,0.00032241375,0.00042137507],"category_scores_gemma":[0.008688883,0.00014222281,0.0006521494,0.00026569312,0.0008928081,0.000025144536,0.00008670919,0.0003352949,0.000084019564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026341903,0.00069204316,0.9528514,0.000033446908,0.00019247843,0.003885804,0.00002547085,0.000007320664,0.00007212929,0.005200294,0.016487718,0.020288453],"study_design_scores_gemma":[0.0011531751,0.0017295959,0.4083741,0.000010975351,0.0001567252,0.0009755559,0.00016381024,0.000064616695,0.000036111876,0.000069741385,0.5871566,0.00010897784],"about_ca_topic_score_codex":0.00017652108,"about_ca_topic_score_gemma":0.0002552262,"teacher_disagreement_score":0.5706689,"about_ca_system_score_codex":0.0000948643,"about_ca_system_score_gemma":0.00031059596,"threshold_uncertainty_score":0.9996613},"labels":[],"label_agreement":null},{"id":"W2098816367","doi":"10.1016/j.ygyno.2015.11.009","title":"Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario; Women's College Hospital","funders":"National Institutes of Health; Canada Research Chairs; National Cancer Institute; Cancer Care Ontario","keywords":"Medicine; Ovarian cancer; BRCA mutation; Oncology; Internal medicine; Cancer; Disease; Mutation; Serous fluid; Gynecology; Genetics; Biology; Gene","score_opus":0.050721896523145064,"score_gpt":0.34499920259877004,"score_spread":0.29427730607562497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098816367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9661752,0.00016088772,0.00019416437,0.009906864,0.0016749275,0.0007691085,0.0002885268,0.00020395116,0.020626383],"genre_scores_gemma":[0.9857208,0.00009333361,0.0010676812,0.010069503,0.00044556902,0.00052251265,0.000097707736,0.000040639334,0.0019422431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772966,0.00032376,0.00038743982,0.0004768381,0.0004354028,0.00064691005],"domain_scores_gemma":[0.99810845,0.0004322238,0.00027828506,0.00028083115,0.00054019043,0.00035999893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063325674,0.0002501197,0.00061653677,0.00013580336,0.000077679346,0.00001821387,0.000102024096,0.00044643055,0.004396207],"category_scores_gemma":[0.0005467498,0.00019440951,0.00008030039,0.0003381331,0.000267343,0.0001073876,0.000042028296,0.00040094784,0.00021959728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024194501,0.0029781687,0.86081576,0.00006941673,0.0018530056,0.0034581434,0.009546432,0.00033780016,0.004062136,0.0009996732,0.038330294,0.05335467],"study_design_scores_gemma":[0.031471185,0.009310276,0.8260287,0.00007890907,0.00041554592,0.00010009135,0.0012316563,0.00015795148,0.003062045,0.001479017,0.12609425,0.0005703756],"about_ca_topic_score_codex":0.0003622457,"about_ca_topic_score_gemma":0.001311508,"teacher_disagreement_score":0.08776396,"about_ca_system_score_codex":0.0023363063,"about_ca_system_score_gemma":0.0019678774,"threshold_uncertainty_score":0.9965139},"labels":[],"label_agreement":null},{"id":"W2099342841","doi":"10.1016/j.ygyno.2009.07.009","title":"BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; PARP inhibitor; Cancer research; Poly ADP ribose polymerase; Epithelial ovarian cancer; Ovarian cancer; Oncology; Cancer; Internal medicine; Biology; DNA; Polymerase; Genetics","score_opus":0.03393218428434309,"score_gpt":0.3599466495170423,"score_spread":0.3260144652326992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099342841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88462424,0.00038135893,0.00020424959,0.081505805,0.0031927638,0.0017811172,0.00008249602,0.00033932456,0.027888639],"genre_scores_gemma":[0.93405807,0.00018295168,0.0013138619,0.058870826,0.0025826287,0.00027852287,0.000024916455,0.00003410563,0.0026541187],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970792,0.00039118828,0.0006512164,0.00068145007,0.00035986403,0.0008370874],"domain_scores_gemma":[0.99800575,0.000508374,0.00024930012,0.00067649747,0.00022118074,0.00033890543],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000771306,0.00037439918,0.00077968626,0.00018694389,0.0004191904,0.000034076216,0.0003104171,0.00046797437,0.0021442827],"category_scores_gemma":[0.00018566864,0.00026419217,0.00020755726,0.00043003965,0.00024440893,0.000070068396,0.000087453125,0.00063259143,0.0006533532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008214435,0.0008880449,0.0012654783,0.000026791027,0.00016299386,0.0006567384,0.0015954887,0.00043344023,0.7387048,0.0028317508,0.16336644,0.089246586],"study_design_scores_gemma":[0.0070982547,0.007868944,0.08695523,0.000086804925,0.00024220062,0.0002429676,0.0005101653,0.00007881623,0.14941244,0.0035342854,0.7433508,0.0006191011],"about_ca_topic_score_codex":0.00017443238,"about_ca_topic_score_gemma":0.00064805057,"teacher_disagreement_score":0.58929235,"about_ca_system_score_codex":0.0010927933,"about_ca_system_score_gemma":0.0005538621,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2099461930","doi":"10.1016/j.ygyno.2009.10.004","title":"HER2 Overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Trastuzumab; Medicine; Paclitaxel; Carboplatin; Ovarian cancer; Targeted therapy; Oncology; Ovarian carcinomas; Cancer research; Internal medicine; Ovarian carcinoma; Cancer; Chemotherapy; Breast cancer; Cisplatin","score_opus":0.04329109243936597,"score_gpt":0.34701284403533467,"score_spread":0.3037217515959687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099461930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901992,0.0003420733,0.000008861395,0.0067033973,0.00008000748,0.0011825701,0.00003374722,0.000024558738,0.0014255706],"genre_scores_gemma":[0.9972256,0.00036882248,0.0013722548,0.000604187,0.00005927737,0.00017817317,0.000029038902,0.00001936632,0.00014331362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984118,0.00019638389,0.0003150329,0.00045652664,0.0002411133,0.00037916514],"domain_scores_gemma":[0.99874026,0.00044339936,0.00014055075,0.00035891793,0.0001320812,0.00018481955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051756925,0.00016896229,0.00049126474,0.00018329344,0.0000624141,0.000010471962,0.00011458565,0.00034757494,0.00052047387],"category_scores_gemma":[0.00020456927,0.00012093196,0.000024421617,0.00022729069,0.00041144248,0.00004149163,0.000067950445,0.0005625505,0.0000012375315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016224158,0.00097212795,0.69064265,0.0001501361,0.00006347373,0.00016194489,0.0048418925,0.0000030902563,0.24816535,0.0002251814,0.0015581725,0.051593542],"study_design_scores_gemma":[0.0049876147,0.00561573,0.95703995,0.000032307125,0.00002016657,0.00014922976,0.0005957195,0.0001990911,0.015651757,0.0002400566,0.01533169,0.00013666507],"about_ca_topic_score_codex":0.00230918,"about_ca_topic_score_gemma":0.0037129857,"teacher_disagreement_score":0.2663973,"about_ca_system_score_codex":0.0002062459,"about_ca_system_score_gemma":0.00066079403,"threshold_uncertainty_score":0.5698824},"labels":[],"label_agreement":null},{"id":"W2099954138","doi":"10.1016/j.ygyno.2005.07.040","title":"Kappa statistics to measure interrater and intrarater agreement for 1790 cervical biopsy specimens among twelve pathologists: Qualitative histopathologic analysis and methodologic issues","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Biopsy; Inter-rater reliability; Cohen's kappa; Cervical cancer; Radiology; Kappa; Family medicine; Cancer; Statistics; Internal medicine","score_opus":0.26558037577816274,"score_gpt":0.4873603395796752,"score_spread":0.22177996380151244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099954138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80787635,0.00060708687,0.1714945,0.015575338,0.00060803816,0.0018162534,0.00025111937,0.00006817509,0.0017031332],"genre_scores_gemma":[0.7277134,0.00009657118,0.26701748,0.0028413984,0.0001637549,0.00042142824,0.000033775174,0.000012922239,0.0016992679],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9901624,0.0045703463,0.0017416966,0.0017557071,0.00091488473,0.00085497013],"domain_scores_gemma":[0.98894143,0.008439044,0.0006521557,0.00073586253,0.00085301115,0.00037848958],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021674277,0.0005250087,0.0016039616,0.0006906674,0.0003879808,0.00023710234,0.0007766491,0.00052692165,0.0024286439],"category_scores_gemma":[0.012183192,0.00034455772,0.00023583593,0.00089731085,0.0011065946,0.00024002348,0.0005930126,0.000406082,0.00019806065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025477973,0.0035297659,0.3018108,0.0001602781,0.0020384856,0.00048300717,0.08651789,0.0019509419,0.017716704,0.016796323,0.08312747,0.48332053],"study_design_scores_gemma":[0.0026249469,0.009718316,0.72090083,0.000022904038,0.0013036733,0.000058716076,0.031557087,0.001814052,0.0010780765,0.13137174,0.09815412,0.0013955601],"about_ca_topic_score_codex":0.000055957084,"about_ca_topic_score_gemma":0.0018151705,"teacher_disagreement_score":0.48192498,"about_ca_system_score_codex":0.00058206933,"about_ca_system_score_gemma":0.000085264975,"threshold_uncertainty_score":0.99990064},"labels":[],"label_agreement":null},{"id":"W2100256708","doi":"10.1016/j.ygyno.2009.08.007","title":"CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute; Université de Sherbrooke","keywords":"Medicine; Apoptosis; Cancer research; Ovarian cancer; Drug; Antigen; Cancer; Immunology; Pharmacology; Internal medicine; Biology; Genetics","score_opus":0.010383744964450534,"score_gpt":0.2675842487006114,"score_spread":0.2572005037361609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100256708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953548,0.00015008476,0.0005629526,0.0017506861,0.00041335844,0.00077799027,0.000057289973,0.000024569576,0.0009082808],"genre_scores_gemma":[0.9940364,0.00020004656,0.0010987537,0.004103204,0.00020679146,0.00007081401,0.00002452997,0.000019719422,0.00023974793],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794984,0.00045642792,0.00036014878,0.00057055533,0.00011442015,0.00054860313],"domain_scores_gemma":[0.9988423,0.00014413371,0.00023267783,0.00044517618,0.0002126844,0.00012300778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006516971,0.00027451327,0.00045014528,0.00007548727,0.00017936586,0.000014621546,0.00032922238,0.0003046219,0.00004970951],"category_scores_gemma":[0.00019478644,0.00021250607,0.00015621854,0.0002578011,0.00009996917,0.000005113369,0.00016430533,0.0002091469,0.000018989256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009476096,0.00025231353,0.0012233888,0.000007079765,0.00009043283,0.000008984399,0.0001945332,0.00060904917,0.9830468,0.0000661439,0.0024765893,0.01192992],"study_design_scores_gemma":[0.00047773606,0.001184195,0.041373845,0.000005992857,0.000050414244,0.000018969733,0.00012627002,0.000219962,0.9450554,0.00011481544,0.011097508,0.00027484781],"about_ca_topic_score_codex":0.0004023007,"about_ca_topic_score_gemma":0.0017130753,"teacher_disagreement_score":0.040150456,"about_ca_system_score_codex":0.00014146141,"about_ca_system_score_gemma":0.0003968109,"threshold_uncertainty_score":0.86657465},"labels":[],"label_agreement":null},{"id":"W2100322752","doi":"10.1016/j.ygyno.2006.08.004","title":"The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; Princess Margaret Cancer Centre; Coalition for Research in Women's Health; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Tamoxifen; Breast cancer; BRCA mutation; Gynecology; Ovarian cancer; Cancer; Oncology; Obstetrics; Incidence (geometry); Prospective cohort study; Internal medicine; Hysterectomy; Surgery","score_opus":0.01301186890634419,"score_gpt":0.3083033465204025,"score_spread":0.2952914776140583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100322752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99337375,0.000973383,0.0000032592802,0.000433366,0.00015444719,0.0017174773,0.000020417927,0.000018506196,0.0033053977],"genre_scores_gemma":[0.9980533,0.00031263256,0.000115205126,0.00006811073,0.00010118498,0.0011395084,0.0000018587897,0.0000080467125,0.0002001183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987002,0.00023999182,0.00032940257,0.00026981294,0.00017171574,0.0002888507],"domain_scores_gemma":[0.99744076,0.0020486703,0.0002103066,0.00013751205,0.0001041661,0.000058586316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054324593,0.00012661432,0.0005056817,0.00017125359,0.00010552835,0.000007964658,0.00006776883,0.00008980931,0.00017286248],"category_scores_gemma":[0.00068548886,0.00006579421,0.000028604743,0.00081377145,0.0002401055,0.000030038645,0.00004199772,0.00020000165,0.000002912605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005734144,0.0017517748,0.9305557,0.00000963432,0.00028728915,0.00009282691,0.00076099735,0.000042353775,0.000058039586,0.00008574492,0.000022235037,0.060599238],"study_design_scores_gemma":[0.023311682,0.014564728,0.95722985,0.0000064585934,0.000193622,0.000010682754,0.0020059966,0.0000062442737,0.000082581195,0.0017642359,0.00075714,0.000066757246],"about_ca_topic_score_codex":0.0023206028,"about_ca_topic_score_gemma":0.008414196,"teacher_disagreement_score":0.06053248,"about_ca_system_score_codex":0.00084440614,"about_ca_system_score_gemma":0.00024501205,"threshold_uncertainty_score":0.4695319},"labels":[],"label_agreement":null},{"id":"W2101234643","doi":"10.1016/j.ygyno.2015.11.007","title":"Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and US perspectives","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Seoul National University Hospital; National Comprehensive Cancer Network","keywords":"Medicine; Triage; Cervical cancer; Willingness to pay; Cost effectiveness; Cost-effectiveness analysis; Quality-adjusted life year; Willingness to accept; Stage (stratigraphy); Incremental cost-effectiveness ratio; Emergency medicine; Medical physics; Cancer; Internal medicine; Risk analysis (engineering)","score_opus":0.07877154801247467,"score_gpt":0.38325092480925155,"score_spread":0.3044793767967769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101234643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836474,0.0029553345,0.00013873576,0.002676319,0.0003152478,0.0020597428,0.0008462722,0.000062827785,0.0072981045],"genre_scores_gemma":[0.9957608,0.00045836443,0.00065105397,0.00045789266,0.00020874837,0.0017646723,0.0002465134,0.000016429425,0.00043553414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982889,0.00023448825,0.00024220406,0.0005934552,0.00013731461,0.00050363364],"domain_scores_gemma":[0.9974551,0.0012157572,0.00009995548,0.00022146564,0.00024438885,0.00076329266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021046534,0.00027056626,0.0010291232,0.0003319029,0.00012673039,0.000034246837,0.00008527333,0.0003017956,0.0007228378],"category_scores_gemma":[0.00026555132,0.00019085662,0.00020560039,0.0005669612,0.00017770332,0.00007496598,0.00003295051,0.00012099273,0.000011945813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058657858,0.0018316979,0.8765377,0.0000682213,0.008192161,0.00075074896,0.0032797602,0.00053527113,0.00018755496,0.0030352455,0.00022680542,0.099489056],"study_design_scores_gemma":[0.022158373,0.013821429,0.87461364,0.000010161565,0.005002308,0.000014569747,0.010651738,0.0006040586,0.00016927677,0.0023241336,0.07029904,0.0003312711],"about_ca_topic_score_codex":0.375172,"about_ca_topic_score_gemma":0.6300353,"teacher_disagreement_score":0.2548633,"about_ca_system_score_codex":0.0047961134,"about_ca_system_score_gemma":0.002425209,"threshold_uncertainty_score":0.9990243},"labels":[],"label_agreement":null},{"id":"W2101991286","doi":"10.1016/j.ygyno.2005.02.015","title":"Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Brachytherapy; Medicine; Cervix; Radiation therapy; Cervical cancer; External beam radiotherapy; Multivariate analysis; Stage (stratigraphy); Internal medicine; Cancer; Surgery; Urology","score_opus":0.06472647054803071,"score_gpt":0.39092528473729365,"score_spread":0.32619881418926294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101991286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326044,0.0005315167,0.000025278508,0.0020388886,0.0004287779,0.0005148122,0.000056111185,0.000022869115,0.0031213246],"genre_scores_gemma":[0.99485856,0.000927222,0.0026001183,0.0007791664,0.00021469335,0.00007785884,0.00002795259,0.000014965782,0.00049948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834156,0.00020701857,0.00070074643,0.0003089721,0.00012075738,0.00032094156],"domain_scores_gemma":[0.99822104,0.00087045674,0.00041332183,0.00024532585,0.00014812865,0.00010170985],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034152318,0.00016695107,0.0007960353,0.00018675081,0.00003397406,0.0000024778328,0.00010515186,0.0002872283,0.0023185378],"category_scores_gemma":[0.00033298664,0.0001311756,0.00012200108,0.0005811546,0.0001318116,0.000060383987,0.00004843158,0.0002444431,0.0000252101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008526099,0.005008568,0.7556917,0.00015596962,0.00041420918,0.00026000437,0.0003843949,0.0010211796,0.010258169,0.00015649328,0.00012071689,0.21800251],"study_design_scores_gemma":[0.021025453,0.0017286012,0.9694846,0.00006915209,0.0001996348,0.00004468045,0.000045485504,0.000069504,0.0051882076,0.00026319493,0.001752222,0.00012924819],"about_ca_topic_score_codex":0.003067543,"about_ca_topic_score_gemma":0.008465695,"teacher_disagreement_score":0.21787328,"about_ca_system_score_codex":0.00078227784,"about_ca_system_score_gemma":0.00042021417,"threshold_uncertainty_score":0.99859345},"labels":[],"label_agreement":null},{"id":"W2102075419","doi":"10.1016/j.ygyno.2015.09.001","title":"Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; McGill University; University of Calgary; University of Manitoba; Princess Margaret Cancer Centre; University of British Columbia; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Lymphovascular invasion; Stage (stratigraphy); Carcinosarcoma; Oncology; Serous fluid; Carcinoma; Cohort; Serous carcinoma; Retrospective cohort study; Survival rate; Overall survival; Survival analysis; Cancer; Gynecology; Ovarian cancer; Metastasis","score_opus":0.08000033407499096,"score_gpt":0.38591814071224106,"score_spread":0.3059178066372501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102075419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97870076,0.0027317838,0.000026515418,0.0019418111,0.010688337,0.0022112695,0.0012130643,0.000074563824,0.0024119238],"genre_scores_gemma":[0.9888933,0.005651876,0.0009370955,0.00079339393,0.0024883698,0.00069806323,0.00011353964,0.000042606,0.00038180553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99387217,0.0018412635,0.0017094667,0.00085616414,0.00062168477,0.0010992292],"domain_scores_gemma":[0.987791,0.008087606,0.0013949071,0.0007316051,0.0006307694,0.0013641021],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038589425,0.00046015906,0.0021745635,0.0009387184,0.00031454276,0.000026758562,0.00054981315,0.00085173646,0.0039104847],"category_scores_gemma":[0.018778028,0.0002976421,0.0005906284,0.002557867,0.00075060246,0.00009023369,0.00017200487,0.0013130361,0.00011390757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003982543,0.0006039186,0.76453704,0.000012482776,0.0010796516,0.00026238256,0.0000962093,0.00012469223,0.00001698215,0.00014564351,0.004053654,0.2250848],"study_design_scores_gemma":[0.07711234,0.020190839,0.8116877,0.000033203174,0.007903265,0.000058978818,0.0005243876,0.000036775116,0.00051188056,0.0013258233,0.08003,0.00058478746],"about_ca_topic_score_codex":0.7906122,"about_ca_topic_score_gemma":0.5699137,"teacher_disagreement_score":0.2245,"about_ca_system_score_codex":0.005718263,"about_ca_system_score_gemma":0.008466631,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W2104056210","doi":"10.1016/j.ygyno.2013.06.036","title":"The wait time creep: Changes in the surgical wait time for women with uterine cancer in Ontario, Canada, during 2000–2009","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"Government of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Uterine cancer; Hysterectomy; Cancer; Uterine sarcoma; Retrospective cohort study; Population; Surgery; Cohort; Internal medicine","score_opus":0.014815931081223123,"score_gpt":0.26996318772821304,"score_spread":0.2551472566469899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104056210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718064,0.00033352876,1.2869953e-7,0.018428534,0.00016198482,0.0016968959,0.00003714379,0.000018691553,0.007516712],"genre_scores_gemma":[0.95672774,0.00015269512,0.000049668673,0.002048547,0.00019421939,0.0039054677,0.00001972303,0.000017467055,0.036884483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981801,0.00015933503,0.00030755938,0.00033086186,0.00022335196,0.0007988182],"domain_scores_gemma":[0.99799716,0.001444488,0.00011060511,0.00023974419,0.00007048872,0.0001374977],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041661944,0.00021672582,0.00059016194,0.0000845721,0.00013673429,0.00001888317,0.00025219793,0.00016751359,0.011566271],"category_scores_gemma":[0.000112560025,0.000103074024,0.000039071623,0.00031240526,0.000109089626,0.000040897437,0.00006683118,0.00034300404,0.00005585402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022161238,0.0037493114,0.6116039,0.00030145192,0.0011798417,0.006099419,0.005846811,0.00026895353,0.0021989446,0.0001624846,0.026083788,0.32034382],"study_design_scores_gemma":[0.008354102,0.0036017948,0.8124382,0.00001851574,0.00003128482,0.00007898373,0.00025836527,0.00004151348,0.00006247487,0.00016550055,0.1748004,0.00014890716],"about_ca_topic_score_codex":0.7203301,"about_ca_topic_score_gemma":0.9915858,"teacher_disagreement_score":0.32019493,"about_ca_system_score_codex":0.0045508523,"about_ca_system_score_gemma":0.0014493143,"threshold_uncertainty_score":0.9992705},"labels":[],"label_agreement":null},{"id":"W2104072698","doi":"10.1016/j.ygyno.2012.09.003","title":"Human epididymis protein 4 (HE4) and ovarian cancer prognosis","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University Health Network; Hôpital du Saint-Sacrement; Toronto General Hospital; Hôtel-Dieu de Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Terry Fox Foundation; Cancer Research Institute","keywords":"Medicine; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Ovarian cancer; Cohort; Oncology; Cancer; Stage (stratigraphy); Clinical endpoint; Gynecology; Gastroenterology; Clinical trial","score_opus":0.04536125832236143,"score_gpt":0.35622402951637144,"score_spread":0.31086277119401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104072698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562733,0.00304832,0.000011362443,0.018660884,0.00046834993,0.0017956342,0.000016013224,0.00012412717,0.019602021],"genre_scores_gemma":[0.9908667,0.00023914457,0.0024408342,0.0020993545,0.0005106412,0.0023969682,0.000014918143,0.000024525336,0.001406919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984107,0.00014363989,0.0003069938,0.00037556828,0.00013257618,0.0006305178],"domain_scores_gemma":[0.9990585,0.00013548836,0.00014965892,0.00023519814,0.000065177395,0.00035596307],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041746488,0.00022677818,0.00058528566,0.000092685295,0.00018627352,0.00001385174,0.000071826515,0.00030777865,0.0023103913],"category_scores_gemma":[0.000115823794,0.00017144758,0.00008763537,0.00015397694,0.00016790749,0.00009345331,0.0000894504,0.00022647493,0.000090451766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069390066,0.0025353516,0.84712577,0.000109823835,0.00035695027,0.00012871462,0.0004166099,5.5527875e-7,0.0022520416,0.00795239,0.0057298974,0.13332254],"study_design_scores_gemma":[0.0030931218,0.0024252003,0.8238855,0.000046089575,0.00037811862,0.00007551905,0.000109188644,0.0000039897864,0.0021329932,0.00052942714,0.16712494,0.00019589001],"about_ca_topic_score_codex":0.00030413718,"about_ca_topic_score_gemma":0.00020097032,"teacher_disagreement_score":0.16139504,"about_ca_system_score_codex":0.0006231404,"about_ca_system_score_gemma":0.0002093797,"threshold_uncertainty_score":0.9986016},"labels":[],"label_agreement":null},{"id":"W2105230882","doi":"10.1016/j.ygyno.2011.04.002","title":"Value of sentinel node mapping in cancer of the cervix","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Sentinel node; Cervix; Value (mathematics); Cancer; Cervical cancer; Gynecology; Internal medicine; Statistics; Mathematics; Breast cancer","score_opus":0.08578719248657748,"score_gpt":0.33791526739671685,"score_spread":0.25212807491013933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105230882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509265,0.00040329748,0.0000061649716,0.0010881253,0.00044261396,0.000319903,0.000007076641,0.000010332861,0.046795987],"genre_scores_gemma":[0.99778736,0.00016656345,0.0006138837,0.0010363873,0.000042192074,0.00006286795,0.0000016522645,0.0000063632524,0.0002827604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990006,0.000120262666,0.00038353287,0.00016494039,0.00011954307,0.00021111895],"domain_scores_gemma":[0.9992004,0.00025602223,0.00022273065,0.00020580245,0.000070416885,0.00004463145],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022114266,0.00009445282,0.00048309352,0.00010769439,0.00001870303,4.789039e-7,0.00014732037,0.00015818673,0.0016017057],"category_scores_gemma":[0.00029338116,0.000055716144,0.000118107535,0.0005029626,0.00014167144,0.00001699686,0.00010595339,0.00014758144,0.000007742722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020803044,0.0009799097,0.9828846,0.00010893903,0.00009430978,0.000028214028,0.00057752914,0.000010097246,0.003607987,0.0006294071,0.0001326625,0.010738319],"study_design_scores_gemma":[0.0033587622,0.00042023498,0.987145,0.000045985453,0.000091044254,0.0000067573083,0.00019714992,0.000024577723,0.006014642,0.0009899753,0.001655514,0.000050329112],"about_ca_topic_score_codex":0.0014713714,"about_ca_topic_score_gemma":0.0002366329,"teacher_disagreement_score":0.046860833,"about_ca_system_score_codex":0.00022904002,"about_ca_system_score_gemma":0.00023654211,"threshold_uncertainty_score":0.999311},"labels":[],"label_agreement":null},{"id":"W2105421433","doi":"10.1016/j.ygyno.2015.07.009","title":"RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Faculty of Medicine and Dentistry, University of Alberta; University of Alberta; Royal Alexandra Hospital Foundation; Canadian Institutes of Health Research; Women and Children's Health Research Institute; Alberta Health Services","keywords":"Carboplatin; Cisplatin; Clonogenic assay; Cancer research; Blot; Apoptosis; Ovarian cancer; Cell culture; Medicine; Biology; Cancer; Chemotherapy; Internal medicine; Gene","score_opus":0.018717679306489914,"score_gpt":0.2881411153859721,"score_spread":0.26942343607948216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105421433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822086,0.0015085672,0.0016635879,0.002870866,0.0018241188,0.00067159615,0.00004166586,0.000024582661,0.009186403],"genre_scores_gemma":[0.9915466,0.00014524948,0.003383799,0.0013628289,0.00024570723,0.00016861617,0.000045334713,0.000015527936,0.003086359],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987039,0.0001568934,0.00028025144,0.0004039317,0.00008903496,0.00036597808],"domain_scores_gemma":[0.9993686,0.000050192477,0.00009461649,0.00023211738,0.00011570256,0.00013875413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005070426,0.00015260742,0.00027135582,0.00008163727,0.000048110178,0.000012392366,0.00017975479,0.00040476536,0.000059604907],"category_scores_gemma":[0.00023175075,0.00013649087,0.000047703346,0.00017201783,0.000054219967,0.0000029189102,0.00012527056,0.00010776013,0.000032960423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052725483,0.00018271724,0.0026761817,0.000010361938,0.000036899342,0.000051534334,0.00020384346,0.0017870205,0.9694254,0.0024302006,0.012263919,0.010404692],"study_design_scores_gemma":[0.0035103278,0.0011534871,0.028315615,0.000014684404,0.000028582164,0.000004358258,0.00020909568,0.00012953517,0.17551471,0.004451239,0.7862995,0.00036882627],"about_ca_topic_score_codex":0.00015968471,"about_ca_topic_score_gemma":0.009301808,"teacher_disagreement_score":0.7939107,"about_ca_system_score_codex":0.00023260959,"about_ca_system_score_gemma":0.0003698179,"threshold_uncertainty_score":0.5565936},"labels":[],"label_agreement":null},{"id":"W2106208059","doi":"10.1016/j.ygyno.2004.11.046","title":"Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Cancer Research Society","keywords":"Medicine; Cervical cancer; Brachytherapy; Proctitis; Radiation therapy; External beam radiotherapy; Chemoradiotherapy; Complication; Surgery; Pelvis; Radiation proctitis; Radiology; Cancer; Internal medicine; Disease","score_opus":0.05777108585585749,"score_gpt":0.39562591087418725,"score_spread":0.33785482501832975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106208059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800708,0.0024206473,0.0016274509,0.01107343,0.0025372873,0.0016484035,0.00010690699,0.00013765342,0.0003774099],"genre_scores_gemma":[0.9770067,0.0014935491,0.008297993,0.010872071,0.0013307881,0.00062791794,0.000095940915,0.000048635568,0.00022643925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99807966,0.000093477545,0.00048405284,0.0005507547,0.00016270728,0.0006293641],"domain_scores_gemma":[0.99867374,0.00045682816,0.0001953119,0.00024380148,0.00015309396,0.00027724224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002730161,0.00032163548,0.0010290125,0.00013404145,0.0001411972,0.000014318285,0.00015731867,0.0003731252,0.0021886753],"category_scores_gemma":[0.00012372369,0.0002427279,0.00022298958,0.00035946415,0.0001772396,0.000079377205,0.000044078017,0.00028355242,0.000026723523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005592155,0.0054467786,0.010496599,0.00044725768,0.0013671354,0.0007582515,0.00037035093,0.0011419542,0.05829081,0.003855535,0.00058122876,0.91165197],"study_design_scores_gemma":[0.21247874,0.054858033,0.35195526,0.00023177193,0.0015616133,0.00074924016,0.00024231413,0.0012258936,0.036415786,0.019708604,0.3186958,0.0018769404],"about_ca_topic_score_codex":0.0006096872,"about_ca_topic_score_gemma":0.00025864632,"teacher_disagreement_score":0.909775,"about_ca_system_score_codex":0.0019966636,"about_ca_system_score_gemma":0.0006717931,"threshold_uncertainty_score":0.99872345},"labels":[],"label_agreement":null},{"id":"W2106439593","doi":"10.1016/j.ygyno.2012.04.029","title":"Ovarian low-grade serous carcinoma: A comprehensive update","year":2012,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Serous fluid; Ovarian carcinoma; Serous carcinoma; Oncology; Internal medicine; Disease; Clinical trial; Chemotherapy; Pathogenesis; Ovarian cancer; Cancer","score_opus":0.11391346383685244,"score_gpt":0.38393609334286577,"score_spread":0.2700226295060133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106439593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016816767,0.9849401,0.0000062287286,0.0013250462,0.0026847732,0.0032020325,0.00014193825,0.00018082655,0.0073508937],"genre_scores_gemma":[0.0016017217,0.99036086,0.001437739,0.0021090836,0.0011891193,0.0016825328,0.0008083167,0.00012017291,0.00069045014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957363,0.00064260286,0.0011016681,0.0010551059,0.00027298366,0.0011913475],"domain_scores_gemma":[0.99627566,0.0011579795,0.0007973197,0.0010290979,0.00015762936,0.00058232486],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028902793,0.00097047054,0.00521009,0.00034040483,0.00017055502,0.000026776856,0.0003548966,0.0016872651,0.0028558623],"category_scores_gemma":[0.00008094282,0.0006923069,0.0010393059,0.00046449868,0.00024963988,0.00006549624,0.00030362644,0.0010886921,0.0030071302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034577333,0.0021490622,0.0005101552,0.007721001,0.0011907544,0.002805293,0.000059481008,2.917261e-7,2.1774069e-7,0.0007308024,0.007319939,0.97747844],"study_design_scores_gemma":[0.0026404331,0.0018549768,0.0029899403,0.0011396826,0.00939362,0.0019160995,0.000031821575,0.0000011608221,8.7295865e-7,0.00006637016,0.97942096,0.00054403447],"about_ca_topic_score_codex":0.00008429146,"about_ca_topic_score_gemma":0.00006810797,"teacher_disagreement_score":0.9769344,"about_ca_system_score_codex":0.0028653014,"about_ca_system_score_gemma":0.0020218052,"threshold_uncertainty_score":0.99960876},"labels":[],"label_agreement":null},{"id":"W2106683366","doi":"10.1016/j.ygyno.2011.10.005","title":"Terminology and classification system of radical hysterectomy","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Terminology; Medicine; Radical Hysterectomy; Anachronism; Saddle; Hysterectomy; Pelvis; General surgery; Gynecology; Radiology; Cancer; Linguistics; Internal medicine","score_opus":0.09355655967276355,"score_gpt":0.3255790209525358,"score_spread":0.23202246127977227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106683366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88467985,0.00027244075,0.000037485686,0.00027008474,0.00032355575,0.00036658347,0.0000042019733,0.00006033646,0.11398549],"genre_scores_gemma":[0.99740756,0.00006596492,0.0019895572,0.00021702773,0.000052083964,0.00007322615,0.000007885894,0.000006455178,0.00018024285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906033,0.00012740068,0.000311801,0.0002312594,0.00007544892,0.00019372768],"domain_scores_gemma":[0.999218,0.00029777858,0.0001528916,0.00016298352,0.00005685184,0.00011148221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016985676,0.00010000676,0.00049566,0.0001213008,0.000029749839,0.0000012230423,0.00006580257,0.00026470772,0.0004202723],"category_scores_gemma":[0.00017658473,0.00007031388,0.000054633223,0.0001446152,0.00026140807,0.000023579314,0.000044698594,0.00011700985,0.000050802642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002872336,0.0023830126,0.52206016,0.00068480277,0.0004667714,0.00054602884,0.00086048257,5.9661005e-8,0.014054938,0.035486102,0.00049256143,0.42009276],"study_design_scores_gemma":[0.0055614654,0.0070176483,0.9772897,0.000025322859,0.00026339988,0.00043848768,0.00057753123,0.000026262585,0.0024139937,0.00043556822,0.0058594313,0.000091226604],"about_ca_topic_score_codex":0.000042873784,"about_ca_topic_score_gemma":0.0000146337225,"teacher_disagreement_score":0.45522952,"about_ca_system_score_codex":0.00020777219,"about_ca_system_score_gemma":0.00010625247,"threshold_uncertainty_score":0.4601687},"labels":[],"label_agreement":null},{"id":"W2109430398","doi":"10.1016/j.ygyno.2014.01.012","title":"Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary","year":2014,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Endometriosis; Medicine; Clear cell carcinoma; Stage (stratigraphy); Ovarian cancer; Ovary; Internal medicine; Serous fluid; Clear cell; Carcinoma; Oncology; Serous carcinoma; Gastroenterology; Endometrial cancer; Gynecology; Cancer; Survival rate","score_opus":0.07607395729341869,"score_gpt":0.4071033568216074,"score_spread":0.3310293995281887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109430398","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44222325,0.5509377,0.00000387103,0.00022958805,0.0006224754,0.0045096017,0.00049681147,0.000020519712,0.0009561329],"genre_scores_gemma":[0.5761304,0.42255238,0.0006254784,0.0002224269,0.00003915831,0.00026277124,0.0000612592,0.000047706555,0.000058443224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540716,0.00095608854,0.0020591558,0.00065894536,0.0005111791,0.00040746806],"domain_scores_gemma":[0.9854598,0.009869158,0.003292108,0.00070245966,0.00045640557,0.00022004845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082631974,0.00052535796,0.0076342393,0.00044064887,0.000060900653,0.000004726989,0.00032918752,0.0007658808,0.00015671599],"category_scores_gemma":[0.0022747878,0.0002610469,0.0005737061,0.0012493741,0.0004074429,0.000023073797,0.00025527872,0.000565816,0.0000026048374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031549012,0.002857652,0.7157244,0.0022403372,0.0016632634,0.000012747308,0.00006174436,0.0000020818288,9.383702e-8,0.000008930899,0.00025683505,0.27685642],"study_design_scores_gemma":[0.0076347846,0.019756392,0.8315806,0.0016965541,0.0065357075,0.0000032800963,0.00003419416,9.25903e-7,0.0000113230835,0.000001782145,0.13252765,0.00021682579],"about_ca_topic_score_codex":0.00035512148,"about_ca_topic_score_gemma":0.00043185492,"teacher_disagreement_score":0.2766396,"about_ca_system_score_codex":0.0005140097,"about_ca_system_score_gemma":0.0013404167,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W2110407467","doi":"10.1016/s0090-8258(03)00441-4","title":"Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Prospective cohort study; Biopsy; Gynecology; Endometrial biopsy; Endometrial cancer; Ultrasound; Endometrium; Cancer; Radiology; Obstetrics; Internal medicine","score_opus":0.04535673847782453,"score_gpt":0.3407582891193949,"score_spread":0.29540155064157037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110407467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937111,0.00019867266,0.000080691316,0.00012578607,0.00028628614,0.0026202954,0.000052903666,0.000031858337,0.0028924034],"genre_scores_gemma":[0.99578124,0.000065245884,0.0014528326,0.00012717811,0.00014085392,0.0022037972,0.00000490694,0.000020101577,0.00020386209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799544,0.00024345814,0.0004922376,0.0004481582,0.00024696367,0.0005737571],"domain_scores_gemma":[0.9966106,0.0025786168,0.00026402308,0.00017793708,0.0002337761,0.00013507862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008213287,0.00022750144,0.0009918121,0.00035937774,0.000092247996,0.000010119986,0.00010227177,0.00015945571,0.000912475],"category_scores_gemma":[0.001389686,0.00015809096,0.00006385178,0.0009857652,0.00013436569,0.00009779744,0.000029560813,0.00022814036,0.000001626173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014103611,0.0029643148,0.9701174,0.00006536656,0.00051116094,0.000090551985,0.0018160588,0.000069277485,0.00012112393,0.000136057,0.000028436156,0.009976659],"study_design_scores_gemma":[0.03722956,0.022328123,0.93221426,0.000040321873,0.00020479214,0.000118925745,0.0068087233,0.0000014527074,0.00019288939,0.00038320434,0.00031951634,0.00015825244],"about_ca_topic_score_codex":0.0007524634,"about_ca_topic_score_gemma":0.0018855316,"teacher_disagreement_score":0.037903145,"about_ca_system_score_codex":0.0013151693,"about_ca_system_score_gemma":0.00038798223,"threshold_uncertainty_score":0.9990961},"labels":[],"label_agreement":null},{"id":"W2110893470","doi":"10.1016/j.ygyno.2011.11.041","title":"Disparities in hospice care among older women dying with ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Maine Medical Center","keywords":"Medicine; Referral; Marital status; Cancer; Residence; Hospice care; Ovarian cancer; Population; End-of-life care; Cohort; Gerontology; Family medicine; Demography; Palliative care; Internal medicine; Nursing; Environmental health","score_opus":0.10498006002873886,"score_gpt":0.3871142487133077,"score_spread":0.28213418868456885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110893470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96289974,0.0013317539,0.000033827997,0.0002480176,0.00024109507,0.00037120385,0.000005349151,0.000044855573,0.03482413],"genre_scores_gemma":[0.99543995,0.0005407622,0.0024136633,0.00072065723,0.00006098616,0.0003538438,0.0000093600975,0.000015485386,0.00044529536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988139,0.00009069173,0.00026579126,0.00027525643,0.000112222784,0.0004421164],"domain_scores_gemma":[0.9991726,0.00025042307,0.00013895526,0.00018687242,0.00014286401,0.00010826535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015797852,0.00016205793,0.0005823134,0.00012959335,0.00004076999,0.0000032211506,0.00011626375,0.00023848064,0.0010698518],"category_scores_gemma":[0.00016816182,0.00011947538,0.000037464848,0.00020785359,0.00027064714,0.000075175834,0.000055017063,0.0002575272,0.000009150119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020732565,0.00017443103,0.96398574,0.00012341236,0.00007492763,0.00032164864,0.026818745,0.000005894984,0.000050128638,0.00014506224,0.00012244094,0.007970254],"study_design_scores_gemma":[0.0023303805,0.0018391084,0.972523,0.00023549852,0.000060363676,0.000006317878,0.01725021,0.000007609036,0.00059199956,0.00010053119,0.0049047545,0.00015022466],"about_ca_topic_score_codex":0.003004024,"about_ca_topic_score_gemma":0.0059547196,"teacher_disagreement_score":0.034378834,"about_ca_system_score_codex":0.0006674425,"about_ca_system_score_gemma":0.0003007201,"threshold_uncertainty_score":0.9998433},"labels":[],"label_agreement":null},{"id":"W2111513937","doi":"10.1016/j.ygyno.2011.08.027","title":"Defining the limits of radical cytoreductive surgery for ovarian cancer","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Comorbidity; Surgery; Complication; Ovarian cancer; Cancer; Radical surgery; Charlson comorbidity index; Retrospective cohort study; Internal medicine","score_opus":0.08564184217394964,"score_gpt":0.34832800996823465,"score_spread":0.262686167794285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111513937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91135377,0.0073329764,0.0004021642,0.030959673,0.004480065,0.0032379325,0.00015798397,0.00012592504,0.041949518],"genre_scores_gemma":[0.9924334,0.0004642525,0.004194754,0.0014432147,0.00019029579,0.0011059411,0.000015182098,0.00001618635,0.00013673413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988344,0.00010995887,0.000343307,0.00028568465,0.000097876255,0.00032882503],"domain_scores_gemma":[0.9970609,0.0022470395,0.000226719,0.0002379528,0.0001311016,0.00009626926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004745661,0.0001417011,0.0005883692,0.00007141027,0.000097354015,0.0000027911567,0.00009994188,0.00021211617,0.0011118237],"category_scores_gemma":[0.0005961365,0.00008525571,0.00020795589,0.0001438134,0.00030399044,0.00002897377,0.000030855463,0.00014178733,0.000015815225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021609103,0.0037933756,0.4572207,0.0001518133,0.0016884971,0.00024572344,0.0033720762,0.000008262385,0.00023548253,0.08995447,0.040003166,0.40116552],"study_design_scores_gemma":[0.003324714,0.003798422,0.9096893,0.000060166454,0.0008928539,0.000090472415,0.00067464594,0.000028384226,0.0061638057,0.0030999025,0.0720012,0.00017616081],"about_ca_topic_score_codex":0.00023527093,"about_ca_topic_score_gemma":0.00016066979,"teacher_disagreement_score":0.45246857,"about_ca_system_score_codex":0.0003495995,"about_ca_system_score_gemma":0.0009190502,"threshold_uncertainty_score":0.9998013},"labels":[],"label_agreement":null},{"id":"W2111658171","doi":"10.1016/j.ygyno.2015.04.009","title":"A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Ovarian cancer; Fallopian tube; Internal medicine; Gastroenterology; Clinical endpoint; Fallopian tube cancer; Phases of clinical research; Progression-free survival; Chemotherapy; Gynecology; Urology; Surgery; Cancer; Randomized controlled trial","score_opus":0.09231435434348424,"score_gpt":0.39577697519004246,"score_spread":0.30346262084655823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111658171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964083,0.00049653027,0.0000011999824,0.0039123646,0.0010249494,0.004181247,0.00017425328,0.000018480412,0.00055015116],"genre_scores_gemma":[0.99797064,0.00034420233,0.00016081925,0.00027564997,0.00013611653,0.000932312,0.000013189073,0.000015723468,0.00015133926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99749666,0.00043986583,0.0008696756,0.00050397735,0.00032451126,0.00036533322],"domain_scores_gemma":[0.99836224,0.00037306355,0.00045196363,0.00039702153,0.00017827368,0.00023740837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063566223,0.00026431165,0.0011608053,0.00012565701,0.00009710189,0.000007273183,0.00020141063,0.00022654129,0.00047775853],"category_scores_gemma":[0.00062995736,0.00014240788,0.00013460446,0.00036414547,0.00031093313,0.00003546812,0.00021890897,0.0002950488,0.0000013148706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.423502,0.22361894,0.15001142,0.0003933917,0.0018864804,0.0015181362,0.018888136,0.0000583204,0.00019653172,0.00021254492,0.0023644618,0.17734964],"study_design_scores_gemma":[0.63976467,0.2906587,0.026706703,0.00016701664,0.0015117141,0.00013292413,0.007651937,0.00038382786,0.00018118239,0.00003280614,0.03253994,0.00026859198],"about_ca_topic_score_codex":0.0009801167,"about_ca_topic_score_gemma":0.0118310675,"teacher_disagreement_score":0.21626265,"about_ca_system_score_codex":0.00082206045,"about_ca_system_score_gemma":0.0021323129,"threshold_uncertainty_score":0.6602013},"labels":[],"label_agreement":null},{"id":"W2111702218","doi":"10.1016/j.ygyno.2013.07.084","title":"Adjuvant treatment for endometrial cancer: Literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO)","year":2013,"lang":"fr","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Jewish General Hospital; Hôpital Maisonneuve-Rosemont; Cégep de Rivière-du-Loup; Montreal General Hospital; Cegep de Saint Jerome; Hôpital du Sacré-Cœur de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Université de Montréal; Hôpital Notre-Dame; Hôtel-Dieu de Québec; Hôpital du Saint-Sacrement; Ministère de la Santé et des Services Sociaux (Québec)","funders":"","keywords":"Medicine; Endometrial cancer; Brachytherapy; Radiation therapy; Adjuvant; Oncology; Chemotherapy; Internal medicine; Cancer; Surgery","score_opus":0.08797518015269958,"score_gpt":0.4273592560835645,"score_spread":0.33938407593086495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111702218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019158777,0.94731915,0.000087570435,0.030276343,0.0032232476,0.014886236,0.0023774547,0.00009760746,0.001540784],"genre_scores_gemma":[0.00013360589,0.9566197,0.0035888238,0.0044209594,0.002167598,0.025255654,0.002094058,0.000070609975,0.0056490325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99175024,0.0038673328,0.0017068678,0.0010974043,0.00022512698,0.0013530343],"domain_scores_gemma":[0.9733534,0.023809345,0.0012921114,0.00056413683,0.00046189196,0.0005191101],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021662614,0.0010983429,0.0047371476,0.00027607323,0.0007056148,0.000098666314,0.00048402362,0.0018279211,0.003707937],"category_scores_gemma":[0.009033651,0.00060462556,0.0008882765,0.0012112658,0.00076161657,0.00018562113,0.0002233115,0.0010278168,0.00011298114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021764587,0.0013650911,0.0003407449,0.014232044,0.0017219066,0.0000457642,0.00023316852,5.436176e-7,0.000013792926,0.0004046682,0.06888365,0.912541],"study_design_scores_gemma":[0.007962344,0.018558595,0.00047621224,0.011692168,0.015482822,0.00035696878,0.00016088109,0.000011758439,0.00002035406,0.0007748764,0.9440129,0.00049015007],"about_ca_topic_score_codex":0.0010386421,"about_ca_topic_score_gemma":0.0014195571,"teacher_disagreement_score":0.91205084,"about_ca_system_score_codex":0.015359139,"about_ca_system_score_gemma":0.00320166,"threshold_uncertainty_score":0.9996405},"labels":[],"label_agreement":null},{"id":"W2113438925","doi":"10.1016/j.ygyno.2007.03.033","title":"Associations between physical activity and quality of life in ovarian cancer survivors","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Quality of life (healthcare); Ovarian cancer; Physical activity; Cancer; Disease; Gerontology; Physical therapy; Internal medicine","score_opus":0.07422460295879874,"score_gpt":0.3988928202195924,"score_spread":0.32466821726079365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113438925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909597,0.00009980016,0.000102640246,0.0017244332,0.0003117449,0.00027898035,0.000082677,0.000024544399,0.0064154956],"genre_scores_gemma":[0.99917936,0.000042653744,0.00006187138,0.00034096462,0.00021526597,0.000021189073,0.000016758737,0.000007811428,0.0001141504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986965,0.0002637181,0.0003240226,0.00025012315,0.0001619335,0.00030367548],"domain_scores_gemma":[0.99722725,0.0021398147,0.00024207888,0.00015015442,0.00009371037,0.00014696723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014151153,0.00011354461,0.00080094754,0.00010887736,0.000041362033,0.0000028171653,0.00006412884,0.00028221402,0.000094921386],"category_scores_gemma":[0.0009390188,0.00010199639,0.00007775311,0.0003126117,0.00014675796,0.000043031097,0.000060073868,0.00032217894,0.000002962021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015481233,0.00039504634,0.96558136,0.00003567011,0.00005674133,0.000007561807,0.0009816643,0.0000016946686,0.0016705272,0.0005432417,0.000033235494,0.030538455],"study_design_scores_gemma":[0.0012896205,0.00041830118,0.9960989,0.0000065762692,0.000052686784,4.720792e-7,0.00038496646,0.0000057188136,0.000577801,0.0002651943,0.0008043203,0.000095452655],"about_ca_topic_score_codex":0.03733058,"about_ca_topic_score_gemma":0.29014808,"teacher_disagreement_score":0.25281748,"about_ca_system_score_codex":0.0004932892,"about_ca_system_score_gemma":0.0003889467,"threshold_uncertainty_score":0.9690799},"labels":[],"label_agreement":null},{"id":"W2114804910","doi":"10.1016/j.ygyno.2011.04.029","title":"New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Parametrial; Medicine; Radical Hysterectomy; Hysterectomy; Resection; Gynecology; Radiology; Surgery; Cervical cancer; Internal medicine; Cancer","score_opus":0.12546696315293535,"score_gpt":0.3540736512922492,"score_spread":0.22860668813931387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114804910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98314637,0.00015148151,0.001006829,0.0005146413,0.0019900682,0.0019446665,0.000032997035,0.00012003098,0.0110928975],"genre_scores_gemma":[0.99114144,0.000010422576,0.007849498,0.00020025308,0.00031505493,0.00023016543,0.00004557749,0.000017107572,0.0001904552],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835026,0.00015383906,0.0005567724,0.00041301997,0.00022267747,0.00030342047],"domain_scores_gemma":[0.9977953,0.001289968,0.00032597827,0.00025296886,0.00013518317,0.00020059594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047348664,0.0001770468,0.0007189735,0.0003288876,0.000080110716,0.000003794977,0.000111649504,0.00042365288,0.0005317384],"category_scores_gemma":[0.0007274247,0.00012912105,0.00022145681,0.00044586504,0.0000934957,0.000038307364,0.000029544495,0.0001743047,0.00006514269],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15193245,0.006744617,0.06856958,0.00089331775,0.0022496989,0.00025155235,0.00039659563,0.000022860082,0.011218445,0.030406268,0.013520221,0.7137944],"study_design_scores_gemma":[0.09864171,0.11897928,0.70895875,0.00034524468,0.0020457348,0.0003664965,0.00046418278,0.0017770339,0.032592803,0.006712877,0.028407024,0.0007088425],"about_ca_topic_score_codex":0.00033449027,"about_ca_topic_score_gemma":0.00021450159,"teacher_disagreement_score":0.71308553,"about_ca_system_score_codex":0.0009594456,"about_ca_system_score_gemma":0.00049512624,"threshold_uncertainty_score":0.58221626},"labels":[],"label_agreement":null},{"id":"W2115250254","doi":"10.1016/j.ygyno.2010.04.014","title":"End of life care for women with gynecologic cancers","year":2010,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; McMaster University; Sunnybrook Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Psychological intervention; End-of-life care; Emergency department; Population; Health care; Cohort; Cervical cancer; Retrospective cohort study; Family medicine; Emergency medicine; Gerontology; Cancer; Palliative care; Nursing; Internal medicine; Environmental health","score_opus":0.1548103511263793,"score_gpt":0.4590269087894764,"score_spread":0.3042165576630971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115250254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027257015,0.9756212,0.000021131204,0.0000930253,0.0009752265,0.0031500375,0.0003602493,0.00006523009,0.016988201],"genre_scores_gemma":[0.001133934,0.9893584,0.005569392,0.00036410283,0.00032876193,0.0021533603,0.00028856634,0.00006915239,0.00073430134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968847,0.0002458021,0.0011493883,0.00069481565,0.00024673133,0.0007785725],"domain_scores_gemma":[0.9922291,0.0047092144,0.0015148547,0.0005998984,0.0006185097,0.000328429],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004965962,0.0006190537,0.0059017134,0.00033973836,0.00007786058,0.000004700139,0.00043951077,0.0017722243,0.0010535424],"category_scores_gemma":[0.003091202,0.00040174302,0.00051094923,0.00039351804,0.00076353434,0.000035986424,0.00012164453,0.00084893126,0.00002208548],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003447429,0.00021810966,0.0008754842,0.030420285,0.00076946797,0.000075704615,0.0011455483,0.0000025614115,0.0000051748225,0.00015192204,0.0011224154,0.9648686],"study_design_scores_gemma":[0.0021090596,0.012439806,0.00022177381,0.002651735,0.0015422992,0.000028578599,0.0022456592,8.654735e-7,0.000010463249,0.00006233675,0.9783206,0.00036683207],"about_ca_topic_score_codex":0.00006670809,"about_ca_topic_score_gemma":0.00095756655,"teacher_disagreement_score":0.9771982,"about_ca_system_score_codex":0.0021009953,"about_ca_system_score_gemma":0.008520806,"threshold_uncertainty_score":0.99985963},"labels":[],"label_agreement":null},{"id":"W2117979764","doi":"10.1006/gyno.2000.6032","title":"Malignant Rhabdoid Tumor of the Vulva: Case Report and Review of the Literature with Emphasis on Clinical Management and Outcome","year":2001,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Vulva; Groin; Wide local excision; Presentation (obstetrics); Radiation therapy; Surgery; Dissection (medical); Chemotherapy","score_opus":0.04993114425066009,"score_gpt":0.39358038988242366,"score_spread":0.3436492456317636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117979764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01240147,0.98441875,0.0000034136647,0.00020369676,0.000337672,0.0011688547,0.00004706577,0.0000044900817,0.0014145678],"genre_scores_gemma":[0.0013865837,0.9961277,0.00031901107,0.0010058184,0.00008167647,0.00010474251,0.000026101963,0.000020216046,0.0009281279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973886,0.00059611246,0.0011169512,0.0005620438,0.00013681446,0.0001994476],"domain_scores_gemma":[0.9975386,0.00017416751,0.0012491673,0.0008841669,0.00010014398,0.000053751257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010458714,0.0003118339,0.0014102913,0.000030071466,0.00007955888,0.000006784679,0.00029631265,0.0004209811,0.00001705927],"category_scores_gemma":[0.00038875913,0.00013673506,0.00037031103,0.00020610545,0.00036839387,0.0000014152627,0.00040728823,0.00033445313,5.167638e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041535684,0.0002709058,0.0012949215,0.047587313,0.0005322027,0.006248548,0.00001617283,0.0000014753118,0.0000036958784,0.000050865918,0.0026617092,0.9412907],"study_design_scores_gemma":[0.0003897031,0.0010977362,0.0002569807,0.01621683,0.0011459873,0.03590266,0.000019861302,7.2524637e-7,0.000006911532,0.0000137776115,0.9447616,0.00018722245],"about_ca_topic_score_codex":0.00000676879,"about_ca_topic_score_gemma":0.000036679845,"teacher_disagreement_score":0.94209987,"about_ca_system_score_codex":0.000050665014,"about_ca_system_score_gemma":0.00026276638,"threshold_uncertainty_score":0.5575894},"labels":[],"label_agreement":null},{"id":"W2118060163","doi":"10.1016/j.ygyno.2014.07.004","title":"The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Debulking; Chemotherapy; Ovarian cancer; Oncology; Neoadjuvant therapy; Internal medicine; General surgery; Gynecology; Surgery; Cancer; Breast cancer","score_opus":0.020369816799317087,"score_gpt":0.3127163489134138,"score_spread":0.2923465321140967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118060163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986673,0.0013192251,0.000016039772,0.008657752,0.00074258697,0.0003438889,0.000024392832,0.000016786606,0.0022063323],"genre_scores_gemma":[0.9941325,0.0041269306,0.00044972976,0.0010284481,0.00012544206,0.000072485214,0.000008670792,0.000014377718,0.000041424453],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987987,0.00016280814,0.00037437078,0.000258907,0.00014102385,0.00026414922],"domain_scores_gemma":[0.99437964,0.0048186807,0.00033817734,0.00028738775,0.000081639344,0.00009447491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050695054,0.00015205482,0.0007299329,0.000053992742,0.000072461386,0.000004855898,0.000073578376,0.00015206821,0.00020925976],"category_scores_gemma":[0.00046285443,0.00009068742,0.000100590245,0.00010148188,0.00018474103,0.000021725218,0.000030766794,0.00012068437,0.0000027155234],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089637114,0.00048179794,0.33802822,0.000030217752,0.00030329628,0.00001851462,0.00019192412,0.000016841106,0.0023325572,0.0009505321,0.0006321152,0.6561176],"study_design_scores_gemma":[0.0037019206,0.0023351272,0.95845276,0.000096687414,0.00012331989,0.000004023582,0.00009534774,0.00005255668,0.007759776,0.00084379484,0.026442738,0.0000919274],"about_ca_topic_score_codex":0.0008197637,"about_ca_topic_score_gemma":0.0011764292,"teacher_disagreement_score":0.6560257,"about_ca_system_score_codex":0.00019658603,"about_ca_system_score_gemma":0.00027416612,"threshold_uncertainty_score":0.36981258},"labels":[],"label_agreement":null},{"id":"W2118514776","doi":"10.1016/j.ygyno.2007.02.015","title":"Intraperitoneal chemotherapy for patients with advanced ovarian cancer: A review of the evidence and standards for the delivery of care","year":2007,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University; McMaster University; Cancer Care Ontario; Ottawa Hospital; University of British Columbia; University of Toronto; Université de Montréal; University of Ottawa","funders":"","keywords":"Medicine; Chemotherapy; Context (archaeology); Regimen; Randomized controlled trial; Oncology; Chemotherapy regimen; Intensive care medicine; Cochrane Library; Adverse effect; Clinical trial; Ovarian cancer; Cancer; Internal medicine","score_opus":0.042317622743555335,"score_gpt":0.40803425185382597,"score_spread":0.36571662911027064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118514776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014430967,0.98572046,0.000029174755,0.0013204416,0.00040539386,0.011373047,0.00092494756,0.000008049363,0.00007417801],"genre_scores_gemma":[0.00037730744,0.99267125,0.001723931,0.0011201119,0.00009469678,0.0039213384,0.000041996478,0.000033519027,0.000015838415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816024,0.00012051575,0.0007021317,0.00041018554,0.000321468,0.00028545718],"domain_scores_gemma":[0.9936395,0.0036178997,0.00097002863,0.00046884618,0.0012434024,0.000060290986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007055101,0.00032845332,0.002328362,0.000049923274,0.00010597641,0.000003823633,0.00024121767,0.0002933568,0.00008433616],"category_scores_gemma":[0.0006213137,0.0001424892,0.0004434931,0.00023112648,0.00031027792,0.000027548727,0.000056958575,0.00018946678,1.1045216e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046792687,0.0002425717,0.000650983,0.096214734,0.0005859287,0.0000015990768,0.00007612735,2.9204617e-7,8.336175e-8,0.00005408058,0.0008687529,0.90083694],"study_design_scores_gemma":[0.0032359366,0.0077605457,0.0022205438,0.07116944,0.004614625,0.000007279556,0.000040933737,5.097121e-7,0.000004759098,0.0000071459353,0.9108091,0.00012916775],"about_ca_topic_score_codex":0.000036723628,"about_ca_topic_score_gemma":0.00018432815,"teacher_disagreement_score":0.90994036,"about_ca_system_score_codex":0.0012817662,"about_ca_system_score_gemma":0.0035847551,"threshold_uncertainty_score":0.63592017},"labels":[],"label_agreement":null},{"id":"W2121019919","doi":"10.1016/j.ygyno.2004.09.025","title":"Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"National Cancer Institute; VGH and UBC Hospital Foundation","keywords":"Pathology; Medicine; Serous fluid; Immunohistochemistry; Immunostaining; H&E stain; Ovary; Ovarian tumor; Ovarian cancer; Clear cell; Cancer; Internal medicine","score_opus":0.025283072494958616,"score_gpt":0.291341168002541,"score_spread":0.2660580955075824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121019919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837496,0.0004694701,0.000106489715,0.0024953787,0.0003565067,0.0008541427,0.000034426095,0.000028983339,0.011904981],"genre_scores_gemma":[0.99441457,0.00012617043,0.0043841116,0.0006709515,0.000099695535,0.00013027606,0.000099756355,0.00001762317,0.000056873792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99797916,0.00010472746,0.0007849367,0.0004220186,0.00027250615,0.00043667265],"domain_scores_gemma":[0.99892014,0.000081322345,0.00036008746,0.00032544107,0.00017371796,0.00013930812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044879818,0.0002171126,0.0009768932,0.00031811013,0.000053974287,0.000005614216,0.00016975559,0.00026869142,0.00051290944],"category_scores_gemma":[0.00006018964,0.00018458009,0.00016634668,0.00033964627,0.0002733382,0.00011139874,0.0001110904,0.00023538213,0.000011409633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068077277,0.11489664,0.17378817,0.003404861,0.0033462055,0.018485155,0.009590248,0.0869825,0.36140367,0.119866475,0.009344672,0.09208366],"study_design_scores_gemma":[0.035457447,0.01978329,0.8912993,0.00037126205,0.0006287085,0.00029029872,0.00061099784,0.0001062555,0.029596731,0.020248376,0.0011372595,0.00047007448],"about_ca_topic_score_codex":0.0011592406,"about_ca_topic_score_gemma":0.00070823915,"teacher_disagreement_score":0.7175111,"about_ca_system_score_codex":0.0013852841,"about_ca_system_score_gemma":0.0011067853,"threshold_uncertainty_score":0.75269574},"labels":[],"label_agreement":null},{"id":"W2123806833","doi":"10.1016/j.ygyno.2013.09.012","title":"The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Hazard ratio; Endometrial cancer; Radiation therapy; Chemoradiotherapy; Stage (stratigraphy); Cohort; Carboplatin; Oncology; Brachytherapy; Carcinoma; Internal medicine; Surgery; Cancer; Chemotherapy; Cisplatin; Confidence interval","score_opus":0.01616148384240287,"score_gpt":0.28863833295193325,"score_spread":0.2724768491095304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123806833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907395,0.0041399435,0.000009238181,0.002133492,0.00040538254,0.0013171075,0.000014968381,0.000024413781,0.0012159469],"genre_scores_gemma":[0.9925442,0.004977706,0.00075159845,0.0007786399,0.00016722927,0.00022419001,0.0000060055354,0.000017527658,0.00053292356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826735,0.00024566654,0.0005409238,0.00033640448,0.00019205418,0.0004175795],"domain_scores_gemma":[0.99687815,0.0022737735,0.0003270445,0.00030008232,0.00008403512,0.00013690731],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054323405,0.00019454517,0.00078601704,0.00018615612,0.000083342966,0.000013870439,0.00015162407,0.00022943495,0.0011923983],"category_scores_gemma":[0.0006457432,0.00011315071,0.0001007175,0.0005394132,0.0002850401,0.00006128695,0.00004335471,0.00029200187,0.000016184249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010655626,0.00031470382,0.8539162,0.000016327469,0.00010616652,0.0000493345,0.0001697895,0.0000012558257,0.0005888723,0.00023873326,0.0001515363,0.14338149],"study_design_scores_gemma":[0.021176334,0.007104695,0.9650065,0.0000053590625,0.000048017493,0.000011934949,0.00016097398,0.000030050625,0.00043288997,0.0011156858,0.004804398,0.000103197424],"about_ca_topic_score_codex":0.0030164265,"about_ca_topic_score_gemma":0.0008806986,"teacher_disagreement_score":0.1432783,"about_ca_system_score_codex":0.00038729786,"about_ca_system_score_gemma":0.00017324768,"threshold_uncertainty_score":0.99972063},"labels":[],"label_agreement":null},{"id":"W2124051475","doi":"10.1016/j.ygyno.2015.04.037","title":"Risk stratification and outcomes of women undergoing surgery for ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; National Cancer Institute, Cairo University; American College of Surgeons","keywords":"Medicine; Perioperative; Ovarian cancer; Logistic regression; Complication; Surgery; Cancer; Internal medicine","score_opus":0.05989864775738174,"score_gpt":0.3495221570306768,"score_spread":0.28962350927329505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124051475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99071544,0.00051335344,0.0001966191,0.006266151,0.00047061683,0.0006368078,0.000036527428,0.000027794616,0.0011366626],"genre_scores_gemma":[0.9952739,0.00083084556,0.0024371915,0.00045996747,0.00006537051,0.00072956574,0.000017939936,0.00000956194,0.0001756732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905884,0.000080958525,0.00029101598,0.00023115458,0.000079277306,0.00025876067],"domain_scores_gemma":[0.9967036,0.0025991153,0.0002484344,0.00015609995,0.00012309056,0.00016962546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006981262,0.00010582243,0.00055239134,0.00007614761,0.000045190332,0.000005851938,0.000032633,0.00014041598,0.0001165169],"category_scores_gemma":[0.0013758332,0.000078773395,0.0000608458,0.00007943658,0.000077810146,0.000038187303,0.000019390985,0.00006149287,0.0000033230913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001811531,0.00045042826,0.9184938,0.00006726626,0.00030340898,0.000009757998,0.0005735339,0.000017308797,0.000028203642,0.0016109542,0.0021108303,0.07615336],"study_design_scores_gemma":[0.0033557606,0.0018521859,0.9796334,0.000015138554,0.00023985491,0.0000073358674,0.0008681014,0.000054480308,0.00016448274,0.0040168483,0.009705073,0.00008732062],"about_ca_topic_score_codex":0.00022744732,"about_ca_topic_score_gemma":0.00082685106,"teacher_disagreement_score":0.07606604,"about_ca_system_score_codex":0.0010096313,"about_ca_system_score_gemma":0.0012954703,"threshold_uncertainty_score":0.32122856},"labels":[],"label_agreement":null},{"id":"W2126306942","doi":"10.1016/j.ygyno.2011.04.043","title":"Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Ovarian cancer; Quality of life (healthcare); Pedometer; Cancer; Oncology; Physical therapy; Physical activity","score_opus":0.058301254219095704,"score_gpt":0.35108533098359923,"score_spread":0.2927840767645035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126306942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991066,0.0002013508,0.00038071512,0.00036814285,0.001424787,0.0011268482,0.00003683505,0.000047436748,0.006503221],"genre_scores_gemma":[0.9972486,0.00007887499,0.001113528,0.0007268814,0.000092600996,0.0003227125,0.00003168435,0.000015719203,0.00036941114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988447,0.00011252866,0.0003951514,0.0002971148,0.000096279065,0.00025425808],"domain_scores_gemma":[0.9989343,0.00019753062,0.00026405053,0.00022383827,0.00029354703,0.00008670863],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047549527,0.00012658224,0.00047959932,0.00006861394,0.000040807736,0.0000022004692,0.000107496584,0.0002318696,0.0015738646],"category_scores_gemma":[0.000392381,0.000105525825,0.00020677457,0.00012295507,0.00009602805,0.000044464305,0.00003971731,0.0001262085,0.0000052874525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014783595,0.0017433193,0.8113316,0.00019975107,0.00008638572,0.0000036335368,0.0022700028,2.723173e-7,0.0003093558,0.00012613123,0.00085800304,0.18159313],"study_design_scores_gemma":[0.0061099604,0.0051650386,0.97816485,0.000057588513,0.00011649991,0.0000028110178,0.00043152206,0.000023306851,0.0013869717,0.0007990195,0.007628833,0.00011362164],"about_ca_topic_score_codex":0.0009349715,"about_ca_topic_score_gemma":0.005921962,"teacher_disagreement_score":0.18147951,"about_ca_system_score_codex":0.00043616694,"about_ca_system_score_gemma":0.00019279442,"threshold_uncertainty_score":0.9993388},"labels":[],"label_agreement":null},{"id":"W2126333005","doi":"10.1016/j.ygyno.2009.03.030","title":"Options in the management of fertility-related issues after radical trachelectomy in patients with early cervical cancer","year":2009,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Trachelectomy; Medicine; Cervical cancer; Fertility; Gynecology; General surgery; Obstetrics; Cancer; Internal medicine; Environmental health","score_opus":0.01100468651198103,"score_gpt":0.31253033177407147,"score_spread":0.3015256452620904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126333005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91730624,0.0027802729,0.0000011643951,0.0022126758,0.07121617,0.003105618,0.00011950382,0.000042311018,0.0032160573],"genre_scores_gemma":[0.9720667,0.0012832925,0.00070980244,0.00049884396,0.02251677,0.0017825236,0.0004965497,0.000040891315,0.00060461275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669385,0.0005382803,0.0008201813,0.00061608595,0.0007755388,0.0005560818],"domain_scores_gemma":[0.9981528,0.000934832,0.00024418804,0.00038921155,0.0001694815,0.00010948384],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005745554,0.0003751452,0.0012584721,0.00033014445,0.000035306468,0.000011343841,0.00033557284,0.0013083873,0.0010665517],"category_scores_gemma":[0.00018926554,0.00021751795,0.00015664371,0.0010211263,0.00023677862,0.00005144017,0.00006860897,0.001416709,0.000021633201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038313437,0.029761577,0.7315362,0.001258011,0.0021601054,0.0033828754,0.0014720495,0.000035519242,0.0000026447808,0.000112302216,0.08764405,0.10432124],"study_design_scores_gemma":[0.015814563,0.007303568,0.8735124,0.00022660328,0.0005912773,8.2772766e-7,0.000045412544,0.0000011749266,0.0000018579759,0.00029075242,0.10203187,0.00017971438],"about_ca_topic_score_codex":0.0008704621,"about_ca_topic_score_gemma":0.0018738771,"teacher_disagreement_score":0.14197618,"about_ca_system_score_codex":0.0013211059,"about_ca_system_score_gemma":0.00037062177,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W2126380984","doi":"10.1016/j.ygyno.2011.06.024","title":"Early adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe?","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Trachelectomy; Adenocarcinoma; Cervical cancer; Stage (stratigraphy); Radical Hysterectomy; Adjuvant therapy; Lymph node; Cervix; Urology; Internal medicine; Gastroenterology; Surgery; Gynecology; Cancer","score_opus":0.05499778788340176,"score_gpt":0.3005836413243545,"score_spread":0.24558585344095274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126380984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91674083,0.0007781775,0.000015133192,0.0022981681,0.00051295536,0.000512439,0.00001128541,0.000033339376,0.07909768],"genre_scores_gemma":[0.9946883,0.00005222118,0.001058054,0.0026681945,0.00013411652,0.00006448962,0.0000032797086,0.000012810204,0.0013185749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848795,0.00018630498,0.00038721238,0.00031169623,0.00023885771,0.00038795793],"domain_scores_gemma":[0.9988697,0.00033426765,0.00017856529,0.00035393843,0.00009331077,0.00017021714],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022141461,0.00017352324,0.0005731837,0.000092153285,0.00007761104,0.000002725771,0.00028388388,0.00031695113,0.009215384],"category_scores_gemma":[0.0002629398,0.00010026191,0.00023944149,0.00047090172,0.0003726272,0.00003607817,0.00010664131,0.00035262667,0.00015583805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015679232,0.0021121658,0.92771316,0.0000666111,0.00036585334,0.00025753383,0.001388245,1.1522368e-7,0.0012672857,0.0013414238,0.0022639125,0.06165577],"study_design_scores_gemma":[0.0051002447,0.0058795013,0.9690574,0.000010725479,0.0003478719,0.000119514414,0.00007450411,0.0000028362344,0.0070826015,0.0019666494,0.010259667,0.00009847659],"about_ca_topic_score_codex":0.0003234822,"about_ca_topic_score_gemma":0.000046594243,"teacher_disagreement_score":0.07794744,"about_ca_system_score_codex":0.00028382987,"about_ca_system_score_gemma":0.00034374176,"threshold_uncertainty_score":0.99169034},"labels":[],"label_agreement":null},{"id":"W2127493308","doi":"10.1016/j.ygyno.2013.08.004","title":"Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Queen's University; Hôpital Notre-Dame; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Medicine; Temsirolimus; Internal medicine; Oncology; Endometrial cancer; Mucositis; PTEN; Chemotherapy; Progression-free survival; Cancer; Adverse effect; Tumor progression; PI3K/AKT/mTOR pathway","score_opus":0.032356460692080105,"score_gpt":0.37690080203805937,"score_spread":0.3445443413459793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127493308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973289,0.0007064465,0.00003272101,0.0004543168,0.00043836562,0.00094932265,0.00002443027,0.000009453246,0.00005605946],"genre_scores_gemma":[0.9956803,0.0005448106,0.0023325821,0.00047221346,0.00012958657,0.0007651052,0.0000033452739,0.000013325169,0.000058740097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979034,0.0006819723,0.0004691414,0.00047469878,0.00011836551,0.00035240367],"domain_scores_gemma":[0.99854934,0.0007594926,0.00020678292,0.00019389171,0.000094462426,0.00019604345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013103331,0.00016769789,0.0004814267,0.00012720225,0.000037133752,0.000010174151,0.00014064561,0.00023930523,0.00012787349],"category_scores_gemma":[0.002085186,0.00011085671,0.000024279223,0.0002107891,0.0003475775,0.000006484293,0.00019157835,0.00016321751,0.0000017969983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056400318,0.0010798424,0.34541273,0.00013133566,0.00029464797,0.000061562925,0.0006744794,0.00007992741,0.32274994,0.00000625819,0.0027027633,0.2704062],"study_design_scores_gemma":[0.012517965,0.08648532,0.84656334,0.00011288895,0.000118713244,0.000052612646,0.0005588588,0.0000654435,0.024861883,0.00013174533,0.02801797,0.0005132732],"about_ca_topic_score_codex":0.000032164004,"about_ca_topic_score_gemma":0.00024912198,"teacher_disagreement_score":0.5011506,"about_ca_system_score_codex":0.0001152429,"about_ca_system_score_gemma":0.0004408248,"threshold_uncertainty_score":0.45206055},"labels":[],"label_agreement":null},{"id":"W2128051007","doi":"10.1016/j.ygyno.2008.12.025","title":"Intraoperative margin assessment of the radical trachelectomy specimen","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Trachelectomy; Adenosquamous carcinoma; Frozen section procedure; Adenocarcinoma; Margin (machine learning); Basal cell; Surgery; Cytopathology; Radiology; Pathology; Cancer; Cytology; Internal medicine; Cervical cancer","score_opus":0.02675736346595479,"score_gpt":0.3624408212684728,"score_spread":0.335683457802518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128051007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8720287,0.0001983922,0.00004254493,0.015926246,0.0005308455,0.00080770813,0.000006769149,0.000033761302,0.11042501],"genre_scores_gemma":[0.99339706,0.00006752664,0.0018123725,0.003463139,0.00016603587,0.000037761794,0.000008062865,0.0000049493847,0.0010430779],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987369,0.00022701675,0.00031989458,0.00023257249,0.00021446803,0.00026915327],"domain_scores_gemma":[0.9990475,0.00042560094,0.0001235205,0.00021838059,0.00007858662,0.00010640025],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026535778,0.00013387542,0.00051868934,0.0000612415,0.00006596094,0.0000042044203,0.00015542904,0.00019198236,0.0024412791],"category_scores_gemma":[0.00031513453,0.000071821494,0.00014813623,0.00039154585,0.00018119354,0.000028469582,0.000039119168,0.00032569066,0.000017929267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022710182,0.016005421,0.32643434,0.00009517302,0.0011184813,0.0007736768,0.00086244615,0.00006950676,0.08444983,0.026285248,0.0154992165,0.5261357],"study_design_scores_gemma":[0.0054985406,0.0076180953,0.96044266,0.000010893425,0.00016849232,0.00005495823,0.000063154715,0.00004099168,0.0063804016,0.0016161833,0.018022917,0.00008272266],"about_ca_topic_score_codex":0.000013354185,"about_ca_topic_score_gemma":0.000027272059,"teacher_disagreement_score":0.63400835,"about_ca_system_score_codex":0.00061204185,"about_ca_system_score_gemma":0.00045785398,"threshold_uncertainty_score":0.9984706},"labels":[],"label_agreement":null},{"id":"W2128228131","doi":"10.1016/j.ygyno.2013.11.025","title":"Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions","year":2013,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Systemic therapy; Disease; Oncology; Vulvar cancer; Vulvar neoplasm; Vulvar Carcinoma; Chemotherapy; Targeted therapy; Clinical trial; MEDLINE; Intensive care medicine; Adjuvant therapy; Neoadjuvant therapy; Quality of life (healthcare); Internal medicine; Cancer; Carcinoma","score_opus":0.0538524194686968,"score_gpt":0.35408959419785746,"score_spread":0.30023717472916067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128228131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020399362,0.97144634,9.32196e-8,0.000119903554,0.0024365473,0.0029188865,0.000045933735,0.0000202731,0.0026126655],"genre_scores_gemma":[0.02204678,0.9762891,0.000020166372,0.000068866655,0.00040363753,0.00087302655,0.00003293108,0.000023886862,0.0002416288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976874,0.00061374495,0.0007131122,0.00042098365,0.000159524,0.0004052645],"domain_scores_gemma":[0.99781346,0.0010789228,0.0005159239,0.0003717764,0.0000832629,0.00013666217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019530754,0.0003598098,0.002243598,0.0002477324,0.00006353408,0.000006135754,0.00017290287,0.0006047703,0.00041256603],"category_scores_gemma":[0.0001353859,0.00017816042,0.00034617298,0.000704858,0.00013801684,0.000021086775,0.00011654029,0.00069827726,0.000027050388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031222775,0.00063681195,0.004001941,0.0049707647,0.00004529568,0.000018433055,0.00009839759,4.7591968e-8,0.0000010554113,0.000022830398,0.00016226116,0.9900109],"study_design_scores_gemma":[0.003004387,0.0022281185,0.013068029,0.0004517616,0.0005923021,0.00009301394,0.0000888226,3.130752e-7,0.0000018636765,0.000029933364,0.9802974,0.0001440403],"about_ca_topic_score_codex":0.00027469816,"about_ca_topic_score_gemma":0.00011265149,"teacher_disagreement_score":0.9898669,"about_ca_system_score_codex":0.0010492775,"about_ca_system_score_gemma":0.0009011285,"threshold_uncertainty_score":0.7265171},"labels":[],"label_agreement":null},{"id":"W2128762264","doi":"10.1016/j.ygyno.2015.01.430","title":"New cases of small cell carcinoma of the ovary, hypercalemic type caused by germline SMARCA4 mutations: An under-diagnosed entity?","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"SMARCA4; Germline; Germline mutation; Medicine; Ovary; Malignancy; Somatic cell; Small-cell carcinoma; Mutation; Oncology; Internal medicine; Carcinoma; Cancer research; Biology; Genetics; Gene; Chromatin; Chromatin remodeling","score_opus":0.043692116904174114,"score_gpt":0.29645506546891903,"score_spread":0.2527629485647449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128762264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621636,0.0015737322,0.00046893378,0.00023364655,0.0004226109,0.0002463972,0.00005246902,0.000010747854,0.00077510823],"genre_scores_gemma":[0.99676627,0.00009877514,0.0015044458,0.00042717208,0.00010057007,0.000014071458,0.00015720076,0.000015705538,0.00091579615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99881154,0.00022735384,0.00035401853,0.00028662206,0.000106361,0.00021411624],"domain_scores_gemma":[0.99885005,0.00014018998,0.00024984614,0.00041751534,0.00022548935,0.000116925614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002428259,0.00014502688,0.00027732932,0.00003265407,0.000045379675,0.00000470792,0.000325089,0.00030078358,0.000085130254],"category_scores_gemma":[0.00036924082,0.000112946924,0.000088066416,0.00013754706,0.00015669769,0.0000040622713,0.00012994722,0.00011210711,0.000004806605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023989317,0.0010602942,0.026174983,0.00007335289,0.0000758675,0.000025881887,0.00038667006,0.004228755,0.9218282,0.000059927028,0.038432356,0.007413837],"study_design_scores_gemma":[0.011005499,0.01772359,0.06064429,0.000034001714,0.00048079668,0.00017123189,0.0024909528,0.0015449873,0.85245734,0.0023937845,0.05011639,0.0009371409],"about_ca_topic_score_codex":0.0010220743,"about_ca_topic_score_gemma":0.0018194435,"teacher_disagreement_score":0.06937085,"about_ca_system_score_codex":0.00008645326,"about_ca_system_score_gemma":0.0011414798,"threshold_uncertainty_score":0.4605842},"labels":[],"label_agreement":null},{"id":"W2128853049","doi":"10.1016/j.ygyno.2010.01.016","title":"“Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases”","year":2010,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Gynecology; Obstetrics; Gestational trophoblastic disease; Gestation; Pregnancy","score_opus":0.016354757127651796,"score_gpt":0.28850466664633356,"score_spread":0.2721499095186818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128853049","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42152637,0.0015304488,0.000015366742,0.5596836,0.0018039799,0.002795374,0.00040288334,0.00008019306,0.012161723],"genre_scores_gemma":[0.56559265,0.0013639864,0.0033259885,0.42343032,0.0014923873,0.0010693254,0.0016925453,0.000091091024,0.001941685],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9976273,0.00021770153,0.0006039414,0.0005320614,0.0005689019,0.00045009243],"domain_scores_gemma":[0.9971807,0.0018606567,0.00035021556,0.00035148297,0.00017473943,0.00008218248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021669999,0.00036939885,0.0008381697,0.00025070243,0.000079247264,0.000010855272,0.0002436371,0.0008762007,0.0004630812],"category_scores_gemma":[0.00036400007,0.00025147918,0.00013207176,0.00022732145,0.00068637886,0.000029802195,0.00015305367,0.0021351038,0.00004265239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019062395,0.0033851457,0.012860799,0.0056336992,0.0019429545,0.02629126,0.0008685187,0.000039642688,0.0002917922,0.0011200507,0.9290007,0.016659241],"study_design_scores_gemma":[0.002463913,0.0010640045,0.66806996,0.00012665955,0.0010493273,0.00011584328,0.0004329271,0.000030478881,0.000002942212,0.0012102938,0.32521302,0.00022062],"about_ca_topic_score_codex":0.000014346973,"about_ca_topic_score_gemma":0.000020841224,"teacher_disagreement_score":0.6552092,"about_ca_system_score_codex":0.0003013582,"about_ca_system_score_gemma":0.0004211509,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W2129361273","doi":"10.1016/j.ygyno.2007.05.019","title":"Final results of a phase 2 study using continuous 5% Imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Imiquimod; Vulva; Colposcopy; Vulvar intraepithelial neoplasia; Cohort; Surgery; Regimen; Stage (stratigraphy); Dermatology; Cervical intraepithelial neoplasia; Cancer; Internal medicine; Cervical cancer","score_opus":0.066374685702731,"score_gpt":0.40846647422493143,"score_spread":0.34209178852220046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129361273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177206,0.00013634043,0.00022986105,0.00063663843,0.00009390696,0.0022690925,0.000032254167,0.000015143872,0.0048147105],"genre_scores_gemma":[0.998745,0.0000688495,0.00064260786,0.0001765074,0.00016620856,0.000114081005,0.000044123182,0.000008959565,0.000033637207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979877,0.0002899687,0.00073619926,0.00031919056,0.00029777602,0.00036914943],"domain_scores_gemma":[0.99762267,0.0015214062,0.00026087396,0.00035564558,0.00015999693,0.00007939912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014300158,0.00014959686,0.0007431742,0.0001976079,0.00004778114,0.000003595128,0.00017502395,0.00019660931,0.00013261454],"category_scores_gemma":[0.0002942715,0.000094835654,0.000085179294,0.00040358672,0.00023368336,0.000024426769,0.000046326488,0.00021926292,0.0000037271575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02427427,0.05432177,0.032014664,0.00009841231,0.00015707797,0.0006059002,0.0057628225,0.000038181297,0.013042044,0.00020364962,0.00010699004,0.8693742],"study_design_scores_gemma":[0.045385465,0.07890089,0.8650969,0.0000069659613,0.00025630987,0.00009671471,0.003176945,0.00021498984,0.0032447136,0.00031031706,0.0031937163,0.00011604862],"about_ca_topic_score_codex":0.0027539271,"about_ca_topic_score_gemma":0.003174885,"teacher_disagreement_score":0.86925817,"about_ca_system_score_codex":0.00075938617,"about_ca_system_score_gemma":0.00047157693,"threshold_uncertainty_score":0.41631323},"labels":[],"label_agreement":null},{"id":"W2129427980","doi":"10.1016/j.ygyno.2005.07.067","title":"Radical vaginal trachelectomy: A fertility-preserving option for young women with early stage cervical cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Trachelectomy; Cervical cancer; Stage (stratigraphy); Fertility; Fertility preservation; Quality of life (healthcare); Radical Hysterectomy; Hysterectomy; Obstetrics; Gynecology; Radiation therapy; Cancer; Surgery; Internal medicine; Population","score_opus":0.032462017812483965,"score_gpt":0.3378106810192822,"score_spread":0.3053486632067982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129427980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866681,0.00045199814,0.00073453237,0.0066702426,0.00024022731,0.0013086012,0.000042199794,0.0001439547,0.0037401293],"genre_scores_gemma":[0.98749745,0.00007736838,0.00549905,0.0019585479,0.0005249486,0.0020706821,0.000031112464,0.000030186899,0.0023106723],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774414,0.00014538872,0.0003977996,0.00056917395,0.00029138426,0.0008521248],"domain_scores_gemma":[0.9984276,0.0005892587,0.00014132173,0.0002701905,0.00016454222,0.0004070343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043629413,0.00026701725,0.0007470852,0.00014221069,0.0001618272,0.000023617506,0.00020135305,0.00036230247,0.003779864],"category_scores_gemma":[0.00032030535,0.00018616188,0.000107472544,0.00039308378,0.00017432864,0.00014180788,0.0000715569,0.0004040198,0.000043419757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045913596,0.0056612375,0.37005785,0.0005005544,0.0012607115,0.0004132838,0.002304103,0.0002059186,0.0048681423,0.0007896643,0.0010008765,0.56702405],"study_design_scores_gemma":[0.020246947,0.017327944,0.85676134,0.000029005801,0.00034479803,0.000056505753,0.0002550201,0.00068210973,0.00086339156,0.0004954072,0.102623165,0.0003143495],"about_ca_topic_score_codex":0.00042741108,"about_ca_topic_score_gemma":0.0018887055,"teacher_disagreement_score":0.5667097,"about_ca_system_score_codex":0.00259493,"about_ca_system_score_gemma":0.0005828515,"threshold_uncertainty_score":0.9971308},"labels":[],"label_agreement":null},{"id":"W2129713301","doi":"10.1016/j.ygyno.2015.05.036","title":"Investigating the disparities in cervical cancer screening among Namibian women","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cervical cancer; Health care; Logistic regression; Health equity; Public health; Cancer screening; Cervical cancer screening; Family medicine; Multivariate analysis; Equity (law); Socioeconomic status; Demography; Environmental health; Cancer; Nursing; Population; Internal medicine","score_opus":0.10265200486438658,"score_gpt":0.38847257575597965,"score_spread":0.2858205708915931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129713301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933473,0.0004962497,0.000019479525,0.017674556,0.00024838472,0.00047575225,0.000004507748,0.00006024601,0.04754786],"genre_scores_gemma":[0.9918176,0.00005624781,0.00034665267,0.0059710555,0.00030924927,0.0005684576,0.000008473777,0.000015963027,0.0009063052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979146,0.00032399324,0.00034027733,0.00031744954,0.0003408946,0.00076277263],"domain_scores_gemma":[0.998279,0.00078425364,0.00007562027,0.00023968231,0.00016532587,0.00045613246],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014214504,0.0001484958,0.00046703275,0.00011030678,0.00011878391,0.000027759696,0.00024758084,0.00026406924,0.002609912],"category_scores_gemma":[0.0018364611,0.00009572516,0.00005345786,0.00043264191,0.000630879,0.00007674362,0.00026572339,0.00086314714,0.00003478112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012697672,0.00011787992,0.91198975,0.000045728575,0.00002975968,0.00009405202,0.0015969403,0.00012147133,0.000020167958,0.0003607362,0.0021802261,0.08331629],"study_design_scores_gemma":[0.002239127,0.0009670459,0.97524536,0.000014674807,0.00001737305,0.000015830614,0.0033999241,0.0017715058,0.000020471683,0.002247005,0.013945607,0.00011606667],"about_ca_topic_score_codex":0.0036735414,"about_ca_topic_score_gemma":0.0146973645,"teacher_disagreement_score":0.083200224,"about_ca_system_score_codex":0.0013367733,"about_ca_system_score_gemma":0.00084197364,"threshold_uncertainty_score":0.99830186},"labels":[],"label_agreement":null},{"id":"W2131979371","doi":"10.1016/j.ygyno.2009.05.006","title":"Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario","year":2009,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Vulvar cancer; Cervical cancer; Vaginal cancer; Anal cancer; Gynecology; Cancer; Obstetrics; Population; Gynecologic cancer; Logistic regression; Ovarian cancer; Oncology; Internal medicine","score_opus":0.028023145211780634,"score_gpt":0.3584166598184268,"score_spread":0.3303935146066462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131979371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95295703,0.0010968605,6.8577896e-7,0.0033108934,0.00009164565,0.0022566102,0.000014676936,0.000038583054,0.04023303],"genre_scores_gemma":[0.99398696,0.0006752212,0.000050702965,0.0024375368,0.000060320355,0.0013734193,0.000011006256,0.000013775633,0.0013910453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665815,0.0005225523,0.0007643182,0.0006133847,0.0004641302,0.0009774514],"domain_scores_gemma":[0.99810225,0.0009001566,0.00024307905,0.000411111,0.0001543858,0.00018900371],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011766931,0.00028763394,0.0010735258,0.00023373673,0.00009677292,0.000014128263,0.00046194458,0.0004920673,0.017513758],"category_scores_gemma":[0.0003808592,0.00016963345,0.00008995636,0.0007296042,0.00040660414,0.00007877272,0.00008748073,0.0013412503,0.000008754005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003908483,0.0035393655,0.61302674,0.00011382448,0.00011401115,0.0035977557,0.00606181,0.00047799593,0.00039975232,0.0003354452,0.000810543,0.36761427],"study_design_scores_gemma":[0.0076384773,0.010967083,0.97022915,0.00003945536,0.00006268121,0.000019781884,0.00038529493,0.000032667947,0.000050344373,0.00074472773,0.009629506,0.00020085092],"about_ca_topic_score_codex":0.022390652,"about_ca_topic_score_gemma":0.62647605,"teacher_disagreement_score":0.6040854,"about_ca_system_score_codex":0.0055673234,"about_ca_system_score_gemma":0.0036917992,"threshold_uncertainty_score":0.9982501},"labels":[],"label_agreement":null},{"id":"W2133791652","doi":"10.1016/j.ygyno.2007.07.050","title":"Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Dysplasia; Pathology","score_opus":0.039041022778609595,"score_gpt":0.36118287187612375,"score_spread":0.32214184909751414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133791652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90392137,0.00059307215,0.009429246,0.001849967,0.00006158613,0.00049436017,0.000003078681,0.000060518552,0.0835868],"genre_scores_gemma":[0.98733836,0.00016299856,0.010499557,0.0018270644,0.000056702982,0.000028489576,0.000010026946,0.000013809341,0.00006301429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787194,0.00023476362,0.0005065826,0.0004821332,0.00025644153,0.0006481649],"domain_scores_gemma":[0.9977527,0.0013247377,0.00010672516,0.0002536453,0.00022319364,0.00033898928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022684478,0.00019626896,0.0008347516,0.00015135849,0.00006685582,0.000004439814,0.00013879631,0.0004898152,0.0014390007],"category_scores_gemma":[0.0012766185,0.00012523256,0.000092447386,0.00027320025,0.0005540355,0.00003046749,0.0001677927,0.00058968074,0.000013512026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019086754,0.0019428044,0.63533205,0.0006659723,0.00031533206,0.0100023765,0.00026435519,0.001196871,0.011719827,0.016245477,0.0003290443,0.30289915],"study_design_scores_gemma":[0.0053085354,0.019481275,0.9555945,0.000021653836,0.0002145729,0.001401441,0.00071630994,0.009328549,0.000887257,0.005051891,0.0016672937,0.00032674457],"about_ca_topic_score_codex":0.000035490983,"about_ca_topic_score_gemma":0.00008454934,"teacher_disagreement_score":0.32026243,"about_ca_system_score_codex":0.00021682197,"about_ca_system_score_gemma":0.00021075612,"threshold_uncertainty_score":0.9994738},"labels":[],"label_agreement":null},{"id":"W2133863965","doi":"10.1016/j.ygyno.2007.07.014","title":"Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Test (biology); Medicine; Cervical cancer; Medical education; Family medicine; Multiple choice; Descriptive statistics; Cervical cancer screening; Training manual; Nursing; Significant difference; Cancer","score_opus":0.07677904267856084,"score_gpt":0.5239309356526745,"score_spread":0.4471518929741136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133863965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805843,0.0007736474,0.00007309418,0.0016660145,0.000113231836,0.0017123118,0.0000020966834,0.000029306924,0.015045958],"genre_scores_gemma":[0.9979485,0.00013560298,0.00084920775,0.00016751616,0.00009936184,0.0006790852,0.0000584165,0.00000781048,0.000054484713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985769,0.00018145947,0.00035462755,0.00028550762,0.00021128399,0.00039027163],"domain_scores_gemma":[0.9989624,0.0006115724,0.000056442077,0.00007931609,0.00018420318,0.00010606831],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024605102,0.00009390744,0.00026282461,0.00031425734,0.000039926847,0.000010496057,0.000047793434,0.00019856659,0.0034814735],"category_scores_gemma":[0.00037987006,0.00008304643,0.00002437568,0.00050191366,0.00007250441,0.00006392742,0.000060722552,0.00027924075,0.000006303999],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023527109,0.0002948281,0.34839424,0.000035527195,0.0000053755975,0.000021040576,0.00068145053,0.0000024762326,0.00030228536,0.000051159066,0.00007819865,0.6498982],"study_design_scores_gemma":[0.003548496,0.0012508652,0.9873786,0.000015725527,0.000021053891,0.000006989111,0.0017358488,0.0022107528,0.00021767343,0.00030107662,0.0032332018,0.00007971265],"about_ca_topic_score_codex":0.0003367621,"about_ca_topic_score_gemma":0.099601835,"teacher_disagreement_score":0.6498184,"about_ca_system_score_codex":0.0011294367,"about_ca_system_score_gemma":0.00030581793,"threshold_uncertainty_score":0.9974295},"labels":[],"label_agreement":null},{"id":"W2134159332","doi":"10.1016/j.ygyno.2006.02.011","title":"Follow-up after primary therapy for endometrial cancer: A systematic review","year":2006,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University of Toronto; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Asymptomatic; Endometrial cancer; MEDLINE; Watchful waiting; Psychological intervention; Cochrane Library; Retrospective cohort study; Surgery; Disease; Cancer; Internal medicine; Randomized controlled trial; Prostate cancer","score_opus":0.0786392147862405,"score_gpt":0.40347866286276984,"score_spread":0.3248394480765293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134159332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028680795,0.96614945,0.00001224026,0.00032368864,0.0033502523,0.025548948,0.00036351915,0.00013469104,0.0041143573],"genre_scores_gemma":[0.0000033318076,0.9325133,0.00034687508,0.0047797994,0.0012112198,0.055024803,0.0008544022,0.00010426597,0.0051619993],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945347,0.0008791899,0.0022773384,0.0010104652,0.0004441831,0.00085412955],"domain_scores_gemma":[0.9913122,0.005930694,0.0014536047,0.0007676137,0.00026794377,0.0002679335],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012335114,0.000940588,0.012951586,0.0005491341,0.00010065786,0.000022057106,0.00042922114,0.0012201131,0.0012909134],"category_scores_gemma":[0.0023427503,0.0005487164,0.0029681893,0.0013272942,0.00012081305,0.000048300248,0.000118433825,0.0005752467,0.00019296147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045055602,0.00043290513,0.0000064598307,0.5369715,0.0011897162,0.00013252231,0.00000275977,8.526432e-9,7.9159896e-8,0.000008068992,0.0061509004,0.4546545],"study_design_scores_gemma":[0.009790844,0.004265876,0.000017958651,0.16979088,0.019199515,0.00011366145,0.0000014081837,8.25988e-8,2.480332e-7,0.000050046143,0.79638064,0.00038881798],"about_ca_topic_score_codex":0.00006761848,"about_ca_topic_score_gemma":0.000080000194,"teacher_disagreement_score":0.79022974,"about_ca_system_score_codex":0.0034014173,"about_ca_system_score_gemma":0.0023704807,"threshold_uncertainty_score":0.99969643},"labels":[],"label_agreement":null},{"id":"W2138700400","doi":"10.1016/j.ygyno.2007.07.067","title":"Human papillomavirus infection: Epidemiology and pathophysiology","year":2007,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":312,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institut National de Santé Publique du Québec","funders":"","keywords":"Medicine; HPV infection; Epidemiology; Chlamydia trachomatis; Cervical cancer; Immunology; Herpes simplex virus; HPV vaccines; Asymptomatic; Chlamydia; Viral load; Virology; Virus; Cancer; Internal medicine","score_opus":0.29713099038549284,"score_gpt":0.5428854063271082,"score_spread":0.2457544159416154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138700400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100742494,0.93358207,0.000014549762,0.00029005206,0.0007001987,0.0014219456,0.000017572827,0.00013915499,0.063733734],"genre_scores_gemma":[0.000065081986,0.9930811,0.00034510344,0.0029218174,0.0011766504,0.00043437525,0.00018844854,0.00005830753,0.0017291172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99469316,0.0015218882,0.0013622185,0.0010935955,0.0001544682,0.0011746853],"domain_scores_gemma":[0.99391806,0.00424951,0.00050411135,0.0005916666,0.00018919967,0.00054747594],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002505055,0.0005980735,0.0056428555,0.00053967105,0.00027150652,0.0000075690377,0.00021101075,0.0028245186,0.0076715285],"category_scores_gemma":[0.002178277,0.00042532053,0.00066529616,0.0004706931,0.0009949156,0.00003208126,0.00046435892,0.0022076038,0.0005095703],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047339327,0.00025432868,0.00039528284,0.0070101465,0.00021399187,0.00051973446,0.000009647443,6.995124e-8,0.0000012380158,0.0015643918,0.0036334645,0.98635036],"study_design_scores_gemma":[0.0009718509,0.0051982803,0.012767287,0.00023921719,0.0008781195,0.00069310167,0.00000618633,9.2805533e-7,1.6287106e-7,0.0031766915,0.9757265,0.0003416756],"about_ca_topic_score_codex":0.00015229077,"about_ca_topic_score_gemma":0.00024483266,"teacher_disagreement_score":0.9860087,"about_ca_system_score_codex":0.0010254649,"about_ca_system_score_gemma":0.00088666833,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W2139580868","doi":"10.1016/j.ygyno.2008.03.011","title":"Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"Michael Smith Health Research BC; VGH and UBC Hospital Foundation; National Cancer Institute; BC Cancer Foundation; Sanofi","keywords":"Carboplatin; Cancer research; Ovarian cancer; Medicine; Transplantation; Pathology; Cancer; Chemotherapy; Internal medicine; Cisplatin","score_opus":0.032534502283381464,"score_gpt":0.28370729887957197,"score_spread":0.2511727965961905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139580868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499136,0.00018610497,0.000028436443,0.0027682616,0.00014462505,0.0012475741,0.000040331935,0.000029225255,0.0005640768],"genre_scores_gemma":[0.99629295,0.0004092362,0.0017849108,0.0011241047,0.00011150602,0.00017831111,0.000027454473,0.00001615836,0.000055387856],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99806404,0.00031468517,0.00059843966,0.0004576357,0.00022181706,0.00034339662],"domain_scores_gemma":[0.99863356,0.00056725665,0.00024291634,0.00030720577,0.00010853794,0.0001405247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041926085,0.00021981962,0.0007499045,0.000110907305,0.00019409983,0.0000047239546,0.00014471731,0.00024439834,0.00084906287],"category_scores_gemma":[0.00007891026,0.00014849007,0.00011785355,0.00023262261,0.0005235294,0.00004567404,0.000053131538,0.00019215555,0.0000049222153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003549418,0.0027472414,0.09273613,0.0003327263,0.0003009817,0.00052727497,0.0033069914,0.00013812535,0.8936887,0.00015482446,0.00036858712,0.002149029],"study_design_scores_gemma":[0.0053252634,0.00574912,0.90992683,0.00002509986,0.0001505721,0.00028557863,0.00021171398,0.0000032200837,0.07787062,0.00017576227,0.00015260205,0.00012361469],"about_ca_topic_score_codex":0.00008715199,"about_ca_topic_score_gemma":0.0003508378,"teacher_disagreement_score":0.8171907,"about_ca_system_score_codex":0.0004757441,"about_ca_system_score_gemma":0.00035024656,"threshold_uncertainty_score":0.9296643},"labels":[],"label_agreement":null},{"id":"W2140241493","doi":"10.1016/j.ygyno.2015.08.020","title":"A model for estimating ovarian cancer risk: Application for preventive oophorectomy","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Ovarian cancer; Medicine; Population; Gynecology; Tubal ligation; Obstetrics; Family history; Oophorectomy; BRCA mutation; Cancer; Oncology; Internal medicine; Family planning; Hysterectomy; Surgery; Environmental health","score_opus":0.07346968011477237,"score_gpt":0.3876878041320141,"score_spread":0.3142181240172417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140241493","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13666226,0.0009095848,0.832647,0.011486592,0.0015186393,0.011943848,0.00046871416,0.00021881612,0.004144518],"genre_scores_gemma":[0.6310523,0.000060330174,0.34810388,0.0007709382,0.0003925932,0.018807964,0.00011007964,0.000026572643,0.00067532546],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987532,0.00005269131,0.00030331925,0.00044622086,0.00009306611,0.00035149005],"domain_scores_gemma":[0.9983275,0.00066585303,0.00029084733,0.00022176206,0.00031166754,0.00018235204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053252256,0.00016999835,0.0004793825,0.00006223588,0.00012308372,0.00000897922,0.00008652532,0.00022736492,0.000039369923],"category_scores_gemma":[0.0007180048,0.00013715809,0.00013936784,0.00010426891,0.000054415115,0.000044242883,0.000034701847,0.00010940709,0.000012931584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00203468,0.0027776284,0.04880782,0.00022771563,0.00084069977,0.000014470835,0.0019328895,0.021921923,0.00023026837,0.004744774,0.043099858,0.87336725],"study_design_scores_gemma":[0.013746463,0.004293595,0.010231449,0.000030600582,0.001052389,0.000012917444,0.00016675968,0.90393865,0.00027593994,0.021907702,0.044123437,0.00022009482],"about_ca_topic_score_codex":0.00014997153,"about_ca_topic_score_gemma":0.00046380467,"teacher_disagreement_score":0.8820167,"about_ca_system_score_codex":0.0012189762,"about_ca_system_score_gemma":0.0011322724,"threshold_uncertainty_score":0.5593145},"labels":[],"label_agreement":null},{"id":"W2144024213","doi":"10.1016/j.ygyno.2005.06.040","title":"Potential markers that complement expression of CA125 in epithelial ovarian cancer","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Epithelial ovarian cancer; Ovarian cancer; Complement (music); Expression (computer science); Oncology; Cancer research; Internal medicine; Cancer; Biology; Gene; Genetics; Phenotype","score_opus":0.030160175818020666,"score_gpt":0.3323007867348419,"score_spread":0.30214061091682126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144024213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715158,0.00063412555,0.000069919945,0.017144725,0.00077018474,0.0009821127,0.00006793078,0.000034570447,0.00878066],"genre_scores_gemma":[0.992718,0.00064853387,0.004454132,0.001302075,0.00023695687,0.00031834317,0.000030049412,0.000013813239,0.00027809961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984835,0.00014909326,0.00042164914,0.00035813777,0.00019779732,0.00038982352],"domain_scores_gemma":[0.99918157,0.00019344929,0.00020722805,0.00024488827,0.00005395786,0.000118890464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031306758,0.00017744368,0.00058948685,0.00014681983,0.000048365106,0.0000045535808,0.00010966373,0.00021214111,0.0066347485],"category_scores_gemma":[0.0000433059,0.00013679343,0.00011552834,0.00012591736,0.00010527351,0.000049125163,0.00008852812,0.00018230539,0.00003349916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021326798,0.005311869,0.55070585,0.00011673184,0.00027274128,0.0007373944,0.00071351085,0.0010134707,0.017924778,0.0006701314,0.014547238,0.4058536],"study_design_scores_gemma":[0.010733599,0.002109437,0.8721383,0.000092270886,0.00017733198,0.000032841657,0.00029867014,0.00018812939,0.016276779,0.00013247077,0.097657025,0.00016312531],"about_ca_topic_score_codex":0.00062045123,"about_ca_topic_score_gemma":0.0019464021,"teacher_disagreement_score":0.40569046,"about_ca_system_score_codex":0.001092627,"about_ca_system_score_gemma":0.0004072081,"threshold_uncertainty_score":0.9942733},"labels":[],"label_agreement":null},{"id":"W2147033348","doi":"10.1016/j.ygyno.2006.10.013","title":"Endometrial cancer—Revisiting the importance of pelvic and para aortic lymph nodes","year":2006,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Lymph node; Cancer; Disease; Stage (stratigraphy); Psychological intervention; General surgery; Oncology; Internal medicine","score_opus":0.09147564349831845,"score_gpt":0.4111908878974742,"score_spread":0.3197152443991558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147033348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002726036,0.98926157,0.0000037606421,0.00044737523,0.0006718909,0.0015855804,0.0000931384,0.000046181478,0.0051644817],"genre_scores_gemma":[0.0028776922,0.99392533,0.00022763498,0.0003326531,0.0013926874,0.00067775504,0.0000991684,0.000040506056,0.00042655444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966794,0.00047806092,0.0013577335,0.0006304354,0.000300202,0.0005541211],"domain_scores_gemma":[0.99236965,0.0056160237,0.0013076721,0.00044124614,0.00011469242,0.00015072308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007485427,0.00050949,0.003938146,0.00031348135,0.00013168737,0.000015506921,0.00028031063,0.0006578073,0.00075131515],"category_scores_gemma":[0.0016798103,0.00027463614,0.0006214416,0.0011228295,0.00038427833,0.000033569188,0.00019484233,0.00047422372,0.000025148047],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009415576,0.00014318676,0.008701685,0.005369229,0.0005182608,0.0001314882,0.000010536893,4.0882588e-7,0.0000012226898,0.00011643018,0.000098872326,0.9848145],"study_design_scores_gemma":[0.0053403294,0.0010568176,0.013876381,0.0019146474,0.0069710896,0.00022567135,0.00003412541,0.000004214044,0.0000024289575,0.0002504748,0.96998763,0.000336218],"about_ca_topic_score_codex":0.00027303462,"about_ca_topic_score_gemma":0.000059618993,"teacher_disagreement_score":0.9844783,"about_ca_system_score_codex":0.0009539103,"about_ca_system_score_gemma":0.0011474153,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W2147585810","doi":"10.1016/j.ygyno.2015.04.004","title":"Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Indocyanine green; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Parametrial; Cervical cancer; Lymph node; Radiology; Lymph; Surgery; Cancer; Breast cancer; Internal medicine; Pathology","score_opus":0.10170434635369167,"score_gpt":0.35401057388257384,"score_spread":0.25230622752888215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147585810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883736,0.0016639571,0.00017331657,0.0029777559,0.0008119267,0.0010749638,0.000015901494,0.000088147906,0.0048204474],"genre_scores_gemma":[0.9944629,0.00022628935,0.0022113584,0.0013931562,0.0005345147,0.0006664787,0.000036286805,0.000020944302,0.0004480747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820685,0.00010123845,0.00051297795,0.0004609086,0.00018546186,0.00053256407],"domain_scores_gemma":[0.9982666,0.0009684865,0.00018166805,0.00017124502,0.00014242767,0.00026956655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006559572,0.00022849209,0.0009605756,0.00050470926,0.00006234874,0.000013071707,0.00012079358,0.0003094927,0.0001310017],"category_scores_gemma":[0.0013974037,0.00018310967,0.00008919308,0.0007808619,0.00012332722,0.000057158817,0.00016373364,0.00021990812,0.0000148968675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017297333,0.0005934873,0.95565367,0.000117724485,0.00015393757,0.00016877471,0.00021696031,0.00005193182,0.0011387314,0.00015467229,0.00038861122,0.039631784],"study_design_scores_gemma":[0.09278446,0.0018156432,0.86017424,0.000096079035,0.00031885543,0.00014142363,0.0007522116,0.00136305,0.00070106797,0.0012635235,0.040176377,0.0004131023],"about_ca_topic_score_codex":0.0011190396,"about_ca_topic_score_gemma":0.000375849,"teacher_disagreement_score":0.095479436,"about_ca_system_score_codex":0.001095467,"about_ca_system_score_gemma":0.0003811071,"threshold_uncertainty_score":0.7466996},"labels":[],"label_agreement":null},{"id":"W2147808471","doi":"10.1016/j.ygyno.2006.03.017","title":"Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study","year":2006,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Sanofi; Eli Lilly and Company","keywords":"Medicine; Oxaliplatin; Gemcitabine; Carboplatin; Internal medicine; Ovarian cancer; Regimen; Neutropenia; Chemotherapy; Phases of clinical research; Nausea; Gastroenterology; Debulking; Urology; Paclitaxel; Oncology; Surgery; Cancer; Cisplatin; Colorectal cancer","score_opus":0.015944914509582388,"score_gpt":0.313273242588668,"score_spread":0.2973283280790856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147808471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837757,0.00080952636,0.00003475633,0.0058202404,0.0004268417,0.008399141,0.00039018362,0.000041281088,0.00030236976],"genre_scores_gemma":[0.994566,0.0005546242,0.0010418156,0.00033357806,0.00023870516,0.0028376135,0.00017864413,0.000041639043,0.00020734439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977971,0.00013507713,0.0006778329,0.00065789826,0.0002681382,0.0004639589],"domain_scores_gemma":[0.99780923,0.0010188363,0.00050342694,0.00033148512,0.00020298769,0.00013401918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043359937,0.00039423272,0.0010030695,0.00008157052,0.00042866133,0.000024091889,0.0001222274,0.00022692235,0.00014879162],"category_scores_gemma":[0.0001542277,0.0002371311,0.0001085465,0.00018786312,0.00028944475,0.00007730655,0.00008327541,0.00018518615,8.952357e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4677642,0.07847199,0.30074787,0.00018117053,0.0026764376,0.00020143484,0.0029344582,0.00025900535,0.001432483,0.0005364794,0.003587198,0.1412073],"study_design_scores_gemma":[0.647134,0.22935127,0.094826244,0.00004824257,0.0010605123,0.000013153038,0.00022770342,0.00012273222,0.00046963198,0.00020796373,0.02617118,0.00036738112],"about_ca_topic_score_codex":0.0015123024,"about_ca_topic_score_gemma":0.0064508943,"teacher_disagreement_score":0.20592162,"about_ca_system_score_codex":0.00030240437,"about_ca_system_score_gemma":0.0003297309,"threshold_uncertainty_score":0.96699256},"labels":[],"label_agreement":null},{"id":"W2148068022","doi":"10.1006/gyno.2000.5885","title":"Better Treatments That Cost More: The Dilemma","year":2000,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Cancer Care Ontario","funders":"","keywords":"Medicine; Dilemma; Epistemology","score_opus":0.05901863187651827,"score_gpt":0.3348983583177693,"score_spread":0.275879726441251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148068022","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016274057,0.0010834174,0.0000021231815,0.91276926,0.0023156912,0.0028386887,0.00020422638,0.00018022531,0.0643323],"genre_scores_gemma":[0.009481629,0.0011339076,0.0001864169,0.95600426,0.0060045733,0.0017146562,0.0015667524,0.00008653986,0.023821281],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965356,0.00042641466,0.0005303834,0.00088134286,0.00056800904,0.001058229],"domain_scores_gemma":[0.9964289,0.0020878715,0.00032255985,0.00090463297,0.00008002143,0.00017597969],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00020581803,0.00069443235,0.0015132125,0.0002196955,0.00024817686,0.000038546368,0.0004895923,0.002182284,0.017385313],"category_scores_gemma":[0.00017445415,0.0003668806,0.00056635286,0.00039047038,0.00047448743,0.000053198488,0.00014337497,0.0023167012,0.0020487842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032446056,0.00043342987,0.0052192127,0.000044809836,0.0009427123,0.006472067,0.000050460516,7.167302e-7,0.0000037543825,0.0000035665255,0.8127778,0.17372698],"study_design_scores_gemma":[0.0058964216,0.0030347959,0.03045239,0.000029649635,0.0017470756,0.00039551425,0.000020467,0.0000018713955,0.000036050864,0.00037758693,0.9576922,0.00031595366],"about_ca_topic_score_codex":0.00022486554,"about_ca_topic_score_gemma":0.00004156388,"teacher_disagreement_score":0.17341101,"about_ca_system_score_codex":0.0017279186,"about_ca_system_score_gemma":0.0004232972,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W2148104916","doi":"10.1016/j.ygyno.2008.07.020","title":"Vaginal radical trachelectomy: An update","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Trachelectomy; Medicine; Context (archaeology); Infertility; Fertility; Fertility preservation; Gynecology; Feeling; Grief; Cervical cancer; Obstetrics; Cancer; Pregnancy; Psychiatry; Internal medicine; Psychology; Social psychology","score_opus":0.050500887778431834,"score_gpt":0.34392991416641117,"score_spread":0.29342902638797935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148104916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703281,0.00046746663,0.000077485915,0.0040877596,0.00043917436,0.00036275343,0.000006335306,0.00017799051,0.02405295],"genre_scores_gemma":[0.9888515,0.0003310166,0.0034391154,0.006050927,0.00040309492,0.00008463172,0.00006996558,0.000015640018,0.00075411715],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847764,0.00017746513,0.0002869372,0.00039091345,0.00020063976,0.00046642407],"domain_scores_gemma":[0.9989299,0.0002812436,0.0000771844,0.00024555853,0.000077459845,0.00038866056],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020758329,0.00017717767,0.0005719696,0.00012788593,0.00015409628,0.0000047795497,0.00013770229,0.00030282387,0.005004976],"category_scores_gemma":[0.00031617982,0.00012859752,0.000116262214,0.00036029218,0.00029375197,0.00008462856,0.000038956332,0.00034880612,0.0005524849],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006375491,0.014345409,0.39521247,0.00008301198,0.0007581301,0.020235227,0.0006941079,0.000012994711,0.007944702,0.003510316,0.019927321,0.5309008],"study_design_scores_gemma":[0.0161492,0.020149637,0.62367857,0.0000058795385,0.0002973833,0.0030270487,0.00006397276,0.00006482058,0.002113219,0.001682304,0.33246043,0.0003075688],"about_ca_topic_score_codex":0.000045298886,"about_ca_topic_score_gemma":0.000048082897,"teacher_disagreement_score":0.5305932,"about_ca_system_score_codex":0.000471289,"about_ca_system_score_gemma":0.00048692056,"threshold_uncertainty_score":0.99590456},"labels":[],"label_agreement":null},{"id":"W2148259196","doi":"10.1016/j.ygyno.2015.11.008","title":"Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Calgary; Foothills Medical Centre; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Chemotherapy; Association (psychology); Gynecology; Cancer","score_opus":0.0604292466459228,"score_gpt":0.3440498561880175,"score_spread":0.28362060954209467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148259196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91155887,0.0012543106,0.000035353405,0.07668075,0.0011527962,0.00055492396,0.00006468988,0.00006522958,0.008633051],"genre_scores_gemma":[0.99359983,0.00075566483,0.00048504482,0.0035204452,0.0008631543,0.00018743961,0.000048198002,0.00001815647,0.00052204484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985862,0.00022854886,0.00026124722,0.00034849005,0.00023852967,0.0003370121],"domain_scores_gemma":[0.9981201,0.0011382584,0.00022471647,0.00022865595,0.00011380209,0.00017444161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271558,0.00017365202,0.0005422571,0.00003923201,0.000111147514,0.000027271868,0.00009947887,0.00034109192,0.00042536762],"category_scores_gemma":[0.0002511962,0.00010955949,0.000065778506,0.000119597906,0.000071287635,0.000044384637,0.00006170719,0.0002731293,0.000025973235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077152916,0.00015897033,0.8818188,0.0000035808785,0.00056851556,0.000040252275,0.0006506702,0.000008963488,0.000022667931,0.00025673426,0.004841055,0.11155268],"study_design_scores_gemma":[0.0055098548,0.0007876931,0.8375543,0.000012311669,0.0004357025,0.0000035666988,0.00026518194,0.00003905969,0.00012397472,0.0012790839,0.15388463,0.000104661274],"about_ca_topic_score_codex":0.00250845,"about_ca_topic_score_gemma":0.00086864387,"teacher_disagreement_score":0.14904357,"about_ca_system_score_codex":0.0019169141,"about_ca_system_score_gemma":0.00044185255,"threshold_uncertainty_score":0.50126636},"labels":[],"label_agreement":null},{"id":"W2148481823","doi":"10.1016/j.ygyno.2014.01.037","title":"Non-radical surgery for small early-stage cervical cancer. Is it time?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Cervical cancer; Radical surgery; Perioperative; Surgery; Adenosquamous carcinoma; Radical Hysterectomy; Lymphovascular invasion; Hysterectomy; Pelvic exenteration; Carcinoma; Adenocarcinoma; Cancer; Metastasis; Internal medicine","score_opus":0.06117044001490402,"score_gpt":0.34544170897377546,"score_spread":0.28427126895887145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148481823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928521,0.00026709496,0.00050611765,0.034297574,0.0016764601,0.0015637437,0.00010829142,0.00015620781,0.032903545],"genre_scores_gemma":[0.9488069,0.0002475154,0.0022807587,0.029167881,0.0013384926,0.0010356711,0.0001047012,0.00004938603,0.016968723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774235,0.00013409645,0.00054423366,0.0006056846,0.00021612244,0.0007575239],"domain_scores_gemma":[0.9950418,0.0038424297,0.00018976929,0.00033615492,0.00014665014,0.00044318734],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006741527,0.0002875884,0.0011815183,0.00016853842,0.00014325474,0.000015240171,0.00018979987,0.00059381314,0.010837641],"category_scores_gemma":[0.0010817186,0.0002158799,0.0004072394,0.00034244303,0.0002047435,0.000038680286,0.00009624522,0.00030793648,0.0007127143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062355194,0.0042730453,0.3563275,0.00072624267,0.0011817144,0.00043328176,0.0005223166,0.000016162316,0.0016881395,0.00079304684,0.21360007,0.41420296],"study_design_scores_gemma":[0.008764579,0.006590721,0.22908503,0.00004139235,0.00046980314,0.00002904982,0.000042523665,0.0006764543,0.0011585578,0.00071239274,0.7520637,0.0003658172],"about_ca_topic_score_codex":0.0003777869,"about_ca_topic_score_gemma":0.00027344312,"teacher_disagreement_score":0.5384636,"about_ca_system_score_codex":0.00060031476,"about_ca_system_score_gemma":0.0005039424,"threshold_uncertainty_score":0.9900666},"labels":[],"label_agreement":null},{"id":"W2148584703","doi":"10.1016/j.ygyno.2008.04.027","title":"Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: A matched case–control study","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Radical Hysterectomy; Cervical cancer; Trachelectomy; Hysterectomy; Stage (stratigraphy); Surgery; Lymphovascular invasion; Radical surgery; Radiation therapy; Cervix; Cancer; Urology; Metastasis; Internal medicine","score_opus":0.052841010504356196,"score_gpt":0.3381509469812881,"score_spread":0.2853099364769319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148584703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876853,0.0006778369,0.0005882324,0.0037628885,0.0007720195,0.0048592472,0.00019150876,0.0002546738,0.0012082566],"genre_scores_gemma":[0.98955566,0.00008761051,0.0022381372,0.0030418392,0.0008080706,0.00288613,0.000027975426,0.000059020862,0.0012955591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588984,0.000629545,0.0008987135,0.0010015251,0.0004088214,0.0011715692],"domain_scores_gemma":[0.9957495,0.0025955352,0.00026519957,0.00043463375,0.00021150084,0.000743651],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000691274,0.0005191549,0.0019297895,0.00027014498,0.00038050336,0.00002177776,0.0003031886,0.0006503456,0.0031273544],"category_scores_gemma":[0.0006709654,0.00039154556,0.00042744097,0.0005909848,0.00044979184,0.000077976765,0.00008592119,0.0007965816,0.00008845702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021241603,0.014878042,0.81016505,0.00026811246,0.0025362477,0.06064637,0.0018641732,0.000015875752,0.00059691624,0.00014345138,0.0011194595,0.08652467],"study_design_scores_gemma":[0.10345483,0.055502724,0.79264253,0.000023215132,0.0021584497,0.006983385,0.00048786102,0.00025867525,0.00030943216,0.00016654751,0.03735238,0.0006599533],"about_ca_topic_score_codex":0.001538944,"about_ca_topic_score_gemma":0.0018871679,"teacher_disagreement_score":0.08586472,"about_ca_system_score_codex":0.0013612398,"about_ca_system_score_gemma":0.000962061,"threshold_uncertainty_score":0.9998537},"labels":[],"label_agreement":null},{"id":"W2151131844","doi":"10.1016/j.ygyno.2005.04.002","title":"Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Phenotype; Epithelial ovarian cancer; Pathology; Cancer research; Ovarian cancer; Internal medicine; Gene; Biology; Genetics; Cancer","score_opus":0.012155281039317524,"score_gpt":0.27322800200128183,"score_spread":0.2610727209619643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151131844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131286,0.000048972975,0.0053880266,0.00023871599,0.000044504675,0.000518134,0.00016076588,0.0000936328,0.0021943755],"genre_scores_gemma":[0.89501727,0.000056808807,0.10427964,0.000056821762,0.000056233355,0.00032210228,0.000059104812,0.000018378629,0.0001336611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835473,0.00008146945,0.00059218874,0.0005040492,0.00010823706,0.0003593128],"domain_scores_gemma":[0.9983294,0.00064951275,0.0004370306,0.00043691814,0.00007602,0.000071109935],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017151397,0.00022427249,0.0007101823,0.00015263245,0.000065299995,0.000010370418,0.00036184044,0.00039045568,0.0019041041],"category_scores_gemma":[0.00018614244,0.00021021916,0.00013778178,0.0005733061,0.00016553179,0.0000672365,0.0001303294,0.0003481104,0.00004112371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001633448,0.0004515063,0.0061385515,0.000022117123,0.00017544086,0.000007375242,0.00024476068,0.015467056,0.97372985,0.00018655286,0.000009356658,0.0034041053],"study_design_scores_gemma":[0.0009287339,0.00018638106,0.012666672,0.000007775367,0.0004425372,0.0000011844118,0.0000736962,0.007559763,0.97381693,0.0032643462,0.0007737629,0.00027819508],"about_ca_topic_score_codex":0.00034917958,"about_ca_topic_score_gemma":0.0008781486,"teacher_disagreement_score":0.098891616,"about_ca_system_score_codex":0.0004901842,"about_ca_system_score_gemma":0.00022004978,"threshold_uncertainty_score":0.9990083},"labels":[],"label_agreement":null},{"id":"W2155276026","doi":"10.1016/j.ygyno.2014.06.009","title":"Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for lynch syndrome","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Lynch syndrome; Endometrial cancer; Oncology; Gynecology; Immunohistochemistry; Internal medicine; Cancer; DNA mismatch repair; Colorectal cancer","score_opus":0.03612483873225393,"score_gpt":0.32703199103335956,"score_spread":0.29090715230110564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155276026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924966,0.00013336066,0.00028522254,0.0005377703,0.0014410202,0.0011555637,0.000039473714,0.000029489962,0.0038814761],"genre_scores_gemma":[0.9934372,0.000051388077,0.0056229094,0.00040091033,0.0000845252,0.00020340984,0.000016445445,0.000015305266,0.00016792327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983601,0.00019427878,0.00046517994,0.0003613071,0.00019946255,0.000419689],"domain_scores_gemma":[0.99683166,0.0024020572,0.00027646142,0.00016760561,0.00021816514,0.000104044295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056857226,0.00016892141,0.00075160747,0.00033014524,0.00004495142,0.0000036333388,0.00018361183,0.00034099203,0.0006302826],"category_scores_gemma":[0.0029403984,0.00014628992,0.00011056344,0.00038356934,0.00039662348,0.000037803264,0.00007853753,0.00020429773,0.0000055849764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030747266,0.0009629442,0.8968239,0.00018925006,0.00022592275,0.000048432754,0.00036966946,0.00044410207,0.013857401,0.0006308813,0.0025399558,0.08083283],"study_design_scores_gemma":[0.030244486,0.036524996,0.87348557,0.000121597936,0.00031933805,0.000057135523,0.0003958313,0.0005499188,0.012800951,0.001524672,0.043510884,0.00046462912],"about_ca_topic_score_codex":0.0002947017,"about_ca_topic_score_gemma":0.00059243996,"teacher_disagreement_score":0.0803682,"about_ca_system_score_codex":0.00064009096,"about_ca_system_score_gemma":0.00052806735,"threshold_uncertainty_score":0.6901152},"labels":[],"label_agreement":null},{"id":"W2155866473","doi":"10.1016/j.ygyno.2003.11.044","title":"Ovarian cancer patients and hormone replacement therapy: a systematic review","year":2004,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Agence Nationale pour la Gestion des Déchets Radioactifs","keywords":"Medicine; Hormone replacement therapy (female-to-male); Observational study; Ovarian cancer; Randomized controlled trial; Internal medicine; Oncology; Meta-analysis; Cancer; Systematic review; Gynecology; Cohort study; Clinical trial; MEDLINE","score_opus":0.0489746827743853,"score_gpt":0.3759801187576179,"score_spread":0.3270054359832326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155866473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010622495,0.9835423,0.0000010543073,0.0012577904,0.0005084515,0.013278618,0.00008075587,0.000073753996,0.001246654],"genre_scores_gemma":[0.000027282693,0.98349077,0.00020113516,0.0034679347,0.00010254194,0.011936734,0.00023462051,0.00006549453,0.0004734978],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99630207,0.00052642386,0.0014410377,0.00091449113,0.00029697592,0.0005189808],"domain_scores_gemma":[0.99712956,0.00058293587,0.0011883802,0.00067179545,0.00015555328,0.0002717824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006218862,0.0007162704,0.0065481756,0.00016813351,0.00011101236,0.00002116144,0.0001892425,0.00066706905,0.0006703024],"category_scores_gemma":[0.00037510513,0.00043102415,0.00054161536,0.0003219804,0.00011093863,0.000037279253,0.00013452588,0.0004556487,0.0001395171],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032029166,0.0012542896,0.00004826309,0.6691328,0.0015429824,0.00015858402,0.000028431159,2.6549206e-8,1.3588482e-8,0.000082712904,0.002870288,0.32484952],"study_design_scores_gemma":[0.0039314847,0.0048484746,0.00020044601,0.35183075,0.011385528,0.00011957875,0.0000049992736,1.1149295e-7,6.689463e-8,0.000026074433,0.62734944,0.0003030612],"about_ca_topic_score_codex":0.000074862444,"about_ca_topic_score_gemma":0.00002446015,"teacher_disagreement_score":0.6244791,"about_ca_system_score_codex":0.0035698672,"about_ca_system_score_gemma":0.0018858847,"threshold_uncertainty_score":0.99981415},"labels":[],"label_agreement":null},{"id":"W2158112449","doi":"10.1016/j.ygyno.2007.01.023","title":"Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis","year":2007,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Concordance; Meta-analysis; Confidence interval; Kappa; Sampling (signal processing); Internal medicine; Human papillomavirus; Papillomaviridae; Gynecology; Cervical cancer; Oncology; Cancer","score_opus":0.4018843549855309,"score_gpt":0.49137145124165166,"score_spread":0.08948709625612078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158112449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010214155,0.96878874,0.00005058966,0.0005079367,0.000065540014,0.020299735,0.00041813805,0.0002674042,0.009591709],"genre_scores_gemma":[0.0000533259,0.9686014,0.0042489767,0.010313153,0.00025268478,0.011823604,0.0004846968,0.00014016958,0.0040819906],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920695,0.0015114488,0.0027314818,0.0016235751,0.00066400296,0.0013999919],"domain_scores_gemma":[0.9850699,0.009821375,0.0017271627,0.001196168,0.0013943313,0.00079110946],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024073562,0.001113067,0.025245246,0.0011921272,0.0005333871,0.000076661054,0.0006543618,0.0010114462,0.0047338414],"category_scores_gemma":[0.004895287,0.00073413673,0.0033233901,0.006298379,0.00019443067,0.000038774182,0.0003825118,0.0010680133,0.00016918406],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063358566,0.0011199345,0.000013378317,0.8573155,0.12715958,0.00022844253,0.000039561186,5.969305e-7,0.0000013519403,0.000110281166,0.007741618,0.0062064],"study_design_scores_gemma":[0.0007753159,0.0019940638,0.0006214614,0.0035714786,0.64484316,0.00007277707,0.000027953942,0.000005876654,7.24985e-7,0.000084180945,0.3474549,0.0005481069],"about_ca_topic_score_codex":0.00009523711,"about_ca_topic_score_gemma":0.0020744451,"teacher_disagreement_score":0.85374403,"about_ca_system_score_codex":0.0019781278,"about_ca_system_score_gemma":0.0010397219,"threshold_uncertainty_score":0.99951094},"labels":[],"label_agreement":null},{"id":"W2158160318","doi":"10.1016/j.ygyno.2013.10.002","title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Paraaortic lymph nodes; Medicine; Endometrial cancer; Radiology; Lymphadenectomy; Inferior mesenteric artery; Prospective cohort study; Population; Dissection (medical); Surgery; Lymph node; Metastasis; Internal medicine; Cancer","score_opus":0.025688808954375014,"score_gpt":0.3447283637022675,"score_spread":0.3190395547478925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158160318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934235,0.0013592462,0.000010567076,0.0011546385,0.0004401382,0.0017406384,0.00004003133,0.00001293467,0.0018183026],"genre_scores_gemma":[0.9965685,0.0010756585,0.00088791817,0.00027732644,0.00005287412,0.0008767502,0.000002240963,0.000009989045,0.00024872881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980394,0.00030065308,0.000655895,0.0003674651,0.00029984827,0.00033673667],"domain_scores_gemma":[0.99764293,0.0013664732,0.00042083528,0.00029410375,0.00017357434,0.00010207605],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037466112,0.00018591827,0.00090807956,0.00019783703,0.000040367617,0.0000049928535,0.00016849028,0.00017111411,0.0021839263],"category_scores_gemma":[0.0010430581,0.000108910746,0.00012678558,0.00082274433,0.0003372624,0.000068914414,0.00014988129,0.00019563234,0.000005618786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027434298,0.00097636395,0.9753986,0.00037741294,0.00023721348,0.000012228511,0.000087925735,0.0000364044,0.0017714526,0.00035247207,0.000021364413,0.020454196],"study_design_scores_gemma":[0.0099484185,0.0016968799,0.9838397,0.00005831493,0.0005728949,0.000010591495,0.000079978985,0.00008264164,0.0021973252,0.0013717486,0.000049523223,0.000092018934],"about_ca_topic_score_codex":0.0020720265,"about_ca_topic_score_gemma":0.00018545704,"teacher_disagreement_score":0.020362176,"about_ca_system_score_codex":0.00070974074,"about_ca_system_score_gemma":0.0005135188,"threshold_uncertainty_score":0.9987282},"labels":[],"label_agreement":null},{"id":"W2159079082","doi":"10.1006/gyno.2001.6367","title":"Bone Metastasis from a Granulosa Cell Tumor of the Ovary","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Ovary; Bone metastasis; Metastasis; Bone scintigraphy; Radiation therapy; Lesion; Radiology; Megestrol acetate; Surgery; Cancer; Internal medicine","score_opus":0.02425748036796751,"score_gpt":0.28445227119358746,"score_spread":0.26019479082561997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159079082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95927286,0.0017302617,0.000016382079,0.00943701,0.0006478718,0.00063572626,0.00006709164,0.000039215236,0.02815356],"genre_scores_gemma":[0.9928962,0.00042568485,0.0023342676,0.003475227,0.00012656489,0.00014461839,0.000021330494,0.000013721864,0.00056237355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867404,0.00017175848,0.00036747273,0.00032234943,0.0001704507,0.00029395468],"domain_scores_gemma":[0.9984995,0.0006028495,0.00024849587,0.00047740777,0.00006967043,0.000102082144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020326275,0.00016787433,0.00062613894,0.000059329243,0.000074917334,0.000004175999,0.00014581563,0.00013652217,0.0031625386],"category_scores_gemma":[0.000142818,0.00009922873,0.00023945948,0.00025835264,0.00016825384,0.000026745758,0.000106430416,0.0001923131,0.000099291574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010140816,0.01000635,0.7986661,0.000093724535,0.0009244887,0.0039172377,0.0005982225,0.000029754945,0.007930166,0.00092836673,0.040466562,0.1354249],"study_design_scores_gemma":[0.005763446,0.0026316678,0.75084025,0.00002831057,0.0010489044,0.00019004992,0.00024409189,0.00002095439,0.0096806185,0.0017263483,0.22767672,0.00014861228],"about_ca_topic_score_codex":0.00041725655,"about_ca_topic_score_gemma":0.00030910812,"teacher_disagreement_score":0.18721016,"about_ca_system_score_codex":0.0003079179,"about_ca_system_score_gemma":0.0003353809,"threshold_uncertainty_score":0.99774873},"labels":[],"label_agreement":null},{"id":"W2159440189","doi":"10.1016/j.ygyno.2015.07.011","title":"Trends over time in the use of laparoscopic hysterectomy for the treatment of endometrial cancer","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Endometrial cancer; Laparotomy; Hysterectomy; Odds ratio; Cancer registry; Laparoscopy; Retrospective cohort study; General surgery; Population; Laparoscopic surgery; Uterine cancer; Comorbidity; Cohort; Cancer; Surgery; Internal medicine","score_opus":0.17762261598211937,"score_gpt":0.40084414135761653,"score_spread":0.22322152537549717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159440189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922199,0.0019423035,0.000007015484,0.0021239957,0.00076483,0.0013498564,0.00010666094,0.000011993691,0.001473423],"genre_scores_gemma":[0.99557096,0.00055149896,0.00032608458,0.0005731673,0.00027028914,0.00093393074,0.000028767443,0.000010156939,0.0017351364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987562,0.00021307089,0.00040334958,0.00019167652,0.00018935303,0.00024638927],"domain_scores_gemma":[0.99377036,0.0055922433,0.00021632375,0.0002650811,0.00009471156,0.00006125483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003262355,0.00014394893,0.00073518814,0.00021190607,0.00002759156,0.000004870226,0.00013621603,0.00014912347,0.000583511],"category_scores_gemma":[0.0007027926,0.00006294204,0.0001934189,0.00070551794,0.00014617169,0.000033535354,0.000019909821,0.000069201786,0.0000063138036],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015976595,0.010158867,0.23487481,0.0000886961,0.001345988,0.00007757816,0.0030157128,0.00023663414,0.0013736662,0.00032384906,0.011743963,0.72078365],"study_design_scores_gemma":[0.080885395,0.055364545,0.30234838,0.00002874537,0.0013396309,0.0000149717,0.00026634397,0.00023436263,0.0024534215,0.0002798299,0.55662155,0.00016281029],"about_ca_topic_score_codex":0.0009969837,"about_ca_topic_score_gemma":0.0008210947,"teacher_disagreement_score":0.7206208,"about_ca_system_score_codex":0.00056084915,"about_ca_system_score_gemma":0.00027043754,"threshold_uncertainty_score":0.6389036},"labels":[],"label_agreement":null},{"id":"W2159935881","doi":"10.1016/j.ygyno.2012.01.048","title":"Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research","keywords":"Myxoma virus; Oncolytic virus; Protein kinase B; PI3K/AKT/mTOR pathway; Cytopathic effect; Biology; Cell culture; Cancer research; Medicine; Virus; Virology; Signal transduction; Cell biology","score_opus":0.0198904255479818,"score_gpt":0.32681663445072157,"score_spread":0.30692620890273975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159935881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99700594,0.0009063203,0.00007268762,0.0003549118,0.00028977095,0.0004917097,0.00039886907,0.00002880593,0.0004509892],"genre_scores_gemma":[0.9976052,0.0007516671,0.0001023476,0.0004907661,0.00025051643,0.00012679712,0.0001760338,0.00004133514,0.00045534715],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973966,0.0006147713,0.0003707881,0.00054123794,0.00023010677,0.00084650086],"domain_scores_gemma":[0.9985582,0.00019043934,0.00030975445,0.0004659543,0.00013869599,0.0003369398],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000462076,0.00034199277,0.00062627514,0.00009691649,0.0001852088,0.000019409275,0.00034754717,0.0007165855,0.0026260035],"category_scores_gemma":[0.00014220233,0.00030635743,0.0001557243,0.00023169703,0.0004555817,0.000015752836,0.0003047603,0.00030630367,0.000020894295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012972576,0.0008913894,0.009754522,0.000021019143,0.00035258956,0.0000034970549,0.000163731,0.0000027623323,0.97132844,0.0000021547658,0.006794903,0.00938772],"study_design_scores_gemma":[0.0022931846,0.0065857763,0.0459304,0.0000037752952,0.0000868816,0.0000039537804,0.000055455756,0.00002968956,0.9367293,0.000016932823,0.007952264,0.00031236067],"about_ca_topic_score_codex":0.00047632476,"about_ca_topic_score_gemma":0.0015567094,"teacher_disagreement_score":0.03617588,"about_ca_system_score_codex":0.00018730247,"about_ca_system_score_gemma":0.00028879798,"threshold_uncertainty_score":0.99993885},"labels":[],"label_agreement":null},{"id":"W2160903241","doi":"10.1016/j.ygyno.2013.04.053","title":"Endometrial cancer and a family history of cancer","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"National Cancer Institute","keywords":"Endometrial cancer; Family history; Medicine; Microsatellite instability; Lynch syndrome; Colorectal cancer; Cancer; Odds ratio; Oncology; Internal medicine; First-degree relatives; Uterine cancer; Population; Gynecology; DNA mismatch repair; Genetics; Microsatellite; Biology; Gene; Allele","score_opus":0.04418813857583493,"score_gpt":0.32510577469523233,"score_spread":0.2809176361193974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160903241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95460933,0.018376602,0.000005443318,0.001501144,0.0034487164,0.0008713665,0.0000109626735,0.000042668493,0.021133754],"genre_scores_gemma":[0.98774314,0.0027222608,0.0013113843,0.0023379775,0.00025327326,0.0008783446,0.0000027631831,0.00001869545,0.004732178],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869096,0.000081964325,0.00036829294,0.0003370548,0.00017963487,0.00034206148],"domain_scores_gemma":[0.99855775,0.00064882496,0.00020984528,0.00020187671,0.0002190844,0.00016259523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018793697,0.00017001243,0.0006540952,0.0001870427,0.000022699764,0.0000028664688,0.00011059359,0.00032471077,0.008269858],"category_scores_gemma":[0.00056422054,0.00013541363,0.00008015516,0.00017131778,0.00044023927,0.000039151342,0.00010378615,0.0002477504,0.000036486625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057226897,0.00041656013,0.26090157,0.00016819275,0.0003017173,0.000037860125,0.00071633514,0.000018895596,0.1921613,0.00010733314,0.118021764,0.4265762],"study_design_scores_gemma":[0.0047063283,0.0037965646,0.6420272,0.000028465489,0.00023126218,0.00002081866,0.0001841434,0.00009634503,0.0019788728,0.00029581605,0.34642678,0.00020740123],"about_ca_topic_score_codex":0.003207959,"about_ca_topic_score_gemma":0.00063380104,"teacher_disagreement_score":0.4263688,"about_ca_system_score_codex":0.002307484,"about_ca_system_score_gemma":0.0015636168,"threshold_uncertainty_score":0.99263674},"labels":[],"label_agreement":null},{"id":"W2161335479","doi":"10.1016/j.ygyno.2009.10.036","title":"Acceptabililty of HPV vaccination among women attending the University of Saskatchewan student health services","year":2010,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Vaccination; Cervical cancer; Family medicine; HPV infection; Medical prescription; Gynecology; Cancer; Nursing; Virology; Internal medicine","score_opus":0.016148206334379103,"score_gpt":0.34374163190008744,"score_spread":0.32759342556570836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161335479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97754,0.000052338823,0.000015467846,0.002120511,0.0002104742,0.0005293429,0.00000703209,0.00002086001,0.019503927],"genre_scores_gemma":[0.9990254,0.00007902392,0.00020135644,0.00032608781,0.000057012832,0.000007734034,0.000008341681,0.0000055591477,0.00028947988],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878407,0.00022450344,0.00024710625,0.00020025007,0.00023422371,0.00030984372],"domain_scores_gemma":[0.99857277,0.0005693832,0.00022472763,0.000277279,0.00021889873,0.00013695523],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013191337,0.00008400619,0.00042064817,0.00007935724,0.0001506869,0.0000034493482,0.00030668033,0.0001613256,0.030621987],"category_scores_gemma":[0.000084796215,0.000058976977,0.0000711031,0.00023543958,0.00020808225,0.00004945829,0.00021534502,0.00049545727,0.000010692338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027676855,0.0006615106,0.46658102,0.00039842722,0.00007870849,0.000011155653,0.021543229,0.00000579161,0.0008195929,0.00013181195,0.0002296424,0.5092623],"study_design_scores_gemma":[0.0012736095,0.0017237666,0.9369196,0.0000019404683,0.0000223579,0.0000036753293,0.05559334,0.00005448861,0.00015354792,0.00014592169,0.004064996,0.00004269877],"about_ca_topic_score_codex":0.0010861356,"about_ca_topic_score_gemma":0.019058375,"teacher_disagreement_score":0.50921965,"about_ca_system_score_codex":0.00047209,"about_ca_system_score_gemma":0.00056971115,"threshold_uncertainty_score":0.9988412},"labels":[],"label_agreement":null},{"id":"W2161401853","doi":"10.1016/j.ygyno.2013.11.015","title":"PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"Calgary Laboratory Services","keywords":"Missense mutation; Exon; Serous fluid; Carcinoma; Medicine; Serous carcinoma; Univariate analysis; Cancer research; Sanger sequencing; Endometrial cancer; Oncology; Clear cell; Mutation; Internal medicine; Pathology; Biology; Gene; Cancer; Multivariate analysis; Genetics; Ovarian cancer","score_opus":0.05053507167520202,"score_gpt":0.3116125368467377,"score_spread":0.2610774651715356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161401853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889534,0.0003725875,0.0000063529956,0.0025475489,0.00063952844,0.0028178077,0.00004024907,0.00009446573,0.004528022],"genre_scores_gemma":[0.99422336,0.000052025152,0.00053046463,0.0027141576,0.00014681005,0.00075348164,0.00011707996,0.00004421097,0.0014184372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957082,0.0006193023,0.0012273177,0.00081595,0.00054805336,0.001081161],"domain_scores_gemma":[0.9937228,0.0048267976,0.00046939732,0.0003838928,0.00025205628,0.00034504785],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009423483,0.00047644085,0.002041871,0.0018158383,0.000093458286,0.00003592273,0.00022736941,0.0006659772,0.0020417746],"category_scores_gemma":[0.0059728567,0.00035090343,0.00022135832,0.003622767,0.00017490088,0.00019373253,0.00009653955,0.00076083076,0.00025635003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002899297,0.0025765973,0.9768312,0.000057288,0.00017495757,0.005828035,0.00041879123,0.00003244305,0.0017660522,0.000034731616,0.00025962433,0.009121014],"study_design_scores_gemma":[0.062311426,0.009008856,0.9236894,0.00002864163,0.00021773155,0.0002812805,0.00059568265,0.00014714786,0.0027073652,0.0002932813,0.00035963833,0.00035949727],"about_ca_topic_score_codex":0.007973633,"about_ca_topic_score_gemma":0.0029641085,"teacher_disagreement_score":0.05941213,"about_ca_system_score_codex":0.0031941128,"about_ca_system_score_gemma":0.0005714693,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W2161780509","doi":"10.1006/gyno.2001.6224","title":"Cutaneous Metastasis of Papillary Serous Uterine Cancer","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Medicine; Occult; Uterus; Radiation therapy; Metastasis; Cancer; Serous fluid; Uterine cancer; Hysterectomy; Radiology; Pathology; Internal medicine","score_opus":0.04010782693971736,"score_gpt":0.37643842746256867,"score_spread":0.3363306005228513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161780509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753502,0.0030083572,0.000012557031,0.005890514,0.0005358779,0.00047455117,0.00004001791,0.00006421275,0.01462374],"genre_scores_gemma":[0.9818519,0.013222632,0.0009213254,0.0020728945,0.00014234176,0.00024781414,0.000020221449,0.000016347512,0.0015045624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998875,0.00006512969,0.000341776,0.0002517307,0.00013866978,0.0003276543],"domain_scores_gemma":[0.99901044,0.00030472907,0.00016578907,0.00027913923,0.00010857268,0.00013134716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010345465,0.00016949883,0.00069178635,0.0000891238,0.000045458804,0.0000033285983,0.00008478685,0.00016664094,0.0065389755],"category_scores_gemma":[0.00008268287,0.0001268629,0.00014619173,0.00020564179,0.000117214084,0.000024648165,0.00007092898,0.00012407663,0.000058695277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072346046,0.0026673046,0.36605278,0.000129396,0.000864688,0.0062565682,0.00025346654,0.00010250637,0.0023245749,0.00024733556,0.010622357,0.6097556],"study_design_scores_gemma":[0.0036915173,0.009017073,0.1643679,0.000040006544,0.0007627492,0.0035353124,0.00022918123,0.00003637624,0.0035372146,0.00027037252,0.8142947,0.00021760828],"about_ca_topic_score_codex":0.0005952072,"about_ca_topic_score_gemma":0.0010621868,"teacher_disagreement_score":0.8036723,"about_ca_system_score_codex":0.00055647496,"about_ca_system_score_gemma":0.0002804112,"threshold_uncertainty_score":0.9943692},"labels":[],"label_agreement":null},{"id":"W2164316325","doi":"10.1016/j.ygyno.2009.06.001","title":"Follow-up for women after treatment for cervical cancer: A systematic review","year":2009,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"Cancer Care Ontario","keywords":"Medicine; Asymptomatic; Cervical cancer; Surgery; Colposcopy; Vaginal vault; Cochrane Library; MEDLINE; Retrospective cohort study; Cancer; Randomized controlled trial; Vagina; Internal medicine","score_opus":0.09092524287729985,"score_gpt":0.4218786934767152,"score_spread":0.33095345059941533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164316325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005198539,0.96470445,0.000018690518,0.0009611524,0.0012761003,0.031317025,0.0006230878,0.00011416877,0.0009801404],"genre_scores_gemma":[0.000008397689,0.8272849,0.00045872497,0.0038575202,0.0005610045,0.15769213,0.00041100263,0.000073209085,0.009653162],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953184,0.00043345577,0.0018494555,0.0010333253,0.0002465768,0.0011187561],"domain_scores_gemma":[0.9938538,0.0037493221,0.00095987844,0.0007072744,0.00024621552,0.0004834912],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072250725,0.0009582316,0.012058534,0.00026129233,0.00011395956,0.000018574026,0.0002885432,0.0010896303,0.001214045],"category_scores_gemma":[0.0014898727,0.0005450591,0.0025637855,0.0005289212,0.00007215137,0.000035001078,0.000060957893,0.00026032756,0.00013017414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040451085,0.0005864709,0.000002153067,0.519021,0.0013815255,0.00006477258,0.000022606624,1.581572e-8,2.0421913e-8,0.000024612618,0.0010452349,0.47744712],"study_design_scores_gemma":[0.007115873,0.016934747,0.0000058009714,0.14620675,0.026554102,0.00009478785,0.00001568196,7.985497e-7,1.6715066e-7,0.00023287584,0.80245376,0.0003846848],"about_ca_topic_score_codex":0.000020181355,"about_ca_topic_score_gemma":0.00013320525,"teacher_disagreement_score":0.80140847,"about_ca_system_score_codex":0.009218729,"about_ca_system_score_gemma":0.0020112682,"threshold_uncertainty_score":0.99970007},"labels":[],"label_agreement":null},{"id":"W2164963563","doi":"10.1016/j.ygyno.2010.12.345","title":"The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":283,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Medicine; Exact test; Proportional hazards model; Cervical cancer; Prospective cohort study; Gynecology; Log-rank test; Survival analysis; Stage (stratigraphy); Histology; Surgery; Internal medicine; Cancer","score_opus":0.05772423732810033,"score_gpt":0.31751476132267975,"score_spread":0.2597905239945794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164963563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921208,0.0027460787,0.0000057658967,0.0006706707,0.00014420893,0.0003079899,0.000013165066,0.000022167305,0.0039691348],"genre_scores_gemma":[0.99725246,0.0009894011,0.0012932242,0.00019255943,0.000039020586,0.00005192346,0.0000065618724,0.0000062700847,0.00016859277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99902606,0.00015665426,0.00030081978,0.00017941723,0.000108549604,0.00022847962],"domain_scores_gemma":[0.9986677,0.00079186726,0.00015921387,0.00017626653,0.0000980467,0.00010687919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026055487,0.00011220692,0.0004683923,0.00005721958,0.00007424052,0.0000028600157,0.000102307626,0.00014118971,0.00039393388],"category_scores_gemma":[0.00074055773,0.00006246927,0.00005777385,0.00017511313,0.0007708691,0.00006557386,0.000049498958,0.0001237097,0.0000032734572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013861606,0.0051238816,0.46070805,0.00040763215,0.00088720786,0.0012285347,0.0027992402,5.464726e-7,0.008266096,0.020370468,0.0006190071,0.48572773],"study_design_scores_gemma":[0.007010848,0.043301553,0.89603305,0.00003903393,0.0005824191,0.0008141393,0.001055353,0.0000059062327,0.026394686,0.00544756,0.01915163,0.00016383381],"about_ca_topic_score_codex":0.00014929954,"about_ca_topic_score_gemma":0.00043907913,"teacher_disagreement_score":0.4855639,"about_ca_system_score_codex":0.00006255199,"about_ca_system_score_gemma":0.00022094257,"threshold_uncertainty_score":0.43133},"labels":[],"label_agreement":null},{"id":"W2165357484","doi":"10.1016/j.ygyno.2010.12.344","title":"Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Gynecologic oncology; General surgery; Surgery; Oncology","score_opus":0.07264087304038074,"score_gpt":0.328575943206568,"score_spread":0.2559350701661873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165357484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698667,0.0006488112,0.00006239768,0.00079712033,0.0030230626,0.0013937063,0.000031731368,0.00016077988,0.024015704],"genre_scores_gemma":[0.9925452,0.00042323337,0.0025747018,0.002565904,0.00013638467,0.00069806597,0.00003731656,0.000047212925,0.00097196613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994,0.0015376568,0.0018026199,0.001096468,0.00029788743,0.0012653351],"domain_scores_gemma":[0.9915422,0.0061649177,0.000734181,0.0009777551,0.00022859036,0.00035233598],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003491693,0.0005261729,0.0027831418,0.0007122535,0.00006452478,0.0000063272064,0.0003393154,0.0013521006,0.008053291],"category_scores_gemma":[0.0048112227,0.0004366007,0.00051751506,0.0007979003,0.00081362826,0.00023466782,0.0003313027,0.000996255,0.0003295208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017275902,0.004457689,0.97146845,0.00022924026,0.00010617088,0.0013422898,0.0009895591,0.0000022993877,0.0020362216,0.00011536438,0.001439206,0.016085893],"study_design_scores_gemma":[0.0024081992,0.0032697613,0.9805702,0.000084370666,0.00013428878,0.00013313787,0.00034383516,0.000014360549,0.004139124,0.0019014752,0.006588265,0.00041296068],"about_ca_topic_score_codex":0.0001611085,"about_ca_topic_score_gemma":0.0023201883,"teacher_disagreement_score":0.023043737,"about_ca_system_score_codex":0.0016645495,"about_ca_system_score_gemma":0.0016350739,"threshold_uncertainty_score":0.9999443},"labels":[],"label_agreement":null},{"id":"W2167080586","doi":"10.1006/gyno.2001.6279","title":"The Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal Cancer","year":2001,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Colorectal cancer; Endometrial cancer; Oncology; Cancer; Internal medicine; Lynch syndrome; Stage (stratigraphy); Carcinoma; Population; Gynecology; DNA mismatch repair; Biology","score_opus":0.03869631389430166,"score_gpt":0.3858032611580291,"score_spread":0.34710694726372743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167080586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.963269,0.005010449,0.0000036238368,0.0116425725,0.0046305624,0.00093418045,0.000031380914,0.00004696973,0.014431251],"genre_scores_gemma":[0.98757553,0.008174361,0.0005456357,0.0014764348,0.00062635716,0.0005974542,0.0000060245825,0.00002678468,0.000971417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727005,0.00042566305,0.00086597214,0.00049726985,0.0002904476,0.00065059675],"domain_scores_gemma":[0.99629277,0.0026665223,0.0003199602,0.00033943623,0.00020325802,0.00017807646],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009925448,0.00025147598,0.00086189754,0.00011543674,0.00012322981,0.000008490437,0.00036265212,0.00066182925,0.0020008124],"category_scores_gemma":[0.0011300688,0.00016601014,0.00021393626,0.0005145983,0.0007528334,0.000035818044,0.00017404031,0.0008254533,0.0000171516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002175414,0.0005171135,0.6685398,0.000023908415,0.00019192178,0.00030905206,0.00019154896,0.00008593726,0.002030966,0.00008120706,0.012802414,0.3130507],"study_design_scores_gemma":[0.0026818144,0.0030963088,0.94702333,0.000038246468,0.00013180058,0.00013105272,0.00028459873,0.00007206355,0.0012278201,0.00031788,0.04482828,0.0001668168],"about_ca_topic_score_codex":0.0024592339,"about_ca_topic_score_gemma":0.049277727,"teacher_disagreement_score":0.31288388,"about_ca_system_score_codex":0.00092703593,"about_ca_system_score_gemma":0.0016562535,"threshold_uncertainty_score":0.9989115},"labels":[],"label_agreement":null},{"id":"W2167276541","doi":"10.1016/j.ygyno.2007.08.088","title":"The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer","year":2007,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Quality of life (healthcare); Oncology; Performance status; Chemotherapy; Progression-free survival; Ovarian cancer; Proportional hazards model; Prognostic variable; Cancer","score_opus":0.026122282792521427,"score_gpt":0.35365728962849485,"score_spread":0.3275350068359734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167276541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197954,0.0029685856,0.00000928547,0.0008786024,0.0006890615,0.0015771859,0.000012201573,0.00002399863,0.0018615546],"genre_scores_gemma":[0.9952133,0.0041658925,0.00017249695,0.0001664562,0.000053445823,0.00016086167,0.00000351585,0.000012177889,0.000051795163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979501,0.00032456743,0.00059225014,0.00032341067,0.00030262306,0.0005070616],"domain_scores_gemma":[0.9906199,0.008448725,0.00039465897,0.00021680033,0.00018771259,0.00013218372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015679332,0.00019830983,0.00076166075,0.00011680545,0.00011570638,0.0000041346234,0.000095260184,0.0001802944,0.0000151504155],"category_scores_gemma":[0.007540634,0.00012879499,0.000040760064,0.00020878749,0.0007146746,0.000049664126,0.0001917769,0.00033179703,5.8980373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046488466,0.0004445052,0.91010946,0.0005330881,0.00012285443,0.000016884278,0.00031770355,0.0000102204,0.00083825906,0.00070248597,0.000024307832,0.082231365],"study_design_scores_gemma":[0.009397133,0.0070940447,0.9812492,0.0003059564,0.00007262045,0.0000019200318,0.00041309226,0.000021540489,0.0007364794,0.00021600383,0.0003702179,0.00012177363],"about_ca_topic_score_codex":0.00022254077,"about_ca_topic_score_gemma":0.0036625026,"teacher_disagreement_score":0.08210959,"about_ca_system_score_codex":0.0002562053,"about_ca_system_score_gemma":0.00034611963,"threshold_uncertainty_score":0.90273875},"labels":[],"label_agreement":null},{"id":"W2169873829","doi":"10.1016/j.ygyno.2014.03.011","title":"Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Cancer Care Ontario; Mount Sinai Hospital","funders":"National Cancer Institute; Fred Hutchinson Cancer Research Center","keywords":"Endometrial cancer; Medicine; Colorectal cancer; Germline mutation; Germline; Cancer; Oncology; Family history; Lynch syndrome; DNA mismatch repair; Mutation; Cancer research; Internal medicine; Gene; Gynecology; Genetics; Biology","score_opus":0.034747227359053126,"score_gpt":0.3308614765551485,"score_spread":0.2961142491960954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169873829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850556,0.0013085821,0.00007992514,0.00029106135,0.008512549,0.0034905828,0.00051073916,0.00009305354,0.00065786013],"genre_scores_gemma":[0.9863599,0.0019470922,0.0032274963,0.00044734398,0.0010182208,0.0058224103,0.000030815583,0.0000684768,0.0010782419],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99550575,0.0007066396,0.0014619951,0.00091314653,0.000558267,0.0008541945],"domain_scores_gemma":[0.99142146,0.005949416,0.0014553242,0.000411118,0.00052528124,0.00023741656],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020778314,0.00046892336,0.0021940146,0.0009925625,0.000059146267,0.0000044508956,0.00031579353,0.00074373494,0.0016160301],"category_scores_gemma":[0.00899558,0.00030978525,0.00035423628,0.0008455676,0.000423671,0.000057965273,0.00010625008,0.000515115,0.0000034522895],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14250696,0.0033040997,0.25285223,0.0013783253,0.0019323596,0.00011686299,0.0063170562,0.0044118986,0.36620575,0.00004115534,0.004868112,0.2160652],"study_design_scores_gemma":[0.13229723,0.098317765,0.45652196,0.00047694088,0.002198852,0.000049515762,0.001663721,0.0069223708,0.17787379,0.0009896045,0.12100087,0.0016873685],"about_ca_topic_score_codex":0.0048009506,"about_ca_topic_score_gemma":0.022358878,"teacher_disagreement_score":0.21437782,"about_ca_system_score_codex":0.010211791,"about_ca_system_score_gemma":0.0044470034,"threshold_uncertainty_score":0.99993545},"labels":[],"label_agreement":null},{"id":"W2169980359","doi":"10.1006/gyno.2002.6678","title":"Discussion: Somatic Genetics and Signaling/Genomics/Proteomics","year":2003,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Proteomics; Genomics; Somatic cell; Medicine; Computational biology; Genetics; Genome; Biology; Gene","score_opus":0.013490952640186632,"score_gpt":0.2615438060785303,"score_spread":0.24805285343834366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169980359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148196,0.0026836528,0.0013015796,0.00049775816,0.00044536561,0.00044790067,0.00002269552,0.000024686738,0.003094398],"genre_scores_gemma":[0.97809213,0.001457292,0.018208425,0.0011503879,0.00023561761,0.00008930625,0.00007157546,0.000029627092,0.00066564465],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998428,0.0002481214,0.0003332422,0.00050515594,0.000082756225,0.0004027587],"domain_scores_gemma":[0.99912703,0.00005609413,0.0001334914,0.00035957666,0.00008192117,0.00024188258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030799635,0.00022763867,0.00027580408,0.000052969222,0.00018776764,0.00002742626,0.00017397344,0.00038845628,0.00017705909],"category_scores_gemma":[0.0003744564,0.00017851162,0.00008867858,0.00006828697,0.00024929878,0.0000031292293,0.000117331765,0.0001126439,0.000027093145],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018526216,0.0008388058,0.03837133,0.00010183093,0.000120253615,0.000055029577,0.00020350775,0.00023196066,0.94418037,0.0012230158,0.005061111,0.009427545],"study_design_scores_gemma":[0.006199051,0.0051593147,0.017375357,0.000018855344,0.00024508947,0.0002786731,0.0014996077,0.00016170608,0.36097893,0.029884502,0.576936,0.0012628993],"about_ca_topic_score_codex":0.0000015770606,"about_ca_topic_score_gemma":0.000027272292,"teacher_disagreement_score":0.5832014,"about_ca_system_score_codex":0.00006289531,"about_ca_system_score_gemma":0.00032403055,"threshold_uncertainty_score":0.72794926},"labels":[],"label_agreement":null},{"id":"W2171174540","doi":"10.1016/j.ygyno.2004.03.029","title":"Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells","year":2004,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"National Cancer Institute","keywords":"XIAP; Ovarian cancer; Apoptosis; Ovarian carcinoma; FADD; Cancer research; Tumor necrosis factor alpha; Caspase 8; Flow cytometry; Medicine; Inhibitor of apoptosis; Biology; Programmed cell death; Internal medicine; Cancer; Caspase 3; Caspase; Immunology","score_opus":0.010774809032967826,"score_gpt":0.24500423332115526,"score_spread":0.23422942428818744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171174540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976653,0.00005617374,0.00045979518,0.00014715706,0.0007995622,0.00040735662,0.000023198681,0.000020213869,0.00042123307],"genre_scores_gemma":[0.9989573,0.000058646394,0.00032519115,0.00007541337,0.00008967318,0.000044565848,0.00021369028,0.000025003666,0.00021054277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982506,0.00013418589,0.0005562647,0.0005386507,0.0001242905,0.0003960142],"domain_scores_gemma":[0.99920726,0.000027519602,0.00032533015,0.0002806993,0.00006922183,0.00008994433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016203149,0.00024805008,0.00042218136,0.00014003579,0.00013220531,0.000014857798,0.00019618751,0.0006840286,0.00011401226],"category_scores_gemma":[0.000046419813,0.00023170005,0.00013427174,0.0001936123,0.00012329152,0.000009654901,0.00012689938,0.00022930856,0.0000054327834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000461462,0.0008902745,0.0011430475,0.00001675853,0.000039321774,0.0000023350137,0.00018489367,0.00014482807,0.99488163,0.00025861032,0.00012305695,0.0022690974],"study_design_scores_gemma":[0.004287793,0.0016374139,0.014464655,0.000012089576,0.00004054864,0.000007416992,0.00014965294,0.000022129374,0.97798795,0.00067310897,0.00046541402,0.0002518611],"about_ca_topic_score_codex":0.0004017991,"about_ca_topic_score_gemma":0.00015363785,"teacher_disagreement_score":0.016893715,"about_ca_system_score_codex":0.0002040536,"about_ca_system_score_gemma":0.00013672725,"threshold_uncertainty_score":0.9448454},"labels":[],"label_agreement":null},{"id":"W2172294021","doi":"10.1016/j.ygyno.2015.02.014","title":"Sentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations","year":2015,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Ottawa; Juravinski Cancer Centre; McMaster University; Cancer Care Ontario; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sentinel lymph node; Systematic review; Vulvar cancer; Guideline; Context (archaeology); MEDLINE; Surgery; General surgery; Breast cancer; Cancer; Internal medicine; Vulva; Pathology","score_opus":0.1911833552134777,"score_gpt":0.46293361199138167,"score_spread":0.271750256777904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172294021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002164022,0.9897979,0.000017618557,0.004195847,0.00029101598,0.0034449713,0.0002765465,0.000060134833,0.0019137881],"genre_scores_gemma":[0.000004717397,0.9865016,0.0015472164,0.004095093,0.00011133485,0.004909664,0.0012101193,0.000039448074,0.0015808158],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934726,0.0016841828,0.0030510684,0.0009218945,0.00034832733,0.00052196],"domain_scores_gemma":[0.9950945,0.0018081901,0.0015993846,0.000780922,0.00036951836,0.00034748582],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00286214,0.00070709083,0.017358711,0.001059439,0.00006780166,0.00001758927,0.00029838056,0.0007116088,0.00381118],"category_scores_gemma":[0.0023960453,0.00041196373,0.0022245604,0.0034136889,0.000100029334,0.00004967919,0.00022580614,0.00046468232,0.00014466408],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002694071,0.00089386554,0.00035994878,0.694255,0.18512437,0.00042954902,0.00001881749,0.0000014737494,8.804026e-8,0.00003325394,0.0042771786,0.11457953],"study_design_scores_gemma":[0.0011343905,0.000111160334,0.00004134343,0.012685051,0.6633296,0.00017366245,0.000015301248,0.0000063191474,2.4210472e-8,0.00003327791,0.3221952,0.00027467718],"about_ca_topic_score_codex":0.0004744209,"about_ca_topic_score_gemma":0.00019145248,"teacher_disagreement_score":0.68156993,"about_ca_system_score_codex":0.0019720953,"about_ca_system_score_gemma":0.0011895242,"threshold_uncertainty_score":0.9998332},"labels":[],"label_agreement":null},{"id":"W2191046015","doi":"10.1016/j.ygyno.2015.12.005","title":"Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case–control study","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; Calgary Laboratory Services; BC Cancer Agency; University of Alberta; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control; University of Calgary; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Wine; White Wine; Odds ratio; Case-control study; Confidence interval; Population; Logistic regression; Demography; Serous fluid; Consumption (sociology); Alcohol consumption; Relative risk; Alcohol; Environmental health; Internal medicine; Food science; Biology","score_opus":0.08173824433871117,"score_gpt":0.3965175028334499,"score_spread":0.3147792584947387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191046015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925811,0.00030065828,0.00004487005,0.0028629226,0.0005378659,0.0033031101,0.00007499352,0.000094386945,0.00020003821],"genre_scores_gemma":[0.9932208,0.00011423326,0.0004918821,0.005196133,0.00016391149,0.00072280626,0.000020673153,0.0000187346,0.00005081512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970999,0.0012360183,0.00055415963,0.0004893116,0.00019313871,0.00042749016],"domain_scores_gemma":[0.99678665,0.001983599,0.0003213966,0.00024082798,0.00025082237,0.00041672116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014552028,0.00022827846,0.0007183298,0.0002991444,0.00014772406,0.000014104562,0.00006214342,0.00038294366,0.00053683517],"category_scores_gemma":[0.0034696737,0.00019467948,0.00005120266,0.00017882776,0.00011233693,0.00006821626,0.00003579626,0.0005051453,0.00012465248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012612389,0.0007701233,0.9796724,0.00006493901,0.000077009456,0.0027245232,0.00080603355,0.00014699266,0.000042596574,0.000048273087,0.00016686764,0.014219041],"study_design_scores_gemma":[0.02841783,0.0038529965,0.9629652,0.000034746146,0.0003437209,0.00041068083,0.000418014,0.0029991313,0.0000064680385,0.00011158505,0.00025987506,0.0001797435],"about_ca_topic_score_codex":0.006174562,"about_ca_topic_score_gemma":0.039916668,"teacher_disagreement_score":0.033742107,"about_ca_system_score_codex":0.00093588943,"about_ca_system_score_gemma":0.0009866306,"threshold_uncertainty_score":0.97760236},"labels":[],"label_agreement":null},{"id":"W2191461938","doi":"10.1016/j.ygyno.2015.09.086","title":"Patient, tumor, and health system factors affecting groin node dissection rates in vulvar carcinoma: A population-based cohort study","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Research Institute","keywords":"Medicine; Vulvar cancer; Vulvar Carcinoma; Cohort; Population; Internal medicine; Retrospective cohort study; Cancer; Carcinoma; Oncology; Surgery","score_opus":0.051034592008476376,"score_gpt":0.3495051733829906,"score_spread":0.2984705813745142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191461938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600583,0.00023266676,0.000008382456,0.00027388844,0.00060926896,0.0022339984,0.000006107556,0.00009189747,0.0005379402],"genre_scores_gemma":[0.9992458,0.0000018293329,0.00012688676,0.00029402462,0.000057878053,0.00017982248,0.00006781926,0.0000141623295,0.000011774427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981112,0.0004937813,0.00045519462,0.0004108872,0.00019612414,0.0003328539],"domain_scores_gemma":[0.99868554,0.0006043455,0.00023759756,0.00015217469,0.00007041146,0.00024990414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007639528,0.0001900826,0.0007489559,0.00024078958,0.00010647194,0.00001084433,0.000039797036,0.00011038819,0.000026883085],"category_scores_gemma":[0.000565532,0.00013828975,0.000043889348,0.0004551334,0.000026053609,0.000047852267,0.000037975988,0.00020322432,0.0000064524606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027387298,0.0010688341,0.99647844,0.00008135728,0.000034299508,0.00018814486,0.0006361913,0.000048069393,0.000007616189,0.000008401328,0.000028786055,0.0011460141],"study_design_scores_gemma":[0.0071065817,0.010664761,0.97566694,0.00002638266,0.000072702576,0.000046192243,0.0060758763,0.00017048017,0.000028657558,0.000017409317,0.000017633969,0.00010641111],"about_ca_topic_score_codex":0.012272706,"about_ca_topic_score_gemma":0.005866707,"teacher_disagreement_score":0.020811502,"about_ca_system_score_codex":0.002935453,"about_ca_system_score_gemma":0.00029146273,"threshold_uncertainty_score":0.99430466},"labels":[],"label_agreement":null},{"id":"W2200660233","doi":"10.1016/j.ygyno.2015.12.002","title":"FIGO Update: Vancouver, Canada, October 2015","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; General surgery","score_opus":0.023505695374828835,"score_gpt":0.31198105530976805,"score_spread":0.2884753599349392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200660233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77576184,0.00080353796,0.000017156628,0.0280862,0.008543893,0.0005627643,0.000042616626,0.00014230772,0.18603969],"genre_scores_gemma":[0.9354083,0.00008654821,0.0010964643,0.048378117,0.00044198736,0.000028115095,0.000038465914,0.000015204451,0.014506806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851966,0.00010008286,0.00031113817,0.00027957567,0.00026360477,0.0005259357],"domain_scores_gemma":[0.99874026,0.00010294055,0.000111595014,0.00024451985,0.0002027404,0.0005979325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029751472,0.00016365026,0.00047304842,0.000041378695,0.00006285872,0.0000046575187,0.00014909964,0.00022829136,0.00134253],"category_scores_gemma":[0.00027987213,0.00012088201,0.000045570236,0.00012386662,0.000067897,0.00003864164,0.00009769421,0.0002896759,0.00042839997],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016249694,0.00018835202,0.03557115,0.000021130436,0.00002778247,0.0006851972,0.00003827564,0.000011667481,0.000012658173,0.00039173855,0.959108,0.003781534],"study_design_scores_gemma":[0.0020901228,0.0013011374,0.06065939,0.000007600179,0.000045274566,0.00019248643,0.0002942282,0.000023733108,0.000037311176,0.0010199047,0.9342039,0.00012489385],"about_ca_topic_score_codex":0.19148523,"about_ca_topic_score_gemma":0.8150042,"teacher_disagreement_score":0.623519,"about_ca_system_score_codex":0.0015090213,"about_ca_system_score_gemma":0.0037659667,"threshold_uncertainty_score":0.99957037},"labels":[],"label_agreement":null},{"id":"W2207118467","doi":"10.1016/j.ygyno.2015.06.004","title":"The more tumors change, the more they stay tame: Do T cells keep POLE ultramutated endometrial carcinomas in check?","year":2015,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"","keywords":"Medicine; Gynecology; Endometrial cancer; Oncology; General surgery; Internal medicine; Cancer","score_opus":0.05920692536352824,"score_gpt":0.33106153543095707,"score_spread":0.27185461006742884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207118467","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1515756,0.009550409,0.000001167364,0.80632997,0.007957985,0.007863195,0.00048351852,0.00024039064,0.0159978],"genre_scores_gemma":[0.44107023,0.002337915,0.0001396364,0.52745837,0.014365628,0.0037730944,0.0012227645,0.00022476797,0.009407611],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937422,0.0011302052,0.0011914566,0.0011241175,0.0010785632,0.0017334555],"domain_scores_gemma":[0.9910911,0.006243973,0.0008037286,0.0011872324,0.00036672098,0.00030726654],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018003978,0.000908649,0.0021894993,0.0006264837,0.00034327415,0.000085550324,0.0011649984,0.0021876195,0.00084585644],"category_scores_gemma":[0.0024788603,0.00045029513,0.00053395366,0.0015944068,0.0008981106,0.00007509425,0.00037361,0.0041803983,0.00028430345],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044365176,0.0015188738,0.0146983005,0.00027772968,0.0015330401,0.01770876,0.0043546166,0.000021938638,0.00019893252,0.000056632784,0.87320316,0.08199152],"study_design_scores_gemma":[0.015669437,0.0062789894,0.01805948,0.00006474089,0.00079521746,0.00023773026,0.0017682302,0.000015215328,0.00019723155,0.0010627066,0.9552702,0.00058084016],"about_ca_topic_score_codex":0.0023475445,"about_ca_topic_score_gemma":0.0010131384,"teacher_disagreement_score":0.28949463,"about_ca_system_score_codex":0.003000658,"about_ca_system_score_gemma":0.0013781042,"threshold_uncertainty_score":0.9997949},"labels":[],"label_agreement":null},{"id":"W2208123493","doi":"10.1016/j.ygyno.2015.12.019","title":"Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":563,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Gynecologic oncology; General surgery; Gynecologic surgical procedures; Surgery; Laparoscopy","score_opus":0.07188068856420583,"score_gpt":0.37082416899614634,"score_spread":0.2989434804319405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208123493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78320587,0.001709911,0.000501638,0.1913723,0.0048342175,0.0029159507,0.00021700037,0.0002938075,0.014949322],"genre_scores_gemma":[0.89661014,0.010209538,0.010802517,0.059432816,0.0012447451,0.006188241,0.00064812857,0.00010349867,0.014760346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99480647,0.0009661031,0.0017263828,0.0010490161,0.00024944425,0.0012025884],"domain_scores_gemma":[0.96351314,0.034084674,0.00046332937,0.0005115106,0.0011186848,0.0003086783],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028836317,0.0005498087,0.0030706837,0.00032914494,0.00032417697,0.000020075584,0.00018672671,0.0012623895,0.0031930974],"category_scores_gemma":[0.01366469,0.00036176422,0.0018014101,0.0004587924,0.00038542616,0.00022944856,0.00018529456,0.00038655172,0.00012143385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004546308,0.0014155951,0.0978218,0.00014153708,0.00056222675,0.0007438685,0.0014111121,0.00001757633,0.0014204084,0.000612421,0.2625029,0.62880427],"study_design_scores_gemma":[0.0031896173,0.0035267156,0.047158636,0.00010908507,0.00019783268,0.0001231963,0.0017126438,0.0000064309634,0.00061883964,0.00024905335,0.9425859,0.0005220825],"about_ca_topic_score_codex":0.000035408942,"about_ca_topic_score_gemma":0.0011251359,"teacher_disagreement_score":0.680083,"about_ca_system_score_codex":0.0022520178,"about_ca_system_score_gemma":0.0022372548,"threshold_uncertainty_score":0.9998834},"labels":[],"label_agreement":null},{"id":"W2244509985","doi":"10.1016/j.ygyno.2016.01.015","title":"First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Queen's University; Ottawa Hospital","funders":"","keywords":"PTEN; Tensin; Medicine; Univariate analysis; Oncology; Ovarian cancer; Internal medicine; Biomarker; Cancer research; Immunohistochemistry; Multivariate analysis; PI3K/AKT/mTOR pathway; Proportional hazards model; Cancer; Biology; Apoptosis","score_opus":0.020015646185428494,"score_gpt":0.34232994125599203,"score_spread":0.32231429507056353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2244509985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96597445,0.0001053011,0.0303588,0.0004608929,0.00011294937,0.0026861657,0.000059229238,0.000030585303,0.00021159714],"genre_scores_gemma":[0.99497455,0.000018119556,0.002266352,0.00006363588,0.000020244614,0.002544127,0.000010866674,0.00001592586,0.00008618372],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778277,0.0006138917,0.00059274543,0.000562212,0.00017773749,0.00027062197],"domain_scores_gemma":[0.99817413,0.00028919228,0.0006495304,0.00058063766,0.0002539952,0.000052507996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006855322,0.00019902142,0.0005367919,0.00021525397,0.00007218185,0.000003165996,0.0004977386,0.0003937573,0.000060598828],"category_scores_gemma":[0.00070690154,0.00012462583,0.000121323166,0.0009357973,0.00018681037,0.000007995412,0.00027415217,0.0001351102,0.000003671959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045131473,0.00068199256,0.09126122,0.00001919085,0.00023385939,0.0000021285678,0.00051852124,0.0021587329,0.9032336,0.0001221975,0.00015010542,0.0011671431],"study_design_scores_gemma":[0.0023874217,0.006130511,0.27894378,0.00012468736,0.00026641006,0.0000020134303,0.0010059717,0.0010250752,0.7076726,0.00034878188,0.0017439391,0.00034879334],"about_ca_topic_score_codex":0.0008447124,"about_ca_topic_score_gemma":0.012380157,"teacher_disagreement_score":0.19556098,"about_ca_system_score_codex":0.0003531898,"about_ca_system_score_gemma":0.00028069876,"threshold_uncertainty_score":0.6908418},"labels":[],"label_agreement":null},{"id":"W2261117489","doi":"10.1016/j.ygyno.2016.02.002","title":"Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University; University of Calgary; Princess Margaret Cancer Centre; University of Manitoba; Public Health Ontario; University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; Hazard ratio; Adjuvant; Proportional hazards model; Radiation therapy; Stage (stratigraphy); Serous fluid; Adjuvant therapy; Cancer; Gynecology; Confidence interval","score_opus":0.027045080941086038,"score_gpt":0.3056907162800619,"score_spread":0.27864563533897585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261117489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780288,0.0012172649,0.0000056855415,0.0062988065,0.006684035,0.002527747,0.0015526118,0.0001390502,0.0035460459],"genre_scores_gemma":[0.98959494,0.0047554,0.00035927317,0.00050133554,0.00072864833,0.0011032074,0.0001141096,0.000058020876,0.0027850836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994391,0.0010993225,0.0013625497,0.0011475423,0.00044095342,0.0015585942],"domain_scores_gemma":[0.989303,0.0081067495,0.0007120384,0.0006556045,0.00019121096,0.0010314033],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008328195,0.0006765364,0.0024714519,0.0020592546,0.00026457512,0.000021800806,0.00031119926,0.0010308854,0.009779696],"category_scores_gemma":[0.00849548,0.00039328574,0.00048735997,0.002043356,0.0003587604,0.00012375879,0.00010147607,0.00058114185,0.0005520278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028700563,0.0011042634,0.8166961,0.000008847892,0.00084451213,0.0012851842,0.000078768266,0.000009175616,0.00011646145,0.00030470183,0.00032139066,0.17636055],"study_design_scores_gemma":[0.11617524,0.014401741,0.84343934,0.000019490435,0.0012534874,0.00004844975,0.00006605487,0.000004594289,0.000636692,0.0012464295,0.02227627,0.0004322183],"about_ca_topic_score_codex":0.64127094,"about_ca_topic_score_gemma":0.5169565,"teacher_disagreement_score":0.17592832,"about_ca_system_score_codex":0.011870133,"about_ca_system_score_gemma":0.0029560765,"threshold_uncertainty_score":0.9998564},"labels":[],"label_agreement":null},{"id":"W2268238083","doi":"10.1016/j.ygyno.2015.10.022","title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Medicine; Statement (logic); Serous fluid; Ovarian carcinoma; Carcinoma; Gynecology; Serous carcinoma; Oncology; General surgery; Internal medicine; Ovarian cancer; Cancer; Linguistics","score_opus":0.02116955579973446,"score_gpt":0.33138953222195067,"score_spread":0.3102199764222162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268238083","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02266099,0.0017145599,0.000037592174,0.06956898,0.866095,0.00576827,0.0010956208,0.00028341403,0.032775547],"genre_scores_gemma":[0.33560902,0.0051296116,0.009484694,0.012776988,0.61762995,0.0046148472,0.0037442732,0.0004386778,0.010571956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99271524,0.0013615291,0.0015796525,0.0017772273,0.0011885662,0.0013777798],"domain_scores_gemma":[0.9803857,0.016410885,0.0013003977,0.0010908309,0.00037033734,0.0004418014],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019371673,0.0009904793,0.0023795664,0.00060232315,0.00018470018,0.000053477357,0.00033117324,0.0020394288,0.00084346096],"category_scores_gemma":[0.0030202523,0.0007433978,0.00026175755,0.0003568965,0.00025859562,0.00008756258,0.0003118039,0.0019945414,0.00055965455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002616168,0.005533619,0.0048100813,0.00031469905,0.0007931081,0.020644069,0.0002290063,0.000050969593,0.00009010974,0.0003493866,0.94610524,0.01846355],"study_design_scores_gemma":[0.020008372,0.010541175,0.028042084,0.0005373029,0.001105524,0.000085184474,0.00015830885,0.0000030743051,0.000077225755,0.00023389109,0.9385373,0.0006705797],"about_ca_topic_score_codex":0.0013318713,"about_ca_topic_score_gemma":0.0013782638,"teacher_disagreement_score":0.31294802,"about_ca_system_score_codex":0.020196965,"about_ca_system_score_gemma":0.0053487453,"threshold_uncertainty_score":0.9995017},"labels":[],"label_agreement":null},{"id":"W2280596730","doi":"10.1016/j.ygyno.2016.02.020","title":"Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Ovarian cancer; Life expectancy; Cancer; Population; Randomized controlled trial; Oncology; Gynecology; Internal medicine; Environmental health","score_opus":0.053290030864508085,"score_gpt":0.38803444125866254,"score_spread":0.3347444103941545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280596730","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064890104,0.0025068123,0.0003597144,0.21330398,0.72591466,0.041943174,0.011155951,0.0001231305,0.004043678],"genre_scores_gemma":[0.005818558,0.01551481,0.0022594437,0.009331834,0.8892442,0.0734613,0.0016055459,0.00023648894,0.0025278423],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9916618,0.00234604,0.0021550604,0.0014979218,0.0012004324,0.0011387612],"domain_scores_gemma":[0.95000774,0.044838127,0.002616162,0.0010971832,0.0011057971,0.00033498838],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042010183,0.0011597546,0.005874549,0.00039591428,0.00047704516,0.000060058283,0.0007740195,0.002851826,0.004120252],"category_scores_gemma":[0.0063293893,0.000639819,0.0014051643,0.0005117639,0.0009384167,0.0000751114,0.000257316,0.0014451911,0.000015685955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48980314,0.001101233,0.00001390611,0.000067632835,0.0035797716,0.000045233923,0.00015603052,0.00000785553,0.000004592322,0.0005365353,0.48893678,0.01574729],"study_design_scores_gemma":[0.50435245,0.01467348,0.00001011797,0.00049561675,0.0031825667,8.180185e-7,0.00009472283,0.000014002692,0.000053829634,0.00044642642,0.47635132,0.00032462119],"about_ca_topic_score_codex":0.0037431868,"about_ca_topic_score_gemma":0.0041556624,"teacher_disagreement_score":0.20397215,"about_ca_system_score_codex":0.003155316,"about_ca_system_score_gemma":0.006487684,"threshold_uncertainty_score":0.9996053},"labels":[],"label_agreement":null},{"id":"W2300386653","doi":"10.1016/j.ygyno.2016.03.008","title":"PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":341,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; BC Cancer Agency; Health Canada; BC Cancer Foundation; U.S. Department of Defense","keywords":"Cancer research; FOXP3; Tissue microarray; Ovarian cancer; Medicine; CD8; Tumor-infiltrating lymphocytes; Granzyme B; Immune system; IL-2 receptor; Immune checkpoint; Immunohistochemistry; Cancer; Immunology; Immunotherapy; T cell; Internal medicine","score_opus":0.020426850567280583,"score_gpt":0.2798248234885831,"score_spread":0.2593979729213025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300386653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915027,0.0004014267,0.000021238193,0.0060925344,0.00027176956,0.0007410642,0.000034223336,0.00008252947,0.00085248967],"genre_scores_gemma":[0.9946339,0.0004101205,0.0011529472,0.0025076836,0.000064545726,0.00029527943,0.000007085564,0.000023164175,0.0009052607],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982995,0.00020145481,0.0003730382,0.000457436,0.00016253808,0.0005060517],"domain_scores_gemma":[0.9987761,0.00060377544,0.0002731453,0.00016735539,0.00007181761,0.000107818],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046679453,0.00022058835,0.00056697364,0.00011772026,0.000111385634,0.000015257452,0.000098295044,0.00029679562,0.0009407246],"category_scores_gemma":[0.00014815156,0.000127684,0.000058293932,0.00028959117,0.0002100799,0.0001009502,0.000048269223,0.00021828916,0.0000078360845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024888576,0.0008371643,0.44057116,0.000059927006,0.00025634145,0.0006007962,0.0006868109,0.000003869581,0.5095878,0.000025021003,0.004459339,0.0404229],"study_design_scores_gemma":[0.023907054,0.00814109,0.79077584,0.00094921765,0.00021234961,0.00016162808,0.00061642495,0.000046934732,0.16296157,0.0002944551,0.01137495,0.0005584571],"about_ca_topic_score_codex":0.0007275551,"about_ca_topic_score_gemma":0.0017688917,"teacher_disagreement_score":0.3502047,"about_ca_system_score_codex":0.00075594377,"about_ca_system_score_gemma":0.00041878398,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W2300491315","doi":"10.1016/j.ygyno.2016.03.013","title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":131,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; Jewish General Hospital; McGill University","funders":"National Cancer Institute; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; SMARCA4; Small-cell carcinoma; Oncology; Chemotherapy; Internal medicine; Germline mutation; Stage (stratigraphy); Germline; Mutation; Biology; Genetics","score_opus":0.03529970001023382,"score_gpt":0.3109381546692534,"score_spread":0.2756384546590196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300491315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987469,0.00030607186,0.000003912004,0.00018484818,0.00027658176,0.00017625463,0.0000064799715,0.000002173897,0.00029679495],"genre_scores_gemma":[0.99926096,0.0003128025,0.00010225107,0.00021170886,0.00002133678,0.000008617413,8.542431e-7,0.000006219062,0.00007524065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988179,0.00023684805,0.00050327595,0.00021958305,0.000057132704,0.00016521475],"domain_scores_gemma":[0.99890167,0.00045021903,0.00022904786,0.0003197362,0.00006648036,0.00003282804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023607908,0.000097639655,0.00022834998,0.000015613497,0.000037964714,0.000001593096,0.00022624747,0.0002288221,0.0000066686644],"category_scores_gemma":[0.00070102065,0.000043642372,0.00007253378,0.000053234704,0.00034912772,9.1810165e-7,0.00016444288,0.00010176409,0.0000015143646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112103044,0.000096754826,0.90787077,0.000009585522,0.000008030378,0.0000015898254,0.00003759274,0.00024384155,0.07789447,0.000015946842,0.000059871392,0.013649453],"study_design_scores_gemma":[0.00069884554,0.0020507986,0.9752095,0.000008096559,0.000011204365,0.0000034675118,0.000054567194,0.00001941455,0.019952329,0.0001237355,0.0017997901,0.0000682815],"about_ca_topic_score_codex":0.000043247397,"about_ca_topic_score_gemma":0.00018336471,"teacher_disagreement_score":0.06733871,"about_ca_system_score_codex":0.000025046415,"about_ca_system_score_gemma":0.00016819926,"threshold_uncertainty_score":0.17796844},"labels":[],"label_agreement":null},{"id":"W2302440761","doi":"10.1016/j.ygyno.2016.03.001","title":"Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Brief Pain Inventory; Hospital Anxiety and Depression Scale; Montreal Cognitive Assessment; Anxiety; Cognition; Depression (economics); Physical therapy; Internal medicine; Psychiatry; Chronic pain; Cognitive impairment","score_opus":0.024907289081497343,"score_gpt":0.2760711593891245,"score_spread":0.25116387030762716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302440761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214506,0.00031378635,0.000037558137,0.0015078215,0.000109113775,0.0014612926,0.000058632762,0.00015764213,0.004209074],"genre_scores_gemma":[0.9964857,0.00054769486,0.000055213884,0.0010478516,0.000023099017,0.00069086393,0.000006834664,0.00002853168,0.0011141765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749905,0.00027906036,0.00036743493,0.000683817,0.00024793213,0.000922692],"domain_scores_gemma":[0.99456006,0.004479339,0.00030184776,0.00014895489,0.00032315077,0.00018662162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004832298,0.00038707125,0.000875953,0.00023757033,0.00014708849,0.000010864455,0.000096959,0.00035386867,0.00070540776],"category_scores_gemma":[0.0032373292,0.0002018845,0.000033651955,0.0004266101,0.0010645075,0.00014189538,0.00012644843,0.0003210584,0.000025231018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019772104,0.00068194256,0.9855267,0.000060237646,0.0003734507,0.0004324345,0.0009874852,0.0000014956616,0.0003995664,0.000034737528,0.000104664294,0.009420089],"study_design_scores_gemma":[0.010033084,0.021134488,0.9635977,0.00058702583,0.00026768257,0.000060559603,0.0033526917,0.000002605874,0.00021118333,0.00017729799,0.000244397,0.00033126934],"about_ca_topic_score_codex":0.000015963817,"about_ca_topic_score_gemma":0.00070335873,"teacher_disagreement_score":0.021928972,"about_ca_system_score_codex":0.0018676588,"about_ca_system_score_gemma":0.00046246714,"threshold_uncertainty_score":0.8232611},"labels":[],"label_agreement":null},{"id":"W2307952750","doi":"10.1016/j.ygyno.2016.02.028","title":"New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Lymphovascular invasion; Stage (stratigraphy); Adenocarcinoma; Lymph node; Stroma; Pathology; Stromal cell; Not Otherwise Specified; Risk stratification; Radiology; Metastasis; Internal medicine; Immunohistochemistry; Cancer; Biology","score_opus":0.0733848854985859,"score_gpt":0.3815207201383154,"score_spread":0.3081358346397295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307952750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9395498,0.000955097,0.02305338,0.03072487,0.00049745827,0.0032647387,0.000313285,0.00027173216,0.0013696091],"genre_scores_gemma":[0.9931516,0.00013072114,0.004931165,0.0005227693,0.00034509512,0.00050350867,0.000063365354,0.00002166978,0.00033007233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976725,0.00025415813,0.0008749629,0.00063760567,0.00016925854,0.000391521],"domain_scores_gemma":[0.9946364,0.003978496,0.00041972764,0.00033986097,0.00015337083,0.00047213255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006104563,0.000230036,0.00083947426,0.00009036499,0.00013153015,0.000013901871,0.00011816526,0.00033702498,0.00044799913],"category_scores_gemma":[0.0005083574,0.000119014025,0.00020253967,0.00017825836,0.00021538124,0.000040306422,0.000029546467,0.0001815607,0.000026988277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018900924,0.00034564544,0.8408921,0.000058604517,0.00014957516,0.00008700097,0.000010727033,1.8752809e-7,0.00006418996,0.0019072761,0.00019308373,0.15440153],"study_design_scores_gemma":[0.03183371,0.009417778,0.9459665,0.000030300293,0.0007789048,0.0002509815,0.000069968584,0.000054922846,0.000093816445,0.0004771682,0.010834818,0.00019114505],"about_ca_topic_score_codex":0.000085597894,"about_ca_topic_score_gemma":0.00015431804,"teacher_disagreement_score":0.15421037,"about_ca_system_score_codex":0.0004526572,"about_ca_system_score_gemma":0.00060587836,"threshold_uncertainty_score":0.49052763},"labels":[],"label_agreement":null},{"id":"W2318970924","doi":"10.1016/j.ygyno.2015.01.257","title":"Access to high quality food and survival from ovarian cancer: An analysis of Cook County, Illinois","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ovarian cancer; Environmental health; Overall survival; Consumption (sociology); Gerontology; Survival analysis; Demography; Cancer; Oncology; Internal medicine","score_opus":0.11633630079080964,"score_gpt":0.4119605093691766,"score_spread":0.29562420857836696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318970924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806053,0.00044859314,0.00011358226,0.007466449,0.0006860957,0.0005575935,0.0008590146,0.000045372217,0.0017627921],"genre_scores_gemma":[0.99509907,0.00027893062,0.0014032761,0.0025393178,0.00017045016,0.0002038135,0.00024186118,0.000013519045,0.00004978098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979661,0.00033719972,0.0005147495,0.0005898724,0.00027779784,0.00031424194],"domain_scores_gemma":[0.99771476,0.00071372476,0.00026913267,0.00047537655,0.00033425976,0.0004927385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006799856,0.00020986355,0.0013175722,0.00023091928,0.000053755804,0.000025768182,0.00020150456,0.00027446734,0.00093414873],"category_scores_gemma":[0.00029301603,0.00016772245,0.00010775228,0.0005981918,0.00013504576,0.00010194737,0.00016068816,0.00013067551,0.0000078858475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005863017,0.001368494,0.9687122,0.000016477463,0.0028278115,0.000062403655,0.0005650202,0.0004024119,0.00009827238,0.0017306089,0.0012124231,0.022417558],"study_design_scores_gemma":[0.0040372624,0.004945035,0.9770194,0.000008766507,0.0030693852,0.0000017132578,0.00040871557,0.00009955814,0.00034287677,0.00076210307,0.009133891,0.00017123563],"about_ca_topic_score_codex":0.022971984,"about_ca_topic_score_gemma":0.05473546,"teacher_disagreement_score":0.031763475,"about_ca_system_score_codex":0.0008611511,"about_ca_system_score_gemma":0.0006844392,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W2320681944","doi":"10.1016/j.ygyno.2013.04.377","title":"Nonascites-forming advanced-stage serous ovarian cancer is related to a superior epithelial antigen presentation and enhanced infiltrating T-cell response","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics; University Health Network; University of Toronto; Toronto General Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Ascites; Serous fluid; Medicine; Ovarian cancer; Antigen; Ovary; Stage (stratigraphy); Cancer antigen; Cancer research; Cancer; Serous ovarian cancer; Differential diagnosis; Pathology; Immunology; Oncology; Internal medicine; Biology","score_opus":0.015505561126462597,"score_gpt":0.32162907924634443,"score_spread":0.3061235181198818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320681944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859173,0.00037643337,0.0000709615,0.007846847,0.00046843756,0.00229955,0.000050007795,0.00009840039,0.0028720591],"genre_scores_gemma":[0.9845284,0.00044301225,0.006671378,0.0037040436,0.000079689824,0.0013806247,0.000020510057,0.00003374193,0.0031385648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99789083,0.00021482771,0.00051749626,0.00063691917,0.00018516483,0.0005547428],"domain_scores_gemma":[0.9982491,0.00076823734,0.00020407254,0.0002992095,0.0001802478,0.000299093],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037761367,0.0002827464,0.00058767153,0.00017274551,0.00021162623,0.00004508325,0.00010277412,0.00029711085,0.0031578718],"category_scores_gemma":[0.00036655276,0.00023591291,0.0000827374,0.00032787953,0.00009676051,0.00022761809,0.00009949752,0.00024946273,0.00020263347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022345933,0.000926667,0.16878352,0.00013132655,0.00028836838,0.0003389729,0.0082442155,0.0003786115,0.59288675,0.000082986764,0.0012199713,0.224484],"study_design_scores_gemma":[0.009053193,0.0068968316,0.88339674,0.00010481096,0.0001678002,0.00006181312,0.0019635982,0.00044910755,0.0804513,0.00014403107,0.01688,0.00043076003],"about_ca_topic_score_codex":0.00095123926,"about_ca_topic_score_gemma":0.00031122167,"teacher_disagreement_score":0.71461326,"about_ca_system_score_codex":0.00065012154,"about_ca_system_score_gemma":0.0005075542,"threshold_uncertainty_score":0.9977534},"labels":[],"label_agreement":null},{"id":"W2321340319","doi":"10.1016/j.ygyno.2011.12.206","title":"Lynch syndrome screening criteria: A new approach to identifying patients at risk via clinical history and pathology (CHiP) criteria","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lynch syndrome; Medicine; Endometrial cancer; Colorectal cancer; Gynecologic oncology; Family history; Internal medicine; Oncology; Clinical Practice; DNA mismatch repair; Bioinformatics; Cancer; Family medicine","score_opus":0.10430724259560127,"score_gpt":0.37709151888076875,"score_spread":0.2727842762851675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321340319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801105,0.0014432318,0.0026424567,0.00032020482,0.0059986543,0.0012142529,0.00001667287,0.00012925298,0.008124758],"genre_scores_gemma":[0.93787706,0.00014669563,0.056384884,0.0034891423,0.0005085842,0.00017074257,0.000054182892,0.00005547241,0.001313224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995759,0.0010193074,0.0009438716,0.00094010576,0.00028498212,0.0010526967],"domain_scores_gemma":[0.9969179,0.0010066038,0.00038832446,0.00056349795,0.0001403976,0.0009832478],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001826018,0.00039940904,0.001218508,0.00025468468,0.00018495476,0.0000132599625,0.00026509885,0.00090416556,0.0036549552],"category_scores_gemma":[0.002652011,0.0003635471,0.00018037962,0.00018164208,0.00032772325,0.00012598396,0.00079964934,0.00073006295,0.0003172658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000876764,0.001242691,0.8750274,0.000098425066,0.0001529958,0.000149832,0.0017149136,0.000001998335,0.0017639723,0.000020492384,0.057719763,0.06123073],"study_design_scores_gemma":[0.0032448638,0.0045448206,0.9036884,0.000018806968,0.00033829478,0.0011104335,0.00010388905,0.0001030519,0.000038871032,0.000101461075,0.08635915,0.0003479965],"about_ca_topic_score_codex":0.00010589509,"about_ca_topic_score_gemma":0.00007822094,"teacher_disagreement_score":0.060882736,"about_ca_system_score_codex":0.00183546,"about_ca_system_score_gemma":0.00028058502,"threshold_uncertainty_score":0.9998816},"labels":[],"label_agreement":null},{"id":"W2325694816","doi":"10.1016/j.ygyno.2014.03.353","title":"Variations in practice for the management of high-risk histologic subtypes in endometrial cancer: A CHREC (Consortium of High Risk Endometrial Cancer) Canadian project","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; Health Sciences Centre; Université de Montréal; Hôpital Notre-Dame; McGill University; Jewish General Hospital; Sunnybrook Health Science Centre; University of Manitoba; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Gynecology; Randomized controlled trial; Oncology; Cancer; Cohort; Cohort study; Internal medicine; Obstetrics","score_opus":0.03307559246323623,"score_gpt":0.33877427317180436,"score_spread":0.30569868070856815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325694816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727843,0.004196474,0.00039451814,0.0051784622,0.004771349,0.0075505143,0.0009615759,0.00004426145,0.004118537],"genre_scores_gemma":[0.9810699,0.010754653,0.004278543,0.00034103947,0.00037559948,0.0029765433,0.00004779634,0.000022085216,0.0001338202],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963387,0.00092753867,0.0011382891,0.00058369385,0.00031732034,0.00069443346],"domain_scores_gemma":[0.9847234,0.013211594,0.0012009003,0.00042848717,0.00028417396,0.00015142704],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025523994,0.00029189326,0.0013862202,0.0013831799,0.00014100315,0.000008853361,0.0003617594,0.0004036394,0.00044526407],"category_scores_gemma":[0.01036413,0.00020135076,0.00021109465,0.002749051,0.00022905318,0.00008488183,0.0000936033,0.00048639142,0.000005645689],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018575875,0.0034061812,0.4340047,0.00038964106,0.0029737677,0.00014419934,0.0005887028,0.0018204444,0.000058369995,0.012936351,0.0007867105,0.52431506],"study_design_scores_gemma":[0.081180856,0.015806718,0.8171248,0.00011872565,0.005307851,0.000018382372,0.0008195334,0.00045615245,0.00041025493,0.0040538814,0.074256524,0.0004463216],"about_ca_topic_score_codex":0.7544401,"about_ca_topic_score_gemma":0.6374187,"teacher_disagreement_score":0.52386874,"about_ca_system_score_codex":0.0028638681,"about_ca_system_score_gemma":0.0017135086,"threshold_uncertainty_score":0.997972},"labels":[],"label_agreement":null},{"id":"W2337474020","doi":"10.1016/j.ygyno.2016.04.011","title":"Talc and ovarian cancer","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Talc; Medicine; Ovarian cancer; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.019896362551018582,"score_gpt":0.3548538928951624,"score_spread":0.33495753034414383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337474020","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011117841,0.0038789758,0.000011494119,0.0060232845,0.9534872,0.0007639905,0.00018911283,0.00012034821,0.024407715],"genre_scores_gemma":[0.015704291,0.0039643114,0.00026682866,0.00086340867,0.96436256,0.0003811652,0.00017483413,0.000037012895,0.0142455865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974962,0.00030990152,0.000401441,0.0011076436,0.00018642783,0.0004983747],"domain_scores_gemma":[0.99646145,0.0021568132,0.00027809152,0.0005732339,0.0003446081,0.00018581163],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086103124,0.00034943986,0.0011645065,0.000109223,0.00012108899,0.00000664963,0.00017441194,0.005144287,0.0020624714],"category_scores_gemma":[0.0064539188,0.00021912034,0.00012264657,0.00007883376,0.00081617053,0.000040449424,0.00021452118,0.0015709791,0.00014798454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020936127,0.00019163919,0.005083854,0.00009152666,0.00025038666,0.00018231769,0.000027943115,1.5685101e-8,0.00038570922,0.0000718802,0.9425602,0.049060915],"study_design_scores_gemma":[0.0017446253,0.001963339,0.09270374,0.00003791089,0.00026762133,0.000028960028,0.000011644049,3.7291883e-7,0.000059702652,0.0012386341,0.90173036,0.0002130655],"about_ca_topic_score_codex":0.000059546805,"about_ca_topic_score_gemma":0.00010834157,"teacher_disagreement_score":0.087619886,"about_ca_system_score_codex":0.00065210427,"about_ca_system_score_gemma":0.001553945,"threshold_uncertainty_score":0.99884975},"labels":[],"label_agreement":null},{"id":"W2338472420","doi":"10.1016/j.ygyno.2016.04.008","title":"Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; University of Calgary","funders":"Calgary Laboratory Services","keywords":"Medicine; Tissue microarray; Hazard ratio; Endometrial cancer; Progesterone receptor; Oncology; Immunohistochemistry; Internal medicine; Estrogen receptor; Carcinoma; Gynecology; Stage (stratigraphy); Serous fluid; Cancer; Breast cancer; Confidence interval; Biology","score_opus":0.035444980224547014,"score_gpt":0.29599744765719815,"score_spread":0.26055246743265115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338472420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895467,0.00051027274,0.000009100289,0.0013839196,0.0037198176,0.0030991177,0.0011865249,0.000090319714,0.00045418277],"genre_scores_gemma":[0.9963828,0.0002003049,0.0004248411,0.00031350736,0.0005955411,0.00069386925,0.00010048674,0.000058837144,0.0012298153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99503475,0.0011998151,0.0010765843,0.00096181827,0.000774487,0.00095254416],"domain_scores_gemma":[0.9932033,0.003984506,0.0011100529,0.00052569865,0.00047615325,0.0007003292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011792232,0.00052907696,0.0020811798,0.0009441205,0.00020483733,0.000016358097,0.0003125618,0.00063252007,0.0068937577],"category_scores_gemma":[0.0048902524,0.00030385613,0.00020886681,0.0012967347,0.0003868312,0.00013105801,0.000111521695,0.00047758772,0.000050642575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01525559,0.0045770556,0.95892507,0.00003772933,0.0016934838,0.0004901609,0.00073043484,0.0000053211875,0.006224153,0.000051236715,0.0019741864,0.010035576],"study_design_scores_gemma":[0.13806729,0.047003407,0.7922262,0.00015013896,0.0020137855,0.000017772223,0.00032591852,0.0000018080178,0.015248592,0.00016751446,0.0041451436,0.00063243357],"about_ca_topic_score_codex":0.17284937,"about_ca_topic_score_gemma":0.16992512,"teacher_disagreement_score":0.16669887,"about_ca_system_score_codex":0.004210623,"about_ca_system_score_gemma":0.0021523717,"threshold_uncertainty_score":0.99994135},"labels":[],"label_agreement":null},{"id":"W2342043466","doi":"10.1016/j.ygyno.2016.04.005","title":"Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment","year":2016,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Niilo Helanderin Säätiö; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Cancer Research Society; Cancer Research Institute","keywords":"Medicine; Germline mutation; Germline; Pathology; Anatomical pathology; Bioinformatics; Mutation; Biology; Immunohistochemistry; Genetics; Gene","score_opus":0.030051304212236563,"score_gpt":0.3328865882124713,"score_spread":0.30283528400023474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342043466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039071413,0.99082905,0.00017723547,0.00009538097,0.0010745164,0.0008923589,0.0003212823,0.000036879952,0.0026661446],"genre_scores_gemma":[0.00035240562,0.99423224,0.0014795917,0.00021964156,0.0009978905,0.00041668635,0.00034953962,0.00007077553,0.0018812248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972783,0.00038719483,0.000635538,0.0010251158,0.000088386456,0.0005855042],"domain_scores_gemma":[0.99844337,0.00020702825,0.00043390578,0.0006644228,0.000070638576,0.00018064491],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002736886,0.00064749416,0.0016385103,0.000098763354,0.00015095435,0.000022773342,0.00034763128,0.0018577628,0.00016379113],"category_scores_gemma":[0.00013231592,0.00042630892,0.0004118366,0.00007808954,0.0003106105,0.0000021965518,0.0003203152,0.00021488921,0.0001299436],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023800585,0.00011199112,0.00001849351,0.00040062625,0.00020358605,0.00011675243,0.000023251447,0.0000020584855,0.0003343085,0.000013420181,0.0012569414,0.99749476],"study_design_scores_gemma":[0.0011625149,0.0029951634,0.000021175954,0.00034678265,0.00045150847,0.00061195355,0.000016124979,0.0000073803812,0.000084326275,0.000068808135,0.9937334,0.0005008446],"about_ca_topic_score_codex":0.000008832687,"about_ca_topic_score_gemma":0.0001105926,"teacher_disagreement_score":0.9969939,"about_ca_system_score_codex":0.00033261953,"about_ca_system_score_gemma":0.001148517,"threshold_uncertainty_score":0.99981886},"labels":[],"label_agreement":null},{"id":"W2342880723","doi":"10.1016/j.ygyno.2016.04.019","title":"A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; McGill University","funders":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Pfizer","keywords":"Medicine; Endometrial cancer; Gynecology; Cancer; Oncology; Internal medicine; Randomized controlled trial","score_opus":0.044225880928494304,"score_gpt":0.3739744415337582,"score_spread":0.3297485606052639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342880723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245304,0.00043810657,0.000012009762,0.00041537057,0.0005719157,0.0048049935,0.00006849923,0.000023288616,0.001212804],"genre_scores_gemma":[0.99817973,0.0002636878,0.00014418307,0.00012905631,0.00010599523,0.0010052158,0.0000178781,0.000013815508,0.00014043652],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972448,0.0005995955,0.0008086729,0.0005606282,0.0003577068,0.00042862495],"domain_scores_gemma":[0.99583477,0.0029978459,0.00047004744,0.00025022557,0.00024453877,0.00020260371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068146986,0.00031045696,0.0023566303,0.00050401984,0.000078169076,0.0000051873817,0.00012906002,0.00018944389,0.0008587887],"category_scores_gemma":[0.0012050751,0.00015352228,0.00011108728,0.00076717086,0.00031684322,0.00009124811,0.00014539565,0.00021354434,0.000008630347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61699843,0.026457079,0.20649455,0.000043089916,0.0009974377,0.00008697739,0.0019315266,0.000002087929,0.00012151362,0.000032878426,0.00018938901,0.14664504],"study_design_scores_gemma":[0.8170725,0.06609524,0.11473737,0.00008225579,0.0005898339,0.0000026893451,0.00032946645,0.000006977017,0.0002503959,0.00008268603,0.00057447655,0.00017607541],"about_ca_topic_score_codex":0.00036989016,"about_ca_topic_score_gemma":0.0009956612,"teacher_disagreement_score":0.2000741,"about_ca_system_score_codex":0.0005658125,"about_ca_system_score_gemma":0.00028228582,"threshold_uncertainty_score":0.94031346},"labels":[],"label_agreement":null},{"id":"W2410360575","doi":"10.1016/j.ygyno.2016.06.006","title":"Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Environmental Health Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Endometrial cancer; Confounding; Body mass index; Medicine; Oncology; Gene; Genome-wide association study; Internal medicine; Obesity; Cancer; Biology; Genetics; Single-nucleotide polymorphism; Genotype","score_opus":0.030890592096839933,"score_gpt":0.3138863502185486,"score_spread":0.2829957581217087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410360575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931242,0.000599865,0.00021646332,0.002588653,0.0011749716,0.001145897,0.00033555663,0.00006682525,0.00074760814],"genre_scores_gemma":[0.99411845,0.0015904803,0.00017637754,0.00031794995,0.0022497785,0.00047460158,0.0000809494,0.000020744988,0.0009706788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977646,0.0003893079,0.00041725292,0.0005527494,0.0003713266,0.00050475076],"domain_scores_gemma":[0.99527645,0.003816269,0.0003926148,0.00024976363,0.00010033365,0.0001645418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035946516,0.0002463015,0.00074137416,0.00013887932,0.00018127765,0.000023550287,0.00019585069,0.00048735025,0.0017760645],"category_scores_gemma":[0.0012855968,0.000118629105,0.00013237083,0.00034874096,0.00015371412,0.00008534702,0.00015665927,0.0002727637,0.000022567561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000856307,0.00008530461,0.91028297,0.00000685991,0.000605038,0.000025368403,0.00007284559,7.1866293e-7,0.06231795,0.000002990282,0.00078393467,0.024959713],"study_design_scores_gemma":[0.014238091,0.0014630678,0.96721447,0.00003021222,0.0006566748,0.0000013489642,0.000049458493,0.0000039413453,0.005164521,0.00027931103,0.010736143,0.00016276147],"about_ca_topic_score_codex":0.0033265937,"about_ca_topic_score_gemma":0.0008899838,"teacher_disagreement_score":0.05715343,"about_ca_system_score_codex":0.003088467,"about_ca_system_score_gemma":0.0004415971,"threshold_uncertainty_score":0.99913645},"labels":[],"label_agreement":null},{"id":"W2413374244","doi":"10.1016/j.ygyno.2016.05.002","title":"Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Radiology; Abdomen; Pelvis; Metastasis; Lymph node; Nuclear medicine; Cancer; Pathology; Internal medicine","score_opus":0.06236968779380056,"score_gpt":0.3880051433631074,"score_spread":0.32563545556930684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413374244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98392195,0.00032554212,0.0000162939,0.0054495838,0.0010082019,0.001440316,0.00036969388,0.000038344893,0.0074300664],"genre_scores_gemma":[0.9964213,0.00046481154,0.00170932,0.00049558113,0.0001429532,0.00032957687,0.000018537383,0.000018897084,0.00039902472],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99630666,0.00060121925,0.0013214,0.0006933871,0.00047565892,0.0006016507],"domain_scores_gemma":[0.9966671,0.0017607247,0.00042302624,0.0005584867,0.00029870492,0.00029200004],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001167503,0.00028292445,0.0016737842,0.0002971081,0.00003613406,0.0000025051875,0.00028688816,0.00011903688,0.0021906765],"category_scores_gemma":[0.004514072,0.00016982046,0.00026801016,0.000860268,0.0002489705,0.0000669368,0.00021327725,0.0001761866,0.000042686148],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35315442,0.004114672,0.08142473,0.00020139509,0.00043152642,0.00072882825,0.00013544432,0.000032921824,0.011564694,0.00010867542,0.00047358376,0.5476291],"study_design_scores_gemma":[0.33613136,0.01867773,0.6051156,0.0002014431,0.0005798793,0.000066503875,0.00020720155,0.000036686226,0.026767533,0.00058052473,0.011289525,0.00034605744],"about_ca_topic_score_codex":0.0013999569,"about_ca_topic_score_gemma":0.0014616707,"teacher_disagreement_score":0.54728305,"about_ca_system_score_codex":0.00085784134,"about_ca_system_score_gemma":0.0008659417,"threshold_uncertainty_score":0.9987215},"labels":[],"label_agreement":null},{"id":"W2461049658","doi":"10.1016/j.ygyno.2016.07.090","title":"Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":220,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of Calgary; McGill University; McGill University Health Centre; Vancouver General Hospital; University Health Network; University of British Columbia; Calgary Laboratory Services; BC Cancer Agency","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Hysterectomy; Gynecology; Carcinoma; Oncology; General surgery; Radiology; Internal medicine","score_opus":0.04177927707509767,"score_gpt":0.31296393014769835,"score_spread":0.2711846530726007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461049658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827003,0.00006892529,0.0004294226,0.0046875263,0.0003831293,0.0022114913,0.00009097526,0.00005025959,0.009378005],"genre_scores_gemma":[0.99647564,0.00006181754,0.0010551809,0.0011964773,0.00012964403,0.0006256394,0.000045769808,0.0000149314355,0.0003949057],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998151,0.00014904581,0.00061342516,0.0003576781,0.00034003708,0.00038881946],"domain_scores_gemma":[0.9956047,0.0032190077,0.00031968433,0.00035406524,0.00025952177,0.00024304078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018242125,0.000268661,0.0007199226,0.00042674318,0.0000503496,0.0000099190665,0.000115197196,0.00017847605,0.00055991067],"category_scores_gemma":[0.002443841,0.0001414246,0.0001267865,0.00055871095,0.00011619412,0.000091906746,0.000039221446,0.00008271709,0.00040841696],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014065448,0.0037525115,0.39392832,0.00011065643,0.00081403117,0.00073563535,0.0006654996,0.000022245786,0.027830243,0.0019968683,0.0019616114,0.5541169],"study_design_scores_gemma":[0.03193415,0.09306306,0.77230215,0.0001225264,0.0006258164,0.000062571606,0.00012419489,0.000010752956,0.041939303,0.00011685762,0.059430007,0.00026858435],"about_ca_topic_score_codex":0.00011707428,"about_ca_topic_score_gemma":0.000048920847,"teacher_disagreement_score":0.5538483,"about_ca_system_score_codex":0.0018209043,"about_ca_system_score_gemma":0.0005375042,"threshold_uncertainty_score":0.6130629},"labels":[],"label_agreement":null},{"id":"W2468546439","doi":"10.1016/j.ygyno.2016.06.014","title":"A model for ovarian cancer progression based on inherent resistance","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Resistance (ecology); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.11630788874398415,"score_gpt":0.40618232406980354,"score_spread":0.28987443532581936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468546439","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20334384,0.00018316483,0.59058,0.08798727,0.0019537096,0.010187556,0.0004987711,0.0014297739,0.10383597],"genre_scores_gemma":[0.8407468,0.000012354508,0.14763643,0.0017541423,0.00011635459,0.0037693612,0.0000052837154,0.000042911233,0.0059163147],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9979664,0.00023417248,0.0004922222,0.000538882,0.00017260824,0.00059571053],"domain_scores_gemma":[0.9929876,0.005947757,0.00033256123,0.00046597264,0.00013237407,0.0001337885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089089153,0.00026399057,0.000580679,0.000090963826,0.0001406051,0.000008194961,0.0003560282,0.0004258175,0.0007904593],"category_scores_gemma":[0.0038793741,0.00014385366,0.00013677166,0.00010254536,0.00022659755,0.0000399146,0.000078326644,0.00015667592,0.000056701243],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017776786,0.0027979983,0.0014836031,0.0005253822,0.00009272443,0.000056899826,0.00023844435,0.000051187373,0.005135832,0.85204464,0.08131382,0.054481797],"study_design_scores_gemma":[0.004326398,0.0017846957,0.0005056921,0.00023680255,0.00008426364,0.0000031612044,0.000017561977,0.03137197,0.0014710379,0.94245803,0.017331162,0.00040924648],"about_ca_topic_score_codex":7.5446354e-7,"about_ca_topic_score_gemma":0.00021289081,"teacher_disagreement_score":0.637403,"about_ca_system_score_codex":0.0005794287,"about_ca_system_score_gemma":0.00034716705,"threshold_uncertainty_score":0.8654975},"labels":[],"label_agreement":null},{"id":"W2472320304","doi":"10.1016/j.ygyno.2016.08.337","title":"Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Sentinel lymph node; Cervical cancer; Biopsy; Lymphadenectomy; Sentinel node; Radiology; Lymph node; General surgery; Cancer; Internal medicine; Breast cancer","score_opus":0.034230704648923964,"score_gpt":0.3328582251664839,"score_spread":0.2986275205175599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472320304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95195985,0.0005520196,0.00016699018,0.036117617,0.0012941717,0.00092875655,0.00012011267,0.00022864439,0.00863184],"genre_scores_gemma":[0.98493123,0.00027015078,0.0013778254,0.004586552,0.00078630855,0.0011035403,0.000032039625,0.00004514225,0.006867218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743015,0.00014089575,0.0005266992,0.00077600277,0.0002581482,0.00086812093],"domain_scores_gemma":[0.996987,0.00168795,0.00023802216,0.0004343547,0.0002330361,0.00041962336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000312286,0.00033429978,0.00091269816,0.00019258671,0.00015386677,0.0000146245175,0.00023896797,0.00049164,0.0019823932],"category_scores_gemma":[0.0009156832,0.0002001971,0.00029978447,0.00044379037,0.00020159145,0.000060813698,0.00012227989,0.00010947393,0.00019276282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026627318,0.0009028176,0.90025514,0.0001215938,0.00040289495,0.00032280065,0.000071416536,0.000001301522,0.0065516615,0.0005522044,0.0015787268,0.0865767],"study_design_scores_gemma":[0.030457957,0.001418879,0.93446875,0.000069030444,0.00051967846,0.00021725173,0.000055756278,0.000018339655,0.0016876273,0.0016228436,0.029106984,0.00035691317],"about_ca_topic_score_codex":0.00060874294,"about_ca_topic_score_gemma":0.00016609994,"teacher_disagreement_score":0.08621979,"about_ca_system_score_codex":0.0019686783,"about_ca_system_score_gemma":0.0008148853,"threshold_uncertainty_score":0.9989299},"labels":[],"label_agreement":null},{"id":"W2476437009","doi":"10.1016/j.ygyno.2016.04.144","title":"Examining selection for resistant clones in high-grade serous ovarian cancer after neoadjuvant chemotherapy","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nonsynonymous substitution; Exome sequencing; Medicine; Ovarian cancer; Exome; COLD-PCR; Serous fluid; Oncology; Chemotherapy; Somatic cell; Cancer; Internal medicine; Mutation; Cancer research; Genetics; Biology; Point mutation; Genome; Gene","score_opus":0.03604255268885277,"score_gpt":0.32108556795464277,"score_spread":0.28504301526579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2476437009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96573627,0.0006537477,0.00028210695,0.030679254,0.000805369,0.0012936336,0.000039710776,0.000085223495,0.00042469963],"genre_scores_gemma":[0.98686534,0.0010035234,0.004776314,0.0027707953,0.00037380503,0.003235596,0.000010126327,0.00003443881,0.0009300892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830717,0.00010609868,0.00039476718,0.0005503611,0.00011488235,0.0005266973],"domain_scores_gemma":[0.99875313,0.00067932304,0.00015726415,0.00020891783,0.00008722724,0.00011414226],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003266055,0.00022829304,0.00061689725,0.00015597184,0.000067185,0.000009881006,0.000075220516,0.00032881484,0.0011121767],"category_scores_gemma":[0.00012496888,0.00014384266,0.00008272163,0.0002034706,0.0000799807,0.00006338702,0.000025383162,0.000120148296,0.000021975902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036020211,0.0015073803,0.6023473,0.00006750655,0.00026808467,0.0002786758,0.00030767402,0.000011711942,0.01057541,0.00081208284,0.00284547,0.37737668],"study_design_scores_gemma":[0.014603501,0.0056370837,0.90969014,0.000119276956,0.00014044807,0.000033438602,0.0000709038,0.000022785604,0.002851108,0.0009581153,0.06567005,0.00020315997],"about_ca_topic_score_codex":0.00056948967,"about_ca_topic_score_gemma":0.0055577783,"teacher_disagreement_score":0.3771735,"about_ca_system_score_codex":0.0019051731,"about_ca_system_score_gemma":0.00042476156,"threshold_uncertainty_score":0.9998009},"labels":[],"label_agreement":null},{"id":"W2477906999","doi":"10.1016/j.ygyno.2016.07.113","title":"Feasibility and safety of same-day discharge after minimally invasive hysterectomy in gynecologic oncology: A systematic review of the literature","year":2016,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Hysterectomy; Laparoscopy; Cochrane Library; MEDLINE; Complication; Systematic review; General surgery; Emergency department; Clinical trial; Surgery; Randomized controlled trial; Internal medicine","score_opus":0.03336260393571374,"score_gpt":0.3465402985180757,"score_spread":0.313177694582362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2477906999","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043096268,0.9790758,4.8127214e-7,0.0008416064,0.0005361235,0.013097879,0.0004720629,0.000028064112,0.0016383736],"genre_scores_gemma":[0.005076523,0.99026555,0.00026459756,0.0009648725,0.00005702748,0.0025455453,0.00009122239,0.000048687984,0.0006859534],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9906305,0.0041887467,0.0031913666,0.0010215329,0.00032222542,0.0006456365],"domain_scores_gemma":[0.9885605,0.006621488,0.002947203,0.0013570621,0.00032244294,0.00019130149],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025070866,0.00089399336,0.010116078,0.00031998107,0.000059424467,0.000009848997,0.0005873593,0.0014919367,0.0005488553],"category_scores_gemma":[0.006784012,0.00040687984,0.0011659069,0.00074787054,0.0006165467,0.000087586566,0.0007507427,0.0008634978,0.000039469596],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001825347,0.0013291176,0.004661913,0.942171,0.00080409547,0.00052409095,0.00024084027,5.57335e-9,0.0000035765406,0.00006212843,0.00015333937,0.049867366],"study_design_scores_gemma":[0.003556693,0.0043408824,0.011856203,0.8499057,0.0062589245,0.00083726656,0.000054693002,1.721701e-7,0.000003123364,0.00014294432,0.12259326,0.00045013113],"about_ca_topic_score_codex":0.00000959359,"about_ca_topic_score_gemma":0.00027117395,"teacher_disagreement_score":0.12243992,"about_ca_system_score_codex":0.00203823,"about_ca_system_score_gemma":0.0021700822,"threshold_uncertainty_score":0.9998383},"labels":[],"label_agreement":null},{"id":"W2479658567","doi":"10.1016/j.ygyno.2016.04.185","title":"Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Canadian Partnership Against Cancer; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Cervical cancer; Population; Demography; Gynecology; Cervical cancer screening; Vaccination; Incidence (geometry); Cancer; Obstetrics; Environmental health; Internal medicine","score_opus":0.1244580015943882,"score_gpt":0.4302066102362323,"score_spread":0.3057486086418441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479658567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97017187,0.0038874599,0.002341833,0.014911974,0.00017791182,0.000762315,0.00003523125,0.000027154298,0.007684281],"genre_scores_gemma":[0.9874597,0.010132639,0.0007733461,0.0013063517,0.00014073722,0.00009529778,0.000001249994,0.000013125813,0.00007754612],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99844843,0.00022421988,0.00035597678,0.00030780473,0.00016045154,0.0005031428],"domain_scores_gemma":[0.9986413,0.00059827237,0.0002201874,0.00028813072,0.00006628101,0.00018582841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083990453,0.0001451684,0.00048699268,0.0000646393,0.0002705213,0.000021458447,0.00023422875,0.00010182891,0.0006683446],"category_scores_gemma":[0.000051481253,0.000063910666,0.000071738286,0.000093553674,0.00045272158,0.00006918608,0.00030859915,0.00029372305,0.000004153379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015194869,0.00015672804,0.44781128,0.00038850465,0.0005736637,0.000015697151,0.001242545,0.012958766,0.00022948277,0.0072367736,0.001721201,0.5261459],"study_design_scores_gemma":[0.0049015325,0.0015243721,0.86978805,0.00010522279,0.00030832988,0.000025494322,0.004037833,0.10902866,0.00009872442,0.0040446934,0.0059256386,0.00021146458],"about_ca_topic_score_codex":0.0066417633,"about_ca_topic_score_gemma":0.015970228,"teacher_disagreement_score":0.5259344,"about_ca_system_score_codex":0.0008818995,"about_ca_system_score_gemma":0.0010863462,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W2482844347","doi":"10.1016/j.ygyno.2016.04.345","title":"Robotic surgery for endometrial cancer (EC): Identifying risk factors for surgical complications using the Clavien-Dindo classification system","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Laparotomy; Body mass index; Surgery; Logistic regression; Endometrial cancer; Retrospective cohort study; Hysterectomy; Lymphadenectomy; Univariate analysis; Multivariate analysis; Cancer; Internal medicine","score_opus":0.21149377117583898,"score_gpt":0.4150737297228244,"score_spread":0.20357995854698543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482844347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471795,0.001041317,0.033592924,0.0055351197,0.0052793105,0.005937416,0.00051064405,0.00022031937,0.000703467],"genre_scores_gemma":[0.99506384,0.00036501035,0.0010634117,0.0001342165,0.0008082484,0.0022536607,0.00008169896,0.000030147274,0.0001997371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976172,0.00034065606,0.000736146,0.0005317138,0.00021599814,0.0005583081],"domain_scores_gemma":[0.9735215,0.025020024,0.0006098152,0.0003542762,0.00031822734,0.00017618487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010733581,0.00024083655,0.00089557865,0.00027461257,0.0005415432,0.00002548399,0.0001930057,0.0003298561,0.00015893303],"category_scores_gemma":[0.003417866,0.00012062324,0.00050235767,0.00057749235,0.00019913001,0.00008294352,0.00005123008,0.00014894803,0.000015395186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008918312,0.0026534898,0.6707747,0.0008843526,0.002721437,0.00004536941,0.00036324954,0.00028349948,0.009491388,0.017206557,0.0048052953,0.28185236],"study_design_scores_gemma":[0.07745426,0.0063561006,0.7458826,0.0005600897,0.0075952318,0.00026790402,0.0037225059,0.00447192,0.003989316,0.0028639524,0.14555646,0.0012796867],"about_ca_topic_score_codex":0.00018772816,"about_ca_topic_score_gemma":0.00010365641,"teacher_disagreement_score":0.28057268,"about_ca_system_score_codex":0.0020189362,"about_ca_system_score_gemma":0.0004932103,"threshold_uncertainty_score":0.5279448},"labels":[],"label_agreement":null},{"id":"W2484471471","doi":"10.1016/j.ygyno.2016.04.184","title":"Impact of invitation and reminder letters on cervical cancer screening participation in Ontario","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Logistic regression; Pap test; Cohort; Test (biology); Cervical cancer; Cervical screening; Cervical cancer screening; Intervention (counseling); Cohort study; Family medicine; Gynecology; Obstetrics; Cancer; Internal medicine","score_opus":0.12160702856242561,"score_gpt":0.42400967836149833,"score_spread":0.3024026497990727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484471471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461585,0.00003676081,0.0001797347,0.0038588492,0.000090685346,0.00020838554,0.0000025857091,0.000011763356,0.0009953928],"genre_scores_gemma":[0.9973709,0.000021358632,0.0007194959,0.001736086,0.000032265805,0.000049014554,0.00000378248,0.000005066312,0.00006204357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999058,0.0000826864,0.00026831529,0.0002153386,0.00013007048,0.00024556185],"domain_scores_gemma":[0.9992032,0.00043015773,0.00012588468,0.00010123717,0.000055684675,0.000083804145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028647974,0.00009778578,0.00030175564,0.0001125454,0.000024265044,0.0000028272068,0.000041300067,0.0001490464,0.0005890344],"category_scores_gemma":[0.00033600343,0.000060874692,0.00005129575,0.00010502459,0.00009316065,0.00008194884,0.00002653487,0.00015265221,0.0000057360367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063806324,0.00008961052,0.92844296,0.000005526236,0.00002862445,0.000037802703,0.00034425184,0.00014545007,0.01070306,0.000055090513,0.0004392742,0.059070293],"study_design_scores_gemma":[0.0019296372,0.0024961755,0.99451023,0.00009810555,0.000034590714,0.000010014969,0.000049103077,0.00005094554,0.00030898958,0.00012336909,0.0003191108,0.000069720474],"about_ca_topic_score_codex":0.021300467,"about_ca_topic_score_gemma":0.14309473,"teacher_disagreement_score":0.12179427,"about_ca_system_score_codex":0.0012377948,"about_ca_system_score_gemma":0.00028649782,"threshold_uncertainty_score":0.9852168},"labels":[],"label_agreement":null},{"id":"W2493509212","doi":"10.1016/j.ygyno.2016.04.165","title":"Is it time to repurpose metformin for the treatment of low-grade ovarian cancer?","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metformin; Medicine; AMPK; Ovarian cancer; In vivo; Pharmacology; Growth inhibition; Cell growth; MTT assay; Internal medicine; IC50; Chemotherapy; In vitro; Endocrinology; Cancer; Oncology; Phosphorylation; Biology; Insulin; Biochemistry; Protein kinase A","score_opus":0.030559707453819765,"score_gpt":0.32838990160716264,"score_spread":0.2978301941533429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2493509212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.864135,0.114939824,0.0012509275,0.010625535,0.0018148966,0.0032000847,0.0007510738,0.00003347825,0.0032491626],"genre_scores_gemma":[0.49341786,0.37665623,0.0070732348,0.029741656,0.0038220275,0.01058422,0.00013988494,0.00015529575,0.078409575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872965,0.00008316627,0.00030352708,0.00040766844,0.000078245226,0.00039775396],"domain_scores_gemma":[0.9988423,0.00030609564,0.00016714503,0.00047049773,0.00011383133,0.00010014289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024260276,0.00018698728,0.00038381226,0.000037872218,0.00008570211,0.0000056160593,0.00028838124,0.00026415192,0.0018311574],"category_scores_gemma":[0.00018913511,0.00009750577,0.00019616827,0.00008258055,0.00012730005,0.0000031692,0.00005760793,0.000027172693,0.00008561489],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023465019,0.0003220714,0.00018409346,0.000010794462,0.00023673732,0.0000020493658,0.00016870222,0.0000102060885,0.09324709,0.00008295975,0.051013477,0.8544872],"study_design_scores_gemma":[0.0014407937,0.003087024,0.0004179618,0.000005100116,0.0000903764,0.0000023563862,0.000041370808,0.000009555857,0.1958042,0.0001541003,0.79882467,0.00012249526],"about_ca_topic_score_codex":0.000035053847,"about_ca_topic_score_gemma":0.00020573096,"teacher_disagreement_score":0.8543647,"about_ca_system_score_codex":0.00014950808,"about_ca_system_score_gemma":0.00029392287,"threshold_uncertainty_score":0.9990813},"labels":[],"label_agreement":null},{"id":"W2497336366","doi":"10.1016/j.ygyno.2016.08.235","title":"Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital","funders":"National Institute of Nursing Research","keywords":"Medicine; Psychological intervention; Intervention (counseling); Quality of life (healthcare); Disease; Randomized controlled trial; Ovarian cancer; Cancer; Internal medicine; Physical therapy; Pediatrics; Psychiatry","score_opus":0.013286280267282837,"score_gpt":0.2880504843899288,"score_spread":0.27476420412264596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2497336366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869634,0.0007429628,0.000004942689,0.005483632,0.0013954263,0.0010268402,0.000039115293,0.000059414375,0.0042842673],"genre_scores_gemma":[0.9851055,0.008626143,0.00003371759,0.0050154426,0.000095497446,0.00067889504,0.00001114678,0.00002643123,0.00040718197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977659,0.00017384351,0.00049001566,0.0006712759,0.00026027203,0.00063867617],"domain_scores_gemma":[0.998593,0.00040730234,0.00030656147,0.000359043,0.000099233206,0.00023488948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046409687,0.00028077443,0.0006540848,0.00020635084,0.0000679045,0.000027207618,0.00014817927,0.0002689309,0.00049758476],"category_scores_gemma":[0.000086636464,0.00017056102,0.00004015185,0.00029171276,0.00021268346,0.00012602325,0.000116526084,0.00024352105,0.000025092215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016394567,0.0004895985,0.39547557,0.000049458038,0.000115447445,0.00028458153,0.000576781,7.832098e-7,0.0000043104874,0.00024313165,0.0004899735,0.60063094],"study_design_scores_gemma":[0.008761601,0.00805796,0.9167219,0.0006329382,0.00010167532,0.00001114686,0.003666149,0.0000030522453,0.000008505537,0.00034708277,0.061395675,0.0002923635],"about_ca_topic_score_codex":0.000096764525,"about_ca_topic_score_gemma":0.0062291347,"teacher_disagreement_score":0.6003386,"about_ca_system_score_codex":0.001648269,"about_ca_system_score_gemma":0.00017722698,"threshold_uncertainty_score":0.6955277},"labels":[],"label_agreement":null},{"id":"W2499684929","doi":"10.1016/j.ygyno.2016.07.007","title":"Being a caregiver to patients with ovarian cancer: A scoping review of the literature","year":2016,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Family Support in Illness","field":"Social Sciences","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Psychosocial; Medicine; Psychological intervention; Ovarian cancer; Quality of life (healthcare); Distress; Population; Disease; Social support; Systematic review; Qualitative research; Health care; MEDLINE; Gerontology; Family medicine; Clinical psychology; Cancer; Psychology; Nursing; Psychiatry; Psychotherapist; Internal medicine","score_opus":0.03074139199905395,"score_gpt":0.37420755920966625,"score_spread":0.3434661672106123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2499684929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003304838,0.9728959,0.0000024894,0.0011760237,0.002231671,0.005410123,0.0001337042,0.000041207368,0.018075803],"genre_scores_gemma":[0.000021970396,0.9956257,0.00014007869,0.0020199316,0.0002391119,0.0011681524,0.00002044223,0.00003251281,0.00073210493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956311,0.0018287274,0.0007712538,0.0006086238,0.0005104358,0.0006498554],"domain_scores_gemma":[0.99605274,0.0015989294,0.0010656387,0.00061357766,0.0005018905,0.00016721104],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011452778,0.00039088205,0.002297851,0.00013538738,0.00040912954,0.00002841856,0.0013151472,0.0007591844,0.0009374425],"category_scores_gemma":[0.002079033,0.00019244818,0.00037817555,0.001282925,0.00045468454,0.00010788982,0.00038913923,0.00046212805,0.000048885933],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004792642,0.000062605184,0.00077904103,0.061847676,0.000085092215,0.000018240604,0.002057148,7.1569175e-8,7.887439e-9,0.00085031387,0.002804516,0.9314905],"study_design_scores_gemma":[0.0001243595,0.000099720666,0.00012047676,0.38991952,0.0002265566,0.0000011846255,0.00004043584,1.7245337e-9,2.4635291e-8,0.00003807781,0.6092477,0.00018193194],"about_ca_topic_score_codex":0.00034714854,"about_ca_topic_score_gemma":0.0037481852,"teacher_disagreement_score":0.93130857,"about_ca_system_score_codex":0.0015069463,"about_ca_system_score_gemma":0.0057651964,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W2502066735","doi":"10.1016/j.ygyno.2016.04.217","title":"Risk factors to predict vaginal, pelvic/abdominal recurrence or distant metastasis in patients with low-grade endometrial endometrioid adenocarcinoma: Multi-institutiona","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Lymphovascular invasion; Lymph node; Proportional hazards model; Univariate analysis; Endometrial cancer; Metastasis; Vagina; Stage (stratigraphy); Radiology; Oncology; Multivariate analysis; Internal medicine; Cancer; Surgery","score_opus":0.03486321133553897,"score_gpt":0.30752695671191643,"score_spread":0.27266374537637744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2502066735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923999,0.0003608294,0.0013641546,0.00057676085,0.0014310707,0.0027344637,0.00068170374,0.000103054954,0.00034808074],"genre_scores_gemma":[0.99362975,0.00028719666,0.004875829,0.00024052788,0.00018401608,0.00043706232,0.00009312305,0.0000322629,0.00022024021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957822,0.0005077223,0.0008852648,0.0010765829,0.00073321664,0.0010150343],"domain_scores_gemma":[0.99380165,0.004324282,0.00041767323,0.0005068228,0.00027225842,0.00067728333],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066466315,0.0005459986,0.0014526066,0.0013610821,0.00018243423,0.000022217306,0.0003698644,0.0003328388,0.001526552],"category_scores_gemma":[0.010750839,0.00026959492,0.00021487936,0.0029006752,0.00037203747,0.0002079368,0.00019431474,0.0004472005,0.00016317567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016801238,0.004297875,0.9164573,0.00003905809,0.00032526837,0.00038483704,0.00011021025,0.000008170426,0.000082484854,0.00003771764,0.00018579765,0.06127002],"study_design_scores_gemma":[0.064677425,0.024563106,0.9033321,0.00009630691,0.0005275297,0.0000195333,0.00011182721,0.0000045363827,0.00066264614,0.000044659762,0.0055982824,0.00036203896],"about_ca_topic_score_codex":0.00036241647,"about_ca_topic_score_gemma":0.00076142396,"teacher_disagreement_score":0.060907982,"about_ca_system_score_codex":0.0026277252,"about_ca_system_score_gemma":0.00081796874,"threshold_uncertainty_score":0.9999756},"labels":[],"label_agreement":null},{"id":"W2507381950","doi":"10.1016/j.ygyno.2016.08.230","title":"Cervical cancer screening in women over 65. PRO: Are we asking the right question?","year":2016,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Cervical cancer; Gynecology; Cancer; Obstetrics; Internal medicine","score_opus":0.05335639109223847,"score_gpt":0.39184411456196355,"score_spread":0.3384877234697251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507381950","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025071453,0.0021701292,0.000040095605,0.95794046,0.0010663539,0.0015818619,0.00006989323,0.000113814436,0.034510225],"genre_scores_gemma":[0.031699196,0.0030457117,0.00014950754,0.93257374,0.012863618,0.0035511984,0.00008741183,0.00010945338,0.015920196],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949964,0.0009303892,0.0006843353,0.0009461293,0.0007557336,0.0016870048],"domain_scores_gemma":[0.9958764,0.0026314948,0.00034350978,0.0006567425,0.00027531217,0.00021658135],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013785384,0.00047890158,0.0013544081,0.00035928865,0.00021388519,0.000043697866,0.0006430982,0.0022897886,0.05606567],"category_scores_gemma":[0.0005182529,0.00025970384,0.00021792242,0.0004467084,0.0005213706,0.00007511649,0.0004564424,0.0049170116,0.00020272321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053024286,0.00014629934,0.027664823,0.00053231715,0.00020142284,0.00378527,0.0002612232,0.0000040836835,0.000009378789,0.000090843554,0.78116417,0.18560995],"study_design_scores_gemma":[0.0022927537,0.0007229173,0.1878331,0.00023493766,0.00007291507,0.000055891738,0.00007510793,0.000029258143,0.0000057679076,0.0012905983,0.80710715,0.00027961368],"about_ca_topic_score_codex":0.0003994148,"about_ca_topic_score_gemma":0.0024126628,"teacher_disagreement_score":0.18533033,"about_ca_system_score_codex":0.0034475238,"about_ca_system_score_gemma":0.0012857979,"threshold_uncertainty_score":0.9999855},"labels":[],"label_agreement":null},{"id":"W2511461890","doi":"10.1016/j.ygyno.2016.08.321","title":"Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Research Foundation of Korea; Ministry of Education","keywords":"Medicine; Lymphadenectomy; Lymph node; Debulking; Metastasis; Stage (stratigraphy); Survival rate; Ovarian cancer; Oncology; Lymph; Surgery; Internal medicine; Cancer; Urology; Pathology","score_opus":0.016224325617222868,"score_gpt":0.32148957413282053,"score_spread":0.30526524851559766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511461890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995354,0.00018075916,0.000018711984,0.0011986648,0.00035608522,0.0008930804,0.00018079951,0.000038957867,0.0017789307],"genre_scores_gemma":[0.9977311,0.00026776656,0.00091519085,0.00025240527,0.00004739095,0.00066676957,0.00002101049,0.000029651843,0.0000687264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978734,0.00022856862,0.0004447438,0.00061268185,0.00029047806,0.00055009854],"domain_scores_gemma":[0.9982455,0.0005716811,0.0003008143,0.0004431003,0.0002563723,0.0001825346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019195043,0.00033537537,0.0009971663,0.00023696345,0.000032463213,0.000005373419,0.00013113103,0.0002037478,0.0020315219],"category_scores_gemma":[0.00024844593,0.00017493861,0.00014800298,0.0004069713,0.00017552244,0.0000942238,0.000051211082,0.00010705614,0.000031517797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005826148,0.0026081128,0.86097205,0.000019709407,0.00040368046,0.00011588588,0.000057729183,0.000036410154,0.000053756507,0.000047881458,0.000042255604,0.12981638],"study_design_scores_gemma":[0.025904983,0.007880773,0.96487623,0.0002484212,0.00023203052,0.0000044970175,0.000013888445,0.0000027016094,0.00025028308,0.00004507175,0.00032978738,0.00021134049],"about_ca_topic_score_codex":0.00041393045,"about_ca_topic_score_gemma":0.0006811932,"teacher_disagreement_score":0.12960504,"about_ca_system_score_codex":0.0030263679,"about_ca_system_score_gemma":0.0009866983,"threshold_uncertainty_score":0.99888074},"labels":[],"label_agreement":null},{"id":"W2515153451","doi":"10.1016/j.ygyno.2016.08.320","title":"Low-grade serous ovarian cancer: A review","year":2016,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Serous fluid; KRAS; Medicine; Ovarian cancer; Grading (engineering); Oncology; Serous ovarian cancer; Internal medicine; Serous carcinoma; Cancer research; Cancer; Colorectal cancer; Biology","score_opus":0.07623875466264035,"score_gpt":0.42072772285630766,"score_spread":0.3444889681936673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515153451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.15997e-7,0.97028387,0.0000052236282,0.010702645,0.0020443492,0.0046147862,0.00023080189,0.00018520564,0.01193232],"genre_scores_gemma":[0.0000025982517,0.9815407,0.0003930393,0.006736322,0.0009977465,0.006572012,0.00019743213,0.000107074295,0.0034531192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99564993,0.00060038787,0.0013230282,0.00121322,0.00029524878,0.0009181517],"domain_scores_gemma":[0.9960466,0.0012887776,0.0010074966,0.0010729299,0.0001442262,0.00043998339],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005723303,0.0008909663,0.006420588,0.00022384124,0.00012226455,0.000015554118,0.0004097314,0.0012556837,0.010110503],"category_scores_gemma":[0.00039005448,0.00051262457,0.0012601139,0.00049567455,0.00019230356,0.000047667963,0.00020528198,0.0007246737,0.0023005058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010913123,0.0008356223,0.000028829969,0.047986895,0.0010080028,0.0014933987,0.000006722049,1.8904258e-8,9.017385e-8,0.0002533859,0.056867823,0.8915083],"study_design_scores_gemma":[0.001648015,0.0016049015,0.00006463463,0.10184604,0.006939782,0.0007611257,0.000001998755,9.52432e-8,6.197086e-7,0.00006527387,0.88662404,0.00044345233],"about_ca_topic_score_codex":0.000059165617,"about_ca_topic_score_gemma":0.0000803257,"teacher_disagreement_score":0.8910648,"about_ca_system_score_codex":0.0041191895,"about_ca_system_score_gemma":0.0044514835,"threshold_uncertainty_score":0.99973255},"labels":[],"label_agreement":null},{"id":"W2518249527","doi":"10.1016/j.ygyno.2016.07.112","title":"Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Centre Hospitalier de l’Université de Montréal","funders":"Amgen","keywords":"Medicine; Paclitaxel; Ascites; Ovarian cancer; Oncology; Progression-free survival; Internal medicine; Overall survival; Cancer","score_opus":0.05375457365311831,"score_gpt":0.3916752352985862,"score_spread":0.3379206616454679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518249527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99522483,0.002653886,0.000043730903,0.0002586215,0.00034367162,0.000717254,0.0005037166,0.000006013337,0.00024824956],"genre_scores_gemma":[0.9977216,0.0017943785,0.00010420443,0.000014753216,0.00008268611,0.00011715329,0.000038032747,0.000014747855,0.00011242866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753207,0.00042963692,0.0008765911,0.0005637048,0.0002125392,0.0003854877],"domain_scores_gemma":[0.9979816,0.00034786543,0.00074047636,0.0005789692,0.00024923583,0.00010184059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009288314,0.00026102655,0.00082024565,0.00015039339,0.000036224246,0.000003963241,0.00038385572,0.00033891137,0.00011045908],"category_scores_gemma":[0.00063855277,0.00016710287,0.00017419182,0.0002364653,0.0003182764,0.000008623987,0.00032277257,0.00009250616,6.0180633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008036856,0.005814665,0.7130136,0.00010283911,0.00047577833,0.00004709745,0.00030321412,0.000021786356,0.115128875,0.00003803111,0.0013400402,0.15567726],"study_design_scores_gemma":[0.029304463,0.031227048,0.9293871,0.00011698405,0.000114377006,0.0000073940937,0.00024611704,0.0000071371223,0.008661979,0.000067738154,0.0005727296,0.00028691196],"about_ca_topic_score_codex":0.0009526207,"about_ca_topic_score_gemma":0.006987743,"teacher_disagreement_score":0.21637356,"about_ca_system_score_codex":0.00018275487,"about_ca_system_score_gemma":0.00070544006,"threshold_uncertainty_score":0.68142575},"labels":[],"label_agreement":null},{"id":"W2520413912","doi":"10.1016/j.ygyno.2016.09.006","title":"The effect of adjuvant radiation on survival in early stage clear cell ovarian carcinoma","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Adjuvant; Stage (stratigraphy); Internal medicine; Log-rank test; Cohort; Radiation therapy; Adjuvant therapy; Oncology; Survival analysis; Gastroenterology; Carcinoma; Chemotherapy","score_opus":0.012463813828159573,"score_gpt":0.2811367931030361,"score_spread":0.2686729792748765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520413912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816129,0.0002220866,0.000005532141,0.0042684865,0.00068477425,0.0008053996,0.00001710373,0.000020838886,0.012362841],"genre_scores_gemma":[0.99843776,0.0003102492,0.000037196573,0.00015368017,0.000090431524,0.00015852782,0.000004529361,0.000013880188,0.00079371466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984052,0.0004924374,0.0003240554,0.00029025093,0.00015728344,0.00033077432],"domain_scores_gemma":[0.995888,0.0034869157,0.0001816659,0.0003276686,0.000032753534,0.00008303113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007865467,0.00015500408,0.00049402897,0.00008818113,0.00006271437,0.0000054221723,0.00010859089,0.0001948996,0.00025451416],"category_scores_gemma":[0.00034101866,0.00007271479,0.00009906916,0.00012978417,0.00011674919,0.000029109755,0.000037733298,0.0001416791,0.00011359319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016018599,0.00037923947,0.82808477,0.000025489675,0.000045417473,0.00022395617,0.000109258624,0.0000062933314,0.00054282905,0.0009660086,0.00042305441,0.1675918],"study_design_scores_gemma":[0.009304215,0.025642997,0.93582517,0.000020352938,0.00006769935,0.0000031758216,0.000035938865,0.000010216245,0.0071944166,0.00005723736,0.021763047,0.000075555494],"about_ca_topic_score_codex":0.00024401436,"about_ca_topic_score_gemma":0.00033292262,"teacher_disagreement_score":0.16751625,"about_ca_system_score_codex":0.0007327912,"about_ca_system_score_gemma":0.00018214744,"threshold_uncertainty_score":0.29652232},"labels":[],"label_agreement":null},{"id":"W2555974971","doi":"10.1016/j.ygyno.2016.11.014","title":"Minimizing pain medication use and its associated costs following robotic surgery","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Laparotomy; Acetaminophen; Ibuprofen; Postoperative pain; Surgery; Robotic surgery; Anesthesia; Opioid; Internal medicine","score_opus":0.05065287302359138,"score_gpt":0.2924416630142486,"score_spread":0.24178878999065723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555974971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97740954,0.0002892224,0.0008936403,0.019813044,0.0002735008,0.00050678465,4.3001927e-7,0.00014014922,0.0006737033],"genre_scores_gemma":[0.9886161,0.00030531394,0.00043106542,0.008835523,0.000057986614,0.000066053435,0.000017986946,0.0000150461865,0.0016549033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980022,0.0008287398,0.00032787622,0.00030685618,0.00016610701,0.0003682369],"domain_scores_gemma":[0.98938364,0.010065874,0.00018228102,0.00015495534,0.00006142973,0.00015184133],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003220296,0.00014363739,0.0004999686,0.00013904744,0.00010085814,0.000011297142,0.00006244794,0.00027878155,0.00019824707],"category_scores_gemma":[0.01055328,0.00009521571,0.000103258666,0.0001345084,0.00006310899,0.000110055276,0.000039023154,0.0001031058,0.00006640157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006373788,0.00028102513,0.8983556,0.000036692294,0.00021256832,0.000790772,0.00010301975,0.0000017974887,0.0014864884,0.00041449352,0.016459731,0.08179407],"study_design_scores_gemma":[0.0014990051,0.0007603344,0.9576331,0.0001716823,0.00028041634,0.000033640677,0.00017094407,0.0004432741,0.000053928896,0.00015812143,0.03860368,0.00019192172],"about_ca_topic_score_codex":0.000011931415,"about_ca_topic_score_gemma":0.000041525436,"teacher_disagreement_score":0.08160214,"about_ca_system_score_codex":0.00050424953,"about_ca_system_score_gemma":0.00014804745,"threshold_uncertainty_score":0.9977813},"labels":[],"label_agreement":null},{"id":"W2556009189","doi":"10.1016/j.ygyno.2016.11.026","title":"Does a groin node dissection in vulvar cancer affect groin recurrence and overall survival?: Results from a population-based cohort study","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Juravinski Cancer Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre","funders":"Health Services Research Programme; Institute of Chemical and Engineering Sciences; Canadian Cancer Society Research Institute; Institute for Clinical Evaluative Sciences; Ontario Institute for Cancer Research; Cancer Research Institute","keywords":"Medicine; Groin; Hazard ratio; Proportional hazards model; Population; Cohort; Cumulative incidence; Retrospective cohort study; Propensity score matching; Vulvar cancer; Cohort study; Internal medicine; Incidence (geometry); Oncology; Surgery; Cancer; Confidence interval","score_opus":0.029398576232207416,"score_gpt":0.3415692923610566,"score_spread":0.31217071612884917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556009189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993497,0.00012971641,0.000023719484,0.0027278166,0.0011998601,0.0016680404,0.00015918812,0.000070319555,0.0005243212],"genre_scores_gemma":[0.9981836,0.00022073793,0.00017598456,0.000353627,0.0001891819,0.0005374024,0.00009201799,0.000014365378,0.00023309697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767226,0.0005321789,0.0004915768,0.00071839296,0.00023861924,0.00034699333],"domain_scores_gemma":[0.9960114,0.0032970582,0.00020538051,0.00027396096,0.00006567891,0.00014653856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066078024,0.00023023924,0.0007307287,0.00018160915,0.000074204596,0.000010810316,0.0000888149,0.00022444462,0.0005493414],"category_scores_gemma":[0.001883523,0.00011352237,0.000062990664,0.00033010307,0.00006613777,0.00007993208,0.000055009623,0.00018727878,0.000017206597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031226713,0.0011976567,0.9775377,0.000014186759,0.00009323514,0.00015687563,0.00010850674,0.00000870987,0.00042846586,0.000010646091,0.00007256278,0.017248798],"study_design_scores_gemma":[0.01921447,0.00317677,0.9762175,0.000080498074,0.00016301614,0.0000041257294,0.00006564845,0.00003821092,0.00009600649,0.00057062204,0.00020654096,0.00016659283],"about_ca_topic_score_codex":0.01903321,"about_ca_topic_score_gemma":0.054825895,"teacher_disagreement_score":0.035792682,"about_ca_system_score_codex":0.001213563,"about_ca_system_score_gemma":0.00016442474,"threshold_uncertainty_score":0.9874991},"labels":[],"label_agreement":null},{"id":"W2556773157","doi":"10.1016/j.ygyno.2016.11.039","title":"Of mice and women - Non-ovarian origins of “ovarian” cancer","year":2016,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Ovarian cancer; Medicine; Gynecology; Cancer; Web of science; Oncology; Internal medicine; Cancer research; MEDLINE; Biology; Meta-analysis","score_opus":0.012250475429220746,"score_gpt":0.32566534320490953,"score_spread":0.3134148677756888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556773157","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048860084,0.0025626111,0.000047104153,0.006693464,0.9237126,0.0021826918,0.0023907789,0.000067524525,0.013483149],"genre_scores_gemma":[0.27311078,0.018393168,0.004183411,0.0007624123,0.6939461,0.0027549043,0.00035937078,0.00019507043,0.0062947255],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971846,0.0001618015,0.0008613969,0.0007583809,0.0004153578,0.00061848445],"domain_scores_gemma":[0.9949025,0.0028462077,0.0009836383,0.00052056304,0.0004820317,0.00026504483],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063064316,0.00045696128,0.0022530404,0.0002577092,0.000054386754,0.000007026977,0.000243682,0.0018563255,0.0024606572],"category_scores_gemma":[0.00063898973,0.0003174173,0.00017922538,0.00020531383,0.000441159,0.0000493708,0.00018267531,0.00052011653,0.000022562816],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011412712,0.0016040297,0.006754066,0.0010544744,0.002065838,0.0003193596,0.0005530719,0.0000011834333,0.00081139023,0.0013730985,0.9206319,0.06369036],"study_design_scores_gemma":[0.009054412,0.0062329364,0.013308318,0.00028757032,0.0009012477,0.000012191457,0.00007895519,0.0000018127309,0.0004295028,0.0004242321,0.96900034,0.00026849186],"about_ca_topic_score_codex":0.0011653485,"about_ca_topic_score_gemma":0.00031933424,"teacher_disagreement_score":0.22976644,"about_ca_system_score_codex":0.0036629566,"about_ca_system_score_gemma":0.004024945,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W2558822568","doi":"10.1016/j.ygyno.2016.11.019","title":"Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Partenariat Canadien Contre Le Cancer; Cancer Research UK; Cancer Institute NSW; Cancer Focus Northern Ireland; University of Kentucky","keywords":"Medicine; Stage (stratigraphy); Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.08238341664024396,"score_gpt":0.37450130669773174,"score_spread":0.2921178900574878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558822568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96643245,0.0038811883,0.00007359964,0.019984407,0.0010363053,0.0007908868,0.000102086924,0.00009303233,0.0076060263],"genre_scores_gemma":[0.99142516,0.0035290904,0.0011679581,0.00095484836,0.00012680232,0.0007843612,0.000014103628,0.000023408866,0.0019742828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997813,0.00024949992,0.0006161718,0.000624255,0.00020711595,0.00048997113],"domain_scores_gemma":[0.9963841,0.0024794159,0.0004143566,0.0003645186,0.00008795366,0.000269663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035767112,0.00027983336,0.0012418163,0.000119841316,0.00011275801,0.0000057431744,0.00013374444,0.0003641692,0.006600555],"category_scores_gemma":[0.00039915106,0.00016688638,0.00014437451,0.00016812782,0.0005071971,0.00005401467,0.00021313083,0.00016188005,0.000046337107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042707252,0.0012888775,0.8307424,0.00004990698,0.00022333361,0.0001759973,0.000107237305,0.0000014058344,0.0009055282,0.0023859644,0.005191292,0.15850098],"study_design_scores_gemma":[0.0053383275,0.003785186,0.7310376,0.00006079088,0.00030569982,0.000016606908,0.00008537323,0.0000078174035,0.0011333023,0.00020409685,0.25785285,0.00017230982],"about_ca_topic_score_codex":0.0005302729,"about_ca_topic_score_gemma":0.0054968833,"teacher_disagreement_score":0.25266156,"about_ca_system_score_codex":0.0015768491,"about_ca_system_score_gemma":0.00021379864,"threshold_uncertainty_score":0.9943075},"labels":[],"label_agreement":null},{"id":"W2560636362","doi":"10.1016/j.ygyno.2016.10.019","title":"The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centers for Disease Control and Prevention; Partenariat Canadien Contre Le Cancer; Swiss Cancer Research Foundation; Swiss Re; National Cancer Institute; Cancer Research UK; Cancer Institute NSW; Cancer Focus Northern Ireland; University of Kentucky","keywords":"Medicine; Histology; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.04423721256409234,"score_gpt":0.35947431701505994,"score_spread":0.3152371044509676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560636362","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2681374,0.002917022,0.021055564,0.6889674,0.0067520034,0.0032699322,0.0019061702,0.000110741006,0.0068838075],"genre_scores_gemma":[0.99442476,0.0018904778,0.0010938952,0.00033317393,0.00017250607,0.0014430566,0.00007242096,0.000007646288,0.0005620749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909115,0.00006859496,0.00031990363,0.00024372418,0.00005467423,0.0002219766],"domain_scores_gemma":[0.99686867,0.0023662404,0.00022778127,0.00019978646,0.00026186812,0.000075665484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026951593,0.00010076164,0.00033848695,0.000032530777,0.00015423176,0.0000053611166,0.00011472412,0.000118762786,0.00012300009],"category_scores_gemma":[0.0005885862,0.000055053784,0.000074222,0.00006695151,0.00033365245,0.000026160162,0.00005547271,0.000060598704,0.0000037884458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031287785,0.0003260224,0.53373384,0.000009022198,0.00025190966,0.0000025762179,0.000018216402,0.0000010490727,0.00047448426,0.05972844,0.02454365,0.3805979],"study_design_scores_gemma":[0.0021980193,0.00058261276,0.5597619,0.000008846484,0.00011188902,0.000010885333,0.000024681458,0.00001428411,0.00008473949,0.0014460734,0.43571532,0.000040761595],"about_ca_topic_score_codex":0.00011602004,"about_ca_topic_score_gemma":0.0017308148,"teacher_disagreement_score":0.72628736,"about_ca_system_score_codex":0.0006925465,"about_ca_system_score_gemma":0.00031980046,"threshold_uncertainty_score":0.22450282},"labels":[],"label_agreement":null},{"id":"W2561042881","doi":"10.1016/j.ygyno.2016.11.046","title":"Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?","year":2016,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Disease; Stage (stratigraphy); Internal medicine; Ovarian cancer; Neoadjuvant therapy; Gynecology; Cancer; Breast cancer","score_opus":0.03723581706763498,"score_gpt":0.34770176101994227,"score_spread":0.3104659439523073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561042881","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007636737,0.0030756115,0.0002462217,0.9860922,0.0025978722,0.0033692906,0.0012379554,0.00010913724,0.0025080366],"genre_scores_gemma":[0.0027395296,0.019292004,0.002802242,0.9483571,0.0051186606,0.006846936,0.00054549443,0.00012255949,0.014175438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731624,0.00020406331,0.0005613259,0.0009274648,0.00018416363,0.0008067341],"domain_scores_gemma":[0.9958902,0.0024141956,0.0006703848,0.0006937093,0.00020680027,0.00012473558],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037424054,0.0005399185,0.0012670243,0.0001404597,0.00036870438,0.000034799887,0.00027183298,0.001200315,0.0026797561],"category_scores_gemma":[0.000192974,0.00030182008,0.00028565974,0.00013299366,0.00030405403,0.00006294392,0.000086376414,0.0009672851,0.000038784176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016552913,0.00014228687,0.0015939426,0.00012541623,0.0005259084,0.00022721024,0.00010143907,8.9503766e-7,0.000025002679,0.00012192839,0.67399347,0.32297698],"study_design_scores_gemma":[0.008428203,0.0021756424,0.0046031377,0.00024112433,0.00057845155,0.00007771201,0.00016878531,0.000014676227,0.000078330275,0.00065100833,0.98264146,0.0003414772],"about_ca_topic_score_codex":0.00009880294,"about_ca_topic_score_gemma":0.00045453446,"teacher_disagreement_score":0.3226355,"about_ca_system_score_codex":0.0013365246,"about_ca_system_score_gemma":0.0006637354,"threshold_uncertainty_score":0.9999434},"labels":[],"label_agreement":null},{"id":"W2566120061","doi":"10.1016/j.ygyno.2016.12.017","title":"Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Osler Library of the History of Medicine, McGill University; McGill University","keywords":"Medicine; Chemotherapy; Oncology; Ovarian cancer; Outcome (game theory); Internal medicine; Cancer; Gynecology","score_opus":0.0735478139779941,"score_gpt":0.44395206691797207,"score_spread":0.370404252939978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566120061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88767254,0.0009789008,0.0017631141,0.09796489,0.0030478775,0.0026667877,0.00014981354,0.00011194949,0.0056441333],"genre_scores_gemma":[0.97686064,0.001927564,0.013450863,0.004779489,0.00033097027,0.0008413061,0.000007666443,0.000026101607,0.0017754248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982773,0.0000790157,0.0007465562,0.00043061163,0.00010433529,0.0003621487],"domain_scores_gemma":[0.9973729,0.0016141107,0.0003450318,0.00034661088,0.0001674665,0.00015383803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048692987,0.00017664763,0.00096556376,0.00006134944,0.000041183142,0.0000021542544,0.000117531155,0.00031022436,0.0018112928],"category_scores_gemma":[0.00047551337,0.000098794735,0.0003008411,0.00008855104,0.00019421516,0.00003679013,0.000033811873,0.00009415153,0.000030739902],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071725214,0.00090399676,0.40449357,0.000028132248,0.00020800969,0.000023804798,0.000022334589,0.0000010848956,0.0008048098,0.0010516031,0.0025265927,0.5892188],"study_design_scores_gemma":[0.024749968,0.008021639,0.6565363,0.000057802892,0.0002415853,0.000012278745,0.000029471115,0.000008290449,0.0018004754,0.0009996494,0.30740085,0.00014169804],"about_ca_topic_score_codex":0.000029959703,"about_ca_topic_score_gemma":0.00012638477,"teacher_disagreement_score":0.5890771,"about_ca_system_score_codex":0.00047015157,"about_ca_system_score_gemma":0.00040208627,"threshold_uncertainty_score":0.99910116},"labels":[],"label_agreement":null},{"id":"W2567860926","doi":"10.1016/j.ygyno.2016.12.002","title":"Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; London Health Sciences Centre; University of Toronto; University Health Network","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; Medicine; MEK inhibitor; PTEN; Oncology; Internal medicine; Selumetinib; Targeted therapy; CDKN2A; Genotype; Cancer; Cancer research; MAPK/ERK pathway; PI3K/AKT/mTOR pathway; Colorectal cancer; Biology","score_opus":0.03371571033672363,"score_gpt":0.3466888840597135,"score_spread":0.31297317372298983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567860926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818088,0.00027717045,0.000037826907,0.0075503276,0.0016663361,0.0028134568,0.00017483476,0.00007433069,0.0055969204],"genre_scores_gemma":[0.9878746,0.0005599534,0.007382736,0.00079705537,0.0003116394,0.0015956592,0.000120552206,0.00003719262,0.0013205677],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99859333,0.000038074417,0.00024847066,0.0005180252,0.00012855387,0.0004735251],"domain_scores_gemma":[0.9983071,0.00025654634,0.00032612946,0.00064787176,0.00027950274,0.0001828127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009538091,0.00027693436,0.00071075116,0.00005256172,0.00041535782,0.000029578503,0.00016176506,0.00023367172,0.00074618805],"category_scores_gemma":[0.00019940903,0.00017598315,0.000116150775,0.000050032595,0.00014743891,0.000080422586,0.00004824604,0.000091309565,0.00006998334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048190686,0.0039698854,0.49339578,0.000042451524,0.00088373205,0.00012724257,0.00023922721,0.000032490454,0.00019927521,0.0005344276,0.0011156021,0.49464083],"study_design_scores_gemma":[0.023535777,0.024105486,0.77331245,0.000029821127,0.00063542713,0.000005256631,0.000030595787,0.000019115387,0.0005408977,0.00023821766,0.17734148,0.00020549145],"about_ca_topic_score_codex":0.00028407743,"about_ca_topic_score_gemma":0.0011051077,"teacher_disagreement_score":0.49443534,"about_ca_system_score_codex":0.0013628765,"about_ca_system_score_gemma":0.0007474638,"threshold_uncertainty_score":0.8170236},"labels":[],"label_agreement":null},{"id":"W2572611801","doi":"10.1016/j.ygyno.2017.01.016","title":"A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Veliparib; Gastroenterology; Internal medicine; Vomiting; Leukopenia; Nausea; Neutropenia; Mucositis; PARP inhibitor; Anemia; Radiation therapy; Oncology; Chemotherapy","score_opus":0.020318732984993104,"score_gpt":0.3261234026123364,"score_spread":0.3058046696273433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572611801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721503,0.00006302272,0.000028817292,0.00039573482,0.0000611682,0.0021193982,0.000013836345,0.000010496138,0.000092498616],"genre_scores_gemma":[0.9987117,0.000069852926,0.0006275439,0.00006234201,0.0000108187205,0.0004336637,0.000059130143,0.000016004607,0.0000089469195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983098,0.00017644979,0.0005903655,0.00041881556,0.00026935607,0.00023519434],"domain_scores_gemma":[0.9984444,0.00014338076,0.00083032495,0.00026824136,0.00024930708,0.00006436608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040820253,0.0002031686,0.0006870837,0.00037018952,0.000094970135,0.000013470013,0.000071268,0.0001601369,0.000014530241],"category_scores_gemma":[0.00010409572,0.00015924325,0.000015390371,0.0002658682,0.00031590558,0.00030456172,0.000022136423,0.00023387579,1.2206101e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021391084,0.004095309,0.95255715,0.000056411125,0.0000637704,0.00025074746,0.0037703265,0.00052695285,0.0019458887,0.0000101649775,0.0000029917549,0.0153292],"study_design_scores_gemma":[0.09073509,0.022425259,0.8837404,0.00017446991,0.000037982136,0.00007945863,0.0012584241,0.00077357405,0.00058054575,0.000027311507,0.00002184208,0.00014560414],"about_ca_topic_score_codex":0.0017349669,"about_ca_topic_score_gemma":0.009466765,"teacher_disagreement_score":0.06934401,"about_ca_system_score_codex":0.0006869172,"about_ca_system_score_gemma":0.0006122844,"threshold_uncertainty_score":0.64937514},"labels":[],"label_agreement":null},{"id":"W2574551019","doi":"10.1016/j.ygyno.2017.01.013","title":"Impact of sentinel lymph node mapping on recurrence patterns in endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fondation de l'Hôpital général juif","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Oncology; Lymph node; General surgery; Cancer; Internal medicine; Radiology; Breast cancer","score_opus":0.08452149631435478,"score_gpt":0.40815636355838364,"score_spread":0.32363486724402885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574551019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837495,0.00018553734,0.00000910859,0.00090792275,0.0010267042,0.00040120786,0.000058399703,0.000020627165,0.013640961],"genre_scores_gemma":[0.99828637,0.00062436255,0.000110923414,0.00032868047,0.0003080025,0.00013173604,0.000016391079,0.000011326691,0.00018220104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984061,0.00012328036,0.00044925246,0.00037821583,0.00020663127,0.00043651366],"domain_scores_gemma":[0.9979919,0.00085828983,0.00045765645,0.0004586673,0.00009127574,0.00014217291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036558957,0.00020040161,0.0008492747,0.00037908624,0.00009834513,0.000013073829,0.00026894207,0.00024946936,0.0016779556],"category_scores_gemma":[0.002564205,0.0001399014,0.0002470108,0.00027765788,0.00012845201,0.000059918093,0.00012897859,0.00024148659,0.000040786737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011939104,0.00093792094,0.90253365,0.000042024345,0.00013914106,0.00019942652,0.0000500352,0.00001845372,0.0006551956,0.000024145402,0.00006357795,0.09414254],"study_design_scores_gemma":[0.0153245125,0.0013980012,0.9822485,0.0001138453,0.00006430222,0.000011615538,0.000026851369,0.00003517823,0.00023843136,0.00013055808,0.00029205822,0.000116165356],"about_ca_topic_score_codex":0.0026848116,"about_ca_topic_score_gemma":0.00013283349,"teacher_disagreement_score":0.09402638,"about_ca_system_score_codex":0.0012275556,"about_ca_system_score_gemma":0.00045356844,"threshold_uncertainty_score":0.9992346},"labels":[],"label_agreement":null},{"id":"W2581549376","doi":"10.1016/j.ygyno.2016.12.025","title":"Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cervical cancer; Chemoradiotherapy; Immunohistochemistry; Oncology; DNA damage; DNA repair; Ku70; Internal medicine; Cisplatin; DNA-PKcs; Regimen; Stage (stratigraphy); Cancer; Radiation therapy; Pathology; Cancer research; Chemotherapy; DNA; Biology","score_opus":0.027775295397004473,"score_gpt":0.33590911056930195,"score_spread":0.3081338151722975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2581549376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936655,0.000094616014,0.0000033374645,0.0022238125,0.000116837706,0.0011443857,0.000028635191,0.00003068139,0.002692178],"genre_scores_gemma":[0.99786025,0.000084667336,0.0007572865,0.00043901085,0.000070755355,0.0003782434,0.000022816575,0.000019493704,0.00036746875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983592,0.0002776468,0.00036606015,0.00038314628,0.00025569653,0.00035822272],"domain_scores_gemma":[0.9985046,0.00041726563,0.00032661777,0.00045814694,0.00011012492,0.00018327872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003123967,0.00020166591,0.0008419506,0.00015653232,0.000118190335,0.000009889361,0.00024280282,0.00033912406,0.0013288336],"category_scores_gemma":[0.00075464847,0.00012463187,0.00007950924,0.0001901287,0.0003813354,0.000077415185,0.00007820963,0.00025668996,0.000009661067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034228787,0.0034484675,0.908633,0.000058756224,0.00006700944,0.00037248843,0.00014365207,0.0000020995403,0.03681768,0.000011740308,0.00014137893,0.016074965],"study_design_scores_gemma":[0.024329506,0.011201687,0.9257881,0.00009595537,0.000062197934,0.000006022776,0.000022481598,0.000010162346,0.035634726,0.00003561161,0.0026896382,0.00012390062],"about_ca_topic_score_codex":0.000456523,"about_ca_topic_score_gemma":0.00043740025,"teacher_disagreement_score":0.017155137,"about_ca_system_score_codex":0.00069238385,"about_ca_system_score_gemma":0.0003707068,"threshold_uncertainty_score":0.9995841},"labels":[],"label_agreement":null},{"id":"W2584725449","doi":"10.1016/j.ygyno.2017.01.034","title":"Outside the operating room: How a robotics program changed resource utilization on the inpatient Ward","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Israel Cancer Research Fund","keywords":"Medicine; Robotics; Resource (disambiguation); Operations management; Medical emergency; Artificial intelligence; Robot; Engineering; Computer science","score_opus":0.16959724056902045,"score_gpt":0.38743934905859734,"score_spread":0.21784210848957689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584725449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5138921,0.00038477223,0.00009299627,0.37662163,0.0015551331,0.0057132407,0.0000129215405,0.00024961884,0.10147761],"genre_scores_gemma":[0.99003744,0.00008785602,0.00062578445,0.006584212,0.00038094635,0.00067808345,0.000025830666,0.000016174361,0.001563687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985302,0.0003205556,0.0002165326,0.00030308837,0.00025585192,0.00037376338],"domain_scores_gemma":[0.997776,0.0010551779,0.0002840927,0.000678391,0.0001100062,0.00009635772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059401715,0.00018136369,0.00037001728,0.000046380483,0.0009862633,0.00009944457,0.00036413086,0.00020305126,0.00023528925],"category_scores_gemma":[0.003826403,0.0000807641,0.00010682147,0.00014210682,0.00021412522,0.000042291995,0.00019824336,0.00036389547,0.00007138195],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007915582,0.002743155,0.03876925,0.000056506437,0.00037366812,0.00023142948,0.0013145363,0.000255156,0.00019857293,0.0038246934,0.013459616,0.93798184],"study_design_scores_gemma":[0.009875479,0.030800961,0.44688815,0.000109022774,0.0006203829,0.00006112881,0.0023379356,0.002729907,0.0012886148,0.0009970502,0.5038955,0.00039583052],"about_ca_topic_score_codex":0.00003751687,"about_ca_topic_score_gemma":0.00021561743,"teacher_disagreement_score":0.937586,"about_ca_system_score_codex":0.0003630892,"about_ca_system_score_gemma":0.00012302292,"threshold_uncertainty_score":0.758564},"labels":[],"label_agreement":null},{"id":"W2588111695","doi":"10.1016/j.ygyno.2017.02.013","title":"Vulvar postoperative care, gestalt or evidence based medicine? A comprehensive systematic review","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Female Genital Mutilation/Cutting Issues","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; MEDLINE; Cochrane Library; Scopus; Family medicine; Randomized controlled trial; Surgery","score_opus":0.37560151330426994,"score_gpt":0.5091606764850334,"score_spread":0.13355916318076344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588111695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000532914,0.9731652,0.000011135376,0.002597988,0.0011704825,0.015941698,0.000042347212,0.00025678857,0.00680899],"genre_scores_gemma":[0.00007931125,0.9832627,0.0014301375,0.007583902,0.00037161747,0.0029022596,0.0003680491,0.00010309771,0.003898889],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911442,0.0030624927,0.0028401176,0.0013930838,0.0007192523,0.0008408539],"domain_scores_gemma":[0.9789955,0.013228762,0.0033140855,0.0024117006,0.0016266507,0.0004232996],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015237817,0.001270978,0.013675394,0.0004844705,0.00044574405,0.00004825203,0.0011590607,0.0013636885,0.0014487626],"category_scores_gemma":[0.04229069,0.0007284428,0.00089759484,0.0005351743,0.0009332171,0.00020714138,0.00036413685,0.0013869627,0.0013241854],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054959488,0.00011411127,0.000005928094,0.9066303,0.0004445293,0.0029221745,0.00018784507,4.5442482e-7,6.3169443e-7,0.0000613521,0.004014782,0.08556298],"study_design_scores_gemma":[0.00047059375,0.0039063967,0.000024001458,0.4909003,0.010611779,0.0013429523,0.0001852219,0.000004041267,2.224545e-7,0.000002883341,0.4921785,0.00037311547],"about_ca_topic_score_codex":0.00006787727,"about_ca_topic_score_gemma":0.00009060422,"teacher_disagreement_score":0.4881637,"about_ca_system_score_codex":0.0022693593,"about_ca_system_score_gemma":0.0053322255,"threshold_uncertainty_score":0.99993277},"labels":[],"label_agreement":null},{"id":"W2589426447","doi":"10.1016/j.ygyno.2017.02.026","title":"Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Meta-analysis; Neutrophil to lymphocyte ratio; Oncology; Lymphocyte; Internal medicine; Systematic review; MEDLINE","score_opus":0.18928827867919787,"score_gpt":0.4387581756323632,"score_spread":0.24946989695316532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589426447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006594714,0.9771701,0.0000040220416,0.0026288535,0.0002954382,0.018598387,0.0002598894,0.000055444303,0.0009219108],"genre_scores_gemma":[0.00074925786,0.98109716,0.0002819885,0.0037227697,0.000031636493,0.01312835,0.000065976215,0.00006115115,0.00086171506],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903674,0.0035602162,0.0033890933,0.0012949686,0.0005642839,0.00082405284],"domain_scores_gemma":[0.98565143,0.0074685477,0.0037001765,0.0024603547,0.00039511448,0.00032435145],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0045477073,0.0011241516,0.025624068,0.0009179218,0.00024177769,0.000052577096,0.0013332015,0.0009969625,0.0011036985],"category_scores_gemma":[0.011269226,0.0005797685,0.0044915006,0.0013024291,0.0006580951,0.00007796913,0.00068541494,0.0007028431,0.00009775603],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003641944,0.00036662133,0.0025183193,0.7856175,0.20334771,0.00053629983,0.000102691025,0.0000017621013,8.583047e-8,0.000085482105,0.00042497367,0.0069621373],"study_design_scores_gemma":[0.00061932375,0.00076611,0.0030401181,0.00976289,0.9413464,0.0000805764,0.000050722436,0.0000076338865,2.2065885e-7,0.000033170003,0.04376821,0.0005246006],"about_ca_topic_score_codex":0.00009213694,"about_ca_topic_score_gemma":0.0006412718,"teacher_disagreement_score":0.7758546,"about_ca_system_score_codex":0.0017758596,"about_ca_system_score_gemma":0.0027885681,"threshold_uncertainty_score":0.99980944},"labels":[],"label_agreement":null},{"id":"W2592342141","doi":"10.1016/j.ygyno.2017.02.021","title":"Corrigendum to “The sooner the better: Genetic testing following ovarian cancer diagnosis” [Gynecol. Oncol. 137 (2015) 423–429]","year":2017,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Regret; Genetic testing; Medicine; Ovarian cancer; Preference; Oncology; Serous fluid; Gynecology; Serous ovarian cancer; Internal medicine; Cancer; Statistics","score_opus":0.07262877616096257,"score_gpt":0.3563011263377028,"score_spread":0.2836723501767402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592342141","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009859876,0.03441946,0.000082887644,0.37078327,0.3993228,0.016660739,0.00090696017,0.0006282113,0.1673358],"genre_scores_gemma":[0.08970508,0.015256026,0.010857664,0.13186988,0.05378894,0.11370519,0.0010809898,0.0010126502,0.58272356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927086,0.00073326746,0.00138829,0.0020711946,0.000976855,0.002121764],"domain_scores_gemma":[0.99139416,0.0026748765,0.0014817688,0.003227858,0.00050787925,0.00071346236],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0015465171,0.0013514925,0.0026731843,0.000312942,0.0022092415,0.00032319425,0.0021032258,0.0021138017,0.0037554684],"category_scores_gemma":[0.0044503463,0.00079462957,0.00096394605,0.0005869937,0.00046557622,0.00011235994,0.0010708148,0.002984721,0.0011623837],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000056706504,0.00065836404,0.04490459,0.00009868536,0.0012197839,0.0021598223,0.00027618147,0.000027146776,0.0000050644135,0.0000242486,0.7347179,0.21585147],"study_design_scores_gemma":[0.0024562953,0.0028884914,0.23067543,0.00048423358,0.0027498794,0.00013615687,0.00011824921,0.000080517886,0.000013973618,0.00016222405,0.7595286,0.0007059981],"about_ca_topic_score_codex":0.0036927485,"about_ca_topic_score_gemma":0.017110026,"teacher_disagreement_score":0.41538778,"about_ca_system_score_codex":0.0045587835,"about_ca_system_score_gemma":0.0058760117,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W2595912885","doi":"10.1016/j.ygyno.2017.03.007","title":"CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Terry Fox Research Institute; Cancer Research Society","keywords":"Ovarian cancer; CXCL10; Immune system; Medicine; Cancer research; Tumor microenvironment; CD31; Chemokine; Immunology; Cancer; Biology; Pathology; Internal medicine; Angiogenesis","score_opus":0.02583383467447646,"score_gpt":0.3147075561880361,"score_spread":0.2888737215135596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595912885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181844,0.0016371779,0.000042311156,0.015517397,0.00018378143,0.00065206375,0.000013051114,0.00001289985,0.00012289268],"genre_scores_gemma":[0.99694085,0.0011967451,0.0010158751,0.00039255875,0.00008114551,0.00016353629,0.000009984637,0.00001504611,0.00018426294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988531,0.0000796381,0.00033268874,0.00030504313,0.00012784085,0.00030173085],"domain_scores_gemma":[0.9990087,0.00011575226,0.0003047059,0.00039105563,0.00002087111,0.00015890245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000333252,0.00016391282,0.0004878922,0.000054878317,0.00017675105,0.000011881331,0.00019716263,0.00012684408,0.00012896574],"category_scores_gemma":[0.00020676159,0.00010234135,0.00006753152,0.000034935318,0.000322924,0.000041065432,0.00024707135,0.00024281492,0.0000021314058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017961347,0.0026175862,0.3779932,0.0004529991,0.00021927552,0.00056701753,0.0010308302,0.003945485,0.49416113,0.00038818768,0.0006484044,0.11617975],"study_design_scores_gemma":[0.0067761545,0.0010823315,0.95416164,0.00023675949,0.0003171884,0.000042719785,0.00017177756,0.0143929925,0.020176554,0.0013323514,0.0010584663,0.00025105148],"about_ca_topic_score_codex":0.00037005663,"about_ca_topic_score_gemma":0.00021393567,"teacher_disagreement_score":0.5761685,"about_ca_system_score_codex":0.0002714196,"about_ca_system_score_gemma":0.00023365402,"threshold_uncertainty_score":0.41733593},"labels":[],"label_agreement":null},{"id":"W2601862570","doi":"10.1016/j.ygyno.2017.02.032","title":"Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Public Health Ontario; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Women's College Hospital; Western University","funders":"","keywords":"Medicine; Breast cancer; Ovarian cancer; BRCA mutation; Prophylactic Mastectomy; Oncology; Mastectomy; Cancer; Internal medicine; Cohort; Gynecology; Prophylactic Surgery","score_opus":0.010757661828931805,"score_gpt":0.3105042229983618,"score_spread":0.29974656116943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601862570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993868,0.0015451947,0.00010617483,0.0012046283,0.00061931304,0.000514288,0.0013597441,0.0000057853927,0.0007769069],"genre_scores_gemma":[0.9956928,0.0019814335,0.00062302296,0.00019610327,0.00012632449,0.0011596384,0.00001869918,0.000020607233,0.0001813994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984183,0.00023665487,0.00045127302,0.00046881184,0.00012423942,0.00030072342],"domain_scores_gemma":[0.9982208,0.00009298329,0.00078221335,0.00055148854,0.00029606197,0.00005643995],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033920878,0.00019110904,0.00041498835,0.00010723623,0.000092387076,0.000010862085,0.00038811716,0.0004191297,0.0013447374],"category_scores_gemma":[0.00033229162,0.00018002294,0.00013703234,0.000114352064,0.00041967176,0.000015463513,0.00019754961,0.00016946354,0.0000035359699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005913815,0.00028760088,0.90389997,0.00007672142,0.0004195997,0.000024222018,0.0012495266,0.00064967346,0.0123360865,0.000011427794,0.0008854879,0.0795683],"study_design_scores_gemma":[0.0021649897,0.0005249325,0.9349349,0.00005181814,0.00016601087,0.000011382413,0.00038580256,0.00010424625,0.057638224,0.0002979557,0.0035112093,0.00020849089],"about_ca_topic_score_codex":0.0027492007,"about_ca_topic_score_gemma":0.015639182,"teacher_disagreement_score":0.07935981,"about_ca_system_score_codex":0.00033914656,"about_ca_system_score_gemma":0.000727492,"threshold_uncertainty_score":0.99956816},"labels":[],"label_agreement":null},{"id":"W2602912039","doi":"10.1016/j.ygyno.2017.03.011","title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Dalhousie University","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Proportional hazards model; Cytology; Adjuvant therapy; Population; Stage (stratigraphy); Cancer; Cohort; Gynecology; Retrospective cohort study; Gastroenterology; Oncology; Pathology","score_opus":0.03686896186789769,"score_gpt":0.35973821995940714,"score_spread":0.32286925809150946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602912039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773766,0.00066970853,0.00001729746,0.001093276,0.0022504756,0.0012354712,0.00008263481,0.000036014088,0.00687746],"genre_scores_gemma":[0.9967152,0.00126976,0.0004310866,0.00023718606,0.00045867506,0.00060340174,0.0000147840165,0.000017608207,0.0002523211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977491,0.00029300418,0.0006595125,0.00050770206,0.00021734835,0.00057334435],"domain_scores_gemma":[0.99649835,0.0019074314,0.00076088426,0.0005076141,0.00014026895,0.00018546294],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055618794,0.00023609295,0.001226792,0.00032604593,0.00015147425,0.000013137455,0.00038695653,0.0004086374,0.0013842004],"category_scores_gemma":[0.0075350762,0.0001807918,0.00018984999,0.00028003723,0.00064897485,0.00007815301,0.000180722,0.000469921,0.000055747303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029451344,0.0012186007,0.8982411,0.000107164924,0.00016643592,0.00060839084,0.00012594859,0.000015147617,0.0014490347,0.00007387243,0.000092493094,0.094956644],"study_design_scores_gemma":[0.015845355,0.005819457,0.97299767,0.000062895335,0.0002610834,0.000023942803,0.000074991,0.000053153268,0.0022137098,0.0006106125,0.0018771782,0.00015997619],"about_ca_topic_score_codex":0.0018611578,"about_ca_topic_score_gemma":0.0030216982,"teacher_disagreement_score":0.094796665,"about_ca_system_score_codex":0.00059957895,"about_ca_system_score_gemma":0.00066879287,"threshold_uncertainty_score":0.99952865},"labels":[],"label_agreement":null},{"id":"W2603491863","doi":"10.1016/j.ygyno.2017.02.031","title":"FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Endometrial cancer; Internal medicine; Oncology; Gynecologic oncology; Stage (stratigraphy); Cohort; Incidence (geometry); Proportional hazards model; Cancer; Mutation; Gene; Genetics; Biology","score_opus":0.05385722503064874,"score_gpt":0.38910447939329934,"score_spread":0.33524725436265057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603491863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805064,0.00021011171,0.000037569233,0.0019803601,0.00154407,0.0035310548,0.0002464618,0.00012076395,0.0042789397],"genre_scores_gemma":[0.9945027,0.00020124743,0.00077893975,0.00069376774,0.00035343587,0.0023411808,0.0003595689,0.0000980693,0.0006710585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910034,0.003239304,0.0012666797,0.0019468304,0.0006452765,0.001898502],"domain_scores_gemma":[0.99200135,0.0035294069,0.0017757382,0.0015846003,0.00056834036,0.00054053083],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035889372,0.0008217098,0.0021444582,0.0010268296,0.0011005333,0.00017179913,0.0023118912,0.001891273,0.000621806],"category_scores_gemma":[0.021261245,0.00067903183,0.0002899924,0.00081159675,0.0013436169,0.00008426368,0.0012127081,0.0014210289,0.0000782981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021910178,0.011633801,0.9406334,0.000019185743,0.00085117214,0.00149095,0.000364378,0.00021093962,0.02153866,0.000050096212,0.00062238507,0.020393992],"study_design_scores_gemma":[0.022185005,0.059214305,0.8959182,0.000017494067,0.00019808685,0.00005097485,0.002527375,0.000060416798,0.0013846655,0.00017028405,0.017448878,0.00082434376],"about_ca_topic_score_codex":0.0011667889,"about_ca_topic_score_gemma":0.11216946,"teacher_disagreement_score":0.11100267,"about_ca_system_score_codex":0.0027100148,"about_ca_system_score_gemma":0.0019720253,"threshold_uncertainty_score":0.9995661},"labels":[],"label_agreement":null},{"id":"W2611490804","doi":"10.1016/j.ygyno.2017.04.015","title":"Frequency of “incidental” serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Center for Plant Conservation; U.S. Department of Defense","keywords":"Medicine; Serous carcinoma; Fallopian tube; Serous fluid; Gynecology; Risk factor; Carcinoma; Obstetrics; Internal medicine; Ovarian cancer; Cancer","score_opus":0.04220505341992481,"score_gpt":0.3131790742655255,"score_spread":0.2709740208456007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611490804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943684,0.00019267187,0.00002402545,0.00008706842,0.00088352687,0.0036141295,0.00040689963,0.00003888548,0.00038442912],"genre_scores_gemma":[0.99415916,0.00002755171,0.0039015783,0.00009688257,0.00007196478,0.0011331545,0.000018723362,0.000035118603,0.00055586116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969314,0.00040192224,0.0010365394,0.00067308557,0.00024037782,0.00071668025],"domain_scores_gemma":[0.9967485,0.00089638855,0.0010831034,0.00082649605,0.00020456272,0.00024093225],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00046844868,0.00039236998,0.0016721218,0.00027302446,0.00017527278,0.000010060463,0.0004709765,0.00046436727,0.0012090649],"category_scores_gemma":[0.0023193692,0.00028581906,0.00018064804,0.00010767673,0.0005647322,0.000093763345,0.00019827051,0.00038277227,0.000023051907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009066382,0.006042076,0.9813606,0.00010776666,0.00023710291,0.0009188688,0.00247122,0.0000044952412,0.0018981482,0.000042391748,0.000069863796,0.005940823],"study_design_scores_gemma":[0.01758709,0.030010624,0.94911975,0.000014872204,0.0004704338,0.000041092717,0.0014184909,0.000028782997,0.0002134845,0.00074182975,0.000119431286,0.00023414001],"about_ca_topic_score_codex":0.003184139,"about_ca_topic_score_gemma":0.0068275714,"teacher_disagreement_score":0.03224088,"about_ca_system_score_codex":0.003433038,"about_ca_system_score_gemma":0.0010171086,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W2613009590","doi":"10.1016/j.ygyno.2017.05.014","title":"Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A Trans PORTEC initiative","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Endometrial cancer; Medicine; Mdm2; Immunohistochemistry; Cancer research; Gene silencing; Hazard ratio; Oncology; Internal medicine; Phenotype; Cancer; Biology; Gene; Confidence interval; Genetics","score_opus":0.03592549368045227,"score_gpt":0.3251561096302117,"score_spread":0.2892306159497594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613009590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794705,0.0006080203,0.000022224227,0.0043612723,0.0011087493,0.0012753444,0.00013020473,0.000023965267,0.01299974],"genre_scores_gemma":[0.99756485,0.0005383752,0.00062675786,0.0006184179,0.00014618799,0.00032497695,0.000012416006,0.00001910109,0.00014890425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997991,0.00039870423,0.00054345524,0.0003904672,0.00026928665,0.00040705502],"domain_scores_gemma":[0.9977391,0.00081377575,0.0006737771,0.0005493482,0.00011917441,0.0001048753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070740964,0.00021718923,0.0008729278,0.00019823824,0.0001492934,0.000009226051,0.00036050283,0.0003249589,0.0007690965],"category_scores_gemma":[0.0031380765,0.00013264157,0.00023965906,0.00042074968,0.00034460588,0.00005732253,0.00012550803,0.00046814443,0.0000068982836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007594208,0.0016146036,0.71089864,0.0001048131,0.0007698079,0.00077971135,0.0004687891,0.00005889405,0.011386721,0.0006537973,0.00006730143,0.2656027],"study_design_scores_gemma":[0.033218812,0.0066772467,0.92673206,0.000085255844,0.0005143395,0.000017464896,0.00032554846,0.000022028902,0.027072215,0.0023396465,0.0027726737,0.00022267617],"about_ca_topic_score_codex":0.0021445435,"about_ca_topic_score_gemma":0.002286936,"teacher_disagreement_score":0.26538002,"about_ca_system_score_codex":0.0005808694,"about_ca_system_score_gemma":0.0006613363,"threshold_uncertainty_score":0.84210676},"labels":[],"label_agreement":null},{"id":"W2616395980","doi":"10.1016/j.ygyno.2017.05.021","title":"Implementation of a referral to discharge glycemic control initiative for reduction of surgical site infections in gynecologic oncology patients","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Glycemic; Gynecologic oncology; Referral; Perioperative; Triage; Emergency medicine; Internal medicine; General surgery; Surgery; Insulin; Nursing","score_opus":0.03747678833119237,"score_gpt":0.39524320640970656,"score_spread":0.35776641807851417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616395980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781097,0.000026691423,0.00022485253,0.0036231652,0.0009289009,0.0027319307,0.00025374533,0.000026119453,0.0043736477],"genre_scores_gemma":[0.99751586,0.00007865043,0.00080749614,0.00041838625,0.00011814178,0.0008258355,0.00015319284,0.000017130575,0.0000653108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742705,0.00024267739,0.0011042975,0.00047873674,0.00019452527,0.0005527101],"domain_scores_gemma":[0.9969069,0.0011504198,0.0007118066,0.0003753486,0.00065803033,0.0001975262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005433513,0.00024394327,0.0012166623,0.00031870708,0.00022134246,0.000009648191,0.00020744298,0.0005183212,0.00042190755],"category_scores_gemma":[0.0013794951,0.0002081896,0.00024095722,0.00015476123,0.00034512262,0.00016156421,0.00011717895,0.00031141992,0.000016053587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014911278,0.0055004186,0.9084564,0.00019404247,0.0002801792,0.000058983554,0.0018799703,0.000029218776,0.0067404136,0.0023596245,0.00082958466,0.058759894],"study_design_scores_gemma":[0.08288046,0.0870739,0.7934744,0.00008798182,0.0005877144,0.00007388081,0.0017393939,0.00015075578,0.0011868316,0.0019120366,0.03040196,0.00043071553],"about_ca_topic_score_codex":0.00032657228,"about_ca_topic_score_gemma":0.0010983781,"teacher_disagreement_score":0.114982024,"about_ca_system_score_codex":0.000648407,"about_ca_system_score_gemma":0.0005482293,"threshold_uncertainty_score":0.84897256},"labels":[],"label_agreement":null},{"id":"W2617976150","doi":"10.1016/j.ygyno.2017.05.019","title":"Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Metformin; Trametinib; MEK inhibitor; Medicine; AMPK; Cancer research; Ovarian cancer; Pharmacology; MAPK/ERK pathway; Growth inhibition; Kinase; Internal medicine; Cell growth; Endocrinology; Cancer; Protein kinase A; Biology; Cell biology; Insulin; Biochemistry","score_opus":0.011196352051634014,"score_gpt":0.3046885871768794,"score_spread":0.2934922351252454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617976150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774757,0.020296449,0.000026023952,0.00011747247,0.000847677,0.0003442466,0.000019917907,0.0000069403814,0.00086557405],"genre_scores_gemma":[0.9892334,0.00998254,0.00011624386,0.00016294171,0.00015495911,0.00018891717,0.000027790913,0.0000129464925,0.00012028509],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987748,0.00023353957,0.00027289614,0.00034225621,0.000083986124,0.00029247298],"domain_scores_gemma":[0.9991011,0.00013414871,0.00029743064,0.00034163764,0.00005664558,0.0000690124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062137406,0.00016928988,0.00044984667,0.00006300738,0.00011446146,0.000017508715,0.00024429217,0.00035147343,0.000056543435],"category_scores_gemma":[0.00075931905,0.00014156588,0.000057031648,0.000044017837,0.00026228253,0.000009424387,0.00015732586,0.00012318211,0.0000027824503],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047385358,0.00049151573,0.081028946,0.00035692207,0.00017160378,0.000059504022,0.00016841742,0.00009597286,0.17476302,0.00090893894,0.0016114748,0.73986983],"study_design_scores_gemma":[0.01260088,0.007105191,0.23189253,0.000087781824,0.00025335918,0.000017615326,0.0000944664,0.00037059435,0.6353888,0.0019288405,0.10955391,0.0007060417],"about_ca_topic_score_codex":0.00023815995,"about_ca_topic_score_gemma":0.0013949042,"teacher_disagreement_score":0.73916376,"about_ca_system_score_codex":0.000068374735,"about_ca_system_score_gemma":0.0001352363,"threshold_uncertainty_score":0.57728887},"labels":[],"label_agreement":null},{"id":"W2619109410","doi":"10.1016/j.ygyno.2017.05.027","title":"Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Gynecologic oncology; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Clinical Oncology; Oncology; Lymph node; Internal medicine; Consensus conference; Sentinel node; Gynecologic cancer; Cancer; Medical physics; General surgery; Ovarian cancer; Breast cancer","score_opus":0.1353963330421402,"score_gpt":0.4338158915177063,"score_spread":0.2984195584755661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619109410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028730198,0.98418283,0.0000048853904,0.005811696,0.0008882869,0.003486221,0.00035170245,0.00006622745,0.0049208743],"genre_scores_gemma":[0.00009754069,0.99052125,0.0038444218,0.0023616191,0.00034639807,0.001634058,0.00055199576,0.00005905519,0.0005836772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448603,0.0011625066,0.0019714353,0.0011807688,0.00031430737,0.00088497036],"domain_scores_gemma":[0.98969144,0.006224685,0.0026799599,0.00073519564,0.0003628262,0.0003058903],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018237554,0.0008570706,0.007584109,0.0007657919,0.0002469336,0.00003515731,0.00042398786,0.0014984009,0.0006659012],"category_scores_gemma":[0.002725102,0.00057023147,0.0008386464,0.0017407197,0.00059229287,0.000074628944,0.0003970342,0.0013900034,0.000014053239],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017727341,0.00083899655,0.0045472137,0.049312282,0.0012505429,0.0008076578,0.000104012855,4.4371032e-7,0.0000018714162,0.000027131762,0.0024502557,0.9404823],"study_design_scores_gemma":[0.011055362,0.0013408752,0.0023914445,0.04822372,0.0038362683,0.0006808752,0.00009476636,0.00000541269,5.5755373e-7,0.000047046047,0.93184155,0.000482119],"about_ca_topic_score_codex":0.0001762709,"about_ca_topic_score_gemma":0.000106254905,"teacher_disagreement_score":0.9400002,"about_ca_system_score_codex":0.002877418,"about_ca_system_score_gemma":0.0037076566,"threshold_uncertainty_score":0.9997979},"labels":[],"label_agreement":null},{"id":"W2620765662","doi":"10.1016/j.ygyno.2017.05.024","title":"Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Adjuvant; Oncology; Lymph node; Internal medicine; Cancer; Breast cancer","score_opus":0.03328490962090471,"score_gpt":0.33031844874745103,"score_spread":0.29703353912654634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620765662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820586,0.0009572693,0.000019153402,0.0043631233,0.0032304772,0.0011056992,0.00016825825,0.0000871206,0.008010305],"genre_scores_gemma":[0.9911422,0.0011288229,0.00020540874,0.0017947382,0.00042649856,0.00060056994,0.0000936844,0.00003462776,0.0045734355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715465,0.00021005943,0.0007696154,0.00078246946,0.00025516338,0.0008280409],"domain_scores_gemma":[0.9976809,0.00068869954,0.00059211854,0.0006653289,0.00008901791,0.00028391238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034798437,0.0004156814,0.0014126722,0.0003967076,0.0003230211,0.00007847601,0.0003686787,0.00033256295,0.003781674],"category_scores_gemma":[0.00043075022,0.00026974024,0.00026367238,0.00034378236,0.0002070256,0.00012893148,0.00019931053,0.00023436999,0.00046667538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020832333,0.003194821,0.8963772,0.00009615436,0.0005081685,0.0017984861,0.00016583042,0.000006079458,0.03573327,0.000008694029,0.0021583845,0.057869684],"study_design_scores_gemma":[0.06740593,0.0013823509,0.89340425,0.00010667123,0.00050625764,0.00006504773,0.0002455275,0.00018676805,0.0102498615,0.00023998873,0.02570486,0.00050246716],"about_ca_topic_score_codex":0.0040839757,"about_ca_topic_score_gemma":0.00041285716,"teacher_disagreement_score":0.065322705,"about_ca_system_score_codex":0.0024158806,"about_ca_system_score_gemma":0.0003744282,"threshold_uncertainty_score":0.9999755},"labels":[],"label_agreement":null},{"id":"W2623239496","doi":"10.1016/j.ygyno.2018.10.047","title":"Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Groin; Sentinel lymph node; Micrometastasis; Biopsy; Vulvar cancer; Surgery; Dissection (medical); Radiology; Cancer; Axilla; Radiation therapy; Lymph node; Primary tumor; Metastasis; Breast cancer; Vulva; Internal medicine","score_opus":0.01226656661077507,"score_gpt":0.28632219201277587,"score_spread":0.2740556254020008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623239496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98480654,0.00016448325,0.000004304656,0.0007795416,0.00016315842,0.0006471937,0.00001730188,0.000027048514,0.013390417],"genre_scores_gemma":[0.996796,0.00014037115,0.00054521684,0.0018614077,0.00007794926,0.00021401554,0.00003422721,0.000014763352,0.0003160178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985358,0.00011475187,0.00029866656,0.00043406358,0.00017110333,0.00044559018],"domain_scores_gemma":[0.99933136,0.0002220283,0.000104888946,0.00014288427,0.00008835064,0.00011047949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018988708,0.00019830391,0.0005348245,0.000266884,0.00005817355,0.0000085429365,0.00007752086,0.00013916267,0.00050624437],"category_scores_gemma":[0.00007496274,0.00013528281,0.000030793355,0.0005138593,0.00021734912,0.000060267623,0.00011435892,0.00013460386,0.000031043983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016047119,0.0011917113,0.97390115,0.000044307268,0.00009994952,0.0003460235,0.0001508199,0.0000026589066,0.000016148575,0.00016519956,0.000038869908,0.022438418],"study_design_scores_gemma":[0.017730791,0.0014078424,0.97968596,0.00008890395,0.000098894176,0.0000057527523,0.00014437297,0.000017375696,0.00006701634,0.00017768137,0.00043153693,0.00014388857],"about_ca_topic_score_codex":0.00057223777,"about_ca_topic_score_gemma":0.0005360577,"teacher_disagreement_score":0.022294529,"about_ca_system_score_codex":0.0007390664,"about_ca_system_score_gemma":0.00009346073,"threshold_uncertainty_score":0.55430204},"labels":[],"label_agreement":null},{"id":"W2623368930","doi":"10.1016/j.ygyno.2017.03.388","title":"Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage endometrioid adenocarcinoma of the uterus","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Pathological; Sentinel node; Biopsy; Uterus; Endometrial biopsy; Adenocarcinoma; Oncology; Gynecology; Radiology; Internal medicine; Cancer; Breast cancer","score_opus":0.04460259356909985,"score_gpt":0.32675907595325177,"score_spread":0.2821564823841519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623368930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966553,0.000118305004,0.000016795797,0.00015735008,0.00018111001,0.0011147044,0.000039494804,0.0000104628325,0.0017064757],"genre_scores_gemma":[0.9994205,0.000032889533,0.00029930583,0.00008893047,0.000017531172,0.0000850529,0.00000807026,0.00000963501,0.000038043265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852484,0.0003095594,0.00033324776,0.00032841225,0.00020993667,0.00029399554],"domain_scores_gemma":[0.9977643,0.0011888937,0.0004209699,0.00041869844,0.00012388964,0.000083282066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049764354,0.00017096363,0.00074892794,0.00016148933,0.00010407191,0.000008840672,0.00022412099,0.0001894007,0.000072379735],"category_scores_gemma":[0.0013952716,0.00009269316,0.00008368451,0.00026574897,0.0005443327,0.000060460225,0.00021038622,0.00023626919,0.0000017898226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021358677,0.00095382694,0.9896832,0.0001313762,0.00006651377,0.0001067246,0.00007013343,0.0000030733736,0.0009547274,0.000061025337,9.551245e-7,0.0058325734],"study_design_scores_gemma":[0.016734565,0.0023566016,0.9784637,0.00007261592,0.000105013794,0.0000151449885,0.0000505303,0.0000034769826,0.0020032907,0.00006802678,0.00003999646,0.00008702811],"about_ca_topic_score_codex":0.00022030031,"about_ca_topic_score_gemma":0.00002017463,"teacher_disagreement_score":0.0145986965,"about_ca_system_score_codex":0.00017742171,"about_ca_system_score_gemma":0.000095419964,"threshold_uncertainty_score":0.37799174},"labels":[],"label_agreement":null},{"id":"W2623550314","doi":"10.1016/j.ygyno.2017.09.026","title":"Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Cervix; Hysterectomy; Cervical cancer; Complication; Radical Hysterectomy; Surgery; Retrospective cohort study; Cancer; Cohort; Fistula; Internal medicine","score_opus":0.056980113595633486,"score_gpt":0.3805543817601614,"score_spread":0.3235742681645279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623550314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881499,0.0017345339,0.000041242394,0.004586244,0.00087319664,0.0015191154,0.000198935,0.00002710676,0.0028697578],"genre_scores_gemma":[0.9960185,0.0005922992,0.0008220487,0.0008819641,0.00021895544,0.0006197138,0.000018038447,0.0000128686315,0.00081560825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859864,0.00011797914,0.00038214214,0.00041926804,0.00012691059,0.0003550567],"domain_scores_gemma":[0.99819696,0.0008099434,0.00025889045,0.00043807196,0.00009661737,0.00019951537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043460066,0.00017889682,0.00088228233,0.000054581476,0.00017961561,0.000012834405,0.00015951187,0.00027951068,0.0014535077],"category_scores_gemma":[0.0011928597,0.00012167252,0.00014337135,0.00005668892,0.00045955376,0.00006987187,0.00014559277,0.00016018696,0.0000094745055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044085463,0.00075183914,0.9233116,0.0003294164,0.00019911249,0.000024297788,0.00013521963,2.188361e-7,0.0005204687,0.00024676934,0.00030877296,0.06976377],"study_design_scores_gemma":[0.015601508,0.002736588,0.95290184,0.000047869064,0.00029726524,0.00000820043,0.000032081884,0.000011478607,0.0008384968,0.0011592718,0.026245851,0.000119571196],"about_ca_topic_score_codex":0.00023766235,"about_ca_topic_score_gemma":0.0009516947,"teacher_disagreement_score":0.0696442,"about_ca_system_score_codex":0.000407181,"about_ca_system_score_gemma":0.00023954452,"threshold_uncertainty_score":0.9994593},"labels":[],"label_agreement":null},{"id":"W2623797673","doi":"10.1016/j.ygyno.2017.03.505","title":"Treatment with olaparib monotherapy in the maintenance setting significantly improves progression-free survival in patients with platinum-sensitive relapsed ovarian cancer: Results from the phase III SOLO2 study","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Olaparib; Oncology; Ovarian cancer; Internal medicine; Progression-free survival; Overall survival; Cancer; Gynecology; Poly ADP ribose polymerase","score_opus":0.02903819638609049,"score_gpt":0.344580774382697,"score_spread":0.3155425779966065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623797673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779229,0.000050716477,0.000029242905,0.013910391,0.00036254924,0.0056909933,0.0002900286,0.000049187212,0.0016939755],"genre_scores_gemma":[0.99553597,0.00008260061,0.0007800544,0.0014630536,0.00019357153,0.0017264839,0.00009502833,0.00003594089,0.00008732497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963429,0.0009770751,0.00071616645,0.00084613386,0.00047021036,0.000647516],"domain_scores_gemma":[0.9945767,0.0026346939,0.0010360177,0.0014636226,0.00020157351,0.000087389395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013062215,0.0004206854,0.0008832277,0.00008342135,0.0005796232,0.000069770984,0.00062360166,0.00023491906,0.00003863508],"category_scores_gemma":[0.0005346222,0.00019036708,0.000062885505,0.0002088416,0.00057216873,0.00014079358,0.000084349515,0.00063327886,0.0000038643393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098121725,0.010244829,0.72779477,0.000006920411,0.00059066206,0.0014570127,0.032042455,0.000071854025,0.0007476596,0.000056264773,0.0005958377,0.12827003],"study_design_scores_gemma":[0.18364497,0.02941713,0.7765718,0.00014444662,0.000119378215,0.00000857959,0.008254242,0.00017367746,0.00022739093,0.00018780566,0.0009969568,0.00025362667],"about_ca_topic_score_codex":0.0043094056,"about_ca_topic_score_gemma":0.025958862,"teacher_disagreement_score":0.12801641,"about_ca_system_score_codex":0.0012105112,"about_ca_system_score_gemma":0.00071510073,"threshold_uncertainty_score":0.99181485},"labels":[],"label_agreement":null},{"id":"W2624409061","doi":"10.1016/j.ygyno.2017.07.125","title":"Unexpected locations of sentinel lymph nodes in endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital; Cancer Research Foundation","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Lymphadenectomy; Lymph node; Dissection (medical); Lymph; Sentinel node; Cervical cancer; Radiology; Parametrial; Surgery; Cancer; Internal medicine; Pathology; Breast cancer; Cervical carcinoma","score_opus":0.06184370240200936,"score_gpt":0.3895929025318756,"score_spread":0.32774920012986625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624409061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612377,0.000580834,0.0000129333375,0.0029770543,0.0008252594,0.00036876425,0.000019090712,0.000030318883,0.03394799],"genre_scores_gemma":[0.997545,0.0004696065,0.000389745,0.00034194882,0.00023262421,0.00020921137,0.000018434772,0.000009722907,0.00078372593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876034,0.000090837275,0.00041855866,0.00027579852,0.00015664562,0.00029780893],"domain_scores_gemma":[0.998309,0.0007070499,0.0003428268,0.00040051903,0.0001378755,0.00010268849],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024167978,0.00013476121,0.00067145814,0.00030301622,0.00012019201,0.000009913744,0.00021682344,0.00022646645,0.0015203932],"category_scores_gemma":[0.0028209044,0.00010317727,0.000116297706,0.00034266218,0.00023919834,0.00005900845,0.00010975593,0.00014026066,0.000036370115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080094405,0.001195409,0.94476783,0.000042254018,0.00014069717,0.000115657735,0.000060608083,0.000012391705,0.004093501,0.0004366714,0.000108348475,0.048225656],"study_design_scores_gemma":[0.015935864,0.00033823823,0.97972214,0.000026958449,0.00013717549,0.000010131361,0.000078616686,0.000038189395,0.001534844,0.0004761541,0.0016133193,0.00008839306],"about_ca_topic_score_codex":0.00170739,"about_ca_topic_score_gemma":0.000371677,"teacher_disagreement_score":0.048137262,"about_ca_system_score_codex":0.0005498661,"about_ca_system_score_gemma":0.00048022083,"threshold_uncertainty_score":0.99939233},"labels":[],"label_agreement":null},{"id":"W2625843461","doi":"10.1016/j.ygyno.2017.06.006","title":"Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?","year":2017,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radical Hysterectomy; Cervical cancer; Hysterectomy; Randomized controlled trial; Stage (stratigraphy); Sexual dysfunction; Surgery; Gynecology; Cancer; Internal medicine","score_opus":0.07676379819376498,"score_gpt":0.37289405003390264,"score_spread":0.29613025184013764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625843461","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008918044,0.0034444735,0.00005254178,0.77717364,0.003912303,0.0066041923,0.0031428963,0.00014146484,0.19661042],"genre_scores_gemma":[0.044761285,0.016221162,0.009596008,0.74675775,0.0077838628,0.0035262294,0.0065945755,0.00028136017,0.1644778],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99522626,0.00045656244,0.001183879,0.0014185085,0.0007765231,0.0009382344],"domain_scores_gemma":[0.99361527,0.0016912041,0.0013668828,0.0028998454,0.00021075673,0.00021602873],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009799758,0.00068839063,0.0041376506,0.00028770845,0.00016841243,0.000035613797,0.0019305319,0.0020974642,0.012352355],"category_scores_gemma":[0.0002941625,0.00048921176,0.00057162024,0.00018846373,0.00083004014,0.000119572265,0.0014848224,0.0017966133,0.0002983257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026773198,0.0011483898,0.0017688702,0.0028155372,0.008086778,0.014044441,0.0003262685,5.027662e-7,0.0000068716317,0.00012712208,0.8634737,0.08142828],"study_design_scores_gemma":[0.12719296,0.0024507188,0.0033323255,0.00022530404,0.0042405585,0.000024164176,0.000038938964,0.000014843571,0.000028977227,0.0009102412,0.8611584,0.00038260073],"about_ca_topic_score_codex":0.0033517198,"about_ca_topic_score_gemma":0.00016703128,"teacher_disagreement_score":0.10041976,"about_ca_system_score_codex":0.00087888306,"about_ca_system_score_gemma":0.0007406044,"threshold_uncertainty_score":0.999756},"labels":[],"label_agreement":null},{"id":"W2632916022","doi":"10.1016/j.ygyno.2017.06.020","title":"Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Ploidy; Endometrial cancer; Internal medicine; Medicine; DNA; Oncology; Cancer; Carcinoma; Cancer research; Biology; Gene; Genetics","score_opus":0.05177726583671645,"score_gpt":0.4016788306287309,"score_spread":0.34990156479201445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2632916022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96953946,0.00040088658,0.000013098547,0.002025996,0.00049346534,0.0010848106,0.000021360129,0.000008529834,0.026412405],"genre_scores_gemma":[0.99820507,0.0002900818,0.00059704366,0.000386378,0.0001052485,0.0003294063,0.0000084173,0.000008212328,0.000070131966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984584,0.00024515274,0.0004778432,0.00024645688,0.00030345086,0.00026871],"domain_scores_gemma":[0.99783766,0.0009507868,0.0005120828,0.0005276555,0.0001075753,0.00006424587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084518944,0.00013860367,0.0007847472,0.00018201346,0.00006880613,0.0000074493905,0.0004003647,0.00019666621,0.0006185578],"category_scores_gemma":[0.0016428631,0.00008152594,0.00016412216,0.00027226316,0.00027242454,0.00004203366,0.00011385758,0.00022945607,0.0000032192834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001989705,0.005203084,0.8479535,0.0002555341,0.00051391457,0.0007239156,0.0003488662,0.000023762785,0.057718266,0.004857687,0.00019471625,0.08021704],"study_design_scores_gemma":[0.015324504,0.005483848,0.9677132,0.000030586336,0.00025772382,0.00001117493,0.00014074518,0.00001616274,0.008414646,0.00091973046,0.0016055354,0.00008217918],"about_ca_topic_score_codex":0.00070895744,"about_ca_topic_score_gemma":0.00043936598,"teacher_disagreement_score":0.11975966,"about_ca_system_score_codex":0.00034179518,"about_ca_system_score_gemma":0.0004827016,"threshold_uncertainty_score":0.6772774},"labels":[],"label_agreement":null},{"id":"W2658524166","doi":"10.1016/j.ygyno.2017.06.025","title":"Paraneoplastic syndromes associated with gynecological cancers: A systematic review","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Cancer; Endocrine system; Disease; Pathophysiology; Sex organ; Gynecologic cancer; Dermatology; Pathology; Ovarian cancer; Internal medicine; Hormone","score_opus":0.1523579855328484,"score_gpt":0.41878679220382986,"score_spread":0.26642880667098146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2658524166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025154726,0.97983193,0.00000448664,0.00028953672,0.0004418282,0.010283212,0.0000702445,0.00030401943,0.008749605],"genre_scores_gemma":[0.00041047385,0.9882813,0.000060762544,0.0019689426,0.000036161367,0.0055255815,0.0005178671,0.000094788236,0.0031041382],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99357456,0.0015777036,0.0018828119,0.001331681,0.000490754,0.0011424806],"domain_scores_gemma":[0.98920083,0.0056930743,0.0030895353,0.0014620196,0.0002003089,0.0003542324],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.00085762417,0.0012778302,0.014989951,0.00021407749,0.0004370427,0.000050394083,0.00083821756,0.0019050537,0.0014011916],"category_scores_gemma":[0.013340115,0.0006613146,0.0013251485,0.00038481937,0.00065190374,0.00007275184,0.00028610058,0.0015032854,0.00084447814],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005702517,0.0016419701,0.000052735388,0.8632849,0.004081145,0.015068861,0.00001116529,6.466745e-7,1.1373692e-8,0.000048209906,0.001480451,0.11427287],"study_design_scores_gemma":[0.0020276678,0.013705957,0.0003315657,0.5038198,0.043087002,0.0036715553,0.000010938029,0.000005360671,7.9797315e-9,0.00006059072,0.43252426,0.0007552706],"about_ca_topic_score_codex":0.000015856764,"about_ca_topic_score_gemma":0.00008778209,"teacher_disagreement_score":0.4310438,"about_ca_system_score_codex":0.0021321217,"about_ca_system_score_gemma":0.0026717733,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W2725295832","doi":"10.1016/j.ygyno.2017.06.021","title":"Recruitment challenges in clinical research: Survey of potential participants in a diagnostic study of ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Medicine; Ovarian cancer; Gynecology; Oncology; Cancer; Internal medicine","score_opus":0.9551520885639606,"score_gpt":0.7315432626554959,"score_spread":0.22360882590846476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2725295832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858474,0.00070500444,6.310915e-7,0.007504873,0.0006400157,0.0027656774,0.000013365712,0.000007326191,0.0025156857],"genre_scores_gemma":[0.982399,0.016400449,0.00011304886,0.00006672154,0.00008002935,0.00080845825,0.0000029632538,0.000015224569,0.00011410223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9869952,0.0077903797,0.0023689123,0.00082899234,0.0010604938,0.0009559842],"domain_scores_gemma":[0.8724398,0.124258466,0.0006519496,0.0013673337,0.0010279119,0.00025454667],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.070230916,0.00014518567,0.0014132046,0.0003424164,0.000099644894,0.000008866483,0.0008330237,0.0009743442,0.00032616753],"category_scores_gemma":[0.4723115,0.000118337106,0.00008457533,0.00026202094,0.0015029226,0.000048135156,0.0010019257,0.003102144,0.000018582748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014470377,0.016439829,0.90752786,0.00013792486,0.00010195927,0.0010202009,0.0009553306,0.000024156843,0.000039591898,0.0003845251,0.00005380226,0.0718678],"study_design_scores_gemma":[0.008042345,0.017273497,0.96833444,0.000207745,0.0000379992,0.0000017149704,0.0017404883,0.00009859426,0.00003149391,0.004036971,0.00011163057,0.00008306338],"about_ca_topic_score_codex":0.0145852985,"about_ca_topic_score_gemma":0.47876722,"teacher_disagreement_score":0.46418193,"about_ca_system_score_codex":0.0004449432,"about_ca_system_score_gemma":0.0024314201,"threshold_uncertainty_score":0.9991977},"labels":[],"label_agreement":null},{"id":"W2732901746","doi":"10.1016/j.ygyno.2017.06.017","title":"Potential of RASSF1A promoter methylation as biomarker for endometrial cancer: A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of the Environment, Conservation and Parks","funders":"","keywords":"Endometrial cancer; Biomarker; Medicine; Meta-analysis; Methylation; DNA methylation; Oncology; Computational biology; Cancer research; Internal medicine; Cancer; Gene; Genetics; Biology; Gene expression","score_opus":0.15816268310979295,"score_gpt":0.45032914456428336,"score_spread":0.29216646145449043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732901746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018219354,0.99194413,0.0010687712,0.00012543116,0.00023738506,0.0059926054,0.00038778078,0.0000075124512,0.00021815069],"genre_scores_gemma":[0.0004624411,0.99362516,0.0008435569,0.00008686509,0.000094037874,0.0032900628,0.00071631005,0.00003602925,0.00084555265],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959685,0.0012639023,0.0014953673,0.0007860014,0.00017445922,0.0003117498],"domain_scores_gemma":[0.995121,0.0005855046,0.003008271,0.000845974,0.00034146913,0.00009776542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026439957,0.00048639698,0.007696724,0.00036412184,0.0001332432,0.000032447642,0.00045053792,0.0010264972,0.00022294302],"category_scores_gemma":[0.0033164986,0.00032959224,0.0029369802,0.0002837911,0.00015168799,0.000005655678,0.00021922542,0.00014361474,0.0000042410493],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050967683,0.00020051906,0.0000031971708,0.6406296,0.24631591,0.00000764148,0.000009367069,0.0000045701568,0.00044455743,0.000035986155,0.00021550208,0.11208222],"study_design_scores_gemma":[0.00037983072,0.0008334571,0.000003845858,0.00087819184,0.7428594,0.00000730428,0.0000021011906,0.0000067086453,0.00010676816,0.00010500297,0.25451243,0.00030492272],"about_ca_topic_score_codex":0.000033125005,"about_ca_topic_score_gemma":0.00008335922,"teacher_disagreement_score":0.6397514,"about_ca_system_score_codex":0.000076559605,"about_ca_system_score_gemma":0.00048657993,"threshold_uncertainty_score":0.9999156},"labels":[],"label_agreement":null},{"id":"W2733813554","doi":"10.1016/j.ygyno.2017.07.002","title":"Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Meta-analysis; Hormonal therapy; Endometrial cancer; Oncology; Gynecology; Cancer; Internal medicine; Breast cancer","score_opus":0.23499138613992446,"score_gpt":0.48897499732285643,"score_spread":0.253983611182932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733813554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008151469,0.9822979,0.0000014571771,0.00066188554,0.00022561998,0.0152510125,0.00027907957,0.000035920453,0.0012389711],"genre_scores_gemma":[0.00009494141,0.975245,0.00010106724,0.0023094332,0.00009331713,0.021090679,0.00009788169,0.000038310936,0.0009293552],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944594,0.0017718447,0.0017033238,0.001118074,0.00037737115,0.0005700075],"domain_scores_gemma":[0.99107647,0.0055988925,0.0019753312,0.0009306143,0.00016174123,0.00025695434],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017270279,0.00085480267,0.027497374,0.0011770828,0.00012309714,0.00002932085,0.00043182494,0.00082963257,0.0026208542],"category_scores_gemma":[0.0032398354,0.00045799534,0.0044053416,0.0019726292,0.0001790525,0.000072035466,0.00017063617,0.0007586234,0.00006141244],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014179619,0.00038859382,0.00002066218,0.36621818,0.24376175,0.00027054598,0.000020646505,8.766911e-8,5.861832e-8,0.000008880178,0.000070976916,0.38909784],"study_design_scores_gemma":[0.0036634859,0.0024952053,0.000112375456,0.007813416,0.7827107,0.000058294394,0.0000047123426,2.4683047e-7,2.868549e-7,0.00003875848,0.20278305,0.00031949047],"about_ca_topic_score_codex":0.00019655131,"about_ca_topic_score_gemma":0.00023948817,"teacher_disagreement_score":0.53894895,"about_ca_system_score_codex":0.0014760501,"about_ca_system_score_gemma":0.000703761,"threshold_uncertainty_score":0.99978715},"labels":[],"label_agreement":null},{"id":"W2736492236","doi":"10.1016/j.ygyno.2017.07.134","title":"Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Jewish General Hospital","keywords":"Medicine; Cohort; Carboplatin; Endometrial cancer; Hazard ratio; Regimen; Internal medicine; Progression-free survival; Oncology; Cancer; Proportional hazards model; Retrospective cohort study; Surgery; Urology; Chemotherapy; Cisplatin; Confidence interval","score_opus":0.031909931849134966,"score_gpt":0.34943266997197076,"score_spread":0.31752273812283577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736492236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851477,0.0003176022,0.0000017290491,0.0015408827,0.0016544169,0.0015594101,0.00005278591,0.000053060125,0.00967239],"genre_scores_gemma":[0.9975422,0.00010442616,0.00083866547,0.00031088895,0.00036292546,0.00043788226,0.000038438033,0.000024876766,0.00033967439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978021,0.00018405494,0.00042966552,0.00054590224,0.00044471992,0.00059356645],"domain_scores_gemma":[0.9975846,0.00081169565,0.00044416953,0.00074225024,0.0001754525,0.0002418372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046043532,0.0002830411,0.00090617867,0.00024515882,0.00024065693,0.000036921774,0.00035872177,0.00036636143,0.0005250861],"category_scores_gemma":[0.0037081877,0.00017611103,0.00010576728,0.00027816297,0.00027617137,0.00013310593,0.00027924817,0.00038470267,0.000023730017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008050278,0.0015085599,0.80684876,0.000032132928,0.00012595214,0.00023379453,0.00005867462,0.0000011739957,0.00018633831,0.000046569356,0.00013374565,0.18277399],"study_design_scores_gemma":[0.056495734,0.010893786,0.92968214,0.000050777195,0.00016315625,0.000002813491,0.000040763025,0.000005892205,0.00019934049,0.00030908472,0.0019662504,0.00019024925],"about_ca_topic_score_codex":0.0010376532,"about_ca_topic_score_gemma":0.003358793,"teacher_disagreement_score":0.18258373,"about_ca_system_score_codex":0.00086616114,"about_ca_system_score_gemma":0.0004508535,"threshold_uncertainty_score":0.7181599},"labels":[],"label_agreement":null},{"id":"W2736512149","doi":"10.1016/j.ygyno.2017.07.123","title":"Single agent trabectedin in heavily pretreated patients with recurrent ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Society of Gynecologic Oncology of Canada; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Trabectedin; Medicine; Ovarian cancer; Oncology; Internal medicine; Cancer; Surgery; Soft tissue sarcoma","score_opus":0.040261372306119106,"score_gpt":0.3261250879985722,"score_spread":0.2858637156924531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736512149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769005,0.0003065299,0.00000342916,0.007061676,0.00092970463,0.0012783592,0.000041696156,0.00005611679,0.0134219965],"genre_scores_gemma":[0.99734974,0.00023978994,0.00062031456,0.00064295245,0.000108065135,0.0006182757,0.00006208269,0.000023280334,0.00033550154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833435,0.00009647107,0.00033377914,0.00054172124,0.00019530517,0.0004983793],"domain_scores_gemma":[0.99867594,0.00014141107,0.00030523495,0.00054385996,0.00014004449,0.00019349538],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015343228,0.00025132904,0.0006298048,0.00011858806,0.00019787946,0.000036415306,0.00017846416,0.00025130497,0.001106504],"category_scores_gemma":[0.00021605766,0.0001745075,0.0000711739,0.00011972043,0.00016738009,0.00009211683,0.000072489136,0.00025963163,0.000040768606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006951048,0.0044541187,0.817487,0.000024301586,0.00014493796,0.0003880057,0.00017100207,0.00000676969,0.00003913414,0.00006218393,0.0014306349,0.17509682],"study_design_scores_gemma":[0.0120093245,0.008739318,0.9543131,0.00013125266,0.00020135357,0.000008249294,0.00003002566,0.000018824067,0.00019226958,0.000057549165,0.024118956,0.00017975313],"about_ca_topic_score_codex":0.0008136627,"about_ca_topic_score_gemma":0.0070579457,"teacher_disagreement_score":0.17491707,"about_ca_system_score_codex":0.0020439962,"about_ca_system_score_gemma":0.0004337349,"threshold_uncertainty_score":0.99980664},"labels":[],"label_agreement":null},{"id":"W2740464630","doi":"10.1016/j.ygyno.2017.07.128","title":"Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Univariate analysis; Chemotherapy; Adjuvant; Internal medicine; Oncology; Adjuvant therapy; Ovarian cancer; Clear cell carcinoma; Cancer; Adjuvant chemotherapy; Surgery; Multivariate analysis; Breast cancer","score_opus":0.04769284563547669,"score_gpt":0.3550731215602443,"score_spread":0.3073802759247676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740464630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92350787,0.0004376749,0.000032682718,0.027556937,0.0011508343,0.0015228438,0.00014654733,0.00006763854,0.04557694],"genre_scores_gemma":[0.98859715,0.00030150122,0.0022810192,0.0032975972,0.000726978,0.0003441067,0.0000423509,0.000038496135,0.00437081],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982396,0.000053497624,0.00035982783,0.00060735235,0.00015806862,0.000581678],"domain_scores_gemma":[0.9981678,0.00038564976,0.0003218167,0.0007736047,0.00011720621,0.0002338956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034324994,0.00026466782,0.0007961424,0.00006704814,0.0004938432,0.00004869712,0.00027605455,0.00044746746,0.003504506],"category_scores_gemma":[0.00010483705,0.00020828741,0.0002962148,0.000040369767,0.00018413833,0.00006281703,0.00009487355,0.00021346979,0.00013623008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007585474,0.009102341,0.57161355,0.00039913875,0.0005973105,0.004233837,0.0012711359,0.000013330138,0.0005052701,0.00906421,0.061029803,0.3345846],"study_design_scores_gemma":[0.018458232,0.007400337,0.41634542,0.000007734848,0.00018955291,0.0000397928,0.00009723904,0.0001087378,0.0020958784,0.00034088801,0.55472296,0.00019321458],"about_ca_topic_score_codex":0.00021315877,"about_ca_topic_score_gemma":0.00014226134,"teacher_disagreement_score":0.49369317,"about_ca_system_score_codex":0.0005435381,"about_ca_system_score_gemma":0.0005021901,"threshold_uncertainty_score":0.9974064},"labels":[],"label_agreement":null},{"id":"W2744054571","doi":"10.1016/j.ygyno.2017.08.006","title":"Neoadjuvant chemotherapy and chemotherapy cycle number: A national multicentre study","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto; University Health Network; University of Manitoba; Princess Margaret Cancer Centre; Western University","funders":"Partenariat Canadien Contre Le Cancer","keywords":"Medicine; Chemotherapy; Regimen; Internal medicine; Oncology; Ovarian cancer; Serous fluid; Chemotherapy regimen; Ovarian carcinoma; Stage (stratigraphy); Retrospective cohort study; Surgery; Cancer","score_opus":0.02901957411004339,"score_gpt":0.3794712618092702,"score_spread":0.3504516876992268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744054571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94463545,0.000107531036,0.000004828341,0.026290558,0.00036388173,0.001240816,0.000009362437,0.00005985428,0.027287746],"genre_scores_gemma":[0.99193674,0.00055674353,0.0015241526,0.0047105076,0.00023801666,0.00022145885,0.0000075939906,0.00002092784,0.0007838613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987057,0.00006636441,0.00024775107,0.00045949922,0.00021088758,0.0003097902],"domain_scores_gemma":[0.99883676,0.00025477982,0.00022551145,0.00040296483,0.00012482042,0.00015517867],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031364054,0.00020216897,0.00051570364,0.00004094157,0.000364482,0.000051901894,0.00015174007,0.00017860679,0.0017595228],"category_scores_gemma":[0.00021955486,0.00015524207,0.00007629124,0.00003732892,0.00017458187,0.00007950097,0.00007391952,0.00016560785,0.00013415434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034961762,0.0047348524,0.79089314,0.000012472166,0.0003618318,0.00029833333,0.0009849523,0.0000019201077,0.00005058694,0.00024736492,0.0029796285,0.19908528],"study_design_scores_gemma":[0.017933646,0.0025179742,0.91738653,0.000011463971,0.000103658305,0.000086282846,0.00041457338,0.00014528878,0.00007651195,0.0006290205,0.060553525,0.0001415347],"about_ca_topic_score_codex":0.00015302721,"about_ca_topic_score_gemma":0.0003111043,"teacher_disagreement_score":0.19894373,"about_ca_system_score_codex":0.00045893897,"about_ca_system_score_gemma":0.00023403067,"threshold_uncertainty_score":0.999153},"labels":[],"label_agreement":null},{"id":"W2751912349","doi":"10.1016/j.ygyno.2017.08.022","title":"Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Germline; Germline mutation; Somatic cell; PARP inhibitor; Poly ADP ribose polymerase; Ovarian carcinoma; Cancer research; Ovarian cancer; Mutation; Oncology; Polymerase; Internal medicine; Cancer; Genetics; Biology; DNA; Gene","score_opus":0.053716048390429094,"score_gpt":0.34390747188256454,"score_spread":0.29019142349213545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751912349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996916,0.000051305316,0.0000389549,0.0009989219,0.00011228975,0.0013277626,0.0004984688,0.000012018301,0.000044289845],"genre_scores_gemma":[0.998433,0.000035790308,0.001132811,0.00011003963,0.000028461776,0.000048268827,0.00014057248,0.00001148186,0.000059558675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808115,0.0003967883,0.0005587729,0.00054935017,0.00021663858,0.00019731732],"domain_scores_gemma":[0.9969353,0.0010083005,0.000826039,0.0009940899,0.00015046773,0.00008578367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005317951,0.00021176427,0.0011293325,0.00019816945,0.00017685334,0.000023918514,0.00026826846,0.00017697884,0.00037784383],"category_scores_gemma":[0.00085343595,0.00011651999,0.000029992854,0.00039421182,0.0007217288,0.00021775947,0.00032247126,0.00024341984,4.1474598e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006735713,0.0017752527,0.9839277,0.000056837365,0.0008730626,0.00008523891,0.0008390877,0.0000059911563,0.0005368621,0.000011330734,0.000055046887,0.0050978777],"study_design_scores_gemma":[0.01710138,0.0041188193,0.9751722,0.000066604036,0.0013496954,0.000010100444,0.00064798235,0.0009337579,0.00033703764,0.0000634766,0.000072519935,0.00012640501],"about_ca_topic_score_codex":0.0021008516,"about_ca_topic_score_gemma":0.022410402,"teacher_disagreement_score":0.02030955,"about_ca_system_score_codex":0.00014795957,"about_ca_system_score_gemma":0.00045119584,"threshold_uncertainty_score":0.9954281},"labels":[],"label_agreement":null},{"id":"W2756712276","doi":"10.1016/j.ygyno.2017.09.014","title":"Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Micrometastasis; Lymphadenectomy; Sentinel lymph node; Paraaortic lymph nodes; Dissection (medical); Lymph node; Radiology; Metastasis; Surgery; Cancer; Internal medicine; Breast cancer","score_opus":0.04271192353466637,"score_gpt":0.3329668634789808,"score_spread":0.29025493994431445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756712276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823551,0.0003996281,0.0000047197545,0.001125536,0.0014788099,0.00041434533,0.000026771777,0.00003157607,0.014163511],"genre_scores_gemma":[0.99515927,0.0025471118,0.0007216276,0.00038224572,0.00042482885,0.00016954514,0.00001346065,0.000014751724,0.0005671316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982234,0.00012796574,0.0005625366,0.00038487514,0.0002294503,0.00047176986],"domain_scores_gemma":[0.9979119,0.0007156003,0.0006424971,0.00048763334,0.000112749294,0.00012966475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005802059,0.00020120469,0.00096673204,0.00036395935,0.00018781834,0.000011926916,0.00029920673,0.00030637218,0.0011697569],"category_scores_gemma":[0.002152136,0.00015349594,0.00014369316,0.00035482505,0.0002334689,0.000100526006,0.00019540735,0.00027441123,0.000057851026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009376755,0.00052369834,0.9009776,0.000091357106,0.00012979779,0.00010251617,0.00004750466,0.00003251388,0.0008743509,0.000036453373,0.000048964797,0.096197546],"study_design_scores_gemma":[0.02194385,0.00067130127,0.9742139,0.00006658104,0.00016195835,0.000012260906,0.000044784894,0.00020816739,0.0008978199,0.00011722656,0.0015280459,0.00013409223],"about_ca_topic_score_codex":0.0025578528,"about_ca_topic_score_gemma":0.0001482002,"teacher_disagreement_score":0.09606346,"about_ca_system_score_codex":0.00069236953,"about_ca_system_score_gemma":0.00037400337,"threshold_uncertainty_score":0.9997433},"labels":[],"label_agreement":null},{"id":"W2763283211","doi":"10.1016/j.ygyno.2017.09.032","title":"LINE-1 retrotransposon-mediated DNA transductions in endometriosis associated ovarian cancers","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; University of British Columbia","funders":"Canadian Cancer Society Research Institute; BC Cancer Foundation","keywords":"Retrotransposon; Endometriosis; Medicine; Ovarian cancer; DNA; Oncology; Cancer research; Internal medicine; Genetics; Transposable element; Cancer; Biology; Gene; Genome","score_opus":0.0265995406153479,"score_gpt":0.3110824689117033,"score_spread":0.2844829282963554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763283211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876924,0.00037258593,0.00025683336,0.001845915,0.001010323,0.00031505505,0.00008758643,0.00004187041,0.008377426],"genre_scores_gemma":[0.9968283,0.0011043351,0.0004650411,0.00050081813,0.00021421321,0.0001322206,0.00017308418,0.000022811326,0.00055916863],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834454,0.00017116308,0.00037955615,0.00050215557,0.00011993638,0.00048264096],"domain_scores_gemma":[0.9988274,0.00015993675,0.00026207062,0.00054128334,0.00010020945,0.000109080975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005339692,0.00020498472,0.00038264,0.000113318376,0.00032906095,0.00003207887,0.00047396932,0.0006392282,0.00022983541],"category_scores_gemma":[0.0025534537,0.00020121892,0.00014443246,0.00015684126,0.0002211909,0.000008489842,0.000060995786,0.0002869965,0.000021061116],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007636728,0.0013354553,0.06978959,0.00006393322,0.0006325096,0.00020319241,0.0006433129,0.0043838643,0.8510052,0.00016591363,0.0065754973,0.06443787],"study_design_scores_gemma":[0.030276489,0.011303154,0.5199523,0.00016250122,0.00043221872,0.000112355105,0.00096068677,0.005461612,0.105266385,0.0016208789,0.32173002,0.0027213977],"about_ca_topic_score_codex":0.000588618,"about_ca_topic_score_gemma":0.009727283,"teacher_disagreement_score":0.7457388,"about_ca_system_score_codex":0.00046461725,"about_ca_system_score_gemma":0.0005755434,"threshold_uncertainty_score":0.8205469},"labels":[],"label_agreement":null},{"id":"W2765198775","doi":"10.1016/j.ygyno.2017.10.019","title":"Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Proportional hazards model; C-reactive protein; Quality of life (healthcare); Oncology; Inflammation","score_opus":0.03775381890921485,"score_gpt":0.33689102313145686,"score_spread":0.299137204222242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765198775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938707,0.00009259134,0.0000017229468,0.0006822067,0.00045752942,0.003741185,0.00004663304,0.000012094826,0.0010953824],"genre_scores_gemma":[0.9986494,0.00003332633,0.000040214956,0.00015281496,0.000025546551,0.0010393244,0.000033305078,0.00001144689,0.00001459924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706286,0.0007615076,0.000928961,0.0004318661,0.00046738583,0.00034743253],"domain_scores_gemma":[0.99665946,0.00086086104,0.0011135971,0.0010115374,0.0002972609,0.00005727246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013221413,0.00022424562,0.00091717823,0.0004400205,0.00017442771,0.000018014738,0.0007618514,0.00025398063,0.00018600692],"category_scores_gemma":[0.0028169819,0.00013433458,0.00024336952,0.00086115906,0.00030028366,0.00007514568,0.00028927453,0.00029563002,0.0000021674998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095504324,0.0039038137,0.97944146,0.00006249752,0.0007746326,0.000033225413,0.002063109,0.0004022733,0.00007892872,0.00010477923,0.000037752336,0.012142455],"study_design_scores_gemma":[0.0049118334,0.0012955363,0.98938024,0.00007138692,0.002137503,7.0149474e-7,0.00075821497,0.0009135466,0.00016889515,0.00021422848,0.000029435108,0.0001184492],"about_ca_topic_score_codex":0.00029401024,"about_ca_topic_score_gemma":0.0038358404,"teacher_disagreement_score":0.012024006,"about_ca_system_score_codex":0.00048681677,"about_ca_system_score_gemma":0.00037044886,"threshold_uncertainty_score":0.54780054},"labels":[],"label_agreement":null},{"id":"W2766088625","doi":"10.1016/j.ygyno.2017.10.016","title":"APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Apelin-related biomedical research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Memorial Sloan-Kettering Cancer Center","keywords":"Cell growth; Biology; Cancer research; Cell culture; Gene knockdown; Ovarian cancer; Cancer; Internal medicine; Medicine; Genetics","score_opus":0.029217211856773218,"score_gpt":0.35669089826414163,"score_spread":0.3274736864073684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766088625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95801383,0.00034574393,0.0000108905,0.029256536,0.00024040834,0.00088338775,0.000005886086,0.000022828357,0.011220504],"genre_scores_gemma":[0.9966489,0.0008523136,0.0004033709,0.000534645,0.000106200336,0.00019989192,0.000010303966,0.000015015442,0.0012293418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980992,0.00021045309,0.00039499602,0.00047425285,0.00026843543,0.0005526591],"domain_scores_gemma":[0.9988287,0.00045747994,0.0001728715,0.0002531879,0.00007333004,0.00021443905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009649595,0.00016760525,0.00047150327,0.0002756741,0.00011956267,0.000028426548,0.0002433555,0.00060907885,0.0006714053],"category_scores_gemma":[0.0024407017,0.00012820173,0.000036668065,0.00014370195,0.0003412359,0.000098824865,0.0002476559,0.00082726555,0.000072147384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007981026,0.001972569,0.7674827,0.00027714236,0.00004817927,0.004915495,0.0010724005,0.0000054663833,0.17348506,0.00043953306,0.0009948475,0.0485085],"study_design_scores_gemma":[0.005055403,0.001495018,0.98708797,0.00006546242,0.000031530057,0.0000466821,0.00021098641,0.0007580592,0.0029333958,0.0011726472,0.0009976234,0.00014520774],"about_ca_topic_score_codex":0.0023761685,"about_ca_topic_score_gemma":0.0136729535,"teacher_disagreement_score":0.21960528,"about_ca_system_score_codex":0.00048884493,"about_ca_system_score_gemma":0.00055834296,"threshold_uncertainty_score":0.7629829},"labels":[],"label_agreement":null},{"id":"W2770295769","doi":"10.1016/j.ygyno.2017.11.008","title":"Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute; Clovis Oncology","keywords":"Medicine; Internal medicine; Ovarian cancer; Platinum; Adjuvant therapy; Chemotherapy; Oncology; Cancer; Surgery","score_opus":0.07339911402699563,"score_gpt":0.39170845418487565,"score_spread":0.31830934015788004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770295769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88481164,0.00020309322,0.00005062207,0.105604954,0.00073779933,0.0025223973,0.00021118384,0.00004895397,0.005809345],"genre_scores_gemma":[0.9757815,0.0013413876,0.0065693846,0.0016646225,0.000089473164,0.008748309,0.000020857093,0.000016334685,0.005768146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988067,0.00002632139,0.00020378864,0.0004845159,0.00007054463,0.00040809423],"domain_scores_gemma":[0.998438,0.0005309247,0.00019817501,0.0004692412,0.000087458546,0.0002761911],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014120134,0.00020880629,0.0005558676,0.000054285745,0.00067717815,0.000038230748,0.000120340796,0.00012008339,0.0010389439],"category_scores_gemma":[0.00022107114,0.00013367453,0.000043843484,0.000042301133,0.00012539595,0.000062957035,0.000095738425,0.00005906102,0.000033883534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054687716,0.00059555855,0.56330633,0.00002602598,0.00027815666,0.000043560314,0.0007574467,0.0000038420576,0.000009749867,0.0002798422,0.0032646486,0.43088797],"study_design_scores_gemma":[0.0048353043,0.013998627,0.6395499,0.000041477026,0.00013502994,0.000017125287,0.00012304078,0.000008687903,0.000060377748,0.0001574512,0.34095186,0.00012109917],"about_ca_topic_score_codex":0.0004737061,"about_ca_topic_score_gemma":0.016572574,"teacher_disagreement_score":0.43076685,"about_ca_system_score_codex":0.0023181082,"about_ca_system_score_gemma":0.00032827735,"threshold_uncertainty_score":0.99987423},"labels":[],"label_agreement":null},{"id":"W2776318570","doi":"10.1016/j.ygyno.2017.12.014","title":"Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Odds ratio; Ethnic group; Odds; Genotype; Logistic regression; Demography; Internal medicine; Genetics; Biology; Gene","score_opus":0.09156542615329943,"score_gpt":0.3599407714533508,"score_spread":0.26837534530005136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776318570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8946015,0.0010218363,0.00001840339,0.00028696517,0.00010889479,0.00034143717,0.000004247294,0.00001957643,0.1035971],"genre_scores_gemma":[0.9968088,0.0008816634,0.00013714712,0.00019210018,0.000055678953,0.00016565621,0.0000070125925,0.0000058395726,0.0017460906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862427,0.00018260453,0.00028079067,0.0002776977,0.00018133323,0.00045331827],"domain_scores_gemma":[0.9987938,0.0004737024,0.0001907745,0.0002480248,0.00013228951,0.00016144663],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050441036,0.00013569296,0.00063061516,0.0001338046,0.00007964415,0.0000115908615,0.00015780477,0.00022461331,0.006640852],"category_scores_gemma":[0.00091098255,0.00008689821,0.00002531956,0.000054459142,0.0014500337,0.00010478089,0.00013075111,0.00039551724,0.0000046779246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030126348,0.0003734109,0.6919888,0.0001272519,0.000042735795,0.00013098744,0.0032216164,4.2879682e-7,0.00019305226,0.0006486365,0.00032898382,0.29993147],"study_design_scores_gemma":[0.0022272703,0.010295222,0.9823844,0.00000766053,0.000024757099,0.000012467693,0.0015540543,0.00004119153,0.000031601445,0.00092996506,0.0023943144,0.00009712399],"about_ca_topic_score_codex":0.0012724072,"about_ca_topic_score_gemma":0.016747452,"teacher_disagreement_score":0.29983434,"about_ca_system_score_codex":0.0016775827,"about_ca_system_score_gemma":0.00065105536,"threshold_uncertainty_score":0.9942672},"labels":[],"label_agreement":null},{"id":"W2779229287","doi":"10.1016/j.ygyno.2017.12.026","title":"The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Lymphadenectomy; Lymph node; Sentinel lymph node; Lymph; Carcinoma; Atypical hyperplasia; Stage (stratigraphy); Cancer; Radiology; Internal medicine; Pathology; Breast cancer","score_opus":0.06695631940263772,"score_gpt":0.35506355661267647,"score_spread":0.2881072372100387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779229287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92611665,0.00032712694,0.000017524448,0.0034147468,0.00056571985,0.0005935021,0.0000064267947,0.000009266818,0.068949044],"genre_scores_gemma":[0.99850386,0.00037653267,0.00048581872,0.00025702413,0.00009946067,0.000087237684,0.0000046328814,0.0000048860243,0.00018054673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984423,0.00024062606,0.00051803765,0.00022818905,0.00026754595,0.000303322],"domain_scores_gemma":[0.99698406,0.00188059,0.00037524707,0.0006459431,0.00006594284,0.000048221646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013230722,0.00012384202,0.00053978374,0.00009024126,0.00020901712,0.000011306841,0.0005084839,0.00015440989,0.00025679768],"category_scores_gemma":[0.0011624562,0.00006142946,0.000167632,0.0002656744,0.00043771308,0.000028029492,0.000227246,0.00017228778,0.000014226274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025429218,0.0013615724,0.83607906,0.0001500511,0.00036701967,0.0002465482,0.00011043216,9.631666e-7,0.00016041473,0.0016995677,0.00021189537,0.15706953],"study_design_scores_gemma":[0.0093207285,0.00029173118,0.9825344,0.000027072809,0.00015470388,0.00002218728,0.0004712665,0.00005053596,0.00011129136,0.00097601843,0.005991181,0.00004888305],"about_ca_topic_score_codex":0.00009544037,"about_ca_topic_score_gemma":0.000024133102,"teacher_disagreement_score":0.15702064,"about_ca_system_score_codex":0.0001270242,"about_ca_system_score_gemma":0.00009509448,"threshold_uncertainty_score":0.28117543},"labels":[],"label_agreement":null},{"id":"W2786430620","doi":"10.1016/j.ygyno.2018.01.016","title":"Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Serous fluid; Surgical pathology; Serous carcinoma; Fallopian tube; Pathology; Gynecology; General surgery; Radiology; Ovarian cancer; Cancer; Internal medicine","score_opus":0.06401480713532656,"score_gpt":0.374758644771803,"score_spread":0.3107438376364764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786430620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882704,0.0023959205,0.0000087813505,0.0010814759,0.00046496742,0.0005278824,0.00006793193,0.00002522218,0.0071574305],"genre_scores_gemma":[0.9959692,0.0008512739,0.0025512131,0.00023526698,0.00025425325,0.00004727764,0.000025256677,0.000013510518,0.00005278715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796575,0.00056817906,0.00057705055,0.00041999563,0.0001712999,0.00029772217],"domain_scores_gemma":[0.9958338,0.0023351107,0.00089162536,0.0002455523,0.0005731146,0.0001207802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013228036,0.00017405162,0.0009490935,0.00021859624,0.00005287167,0.0000065230142,0.00009444183,0.00033117292,0.0006132786],"category_scores_gemma":[0.0030351193,0.00013239274,0.000056523437,0.0005390478,0.0007772163,0.00007437524,0.0001011883,0.00017886705,0.000010607963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031190175,0.0029714066,0.92028916,0.00019417383,0.00033992223,0.0011536798,0.00041956987,5.173947e-7,0.0031971135,0.0006655524,0.0010497223,0.066600166],"study_design_scores_gemma":[0.008403614,0.0138425045,0.94088686,0.0000384974,0.00026035914,0.0002491644,0.000115668525,0.000015063315,0.004388679,0.00008492044,0.031591207,0.00012344128],"about_ca_topic_score_codex":0.00026254877,"about_ca_topic_score_gemma":0.0007882076,"teacher_disagreement_score":0.066476725,"about_ca_system_score_codex":0.00015397361,"about_ca_system_score_gemma":0.00073345256,"threshold_uncertainty_score":0.67149705},"labels":[],"label_agreement":null},{"id":"W2786653356","doi":"10.1016/j.ygyno.2018.01.017","title":"Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"AstraZeneca Canada; Israel Cancer Research Fund","keywords":"Medicine; Debulking; Chemotherapy; Oncology; Ovarian cancer; RAD51; Internal medicine; Proportional hazards model; Cancer; Homologous recombination; Carboplatin; Gene; Cisplatin; Biology; Genetics","score_opus":0.03326885898247156,"score_gpt":0.3608988695318598,"score_spread":0.32763001054938823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2786653356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394304,0.000046916906,0.00015834818,0.0021699707,0.0007319144,0.0014470147,0.00004022157,0.00012250361,0.0013400554],"genre_scores_gemma":[0.9919281,0.000035863235,0.0029174043,0.003460748,0.00023372764,0.0008299459,0.00013422956,0.000044868997,0.00041510956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973335,0.00046805514,0.0007445789,0.00064636435,0.00029456435,0.0005128957],"domain_scores_gemma":[0.9980945,0.00045593648,0.0005178574,0.00035285484,0.00042939806,0.00014945418],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007408113,0.00029014173,0.0008282347,0.00016103206,0.000101700316,0.000011809673,0.0001423478,0.0005348883,0.0020467336],"category_scores_gemma":[0.00036601734,0.00018931265,0.00007076731,0.0003487269,0.0005494606,0.00009935353,0.000044885805,0.00048512442,0.000037210833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060516912,0.0021890819,0.97131914,0.000010959321,0.00009421287,0.000117720934,0.00019664838,0.0000018787827,0.00015882078,0.000007236629,0.0006608246,0.019191813],"study_design_scores_gemma":[0.02285111,0.012869529,0.96105874,0.00013109461,0.00006341976,0.000010685795,0.00002626206,0.000026942984,0.0009237277,0.00015211849,0.0016309309,0.00025542086],"about_ca_topic_score_codex":0.00004480594,"about_ca_topic_score_gemma":0.000618068,"teacher_disagreement_score":0.018936392,"about_ca_system_score_codex":0.0012711089,"about_ca_system_score_gemma":0.00044171148,"threshold_uncertainty_score":0.99886554},"labels":[],"label_agreement":null},{"id":"W2787266690","doi":"10.1016/j.ygyno.2018.01.019","title":"Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"Astellas Pharma","keywords":"Medicine; Paclitaxel; Tolerability; Internal medicine; Clinical endpoint; Ovarian cancer; Adverse effect; Oncology; Discontinuation; Chemotherapy; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Urology; Phases of clinical research; Gastroenterology; Cancer; Randomized controlled trial","score_opus":0.032654111395771096,"score_gpt":0.3527039054452852,"score_spread":0.32004979404951406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787266690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550045,0.00017792449,0.0000061651817,0.0007287325,0.00050581223,0.0020124437,0.00004743876,0.000047151523,0.0009738749],"genre_scores_gemma":[0.99823904,0.000037557715,0.00059300347,0.00061164517,0.00020183403,0.00017858145,0.000026989766,0.00002522536,0.00008611097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750775,0.00036759677,0.0006746189,0.0006541506,0.00027657728,0.00051929784],"domain_scores_gemma":[0.9985101,0.00038891932,0.00031359206,0.00024878926,0.00031334034,0.00022522685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008404196,0.00030473652,0.0008205144,0.000214259,0.00016584981,0.00002448698,0.000091881506,0.000232451,0.00014099448],"category_scores_gemma":[0.0007632043,0.00021807094,0.00003118909,0.00022333906,0.00036520773,0.00009666745,0.00015733055,0.00043968717,0.000009108625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008786347,0.005050383,0.75372773,0.000039233168,0.00014739204,0.00017466467,0.0040938077,1.7119947e-7,0.0012707287,0.000024914641,0.00025668042,0.22642794],"study_design_scores_gemma":[0.03171826,0.13155627,0.8329652,0.00007758262,0.00021057691,0.000011142374,0.0021267808,0.00011255725,0.000052526557,0.000059339076,0.0008854529,0.00022432233],"about_ca_topic_score_codex":0.00021574572,"about_ca_topic_score_gemma":0.0009187389,"teacher_disagreement_score":0.22620362,"about_ca_system_score_codex":0.00031578512,"about_ca_system_score_gemma":0.00028406488,"threshold_uncertainty_score":0.8892675},"labels":[],"label_agreement":null},{"id":"W2788094725","doi":"10.1016/j.ygyno.2018.02.003","title":"Hyperglycemia promotes insulin-independent ovarian tumor growth","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Internal medicine; Endocrinology; Ovarian cancer; Type 2 diabetes; Insulin; Carbohydrate metabolism; Diabetes mellitus; Cancer; Growth factor; Impaired glucose tolerance; Glucose uptake; Cancer research; Receptor","score_opus":0.012310080098896812,"score_gpt":0.26556238603623517,"score_spread":0.25325230593733833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788094725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563689,0.0012865721,0.00039303637,0.00088915526,0.006121973,0.0005556332,0.000029778117,0.000080707134,0.034274228],"genre_scores_gemma":[0.9858522,0.00044771985,0.0028136268,0.0032716976,0.0056795836,0.0001375401,0.000072414776,0.00003681075,0.0016884463],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788934,0.00019864521,0.000374915,0.00072523375,0.00016151555,0.00065035175],"domain_scores_gemma":[0.99876755,0.000060677175,0.00020133179,0.00048112724,0.00028489402,0.00020440486],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044934754,0.00028751293,0.00041410365,0.00008521794,0.00021461022,0.000025379244,0.00045816728,0.00049636466,0.00059836876],"category_scores_gemma":[0.0007372542,0.0002552575,0.00014489214,0.00016863257,0.00040598743,0.0000070889655,0.0003254662,0.00023780126,0.00029453286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001151414,0.0011373659,0.0073197205,0.000048610145,0.00030871294,0.00008352147,0.00035305833,0.000005720808,0.84519863,0.0031549418,0.06626991,0.07496842],"study_design_scores_gemma":[0.002402098,0.004017857,0.025194924,0.0000045814527,0.00006922992,0.00024193805,0.00011497709,0.000019011324,0.0725362,0.0013137695,0.8936589,0.00042656634],"about_ca_topic_score_codex":0.000069213216,"about_ca_topic_score_gemma":0.0005954746,"teacher_disagreement_score":0.82738894,"about_ca_system_score_codex":0.00010149551,"about_ca_system_score_gemma":0.00060243206,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W2788889277","doi":"10.1016/j.ygyno.2018.02.005","title":"Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report","year":2018,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"National Institutes of Health","keywords":"Medicine; Clinical trial; Endometrial cancer; Randomized controlled trial; Cancer; Incidence (geometry); Oncology; Internal medicine; Gynecology","score_opus":0.4019390373719259,"score_gpt":0.517148717867781,"score_spread":0.11520968049585517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788889277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000642874,0.98616046,0.000026193817,0.0003616964,0.0021126969,0.0029351478,0.00004353855,0.00009140038,0.0076259975],"genre_scores_gemma":[0.00057982263,0.99308395,0.00080534373,0.00060784287,0.0020809448,0.0014973622,0.00018625183,0.00006504986,0.0010934474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991962,0.0027405142,0.0030954762,0.001054557,0.0003933082,0.0007541058],"domain_scores_gemma":[0.9782286,0.018214112,0.0025930367,0.00039600025,0.00019547298,0.00037277522],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010669556,0.00064098765,0.00754701,0.0008729149,0.00017146328,0.000039123224,0.00019711103,0.0012837005,0.00078228436],"category_scores_gemma":[0.01103003,0.0003895459,0.000662615,0.00072246045,0.00037101933,0.00009889295,0.0001828948,0.0010677293,0.000012955089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013793377,0.0003988926,0.0029292917,0.0023324916,0.0016349504,0.0043263324,0.000054414442,0.0000012191615,3.0715105e-7,0.000026500704,0.0005060839,0.9864102],"study_design_scores_gemma":[0.008576056,0.0062468117,0.00043551842,0.0037092052,0.0043908264,0.0011618646,0.00020830527,0.000005110299,9.583681e-7,0.0001365076,0.9747503,0.00037855053],"about_ca_topic_score_codex":0.00021749879,"about_ca_topic_score_gemma":0.00019006127,"teacher_disagreement_score":0.98603165,"about_ca_system_score_codex":0.0014324128,"about_ca_system_score_gemma":0.0035271687,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W2791829934","doi":"10.1016/j.ygyno.2018.03.002","title":"The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; University of Toronto; Sunnybrook Health Science Centre; Western University; University of British Columbia; McMaster University; Queen's University","funders":"","keywords":"Medicine; Endometrial cancer; Hazard ratio; Serous fluid; Log-rank test; Brachytherapy; Internal medicine; Proportional hazards model; Stage (stratigraphy); Adjuvant; Oncology; External beam radiotherapy; Chemotherapy; Confidence interval; Radiation therapy; Cancer","score_opus":0.02520832342364666,"score_gpt":0.3510108801043206,"score_spread":0.3258025566806739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791829934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162114,0.0044486523,0.000021375383,0.00071219757,0.00017625108,0.0004080014,0.000037800222,0.000018384284,0.002556215],"genre_scores_gemma":[0.9938937,0.00418772,0.00059053866,0.00051735295,0.0000859649,0.00009766409,0.000011485818,0.000005939188,0.0006096542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989227,0.00012777137,0.00030925102,0.0002535873,0.00012537169,0.00026132033],"domain_scores_gemma":[0.99911904,0.00037511313,0.00014144901,0.00017247042,0.00010416844,0.00008773978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002741936,0.00013326724,0.00054702983,0.00015650412,0.000109901586,0.000005772318,0.00010154331,0.00013755655,0.00082989054],"category_scores_gemma":[0.000110936664,0.000073102536,0.00009819679,0.00060987624,0.00035536877,0.000026798858,0.00006782805,0.00013476612,0.00001093812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004332447,0.0017897721,0.4920635,0.000032347212,0.0013092655,0.00013448136,0.00048247585,0.000059630103,0.010577401,0.00033162118,0.000031344534,0.48885572],"study_design_scores_gemma":[0.011341307,0.007942479,0.91512626,0.000007495353,0.00046162657,0.000008138259,0.00036429992,0.00092205906,0.0050775562,0.00019081493,0.05844406,0.00011390144],"about_ca_topic_score_codex":0.0014813353,"about_ca_topic_score_gemma":0.007939768,"teacher_disagreement_score":0.48874182,"about_ca_system_score_codex":0.00027716774,"about_ca_system_score_gemma":0.00023833878,"threshold_uncertainty_score":0.9086719},"labels":[],"label_agreement":null},{"id":"W2794542866","doi":"10.1016/j.ygyno.2017.12.024","title":"First nations people's perspectives on barriers and supports for enhancing HPV vaccination: Foundations for sustainable, community-driven strategies","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Assembly of First Nations; University nuhelot'ine thaiyots'i nistameyimâkanak Blue Quills; Ministry of Health; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Indigenous and Northern Affairs Canada","keywords":"Medicine; Cervical cancer; Vaccination; Indigenous; Community engagement; Health care; General partnership; HPV vaccines; Family medicine; Economic growth; Cancer; Political science; Public relations; HPV infection; Immunology","score_opus":0.03189254010944936,"score_gpt":0.39022900428371216,"score_spread":0.3583364641742628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794542866","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32594863,0.00038825878,0.030046174,0.041963216,0.0007228599,0.01095766,0.00013731568,0.00036634193,0.58946955],"genre_scores_gemma":[0.9942566,0.000128739,0.0017849333,0.0004774676,0.00032904418,0.00123011,0.00009418755,0.000018143835,0.0016807802],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99870324,0.0001414807,0.0002495877,0.00029540688,0.00012924484,0.00048106062],"domain_scores_gemma":[0.9928468,0.0051550893,0.00008927028,0.00023665262,0.0014762251,0.00019597217],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077204895,0.00014559967,0.00035332484,0.0002973765,0.0022713991,0.00007389978,0.00013348284,0.00020430762,0.0060230866],"category_scores_gemma":[0.0064758807,0.00012956942,0.000084579886,0.00030901568,0.00025255227,0.00017905016,0.00009390078,0.0002982702,0.000008754666],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033637288,0.0021139386,0.007903235,0.0027913286,0.00055364653,0.00004607447,0.05618052,0.00017194042,0.00016564851,0.85506564,0.02337266,0.04827165],"study_design_scores_gemma":[0.0068510273,0.027985848,0.40745217,0.000012086311,0.00023391095,0.000042531887,0.35566634,0.0013808492,0.00016951597,0.028198417,0.17166914,0.0003381707],"about_ca_topic_score_codex":0.00013743395,"about_ca_topic_score_gemma":0.05134878,"teacher_disagreement_score":0.8268672,"about_ca_system_score_codex":0.00085354364,"about_ca_system_score_gemma":0.0012865145,"threshold_uncertainty_score":0.9990275},"labels":[],"label_agreement":null},{"id":"W2795756220","doi":"10.1016/j.ygyno.2018.03.058","title":"Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer","year":2018,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"Wellbeing of Women; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ovarian cancer; Diarrhea; Internal medicine; Adverse effect; Oncology; Chemotherapy; Cancer","score_opus":0.041857910509324955,"score_gpt":0.38598834507433744,"score_spread":0.34413043456501247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795756220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013360701,0.97300994,0.0000026400542,0.000307462,0.001072749,0.0062804455,0.00012535579,0.000036744834,0.005803958],"genre_scores_gemma":[0.0033614514,0.9881149,0.003958787,0.000086938984,0.000099836936,0.0037849937,0.00025492147,0.000054233522,0.00028394518],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732566,0.00026208692,0.0008073397,0.00085706497,0.00025235378,0.00049552246],"domain_scores_gemma":[0.998359,0.00035179296,0.00056387164,0.00048462476,0.00006717624,0.00017350126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028352492,0.0005800255,0.0030688867,0.00026957932,0.00006453883,0.000011874475,0.00012676879,0.0004788938,0.00047594743],"category_scores_gemma":[0.000011736907,0.0003598142,0.00031553418,0.00034691373,0.00013450992,0.00004082814,0.00011845271,0.00021483185,0.000019594343],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084264764,0.00303988,0.10170432,0.0046299472,0.0030116043,0.00029709295,0.00005579846,3.5512423e-7,1.7169244e-8,0.00020833999,0.00029271422,0.88667566],"study_design_scores_gemma":[0.008551964,0.010388053,0.1960176,0.007552811,0.005436629,0.0000049253913,0.000030621624,6.1960435e-7,5.089645e-7,0.000014822278,0.77169925,0.00030223],"about_ca_topic_score_codex":0.00018422882,"about_ca_topic_score_gemma":0.000323333,"teacher_disagreement_score":0.88637346,"about_ca_system_score_codex":0.0050241994,"about_ca_system_score_gemma":0.0011096614,"threshold_uncertainty_score":0.9998854},"labels":[],"label_agreement":null},{"id":"W2799749455","doi":"10.1016/j.ygyno.2018.04.558","title":"Prospective cohort study comparing quality of life and sexual health outcomes between women undergoing robotic, laparoscopic and open surgery for endometrial cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Saskatchewan; Centre Hospitalier de l’Université de Montréal; McGill University; Princess Margaret Cancer Centre; University of Ottawa; Jewish General Hospital; Public Health Ontario; University of Toronto","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Quality of life (healthcare); Laparotomy; Laparoscopy; Endometrial cancer; Visual analogue scale; Sexual function; Cohort; Prospective cohort study; Robotic surgery; Pelvic pain; Cohort study; Surgery; Cancer; Physical therapy; Internal medicine; Nursing","score_opus":0.17188052199931966,"score_gpt":0.447956339704872,"score_spread":0.27607581770555234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799749455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286175,0.00038058436,0.000045097186,0.0010109368,0.00053141423,0.0047037494,0.00003482273,0.00003171371,0.00039996073],"genre_scores_gemma":[0.9973528,0.00011514029,0.00046012682,0.00063623686,0.00028961556,0.0009694159,0.000015277948,0.000015121196,0.00014626863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975193,0.0004292238,0.0008173706,0.00055626786,0.00019901739,0.0004787939],"domain_scores_gemma":[0.9908369,0.007971188,0.0005120047,0.00019869836,0.00015883145,0.00032233214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024436016,0.00021058247,0.0028158948,0.00020229856,0.00020978515,0.000025383739,0.00012762811,0.00013827419,0.00012345037],"category_scores_gemma":[0.0040832623,0.00015655375,0.00005164543,0.0003576514,0.0002782827,0.00008395779,0.0003191941,0.00014338383,0.0000016748356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018302064,0.00085314974,0.9872961,0.0001891887,0.0010649984,0.0000022176962,0.000657012,0.0000010267577,0.000010779281,0.00005967783,0.00009937254,0.00793626],"study_design_scores_gemma":[0.020592935,0.013840192,0.9632457,0.00001518763,0.00017662428,0.0000011467624,0.0015274712,0.0000042641036,0.000019247173,0.00035193955,0.00009786145,0.0001274164],"about_ca_topic_score_codex":0.0031357876,"about_ca_topic_score_gemma":0.005745462,"teacher_disagreement_score":0.024050398,"about_ca_system_score_codex":0.0009357229,"about_ca_system_score_gemma":0.0010670624,"threshold_uncertainty_score":0.6384077},"labels":[],"label_agreement":null},{"id":"W2803094090","doi":"10.1016/j.ygyno.2018.04.004","title":"Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; Jewish General Hospital; McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cervical cancer; Cervical cancer screening; Sampling (signal processing); Sample (material); Cancer; Gynecology; Obstetrics; Internal medicine; Telecommunications","score_opus":0.14327738847960497,"score_gpt":0.4404566031306171,"score_spread":0.2971792146510121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803094090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982542,0.00038094717,0.0053235805,0.006863768,0.00021167757,0.0027958932,0.000021174974,0.000108593005,0.0017523927],"genre_scores_gemma":[0.97174317,0.00009730427,0.025793636,0.0012298417,0.00066583743,0.00037448938,0.000017806877,0.000026822621,0.000051100407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974864,0.0003237472,0.00061724044,0.00057474064,0.00036856547,0.00062927976],"domain_scores_gemma":[0.99498296,0.0037907078,0.00018281233,0.00033148535,0.0004520122,0.00026001886],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016080682,0.00022308303,0.000724434,0.00018905732,0.00023940756,0.000029433862,0.0002815649,0.00032206145,0.002319971],"category_scores_gemma":[0.0013262315,0.00015639408,0.00010220193,0.0005976462,0.00018940162,0.00008266899,0.00031312095,0.00047779584,0.0000060916227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023702262,0.0023055575,0.6390221,0.00028623364,0.00038625853,0.000021281152,0.0066140755,0.000088373556,0.00014179063,0.0002367747,0.00061958545,0.34790775],"study_design_scores_gemma":[0.007415348,0.007661916,0.9455894,0.000017087037,0.00034614466,0.00001699979,0.0027025682,0.0062465877,0.0002798745,0.00060662103,0.028924318,0.00019313587],"about_ca_topic_score_codex":0.002821186,"about_ca_topic_score_gemma":0.00852634,"teacher_disagreement_score":0.34771463,"about_ca_system_score_codex":0.000328646,"about_ca_system_score_gemma":0.0006159995,"threshold_uncertainty_score":0.998592},"labels":[],"label_agreement":null},{"id":"W2803852062","doi":"10.1016/j.ygyno.2018.05.011","title":"Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Public Health Ontario; London Health Sciences Centre; Women's College Hospital; University of Toronto","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Ovarian cancer; Fallopian tube; BRCA mutation; Fallopian tube cancer; Gynecology; Prophylactic Surgery; Incidence (geometry); Oophorectomy; Obstetrics; Breast cancer; Cancer; Oncology; Internal medicine; Hysterectomy; Surgery","score_opus":0.06164547199410488,"score_gpt":0.3512960315957402,"score_spread":0.2896505596016353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803852062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718591,0.00022350503,0.00014403912,0.0048629753,0.00082618283,0.0010973654,0.00002000968,0.00015558988,0.02081122],"genre_scores_gemma":[0.989229,0.00042949244,0.002881387,0.0024271547,0.00076012075,0.0016100317,0.000025895171,0.00003637569,0.0026004987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99801874,0.00013714831,0.0003491278,0.0006286855,0.0002110994,0.0006551759],"domain_scores_gemma":[0.9985261,0.00035618307,0.00023391364,0.00039957982,0.00020491192,0.00027932558],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030416658,0.0002735016,0.0006529062,0.00014280209,0.0002034038,0.000031659303,0.000129339,0.00031713524,0.0127659505],"category_scores_gemma":[0.000095402815,0.00017225627,0.00005524632,0.00040201438,0.00052719435,0.00008985847,0.000054253942,0.00024793492,0.00028117344],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067460975,0.0032585473,0.3151225,0.00009134281,0.0014509392,0.011914675,0.006278358,0.000052887335,0.00030629052,0.00091854075,0.031791937,0.62206787],"study_design_scores_gemma":[0.007064946,0.014833756,0.79250914,0.000045009525,0.0001904973,0.0001733844,0.0006836155,0.000029845263,0.00026509995,0.00026107355,0.18373117,0.0002124753],"about_ca_topic_score_codex":0.00051056384,"about_ca_topic_score_gemma":0.005078456,"teacher_disagreement_score":0.62185544,"about_ca_system_score_codex":0.002242492,"about_ca_system_score_gemma":0.0007616546,"threshold_uncertainty_score":0.98813653},"labels":[],"label_agreement":null},{"id":"W2805139265","doi":"10.1016/j.ygyno.2018.04.570","title":"Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute","keywords":"Medicine; Lymphovascular invasion; Lymph node; Stage (stratigraphy); Stromal cell; Adenocarcinoma; Metastasis; Pathology; Lymph node metastasis; Oncology; Internal medicine; Cancer; Biology","score_opus":0.024570907777875906,"score_gpt":0.2793151791331371,"score_spread":0.2547442713552612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805139265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502945,0.0004591952,0.0000060030206,0.00048020744,0.0004554055,0.0010659564,0.00040778582,0.000064078944,0.0020319265],"genre_scores_gemma":[0.9978111,0.00026626824,0.00015466017,0.00092313136,0.00008457895,0.00015391964,0.00028363042,0.00004704143,0.00027571266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995277,0.00086162967,0.0012275568,0.00092194596,0.0006965025,0.0010154058],"domain_scores_gemma":[0.9965895,0.0013828027,0.0008562657,0.00045661937,0.0004349078,0.00027992955],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007232762,0.0004981108,0.0017077518,0.0006151606,0.00014292556,0.000015791062,0.00033287643,0.0006612655,0.0031721604],"category_scores_gemma":[0.0015198023,0.00037251008,0.0002292579,0.0013422149,0.00044376732,0.00012999373,0.00037760206,0.0005125327,0.00015233173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025514595,0.0036289587,0.9796787,0.00008190152,0.00047601716,0.00048753523,0.00070906355,0.000005806767,0.00026866244,0.0000029766966,0.00018312134,0.011925779],"study_design_scores_gemma":[0.027086305,0.008623449,0.9595357,0.00008215324,0.0006498058,0.000022887149,0.00046738912,0.00007878954,0.0029261135,0.00012286767,0.00008913571,0.0003154051],"about_ca_topic_score_codex":0.0058570476,"about_ca_topic_score_gemma":0.017895974,"teacher_disagreement_score":0.024534844,"about_ca_system_score_codex":0.0037069628,"about_ca_system_score_gemma":0.00044673457,"threshold_uncertainty_score":0.9998727},"labels":[],"label_agreement":null},{"id":"W2805869755","doi":"10.1016/j.ygyno.2018.05.025","title":"Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"St. Baldrick's Foundation","keywords":"Carboplatin; Medicine; Dysgerminoma; Gynecologic oncology; Chemotherapy; Germ cell tumors; Cisplatin; Stage (stratigraphy); Oncology; Internal medicine; Gynecology; Ovary","score_opus":0.00793091688380209,"score_gpt":0.30477920324045105,"score_spread":0.29684828635664895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805869755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941969,0.00079558004,0.000005081046,0.0007044429,0.00010677236,0.0034005258,0.000031907388,0.00003406164,0.00072473875],"genre_scores_gemma":[0.9953916,0.00014821469,0.0004185061,0.0034062879,0.00006118594,0.00044838522,0.0000441113,0.000029748337,0.000051949406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814135,0.00023858287,0.0004056541,0.0005714827,0.00021113637,0.00043181586],"domain_scores_gemma":[0.9986443,0.00045534957,0.00027753314,0.00041769093,0.00008306365,0.00012207493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016570113,0.00036146995,0.0007195898,0.00019348285,0.000071716284,0.000008793337,0.0001258087,0.00026635994,0.00028129487],"category_scores_gemma":[0.00014668699,0.00024215007,0.00014805184,0.00032384373,0.0003362239,0.000031492153,0.000011764744,0.0001441188,0.000023657562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030515066,0.005349354,0.86746055,0.000053612577,0.00010380724,0.0002527746,0.0011652609,0.000020700158,0.0003001009,0.000011876889,0.000010587573,0.12221988],"study_design_scores_gemma":[0.035650607,0.023956368,0.93487763,0.00014105096,0.00012887291,0.000044393597,0.0002596375,0.0006630465,0.0037564773,0.00007769476,0.00026139844,0.00018282674],"about_ca_topic_score_codex":0.00088277104,"about_ca_topic_score_gemma":0.00061935093,"teacher_disagreement_score":0.12203706,"about_ca_system_score_codex":0.00059095933,"about_ca_system_score_gemma":0.0003674902,"threshold_uncertainty_score":0.98745936},"labels":[],"label_agreement":null},{"id":"W2807256081","doi":"10.1016/j.ygyno.2018.05.030","title":"First-line hysterectomy for women with low-risk non-metastatic gestational trophoblastic neoplasia no longer wishing to conceive","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Fondation pour la Recherche Nuovo-Soldati; Ligue Contre le Cancer; Collège National des Gynécologues et Obstétriciens Français","keywords":"Medicine; Hysterectomy; Chemotherapy; Choriocarcinoma; Salvage therapy; Methotrexate; Confidence interval; Surgery; Obstetrics; Internal medicine","score_opus":0.013975489192869206,"score_gpt":0.2948616197081207,"score_spread":0.28088613051525146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807256081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97288865,0.000026225425,0.017956756,0.0020530305,0.0008176706,0.0025480904,0.000265036,0.00011028745,0.0033342582],"genre_scores_gemma":[0.9518468,0.000016826898,0.041276667,0.002360103,0.00055930665,0.002151784,0.00006923904,0.000053739288,0.0016655419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730986,0.00011917682,0.0005674035,0.0007362532,0.00039411426,0.0008732062],"domain_scores_gemma":[0.9931064,0.004082749,0.00034113694,0.00028507566,0.0017055094,0.00047911677],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035962474,0.0003982726,0.00088271126,0.00023373583,0.00036972482,0.00003727891,0.00018992515,0.00013523198,0.0011104452],"category_scores_gemma":[0.0056258906,0.0003043465,0.0000889789,0.00038160666,0.0005711214,0.0001254137,0.00010253905,0.000258219,0.0009669386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20036472,0.025031878,0.27134046,0.010557029,0.018507415,0.008557957,0.08206736,0.05776752,0.010024326,0.005438649,0.19414374,0.11619894],"study_design_scores_gemma":[0.022101402,0.091847494,0.83067936,0.00033339707,0.0010784277,0.00024942172,0.004435142,0.007728843,0.00014512363,0.004171762,0.036248762,0.0009808784],"about_ca_topic_score_codex":0.000019586814,"about_ca_topic_score_gemma":0.00036912842,"teacher_disagreement_score":0.55933887,"about_ca_system_score_codex":0.0011409563,"about_ca_system_score_gemma":0.0012094326,"threshold_uncertainty_score":0.9999409},"labels":[],"label_agreement":null},{"id":"W2808201256","doi":"10.1016/j.ygyno.2018.06.001","title":"Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Stage (stratigraphy); Lymphadenectomy; Radiology; Lymph node; Lymph; Carcinoma; Biopsy; Cancer; Surgery; Breast cancer; Internal medicine; Pathology","score_opus":0.03370454170958992,"score_gpt":0.32399902508164846,"score_spread":0.29029448337205854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808201256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812926,0.00031036042,0.000087692235,0.0037691675,0.0006199719,0.0009095203,0.000016432059,0.000056867135,0.0129373735],"genre_scores_gemma":[0.9912694,0.000114003466,0.0015375755,0.004678201,0.00087055814,0.00038357338,0.000009069594,0.000020428204,0.0011171714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981686,0.0001222014,0.0003894551,0.00055519445,0.00020440311,0.0005601605],"domain_scores_gemma":[0.9985439,0.0007053999,0.00013967333,0.00020208258,0.0001317875,0.00027711692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037344053,0.00023181067,0.0007659031,0.00059174607,0.00008124005,0.000013154562,0.00011470129,0.00025871745,0.00079683075],"category_scores_gemma":[0.00070207956,0.00015941595,0.00005440055,0.0014254159,0.00017409764,0.00005385106,0.00014955815,0.00021201961,0.000079185294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047133495,0.00057540485,0.6976707,0.00005737159,0.00020070681,0.00043250606,0.00041146835,0.0000012556133,0.003618073,0.00004854936,0.0002783332,0.2919923],"study_design_scores_gemma":[0.04117316,0.0055448823,0.9219829,0.00005762399,0.00018827213,0.00012361546,0.00030165905,0.00004998309,0.001086336,0.0001917299,0.029002996,0.0002968529],"about_ca_topic_score_codex":0.0018113459,"about_ca_topic_score_gemma":0.0007785093,"teacher_disagreement_score":0.29169545,"about_ca_system_score_codex":0.0008313028,"about_ca_system_score_gemma":0.00037452142,"threshold_uncertainty_score":0.8724738},"labels":[],"label_agreement":null},{"id":"W2809644041","doi":"10.1016/j.ygyno.2018.05.019","title":"Pap tests in the diagnosis of cervical cancer: Help or hinder?","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Gynecology; Pap test; Cancer; Obstetrics; Medical physics; Intensive care medicine; Cervical cancer screening; Internal medicine","score_opus":0.1086465719060708,"score_gpt":0.4435833838669382,"score_spread":0.3349368119608674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809644041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8875368,0.0006517603,0.0000053810804,0.030762574,0.00040219227,0.0009005222,0.00001543862,0.000034830464,0.07969048],"genre_scores_gemma":[0.9904596,0.0007504355,0.00015783413,0.007179894,0.00050733914,0.0005548349,0.0000055240325,0.000010432905,0.00037409802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823743,0.00029374854,0.000367118,0.00030240565,0.00031317605,0.00048612224],"domain_scores_gemma":[0.9968203,0.0024084416,0.00008383058,0.00033015845,0.00023642725,0.00012086914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077712256,0.00013072096,0.0005172847,0.00011803983,0.00007512557,0.0000070286337,0.0003393641,0.00029712697,0.0327808],"category_scores_gemma":[0.0013518479,0.000069745205,0.00008275839,0.0005731679,0.0005392304,0.000030303427,0.00014324248,0.0004479612,0.00011696464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011645167,0.0012056883,0.6242336,0.00012498032,0.000041664734,0.000280478,0.00083387725,0.0000012986193,0.000103276325,0.00045496982,0.017703071,0.35385254],"study_design_scores_gemma":[0.002160686,0.0069207475,0.88506734,0.000011847204,0.000048012957,0.00003859224,0.0005477539,0.000047000332,0.00045090323,0.00071109686,0.1039147,0.00008134459],"about_ca_topic_score_codex":0.0008805214,"about_ca_topic_score_gemma":0.024318982,"teacher_disagreement_score":0.3537712,"about_ca_system_score_codex":0.0004059525,"about_ca_system_score_gemma":0.00080178655,"threshold_uncertainty_score":0.9934847},"labels":[],"label_agreement":null},{"id":"W2810500205","doi":"10.1016/j.ygyno.2018.04.226","title":"Investigating the time intervals between primary cytoreductive surgery and initiation of adjuvant chemotherapy in patients with advanced epithelial ovarian cancer who had optimal cytoreduction surgery with bowel resection","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Chemotherapy; Epithelial ovarian cancer; Bowel resection; Ovarian cancer; Adjuvant; Surgery; Adjuvant chemotherapy; Resection; Colorectal cancer; Cancer; Oncology; Internal medicine; Breast cancer","score_opus":0.019435398314631293,"score_gpt":0.28104337060184525,"score_spread":0.26160797228721394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810500205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952508,0.00011483688,0.000028894898,0.003022155,0.00026661178,0.0010095547,0.00003975719,0.000028709086,0.00023865778],"genre_scores_gemma":[0.9972962,0.00017450782,0.0012025567,0.0005085041,0.00036806785,0.0002952707,0.00009860608,0.000028306917,0.000027969225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823415,0.0002916662,0.0004931782,0.00044159062,0.00022487697,0.00031452044],"domain_scores_gemma":[0.99778277,0.0010424466,0.0005562345,0.00021014235,0.00031971183,0.000088675726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490452,0.00022855263,0.00082933955,0.00021328877,0.00012520941,0.000012333209,0.00005554962,0.00018791368,0.00009640391],"category_scores_gemma":[0.00022481686,0.00014070176,0.0000588305,0.00036237255,0.00061069406,0.00021085158,0.000034983488,0.00021977823,0.0000026049045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020697375,0.0004644538,0.9091168,0.000056451485,0.0002618957,0.00000822768,0.0010331512,0.000031091873,0.00037081802,0.000008301305,0.0004015157,0.086177535],"study_design_scores_gemma":[0.003640357,0.0051827477,0.98628,0.00032673488,0.00017258764,0.000010797893,0.00017960941,0.000024391344,0.0036871699,0.00005125671,0.0002921879,0.00015213295],"about_ca_topic_score_codex":0.00025152756,"about_ca_topic_score_gemma":0.00015913503,"teacher_disagreement_score":0.0860254,"about_ca_system_score_codex":0.000866977,"about_ca_system_score_gemma":0.00084605126,"threshold_uncertainty_score":0.5737651},"labels":[],"label_agreement":null},{"id":"W2810524865","doi":"10.1016/j.ygyno.2019.03.010","title":"Uptake of sentinel lymph node procedures in women with vulvar cancer over time in a population based study","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Vulvar cancer; Sentinel lymph node; Population; Vulvar neoplasm; Lymph node; Gynecology; Oncology; Cancer; Vulva; Surgery; Breast cancer; Internal medicine; Environmental health","score_opus":0.01608884649378762,"score_gpt":0.31165750305069095,"score_spread":0.29556865655690334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810524865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968964,0.00007101364,3.1775767e-7,0.00029919358,0.000090073365,0.0011706994,0.000006377938,0.000022201573,0.0014437346],"genre_scores_gemma":[0.99806684,0.00000941434,0.00011495386,0.0009382923,0.000029349907,0.00045815436,0.000012376759,0.00001298229,0.00035763608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986467,0.00011445009,0.0003944338,0.0003259279,0.00019378142,0.000324749],"domain_scores_gemma":[0.99928707,0.00026056438,0.00016560234,0.00016911479,0.000051029583,0.00006662547],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002940701,0.00015014317,0.0006791833,0.00027583222,0.0000124564,0.0000027959688,0.000075184485,0.00015056728,0.0027586636],"category_scores_gemma":[0.0001952363,0.000102888196,0.000028996763,0.00065651775,0.000021577194,0.000041662926,0.000031443687,0.0001226738,0.000031871346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038297188,0.0028199365,0.988385,0.00009655111,0.00006297217,0.000090114976,0.0002677701,0.0004386332,0.00049354247,0.000003090187,0.00000815367,0.0035044912],"study_design_scores_gemma":[0.022106625,0.0023848603,0.97477835,0.000055537213,0.000050296683,0.0000025496422,0.00019603575,0.00020623163,0.000020693933,0.000034798446,0.00006809279,0.000095916126],"about_ca_topic_score_codex":0.0011447106,"about_ca_topic_score_gemma":0.0011202449,"teacher_disagreement_score":0.018276906,"about_ca_system_score_codex":0.0013220026,"about_ca_system_score_gemma":0.00046556958,"threshold_uncertainty_score":0.998153},"labels":[],"label_agreement":null},{"id":"W2810545657","doi":"10.1016/j.ygyno.2018.04.406","title":"Ember trial: Evaluation of multiple protein and molecular biomarkers to estimate risk of cancer in gynecology patients presenting with a pelvic mass","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axela (Canada)","funders":"","keywords":"Medicine; Biopsy; Liquid biopsy; Cancer; Biomarker; Oncology; Internal medicine; Gynecology; Pathology","score_opus":0.01413931191931574,"score_gpt":0.3263808058177127,"score_spread":0.312241493898397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810545657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996578,0.00021909883,0.00019709492,0.000109003646,0.00020490875,0.0019918357,0.000057771827,0.0000042968963,0.0006379884],"genre_scores_gemma":[0.99547637,0.000053110663,0.0037822984,0.00008737015,0.00004079967,0.00050514017,0.00002529826,0.000017256736,0.000012389805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998385,0.00034241777,0.00040848335,0.00041695486,0.00015772543,0.00028941187],"domain_scores_gemma":[0.9985604,0.00022300657,0.00040114383,0.0002480295,0.00049594074,0.00007144781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008442539,0.00015563141,0.00034429162,0.00011506138,0.00003946999,0.0000053024914,0.00013777593,0.00024097627,0.000058508693],"category_scores_gemma":[0.003049106,0.00013751237,0.00004152801,0.0001731123,0.00023753023,0.0000039315237,0.00015468095,0.00007479813,0.000001439658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009271861,0.0006993847,0.73417586,0.00005985311,0.00031171626,0.0000065840777,0.00025286782,0.0032590241,0.2233312,0.00004023448,0.00019544354,0.028395962],"study_design_scores_gemma":[0.06270381,0.020941945,0.67571354,0.000041458283,0.0004668319,0.0000025630168,0.00018638466,0.0056575304,0.22965656,0.00082231866,0.0032738987,0.00053314934],"about_ca_topic_score_codex":0.00041390685,"about_ca_topic_score_gemma":0.010731098,"teacher_disagreement_score":0.058462325,"about_ca_system_score_codex":0.00011474866,"about_ca_system_score_gemma":0.00041184924,"threshold_uncertainty_score":0.59882045},"labels":[],"label_agreement":null},{"id":"W2811019576","doi":"10.1016/j.ygyno.2018.04.213","title":"Does the use of manipulator for endometrial cancer surgery lead to increased use of adjuvant therapy?","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Adjuvant therapy; Adjuvant; Surgery; Oncology; Cancer; Internal medicine","score_opus":0.21602892890619357,"score_gpt":0.38052961240036187,"score_spread":0.1645006834941683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811019576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99294686,0.00028849335,0.0000742347,0.0022615674,0.002119677,0.0019744781,0.00021704652,0.000030217783,0.00008741275],"genre_scores_gemma":[0.992157,0.00054012315,0.0018308796,0.0037553525,0.0007273453,0.00051962637,0.00002637122,0.000021509348,0.0004218234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817866,0.00024534346,0.0006330057,0.00032959454,0.0002292698,0.00038412114],"domain_scores_gemma":[0.98692733,0.011758832,0.00035794734,0.0003736089,0.00043929083,0.00014299924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005066766,0.00019671567,0.0010772753,0.00029458554,0.00007921826,0.000008855788,0.00014367411,0.00022907466,0.000989893],"category_scores_gemma":[0.0060165985,0.00008731151,0.0003102135,0.00070056756,0.00030634695,0.000073070456,0.00007525955,0.00010672425,0.000011758646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03494539,0.002550879,0.42477393,0.00013955346,0.0013735861,0.000042797878,0.00033720146,0.000018803881,0.023920907,0.00026648614,0.01677045,0.49486002],"study_design_scores_gemma":[0.013372768,0.013455609,0.43986017,0.000061262974,0.0005526681,0.000009421963,0.00008403028,0.00004664704,0.044628143,0.00021260878,0.4874784,0.00023827083],"about_ca_topic_score_codex":0.0024846445,"about_ca_topic_score_gemma":0.0013628314,"teacher_disagreement_score":0.49462175,"about_ca_system_score_codex":0.000279868,"about_ca_system_score_gemma":0.00044235203,"threshold_uncertainty_score":0.99992335},"labels":[],"label_agreement":null},{"id":"W2811100281","doi":"10.1016/j.ygyno.2018.04.548","title":"The economics of prevention in the BRCA mutation carrier: Epithelial ovarian cancer (EOC) prevention by risk-reducing surgery (RRS) is cost effective compared to treatment upon cancer development","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); BC Cancer Agency","funders":"","keywords":"Medicine; Epithelial ovarian cancer; Oncology; BRCA mutation; Ovarian cancer; Germline; Germline mutation; Cancer prevention; Internal medicine; Cancer; Gynecology; Mutation; Surgery; Genetics; Gene","score_opus":0.023381665258288664,"score_gpt":0.332365687865482,"score_spread":0.3089840226071933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811100281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938332,0.0006982954,0.0007349154,0.000989441,0.0010802547,0.0021822413,0.00024909133,0.000008347154,0.00022425609],"genre_scores_gemma":[0.99288267,0.0011644558,0.00053082587,0.0003569518,0.0002728905,0.004399569,0.0001375218,0.000017898185,0.00023721548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978692,0.0007057135,0.00052165164,0.0004683464,0.00009373118,0.0003413541],"domain_scores_gemma":[0.9985513,0.00044575805,0.00048551,0.00031081348,0.00015605027,0.000050562507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001064358,0.00020620889,0.00031217924,0.000074165655,0.0003276925,0.000022986103,0.00023652375,0.00023592183,0.00009520197],"category_scores_gemma":[0.00019672408,0.00014725149,0.00010961005,0.00018448074,0.00015589196,0.000009519256,0.00007102141,0.00010316049,0.0000063839548],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073850696,0.0004367802,0.014284042,0.000016784335,0.0004526435,0.000001988522,0.0042226464,0.0052293614,0.01707478,0.000022330383,0.0052920207,0.9522281],"study_design_scores_gemma":[0.0031306595,0.0034953495,0.17443128,0.000056333618,0.00025485054,0.000013708346,0.0018905906,0.0006244297,0.39104807,0.00049390283,0.42404062,0.00052019546],"about_ca_topic_score_codex":0.0010990823,"about_ca_topic_score_gemma":0.036610108,"teacher_disagreement_score":0.9517079,"about_ca_system_score_codex":0.0016347098,"about_ca_system_score_gemma":0.0015006247,"threshold_uncertainty_score":0.98096925},"labels":[],"label_agreement":null},{"id":"W2811118716","doi":"10.1016/j.ygyno.2019.05.019","title":"Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population based study","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Cervical cancer; Invasive surgery; Variation (astronomy); Radical surgery; Cancer; Population; Surgery; General surgery; Gynecology; Internal medicine; Environmental health","score_opus":0.03722008758247679,"score_gpt":0.3331285734065511,"score_spread":0.2959084858240743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811118716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960135,0.00015365926,0.0000085960855,0.0018245395,0.00024170802,0.0015701785,0.000030139297,0.000022425767,0.00013522059],"genre_scores_gemma":[0.9974786,0.000028052917,0.0006401972,0.0011768257,0.00011709573,0.00024487177,0.0001500235,0.000010713745,0.00015359717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987491,0.00017494161,0.00038474784,0.00031570648,0.00017698699,0.00019854204],"domain_scores_gemma":[0.9946689,0.0047705066,0.00022483994,0.0001187621,0.000120805176,0.00009616174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003859137,0.00013001308,0.0006872978,0.00015103485,0.000037972724,0.000004566177,0.000045885186,0.00021228314,0.0017104511],"category_scores_gemma":[0.0007606472,0.00009832141,0.000108854256,0.00020825514,0.00004024148,0.00004504483,0.000027971346,0.0000877927,0.000012915479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032872595,0.0014908469,0.98688936,0.000114573064,0.000183454,0.000014686129,0.00008514803,0.000017819708,0.0018689466,0.00004414347,0.00027054443,0.005733242],"study_design_scores_gemma":[0.00828275,0.005923193,0.9840285,0.00002308377,0.00025934735,0.000004027737,0.000031080875,0.00046744526,0.00010166763,0.00025498852,0.0005331074,0.000090812246],"about_ca_topic_score_codex":0.000416751,"about_ca_topic_score_gemma":0.00031687817,"teacher_disagreement_score":0.0056424295,"about_ca_system_score_codex":0.00034261262,"about_ca_system_score_gemma":0.00045030462,"threshold_uncertainty_score":0.99920213},"labels":[],"label_agreement":null},{"id":"W2811285388","doi":"10.1016/j.ygyno.2018.08.020","title":"Does MMR status in endometrial cancer influence response to adjuvant therapy?","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Université de Montréal; Women's Health Research Institute; University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Endometrial cancer; Oncology; Adjuvant therapy; Adjuvant; Internal medicine; Gynecology; Cancer","score_opus":0.031158157705747903,"score_gpt":0.3718189022306165,"score_spread":0.34066074452486855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811285388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872008,0.0003807872,0.000009315598,0.0050433534,0.0036208811,0.0015022885,0.000028798035,0.00008926503,0.0021245151],"genre_scores_gemma":[0.988427,0.0005122497,0.0018544868,0.0072405534,0.00050650054,0.0006480159,0.0000031408895,0.00002741627,0.00078063953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710566,0.0005407849,0.0005212065,0.0006382263,0.0003002045,0.0008939321],"domain_scores_gemma":[0.99662,0.0021652118,0.00014474742,0.00044032204,0.00029591014,0.00033381782],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011085604,0.0002623945,0.00072777877,0.0005268943,0.00008142534,0.0000133474305,0.0002586992,0.00040405118,0.0044981935],"category_scores_gemma":[0.006303195,0.0001590818,0.00008196949,0.0009871076,0.00040583903,0.0000515364,0.0001761128,0.00037947518,0.00027876566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044857807,0.0006538977,0.50651693,0.000019672072,0.00009442088,0.00035771183,0.002541758,0.00012657215,0.25866863,0.00001862936,0.0033661316,0.18277779],"study_design_scores_gemma":[0.0058761765,0.014318778,0.6975379,0.000023124034,0.000020402496,0.0000136875515,0.00018902357,0.00001233243,0.016310174,0.00018344134,0.26531497,0.0001999941],"about_ca_topic_score_codex":0.00063453236,"about_ca_topic_score_gemma":0.0048813852,"teacher_disagreement_score":0.26194882,"about_ca_system_score_codex":0.0020570226,"about_ca_system_score_gemma":0.0017286801,"threshold_uncertainty_score":0.9964118},"labels":[],"label_agreement":null},{"id":"W2811412288","doi":"10.1016/j.ygyno.2021.02.017","title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Université Laval","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Internal medicine; Chemotherapy; Hazard ratio; Sentinel lymph node; Cancer; Oncology; Lymph node; Univariate analysis; Gastroenterology; Urology; Breast cancer; Multivariate analysis","score_opus":0.04268703764478513,"score_gpt":0.35289385405258406,"score_spread":0.3102068164077989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811412288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773823,0.0006708403,0.000045043027,0.0056150393,0.0018035128,0.0019975733,0.0004055112,0.00019949947,0.011880659],"genre_scores_gemma":[0.94003856,0.000893064,0.0021210993,0.017113741,0.0008466075,0.0010600568,0.000111926245,0.000101197904,0.037713774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9947798,0.00052245794,0.0012206591,0.0014365674,0.0005813654,0.0014591325],"domain_scores_gemma":[0.99418926,0.0034462267,0.00029477017,0.00074125413,0.0003245195,0.0010039811],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006240418,0.0006819466,0.0022916466,0.0016889967,0.00020713273,0.00004686612,0.00039189553,0.0005137402,0.017017717],"category_scores_gemma":[0.0047039636,0.0005129942,0.00038735464,0.0066567073,0.000100512916,0.0001014769,0.00048374795,0.00045242935,0.00072784984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097636305,0.01749717,0.09482049,0.0006910369,0.0009498774,0.038413372,0.0025031504,0.00092874357,0.48480278,0.00012905351,0.00807204,0.25355595],"study_design_scores_gemma":[0.20842345,0.027745374,0.15081374,0.00035072974,0.0019547252,0.00062727917,0.0022654717,0.00016114015,0.36890703,0.00008249813,0.23622265,0.0024458726],"about_ca_topic_score_codex":0.002272112,"about_ca_topic_score_gemma":0.0013529945,"teacher_disagreement_score":0.25111008,"about_ca_system_score_codex":0.0038757017,"about_ca_system_score_gemma":0.0017828932,"threshold_uncertainty_score":0.99994826},"labels":[],"label_agreement":null},{"id":"W28196674","doi":"10.1016/j.ygyno.2017.02.014","title":"Why Quebec’s Foster-to-Adopt Parents Do Not Seem to Consider Contact After Adoption as a Positive","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Child Welfare and Adoption","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Public relations; Foster parents; Social psychology; Psychology; Business; Sociology; Political science; Foster care; Nursing; Medicine","score_opus":0.02197382358212696,"score_gpt":0.32085648671424594,"score_spread":0.298882663132119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W28196674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.899794,0.000036874557,0.00019226281,0.062509984,0.0012161243,0.0018493498,0.000021273041,0.00013708738,0.03424304],"genre_scores_gemma":[0.91725403,0.0000261675,0.00068280107,0.07968928,0.0003162301,0.00048550044,0.000021114358,0.000014996364,0.0015099002],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973715,0.0006459543,0.00037601482,0.0005616495,0.00031776904,0.00072709343],"domain_scores_gemma":[0.99804926,0.0007658906,0.00014977776,0.0002410095,0.00033998338,0.00045407543],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005200688,0.00023713434,0.00041437492,0.00016284335,0.0004104149,0.00017183434,0.00027174863,0.00044516113,0.005069253],"category_scores_gemma":[0.00085317326,0.00021673214,0.000120381665,0.00031717855,0.00015596945,0.00036404043,0.00019142743,0.00024687345,0.005845745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001348777,0.0023200319,0.101933494,0.000040091807,0.0003129689,0.000682505,0.07820369,0.00012195046,0.004747682,0.027793901,0.30555508,0.47693983],"study_design_scores_gemma":[0.0009184536,0.002393541,0.54298484,0.000036990914,0.000057036195,0.000012270276,0.010056942,0.0000048118045,0.00012983005,0.002291769,0.44062585,0.00048767333],"about_ca_topic_score_codex":0.018752318,"about_ca_topic_score_gemma":0.080950655,"teacher_disagreement_score":0.47645217,"about_ca_system_score_codex":0.001055388,"about_ca_system_score_gemma":0.0004016543,"threshold_uncertainty_score":0.99584025},"labels":[],"label_agreement":null},{"id":"W2883322855","doi":"10.1016/j.ygyno.2018.07.008","title":"Patient reported outcomes in evaluation of chemotherapy toxicity in women with gynecologic malignancies: A pilot study","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Royal College of Physicians and Surgeons of Canada","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Adverse effect; Patient satisfaction; Gynecologic oncology; Cervical cancer; Family medicine; Chemotherapy; Clinical trial; Cancer; Internal medicine; Physical therapy; Surgery","score_opus":0.06765259197856852,"score_gpt":0.3632371313208014,"score_spread":0.29558453934223283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883322855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116516,0.000054013097,0.0000025435543,0.0005443781,0.00022985734,0.003193063,0.0000033380036,0.000036010773,0.0047716466],"genre_scores_gemma":[0.99692726,0.000021224498,0.00030408887,0.0014099121,0.000030478475,0.0012293934,0.0000042777415,0.000013302657,0.00006003624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711937,0.0005572247,0.0008292653,0.0004966141,0.0005181188,0.00047939565],"domain_scores_gemma":[0.998045,0.00068936753,0.00042459785,0.000356328,0.0003815193,0.000103131766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019743862,0.00022807655,0.0010631166,0.00036675698,0.000038090835,0.0000041236603,0.00010804172,0.00014791074,0.0017816195],"category_scores_gemma":[0.0018597472,0.0001463821,0.00003727315,0.0009895993,0.00020050355,0.00005279924,0.000060360213,0.00019104035,0.000013788794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071954937,0.018744782,0.91569024,0.000019023712,0.00022574677,0.00024909218,0.0026705205,0.000021964997,0.0011328027,0.0000069587877,0.000021473428,0.054021917],"study_design_scores_gemma":[0.023740942,0.14080232,0.8317015,0.000018129389,0.00010160437,0.000013436753,0.0023753112,0.000027681888,0.00052568055,0.00045622748,0.00011714945,0.00011999033],"about_ca_topic_score_codex":0.0003944964,"about_ca_topic_score_gemma":0.0048532686,"teacher_disagreement_score":0.12205754,"about_ca_system_score_codex":0.0026000575,"about_ca_system_score_gemma":0.0005966043,"threshold_uncertainty_score":0.9991309},"labels":[],"label_agreement":null},{"id":"W2887491075","doi":"10.1016/j.ygyno.2018.08.016","title":"Histotype classification of ovarian carcinoma: A comparison of approaches","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health; Huntsman Cancer Foundation; Calgary Laboratory Services","keywords":"Serous fluid; Medicine; Serous carcinoma; Immunohistochemistry; Ovarian carcinoma; Clear cell; Not Otherwise Specified; Pathology; Ovarian cancer; Population; Oncology; Cystadenocarcinoma; Internal medicine; Cancer","score_opus":0.1684320268760851,"score_gpt":0.37261912968287525,"score_spread":0.20418710280679014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887491075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.933056,0.00046671455,0.0001698533,0.0028642223,0.0003976502,0.00048750715,0.000008895252,0.000024751842,0.06252439],"genre_scores_gemma":[0.99513596,0.0000127472285,0.0043813316,0.000097557364,0.00011619942,0.00007073968,0.000025113037,0.000008843171,0.00015149331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989185,0.00009231938,0.00044078077,0.00025526749,0.000116329335,0.00017684045],"domain_scores_gemma":[0.99882907,0.00024431292,0.00035142596,0.00031768432,0.00018918052,0.00006835224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022332533,0.00010989984,0.0006110611,0.000101812744,0.000040553892,0.0000014708315,0.00008938367,0.0002170791,0.00068407145],"category_scores_gemma":[0.00016224138,0.00008650786,0.00008738292,0.00018364671,0.0003918188,0.000020883966,0.00003440441,0.00009879571,0.00003532903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046611505,0.0037859832,0.890892,0.00010961717,0.00017084554,0.000013648282,0.0011227283,0.0000022814318,0.00310259,0.013519032,0.0043579726,0.08245715],"study_design_scores_gemma":[0.0022036377,0.008552941,0.96292114,0.000012875367,0.0002789138,0.000012959749,0.00044488066,0.0003988599,0.0061184294,0.00033690792,0.018647403,0.00007106813],"about_ca_topic_score_codex":0.00008250923,"about_ca_topic_score_gemma":0.00019618949,"teacher_disagreement_score":0.082386084,"about_ca_system_score_codex":0.00037853586,"about_ca_system_score_gemma":0.0003723548,"threshold_uncertainty_score":0.74901026},"labels":[],"label_agreement":null},{"id":"W2887837124","doi":"10.1016/j.ygyno.2018.08.007","title":"Enhanced Recovery After Surgery (ERAS) in gynecologic oncology: System-wide implementation and audit leads to improved value and patient outcomes","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Gynecologic oncology; Guideline; Debulking; Audit; Internal medicine; Emergency medicine; Surgery; Cancer; Ovarian cancer","score_opus":0.01470967537250818,"score_gpt":0.30754436456411716,"score_spread":0.292834689191609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887837124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865716,0.00031345632,0.0003367822,0.0046431106,0.0031981037,0.0022325066,0.00003279618,0.00019417408,0.0024774896],"genre_scores_gemma":[0.98016125,0.00026167868,0.003228934,0.014318686,0.00016780106,0.0015019393,0.000034340817,0.00005132497,0.00027403765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99514157,0.000807778,0.0014289409,0.0012233873,0.00025245565,0.0011458505],"domain_scores_gemma":[0.9919277,0.0063410997,0.0005462252,0.0005104509,0.0002457236,0.00042880038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016178377,0.0005580346,0.0019035725,0.0007853787,0.00017399869,0.00004028283,0.00013727383,0.00081030326,0.0005630663],"category_scores_gemma":[0.0025114322,0.00047160874,0.00019216428,0.0005233547,0.0003807312,0.0002862489,0.00039555592,0.0005080208,0.00014231744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032570062,0.00079168717,0.6612113,0.00030442714,0.00023684668,0.000954657,0.0014196375,0.000010402592,0.02203327,0.0000652806,0.0044861645,0.3052293],"study_design_scores_gemma":[0.003013068,0.013032284,0.95662034,0.00013628585,0.00017244504,0.000202386,0.0021228285,0.000041590156,0.008677851,0.00019852561,0.0151340095,0.0006484136],"about_ca_topic_score_codex":0.00015104846,"about_ca_topic_score_gemma":0.003834622,"teacher_disagreement_score":0.3045809,"about_ca_system_score_codex":0.0024181136,"about_ca_system_score_gemma":0.0008376242,"threshold_uncertainty_score":0.99977356},"labels":[],"label_agreement":null},{"id":"W2900372855","doi":"10.1016/j.ygyno.2018.10.040","title":"Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Public Health Ontario; University of Toronto; Women's College Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Medicine; Surgical Menopause; Oophorectomy; Quality of life (healthcare); Menopause; Prophylactic Surgery; Gynecology; BRCA mutation; Breast cancer; Hysterectomy; Obstetrics; Cancer; Internal medicine; Surgery","score_opus":0.007103690263546718,"score_gpt":0.2599005102989529,"score_spread":0.25279682003540616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900372855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755603,0.0000808101,0.00040024274,0.0000915704,0.00044294182,0.00044398825,0.000005828152,0.000030456482,0.0009481106],"genre_scores_gemma":[0.997176,0.000018465362,0.0011126486,0.00049753475,0.0002917363,0.0002927247,0.000025155594,0.000026040507,0.00055970124],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99860215,0.00017297974,0.00024674047,0.00050483854,0.0001142916,0.00035900186],"domain_scores_gemma":[0.9991057,0.00023189362,0.00021153483,0.00021273168,0.00015089622,0.00008727498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025036783,0.00020203658,0.000283208,0.000105211155,0.00014239883,0.000017209984,0.00012590819,0.0003026008,0.000116037394],"category_scores_gemma":[0.00025206566,0.00015162895,0.000013989526,0.00018816607,0.0005648302,0.000008827549,0.00009702025,0.00012480133,0.000010179717],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006435944,0.00070454733,0.037753683,0.00022903759,0.00096321997,0.00016201712,0.0035991953,0.0005891598,0.83360624,0.00011449337,0.0025703527,0.113272086],"study_design_scores_gemma":[0.008259839,0.1400102,0.5644712,0.000054902193,0.00020294517,0.00031356447,0.0013089901,0.00029743632,0.26674065,0.0002582267,0.0172922,0.0007898699],"about_ca_topic_score_codex":0.000025242793,"about_ca_topic_score_gemma":0.00030168047,"teacher_disagreement_score":0.5668656,"about_ca_system_score_codex":0.0002795316,"about_ca_system_score_gemma":0.00035122447,"threshold_uncertainty_score":0.6183249},"labels":[],"label_agreement":null},{"id":"W2900419858","doi":"10.1016/j.ygyno.2018.10.038","title":"Justifying conservative management of CIN2 in women younger than 25 years - A population-based study","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Guideline; Colposcopy; Conservative management; Retrospective cohort study; Population; Cervical intraepithelial neoplasia; Gynecology; Obstetrics; Cohort; Cervical cancer; Surgery; Cancer; Internal medicine","score_opus":0.06332397786217406,"score_gpt":0.40466750231583154,"score_spread":0.34134352445365745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900419858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97514117,0.000035353612,0.000012432164,0.0007601015,0.00017432513,0.001071941,0.000003960748,0.00002674726,0.022773983],"genre_scores_gemma":[0.9977157,0.000010042356,0.0004653529,0.0010653242,0.0000630429,0.00025637695,0.000009323723,0.000009967809,0.00040483536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853826,0.00020090312,0.0003414726,0.0002944601,0.00024183084,0.00038306796],"domain_scores_gemma":[0.9990427,0.00037693887,0.00009311207,0.00023272436,0.0001560976,0.00009841697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000759051,0.00010494063,0.00044969513,0.0002119695,0.000044287368,0.0000047660096,0.00013018708,0.0001238358,0.005289333],"category_scores_gemma":[0.00018036732,0.00009028742,0.000040317136,0.00046281487,0.00013593507,0.00003381825,0.000107304804,0.0002084995,0.000052290885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015140445,0.0017467357,0.9413892,0.00014956539,0.0001247089,0.00034769104,0.0020323058,0.000010151425,0.000044908364,0.00023611692,0.00021241668,0.05219214],"study_design_scores_gemma":[0.0047367127,0.0060434295,0.98210686,0.000014889406,0.000047278507,0.0000015005394,0.004722388,0.00012065551,0.000015774298,0.0002719699,0.0018388857,0.00007964516],"about_ca_topic_score_codex":0.0005814138,"about_ca_topic_score_gemma":0.0014516345,"teacher_disagreement_score":0.052112497,"about_ca_system_score_codex":0.0009248591,"about_ca_system_score_gemma":0.00019682157,"threshold_uncertainty_score":0.99561995},"labels":[],"label_agreement":null},{"id":"W2901022488","doi":"10.1016/j.ygyno.2018.08.036","title":"Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Princess Margaret Cancer Centre; University Health Network","funders":"Medical Research Council; National Cancer Research Institute; Cancer Research UK; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bevacizumab; Carboplatin; Paclitaxel; Oncology; Ovarian cancer; Internal medicine; Stage (stratigraphy); Outcome (game theory); Chemotherapy; Cancer; Cisplatin","score_opus":0.16791034337082325,"score_gpt":0.45109152124661667,"score_spread":0.28318117787579344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901022488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98988223,0.00026480682,0.000054446173,0.0059182514,0.00021576979,0.0033515615,0.00013126238,0.00002149126,0.00016019918],"genre_scores_gemma":[0.9922753,0.0001711079,0.0022919062,0.0021256246,0.00032502552,0.0026379377,0.000010365924,0.00002114321,0.00014157646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982369,0.00024622565,0.0004861714,0.00049167045,0.00017675922,0.00036230066],"domain_scores_gemma":[0.99689233,0.0022157235,0.00023377212,0.00033014768,0.000116229625,0.00021179236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006096359,0.0002388435,0.00087694905,0.00017078397,0.00011992039,0.000023039885,0.00011256961,0.00013723153,0.0001452877],"category_scores_gemma":[0.0011866948,0.0001189776,0.000052984462,0.000283718,0.00026026976,0.00007624238,0.00007059472,0.00013094915,0.0000013392399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15840417,0.0014599485,0.79956967,0.00019577709,0.00039268014,0.0007311909,0.0037562642,0.000025059513,0.00011707985,0.0002794616,0.00056481967,0.034503877],"study_design_scores_gemma":[0.14689894,0.046636246,0.78954583,0.00014242333,0.0013351656,0.000016287167,0.009464586,0.00013362581,0.00016026052,0.000109019835,0.005240151,0.00031747707],"about_ca_topic_score_codex":0.00076561613,"about_ca_topic_score_gemma":0.01690494,"teacher_disagreement_score":0.045176297,"about_ca_system_score_codex":0.0002891439,"about_ca_system_score_gemma":0.000928003,"threshold_uncertainty_score":0.94333535},"labels":[],"label_agreement":null},{"id":"W2901496541","doi":"10.1016/j.ygyno.2018.11.002","title":"Adjuvant therapy in stage III endometrial cancer confined to the pelvis","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Chemoradiotherapy; Adjuvant therapy; Adjuvant; Lymph node; Internal medicine; Radiation therapy; Hysterectomy; Chemotherapy; Surgery; Dissection (medical); Cancer; Oncology; Urology; Gastroenterology","score_opus":0.06098054919078709,"score_gpt":0.3796690024529176,"score_spread":0.3186884532621305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901496541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488658,0.0010715954,0.000029355655,0.017204035,0.0025879506,0.0019589164,0.000037717535,0.000067711226,0.02817692],"genre_scores_gemma":[0.97965974,0.0008296379,0.00021451116,0.013371567,0.0013065408,0.00065092614,0.000012635808,0.00001652231,0.0039379424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810827,0.00023843274,0.00042689047,0.00042953508,0.00024445436,0.00055242307],"domain_scores_gemma":[0.9979587,0.0012219765,0.00012590348,0.0003344693,0.00015790187,0.00020105143],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006317546,0.00021178546,0.00072709675,0.00029839962,0.00011832037,0.00001269326,0.00024458228,0.00023040723,0.013901676],"category_scores_gemma":[0.0010692691,0.00011634506,0.000121040415,0.001246465,0.00020287497,0.000030886815,0.00010410857,0.0002748095,0.0003901415],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014892957,0.0017004522,0.061612874,0.000016305194,0.00035619934,0.0004057526,0.0014615234,0.000016202472,0.004418505,0.0006374715,0.010734342,0.90374744],"study_design_scores_gemma":[0.031015677,0.02121808,0.254312,0.000014884631,0.0000725359,0.000014355749,0.00034650924,0.000022286984,0.0027833518,0.000164061,0.6898466,0.00018967132],"about_ca_topic_score_codex":0.0018660876,"about_ca_topic_score_gemma":0.006603555,"teacher_disagreement_score":0.9035577,"about_ca_system_score_codex":0.0007356556,"about_ca_system_score_gemma":0.0004810968,"threshold_uncertainty_score":0.98699975},"labels":[],"label_agreement":null},{"id":"W2907139891","doi":"10.1016/j.ygyno.2018.12.018","title":"Endocrine therapy in endometrial cancer: An old dog with new tricks","year":2019,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Endocrine system; Endometrial cancer; Aromatase; Oncology; Cancer; Clinical trial; Estrogen receptor; Internal medicine; Targeted therapy; Bioinformatics; Breast cancer; Hormone; Biology","score_opus":0.1377326097421935,"score_gpt":0.43601594963681123,"score_spread":0.29828333989461775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907139891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010575963,0.98315847,0.0000037620907,0.00032858757,0.0019874312,0.005227189,0.000068687616,0.000117434516,0.008050816],"genre_scores_gemma":[0.00028118462,0.98891306,0.00033941373,0.0010005523,0.0016315102,0.0012558292,0.00031995281,0.000094966315,0.006163512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568,0.0005590875,0.0011539203,0.0011946597,0.00043180204,0.0009805836],"domain_scores_gemma":[0.9952778,0.0026512146,0.0007168551,0.00074865145,0.00009107735,0.00051435723],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044797943,0.0008563224,0.0061385194,0.001300097,0.000054580407,0.000025176236,0.000483553,0.0010230573,0.005296264],"category_scores_gemma":[0.00052001333,0.00049629074,0.0006003361,0.002664701,0.0001203648,0.000097875905,0.00011402767,0.0012051418,0.0002730768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014819476,0.0013660504,0.00252494,0.0013825985,0.00070394494,0.0008703429,0.000031631615,0.0000014348144,7.073902e-7,0.00005215662,0.0005205855,0.99106365],"study_design_scores_gemma":[0.029913835,0.027192011,0.001075586,0.0009916435,0.0016443795,0.00026730698,0.00001842013,5.454719e-7,0.0000034625457,0.00005819356,0.93836695,0.00046768034],"about_ca_topic_score_codex":0.00215024,"about_ca_topic_score_gemma":0.0010932636,"teacher_disagreement_score":0.990596,"about_ca_system_score_codex":0.0027851406,"about_ca_system_score_gemma":0.004609167,"threshold_uncertainty_score":0.9997489},"labels":[],"label_agreement":null},{"id":"W2908639608","doi":"10.1016/j.ygyno.2018.12.009","title":"Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; BC Cancer Agency","funders":"Medac; Clovis Oncology; Russian Science Foundation; Merck KGaA; Teva Pharmaceutical Industries; Genentech; PharmaMar; Mersana Therapeutics; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Ovarian cancer; Adverse effect; Population; Clinical endpoint; Placebo; Surgery; Anemia; Randomized controlled trial; Confidence interval; Cancer; Oncology; Pathology","score_opus":0.027992143018052515,"score_gpt":0.3271328342064086,"score_spread":0.29914069118835607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908639608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866237,0.0002773281,0.0000067336955,0.003734876,0.0010853164,0.0034294287,0.00018341954,0.00002600853,0.0046331566],"genre_scores_gemma":[0.99660367,0.0010965735,0.00028577686,0.0010906596,0.00017572536,0.00025982913,0.00012193837,0.000017769109,0.00034808647],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979937,0.00030732562,0.000610824,0.000524324,0.00021334211,0.00035048305],"domain_scores_gemma":[0.99735534,0.0016043533,0.00040431385,0.0004400258,0.00010679668,0.00008916382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939452,0.00021846913,0.0007095262,0.000075821124,0.000039801187,0.0000066998086,0.0001352403,0.00024399688,0.0008427109],"category_scores_gemma":[0.00028024477,0.00013160246,0.000062481486,0.00023312852,0.00022327795,0.000040804458,0.000049285572,0.0002821439,0.000041490694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50915134,0.0053992225,0.19325638,0.000027060836,0.00054715254,0.00012469233,0.0063468744,0.00011290023,0.0003915409,0.00063642743,0.0037011874,0.28030524],"study_design_scores_gemma":[0.28542638,0.015873661,0.6477721,0.00015167137,0.000087219065,0.0000060963994,0.00019601421,0.000018067482,0.00013977017,0.00015475319,0.050031256,0.00014302855],"about_ca_topic_score_codex":0.0016176433,"about_ca_topic_score_gemma":0.0019448886,"teacher_disagreement_score":0.45451573,"about_ca_system_score_codex":0.0010205504,"about_ca_system_score_gemma":0.0006243583,"threshold_uncertainty_score":0.92270935},"labels":[],"label_agreement":null},{"id":"W2909745319","doi":"10.1016/j.ygyno.2018.12.027","title":"Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Ovarian cancer; Psychosocial; Randomized controlled trial; Test (biology); Genetic counseling; Genetic testing; Distress; Anxiety; Cancer; Internal medicine; Clinical psychology; Psychiatry","score_opus":0.026438421222154604,"score_gpt":0.327965480759758,"score_spread":0.3015270595376034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909745319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97604084,0.00037719336,0.014502164,0.00051862915,0.0018545806,0.0057984507,0.000057771416,0.000043885237,0.0008065056],"genre_scores_gemma":[0.9875901,0.00008274545,0.0064741895,0.0013362482,0.00033739576,0.0035588401,0.000094878174,0.00004271208,0.00048289006],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99716014,0.0005452038,0.00062815694,0.00095200015,0.00016359262,0.00055090524],"domain_scores_gemma":[0.99779433,0.00067174993,0.00030757426,0.00073977193,0.00038097182,0.000105629966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016074699,0.0003205438,0.0008868728,0.00008882533,0.00016295214,0.000031362975,0.00040692094,0.0005065089,0.00037825355],"category_scores_gemma":[0.00067865656,0.0002890602,0.00028105555,0.00015774916,0.00022798414,0.0000048108013,0.00011434686,0.00019251446,0.00003374659],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1302119,0.0068815267,0.18329534,0.00055615744,0.0030496593,0.00006667447,0.003767678,0.2012063,0.39961797,0.00024586587,0.0058806683,0.065220274],"study_design_scores_gemma":[0.7159882,0.020673681,0.07129496,0.000043015454,0.0017660231,0.000031503696,0.0035330215,0.08200875,0.021354906,0.0028888555,0.07753065,0.002886374],"about_ca_topic_score_codex":0.00018028388,"about_ca_topic_score_gemma":0.0014826682,"teacher_disagreement_score":0.5857763,"about_ca_system_score_codex":0.00046961548,"about_ca_system_score_gemma":0.001574517,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W2914302931","doi":"10.1016/j.ygyno.2019.01.018","title":"Targeted surgical prevention of epithelial ovarian cancer is cost effective and saves money in BRCA mutation carrying family members of women with epithelial ovarian cancer. A Canadian model","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; BRCA mutation; Oncology; Ovarian cancer; Cost effectiveness; Incidence (geometry); Cancer prevention; Cancer; Internal medicine; Gynecology","score_opus":0.010506405277156005,"score_gpt":0.28438521981717735,"score_spread":0.27387881454002133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914302931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958282,0.00048795182,0.00015773745,0.00033153733,0.00029442974,0.0015970632,0.00041521664,0.000007444253,0.0008804056],"genre_scores_gemma":[0.99680066,0.0003265526,0.0012346556,0.00023958289,0.00006604437,0.001087048,0.00007065702,0.000025875757,0.0001489252],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981334,0.00027797392,0.0004149442,0.0005342462,0.0001410502,0.00049836875],"domain_scores_gemma":[0.9989685,0.0001140461,0.00032461004,0.00023110709,0.00020587562,0.00015585704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051102246,0.00022231767,0.00051546,0.00019673131,0.00006258032,0.000008176126,0.00016382085,0.00045409956,0.00019051356],"category_scores_gemma":[0.00008441139,0.00020751987,0.0000557502,0.00025936335,0.00022788577,0.000015645885,0.000066461,0.00018354335,0.0000014908852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004497921,0.00044029765,0.109542966,0.000308318,0.0010254576,0.00007807885,0.010389838,0.17751062,0.56931186,0.00033215864,0.0002686009,0.1262939],"study_design_scores_gemma":[0.03097841,0.012147216,0.6792377,0.00026245142,0.0004524329,0.00010801564,0.006336113,0.03732,0.21161234,0.0019004982,0.01786071,0.0017840647],"about_ca_topic_score_codex":0.043345843,"about_ca_topic_score_gemma":0.15199086,"teacher_disagreement_score":0.56969476,"about_ca_system_score_codex":0.0015115145,"about_ca_system_score_gemma":0.0028557174,"threshold_uncertainty_score":0.9630246},"labels":[],"label_agreement":null},{"id":"W2917802131","doi":"10.1016/j.ygyno.2019.02.005","title":"Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Intas Pharmaceuticals; Sociedad Española de Oncología Médica; University of Toronto; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation; Cancer Care Ontario","keywords":"Medicine; KRAS; Neuroblastoma RAS viral oncogene homolog; Clinical trial; Oncology; Internal medicine; Genotype; Ovarian cancer; Serous fluid; Cancer; Colorectal cancer; Gene","score_opus":0.05141778133780034,"score_gpt":0.43007901925180625,"score_spread":0.3786612379140059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917802131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905023,0.000084736384,0.0000013340427,0.00077898375,0.0019655982,0.0038467865,0.00006613122,0.00003840815,0.0027157352],"genre_scores_gemma":[0.9976624,0.00013750879,0.00046861148,0.000837643,0.00009082476,0.0006018543,0.000047637335,0.000025215893,0.00012827425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996953,0.00047213343,0.0011597597,0.0006093987,0.00027467523,0.0005310429],"domain_scores_gemma":[0.99659926,0.0020970197,0.00055906246,0.00044633698,0.00013741126,0.00016090834],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006259227,0.00031918404,0.0016980878,0.00021655779,0.000029708723,0.0000069727107,0.00018151938,0.00054283557,0.001980643],"category_scores_gemma":[0.0014825795,0.00020710929,0.00057896855,0.00022789369,0.00010970019,0.000046674228,0.0000905454,0.0004287493,0.00018046434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008521465,0.010390644,0.96149504,0.000049668153,0.0004610712,0.00016271255,0.00005306638,0.00018311456,0.00014057446,0.00011872856,0.00010907805,0.01831486],"study_design_scores_gemma":[0.09323194,0.055717137,0.8499096,0.0000488339,0.00018633295,0.0000019230818,0.00003036483,0.00005530714,0.00028686496,0.0002239997,0.00014377756,0.00016391935],"about_ca_topic_score_codex":0.00013972218,"about_ca_topic_score_gemma":0.000092737115,"teacher_disagreement_score":0.111585416,"about_ca_system_score_codex":0.0015098635,"about_ca_system_score_gemma":0.0010616273,"threshold_uncertainty_score":0.9989317},"labels":[],"label_agreement":null},{"id":"W2919621058","doi":"10.1016/j.ygyno.2019.02.028","title":"GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; University of California, San Francisco; National Cancer Institute; University of Washington; Amgen","keywords":"Single-nucleotide polymorphism; Medicine; Oncology; Endometrial cancer; Internal medicine; Hazard ratio; Gynecologic oncology; Odds ratio; Metastasis; Genotype; Cancer; Confidence interval; Biology; Gene; Genetics","score_opus":0.03873873871554044,"score_gpt":0.3464759800099057,"score_spread":0.30773724129436525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919621058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102926,0.002177439,0.00031735812,0.0002916743,0.0022519734,0.0028745467,0.00026823327,0.00005448352,0.0007350021],"genre_scores_gemma":[0.98933953,0.0011077941,0.008169576,0.00025975765,0.00033148515,0.00048549933,0.00020055409,0.000069012196,0.000036816993],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99150115,0.0038863204,0.0014523682,0.0017220575,0.00046443086,0.00097364414],"domain_scores_gemma":[0.9956919,0.00089133496,0.0016573184,0.0010237518,0.00027794202,0.00045776862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036030274,0.0006326425,0.0016513226,0.000503591,0.00021444184,0.000041599244,0.0007666697,0.0008937128,0.00046928631],"category_scores_gemma":[0.001480363,0.00058201887,0.00022186965,0.0006324379,0.00049046485,0.00006221122,0.00058934186,0.00048897596,0.000012559905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004616007,0.008400249,0.29180017,0.00007293056,0.00040171688,0.00014588193,0.0002962802,0.0009911478,0.50747335,0.000176263,0.000045920908,0.18558012],"study_design_scores_gemma":[0.04680614,0.09182768,0.74949783,0.00011099126,0.002700901,0.00010028984,0.007618555,0.002396604,0.06930116,0.002330693,0.024339952,0.0029692207],"about_ca_topic_score_codex":0.00062320963,"about_ca_topic_score_gemma":0.0033583757,"teacher_disagreement_score":0.45769766,"about_ca_system_score_codex":0.0011665152,"about_ca_system_score_gemma":0.0014372389,"threshold_uncertainty_score":0.9996631},"labels":[],"label_agreement":null},{"id":"W2921753682","doi":"10.1016/j.ygyno.2018.10.014","title":"BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; BRCA mutation; Serous fluid; Ovarian cancer; Serous ovarian cancer; First-degree relatives; Oncology; Internal medicine; Gynecology; Cancer; Obstetrics; Family history","score_opus":0.02834728898448401,"score_gpt":0.2944678059368392,"score_spread":0.26612051695235517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921753682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949619,0.00020476272,0.0010904274,0.0007475821,0.00044498467,0.00082709355,0.000052111303,0.00002343355,0.0016476711],"genre_scores_gemma":[0.9749643,0.000026877256,0.023140695,0.00029312551,0.0001381587,0.0007931363,0.000060910497,0.000028305392,0.0005544983],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998683,0.00008890726,0.0002867919,0.00043997393,0.00009134591,0.0004100171],"domain_scores_gemma":[0.9986557,0.00040778067,0.0003330207,0.00028141326,0.00025918192,0.00006290384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032617347,0.00017088409,0.00031740445,0.00006234482,0.00009381119,0.000007696886,0.00020118349,0.00031314266,0.00017189916],"category_scores_gemma":[0.00037741635,0.00014647239,0.000039440307,0.00018965508,0.00014823432,0.000008024301,0.000074256466,0.0001075784,0.000008884183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027691545,0.0010101033,0.21089463,0.0005372727,0.0014200917,0.00003486113,0.0043997914,0.05006704,0.57112914,0.002339338,0.0037548256,0.15164375],"study_design_scores_gemma":[0.015593604,0.040336538,0.73476964,0.000084790816,0.0002776064,0.00014611548,0.0036872493,0.0012386437,0.1063269,0.0062242383,0.09000002,0.0013146716],"about_ca_topic_score_codex":0.00009831606,"about_ca_topic_score_gemma":0.0006473243,"teacher_disagreement_score":0.523875,"about_ca_system_score_codex":0.0006316856,"about_ca_system_score_gemma":0.00076267956,"threshold_uncertainty_score":0.5972971},"labels":[],"label_agreement":null},{"id":"W2922317032","doi":"10.1016/j.ygyno.2018.09.008","title":"Impact of a preventive bundle to reduce surgical site infections in gynecologic oncology","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Surgical site infection prevention","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"World Health Organization","keywords":"Medicine; Gynecologic oncology; Surgery; Surgical site infection; Logistic regression; Antibiotic prophylaxis; Internal medicine; Antibiotics","score_opus":0.02079749825234615,"score_gpt":0.38673358456813317,"score_spread":0.365936086315787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922317032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9279621,0.000069905356,0.00005600236,0.0008786093,0.00089197565,0.0023793415,0.000017681672,0.00013896801,0.06760538],"genre_scores_gemma":[0.99553335,0.000082655,0.000706052,0.0003142386,0.000119904624,0.00035183688,0.000057189325,0.000027767726,0.0028070232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597317,0.0011088026,0.001082773,0.0007809439,0.00025696162,0.0007973554],"domain_scores_gemma":[0.99506706,0.0033086985,0.0004616502,0.00047623715,0.00031445504,0.0003719129],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015620984,0.00035235533,0.0014902466,0.0007853182,0.00007048091,0.000010008087,0.00018920319,0.000968085,0.028418388],"category_scores_gemma":[0.001533614,0.00028903328,0.0006151487,0.0014871663,0.00019208854,0.00015024972,0.00026682543,0.00081610185,0.0019315196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016465551,0.010632022,0.9189639,0.00005746058,0.000256079,0.00041807455,0.0003486857,0.0011378864,0.012761676,0.00040499982,0.00064964214,0.052722983],"study_design_scores_gemma":[0.0077819037,0.04319767,0.8884766,0.000050366558,0.00012587757,0.0009793201,0.00012769694,0.000108200344,0.000476422,0.0007247983,0.05764761,0.00030354128],"about_ca_topic_score_codex":0.00046640093,"about_ca_topic_score_gemma":0.00075393333,"teacher_disagreement_score":0.0675712,"about_ca_system_score_codex":0.003638467,"about_ca_system_score_gemma":0.0010879568,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W2923658704","doi":"10.1016/j.ygyno.2019.03.103","title":"Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Krebsliga Schweiz","keywords":"Medicine; Indocyanine green; Methylene blue; Endometrial cancer; Randomized controlled trial; Sentinel lymph node; Cancer; Surgery; Internal medicine; Breast cancer","score_opus":0.037046664564058876,"score_gpt":0.33105878968938013,"score_spread":0.29401212512532127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923658704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780817,0.0005946212,0.0002503408,0.0010235048,0.00356267,0.013006249,0.000014958975,0.00010365323,0.0033622843],"genre_scores_gemma":[0.9899968,0.00023221989,0.00053638656,0.0004479291,0.0011011933,0.006032816,0.000054866123,0.000042774504,0.001555027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960946,0.00083896617,0.0012069421,0.00072074577,0.00040334242,0.0007354056],"domain_scores_gemma":[0.98790324,0.010636424,0.0006980771,0.0003095739,0.0002466967,0.00020599947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021185763,0.0004446471,0.0045767017,0.0007291114,0.00010379924,0.000018928264,0.00019471072,0.00048749777,0.00079340267],"category_scores_gemma":[0.0023264734,0.00028500173,0.00062731607,0.0009837385,0.00016319942,0.000100474404,0.00007471735,0.0003746094,0.000044883396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9750259,0.0009794284,0.007383796,0.000081867554,0.0017749541,0.000060901315,0.000100084515,0.00021831793,0.0010023392,0.000049502883,0.000008288698,0.013314652],"study_design_scores_gemma":[0.9829453,0.006575062,0.0040671336,0.000037110247,0.0019807029,0.000015306961,0.00011711725,0.0017282045,0.0010077569,0.000073226955,0.0011611871,0.00029189847],"about_ca_topic_score_codex":0.0035403823,"about_ca_topic_score_gemma":0.0028559521,"teacher_disagreement_score":0.013022754,"about_ca_system_score_codex":0.0014554074,"about_ca_system_score_gemma":0.0006636821,"threshold_uncertainty_score":0.9999602},"labels":[],"label_agreement":null},{"id":"W2923773929","doi":"10.1016/j.ygyno.2019.02.023","title":"Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Niilo Helanderin Säätiö; Program for Changjiang Scholars and Innovative Research Team in University; National Institute of Environmental Health Sciences; National Cancer Institute; National Key Research and Development Program of China; National Center for Advancing Translational Sciences; Medical Research Council; Bezmialem Vakıf Üniversitesi; Canadian Institutes of Health Research; National Coordination Office; University of California, Irvine; Ministry of Health, Labour and Welfare; National Natural Science Foundation of China; Ministry of Education, Culture, Sports, Science and Technology; National Institute on Aging; National Institute for Health and Care Research; Fundação de Amparo à Pesquisa do Estado de São Paulo; National Health and Medical Research Council; Wellcome Trust; Cancer Research UK; Dover Foundation; National Center for Research Resources; Roswell Park Cancer Institute; National Institutes of Health; Tianjin Science and Technology Committee; Ovarian Cancer Research Fund; National Engineering College; U.S. Department of Defense; European Commission; Breast Cancer Research Foundation","keywords":"Single-nucleotide polymorphism; Genome-wide association study; Quantitative trait locus; Expression quantitative trait loci; Genetic association; Genotyping; Genetics; Locus (genetics); Odds ratio; SNP; Oncology; Biology; Genotype; Medicine; Internal medicine; Gene","score_opus":0.022706603206373754,"score_gpt":0.33009526401102146,"score_spread":0.3073886608046477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923773929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948437,0.00045617583,0.00018075525,0.0063887127,0.0011420845,0.0009883567,0.00011541595,0.000019077106,0.0012250415],"genre_scores_gemma":[0.99224573,0.0004206642,0.0008869118,0.0019840999,0.0003171173,0.00077340915,0.0001427738,0.0000207609,0.0032085069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972847,0.00053720915,0.00059054414,0.00067451637,0.00010256025,0.0008104536],"domain_scores_gemma":[0.9981873,0.0006719531,0.00045318724,0.00032577987,0.00027307382,0.00008868633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024946462,0.00022446446,0.0006602203,0.00008628004,0.00011230648,0.00001209043,0.00026716635,0.0007411764,0.00038130104],"category_scores_gemma":[0.005442596,0.00021276456,0.00014325825,0.00014625218,0.00008448405,0.0000067302144,0.00018826312,0.00019635697,0.00007622099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013912753,0.00019366613,0.96898156,0.00003639437,0.00028179216,0.0000021747842,0.00073639135,0.00064750813,0.022302452,0.000036175938,0.0026333472,0.00400939],"study_design_scores_gemma":[0.0019493104,0.00125973,0.9220079,0.0000031382972,0.000030355424,0.0000011503408,0.002641245,0.000041768566,0.00017375755,0.0022254544,0.06942098,0.00024516694],"about_ca_topic_score_codex":0.000045874145,"about_ca_topic_score_gemma":0.0036039993,"teacher_disagreement_score":0.06678763,"about_ca_system_score_codex":0.0017682391,"about_ca_system_score_gemma":0.00037798836,"threshold_uncertainty_score":0.8676287},"labels":[],"label_agreement":null},{"id":"W2925280531","doi":"10.1016/j.ygyno.2019.03.098","title":"Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation","keywords":"Medicine; Endometrial cancer; Fertility preservation; Oncology; Cohort; Internal medicine; Retrospective cohort study; Fertility; Hysterectomy; Young adult; Cohort study; Carcinoma; Stage (stratigraphy); Gynecology; Cancer; Population; Pathology","score_opus":0.05397996142927618,"score_gpt":0.3062470664755212,"score_spread":0.252267105046245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925280531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704007,0.00028001962,0.0000055518103,0.0021045718,0.00028255233,0.00070823124,0.000005866464,0.000036079495,0.026176415],"genre_scores_gemma":[0.9975739,0.0001460641,0.00026445635,0.0010443914,0.00003426257,0.0002556051,0.000020635298,0.00001274181,0.0006479257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987724,0.00012255614,0.00027810567,0.00031761476,0.00016480505,0.00034453417],"domain_scores_gemma":[0.998892,0.00061117724,0.000113023,0.00018561055,0.00005981078,0.00013834934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028165666,0.00016731,0.0006397567,0.00034344714,0.000028399008,0.000010811836,0.0000675534,0.00018137858,0.0005068405],"category_scores_gemma":[0.00028293638,0.00011007586,0.000036720656,0.0003095171,0.00010298416,0.000059172595,0.000048927366,0.00015918288,0.00003101525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001546238,0.00032119374,0.9700437,0.00004058849,0.00008362721,0.0002956033,0.00017504767,0.0000020038146,0.00096920773,0.0014921598,0.000012319494,0.025018314],"study_design_scores_gemma":[0.01434408,0.0065077255,0.9758848,0.000007759035,0.00006477239,0.00007426499,0.0010481171,0.000016606982,0.000116184616,0.00034319863,0.0014679168,0.0001245844],"about_ca_topic_score_codex":0.000136204,"about_ca_topic_score_gemma":0.00015381462,"teacher_disagreement_score":0.027173206,"about_ca_system_score_codex":0.00057151105,"about_ca_system_score_gemma":0.00022718243,"threshold_uncertainty_score":0.55495477},"labels":[],"label_agreement":null},{"id":"W2939062972","doi":"10.1016/j.ygyno.2019.03.253","title":"Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Merck Sharp and Dohme","keywords":"Medicine; Placebo; Internal medicine; Population; Oncology; Alternative medicine; Environmental health; Pathology","score_opus":0.029203599978426205,"score_gpt":0.3352384615263622,"score_spread":0.306034861547936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939062972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445677,0.0027819246,0.000004858331,0.0013420526,0.00028853177,0.0013169396,0.000008189043,0.000107333726,0.049582474],"genre_scores_gemma":[0.99670064,0.000826241,0.00012981771,0.0008523707,0.000090434456,0.00008247335,0.0001688781,0.000023071421,0.0011260696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836683,0.00020704085,0.00033804856,0.00044980593,0.00025204688,0.00038622666],"domain_scores_gemma":[0.9982488,0.0009696154,0.00014781613,0.00024031468,0.00015969102,0.00023372598],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002270315,0.0002008271,0.0006918103,0.00015367476,0.00010399823,0.000010983859,0.00008665052,0.00023601207,0.0050885496],"category_scores_gemma":[0.00026316615,0.00013792772,0.000065586835,0.0002729337,0.00008047634,0.000054225806,0.00006918572,0.00042780046,0.00012700233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058957958,0.0009800392,0.77684796,0.00007050209,0.00012248055,0.00008871661,0.00025240093,0.00008712668,0.000095071075,0.0002476754,0.0019843003,0.21332794],"study_design_scores_gemma":[0.01404618,0.007826653,0.9558693,0.000010362968,0.000099223624,0.000025890084,0.00015900124,0.0004387167,0.00002153238,0.0000919567,0.021245714,0.00016543202],"about_ca_topic_score_codex":0.00007130936,"about_ca_topic_score_gemma":0.00010113352,"teacher_disagreement_score":0.21316251,"about_ca_system_score_codex":0.00079927285,"about_ca_system_score_gemma":0.00021752968,"threshold_uncertainty_score":0.99582094},"labels":[],"label_agreement":null},{"id":"W2945550010","doi":"10.1016/j.ygyno.2019.04.679","title":"Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data","year":2019,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Barts Charity","keywords":"Medicine; Pathological; Serous fluid; Chemotherapy; Oncology; Internal medicine; Serous carcinoma; Meta-analysis; Ovarian carcinoma; Carcinoma; Gynecology; Ovarian cancer; Cancer","score_opus":0.237294401151195,"score_gpt":0.4067019604507278,"score_spread":0.16940755929953283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945550010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017096873,0.9803337,0.000001917376,0.0026435223,0.00010069149,0.012811051,0.0023296971,0.000032547207,0.000037208323],"genre_scores_gemma":[0.008136713,0.9813886,0.0008808906,0.004365758,0.00001946474,0.0035499462,0.0015148743,0.0000566416,0.0000870572],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99074566,0.0036971122,0.002695832,0.0017298417,0.00052676315,0.00060477824],"domain_scores_gemma":[0.98969716,0.005300171,0.002088055,0.0025577075,0.00014315864,0.0002137483],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032471812,0.0009196351,0.020492075,0.000850764,0.00005050376,0.000026986454,0.0008221682,0.0010499217,0.0012180499],"category_scores_gemma":[0.0018432585,0.000532483,0.0015569115,0.0016446408,0.00022773072,0.00006464027,0.0006699227,0.0007062035,0.00003906908],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017278928,0.003954704,0.0017072161,0.76004153,0.20223328,0.0027726807,0.00036562546,0.0000010630874,1.01984824e-7,0.00007465826,0.001299658,0.027376657],"study_design_scores_gemma":[0.001514439,0.0046820445,0.00911236,0.01139407,0.954191,0.00040227268,0.00004392192,0.000005214034,1.7966036e-7,0.000014641226,0.018205168,0.00043464254],"about_ca_topic_score_codex":0.00007532592,"about_ca_topic_score_gemma":0.0000841161,"teacher_disagreement_score":0.7519578,"about_ca_system_score_codex":0.0007463197,"about_ca_system_score_gemma":0.0013115028,"threshold_uncertainty_score":0.99971265},"labels":[],"label_agreement":null},{"id":"W2946550609","doi":"10.1016/j.ygyno.2019.03.097","title":"Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Endometrial cancer; Hazard ratio; Internal medicine; Oncology; Radiation therapy; Brachytherapy; Proportional hazards model; Adjuvant; Retrospective cohort study; External beam radiotherapy; Cancer; Confidence interval","score_opus":0.02076508822141784,"score_gpt":0.35266197271925137,"score_spread":0.33189688449783356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946550609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812369,0.001306597,0.00013102204,0.004388977,0.0032769977,0.0055026463,0.000049400252,0.00013926603,0.003968191],"genre_scores_gemma":[0.98206085,0.0002119133,0.0074240863,0.0042061456,0.00023330058,0.002402515,0.000007440409,0.000044019525,0.0034097058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972308,0.00035105317,0.0005705642,0.0008029842,0.0002953164,0.00074925646],"domain_scores_gemma":[0.99476767,0.00418844,0.00016364465,0.0004504044,0.000200215,0.00022960528],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018238907,0.00027981593,0.00094540237,0.0005182232,0.000052862248,0.000008240083,0.00023322285,0.0005028153,0.0038279153],"category_scores_gemma":[0.0047715716,0.00023348062,0.0002300241,0.0007549325,0.00011217451,0.000039561655,0.000092696,0.0003314547,0.00013425943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25395137,0.0018196496,0.4913489,0.00021790818,0.0003239082,0.00031307447,0.0033020743,0.0015313416,0.17814787,0.000093313814,0.018549984,0.050400626],"study_design_scores_gemma":[0.021319602,0.065142855,0.65338,0.00007723368,0.00012102696,0.00010966716,0.0007380167,0.0011166264,0.0033396338,0.00037376705,0.253832,0.0004495782],"about_ca_topic_score_codex":0.00015921776,"about_ca_topic_score_gemma":0.0003348291,"teacher_disagreement_score":0.23528203,"about_ca_system_score_codex":0.0031797825,"about_ca_system_score_gemma":0.0019123794,"threshold_uncertainty_score":0.9970827},"labels":[],"label_agreement":null},{"id":"W2946792616","doi":"10.1016/j.ygyno.2019.04.682","title":"Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Urinary system; Prostate cancer; Radiation therapy; Colorectal cancer; EPIC; Quality of life (healthcare); Urology; Cancer; Cervical cancer; Internal medicine; Oncology","score_opus":0.026882910906896696,"score_gpt":0.3165449536381368,"score_spread":0.2896620427312401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946792616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471325,0.00040406577,0.000027593009,0.0019284099,0.00026384206,0.0020560226,0.000016190394,0.000017598773,0.0005730517],"genre_scores_gemma":[0.9948241,0.00056238665,0.001312286,0.0020970104,0.000032119147,0.0006442864,0.000006646907,0.000013510399,0.00050762354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987804,0.00019375962,0.00027207978,0.0003201531,0.00011290849,0.0003206874],"domain_scores_gemma":[0.99743056,0.002053156,0.00018177406,0.00018714559,0.00007934045,0.000068030415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026901954,0.00016091974,0.00054877717,0.000108413464,0.00006558584,0.000008195115,0.00008771475,0.00018661669,0.000535501],"category_scores_gemma":[0.000269559,0.000088544584,0.00004878074,0.0002917287,0.0001388114,0.00009242547,0.000045967692,0.00014635743,0.0000018074983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008457771,0.0012275549,0.9622555,0.00015470195,0.0003329622,0.00004151721,0.0014795315,0.00028773322,0.0062510152,0.0003613682,0.0000707827,0.01907961],"study_design_scores_gemma":[0.021823172,0.021565678,0.9513601,0.000058852755,0.00008387066,0.0000395796,0.0008760452,0.00006720411,0.001829142,0.0007363545,0.0014144388,0.00014553605],"about_ca_topic_score_codex":0.00010082744,"about_ca_topic_score_gemma":0.0004777648,"teacher_disagreement_score":0.020338122,"about_ca_system_score_codex":0.0011615729,"about_ca_system_score_gemma":0.00042666463,"threshold_uncertainty_score":0.586336},"labels":[],"label_agreement":null},{"id":"W2951120912","doi":"10.1016/j.ygyno.2019.06.005","title":"Financial Toxicity: A Severe But Underrecognized Side Effect for Cancer Patients","year":2019,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Discontinuation; Medicine; Bankruptcy; Cancer; Population; Debt; Quality of life (healthcare); Finance; Internal medicine; Environmental health; Nursing; Business","score_opus":0.03324717599297936,"score_gpt":0.2694379890165691,"score_spread":0.23619081302358977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951120912","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2195155,0.00601068,0.0013191177,0.52074414,0.052830685,0.013363432,0.01960436,0.00048486982,0.16612719],"genre_scores_gemma":[0.03318861,0.0009801344,0.0007119481,0.9221181,0.0084557645,0.0029457037,0.0014777184,0.00026548482,0.029856492],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506706,0.000121841964,0.0015770909,0.0015855934,0.000074148666,0.0015742893],"domain_scores_gemma":[0.9945018,0.0025164378,0.0020464289,0.0006458351,0.00018389738,0.00010556504],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000885521,0.00086081686,0.0031841688,0.0004458078,0.00024357898,0.000099745645,0.00088249723,0.0040513766,0.002032249],"category_scores_gemma":[0.0029834209,0.0009228375,0.00080026576,0.00019183203,0.00020916942,0.00028710708,0.00023965944,0.0018335483,0.0023145564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024708934,0.00016707159,0.010654309,0.00035043975,0.00023307835,0.000037898142,0.00006152851,0.000029506136,0.000002089935,0.0011040077,0.9651054,0.022007583],"study_design_scores_gemma":[0.005081102,0.0034887467,0.005839608,0.000041176074,0.000105151186,0.000005939934,0.0000045980482,0.00009916942,0.00002152398,0.023024721,0.96114045,0.001147826],"about_ca_topic_score_codex":0.00046544697,"about_ca_topic_score_gemma":0.0005690644,"teacher_disagreement_score":0.40137398,"about_ca_system_score_codex":0.002849525,"about_ca_system_score_gemma":0.0008617446,"threshold_uncertainty_score":0.99932224},"labels":[],"label_agreement":null},{"id":"W2953612583","doi":"10.1016/j.ygyno.2019.04.356","title":"Efficacy of TAP blocks following ovarian cancer surgery","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Transversus abdominis; Ovarian cancer; Cytoreductive surgery; Surgery; Opioid; Cancer; Oncology; Internal medicine","score_opus":0.026225655515420384,"score_gpt":0.3099510128313646,"score_spread":0.2837253573159442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953612583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688786,0.00025790159,0.00002646537,0.0029996196,0.000626975,0.0008092818,4.6371386e-7,0.000061785955,0.026338901],"genre_scores_gemma":[0.9893117,0.00008391661,0.00055651215,0.0045883786,0.000107587985,0.00009584717,0.00001146366,0.000014156248,0.005230464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987219,0.00014912289,0.00035637547,0.00028002955,0.00015728072,0.00033527397],"domain_scores_gemma":[0.9977067,0.0016867284,0.00017598024,0.00030130148,0.000042877247,0.00008640035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007574566,0.00013868733,0.0007102263,0.00013647505,0.000037144804,0.0000032679309,0.00010866427,0.00023118623,0.0037655835],"category_scores_gemma":[0.0002782438,0.000111061134,0.0002649272,0.00019913523,0.000058835994,0.000026687554,0.000045493078,0.0001642749,0.00018397186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020404745,0.00048489403,0.96118385,0.000078336125,0.0002211955,0.0004437972,0.0001263369,0.000044463595,0.00077437435,0.00048748348,0.00859636,0.027354846],"study_design_scores_gemma":[0.0017564665,0.00058617734,0.76895446,0.000037255348,0.00024999917,0.000020696089,0.00014406073,0.000060452647,0.00011478267,0.00007999592,0.22787726,0.00011839643],"about_ca_topic_score_codex":0.00008560889,"about_ca_topic_score_gemma":0.000022633276,"teacher_disagreement_score":0.2192809,"about_ca_system_score_codex":0.00017829622,"about_ca_system_score_gemma":0.00031895319,"threshold_uncertainty_score":0.9971451},"labels":[],"label_agreement":null},{"id":"W2954005467","doi":"10.1016/j.ygyno.2019.06.021","title":"Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Chemotherapy; Hazard ratio; Lymphadenectomy; Ovarian cancer; Surgery; Cancer; Stage (stratigraphy); Internal medicine; Confidence interval; Retrospective cohort study; Oncology","score_opus":0.019839890127430027,"score_gpt":0.3431664510514473,"score_spread":0.32332656092401724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954005467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449564,0.0006257226,0.00016196634,0.0039644027,0.0008556061,0.0034089086,0.0000813644,0.000039314717,0.006367052],"genre_scores_gemma":[0.99444616,0.0002603594,0.001266915,0.0016342789,0.000052782732,0.0010674073,0.00003066758,0.000024274139,0.0012171514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987561,0.00016128238,0.00026154524,0.00040992626,0.0000993589,0.00031177403],"domain_scores_gemma":[0.9982795,0.0009975284,0.0001644106,0.00027657527,0.00019873446,0.00008325794],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041615043,0.00018658704,0.00080360833,0.00007975375,0.000045442706,0.00000475751,0.00008781193,0.00024055055,0.0020107734],"category_scores_gemma":[0.00008638177,0.00013795691,0.00015713487,0.00013328473,0.00008180509,0.000038006332,0.00002681086,0.00011827801,0.00003833798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009162708,0.00623686,0.76092803,0.0017844219,0.0023188489,0.0001666187,0.0013167555,0.00031038793,0.07372972,0.017495785,0.0017190063,0.12483084],"study_design_scores_gemma":[0.022247093,0.018259693,0.8625545,0.00014479514,0.00023332755,0.00001961129,0.00020382399,0.00008788193,0.045326177,0.00039019037,0.05031635,0.00021657151],"about_ca_topic_score_codex":0.00021439396,"about_ca_topic_score_gemma":0.000080682956,"teacher_disagreement_score":0.12461427,"about_ca_system_score_codex":0.0007944004,"about_ca_system_score_gemma":0.00066437206,"threshold_uncertainty_score":0.99890155},"labels":[],"label_agreement":null},{"id":"W2954169217","doi":"10.1016/j.ygyno.2019.04.016","title":"Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Placebo; Toxicity; Ovarian cancer; Quality of life (healthcare); Internal medicine; Oncology; Clinical trial; Gynecology; Cancer; Pathology","score_opus":0.03176221160617492,"score_gpt":0.3358377955198109,"score_spread":0.304075583913636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954169217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009067,0.000046160898,0.00001124618,0.0009424236,0.0015986591,0.0032575247,0.00009956708,0.000042802363,0.0039109197],"genre_scores_gemma":[0.9971257,0.0000680358,0.0002668159,0.00048493734,0.000098583245,0.000537076,0.000049842707,0.00002391522,0.0013451332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734324,0.00047625843,0.0006818178,0.0006140961,0.0003624341,0.0005221687],"domain_scores_gemma":[0.99742234,0.00097334996,0.00064842706,0.0006455205,0.00020100034,0.00010937875],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004968594,0.00032229206,0.001343423,0.0003053988,0.00006542364,0.0000089759915,0.00023931472,0.0003023228,0.004392539],"category_scores_gemma":[0.0003258099,0.00017829942,0.00023531854,0.0013674961,0.00028935756,0.00006310056,0.000069880334,0.00032486368,0.000037505244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3832473,0.0033745335,0.58856165,0.000035716857,0.0031032006,0.000019112322,0.0011363091,0.0011000212,0.0003119759,0.00006171248,0.0004947203,0.01855376],"study_design_scores_gemma":[0.29676685,0.032914326,0.6594246,0.00018768346,0.0018839783,0.0000034389136,0.0001643488,0.0010674811,0.00031900307,0.000015623229,0.0069019254,0.00035075122],"about_ca_topic_score_codex":0.00031156998,"about_ca_topic_score_gemma":0.005688313,"teacher_disagreement_score":0.08648044,"about_ca_system_score_codex":0.0037701207,"about_ca_system_score_gemma":0.0010728291,"threshold_uncertainty_score":0.9965176},"labels":[],"label_agreement":null},{"id":"W2954976904","doi":"10.1016/j.ygyno.2019.04.053","title":"Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer: Primary and biomarker analysis of the phase III JAVELIN Ovarian 200 trial","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Avelumab; Ovarian cancer; Refractory (planetary science); Doxorubicin; Internal medicine; Oncology; Chemotherapy; Pharmacology; Cancer; Immunotherapy; Nivolumab","score_opus":0.029138449865378058,"score_gpt":0.320123002246093,"score_spread":0.29098455238071497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954976904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897215,0.0003959385,0.000009464505,0.0033539524,0.0010600155,0.00421466,0.00022190603,0.00005643531,0.0009661671],"genre_scores_gemma":[0.9970176,0.00047595412,0.0005506107,0.00045182265,0.00010507641,0.00045603365,0.0003129382,0.000051516163,0.00057841593],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950092,0.0008852073,0.0016346194,0.0010904848,0.00057540595,0.0008051055],"domain_scores_gemma":[0.9956389,0.0021271366,0.0010341689,0.00074589805,0.00023450569,0.00021940496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001102051,0.0005912646,0.0024895181,0.0010339211,0.00013802672,0.000030616673,0.0002950448,0.0007863643,0.0024925282],"category_scores_gemma":[0.00043732006,0.00035607643,0.00020848947,0.0028721641,0.00035037208,0.00017594112,0.00017750141,0.000680912,0.0000106149055],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82948726,0.015091819,0.079622254,0.00018731118,0.005602912,0.0020854285,0.0017517101,0.00037523572,0.027002294,0.00020550836,0.00025215145,0.0383361],"study_design_scores_gemma":[0.40647367,0.028327852,0.5560339,0.00022077606,0.003228305,0.000040037605,0.00043227288,0.0026383924,0.0009994572,0.00001717594,0.0011680799,0.0004200775],"about_ca_topic_score_codex":0.005692434,"about_ca_topic_score_gemma":0.044705052,"teacher_disagreement_score":0.47641164,"about_ca_system_score_codex":0.0024758184,"about_ca_system_score_gemma":0.0024630374,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W2955360239","doi":"10.1016/j.ygyno.2019.04.062","title":"Impact of surgical approach on survival outcomes in women undergoing radical hysterectomy for cervical cancer: A population-based cohort study","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radical Hysterectomy; Cervical cancer; Hysterectomy; Cohort study; Cohort; Cancer; Population; Retrospective cohort study; Gynecology; Obstetrics; Surgery; Internal medicine","score_opus":0.03424006012323961,"score_gpt":0.37208336193435976,"score_spread":0.33784330181112016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955360239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926422,0.00003377342,0.000009986091,0.00039232167,0.00041917106,0.0038215765,0.000039324143,0.000043265612,0.0025983416],"genre_scores_gemma":[0.9979121,0.0000132790865,0.00021626658,0.00021146955,0.00007953096,0.0013172663,0.000071527626,0.000022896498,0.00015567605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748427,0.00039384494,0.00064345804,0.00055882253,0.00035686587,0.0005627577],"domain_scores_gemma":[0.9946077,0.00460653,0.00021295097,0.0002933366,0.00007540677,0.00020408518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00077071344,0.00027044714,0.0017332634,0.0002958572,0.000039390754,0.0000067790106,0.00015079229,0.00030858815,0.001176066],"category_scores_gemma":[0.0004109237,0.00017672713,0.00030749507,0.00046162712,0.00005420268,0.000032501186,0.00004537106,0.00027464886,0.000014627218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006153006,0.007897017,0.98082405,0.00011039655,0.0004903727,0.000049223072,0.00009988242,0.0007393022,0.000009676682,0.000060106253,0.000012981418,0.0035539754],"study_design_scores_gemma":[0.033844262,0.02225965,0.9428284,0.000019585037,0.000118577234,0.0000038976304,0.00017685755,0.00039154605,0.0000040241935,0.000088693414,0.00011163163,0.00015282986],"about_ca_topic_score_codex":0.0015580226,"about_ca_topic_score_gemma":0.00055529765,"teacher_disagreement_score":0.037995618,"about_ca_system_score_codex":0.0032892097,"about_ca_system_score_gemma":0.0006567455,"threshold_uncertainty_score":0.99973696},"labels":[],"label_agreement":null},{"id":"W2955542912","doi":"10.1016/j.ygyno.2019.04.345","title":"ERAS interactive audit system (EIAS) gynecologic oncology project: Audit of international surgical practice informs perioperative care","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; London Health Sciences Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Audit; Gynecologic oncology; General surgery; Perioperative; Surgery; Accounting","score_opus":0.013988206122925,"score_gpt":0.3331877322836602,"score_spread":0.3191995261607352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955542912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64578795,0.00034243235,0.00006194987,0.0021386223,0.0070971292,0.00248872,0.000072370545,0.00023161461,0.3417792],"genre_scores_gemma":[0.9876157,0.00039799817,0.0041501485,0.0016963044,0.0005290204,0.00067049626,0.0002510491,0.000053682765,0.0046355673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949399,0.00096337474,0.0015354945,0.0010612714,0.0006103918,0.00088951463],"domain_scores_gemma":[0.98802364,0.007740005,0.0015340772,0.00069426006,0.001769166,0.00023887018],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011205461,0.00059292186,0.0021009482,0.0006374019,0.00014337341,0.000037030608,0.0005789668,0.0012774649,0.00323223],"category_scores_gemma":[0.004328446,0.00045837704,0.00046470886,0.0005867723,0.00044491605,0.0007858922,0.0005993846,0.0015013515,0.0011130963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0629277,0.020035611,0.31453538,0.0058853086,0.012763759,0.04153977,0.08936039,0.0031017123,0.0272867,0.019093798,0.034777816,0.36869204],"study_design_scores_gemma":[0.008846558,0.019066282,0.02571857,0.00028619493,0.00044195476,0.0044424725,0.05721702,0.00050306384,0.0027219215,0.000023178192,0.87999713,0.00073563255],"about_ca_topic_score_codex":0.00013140228,"about_ca_topic_score_gemma":0.00018467536,"teacher_disagreement_score":0.8452193,"about_ca_system_score_codex":0.0061084814,"about_ca_system_score_gemma":0.0038719468,"threshold_uncertainty_score":0.9997868},"labels":[],"label_agreement":null},{"id":"W2956072385","doi":"10.1016/j.ygyno.2019.04.309","title":"Impact of gynecologic oncology clinic-initiated testing on patient pathways and resource utilization in Southern Alberta","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Oncology; Genetic testing; Internal medicine; Gynecologic cancer; BRCA mutation; Ovarian cancer; Serous fluid; Serous ovarian cancer; Cancer","score_opus":0.06790642883216147,"score_gpt":0.3454772318720119,"score_spread":0.27757080303985043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956072385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643622,0.00021215061,0.0000144592,0.00014670081,0.00029748474,0.000767697,0.000048206297,0.000020883688,0.03413022],"genre_scores_gemma":[0.9977265,0.00006643461,0.000815619,0.0007115076,0.000056444747,0.000112388225,0.00016477652,0.000032665343,0.00031366557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728495,0.00066742743,0.00072005973,0.0007177404,0.00012272804,0.00048708817],"domain_scores_gemma":[0.9970633,0.0016518044,0.00056059076,0.00044841648,0.00017909688,0.00009679458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006314594,0.0002879498,0.0005631001,0.00018578551,0.00006868379,0.000009466204,0.00025096312,0.0008328122,0.0004888304],"category_scores_gemma":[0.0025821563,0.00025016515,0.00011920925,0.00033126466,0.00022518203,0.000006695093,0.0002509754,0.00030516562,0.00010951098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021012342,0.0027323903,0.6331647,0.000075364,0.0003105774,0.00007626686,0.0028686665,0.01028364,0.11361918,0.00015608428,0.002627388,0.23198451],"study_design_scores_gemma":[0.012011076,0.11437494,0.8038793,0.00008929426,0.00013417014,0.00018405178,0.007979045,0.0029230346,0.009295096,0.001524327,0.046087343,0.0015183025],"about_ca_topic_score_codex":0.00021857988,"about_ca_topic_score_gemma":0.001356666,"teacher_disagreement_score":0.2304662,"about_ca_system_score_codex":0.0006252648,"about_ca_system_score_gemma":0.00082893774,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W2963040485","doi":"10.1016/j.ygyno.2019.07.012","title":"Molecular profiling and molecular classification of endometrioid ovarian carcinomas","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Ovarian carcinomas; Profiling (computer programming); Oncology; Pathology; Ovarian cancer; Ovarian carcinoma; Internal medicine; Cancer; Computer science","score_opus":0.027183231843289007,"score_gpt":0.3080079714495773,"score_spread":0.2808247396062883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963040485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641448,0.0011805985,0.00014026534,0.00090931024,0.00024613016,0.00090686674,0.0000064618275,0.000034451994,0.03243109],"genre_scores_gemma":[0.99575937,0.000079798636,0.0032756734,0.000614453,0.000027389873,0.000069389505,0.000032878183,0.00001328248,0.00012779413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875635,0.0001234609,0.0003336622,0.00035127657,0.00018036285,0.00025486597],"domain_scores_gemma":[0.99888575,0.00043156586,0.00017426006,0.00026271588,0.000118312324,0.00012738028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002739186,0.00014283288,0.00056029216,0.00025018756,0.00002434972,0.0000046999585,0.00008216463,0.00024160117,0.00037712252],"category_scores_gemma":[0.00055637374,0.00011296046,0.00009597033,0.0005001874,0.0000936726,0.00003332122,0.00006794085,0.00017089644,0.00004603979],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000615811,0.0006032138,0.27401093,0.00019643368,0.0002239786,0.00024516575,0.00006309158,0.0000099123845,0.67283165,0.012462863,0.000018006094,0.038718954],"study_design_scores_gemma":[0.016913226,0.0120036295,0.75685513,0.000033201337,0.00053800683,0.00015508023,0.00038478847,0.00027626375,0.20409532,0.0024998705,0.005942991,0.00030251232],"about_ca_topic_score_codex":0.000036408008,"about_ca_topic_score_gemma":0.000003650452,"teacher_disagreement_score":0.48284417,"about_ca_system_score_codex":0.00023054691,"about_ca_system_score_gemma":0.00019401645,"threshold_uncertainty_score":0.4606394},"labels":[],"label_agreement":null},{"id":"W2963662989","doi":"10.1016/j.ygyno.2019.07.016","title":"Risk factors for lymph nodes involvement in obese women with endometrial carcinomas","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; Jewish General Hospital; McGill University","funders":"Israel Cancer Research Fund","keywords":"Medicine; Lymph node; Body mass index; Endometrial cancer; Hazard ratio; Proportional hazards model; Quartile; Confidence interval; Odds ratio; Lymph; Carcinoma; Internal medicine; Retrospective cohort study; Gynecology; Urology; Cancer; Pathology","score_opus":0.03197390081812814,"score_gpt":0.3001384813552787,"score_spread":0.2681645805371506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963662989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916238,0.00023144252,0.000020431255,0.0002508528,0.0007438255,0.0021339175,0.000051004976,0.00005463176,0.0048900964],"genre_scores_gemma":[0.9965106,0.00013615553,0.0009021497,0.00056538905,0.00015931454,0.0008363674,0.000055980232,0.000023285405,0.00081071776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979933,0.0001554496,0.00041155654,0.00051394186,0.00022781125,0.0006979481],"domain_scores_gemma":[0.9964403,0.0027532526,0.00020979105,0.00028111067,0.00009219396,0.00022333478],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053705525,0.00025906513,0.0009584592,0.00041672442,0.000059626796,0.000010427208,0.00014558002,0.00027574456,0.0015523073],"category_scores_gemma":[0.0010337294,0.00016283801,0.00011092981,0.0006793394,0.00008672447,0.00006103857,0.000072838746,0.00020321019,0.000083079336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006397943,0.001183757,0.9776239,0.00007845965,0.00023715755,0.00006376756,0.0005579307,0.000037314177,0.00036073188,0.00010817412,0.00004525416,0.01330562],"study_design_scores_gemma":[0.047938257,0.01938395,0.9209759,0.000017326618,0.00015929714,0.00000811532,0.0020284131,0.0000296737,0.0006525275,0.00060704874,0.007980666,0.00021879147],"about_ca_topic_score_codex":0.0005661081,"about_ca_topic_score_gemma":0.00029235028,"teacher_disagreement_score":0.05664796,"about_ca_system_score_codex":0.002581353,"about_ca_system_score_gemma":0.000443258,"threshold_uncertainty_score":0.9993604},"labels":[],"label_agreement":null},{"id":"W2967146499","doi":"10.1016/j.ygyno.2019.08.009","title":"OVQUEST – Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ovarian cancer; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.043208356456737984,"score_gpt":0.34831643379776084,"score_spread":0.30510807734102285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967146499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927363,0.0022295327,0.0000016138943,0.0018845277,0.0012381648,0.0007018025,0.00030677504,0.000010200453,0.0008911042],"genre_scores_gemma":[0.9923745,0.0059976503,0.00001822274,0.0006695465,0.000109984176,0.0006019482,0.00003956212,0.000014442415,0.00017414104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985131,0.00036667468,0.000381054,0.00035815113,0.00014799948,0.00023304709],"domain_scores_gemma":[0.9983628,0.0008870834,0.00020283433,0.00025928585,0.00016807637,0.00011992799],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045611963,0.00017823992,0.0006407875,0.00010992637,0.000023315826,0.000008733381,0.00011886874,0.00022546007,0.0017785319],"category_scores_gemma":[0.0001404939,0.00011952483,0.000047144356,0.00017900931,0.00027229276,0.00007697182,0.000068963185,0.00012152459,0.0000017454533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093693804,0.0003719618,0.96785086,0.000037439262,0.0001801674,0.000019104795,0.0023257695,0.000016015227,0.0000851138,0.00013271645,0.000024990812,0.02801891],"study_design_scores_gemma":[0.0027097312,0.0023892864,0.9880485,0.000041366246,0.000096828946,0.0000067146407,0.0005343732,0.00008629438,0.00011921534,0.000026272412,0.0058265748,0.00011487422],"about_ca_topic_score_codex":0.18655176,"about_ca_topic_score_gemma":0.6054451,"teacher_disagreement_score":0.4188933,"about_ca_system_score_codex":0.00037992402,"about_ca_system_score_gemma":0.00048100488,"threshold_uncertainty_score":0.999134},"labels":[],"label_agreement":null},{"id":"W2969860872","doi":"10.1016/j.ygyno.2019.08.015","title":"Long term outcomes in patients with sentinel lymph nodes (SLNs) identified by injecting remaining scar after previously excised vulvar cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vulvar cancer; Biopsy; Vulvar intraepithelial neoplasia; Sentinel lymph node; Wide local excision; Surgery; Groin; Vulva; Vulvar Carcinoma; Carcinoma; Cancer; Radiology; Breast cancer; Pathology; Internal medicine","score_opus":0.01622398674734725,"score_gpt":0.30567914710774235,"score_spread":0.2894551603603951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969860872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521977,0.00043897514,0.000006215446,0.00029299987,0.00064981024,0.0012966003,0.000016776376,0.000085691485,0.0019931835],"genre_scores_gemma":[0.99563247,0.00006639433,0.00018901248,0.0017099198,0.000072629286,0.0004385379,0.00007354184,0.000039943163,0.00177758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974511,0.00019140494,0.0005891925,0.0006799837,0.00035720522,0.0007310735],"domain_scores_gemma":[0.9984035,0.000621644,0.0003080492,0.00034525286,0.0001430452,0.00017852403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003574596,0.00034517076,0.0010879897,0.00024551226,0.00007036806,0.000026472497,0.0001683513,0.0003114867,0.0016792105],"category_scores_gemma":[0.00033421488,0.00023615621,0.00012613884,0.00049959467,0.000090765214,0.0001467719,0.00014064115,0.00029935458,0.000120315475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018883931,0.0010228782,0.9817226,0.0001280286,0.00023166077,0.00014467341,0.00024306036,0.000011073078,0.00015845512,0.0000020355772,0.000035355475,0.014411815],"study_design_scores_gemma":[0.02233914,0.0010105514,0.9757181,0.00014760911,0.00021325819,0.00000641281,0.000111061156,0.000008180914,0.00010106839,0.000015736572,0.00007277124,0.00025612794],"about_ca_topic_score_codex":0.0002404116,"about_ca_topic_score_gemma":0.0002464594,"teacher_disagreement_score":0.020450747,"about_ca_system_score_codex":0.0012106631,"about_ca_system_score_gemma":0.0002512379,"threshold_uncertainty_score":0.99923337},"labels":[],"label_agreement":null},{"id":"W2970298493","doi":"10.1016/j.ygyno.2019.08.001","title":"Precision medicine in endometrial cancer","year":2019,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Endometrial cancer; Medicine; Ovarian cancer; Oncology; Cancer; Internal medicine; Disease; Gynecology; Uterine cancer; Breast cancer","score_opus":0.03428407071282693,"score_gpt":0.3863640530262684,"score_spread":0.3520799823134415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970298493","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033330412,0.0070406655,0.000003898598,0.0022993798,0.9357126,0.0022474495,0.00016416023,0.00009710845,0.04910175],"genre_scores_gemma":[0.0075308597,0.013840336,0.00022114765,0.00096325733,0.96070427,0.00091020996,0.0010224604,0.00009098865,0.014716489],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951725,0.0004468549,0.0012078261,0.0011593999,0.0011629055,0.0008505188],"domain_scores_gemma":[0.9819659,0.016141351,0.00060468714,0.00061359425,0.000377139,0.00029733367],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012988241,0.0006217151,0.0032033983,0.0013021077,0.000055092794,0.000011215215,0.0004334654,0.0034685382,0.011473383],"category_scores_gemma":[0.020201357,0.00042158904,0.00030864388,0.0014985995,0.00024022318,0.000062320396,0.00025387533,0.002108405,0.0005852936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043511456,0.00075347885,0.002439844,0.00022394407,0.00025736282,0.0005935154,0.00006558824,0.0000064609308,0.00008664423,0.000015843478,0.8976249,0.09358129],"study_design_scores_gemma":[0.034396388,0.0130102215,0.0041420804,0.00036089946,0.00060272287,0.000009257968,0.000041231662,0.0000055809933,0.000026732429,0.00035732452,0.94671553,0.00033202965],"about_ca_topic_score_codex":0.0019312471,"about_ca_topic_score_gemma":0.0013569026,"teacher_disagreement_score":0.09324926,"about_ca_system_score_codex":0.0048912554,"about_ca_system_score_gemma":0.0028065674,"threshold_uncertainty_score":0.9998236},"labels":[],"label_agreement":null},{"id":"W2971357163","doi":"10.1016/j.ygyno.2019.08.034","title":"A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"Canadian Cancer Society Research Institute; Canada Research Chairs","keywords":"Medicine; Oophorectomy; Ovarian cancer; Hazard ratio; Gynecology; Cohort; Cohort study; Obstetrics; Prospective cohort study; Cancer; Internal medicine; Hysterectomy; Surgery; Confidence interval","score_opus":0.024650759195519168,"score_gpt":0.3559726630542547,"score_spread":0.3313219038587355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971357163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957505,0.00022852476,0.00093979115,0.00012244067,0.00024503854,0.0006320972,0.00008619725,0.00001408505,0.0019813138],"genre_scores_gemma":[0.99396604,0.00007011322,0.0047694766,0.00021264481,0.000056902772,0.0003986678,0.000063531195,0.000020244079,0.00044235916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832,0.0002577148,0.00041795135,0.00047753408,0.00013349751,0.0003932936],"domain_scores_gemma":[0.99874955,0.00040907977,0.0003227989,0.0002947008,0.000160355,0.00006348495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037122026,0.00018116971,0.00043590146,0.00008162397,0.00006216426,0.000009518869,0.00022813906,0.0002779167,0.0006441137],"category_scores_gemma":[0.00027844755,0.00015228287,0.000041875322,0.0003461182,0.00020224582,0.000011741851,0.00009634335,0.00019120607,0.000006918957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012305409,0.00056781503,0.92875046,0.00007194171,0.00045462252,0.000015283056,0.0033549452,0.02026591,0.035850026,0.000070366106,0.00050304236,0.00886506],"study_design_scores_gemma":[0.0035934546,0.004191938,0.959221,0.000043959255,0.00006693743,0.000023665041,0.0119068725,0.00014939705,0.013695029,0.0002114437,0.006555906,0.00034037756],"about_ca_topic_score_codex":0.00018167481,"about_ca_topic_score_gemma":0.00981383,"teacher_disagreement_score":0.030470574,"about_ca_system_score_codex":0.0005030894,"about_ca_system_score_gemma":0.0015026882,"threshold_uncertainty_score":0.7052593},"labels":[],"label_agreement":null},{"id":"W2979427329","doi":"10.1016/j.ygyno.2019.09.010","title":"Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University","funders":"Fonds de Recherche du Québec - Santé; Maud Kuistilan Muistosäätiö; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Medicine; Viral load; Cervical intraepithelial neoplasia; Cervical cancer; Internal medicine; Receiver operating characteristic; Odds ratio; Human papillomavirus; Cytology; Gastroenterology; Cancer; Oncology; Area under the curve; Pathology; Virus; Immunology","score_opus":0.023968094507693286,"score_gpt":0.35550475922076175,"score_spread":0.3315366647130685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979427329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91320765,0.0015195899,0.000001999678,0.00069577724,0.00030140116,0.0007101853,0.000118567266,0.000033877404,0.08341095],"genre_scores_gemma":[0.9946925,0.0007420425,0.00006341054,0.00080424896,0.00018782855,0.000078007695,0.000034864413,0.000019776158,0.0033772958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980752,0.00014612253,0.0004978002,0.00041602974,0.00040191284,0.00046293664],"domain_scores_gemma":[0.99862874,0.00044809075,0.00017598298,0.00028784326,0.00021391592,0.0002454407],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038199697,0.00019892163,0.00094395975,0.00009858122,0.000049760136,0.000007088177,0.00020907493,0.0004728863,0.025421927],"category_scores_gemma":[0.00026737977,0.00015389141,0.00011405824,0.00017248283,0.00052896637,0.000046838446,0.0002115139,0.00047800058,0.00007615109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007750087,0.0026834013,0.41071886,0.0017984986,0.000747252,0.0003423894,0.0014554138,0.00000654873,0.23284332,0.003113251,0.034929868,0.3036111],"study_design_scores_gemma":[0.014988426,0.02921773,0.7832024,0.00006022558,0.00038771,0.00006772408,0.0004221737,0.00007434877,0.018072564,0.0036308456,0.14947517,0.0004006916],"about_ca_topic_score_codex":0.0017928127,"about_ca_topic_score_gemma":0.0011250268,"teacher_disagreement_score":0.37248352,"about_ca_system_score_codex":0.00053152593,"about_ca_system_score_gemma":0.000816146,"threshold_uncertainty_score":0.975469},"labels":[],"label_agreement":null},{"id":"W2979870560","doi":"10.1016/j.ygyno.2019.06.017","title":"Reproductive and Hormonal Considerations in Women at Increased Risk for Hereditary Gynecologic Cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review","year":2019,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre","funders":"","keywords":"Medicine; Gynecology; Gynecologic oncology; Reproductive medicine; Hysterectomy; Fertility preservation; Obstetrics; Fertility; Gynecologic cancer; Population; Genetic testing; Pregnancy; Ovarian cancer; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.0902328413148883,"score_gpt":0.39210243218150653,"score_spread":0.30186959086661824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979870560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067642066,0.97699785,0.00013271479,0.0045273216,0.0007780218,0.0096456455,0.0010127565,0.000034499637,0.00010699697],"genre_scores_gemma":[0.0013238515,0.96270406,0.017565085,0.0045666588,0.0007578028,0.012123674,0.0006970696,0.00008423691,0.00017756828],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924682,0.0015288378,0.0018907224,0.0029157863,0.0002269062,0.0009695424],"domain_scores_gemma":[0.98413783,0.010677055,0.0029583194,0.0011830323,0.000837561,0.00020618462],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0056159026,0.0009100855,0.0045203064,0.00017856872,0.00036933698,0.000012685809,0.00044834425,0.0014596235,0.0001606281],"category_scores_gemma":[0.014893955,0.0007563555,0.00088369235,0.00054726633,0.00341611,0.000028371378,0.0005374628,0.0007080845,0.0000027197918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00088304875,0.0006608393,0.00091754366,0.032790266,0.0031212068,0.000018122973,0.00084563653,0.00015770092,0.00058093615,0.000094963114,0.20972791,0.7502018],"study_design_scores_gemma":[0.0032922702,0.017405733,0.0010673043,0.0024158303,0.0028758068,0.00013711362,0.0014176855,0.0000696319,0.00006947573,0.0010377717,0.96928334,0.0009280069],"about_ca_topic_score_codex":0.00021654535,"about_ca_topic_score_gemma":0.0007726911,"teacher_disagreement_score":0.75955546,"about_ca_system_score_codex":0.0050580115,"about_ca_system_score_gemma":0.007772224,"threshold_uncertainty_score":0.9998367},"labels":[],"label_agreement":null},{"id":"W2983632557","doi":"10.1016/j.ygyno.2019.11.019","title":"Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis","year":2019,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Terry Fox Research Institute","keywords":"Medicine; Loss of heterozygosity; Ovarian cancer; Germline mutation; Internal medicine; Serous fluid; Oncology; Mutation; Immunohistochemistry; Germline; Cancer; Microsatellite instability; Cancer research; Pathology; Biology; Gene; Genetics; Microsatellite; Allele","score_opus":0.04220899966440079,"score_gpt":0.38478067590078324,"score_spread":0.34257167623638246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983632557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015617996,0.97958183,0.00007143553,0.000111217545,0.00013306398,0.0040908772,0.00030885354,0.000011015751,0.00007371689],"genre_scores_gemma":[0.0037869732,0.9905956,0.0014775743,0.00040856356,0.00007636379,0.0031485755,0.00018030326,0.000031876785,0.0002941741],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969171,0.00046556187,0.0010518909,0.0010632366,0.00009546837,0.00040673107],"domain_scores_gemma":[0.99708325,0.00049359497,0.0013979567,0.0006756146,0.00020266563,0.00014691842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018059448,0.0004490927,0.0041266205,0.00014317689,0.00010846385,0.000024566169,0.0001941697,0.00087478955,0.000029784278],"category_scores_gemma":[0.00063239294,0.0002960819,0.0002514731,0.00026499454,0.0003896495,0.000005623774,0.00029617484,0.00024967533,6.2481286e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034353675,0.00024684038,0.00069946604,0.8924209,0.007409958,0.0027007433,0.00019376804,0.0000062224062,0.000026612894,0.000059266767,0.00049460365,0.0953981],"study_design_scores_gemma":[0.008767734,0.01769678,0.0021323604,0.039125033,0.19902037,0.17346881,0.0005810132,0.000011186884,0.00004560142,0.00014654834,0.5557906,0.0032139528],"about_ca_topic_score_codex":0.000042290318,"about_ca_topic_score_gemma":0.0004179194,"teacher_disagreement_score":0.85329586,"about_ca_system_score_codex":0.00035405954,"about_ca_system_score_gemma":0.0007642318,"threshold_uncertainty_score":0.99994916},"labels":[],"label_agreement":null},{"id":"W2985587430","doi":"10.1016/j.ygyno.2019.10.021","title":"Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"Alberta Health Services","keywords":"Medicine; Ovarian cancer; Metastasis; Serous fluid; Pathology; Cancer; Implant; Gene signature; Cancer research; Oncology; Gene; Gene expression; Internal medicine; Biology; Surgery","score_opus":0.06676854889400057,"score_gpt":0.3557926784090974,"score_spread":0.2890241295150968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985587430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771935,0.0008328624,0.000015647132,0.0000844738,0.00042224737,0.0006212132,0.00013654649,0.000022335324,0.00014530755],"genre_scores_gemma":[0.9988038,0.0002968627,0.00042438446,0.00010260268,0.00005913841,0.00011220624,0.00012763392,0.000015500038,0.00005785789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804133,0.00017908555,0.00057136524,0.00059805956,0.00019082552,0.0004193194],"domain_scores_gemma":[0.9989355,0.00016403545,0.0003534279,0.00036927758,0.00008063261,0.00009710098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001739516,0.000242373,0.0011524927,0.00043336177,0.000077338875,0.00001363783,0.0001597149,0.00038942552,0.0012882024],"category_scores_gemma":[0.000023358398,0.00018777294,0.00021425856,0.00038854787,0.00007670978,0.00005448199,0.00013521893,0.00025576435,0.00000681184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014649372,0.0004388129,0.4569869,0.000048092665,0.0005159836,0.00012425982,0.000183134,0.00044435033,0.54038453,0.000012388676,0.000010316547,0.00070470513],"study_design_scores_gemma":[0.0023816128,0.0007410051,0.8692863,0.0000996632,0.0013256192,0.00002162474,0.00018837067,0.00042976352,0.12526721,0.000014848836,0.000076881995,0.00016710542],"about_ca_topic_score_codex":0.0013088677,"about_ca_topic_score_gemma":0.0027478912,"teacher_disagreement_score":0.41511735,"about_ca_system_score_codex":0.00095987716,"about_ca_system_score_gemma":0.00025882357,"threshold_uncertainty_score":0.9996247},"labels":[],"label_agreement":null},{"id":"W2991411477","doi":"10.1016/j.ygyno.2019.11.014","title":"Same-day discharge of Gynecologic Oncology patients following ileostomy closure is feasible and safe","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Stoma care and complications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Ileostomy; Surgery; Bowel obstruction; Adverse effect; Malignancy; Sepsis; Gynecologic oncology; Retrospective cohort study; Internal medicine","score_opus":0.017704190970160086,"score_gpt":0.3115919016095887,"score_spread":0.29388771063942865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991411477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9199327,0.00049412105,0.000028202074,0.0038349645,0.0012412025,0.0016000606,0.000043029773,0.000100546844,0.07272513],"genre_scores_gemma":[0.9888946,0.00016361814,0.0017640555,0.0061746193,0.00008771453,0.0002211727,0.000100956124,0.00003117111,0.002562107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727255,0.00032904476,0.0007316593,0.00073321216,0.00027991095,0.0006535928],"domain_scores_gemma":[0.99647015,0.0019123921,0.00044168567,0.00063244626,0.00029051927,0.0002528158],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00060160086,0.00033446672,0.001294608,0.0002653568,0.00015929967,0.000010659066,0.00028915907,0.0007566185,0.0028010856],"category_scores_gemma":[0.00081954076,0.00027621296,0.00031562938,0.00042821906,0.00023405624,0.00011631352,0.00029422436,0.00048893696,0.0005626348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018999854,0.0015895362,0.93884957,0.00009855451,0.00027535902,0.000059375277,0.00079683,0.0000020184539,0.0027929433,0.0015455633,0.011160342,0.042639893],"study_design_scores_gemma":[0.005187457,0.009101847,0.80669016,0.000029813955,0.000327301,0.000052521627,0.00073847885,0.0000400901,0.0004282622,0.0011289822,0.17598858,0.00028651574],"about_ca_topic_score_codex":0.000047667992,"about_ca_topic_score_gemma":0.00009527718,"teacher_disagreement_score":0.16482826,"about_ca_system_score_codex":0.00054703804,"about_ca_system_score_gemma":0.000634217,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W2995634960","doi":"10.1016/j.ygyno.2019.10.001","title":"Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen; Pfizer UK; Ipsen Fund; Sanofi; AstraZeneca; Janssen Biotech; Astellas Pharma; Roche; Astellas Pharma US; Pfizer","keywords":"Medicine; Chemotherapy; Oncology; Ovarian cancer; Internal medicine; Progression-free survival; Cancer; Gynecology","score_opus":0.019248039451430218,"score_gpt":0.3012838327553,"score_spread":0.2820357933038698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995634960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218243,0.00020715363,0.000015334292,0.0031836168,0.00053135835,0.003451216,0.0000429131,0.000033705903,0.0003522894],"genre_scores_gemma":[0.9979732,0.00076416414,0.0003524253,0.00025631124,0.00011561245,0.00040259867,0.000011571569,0.00003517448,0.00008895067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735683,0.0003386575,0.0007472628,0.00058078073,0.0005129211,0.00046354017],"domain_scores_gemma":[0.9975756,0.00078628404,0.00078982726,0.00045638223,0.00028182357,0.000110120716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011697327,0.00033125043,0.0010864461,0.00014474533,0.00007149389,0.000017763094,0.00017642134,0.00023910032,0.00028324366],"category_scores_gemma":[0.000100229605,0.0001891241,0.00006307378,0.00031528206,0.00017589836,0.00009523369,0.000095106894,0.00030329605,0.0000011117667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010869501,0.0031310036,0.932171,0.00011919148,0.00090610294,0.00006103995,0.009701724,0.00020588585,0.001000571,0.0001266162,0.000037632257,0.04166972],"study_design_scores_gemma":[0.02048635,0.023689326,0.9500549,0.0002518325,0.00016740372,0.000004816073,0.003703249,0.000112368325,0.0010132965,0.00015586916,0.0001731841,0.00018743923],"about_ca_topic_score_codex":0.00097513356,"about_ca_topic_score_gemma":0.0035720808,"teacher_disagreement_score":0.04148228,"about_ca_system_score_codex":0.00080497365,"about_ca_system_score_gemma":0.00060285174,"threshold_uncertainty_score":0.7712257},"labels":[],"label_agreement":null},{"id":"W2995949931","doi":"10.1016/j.ygyno.2019.12.002","title":"EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer","year":2019,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Clinical endpoint; Placebo; Internal medicine; Discontinuation; Adverse effect; Sorafenib; Gastroenterology; Randomized controlled trial; Combination therapy; Surgery; Hepatocellular carcinoma; Pathology","score_opus":0.024210691035109453,"score_gpt":0.3185982818749869,"score_spread":0.2943875908398774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995949931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96146953,0.00025701706,0.000028803932,0.0039236015,0.00058212935,0.032884203,0.000031623105,0.00007175187,0.00075133593],"genre_scores_gemma":[0.9897475,0.00008971993,0.00040128813,0.0006211041,0.0001514805,0.008035074,0.00025956254,0.00006207663,0.00063214457],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99535596,0.00081015466,0.0014797066,0.00087375095,0.00061773043,0.0008626887],"domain_scores_gemma":[0.9957161,0.0019014518,0.00096425303,0.0006168707,0.0005122972,0.00028901943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013971167,0.00062258187,0.0036207044,0.00043007184,0.00020308916,0.000040655825,0.00025194316,0.0003595087,0.0008571803],"category_scores_gemma":[0.0003699827,0.00032180763,0.00022160301,0.0010276856,0.00026949847,0.00017927226,0.00011964197,0.00048547867,0.000018105831],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92666787,0.02125738,0.04648811,0.00010611339,0.0012496972,0.000100731,0.00086602307,0.0010644168,0.00011934118,0.00007076618,0.00047396854,0.0015355805],"study_design_scores_gemma":[0.9189558,0.06928992,0.006833321,0.00041636892,0.0014396847,0.0000084763005,0.00014475873,0.0008312777,0.0011572022,0.0000145961985,0.0005478012,0.00036081343],"about_ca_topic_score_codex":0.0017844202,"about_ca_topic_score_gemma":0.009149679,"teacher_disagreement_score":0.04803254,"about_ca_system_score_codex":0.0013313907,"about_ca_system_score_gemma":0.0014210186,"threshold_uncertainty_score":0.9999234},"labels":[],"label_agreement":null},{"id":"W2996972368","doi":"10.1016/j.ygyno.2019.12.015","title":"Therapeutic options for mucinous ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"Cancer Council Tasmania; National Institutes of Health; Cancer Council South Australia; Medical Research Council; Peter MacCallum Foundation; Hudson Institute of Medical Research; Terry Fox Research Institute; BC Cancer Foundation; Cancer Council Victoria; Cancer Australia; Australian Cancer Research Foundation; Australian Government; Cancer Institute NSW; National Cancer Institute; Ovarian Cancer Australia; Peter MacCallum Cancer Centre; Medical Research and Materiel Command; Victorian Cancer Agency; Mayo Foundation for Medical Education and Research; Cancer Council NSW; National Health and Medical Research Council; Minnesota Ovarian Cancer Alliance","keywords":"Medicine; Mucinous carcinoma; Ovarian carcinoma; Oncology; Carcinoma; Ovary; Internal medicine; General surgery; Gynecology; Ovarian cancer; Adenocarcinoma; Cancer","score_opus":0.08267601124765372,"score_gpt":0.33959710976708657,"score_spread":0.25692109851943284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996972368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4525995,0.004374751,0.005440432,0.47818282,0.0021889966,0.006725585,0.00016695418,0.00061243994,0.049708508],"genre_scores_gemma":[0.97014713,0.00011942925,0.0071129543,0.02108466,0.00041725504,0.00073900976,0.000054426382,0.000021632353,0.00030350577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998831,0.00006621818,0.00025549842,0.0004064536,0.000083147745,0.0003576795],"domain_scores_gemma":[0.9988973,0.00046804166,0.000090286696,0.00021054909,0.000090096386,0.00024373489],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012398552,0.00016556606,0.00047782785,0.000045665438,0.00012416265,0.000010786206,0.00009711057,0.00021374912,0.0010826339],"category_scores_gemma":[0.0001660242,0.00012946592,0.00017409257,0.00015154791,0.00007485372,0.00002947505,0.000038088197,0.0001469045,0.00014641254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00225091,0.0058266334,0.25720936,0.00036734168,0.0015912154,0.0015508812,0.0028416244,0.0001337954,0.003379148,0.08673959,0.07651683,0.5615927],"study_design_scores_gemma":[0.009180643,0.015745662,0.3589361,0.0000069986577,0.00072108564,0.000110963025,0.00032676998,0.0007143833,0.00051418704,0.0016636236,0.6118598,0.00021976921],"about_ca_topic_score_codex":0.00002190645,"about_ca_topic_score_gemma":0.00002960929,"teacher_disagreement_score":0.5613729,"about_ca_system_score_codex":0.0003712834,"about_ca_system_score_gemma":0.0004385293,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W2999820772","doi":"10.1016/j.ygyno.2019.12.029","title":"Corrigendum to “Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for reproductive medicine evidence-based review” [Gynecol. Oncol. 155 (2019) 508–514]","year":2020,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CReATe Fertility Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Gynecology; Reproductive medicine; Regret; Hysterectomy; Obstetrics; Fertility preservation; Population; Genetic testing; Fertility; Pregnancy; Family medicine; Oncology; Internal medicine; Surgery","score_opus":0.07727465915859572,"score_gpt":0.3532589585618983,"score_spread":0.2759842994033026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999820772","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09627661,0.24566208,0.00036692052,0.52213174,0.039896347,0.08142646,0.009667503,0.000541288,0.004031055],"genre_scores_gemma":[0.07045066,0.49856207,0.09607442,0.19120586,0.013230099,0.106159315,0.004825935,0.00064851996,0.018843105],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98926705,0.0012306363,0.0026601865,0.004382514,0.0006475266,0.0018120572],"domain_scores_gemma":[0.97682303,0.015815714,0.003236413,0.001374164,0.0017299516,0.001020698],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0050539374,0.0015169618,0.006854525,0.0003966564,0.0006935483,0.000027452677,0.00045910396,0.0019824484,0.001244629],"category_scores_gemma":[0.02601759,0.0012656313,0.0010201179,0.001140372,0.0033623315,0.00021349422,0.0006393702,0.001990676,0.000015646494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028187144,0.0015598367,0.008293745,0.0033432494,0.0023403778,0.00020751164,0.0020190105,0.00003955055,0.00015884775,0.00007531046,0.9494825,0.029661326],"study_design_scores_gemma":[0.015338551,0.08859336,0.096097924,0.0021868474,0.005342181,0.00019617515,0.005261186,0.00043707585,0.00010721883,0.0019426994,0.78304774,0.001449022],"about_ca_topic_score_codex":0.0020047836,"about_ca_topic_score_gemma":0.005044954,"teacher_disagreement_score":0.33092588,"about_ca_system_score_codex":0.015710175,"about_ca_system_score_gemma":0.0114458,"threshold_uncertainty_score":0.99975795},"labels":[],"label_agreement":null},{"id":"W3000709336","doi":"10.1016/j.ygyno.2019.11.029","title":"Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Western University; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Nova Scotia Health Authority; Dalhousie University; University of British Columbia Hospital","funders":"University of British Columbia; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Battle Creek Community Foundation","keywords":"Medicine; Oncology; Internal medicine; Serous fluid; Ovarian carcinoma; Hormone receptor; Serous carcinoma; Carcinoma; Gynecology; Cancer research; Ovarian cancer; Cancer","score_opus":0.029883691498491793,"score_gpt":0.2953731901283535,"score_spread":0.2654894986298617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000709336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479523,0.00083355786,0.000012678768,0.048132867,0.00023818425,0.00068959617,0.0000143459865,0.00006839182,0.002058099],"genre_scores_gemma":[0.9901307,0.0003941362,0.0027321319,0.0062533505,0.00012294426,0.00019556966,0.00002494049,0.000017594342,0.00012860671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985931,0.0001283235,0.00033016907,0.00048133795,0.00011798214,0.00034911858],"domain_scores_gemma":[0.999031,0.000373932,0.00010311795,0.00018853912,0.000028144654,0.00027525588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013544517,0.00020465635,0.00069549953,0.00007456442,0.000056599878,0.000010650548,0.00008133561,0.00028245416,0.0004910719],"category_scores_gemma":[0.00026103665,0.00015119104,0.00006862931,0.00016582331,0.00008480674,0.000051810744,0.000110652814,0.0002617875,0.00008656561],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040628185,0.0013250341,0.9646984,0.00006390876,0.00007171987,0.0011415702,0.0010493938,0.000006520328,0.0065436927,0.00021187987,0.0062860725,0.018195525],"study_design_scores_gemma":[0.008263004,0.004560413,0.96745837,0.000020338786,0.00007303771,0.000032947388,0.00031886625,0.00006866688,0.0012053036,0.0001037082,0.01773652,0.00015879907],"about_ca_topic_score_codex":0.00008260717,"about_ca_topic_score_gemma":0.00006740418,"teacher_disagreement_score":0.042178445,"about_ca_system_score_codex":0.00036241135,"about_ca_system_score_gemma":0.00017756101,"threshold_uncertainty_score":0.6165392},"labels":[],"label_agreement":null},{"id":"W3001732993","doi":"10.1016/j.ygyno.2020.01.021","title":"Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; McMaster University; Alberta Health Services; University of Calgary; Impact; Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre; University of British Columbia; Dalhousie University; Hamilton Health Sciences; Nova Scotia Health Authority","funders":"University of British Columbia; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Medicine; Internal medicine; Proportional hazards model; Oncology; Retrospective cohort study; Referral; Cohort; Chemotherapy; Progression-free survival; Family medicine","score_opus":0.021123327090286508,"score_gpt":0.2955146217899536,"score_spread":0.27439129469966705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001732993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87140983,0.0033996308,0.0000030597519,0.1203407,0.00024151598,0.00089552626,0.00005820809,0.000030581654,0.0036209675],"genre_scores_gemma":[0.86047006,0.0022310757,0.0005781963,0.13657326,0.000038699032,0.00004618522,0.00002070809,0.000011395901,0.00003040706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985175,0.00017121843,0.00045903446,0.00030546216,0.00015396357,0.00039282462],"domain_scores_gemma":[0.99857455,0.0004515753,0.00022515818,0.00015886144,0.00015248943,0.0004373587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014581518,0.00018453348,0.00071636686,0.000051333707,0.000064732434,0.000005377489,0.00009663898,0.00016644603,0.0005674327],"category_scores_gemma":[0.0013065401,0.00013592085,0.00009294569,0.00011494974,0.00011626223,0.000064124986,0.00007927989,0.00026274507,0.000045969064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054230256,0.0019009461,0.8352265,0.014392199,0.00049224606,0.010401976,0.0073549123,0.000002283146,0.002572209,0.00081805495,0.02146257,0.10483381],"study_design_scores_gemma":[0.0029300253,0.0091669345,0.59150606,0.0010924789,0.0005741659,0.0005078854,0.0029395376,0.00006163395,0.001440387,0.000015954978,0.3894011,0.00036382762],"about_ca_topic_score_codex":0.010356103,"about_ca_topic_score_gemma":0.007031853,"teacher_disagreement_score":0.36793855,"about_ca_system_score_codex":0.00017059401,"about_ca_system_score_gemma":0.00037876042,"threshold_uncertainty_score":0.996234},"labels":[],"label_agreement":null},{"id":"W3002742562","doi":"10.1016/j.ygyno.2019.12.033","title":"Low-grade serous ovarian cancer: State of the science","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre; University of British Columbia","funders":"Leonard M. Miller School of Medicine; Cancer Research UK; Sylvester Comprehensive Cancer Center, University of Miami Health Systems","keywords":"Medicine; Serous ovarian cancer; Serous fluid; Ovarian cancer; Oncology; Gynecology; Internal medicine; Cancer","score_opus":0.06310527820407179,"score_gpt":0.38466123059428164,"score_spread":0.32155595239020984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002742562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000205189,0.9870258,0.0000022921402,0.0044919048,0.002060024,0.00248882,0.00016566961,0.00005364518,0.0035066423],"genre_scores_gemma":[0.0016102083,0.9957672,0.00031062364,0.0009055078,0.00022115385,0.00076381874,0.0000151593285,0.00003825904,0.00036810833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709904,0.0002819305,0.00082247815,0.00081256276,0.00039907053,0.0005849277],"domain_scores_gemma":[0.9973152,0.00061338535,0.0009068432,0.00074954965,0.00015378676,0.00026123156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004529823,0.00044775908,0.002906557,0.00016546514,0.0001793403,0.000017279388,0.0007239555,0.00034747046,0.0004576325],"category_scores_gemma":[0.00040522852,0.00024548284,0.000596499,0.0013347885,0.0009155971,0.000039679067,0.00042353087,0.0006745626,0.00008577571],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014189719,0.0005543415,0.00015006089,0.0034351852,0.0003552507,0.00028326162,0.000086043154,0.0000043918935,0.0000031998868,0.00022414114,0.0012226135,0.9936673],"study_design_scores_gemma":[0.001004022,0.0013902261,0.0017465245,0.0024031003,0.002227119,0.0001557594,0.000011897785,0.000006248328,0.000048932834,0.00011399079,0.99068844,0.00020372869],"about_ca_topic_score_codex":0.00013601569,"about_ca_topic_score_gemma":0.00016564273,"teacher_disagreement_score":0.9934636,"about_ca_system_score_codex":0.0027261698,"about_ca_system_score_gemma":0.010801837,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W3003957666","doi":"10.1016/j.ygyno.2019.12.047","title":"Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Partnership Against Cancer; Saskatchewan Cancer Agency; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; Cancer Care Ontario; Alberta Health Services; University of British Columbia; Nova Scotia Health Authority","funders":"Cancer Council Victoria; Partenariat Canadien Contre Le Cancer; Department of Health, Government of Western Australia; Public Health Agency; Cancer Society of New Zealand; Cancer Research UK; World Health Organization; Kreftforeningen; Kræftens Bekæmpelse; Cancer Institute NSW; Heart of England NHS Foundation Trust","keywords":"Medicine; Demography; Stage (stratigraphy); Population; Cancer; Internal medicine; Environmental health; Biology","score_opus":0.18216256031331557,"score_gpt":0.36064141489954044,"score_spread":0.17847885458622487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003957666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826463,0.00018317372,0.00009633235,0.014266001,0.00041821436,0.0013683768,0.0000834215,0.00006712766,0.0008710745],"genre_scores_gemma":[0.9958175,0.00013237658,0.0005602989,0.0019673489,0.00011444523,0.0012000677,0.0001004559,0.000021559852,0.00008595495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824005,0.00032097817,0.0004053565,0.0005331604,0.00017144284,0.00032903661],"domain_scores_gemma":[0.9986761,0.00074577506,0.00013454632,0.000186408,0.00003981729,0.00021736008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035835826,0.00020482572,0.00063035364,0.000102925515,0.00009875188,0.00002125327,0.00007704173,0.00012501176,0.0008226908],"category_scores_gemma":[0.00032237972,0.00018093416,0.000050826504,0.00036579097,0.000029246945,0.00009227714,0.00005780302,0.00026245188,0.000010275714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019566577,0.0016922544,0.9876396,0.000034450335,0.00012653809,0.00073099765,0.0011041292,0.0001863974,0.000102144884,0.00024345552,0.0002145429,0.0077298135],"study_design_scores_gemma":[0.0073500895,0.00254762,0.9832579,0.0000123879345,0.00015281781,0.0000010168454,0.00070674357,0.0003764912,0.000020204487,0.000026768803,0.00538894,0.00015902783],"about_ca_topic_score_codex":0.004862784,"about_ca_topic_score_gemma":0.011923356,"teacher_disagreement_score":0.013171214,"about_ca_system_score_codex":0.0007175861,"about_ca_system_score_gemma":0.00032391254,"threshold_uncertainty_score":0.9007887},"labels":[],"label_agreement":null},{"id":"W3006968401","doi":"10.1016/j.ygyno.2020.02.023","title":"Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"Barts Charity","keywords":"Medicine; Kingdom; Family medicine; Library science","score_opus":0.19489248194265377,"score_gpt":0.3903486375939709,"score_spread":0.19545615565131716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006968401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010049896,0.96544963,0.000008353986,0.0074363668,0.00035940943,0.021208355,0.004403992,0.000074464006,0.00005446721],"genre_scores_gemma":[0.005019776,0.9672378,0.0022839648,0.013342538,0.0000626864,0.009914576,0.0018113959,0.00011557742,0.00021168796],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98741674,0.00429544,0.0037783193,0.002590647,0.0008504386,0.0010684149],"domain_scores_gemma":[0.9897356,0.0042512813,0.0024147932,0.002566751,0.00026756313,0.000764033],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0037874002,0.0013994516,0.023515379,0.0011803437,0.000108797205,0.000052664203,0.0012369803,0.0013141219,0.0019111055],"category_scores_gemma":[0.004559398,0.0008974672,0.0019115277,0.0032682342,0.00025862228,0.00009124972,0.0011003461,0.0010839414,0.0001096764],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007104913,0.008368114,0.001807795,0.5941531,0.25238496,0.013097655,0.0015086324,0.000003169008,6.969124e-7,0.00012644322,0.020892803,0.10694613],"study_design_scores_gemma":[0.0018241402,0.008628559,0.0093741445,0.00893694,0.8176735,0.00045511217,0.000092996845,0.000009482895,6.236238e-7,0.000014004397,0.15224454,0.00074596767],"about_ca_topic_score_codex":0.00017475909,"about_ca_topic_score_gemma":0.00031133188,"teacher_disagreement_score":0.58521616,"about_ca_system_score_codex":0.0018669227,"about_ca_system_score_gemma":0.002621378,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W3007397555","doi":"10.1016/j.ygyno.2019.11.045","title":"Safety and Efficacy Results of Retreatment With a PARP Inhibitor Monotherapy in Late-Line Recurrent Ovarian Cancer: Results From a Subset of the QUADRA Trial","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; PARP inhibitor; Internal medicine; Adverse effect; Ovarian cancer; Oncology; Clinical trial; Cancer; Poly ADP ribose polymerase; Surgery; Polymerase","score_opus":0.05037637286026122,"score_gpt":0.3320429756358292,"score_spread":0.281666602775568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007397555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95831496,0.00062021834,0.00002071977,0.036680795,0.00044537566,0.0021879976,0.0010585993,0.00003305758,0.000638262],"genre_scores_gemma":[0.9951781,0.001967736,0.0009853886,0.0012734684,0.0002849699,0.0001341674,0.000111463756,0.000017703227,0.00004697419],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99711514,0.00052018615,0.0012234001,0.00058405276,0.00027126467,0.00028597662],"domain_scores_gemma":[0.9969931,0.0014577858,0.0008593636,0.00042522035,0.00012291143,0.00014161188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057078834,0.0002510026,0.001049182,0.00007825171,0.000049097696,0.0000043546634,0.0001641709,0.00030491233,0.00011040552],"category_scores_gemma":[0.00075636903,0.00015487395,0.00010657742,0.0004927187,0.00035712685,0.000036311216,0.000063662046,0.00039175208,0.0000020928526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9325185,0.0020597922,0.0052151284,0.000045414796,0.00037417677,0.00009838233,0.00773641,0.0006984756,0.0044283043,0.00008729485,0.0014421529,0.045295995],"study_design_scores_gemma":[0.77844244,0.047670778,0.11041918,0.0005075854,0.0003155176,0.000010048268,0.000448371,0.00076001155,0.015616874,0.00046471224,0.04497695,0.00036755038],"about_ca_topic_score_codex":0.0010167527,"about_ca_topic_score_gemma":0.0021157046,"teacher_disagreement_score":0.15407605,"about_ca_system_score_codex":0.0005191848,"about_ca_system_score_gemma":0.0007869422,"threshold_uncertainty_score":0.63155764},"labels":[],"label_agreement":null},{"id":"W3007877035","doi":"10.1016/j.ygyno.2020.01.037","title":"Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Ovarian cancer; Adverse effect; Internal medicine; Gastroenterology; Combination therapy; Oncology; Pharmacology; Cancer; Chemotherapy","score_opus":0.029979538483348143,"score_gpt":0.36143151902576276,"score_spread":0.3314519805424146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007877035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918165,0.00015416057,0.000026155298,0.0030615465,0.00016641161,0.004058216,0.00007830602,0.00006514177,0.0005735548],"genre_scores_gemma":[0.9975169,0.000049895905,0.0012554857,0.00051939284,0.000048577298,0.00032938152,0.00017771499,0.000058804722,0.000043899254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958949,0.00074717833,0.0010271345,0.0008395578,0.000713551,0.0007776493],"domain_scores_gemma":[0.99785256,0.0005237007,0.0005268204,0.00032944276,0.0005046332,0.00026281312],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009810947,0.00037648078,0.0013186061,0.00036936277,0.00009191405,0.000019424784,0.00028950028,0.00025033584,0.0006162657],"category_scores_gemma":[0.0007343756,0.0002896686,0.000043103348,0.0013202943,0.00022761589,0.00016107707,0.00013667082,0.00090356247,0.000015400932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03514999,0.02172833,0.90685475,0.0004126655,0.00029482986,0.000994665,0.009606511,0.00023990321,0.006972606,0.000057482823,0.0007617205,0.016926566],"study_design_scores_gemma":[0.18995503,0.13512728,0.6640524,0.00041092664,0.00020361766,0.000005538083,0.0045662774,0.0018435188,0.0009847786,0.000048353075,0.0021937948,0.0006084651],"about_ca_topic_score_codex":0.0019586347,"about_ca_topic_score_gemma":0.0077171503,"teacher_disagreement_score":0.24280229,"about_ca_system_score_codex":0.0012888138,"about_ca_system_score_gemma":0.0012752902,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W3009376198","doi":"10.1016/j.ygyno.2020.02.005","title":"Single or two drug combination therapy as initial treatment for low risk, gestational trophoblastic neoplasia. A Canadian analysis","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Vancouver General Hospital; Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency","funders":"","keywords":"Medicine; Gestational trophoblastic neoplasia; Obstetrics; Drug; Gynecology; Oncology; Placental site trophoblastic tumor; Pregnancy; Chemotherapy; Internal medicine; Pharmacology; Placenta; Fetus","score_opus":0.05287958336612329,"score_gpt":0.3494229084607621,"score_spread":0.2965433250946388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009376198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98205084,0.00009333907,0.00079506775,0.011885159,0.00030665705,0.0015707376,0.00044761974,0.00009038519,0.002760173],"genre_scores_gemma":[0.9899187,0.000110830326,0.003837366,0.004012341,0.00022150915,0.0006670336,0.00065843476,0.000025170038,0.0005486292],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981352,0.000217271,0.00042694216,0.00051064824,0.0002417196,0.00046823238],"domain_scores_gemma":[0.99599946,0.0026705319,0.00023668227,0.0001393758,0.0004012664,0.0005526618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013351778,0.000279533,0.0007148795,0.00033146975,0.00030708383,0.0000242826,0.000100710924,0.000118077034,0.0018383376],"category_scores_gemma":[0.002612491,0.0002115846,0.0002625763,0.0006468249,0.00017718985,0.00005649471,0.000020400821,0.00013921628,0.00016841588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08074467,0.034987602,0.32237583,0.0006264271,0.04794978,0.0105740195,0.035223376,0.042583536,0.0039391965,0.021723725,0.046837736,0.3524341],"study_design_scores_gemma":[0.058711894,0.074082136,0.75521195,0.000028501603,0.008779991,0.000101673046,0.0046241945,0.026971357,0.00078334264,0.0045530186,0.065141216,0.0010107552],"about_ca_topic_score_codex":0.004956967,"about_ca_topic_score_gemma":0.052072637,"teacher_disagreement_score":0.4328361,"about_ca_system_score_codex":0.0013619275,"about_ca_system_score_gemma":0.0026980657,"threshold_uncertainty_score":0.9990741},"labels":[],"label_agreement":null},{"id":"W3013603077","doi":"10.1016/j.ygyno.2020.03.009","title":"Supported self-management as a model for end-of-life care in the setting of malignant bowel obstruction: A qualitative study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Queen's University; University of Toronto","funders":"Canadian Institutes of Health Research; Princess Margaret Cancer Foundation; University Health Network; American College of Surgeons","keywords":"Medicine; Psychological intervention; Distress; Quality of life (healthcare); End-of-life care; Population; Feeling; Bowel obstruction; Gynecologic oncology; Social support; Palliative care; Nursing; Internal medicine; Surgery; Clinical psychology","score_opus":0.06274433373064549,"score_gpt":0.38493992823425277,"score_spread":0.3221955945036073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013603077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879217,0.00006168512,0.00015542084,0.006217682,0.00009356158,0.0022114848,0.000037933583,0.00003247857,0.003268011],"genre_scores_gemma":[0.98829436,0.0000105384,0.009329552,0.0018072093,0.000045960936,0.0004177894,0.000029250796,0.000008613063,0.00005672333],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9984159,0.0003390673,0.0005631875,0.00026819983,0.00018031374,0.00023336524],"domain_scores_gemma":[0.99823,0.0010841165,0.0002486788,0.00014878876,0.0002129082,0.000075553886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000566468,0.00013491993,0.000511091,0.00007108718,0.000070623195,0.00000247866,0.00016221296,0.000100775054,0.00010476572],"category_scores_gemma":[0.0007752852,0.00008781217,0.00010546224,0.0002559135,0.00008191876,0.000023712759,0.000078471516,0.00018570872,0.0000060110856],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002351785,0.0028022227,0.019497827,0.0012560237,0.00035980658,0.00037358428,0.95971334,0.0007632122,0.0011992948,0.0046224375,0.00083737687,0.0062231175],"study_design_scores_gemma":[0.0053630383,0.022462565,0.03976737,0.000046691068,0.00047790576,0.000047486796,0.9145776,0.013370965,0.00020860603,0.0014062836,0.002095601,0.0001759148],"about_ca_topic_score_codex":0.000084348794,"about_ca_topic_score_gemma":0.0002416507,"teacher_disagreement_score":0.045135736,"about_ca_system_score_codex":0.00011052458,"about_ca_system_score_gemma":0.0003593951,"threshold_uncertainty_score":0.35808763},"labels":[],"label_agreement":null},{"id":"W3014455410","doi":"10.1016/j.ygyno.2020.06.025","title":"Avelumab in combination with and/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: Results from the phase 3 javelin ovarian 100 trial","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Javelin; Medicine; Avelumab; Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.02442599975128795,"score_gpt":0.30343557135918664,"score_spread":0.2790095716078987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014455410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94656295,0.00012415108,0.000037524158,0.048240546,0.00020707936,0.0044283555,0.00012959848,0.000060398073,0.00020942226],"genre_scores_gemma":[0.98927903,0.00045729714,0.0012856852,0.007667229,0.00021543584,0.00063347066,0.00036477146,0.000046889134,0.000050204904],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736005,0.0003455519,0.00068258494,0.0008180339,0.00029663267,0.00049716706],"domain_scores_gemma":[0.99825734,0.0007876989,0.0003558056,0.00032852692,0.00008642999,0.00018420604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044014465,0.00038523824,0.001072865,0.00010208221,0.00010883566,0.000035920417,0.0001706563,0.00031450292,0.00041886838],"category_scores_gemma":[0.00026633823,0.00021679541,0.00007380886,0.00059892697,0.0001297344,0.00010251544,0.000035743065,0.00039422995,0.000007452326],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52891105,0.007704665,0.28625774,0.000019917881,0.0007113917,0.0005343147,0.005785251,0.00003767642,0.000035686757,0.00004043348,0.0005424013,0.16941944],"study_design_scores_gemma":[0.5155744,0.032114137,0.44723877,0.0001092007,0.00021665377,0.0000030552885,0.00015278057,0.0002480997,0.00012612862,0.00005209151,0.003944055,0.00022061125],"about_ca_topic_score_codex":0.0032755095,"about_ca_topic_score_gemma":0.005855232,"teacher_disagreement_score":0.16919883,"about_ca_system_score_codex":0.0008906549,"about_ca_system_score_gemma":0.00083626184,"threshold_uncertainty_score":0.884066},"labels":[],"label_agreement":null},{"id":"W3018085467","doi":"10.1016/j.ygyno.2020.04.043","title":"Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BC Cancer Agency; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Endometrium; Immunohistochemistry; Endometrial cancer; Internal medicine; Pathological; Oncology; Carcinoma; Stage (stratigraphy); Cancer; Biology","score_opus":0.07000639622894159,"score_gpt":0.29420214410162565,"score_spread":0.22419574787268406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018085467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067765,0.0006572475,0.00012552913,0.0033103472,0.00009069621,0.0011409542,0.00007598514,0.000009975322,0.0039116056],"genre_scores_gemma":[0.99878263,0.0000707259,0.00044816599,0.0004918613,0.000032188993,0.0001010487,0.000020927735,0.0000067475544,0.000045677756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992538,0.00009278059,0.00025974354,0.00016610694,0.00010782678,0.000119733646],"domain_scores_gemma":[0.9985907,0.0008677771,0.00020381836,0.00010530356,0.00015334792,0.00007902778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001191044,0.00008414433,0.0003472521,0.000053968033,0.000029293782,0.000001881446,0.000077943536,0.000109128465,0.000056292825],"category_scores_gemma":[0.0010660266,0.000053507512,0.00008024243,0.00023408025,0.0001862533,0.000019219244,0.000043756165,0.000077289886,5.955924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0154777765,0.004521671,0.65664876,0.0039496343,0.0008846748,0.00017247605,0.0034900482,0.00013843954,0.19752425,0.009104195,0.0014400026,0.106648065],"study_design_scores_gemma":[0.01166526,0.051835526,0.7125689,0.000024348978,0.0012920516,0.000015475543,0.00343632,0.00043104382,0.21444173,0.0014534147,0.002678221,0.00015775331],"about_ca_topic_score_codex":0.0000092118835,"about_ca_topic_score_gemma":0.0000030415222,"teacher_disagreement_score":0.106490314,"about_ca_system_score_codex":0.000048984148,"about_ca_system_score_gemma":0.00021615397,"threshold_uncertainty_score":0.21819732},"labels":[],"label_agreement":null},{"id":"W3019504517","doi":"10.1016/j.ygyno.2020.04.693","title":"Endometrial cancer presentation is associated with social determinants of health in a public healthcare system: A population-based cohort study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Juravinski Cancer Centre","funders":"Hamilton Health Sciences","keywords":"Medicine; Presentation (obstetrics); Endometrial cancer; Cohort; Health care; Cohort study; Public health; Family medicine; Cancer; Population; Gynecology; Environmental health; Obstetrics; Internal medicine; Nursing; Economic growth","score_opus":0.18958001147099102,"score_gpt":0.4375179830254693,"score_spread":0.24793797155447828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019504517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829725,0.00013658777,0.00002411735,0.0138554955,0.00016703403,0.0025989946,0.00005094579,0.00005890214,0.00013541052],"genre_scores_gemma":[0.99554104,0.000008214931,0.00009335483,0.0038089599,0.000100525154,0.00036121157,0.00006807172,0.000012384547,0.000006262634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971697,0.00082757935,0.0007900609,0.00039286612,0.00041310274,0.00040672498],"domain_scores_gemma":[0.9982964,0.00041526198,0.0007571974,0.000108146785,0.0002728572,0.00015017133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011148136,0.00015254109,0.0011442066,0.00020031031,0.00012728036,0.000009644091,0.00011597058,0.00019514127,0.000099185796],"category_scores_gemma":[0.0011747514,0.0001265343,0.00006613312,0.0010857048,0.00004996248,0.0000743464,0.000032581316,0.00024532128,0.0000022453455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073272025,0.0003708309,0.9882989,0.00013165046,0.00007647158,0.000092378934,0.0011731166,0.000036236917,0.000005152363,0.00001314233,0.000226359,0.00884306],"study_design_scores_gemma":[0.007028842,0.008091004,0.98069084,0.000079699246,0.00008553397,0.0000044396943,0.0027761443,0.001068645,0.0000073693313,0.0000056479794,0.000066345114,0.00009547895],"about_ca_topic_score_codex":0.0134922415,"about_ca_topic_score_gemma":0.025929987,"teacher_disagreement_score":0.012568503,"about_ca_system_score_codex":0.0022351712,"about_ca_system_score_gemma":0.0018873375,"threshold_uncertainty_score":0.993077},"labels":[],"label_agreement":null},{"id":"W3020340344","doi":"10.1016/j.ygyno.2020.04.687","title":"The added value of sentinel node mapping in endometrial cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"Azrieli Foundation; Israel Cancer Research Fund","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Dissection (medical); Lymph node; Stage (stratigraphy); Internal medicine; Cancer; Urology; Surgery; Oncology; Breast cancer","score_opus":0.06429567455579747,"score_gpt":0.3458860641144258,"score_spread":0.2815903895586283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020340344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450699,0.0020442756,0.000030296329,0.033642553,0.0008837476,0.00077785517,0.000016017653,0.00004767398,0.017487677],"genre_scores_gemma":[0.9929804,0.00093722844,0.00039242476,0.004953375,0.0004135702,0.0001566511,0.000008690828,0.000010520961,0.00014712792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846995,0.00020362166,0.00050261663,0.00027252384,0.0001967502,0.00035456693],"domain_scores_gemma":[0.9973291,0.0021072233,0.00020177076,0.00014760958,0.00007369622,0.00014060701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037464322,0.00013686568,0.0006344163,0.00012244153,0.000062589475,0.0000052434093,0.0001650515,0.00017740829,0.00074942166],"category_scores_gemma":[0.0029203477,0.00008347788,0.00014216312,0.0010895482,0.00013260776,0.00002417863,0.00010870397,0.00027126604,0.000036372283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055745183,0.001383246,0.7657811,0.00022805108,0.00071199477,0.0005641669,0.0010293534,0.00020474577,0.0176478,0.0018359467,0.0050714267,0.19996762],"study_design_scores_gemma":[0.0410157,0.00333662,0.7713286,0.000055574186,0.00031607813,0.00001958441,0.00089396205,0.0007607891,0.0037250314,0.0008635934,0.17741099,0.00027345459],"about_ca_topic_score_codex":0.00022269858,"about_ca_topic_score_gemma":0.000071089235,"teacher_disagreement_score":0.19969417,"about_ca_system_score_codex":0.00032721137,"about_ca_system_score_gemma":0.00034608308,"threshold_uncertainty_score":0.82056415},"labels":[],"label_agreement":null},{"id":"W3022180314","doi":"10.1016/j.ygyno.2020.03.034","title":"Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Cochrane Library; Cohort study; Hyperthermic intraperitoneal chemotherapy; Perioperative; Meta-analysis; Internal medicine; Cohort; Surgery; Ovarian cancer; Oncology; Cancer; Cytoreductive surgery","score_opus":0.10950800586543047,"score_gpt":0.3990603436107306,"score_spread":0.28955233774530015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022180314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012645584,0.97262007,0.000010938692,0.013184599,0.00040089272,0.012631056,0.0008313718,0.00010731828,0.00008732604],"genre_scores_gemma":[0.00019205816,0.97270447,0.0009791235,0.0076583424,0.0001420015,0.017483294,0.0004711801,0.000080336555,0.0002892203],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942569,0.0012363407,0.0019891635,0.0015582159,0.00029144424,0.0006678969],"domain_scores_gemma":[0.99101216,0.006253198,0.0015507505,0.00062202895,0.00014251379,0.0004193569],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014748482,0.0011250123,0.028137607,0.0003495553,0.00025791657,0.000039680177,0.00020756926,0.00092795695,0.0005845392],"category_scores_gemma":[0.00088755134,0.00067291,0.005535105,0.0007959626,0.00023393652,0.00007062679,0.00020347214,0.00047006292,0.000010943504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087404274,0.00059911306,0.00038880558,0.49454924,0.44610214,0.00059304154,0.000083183164,2.3763043e-7,6.37868e-7,0.000024467005,0.0011868572,0.056384858],"study_design_scores_gemma":[0.0012255325,0.0010511372,0.0007909756,0.004136175,0.82859135,0.0001867133,0.00001632766,0.0000015156579,8.545726e-7,0.000020844202,0.16347922,0.0004993823],"about_ca_topic_score_codex":0.00015555794,"about_ca_topic_score_gemma":0.00019114427,"teacher_disagreement_score":0.49041307,"about_ca_system_score_codex":0.0032136806,"about_ca_system_score_gemma":0.0016488486,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W3025418957","doi":"10.1016/j.ygyno.2020.05.008","title":"The use of indocyanine green fluorescence angiography to assess anastomotic perfusion following bowel resection in surgery for gynecologic malignancies - A report of 100 consecutive anastomoses","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Indocyanine green; Anastomosis; Perfusion; Surgery; Angiography; Colectomy; Malignancy; Radiology; Colorectal cancer; Cancer; Internal medicine","score_opus":0.1317683767783646,"score_gpt":0.34774643151220036,"score_spread":0.21597805473383577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025418957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929064,0.00032433335,0.00013120922,0.0034824712,0.0005312688,0.0023158605,0.000034819554,0.000058173606,0.00021546659],"genre_scores_gemma":[0.99594676,0.00012557833,0.0026798618,0.0005889247,0.000049369155,0.00047887783,0.000035883266,0.00002236345,0.00007238885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689597,0.00045324102,0.0011029218,0.0006267172,0.00034528543,0.0005758782],"domain_scores_gemma":[0.9886488,0.0097913705,0.0006011153,0.00034049514,0.00039825923,0.00021999881],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010711408,0.0002839817,0.0012332315,0.00040272833,0.00014772979,0.000013076652,0.00019365615,0.0003078805,0.00005701379],"category_scores_gemma":[0.0105729075,0.00020272894,0.0006564826,0.0016403976,0.00033400508,0.00012063592,0.00020852726,0.00024203282,0.0000028936834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062055853,0.00089113077,0.9585008,0.00019116479,0.00035763052,0.0029732788,0.0007608533,0.00014201147,0.0107671525,0.00005818236,0.0019852568,0.017166948],"study_design_scores_gemma":[0.0023469767,0.013754319,0.97094613,0.00014596798,0.00031032486,0.00016688804,0.0008037449,0.00039643317,0.0053262897,0.00013613871,0.0054286034,0.00023817265],"about_ca_topic_score_codex":0.00050379155,"about_ca_topic_score_gemma":0.0017787396,"teacher_disagreement_score":0.016928775,"about_ca_system_score_codex":0.0004741649,"about_ca_system_score_gemma":0.0006685674,"threshold_uncertainty_score":0.9977614},"labels":[],"label_agreement":null},{"id":"W3026921722","doi":"10.1016/j.ygyno.2020.04.689","title":"The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria","funders":"Networks of Centres of Excellence of Canada; Carraresi Foundation; BC Cancer Foundation; Terry Fox Research Institute; Canadian Cancer Society; Canadian HIV Trials Network, Canadian Institutes of Health Research; Michael Smith Health Research BC; VGH and UBC Hospital Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Immune system; Medicine; Ovarian cancer; Immunology; Immune modulation; Oncology; Cancer research; Internal medicine; Cancer","score_opus":0.022917289350521793,"score_gpt":0.279446881998267,"score_spread":0.2565295926477452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026921722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98480487,0.008687736,0.00002586351,0.0048658424,0.0003093621,0.00060842186,0.000022722546,0.000031899533,0.0006432616],"genre_scores_gemma":[0.9964618,0.0017698806,0.000066719316,0.0014855878,0.000058533198,0.000052942672,0.000008831333,0.000018432467,0.000077252946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998581,0.00019281112,0.00040331413,0.00036549047,0.000090374735,0.00036704316],"domain_scores_gemma":[0.99817365,0.0013297745,0.00021010621,0.00013572002,0.00002849936,0.00012224926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033747358,0.00021499988,0.00051097147,0.000048233687,0.00022488671,0.00003423288,0.00009390876,0.0002678189,0.00021157615],"category_scores_gemma":[0.00039518788,0.00013500759,0.000047471174,0.00010197881,0.00040494112,0.000063342835,0.00012918162,0.0003741926,0.0000010256346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040590246,0.00008075646,0.80378246,0.00009397316,0.00020583742,0.00014835376,0.0063887388,0.000005148046,0.14813443,0.00007388869,0.0002127092,0.03681467],"study_design_scores_gemma":[0.006468253,0.0018664744,0.9694242,0.00011857496,0.00007200789,0.00006165486,0.0064952755,0.00036041086,0.0074096164,0.00007665961,0.0074414564,0.00020540309],"about_ca_topic_score_codex":0.0007037548,"about_ca_topic_score_gemma":0.00052692747,"teacher_disagreement_score":0.16564174,"about_ca_system_score_codex":0.00017066106,"about_ca_system_score_gemma":0.00013070533,"threshold_uncertainty_score":0.550545},"labels":[],"label_agreement":null},{"id":"W3029876840","doi":"10.1016/j.ygyno.2020.05.016","title":"The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Univariate analysis; Multivariate analysis; Cancer staging; Oncology; Internal medicine; Cervical carcinoma; Univariate; Prognostic variable; Cancer; Carcinoma; Surgery; Multivariate statistics","score_opus":0.030379535481213586,"score_gpt":0.3180751815279674,"score_spread":0.2876956460467538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029876840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96098053,0.006641588,0.00011849731,0.028526906,0.00036660442,0.002568497,0.00014679514,0.00004184639,0.0006087058],"genre_scores_gemma":[0.9978359,0.00032754597,0.00009128976,0.00049598655,0.0001932716,0.0010166675,0.000016205488,0.0000090524045,0.000014079007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989677,0.00008943092,0.00033557386,0.00024507134,0.000089859925,0.00027234218],"domain_scores_gemma":[0.9971249,0.0024114077,0.00013994433,0.00013771455,0.000078685356,0.000107365566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000202252,0.00011175515,0.000373242,0.000030879146,0.00015202338,0.000010624537,0.00014847833,0.00007834135,0.0000457889],"category_scores_gemma":[0.00046870895,0.000058320224,0.00007987559,0.00022401764,0.0001231412,0.000019661888,0.00009021628,0.00015726405,0.0000035842654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002000293,0.0005844368,0.6293276,0.0003261284,0.00037346932,0.000025008494,0.000556573,0.000027193493,0.0054374165,0.009206995,0.0006978985,0.35143697],"study_design_scores_gemma":[0.0042611924,0.0028518997,0.98253435,0.000027282904,0.00033280067,0.000020924286,0.0014295382,0.0006674708,0.00025237625,0.00045030643,0.0070907203,0.00008115565],"about_ca_topic_score_codex":0.00028487356,"about_ca_topic_score_gemma":0.0004543495,"teacher_disagreement_score":0.35320672,"about_ca_system_score_codex":0.00029214038,"about_ca_system_score_gemma":0.00025777472,"threshold_uncertainty_score":0.23782298},"labels":[],"label_agreement":null},{"id":"W3033672876","doi":"10.1016/j.ygyno.2020.05.014","title":"Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"AstraZeneca Canada","keywords":"Medicine; Referral; Genetic counseling; Genetic testing; Ovarian cancer; Cancer; Family history; Family medicine; Baseline (sea); Internal medicine; Oncology; Gynecology; Genetics","score_opus":0.06725530508876894,"score_gpt":0.4366544256390098,"score_spread":0.3693991205502409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033672876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000989537,0.9920962,0.0002936469,0.0012225173,0.00036506553,0.0039047764,0.0010171117,0.00002025416,0.00009089689],"genre_scores_gemma":[0.00035536935,0.94626427,0.048698924,0.0014930243,0.00019042952,0.00231352,0.00059885066,0.00005541057,0.000030206003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674517,0.00055809633,0.0014392067,0.00074496254,0.00013637725,0.00037620027],"domain_scores_gemma":[0.99627554,0.0013378827,0.001449997,0.0003395977,0.0004744705,0.0001225034],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010112206,0.0004138656,0.0020351065,0.00011916958,0.00007774922,0.000008392263,0.00036546876,0.0005268293,0.00010225625],"category_scores_gemma":[0.005386239,0.00034827885,0.00026109038,0.00040762208,0.00013798542,0.0000039840575,0.00032786385,0.00019111818,0.0000032798187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026872385,0.000053212487,0.0012832145,0.02652138,0.0003635549,0.000005639416,0.000047834423,0.000007625318,0.0003975236,0.000008567537,0.0035580331,0.9677265],"study_design_scores_gemma":[0.00102265,0.002506541,0.0015606523,0.0034120814,0.0013420599,0.000029216586,0.00016034582,0.000011542732,0.00017932316,0.000017312059,0.9893528,0.0004054256],"about_ca_topic_score_codex":0.00009215991,"about_ca_topic_score_gemma":0.0004671733,"teacher_disagreement_score":0.98579484,"about_ca_system_score_codex":0.0003954745,"about_ca_system_score_gemma":0.00342772,"threshold_uncertainty_score":0.99989694},"labels":[],"label_agreement":null},{"id":"W3035310940","doi":"10.1016/j.ygyno.2020.06.478","title":"Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Perioperative; Chemotherapy; Bowel obstruction; Surgery; Ovarian cancer; Bowel resection; Carboplatin; Retrospective cohort study; Cancer; Internal medicine; Cisplatin","score_opus":0.016225899678793936,"score_gpt":0.29164223842439846,"score_spread":0.2754163387456045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035310940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952404,0.0000334854,0.000025654805,0.0029885336,0.00031609816,0.00082630094,0.0000217991,0.000055876695,0.00049185706],"genre_scores_gemma":[0.9969339,0.000043441236,0.0012588669,0.0014329102,0.00010199076,0.00011721136,0.00007343181,0.000026315323,0.000011948201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984383,0.000116274365,0.000428284,0.00037683448,0.00025233306,0.00038795106],"domain_scores_gemma":[0.99894017,0.00036903226,0.0003147483,0.00012189997,0.00013606632,0.000118102165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017788228,0.0002432627,0.00093503087,0.00014465244,0.00007673962,0.0000081218905,0.000075524564,0.00019439412,0.00013844062],"category_scores_gemma":[0.00015125464,0.00012909289,0.000119735785,0.00038179048,0.00014556776,0.00022745272,0.000025618989,0.00028880467,0.0000015578082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00812686,0.0006119794,0.96848685,0.00012502892,0.00025453212,0.00012650822,0.0013857022,0.00011658152,0.004955763,0.000009070988,0.000040693343,0.015760407],"study_design_scores_gemma":[0.004879169,0.007415765,0.98341167,0.00010998011,0.00008331705,0.000004980171,0.00061120425,0.00003607858,0.003155333,0.000021474754,0.00008282747,0.0001881817],"about_ca_topic_score_codex":0.00020436507,"about_ca_topic_score_gemma":0.000146365,"teacher_disagreement_score":0.015572225,"about_ca_system_score_codex":0.00060975924,"about_ca_system_score_gemma":0.000672055,"threshold_uncertainty_score":0.52642554},"labels":[],"label_agreement":null},{"id":"W3036237747","doi":"10.1016/j.ygyno.2020.06.480","title":"Perioperative outcomes of women with and without class III obesity undergoing hysterectomy for endometrioid endometrial cancer: A population-based study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"Government of Ontario; Cancer Care Ontario","keywords":"Medicine; Endometrial cancer; Hysterectomy; Perioperative; Cancer; Gynecology; Obesity; Population; Obstetrics; Internal medicine; Surgery; Environmental health","score_opus":0.0422939395422266,"score_gpt":0.3425712162537506,"score_spread":0.300277276711524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036237747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378747,0.00019981789,0.00021479328,0.0014430027,0.00020900925,0.0036860025,0.000053660064,0.00006455828,0.00034167065],"genre_scores_gemma":[0.9955948,0.000027376966,0.0014800273,0.0013841792,0.00012846886,0.001268328,0.000023006834,0.000022987879,0.00007082148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797004,0.0002339459,0.000524905,0.000536703,0.0002771257,0.00045727583],"domain_scores_gemma":[0.99544036,0.0035331915,0.0003360739,0.00016315488,0.00020216545,0.00032506764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039282514,0.00028474454,0.0016490311,0.00028785932,0.0001431442,0.000016098471,0.000109583736,0.00015983949,0.00031006738],"category_scores_gemma":[0.0026534887,0.00018557391,0.00010078563,0.00088445336,0.00009387418,0.00006771249,0.0000632232,0.00018554978,0.0000020051793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011316918,0.0013506437,0.97678316,0.00014296419,0.0008513593,0.00002154501,0.0013933254,0.000057456968,0.00023354389,0.00004241768,0.000005073401,0.00780159],"study_design_scores_gemma":[0.08382733,0.05003194,0.86183023,0.000019493325,0.0005928215,0.000003870645,0.0024357087,0.00010897754,0.00031578334,0.000026749614,0.00060046057,0.00020665243],"about_ca_topic_score_codex":0.00051846897,"about_ca_topic_score_gemma":0.0011798834,"teacher_disagreement_score":0.11495295,"about_ca_system_score_codex":0.0012363205,"about_ca_system_score_gemma":0.0006487072,"threshold_uncertainty_score":0.75674844},"labels":[],"label_agreement":null},{"id":"W3037169759","doi":"10.1016/j.ygyno.2020.06.488","title":"Prospective cohort study of metabolic syndrome and endometrial cancer survival","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Health Services","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Cancer Society; Alberta Cancer Board","keywords":"Medicine; Endometrial cancer; Metabolic syndrome; Hazard ratio; Waist; Internal medicine; Proportional hazards model; Population; Cancer; Cohort; Prospective cohort study; Oncology; Gynecology; Body mass index; Confidence interval; Obesity","score_opus":0.0576840302394719,"score_gpt":0.3524209257391883,"score_spread":0.29473689549971643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037169759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988326,0.0015771944,0.000004108715,0.0010876649,0.00060926325,0.002454477,0.000024744017,0.000049760205,0.00586678],"genre_scores_gemma":[0.9979789,0.0005181672,0.000121921774,0.00055696134,0.00021474894,0.00046542796,0.0000063934817,0.000013159566,0.0001242733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831796,0.00022510733,0.00041751823,0.00047835943,0.00028739675,0.0002736795],"domain_scores_gemma":[0.9985068,0.0007696548,0.00019172825,0.0001482292,0.00012984892,0.000253728],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030485357,0.00018880056,0.0013712228,0.00014306899,0.000056069155,0.0000052229243,0.000099107114,0.00016080272,0.0014920966],"category_scores_gemma":[0.0012573247,0.00013558734,0.00008925297,0.0008735018,0.00012836601,0.000041413365,0.00012948357,0.00023316588,0.000022704873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017473699,0.0016889562,0.98512894,0.00003268032,0.0010083286,0.00032285112,0.00041464565,0.000003391667,0.00025341404,0.00018669778,0.000047359168,0.009165369],"study_design_scores_gemma":[0.019460505,0.01963732,0.9567405,0.000003818056,0.0009787136,0.000033000102,0.0005945793,0.000006507977,0.00018826923,0.000089864276,0.0021570283,0.00010986989],"about_ca_topic_score_codex":0.0005201877,"about_ca_topic_score_gemma":0.00022513956,"teacher_disagreement_score":0.028388413,"about_ca_system_score_codex":0.00014554654,"about_ca_system_score_gemma":0.00020974556,"threshold_uncertainty_score":0.9994207},"labels":[],"label_agreement":null},{"id":"W3039580871","doi":"10.1016/j.ygyno.2020.06.493","title":"Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; AstraZeneca; Genentech; Bristol-Myers Squibb Canada; AbbVie; Eli Lilly and Company","keywords":"Medicine; Gynecologic oncology; Internal medicine; Cervical cancer; Progression-free survival; Oncology; Bevacizumab; Population; Adverse effect; Phases of clinical research; Stage (stratigraphy); Chemotherapy; Cancer","score_opus":0.060167076460968326,"score_gpt":0.34634468534801066,"score_spread":0.28617760888704236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039580871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826824,0.002512369,0.00011764712,0.0015305289,0.003360863,0.007546606,0.00028545925,0.00041809527,0.001545998],"genre_scores_gemma":[0.9926502,0.00014701554,0.0005940978,0.0030870277,0.00030782662,0.0021288514,0.0005125203,0.00012439303,0.00044808112],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9856206,0.0072596655,0.0028553244,0.002102784,0.0002154485,0.0019461323],"domain_scores_gemma":[0.98869723,0.007325444,0.0018577618,0.0013294822,0.0005089518,0.00028112467],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030033204,0.0011798657,0.0037624536,0.0005114764,0.0013871223,0.00002886952,0.0020919696,0.0027118914,0.005669525],"category_scores_gemma":[0.002317128,0.0010312652,0.0005809658,0.0007766709,0.001150324,0.00038860083,0.0010893833,0.0019333787,0.00027788835],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049772203,0.20959587,0.012343057,0.00012190978,0.0029828409,0.0007413721,0.04077453,0.00006337816,0.47118402,0.00032856615,0.0043345224,0.20775773],"study_design_scores_gemma":[0.0705254,0.5754072,0.036731392,0.0000066257794,0.0009167283,0.00014438586,0.042609237,0.00004857175,0.006796166,0.00014847037,0.2656398,0.0010259872],"about_ca_topic_score_codex":0.0004405513,"about_ca_topic_score_gemma":0.001349897,"teacher_disagreement_score":0.46438786,"about_ca_system_score_codex":0.0014601867,"about_ca_system_score_gemma":0.0014249327,"threshold_uncertainty_score":0.9999129},"labels":[],"label_agreement":null},{"id":"W3039728826","doi":"10.1016/j.ygyno.2020.06.481","title":"Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute; National Health and Medical Research Council; Medical Research Council; National Institutes of Health; Peter MacCallum Foundation; Fred C. and Katherine B. Andersen Foundation; Peter MacCallum Cancer Centre; Ovarian Cancer Research Fund; Cancer Australia; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; U.S. Department of Defense; State of Connecticut Department of Public Health; Lon V. Smith Foundation; Cancer Research UK; University College London; Danish Cancer Society Research Center; Ovarian Cancer Australia; Deutsches Krebsforschungszentrum; U.S. Army Medical Research and Development Command; University of Pittsburgh; Mayo Foundation for Medical Education and Research; Rutgers Cancer Institute of New Jersey; Minnesota Ovarian Cancer Alliance; California Breast Cancer Research Program; Kræftens Bekæmpelse; National Center for Research Resources; Oak Foundation; Roswell Park Cancer Institute","keywords":"Medicine; Debulking; Ovarian cancer; Oncology; Proportional hazards model; Internal medicine; Hormone therapy; Hazard ratio; Ovarian carcinoma; Gynecology; Serous fluid; Prognostic variable; Cancer; Breast cancer; Confidence interval","score_opus":0.07308547040742505,"score_gpt":0.35691794739583926,"score_spread":0.2838324769884142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039728826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8908738,0.00093175896,0.000014404316,0.10408971,0.00024861214,0.0020865977,0.000110796514,0.0000628854,0.0015814375],"genre_scores_gemma":[0.9670763,0.0010080993,0.00035446,0.030493975,0.00013608843,0.00063894683,0.00002293075,0.000029192057,0.00024000993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814945,0.000248454,0.00041463,0.00038800103,0.0002480671,0.0005514015],"domain_scores_gemma":[0.99793977,0.0008161195,0.00031400422,0.0002775084,0.00020189295,0.00045068306],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042558828,0.00024199259,0.00081624143,0.00004887453,0.00015142502,0.000009600808,0.00018481357,0.00023083514,0.0018722137],"category_scores_gemma":[0.0007459758,0.00012697802,0.000018747893,0.00043283292,0.000100064724,0.000036602712,0.00006678476,0.00027272917,0.00004245387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030754177,0.0095452005,0.36913267,0.00024539552,0.008821634,0.0013401629,0.017457083,0.000054100958,0.10351103,0.00035741884,0.096846685,0.36193442],"study_design_scores_gemma":[0.019844394,0.13384265,0.7665575,0.000032330183,0.0005600386,0.000012510518,0.00027753372,0.00006312988,0.0024203223,0.000031199575,0.07611075,0.00024765785],"about_ca_topic_score_codex":0.0008194054,"about_ca_topic_score_gemma":0.0010130886,"teacher_disagreement_score":0.39742482,"about_ca_system_score_codex":0.0004827535,"about_ca_system_score_gemma":0.0008656549,"threshold_uncertainty_score":0.9990402},"labels":[],"label_agreement":null},{"id":"W3040248497","doi":"10.1016/j.ygyno.2020.06.504","title":"Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Surgery; Bowel resection; Dehiscence; Colostomy; Malignancy; Anastomosis; Colectomy; Complication; Wound dehiscence; Odds ratio; Colorectal cancer; Cancer; Internal medicine","score_opus":0.06240470341107937,"score_gpt":0.32827097630297875,"score_spread":0.26586627289189935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040248497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820027,0.00006277666,0.000023359644,0.013441557,0.00012305308,0.0034861218,0.00012500296,0.00012242439,0.0006130294],"genre_scores_gemma":[0.99499667,0.000023266699,0.00027735357,0.0023953223,0.00014350038,0.0013398975,0.0002893935,0.000027000853,0.0005076082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978848,0.00064537895,0.00045134296,0.00056322827,0.00017059012,0.00028465144],"domain_scores_gemma":[0.9961334,0.0024995508,0.00047738923,0.0003819347,0.00036426008,0.00014346711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008982349,0.00020530664,0.0007348068,0.00006465409,0.0002388851,0.000008874962,0.00010242802,0.00019937046,0.00078892405],"category_scores_gemma":[0.0012617464,0.000118793774,0.00012965663,0.00039057844,0.00015217449,0.00007129813,0.000054098222,0.00013349358,0.000024240642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04227995,0.021663021,0.7744728,0.00023181434,0.005563297,0.0006816148,0.009886944,0.000054724343,0.004627809,0.00024241373,0.13443004,0.00586557],"study_design_scores_gemma":[0.007126558,0.026771516,0.9567047,0.000042173793,0.0010770446,0.000028017073,0.0013977136,0.00025211746,0.0023471797,0.00008516635,0.00399241,0.00017541966],"about_ca_topic_score_codex":0.00015348505,"about_ca_topic_score_gemma":0.0009669601,"teacher_disagreement_score":0.18223189,"about_ca_system_score_codex":0.00089985086,"about_ca_system_score_gemma":0.00061550806,"threshold_uncertainty_score":0.8638165},"labels":[],"label_agreement":null},{"id":"W3041053722","doi":"10.1016/j.ygyno.2020.06.506","title":"PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Cervical cancer; Chemoradiotherapy; Oncology; Internal medicine; Cancer; Gynecology","score_opus":0.020196714151524086,"score_gpt":0.2987619440301668,"score_spread":0.27856522987864274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041053722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909364,0.00064556726,0.000006323636,0.0069029545,0.000118547076,0.0005469277,0.000024693401,0.000030683223,0.00078787835],"genre_scores_gemma":[0.9932144,0.00036949938,0.0004643985,0.005726443,0.000076353965,0.00006506282,0.000046167945,0.000012788264,0.000024878527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896276,0.00009242355,0.00019389376,0.00032883955,0.00014158415,0.000280492],"domain_scores_gemma":[0.99922705,0.00030252791,0.00007296925,0.000064843116,0.000080182275,0.00025242893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007228308,0.00014415248,0.0004967922,0.00006608226,0.000036827372,0.0000084303165,0.000032927976,0.00015040852,0.0005026185],"category_scores_gemma":[0.00018020482,0.00009822848,0.000020251382,0.00026364214,0.00010802991,0.00005151607,0.000032878666,0.00017360064,0.0000049574824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033875827,0.00034973354,0.90897393,0.000050014398,0.00006856432,0.00009792018,0.0004516716,0.0000037914358,0.000072425195,0.000039847397,0.000021985159,0.08648252],"study_design_scores_gemma":[0.018168367,0.01030556,0.9694893,0.000008170095,0.00007207917,0.0000043606988,0.00016963216,0.000032645214,0.00003367615,0.00006329151,0.0015475063,0.00010545551],"about_ca_topic_score_codex":0.00038027216,"about_ca_topic_score_gemma":0.00064635114,"teacher_disagreement_score":0.08637706,"about_ca_system_score_codex":0.00027390008,"about_ca_system_score_gemma":0.0001674798,"threshold_uncertainty_score":0.550332},"labels":[],"label_agreement":null},{"id":"W3041794099","doi":"10.1016/j.ygyno.2020.06.483","title":"Following chemotherapy for gestational trophoblastic neoplasia, do residual lung lesions increase the risk of relapse?","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Lung; Cohort; Chemotherapy; Lesion; Internal medicine; Retrospective cohort study; Residual; Radiology; Gastroenterology; Surgery","score_opus":0.020886431193048033,"score_gpt":0.30518598301148275,"score_spread":0.2842995518184347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041794099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97327954,0.0004892046,0.002307883,0.019512143,0.00035315525,0.0013942709,0.00020684206,0.00007409877,0.0023828784],"genre_scores_gemma":[0.9827496,0.000177588,0.013369958,0.0028168252,0.0002588621,0.00032231875,0.00006924382,0.000028897039,0.00020672896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817014,0.0002513564,0.0005160761,0.00039049744,0.00032898964,0.0003429643],"domain_scores_gemma":[0.99201304,0.0070011364,0.00032403631,0.00019517276,0.00025873387,0.00020790915],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00039685267,0.00021679768,0.000603462,0.000073229654,0.00028962537,0.000009358229,0.0001763333,0.0001520334,0.0004062832],"category_scores_gemma":[0.010296473,0.00014698369,0.00027782336,0.0002593218,0.00028651,0.000043637734,0.00007940845,0.00027672,0.000032011492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025477786,0.00528908,0.48573276,0.0014320116,0.0088610165,0.0012766136,0.013611686,0.009177597,0.014434566,0.03586247,0.36785665,0.030987764],"study_design_scores_gemma":[0.012627163,0.0069325217,0.94494134,0.000058886086,0.0022600899,0.000040294635,0.0035725601,0.003758881,0.00017627502,0.0050025275,0.020313865,0.00031559585],"about_ca_topic_score_codex":0.000021845623,"about_ca_topic_score_gemma":0.00001988323,"teacher_disagreement_score":0.45920858,"about_ca_system_score_codex":0.00017509393,"about_ca_system_score_gemma":0.00083691475,"threshold_uncertainty_score":0.9980402},"labels":[],"label_agreement":null},{"id":"W3042725909","doi":"10.1016/j.ygyno.2020.06.510","title":"Evaluating the diagnostic performance of preoperative endometrial biopsies in patients diagnosed with high grade endometrial cancer: A study of the Society of Gynecologic Oncology (GOC) Community of Practice (CoP)","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of British Columbia; Hôtel-Dieu de Québec; McGill University; Université Laval; Université de Montréal; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Biopsy; Univariate analysis; Cancer; Medical record; Retrospective cohort study; Internal medicine; Logistic regression; Cohort; Radiology; Oncology; Gynecology; Multivariate analysis","score_opus":0.09685911378321534,"score_gpt":0.38647931032539357,"score_spread":0.28962019654217824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042725909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123967,0.00040442825,0.0000016792163,0.0017072172,0.000610612,0.0056304517,0.000105071354,0.000017229784,0.00028367006],"genre_scores_gemma":[0.9967569,0.0007126656,0.0006962619,0.0008802488,0.000119837605,0.0007883488,0.00001799794,0.000020427382,0.000007296695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99213415,0.0045279353,0.0016139061,0.00041964184,0.000856138,0.0004482095],"domain_scores_gemma":[0.9366279,0.059548862,0.0022965535,0.00053178123,0.00088663085,0.0001082749],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025630014,0.00035772732,0.0021067802,0.00021906012,0.0002116303,0.0000048073343,0.0007016452,0.000315652,0.00022336512],"category_scores_gemma":[0.047231868,0.00018702188,0.00031019008,0.0032980253,0.0009989,0.00012848801,0.00054217567,0.0010734343,0.0000012815545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018818093,0.019984769,0.9241094,0.00036659808,0.0015007779,0.00001427107,0.017245341,0.0024669527,0.0010943227,0.000020349315,0.0000810598,0.014298087],"study_design_scores_gemma":[0.059372067,0.1739685,0.7492742,0.00008526889,0.0014359815,0.0000034369994,0.011985527,0.00012870911,0.003490144,0.000018063907,0.00009541536,0.00014266817],"about_ca_topic_score_codex":0.006437936,"about_ca_topic_score_gemma":0.001328927,"teacher_disagreement_score":0.17483516,"about_ca_system_score_codex":0.0008506299,"about_ca_system_score_gemma":0.0013823521,"threshold_uncertainty_score":0.9732276},"labels":[],"label_agreement":null},{"id":"W3043469226","doi":"10.1016/j.ygyno.2020.06.507","title":"Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; University of Toronto; Canada Research Chairs; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ovarian cancer; Serous ovarian cancer; Tertiary care; Serous fluid; Cancer; Gynecology; Oncology; Internal medicine","score_opus":0.03123093978443572,"score_gpt":0.3387598930164984,"score_spread":0.3075289532320627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043469226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688274,0.00052555755,0.00008521467,0.0014983017,0.00028677288,0.00059013785,0.00007875122,0.000012256358,0.000040245148],"genre_scores_gemma":[0.99307036,0.000027067415,0.005987777,0.000571669,0.000081506136,0.00020275694,0.00004091908,0.000013317509,0.000004610445],"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","domain_scores_codex":[0.9988259,0.0001311185,0.00035918684,0.00036025455,0.00007531197,0.00024819197],"domain_scores_gemma":[0.99936426,0.000101512946,0.0002770094,0.00010614305,0.00008521205,0.00006589379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017107135,0.00012025447,0.0002937601,0.000048303853,0.000043757933,0.0000043212503,0.00013978724,0.00013344472,0.000014826932],"category_scores_gemma":[0.00010849634,0.00012218345,0.000048641876,0.00015632425,0.00008075169,0.000007665947,0.000083223385,0.000066256805,1.6992026e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008023519,0.00016491262,0.36818162,0.0014787854,0.0005950955,0.00010298202,0.051914196,0.0019832784,0.5266995,0.0007246974,0.001620402,0.045732185],"study_design_scores_gemma":[0.015013,0.0098004835,0.15229757,0.0002308173,0.00035457438,0.00003947639,0.5909379,0.0018004314,0.2216629,0.00014601364,0.006748082,0.00096876605],"about_ca_topic_score_codex":0.0020232615,"about_ca_topic_score_gemma":0.0043852082,"teacher_disagreement_score":0.5390237,"about_ca_system_score_codex":0.00047833868,"about_ca_system_score_gemma":0.000964778,"threshold_uncertainty_score":0.49824965},"labels":[],"label_agreement":null},{"id":"W3048246007","doi":"10.1016/j.ygyno.2020.07.003","title":"Cone biopsy (with pelvic lymphadenectomy) for fertility preservation in early stage cervical cancer: Ready for prime time?","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Cancer; Gynecology; Penile cancer; Stage (stratigraphy); Family medicine; Oncology; Internal medicine","score_opus":0.07848178916856123,"score_gpt":0.3565545269735041,"score_spread":0.27807273780494285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048246007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97896564,0.0003040389,0.00054808974,0.014305645,0.00016973822,0.0038717594,0.00025901556,0.0001200208,0.0014560582],"genre_scores_gemma":[0.9893703,0.000038627968,0.003351932,0.0032408151,0.00022702263,0.002375669,0.00025837217,0.000030027228,0.001107234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981228,0.00011589341,0.00046124693,0.0006038444,0.0001800893,0.00051611505],"domain_scores_gemma":[0.99779093,0.0013237298,0.00018875675,0.000204311,0.00023099923,0.00026125662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029025236,0.00023335626,0.00085391913,0.000095833864,0.0000735684,0.000013034346,0.00016199598,0.00033963198,0.00069597707],"category_scores_gemma":[0.0009429866,0.0001677339,0.00011145338,0.0004915867,0.00009963166,0.00010737542,0.000058919482,0.00015496783,0.000038111648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068759486,0.0036651434,0.84303415,0.0011651786,0.0007356646,0.00026158875,0.0009875096,0.00009979956,0.010568351,0.0006920885,0.0013202,0.06871082],"study_design_scores_gemma":[0.03426997,0.021612952,0.90392953,0.000028947488,0.00034308794,0.000007212852,0.000083194405,0.0016819804,0.002467278,0.0004430153,0.034849916,0.0002829381],"about_ca_topic_score_codex":0.0007215872,"about_ca_topic_score_gemma":0.0006096817,"teacher_disagreement_score":0.06842788,"about_ca_system_score_codex":0.00084700703,"about_ca_system_score_gemma":0.00061764853,"threshold_uncertainty_score":0.7620461},"labels":[],"label_agreement":null},{"id":"W3048856621","doi":"10.1016/j.ygyno.2020.07.007","title":"Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Dansk Kræftforsknings Fond; Medizinische Universität Wien; Varian Medical Systems; Universität Wien; Austrian Science Fund; Elekta; Kræftens Bekæmpelse","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Radiology; Cancer; Oncology; General surgery; Internal medicine","score_opus":0.058053503661635385,"score_gpt":0.40678823667181097,"score_spread":0.3487347330101756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048856621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855853,0.0011126974,0.0000066036814,0.01238873,0.000082988285,0.00056388177,0.000052105363,0.000029738361,0.00017797005],"genre_scores_gemma":[0.99182254,0.00047145033,0.000072036935,0.007372852,0.00017035827,0.000052461037,0.000018164945,0.000010694227,0.000009445373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981274,0.0004523081,0.00038498436,0.0006302085,0.000115256866,0.00028986673],"domain_scores_gemma":[0.99629384,0.003092549,0.00009261617,0.00017844512,0.000030483558,0.0003120427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058090966,0.00022424995,0.00091880513,0.000104875726,0.00010704134,0.000035004436,0.000102858925,0.0001309576,0.0003914234],"category_scores_gemma":[0.0005730758,0.00011309754,0.00009321278,0.00053548283,0.00019906953,0.00006831652,0.00017116999,0.0004512976,0.0000026763341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000941784,0.0005034098,0.9230991,0.0000062783784,0.00049446424,0.00012751379,0.0020753734,0.000013512427,0.00003247949,0.000006520097,0.0000349557,0.07266463],"study_design_scores_gemma":[0.0062439498,0.0045433003,0.9819685,0.000008585793,0.0007162396,0.0000035312364,0.0037487696,0.002221726,0.0000074315553,0.00014837977,0.0002777223,0.000111827576],"about_ca_topic_score_codex":0.0021904297,"about_ca_topic_score_gemma":0.0023839618,"teacher_disagreement_score":0.0725528,"about_ca_system_score_codex":0.00015241235,"about_ca_system_score_gemma":0.00009207529,"threshold_uncertainty_score":0.4611984},"labels":[],"label_agreement":null},{"id":"W3080218538","doi":"10.1016/j.ygyno.2020.05.045","title":"The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Iovance Biotherapeutics; Merck Sharp and Dohme; Bristol-Myers Squibb Canada; National Cancer Institute; AbbVie Deutschland; Janssen Research and Development; EMD Serono; Genentech; Yale University; PharmaMar; V Foundation for Cancer Research; Eisai; Takeda Oncology; ImmunoGen; Syndax Pharmaceuticals; Ajinomoto; Clovis Oncology; Ovarian Cancer Research Fund; Gateway Foundation; Janssen Biotech; Les Laboratories Pierre Fabre; Syneos Health; AstraZeneca; Novocure; National Institutes of Health; Regeneron Pharmaceuticals; Ludwig Institute for Cancer Research; Array BioPharma; F. Hoffmann-La Roche; AbbVie; Sanofi; Merck; Amgen; Pfizer","keywords":"Medicine; Post-hoc analysis; Oncology; Ovarian carcinoma; Ovarian cancer; Internal medicine; Post hoc; Exploratory analysis; Cancer; Data science","score_opus":0.017801241321812575,"score_gpt":0.29966237430249415,"score_spread":0.28186113298068155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080218538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941024,0.00012830064,0.000038890503,0.0011436464,0.00011091804,0.004215584,0.00008157898,0.000021979482,0.00015669492],"genre_scores_gemma":[0.9986793,0.000038412338,0.00008819161,0.00078434794,0.0000087047265,0.00032394798,0.000055396238,0.000017590746,0.0000041357675],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965884,0.001437853,0.0008460835,0.00047320029,0.0003430676,0.00031136387],"domain_scores_gemma":[0.9952666,0.0033083255,0.00071199227,0.0003813165,0.00018885353,0.00014286693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076193124,0.00029588214,0.0021651813,0.00023913023,0.00007657072,0.000007418408,0.00014567266,0.00011174355,0.000037544505],"category_scores_gemma":[0.00092721224,0.00014730848,0.00017338422,0.0007165582,0.00057027984,0.00003466872,0.00006467545,0.00031385612,0.0000011149367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50020814,0.0025582195,0.4791204,0.00003173815,0.0015414107,0.00011015614,0.0034764288,0.000057523044,0.000027599084,0.00002752484,0.000025684807,0.012815182],"study_design_scores_gemma":[0.36615056,0.0943552,0.5369074,0.000043507855,0.0012233959,0.0000011744274,0.0009046944,0.000094981806,0.00006056009,0.00000257158,0.00014015117,0.000115797884],"about_ca_topic_score_codex":0.000039615625,"about_ca_topic_score_gemma":0.00046022423,"teacher_disagreement_score":0.13405757,"about_ca_system_score_codex":0.0002795134,"about_ca_system_score_gemma":0.00017560353,"threshold_uncertainty_score":0.6007066},"labels":[],"label_agreement":null},{"id":"W3082329399","doi":"10.1016/j.ygyno.2020.08.004","title":"Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lymphovascular invasion; Cervical cancer; Stage (stratigraphy); Hazard ratio; Hysterectomy; Radiology; Cancer; Odds ratio; Retrospective cohort study; Oncology; Internal medicine; Confidence interval; Metastasis","score_opus":0.04679052715779036,"score_gpt":0.37175758496393807,"score_spread":0.3249670578061477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082329399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524134,0.00043777807,0.000008902143,0.04083494,0.0005759385,0.0007133002,0.000049435883,0.00007289145,0.004893432],"genre_scores_gemma":[0.9572134,0.0010120143,0.0010874327,0.039572317,0.00037026266,0.00020301506,0.000007924398,0.000018960487,0.0005146607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743086,0.00036409014,0.00073806,0.00075989595,0.00017531954,0.00053177064],"domain_scores_gemma":[0.99711406,0.0019945798,0.00020136966,0.00020921933,0.000045230587,0.000435565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036346714,0.00026572752,0.0011127702,0.0000575358,0.0000617143,0.000016203356,0.00018286584,0.00030072688,0.0034454195],"category_scores_gemma":[0.0014568677,0.0001634452,0.00015191265,0.00040581785,0.00033541405,0.00006878153,0.00024357371,0.0006333217,0.00022391231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014194798,0.00080337125,0.9776714,0.000096735355,0.00006145113,0.0041265525,0.00025664517,0.0000028230204,0.00012977935,0.00004839791,0.00048980943,0.014893551],"study_design_scores_gemma":[0.009368188,0.0054698,0.97274876,0.000025489842,0.00013005122,0.000050191647,0.00038825138,0.000049535432,0.000050058152,0.0003441356,0.011175561,0.00019997341],"about_ca_topic_score_codex":0.00037318794,"about_ca_topic_score_gemma":0.0011130266,"teacher_disagreement_score":0.014693578,"about_ca_system_score_codex":0.00029391216,"about_ca_system_score_gemma":0.00021515912,"threshold_uncertainty_score":0.99746555},"labels":[],"label_agreement":null},{"id":"W3083732107","doi":"10.1016/j.ygyno.2020.08.032","title":"Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Paclitaxel; Oncology; Epithelial ovarian cancer; Ovarian cancer; Internal medicine; Outcome (game theory); Gynecology; Cancer","score_opus":0.06614972565820502,"score_gpt":0.3667957333078498,"score_spread":0.3006460076496448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083732107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8265181,0.0003145051,0.00006271866,0.16275401,0.0006513238,0.0011191597,0.000098655655,0.000049698527,0.008431786],"genre_scores_gemma":[0.9821826,0.00012222174,0.0038960637,0.013134566,0.00016189997,0.0003208006,0.000009918229,0.000016616663,0.00015529856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983932,0.00011340885,0.0005570156,0.00042477576,0.00014307204,0.00036857516],"domain_scores_gemma":[0.9989395,0.00034232053,0.00014693674,0.00020883455,0.00006542737,0.0002969507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025523145,0.00017851761,0.00079652027,0.00013199172,0.00002469423,0.00000407395,0.00012960681,0.0002211321,0.00195234],"category_scores_gemma":[0.0005164974,0.00014165632,0.00012589428,0.00044452213,0.00008221565,0.000028995557,0.00008862224,0.0001721633,0.00013184658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088835857,0.0009800434,0.8894223,0.000092945294,0.00027533615,0.00059514755,0.00091187475,0.000058633148,0.0023776733,0.00059915375,0.0062216977,0.097576864],"study_design_scores_gemma":[0.0061663026,0.0057200603,0.9024397,0.00003136286,0.00016786355,0.000009749224,0.00033481428,0.000042618227,0.00098616,0.00014441955,0.08379778,0.00015918333],"about_ca_topic_score_codex":0.00090877607,"about_ca_topic_score_gemma":0.0009867391,"teacher_disagreement_score":0.15566447,"about_ca_system_score_codex":0.0006446946,"about_ca_system_score_gemma":0.00038568425,"threshold_uncertainty_score":0.99896},"labels":[],"label_agreement":null},{"id":"W3085516910","doi":"10.1016/j.ygyno.2020.08.029","title":"Disparities in surgical management of endometrial cancers in a public healthcare system: A question of equity","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Medicine; Endometrial cancer; Logistic regression; Hysterectomy; Odds ratio; Health equity; Ethnic group; Health care; Cancer; Public health; Internal medicine; Surgery; Nursing","score_opus":0.10182035691754023,"score_gpt":0.387664692811369,"score_spread":0.2858443358938288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085516910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97097534,0.0017863292,0.000015595317,0.008281178,0.00045789866,0.0013114217,0.000037424816,0.00003989912,0.017094923],"genre_scores_gemma":[0.998404,0.00068917254,0.00033150282,0.0002561359,0.00007563849,0.0001929028,0.000024858298,0.0000066689277,0.00001911789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800146,0.00036887362,0.00073079224,0.00028997374,0.00026479378,0.0003441291],"domain_scores_gemma":[0.99880993,0.0005904417,0.00023284923,0.00012330887,0.000076026256,0.00016745014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006652036,0.00012948985,0.0009909449,0.00032135978,0.0000149989355,0.000002831183,0.00012752018,0.00021244456,0.00014632274],"category_scores_gemma":[0.00044333126,0.00010415661,0.00010215434,0.0013522166,0.00011789425,0.000042198622,0.00016074437,0.00021663164,0.0000043058567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010740282,0.0018383781,0.7577708,0.006775306,0.00033023919,0.002922009,0.00034124067,0.00008838827,0.000098383214,0.06558553,0.00008198693,0.1534275],"study_design_scores_gemma":[0.06172363,0.021684721,0.9069671,0.0006780916,0.0002742691,0.00005762284,0.0025771218,0.0002916363,0.0003684492,0.0010226008,0.0040560723,0.00029870542],"about_ca_topic_score_codex":0.0036522385,"about_ca_topic_score_gemma":0.0016445155,"teacher_disagreement_score":0.15312879,"about_ca_system_score_codex":0.0020649172,"about_ca_system_score_gemma":0.0004007834,"threshold_uncertainty_score":0.5521116},"labels":[],"label_agreement":null},{"id":"W3089254712","doi":"10.1016/j.ygyno.2020.09.006","title":"Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke","funders":"Genentech; Medac; Eisai; Merck KGaA; Clovis Oncology; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Takeda Oncology; Amgen; Pfizer; PharmaMar; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Placebo; Ovarian cancer; Oncology; Internal medicine; Nova (rocket); Term (time); Gynecology; Cancer; Pathology; Alternative medicine","score_opus":0.06628635318853937,"score_gpt":0.35598437165624364,"score_spread":0.28969801846770427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089254712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781489,0.0001395185,0.00005997878,0.011712954,0.0011830238,0.0039046472,0.0004999311,0.00013201141,0.0042190403],"genre_scores_gemma":[0.9938486,0.00016153329,0.00027501368,0.0033640778,0.0006964126,0.0005305002,0.0010214725,0.00003888419,0.00006350031],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968359,0.0005283921,0.0008107406,0.00084823486,0.00040024158,0.0005764917],"domain_scores_gemma":[0.99673045,0.0017909969,0.0005269957,0.00048726812,0.00019616904,0.00026813385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039904797,0.0003962374,0.00094038725,0.00008257966,0.00014724083,0.000020165016,0.00028066468,0.00036647724,0.0019343538],"category_scores_gemma":[0.0004482063,0.00023555601,0.00008598138,0.0006315717,0.00034016007,0.000091945985,0.00006834948,0.00079177687,0.000043958975],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8929302,0.0018864955,0.05278011,0.000009033079,0.000425346,0.0002472392,0.0013149285,0.0000719762,0.00004045326,0.000019850148,0.0036085253,0.04666583],"study_design_scores_gemma":[0.73870665,0.03946495,0.20358846,0.000100004254,0.0003213662,0.0000028111929,0.0001459739,0.000059182512,0.00012316916,0.0000066132907,0.017173026,0.0003077695],"about_ca_topic_score_codex":0.0005496535,"about_ca_topic_score_gemma":0.0047222185,"teacher_disagreement_score":0.15422355,"about_ca_system_score_codex":0.0014000885,"about_ca_system_score_gemma":0.0009871363,"threshold_uncertainty_score":0.998978},"labels":[],"label_agreement":null},{"id":"W3090356629","doi":"10.1016/j.ygyno.2020.09.037","title":"Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; McMaster University; Women's College Hospital; Public Health Ontario","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Breastfeeding; Odds ratio; BRCA mutation; Ovarian cancer; Family history; Confidence interval; Breast cancer; Obstetrics; Population; Gynecology; Demography; Cancer; Internal medicine; Pediatrics; Environmental health","score_opus":0.011893348297234808,"score_gpt":0.26395389105876005,"score_spread":0.25206054276152523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090356629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195385,0.0002699076,0.0010406155,0.0050215377,0.00015574801,0.0004187763,0.00005827956,0.000015466554,0.0010658256],"genre_scores_gemma":[0.9961413,0.00039926046,0.0014505358,0.0012453969,0.00025751774,0.00035130428,0.000011225938,0.000016858388,0.00012661546],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99878836,0.00026453298,0.00024702618,0.00035425703,0.000095829004,0.0002499826],"domain_scores_gemma":[0.999113,0.00021872245,0.00030071943,0.00016475625,0.000116122224,0.00008666887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041976554,0.00014550664,0.00028726726,0.000026617108,0.00012313874,0.000013485386,0.00018854273,0.00020029293,0.00022868103],"category_scores_gemma":[0.00053653616,0.000085329324,0.000035868317,0.00017143934,0.0006580831,0.000006105269,0.00012663077,0.00015734519,0.0000025587653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033659868,0.0004906477,0.21931076,0.0002809869,0.0037616624,0.00016606736,0.036102857,0.01588063,0.12535088,0.0012240215,0.0057709515,0.5580007],"study_design_scores_gemma":[0.03267747,0.014893647,0.8335098,0.000035212935,0.0008114846,0.00027487907,0.00922826,0.00398788,0.035407178,0.0014226,0.066745035,0.0010065291],"about_ca_topic_score_codex":0.00016216679,"about_ca_topic_score_gemma":0.00090601976,"teacher_disagreement_score":0.61419904,"about_ca_system_score_codex":0.00012670374,"about_ca_system_score_gemma":0.0005128039,"threshold_uncertainty_score":0.3479629},"labels":[],"label_agreement":null},{"id":"W3091473338","doi":"10.1016/j.ygyno.2020.09.001","title":"Feasibility, acceptability and effects of multimodal pelvic floor physical therapy for gynecological cancer survivors suffering from painful sexual intercourse: A multicenter prospective interventional study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Université de Montréal; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Canada Foundation for Innovation; Réseau québécois de recherche sur le vieillissement","keywords":"Medicine; Physical therapy; Quality of life (healthcare); Sexual function; Sexual dysfunction; Pelvic floor; Pelvic Floor Muscle; Pelvic pain; Patient satisfaction; Randomized controlled trial; Surgery; Internal medicine; Nursing","score_opus":0.03980570666227242,"score_gpt":0.36707211536618467,"score_spread":0.32726640870391227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091473338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912162,0.00046291482,0.0003465939,0.0012588082,0.0009251535,0.005481053,0.00015327762,0.00010798869,0.000048040496],"genre_scores_gemma":[0.99665135,0.000030836414,0.00038703706,0.00086938037,0.0004409908,0.001528971,0.000040494506,0.000029675206,0.00002125713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707824,0.00063415925,0.000554246,0.001020941,0.000264736,0.0004476766],"domain_scores_gemma":[0.9960195,0.0028694873,0.00024424936,0.0002832945,0.0003124798,0.000270995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047811074,0.0003762889,0.0012726708,0.000059990434,0.00009546626,0.00001935478,0.00022755952,0.000286251,0.00080721575],"category_scores_gemma":[0.001146443,0.00028846844,0.0003061149,0.00018408174,0.00038850444,0.00010044275,0.0003060301,0.0004825248,0.0000052460396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056160674,0.00935394,0.90429527,0.0003403015,0.0005285084,0.000048459064,0.014288259,0.0000076209208,0.0032718554,0.000010995278,0.00004463335,0.06219412],"study_design_scores_gemma":[0.013807362,0.027639544,0.9471646,0.000021010806,0.00024564617,0.0000021088772,0.007677982,0.0018260286,0.0008750303,0.00017695046,0.0003037455,0.0002599712],"about_ca_topic_score_codex":0.0026137545,"about_ca_topic_score_gemma":0.015945626,"teacher_disagreement_score":0.06193415,"about_ca_system_score_codex":0.0005208804,"about_ca_system_score_gemma":0.00021616429,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W3091787400","doi":"10.1016/j.ygyno.2020.09.051","title":"Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Letrozole; Cost effectiveness; Cost-effectiveness analysis; Quality-adjusted life year; Maintenance therapy; Ovarian cancer; Oncology; Internal medicine; Gynecology; Cancer; Breast cancer; Tamoxifen; Chemotherapy","score_opus":0.03953761207892361,"score_gpt":0.32004834439724095,"score_spread":0.28051073231831736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091787400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924671,0.00037945644,0.000058453672,0.003747047,0.00019516944,0.0024418659,0.000049453392,0.00003403457,0.0006274092],"genre_scores_gemma":[0.99528915,0.0005687331,0.00084198266,0.0021289357,0.00004170717,0.001053585,0.000043365166,0.000021705104,0.000010859767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985107,0.00020332282,0.00029462826,0.00044619563,0.00017746596,0.00036765033],"domain_scores_gemma":[0.9988985,0.00042076368,0.00019071487,0.0001824263,0.00015665968,0.0001509172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016635895,0.0002153406,0.00075554854,0.00006119811,0.000031755404,0.000003679145,0.00010986124,0.00016734308,0.00026925927],"category_scores_gemma":[0.000097457385,0.00014633464,0.00007030782,0.00033531536,0.00013146969,0.000058003217,0.00003605474,0.00022359511,0.000008685774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065513384,0.0026536444,0.8537801,0.0001029026,0.00021392955,0.00019953432,0.00024490422,0.00049289485,0.00028736948,0.00019055711,0.00015418508,0.13512866],"study_design_scores_gemma":[0.02593501,0.015807848,0.9535446,0.00011019793,0.000056447698,0.0000034939485,0.000052594434,0.00003828284,0.0010860555,0.00007180154,0.0031497912,0.00014384398],"about_ca_topic_score_codex":0.000112157104,"about_ca_topic_score_gemma":0.00014386565,"teacher_disagreement_score":0.13498482,"about_ca_system_score_codex":0.0007564496,"about_ca_system_score_gemma":0.0004603791,"threshold_uncertainty_score":0.59673536},"labels":[],"label_agreement":null},{"id":"W3093257926","doi":"10.1016/j.ygyno.2020.10.007","title":"Evaluating the effect of a group pre-treatment chemotherapy psycho-education session for chemotherapy-naive gynecologic cancer patients and their caregivers","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canada Research Chairs; Cancer Care Ontario; Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Medicine; Chemotherapy; Session (web analytics); Gynecologic cancer; Cancer; Oncology; Gynecology; Internal medicine; Ovarian cancer","score_opus":0.03144828410565701,"score_gpt":0.38032677175106466,"score_spread":0.34887848764540763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093257926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864315,0.0011545853,0.00005804502,0.0072165267,0.0008749094,0.0037291446,0.00003959875,0.000052248783,0.00044346516],"genre_scores_gemma":[0.9924635,0.0007366228,0.00020461252,0.0044615455,0.00021545064,0.0017294955,0.000064861764,0.000023185095,0.00010071801],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984283,0.0003348317,0.00031274033,0.00048313173,0.00013939907,0.00030160946],"domain_scores_gemma":[0.99785125,0.001302888,0.00033632386,0.0002043279,0.00017586489,0.00012936453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035945454,0.00028697113,0.00067873404,0.000047879435,0.00015518903,0.000009895667,0.00013960176,0.00026595104,0.00025987485],"category_scores_gemma":[0.00031294412,0.00015463436,0.00018425923,0.00019266162,0.00016805796,0.00004410083,0.000037182457,0.00015131057,0.0000017479457],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003555598,0.00050013216,0.120133124,0.00024934488,0.0002600876,9.2875587e-7,0.012965883,0.000016758318,0.007259313,0.000015518923,0.001219161,0.85382414],"study_design_scores_gemma":[0.044914454,0.28420168,0.54605055,0.00020103506,0.0011939071,0.000015138015,0.011818705,0.0021845,0.032698862,0.0004773502,0.07545051,0.0007932903],"about_ca_topic_score_codex":0.0003007367,"about_ca_topic_score_gemma":0.00031790283,"teacher_disagreement_score":0.85303086,"about_ca_system_score_codex":0.0006495624,"about_ca_system_score_gemma":0.00037578982,"threshold_uncertainty_score":0.6305806},"labels":[],"label_agreement":null},{"id":"W3095141816","doi":"10.1016/j.ygyno.2020.10.021","title":"3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experience","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; London Health Sciences Centre","funders":"","keywords":"Medicine; Brachytherapy; Vaginal cancer; Proportional hazards model; Genitourinary system; Radiation therapy; Stage (stratigraphy); Cancer; Confidence interval; Cervical cancer; Oncology; Internal medicine; Gynecology; Urology; Radiology","score_opus":0.08507211445017884,"score_gpt":0.3913307742342043,"score_spread":0.30625865978402544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095141816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8743453,0.0028529572,0.04508973,0.052787036,0.004059492,0.0044432483,0.00033055173,0.00052341085,0.015568254],"genre_scores_gemma":[0.8953802,0.0005007728,0.060117416,0.040365078,0.0013218661,0.0017515554,0.00015123303,0.000025932284,0.00038594592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984767,0.00006701796,0.0003705159,0.0004985311,0.00017776585,0.00040948117],"domain_scores_gemma":[0.9988877,0.00038925358,0.00013007315,0.00012937968,0.00016672054,0.00029683622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000111816036,0.00022818215,0.000641365,0.000067049106,0.00015515268,0.000013158983,0.0001681758,0.00019724408,0.002056059],"category_scores_gemma":[0.00058254175,0.00016633772,0.00018229625,0.00026099608,0.00031252022,0.00010640745,0.00007543102,0.00021488387,0.000065349],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021747714,0.0052404813,0.061987847,0.00081156986,0.0012652628,0.002172247,0.0044553387,0.00015791452,0.08062807,0.0017935075,0.018505106,0.80123496],"study_design_scores_gemma":[0.08233933,0.030267451,0.15049542,0.00008335899,0.0007269042,0.0004194071,0.0006549117,0.0028251035,0.006757253,0.00038809553,0.72411394,0.00092881004],"about_ca_topic_score_codex":0.00009345074,"about_ca_topic_score_gemma":0.000052270792,"teacher_disagreement_score":0.80030614,"about_ca_system_score_codex":0.00089217577,"about_ca_system_score_gemma":0.0008151164,"threshold_uncertainty_score":0.9988562},"labels":[],"label_agreement":null},{"id":"W3095634877","doi":"10.1016/j.ygyno.2020.10.026","title":"Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Lymphedema; Medicine; Gynecologic cancer; Standardization; Clinical trial; Physical therapy; Clinical Practice; Gynecologic oncology; Intensive care medicine; Cancer; Oncology; Breast cancer; Internal medicine","score_opus":0.11994480626915244,"score_gpt":0.39742338561370405,"score_spread":0.2774785793445516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095634877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012722994,0.97753584,0.000050433337,0.00015067599,0.0011256895,0.003981781,0.00021438397,0.00010734781,0.0041108695],"genre_scores_gemma":[0.065487415,0.93252575,0.00050756265,0.0004424164,0.000031273066,0.00054439,0.00029914157,0.00005670666,0.000105335865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948029,0.0013027663,0.0020497134,0.00080688053,0.00054544286,0.00049232104],"domain_scores_gemma":[0.9940356,0.002628563,0.0023197404,0.0003420796,0.00040124514,0.0002727697],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000916793,0.000594045,0.005278979,0.00034573043,0.000073662224,0.000013203601,0.00016825968,0.0009786837,0.0003537282],"category_scores_gemma":[0.014526372,0.00043005942,0.00045948205,0.00069874205,0.00026468176,0.00007568733,0.0001552002,0.00009119488,0.000015636162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005466611,0.002581055,0.1836364,0.011003447,0.003375936,0.0022044547,0.0005576471,0.000031058902,0.000008155169,0.000070072245,0.0012679512,0.7947172],"study_design_scores_gemma":[0.021376815,0.018555181,0.115321524,0.014043884,0.017386468,0.00035487977,0.0020569882,0.00012027861,0.000008333337,0.00045773262,0.80808586,0.0022320533],"about_ca_topic_score_codex":0.00011594142,"about_ca_topic_score_gemma":0.00042600025,"teacher_disagreement_score":0.8068179,"about_ca_system_score_codex":0.0050069084,"about_ca_system_score_gemma":0.0050314693,"threshold_uncertainty_score":0.9998151},"labels":[],"label_agreement":null},{"id":"W3096566543","doi":"10.1016/j.ygyno.2020.06.003","title":"Sentinel lymph node biopsy versus lymphadenectomy for high-grade endometrial cancer staging (SENTOR trial): A prospective multicenter cohort study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Credit Valley Hospital; Sunnybrook Health Science Centre; Trillium Health Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Sentinel lymph node; Prospective cohort study; Biopsy; Multicenter trial; Indocyanine green; Lymph node; Cohort; Sentinel node; Radiology; Multicenter study; Surgery; Cancer; Oncology; Internal medicine; Randomized controlled trial; Breast cancer","score_opus":0.05794427059482087,"score_gpt":0.3671476624213628,"score_spread":0.30920339182654194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096566543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779337,0.0003117081,0.00010901186,0.004872288,0.0047823437,0.010346102,0.00012501878,0.00026245255,0.0012573513],"genre_scores_gemma":[0.98770416,0.00010621406,0.0011160258,0.0019886023,0.0025942319,0.006088725,0.000091177775,0.000060941755,0.0002499277],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962222,0.00033390298,0.000858374,0.0011900424,0.00052400376,0.0008714777],"domain_scores_gemma":[0.9958056,0.0026219632,0.00043841582,0.00033919467,0.00029250377,0.0005022735],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000528243,0.00049044023,0.0016905583,0.00029178412,0.00022036895,0.000041975203,0.0002796311,0.00033521655,0.0010546654],"category_scores_gemma":[0.0036784587,0.0003792265,0.0003784959,0.0011398984,0.00014160905,0.00010198829,0.00020090493,0.0002546856,0.00007942081],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20452984,0.0054784906,0.78163517,0.00008450571,0.0023686958,0.0003464235,0.00041035004,0.000013860047,0.00082440313,0.000052874333,0.0002457482,0.004009663],"study_design_scores_gemma":[0.507154,0.008866488,0.47836784,0.00001277641,0.002043783,0.00000556926,0.0006633932,0.0001201031,0.0005452066,0.00004528099,0.001848279,0.0003273077],"about_ca_topic_score_codex":0.0007351671,"about_ca_topic_score_gemma":0.000045267327,"teacher_disagreement_score":0.30326733,"about_ca_system_score_codex":0.00242173,"about_ca_system_score_gemma":0.00059994205,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W3112183187","doi":"10.1016/j.ygyno.2020.12.004","title":"Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Vancouver General Hospital; BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; Spinal Cord Injury BC; University of British Columbia","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Terry Fox Research Institute","keywords":"SMARCA4; Ovarian cancer; Ovarian carcinoma; Cancer research; Immunohistochemistry; Cancer; Small-cell carcinoma; Ovary; Medicine; Carcinoma; Exome sequencing; Pathology; Cell culture; Biology; Internal medicine; Gene expression; Gene; Mutation; Genetics","score_opus":0.028195551859431414,"score_gpt":0.28886099987295866,"score_spread":0.26066544801352726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112183187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748611,0.010257882,0.000588274,0.004432373,0.00042404493,0.00022830116,0.000022654298,0.000027121385,0.009158235],"genre_scores_gemma":[0.9925186,0.0024926437,0.0008627475,0.0032595217,0.00025288502,0.000055665514,0.000016573113,0.000012166181,0.00052920403],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989442,0.00014870995,0.0002853729,0.00032300036,0.00007854727,0.00022012863],"domain_scores_gemma":[0.9993311,0.00012261803,0.00021145912,0.00018537,0.000084938954,0.00006451171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002173876,0.00014509408,0.00028035016,0.000012329367,0.00011841788,0.000011610895,0.0002387296,0.00025534266,0.00023700685],"category_scores_gemma":[0.00023132299,0.000102883154,0.00007224558,0.00006492813,0.00026504914,0.000004256592,0.00019567089,0.00012408098,0.0000038053536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049017835,0.00025026425,0.012906357,0.00033994825,0.0002368053,0.00004407461,0.002543211,0.0027819804,0.8827002,0.0004872972,0.05903167,0.03818801],"study_design_scores_gemma":[0.0076545547,0.01481314,0.017253183,0.00007281376,0.0006843833,0.000092705406,0.016997842,0.00793153,0.40625313,0.0031887852,0.5233117,0.0017462462],"about_ca_topic_score_codex":0.00012588128,"about_ca_topic_score_gemma":0.0005281205,"teacher_disagreement_score":0.47644708,"about_ca_system_score_codex":0.00005174138,"about_ca_system_score_gemma":0.0002006574,"threshold_uncertainty_score":0.41954532},"labels":[],"label_agreement":null},{"id":"W3112202821","doi":"10.1016/j.ygyno.2020.12.005","title":"Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Victoria; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Chimeric antigen receptor; Medicine; Ovarian cancer; Antigen; Cancer research; Immunology; Cancer; Internal medicine; T cell; Immune system","score_opus":0.03555750875034905,"score_gpt":0.3374122596685919,"score_spread":0.3018547509182429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112202821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987126,0.0014126552,0.000052305033,0.0033705106,0.00031801042,0.0010381676,0.00008238361,0.00004330777,0.006556642],"genre_scores_gemma":[0.98961955,0.005765618,0.001729425,0.0019167287,0.00022039184,0.00010101888,0.00012726194,0.00003291114,0.0004871082],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978638,0.00036457225,0.0004868489,0.0005320785,0.00025994843,0.0004927125],"domain_scores_gemma":[0.99885994,0.00034457844,0.00020886779,0.00023378042,0.00008290775,0.0002699298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004147706,0.00021329241,0.000829577,0.000158939,0.000050818686,0.0000066697753,0.000180172,0.0003202396,0.011055661],"category_scores_gemma":[0.00016308216,0.00017891375,0.00008766481,0.0002957867,0.00015942384,0.00004878443,0.00014134796,0.0005489422,0.000032125245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071614236,0.0004114206,0.37947246,0.00021140299,0.00002974281,0.00008600941,0.00081661344,0.000005846044,0.5860498,0.000003013667,0.0021728573,0.030024666],"study_design_scores_gemma":[0.0053162915,0.005487062,0.7132031,0.00008092648,0.000033705506,0.000014598893,0.0004907396,0.00016035135,0.14895895,0.000019736495,0.12597321,0.00026134457],"about_ca_topic_score_codex":0.0001778968,"about_ca_topic_score_gemma":0.00005451796,"teacher_disagreement_score":0.43709087,"about_ca_system_score_codex":0.00035016148,"about_ca_system_score_gemma":0.0005334711,"threshold_uncertainty_score":0.9898484},"labels":[],"label_agreement":null},{"id":"W3114147615","doi":"10.1016/j.ygyno.2021.04.007","title":"The attributive value of comprehensive surgical staging in clinically early-stage epithelial ovarian carcinoma: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stage (stratigraphy); Meta-analysis; Confidence interval; Cochrane Library; Internal medicine; Serous fluid; Oncology; Radiology","score_opus":0.13709746604118384,"score_gpt":0.42873708932970644,"score_spread":0.2916396232885226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114147615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117624404,0.99156344,0.0000056299123,0.0014237629,0.00013003076,0.005887421,0.0004906507,0.000016811238,0.00036463307],"genre_scores_gemma":[0.0016545049,0.9944464,0.00027862826,0.00058016967,0.000040006762,0.0023368201,0.00017522596,0.000031885527,0.00045636587],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895917,0.005163796,0.0033214372,0.0010021876,0.00035567355,0.0005651615],"domain_scores_gemma":[0.9804012,0.015759733,0.0021714002,0.0010608836,0.00039729523,0.0002094703],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002974901,0.0006753499,0.021110505,0.0002711482,0.00012434919,0.000028733291,0.0003295884,0.0006827529,0.0004345878],"category_scores_gemma":[0.0012440144,0.00034689793,0.003994385,0.001251792,0.00037723628,0.000028970891,0.00035493902,0.0008838702,0.000017302473],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057108038,0.001382763,0.0012253743,0.6928683,0.28166217,0.006818842,0.00013209421,0.0000032617422,1.96362e-8,0.0038073047,0.00014206332,0.011900685],"study_design_scores_gemma":[0.0012131736,0.0014992913,0.0010699121,0.008348802,0.85724443,0.00015958106,0.000107617234,0.0000030952917,1.0005985e-7,0.000016616958,0.13007154,0.00026584166],"about_ca_topic_score_codex":0.00025850607,"about_ca_topic_score_gemma":0.00013944958,"teacher_disagreement_score":0.6845195,"about_ca_system_score_codex":0.00083432125,"about_ca_system_score_gemma":0.0014933709,"threshold_uncertainty_score":0.9998983},"labels":[],"label_agreement":null},{"id":"W3117931050","doi":"10.1016/j.ygyno.2020.12.035","title":"Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology – A systematic review and meta-analysis.","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital","funders":"ERAS Labo; GlaxoSmithKline","keywords":"Medicine; Meta-analysis; Subgroup analysis; Gynecologic oncology; Odds ratio; Confidence interval; Randomized controlled trial; MEDLINE; Clinical endpoint; Internal medicine; Cohort study; Cochrane Library; Oncology; Surgery","score_opus":0.09047952068854936,"score_gpt":0.38055543113624807,"score_spread":0.2900759104476987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117931050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013665164,0.9870514,0.000049057166,0.0015294309,0.00066016376,0.008760928,0.00019923599,0.00013513233,0.0014779613],"genre_scores_gemma":[0.0007091264,0.97792584,0.0008858841,0.008657599,0.00005101005,0.010190905,0.00022105726,0.000115949646,0.0012426389],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9828157,0.006258714,0.0069701145,0.0021638859,0.0005483162,0.0012432573],"domain_scores_gemma":[0.96051234,0.031995554,0.005029129,0.0016553352,0.0003209208,0.00048675016],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0054056137,0.0017440697,0.061542533,0.0022708026,0.000061411396,0.00002321836,0.00061115035,0.0027022592,0.003489729],"category_scores_gemma":[0.014401293,0.0011362426,0.009769571,0.0034134304,0.00047011144,0.00019613291,0.0006300829,0.0019469567,0.00024012147],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013702783,0.0010110606,0.0002658733,0.7794996,0.17890377,0.0030717198,0.000056316883,0.0000014569973,0.0000012027634,0.000010590262,0.00062193227,0.036419466],"study_design_scores_gemma":[0.0004906284,0.0018219947,0.0005812797,0.013458121,0.86248285,0.00037448693,0.00003209778,8.5439245e-7,0.0000025125998,0.000068391666,0.119730614,0.0009561728],"about_ca_topic_score_codex":0.000024522164,"about_ca_topic_score_gemma":0.00050304295,"teacher_disagreement_score":0.76604146,"about_ca_system_score_codex":0.0020048025,"about_ca_system_score_gemma":0.0030238305,"threshold_uncertainty_score":0.99953055},"labels":[],"label_agreement":null},{"id":"W3123824117","doi":"10.1016/j.ygyno.2021.01.002","title":"Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; McMaster University; Health Sciences Centre; Mount Sinai Hospital; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Sinai Health System; Toronto Metropolitan University; University of Toronto; University Health Network","funders":"Canadian Cancer Society Research Institute","keywords":"Medicine; Endometrial cancer; Oncology; Gynecology; Prospective cohort study; Internal medicine; Cancer","score_opus":0.20686181152033487,"score_gpt":0.44562570105883254,"score_spread":0.23876388953849767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123824117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765968,0.0023432132,0.00024461714,0.0018855822,0.0011280017,0.002516887,0.000016870676,0.00006590332,0.015202145],"genre_scores_gemma":[0.9969519,0.0009044788,0.0006863351,0.00048185294,0.0002166607,0.00057040027,0.000008826985,0.0000132566975,0.00016628456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968332,0.0007707229,0.0010344856,0.00061294704,0.00035284134,0.0003958172],"domain_scores_gemma":[0.9928274,0.006045255,0.00037451662,0.00043054484,0.00023883372,0.00008343579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015684281,0.00018818605,0.0010208602,0.00023124008,0.0001122177,0.000008641813,0.00016846713,0.00025772778,0.000670862],"category_scores_gemma":[0.006475326,0.000119275704,0.00030577433,0.0032565484,0.00023993032,0.00006267429,0.00015636612,0.00047123496,0.000012918078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017203421,0.0073978305,0.9794693,0.00004226091,0.00035596965,0.00028541766,0.0012943897,0.000015292682,0.00039214198,0.0017019765,0.00020959592,0.007115467],"study_design_scores_gemma":[0.029077085,0.011916616,0.9405868,0.000026983158,0.00055350224,0.000059447924,0.008483163,0.000013670534,0.0007371765,0.0067111887,0.0016735927,0.00016076985],"about_ca_topic_score_codex":0.00036381918,"about_ca_topic_score_gemma":0.0014799915,"teacher_disagreement_score":0.038882513,"about_ca_system_score_codex":0.0018688595,"about_ca_system_score_gemma":0.0009265936,"threshold_uncertainty_score":0.77520376},"labels":[],"label_agreement":null},{"id":"W3127453442","doi":"10.1016/j.ygyno.2021.01.036","title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":330,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Medical Association","funders":"","keywords":"Medicine; Incidence (geometry); Endometrial cancer; Confidence interval; Demography; Burden of disease; Disease burden; Epidemiology; Disease; Mortality rate; Environmental health; Cancer; Population; Internal medicine","score_opus":0.10475912220738326,"score_gpt":0.41324121877678377,"score_spread":0.3084820965694005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127453442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831126,0.006504416,0.000008524862,0.006660168,0.00029191835,0.00032080346,0.00015082512,0.000008136105,0.0029426548],"genre_scores_gemma":[0.99516124,0.0024225602,0.000307858,0.0016294713,0.00011013547,0.00008801937,0.000037070724,0.0000031449777,0.00024049403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884117,0.00019902478,0.00030400723,0.00026731665,0.00022528422,0.0001632299],"domain_scores_gemma":[0.9973675,0.002114741,0.00014066885,0.00010865336,0.00019867592,0.000069781134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004516835,0.000098764955,0.00038503626,0.00006656728,0.000078568155,0.000006440719,0.00005403718,0.00014321624,0.0008226095],"category_scores_gemma":[0.002340633,0.00006540481,0.000044256827,0.00066716684,0.00023510953,0.000043126325,0.00014368207,0.00011255501,0.0000041344288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002935107,0.0003471658,0.9853455,0.000029343852,0.00016518138,0.00006481361,0.00007067796,0.000010925654,0.00052036333,0.004635709,0.00086314423,0.007653662],"study_design_scores_gemma":[0.0046829768,0.00043535666,0.9807621,0.000013218018,0.000107878885,0.00006848564,0.00005857797,0.000022405678,0.00020503678,0.0066741654,0.006911272,0.000058482914],"about_ca_topic_score_codex":0.001270191,"about_ca_topic_score_gemma":0.008654184,"teacher_disagreement_score":0.012048693,"about_ca_system_score_codex":0.00073315273,"about_ca_system_score_gemma":0.0007733844,"threshold_uncertainty_score":0.90069973},"labels":[],"label_agreement":null},{"id":"W3128685317","doi":"10.1016/j.ygyno.2021.01.028","title":"The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Meta-analysis; Oncology; Hazard ratio; Cochrane Library; Randomized controlled trial; Progression-free survival; Ovarian cancer; Publication bias; Confidence interval; Chemotherapy; Cancer","score_opus":0.2353284532147614,"score_gpt":0.4281566750376063,"score_spread":0.1928282218228449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128685317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005205927,0.9834729,0.000019744723,0.005413521,0.00006587126,0.010629077,0.00035817438,0.0000064918963,0.000029010527],"genre_scores_gemma":[0.00014633896,0.9815889,0.00059771363,0.0016314615,0.000017590011,0.015729098,0.0001271238,0.000023212413,0.00013856048],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950476,0.0020969452,0.0018017705,0.0005167022,0.00023183497,0.00030514054],"domain_scores_gemma":[0.98771715,0.0091889575,0.0017395689,0.001017602,0.00028315285,0.00005357644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018375702,0.00043232494,0.012579269,0.00013943782,0.00008059175,0.000019545838,0.00031923354,0.00036911963,0.00025153818],"category_scores_gemma":[0.0009852122,0.00017125053,0.0027717217,0.0009182377,0.00015532467,0.000027683669,0.00006393737,0.00036216038,7.1174117e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003881514,0.0009758358,0.000021689133,0.46739915,0.3146928,0.00006969131,0.0002512434,0.000008090628,6.809152e-8,0.000575813,0.0010580716,0.21490873],"study_design_scores_gemma":[0.00082345936,0.000908634,0.000045944187,0.0078505585,0.7805704,0.000035960456,0.000028882863,0.00001403313,2.9160515e-7,0.00007144212,0.20951866,0.00013176346],"about_ca_topic_score_codex":0.0002303071,"about_ca_topic_score_gemma":0.0009542259,"teacher_disagreement_score":0.46587756,"about_ca_system_score_codex":0.00036493776,"about_ca_system_score_gemma":0.0011400111,"threshold_uncertainty_score":0.8598937},"labels":[],"label_agreement":null},{"id":"W3128939736","doi":"10.1016/j.ygyno.2021.01.014","title":"A pneumococcal pneumonia and influenza vaccination quality improvement program for women receiving chemotherapy for gynecologic cancers at a major tertiary cancer Centre","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Cancer Centre; Juravinski Hospital; McMaster University","funders":"Pfizer Canada; AstraZeneca Canada","keywords":"Medicine; Pneumococcal vaccination; Chemotherapy; Pneumonia; Vaccination; Pneumococcal pneumonia; Internal medicine; Oncology; Cervical cancer; Cancer; Immunology; Streptococcus pneumoniae; Antibiotics","score_opus":0.03816092488588417,"score_gpt":0.4124796025188538,"score_spread":0.3743186776329696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128939736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776411,0.00094804063,0.000052448784,0.01323161,0.0004612246,0.0055715414,0.000116529576,0.00015246091,0.0018250415],"genre_scores_gemma":[0.9643213,0.001072849,0.002436389,0.011248911,0.00040674437,0.016071176,0.00012708957,0.00005904343,0.004256482],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99687463,0.00018501244,0.0006464975,0.00091116683,0.00024622932,0.0011364418],"domain_scores_gemma":[0.9967573,0.0016144955,0.00025213152,0.00031344098,0.0006763178,0.00038627055],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010378754,0.0003122594,0.0008792271,0.00010488972,0.0003297656,0.000043341828,0.00015480041,0.00047434814,0.004908273],"category_scores_gemma":[0.0013048557,0.00026389057,0.00019110985,0.0002618976,0.00012451543,0.000082751445,0.00021396214,0.00031619446,0.0000055471687],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002308523,0.0008661296,0.08333247,0.0010667484,0.00029519113,0.000028926297,0.0008650775,0.000009292315,0.033817027,0.00008635683,0.0010380534,0.8762862],"study_design_scores_gemma":[0.011976283,0.005396866,0.8023293,0.000013837951,0.00010547243,0.00001647127,0.00083077216,0.0005344842,0.0036230357,0.0010421658,0.17382306,0.00030822755],"about_ca_topic_score_codex":0.00015618364,"about_ca_topic_score_gemma":0.006853904,"teacher_disagreement_score":0.875978,"about_ca_system_score_codex":0.0061392267,"about_ca_system_score_gemma":0.0015511421,"threshold_uncertainty_score":0.99998134},"labels":[],"label_agreement":null},{"id":"W3132331214","doi":"10.1016/j.ygyno.2021.02.018","title":"Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Prom; Medicine; Clinical trial; Clinical endpoint; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Surgery; Internal medicine","score_opus":0.06518914206641746,"score_gpt":0.3698441545332145,"score_spread":0.30465501246679705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132331214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011612648,0.9733404,0.0000030972685,0.0053603407,0.0011121497,0.007066618,0.000665967,0.00002831891,0.0008104911],"genre_scores_gemma":[0.021266475,0.96824485,0.0011349358,0.0019034148,0.00016662067,0.006325693,0.0008679576,0.00005758472,0.00003246568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898553,0.004576273,0.0037241043,0.00093850004,0.00033364032,0.0005722098],"domain_scores_gemma":[0.978196,0.01737058,0.0033743822,0.00072643236,0.00021917153,0.00011341746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003169931,0.0007249927,0.011110557,0.0002809873,0.000086013635,0.00002829501,0.0003341673,0.00083093083,0.0014884897],"category_scores_gemma":[0.0036028975,0.0004226893,0.0013534288,0.0006225844,0.00023749603,0.00008919143,0.00021637163,0.00078971824,0.00001694854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052699293,0.0013800773,0.0012216847,0.0006819794,0.0015052878,0.00044531102,0.0007396232,0.00004228297,0.0000042991255,0.0023285337,0.00022486679,0.9861561],"study_design_scores_gemma":[0.33591864,0.0034973396,0.010595125,0.07871308,0.008311351,0.00016817286,0.0016966533,0.000029138857,0.00004556698,0.0066303373,0.55315197,0.0012426258],"about_ca_topic_score_codex":0.0028131274,"about_ca_topic_score_gemma":0.008607226,"teacher_disagreement_score":0.9849135,"about_ca_system_score_codex":0.0024699534,"about_ca_system_score_gemma":0.0017200123,"threshold_uncertainty_score":0.9998225},"labels":[],"label_agreement":null},{"id":"W3134168476","doi":"10.1016/j.ygyno.2021.02.038","title":"Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Strong; CancerCare Manitoba Foundation; Diagnostic Services Manitoba; Cancer Research Society","keywords":"Serous fluid; Chromosome instability; Medicine; Ascites; Malignancy; Aneuploidy; Ovarian cancer; Disease; Cancer; Genome instability; Cancer research; Oncology; Internal medicine; Pathology; Chromosome; Biology; Genetics; Gene; DNA damage","score_opus":0.013304032012414955,"score_gpt":0.2745615524562043,"score_spread":0.2612575204437893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134168476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940462,0.0030167953,0.00008325616,0.0016437019,0.00042486176,0.00037027616,0.00015388097,0.000015076512,0.00024591523],"genre_scores_gemma":[0.9910984,0.0045525064,0.0015728548,0.0021755542,0.00005192262,0.00017155914,0.00017959473,0.000017326069,0.00018029562],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981805,0.00026843976,0.00036272674,0.00069494644,0.00008061043,0.0004127411],"domain_scores_gemma":[0.99924046,0.00007441941,0.0001223284,0.00038031978,0.000086081076,0.00009641773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001781271,0.00021275689,0.00036416706,0.000044983117,0.000076593045,0.000016020176,0.00014563919,0.00045543406,0.00029419624],"category_scores_gemma":[0.00016770854,0.00020451505,0.00006849801,0.00012880091,0.00014978708,0.0000052873474,0.00034451866,0.00019654234,0.000005643693],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015268846,0.0016761809,0.13753116,0.00017847972,0.00018734612,0.00020419598,0.0007289293,0.0002360616,0.7675042,0.00034545988,0.0011751543,0.09008016],"study_design_scores_gemma":[0.005047346,0.0034543267,0.67993855,0.0000476591,0.00013917749,0.00025196333,0.00095530663,0.00045035657,0.11562834,0.0023028685,0.19071265,0.0010714884],"about_ca_topic_score_codex":0.00026882728,"about_ca_topic_score_gemma":0.010678443,"teacher_disagreement_score":0.65187585,"about_ca_system_score_codex":0.00026669537,"about_ca_system_score_gemma":0.00043609118,"threshold_uncertainty_score":0.83398813},"labels":[],"label_agreement":null},{"id":"W3135122043","doi":"10.1016/j.ygyno.2021.02.019","title":"Implications for management of ovarian cancer in a transgender man: Impact of androgens and androgen receptor status","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Male Breast Health Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Testosterone (patch); Androgen receptor; Transgender; Oncology; Androgen; Internal medicine; Gynecology; Hormone; Cancer; Endocrinology; Prostate cancer; Gender studies","score_opus":0.057208802417026715,"score_gpt":0.41303861490412336,"score_spread":0.35582981248709666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135122043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850706,0.0032279103,0.00012445559,0.005695529,0.000093992996,0.0012915186,0.0004202196,0.000013267256,0.0040625036],"genre_scores_gemma":[0.98904383,0.004339079,0.005699986,0.00021887485,0.000019622561,0.0004864474,0.000035938137,0.000009951421,0.00014628281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988581,0.00006518332,0.00041442472,0.0002647834,0.000055025383,0.00034247022],"domain_scores_gemma":[0.99912006,0.00027178263,0.00014734076,0.00017964447,0.00017482018,0.00010636365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021965723,0.00011240378,0.0005827382,0.00009465329,0.000036591333,0.0000012143819,0.00004189463,0.00013368945,0.00060844026],"category_scores_gemma":[0.00006432431,0.00009388685,0.00009339973,0.00024139452,0.000109359535,0.000017433807,0.00004729494,0.00007976143,6.117392e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007790326,0.0010546154,0.85825014,0.001391804,0.00093801937,0.00004144085,0.0010228008,0.000042653217,0.0041504297,0.0029133267,0.001130987,0.12828474],"study_design_scores_gemma":[0.0040502367,0.0012829679,0.9876566,0.000042110813,0.00020026664,0.00004391537,0.00068356364,0.000024896219,0.00032478516,0.000668491,0.004946309,0.00007584921],"about_ca_topic_score_codex":0.00014094436,"about_ca_topic_score_gemma":0.00067149254,"teacher_disagreement_score":0.12940647,"about_ca_system_score_codex":0.00036178817,"about_ca_system_score_gemma":0.0005640261,"threshold_uncertainty_score":0.6661994},"labels":[],"label_agreement":null},{"id":"W3135525686","doi":"10.1016/j.ygyno.2021.02.021","title":"The use of imaging in endometrial cancer prior to potential surgery: Are guidelines being followed?","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; General surgery; Cancer; Gynecology; Internal medicine","score_opus":0.11238384962862857,"score_gpt":0.38388101994899576,"score_spread":0.2714971703203672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135525686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96577823,0.0027599998,0.00007858881,0.02677018,0.0033867,0.00066415657,0.000028618308,0.000036828063,0.00049672194],"genre_scores_gemma":[0.9899881,0.0017391358,0.0024036993,0.004246166,0.0005462584,0.00021788124,0.000017445973,0.000019394145,0.0008219534],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776554,0.00029049136,0.0007953079,0.00038627643,0.0002812074,0.00048115087],"domain_scores_gemma":[0.9945221,0.0042992802,0.00025873457,0.00028074102,0.0004844358,0.00015469367],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006609443,0.00017542986,0.0008575475,0.00029608014,0.00011383613,0.000023635595,0.000117399446,0.00014415002,0.00051315647],"category_scores_gemma":[0.015091262,0.000115225805,0.00025943405,0.0012887594,0.000084089406,0.00006482521,0.00017957215,0.00019146598,0.000014280774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017164665,0.00049254583,0.4752215,0.00003180216,0.00016672854,0.0017848267,0.000058131864,0.00016863077,0.0032509791,0.000056703182,0.006528005,0.5105237],"study_design_scores_gemma":[0.012708466,0.0009536207,0.6745519,0.00019133215,0.00045741076,0.00011628307,0.00053672143,0.00013778418,0.005632945,0.00046436896,0.30392835,0.00032078833],"about_ca_topic_score_codex":0.00064195367,"about_ca_topic_score_gemma":0.00253316,"teacher_disagreement_score":0.5102029,"about_ca_system_score_codex":0.0006003893,"about_ca_system_score_gemma":0.00082165824,"threshold_uncertainty_score":0.9932051},"labels":[],"label_agreement":null},{"id":"W3135640741","doi":"10.1016/j.ygyno.2021.02.020","title":"The levonorgestrel intrauterine system for prevention of endometrial cancer in women with obesity: A cost-effectiveness study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Ottawa; Sinai Health System; Princess Margaret Cancer Centre; St. Michael's Hospital; University of British Columbia; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Levonorgestrel; Endometrial cancer; Body mass index; Cost effectiveness; Incidence (geometry); Obstetrics; Gynecology; Obesity; Population; Cancer; Family planning; Environmental health; Internal medicine","score_opus":0.04638600562689959,"score_gpt":0.3687974395319958,"score_spread":0.3224114339050962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135640741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936628,0.0005037136,0.00011378267,0.00033538678,0.0006896131,0.004199255,0.00002686337,0.000025401365,0.00044322704],"genre_scores_gemma":[0.99298644,0.00027658918,0.00014139507,0.00004093847,0.000119276956,0.0062716934,0.000009145525,0.000011752965,0.00014274287],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982083,0.00056247675,0.00039329697,0.00032544555,0.00016191497,0.0003486096],"domain_scores_gemma":[0.9964031,0.0028772196,0.00020040247,0.00021156756,0.0002255188,0.000082180544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092412636,0.00014686171,0.00078625843,0.00012603328,0.000081013735,0.00000896627,0.00009665895,0.00012215877,0.00009756379],"category_scores_gemma":[0.00074004,0.00008597407,0.00007119103,0.0007963925,0.00007461087,0.000035660476,0.000067626446,0.0001436698,0.000001887315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04115125,0.00898171,0.26715222,0.0006982403,0.0014183758,0.0006160118,0.00056645396,0.00012204214,0.0018513576,0.00041220238,0.000020925672,0.6770092],"study_design_scores_gemma":[0.05686631,0.034976035,0.8949265,0.0001457416,0.00041244293,0.000049642913,0.004323622,0.000021102536,0.0035581798,0.0003113618,0.004265723,0.0001433223],"about_ca_topic_score_codex":0.00015424086,"about_ca_topic_score_gemma":0.0016738701,"teacher_disagreement_score":0.6768659,"about_ca_system_score_codex":0.0018579038,"about_ca_system_score_gemma":0.0005449188,"threshold_uncertainty_score":0.48583537},"labels":[],"label_agreement":null},{"id":"W3137015334","doi":"10.1016/j.ygyno.2021.03.019","title":"Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary—Clinical significance of BRCA2 gene variants in genomically stable tumors","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Serous fluid; KRAS; Clinical significance; Ovarian cancer; Germline; Medicine; Microsatellite instability; Cancer research; Loss of heterozygosity; Missense mutation; Ovarian carcinoma; Oncology; Cancer; Internal medicine; Mutation; Gene; Biology; Allele; Genetics; Colorectal cancer; Microsatellite","score_opus":0.031531234541806875,"score_gpt":0.33349246076480316,"score_spread":0.30196122622299626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137015334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899068,0.0008053691,0.000032236032,0.00652809,0.000600741,0.0011410872,0.00010575464,0.000016401611,0.0008635099],"genre_scores_gemma":[0.99257153,0.00039531893,0.004999469,0.0014808468,0.0001511507,0.00017053918,0.000065582375,0.000029555129,0.00013600357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497694,0.0009302311,0.0023193725,0.00082929217,0.00034402809,0.00060013856],"domain_scores_gemma":[0.9947184,0.002889613,0.0013167773,0.0006491153,0.00025281706,0.0001733152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012270457,0.00030233333,0.0016610053,0.00014897952,0.00005100001,0.0000074019663,0.0003479042,0.00042240365,0.0006117976],"category_scores_gemma":[0.0024387203,0.00023272754,0.0003047556,0.00073776685,0.00049895764,0.000050775838,0.00023652079,0.00070184836,0.000012939757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008966343,0.008142509,0.9748366,0.00011634097,0.00019907458,0.0069358456,0.00032495146,0.0015684183,0.001686602,0.0005087881,0.0001819008,0.0046023712],"study_design_scores_gemma":[0.009131309,0.003101347,0.9807753,0.00017448743,0.00014268469,0.00027397554,0.0002631156,0.00038753537,0.0038460386,0.0015538777,0.00016094532,0.00018940274],"about_ca_topic_score_codex":0.0005749987,"about_ca_topic_score_gemma":0.0029347385,"teacher_disagreement_score":0.008234674,"about_ca_system_score_codex":0.00080550805,"about_ca_system_score_gemma":0.0047250367,"threshold_uncertainty_score":0.94903535},"labels":[],"label_agreement":null},{"id":"W3137926322","doi":"10.1016/j.ygyno.2021.03.015","title":"Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"National Cancer Institute; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Internal medicine; Cmax; Adverse effect; Gastroenterology; Aspartate transaminase; Population; Response Evaluation Criteria in Solid Tumors; Urology; Oncology; Alanine transaminase; Pharmacokinetics; Surgery; Progressive disease; Chemotherapy","score_opus":0.05311737377274775,"score_gpt":0.3609906774511664,"score_spread":0.3078733036784187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137926322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625134,0.0006230128,0.00011459313,0.00066654163,0.00030350804,0.0016141918,0.000061101455,0.000033687236,0.00033200678],"genre_scores_gemma":[0.99636865,0.00004498923,0.0022675272,0.0004108853,0.00009505102,0.00023794732,0.0004779963,0.000017866216,0.00007908357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981011,0.00032816923,0.0005138956,0.000603837,0.00017095098,0.0002820591],"domain_scores_gemma":[0.998297,0.0008824158,0.00020971979,0.00028141958,0.00020463746,0.00012480917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030252375,0.0002110856,0.00071093586,0.00013096083,0.000116127936,0.000019750247,0.000053445405,0.00021985517,0.00037720578],"category_scores_gemma":[0.0004440945,0.00017271475,0.00003840668,0.0002316394,0.00009214204,0.000078546705,0.000057143923,0.00020667087,0.0000021231904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042759655,0.002193672,0.96403277,0.000019472242,0.00013497901,0.00006110664,0.0008089007,0.000019628129,0.00014196416,0.000052899646,0.00012702637,0.02813163],"study_design_scores_gemma":[0.028825764,0.012938034,0.9552389,0.000027143798,0.00021596107,0.00000691574,0.00061964657,0.000046234385,0.00007233309,0.00031094556,0.0015236533,0.00017450537],"about_ca_topic_score_codex":0.0001734746,"about_ca_topic_score_gemma":0.00152497,"teacher_disagreement_score":0.027957125,"about_ca_system_score_codex":0.00037164238,"about_ca_system_score_gemma":0.00021322601,"threshold_uncertainty_score":0.7043103},"labels":[],"label_agreement":null},{"id":"W3139217070","doi":"10.1016/j.ygyno.2021.02.026","title":"Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Clovis Oncology; Meso Scale Diagnostics; Merck","keywords":"Medicine; Cervical cancer; Oncology; Internal medicine; Adenosquamous carcinoma; Cancer; Proportional hazards model; Brachytherapy; Hazard ratio; Chemoradiotherapy; Stage (stratigraphy); Radiation therapy; Adenocarcinoma","score_opus":0.04252806843159199,"score_gpt":0.3502046381346354,"score_spread":0.30767656970304347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139217070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831597,0.0020256587,0.000008577961,0.0111079,0.00017957446,0.0004777091,0.00007684676,0.000054506138,0.0029095248],"genre_scores_gemma":[0.9924848,0.0041957716,0.00021526386,0.0015374703,0.00020816177,0.00029228165,0.00006891456,0.000015742839,0.0009815716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844,0.000285387,0.00034601465,0.00038258536,0.00015968557,0.0003863011],"domain_scores_gemma":[0.9970859,0.002319257,0.0001640129,0.0001756123,0.0001374118,0.00011780385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032976974,0.0001623812,0.00065870356,0.000058845635,0.00013744361,0.00001224161,0.00009150716,0.0003030855,0.0008844944],"category_scores_gemma":[0.0005585532,0.000116934,0.00007701192,0.0004779046,0.0000893775,0.000045399403,0.000077744895,0.00037249931,0.000030521096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024257583,0.00022213375,0.891658,0.000017650947,0.00021859304,0.00004787311,0.00010487334,0.000009488664,0.0032883796,0.00005425488,0.000017830422,0.10411832],"study_design_scores_gemma":[0.007639683,0.0005065204,0.98642683,0.000015406178,0.00016882074,0.000027582782,0.00010231379,0.000010763845,0.0005809118,0.0006354696,0.0037691984,0.00011651333],"about_ca_topic_score_codex":0.00023547026,"about_ca_topic_score_gemma":0.0021039897,"teacher_disagreement_score":0.104001805,"about_ca_system_score_codex":0.002276618,"about_ca_system_score_gemma":0.00039989446,"threshold_uncertainty_score":0.96845937},"labels":[],"label_agreement":null},{"id":"W3155412891","doi":"10.1016/j.ygyno.2021.04.011","title":"The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Genetic testing; Ovarian cancer; Oncology; Outreach; Genetic counseling; Serous fluid; Internal medicine; Cohort; Cancer; Gynecology; Genetics; Biology","score_opus":0.10888461054577853,"score_gpt":0.3841439055014802,"score_spread":0.27525929495570167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155412891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863325,0.003637201,0.002258646,0.0023665337,0.001477197,0.0031496154,0.0004810735,0.000022226734,0.00027502078],"genre_scores_gemma":[0.96766216,0.002282013,0.012382365,0.000372763,0.00039895278,0.015318355,0.00046237468,0.000037268208,0.0010837257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776125,0.0004169423,0.000582681,0.0005752698,0.00013402353,0.0005298173],"domain_scores_gemma":[0.99838626,0.00018218698,0.0005973368,0.00050160097,0.00025177415,0.0000808509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010645834,0.00018832811,0.00029390256,0.000032406817,0.00046034544,0.000025180147,0.00030348328,0.00023704101,0.00023133926],"category_scores_gemma":[0.00018265999,0.00015649441,0.0001288653,0.00016684334,0.0002314302,0.000006735132,0.0002978603,0.000110273075,0.0000016615977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007224769,0.0016021716,0.020167615,0.0001702826,0.0020339324,0.0000068071045,0.0016244325,0.0109497,0.24707645,0.0010710917,0.006025105,0.7085499],"study_design_scores_gemma":[0.002597305,0.0013526006,0.0256885,0.0000138103715,0.00036652043,0.000020246807,0.0023624953,0.0026081954,0.21588737,0.0016015399,0.7471028,0.00039865676],"about_ca_topic_score_codex":0.00016858762,"about_ca_topic_score_gemma":0.004009468,"teacher_disagreement_score":0.74107766,"about_ca_system_score_codex":0.00253564,"about_ca_system_score_gemma":0.0013986463,"threshold_uncertainty_score":0.663061},"labels":[],"label_agreement":null},{"id":"W3156567655","doi":"10.1016/j.ygyno.2021.04.014","title":"Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21)","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"AstraZeneca Schweiz","keywords":"Medicine; Ovarian cancer; Oncology; Retrospective cohort study; Outcome (game theory); Multicenter study; Epithelial ovarian cancer; BRCA mutation; Gynecology; Internal medicine; Cancer","score_opus":0.014594317779624996,"score_gpt":0.3112247860123599,"score_spread":0.2966304682327349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156567655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762255,0.00011620814,0.000019670262,0.00025023727,0.00085462746,0.00052558084,0.00019259792,0.000008646474,0.0004098909],"genre_scores_gemma":[0.9983553,0.00014752444,0.00053925515,0.00036368467,0.00009605563,0.00016501421,0.00011294325,0.0000189266,0.00020128116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983045,0.00027241505,0.0005102883,0.00052423653,0.00011175712,0.00027680767],"domain_scores_gemma":[0.999017,0.00007624595,0.00024709335,0.00026128246,0.00033989217,0.000058491125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002387176,0.00017730924,0.00042896278,0.00007320886,0.000051968887,0.000010836664,0.00014046326,0.00027365022,0.00015997085],"category_scores_gemma":[0.000770095,0.00017272787,0.000053498443,0.00018667856,0.00014362573,0.0000056228323,0.0002586843,0.00017817986,0.000004507239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016280034,0.0012838691,0.97981024,0.000016196444,0.0001048755,0.00005454464,0.0005555666,0.000016870468,0.0147019215,0.000010774754,0.000097613185,0.0031847511],"study_design_scores_gemma":[0.003604286,0.0014419919,0.9845926,0.0000057700368,0.000060676313,0.0000036908293,0.00054823427,0.000035526587,0.007997455,0.000042449396,0.001492596,0.00017467827],"about_ca_topic_score_codex":0.00014619165,"about_ca_topic_score_gemma":0.0035882755,"teacher_disagreement_score":0.0067044664,"about_ca_system_score_codex":0.00038196548,"about_ca_system_score_gemma":0.0003335106,"threshold_uncertainty_score":0.7043638},"labels":[],"label_agreement":null},{"id":"W3157256916","doi":"10.1016/j.ygyno.2021.04.030","title":"Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gynecologic oncology; Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; Surgical oncology; Logistic regression; Retrospective cohort study; Confounding; Clinical Oncology; Internal medicine; Cancer; Gynecology; Oncology; Disease","score_opus":0.2700131010120187,"score_gpt":0.4839908914178116,"score_spread":0.2139777904057929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157256916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7836,0.00022342829,0.0000610252,0.21213517,0.0007478428,0.0023636427,0.000115499904,0.00015238482,0.00060102646],"genre_scores_gemma":[0.914615,0.0016087219,0.0006957278,0.07907317,0.00015493568,0.0027796177,0.00013236604,0.00003825745,0.0009022233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927885,0.0029425006,0.0011731057,0.0012417198,0.00030760618,0.0015465576],"domain_scores_gemma":[0.98423916,0.012957019,0.0004370778,0.0010343749,0.0002634279,0.0010689368],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017353414,0.00050637336,0.0014257508,0.00075160887,0.00030419868,0.000038788974,0.0004889072,0.00054944074,0.001208552],"category_scores_gemma":[0.014787683,0.0003397289,0.00019297484,0.0025316905,0.0004264941,0.000109855675,0.00032762976,0.000913889,0.00014557954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.023727352,0.0033721898,0.87424487,0.000056576675,0.00016274466,0.0037773957,0.002836495,0.00084722263,0.00035760802,0.00006241682,0.0034232396,0.08713189],"study_design_scores_gemma":[0.010033704,0.0096445605,0.6448849,0.000010366016,0.00008673851,0.00025316273,0.0015900036,0.00012885297,0.000014814649,0.000042424435,0.33306515,0.0002453344],"about_ca_topic_score_codex":0.013760112,"about_ca_topic_score_gemma":0.8406253,"teacher_disagreement_score":0.8268652,"about_ca_system_score_codex":0.022884255,"about_ca_system_score_gemma":0.015515062,"threshold_uncertainty_score":0.99990547},"labels":[],"label_agreement":null},{"id":"W3158705568","doi":"10.1016/j.ygyno.2021.04.029","title":"Uterine serous carcinoma","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Endometrial cancer; Serous fluid; Oncology; Serous carcinoma; Internal medicine; Cancer; Radiation therapy; Ovarian cancer","score_opus":0.11510776056737307,"score_gpt":0.43149057793408174,"score_spread":0.3163828173667087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158705568","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008160896,0.96453667,0.0000035810676,0.00026542586,0.0017061705,0.0011565121,0.000058457797,0.000109184024,0.032082424],"genre_scores_gemma":[0.000066172215,0.9882751,0.00072562066,0.0009707064,0.0007731618,0.00057754474,0.00057876366,0.000053752097,0.007979193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972858,0.00040457895,0.0007764854,0.0007501068,0.00020843437,0.00057462516],"domain_scores_gemma":[0.9975669,0.001085475,0.00034919137,0.0005705076,0.00011924834,0.00030867674],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022762659,0.0005270209,0.0046901284,0.0002471331,0.00007337325,0.00001448753,0.00022467105,0.0011106811,0.0077101765],"category_scores_gemma":[0.0005579203,0.00035262594,0.00094927766,0.00075362006,0.00010331285,0.000023549557,0.0002852474,0.0006973353,0.0008061606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028032255,0.0005754318,0.000073450086,0.0057541784,0.00046794963,0.005755586,0.000008275026,3.2288774e-8,2.0594348e-7,0.00009431937,0.002215048,0.9850275],"study_design_scores_gemma":[0.001990414,0.0033054275,0.00021122457,0.00092334946,0.0027293905,0.0019262527,0.000013478402,2.2779797e-7,8.304214e-7,0.000032474432,0.9885928,0.00027415162],"about_ca_topic_score_codex":0.000040086208,"about_ca_topic_score_gemma":0.000032101645,"teacher_disagreement_score":0.9863777,"about_ca_system_score_codex":0.001657706,"about_ca_system_score_gemma":0.0018004461,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W3162780328","doi":"10.1016/j.ygyno.2020.05.257","title":"The impact of a universal HPV vaccination program on lower genital tract dysplasia and genital warts","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Colposcopy; Medicine; Cryotherapy; Genital warts; Dysplasia; Genital tract; Vaccination; Cervix; HPV infection; Sex organ; Human papillomavirus; Gynecology; Cervical cancer; Surgery; Virology; Internal medicine; Cancer; Physiology","score_opus":0.0370993600417093,"score_gpt":0.3774928437428416,"score_spread":0.3403934837011323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162780328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335806,0.00019016604,0.0000070448627,0.0038187266,0.00010286722,0.0008886675,0.000012801092,0.000053715106,0.06134546],"genre_scores_gemma":[0.9991824,0.000117560594,0.00008854195,0.00025679427,0.0001394133,0.000041460185,0.000013954445,0.0000106438965,0.0001492354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99889565,0.00011875827,0.0002082028,0.0002484632,0.00019589839,0.000333039],"domain_scores_gemma":[0.99865794,0.0007342645,0.000078052835,0.00012869896,0.00016123927,0.00023982933],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021733169,0.00013024974,0.00031646906,0.00005415179,0.00011018847,0.000015796348,0.00011221016,0.00018886184,0.004540091],"category_scores_gemma":[0.00060838973,0.00007680195,0.00013224011,0.00020626918,0.0001540369,0.00004983412,0.00007864828,0.00037916264,0.000037793467],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003300683,0.0013519094,0.012281189,0.000042043393,0.00013524569,0.0003541319,0.00039792326,0.000015934116,0.0003694654,0.00025877214,0.0031571605,0.97833556],"study_design_scores_gemma":[0.0029309127,0.040783692,0.9454959,0.0000010003546,0.000063298765,0.00006927791,0.0003057197,0.0013442431,0.00013595157,0.00013425261,0.008649194,0.00008654357],"about_ca_topic_score_codex":0.000033998967,"about_ca_topic_score_gemma":0.000064694934,"teacher_disagreement_score":0.978249,"about_ca_system_score_codex":0.00034812206,"about_ca_system_score_gemma":0.00041189187,"threshold_uncertainty_score":0.9963699},"labels":[],"label_agreement":null},{"id":"W3163069657","doi":"10.1016/j.ygyno.2020.05.233","title":"GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase III trial of cemiplimab, an anti-programmed death (PD)-1, versus investigator's choice (IC) chemotherapy in ≥2 line recurrent or metastatic cervical cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bevacizumab; Taxane; Chemotherapy; Oncology; Internal medicine; Phases of clinical research; Cancer","score_opus":0.2867256213653118,"score_gpt":0.4777661927906862,"score_spread":0.1910405714253744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163069657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97659236,0.0010434933,0.00015017243,0.013191578,0.0013434816,0.007167232,0.0001128679,0.000114270275,0.00028452885],"genre_scores_gemma":[0.9678333,0.002855952,0.011865097,0.0136311315,0.00070550194,0.0024873647,0.0004437769,0.000080070015,0.00009785214],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950015,0.0013407869,0.0015940216,0.00092717295,0.00048402828,0.00065247045],"domain_scores_gemma":[0.99562126,0.0021842879,0.0007945729,0.00040566575,0.0003412327,0.00065294997],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023973382,0.00048523786,0.0024889414,0.00021151025,0.00011781245,0.000046644072,0.0006916661,0.00042856843,0.0018022088],"category_scores_gemma":[0.0037661102,0.00035327123,0.00018368491,0.0008501285,0.0006211904,0.0002853495,0.00015274568,0.0005972973,0.000008463839],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8913433,0.014670745,0.00023172681,0.00011193227,0.00069109834,0.000095520765,0.0010108496,0.000019762198,0.008154764,0.00007485162,0.0007674629,0.08282801],"study_design_scores_gemma":[0.9246192,0.045026477,0.0006799,0.000053450727,0.00047978666,0.000011568773,0.0003604438,0.0075059445,0.0011566296,0.000057445228,0.019660313,0.0003888338],"about_ca_topic_score_codex":0.0012854226,"about_ca_topic_score_gemma":0.0034991957,"teacher_disagreement_score":0.08243918,"about_ca_system_score_codex":0.0008554489,"about_ca_system_score_gemma":0.0033352613,"threshold_uncertainty_score":0.99989194},"labels":[],"label_agreement":null},{"id":"W3164890381","doi":"10.1016/j.ygyno.2021.05.010","title":"Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Kingston Health Sciences Centre; Hospital for Sick Children; SickKids Foundation; Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Ontario Ministry of Research, Innovation and Science","keywords":"FOXP3; Immune system; Immune checkpoint; Tissue microarray; Cytotoxic T cell; CD20; CD8; Medicine; Cancer research; CD68; T cell; Immunotherapy; Immunohistochemistry; Pathology; Immunology; Biology","score_opus":0.014276331882922799,"score_gpt":0.2546512290902594,"score_spread":0.2403748972073366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164890381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912978,0.004426738,0.0000016404746,0.0010526956,0.0003269326,0.0005743593,0.000020275551,0.000012192511,0.0022874007],"genre_scores_gemma":[0.99828416,0.0004619168,0.00027511583,0.00031609923,0.000018809473,0.000034746914,0.000008688636,0.000013174311,0.0005872741],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998336,0.0003744469,0.00060028,0.0002726349,0.0001397125,0.00027691812],"domain_scores_gemma":[0.9985819,0.0005964596,0.00039793985,0.00025007981,0.0001330143,0.000040611383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057079503,0.00014481903,0.00060444785,0.000063751664,0.000043108026,0.000003509445,0.00013699126,0.00024605566,0.00031435973],"category_scores_gemma":[0.00043369882,0.00010522809,0.00014825755,0.00041388464,0.00035946054,0.000021385657,0.00012551258,0.00028864454,0.0000024856129],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089498906,0.0010027492,0.13461326,0.00019724377,0.00005941548,0.00022319541,0.00039778624,0.0000060174757,0.8601941,0.000008515077,0.00018134541,0.0022213883],"study_design_scores_gemma":[0.0025188178,0.0013585932,0.6430524,0.00003949754,0.00006502577,0.000025045307,0.0005242653,0.000024524616,0.35187483,0.00004583073,0.00040379204,0.00006741137],"about_ca_topic_score_codex":0.00026649114,"about_ca_topic_score_gemma":0.00024450768,"teacher_disagreement_score":0.5084391,"about_ca_system_score_codex":0.000253944,"about_ca_system_score_gemma":0.0006333981,"threshold_uncertainty_score":0.4291077},"labels":[],"label_agreement":null},{"id":"W3164958508","doi":"10.1016/j.ygyno.2021.05.023","title":"Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Radiation therapy; Brachytherapy; Multivariate analysis; Chemoradiotherapy; Proportional hazards model; Cohort; Retrospective cohort study; Oncology; Cancer; Internal medicine; External beam radiotherapy; Radiology","score_opus":0.08167160823317504,"score_gpt":0.38575108054162405,"score_spread":0.304079472308449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164958508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865393,0.0036183686,0.00029612248,0.0059982645,0.00086950324,0.0012287535,0.000053342963,0.00003530732,0.0013610072],"genre_scores_gemma":[0.9943851,0.0005576318,0.0014869017,0.0028204848,0.00018032514,0.0004414486,0.000036224574,0.000013303952,0.00007854842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982262,0.00036930625,0.0005030068,0.0003313629,0.0002093182,0.00036078758],"domain_scores_gemma":[0.99724126,0.0020587398,0.00023815755,0.00024247688,0.00015681359,0.000062537314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005354005,0.00017444209,0.0008315761,0.000088260174,0.00009045747,0.000009735992,0.000147298,0.00027279247,0.0002860568],"category_scores_gemma":[0.00039882466,0.000103076636,0.00019372816,0.00043188027,0.000072276765,0.000047157057,0.00004288251,0.00025542045,0.000003508085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015390413,0.0026774658,0.5389384,0.00035822263,0.00048899534,0.00034338504,0.0012828569,0.0007371908,0.005224748,0.0007460702,0.0002536942,0.44740996],"study_design_scores_gemma":[0.03047129,0.0063894005,0.939702,0.000116336116,0.00051988376,0.00009386986,0.0023501855,0.004146287,0.0044832216,0.0023133499,0.009077684,0.00033649872],"about_ca_topic_score_codex":0.00029145094,"about_ca_topic_score_gemma":0.0003767092,"teacher_disagreement_score":0.44707346,"about_ca_system_score_codex":0.0013215442,"about_ca_system_score_gemma":0.0007232437,"threshold_uncertainty_score":0.4203343},"labels":[],"label_agreement":null},{"id":"W3169489091","doi":"10.1016/j.ygyno.2021.05.021","title":"Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Regina; University of British Columbia","funders":"National Cancer Institute; Canadian Institutes of Health Research; Michael Smith Health Research BC; AstraZeneca; National Health and Medical Research Council; U.S. Department of Defense","keywords":"Medicine; Hazard ratio; Ovarian cancer; Proportional hazards model; Statin; Oncology; Internal medicine; Cohort; Population; Cancer; Cohort study; Gynecology; Confidence interval; Environmental health","score_opus":0.005314143586539293,"score_gpt":0.2270450625585649,"score_spread":0.22173091897202563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169489091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229723,0.0031736488,0.00007288745,0.00036607438,0.002936344,0.0005651958,0.000176617,0.000011027985,0.00040097267],"genre_scores_gemma":[0.99580365,0.00062002416,0.00028435283,0.0006648684,0.0012362704,0.0005003876,0.000569187,0.00001667912,0.00030458326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998271,0.00035633266,0.00026131622,0.00061796606,0.0002112162,0.00028218605],"domain_scores_gemma":[0.9991593,0.00011413138,0.00008502073,0.0003811102,0.00014089551,0.000119589946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003234798,0.000120331395,0.0005219812,0.00001931262,0.0001329224,0.000041369363,0.00012670395,0.00018705138,0.00028454445],"category_scores_gemma":[0.00020709092,0.00016069581,0.00005701937,0.0001949691,0.00005760173,0.0000037583989,0.00007553873,0.00013922463,3.955513e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001795184,0.00019958183,0.9900898,0.0000060793595,0.00035049868,0.00001887738,0.000031801737,0.0003646991,0.00013252128,0.0000017201918,0.0037345015,0.0050520175],"study_design_scores_gemma":[0.0020040986,0.00016736283,0.8501423,0.000004527525,0.00018774145,0.00001386674,0.00036496072,0.00002045996,0.000009784223,0.000011934195,0.14690243,0.00017052046],"about_ca_topic_score_codex":0.9808181,"about_ca_topic_score_gemma":0.9998356,"teacher_disagreement_score":0.14316793,"about_ca_system_score_codex":0.0002759062,"about_ca_system_score_gemma":0.0036190003,"threshold_uncertainty_score":0.65529853},"labels":[],"label_agreement":null},{"id":"W3172696687","doi":"10.1016/j.ygyno.2021.05.040","title":"Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Israel Cancer Research Fund","keywords":"Medicine; Endometrial cancer; Internal medicine; Cohort; Stage (stratigraphy); Oncology; Retrospective cohort study; Lymph; Gastroenterology; Lymph node; Sentinel lymph node; Cancer; Breast cancer; Pathology","score_opus":0.018150780128032482,"score_gpt":0.2838125201109402,"score_spread":0.2656617399829077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172696687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707,0.0009802221,0.000009543324,0.00027834807,0.00017613686,0.00054219615,0.00001904333,0.000010168416,0.0009143461],"genre_scores_gemma":[0.99768716,0.000526411,0.0014183822,0.0001681068,0.000035976554,0.00007667779,0.000021577265,0.000010117353,0.00005559788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998558,0.00018404388,0.00038740275,0.00034795704,0.0002777515,0.00024485952],"domain_scores_gemma":[0.9976373,0.0015192612,0.00025964042,0.0001705601,0.00032185845,0.00009141784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021844739,0.00015700341,0.000810357,0.00021007098,0.000025894244,0.0000030423084,0.00006179215,0.00016652963,0.00020897869],"category_scores_gemma":[0.0026332217,0.00010913064,0.00007084351,0.0009970542,0.00021698096,0.000046515812,0.00010185694,0.000096716474,0.0000019070858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016281499,0.0014588807,0.98309183,0.00016662058,0.0002159172,0.00010722621,0.000116933865,0.000038009268,0.00076647475,0.00013063707,0.0000046459527,0.012274669],"study_design_scores_gemma":[0.029151142,0.0014283574,0.96342534,0.00013814807,0.00023026559,0.000009189405,0.00014468591,0.000020955937,0.0051124212,0.00021126887,0.00003436211,0.00009385733],"about_ca_topic_score_codex":0.00044190473,"about_ca_topic_score_gemma":0.000089143534,"teacher_disagreement_score":0.027522992,"about_ca_system_score_codex":0.00034107588,"about_ca_system_score_gemma":0.0006324349,"threshold_uncertainty_score":0.44502184},"labels":[],"label_agreement":null},{"id":"W3176092375","doi":"10.1016/j.ygyno.2021.06.022","title":"Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Medicine; Hysterectomy; Dyslipidemia; Oophorectomy; BRCA mutation; Internal medicine; Diabetes mellitus; Population; Salpingectomy; Gynecology; Disease; Retrospective cohort study; Ovarian cancer; Obstetrics; Cancer; Surgery; Endocrinology; Pregnancy","score_opus":0.009116142398959883,"score_gpt":0.2641957886646174,"score_spread":0.25507964626565754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176092375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606746,0.0015553457,0.0006687174,0.000055851535,0.0006331071,0.00066667364,0.00017830242,0.00003645154,0.00013810705],"genre_scores_gemma":[0.9961786,0.00010290612,0.0019946417,0.00011565256,0.00019119892,0.0010339408,0.00026507583,0.0000409481,0.00007699015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678636,0.0011387801,0.0005453512,0.0008290494,0.00023775932,0.00046269095],"domain_scores_gemma":[0.99800205,0.00022985665,0.0003520314,0.0008967466,0.0003379086,0.00018139798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007750093,0.0002663457,0.0005196791,0.00014159393,0.00024353796,0.000028163457,0.00021681492,0.000263549,0.00025728467],"category_scores_gemma":[0.0015598092,0.00026920214,0.00036090368,0.0003861512,0.0001368431,0.000010247396,0.00017874077,0.00025337696,0.0000077972345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014528826,0.0005088664,0.8408831,0.00002660827,0.0012358766,0.00011229586,0.0009002183,0.14915659,0.0009912816,0.0000015207551,0.000037448324,0.0060009398],"study_design_scores_gemma":[0.0017873589,0.0007475208,0.98968416,0.000010567901,0.0007807963,0.000004774261,0.0012192014,0.0010712419,0.0019062962,0.00017611963,0.0022763931,0.00033557508],"about_ca_topic_score_codex":0.00071979297,"about_ca_topic_score_gemma":0.0006877707,"teacher_disagreement_score":0.14880109,"about_ca_system_score_codex":0.0006760238,"about_ca_system_score_gemma":0.0011191898,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W3176554303","doi":"10.1016/j.ygyno.2021.06.013","title":"Factors associated with an increased risk of recurrence in patients diagnosed with high-grade endometrial cancer undergoing minimally invasive surgery: A study of the society of gynecologic oncology of Canada (GOC) community of practice (CoP)","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Jewish General Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of British Columbia; McMaster University; Hôtel-Dieu de Québec; McGill University; Université Laval; Trillium Health Centre; Université de Montréal; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Interquartile range; Retrospective cohort study; Proportional hazards model; Percentile; Hazard ratio; Surgery; Stage (stratigraphy); Univariate analysis; Cancer; Internal medicine; Multivariate analysis; Confidence interval","score_opus":0.06216284913549083,"score_gpt":0.3153934166243401,"score_spread":0.2532305674888493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176554303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997111,0.00015188957,6.949015e-7,0.00016359691,0.00033194796,0.0016353432,0.00040570763,0.000008651849,0.00019115674],"genre_scores_gemma":[0.99896944,0.00029976218,0.00024495518,0.00022153146,0.000015749985,0.00012936394,0.000095562056,0.000018489582,0.0000051665784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99141514,0.0056825043,0.001388568,0.00039065164,0.00068806997,0.00043504004],"domain_scores_gemma":[0.9254211,0.0686928,0.0037637078,0.00052501395,0.0014581304,0.00013922004],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001756964,0.00032741218,0.0025148375,0.00021401544,0.00011569995,0.0000022972258,0.00036800336,0.0003426593,0.00014250255],"category_scores_gemma":[0.04199235,0.0001996331,0.0002223298,0.0025008558,0.0005538588,0.00009972947,0.00023149505,0.00074446545,3.9268002e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051935185,0.025208466,0.96298116,0.00021739257,0.0022545243,0.000041890467,0.0024009848,0.00018770952,0.0003710645,0.0000052073156,0.00007631981,0.0010617326],"study_design_scores_gemma":[0.0286574,0.03959949,0.9076807,0.00020341488,0.0014575756,0.0000014118476,0.016707374,0.0000032335802,0.0054938584,0.000027487276,0.00001823569,0.00014982204],"about_ca_topic_score_codex":0.47132552,"about_ca_topic_score_gemma":0.8977108,"teacher_disagreement_score":0.42638525,"about_ca_system_score_codex":0.0023380464,"about_ca_system_score_gemma":0.014067091,"threshold_uncertainty_score":0.99152225},"labels":[],"label_agreement":null},{"id":"W3179290714","doi":"10.1016/j.ygyno.2021.06.031","title":"Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Interquartile range; Internal medicine; Oncology; Lymphovascular invasion; Stage (stratigraphy); Metastasis; Adjuvant therapy; Cancer; Gastroenterology; Gynecology","score_opus":0.04264592062410075,"score_gpt":0.3614786743964166,"score_spread":0.3188327537723159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179290714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577284,0.00010403223,0.000014314473,0.0009605643,0.0007829517,0.0010147522,0.00009349319,0.000018256216,0.0012388233],"genre_scores_gemma":[0.9973409,0.00006136212,0.00081015425,0.0010319677,0.00008468499,0.0004183283,0.00013138655,0.000009853837,0.00011133057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973424,0.00062204135,0.0006646354,0.0004891238,0.0005397185,0.00034205295],"domain_scores_gemma":[0.99810606,0.00096399215,0.0002504512,0.00028950238,0.00030601714,0.00008399281],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007030421,0.00023968174,0.00094881834,0.00041233818,0.000060588096,0.000013804554,0.00029868,0.00017077912,0.0015338651],"category_scores_gemma":[0.0016323596,0.0001307987,0.00012922981,0.0011960263,0.00016825514,0.00013597043,0.00012045585,0.00026753842,0.00001246791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016413273,0.022367211,0.9577626,0.000015452484,0.00039839512,0.00058299844,0.00032743893,0.0002510264,0.00002186685,0.00004553112,0.0000056504095,0.016580492],"study_design_scores_gemma":[0.04998807,0.0020781986,0.9461824,0.0000152323955,0.00022842226,0.000009265305,0.0009962704,0.000061059756,0.000021312555,0.000022858816,0.00027619916,0.00012069435],"about_ca_topic_score_codex":0.0006254997,"about_ca_topic_score_gemma":0.0019725284,"teacher_disagreement_score":0.048346743,"about_ca_system_score_codex":0.0011332092,"about_ca_system_score_gemma":0.00073430233,"threshold_uncertainty_score":0.99937886},"labels":[],"label_agreement":null},{"id":"W3179306134","doi":"10.1016/j.ygyno.2021.07.010","title":"The correlation between BRCA status and surgical cytoreduction in high-grade serous ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Perioperative; Internal medicine; Oncology; Disease; Stage (stratigraphy); Ovarian carcinoma; Ovarian cancer; Surgery; Cancer","score_opus":0.02330149462210738,"score_gpt":0.29998367370456885,"score_spread":0.27668217908246145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179306134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892755,0.001506697,0.000011128398,0.016418194,0.0007776459,0.0003897981,0.000010714043,0.000031762414,0.0019264828],"genre_scores_gemma":[0.9973282,0.0011191412,0.00044428074,0.00020969805,0.0002959363,0.00010804589,0.00010523456,0.000011153974,0.00037826234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985144,0.00029113956,0.00031603494,0.00037127256,0.00012327645,0.0003838753],"domain_scores_gemma":[0.998327,0.0011470192,0.00010261606,0.00021399696,0.000069262256,0.00014005978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029300104,0.00013915391,0.00040321148,0.000059752685,0.00016321758,0.000022860318,0.000033856046,0.0002716118,0.00017004553],"category_scores_gemma":[0.0001856346,0.00009755044,0.00005008354,0.00023644768,0.00013570358,0.00004538881,0.00006017044,0.00028565963,0.00002064447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009997375,0.0003565581,0.922609,0.000010924599,0.00007374158,0.0014719779,0.00017869273,0.000020406547,0.000022065598,0.003275588,0.00042984425,0.07145126],"study_design_scores_gemma":[0.0047044437,0.0011768059,0.9363783,0.000009072894,0.00014416352,0.00032015343,0.0003164312,0.00004369276,0.00011596681,0.0012004484,0.055503294,0.00008722369],"about_ca_topic_score_codex":0.00043032685,"about_ca_topic_score_gemma":0.001042194,"teacher_disagreement_score":0.07136404,"about_ca_system_score_codex":0.00090415817,"about_ca_system_score_gemma":0.0005161552,"threshold_uncertainty_score":0.39779913},"labels":[],"label_agreement":null},{"id":"W3185037356","doi":"10.1016/j.ygyno.2021.07.027","title":"Hormone maintenance therapy for women with low-grade serous ovarian cancer in the front-line setting: A systematic review","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Health Sciences Centre; Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Medicine; Serous fluid; Ovarian cancer; Oncology; MEDLINE; Internal medicine; Systematic review; Population; Randomized controlled trial; Cancer; Gynecology","score_opus":0.04461794821240529,"score_gpt":0.3681142875515476,"score_spread":0.32349633933914235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185037356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021733515,0.9708037,0.000023083281,0.009068696,0.00031990928,0.019069383,0.00017848749,0.000048833328,0.00046619],"genre_scores_gemma":[0.000090377034,0.92149025,0.00058141124,0.008708681,0.00025772522,0.06772236,0.0001883048,0.000081910584,0.0008789552],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.994908,0.0012917226,0.0015037591,0.0009954345,0.00032055963,0.000980576],"domain_scores_gemma":[0.9945821,0.00272326,0.0012472973,0.0010716572,0.0002100866,0.00016558202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021241752,0.0008018956,0.0074459934,0.00014510052,0.000118571246,0.000036013444,0.0005034243,0.00060891925,0.00039514567],"category_scores_gemma":[0.000618079,0.00037707915,0.00054803037,0.0005850829,0.00012465553,0.00003882802,0.00006770824,0.00072817924,0.000030235917],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001241487,0.00182111,0.000021135318,0.58711654,0.0020494931,0.0016390895,0.00040182853,0.0000017968773,1.2602848e-7,0.00012570573,0.008488911,0.39821014],"study_design_scores_gemma":[0.004241678,0.00505662,0.00012805292,0.28979212,0.0043723476,0.0006720779,0.00026349048,0.0000034855084,1.2217383e-7,0.000038900016,0.69505274,0.00037833166],"about_ca_topic_score_codex":0.000060515522,"about_ca_topic_score_gemma":0.00041763452,"teacher_disagreement_score":0.68656385,"about_ca_system_score_codex":0.0035994907,"about_ca_system_score_gemma":0.0030272268,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W3190145293","doi":"10.1016/j.ygyno.2021.07.016","title":"Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Olaparib; Medicine; Tolerability; Adverse effect; Discontinuation; Internal medicine; Neutropenia; Nausea; Vomiting; Placebo; Oncology; Anemia; Ovarian cancer; Surgery; Cancer; Chemotherapy","score_opus":0.01888383592380004,"score_gpt":0.3414188082779412,"score_spread":0.32253497235414114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190145293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904302,0.0003290626,0.00018360383,0.0043789386,0.0003507877,0.003362216,0.000023879475,0.000015516163,0.0009258011],"genre_scores_gemma":[0.9943642,0.00033279264,0.0010744896,0.002239416,0.00004761852,0.0018456314,0.000055578446,0.0000094522775,0.000030846295],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99735916,0.0009977306,0.0007471813,0.00040175582,0.00019679077,0.00029741158],"domain_scores_gemma":[0.9961617,0.0029070403,0.00038222468,0.00025965806,0.00023448792,0.000054865504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013242575,0.00016722549,0.0011415058,0.00009942799,0.000042427473,0.000006980739,0.0000874211,0.0001941986,0.00030657306],"category_scores_gemma":[0.0019201885,0.000106663654,0.000074901356,0.00041785542,0.00039795454,0.00008315196,0.000026941154,0.00032351416,9.103993e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88499534,0.004983613,0.02786956,0.000064566484,0.000099148645,0.00044035382,0.003762201,0.00024345811,0.0004529977,0.00042665916,0.00016781614,0.07649431],"study_design_scores_gemma":[0.91324234,0.0034384232,0.080166794,0.00007857393,0.000077129625,0.000014741084,0.0006648155,0.0001931157,0.00021981035,0.00109192,0.00069995475,0.00011236953],"about_ca_topic_score_codex":0.00026865955,"about_ca_topic_score_gemma":0.003285401,"teacher_disagreement_score":0.07638194,"about_ca_system_score_codex":0.0004799962,"about_ca_system_score_gemma":0.00077630824,"threshold_uncertainty_score":0.43496177},"labels":[],"label_agreement":null},{"id":"W3192610771","doi":"10.1016/j.ygyno.2020.05.346","title":"Dose dense carboplatin-paclitaxel improves survival in patients with endometrial cancer: Long term follow-up","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Carboplatin; Medicine; Paclitaxel; Endometrial cancer; Regimen; Oncology; Internal medicine; Adjuvant; Overall survival; Cancer; Urology; Chemotherapy; Gynecology; Cisplatin","score_opus":0.03425271829069047,"score_gpt":0.30756668606113174,"score_spread":0.27331396777044126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192610771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912439,0.0004520647,0.000008008963,0.0018891477,0.0016227473,0.0015865975,0.000056116616,0.00009594893,0.0030454881],"genre_scores_gemma":[0.99648076,0.00013252637,0.0002775055,0.0020112095,0.00047847483,0.00026988512,0.00009598116,0.00003395303,0.00021968558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741983,0.00024175667,0.0005732991,0.0006771435,0.00041659042,0.0006713808],"domain_scores_gemma":[0.9977889,0.0011090448,0.00025628574,0.00024468877,0.00016007182,0.00044101168],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024759077,0.00034888968,0.0011912588,0.0002454795,0.00007758506,0.000017097098,0.00019163197,0.0003391152,0.000917543],"category_scores_gemma":[0.0016785308,0.0002419961,0.00016320436,0.0011641732,0.0001449898,0.00009460473,0.00013750476,0.00046295236,0.000055907643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014197341,0.0009075629,0.88773805,0.00006740404,0.00026935496,0.000423593,0.00023056768,0.0000047857056,0.00035285775,0.000021740205,0.00010890075,0.09567782],"study_design_scores_gemma":[0.068984345,0.015904885,0.91326183,0.000023487219,0.00030283403,0.0000036796164,0.00007919056,0.000008763737,0.00019631599,0.000032104257,0.00095836766,0.00024418643],"about_ca_topic_score_codex":0.00044964673,"about_ca_topic_score_gemma":0.0016632763,"teacher_disagreement_score":0.09543364,"about_ca_system_score_codex":0.0009600351,"about_ca_system_score_gemma":0.00056093035,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W3194425665","doi":"10.1016/s0090-8258(21)00815-5","title":"Assessing cultural and linguistic diversity and distress screening completion in gynecologic oncology patients (iCALD)","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Interpreting and Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Family medicine; Portuguese; Distress; Mandarin Chinese; Limited English proficiency; First language; MEDLINE; Cancer; Health care; Internal medicine","score_opus":0.21147458761116839,"score_gpt":0.4902574206963298,"score_spread":0.27878283308516144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194425665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776926,0.00044051048,0.00012853392,0.0030675987,0.0010935299,0.00051157223,0.000020849124,0.00009794398,0.016946869],"genre_scores_gemma":[0.9925481,0.00043612358,0.0034477187,0.003035332,0.00010173362,0.000118471515,0.00015610759,0.000011729514,0.00014466674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937568,0.004117865,0.00076119514,0.000547627,0.00015192505,0.00066464307],"domain_scores_gemma":[0.99053895,0.007907509,0.00046291878,0.00030250484,0.00060181704,0.00018630965],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.001275661,0.00021396334,0.0006623633,0.000107133754,0.0029625192,0.000024993999,0.00025238196,0.00075677916,0.00033842245],"category_scores_gemma":[0.007448039,0.00019387243,0.000046275574,0.00022280516,0.0003618443,0.0001351629,0.002541695,0.0014553408,0.000021287187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006399985,0.00027775895,0.9589927,0.00013971566,0.000015935344,0.00008495117,0.0068235695,0.000007505594,0.000021722974,0.0015486144,0.0003610576,0.03166243],"study_design_scores_gemma":[0.001867797,0.0006279153,0.96344554,0.00014551874,0.000033738346,0.00001356521,0.015875326,0.00088519574,0.000001993877,0.0013658053,0.015525836,0.00021174335],"about_ca_topic_score_codex":0.0006276971,"about_ca_topic_score_gemma":0.0029408305,"teacher_disagreement_score":0.03145069,"about_ca_system_score_codex":0.0009825008,"about_ca_system_score_gemma":0.00031725652,"threshold_uncertainty_score":0.9983355},"labels":[],"label_agreement":null},{"id":"W3194498958","doi":"10.1016/s0090-8258(21)01166-5","title":"Sentinel lymph node biopsy versus complete lymphadenectomy in high grade endometrial cancer: a systematic review and meta-analysis of performance characteristics","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Biopsy; Lymphadenectomy; Meta-analysis; Radiology; Lymph node; Cancer; Oncology; Gynecology; Internal medicine; Breast cancer","score_opus":0.16495932654057635,"score_gpt":0.40053035709324336,"score_spread":0.235571030552667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194498958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005257704,0.9946982,0.0000019896204,0.00028424704,0.0005242199,0.0029667611,0.0007631323,0.000031151638,0.00020447523],"genre_scores_gemma":[0.0013243217,0.99390125,0.00020185488,0.0005606561,0.000097099124,0.0027199886,0.0009638259,0.000041487787,0.00018953341],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937181,0.0014209978,0.0028662684,0.0009420239,0.0004635044,0.000589128],"domain_scores_gemma":[0.9912381,0.0052597816,0.002265559,0.0007551411,0.00025097458,0.00023043915],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011155013,0.00079489837,0.027715974,0.0014951102,0.00006316852,0.000017653252,0.00035089467,0.00068136456,0.0018464492],"category_scores_gemma":[0.0025254688,0.00050800026,0.002813196,0.0053848913,0.00018798867,0.000046750276,0.00026555106,0.00038602945,0.00002036632],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014481274,0.0007621934,0.00060585793,0.7401632,0.24476005,0.00047184443,0.0000116819365,8.93172e-7,6.03705e-7,0.000059746653,0.0000111848985,0.013007935],"study_design_scores_gemma":[0.005908324,0.00036677066,0.0013539101,0.014113131,0.96383536,0.00012878397,0.000009065707,0.000008887757,3.2481736e-7,0.0000013950997,0.013887781,0.0003862738],"about_ca_topic_score_codex":0.00022377372,"about_ca_topic_score_gemma":0.000026669239,"teacher_disagreement_score":0.7260501,"about_ca_system_score_codex":0.0015061363,"about_ca_system_score_gemma":0.00096747675,"threshold_uncertainty_score":0.99973714},"labels":[],"label_agreement":null},{"id":"W3194607634","doi":"10.1016/s0090-8258(21)01205-1","title":"The effect of lymphadenectomy and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Lymphadenectomy; Hazard ratio; Internal medicine; Proportional hazards model; Surgery; Retrospective cohort study; Ovarian cancer; Chemotherapy; Adjuvant therapy; Cancer; Carcinoma; Gastroenterology; Oncology","score_opus":0.015443661846621095,"score_gpt":0.30436872045171476,"score_spread":0.28892505860509365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194607634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855869,0.0048628454,0.000001737251,0.0058182394,0.0003060345,0.0005819448,0.00001027822,0.000013092572,0.002818953],"genre_scores_gemma":[0.99585944,0.0030940268,0.00013664691,0.00047119363,0.000051860028,0.00012820215,0.00000877444,0.000012676728,0.00023718324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985369,0.0004043989,0.00027360316,0.0003633033,0.00013320957,0.0002886116],"domain_scores_gemma":[0.9950348,0.0044727437,0.00011012928,0.0002499472,0.00003466241,0.000097719625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005980404,0.00017512406,0.0006944236,0.00010673377,0.000075171025,0.000012131021,0.000056565943,0.00016882105,0.00013252714],"category_scores_gemma":[0.00054793444,0.00010590411,0.00006326544,0.0002666311,0.0001783743,0.000018719495,0.000057965754,0.00014974912,0.0000026639432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063209893,0.00041284415,0.86633086,0.000059730766,0.0001379749,0.0009669269,0.00014369797,0.0000022012755,0.0007643147,0.00092153717,0.00011061146,0.12951721],"study_design_scores_gemma":[0.01630301,0.008688292,0.94651854,0.000022655022,0.000088797606,0.00009349938,0.00015862328,0.00002311668,0.011369018,0.00009290603,0.016552651,0.000088896195],"about_ca_topic_score_codex":0.00012881674,"about_ca_topic_score_gemma":0.00045780753,"teacher_disagreement_score":0.12942833,"about_ca_system_score_codex":0.0003095728,"about_ca_system_score_gemma":0.0002152815,"threshold_uncertainty_score":0.4318644},"labels":[],"label_agreement":null},{"id":"W3195200333","doi":"10.1016/s0090-8258(21)00972-0","title":"Immune profiling of advanced, recurrent metastatic endometrial cancer using high-dimensional time-of-flight mass cytometry (CyTOF)","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Immune system; TIGIT; CD8; Mass cytometry; Immune checkpoint; Immunotherapy; Cancer research; Oncology; Immunology; Internal medicine; Biology","score_opus":0.04750107262733373,"score_gpt":0.3620725069446522,"score_spread":0.3145714343173185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195200333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836393,0.011092111,0.0002721159,0.0004559133,0.0023763748,0.0008521627,0.00017892182,0.00004037256,0.0010927168],"genre_scores_gemma":[0.93632686,0.0006677594,0.06185511,0.00023887717,0.00024304746,0.00011711104,0.00015860726,0.000031041465,0.00036157115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702734,0.00037402305,0.0010759458,0.0005277522,0.0004998691,0.00049507915],"domain_scores_gemma":[0.9962101,0.002002903,0.0006672933,0.0003498725,0.0005872984,0.0001825346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005386415,0.00029056348,0.0017309686,0.00049390085,0.000076917684,0.000004845306,0.00015335211,0.00023837357,0.004756985],"category_scores_gemma":[0.002376173,0.00022666626,0.00034324356,0.0019240818,0.00020113455,0.000074661766,0.00017030911,0.0003298173,0.00003101005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049912645,0.002752323,0.0084937215,0.00046349945,0.0014893872,0.00085006113,0.000063599975,0.0007694727,0.89461803,0.00031638614,0.000063332904,0.08512892],"study_design_scores_gemma":[0.036771886,0.010660084,0.016576078,0.00031778374,0.0025608328,0.0002610709,0.00028384864,0.0006567546,0.92806333,0.0013360803,0.0020089436,0.00050331734],"about_ca_topic_score_codex":0.000085452826,"about_ca_topic_score_gemma":0.000015094156,"teacher_disagreement_score":0.084625594,"about_ca_system_score_codex":0.00088392524,"about_ca_system_score_gemma":0.0013636405,"threshold_uncertainty_score":0.9961528},"labels":[],"label_agreement":null},{"id":"W3195241595","doi":"10.1016/s0090-8258(21)00656-9","title":"1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; BRCA mutation; Internal medicine; Oncology; Clinical endpoint; Ovarian cancer; Olaparib; Population; PARP inhibitor; Cisplatin; Chemotherapy; Phases of clinical research; Cancer; Randomized controlled trial","score_opus":0.016220450158818758,"score_gpt":0.33061010917231853,"score_spread":0.3143896590134998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195241595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923113,0.00096832414,0.00022290931,0.0022113041,0.0005159063,0.00300426,0.000040020936,0.0000602655,0.0006656971],"genre_scores_gemma":[0.9933257,0.0007957604,0.0026669907,0.002134335,0.00007906004,0.00073470897,0.0001735031,0.000028883249,0.00006105522],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99768484,0.00048043352,0.00060433923,0.0006838327,0.0002101227,0.00033642232],"domain_scores_gemma":[0.99722755,0.0018463472,0.0002898737,0.00029060495,0.00018838533,0.00015723179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039149448,0.0002816731,0.0013126879,0.00010658861,0.000121630634,0.000021472906,0.00006569319,0.00023693616,0.0008268187],"category_scores_gemma":[0.00040096635,0.00022728505,0.000051181803,0.00029736356,0.0003295453,0.00009386785,0.000047655038,0.00035134726,0.000002984011],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82172674,0.00493645,0.022149568,0.000019486182,0.0008122376,0.00079165684,0.0062188385,0.000041478143,0.00042027904,0.00005761358,0.000062884545,0.14276275],"study_design_scores_gemma":[0.8644645,0.008193548,0.1229471,0.000053250064,0.00027738325,0.000019987121,0.0010030912,0.000089877125,0.000111422865,0.00013737402,0.0024673378,0.0002351095],"about_ca_topic_score_codex":0.00017718339,"about_ca_topic_score_gemma":0.0010214787,"teacher_disagreement_score":0.14252764,"about_ca_system_score_codex":0.0005453692,"about_ca_system_score_gemma":0.000507091,"threshold_uncertainty_score":0.92684156},"labels":[],"label_agreement":null},{"id":"W3204649495","doi":"10.1016/j.ygyno.2021.08.030","title":"Characterization of patients with long-term responses to rucaparib treatment in recurrent ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre Hospitalier de l’Université de Montréal; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Loss of heterozygosity; Ovarian cancer; Oncology; BRCA mutation; Gastroenterology; Cancer; PARP inhibitor; Poly ADP ribose polymerase; Polymerase; Genetics; Gene; Allele; Biology","score_opus":0.03602718748914839,"score_gpt":0.3533486661188181,"score_spread":0.3173214786296697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204649495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485034,0.000090901354,0.00007698865,0.0029682722,0.00049763627,0.0008974925,0.00010825296,0.000024604165,0.0004855343],"genre_scores_gemma":[0.9962012,0.00030688907,0.0005929621,0.0013749901,0.000071089264,0.00059803214,0.0003008224,0.000014747311,0.00053922716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986803,0.00023062636,0.00036033773,0.00033404198,0.00014451171,0.00025020164],"domain_scores_gemma":[0.99904555,0.00018722568,0.00017614188,0.00023912932,0.00024680156,0.00010515803],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000117108626,0.00014910488,0.0004900317,0.00016235175,0.00003066856,0.000004645642,0.000053421787,0.00014919054,0.0015600112],"category_scores_gemma":[0.000119596974,0.00011579374,0.000043530952,0.00037063225,0.00006491163,0.000042153668,0.00002820746,0.00010093077,0.000016044913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037854747,0.002184779,0.9131271,0.000033727465,0.00007733348,0.00017696363,0.00062585814,0.0000065353715,0.022197807,0.00004591263,0.00004329617,0.057695165],"study_design_scores_gemma":[0.0064014955,0.005715629,0.965061,0.00008980409,0.000057130906,0.000009860754,0.000028753153,0.0000023524883,0.016167656,0.000014823316,0.0063422914,0.00010918747],"about_ca_topic_score_codex":0.000033327808,"about_ca_topic_score_gemma":0.0011268225,"teacher_disagreement_score":0.05758598,"about_ca_system_score_codex":0.0014952496,"about_ca_system_score_gemma":0.0009991305,"threshold_uncertainty_score":0.9993527},"labels":[],"label_agreement":null},{"id":"W3206717762","doi":"10.1016/j.ygyno.2021.09.025","title":"Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Center for Advancing Translational Sciences; Stranahan Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Amgen","keywords":"Medicine; Carboplatin; Placebo; Internal medicine; Clinical endpoint; Chemotherapy; Paclitaxel; Neutropenia; Ovarian cancer; Oncology; Multicenter trial; Progression-free survival; Gastroenterology; Surgery; Randomized controlled trial; Cancer; Pathology; Multicenter study; Cisplatin","score_opus":0.030084491948910434,"score_gpt":0.3480903884809034,"score_spread":0.31800589653199296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206717762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675232,0.002221278,0.000018787061,0.004282788,0.004925439,0.009414259,0.0005571422,0.000059537146,0.010997571],"genre_scores_gemma":[0.99055386,0.002015996,0.0020712428,0.00032942518,0.00049221993,0.0036396147,0.00017303933,0.00005123794,0.0006733887],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99269825,0.0018385787,0.0029692568,0.0010545288,0.00058735046,0.00085204956],"domain_scores_gemma":[0.98304534,0.013482195,0.001711466,0.0008474791,0.0005938846,0.00031961134],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002373504,0.000623046,0.0050535095,0.00042694784,0.00012305041,0.00001595417,0.00025671293,0.00074045575,0.0011078225],"category_scores_gemma":[0.014476493,0.000497421,0.0009890881,0.00065488555,0.00046828217,0.00009968191,0.00019713542,0.00062171853,0.00001028168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94853604,0.016725136,0.000317825,0.000108556575,0.0020527325,0.0018396184,0.0019304162,0.00019080397,0.001949882,0.00035186505,0.00056108,0.02543604],"study_design_scores_gemma":[0.9693875,0.018557217,0.0009262297,0.00020508561,0.0025013203,0.000017997798,0.00071420986,0.00080793997,0.0040666256,0.00015268655,0.002303674,0.00035956458],"about_ca_topic_score_codex":0.003548344,"about_ca_topic_score_gemma":0.008332286,"teacher_disagreement_score":0.025076477,"about_ca_system_score_codex":0.0014295895,"about_ca_system_score_gemma":0.003401231,"threshold_uncertainty_score":0.9998053},"labels":[],"label_agreement":null},{"id":"W3208966134","doi":"10.1016/j.ygyno.2021.10.080","title":"Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Meta-analysis; Oncology; Internal medicine; Serous fluid; Progression-free survival; MEDLINE; Randomized controlled trial; Surgery; Overall survival","score_opus":0.1514104611078758,"score_gpt":0.40087005714800295,"score_spread":0.24945959604012716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208966134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028503582,0.98413575,0.00001892734,0.0026101784,0.00051524566,0.011541577,0.0008576288,0.00005606076,0.00026175566],"genre_scores_gemma":[0.000099173354,0.97311,0.00085479196,0.0019343054,0.00014776182,0.021526733,0.0016002742,0.00007426962,0.0006526657],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99325716,0.0018823687,0.0023110176,0.0015866326,0.0002667627,0.00069605507],"domain_scores_gemma":[0.98957837,0.006666793,0.0018544832,0.0011613289,0.0003694856,0.00036955526],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018122903,0.0010312075,0.028736059,0.0005656929,0.00016080648,0.000043211574,0.00021749831,0.000885247,0.0017176146],"category_scores_gemma":[0.00145133,0.0006497461,0.007849718,0.0011564814,0.00015846408,0.000056665256,0.00017400675,0.0006472576,0.000031606938],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009454826,0.0008537181,0.000007172618,0.7168794,0.2493844,0.00071264425,0.000032943048,7.379866e-8,5.086928e-9,0.0001319585,0.004989258,0.026998926],"study_design_scores_gemma":[0.00042562417,0.0008436987,0.000029242981,0.011687531,0.7567037,0.00065992924,0.00003670657,6.082825e-7,1.5510234e-7,0.00002246614,0.22920081,0.00038955547],"about_ca_topic_score_codex":0.000031562813,"about_ca_topic_score_gemma":0.00011815755,"teacher_disagreement_score":0.7051919,"about_ca_system_score_codex":0.0017903945,"about_ca_system_score_gemma":0.0032826266,"threshold_uncertainty_score":0.9995954},"labels":[],"label_agreement":null},{"id":"W3211375066","doi":"10.1016/j.ygyno.2021.10.088","title":"Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Australia; Medical Research Council; Peter MacCallum Foundation; National Cancer Institute; Ovarian Cancer Australia; Deutsches Krebsforschungszentrum; Lon V. Smith Foundation; Bundesministerium für Bildung und Forschung; Memorial Sloan-Kettering Cancer Center; Medical Research and Materiel Command; University of Pittsburgh; U.S. Department of Defense","keywords":"Medicine; Endometriosis; Hysterectomy; Gynecology; Hormone therapy; Oncology; Ovarian cancer; Cancer; Internal medicine; Breast cancer; Surgery","score_opus":0.03902181364942791,"score_gpt":0.3791837189412126,"score_spread":0.3401619052917847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211375066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95416003,0.020685557,0.000010140408,0.017847376,0.00023978678,0.0008088951,0.000050038878,0.000051593463,0.006146563],"genre_scores_gemma":[0.95777416,0.03831827,0.0002603861,0.0015564171,0.00016004141,0.00036890834,0.000032835993,0.000014758075,0.0015142245],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979606,0.0005576785,0.00026150918,0.00034215493,0.00033684977,0.00054115534],"domain_scores_gemma":[0.98848456,0.010615239,0.00016041833,0.00025733668,0.00027641142,0.00020605304],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084416283,0.0001844787,0.00056418765,0.0001805565,0.00019450499,0.000044626333,0.000089932764,0.00024014614,0.0014348684],"category_scores_gemma":[0.009522521,0.00010097419,0.000103598504,0.0008478506,0.00007652194,0.000057890415,0.000093411094,0.00036108197,0.00004102659],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095916516,0.0019953214,0.31327006,0.00002276551,0.0035142414,0.0010804778,0.00043763945,0.0000046815962,0.05914145,0.00018612118,0.014408109,0.60497993],"study_design_scores_gemma":[0.011383954,0.008751141,0.8242684,0.000008189463,0.00021697939,0.00020175365,0.00019192966,0.000020636977,0.004826569,0.00026236995,0.14972147,0.0001466127],"about_ca_topic_score_codex":0.00032393693,"about_ca_topic_score_gemma":0.00034232347,"teacher_disagreement_score":0.60483336,"about_ca_system_score_codex":0.0019209608,"about_ca_system_score_gemma":0.0007504077,"threshold_uncertainty_score":0.999478},"labels":[],"label_agreement":null},{"id":"W3212808084","doi":"10.1016/j.ygyno.2021.11.006","title":"Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Cancer Research Society; Beth Israel Deaconess Medical Center; Terry Fox Research Institute; Eli Lilly and Company","keywords":"In vivo; In vitro; Cancer research; Receptor; Thrombospondin; Medicine; CD36; Pathology; Molecular biology; Biology; Internal medicine; Biochemistry; Metalloproteinase","score_opus":0.028219444994466287,"score_gpt":0.28613373744543236,"score_spread":0.2579142924509661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212808084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771965,0.0016460075,0.0000030910476,0.00011400673,0.000059989936,0.00028087382,0.0001208915,0.0000020219998,0.00005348189],"genre_scores_gemma":[0.9979988,0.0013422252,0.00037008635,0.0001362674,0.00001632664,0.000055165565,0.000012536873,0.000008792017,0.000059848255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989585,0.00025518227,0.0003188803,0.00025653132,0.00006004313,0.000150826],"domain_scores_gemma":[0.9994329,0.00006451683,0.00020317227,0.00020460339,0.000073885516,0.000020915491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027464327,0.00010631415,0.00031586032,0.000048109563,0.000028182316,0.000003566593,0.0001249761,0.00014740504,0.000028113944],"category_scores_gemma":[0.0002737017,0.00006953631,0.000028702163,0.00015193495,0.00022347926,0.000010702878,0.00019063932,0.00008658565,4.198992e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006348049,0.000246337,0.0060771042,0.00005677938,0.00001775324,0.0000022531387,0.00027402307,0.0030286391,0.98770887,0.000010324457,0.000008219109,0.0019348797],"study_design_scores_gemma":[0.0011813972,0.00046499204,0.044428665,0.000054328055,0.000012772383,0.000003321754,0.00086506805,0.0008435418,0.9518853,0.000014832638,0.00015311282,0.00009265908],"about_ca_topic_score_codex":0.00036163445,"about_ca_topic_score_gemma":0.0045141927,"teacher_disagreement_score":0.038351562,"about_ca_system_score_codex":0.000046017874,"about_ca_system_score_gemma":0.00029794843,"threshold_uncertainty_score":0.28356084},"labels":[],"label_agreement":null},{"id":"W3217140412","doi":"10.1016/j.ygyno.2020.05.070","title":"ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Olaparib; Pembrolizumab; Oncology; Internal medicine; PARP inhibitor; Ovarian cancer; Carboplatin; Chemotherapy; Regimen; BRCA mutation; Placebo; Gynecology; Cancer; Immunotherapy; Poly ADP ribose polymerase; Cisplatin; Pathology","score_opus":0.032601625682014336,"score_gpt":0.348120337627277,"score_spread":0.31551871194526265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217140412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742504,0.0004632201,0.0015227989,0.010944012,0.00040579014,0.0111369295,0.0004057939,0.00009427158,0.0007768048],"genre_scores_gemma":[0.98653215,0.0023742844,0.0029831685,0.0017786777,0.00046519254,0.0052986154,0.000098263365,0.000057885514,0.00041174534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997368,0.00018146676,0.0009691062,0.0006961948,0.00023188542,0.00055333995],"domain_scores_gemma":[0.99662936,0.0013936487,0.0010165063,0.00030839862,0.00038130573,0.00027076248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025471993,0.00045645397,0.0025300267,0.00013169646,0.000111737936,0.000006418509,0.0001459598,0.0003605955,0.00087651936],"category_scores_gemma":[0.0003092816,0.0003232794,0.00025008802,0.00027898676,0.00046640143,0.00008449998,0.00002371447,0.00020058481,0.00000230645],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8662546,0.0033303767,0.000048264385,0.00011698202,0.0011509301,0.00006205364,0.001954129,0.0005221433,0.024559107,0.00010793439,0.00028616044,0.1016073],"study_design_scores_gemma":[0.86868256,0.08017229,0.00022996002,0.000063271655,0.0005498094,0.00003656747,0.00027788413,0.0025988582,0.022370122,0.0001445664,0.024606321,0.00026779843],"about_ca_topic_score_codex":0.00011162789,"about_ca_topic_score_gemma":0.000280486,"teacher_disagreement_score":0.101339504,"about_ca_system_score_codex":0.001063002,"about_ca_system_score_gemma":0.0013176913,"threshold_uncertainty_score":0.9999219},"labels":[],"label_agreement":null},{"id":"W32354470","doi":"10.1016/j.ygyno.2020.04.693","title":"The Structure of Reality in a Cadaster","year":2000,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"3D Modeling in Geospatial Applications","field":"Engineering","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hamilton Health Sciences","keywords":"Cadastre; Social reality; Construct (python library); Field (mathematics); Computer science; Political science; Epistemology; Mathematics; Philosophy; Law","score_opus":0.012315868577631638,"score_gpt":0.26021865333292055,"score_spread":0.2479027847552889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32354470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813376,0.00011597139,0.00041075097,0.000635957,0.00016019588,0.00022975703,0.000015752177,0.00007469792,0.017019289],"genre_scores_gemma":[0.99834746,0.00011178551,0.0012955164,0.00007713284,0.000027317112,0.000024698144,0.000004899294,0.000006977967,0.000104206534],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993643,0.000049203412,0.00024824988,0.0001005462,0.000049260514,0.00018842416],"domain_scores_gemma":[0.99936056,0.0003496865,0.000025794876,0.00022194251,0.000019647368,0.000022387332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013007902,0.00007073385,0.00014925194,0.000022103864,0.000039303755,0.00000365257,0.00019146307,0.000150529,0.00049148366],"category_scores_gemma":[0.00004200316,0.00005054095,0.000022314067,0.00012541152,0.000079236095,0.000018980612,0.000017266746,0.00017667303,0.000025587922],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002849844,0.000096019096,0.0035935594,0.000027420032,0.000032421765,0.000007693963,0.00067220145,0.50730413,0.005481024,0.0029692436,0.0036863706,0.4761014],"study_design_scores_gemma":[0.0016738231,0.0006229873,0.2546482,0.000015347963,0.0000437568,0.00003339903,0.00026713745,0.20854208,0.0033438269,0.070121646,0.46014586,0.0005419143],"about_ca_topic_score_codex":0.000092981965,"about_ca_topic_score_gemma":0.0040087616,"teacher_disagreement_score":0.47555947,"about_ca_system_score_codex":0.00012031519,"about_ca_system_score_gemma":0.00003375154,"threshold_uncertainty_score":0.5381401},"labels":[],"label_agreement":null},{"id":"W33890565","doi":"10.1016/j.ygyno.2007.11.016","title":"HPV genotyping in cervical cancer in Northern Thailand","year":2008,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Genotyping; Medicine; Cervical cancer; HPV infection; Genotype; Population; Cancer; HPV vaccines; Virology; Internal medicine; Gynecology; Oncology; Biology; Gene; Genetics","score_opus":0.057977640806470214,"score_gpt":0.3690063652032756,"score_spread":0.3110287243968054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W33890565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9003345,0.001287456,0.000006400395,0.004449228,0.0002058241,0.0004482176,0.0000039173783,0.000035145487,0.09322936],"genre_scores_gemma":[0.99592227,0.0010991099,0.0001102573,0.0019001835,0.00018924924,0.00018435111,0.00000830566,0.000014381302,0.00057186955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833363,0.00014813418,0.00034796185,0.00036701033,0.00020142854,0.0006018425],"domain_scores_gemma":[0.9990998,0.0004128586,0.000044652286,0.0001895883,0.0000894351,0.00016368926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000356035,0.00013629539,0.00054144225,0.00022840309,0.000059672664,0.0000035699663,0.00014751796,0.0003318728,0.0130050415],"category_scores_gemma":[0.00031206093,0.00010967865,0.00006494311,0.00046320946,0.00018432034,0.00003790659,0.00011352033,0.0006778718,0.00015963374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045094188,0.00038409416,0.8701487,0.000041608753,0.000012363498,0.0014613704,0.0004163356,0.000085139756,0.00010248759,0.00004070064,0.0002604896,0.12659577],"study_design_scores_gemma":[0.003511683,0.00077286205,0.9774428,0.0000062070226,0.000009242652,0.000088576846,0.0001222512,0.00029206296,0.000042187898,0.0002478355,0.017349094,0.000115187315],"about_ca_topic_score_codex":0.0016601697,"about_ca_topic_score_gemma":0.17070714,"teacher_disagreement_score":0.16904695,"about_ca_system_score_codex":0.0012579834,"about_ca_system_score_gemma":0.00091998436,"threshold_uncertainty_score":0.9878972},"labels":[],"label_agreement":null},{"id":"W4200040154","doi":"10.1016/j.ygyno.2021.11.016","title":"Pre-operative wait times in high-grade non-endometrioid endometrial cancer: Do surgical delays impact patient survival?","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Medicine; Endometrial cancer; Hysterectomy; Gynecologic oncology; Retrospective cohort study; Proportional hazards model; Cohort; Population; Internal medicine; Cancer; Gynecology; Surgery; Oncology","score_opus":0.025584818977977625,"score_gpt":0.35710342311657356,"score_spread":0.3315186041385959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200040154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97357535,0.0054512736,0.000012277981,0.0017623618,0.0025020437,0.0013433467,0.00020013939,0.00008163048,0.015071572],"genre_scores_gemma":[0.99244153,0.0040305783,0.00062303664,0.0005728132,0.0006466013,0.00057340314,0.00022705799,0.000039445807,0.0008455383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955489,0.00082566834,0.0009890172,0.0009838359,0.0006040222,0.0010485676],"domain_scores_gemma":[0.993408,0.0049946415,0.00029316003,0.00045233528,0.00033448447,0.00051737356],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00063372805,0.00051059446,0.0020305638,0.0007957076,0.00014219237,0.00004453972,0.0002269085,0.00064412085,0.01516324],"category_scores_gemma":[0.0025848495,0.00036273026,0.0004873313,0.0034524053,0.00019785782,0.00012914221,0.00028116125,0.00079836696,0.00016198082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016023686,0.013770396,0.6283799,0.00015704612,0.0025703423,0.025155533,0.0012599577,0.0009946586,0.0031971994,0.0012778022,0.0034590592,0.30375442],"study_design_scores_gemma":[0.13547403,0.042052545,0.7370531,0.00018096832,0.0010822112,0.0008074311,0.0011171225,0.00021916752,0.012485195,0.0014365441,0.06673982,0.0013518445],"about_ca_topic_score_codex":0.0019138812,"about_ca_topic_score_gemma":0.0012098146,"teacher_disagreement_score":0.30240256,"about_ca_system_score_codex":0.0032215326,"about_ca_system_score_gemma":0.0017663373,"threshold_uncertainty_score":0.99988246},"labels":[],"label_agreement":null},{"id":"W4200587280","doi":"10.1016/j.ygyno.2021.12.011","title":"Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Laparotomy; Incidence (geometry); Perioperative; Surgery; Odds ratio; Uterine cancer; Internal medicine; Cancer","score_opus":0.019480169252571043,"score_gpt":0.2949709049214511,"score_spread":0.27549073566888005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200587280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620369,0.0022301541,0.000042222586,0.0058106175,0.0019574976,0.0011941231,0.00009756089,0.00018039545,0.02645053],"genre_scores_gemma":[0.9737761,0.009103872,0.0012223116,0.012696266,0.00030106053,0.0005727065,0.00010101858,0.00007101451,0.0021556611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943374,0.00096632,0.0014503166,0.0013396465,0.00053521607,0.0013711179],"domain_scores_gemma":[0.99247164,0.004095353,0.0010762833,0.0012154203,0.0006844389,0.00045688235],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015490162,0.000632871,0.0039896,0.00037745028,0.00032820858,0.00002537543,0.0004067412,0.0011900939,0.0147172185],"category_scores_gemma":[0.0029357432,0.00055757735,0.0006850509,0.0008021333,0.00078306434,0.00015039665,0.0010272814,0.0007786363,0.0009180739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010441472,0.024491927,0.5936731,0.0011858684,0.0024610665,0.02156731,0.004682768,0.00014016664,0.0035571523,0.0009049262,0.16337374,0.18291779],"study_design_scores_gemma":[0.00210506,0.0063757254,0.82619685,0.00013577714,0.0013002071,0.00056055986,0.0006195545,0.00005941012,0.0073372354,0.001348819,0.15339987,0.00056093594],"about_ca_topic_score_codex":0.00033731273,"about_ca_topic_score_gemma":0.0022065241,"teacher_disagreement_score":0.23252371,"about_ca_system_score_codex":0.0020914888,"about_ca_system_score_gemma":0.0018806694,"threshold_uncertainty_score":0.9998598},"labels":[],"label_agreement":null},{"id":"W4205422786","doi":"10.1016/j.ygyno.2021.12.025","title":"Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck; AstraZeneca","keywords":"Medicine; Olaparib; Clinical endpoint; Internal medicine; Oncology; Adverse effect; Ovarian cancer; BRCA mutation; Tolerability; Progression-free survival; Discontinuation; Progressive disease; Population; Nausea; Chemotherapy; Cancer; Surgery; Clinical trial","score_opus":0.021674573050316847,"score_gpt":0.326532917806484,"score_spread":0.3048583447561672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205422786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807679,0.00036626015,0.000841031,0.0068339757,0.0016272158,0.0018154442,0.00024272577,0.00016165394,0.007343808],"genre_scores_gemma":[0.9800306,0.00034105446,0.0024231153,0.01353447,0.00021044967,0.001717189,0.00080968253,0.00004412569,0.00088931294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963952,0.0007812716,0.00090368313,0.0008291636,0.0004801754,0.0006105496],"domain_scores_gemma":[0.99789315,0.00060137635,0.0006505568,0.00041904746,0.00028597735,0.00014986655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008610321,0.00032768562,0.0011533174,0.0006752813,0.0002782915,0.00001290194,0.00020525351,0.00027983944,0.00352997],"category_scores_gemma":[0.0001890806,0.00031776677,0.0002475748,0.0017744997,0.00020460463,0.00011475058,0.00012239952,0.00083667727,0.000025160958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013383544,0.0056459154,0.8666165,0.00009710408,0.002817749,0.0010597659,0.007078984,0.017540809,0.0041020913,0.0008288783,0.011272814,0.06955586],"study_design_scores_gemma":[0.031178921,0.0044493256,0.9077471,0.000042424654,0.00037011204,0.00008937546,0.0007041898,0.0032059364,0.00032334047,0.00070480525,0.050666843,0.00051765004],"about_ca_topic_score_codex":0.00041451104,"about_ca_topic_score_gemma":0.00062097353,"teacher_disagreement_score":0.069038205,"about_ca_system_score_codex":0.0050744885,"about_ca_system_score_gemma":0.00091964705,"threshold_uncertainty_score":0.99992746},"labels":[],"label_agreement":null},{"id":"W4205495006","doi":"10.1016/j.ygyno.2022.01.014","title":"Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto; McMaster University; Women's College Hospital","funders":"","keywords":"BRCA mutation; Ovarian cancer; Odds ratio; Case-control study; Logistic regression; Confidence interval; Breast cancer; Population","score_opus":0.012383663538488278,"score_gpt":0.26789218494574685,"score_spread":0.25550852140725855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205495006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971329,0.00034033952,0.00035824397,0.0007222822,0.00020733583,0.0006284753,0.0001294403,0.000010447571,0.00047051779],"genre_scores_gemma":[0.9954894,0.0003211027,0.00086142105,0.00072542776,0.000061542254,0.0017328478,0.000025240535,0.00001540717,0.00076757406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839634,0.000683169,0.00022776102,0.00033310088,0.00011441159,0.0002452062],"domain_scores_gemma":[0.99875736,0.00047236745,0.00035310086,0.0002427413,0.00012894692,0.00004550273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006673917,0.00013001924,0.00026252217,0.00004290615,0.0002770082,0.000014057964,0.00018042659,0.00011930467,0.0006060519],"category_scores_gemma":[0.00046789178,0.00008091789,0.000034113247,0.00016963365,0.00072293676,0.0000073308224,0.00020111505,0.00020602469,7.977232e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056536887,0.0016570663,0.5639661,0.00011012272,0.0062740035,0.00033274933,0.04427994,0.08658618,0.03535772,0.0027309447,0.015419015,0.18674931],"study_design_scores_gemma":[0.019446844,0.011200704,0.8416532,0.000006749929,0.00043302422,0.00022578264,0.015894013,0.0009852406,0.00390866,0.0010921971,0.1046263,0.00052724977],"about_ca_topic_score_codex":0.00043065244,"about_ca_topic_score_gemma":0.0031099163,"teacher_disagreement_score":0.27768716,"about_ca_system_score_codex":0.00035171516,"about_ca_system_score_gemma":0.0006544188,"threshold_uncertainty_score":0.66358435},"labels":[],"label_agreement":null},{"id":"W4205664053","doi":"10.1016/j.ygyno.2022.01.003","title":"Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Hazard ratio; Proportional hazards model; Ovarian cancer; Multivariate analysis; Internal medicine; Oncology; Population; Gynecology; Cancer; Confidence interval","score_opus":0.037824588554583864,"score_gpt":0.37800112823011855,"score_spread":0.3401765396755347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205664053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856742,0.0007554048,0.0000041050716,0.0021242732,0.001242918,0.0031729545,0.0005673466,0.00014410389,0.006314706],"genre_scores_gemma":[0.993512,0.000053182146,0.00022883178,0.0018613393,0.00010209665,0.0032793547,0.00067597214,0.000046356156,0.00024086535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961581,0.0010008994,0.0007481055,0.0008790958,0.0005722246,0.0006415592],"domain_scores_gemma":[0.99641234,0.0018735072,0.0006131113,0.0006693206,0.00020587716,0.00022587024],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006258389,0.00043797307,0.0014864184,0.00028880194,0.00037934267,0.000012045856,0.00032160868,0.0002739997,0.007999096],"category_scores_gemma":[0.00031934804,0.0003416153,0.00043734428,0.00060375326,0.00009502165,0.00003964955,0.00020811048,0.0005891102,0.000017838232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017116345,0.014402445,0.94654214,0.000059821847,0.000626216,0.00048276928,0.0004335444,0.0038783322,0.00009824856,0.00004820127,0.0049459273,0.026770744],"study_design_scores_gemma":[0.0105599,0.072315715,0.9089148,0.00001199048,0.00049455464,0.000009003101,0.0009007477,0.000044176402,0.000023573017,0.000041981715,0.0064107208,0.0002728353],"about_ca_topic_score_codex":0.0038639659,"about_ca_topic_score_gemma":0.0015984032,"teacher_disagreement_score":0.057913274,"about_ca_system_score_codex":0.012656754,"about_ca_system_score_gemma":0.0022052259,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W4206171510","doi":"10.1016/j.ygyno.2022.01.012","title":"Clear cell carcinoma of the endometrium","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Meso Scale Diagnostics; Roche; GlaxoSmithKline; AstraZeneca","keywords":"Endometrial cancer; Clear cell carcinoma; Cabozantinib; Clear cell; Carcinoma; Clear cell renal cell carcinoma; Lenvatinib; Immunotherapy; Clinical trial","score_opus":0.026987396344618074,"score_gpt":0.2867312603082612,"score_spread":0.25974386396364313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206171510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9080767,0.00061019615,0.0000017910968,0.0022550516,0.0011050203,0.0005035853,0.00002600959,0.000021860931,0.08739976],"genre_scores_gemma":[0.99420977,0.000020036776,0.00016677327,0.0022166895,0.00007841335,0.00013524522,0.000008208205,0.000009749135,0.0031550927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871516,0.00027566764,0.0002710079,0.00021386126,0.00026857763,0.00025571056],"domain_scores_gemma":[0.9986959,0.000707792,0.00017449202,0.00029340666,0.00005131334,0.000077058256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030264465,0.000100562975,0.00039648172,0.00013477144,0.00016745988,0.0000016470415,0.00023330138,0.00008146564,0.006871537],"category_scores_gemma":[0.00036389183,0.00006264631,0.0001978527,0.0009182027,0.00011190655,0.000012526082,0.00037174032,0.00032493696,0.000033941757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055182707,0.010234784,0.84411067,0.00023986892,0.0003016544,0.0007889639,0.000874759,0.00017030993,0.022177072,0.002208102,0.022165533,0.09121],"study_design_scores_gemma":[0.012402466,0.020142311,0.67724985,0.0000019804118,0.00029597973,0.00014551205,0.00088381965,0.000015715983,0.011954548,0.000648008,0.2761238,0.00013601108],"about_ca_topic_score_codex":0.000090925285,"about_ca_topic_score_gemma":0.000011724933,"teacher_disagreement_score":0.25395826,"about_ca_system_score_codex":0.00059240736,"about_ca_system_score_gemma":0.00032021504,"threshold_uncertainty_score":0.9940363},"labels":[],"label_agreement":null},{"id":"W4210274145","doi":"10.1016/j.ygyno.2022.01.024","title":"Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Tolerability; Hazard ratio; Internal medicine; Oncology; Discontinuation; Placebo; Ovarian cancer; Cohort; PARP inhibitor; Confidence interval; Cancer; Adverse effect; Pathology","score_opus":0.026386577534941197,"score_gpt":0.3524282690015788,"score_spread":0.32604169146663764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210274145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954862,0.00004494266,0.00004403253,0.00064033153,0.00031270357,0.0027360127,0.00022222377,0.000021584594,0.00049196836],"genre_scores_gemma":[0.9986023,0.000021488104,0.00015637759,0.0006885123,0.000019173101,0.00039662994,0.00007739491,0.000014701537,0.000023441637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973027,0.0007726722,0.000765963,0.00048060404,0.0003585397,0.00031951416],"domain_scores_gemma":[0.9978547,0.0009007857,0.0005913502,0.0003602726,0.00019668412,0.00009619864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007608417,0.00020495136,0.0011604667,0.0004868347,0.00017795687,0.000004011613,0.00017699003,0.00009327274,0.00038920544],"category_scores_gemma":[0.00026965895,0.00014935713,0.00009337131,0.0021594716,0.00018781936,0.000034277473,0.00026622356,0.00044685043,5.2103127e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029122967,0.0097506875,0.87280047,0.000029063858,0.0029383604,0.00017544962,0.018109087,0.009984899,0.0029322002,0.00006292248,0.00018293655,0.05391093],"study_design_scores_gemma":[0.047788057,0.013075934,0.930646,0.00003954642,0.0012344867,0.0000052578584,0.0056530875,0.0003758405,0.00035361986,0.000015122836,0.00064345356,0.0001695887],"about_ca_topic_score_codex":0.0004805538,"about_ca_topic_score_gemma":0.0024788347,"teacher_disagreement_score":0.057845507,"about_ca_system_score_codex":0.0011373805,"about_ca_system_score_gemma":0.0003530767,"threshold_uncertainty_score":0.6090607},"labels":[],"label_agreement":null},{"id":"W4210762341","doi":"10.1016/j.ygyno.2022.01.019","title":"The impact of hysterectomy on oncological outcomes in patients with borderline ovarian tumors: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hysterectomy; Subgroup analysis; Serous fluid; Odds ratio; Confidence interval; Stage (stratigraphy); Meta-analysis; Cystectomy; Surgery; Gynecology; Internal medicine; Cancer; Bladder cancer","score_opus":0.083327293528366,"score_gpt":0.4058479429358419,"score_spread":0.32252064940747593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210762341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014465753,0.98743147,4.868735e-7,0.00086187373,0.00004715342,0.010580201,0.00022699339,0.000023635823,0.0006835093],"genre_scores_gemma":[0.0015037816,0.9892089,0.00010370426,0.0008268287,0.000010060156,0.007863767,0.000230946,0.000036731468,0.00021530938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99392337,0.0023868743,0.001989335,0.0007970872,0.0004186331,0.00048467537],"domain_scores_gemma":[0.98943955,0.007204799,0.002034346,0.0010188638,0.0001439611,0.00015848907],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016158267,0.0007690727,0.018281534,0.00043222145,0.00012640865,0.000019086796,0.00035023177,0.0003365804,0.002052778],"category_scores_gemma":[0.0014703665,0.00028437062,0.0030452134,0.0012614039,0.00017583116,0.000027797421,0.00018748481,0.00070689124,0.000011675221],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022848682,0.008731556,0.010793882,0.3644743,0.5804583,0.0005891131,0.00004709565,0.000009392539,8.568511e-10,0.00017596559,0.00042978342,0.034062155],"study_design_scores_gemma":[0.0021845251,0.01849652,0.020900268,0.0057112686,0.9217686,0.000037196947,0.000019836683,9.08751e-7,4.3973465e-9,0.000014246159,0.030551374,0.00031524626],"about_ca_topic_score_codex":0.00012317623,"about_ca_topic_score_gemma":0.00021018436,"teacher_disagreement_score":0.358763,"about_ca_system_score_codex":0.002146941,"about_ca_system_score_gemma":0.00095703895,"threshold_uncertainty_score":0.99996084},"labels":[],"label_agreement":null},{"id":"W4214768201","doi":"10.1016/j.ygyno.2022.02.016","title":"Hormonal therapy or chemotherapy for early-stage, low-grade endometrial cancer with malignant peritoneal cytology: A comparative effectiveness study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Hazard ratio; Endometrial cancer; Stage (stratigraphy); Internal medicine; Oncology; Confidence interval; Proportional hazards model; Population; Hysterectomy; Radiation therapy; Cancer; Hormonal therapy; Chemotherapy; Adjuvant therapy; Logistic regression; Gynecology; Urology; Surgery; Breast cancer","score_opus":0.09323535615252673,"score_gpt":0.40255486877185503,"score_spread":0.30931951261932833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214768201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886349,0.000687442,0.000067732304,0.00089812354,0.00094557216,0.007920425,0.00022268365,0.000107346554,0.0005158048],"genre_scores_gemma":[0.9823035,0.00019067909,0.00046929484,0.0012722764,0.0003662057,0.014584503,0.000053492917,0.00004239028,0.00071768084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966186,0.0009633851,0.00045737933,0.0008154966,0.00044830222,0.00069678016],"domain_scores_gemma":[0.99549407,0.0035206755,0.00030309387,0.00028997762,0.00018864071,0.00020352735],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00080649386,0.00041471826,0.0016529736,0.00032770255,0.00050389156,0.000019692165,0.00027773913,0.00017898442,0.0033978485],"category_scores_gemma":[0.00014486242,0.00025199508,0.00022603117,0.001083218,0.00026623136,0.00006089798,0.00011549904,0.00047643858,0.00000801455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4321854,0.03218422,0.46604213,0.00014158883,0.005788462,0.0022537012,0.004989293,0.00035103044,0.0056961384,0.00019106212,0.00058953057,0.049587436],"study_design_scores_gemma":[0.1342889,0.20532776,0.6213258,0.0000137494,0.00041518005,0.0001428159,0.0028003205,0.000046715435,0.0026240707,0.00010999613,0.032461207,0.0004434661],"about_ca_topic_score_codex":0.00061046256,"about_ca_topic_score_gemma":0.0004975682,"teacher_disagreement_score":0.2978965,"about_ca_system_score_codex":0.0015214124,"about_ca_system_score_gemma":0.00095664355,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W4214880063","doi":"10.1016/j.ygyno.2022.02.001","title":"Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Toronto; McMaster University; University of Saskatchewan; Université Laval; Université de Montréal; University of Manitoba; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Lymphadenectomy; Internal medicine; Cohort; Cancer; Adjuvant therapy; Oncology","score_opus":0.0416379413977208,"score_gpt":0.38998832251408355,"score_spread":0.34835038111636274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214880063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98008263,0.0046473546,0.0003803579,0.008017281,0.0008727083,0.0025763928,0.00007950484,0.000025050993,0.0033187417],"genre_scores_gemma":[0.99264276,0.000906757,0.0033311704,0.0014758874,0.00008691598,0.001461867,0.00006310079,0.00000845703,0.000023098697],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988008,0.00023014203,0.00027697659,0.00034925053,0.00011382236,0.00022901039],"domain_scores_gemma":[0.9986081,0.0010229539,0.00015683878,0.00009002185,0.000074151845,0.000047923564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047302214,0.00010117434,0.00034679947,0.00017621853,0.00008698895,0.000009133845,0.000050512237,0.00013647255,0.000106380525],"category_scores_gemma":[0.0017979218,0.00009205255,0.000035697467,0.0004395427,0.000043411736,0.000086051514,0.00015162272,0.0002234765,4.057671e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01699357,0.0023198056,0.012213359,0.00022037402,0.0002659439,0.00030766107,0.0038084013,0.00028002835,0.055548165,0.0046032513,0.00007880048,0.90336066],"study_design_scores_gemma":[0.14029205,0.03630198,0.7214105,0.000026115398,0.0014390592,0.00018048513,0.010698821,0.0029615953,0.0007337465,0.012484824,0.07284622,0.00062458176],"about_ca_topic_score_codex":0.0007957959,"about_ca_topic_score_gemma":0.0003581851,"teacher_disagreement_score":0.90273607,"about_ca_system_score_codex":0.001240045,"about_ca_system_score_gemma":0.00028657546,"threshold_uncertainty_score":0.3753794},"labels":[],"label_agreement":null},{"id":"W4214914029","doi":"10.1016/j.ygyno.2022.01.025","title":"Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Dissection (medical); Context (archaeology); Lymph node; Carcinoma; Stage (stratigraphy); Internal medicine; Cohort; Retrospective cohort study; Oncology; Radiology; Gastroenterology; Cancer","score_opus":0.02408915362501802,"score_gpt":0.2887236015184381,"score_spread":0.2646344478934201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214914029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566884,0.0020849383,0.000054774377,0.0031996602,0.0005299829,0.00075203757,0.00006757015,0.00003682101,0.0076053618],"genre_scores_gemma":[0.99715257,0.000040771105,0.00045413364,0.0014944334,0.00006133716,0.00035439408,0.00004252373,0.000014417161,0.00038543035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817544,0.0004933794,0.00028873153,0.00031176978,0.0004000095,0.00033064003],"domain_scores_gemma":[0.99661285,0.0026052373,0.00024702892,0.0003320776,0.00010495103,0.00009784934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005031561,0.00016564102,0.0005985791,0.00017772244,0.0001803334,0.0000048560873,0.00026346755,0.000106975225,0.0028564841],"category_scores_gemma":[0.00091485906,0.00009223719,0.0001445423,0.0010495265,0.0002652092,0.000026089996,0.0002459838,0.00036454902,0.000016473976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0320036,0.0074310056,0.83924645,0.00021119224,0.002877927,0.006965352,0.000991892,0.0034026029,0.022691796,0.0073573277,0.0064711464,0.07034973],"study_design_scores_gemma":[0.09601273,0.08787704,0.6293893,0.000031935564,0.0057624537,0.0022612696,0.0058677993,0.00039621882,0.029567499,0.0023529597,0.13946488,0.0010159422],"about_ca_topic_score_codex":0.00023008688,"about_ca_topic_score_gemma":0.000021163605,"teacher_disagreement_score":0.20985717,"about_ca_system_score_codex":0.000379558,"about_ca_system_score_gemma":0.00049307843,"threshold_uncertainty_score":0.99805504},"labels":[],"label_agreement":null},{"id":"W4214917025","doi":"10.1016/j.ygyno.2022.02.019","title":"The impact of preoperative imaging on wait times, surgical approach and overall survival in endometrioid endometrial cancers","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; McMaster University; Juravinski Hospital; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Lymphadenectomy; Endometrial cancer; Odds ratio; Hysterectomy; Preoperative care; Radical surgery; Surgery; Magnetic resonance imaging; Radiology; Cancer; Internal medicine","score_opus":0.02881757972054039,"score_gpt":0.3349664959630226,"score_spread":0.3061489162424822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214917025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94630355,0.0021765486,0.000002375009,0.0005266964,0.0005364981,0.0011729163,0.00007555127,0.000024995206,0.04918088],"genre_scores_gemma":[0.9981334,0.00058168813,0.00008712375,0.0001386178,0.00014228195,0.00038077607,0.000043195836,0.0000151579725,0.00047771275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731624,0.0008525205,0.00049203634,0.00044298513,0.00039096226,0.00050523697],"domain_scores_gemma":[0.99324954,0.006101751,0.00020929793,0.00022390592,0.00006324766,0.00015224265],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001321685,0.00023070532,0.0008851795,0.00046332538,0.00024316304,0.000013876242,0.00018833396,0.00009521968,0.0012277213],"category_scores_gemma":[0.0014254814,0.00013613675,0.00022203357,0.001200896,0.00025066923,0.000042730037,0.00024511153,0.0005971696,0.000003943324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04481218,0.0055007306,0.8042456,0.000059711518,0.0013145859,0.001534414,0.0010437954,0.003831299,0.00047158718,0.0067545464,0.0021799626,0.1282516],"study_design_scores_gemma":[0.09846338,0.05015748,0.82369536,0.00001789422,0.00028474611,0.0005290763,0.0019680625,0.0021420962,0.0002448931,0.0014723537,0.020481234,0.00054342137],"about_ca_topic_score_codex":0.0017421622,"about_ca_topic_score_gemma":0.000071269365,"teacher_disagreement_score":0.12770817,"about_ca_system_score_codex":0.0030916294,"about_ca_system_score_gemma":0.0007863515,"threshold_uncertainty_score":0.9996853},"labels":[],"label_agreement":null},{"id":"W4225534584","doi":"10.1016/j.ygyno.2021.11.020","title":"The accuracy of intraoperative frozen section examination of sentinel lymph nodes in squamous cell cancer of the vulva","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Micrometastasis; Frozen section procedure; Groin; Vulvar cancer; Lymph; Cancer; Radiology; Biopsy; Vulva; Sentinel lymph node; Surgery; Lymphadenectomy; Pathology; Metastasis; Breast cancer; Internal medicine","score_opus":0.02565469141825435,"score_gpt":0.3221864134949468,"score_spread":0.2965317220766925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225534584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987195,0.001058198,0.000005952839,0.0011126032,0.0005667772,0.0002979221,0.000013099216,0.000005254976,0.009745176],"genre_scores_gemma":[0.9984676,0.0005754,0.000060064936,0.00019137676,0.00007013518,0.0000724743,0.000008080833,0.0000052877085,0.00054956006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869895,0.0004130205,0.0004210013,0.00016113617,0.00015796098,0.00014792073],"domain_scores_gemma":[0.9968902,0.0022557683,0.00034668524,0.00018129969,0.00030151947,0.000024561205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034032238,0.000090087764,0.00038968006,0.000057046054,0.000049228496,0.000002245736,0.000102035876,0.00015096017,0.0003637184],"category_scores_gemma":[0.001749777,0.00004807723,0.000086630156,0.00055637665,0.00016805812,0.0000300187,0.00008014727,0.00013300801,0.0000013146522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009038348,0.0032223044,0.6487709,0.0003663103,0.00019362876,0.0000461901,0.0023417568,0.00032512873,0.17587422,0.0004612862,0.00013391646,0.16736047],"study_design_scores_gemma":[0.004002255,0.00034238584,0.87072027,0.000022343815,0.000109312015,0.000006112427,0.001012002,0.0000870425,0.12312081,0.00016078027,0.00037655528,0.000040141018],"about_ca_topic_score_codex":0.0005456941,"about_ca_topic_score_gemma":0.0006267391,"teacher_disagreement_score":0.22194931,"about_ca_system_score_codex":0.00035614727,"about_ca_system_score_gemma":0.00047811848,"threshold_uncertainty_score":0.39824614},"labels":[],"label_agreement":null},{"id":"W4226379735","doi":"10.1016/j.ygyno.2021.10.056","title":"Adoption of universal next generation sequencing for lynch syndrome screening in endometrial cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lynch syndrome; Endometrial cancer; Microsatellite instability; Medicine; Microsatellite; DNA sequencing; Oncology; Cancer; Gynecology; DNA mismatch repair; Computational biology; Internal medicine; Genetics; Biology; Gene; Colorectal cancer; Allele","score_opus":0.15301866005898618,"score_gpt":0.35190947026822134,"score_spread":0.19889081020923516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226379735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933614,0.0006983175,0.002300144,0.00062675774,0.0014207736,0.0007087067,0.000019228386,0.000024954092,0.00083972194],"genre_scores_gemma":[0.9743325,0.00023019814,0.02444431,0.0003111309,0.00022019575,0.00016364992,0.00008216842,0.00001466964,0.00020114401],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99862254,0.00015912949,0.0004079418,0.00034733862,0.00015729909,0.00030573126],"domain_scores_gemma":[0.9985565,0.00075102365,0.00018602281,0.00015956616,0.00027860593,0.000068280635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043232835,0.00012997951,0.00053475675,0.0002452074,0.000046533663,0.0000065550857,0.000075637,0.00033584554,0.0008652205],"category_scores_gemma":[0.0014159376,0.00012941519,0.0001049884,0.00052006025,0.00008256592,0.000066894405,0.000059939826,0.00020048166,0.000003505939],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011332324,0.00038081856,0.062934674,0.00021201426,0.00020358637,0.00066129694,0.00056800194,0.005982463,0.80838066,0.00037158467,0.0011090054,0.11806263],"study_design_scores_gemma":[0.056379948,0.031587645,0.4964999,0.0004631778,0.0013036034,0.0017654224,0.007463707,0.081102535,0.28706625,0.0010387348,0.033914592,0.0014144665],"about_ca_topic_score_codex":0.00015922415,"about_ca_topic_score_gemma":0.0016061176,"teacher_disagreement_score":0.52131444,"about_ca_system_score_codex":0.001475859,"about_ca_system_score_gemma":0.0015333397,"threshold_uncertainty_score":0.9473558},"labels":[],"label_agreement":null},{"id":"W4231137381","doi":"10.1016/j.ygyno.2018.04.345","title":"Uptake of sentinel lymph node procedures in women with vulvar cancer over time in population-based study","year":2018,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Vulvar cancer; Sentinel lymph node; Population; Vulvar neoplasm; Gynecology; General surgery; Vulva; Cancer; Surgery; Breast cancer; Internal medicine; Environmental health","score_opus":0.019859062903630265,"score_gpt":0.32755023987782683,"score_spread":0.30769117697419657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231137381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969778,0.00006570363,7.200323e-7,0.00040359382,0.000102813974,0.00078850973,0.000007949401,0.000026880985,0.0016260291],"genre_scores_gemma":[0.99762976,0.000007738561,0.00018058957,0.0013394743,0.00009253423,0.00048661645,0.0000094367715,0.000013908786,0.00023993602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855727,0.00011279666,0.00043114502,0.00033581912,0.00019525827,0.0003677162],"domain_scores_gemma":[0.9991873,0.00028811547,0.00016866568,0.00017632807,0.00009431154,0.00008526915],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002965321,0.0001612341,0.0006477119,0.000283051,0.000027785765,0.000003192626,0.00009181314,0.0001528582,0.0027055293],"category_scores_gemma":[0.00035666922,0.00011011462,0.000027446149,0.00078143616,0.00007486062,0.00003413182,0.000033555145,0.000111293215,0.000025688294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003607167,0.00301948,0.98784596,0.000051031384,0.00007376984,0.00010865092,0.00037703876,0.00009254595,0.0002405316,0.0000034146601,0.000024306308,0.004556131],"study_design_scores_gemma":[0.017436735,0.0032665269,0.9785793,0.000046290428,0.000059305967,0.0000026015005,0.0001721532,0.00011486668,0.000044245407,0.000058503814,0.00011785177,0.00010161786],"about_ca_topic_score_codex":0.0015471273,"about_ca_topic_score_gemma":0.003303852,"teacher_disagreement_score":0.013829568,"about_ca_system_score_codex":0.0012520622,"about_ca_system_score_gemma":0.0006073565,"threshold_uncertainty_score":0.99820614},"labels":[],"label_agreement":null},{"id":"W4232358837","doi":"10.1016/s0090-8258(21)01092-1","title":"Performance characteristics of brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed ovarian cancers","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto Metropolitan University; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Family history; Lynch syndrome; Ovarian cancer; Gynecology; Endometrial cancer; Cohort; Referral; Internal medicine; Population; Malignancy; Oncology; Cancer; Family medicine; DNA mismatch repair","score_opus":0.019972118393181297,"score_gpt":0.26570731657211827,"score_spread":0.24573519817893696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232358837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941996,0.00032248136,0.00020708343,0.001099065,0.00090724556,0.0010846447,0.000036581816,0.00004228087,0.0021010356],"genre_scores_gemma":[0.98674405,0.00015797542,0.007623592,0.0038300045,0.00007538501,0.00092441804,0.000028824032,0.000031482658,0.00058424694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814695,0.00010764104,0.0004946123,0.000488456,0.00020450883,0.0005578559],"domain_scores_gemma":[0.9984628,0.00040150565,0.00020808048,0.00035212372,0.00035458957,0.0002209224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038800098,0.00022108796,0.0008422386,0.00017306162,0.000041336476,0.0000039806723,0.00016695831,0.00030192066,0.00040281928],"category_scores_gemma":[0.0008692926,0.00020285932,0.00004906968,0.00032935556,0.00019584713,0.000044400174,0.00007883056,0.00025529062,0.000009916354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010314275,0.0015330723,0.6451339,0.0012108403,0.000385809,0.0029340559,0.0050139683,0.0011863069,0.018697405,0.00022894426,0.00954121,0.3038202],"study_design_scores_gemma":[0.003967622,0.0119338045,0.9444512,0.00017356095,0.00006083392,0.0001477976,0.00032641794,0.00017504378,0.000250863,0.00002166523,0.038272925,0.00021825584],"about_ca_topic_score_codex":0.00030472002,"about_ca_topic_score_gemma":0.0012403058,"teacher_disagreement_score":0.30360192,"about_ca_system_score_codex":0.0073669925,"about_ca_system_score_gemma":0.0041905525,"threshold_uncertainty_score":0.99644357},"labels":[],"label_agreement":null},{"id":"W4232790050","doi":"10.1016/j.ygyno.2020.05.477","title":"Predictors of Minimally Invasive Surgery for Uterine and Cervix Cancer from 2000 – 2017 in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Hospital; Hamilton Health Sciences","funders":"","keywords":"Medicine; Invasive surgery; Cervix; Uterine cervix; Perioperative; Cancer; Gynecology; Cervical cancer; General surgery; Surgery; Internal medicine; Carcinoma","score_opus":0.19670357645841588,"score_gpt":0.4199469549658884,"score_spread":0.22324337850747253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232790050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96914154,0.00014252652,0.000016105454,0.028880913,0.00063292653,0.00071763137,0.00022024362,0.0000115291705,0.00023655753],"genre_scores_gemma":[0.98555666,0.00023167056,0.0019471059,0.011595951,0.00018535383,0.00013684478,0.000213365,0.000011145705,0.00012190822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982916,0.000104075094,0.00091663346,0.00032521007,0.00012570151,0.00023674748],"domain_scores_gemma":[0.9902888,0.008854432,0.0004243797,0.0001210789,0.00014341793,0.00016791646],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037452937,0.00012730325,0.0006814962,0.0000464795,0.000023635048,0.0000032586522,0.00007641289,0.00015938938,0.0022128148],"category_scores_gemma":[0.007565594,0.0001158691,0.000053131553,0.00008658148,0.00007336688,0.000067756664,0.00008352477,0.00021780639,0.0000015632726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011980226,0.00015713424,0.91309375,0.00007772275,0.0001192908,0.00016709103,0.00044158785,0.000021247777,0.0011782937,0.00000263737,0.075475864,0.008067385],"study_design_scores_gemma":[0.0025558874,0.0015470167,0.86416554,0.000019199528,0.00015041976,0.000006004231,0.00048825232,0.00011205052,0.0002482961,0.000047585745,0.1305629,0.00009684785],"about_ca_topic_score_codex":0.94585717,"about_ca_topic_score_gemma":0.99869627,"teacher_disagreement_score":0.055087045,"about_ca_system_score_codex":0.0009895419,"about_ca_system_score_gemma":0.010746915,"threshold_uncertainty_score":0.9986993},"labels":[],"label_agreement":null},{"id":"W4235037090","doi":"10.1016/j.ygyno.2020.05.207","title":"Biomarkers of outcome with weekly paclitaxel in platinum-resistant high-grade serous or endometrioid ovarian carcinoma","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Ontario Institute for Cancer Research; Credit Valley Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Paclitaxel; Oncology; Internal medicine; Serous fluid; Ovarian carcinoma; Carcinoma; Ovarian cancer; Chemotherapy; Cancer","score_opus":0.05811571679446622,"score_gpt":0.3125169968771578,"score_spread":0.2544012800826916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235037090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96818423,0.00036646877,0.000040266732,0.026568793,0.00024746088,0.0013006913,0.00009108149,0.00007029416,0.0031306955],"genre_scores_gemma":[0.98885834,0.00007185106,0.008123592,0.0024067108,0.00009088674,0.0002257748,0.000040762625,0.000032499327,0.00014955559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997521,0.00021009355,0.0008192502,0.00062651414,0.0002772009,0.000545974],"domain_scores_gemma":[0.9974319,0.001440698,0.00037059258,0.00035804085,0.00008701688,0.00031178835],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00032391018,0.0003243866,0.0013345821,0.00029094703,0.00005270239,0.000009685849,0.0001842248,0.00031537493,0.0011202238],"category_scores_gemma":[0.00079764216,0.00020938368,0.00011090494,0.0010641494,0.00021041445,0.00005585923,0.00008998114,0.00030415674,0.00003767817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065336823,0.0020440773,0.9685014,0.0002448728,0.00056143507,0.0066254498,0.0005995317,0.000029459497,0.0015295256,0.00084570167,0.0013478531,0.0111369975],"study_design_scores_gemma":[0.020479986,0.028734947,0.94018745,0.000040399038,0.00037063358,0.00010471992,0.0008589662,0.000043741184,0.00096021337,0.000077129574,0.007897367,0.00024445282],"about_ca_topic_score_codex":0.001052085,"about_ca_topic_score_gemma":0.0019429228,"teacher_disagreement_score":0.028313968,"about_ca_system_score_codex":0.0008482265,"about_ca_system_score_gemma":0.0006693945,"threshold_uncertainty_score":0.9997929},"labels":[],"label_agreement":null},{"id":"W4237146049","doi":"10.1016/j.ygyno.2020.05.444","title":"Assessment of strategies to identify Lynch syndrome in women with synchronous endometrial and ovarian cancers","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Juravinski Hospital; Mount Sinai Hospital; Toronto Metropolitan University; University of Toronto; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre","funders":"","keywords":"Lynch syndrome; Medicine; Concordance; Endometrial cancer; Gynecology; Incidence (geometry); Ovarian cancer; Oncology; Endometrium; Population; Internal medicine; Cancer; DNA mismatch repair","score_opus":0.026610801387255714,"score_gpt":0.3481561937078521,"score_spread":0.3215453923205964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237146049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905121,0.00011765872,0.00026842995,0.0022909478,0.0003313619,0.0011050251,0.000012240388,0.000035670913,0.0053266156],"genre_scores_gemma":[0.99211425,0.000061349056,0.00606944,0.001344019,0.000058457415,0.00031561492,0.0000032343532,0.000017086331,0.000016537213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982937,0.00014180534,0.00041325676,0.00046113462,0.0002413172,0.00044876267],"domain_scores_gemma":[0.9987682,0.00052917836,0.00015237511,0.0001767296,0.00008115605,0.0002923711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003839411,0.0001923336,0.0008360862,0.00022965595,0.000030631967,0.000015450878,0.00014903824,0.00021142703,0.00082129246],"category_scores_gemma":[0.00042542684,0.00015580829,0.000028412023,0.0006818907,0.00019770721,0.00005321697,0.00012932098,0.0003036649,0.0000068518816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016427165,0.0017230667,0.7132488,0.0017073902,0.0015900083,0.0075142207,0.016452262,0.011633184,0.11992965,0.0019195202,0.0016314322,0.10622332],"study_design_scores_gemma":[0.0053463527,0.032206543,0.9571213,0.00003137489,0.00006169836,0.00014834212,0.0029279867,0.00011138443,0.00022259125,0.00013804738,0.0015119235,0.00017244322],"about_ca_topic_score_codex":0.00021564406,"about_ca_topic_score_gemma":0.0005383385,"teacher_disagreement_score":0.24387254,"about_ca_system_score_codex":0.0019043365,"about_ca_system_score_gemma":0.002246935,"threshold_uncertainty_score":0.89925766},"labels":[],"label_agreement":null},{"id":"W4240662635","doi":"10.1016/j.ygyno.2020.05.189","title":"Appendectomy at time of surgery for ovarian malignancy: An ACS-NSQIP propensity score-stratified analysis","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Malignancy; Propensity score matching; Gynecologic oncology; General surgery; Surgery; Complication; Internal medicine","score_opus":0.12877906336633343,"score_gpt":0.3203669317582048,"score_spread":0.19158786839187136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240662635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828343,0.00016913576,0.00018962429,0.011260063,0.00017670366,0.0017263688,0.00013144112,0.000097801,0.003414612],"genre_scores_gemma":[0.99346054,0.00004761879,0.0022757554,0.0026716643,0.0001617474,0.000322935,0.00046545017,0.00002257726,0.0005717121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978233,0.00021049516,0.0006314841,0.00070680963,0.00018953551,0.00043837822],"domain_scores_gemma":[0.9976674,0.0009498797,0.0003997923,0.00043612244,0.00021004405,0.00033677527],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000517809,0.00025848034,0.001618864,0.0001663077,0.00011462288,0.000011703242,0.00014655878,0.00032129136,0.0024777218],"category_scores_gemma":[0.00045193257,0.0002021817,0.0004403507,0.0006333117,0.00014317299,0.00007367088,0.00009383489,0.0001285391,0.00010163069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034215774,0.003247161,0.9443596,0.00036361872,0.004765828,0.0007771886,0.000800122,0.00008680494,0.0060005602,0.00076502346,0.017870938,0.017541546],"study_design_scores_gemma":[0.005273882,0.0059356852,0.94734424,0.00003035781,0.0055990065,0.000028712151,0.00008256004,0.000445406,0.013118992,0.00029545062,0.021457138,0.00038858133],"about_ca_topic_score_codex":0.000049232007,"about_ca_topic_score_gemma":0.00043806914,"teacher_disagreement_score":0.017152965,"about_ca_system_score_codex":0.00041725003,"about_ca_system_score_gemma":0.0006907489,"threshold_uncertainty_score":0.9984341},"labels":[],"label_agreement":null},{"id":"W4242322918","doi":"10.1016/j.ygyno.2010.12.072","title":"The vaginal radical trachelectomy: An update of a series of 125 cases and 106 pregnancies","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Urinary and Genital Oncology Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Trachelectomy; Medicine; Obstetrics; Fertility; Gynecology; Series (stratigraphy); Population","score_opus":0.05790385728639215,"score_gpt":0.3092382527841175,"score_spread":0.25133439549772535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242322918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876804,0.0038830019,0.000005103889,0.0016032049,0.00017549114,0.0003340938,0.0000102208705,0.000031257026,0.006277278],"genre_scores_gemma":[0.9961376,0.0010859751,0.001956819,0.00024797066,0.000040934814,0.000058377274,0.000004309292,0.0000074112813,0.0004605668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876136,0.00023868233,0.00038253018,0.00022616613,0.00009090415,0.000300357],"domain_scores_gemma":[0.99834305,0.0009993395,0.00021032966,0.0002164462,0.00013938361,0.00009142108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042574177,0.0001509322,0.000604582,0.000060265473,0.00017673816,0.0000023007635,0.0001335676,0.0002126124,0.00014029136],"category_scores_gemma":[0.0007727673,0.000092234055,0.00006640984,0.00012197846,0.0024270986,0.000104542734,0.00011276971,0.00021091521,0.0000042618326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012425871,0.0068302364,0.7903634,0.00048974744,0.0014201235,0.0035249658,0.010824272,9.1494104e-7,0.010044376,0.031160211,0.0032318637,0.12968402],"study_design_scores_gemma":[0.0024118358,0.055610485,0.8857567,0.000024773492,0.0005320995,0.0029324072,0.003693582,0.0000062646895,0.008522609,0.0039229067,0.03640981,0.0001765458],"about_ca_topic_score_codex":0.000037143705,"about_ca_topic_score_gemma":0.00055221905,"teacher_disagreement_score":0.12950748,"about_ca_system_score_codex":0.00004343701,"about_ca_system_score_gemma":0.0002612725,"threshold_uncertainty_score":0.8942746},"labels":[],"label_agreement":null},{"id":"W4242475944","doi":"10.1016/j.ygyno.2020.05.568","title":"Supported self-management as an innovative model of care for advanced gynecologic cancer patients with malignant bowel obstruction: A qualitative study","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Bridgepoint Active Healthcare; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Gynecologic cancer; Abandonment (legal); Ambulatory; Bowel obstruction; Cancer; Ambulatory care; Isolation (microbiology); Feeling; Population; General surgery; Intensive care medicine; Surgery; Health care; Internal medicine; Ovarian cancer","score_opus":0.036556141325561585,"score_gpt":0.3661343184453269,"score_spread":0.32957817711976534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242475944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144113,0.000031020652,0.00013687063,0.0011561974,0.00019741681,0.0045388644,0.00019882,0.00013490467,0.0021647874],"genre_scores_gemma":[0.9755799,0.000014764679,0.020512221,0.0018004914,0.00005047587,0.001637289,0.00021254129,0.00002722463,0.000165087],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99780816,0.0002260598,0.0006107691,0.00065602426,0.00027310898,0.00042587455],"domain_scores_gemma":[0.9969964,0.00043327277,0.0004448657,0.00021283027,0.001706441,0.00020617196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019182933,0.00030944837,0.00085339,0.000114314054,0.0001917493,0.000005934089,0.00018730211,0.00017957107,0.00028744552],"category_scores_gemma":[0.00038560882,0.00021634981,0.00007857958,0.00054578733,0.00016620033,0.00011350544,0.000108286535,0.00025611158,0.000009776295],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0327194,0.024298498,0.16967383,0.002583171,0.0027885437,0.00068337366,0.71947783,0.004500419,0.0040207985,0.005608851,0.00081392913,0.032831367],"study_design_scores_gemma":[0.030958243,0.28906426,0.17515805,0.0001181942,0.001589252,0.000017879642,0.4912054,0.0031507001,0.0021130878,0.0014530538,0.0041908207,0.0009810713],"about_ca_topic_score_codex":0.00004928582,"about_ca_topic_score_gemma":0.0002318075,"teacher_disagreement_score":0.26476574,"about_ca_system_score_codex":0.00045599884,"about_ca_system_score_gemma":0.0005328658,"threshold_uncertainty_score":0.88224894},"labels":[],"label_agreement":null},{"id":"W4243421328","doi":"10.1016/j.ygyno.2010.12.040","title":"Adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe?","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trachelectomy; Medicine; Cervix; Radical Hysterectomy; Adenocarcinoma; Cervical cancer; Gynecology; Obstetrics; Hysterectomy; Clear-cell adenocarcinoma; General surgery; Cancer; Surgery; Internal medicine","score_opus":0.06168132290839335,"score_gpt":0.3078981064924182,"score_spread":0.24621678358402488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243421328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87513894,0.001087678,0.000020005682,0.0035189518,0.00062069553,0.0005694705,0.000012485077,0.000036976002,0.11899478],"genre_scores_gemma":[0.993647,0.000068565954,0.0012337199,0.00355874,0.00012976419,0.00006121151,0.0000040740088,0.000011534305,0.0012853964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985742,0.000175367,0.00037201282,0.00029565764,0.00022050976,0.00036223952],"domain_scores_gemma":[0.99891204,0.00033305844,0.00016935171,0.00034272225,0.00008584337,0.00015697649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022153897,0.00016371049,0.0005551687,0.00008529268,0.00007384228,0.0000020289642,0.00026613797,0.0002957338,0.012037824],"category_scores_gemma":[0.00029129884,0.00009306925,0.00023025414,0.00045250545,0.00036197255,0.000029464996,0.00010524797,0.00032209186,0.00013353022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001839264,0.0030358536,0.88658315,0.00010259263,0.00045626573,0.0003172539,0.0012887096,2.1644867e-7,0.0017668902,0.001971985,0.0051549044,0.09748289],"study_design_scores_gemma":[0.0054464326,0.005052202,0.95361674,0.000011375067,0.000385841,0.00017905647,0.00010807795,0.0000052091195,0.011359457,0.0023277805,0.021404294,0.00010355995],"about_ca_topic_score_codex":0.00017588673,"about_ca_topic_score_gemma":0.000053318625,"teacher_disagreement_score":0.11850803,"about_ca_system_score_codex":0.00029361394,"about_ca_system_score_gemma":0.0003667803,"threshold_uncertainty_score":0.9888653},"labels":[],"label_agreement":null},{"id":"W4244927425","doi":"10.1016/j.ygyno.2020.05.348","title":"Predicting histologic upgrading in endometrial cancer","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Histology; Biopsy; Endometrial biopsy; Cancer; Gynecology; Radiology; Internal medicine","score_opus":0.07581862249942695,"score_gpt":0.35480007281025355,"score_spread":0.2789814503108266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244927425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.944757,0.0023862123,0.000026679474,0.01626632,0.0011784092,0.00083161384,0.000013949668,0.00018000111,0.03435981],"genre_scores_gemma":[0.9902636,0.0004981666,0.0007527416,0.007324127,0.00071468065,0.00024754799,0.000015036029,0.00001562156,0.00016849511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815214,0.00017251397,0.0004901529,0.00048706558,0.00019606446,0.0005020423],"domain_scores_gemma":[0.99825287,0.0011079133,0.0001667859,0.00012471963,0.0000512298,0.00029647662],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028186222,0.00019802565,0.0008364427,0.00023912461,0.00006663191,0.00000754084,0.00014720322,0.00030809623,0.002723814],"category_scores_gemma":[0.0033995472,0.00015235516,0.00014434718,0.0012129907,0.0000962015,0.000056459365,0.000101517755,0.00045738017,0.000102908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022809217,0.0006056005,0.86819744,0.000080366786,0.00014118681,0.001325791,0.00042744813,0.000059340797,0.0025102533,0.0003262201,0.0009322707,0.12311318],"study_design_scores_gemma":[0.064989656,0.02517018,0.7186965,0.000088146415,0.00070394354,0.00017008223,0.0009118803,0.0017672902,0.0021016293,0.0012832391,0.18337032,0.00074715284],"about_ca_topic_score_codex":0.0002892884,"about_ca_topic_score_gemma":0.0002422085,"teacher_disagreement_score":0.18243805,"about_ca_system_score_codex":0.0012281839,"about_ca_system_score_gemma":0.00034137702,"threshold_uncertainty_score":0.99818784},"labels":[],"label_agreement":null},{"id":"W4244983916","doi":"10.1016/j.ygyno.2016.04.081","title":"Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?","year":2016,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Sentinel lymph node; Lymphadenectomy; Cervical cancer; Biopsy; Lymph node; Surgery; Sentinel node; Lymph; Radiology; Cancer; Internal medicine; Pathology; Breast cancer","score_opus":0.034230704648923964,"score_gpt":0.3328582251664839,"score_spread":0.2986275205175599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244983916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95195985,0.0005520196,0.00016699018,0.036117617,0.0012941717,0.00092875655,0.00012011267,0.00022864439,0.00863184],"genre_scores_gemma":[0.98493123,0.00027015078,0.0013778254,0.004586552,0.00078630855,0.0011035403,0.000032039625,0.00004514225,0.006867218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743015,0.00014089575,0.0005266992,0.00077600277,0.0002581482,0.00086812093],"domain_scores_gemma":[0.996987,0.00168795,0.00023802216,0.0004343547,0.0002330361,0.00041962336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000312286,0.00033429978,0.00091269816,0.00019258671,0.00015386677,0.0000146245175,0.00023896797,0.00049164,0.0019823932],"category_scores_gemma":[0.0009156832,0.0002001971,0.00029978447,0.00044379037,0.00020159145,0.000060813698,0.00012227989,0.00010947393,0.00019276282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026627318,0.0009028176,0.90025514,0.0001215938,0.00040289495,0.00032280065,0.000071416536,0.000001301522,0.0065516615,0.0005522044,0.0015787268,0.0865767],"study_design_scores_gemma":[0.030457957,0.001418879,0.93446875,0.000069030444,0.00051967846,0.00021725173,0.000055756278,0.000018339655,0.0016876273,0.0016228436,0.029106984,0.00035691317],"about_ca_topic_score_codex":0.00060874294,"about_ca_topic_score_gemma":0.00016609994,"teacher_disagreement_score":0.08621979,"about_ca_system_score_codex":0.0019686783,"about_ca_system_score_gemma":0.0008148853,"threshold_uncertainty_score":0.9989299},"labels":[],"label_agreement":null},{"id":"W4246062211","doi":"10.1016/j.ygyno.2015.11.015","title":"Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part I","year":2015,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":462,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Gynecologic oncology; Surgery; General surgery","score_opus":0.08828822455311072,"score_gpt":0.40001240024519813,"score_spread":0.31172417569208744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246062211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9262668,0.0036437972,0.00041919923,0.05181037,0.0036558004,0.0029165547,0.00010311744,0.00021267726,0.010971714],"genre_scores_gemma":[0.9252902,0.008316557,0.016847497,0.03748391,0.0012236583,0.005215437,0.00089526566,0.00009312929,0.0046342914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956111,0.00097333896,0.0014070962,0.00087965745,0.00022372903,0.0009051306],"domain_scores_gemma":[0.9769289,0.020890148,0.00036211032,0.0003643396,0.0010295565,0.00042495725],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034479727,0.0004666783,0.00273337,0.00025892394,0.00015855227,0.000035434492,0.00012276135,0.0010812778,0.0005055845],"category_scores_gemma":[0.013022506,0.00037131616,0.0008363762,0.00039735867,0.00036810862,0.00020509707,0.00013602381,0.0004849625,0.000034899447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072946297,0.0014907221,0.25245494,0.00034431636,0.0007041227,0.0008700645,0.0060430723,0.00015094654,0.0002746489,0.00041783162,0.27483505,0.45511964],"study_design_scores_gemma":[0.0035389927,0.0035315605,0.081758685,0.00006687536,0.00026246562,0.00018578951,0.0062466995,0.00006554687,0.00020684733,0.0003486673,0.90326196,0.00052591565],"about_ca_topic_score_codex":0.000067246634,"about_ca_topic_score_gemma":0.001247514,"teacher_disagreement_score":0.6284269,"about_ca_system_score_codex":0.0014982523,"about_ca_system_score_gemma":0.0023508202,"threshold_uncertainty_score":0.9998739},"labels":[],"label_agreement":null},{"id":"W4247202882","doi":"10.1016/j.ygyno.2020.05.131","title":"Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Cytoreductive surgery; Epithelial ovarian cancer; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Ovarian cancer; Perioperative; Meta-analysis; Chemotherapy; Oncology; Randomized controlled trial; Internal medicine; Surgery; Cancer","score_opus":0.10950800586543047,"score_gpt":0.3990603436107306,"score_spread":0.28955233774530015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247202882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012645584,0.97262007,0.000010938692,0.013184599,0.00040089272,0.012631056,0.0008313718,0.00010731828,0.00008732604],"genre_scores_gemma":[0.00019205816,0.97270447,0.0009791235,0.0076583424,0.0001420015,0.017483294,0.0004711801,0.000080336555,0.0002892203],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942569,0.0012363407,0.0019891635,0.0015582159,0.00029144424,0.0006678969],"domain_scores_gemma":[0.99101216,0.006253198,0.0015507505,0.00062202895,0.00014251379,0.0004193569],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0014748482,0.0011250123,0.028137607,0.0003495553,0.00025791657,0.000039680177,0.00020756926,0.00092795695,0.0005845392],"category_scores_gemma":[0.00088755134,0.00067291,0.005535105,0.0007959626,0.00023393652,0.00007062679,0.00020347214,0.00047006292,0.000010943504],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087404274,0.00059911306,0.00038880558,0.49454924,0.44610214,0.00059304154,0.000083183164,2.3763043e-7,6.37868e-7,0.000024467005,0.0011868572,0.056384858],"study_design_scores_gemma":[0.0012255325,0.0010511372,0.0007909756,0.004136175,0.82859135,0.0001867133,0.00001632766,0.0000015156579,8.545726e-7,0.000020844202,0.16347922,0.0004993823],"about_ca_topic_score_codex":0.00015555794,"about_ca_topic_score_gemma":0.00019114427,"teacher_disagreement_score":0.49041307,"about_ca_system_score_codex":0.0032136806,"about_ca_system_score_gemma":0.0016488486,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W4248369251","doi":"10.1016/j.ygyno.2011.12.074","title":"Common screening criteria for lynch syndrome: Who are we missing?","year":2012,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Lynch syndrome; Medicine; Endometrial cancer; Family history; Colorectal cancer; Internal medicine; Oncology; Gynecology; Cancer; DNA mismatch repair","score_opus":0.09132939016601462,"score_gpt":0.3907375835558276,"score_spread":0.299408193389813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248369251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96493405,0.0031983808,0.0017901994,0.013527914,0.0034192228,0.0015810734,0.000038187405,0.00021007755,0.011300867],"genre_scores_gemma":[0.9674146,0.000113672446,0.02670579,0.003620246,0.0004639146,0.0003540454,0.000031730517,0.00004657288,0.0012493873],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783224,0.00019732647,0.00045127652,0.00039217263,0.00019180817,0.0009351653],"domain_scores_gemma":[0.9975977,0.0012523414,0.00025969918,0.00038516332,0.00014132161,0.000363795],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007301932,0.00028375958,0.0009615466,0.00014118478,0.00020064942,0.000017563016,0.00021191342,0.0005930177,0.0020713727],"category_scores_gemma":[0.00085050135,0.00024245775,0.00017923102,0.00019560439,0.0002218337,0.00008409058,0.00014856998,0.0003583293,0.0000670306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014970414,0.0018587718,0.49405444,0.0007956611,0.00042812858,0.00037807482,0.0013949021,0.000025137264,0.010599818,0.00041560252,0.22893059,0.25962186],"study_design_scores_gemma":[0.003335954,0.00593095,0.45174947,0.000157997,0.00031893578,0.0012725393,0.0005957606,0.00042619847,0.0022222644,0.00081272615,0.5327578,0.00041939036],"about_ca_topic_score_codex":0.000012970282,"about_ca_topic_score_gemma":0.000043952445,"teacher_disagreement_score":0.30382723,"about_ca_system_score_codex":0.00059333345,"about_ca_system_score_gemma":0.00021543534,"threshold_uncertainty_score":0.99884087},"labels":[],"label_agreement":null},{"id":"W4249718598","doi":"10.1016/j.ygyno.2020.05.349","title":"Prolonged waiting times for surgery in patients with endometrial cancer is associated with lymph-vascular space invasion but has limited effect on clinical outcome","year":2020,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Lymph; Oncology; Internal medicine; Surgery; Gynecology; General surgery; Cancer; Pathology","score_opus":0.10651323010684695,"score_gpt":0.3500466206170283,"score_spread":0.24353339051018136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249718598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901015,0.00012523743,0.000008727429,0.0055477787,0.00047128898,0.0032839987,0.000068704256,0.00011345976,0.00027929142],"genre_scores_gemma":[0.9922819,0.000043744345,0.00022181454,0.006055729,0.00031160243,0.0007512491,0.00021575742,0.00004669216,0.00007147989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964625,0.00075578707,0.00084283116,0.0008072779,0.00046850514,0.00066307513],"domain_scores_gemma":[0.9851792,0.013499257,0.00053765444,0.00022478534,0.00023474354,0.00032439886],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013294646,0.00038678883,0.0020343522,0.00030031672,0.00013066083,0.000021175145,0.0001337889,0.0005427789,0.00034543025],"category_scores_gemma":[0.016490407,0.00023232609,0.00031794276,0.0011777469,0.0001759021,0.00006520935,0.000068051304,0.00045508367,0.000027429964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028032335,0.0016990278,0.9417096,0.000084810024,0.0008028778,0.00016873499,0.00006119904,0.000020043843,0.000016014892,0.0000042354304,0.00050880335,0.026892338],"study_design_scores_gemma":[0.070887975,0.054090917,0.8720156,0.00013602887,0.00075644563,0.0000015838963,0.000026265714,0.00010216237,0.0002837459,0.000009500429,0.0014089186,0.00028088325],"about_ca_topic_score_codex":0.00009781524,"about_ca_topic_score_gemma":0.00014816079,"teacher_disagreement_score":0.06969401,"about_ca_system_score_codex":0.000980979,"about_ca_system_score_gemma":0.00059983163,"threshold_uncertainty_score":0.9917941},"labels":[],"label_agreement":null},{"id":"W4250684301","doi":"10.1016/j.ygyno.2013.04.155","title":"The wait time creep: Changes in the surgical wait time for women with uterine cancer in Ontario, Canada during 2000-2009","year":2013,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Uterine cancer; Cancer; Creep; Gynecology; Surgery; Internal medicine","score_opus":0.024404769521609943,"score_gpt":0.28972972267967684,"score_spread":0.2653249531580669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250684301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724365,0.00028716042,3.742022e-7,0.018113006,0.00013211017,0.0013184488,0.000020306901,0.00002001201,0.0076720705],"genre_scores_gemma":[0.97554266,0.000090323476,0.00009216348,0.00306217,0.00016728179,0.002094041,0.000011105832,0.000014486351,0.018925738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980261,0.00014597688,0.00032008305,0.00033880235,0.0002582834,0.0009107814],"domain_scores_gemma":[0.9985239,0.00085776,0.00012588347,0.00026958348,0.0000975945,0.00012528436],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066760584,0.00021044593,0.0005236247,0.000061753635,0.00016929132,0.000026464917,0.00033652858,0.00017505989,0.0059290924],"category_scores_gemma":[0.00011893689,0.000110701556,0.000032806114,0.00022077268,0.00013236751,0.00006768682,0.00007978359,0.0004426663,0.00003896345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008970943,0.0007545603,0.77351934,0.00018113763,0.000410245,0.006813878,0.007837191,0.0011103323,0.0024639675,0.00017529496,0.07790584,0.11985726],"study_design_scores_gemma":[0.00280115,0.0022363884,0.75661916,0.00003615374,0.000018247412,0.00020895671,0.00090899854,0.00020504225,0.000042177246,0.00012023699,0.23663291,0.00017060134],"about_ca_topic_score_codex":0.81275606,"about_ca_topic_score_gemma":0.9963703,"teacher_disagreement_score":0.18361428,"about_ca_system_score_codex":0.00442416,"about_ca_system_score_gemma":0.0023155275,"threshold_uncertainty_score":0.9993977},"labels":[],"label_agreement":null},{"id":"W4250686611","doi":"10.1016/s0090-8258(21)01068-4","title":"Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Cervical cancer; Brachytherapy; Stage (stratigraphy); Radiation therapy; Retrospective cohort study; Radiology; Cohort; Cancer; Oncology; Internal medicine","score_opus":0.08167160823317504,"score_gpt":0.38575108054162405,"score_spread":0.304079472308449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250686611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865393,0.0036183686,0.00029612248,0.0059982645,0.00086950324,0.0012287535,0.000053342963,0.00003530732,0.0013610072],"genre_scores_gemma":[0.9943851,0.0005576318,0.0014869017,0.0028204848,0.00018032514,0.0004414486,0.000036224574,0.000013303952,0.00007854842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982262,0.00036930625,0.0005030068,0.0003313629,0.0002093182,0.00036078758],"domain_scores_gemma":[0.99724126,0.0020587398,0.00023815755,0.00024247688,0.00015681359,0.000062537314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005354005,0.00017444209,0.0008315761,0.000088260174,0.00009045747,0.000009735992,0.000147298,0.00027279247,0.0002860568],"category_scores_gemma":[0.00039882466,0.000103076636,0.00019372816,0.00043188027,0.000072276765,0.000047157057,0.00004288251,0.00025542045,0.000003508085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015390413,0.0026774658,0.5389384,0.00035822263,0.00048899534,0.00034338504,0.0012828569,0.0007371908,0.005224748,0.0007460702,0.0002536942,0.44740996],"study_design_scores_gemma":[0.03047129,0.0063894005,0.939702,0.000116336116,0.00051988376,0.00009386986,0.0023501855,0.004146287,0.0044832216,0.0023133499,0.009077684,0.00033649872],"about_ca_topic_score_codex":0.00029145094,"about_ca_topic_score_gemma":0.0003767092,"teacher_disagreement_score":0.44707346,"about_ca_system_score_codex":0.0013215442,"about_ca_system_score_gemma":0.0007232437,"threshold_uncertainty_score":0.4203343},"labels":[],"label_agreement":null},{"id":"W4253972670","doi":"10.1016/j.ygyno.2014.03.046","title":"Nonradical surgery for small early-stage cervical cancer: Is it time?","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Radical Hysterectomy; Hysterectomy; Surgery; Cancer; Gynecology; Internal medicine","score_opus":0.06738680188905001,"score_gpt":0.34715781918320865,"score_spread":0.27977101729415865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253972670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8953258,0.00040396836,0.0005918582,0.06520397,0.0019790162,0.0017612245,0.00016055937,0.00022971915,0.034343917],"genre_scores_gemma":[0.93406814,0.00036875674,0.0028488874,0.035871007,0.0015308922,0.0010861793,0.0001266145,0.00005552494,0.024044024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977652,0.0001956436,0.0005237645,0.0005810225,0.00021352067,0.00072085316],"domain_scores_gemma":[0.9942591,0.004662241,0.00017962845,0.00032078015,0.00014826664,0.00042996963],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006866415,0.00027108338,0.0011382026,0.0001637885,0.00013395287,0.000015129899,0.00017495158,0.0005619947,0.012310143],"category_scores_gemma":[0.0013862723,0.0001819538,0.00039879867,0.000318163,0.00017890477,0.000036641377,0.000089194546,0.00028898867,0.00067319296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004191887,0.0030058199,0.20734164,0.00041556702,0.000798472,0.00027560547,0.00031920476,0.000007128821,0.00081845577,0.00053897925,0.10212983,0.6801574],"study_design_scores_gemma":[0.006909715,0.0052907565,0.12136573,0.000028272014,0.0003869856,0.000027580709,0.00003071628,0.0003602442,0.000712797,0.00069024035,0.86391014,0.00028680553],"about_ca_topic_score_codex":0.00031913337,"about_ca_topic_score_gemma":0.00026791854,"teacher_disagreement_score":0.7617803,"about_ca_system_score_codex":0.00057478365,"about_ca_system_score_gemma":0.00046408898,"threshold_uncertainty_score":0.98859274},"labels":[],"label_agreement":null},{"id":"W4255252333","doi":"10.1016/j.ygyno.2021.01.032","title":"Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448","year":2021,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Vancouver General Hospital","funders":"","keywords":"Medicine; Kingdom; Family medicine; Library science","score_opus":0.2013144971495261,"score_gpt":0.3988083380898772,"score_spread":0.1974938409403511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255252333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016504923,0.9724942,0.0000074637546,0.0039415667,0.00043291703,0.017612418,0.003749361,0.000056145353,0.00005542545],"genre_scores_gemma":[0.0035333664,0.971502,0.0024201397,0.00947577,0.00005268597,0.009944176,0.0025718154,0.00010669159,0.00039332657],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9863838,0.005200485,0.0038085624,0.0026186279,0.00086622016,0.0011223231],"domain_scores_gemma":[0.9885884,0.004974038,0.0023156248,0.0031058213,0.00038356296,0.0006325408],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004807206,0.0013653743,0.024193296,0.0013093873,0.000116176045,0.000060819504,0.0010977057,0.0014301728,0.0028892732],"category_scores_gemma":[0.0049670734,0.0008875496,0.0020917328,0.0033673246,0.000254232,0.000090590365,0.0011315298,0.0010295075,0.00006328871],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038682873,0.011701362,0.0021402186,0.5700643,0.28226718,0.014924947,0.0012246314,0.000004254342,6.474431e-7,0.0001652145,0.021174194,0.09594623],"study_design_scores_gemma":[0.0018029215,0.0061725453,0.010546805,0.014139507,0.86530083,0.0006558884,0.00013018394,0.00000552332,8.4215446e-7,0.0000104868695,0.10044884,0.0007856227],"about_ca_topic_score_codex":0.00020305262,"about_ca_topic_score_gemma":0.00045422703,"teacher_disagreement_score":0.5830336,"about_ca_system_score_codex":0.0019754602,"about_ca_system_score_gemma":0.0031166445,"threshold_uncertainty_score":0.9999097},"labels":[],"label_agreement":null},{"id":"W4280526636","doi":"10.1016/j.ygyno.2022.05.005","title":"Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Stand Up To Cancer Canada; Cure JM Foundation; Fondazione Guido Berlucchi; Honorable Tina Brozman Foundation; Deborah Bunn Alley Ovarian Cancer Research Foundation; Stand Up To Cancer; Gilead Sciences","keywords":"Olaparib; PARP inhibitor; Medicine; In vivo; Cancer research; Ovarian cancer; Apoptosis; Poly ADP ribose polymerase; Biology; Internal medicine; Cancer; Polymerase; Enzyme; Biochemistry; Genetics","score_opus":0.020725371044592197,"score_gpt":0.316739489115801,"score_spread":0.2960141180712088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280526636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97360075,0.0022012517,0.00035936362,0.019238584,0.0013586092,0.0017696668,0.000101083744,0.00015742723,0.0012132674],"genre_scores_gemma":[0.98961014,0.000099246565,0.0018442863,0.007022946,0.00017618625,0.0006360758,0.000111516085,0.000045104818,0.0004544983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959637,0.0010498433,0.0007812291,0.0010304039,0.0003973733,0.0007774833],"domain_scores_gemma":[0.9971502,0.0015688011,0.0003445372,0.0004516369,0.00014243033,0.0003424267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015638218,0.00039908243,0.0009993407,0.00046230637,0.00036108514,0.00002493584,0.00016732486,0.00039216568,0.0007393053],"category_scores_gemma":[0.00058214396,0.0003610352,0.0000907062,0.0009464468,0.00035452138,0.00012852356,0.00037441205,0.0013082912,0.000023714365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030726127,0.017704137,0.6390379,0.00033440418,0.00044492897,0.023058232,0.0067153014,0.0017437739,0.13769491,0.0045395303,0.012615958,0.12538478],"study_design_scores_gemma":[0.0381792,0.060130727,0.8338773,0.00015050216,0.00035450765,0.0083412025,0.0013156477,0.0014949423,0.01749105,0.0023423147,0.034749243,0.0015733307],"about_ca_topic_score_codex":0.00042442937,"about_ca_topic_score_gemma":0.0005787159,"teacher_disagreement_score":0.1948394,"about_ca_system_score_codex":0.0014316747,"about_ca_system_score_gemma":0.0006503717,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W4281739800","doi":"10.1016/j.ygyno.2022.05.011","title":"Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Sunnybrook Health Science Centre; Juravinski Cancer Centre; Trillium Health Centre; Children's Hospital of Winnipeg; Vancouver Coastal Health; Alberta Health; Health Canada; Centre hospitalier de l'Université Laval; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Hysterectomy; Stage (stratigraphy); Radical Hysterectomy; Retrospective cohort study; Surgery; Lymph node; Cancer; Gynecology; Urology; Internal medicine","score_opus":0.03422278134571292,"score_gpt":0.35635168269380896,"score_spread":0.322128901348096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281739800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922299,0.0004034927,4.2882778e-7,0.0023612748,0.00034898106,0.0032000851,0.0006022466,0.000029282059,0.00082433166],"genre_scores_gemma":[0.9970406,0.000032096897,0.00018969372,0.0009193912,0.00004153529,0.0014170583,0.0001193241,0.000031004525,0.00020927568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646735,0.0007311608,0.0008570933,0.00070767256,0.0005614873,0.00067521527],"domain_scores_gemma":[0.9971345,0.0013596938,0.0004545509,0.00030291584,0.00028690547,0.00046144333],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033931262,0.0004000244,0.0021734901,0.0005111812,0.00024157576,0.000018910494,0.00029367424,0.00020087467,0.0022487955],"category_scores_gemma":[0.00020789956,0.00030669596,0.00007395594,0.0012574629,0.00025286461,0.00007913936,0.00027033925,0.0006206902,0.0000061214055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00357271,0.0043606507,0.9846135,0.0001350474,0.00060746877,0.0001557538,0.0016599662,0.000029314398,0.000015152955,0.000014571053,0.00012626345,0.004709629],"study_design_scores_gemma":[0.035608683,0.03278931,0.9253025,0.00003176593,0.0005392079,8.8766654e-7,0.003561407,0.000010834917,0.00006601599,0.00002271292,0.0018046064,0.0002620582],"about_ca_topic_score_codex":0.039963525,"about_ca_topic_score_gemma":0.32054958,"teacher_disagreement_score":0.28058606,"about_ca_system_score_codex":0.0025318784,"about_ca_system_score_gemma":0.0019900124,"threshold_uncertainty_score":0.9999385},"labels":[],"label_agreement":null},{"id":"W4282945225","doi":"10.1016/j.ygyno.2022.05.012","title":"The five-factor modified frailty index predicts adverse postoperative and chemotherapy outcomes in gynecologic oncology","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Gynecologic oncology; Chemotherapy; Retrospective cohort study; Comorbidity; Logistic regression; Internal medicine; Surgery","score_opus":0.03174631769533264,"score_gpt":0.3246753326027804,"score_spread":0.29292901490744777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282945225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92851645,0.00031640704,0.000018850771,0.05363768,0.0015158806,0.0026263096,0.00008914394,0.00018665665,0.013092606],"genre_scores_gemma":[0.9735821,0.00045228587,0.00044431648,0.017274065,0.00008153817,0.0012894257,0.00004919492,0.000044759377,0.006782327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953416,0.0012999662,0.0009064208,0.0009241989,0.00045978278,0.0010680368],"domain_scores_gemma":[0.9926264,0.0058698677,0.00041343996,0.000641852,0.0001622047,0.0002862088],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011986276,0.0004969273,0.00135255,0.00029564282,0.00078937697,0.000020959027,0.0005702355,0.00064924697,0.0021993087],"category_scores_gemma":[0.002777439,0.00034849398,0.00018720808,0.00047861575,0.0008300275,0.00012477419,0.0007119576,0.0017980868,0.000051338517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041876733,0.004949966,0.7379723,0.00005764689,0.000750477,0.0030800966,0.010654517,0.0015035351,0.0011303149,0.0018107202,0.019266065,0.21463667],"study_design_scores_gemma":[0.012357956,0.012062622,0.7864964,0.0000065386935,0.000060548467,0.0003288803,0.0046135345,0.0016570331,0.00004565985,0.0011190721,0.18090102,0.00035072662],"about_ca_topic_score_codex":0.00021861978,"about_ca_topic_score_gemma":0.0024456407,"teacher_disagreement_score":0.21428594,"about_ca_system_score_codex":0.0029325085,"about_ca_system_score_gemma":0.0012855334,"threshold_uncertainty_score":0.9998967},"labels":[],"label_agreement":null},{"id":"W4283016037","doi":"10.1016/j.ygyno.2022.05.024","title":"Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; Cancer Australia; Cancer Research UK; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research; Australian Government","keywords":"Medicine; Quality of life (healthcare); Nausea; Ovarian cancer; Disease; Prospective cohort study; Physical therapy; Internal medicine; Cancer","score_opus":0.059053881260911906,"score_gpt":0.3400430872003277,"score_spread":0.2809892059394158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283016037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874659,0.004463513,0.0000062302547,0.0058208783,0.00028858078,0.000762868,0.0003751898,0.000020632277,0.0007961809],"genre_scores_gemma":[0.9985482,0.00040825424,0.000032239353,0.00055371906,0.000023645518,0.00029516258,0.000061993305,0.000009939594,0.00006686231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979473,0.0007621635,0.000597697,0.00029027864,0.0001641471,0.00023846455],"domain_scores_gemma":[0.9984361,0.00061161513,0.00056059944,0.0001634596,0.00010255933,0.00012568822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088778726,0.00015270637,0.00097008655,0.00011670724,0.00010866941,0.0000028556474,0.000059377857,0.00014323909,0.00029518854],"category_scores_gemma":[0.00018961453,0.000111950096,0.00004659657,0.0003535714,0.00017752578,0.000023762539,0.00007076162,0.00026229236,1.3547671e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009672105,0.0007315376,0.9162324,0.00007483771,0.0003514679,0.000009333148,0.012850979,0.000040199695,0.0000940991,0.001183204,0.00009143239,0.06737327],"study_design_scores_gemma":[0.0066645145,0.008516103,0.97529316,0.000035528312,0.00007850745,0.000012228094,0.0066865785,0.000038871713,0.000027675094,0.00020336293,0.002319607,0.00012383892],"about_ca_topic_score_codex":0.02526226,"about_ca_topic_score_gemma":0.13168107,"teacher_disagreement_score":0.1064188,"about_ca_system_score_codex":0.001347984,"about_ca_system_score_gemma":0.0017554299,"threshold_uncertainty_score":0.9812286},"labels":[],"label_agreement":null},{"id":"W4283071962","doi":"10.1016/j.ygyno.2022.06.002","title":"Social media in gynecologic oncology: A new frontier","year":2022,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Social media; Gynecologic oncology; Frontier; Medicine; Convention; The Internet; Family medicine; Public relations; Oncology; Internal medicine; Political science; Social science; Sociology; World Wide Web","score_opus":0.11250853145692091,"score_gpt":0.44768798791570286,"score_spread":0.33517945645878194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283071962","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033259508,0.0012736589,0.0000034775949,0.022192769,0.9078716,0.0036920123,0.00010410822,0.000412059,0.06112437],"genre_scores_gemma":[0.0020365866,0.003938475,0.0013185545,0.0013738071,0.97834605,0.008786561,0.0010055557,0.00013457557,0.003059815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9831938,0.008433954,0.0018660292,0.0017467933,0.0020543681,0.0027050525],"domain_scores_gemma":[0.8794247,0.11635431,0.0021634742,0.0006086841,0.0005518791,0.00089698954],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009187386,0.0007951094,0.0026947933,0.0009975238,0.0020663824,0.0000971814,0.0024839302,0.009545055,0.022891177],"category_scores_gemma":[0.16446775,0.000902858,0.0004261845,0.0019718956,0.0015367782,0.00027965524,0.0007321093,0.0064166454,0.0006417376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00013224718,0.0007690221,0.0010050397,0.00003709733,0.000048906317,0.00022488424,0.060143787,0.0000029481596,7.1352963e-7,0.0012791654,0.8054793,0.13087691],"study_design_scores_gemma":[0.002042478,0.0011863142,0.003946433,0.000012489094,0.0001435717,0.0000013432053,0.023448039,0.000001522276,2.541699e-7,0.011003561,0.9574359,0.0007780964],"about_ca_topic_score_codex":0.012822106,"about_ca_topic_score_gemma":0.25007138,"teacher_disagreement_score":0.23724927,"about_ca_system_score_codex":0.033525996,"about_ca_system_score_gemma":0.058593415,"threshold_uncertainty_score":0.9993422},"labels":[],"label_agreement":null},{"id":"W4283365026","doi":"10.1016/j.ygyno.2022.06.013","title":"Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group","year":2022,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; Stollery Children's Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; St. Baldrick's Foundation","keywords":"Medicine; Germ cell tumors; Frozen section procedure; Malignancy; Gynecologic oncology; Concordance; Immature teratoma; Pathology; Surgical pathology; Teratoma; Ovarian Teratoma; Germ cell; Radiology; Oncology; Surgery; Internal medicine; Chemotherapy","score_opus":0.03758485446169797,"score_gpt":0.32111924164978034,"score_spread":0.2835343871880824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283365026","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05391972,0.93999565,0.0000060646075,0.000117942596,0.00076523307,0.0035388223,0.0002736387,0.0000634921,0.0013194566],"genre_scores_gemma":[0.06460851,0.9323711,0.00032970213,0.00021661876,0.0003862681,0.0006526994,0.001326382,0.000048851143,0.000059875918],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99520767,0.0014481423,0.0014977533,0.0010563635,0.0002815074,0.0005085516],"domain_scores_gemma":[0.9944965,0.0025696731,0.0018614338,0.00080859184,0.000046927264,0.00021684782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008912753,0.0005499636,0.0029560833,0.0002504606,0.00014116065,0.00001078743,0.00028314418,0.00079025835,0.0008643017],"category_scores_gemma":[0.0009723086,0.00035910608,0.0005390084,0.00047618937,0.00020215749,0.000029482033,0.0004652042,0.0010288447,0.00001382995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017575306,0.0066632773,0.38296467,0.0031885938,0.0003353834,0.012051398,0.00008594781,3.6149913e-7,4.1512197e-7,0.000008477253,0.0016126342,0.5929131],"study_design_scores_gemma":[0.0021293224,0.002286588,0.6366801,0.0004280183,0.004864054,0.003336267,0.00007454609,0.000005380656,2.2327387e-7,0.00007702414,0.34985965,0.00025879615],"about_ca_topic_score_codex":0.00082545064,"about_ca_topic_score_gemma":0.0003035808,"teacher_disagreement_score":0.5926543,"about_ca_system_score_codex":0.0009549604,"about_ca_system_score_gemma":0.0024925168,"threshold_uncertainty_score":0.9998861},"labels":[],"label_agreement":null},{"id":"W4283809062","doi":"10.1016/j.ygyno.2022.06.017","title":"Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Manitoba; CancerCare Manitoba","funders":"National Cancer Institute; Merck Sharp and Dohme; Memorial Sloan-Kettering Cancer Center; Merck; AstraZeneca","keywords":"Olaparib; Medicine; Homologous recombination; Ovarian cancer; Oncology; BRCA mutation; Cancer research; Mutation; Internal medicine; Cancer; Genetics; Poly ADP ribose polymerase; Gene; Biology; Polymerase","score_opus":0.027858502885559872,"score_gpt":0.3588367873183201,"score_spread":0.33097828443276023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283809062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806196,0.00070710795,0.00073561084,0.0037171654,0.0005996893,0.0034515935,0.0005644599,0.00011791667,0.002044471],"genre_scores_gemma":[0.99032605,0.00022375712,0.0009693416,0.001506039,0.000055703615,0.0045970134,0.0011989892,0.000024921712,0.0010981591],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.997376,0.0005844866,0.000577711,0.0007337675,0.00025775592,0.00047028312],"domain_scores_gemma":[0.99809116,0.00084141066,0.00047536066,0.00026212027,0.000190702,0.0001392164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069457205,0.00026427535,0.00083541044,0.000422567,0.00087955606,0.00001461916,0.0000781218,0.0001727692,0.000903577],"category_scores_gemma":[0.0001641074,0.00024289273,0.00014958812,0.0007901409,0.00010914817,0.00008640582,0.000080768295,0.0002514439,0.0000026785954],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02043008,0.08319217,0.05529848,0.00012237717,0.00863863,0.0016703996,0.057362087,0.0025344868,0.044572454,0.00089224026,0.02520795,0.70007867],"study_design_scores_gemma":[0.23219158,0.4533137,0.13114838,0.000022094135,0.013770903,0.00055221055,0.031393025,0.005682518,0.007440542,0.0029526865,0.119901784,0.0016305703],"about_ca_topic_score_codex":0.00032693628,"about_ca_topic_score_gemma":0.00041704698,"teacher_disagreement_score":0.69844806,"about_ca_system_score_codex":0.0050595896,"about_ca_system_score_gemma":0.00062849786,"threshold_uncertainty_score":0.9987598},"labels":[],"label_agreement":null},{"id":"W4284992290","doi":"10.1016/j.ygyno.2022.06.026","title":"Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Cytoreductive surgery; Triage; Ovarian cancer; Retrospective cohort study; Surgery; Internal medicine; Cancer; Oncology; Emergency medicine","score_opus":0.07508663882871011,"score_gpt":0.350768034106301,"score_spread":0.27568139527759083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284992290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406874,0.00032872605,0.000012808938,0.001893814,0.00026992973,0.0017502337,0.0011954084,0.00003768642,0.00044264048],"genre_scores_gemma":[0.9968107,0.00021359,0.0013335035,0.00012443068,0.000022183829,0.0012841503,0.00014679607,0.000012030877,0.000052632116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980048,0.0003392478,0.0005788061,0.00058419944,0.00019035945,0.00030258173],"domain_scores_gemma":[0.9988789,0.0004570461,0.00016501307,0.00022615386,0.00007839083,0.0001945018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030404446,0.00022828931,0.00078544725,0.00017456867,0.00012776867,0.0000051026173,0.000059709182,0.000118366406,0.00029777596],"category_scores_gemma":[0.00018734756,0.0001678612,0.000060956387,0.00021892237,0.00021267342,0.00004590318,0.0001688996,0.00021959991,2.9421247e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019805438,0.0019561406,0.96724206,0.000028639717,0.00013308178,0.00008776307,0.001824046,0.0036959841,0.00021798264,0.0003241324,0.00012108398,0.022388548],"study_design_scores_gemma":[0.0067536435,0.015863968,0.9669644,0.00002192594,0.00014723478,0.000038665483,0.0019430631,0.0033861839,0.0003508706,0.00041336223,0.0039774454,0.0001391971],"about_ca_topic_score_codex":0.0027456416,"about_ca_topic_score_gemma":0.0031344364,"teacher_disagreement_score":0.02224935,"about_ca_system_score_codex":0.0032795796,"about_ca_system_score_gemma":0.0004890065,"threshold_uncertainty_score":0.85759866},"labels":[],"label_agreement":null},{"id":"W4285019171","doi":"10.1016/j.ygyno.2022.07.001","title":"Change in cancer-related fatigue over time predicts health-related quality of life in ovarian cancer patients","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Toronto Metropolitan University","funders":"","keywords":"Medicine; Cancer-related fatigue; Ovarian cancer; Quality of life (healthcare); Longitudinal study; Cancer; Internal medicine; Oncology; Pathology","score_opus":0.07613596340622944,"score_gpt":0.37187143149181684,"score_spread":0.29573546808558737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285019171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517215,0.002396862,3.860754e-7,0.006175458,0.001925946,0.0016836601,0.0002804246,0.00006976169,0.0022953644],"genre_scores_gemma":[0.99313825,0.0003551556,0.000013715636,0.004323073,0.00005209187,0.0015876098,0.00020422952,0.00002508356,0.00030078628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595326,0.0012462968,0.0013136828,0.0005053518,0.0003878637,0.00059357006],"domain_scores_gemma":[0.9982788,0.00042759598,0.000706214,0.00028072088,0.00010006308,0.00020658552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013483267,0.00022123122,0.0012324898,0.00036049736,0.000085169595,0.0000026080677,0.00020957357,0.0003480882,0.010180457],"category_scores_gemma":[0.00035505363,0.00021885232,0.00011074825,0.0010985278,0.00009849062,0.00006695358,0.00022097635,0.0008166973,0.000009529545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072879076,0.0019918894,0.97484267,0.0001774985,0.00009622417,0.0000471818,0.009271012,0.00021302319,0.00007814873,0.00013914108,0.0014355786,0.010978815],"study_design_scores_gemma":[0.008629127,0.0027590173,0.9830679,0.000057936442,0.000031612024,0.0000021180522,0.0003582001,0.00038665137,0.000008843647,0.000118088785,0.0043941373,0.00018634333],"about_ca_topic_score_codex":0.119553804,"about_ca_topic_score_gemma":0.11482707,"teacher_disagreement_score":0.010792472,"about_ca_system_score_codex":0.0038671342,"about_ca_system_score_gemma":0.001786705,"threshold_uncertainty_score":0.99995685},"labels":[],"label_agreement":null},{"id":"W4285045599","doi":"10.1016/j.ygyno.2022.06.005","title":"Health-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient endometrial cancer in the KEYNOTE-158 study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Discontinuation; Pembrolizumab; Quality of life (healthcare); Internal medicine; Microsatellite instability; Visual analogue scale; Population; Cancer; Oncology; Clinical endpoint; Physical therapy; Clinical trial","score_opus":0.029175932597797213,"score_gpt":0.32608960155268324,"score_spread":0.296913668954886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285045599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967737,0.0014916244,0.0000014609927,0.0009573832,0.00023320601,0.0072630546,0.000112128735,0.00007194753,0.00019183932],"genre_scores_gemma":[0.99715286,0.00014066801,0.0001425777,0.0008784079,0.00001745675,0.0014877362,0.00011829942,0.00002707559,0.000034918474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99322915,0.0030764423,0.0015352124,0.00079225155,0.00070977083,0.00065717945],"domain_scores_gemma":[0.996625,0.0015657599,0.0008666206,0.00061121624,0.00017743836,0.00015396251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023249718,0.00035279008,0.0018519743,0.00042630083,0.0001631511,0.0000069862867,0.00029365972,0.0001447253,0.00052559073],"category_scores_gemma":[0.00053611415,0.00020498899,0.00014077306,0.0029764732,0.0001978464,0.000059690126,0.00010722986,0.0006688452,0.0000021745325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07800295,0.01657982,0.8838482,0.00007805743,0.0002603549,0.000059966213,0.0034183876,0.0011606901,0.0000188357,0.000017661177,0.000008460804,0.016546622],"study_design_scores_gemma":[0.09861485,0.04959924,0.84956867,0.000025998941,0.000087759196,0.000003927543,0.0016183981,0.0000078436315,0.000012749332,0.00003906461,0.0002481121,0.00017336852],"about_ca_topic_score_codex":0.014532584,"about_ca_topic_score_gemma":0.013621002,"teacher_disagreement_score":0.034279503,"about_ca_system_score_codex":0.0029822113,"about_ca_system_score_gemma":0.001068056,"threshold_uncertainty_score":0.9920297},"labels":[],"label_agreement":null},{"id":"W4286515291","doi":"10.1016/j.ygyno.2022.07.002","title":"The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Radical Hysterectomy; Cervical cancer; Hysterectomy; Adenosquamous carcinoma; Stage (stratigraphy); Lymphovascular invasion; Retrospective cohort study; Surgery; Adjuvant therapy; Interquartile range; Adenocarcinoma; Cancer; Internal medicine; Metastasis","score_opus":0.11980001827245053,"score_gpt":0.39563727835698587,"score_spread":0.27583726008453535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286515291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877721,0.00018302782,1.2610145e-7,0.0017692465,0.0014302622,0.004841596,0.000029646611,0.000012592865,0.003961366],"genre_scores_gemma":[0.99656826,0.00011124097,0.000031531043,0.00039339135,0.000035010133,0.0024687473,0.000009124184,0.000014669391,0.0003680361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953637,0.002200862,0.00088169466,0.0004370907,0.00070472516,0.00041189423],"domain_scores_gemma":[0.98975474,0.009149597,0.00041050633,0.00053212646,0.00007493606,0.00007809352],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023968231,0.00022029215,0.0011670837,0.00014792926,0.00022849558,0.00001625004,0.0009591308,0.00007410092,0.0010468976],"category_scores_gemma":[0.00033325338,0.000119776,0.00017456648,0.000691669,0.00018063273,0.000043966273,0.0012586194,0.00041637276,0.0000048166307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013395704,0.016233742,0.9491185,0.00007907922,0.0016836517,0.0012396749,0.003401367,0.00002884887,0.0000075172024,0.00004549367,0.00016341233,0.014603001],"study_design_scores_gemma":[0.028193096,0.0149870645,0.8835045,0.000009758005,0.0005306142,0.0000016399837,0.0711284,0.000002876818,0.000011849738,0.000013252849,0.0015186032,0.00009834314],"about_ca_topic_score_codex":0.0043445597,"about_ca_topic_score_gemma":0.013758407,"teacher_disagreement_score":0.06772703,"about_ca_system_score_codex":0.00064779265,"about_ca_system_score_gemma":0.0003463856,"threshold_uncertainty_score":0.9998663},"labels":[],"label_agreement":null},{"id":"W4289525812","doi":"10.1016/j.ygyno.2022.07.020","title":"Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Subtyping; Logistic regression; Serous fluid; Ovarian cancer; Disease; Stage (stratigraphy); Internal medicine; Oncology; Multivariate analysis; Radiology; Serous ovarian cancer; Predictive value of tests; Cancer","score_opus":0.020715232957499198,"score_gpt":0.3221683117156931,"score_spread":0.3014530787581939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289525812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95644456,0.000809897,0.000032534557,0.036781903,0.0006319549,0.0038745012,0.000008814382,0.000059171878,0.001356684],"genre_scores_gemma":[0.9861267,0.000022101463,0.0013215196,0.0040247864,0.00012730582,0.008308925,0.000011366804,0.000025786054,0.000031465133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973807,0.0007456057,0.00037509596,0.00067258114,0.00034996012,0.0004760615],"domain_scores_gemma":[0.998719,0.00042327147,0.0001255166,0.0005166002,0.000082513565,0.00013310235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013642437,0.00021754405,0.0005224941,0.00015485543,0.00036177662,0.00001812305,0.00025204942,0.000035272467,0.00063285703],"category_scores_gemma":[0.00013984014,0.00014041121,0.00004382996,0.0007505501,0.00008891438,0.000037471193,0.0003729779,0.00062307215,0.0000053572385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017679479,0.0054181274,0.96532166,0.000020865573,0.00018409218,0.0018251897,0.003915206,0.0013323226,0.0006749668,0.00034244897,0.00027103993,0.018926136],"study_design_scores_gemma":[0.009689567,0.040854827,0.9220558,0.000021020189,0.00027380636,0.000081312,0.016929857,0.00020523608,0.00022108734,0.00034504288,0.009102836,0.0002196472],"about_ca_topic_score_codex":0.002108157,"about_ca_topic_score_gemma":0.0075839725,"teacher_disagreement_score":0.043265894,"about_ca_system_score_codex":0.0025317664,"about_ca_system_score_gemma":0.0009474748,"threshold_uncertainty_score":0.69293404},"labels":[],"label_agreement":null},{"id":"W4293559767","doi":"10.1016/j.ygyno.2022.08.006","title":"Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network; Princess Margaret Cancer Centre","funders":"Universitat Autònoma de Barcelona; Universitat de Barcelona; Eisai; Regeneron Pharmaceuticals; Princess Margaret Cancer Foundation; AstraZeneca; National Cancer Institute; Novocure; U.S. Department of Defense","keywords":"Medicine; Gemcitabine; Placebo; Tolerability; Internal medicine; Adverse effect; Common Terminology Criteria for Adverse Events; Brief Pain Inventory; Surgery; Physical therapy; Cancer","score_opus":0.0519709187733715,"score_gpt":0.32940325350043226,"score_spread":0.27743233472706075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293559767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781633,0.0000387457,0.000010672913,0.0003715683,0.00032952247,0.02063481,0.000021271531,0.000042596654,0.00038752682],"genre_scores_gemma":[0.99164164,0.000003763773,0.0019742786,0.00008825386,0.000034367396,0.00609196,0.00010977297,0.00003589692,0.000020093214],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992644,0.0017184586,0.0035680144,0.0008263151,0.0006172274,0.0006259721],"domain_scores_gemma":[0.9934737,0.002304986,0.0034361084,0.00041983614,0.00023580431,0.00012954885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043287394,0.0004340014,0.003757785,0.00068347127,0.0002100021,0.000014538662,0.00013978615,0.00022168763,0.0003438386],"category_scores_gemma":[0.0017739364,0.00027056647,0.00014105806,0.00087017985,0.00015277676,0.00013476743,0.0001913419,0.0006990952,3.9900902e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76217294,0.030486746,0.20033193,0.000095198506,0.00028228876,0.0008261149,0.0023685675,0.0018181487,0.000046435205,0.000033771736,0.0000036154777,0.001534249],"study_design_scores_gemma":[0.8613225,0.07252816,0.060181126,0.0001375544,0.00044972714,0.000019743085,0.00076634175,0.004186121,0.00006922282,0.00002139112,0.000052088202,0.00026600325],"about_ca_topic_score_codex":0.0016665909,"about_ca_topic_score_gemma":0.009424105,"teacher_disagreement_score":0.1401508,"about_ca_system_score_codex":0.004680276,"about_ca_system_score_gemma":0.003095775,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W4295025149","doi":"10.1016/j.ygyno.2022.07.017","title":"Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Toronto","funders":"KWF Kankerbestrijding","keywords":"Medicine; Sentinel lymph node; Vulvar cancer; Lymphadenectomy; Vulvar Carcinoma; Sentinel node; Stage (stratigraphy); Surgery; Basal cell; Lymph node; Vulva; Internal medicine; Cancer","score_opus":0.017137257789312615,"score_gpt":0.26580593719772183,"score_spread":0.24866867940840923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295025149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938876,0.00015522129,0.0000020209154,0.00067968504,0.00029518793,0.00084012945,0.00007481094,0.000051391704,0.004013976],"genre_scores_gemma":[0.9927269,0.00000712609,0.0005394437,0.004367865,0.000039636376,0.00022991159,0.00014628655,0.000037296388,0.0019055011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973259,0.00040471033,0.00051103474,0.0006486165,0.00039552056,0.0007141977],"domain_scores_gemma":[0.9987873,0.00034927623,0.00023123148,0.00029305104,0.00008861289,0.00025053392],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026460522,0.00035557384,0.0008807701,0.00038441396,0.00021044101,0.00002113034,0.00017702309,0.00012948025,0.001973405],"category_scores_gemma":[0.00007552856,0.00027457377,0.00009177019,0.00072222855,0.0001455896,0.00008891472,0.00033606638,0.0003296716,0.000023871864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002525918,0.0018477669,0.9919561,0.00008281758,0.000060599617,0.0015156674,0.00065094413,0.000056135515,0.000053663014,0.000030225192,0.00006483183,0.0011553431],"study_design_scores_gemma":[0.03962318,0.004577102,0.95276165,0.00000557806,0.00022701891,0.00005568067,0.00021893205,0.00011200179,0.000081659906,0.000075602744,0.0019844691,0.00027715496],"about_ca_topic_score_codex":0.0009164852,"about_ca_topic_score_gemma":0.000047753194,"teacher_disagreement_score":0.039194465,"about_ca_system_score_codex":0.0013020107,"about_ca_system_score_gemma":0.00035936324,"threshold_uncertainty_score":0.9999706},"labels":[],"label_agreement":null},{"id":"W4295226684","doi":"10.1016/s0090-8258(22)01548-7","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa, a novel engineered cytokine, in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (326)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pembrolizumab; Oncology; Internal medicine; Tolerability; Ovarian cancer; Carboplatin; Chemotherapy; Fallopian tube; Bevacizumab; Cancer; Immunotherapy; Cisplatin; Surgery; Adverse effect","score_opus":0.01954682296436472,"score_gpt":0.2973953425600409,"score_spread":0.2778485195956762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295226684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949939,0.00003014876,0.000017411121,0.0008060804,0.00030258173,0.0032932747,0.00029454677,0.000030527342,0.00023147967],"genre_scores_gemma":[0.9961483,0.000019858291,0.0010221503,0.0003682431,0.000037268346,0.0020916758,0.00020339522,0.000040374234,0.000068732224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771315,0.00018263808,0.0006138285,0.00058802764,0.00045403183,0.00044831162],"domain_scores_gemma":[0.9987999,0.00033334264,0.0003172238,0.00032372613,0.00012356586,0.000102250604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022238164,0.00031973672,0.00089619064,0.00029203246,0.000088603854,0.00000992592,0.00016099829,0.00012588297,0.0007556815],"category_scores_gemma":[0.000055394576,0.00023280672,0.000043352156,0.00056540297,0.000088590896,0.000076024895,0.0000845005,0.0004015972,0.0000010191675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21595345,0.091589734,0.6720445,0.00011753514,0.00069304963,0.0011487489,0.003538321,0.0021716661,0.00075882074,0.000062269915,0.00012822202,0.011793668],"study_design_scores_gemma":[0.24782048,0.061791893,0.6874438,0.000039546958,0.00016669395,0.000007492632,0.0008619707,0.00042322034,0.00006816097,0.0000012923161,0.0011889107,0.00018655937],"about_ca_topic_score_codex":0.0015015437,"about_ca_topic_score_gemma":0.009160836,"teacher_disagreement_score":0.031867016,"about_ca_system_score_codex":0.002985352,"about_ca_system_score_gemma":0.0009170695,"threshold_uncertainty_score":0.9493582},"labels":[],"label_agreement":null},{"id":"W4295226840","doi":"10.1016/s0090-8258(22)01519-0","title":"FLORA-5: A phase III double blind placebo controlled multicenter clinical study of front-line chemo-immunotherapy (paclitaxel and carboplatin +/- oregovomab) in patients with advanced epithelial ovarian cancer (GOG-3035) (298)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Internal medicine; Placebo; Phases of clinical research; Immunotherapy; Ovarian cancer; Front line; Double blind; Clinical trial; Cancer; Chemotherapy; Pathology; Cisplatin","score_opus":0.03521650387064424,"score_gpt":0.37107032392555556,"score_spread":0.3358538200549113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295226840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888214,0.0005690329,0.000010359567,0.0010100396,0.00071763195,0.008363954,0.00013628295,0.00003688638,0.00033440397],"genre_scores_gemma":[0.993572,0.00019964203,0.0007893025,0.0008330006,0.00011164044,0.0041997535,0.00007380203,0.00004246887,0.00017839133],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963764,0.0005742798,0.0012954468,0.00082423916,0.00041039282,0.0005192656],"domain_scores_gemma":[0.997502,0.000948561,0.00075300067,0.00042233357,0.00019329679,0.000180775],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009895187,0.00038959325,0.0020828645,0.00021223076,0.00017099133,0.000011889663,0.00017984366,0.00021178626,0.0014482099],"category_scores_gemma":[0.00014590888,0.00028374366,0.00013120112,0.00027339187,0.00019465694,0.00007449964,0.00016900826,0.00059507485,0.0000032601847],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40723014,0.04091571,0.4923152,0.000024497249,0.0013217361,0.00021719407,0.002086195,0.00037124753,0.00009939515,0.00001578661,0.00012964247,0.05527326],"study_design_scores_gemma":[0.67576283,0.05303828,0.26637596,0.00002587719,0.00054497836,0.0000046475993,0.0015866681,0.0004732252,0.000043073986,0.000012177714,0.0019067682,0.00022554556],"about_ca_topic_score_codex":0.0010831903,"about_ca_topic_score_gemma":0.0030232414,"teacher_disagreement_score":0.26853266,"about_ca_system_score_codex":0.0009298911,"about_ca_system_score_gemma":0.00058572565,"threshold_uncertainty_score":0.9999615},"labels":[],"label_agreement":null},{"id":"W4295227034","doi":"10.1016/s0090-8258(22)01435-4","title":"Antitumor activity and safety of dostarlimab therapy in patients with endometrial cancer by age subgroups: A post-hoc analysis from the GARNET trial (210)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Endometrial cancer; Interim analysis; Cohort; Post-hoc analysis; Microsatellite instability; Oncology; Regimen; Cancer; Interim; Post hoc; Clinical trial","score_opus":0.016719146559431283,"score_gpt":0.28326942977780095,"score_spread":0.26655028321836965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295227034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943766,0.0008404305,0.0000062109293,0.0008356509,0.0006606488,0.0022813482,0.0007701802,0.000020002757,0.00020891259],"genre_scores_gemma":[0.99768066,0.0004662918,0.00017233637,0.00084761594,0.00008030417,0.00048531714,0.000210905,0.000017855999,0.000038727674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973283,0.00085252203,0.00044785946,0.00053439505,0.0004605512,0.00037636622],"domain_scores_gemma":[0.99658614,0.002468689,0.00040302696,0.00036015708,0.00009913502,0.000082827784],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007076657,0.00023363331,0.0010640245,0.00025899863,0.00014361565,0.000009847009,0.00024677644,0.00016260364,0.003043386],"category_scores_gemma":[0.00042027357,0.00014941399,0.0001420504,0.0012536672,0.0003217102,0.000039538067,0.00021687946,0.00053361413,7.925966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34989637,0.0019665244,0.6069115,0.0000066722855,0.0010609378,0.00004765898,0.0007346713,0.00011195183,0.0019474205,0.0000036980393,0.0005539563,0.03675864],"study_design_scores_gemma":[0.10730519,0.04028569,0.8460335,0.0000035255712,0.0005014806,0.0000014110173,0.0002706288,0.000028746243,0.00022087149,0.000023423736,0.0051626107,0.00016290536],"about_ca_topic_score_codex":0.003817728,"about_ca_topic_score_gemma":0.0063076816,"teacher_disagreement_score":0.24259119,"about_ca_system_score_codex":0.0008975447,"about_ca_system_score_gemma":0.00052907673,"threshold_uncertainty_score":0.99786794},"labels":[],"label_agreement":null},{"id":"W4295227471","doi":"10.1016/s0090-8258(22)01493-7","title":"Are mismatch repair deficient endometrial cancer recurrences more salvageable than intact cohort? (272)","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Juravinski Hospital; McMaster University","funders":"","keywords":"Medicine; Lymphovascular invasion; Endometrial cancer; Cohort; Oncology; Lymph node; Immunohistochemistry; Internal medicine; Cancer; Urology; Pathology; Gastroenterology; Metastasis","score_opus":0.05038449561185216,"score_gpt":0.3525984938323121,"score_spread":0.30221399822045997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295227471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97345376,0.0044474746,0.000005963329,0.0057435343,0.004860216,0.0016237805,0.00020281589,0.0004918464,0.00917063],"genre_scores_gemma":[0.9895643,0.00067614036,0.0004780514,0.0046104603,0.0005144878,0.0021690761,0.00010439714,0.00003737418,0.0018457004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662846,0.0004980719,0.00062644575,0.00081456266,0.000672485,0.000759961],"domain_scores_gemma":[0.9971425,0.0013979357,0.0005770204,0.0004389058,0.00014641625,0.00029722124],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009589985,0.00032487966,0.0011312718,0.00041895043,0.0004941747,0.000016475886,0.0003171281,0.00031352753,0.0099933315],"category_scores_gemma":[0.0016448132,0.00025275743,0.00040519124,0.0016692135,0.00018310364,0.000059983886,0.00040005497,0.00095592864,0.000100727804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029599497,0.0028811237,0.928304,0.000090842055,0.00072513777,0.0014678554,0.00033457743,0.0002959426,0.00018562631,0.00013488898,0.028966093,0.033653967],"study_design_scores_gemma":[0.012067457,0.009582935,0.6071397,0.000028538814,0.00081137393,0.00018784402,0.0025390584,0.00008198648,0.00030769137,0.0005276709,0.3663013,0.00042440146],"about_ca_topic_score_codex":0.0010842459,"about_ca_topic_score_gemma":0.0004491257,"teacher_disagreement_score":0.33733523,"about_ca_system_score_codex":0.0026776593,"about_ca_system_score_gemma":0.00067397254,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W4296474625","doi":"10.1016/j.ygyno.2022.09.010","title":"Usability and acceptability of the electronic self-assessment and care (eSAC) program in advanced ovarian cancer: A mixed methods study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"National Comprehensive Cancer Network; AstraZeneca","keywords":"Medicine; Thematic analysis; Usability; Focus group; Qualitative research; Qualitative property; Family medicine; Patient-reported outcome; Quality of life (healthcare); Nursing","score_opus":0.016741173060730207,"score_gpt":0.40733876135255326,"score_spread":0.39059758829182306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296474625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232465,0.0016873897,0.000008436664,0.0011381331,0.00056020333,0.0035866038,0.000016619393,0.000058496877,0.00061944284],"genre_scores_gemma":[0.9937007,0.00012230537,0.0025112885,0.00017811905,0.000017502092,0.0034446388,0.000004521691,0.000010652745,0.000010296919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961835,0.0022621965,0.00040739143,0.0005527836,0.00019801651,0.0003961032],"domain_scores_gemma":[0.9985765,0.0006384606,0.00017962292,0.00043501722,0.000094868556,0.00007548908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018332901,0.00017134332,0.0006625757,0.00006586261,0.0001994801,0.000006361929,0.00018067916,0.000110200905,0.00047243127],"category_scores_gemma":[0.00014428893,0.00012666799,0.00007656001,0.00048519534,0.0001803254,0.00003396605,0.00056000997,0.00066732895,6.839545e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017779968,0.0011861695,0.587239,0.00007842464,0.000044485972,0.0000055220003,0.0060851495,0.000012901591,0.00008183096,0.000051514427,0.000004506101,0.40503266],"study_design_scores_gemma":[0.0030291122,0.007669783,0.9255544,0.0000024370531,0.00016289939,0.000012507635,0.05280058,0.00007734143,0.00005630003,0.0004029838,0.010123712,0.00010796792],"about_ca_topic_score_codex":0.001864073,"about_ca_topic_score_gemma":0.04951945,"teacher_disagreement_score":0.4049247,"about_ca_system_score_codex":0.0028977403,"about_ca_system_score_gemma":0.0013484186,"threshold_uncertainty_score":0.96782434},"labels":[],"label_agreement":null},{"id":"W4296875653","doi":"10.1016/j.ygyno.2022.09.008","title":"Trends in quality indicators of end-of-life care for women with gynecologic malignancies in Ontario, Canada","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Palliative care; End-of-life care; Retrospective cohort study; Population; Emergency medicine; Intensive care unit; Cancer; Gynecologic cancer; Internal medicine; Ovarian cancer; Nursing","score_opus":0.08154909507342287,"score_gpt":0.37952959423347166,"score_spread":0.29798049916004876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296875653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899049,0.00073776144,0.00000318793,0.0004188025,0.00025625623,0.0005759186,0.00016618919,0.000012334733,0.00792465],"genre_scores_gemma":[0.99718136,0.000037741695,0.00096099306,0.0005649769,0.000012483282,0.00066454854,0.00011909263,0.000013335836,0.00044547184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745494,0.0003639469,0.0009356426,0.00037816766,0.0003303937,0.00053688174],"domain_scores_gemma":[0.9968664,0.0019365366,0.00066102744,0.0002739145,0.0001386486,0.00012349144],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008336368,0.00021396572,0.0014713337,0.00062027905,0.000055242603,0.00000112583,0.000261791,0.00018904184,0.0023720616],"category_scores_gemma":[0.0009467835,0.0001793532,0.000085656255,0.0008286139,0.00027074464,0.000031403615,0.00014724156,0.00040243886,2.4438432e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014854872,0.0005474257,0.97288185,0.00025812947,0.00009412687,0.00011874279,0.012085127,0.00032923117,0.00020523726,0.0003475116,0.0005001772,0.011146978],"study_design_scores_gemma":[0.00451596,0.007379752,0.8635815,0.000037558584,0.000036429676,0.0000038706326,0.045732975,0.0000033502781,0.00044290276,0.00011649508,0.077979356,0.00016988056],"about_ca_topic_score_codex":0.6591608,"about_ca_topic_score_gemma":0.9910208,"teacher_disagreement_score":0.33185998,"about_ca_system_score_codex":0.0052084997,"about_ca_system_score_gemma":0.0073504644,"threshold_uncertainty_score":0.9986103},"labels":[],"label_agreement":null},{"id":"W4296906762","doi":"10.1016/j.ygyno.2022.08.020","title":"Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; BRCA mutation; Ovarian cancer; Germline mutation; Oncology; Internal medicine; Germline; Cancer; Serous fluid; Mutation; Gynecology; Genetics","score_opus":0.035754253583514875,"score_gpt":0.3307548590159046,"score_spread":0.29500060543238976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296906762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.908316,0.0003739256,0.0006375986,0.08121616,0.00392155,0.0033010426,0.00096318265,0.0001674878,0.001103062],"genre_scores_gemma":[0.9831894,0.000060275645,0.0023130905,0.007901194,0.0004739299,0.004568176,0.00035494147,0.00005041336,0.0010885958],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99769324,0.00024617187,0.00046811087,0.0007441551,0.0002710879,0.0005772156],"domain_scores_gemma":[0.99693346,0.0018467392,0.0003710114,0.00029808228,0.00027060136,0.00028013292],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049437804,0.00028704124,0.0008668135,0.0002703176,0.0004592714,0.000015961165,0.00009356637,0.0002094883,0.0010917814],"category_scores_gemma":[0.0006314663,0.00026936329,0.00024789255,0.0004547232,0.00010966805,0.00006141294,0.00012095382,0.00032527174,0.000018126455],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012741534,0.0061195,0.29249683,0.00039130758,0.0043777316,0.010150462,0.012502433,0.025059557,0.0014665955,0.003934053,0.40365854,0.22710145],"study_design_scores_gemma":[0.009841347,0.007925126,0.76147616,0.00006835874,0.0011214879,0.0005693912,0.012528837,0.0006050825,0.000986737,0.0008845257,0.20329979,0.00069313566],"about_ca_topic_score_codex":0.00046950765,"about_ca_topic_score_gemma":0.00075756974,"teacher_disagreement_score":0.46897936,"about_ca_system_score_codex":0.0042109312,"about_ca_system_score_gemma":0.0016188537,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W4298119685","doi":"10.1016/j.ygyno.2022.09.015","title":"Disparities in the survival of endometrial cancer patients in a public healthcare system: A population-based cohort study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Endometrial cancer; Socioeconomic status; Proportional hazards model; Retrospective cohort study; Cohort; Cancer; Internal medicine; Health care; Health equity; Hazard ratio; Population; Cohort study; Demography; Oncology; Ethnic group; Disease; Social determinants of health; Public health; Gerontology; Environmental health; Confidence interval; Pathology","score_opus":0.053753289288919745,"score_gpt":0.3486115584075396,"score_spread":0.29485826911861984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298119685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204046,0.00022003516,5.6782983e-7,0.0023070327,0.0011617935,0.0034343712,0.00010128193,0.00002263222,0.00071180303],"genre_scores_gemma":[0.99534637,0.000017039189,0.00001182463,0.0006304687,0.00006875227,0.0037374706,0.00016059267,0.0000098511255,0.000017619688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614376,0.0018763432,0.0006867289,0.0003294987,0.00060147204,0.00036221274],"domain_scores_gemma":[0.9971614,0.0021784161,0.0002655611,0.00022753769,0.000099968594,0.000067121466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016695932,0.00014678226,0.0008485695,0.00057041843,0.00012307733,0.0000069951325,0.00022404752,0.000095849646,0.00040705013],"category_scores_gemma":[0.0010624953,0.00010010915,0.00009255031,0.0018112692,0.00004388998,0.000032229156,0.00010027475,0.00037886505,0.0000016664098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011281209,0.0051857233,0.9903636,0.000089405534,0.0000627253,0.00009051781,0.00021772459,0.00008177868,7.528301e-7,0.00028649866,0.000024075422,0.0024690668],"study_design_scores_gemma":[0.016485311,0.008111539,0.97296673,0.0000100549705,0.000080046004,0.000002019517,0.0019222563,0.000036298872,6.939723e-7,0.00004923154,0.0002591054,0.00007668511],"about_ca_topic_score_codex":0.04597516,"about_ca_topic_score_gemma":0.03602049,"teacher_disagreement_score":0.017396852,"about_ca_system_score_codex":0.0029379872,"about_ca_system_score_gemma":0.0005007942,"threshold_uncertainty_score":0.98156965},"labels":[],"label_agreement":null},{"id":"W4304892381","doi":"10.1016/j.ygyno.2022.09.025","title":"Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Cotinga Pharmaceuticals; EQRx; Bayer Fund; Eisai; Meso Scale Diagnostics; Clovis Oncology; Roche; GlaxoSmithKline; AstraZeneca","keywords":"Medicine; Brachytherapy; Serous fluid; Carcinosarcoma; Serous carcinoma; Adjuvant therapy; Stage (stratigraphy); Internal medicine; Chemotherapy; Endometrial cancer; Radiation therapy; Oncology; Carcinoma; Surgery; Cancer; Ovarian cancer","score_opus":0.04753256803806285,"score_gpt":0.3339194070002304,"score_spread":0.28638683896216754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304892381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958508,0.0002495245,0.000010569528,0.0005151083,0.0003247054,0.001673251,0.000044253207,0.00006256612,0.0012692041],"genre_scores_gemma":[0.99432087,0.000039507282,0.0003636799,0.001542879,0.000059295024,0.0023771331,0.000018856761,0.000014944015,0.0012628414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820113,0.00029843018,0.0003037387,0.00043399824,0.00029658581,0.0004661047],"domain_scores_gemma":[0.9992623,0.00021106534,0.00010320622,0.00022695451,0.000049161474,0.00014735716],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040198155,0.0002061546,0.00064233755,0.00021989981,0.0001861615,0.0000068038726,0.0001551811,0.000071376344,0.0037285485],"category_scores_gemma":[0.00006236387,0.00013387382,0.00004445604,0.0005992626,0.000096316115,0.00004535767,0.00017132804,0.00039786147,0.000023629753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012712836,0.013546996,0.89828825,0.000017239983,0.00022909344,0.009212302,0.0032757574,0.00023806666,0.00023586364,0.000034353874,0.000027241604,0.062181994],"study_design_scores_gemma":[0.03653658,0.0645142,0.8786243,0.0000017429812,0.000023470026,0.00010467597,0.0024881037,0.000022407732,0.000015644133,0.000020624784,0.017518215,0.00013003442],"about_ca_topic_score_codex":0.0010458657,"about_ca_topic_score_gemma":0.000792058,"teacher_disagreement_score":0.06205196,"about_ca_system_score_codex":0.0023768586,"about_ca_system_score_gemma":0.00050218974,"threshold_uncertainty_score":0.9971822},"labels":[],"label_agreement":null},{"id":"W4306926620","doi":"10.1016/j.ygyno.2022.08.021","title":"Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"National Cancer Institute; Genentech; National Institutes of Health; PharmaMar; Seagen; NRG Oncology; Ipsen; Clovis Oncology; Gateway Foundation; Eisai; National Comprehensive Cancer Network; Regeneron Pharmaceuticals; Mersana Therapeutics; Shire; American Society of Clinical Oncology; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Internal medicine; Oncology; Clinical trial; PARP inhibitor; Loss of heterozygosity; Placebo; Randomized controlled trial; Polymerase; Pathology; Gene; Genetics; Poly ADP ribose polymerase; Biology","score_opus":0.038899492123703604,"score_gpt":0.33057337883320553,"score_spread":0.29167388670950195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306926620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293226,0.000112866524,0.0009135223,0.0025342472,0.00095217547,0.00108681,0.0012453127,0.000027304637,0.00019551573],"genre_scores_gemma":[0.98915976,0.00012981314,0.0056468905,0.0029476052,0.00017568689,0.0008411815,0.0009342426,0.000022274262,0.00014257162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814004,0.00020593265,0.00069066783,0.00047746554,0.00018121448,0.00030470188],"domain_scores_gemma":[0.9981637,0.00084638206,0.000419091,0.00027097433,0.00016106568,0.00013881113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025612098,0.00019439496,0.0008206252,0.00007482941,0.00015275468,0.000005084022,0.00011307833,0.000209007,0.001031247],"category_scores_gemma":[0.00020444475,0.00017671485,0.0001510756,0.000084547486,0.00031032469,0.00002534098,0.000102286824,0.00021516897,0.000003634018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037196467,0.0036579836,0.9242523,0.00003340691,0.0004354936,0.0001373192,0.00044010917,0.00002018227,0.005722274,0.006940955,0.0018564758,0.0527839],"study_design_scores_gemma":[0.01588806,0.011677186,0.94276565,0.000009875225,0.0001900348,0.000015387339,0.00010768242,0.00013217927,0.0007143487,0.0069191596,0.021421032,0.00015939481],"about_ca_topic_score_codex":0.000116677686,"about_ca_topic_score_gemma":0.000028087892,"teacher_disagreement_score":0.052624505,"about_ca_system_score_codex":0.00067713147,"about_ca_system_score_gemma":0.00033884903,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W4307721163","doi":"10.1016/j.ygyno.2022.10.015","title":"Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis","year":2022,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; Cancer Council Tasmania; Alberta Heritage Foundation for Medical Research; Medical Research Council; Canadian Institutes of Health Research; National Health and Medical Research Council; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; Fondation pour la Recherche Médicale; National Heart, Lung, and Blood Institute; Vetenskapsrådet","keywords":"Medicine; Endometrial cancer; Odds ratio; Overweight; Quartile; Prospective cohort study; Body mass index; Internal medicine; Epidemiology; Cancer; Eicosapentaenoic acid; Gynecology; Cohort study; Confidence interval; Polyunsaturated fatty acid; Fatty acid; Biology","score_opus":0.5258534039493777,"score_gpt":0.5167088666955231,"score_spread":0.009144537253854668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307721163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003995525,0.9846657,0.000007229954,0.0015699598,0.0021879966,0.0038838466,0.003501671,0.000045331133,0.00014274215],"genre_scores_gemma":[0.0076453174,0.98230237,0.0006891741,0.0012556205,0.00054686563,0.006976083,0.0005113839,0.000054781118,0.000018417559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9527582,0.039149042,0.0036616893,0.001642765,0.00080224086,0.0019860512],"domain_scores_gemma":[0.92056507,0.07439584,0.0033443503,0.0011396349,0.00012088846,0.0004342398],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.027024848,0.0009110471,0.014168774,0.0034628832,0.0005948208,0.00003091986,0.0017892703,0.0013850917,0.007595552],"category_scores_gemma":[0.025155654,0.00054838916,0.0030412215,0.0059641693,0.0013235135,0.00015477033,0.00071185833,0.0038776202,0.000012197634],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013141176,0.0012951861,0.02019437,0.0023507224,0.09335186,0.00016240554,0.0011777492,0.0002598369,0.000001571796,0.000102048456,0.00084227405,0.87894785],"study_design_scores_gemma":[0.0030607667,0.0062589208,0.010205257,0.000038708782,0.3518227,0.000030381423,0.0004930863,0.000038158178,0.0000023805844,0.000465533,0.6270155,0.0005686244],"about_ca_topic_score_codex":0.01266686,"about_ca_topic_score_gemma":0.030332826,"teacher_disagreement_score":0.8783792,"about_ca_system_score_codex":0.0011376737,"about_ca_system_score_gemma":0.0019729761,"threshold_uncertainty_score":0.9999113},"labels":[],"label_agreement":null},{"id":"W4307953076","doi":"10.1016/j.ygyno.2022.10.009","title":"Corrigendum to “Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes” [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36–45]","year":2022,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; McMaster University; Alberta Health Services; Juravinski Cancer Centre; University of Calgary; Impact; Centre Hospitalier de l’Université de Montréal; University of British Columbia; Hamilton Health Sciences; Dalhousie University","funders":"","keywords":"Medicine; Regret; Gynecologic oncology; Serous carcinoma; Serous fluid; Oncology; Internal medicine; Clinical Practice; Family medicine; Cancer; Ovarian cancer; Statistics","score_opus":0.0244785991403295,"score_gpt":0.3157471784248316,"score_spread":0.29126857928450206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307953076","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027568473,0.122362554,0.000008058595,0.56350523,0.15266287,0.02452631,0.0060973503,0.00038916006,0.102880016],"genre_scores_gemma":[0.12550263,0.28394943,0.0042310255,0.4387128,0.0021926134,0.012869086,0.0063557513,0.00055507186,0.12563157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909125,0.0018983763,0.0022342734,0.0022049514,0.00085356523,0.0018963453],"domain_scores_gemma":[0.99198806,0.0019323073,0.0020652777,0.001595055,0.0007397911,0.0016795135],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0013187444,0.0013636366,0.004716137,0.00067623524,0.0004445032,0.000042640026,0.000758821,0.0020676935,0.019214017],"category_scores_gemma":[0.004863638,0.0011528411,0.0006642542,0.00068973197,0.0003341369,0.00014256852,0.0009792902,0.00286835,0.0003921447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002420983,0.0034033153,0.054061558,0.0032426948,0.0010967389,0.01065937,0.00086941174,0.0000033138494,0.0000028000873,0.000014739972,0.8720566,0.054347366],"study_design_scores_gemma":[0.0029433272,0.016014371,0.21514562,0.0010786154,0.0024720228,0.0005569944,0.001320053,0.000014046352,0.0000049813198,0.000008062104,0.75972456,0.0007173312],"about_ca_topic_score_codex":0.050516177,"about_ca_topic_score_gemma":0.15998492,"teacher_disagreement_score":0.16158688,"about_ca_system_score_codex":0.010685661,"about_ca_system_score_gemma":0.0072531253,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W4308027634","doi":"10.1016/j.ygyno.2022.10.014","title":"Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Ovarian cancer; Bevacizumab; Progression-free survival; Chemotherapy; Stage (stratigraphy); Serous fluid; Cohort; Oncology; Retrospective cohort study; Cancer; Gastroenterology","score_opus":0.015959832280266983,"score_gpt":0.2872009373481282,"score_spread":0.2712411050678612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308027634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899271,0.0000903551,0.0000017029689,0.0066983956,0.00044440938,0.002485399,0.00019786826,0.000016060454,0.00013869215],"genre_scores_gemma":[0.9966916,0.000035364876,0.00043489822,0.0006228288,0.00001976215,0.0019564368,0.000041700307,0.000016639397,0.0001807854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982767,0.00042665392,0.00039240907,0.00034520132,0.00030199066,0.00025700757],"domain_scores_gemma":[0.99873984,0.00037806455,0.00030934642,0.00038413625,0.000104341176,0.00008426513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023673465,0.00017199543,0.00056137244,0.00014610177,0.00008152528,0.0000021351555,0.00011701029,0.000079011515,0.0006595674],"category_scores_gemma":[0.00014897132,0.000104748266,0.00007461339,0.00046914612,0.00007304732,0.000027871432,0.00011379234,0.00012846362,0.0000026408445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130570475,0.005641895,0.95145744,0.000023879633,0.00021824395,0.000095492156,0.001412925,0.005048727,0.0007633907,0.00012672877,0.00015296908,0.022001268],"study_design_scores_gemma":[0.015273528,0.035374902,0.9418411,0.000047833273,0.00020628393,0.000008155536,0.00023162166,0.000005964337,0.00347819,0.00008859646,0.0033559995,0.00008779824],"about_ca_topic_score_codex":0.0010916891,"about_ca_topic_score_gemma":0.00050920626,"teacher_disagreement_score":0.029733006,"about_ca_system_score_codex":0.0025515012,"about_ca_system_score_gemma":0.0010415055,"threshold_uncertainty_score":0.72218007},"labels":[],"label_agreement":null},{"id":"W4308544300","doi":"10.1016/j.ygyno.2022.10.022","title":"Profiling the immune landscape in mucinous ovarian carcinoma","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Vancouver General Hospital; Canada's Michael Smith Genome Sciences Centre; Foothills Medical Centre; BC Cancer Agency","funders":"National Cancer Institute; Cancer Council Tasmania; National Health and Medical Research Council; Medical Research Council; Horizon 2020 Framework Programme; Oak Foundation; BC Cancer Foundation; Canada Research Chairs; Cancer Research Society; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Cancer Council Victoria; University of New South Wales; Canadian Institutes of Health Research; Cancer Institute NSW; European Commission; Calgary Laboratory Services; University of Cambridge; University College London; Cancer Research UK; Michael Smith Health Research BC; Faculty of Medicine and Health, University of Sydney; Translational Cancer Research Network; European Regional Development Fund; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Cancer Council NSW; Ovarian Cancer Australia; Peter MacCallum Foundation; Medical Research and Materiel Command; NSW Ministry of Health; Cancer Council South Australia; Deutsches Krebsforschungszentrum; Ovarian Cancer Research Fund; Cancer Australia; National Institutes of Health","keywords":"CD20; FOXP3; CD68; Stromal cell; Immune system; CD8; Medicine; Cancer research; Tissue microarray; CD3; Tumor microenvironment; Pathology; Immunohistochemistry; Oncology; Immunology","score_opus":0.021461663216129596,"score_gpt":0.2847816725541987,"score_spread":0.2633200093380691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308544300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961761,0.0026687451,0.000004146695,0.009818392,0.0009463933,0.00083569495,0.000007711991,0.000055207507,0.023902688],"genre_scores_gemma":[0.9945167,0.00006493059,0.00028204775,0.0035130586,0.000097694756,0.00044646798,0.000034192544,0.000013889915,0.0010310627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845326,0.00034696536,0.00037468367,0.00027746518,0.00015989349,0.00038774958],"domain_scores_gemma":[0.9990833,0.00038952677,0.00013080963,0.00032977696,0.000026836316,0.00003978641],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011559937,0.0001295773,0.0003587081,0.00013185466,0.00028882344,0.0000073705824,0.00023482597,0.00011353579,0.003517952],"category_scores_gemma":[0.00011558627,0.000088168825,0.00012029353,0.00043977873,0.000111969806,0.000022478966,0.0001809413,0.00056599046,0.000019787994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009580609,0.0021305382,0.80986,0.00007018086,0.00026888406,0.0028292998,0.0030930843,0.00023056433,0.029607777,0.0025218066,0.0052777487,0.13452949],"study_design_scores_gemma":[0.0073304754,0.0046027717,0.8371256,0.000004396717,0.00005799427,0.00086659694,0.0047708126,0.000481851,0.00062685786,0.00021926188,0.14373566,0.00017773184],"about_ca_topic_score_codex":0.00023771453,"about_ca_topic_score_gemma":0.00018677126,"teacher_disagreement_score":0.13845791,"about_ca_system_score_codex":0.0006381346,"about_ca_system_score_gemma":0.0005327478,"threshold_uncertainty_score":0.99739295},"labels":[],"label_agreement":null},{"id":"W4309205382","doi":"10.1016/j.ygyno.2022.10.018","title":"Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research and Materiel Command; Wellcome Trust; National Center for Advancing Translational Sciences; Peter MacCallum Foundation; Medical Research Council; Ovarian Cancer Australia; National Cancer Institute; Ovarian Cancer Research Fund; National Institutes of Health; Cancer Australia; Cancer Research UK; Roswell Park Cancer Institute","keywords":"Medicine; Ovarian cancer; Tubal ligation; Odds ratio; Disease; Body mass index; Gynecology; Debulking; Logistic regression; Breast cancer; Oncology; Obstetrics; Internal medicine; Cancer; Population; Family planning","score_opus":0.029169754675463226,"score_gpt":0.2865152862184236,"score_spread":0.25734553154296036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309205382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037194,0.0016641023,0.0000013067141,0.0060000364,0.00056134386,0.0005998538,0.0003574984,0.000070087255,0.00037382083],"genre_scores_gemma":[0.9949171,0.00012947987,0.000074110954,0.0023169655,0.00015315412,0.0015256795,0.00022894572,0.00003072655,0.0006238594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981144,0.00031640506,0.00024408674,0.0005692864,0.0002888814,0.0004669496],"domain_scores_gemma":[0.99842733,0.0008619396,0.00018248758,0.00016534764,0.00006835891,0.00029454872],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002918051,0.0002457488,0.0006237232,0.00012713729,0.00034680075,0.000019355239,0.000058560643,0.000110217225,0.0027735864],"category_scores_gemma":[0.00022074624,0.00018958154,0.000089060886,0.000208512,0.00022370562,0.00006990905,0.00015809937,0.0003527308,0.0000026734995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086368603,0.0011456304,0.9888844,0.00003365369,0.00043684195,0.0016527161,0.00087325973,0.000010797054,0.000034481254,0.00001754013,0.002129196,0.0039177993],"study_design_scores_gemma":[0.0022086434,0.0015301107,0.9909974,0.00004204346,0.00058187556,0.000026327238,0.0006326122,0.000009030915,0.000021041422,0.000037456906,0.0037113875,0.00020211209],"about_ca_topic_score_codex":0.00023415918,"about_ca_topic_score_gemma":0.0003022283,"teacher_disagreement_score":0.004545128,"about_ca_system_score_codex":0.0025428487,"about_ca_system_score_gemma":0.0018417761,"threshold_uncertainty_score":0.998138},"labels":[],"label_agreement":null},{"id":"W4309504047","doi":"10.1016/j.ygyno.2022.10.023","title":"Is sentinel lymph node assessment useful in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia?","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Hysterectomy; Endometrial cancer; Lymphovascular invasion; Sentinel lymph node; Brachytherapy; Lymph node; Serous carcinoma; External beam radiotherapy; Stage (stratigraphy); Carcinoma; Gynecologic oncology; Radiation therapy; Radiology; Surgery; Cancer; Internal medicine; Ovarian cancer; Metastasis; Breast cancer","score_opus":0.021850384404835662,"score_gpt":0.3081036706407582,"score_spread":0.28625328623592255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309504047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141306,0.000053714273,0.000008556604,0.0019919588,0.00050827995,0.0012427896,0.00015799055,0.000029737957,0.004593933],"genre_scores_gemma":[0.9958007,0.000040341274,0.00075076474,0.001741762,0.00011229744,0.001292748,0.000106581414,0.000020010637,0.0001348296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755704,0.00042403187,0.000578481,0.0004822388,0.00053479645,0.0004233926],"domain_scores_gemma":[0.9978959,0.0012680999,0.00030650382,0.00025012268,0.00014827985,0.00013107967],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037069118,0.00023640941,0.00093730737,0.00044757573,0.0001199811,0.0000068514914,0.00017465265,0.00013802295,0.0045937807],"category_scores_gemma":[0.00041233315,0.0001722216,0.00013720055,0.0014931894,0.00013253184,0.000059073318,0.00023412424,0.00035777487,0.000012989771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044957623,0.0059497925,0.98053414,0.000032563163,0.00027743026,0.00013361161,0.00048447362,0.00010903669,0.000023153265,0.00004366277,0.00027452508,0.007641858],"study_design_scores_gemma":[0.04346903,0.008850719,0.9446942,0.000013483942,0.00022744725,0.000009328991,0.00028466192,0.000029092278,0.0001979288,0.00009448436,0.0019770064,0.00015257057],"about_ca_topic_score_codex":0.00039318937,"about_ca_topic_score_gemma":0.000032511693,"teacher_disagreement_score":0.038973268,"about_ca_system_score_codex":0.0015738922,"about_ca_system_score_gemma":0.00070741796,"threshold_uncertainty_score":0.99631613},"labels":[],"label_agreement":null},{"id":"W4310815716","doi":"10.1016/j.ygyno.2022.11.019","title":"Clinical commentary: Extra-uterine high-grade serous carcinoma: two pathways, two preventions?","year":2022,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Serous carcinoma; Serous fluid; Carcinoma; Gynecology; Oncology; Internal medicine; Cancer; Ovarian cancer","score_opus":0.04897207960213712,"score_gpt":0.39348844030266655,"score_spread":0.34451636070052943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310815716","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04383843,0.0024608588,0.000016054808,0.013264368,0.9323225,0.002927955,0.0020131338,0.0003178579,0.0028388342],"genre_scores_gemma":[0.09802254,0.0054604607,0.0055515654,0.007253319,0.8608835,0.004563795,0.013588345,0.00023306537,0.004443449],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928949,0.0016222603,0.0017830036,0.0017812642,0.00084899913,0.0010695818],"domain_scores_gemma":[0.9910035,0.0058553163,0.0010235932,0.001365726,0.00022471414,0.000527161],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0016983974,0.0008714376,0.0028854948,0.00028037585,0.0004259318,0.00004318447,0.000641527,0.0013846015,0.013025147],"category_scores_gemma":[0.00062293065,0.0007725548,0.0008738883,0.00033824675,0.00037178246,0.00007944384,0.00086596375,0.0030611658,0.00021531903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045751335,0.007943136,0.015330377,0.00016288625,0.0011041961,0.0054110372,0.00007581246,0.000011077081,0.0000064197084,0.00022608506,0.9363608,0.032910667],"study_design_scores_gemma":[0.0228606,0.016667943,0.01703302,0.00005568617,0.0020871595,0.00012252176,0.00010868989,0.000010702562,0.000007723425,0.0007708461,0.9397021,0.00057302974],"about_ca_topic_score_codex":0.0022412443,"about_ca_topic_score_gemma":0.0022467528,"teacher_disagreement_score":0.07143905,"about_ca_system_score_codex":0.0047707334,"about_ca_system_score_gemma":0.0025286293,"threshold_uncertainty_score":0.9999118},"labels":[],"label_agreement":null},{"id":"W4311171503","doi":"10.1016/j.ygyno.2022.11.020","title":"Acceptability of bariatric surgery in people with endometrial cancer and atypical hyperplasia: A qualitative study","year":2022,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University Health Network; University of Toronto; St. Michael's Hospital; Sinai Health System; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Endometrial cancer; Weight loss; Population; Obesity; Hysterectomy; Infertility; Qualitative research; Fertility preservation; Gynecology; Cancer; Surgery; Fertility; Pregnancy; Internal medicine","score_opus":0.04137359655374873,"score_gpt":0.3622860651149014,"score_spread":0.3209124685611527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311171503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960562,0.00038827877,0.000004259683,0.0012767357,0.00064960454,0.0011167479,0.000022664864,0.000028880166,0.00045663895],"genre_scores_gemma":[0.99873257,0.000058431815,0.00020964823,0.00023905998,0.000072281306,0.0006010901,0.000008749942,0.000011046195,0.00006711863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657255,0.001719795,0.00063695345,0.0004435148,0.00028515153,0.00034205327],"domain_scores_gemma":[0.9844865,0.0148612,0.0002647502,0.00021162373,0.00007468787,0.000101225996],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033332456,0.00017019399,0.0013334461,0.00053539616,0.00011346246,0.0000036441522,0.00009359719,0.00013136302,0.003611036],"category_scores_gemma":[0.0028156259,0.00012767797,0.00010865747,0.0016161408,0.00014610757,0.000052494164,0.00021683644,0.00050827814,0.0000018221788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070791836,0.002674203,0.96338475,0.000036239908,0.00013623883,0.00020938677,0.012810806,0.000019923547,0.000009527542,0.00006140113,0.00020527963,0.013373059],"study_design_scores_gemma":[0.0050655343,0.0042203837,0.94262826,0.00000138756,0.00020005723,0.00008880194,0.046630587,0.000010945631,0.000006798558,0.000091676644,0.00093483366,0.00012073699],"about_ca_topic_score_codex":0.0007099995,"about_ca_topic_score_gemma":0.00195891,"teacher_disagreement_score":0.033819783,"about_ca_system_score_codex":0.00055484305,"about_ca_system_score_gemma":0.00096564624,"threshold_uncertainty_score":0.9972998},"labels":[],"label_agreement":null},{"id":"W4316340207","doi":"10.1016/j.ygyno.2023.01.002","title":"A comparison of synoptic reports and dictated reports to enhance and standardize surgical documentation and quality of care in epithelial ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh; University of Manitoba","keywords":"Medicine; Checklist; Ovarian cancer; Documentation; Medical record; Cancer; Gynecology; General surgery; Surgery; Internal medicine","score_opus":0.03295835824916354,"score_gpt":0.45548352506829415,"score_spread":0.4225251668191306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316340207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494594,0.00089707423,0.000013186751,0.001355022,0.0002544651,0.0006517172,0.000016970884,0.000036788544,0.0018288172],"genre_scores_gemma":[0.998715,0.00025524668,0.00067867694,0.00011250126,0.000023496064,0.000060899616,0.000028414212,0.000008903253,0.000116866904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980858,0.00014902103,0.0009305319,0.00038995367,0.00022736771,0.00021731455],"domain_scores_gemma":[0.99837524,0.0007174156,0.00042502757,0.00018004143,0.00017147121,0.00013082928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011509429,0.00012452881,0.00093998323,0.00018758196,0.000025446612,0.000007167772,0.000024446264,0.00012783031,0.00004339716],"category_scores_gemma":[0.0018934755,0.00010404461,0.000023315937,0.00033267768,0.00033397533,0.00006615917,0.00010201351,0.00014858124,4.1369182e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077218056,0.0001574463,0.9314885,0.0005636712,0.000052437743,0.0021706857,0.0040166466,0.00003202858,0.012954369,0.000045205543,0.0002591139,0.047487695],"study_design_scores_gemma":[0.0018724552,0.0032475663,0.98328096,0.00022776978,0.00009847595,0.0003467976,0.0030070604,0.000056994646,0.0047872285,0.00027364554,0.0026768276,0.00012422133],"about_ca_topic_score_codex":0.00047327715,"about_ca_topic_score_gemma":0.00070733076,"teacher_disagreement_score":0.051792435,"about_ca_system_score_codex":0.00017073726,"about_ca_system_score_gemma":0.00020626262,"threshold_uncertainty_score":0.4242816},"labels":[],"label_agreement":null},{"id":"W4317778304","doi":"10.1016/j.ygyno.2022.12.008","title":"Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; University Health Network; Sinai Health System; Sunnybrook Health Science Centre","funders":"","keywords":"Microsatellite instability; Serous fluid; Medicine; Lynch syndrome; Endometrial cancer; MLH1; Oncology; Internal medicine; Meta-analysis; Ovarian cancer; DNA mismatch repair; Gynecology; Cancer; Microsatellite; Colorectal cancer; Biology; Genetics; Allele","score_opus":0.13208689706787544,"score_gpt":0.4031409678496706,"score_spread":0.2710540707817951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317778304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004903762,0.98806524,0.0000021229173,0.0008006017,0.00021150832,0.009805478,0.00020575494,0.00015401062,0.0002649282],"genre_scores_gemma":[0.00046908093,0.9905726,0.0005540494,0.0011466156,0.00001356952,0.0063603544,0.00007171267,0.000073077026,0.000738939],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99267226,0.0018681654,0.0026717933,0.0016183765,0.0003631653,0.0008062636],"domain_scores_gemma":[0.9940401,0.003273522,0.0011284077,0.0010938467,0.00016130129,0.00030284646],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033986962,0.00094134593,0.020045953,0.0009203298,0.000098409444,0.000031473384,0.0003971851,0.0011892801,0.00090557337],"category_scores_gemma":[0.0019024172,0.00062262925,0.0021693322,0.0028638574,0.00044795402,0.000042729065,0.0005472895,0.00094022165,0.00007349942],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067581263,0.00017685362,0.00019646299,0.9487804,0.04702179,0.0006119891,0.000097305034,9.813846e-7,3.7182278e-7,0.000025566163,0.000111942165,0.0029695597],"study_design_scores_gemma":[0.0003780759,0.0009527287,0.00064021157,0.017462872,0.944602,0.0013099748,0.00004852559,0.00000554561,1.4567455e-7,0.0000969812,0.033897314,0.0006056403],"about_ca_topic_score_codex":0.0002969159,"about_ca_topic_score_gemma":0.0025929646,"teacher_disagreement_score":0.93131757,"about_ca_system_score_codex":0.0015457796,"about_ca_system_score_gemma":0.0013767941,"threshold_uncertainty_score":0.9996225},"labels":[],"label_agreement":null},{"id":"W4318262272","doi":"10.1016/j.ygyno.2023.01.021","title":"Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Mayo Foundation for Medical Education and Research; Amgen; Mayo Clinic","keywords":"Medicine; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Internal medicine; Adverse effect; Progression-free survival; Phases of clinical research; Gastroenterology; Confidence interval; Oncology; Surgery; Clinical trial; Chemotherapy","score_opus":0.04460680893063991,"score_gpt":0.36164281846651397,"score_spread":0.3170360095358741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318262272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99402696,0.000056622077,4.0870174e-7,0.00087442674,0.00027914174,0.003964837,0.00027507122,0.000010092361,0.00051242433],"genre_scores_gemma":[0.99936086,0.00013314112,0.00013218692,0.0000811358,0.000014298253,0.0001802094,0.000037439928,0.000011870628,0.00004883147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981279,0.0003054015,0.0007315077,0.00038343063,0.00021453075,0.00023726035],"domain_scores_gemma":[0.9977626,0.00098553,0.00062395167,0.00033623617,0.000228674,0.00006300726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042938645,0.00017422932,0.00085021823,0.00013366922,0.00007428872,0.000003007065,0.00015455071,0.00011234293,0.0000464793],"category_scores_gemma":[0.00053137017,0.00010427391,0.000027875838,0.00055582926,0.00017533338,0.000038003,0.00032925667,0.00017891274,0.0000010204797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081186235,0.124045126,0.5734696,0.00016253078,0.0012129715,0.00017401921,0.01586481,0.00013773804,0.00029317226,0.000083538995,0.001022141,0.20234813],"study_design_scores_gemma":[0.18413469,0.04946476,0.76413524,0.00020621414,0.00030078046,0.00000112053,0.0010382459,0.00006445695,0.0002544193,0.0000066304365,0.00031934463,0.000074093216],"about_ca_topic_score_codex":0.00082355476,"about_ca_topic_score_gemma":0.003386549,"teacher_disagreement_score":0.20227404,"about_ca_system_score_codex":0.00033242296,"about_ca_system_score_gemma":0.0003565612,"threshold_uncertainty_score":0.42521665},"labels":[],"label_agreement":null},{"id":"W4319216343","doi":"10.1016/j.ygyno.2023.01.020","title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Internal medicine; Ovarian cancer; Gastroenterology; Regimen; Oncology; Nausea; Adverse effect; Cancer; Surgery; Chemotherapy","score_opus":0.010506058466405052,"score_gpt":0.28449790342106374,"score_spread":0.27399184495465867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319216343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941256,0.0002550337,0.000008758574,0.0030793983,0.0001813291,0.0016730397,0.00009245417,0.00005932657,0.0005250697],"genre_scores_gemma":[0.99741036,0.00050386565,0.0012315284,0.00019057773,0.00002248673,0.0001445178,0.00038392795,0.00003403615,0.00007868059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977777,0.00022184242,0.000662021,0.0005750849,0.00026007363,0.0005032875],"domain_scores_gemma":[0.9983889,0.00071237684,0.00038609715,0.00021947932,0.00017797148,0.000115205024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005504336,0.00028864888,0.0009531622,0.0003471849,0.0000819299,0.000011996697,0.00008647607,0.00019979116,0.0001799864],"category_scores_gemma":[0.00020104501,0.00020859073,0.000037554004,0.000841703,0.00017323116,0.000102124206,0.00006554179,0.00028619848,0.0000095587175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011310193,0.0027719382,0.9580286,0.0001548031,0.00024858268,0.0003108954,0.0011561142,0.00021537961,0.00041750263,0.00039690713,0.00025458206,0.024734464],"study_design_scores_gemma":[0.050458256,0.007872648,0.9389738,0.00034007785,0.00014121854,0.000003295699,0.00021934955,0.000244099,0.00016226686,0.00006819199,0.0012996327,0.00021715787],"about_ca_topic_score_codex":0.0009656074,"about_ca_topic_score_gemma":0.0036598365,"teacher_disagreement_score":0.039148062,"about_ca_system_score_codex":0.0008465936,"about_ca_system_score_gemma":0.0004624431,"threshold_uncertainty_score":0.8506083},"labels":[],"label_agreement":null},{"id":"W4319262134","doi":"10.1016/j.ygyno.2022.12.019","title":"The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype","year":2023,"lang":"en","type":"editorial","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; BC Cancer Foundation; Michael Smith Health Research BC","keywords":"Risk stratification; Medicine; Carcinoma; Stratification (seeds); Oncology; Internal medicine; Gynecology; Biology","score_opus":0.02263210079343046,"score_gpt":0.30459894967958867,"score_spread":0.2819668488861582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319262134","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06248956,0.0063475114,0.00031709252,0.001338928,0.91574657,0.0046452917,0.00043739058,0.00021353258,0.008464137],"genre_scores_gemma":[0.7766404,0.002025878,0.00065728865,0.00004990677,0.21570958,0.0015476702,0.0013538599,0.00012220356,0.0018932068],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994573,0.0014192758,0.0013732694,0.00087204704,0.0011683073,0.000594114],"domain_scores_gemma":[0.982319,0.012980836,0.0020595863,0.0011440575,0.0013384524,0.0001580975],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028235374,0.0004818188,0.0011725248,0.00030991592,0.0003074271,0.000060970902,0.0006997879,0.0021010737,0.0002039679],"category_scores_gemma":[0.023663744,0.00027826134,0.00045768637,0.0015802365,0.00061898184,0.00005007988,0.00016636642,0.0022026594,0.0003802658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009841306,0.0014909089,0.002833974,0.0004178286,0.0020575402,0.000526777,0.00053791906,0.000069470436,0.024470406,0.011186794,0.886726,0.059841044],"study_design_scores_gemma":[0.012250181,0.009781735,0.019453852,0.00010972543,0.0021228418,0.000013027135,0.0010033499,0.00023388588,0.002991428,0.0032998296,0.9481547,0.0005854285],"about_ca_topic_score_codex":0.00026317692,"about_ca_topic_score_gemma":0.00014225124,"teacher_disagreement_score":0.71415085,"about_ca_system_score_codex":0.0019291787,"about_ca_system_score_gemma":0.0016993989,"threshold_uncertainty_score":0.999967},"labels":[],"label_agreement":null},{"id":"W4319301482","doi":"10.1016/j.ygyno.2023.01.025","title":"Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Dalhousie University; University of Toronto; McMaster University; Université Laval; Université de Montréal; University of Saskatchewan; McGill University; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Oncology; Serous fluid; Endometrial cancer; Cohort; Radiation therapy; Stage (stratigraphy); Adjuvant; Population; Cancer; Adjuvant therapy","score_opus":0.07537246766896669,"score_gpt":0.39754614181292425,"score_spread":0.3221736741439576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319301482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984516,0.00041623483,0.0000094473935,0.007106525,0.001551134,0.001251224,0.000017643224,0.0001644942,0.0049672793],"genre_scores_gemma":[0.99347126,0.0006774254,0.00022565904,0.004281905,0.0001672468,0.0006745926,0.000030859082,0.000022951075,0.00044809145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806803,0.00016679172,0.00043871562,0.0004631452,0.00026243788,0.000600875],"domain_scores_gemma":[0.9981261,0.0012352745,0.000098260134,0.00024505446,0.000074338146,0.00022100193],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00047737436,0.00022514137,0.00091170304,0.0007305978,0.00005438762,0.000013049269,0.00017116577,0.00025838136,0.0010343969],"category_scores_gemma":[0.0015386576,0.00015979547,0.00016231848,0.0024075562,0.000044504824,0.000041346764,0.00009802221,0.00025775377,0.00034468307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022833862,0.00062928896,0.60222137,0.000019603292,0.00025116815,0.0015535008,0.0001744419,0.00020676765,0.015871648,0.00026637787,0.0005576692,0.37596476],"study_design_scores_gemma":[0.020999415,0.007095428,0.9542751,0.000020514079,0.00007901287,0.000009094361,0.00046287978,0.000029851439,0.0050147385,0.0008136588,0.010937214,0.00026311143],"about_ca_topic_score_codex":0.00054015266,"about_ca_topic_score_gemma":0.0006041752,"teacher_disagreement_score":0.37570164,"about_ca_system_score_codex":0.00070223276,"about_ca_system_score_gemma":0.0003869282,"threshold_uncertainty_score":0.99987876},"labels":[],"label_agreement":null},{"id":"W4323870332","doi":"10.1016/j.ygyno.2023.02.014","title":"Robotic-assisted surgery for endometrial cancer is safe in morbidly and extremely morbidly obese patients","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Endometrial cancer; Perioperative; Surgery; Laparotomy; Hysterectomy; Cancer; Internal medicine","score_opus":0.09862190385362832,"score_gpt":0.3696395281202986,"score_spread":0.2710176242666703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323870332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894762,0.0009828734,0.000015235234,0.0037197762,0.0021522301,0.0016625328,0.00009733268,0.000115024726,0.0017787871],"genre_scores_gemma":[0.9924143,0.0019176841,0.00048406978,0.0022245718,0.00033538617,0.0010808454,0.00017015048,0.000033801065,0.0013392032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975619,0.00016268525,0.0006607896,0.0006132606,0.00027328564,0.0007281184],"domain_scores_gemma":[0.994522,0.004613132,0.00021259654,0.00022237834,0.00017436103,0.0002555459],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00061489514,0.00027595615,0.001170499,0.0008402081,0.00010143696,0.000015755795,0.000110404326,0.00039393327,0.0010233189],"category_scores_gemma":[0.0032975513,0.00021839829,0.00022026873,0.0017246411,0.00012345955,0.00007645749,0.00011593107,0.00022434557,0.00008476594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031050488,0.0012673433,0.6446708,0.00018126743,0.00023595107,0.0002573164,0.00015500988,0.000017792223,0.00030081242,0.000039947823,0.012728758,0.33704],"study_design_scores_gemma":[0.01852073,0.002661694,0.9581307,0.0000512362,0.0002295215,0.000008716486,0.00008368892,0.00014228435,0.00017650389,0.0006835764,0.019083373,0.00022797594],"about_ca_topic_score_codex":0.00049612793,"about_ca_topic_score_gemma":0.00092641974,"teacher_disagreement_score":0.33681202,"about_ca_system_score_codex":0.0008116703,"about_ca_system_score_gemma":0.00040966523,"threshold_uncertainty_score":0.9998899},"labels":[],"label_agreement":null},{"id":"W4323870559","doi":"10.1016/j.ygyno.2023.02.012","title":"Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Apixaban; Gynecologic oncology; Laparotomy; Venous thromboembolism; Surgery; Internal medicine; Rivaroxaban; Thrombosis; Warfarin","score_opus":0.03371290757443042,"score_gpt":0.3473463095019757,"score_spread":0.3136334019275453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323870559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522399,0.000086592,0.000044648717,0.007709445,0.0017892033,0.006314822,0.000034861725,0.00040891286,0.031371627],"genre_scores_gemma":[0.98487455,0.000614185,0.002203547,0.007012807,0.0001634586,0.0036338367,0.000340021,0.000064248125,0.0010933717],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99584335,0.00046534115,0.0009538928,0.0010701107,0.00030016652,0.0013671485],"domain_scores_gemma":[0.99548745,0.0030861113,0.00035909613,0.0004948228,0.00031510578,0.0002574199],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001303986,0.0004750313,0.0017987569,0.0007142711,0.00031860953,0.000028686094,0.0003603614,0.0007696537,0.0009112555],"category_scores_gemma":[0.0026208265,0.00040244483,0.00028258844,0.0009873712,0.0002933909,0.00014767025,0.00040201982,0.0005193765,0.0006684808],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022965628,0.03379087,0.30622792,0.0012551309,0.0017251595,0.0033340445,0.0085948,0.0011229859,0.0034274696,0.023435475,0.187204,0.42758557],"study_design_scores_gemma":[0.0117488485,0.03183151,0.8273245,0.000049896615,0.00016531599,0.000017652053,0.002640775,0.0003319069,0.00026230235,0.006706843,0.11841753,0.00050288654],"about_ca_topic_score_codex":0.000076106655,"about_ca_topic_score_gemma":0.0019556463,"teacher_disagreement_score":0.5210966,"about_ca_system_score_codex":0.0022484642,"about_ca_system_score_gemma":0.0009594037,"threshold_uncertainty_score":0.99984276},"labels":[],"label_agreement":null},{"id":"W4362677814","doi":"10.1016/j.ygyno.2023.03.019","title":"Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; AstraZeneca","keywords":"Medicine; Olaparib; Tolerability; Oncology; Internal medicine; BRCA mutation; Ovarian cancer; Cancer; Adverse effect","score_opus":0.018461943462107312,"score_gpt":0.30804972464802394,"score_spread":0.2895877811859166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362677814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925115,0.00008042003,0.000025907008,0.0042492226,0.0003272647,0.0022320303,0.00007866401,0.000103014194,0.0003919527],"genre_scores_gemma":[0.9948406,0.00016023648,0.00068177516,0.0033082997,0.000031368032,0.00063557015,0.00014905518,0.000022897353,0.00017015502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977282,0.0006828957,0.0005284664,0.00043301488,0.00020784231,0.00041955756],"domain_scores_gemma":[0.9977383,0.0015874872,0.00031337712,0.00019762492,0.00009984863,0.00006338411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011501873,0.00020371319,0.0005688775,0.0002412722,0.00009225309,0.000013760481,0.0000592469,0.00025996743,0.00006264646],"category_scores_gemma":[0.00073744124,0.00013687275,0.000034523335,0.00050601823,0.00022976001,0.000086616456,0.00003083063,0.00033601135,0.000006905202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02427852,0.0012836381,0.944186,0.0000686493,0.00016897943,0.00047695552,0.005663232,0.00011391664,0.00027705345,0.00034866633,0.0030829958,0.020051444],"study_design_scores_gemma":[0.09824022,0.004788321,0.89314824,0.000052418814,0.00004978121,0.000031413143,0.00070847076,0.0005466852,0.000056006334,0.001081286,0.0011287511,0.00016843107],"about_ca_topic_score_codex":0.0003876259,"about_ca_topic_score_gemma":0.0012313818,"teacher_disagreement_score":0.073961705,"about_ca_system_score_codex":0.0006988929,"about_ca_system_score_gemma":0.00022264296,"threshold_uncertainty_score":0.5581509},"labels":[],"label_agreement":null},{"id":"W4366254430","doi":"10.1016/j.ygyno.2023.04.004","title":"Diagnostic accuracy of frozen section and patterns of nodal spread in high grade endometrial cancer: A secondary outcome of the SENTOR prospective cohort study","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Sunnybrook Health Science Centre; Sinai Health System; University Health Network; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Prospective cohort study; Stage (stratigraphy); Lymphadenectomy; Biopsy; Lymph node; Radiology; Cancer; Sentinel node; Internal medicine; Breast cancer","score_opus":0.03270746365152516,"score_gpt":0.3484616413753762,"score_spread":0.31575417772385106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366254430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944377,0.0001513564,0.0000013717992,0.00041461943,0.0014108528,0.0031404444,0.00017310609,0.000023146064,0.00024740706],"genre_scores_gemma":[0.99881774,0.00029738658,0.000017825892,0.00006305033,0.00015169835,0.00052919146,0.000016066264,0.000011367118,0.00009567469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981159,0.00031730352,0.00071524916,0.00032740284,0.00028164464,0.00024251026],"domain_scores_gemma":[0.99354625,0.0055669835,0.0004871323,0.00022800999,0.000109995424,0.00006165418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056252786,0.00016117934,0.0010543076,0.00036080147,0.00003461752,0.0000023337159,0.00013029344,0.00017589796,0.0003598325],"category_scores_gemma":[0.0050534103,0.00010319243,0.00011862235,0.0011358447,0.00013593562,0.00004300709,0.00018641682,0.00028107132,0.000002112378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007918629,0.0016346177,0.98987424,0.00014889197,0.00033802193,0.000059390004,0.0005607801,0.000015085726,0.00060250727,0.000019586729,0.000027130294,0.0059278985],"study_design_scores_gemma":[0.016208097,0.0054756133,0.9752994,0.000037952297,0.00039164216,0.0000071536083,0.00064124254,0.000005065025,0.001573367,0.00022778574,0.000058229754,0.00007445455],"about_ca_topic_score_codex":0.00836509,"about_ca_topic_score_gemma":0.0054821246,"teacher_disagreement_score":0.015416235,"about_ca_system_score_codex":0.000443058,"about_ca_system_score_gemma":0.00020230157,"threshold_uncertainty_score":0.99823827},"labels":[],"label_agreement":null},{"id":"W4366607774","doi":"10.1016/j.ygyno.2023.04.009","title":"Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update","year":2023,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Guideline; Stakeholder; MEDLINE; Grading (engineering); Randomized controlled trial; Stakeholder engagement; Perioperative; Evidence-based medicine; Intensive care medicine; Medical physics; Oncology; Internal medicine; Alternative medicine; Surgery; Pathology; Public relations","score_opus":0.3638619926052853,"score_gpt":0.49655731601584385,"score_spread":0.13269532341055856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366607774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055083993,0.97279847,0.0005775023,0.004265978,0.011663045,0.0071463194,0.000753731,0.0009461145,0.001298004],"genre_scores_gemma":[0.00003635047,0.9601424,0.00927414,0.0051906956,0.0027437212,0.016146792,0.003286524,0.00038361287,0.0027958099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98766005,0.0016597089,0.004790818,0.0027805036,0.00061236974,0.0024965426],"domain_scores_gemma":[0.97005117,0.023441548,0.0034125072,0.0013222016,0.0012619906,0.0005106104],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0066310214,0.0018260592,0.009695648,0.0010843662,0.00044141707,0.00009006332,0.0006514633,0.004621084,0.0021490958],"category_scores_gemma":[0.0074110404,0.0015086943,0.004709734,0.0011832566,0.00045231186,0.00040578327,0.00071408035,0.0017793799,0.0012623627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00037287406,0.00044563485,0.000015096172,0.017902512,0.0018859042,0.000525502,0.00009278575,0.0000046429054,0.000018504472,0.000016403636,0.11842911,0.860291],"study_design_scores_gemma":[0.0015608231,0.0027703966,0.00024110188,0.0052800933,0.0037491624,0.00025659893,0.0006192067,0.000012143212,0.00003465808,0.0007023871,0.98336965,0.0014037784],"about_ca_topic_score_codex":0.00001995932,"about_ca_topic_score_gemma":0.0008175606,"teacher_disagreement_score":0.8649405,"about_ca_system_score_codex":0.004967923,"about_ca_system_score_gemma":0.0072493516,"threshold_uncertainty_score":0.9995153},"labels":[],"label_agreement":null},{"id":"W4367841003","doi":"10.1016/j.ygyno.2023.03.005","title":"Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval; Université de Montréal; University of Alberta; Juravinski Cancer Centre; University of Manitoba; Trillium Health Centre; University of British Columbia; University of Toronto; Martec (Canada); McGill University; University of Calgary","funders":"","keywords":"Medicine; Cervical cancer; Stage (stratigraphy); Radical Hysterectomy; Surgical margin; Hysterectomy; Surgery; Univariate analysis; Retrospective cohort study; Cancer; Proportional hazards model; Gynecology; Multivariate analysis; Internal medicine","score_opus":0.04727351020290064,"score_gpt":0.36241787918890067,"score_spread":0.315144368986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367841003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96834046,0.00036630215,9.881963e-7,0.0054475255,0.00032877532,0.0038631698,0.0001529526,0.000044245313,0.021455586],"genre_scores_gemma":[0.99459815,0.00078959577,0.00017256066,0.0005030906,0.000112810245,0.0030244198,0.00008845489,0.000022309448,0.00068863586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960129,0.0009163385,0.00078475813,0.0007022122,0.000568381,0.0010153606],"domain_scores_gemma":[0.9979907,0.000947987,0.00013905008,0.00034741993,0.00012748179,0.00044731644],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012721034,0.00029875134,0.000991436,0.00073654443,0.0000963982,0.000017245979,0.00030820374,0.00036594004,0.0013316419],"category_scores_gemma":[0.00007802938,0.00020432769,0.00010649806,0.005260709,0.00011881999,0.00005739116,0.0001714621,0.00058077223,0.00006693596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002930033,0.0025738147,0.9611033,0.00013857022,0.00027747362,0.0077460525,0.004461129,0.0012218029,0.0000024939952,0.001177166,0.0003066438,0.01806152],"study_design_scores_gemma":[0.012159492,0.0033678492,0.9485186,0.000041132054,0.00014333591,0.000010774519,0.0074633267,0.00017986957,0.000002722504,0.000085163105,0.027838895,0.00018887386],"about_ca_topic_score_codex":0.15152872,"about_ca_topic_score_gemma":0.3776361,"teacher_disagreement_score":0.22610739,"about_ca_system_score_codex":0.0027789408,"about_ca_system_score_gemma":0.0009401872,"threshold_uncertainty_score":0.9995813},"labels":[],"label_agreement":null},{"id":"W4376289035","doi":"10.1016/j.ygyno.2023.05.003","title":"Safety of fertility sparing management in invasive mucinous ovarian carcinoma","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"Sunnybrook Research Institute","keywords":"Medicine; Fertility; Hazard ratio; Fertility preservation; Radical surgery; Surgery; Retrospective cohort study; Hysterectomy; Proportional hazards model; Stage (stratigraphy); Cancer; Internal medicine; Confidence interval; Population","score_opus":0.040373967114337286,"score_gpt":0.3130041463989331,"score_spread":0.2726301792845958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376289035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93641734,0.00012672204,0.000009376354,0.0033386347,0.00041161623,0.0010386568,0.000011236528,0.00007940755,0.05856703],"genre_scores_gemma":[0.9972683,0.00041658143,0.000993467,0.000508257,0.000035217996,0.00026141637,0.0000424643,0.000013413698,0.00046083867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983146,0.00013094963,0.0005089789,0.00044829043,0.00015317797,0.00044400737],"domain_scores_gemma":[0.99874914,0.00055603916,0.00013850429,0.00039506765,0.000053644613,0.0001075853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052597804,0.00016879383,0.00064459967,0.00029149943,0.000051511317,0.0000038235607,0.00012293445,0.00019638373,0.00055528356],"category_scores_gemma":[0.00018686254,0.00014383667,0.000107385466,0.0006019966,0.000096868716,0.000032155785,0.0001919357,0.00017487745,0.00014729361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006222116,0.0012395947,0.9163818,0.0002166061,0.00023522662,0.0035316367,0.00047982033,0.00012934463,0.00012565385,0.0021675862,0.0008754548,0.07399511],"study_design_scores_gemma":[0.005148897,0.0014520854,0.9865479,0.000039373663,0.0001438653,0.000019372017,0.0005209888,0.00008252946,0.000506401,0.0008925752,0.0045411326,0.000104862556],"about_ca_topic_score_codex":0.00033399856,"about_ca_topic_score_gemma":0.0011955777,"teacher_disagreement_score":0.07389025,"about_ca_system_score_codex":0.0010104756,"about_ca_system_score_gemma":0.00027744914,"threshold_uncertainty_score":0.6079966},"labels":[],"label_agreement":null},{"id":"W4380841452","doi":"10.1016/j.ygyno.2023.05.073","title":"Harmonized molecular classification; assessment of a single-test ProMisE NGS tool","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Concordance; Microsatellite instability; Amplicon; Medicine; Molecular diagnostics; DNA sequencing; Computational biology; Oncology; Molecular biomarkers; DNA mismatch repair; Bioinformatics; Internal medicine; Microsatellite; Pathology; Biology; DNA; Genetics; Gene; Polymerase chain reaction; Cancer; Colorectal cancer","score_opus":0.07983768462977299,"score_gpt":0.38082970938013994,"score_spread":0.30099202475036696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380841452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462768,0.000098638164,0.000092489645,0.006130818,0.00039222266,0.0011145965,0.00002330855,0.00020608597,0.04566503],"genre_scores_gemma":[0.9942054,0.00009496445,0.0029853208,0.0007304925,0.00006155442,0.00040263587,0.0000986497,0.000016694892,0.0014042789],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985018,0.00012085811,0.00045254178,0.00034318998,0.00024870137,0.00033294637],"domain_scores_gemma":[0.9980822,0.0011219817,0.00021390736,0.0002924296,0.00016730624,0.0001221606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003704075,0.00015394494,0.00059326255,0.00020388336,0.00005091709,0.000006835448,0.00012794633,0.00022089497,0.0013001062],"category_scores_gemma":[0.0014917989,0.00011767886,0.00015624458,0.0008876976,0.00012643046,0.000034310215,0.00008622444,0.00016477481,0.00017599545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005678058,0.0057148673,0.088211454,0.00022324215,0.0004284285,0.0012744089,0.0001249881,0.00001643497,0.7768014,0.0026002063,0.0027599381,0.1212768],"study_design_scores_gemma":[0.014828274,0.011410645,0.93009204,0.000032574375,0.0004752528,0.000057011228,0.00022147423,0.000643595,0.014793647,0.0020283232,0.0251803,0.00023686419],"about_ca_topic_score_codex":0.000012979382,"about_ca_topic_score_gemma":0.0000055763826,"teacher_disagreement_score":0.84188056,"about_ca_system_score_codex":0.00055666134,"about_ca_system_score_gemma":0.00042681137,"threshold_uncertainty_score":0.99961287},"labels":[],"label_agreement":null},{"id":"W4381429702","doi":"10.1016/j.ygyno.2023.06.013","title":"Treatment patterns and outcomes of patients with locally advanced vulvar or vaginal cancer in British Columbia","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbotsford Veterinary Clinic; Vancouver Island University; University of the Fraser Valley; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Vulvar cancer; Vaginal cancer; Cervical cancer; Cancer; Retrospective cohort study; Hazard ratio; Radiation therapy; Chemotherapy; Proportional hazards model; Internal medicine; Survival analysis; Surgery; Confidence interval","score_opus":0.018879614154510664,"score_gpt":0.313549126524296,"score_spread":0.29466951236978534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381429702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978379,0.00009127062,0.000003169893,0.00037799496,0.00019211514,0.00092230574,0.00018420214,0.000048282232,0.00034275634],"genre_scores_gemma":[0.9965454,0.0009652835,0.00019635423,0.00033484615,0.000019885689,0.00042844863,0.00008789535,0.000014422178,0.0014075139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988079,0.000064106775,0.000302625,0.00032982937,0.00016041238,0.0003351341],"domain_scores_gemma":[0.9990953,0.00045697475,0.000117433876,0.00012660044,0.0000842112,0.000119453136],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006839841,0.00012811007,0.0007363544,0.00009070985,0.000041420397,0.000010919353,0.000056855257,0.00013184448,0.0012940571],"category_scores_gemma":[0.00013719546,0.00010565885,0.00004261641,0.00044221073,0.000101145066,0.000041695363,0.000048140257,0.00009139024,0.000008003539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006718233,0.0008386641,0.76356053,0.000041282387,0.00012768997,0.00049719156,0.000060177343,0.000009546087,0.0000062155323,8.515679e-7,0.000025874459,0.23416017],"study_design_scores_gemma":[0.022507375,0.014173536,0.96155095,0.00004390282,0.00013353422,0.000010705191,0.00016048345,0.000007908118,0.000008671393,0.000035659057,0.0012622214,0.00010506442],"about_ca_topic_score_codex":0.01619362,"about_ca_topic_score_gemma":0.3713284,"teacher_disagreement_score":0.3551348,"about_ca_system_score_codex":0.0005510543,"about_ca_system_score_gemma":0.00027094124,"threshold_uncertainty_score":0.9996189},"labels":[],"label_agreement":null},{"id":"W4382600403","doi":"10.1016/j.ygyno.2023.06.016","title":"Palliative care utilization across health sectors for patients with gynecologic malignancies in Ontario, Canada from 2006 to 2018","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Palliative care; Gynecologic cancer; Family medicine; Nursing; Cancer; Internal medicine; Ovarian cancer","score_opus":0.14992754748002562,"score_gpt":0.4188272534027768,"score_spread":0.2688997059227512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382600403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944264,0.00032523207,0.000090516325,0.0011238066,0.0007872954,0.0019151173,0.0007459365,0.00006401717,0.0005216278],"genre_scores_gemma":[0.99118483,0.00011969715,0.0029299315,0.002929455,0.000051467134,0.0004286673,0.0018205979,0.000024986048,0.0005103585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785894,0.00012829923,0.00052222057,0.00050641026,0.00025501344,0.0007290888],"domain_scores_gemma":[0.9973601,0.0015000748,0.0002947883,0.00022750084,0.00042529323,0.00019222256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022431336,0.00025416238,0.00088281126,0.0001355178,0.00012845433,0.0000064200253,0.00015592824,0.00023925105,0.00023834946],"category_scores_gemma":[0.0010992159,0.0001996257,0.00006152586,0.0005485282,0.00009425048,0.000047016198,0.00008811301,0.00020156367,0.000015229457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040475203,0.00018504789,0.9685421,0.000083620245,0.000062511484,0.000043864038,0.009523152,0.0002900912,0.000011788566,0.000018776993,0.016961662,0.0038726097],"study_design_scores_gemma":[0.0029201827,0.005278175,0.8687279,0.00013618094,0.000027154905,1.8561009e-7,0.00867402,0.000017966599,0.00011963846,0.00006923451,0.11385255,0.00017676516],"about_ca_topic_score_codex":0.79735535,"about_ca_topic_score_gemma":0.99745435,"teacher_disagreement_score":0.20009899,"about_ca_system_score_codex":0.004830037,"about_ca_system_score_gemma":0.003641427,"threshold_uncertainty_score":0.99899024},"labels":[],"label_agreement":null},{"id":"W4382753522","doi":"10.1016/j.ygyno.2023.05.074","title":"Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; London Health Sciences Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Gynecologic oncology; Endometrial cancer; Visual analogue scale; Hysterectomy; Cervical cancer; Surgery; Cancer; Internal medicine","score_opus":0.0855321440746433,"score_gpt":0.36091768341352287,"score_spread":0.27538553933887955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382753522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99050623,0.00012869053,0.0000030754163,0.0016130168,0.0013676746,0.0025598542,0.000031343483,0.00029482337,0.003495303],"genre_scores_gemma":[0.9951292,0.00017413711,0.00016751053,0.0009559369,0.000095842115,0.0027037957,0.000060694845,0.000048881288,0.00066399784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933024,0.0017310557,0.0018193617,0.001041138,0.00073628087,0.001369786],"domain_scores_gemma":[0.9896277,0.007978924,0.00097431673,0.00067676767,0.0003821996,0.0003600966],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003983887,0.00054216303,0.003088406,0.0010851311,0.00012025791,0.000014131409,0.00026741202,0.0006333293,0.0014742435],"category_scores_gemma":[0.0043488475,0.0003825157,0.00020956644,0.0034318021,0.00031944108,0.00011587819,0.00033459294,0.00062100025,0.00010937163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009844622,0.007502326,0.94075036,0.00018479011,0.00058224384,0.005939103,0.0029385667,0.00005820082,0.00026929792,0.000015839812,0.00029875792,0.031615864],"study_design_scores_gemma":[0.014031576,0.025052367,0.9436486,0.00005861359,0.00021649842,0.000054169916,0.013568477,0.000008624413,0.000047948666,0.00015875767,0.002779016,0.00037538641],"about_ca_topic_score_codex":0.0008739437,"about_ca_topic_score_gemma":0.007625492,"teacher_disagreement_score":0.031240476,"about_ca_system_score_codex":0.0031768805,"about_ca_system_score_gemma":0.0012050375,"threshold_uncertainty_score":0.9998627},"labels":[],"label_agreement":null},{"id":"W4383500034","doi":"10.1016/j.ygyno.2023.06.580","title":"To the editor","year":2023,"lang":"en","type":"letter","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; General surgery","score_opus":0.04857517197388913,"score_gpt":0.34624822939757216,"score_spread":0.29767305742368305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383500034","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027918143,0.00017548648,0.00000544582,0.94383264,0.03040114,0.001287108,0.00007391401,0.00024224768,0.023702852],"genre_scores_gemma":[0.00023354478,0.0001163707,0.00017524343,0.8465379,0.10573817,0.00082126324,0.00028611257,0.00005032905,0.04604106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978088,0.0002131687,0.00036059093,0.0005524079,0.00039551215,0.00066950446],"domain_scores_gemma":[0.99639297,0.002648798,0.00013755173,0.00055524276,0.00011922135,0.00014619196],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034056115,0.0003079739,0.0008828241,0.00022564747,0.00012615461,0.000015982896,0.00037928755,0.0014880907,0.002619567],"category_scores_gemma":[0.0016041615,0.00016423027,0.00026991218,0.0006990256,0.00009870018,0.000012779961,0.00023773396,0.0018044665,0.012283167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009294844,0.00007877328,0.0001701275,0.000048784314,0.00020127653,0.0023734106,0.00003207247,0.0000011115327,0.0000040697273,0.000005998996,0.9758076,0.0211838],"study_design_scores_gemma":[0.0012808677,0.004260194,0.0037241888,0.000019419314,0.00035243607,0.00004986641,0.000026355288,9.544573e-7,0.000006979837,0.0002817665,0.9898344,0.00016253469],"about_ca_topic_score_codex":0.00009162959,"about_ca_topic_score_gemma":0.00012967814,"teacher_disagreement_score":0.09729472,"about_ca_system_score_codex":0.00095554657,"about_ca_system_score_gemma":0.0004750703,"threshold_uncertainty_score":0.9998082},"labels":[],"label_agreement":null},{"id":"W4385513487","doi":"10.1016/j.ygyno.2023.07.011","title":"Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute; National Institutes of Health; Mylan","keywords":"Medicine; Lymphovascular invasion; Cervix; Retrospective cohort study; Oncology; Basal cell; Carcinoma; Internal medicine; Pathology; Gynecology; Cancer; Metastasis","score_opus":0.06853142766457895,"score_gpt":0.3560193391213679,"score_spread":0.287487911456789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385513487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99106765,0.00029517701,0.0000019001974,0.00078501453,0.003021771,0.0018729294,0.000020090161,0.00005870096,0.0028767884],"genre_scores_gemma":[0.9986072,0.00015119284,0.00008624347,0.00064534706,0.00010709985,0.00020981881,0.000026801692,0.000017424967,0.0001488402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974054,0.0005880842,0.0006283822,0.0005847357,0.00040246174,0.00039090248],"domain_scores_gemma":[0.99693143,0.001828665,0.00031438484,0.0004668935,0.0003654062,0.00009324073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004489212,0.00023419062,0.0008352572,0.00029847457,0.000081723,0.0000061090695,0.00034629644,0.00026991294,0.00024932387],"category_scores_gemma":[0.0020617223,0.00015214384,0.00029215933,0.0010901616,0.00020887006,0.000042390333,0.00051919447,0.00035779877,0.000106755724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004378447,0.005103051,0.97945154,0.00004577431,0.00011775219,0.0019142171,0.001262991,0.000110323104,0.0011851275,0.00002078245,0.0002518413,0.006158127],"study_design_scores_gemma":[0.038160387,0.0115807075,0.943523,0.000013270945,0.00022296941,0.000018931778,0.004961699,0.00015249659,0.0006220109,0.00014459183,0.0004804373,0.00011949327],"about_ca_topic_score_codex":0.00037886546,"about_ca_topic_score_gemma":0.0005195083,"teacher_disagreement_score":0.035928562,"about_ca_system_score_codex":0.0012606775,"about_ca_system_score_gemma":0.00021854219,"threshold_uncertainty_score":0.62042457},"labels":[],"label_agreement":null},{"id":"W4385628249","doi":"10.1016/j.ygyno.2023.07.016","title":"Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Calgary; University of Alberta; Queen's University; University of British Columbia; Calgary Laboratory Services; BC Cancer Agency","funders":"","keywords":"SMARCA4; ARID1A; Cancer research; Medicine; Endometrial cancer; Epigenetics; In vivo; Cancer; Oncology; Internal medicine; Biology; Mutation; Gene; Chromatin remodeling; Genetics","score_opus":0.049187697683639196,"score_gpt":0.33439681996193493,"score_spread":0.28520912227829576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385628249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978976,0.0002179796,0.0004474713,0.00010531835,0.00024922384,0.00036739217,0.00005447442,0.000031666445,0.0006288193],"genre_scores_gemma":[0.9985224,0.00052160805,0.00039172036,0.000035167144,0.00006431506,0.000039752988,0.00033486966,0.000015657184,0.00007450093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998363,0.00026363757,0.0005337547,0.00043162153,0.00014041066,0.0002675442],"domain_scores_gemma":[0.99871093,0.000442203,0.00034728262,0.0002330782,0.00017934186,0.00008714922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005814255,0.00017436713,0.0004942095,0.00016744359,0.000060963725,0.000010063142,0.00013015975,0.0004401266,0.00003575976],"category_scores_gemma":[0.0008617713,0.00015602131,0.00006981477,0.0002829822,0.00023820436,0.000010187527,0.00019196622,0.00014194357,0.0000011960645],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011807407,0.0003840069,0.02694784,0.00012846709,0.0002112268,0.000007847403,0.00016742978,0.0011506028,0.9564105,0.000100785444,0.00091995246,0.012390586],"study_design_scores_gemma":[0.0070753996,0.0051973076,0.057629146,0.000027671178,0.00015585659,0.00002423844,0.00034821394,0.011713406,0.91496754,0.0016438492,0.000881204,0.00033614304],"about_ca_topic_score_codex":0.000117472104,"about_ca_topic_score_gemma":0.000019845102,"teacher_disagreement_score":0.04144295,"about_ca_system_score_codex":0.000057481906,"about_ca_system_score_gemma":0.00020516192,"threshold_uncertainty_score":0.6362364},"labels":[],"label_agreement":null},{"id":"W4386175036","doi":"10.1016/j.ygyno.2023.08.005","title":"Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"NRG Oncology; National Cancer Institute; National Institutes of Health; Case Western Reserve University; Memorial Sloan-Kettering Cancer Center; Maine Medical Center; Mayo Clinic","keywords":"Serous carcinoma; Medicine; Clear cell; Clear cell carcinoma; Serous fluid; Endometrial cancer; Carcinoma; Oncology; Gynecologic oncology; Internal medicine; Cancer; Not Otherwise Specified; Pathology; Ovarian cancer","score_opus":0.056781890748017684,"score_gpt":0.32070904083739477,"score_spread":0.26392715008937706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386175036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363113,0.00064120366,0.0000044819235,0.0017147141,0.0022107626,0.0052428283,0.00017450811,0.0002707499,0.006109593],"genre_scores_gemma":[0.9928401,0.00055692997,0.0011941086,0.0031355561,0.00035397973,0.00094577926,0.000057641322,0.000125608,0.0007902922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9882051,0.003927798,0.0026125489,0.0021963117,0.00095574424,0.0021025038],"domain_scores_gemma":[0.9881513,0.006441319,0.0019793266,0.001703788,0.00058913726,0.001135128],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003842387,0.0010557222,0.004223832,0.0011575811,0.0005396618,0.00003453429,0.0015086256,0.0020597149,0.0009968097],"category_scores_gemma":[0.0028068363,0.0007439418,0.00058237516,0.0037251364,0.00097442337,0.0001589563,0.0019356486,0.0017939851,0.00023761898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025949072,0.049064215,0.8217177,0.00095118146,0.00047387552,0.008471134,0.012647224,0.00031142012,0.018362302,0.000072058494,0.0042993515,0.05768046],"study_design_scores_gemma":[0.025939256,0.21683653,0.71435845,0.000018707191,0.0007482992,0.00010817638,0.026767246,0.000041428488,0.0017141503,0.00025882793,0.012624212,0.000584733],"about_ca_topic_score_codex":0.0002947051,"about_ca_topic_score_gemma":0.0010533157,"teacher_disagreement_score":0.16777231,"about_ca_system_score_codex":0.0025357166,"about_ca_system_score_gemma":0.0010501771,"threshold_uncertainty_score":0.99991643},"labels":[],"label_agreement":null},{"id":"W4386281917","doi":"10.1016/j.ygyno.2023.08.007","title":"The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"KRAS; Neuroblastoma RAS viral oncogene homolog; HRAS; Medicine; MAPK/ERK pathway; Cancer research; Serous fluid; Gynecologic oncology; Ovarian cancer; Oncology; Cervix; Cancer; Internal medicine; Biology; Signal transduction; Colorectal cancer; Genetics","score_opus":0.14032292412891686,"score_gpt":0.28610429681241273,"score_spread":0.14578137268349586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386281917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628664,0.00068130135,0.0012687305,0.0027684772,0.00088348123,0.0012195756,0.0001535305,0.00005126913,0.006687018],"genre_scores_gemma":[0.9939276,0.0005692588,0.0006555875,0.0005457199,0.00017242946,0.00093725725,0.00026976882,0.00002670683,0.0028956502],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981106,0.00019618477,0.0005341607,0.00044130386,0.00009229781,0.00062546425],"domain_scores_gemma":[0.9984079,0.00078121806,0.0002531712,0.00042808917,0.000062423795,0.000067170826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011233025,0.00023053028,0.00037888167,0.00012534576,0.00026212606,0.000022009253,0.00046528928,0.0003871914,0.000032641685],"category_scores_gemma":[0.0003968917,0.00016939135,0.0001636763,0.00019134898,0.0003168569,0.0000060176612,0.00020879813,0.00013534886,0.00001634459],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047146875,0.0008419011,0.004364346,0.00013260535,0.0002731178,0.000059417736,0.0006654429,0.0013554256,0.8681508,0.081174366,0.0057459604,0.036765203],"study_design_scores_gemma":[0.0053572785,0.012575689,0.08811308,0.000022501408,0.000117434356,0.0000961504,0.013307511,0.0028824292,0.12194403,0.022804925,0.73163086,0.0011480981],"about_ca_topic_score_codex":0.000011872315,"about_ca_topic_score_gemma":0.0009033187,"teacher_disagreement_score":0.7462067,"about_ca_system_score_codex":0.00009140587,"about_ca_system_score_gemma":0.0005569476,"threshold_uncertainty_score":0.6907579},"labels":[],"label_agreement":null},{"id":"W4386879005","doi":"10.1016/j.ygyno.2023.09.003","title":"Effect of transversus abdominis plane block on postoperative outcomes in gynecologic oncology patients managed on an Enhanced Recovery After Surgery pathway","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Medicine; Opioid; Laparotomy; Morphine; Retrospective cohort study; Internal medicine; Surgery; Subgroup analysis; Anesthesia; Confidence interval","score_opus":0.016825599932209535,"score_gpt":0.2982785787272536,"score_spread":0.28145297879504405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386879005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854562,0.000015407159,0.0000030250449,0.002246839,0.0008395547,0.0025456168,0.000022298535,0.00017960838,0.008691407],"genre_scores_gemma":[0.9904656,0.00015349171,0.00008623947,0.006987027,0.00005063458,0.0008932974,0.00021651865,0.000044119937,0.0011031041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99397784,0.0029178867,0.0009583693,0.00088722084,0.0003799519,0.0008787392],"domain_scores_gemma":[0.9829481,0.0158384,0.00036959432,0.0005540468,0.00008766128,0.00020217945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028677664,0.0005437713,0.0021274078,0.0009479939,0.00010502323,0.000009774509,0.00025962255,0.00080551405,0.0007068174],"category_scores_gemma":[0.0017602162,0.0003991989,0.00035899153,0.0006135002,0.00024376645,0.00008600048,0.00006878506,0.00061991357,0.00051385333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05820822,0.00977243,0.6363713,0.0005550275,0.0007163598,0.010815626,0.0020836906,0.0011275051,0.0011955134,0.00021073932,0.0051895427,0.27375403],"study_design_scores_gemma":[0.0093401605,0.11798579,0.85972047,0.000075096366,0.00018152603,0.000010085169,0.0005083251,0.000050732087,0.0023497043,0.00008683642,0.009265714,0.00042556008],"about_ca_topic_score_codex":0.000032002914,"about_ca_topic_score_gemma":0.0003832029,"teacher_disagreement_score":0.27332848,"about_ca_system_score_codex":0.00091224175,"about_ca_system_score_gemma":0.00025902115,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W4386947947","doi":"10.1016/j.ygyno.2023.06.096","title":"Effect of transversus abdominis plane block on postoperative opioid use in gynecologic oncology patients undergoing laparotomy with enhanced recovery after surgery (ERAS) (1176)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Laparotomy; Transversus abdominis; Gynecologic oncology; Opioid; Postoperative pain; Surgery; Malignancy; Internal medicine","score_opus":0.016859956122521044,"score_gpt":0.27760776493660483,"score_spread":0.26074780881408377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991647,0.000027928369,0.000011644136,0.0011077186,0.0004594997,0.003170375,0.000013265223,0.00015390605,0.0034086402],"genre_scores_gemma":[0.99331367,0.00035774324,0.00026865044,0.003867311,0.000053109463,0.001208318,0.00016322314,0.000046998695,0.0007209604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952155,0.0018399317,0.00085945905,0.00082515966,0.000355262,0.00090472825],"domain_scores_gemma":[0.9753249,0.023543214,0.00039212176,0.00043032286,0.00012868243,0.00018074347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018275962,0.00051742553,0.0018348347,0.0007706474,0.00010617053,0.000015548405,0.00019624742,0.00069590454,0.000514169],"category_scores_gemma":[0.0016959356,0.00037557643,0.0002398216,0.0008125713,0.00030699634,0.0001358943,0.00007477139,0.00057233725,0.00024998016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048779037,0.002694012,0.8979591,0.0006453319,0.00054615387,0.006432837,0.0011664624,0.0013092702,0.0006864947,0.00006475063,0.0044328785,0.03528365],"study_design_scores_gemma":[0.014881777,0.1034316,0.86283964,0.00026048505,0.00034831843,0.000043175743,0.0005182716,0.000063760286,0.0026188693,0.00004949851,0.0144058205,0.00053881214],"about_ca_topic_score_codex":0.000058660273,"about_ca_topic_score_gemma":0.0013274091,"teacher_disagreement_score":0.10073759,"about_ca_system_score_codex":0.0010196369,"about_ca_system_score_gemma":0.0006127837,"threshold_uncertainty_score":0.99986964},"labels":[],"label_agreement":null},{"id":"W4386947976","doi":"10.1016/j.ygyno.2023.06.123","title":"Simple perinephric fat measurement for prediction of failed sentinel lymph node mapping in endometrial cancer (1208)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lakeridge Health; University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Sentinel lymph node; Lymph node; Adipose capsule of kidney; Radiology; Cancer; Oncology; Pathology; Internal medicine; Breast cancer","score_opus":0.1096273237561621,"score_gpt":0.3490813132790601,"score_spread":0.239453989522898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260926,0.00046114868,0.00020115913,0.0013486568,0.0013932395,0.0015747674,0.00016240138,0.00014361729,0.0021057352],"genre_scores_gemma":[0.99651194,0.0004722571,0.0003493638,0.0003865163,0.00049281056,0.0013918255,0.00014860505,0.000020492565,0.00022621657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791855,0.0001246194,0.0006619773,0.00040900565,0.00037124724,0.0005145886],"domain_scores_gemma":[0.99831486,0.00090045814,0.00022864233,0.00019179878,0.00024773765,0.00011651033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084933115,0.00019392336,0.0008241999,0.000733727,0.00006648366,0.0000055698533,0.00011236156,0.000255605,0.00063219666],"category_scores_gemma":[0.002315401,0.00015507112,0.00019833789,0.001764578,0.00006630388,0.000045584537,0.0000858435,0.00012891571,0.00002761783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018407798,0.0008786897,0.91789395,0.00038081803,0.00037060378,0.00007246829,0.00018543957,0.00027762644,0.025889937,0.00006355305,0.0016795254,0.050466605],"study_design_scores_gemma":[0.028255403,0.00096508703,0.95150805,0.000045474088,0.0001897287,0.000004258167,0.00031939923,0.0008689551,0.0012995066,0.0004404264,0.015981223,0.00012249374],"about_ca_topic_score_codex":0.00027242748,"about_ca_topic_score_gemma":0.00011121284,"teacher_disagreement_score":0.050344113,"about_ca_system_score_codex":0.0015479912,"about_ca_system_score_gemma":0.00034576797,"threshold_uncertainty_score":0.69221103},"labels":[],"label_agreement":null},{"id":"W4386947981","doi":"10.1016/j.ygyno.2023.06.127","title":"Evaluating the real-world impact of first line PARP inhibitor maintenance therapy in patients with BRCA mutated ovarian tumors (1213)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; PARP inhibitor; Oncology; Ovarian cancer; BRCA mutation; Poly ADP ribose polymerase; Cancer research; Internal medicine; Gynecology; Cancer; Genetics; Gene; Biology; Polymerase","score_opus":0.06548004029207989,"score_gpt":0.40365563801673904,"score_spread":0.33817559772465916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914298,0.00003554303,0.000010925032,0.0034234447,0.0003541636,0.0018032849,0.000044353867,0.00015275225,0.002745751],"genre_scores_gemma":[0.9972451,0.00023531607,0.00035497293,0.0009827504,0.00016462783,0.00039147932,0.00012750101,0.00004431028,0.00045394854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971983,0.00044875962,0.0007850378,0.0004833887,0.0004048899,0.0006796449],"domain_scores_gemma":[0.9968715,0.0014581516,0.00055398035,0.0005166783,0.00047884134,0.00012087276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014738297,0.0003021642,0.0008112291,0.00037945912,0.00014315211,0.000010211218,0.00023758055,0.00020027507,0.0008478282],"category_scores_gemma":[0.0007462062,0.00017225425,0.00015074175,0.0018520259,0.00038860843,0.0000754118,0.00007076179,0.0005034186,0.00005342729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061245873,0.0010854674,0.9616224,0.000036335114,0.00021430463,0.0001491959,0.0009246761,0.0030640194,0.0011884967,0.00006222555,0.0036211563,0.021907147],"study_design_scores_gemma":[0.016286448,0.025092846,0.95500314,0.00015427869,0.0000330191,0.000009740925,0.00014892299,0.0014327086,0.0003437162,0.0005215967,0.00078059686,0.00019296187],"about_ca_topic_score_codex":0.000678636,"about_ca_topic_score_gemma":0.0017412261,"teacher_disagreement_score":0.024007378,"about_ca_system_score_codex":0.0015060266,"about_ca_system_score_gemma":0.0008600761,"threshold_uncertainty_score":0.9283124},"labels":[],"label_agreement":null},{"id":"W4386947996","doi":"10.1016/j.ygyno.2023.06.126","title":"Utilizing the KELIM score and the chemo-response score to predict chemosensitivity in ovarian cancer (1212)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Oncology; Ovarian cancer; Cohort; Serous carcinoma; Chemotherapy; Progression-free survival; Stage (stratigraphy); Cancer; Gynecologic oncology; Serous fluid; Retrospective cohort study","score_opus":0.04989889377759566,"score_gpt":0.33870280247662016,"score_spread":0.2888039086990245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386947996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.841586,0.00040518882,0.0000032118742,0.15277904,0.00051149103,0.0016632442,0.000023792267,0.000081707076,0.0029463046],"genre_scores_gemma":[0.98776513,0.0007518845,0.000087877735,0.009460506,0.00021163796,0.0011853672,0.000010693536,0.000022362112,0.00050455524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978248,0.0005444203,0.00033521943,0.0005237994,0.00020286067,0.0005688839],"domain_scores_gemma":[0.9956805,0.0035326106,0.000107258136,0.0004518813,0.00007159885,0.00015613779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023244848,0.00023821283,0.0006395294,0.00014068396,0.00022806936,0.00002633522,0.00013911007,0.0002277964,0.00025378322],"category_scores_gemma":[0.0014553702,0.00012586465,0.000098811186,0.0007604171,0.0004240598,0.00003867008,0.00027019728,0.00039186678,0.00008553871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016529987,0.0011714988,0.70114416,0.00014731697,0.00066175463,0.0042024595,0.007490368,0.00029658308,0.0033061174,0.0035520806,0.035691593,0.22580607],"study_design_scores_gemma":[0.0075379563,0.0009734224,0.9675111,0.00008213075,0.00017295241,0.00011324362,0.0010110835,0.00035939197,0.0006297493,0.00040144983,0.02107451,0.00013301731],"about_ca_topic_score_codex":0.0006361592,"about_ca_topic_score_gemma":0.0024925033,"teacher_disagreement_score":0.26636693,"about_ca_system_score_codex":0.0007180879,"about_ca_system_score_gemma":0.0005835547,"threshold_uncertainty_score":0.51326114},"labels":[],"label_agreement":null},{"id":"W4386948038","doi":"10.1016/j.ygyno.2023.06.114","title":"Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer (1198)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cytoreductive surgery; Stage (stratigraphy); Chemotherapy; Ovarian cancer; Epithelial ovarian cancer; Oncology; Internal medicine; Disease; Surgery; Cancer","score_opus":0.030866287699798746,"score_gpt":0.3337528490146308,"score_spread":0.30288656131483205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887357,0.00012902616,0.0000046170144,0.004838284,0.0013194955,0.0011511075,0.000054348617,0.00014195126,0.0036255117],"genre_scores_gemma":[0.9962086,0.00022324314,0.00025898806,0.0014272055,0.00020477475,0.00082778314,0.00016029738,0.000046087465,0.0006429848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779594,0.00016474517,0.0004058902,0.0006004575,0.00028617293,0.00074679084],"domain_scores_gemma":[0.9984159,0.0008437127,0.00017552862,0.0002987531,0.000097936776,0.000168183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044077958,0.00028319456,0.0009202817,0.00035803678,0.000112748174,0.000017338114,0.00010062487,0.00027360403,0.0016418544],"category_scores_gemma":[0.00018878993,0.00021168712,0.00015072526,0.0008634525,0.00010031957,0.000120162964,0.000059871534,0.000292081,0.000080356534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001325817,0.0014567905,0.94876194,0.00003254665,0.00041190616,0.001419941,0.0004667292,0.00011228068,0.000027310638,0.000096330026,0.00331531,0.042573124],"study_design_scores_gemma":[0.011902401,0.0024599626,0.97035897,0.00008324076,0.000112597096,0.0000038342914,0.00031635063,0.000035586778,0.00021020751,0.000107559856,0.014178757,0.00023054687],"about_ca_topic_score_codex":0.0008377902,"about_ca_topic_score_gemma":0.0010449269,"teacher_disagreement_score":0.042342577,"about_ca_system_score_codex":0.0016327818,"about_ca_system_score_gemma":0.0011482905,"threshold_uncertainty_score":0.9992708},"labels":[],"label_agreement":null},{"id":"W4386948064","doi":"10.1016/j.ygyno.2023.06.213","title":"GD2 and GD3 tumor gangliosides as diagnostic markers for all subtypes and stages of ovarian cancer (OC) in liquid biopsies (1310)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Epithelial ovarian cancer; Gynecologic cancer; Gynecology; Oncology; Internal medicine; Liquid biopsy; Cancer; Pathology","score_opus":0.04024976752712966,"score_gpt":0.37925773847447364,"score_spread":0.339007970947344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98790544,0.0015079116,0.0000068643003,0.007410838,0.0001791564,0.0013100804,0.000049779857,0.000058195892,0.0015717427],"genre_scores_gemma":[0.99060565,0.0054396684,0.0011850758,0.0010043714,0.00006770472,0.0007579032,0.000027209022,0.000021103751,0.0008913085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982323,0.00021619843,0.00042646567,0.0004110648,0.00013718792,0.0005767864],"domain_scores_gemma":[0.9904954,0.008892337,0.00014708041,0.00017773896,0.00011171327,0.00017576615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011642986,0.00018889678,0.00093190395,0.00038390758,0.00007776608,0.00000824809,0.00010445604,0.00029111566,0.00041329468],"category_scores_gemma":[0.007164505,0.00015152199,0.000051828527,0.00032477305,0.00065435463,0.000051772815,0.00015397996,0.00022527433,0.00001941432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021995278,0.00026887815,0.9798434,0.0005102022,0.00023835409,0.00079532404,0.00079373707,0.000004203578,0.003922502,0.0009608617,0.0034631235,0.00699992],"study_design_scores_gemma":[0.0045818863,0.009117178,0.97574866,0.00010694738,0.00028785877,0.000116655734,0.0012824383,0.00030234232,0.00070673006,0.0022429156,0.0053322744,0.00017409539],"about_ca_topic_score_codex":0.0008609487,"about_ca_topic_score_gemma":0.001752879,"teacher_disagreement_score":0.008848299,"about_ca_system_score_codex":0.00018864928,"about_ca_system_score_gemma":0.0005721881,"threshold_uncertainty_score":0.8577099},"labels":[],"label_agreement":null},{"id":"W4386948179","doi":"10.1016/j.ygyno.2023.06.285","title":"Thoracic epidural analgesia in Gynecologic Oncology ERAS: A waste of time or time to consider it as a standard of care? (2162)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Perioperative; Nausea; Visual analogue scale; Statistical significance; Institutional review board; Clinical trial; Anesthesia; Surgery; Internal medicine","score_opus":0.03160022300558705,"score_gpt":0.37209404621015246,"score_spread":0.3404938232045654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535085,0.0002473781,0.000021596472,0.0074204123,0.0006815438,0.0020245023,0.00011148545,0.0002140826,0.0357705],"genre_scores_gemma":[0.97892064,0.00026149323,0.0036923809,0.0044259992,0.00014487561,0.0004826985,0.00012173717,0.00007573974,0.011874461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99422944,0.0012455763,0.0018347886,0.00096551725,0.00048433596,0.0012403692],"domain_scores_gemma":[0.98881394,0.008701423,0.0007761267,0.0007603441,0.0005631865,0.00038498567],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002305527,0.00052372046,0.0032836657,0.0013766901,0.00008010879,0.000009055987,0.0004216476,0.0011302785,0.013345595],"category_scores_gemma":[0.008219853,0.0004178858,0.00037563097,0.0022285797,0.00056145847,0.00013184258,0.0004822986,0.0007184411,0.0032653427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06978829,0.0058126617,0.074815154,0.0033664103,0.002298224,0.0387164,0.015308018,0.0058678985,0.19618064,0.00033688368,0.28459454,0.3029149],"study_design_scores_gemma":[0.027726056,0.24387214,0.17600465,0.0019565602,0.0021255224,0.0029322652,0.02327204,0.0017199917,0.09708708,0.004091096,0.41539428,0.0038183255],"about_ca_topic_score_codex":0.00006119019,"about_ca_topic_score_gemma":0.0009663252,"teacher_disagreement_score":0.29909655,"about_ca_system_score_codex":0.0018426822,"about_ca_system_score_gemma":0.0034417147,"threshold_uncertainty_score":0.9998273},"labels":[],"label_agreement":null},{"id":"W4386948191","doi":"10.1016/j.ygyno.2023.06.269","title":"Modern associations of uterine carcinomas with prior exposure to tamoxifen (2144)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tamoxifen; Malignancy; Cohort; Gynecology; Oncology; Internal medicine; Cancer; Breast cancer","score_opus":0.015922817491314415,"score_gpt":0.2918084332604246,"score_spread":0.2758856157691102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953821,0.00016559617,0.00013072656,0.0006408564,0.0001980831,0.0004096092,0.000046472833,0.000054808897,0.0029717707],"genre_scores_gemma":[0.99583024,0.00007003131,0.0013495114,0.00031051284,0.00009182742,0.00010306737,0.00015107222,0.000021308799,0.0020724598],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998853,0.00012618044,0.00022756094,0.00033156452,0.000106726045,0.0003549582],"domain_scores_gemma":[0.9992745,0.00009371748,0.00012965866,0.00028266036,0.00010749527,0.000112001966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026271783,0.00015119143,0.00028956283,0.000091112626,0.00008577838,0.0000058093083,0.00020105025,0.00039005638,0.000036052268],"category_scores_gemma":[0.00021675258,0.00011913563,0.00007381293,0.00029238383,0.00007504396,0.0000028420548,0.00017901674,0.00013077057,0.0000685634],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037242618,0.00042244527,0.0674782,0.000048070535,0.00039638524,0.00018209328,0.0005846886,0.0032135926,0.88696206,0.00018074895,0.010133193,0.030026073],"study_design_scores_gemma":[0.004393203,0.02947584,0.7063078,0.000018201856,0.00016357182,0.00010570403,0.00032692886,0.00031524568,0.16448407,0.00052724796,0.09311177,0.0007704086],"about_ca_topic_score_codex":0.000016827385,"about_ca_topic_score_gemma":0.000099812685,"teacher_disagreement_score":0.72247803,"about_ca_system_score_codex":0.00005941815,"about_ca_system_score_gemma":0.0002085187,"threshold_uncertainty_score":0.485821},"labels":[],"label_agreement":null},{"id":"W4386948224","doi":"10.1016/j.ygyno.2023.06.056","title":"Conversion from robotic surgery to laparotomy: Association of timing of conversion with clinical outcomes (1135)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Laparotomy; General surgery; Robotic surgery; Association (psychology); Surgery","score_opus":0.10358063329433806,"score_gpt":0.38594722901738626,"score_spread":0.28236659572304823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396473,0.0000058899004,0.0000776193,0.002240377,0.0006520311,0.00039715707,0.0000069011526,0.00008780366,0.0025675057],"genre_scores_gemma":[0.99721026,0.000024004163,0.00079707114,0.0013462811,0.000045617347,0.000012454963,0.00007571276,0.000009809793,0.00047880627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998348,0.000268736,0.00062631175,0.0002509138,0.0002629069,0.00024316016],"domain_scores_gemma":[0.98587954,0.013184362,0.00044215916,0.00015434515,0.00020087625,0.00013874404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013001591,0.00011058348,0.00096853566,0.00018381591,0.00003915095,0.0000023258444,0.00006408892,0.0003214719,0.0010839626],"category_scores_gemma":[0.0035907924,0.00008163915,0.0001828623,0.00040409766,0.00007550286,0.0000365239,0.00006398815,0.00018002871,0.00017139594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004807219,0.00021217199,0.9896283,0.00003257185,0.00017279264,0.00007203815,0.0001561132,0.0003679321,0.000083242565,0.00001613507,0.0016409183,0.0071370476],"study_design_scores_gemma":[0.003495307,0.0010367319,0.98046845,0.000044041964,0.00016871099,0.000001155573,0.00040793998,0.0010472636,0.0002574958,0.0000343868,0.012951265,0.00008723796],"about_ca_topic_score_codex":0.000067986985,"about_ca_topic_score_gemma":0.000026214042,"teacher_disagreement_score":0.012915626,"about_ca_system_score_codex":0.00021861648,"about_ca_system_score_gemma":0.00022609354,"threshold_uncertainty_score":0.9998292},"labels":[],"label_agreement":null},{"id":"W4386948292","doi":"10.1016/j.ygyno.2023.06.161","title":"Open-label, phase 2, randomized controlled multicenter study comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in participants with homologous recombination deficient stage III/IV ovarian cancer: Trial in progress (1252)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Taxane; Medicine; Oncology; Chemotherapy; Ovarian cancer; Internal medicine; Randomized controlled trial; Neoadjuvant therapy; Homologous recombination; Cancer; Breast cancer; Biology","score_opus":0.11680953418393418,"score_gpt":0.4368824457352764,"score_spread":0.3200729115513422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95996517,0.0003677466,0.000003257475,0.003549421,0.0014239756,0.033094324,0.000020669198,0.00013173553,0.0014437212],"genre_scores_gemma":[0.96277255,0.0006233044,0.00029029732,0.00025065514,0.000078639285,0.035281677,0.0001304704,0.000046215722,0.00052619126],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99451154,0.0013631465,0.0015473716,0.0010917996,0.00038821722,0.001097946],"domain_scores_gemma":[0.9957661,0.0025212732,0.0008293585,0.00050615304,0.0001350624,0.00024204518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027085375,0.00058065436,0.0042630965,0.0005377715,0.000169764,0.000099330624,0.00030807004,0.00029402462,0.0006049077],"category_scores_gemma":[0.00040110838,0.00038133012,0.00015548118,0.0008146611,0.00023784938,0.00013230428,0.00015451017,0.00035469036,0.000043414348],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85694253,0.056736544,0.04252549,0.000019646488,0.0016640234,0.0032154704,0.0038103536,0.0006119923,0.000020013082,0.00012714726,0.000074498086,0.03425231],"study_design_scores_gemma":[0.9185515,0.056824747,0.012769048,0.00010180398,0.00097080524,0.0000073488695,0.0023801907,0.0074873134,0.00009049266,0.000027359261,0.00045954634,0.00032981255],"about_ca_topic_score_codex":0.004504871,"about_ca_topic_score_gemma":0.017810527,"teacher_disagreement_score":0.061609015,"about_ca_system_score_codex":0.003384249,"about_ca_system_score_gemma":0.0011273507,"threshold_uncertainty_score":0.99986386},"labels":[],"label_agreement":null},{"id":"W4386948431","doi":"10.1016/j.ygyno.2023.06.210","title":"ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (1307)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; London Health Sciences Centre; Hamilton Health Sciences","funders":"","keywords":"Medicine; Fallopian tube; Pembrolizumab; Ovarian cancer; Chemotherapy; Oncology; Epithelial ovarian cancer; Gynecology; Fallopian tube cancer; Internal medicine; Cancer; Immunotherapy","score_opus":0.02552190575230495,"score_gpt":0.328918895938515,"score_spread":0.30339699018621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504745,0.000023209,0.0000027190126,0.0011216248,0.00029948485,0.0029219817,0.00008838145,0.000049679966,0.0004454682],"genre_scores_gemma":[0.9978682,0.00006945215,0.00037156485,0.00029048254,0.000044824214,0.0010287226,0.00016875495,0.000036318193,0.00012172987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780256,0.00019784574,0.00058053224,0.00057206576,0.00036571204,0.0004812984],"domain_scores_gemma":[0.9987461,0.0004141462,0.0002798204,0.0003138513,0.00013867341,0.0001074363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002275444,0.0002968255,0.0008673366,0.00030722594,0.000058545873,0.00001175109,0.00012864196,0.0001941262,0.00039092597],"category_scores_gemma":[0.00007310854,0.00019848508,0.00003818259,0.00070551434,0.00012652228,0.00008732982,0.00005356753,0.00027043745,0.000007910673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10817488,0.028455175,0.83257914,0.000106134365,0.00038499062,0.0012912664,0.0025593427,0.00021129021,0.000110925364,0.000026840124,0.00015615637,0.025943844],"study_design_scores_gemma":[0.20072295,0.048386272,0.7487305,0.00009043936,0.00014213544,0.0000024364924,0.0008871233,0.00018648758,0.00006337508,0.0000046535374,0.00062119524,0.0001624537],"about_ca_topic_score_codex":0.0012571388,"about_ca_topic_score_gemma":0.018776566,"teacher_disagreement_score":0.09254807,"about_ca_system_score_codex":0.0016879869,"about_ca_system_score_gemma":0.0007434365,"threshold_uncertainty_score":0.9991282},"labels":[],"label_agreement":null},{"id":"W4386948446","doi":"10.1016/j.ygyno.2023.06.275","title":"Acceptability and preferences of dry HPV self-sampling among Canadian women: A cross-sectional study (2150)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cross-sectional study; Cervical cancer; Sampling (signal processing); Population; Demography; Gynecology; Environmental health; Cancer; Internal medicine; Pathology","score_opus":0.0810117252407598,"score_gpt":0.41169437484762017,"score_spread":0.3306826496068604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778501,0.00004009152,0.0000013530632,0.00016415466,0.0002999543,0.00084400125,0.00002532484,0.00009794883,0.02067711],"genre_scores_gemma":[0.9989837,0.000047500853,0.00011924246,0.00012516204,0.00010941626,0.0003027401,0.000017519036,0.000009148525,0.00028561268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981062,0.00018529853,0.00039029552,0.0004429652,0.00027157704,0.0006036765],"domain_scores_gemma":[0.99799395,0.001011905,0.00007403869,0.00022306279,0.00026161582,0.00043542014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015965033,0.00012830879,0.00046801436,0.00027783742,0.00019791954,0.000025733345,0.00015748215,0.00026708026,0.015001428],"category_scores_gemma":[0.0010597121,0.000104368846,0.000053408727,0.0005105451,0.00035328537,0.00006185318,0.000175747,0.0004067085,0.000042995296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015215373,0.00038500142,0.97525537,0.00008834005,0.00008097815,0.000044358716,0.0013011381,0.000014036477,0.000010660899,0.000026116733,0.000046167075,0.022595705],"study_design_scores_gemma":[0.0014674526,0.0036302446,0.98931867,7.059515e-7,0.000018305025,0.0000039227853,0.0029622775,0.00012555334,0.000005908357,0.0007914245,0.0015860662,0.00008947178],"about_ca_topic_score_codex":0.019761726,"about_ca_topic_score_gemma":0.20251152,"teacher_disagreement_score":0.18274978,"about_ca_system_score_codex":0.0009943036,"about_ca_system_score_gemma":0.0013636685,"threshold_uncertainty_score":0.98676574},"labels":[],"label_agreement":null},{"id":"W4386948492","doi":"10.1016/j.ygyno.2023.06.524","title":"Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY) (LBA 11)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Placebo; Randomized controlled trial; Chemotherapy; Oncology; Gynecology; Internal medicine; Cancer; Alternative medicine","score_opus":0.04580516515268085,"score_gpt":0.37405272167996534,"score_spread":0.3282475565272845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95295954,0.0024541058,0.00019685326,0.006950196,0.0024429713,0.033975203,0.00013546675,0.00014482348,0.00074084697],"genre_scores_gemma":[0.93166983,0.02067463,0.0010956301,0.0007691907,0.0007256899,0.04318027,0.0003876388,0.00006592183,0.0014312166],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964732,0.00067525526,0.0011999038,0.0005967693,0.00041155462,0.00064329675],"domain_scores_gemma":[0.97722113,0.021298615,0.00076666736,0.0003482038,0.00022379242,0.0001415658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016674607,0.00043915937,0.0034781836,0.0006352915,0.00014101592,0.000015116614,0.00019740684,0.0003028875,0.000522786],"category_scores_gemma":[0.0026752946,0.00020912701,0.000611176,0.0016335101,0.00028302646,0.00007066983,0.00002888424,0.00018301011,0.000007923088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6846396,0.0068992334,0.00010727639,0.00005461056,0.0009397987,0.00005690083,0.00041968966,0.00005158218,0.00018241644,0.00005213977,0.00011603353,0.30648077],"study_design_scores_gemma":[0.8942236,0.086365074,0.00045616957,0.000041863193,0.0013090736,0.000006477104,0.00024833818,0.0006352975,0.00057643827,0.00025857426,0.015686989,0.00019213022],"about_ca_topic_score_codex":0.0002744063,"about_ca_topic_score_gemma":0.0012775193,"teacher_disagreement_score":0.30628863,"about_ca_system_score_codex":0.0021340377,"about_ca_system_score_gemma":0.0011543712,"threshold_uncertainty_score":0.8527952},"labels":[],"label_agreement":null},{"id":"W4386948541","doi":"10.1016/j.ygyno.2023.06.512","title":"ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma (039)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Serous fluid; Internal medicine; Oncology; Chemotherapy; Phases of clinical research; Carcinoma","score_opus":0.18872423698836044,"score_gpt":0.45938250563496513,"score_spread":0.2706582686466047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828349,0.00055804255,0.000007967794,0.007157592,0.00075667806,0.0077130464,0.00009004426,0.00007245873,0.0008092689],"genre_scores_gemma":[0.9949689,0.00044352037,0.00095554395,0.0006022374,0.00012299903,0.0017264914,0.000096476324,0.00003781237,0.001046036],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974224,0.00034510036,0.0007112305,0.000745367,0.00020638526,0.0005694944],"domain_scores_gemma":[0.9963412,0.002383219,0.00035234937,0.00053183583,0.00017680302,0.00021455443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058644445,0.00038580253,0.0010754488,0.00012915704,0.00034274868,0.0000669648,0.00025229275,0.00016447727,0.00034795757],"category_scores_gemma":[0.00044495324,0.00021727323,0.00014026192,0.00031559408,0.00017659248,0.000095112126,0.0003362568,0.00015128724,0.00002034315],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0259934,0.13805372,0.03863842,0.00026194725,0.0028670225,0.0019864943,0.006026027,0.00003550761,0.0011141615,0.00007485326,0.0025922991,0.78235614],"study_design_scores_gemma":[0.20365997,0.44795287,0.22094496,0.00018855669,0.0035452303,0.00021223768,0.01145592,0.0016400006,0.00068040384,0.00003423512,0.109208494,0.00047712738],"about_ca_topic_score_codex":0.00022755074,"about_ca_topic_score_gemma":0.0006967414,"teacher_disagreement_score":0.781879,"about_ca_system_score_codex":0.0012805149,"about_ca_system_score_gemma":0.0005629451,"threshold_uncertainty_score":0.8860145},"labels":[],"label_agreement":null},{"id":"W4386948542","doi":"10.1016/j.ygyno.2023.06.523","title":"Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study (LBA 10)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Carboplatin; Medicine; Pembrolizumab; Endometrial cancer; Oncology; Paclitaxel; Internal medicine; Chemotherapy; Placebo; Stage (stratigraphy); Cancer; Pathology; Cisplatin; Immunotherapy","score_opus":0.1841982525081639,"score_gpt":0.4523627754498964,"score_spread":0.2681645229417325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843665,0.0003521121,0.00000987036,0.0019618259,0.0026304796,0.008138626,0.0011035245,0.00013348916,0.0013035691],"genre_scores_gemma":[0.9839236,0.00049963314,0.00017517467,0.0004208872,0.000539083,0.007206784,0.00020070747,0.000038363203,0.0069957445],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99688554,0.0005319901,0.00067381765,0.0007224431,0.0004091415,0.0007770637],"domain_scores_gemma":[0.98900133,0.0099578155,0.00023772861,0.00034442314,0.0001638483,0.0002948282],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015248698,0.0003424883,0.0010236131,0.0005561395,0.00024608057,0.000032804546,0.00020664431,0.00024950088,0.0051133353],"category_scores_gemma":[0.010244803,0.0001963213,0.000119544085,0.002014872,0.00010782437,0.00007896837,0.00016317559,0.0003298275,0.00007912123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55231136,0.006071212,0.0031669028,0.0002585731,0.00083473005,0.001298745,0.00229483,0.00015429137,0.0004907873,0.000090700654,0.017778667,0.4152492],"study_design_scores_gemma":[0.49080124,0.20463164,0.02713427,0.00009692395,0.0010364273,0.000020889158,0.013674787,0.00061571936,0.0004912147,0.00011249071,0.2607064,0.0006780152],"about_ca_topic_score_codex":0.0008065632,"about_ca_topic_score_gemma":0.018605243,"teacher_disagreement_score":0.41457117,"about_ca_system_score_codex":0.0016728461,"about_ca_system_score_gemma":0.00086644036,"threshold_uncertainty_score":0.9993026},"labels":[],"label_agreement":null},{"id":"W4386948615","doi":"10.1016/j.ygyno.2023.06.508","title":"Final overall survival and long-term safety in the ENGOT-OV16/NOVA phase III trial of niraparib in patients with recurrent ovarian cancer (LBA 6)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Germline; Cancer; Gene; Genetics; Biology","score_opus":0.07166682431699495,"score_gpt":0.3849911861315105,"score_spread":0.31332436181451556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217296,0.00010659144,0.000014966208,0.0027447771,0.0011190041,0.0019526877,0.000056985922,0.000032967637,0.0017990767],"genre_scores_gemma":[0.9980225,0.00049550284,0.000059565453,0.0006706463,0.00017912331,0.0003413242,0.00013955342,0.000014976847,0.000076838434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768656,0.00049854536,0.0006545264,0.0004053424,0.0003175251,0.00043748727],"domain_scores_gemma":[0.998354,0.00090700097,0.00028656374,0.00028252412,0.000095630036,0.00007428272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012013855,0.00020926118,0.00073439156,0.0002623883,0.00005537499,0.000007418924,0.00016399914,0.000248658,0.0006760608],"category_scores_gemma":[0.00019299191,0.00014071006,0.000058651607,0.00060053676,0.00025399655,0.00006335247,0.0000618258,0.0004775094,0.000007651791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2250956,0.005464049,0.6510623,0.000096765296,0.00015137008,0.00033016587,0.0020992379,0.000062415864,0.00014836976,0.00069097755,0.0015760623,0.11322268],"study_design_scores_gemma":[0.25228214,0.009545676,0.73545814,0.00007041132,0.0000449731,0.0000054848556,0.000099284414,0.000028114844,0.000018676335,0.00014389471,0.0021783733,0.00012482404],"about_ca_topic_score_codex":0.00019347637,"about_ca_topic_score_gemma":0.0035651948,"teacher_disagreement_score":0.113097854,"about_ca_system_score_codex":0.00054553413,"about_ca_system_score_gemma":0.000506897,"threshold_uncertainty_score":0.74023914},"labels":[],"label_agreement":null},{"id":"W4386948636","doi":"10.1016/j.ygyno.2023.06.534","title":"Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva (059)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Vulva; Groin; Inguinal lymph nodes; Lymph node; Radiation therapy; Basal cell; Vulvar cancer; Carcinoma; Lymph; Surgery; Radiology; General surgery; Internal medicine; Pathology","score_opus":0.022925517528897554,"score_gpt":0.30286058584844494,"score_spread":0.2799350683195474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9352346,0.0005104195,0.0000058347287,0.00060768065,0.00044377107,0.0006583751,0.000013710201,0.000032986605,0.062492598],"genre_scores_gemma":[0.9970401,0.00023526943,0.00043778407,0.00023672082,0.000035589474,0.000121342186,0.000013702749,0.000014100129,0.001865386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811584,0.00019878394,0.00059142837,0.00033178276,0.00031428612,0.00044785338],"domain_scores_gemma":[0.998246,0.0009641409,0.00024058098,0.00034529844,0.0001151719,0.0000887771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046882778,0.00017699842,0.00068377546,0.00022563193,0.000044194,0.0000023984967,0.00029080352,0.00020101901,0.0004752731],"category_scores_gemma":[0.00028016043,0.000112985195,0.00016197869,0.0015179542,0.00019727032,0.000026046007,0.0003021037,0.00018011521,0.000035536283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037041977,0.0031560059,0.8802984,0.001219444,0.00012731162,0.0028781951,0.0002781304,0.000908731,0.0024298306,0.0015278397,0.00024908903,0.10322286],"study_design_scores_gemma":[0.013619698,0.0024188913,0.97763115,0.000055703167,0.00013110283,0.000019872161,0.00046712253,0.000072531075,0.002466226,0.0007022168,0.002304151,0.00011134227],"about_ca_topic_score_codex":0.00024833495,"about_ca_topic_score_gemma":0.0001254712,"teacher_disagreement_score":0.10311152,"about_ca_system_score_codex":0.00045486103,"about_ca_system_score_gemma":0.00026643302,"threshold_uncertainty_score":0.5203907},"labels":[],"label_agreement":null},{"id":"W4386948660","doi":"10.1016/j.ygyno.2023.06.554","title":"Lunchbox trial: A randomized phase III trial of Cisplatin and irradiation followed by Carboplatin and Paclitaxel vs. sandwich therapy of Carboplatin and Paclitaxel followed by irradiation then Carboplatin and Paclitaxel for advanced endometrial carcinoma (168)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Paclitaxel; Medicine; Cisplatin; Randomized controlled trial; Chemotherapy; Oncology; Irradiation; Internal medicine","score_opus":0.02741821178592684,"score_gpt":0.3401648152750643,"score_spread":0.31274660348913746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733088,0.0104102325,0.000062014726,0.00093022804,0.0010736305,0.012761234,0.0008540369,0.000105634484,0.00049416453],"genre_scores_gemma":[0.9899224,0.0053902618,0.0008794104,0.0002332541,0.00030707064,0.0021888062,0.0007465337,0.00007448264,0.00025779527],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99399376,0.0012615012,0.0021940994,0.0011536723,0.0005934226,0.00080357393],"domain_scores_gemma":[0.9816988,0.01559898,0.0015765578,0.00042718687,0.0002489437,0.00044951428],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035110246,0.0007344079,0.004024938,0.0007911473,0.00025152462,0.00004492629,0.00015298509,0.00087170885,0.00007475464],"category_scores_gemma":[0.008470386,0.0005756242,0.00042320308,0.0011432604,0.000606912,0.00021019616,0.00012519477,0.00038052985,9.5039445e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8887549,0.0012117475,0.0024776745,0.00021176749,0.00091261824,0.000020754176,0.0017211543,0.0000030488952,0.047360603,0.00016682048,0.001212852,0.055946082],"study_design_scores_gemma":[0.95036346,0.034208175,0.008004184,0.000048299033,0.0011688943,0.000012789185,0.0007726288,0.0010593057,0.0016811539,0.0011745989,0.0010232755,0.00048322623],"about_ca_topic_score_codex":0.00079680444,"about_ca_topic_score_gemma":0.0001361932,"teacher_disagreement_score":0.061608594,"about_ca_system_score_codex":0.00031207665,"about_ca_system_score_gemma":0.00038867677,"threshold_uncertainty_score":0.9998817},"labels":[],"label_agreement":null},{"id":"W4386948667","doi":"10.1016/j.ygyno.2023.06.566","title":"Maveropepimut-S, an immune-educating therapy with durable clinical benefit in patients with recurrent ovarian cancer (180)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Princess Margaret Cancer Centre","funders":"","keywords":"Survivin; Medicine; Ovarian cancer; Immune system; CD8; Cyclophosphamide; Oncology; Chemotherapy; Immunotherapy; T cell; Internal medicine; Cancer; Cancer research; Immunology","score_opus":0.034237935522048776,"score_gpt":0.33174962631568133,"score_spread":0.29751169079363254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244326,0.0024480955,0.000004516642,0.0008442189,0.0020394719,0.0010177233,0.000033630273,0.00021895314,0.00095011544],"genre_scores_gemma":[0.9930014,0.0025965613,0.00021595652,0.0007519065,0.000055231765,0.00045256483,0.00035032196,0.000060802256,0.002515281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582154,0.0013418335,0.00089931197,0.00077606866,0.00008406397,0.001077203],"domain_scores_gemma":[0.9974796,0.0011584396,0.00046740033,0.0006406968,0.00020028102,0.000053593376],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014167831,0.0004259792,0.00095949986,0.0003302869,0.00040240516,0.000028877621,0.0005856404,0.0006853276,0.0023071074],"category_scores_gemma":[0.00019530654,0.00029005788,0.00010821679,0.0007561009,0.00051779056,0.0002328836,0.00011817431,0.0009547441,0.00047923715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0144317765,0.0033615024,0.6287747,0.000014247481,0.0005382376,0.00004944358,0.0012494217,0.000108551845,0.0034325966,0.00024412005,0.0008896327,0.34690574],"study_design_scores_gemma":[0.012357598,0.013915682,0.91456383,0.00005872544,0.000032942786,0.00001806043,0.00071439013,0.000006092463,0.00063268666,0.000083007726,0.05717857,0.0004384013],"about_ca_topic_score_codex":0.0005941097,"about_ca_topic_score_gemma":0.0009945082,"teacher_disagreement_score":0.34646735,"about_ca_system_score_codex":0.00032237032,"about_ca_system_score_gemma":0.00069172826,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W4386948684","doi":"10.1016/j.ygyno.2023.06.368","title":"Fragmentation of surgery and adjuvant treatment in high-grade endometrial cancer: Does it impact survival? (2250)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; University Health Network; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endometrial cancer; Adjuvant; Retrospective cohort study; Population; Internal medicine; Adjuvant therapy; Gynecologic oncology; Surgery; Adverse effect; Cohort; Oncology; Cancer","score_opus":0.07756132186539855,"score_gpt":0.391067932291566,"score_spread":0.31350661042616745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99327147,0.00079258485,0.0000016214226,0.0030695777,0.0014560522,0.0008116573,0.00010709301,0.00006238338,0.00042755905],"genre_scores_gemma":[0.98955137,0.009094168,0.000083825165,0.00019053393,0.00022247955,0.00037554995,0.00016298486,0.00001574488,0.0003033513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980696,0.00029053373,0.00058331137,0.00038542462,0.00022697148,0.00044416392],"domain_scores_gemma":[0.9946104,0.004761909,0.00023426123,0.00017063206,0.0000566947,0.00016608689],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005769897,0.00022810255,0.0012492134,0.00077685795,0.000046374815,0.0000065247505,0.00005882081,0.00023994775,0.001178917],"category_scores_gemma":[0.0008561734,0.00013334904,0.00019023854,0.0013946973,0.00012061696,0.00005620193,0.00005229138,0.00012231064,0.000024821073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017820916,0.0010318459,0.8300492,0.000061217535,0.00036112135,0.0003670322,0.00027608778,0.000058929203,0.0017127442,0.000041663163,0.00037565117,0.16388237],"study_design_scores_gemma":[0.014830429,0.0047391756,0.9751695,0.000032441043,0.0002468972,0.000009150274,0.0004934341,0.000028259894,0.0019152156,0.0005715175,0.0018239943,0.00014002367],"about_ca_topic_score_codex":0.006621206,"about_ca_topic_score_gemma":0.004451162,"teacher_disagreement_score":0.16374235,"about_ca_system_score_codex":0.0013400356,"about_ca_system_score_gemma":0.0004850115,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W4386948690","doi":"10.1016/j.ygyno.2023.06.558","title":"Extent of disease and oncologic outcomes in cervical cancer patients undergoing minimally invasive and open radical hysterectomy (172)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; North York General Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radical Hysterectomy; Cervical cancer; Hysterectomy; Invasive surgery; Stage (stratigraphy); Surgery; Radical surgery; Open surgery; Disease; Cancer; Internal medicine","score_opus":0.047643132090908584,"score_gpt":0.3570677346456781,"score_spread":0.3094246025547695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159354,0.00044791974,3.9709028e-7,0.0045176325,0.0002808593,0.0014054523,0.000044454722,0.000039555933,0.0016701773],"genre_scores_gemma":[0.99565506,0.0015137651,0.00027506708,0.0017354069,0.000035425095,0.00043225085,0.000042003478,0.000014588248,0.00029642615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809283,0.00025510232,0.000516567,0.0005124493,0.0002077174,0.00041535942],"domain_scores_gemma":[0.99624604,0.0029814567,0.0001862832,0.00015959126,0.000074145835,0.00035246857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032217056,0.00021756321,0.0010202752,0.00025619948,0.000065332075,0.000016199678,0.00018604462,0.0002241325,0.00038244735],"category_scores_gemma":[0.0018569432,0.00015242778,0.00007262898,0.0004955952,0.00027176962,0.00008750605,0.0006474341,0.00020420419,0.000017440783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016041963,0.0013295187,0.9737392,0.00021841703,0.00014611974,0.00032919293,0.00015395605,0.0000029985904,0.00012149857,0.00011333093,0.0001938833,0.02204766],"study_design_scores_gemma":[0.015981317,0.0062661716,0.9751717,0.000086742504,0.00020010165,0.0000037619257,0.00020984319,0.000024914814,0.00005069228,0.0012702021,0.0005905901,0.00014396489],"about_ca_topic_score_codex":0.00031348178,"about_ca_topic_score_gemma":0.0024931906,"teacher_disagreement_score":0.021903694,"about_ca_system_score_codex":0.00052404683,"about_ca_system_score_gemma":0.0006583246,"threshold_uncertainty_score":0.6215824},"labels":[],"label_agreement":null},{"id":"W4386948736","doi":"10.1016/j.ygyno.2023.06.563","title":"Characterization of tumor response with lenvatinib plus pembrolizumab in study 309/KEYNOTE-775 (177)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Internal medicine; Population; Gynecology; Cancer; Immunotherapy","score_opus":0.04206576571139336,"score_gpt":0.3398914948704291,"score_spread":0.2978257291590357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957508,0.000018003228,0.0000074427858,0.0011750283,0.0002855,0.0014785918,0.000020047823,0.00010870671,0.0011558955],"genre_scores_gemma":[0.9980557,0.000029887944,0.000090556816,0.00045984128,0.00007146117,0.00037934264,0.00007855246,0.000020061922,0.0008145942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801934,0.0004783814,0.00049306906,0.00037939657,0.00025720824,0.00037263203],"domain_scores_gemma":[0.99816155,0.0011284756,0.00023192451,0.0002672898,0.00011013106,0.00010060595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007600677,0.0001831857,0.00079276133,0.00047437995,0.00004872874,0.0000050489625,0.0001238074,0.00014363899,0.00054542645],"category_scores_gemma":[0.0009938478,0.00012756167,0.000056870467,0.0015390974,0.000102450846,0.000057085785,0.00008757764,0.0002176806,0.00011186844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14951341,0.0066992217,0.7529453,0.0001887834,0.00035755348,0.005912528,0.0033085463,0.000097276294,0.056257658,0.00008669401,0.00012710973,0.024505936],"study_design_scores_gemma":[0.023236161,0.02233539,0.9506255,0.000026667909,0.00010278343,0.00003756225,0.00088714546,0.000052253123,0.0012458543,0.00005001624,0.0012841005,0.000116590265],"about_ca_topic_score_codex":0.0000899028,"about_ca_topic_score_gemma":0.00030907232,"teacher_disagreement_score":0.19768019,"about_ca_system_score_codex":0.00062400923,"about_ca_system_score_gemma":0.0005870511,"threshold_uncertainty_score":0.59720373},"labels":[],"label_agreement":null},{"id":"W4386948749","doi":"10.1016/j.ygyno.2023.06.435","title":"Impact factor bias in randomized controlled trials in gynecologic oncology (2318)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gynecologic oncology; Medicine; Randomized controlled trial; Oncology; Impact factor; Gynecology; Publication bias; Internal medicine; Meta-analysis","score_opus":0.4502159516478472,"score_gpt":0.5601831202960488,"score_spread":0.10996716864820155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9148212,0.0008163247,0.000029194873,0.047875468,0.0014051873,0.012474591,0.000036990197,0.00030976615,0.022231298],"genre_scores_gemma":[0.97605217,0.005948164,0.00033587974,0.011843868,0.00038115098,0.0034975472,0.00011917538,0.000046036577,0.0017759862],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9658942,0.022796528,0.00529425,0.0010033109,0.00095419755,0.004057498],"domain_scores_gemma":[0.6561894,0.33359674,0.0021846278,0.00091608404,0.00050043414,0.0066127004],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.100330696,0.0006329047,0.016526852,0.002824045,0.000114899274,0.000029835768,0.0004318273,0.001989873,0.008686967],"category_scores_gemma":[0.80088663,0.00036053857,0.0017426454,0.002270955,0.000763622,0.00012823012,0.00024066688,0.002299876,0.0013886618],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.4928031,0.005214948,0.07552548,0.0003234693,0.0010192201,0.016871309,0.0015044076,0.00013363478,0.001500274,0.0004786685,0.049075723,0.35554978],"study_design_scores_gemma":[0.7287633,0.013473134,0.20477769,0.00011003765,0.00023171131,0.00011870762,0.0005778284,0.0022219042,0.000030301479,0.0023475129,0.04697186,0.00037600912],"about_ca_topic_score_codex":0.0006548693,"about_ca_topic_score_gemma":0.0019304953,"teacher_disagreement_score":0.7005559,"about_ca_system_score_codex":0.005664837,"about_ca_system_score_gemma":0.024267428,"threshold_uncertainty_score":0.99988467},"labels":[],"label_agreement":null},{"id":"W4386948750","doi":"10.1016/j.ygyno.2023.06.561","title":"The use of Indocyanine Green (ICG) for sentinel lymph node detection in vulvar cancer (175)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Indocyanine green; Medicine; Vulvar cancer; Sentinel lymph node; Lymph node; Lymph; Radiology; Nuclear medicine; Surgery; Cancer; Pathology; Internal medicine; Vulva; Breast cancer","score_opus":0.0914912407769173,"score_gpt":0.3568166360473682,"score_spread":0.2653253952704509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933408,0.00023303185,0.000045009776,0.004191129,0.0007723109,0.0008140349,0.00003120584,0.00007360972,0.00049886666],"genre_scores_gemma":[0.99434423,0.0009072239,0.0002486744,0.0011020718,0.00021792941,0.000874655,0.000032637243,0.0000181581,0.0022544437],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986956,0.00011241517,0.00040554395,0.0002545904,0.00013729058,0.00039451834],"domain_scores_gemma":[0.99693567,0.002518064,0.0001706968,0.00018636567,0.000117060525,0.00007214452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003780759,0.00013132143,0.00046031034,0.00019018709,0.00009901374,0.0000063631755,0.00009967777,0.00021132061,0.00013546653],"category_scores_gemma":[0.0010997334,0.00008234797,0.00011291255,0.00080653845,0.000105534134,0.000043230375,0.000074994,0.00012843928,0.000031058513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037231774,0.0006811888,0.46825832,0.00017870626,0.00033061806,0.00014133236,0.00015516518,0.0002959379,0.010736618,0.00013638053,0.001302404,0.51406014],"study_design_scores_gemma":[0.009988664,0.0010870212,0.9315831,0.000020282205,0.00015937065,0.000012501698,0.000096015734,0.0010904782,0.0021665846,0.0005504862,0.053141963,0.00010351973],"about_ca_topic_score_codex":0.0011832372,"about_ca_topic_score_gemma":0.0021692407,"teacher_disagreement_score":0.5139566,"about_ca_system_score_codex":0.0005305403,"about_ca_system_score_gemma":0.00020648394,"threshold_uncertainty_score":0.33580527},"labels":[],"label_agreement":null},{"id":"W4386948910","doi":"10.1016/j.ygyno.2023.06.339","title":"Surgical stage at presentation for endometrial cancer during the COVID-19 pandemic in Ontario, Canada (2219)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Stage (stratigraphy); Endometrial cancer; 2019-20 coronavirus outbreak; Cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); General surgery; Presentation (obstetrics); Gynecology; Surgery; Internal medicine; Pathology; Disease; Infectious disease (medical specialty)","score_opus":0.18234084587785399,"score_gpt":0.4593986244919698,"score_spread":0.2770577786141158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669989,0.00014782386,0.0000048184393,0.028910602,0.0013426705,0.0019609989,0.0000832406,0.00009064096,0.00046032303],"genre_scores_gemma":[0.9785193,0.0002985728,0.000018606564,0.007732,0.0003139437,0.0008010007,0.000108462096,0.000015664746,0.012192431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979134,0.0002616049,0.00045875172,0.00038067193,0.00026603616,0.0007195026],"domain_scores_gemma":[0.9909546,0.008228778,0.00016762399,0.00021746836,0.00006783409,0.00036370222],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011309378,0.00016055275,0.0005173119,0.00023685284,0.00027893568,0.0000083112955,0.00014465411,0.00027555894,0.0024534874],"category_scores_gemma":[0.0046477146,0.000113031485,0.00008566493,0.000534272,0.00009044517,0.00003611557,0.00012292048,0.0004304969,0.000013347869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023902908,0.00006506174,0.97530395,0.00019946473,0.00004340711,0.001039957,0.0007832312,0.00077686907,0.00026692398,0.00005311344,0.017001837,0.0020758808],"study_design_scores_gemma":[0.006617326,0.0004807661,0.52966887,0.0000047180138,0.000025561589,0.000058431204,0.00023657292,0.00006214291,0.000021808999,0.000054388744,0.46269202,0.00007738514],"about_ca_topic_score_codex":0.9678776,"about_ca_topic_score_gemma":0.999646,"teacher_disagreement_score":0.44569018,"about_ca_system_score_codex":0.020695949,"about_ca_system_score_gemma":0.016295465,"threshold_uncertainty_score":0.9984584},"labels":[],"label_agreement":null},{"id":"W4386948919","doi":"10.1016/j.ygyno.2023.06.326","title":"Gestational trophoblastic neoplasia (GTN): Does centralization of care impact clinical management? (2206)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Gestational trophoblastic neoplasia; Medicine; Referral; Malignancy; Obstetrics; Health care; Gestation; Gynecology; Choriocarcinoma; Pregnancy; Internal medicine; Family medicine","score_opus":0.024591107954112505,"score_gpt":0.39834335706082197,"score_spread":0.37375224910670946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386948919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98840284,0.00012027252,0.00024726617,0.0008493577,0.0011364566,0.0008012944,0.00015947809,0.00019414083,0.008088917],"genre_scores_gemma":[0.99437207,0.00062809984,0.003124697,0.00026001644,0.00014402693,0.00010073007,0.0005802966,0.000023715067,0.00076635263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782413,0.00021005554,0.0007200359,0.00042296937,0.0003761131,0.0004466916],"domain_scores_gemma":[0.99734765,0.0015651789,0.00027733954,0.00022075666,0.000389492,0.00019955968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026427006,0.00021636565,0.000635778,0.00028529708,0.00011369531,0.000007883476,0.0001268712,0.00018678309,0.0009845629],"category_scores_gemma":[0.0013952036,0.0001515824,0.0002519597,0.0005780293,0.00033749433,0.00005332741,0.00012212204,0.00017372835,0.00034791176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024557377,0.0016291543,0.92030907,0.0011952863,0.0015581748,0.0017464475,0.0013573121,0.004039567,0.0003273859,0.010663035,0.030467685,0.024251167],"study_design_scores_gemma":[0.0030809632,0.00290231,0.9843787,0.00004365358,0.00042948537,0.00001816364,0.0029498423,0.0004628146,0.00002039912,0.0014715218,0.004102273,0.00013990063],"about_ca_topic_score_codex":0.0000102336835,"about_ca_topic_score_gemma":0.00003261356,"teacher_disagreement_score":0.06406963,"about_ca_system_score_codex":0.00036118188,"about_ca_system_score_gemma":0.0004926606,"threshold_uncertainty_score":0.99992865},"labels":[],"label_agreement":null},{"id":"W4386949040","doi":"10.1016/j.ygyno.2023.06.329","title":"Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer: Retrospective US cohort study (2209)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Tolerability; Ovarian cancer; Oncology; Retrospective cohort study; PARP inhibitor; Cohort; Internal medicine; Gynecology; Cancer; Poly ADP ribose polymerase; Adverse effect","score_opus":0.05951657630883816,"score_gpt":0.42353143367182217,"score_spread":0.364014857362984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386949040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756765,0.00009686295,0.0000032880334,0.0015774609,0.0014554583,0.004963355,0.00004077082,0.00019279761,0.01599352],"genre_scores_gemma":[0.9951386,0.00029200196,0.00022845532,0.0002446941,0.0002092407,0.003356127,0.000054333384,0.000026620344,0.00044996894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580896,0.0011199113,0.0009810368,0.0008060254,0.0007773339,0.00050672615],"domain_scores_gemma":[0.9973704,0.00069720525,0.0004648827,0.00060408766,0.00074129284,0.00012209125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005244164,0.00024966017,0.0011619993,0.0004970227,0.00008758678,0.000005797815,0.00015812546,0.00026489215,0.0020789285],"category_scores_gemma":[0.0013140639,0.0002334297,0.00011153113,0.0018251612,0.00023321122,0.000100244826,0.00009124727,0.00047096037,0.00005238276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078418053,0.0014650886,0.97677344,0.000030457553,0.00013066696,0.00006525822,0.0007651423,0.001187782,0.0028997152,0.00014888599,0.0008948698,0.014854523],"study_design_scores_gemma":[0.010938182,0.0033892065,0.97944903,0.000045116954,0.00021350944,0.000004356269,0.0007602629,0.0007422246,0.0010076656,0.002134528,0.0011280167,0.00018791427],"about_ca_topic_score_codex":0.0017554759,"about_ca_topic_score_gemma":0.018589377,"teacher_disagreement_score":0.019462073,"about_ca_system_score_codex":0.0062958016,"about_ca_system_score_gemma":0.0015356619,"threshold_uncertainty_score":0.9993188},"labels":[],"label_agreement":null},{"id":"W4386954022","doi":"10.1016/j.ygyno.2023.06.150","title":"ROSELLA – GOG-3073 – ENGOT-OV72/MITO: A phase 3 study of relacorilant + nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer (1241)","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Paclitaxel; Medicine; Ovarian cancer; Oncology; Internal medicine; Chemotherapy; Population; Phases of clinical research; Cancer; Refractory (planetary science); Biology","score_opus":0.0391776564910209,"score_gpt":0.3837468036909214,"score_spread":0.3445691471999005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386954022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249876,0.0014747065,0.0000060201846,0.0048649884,0.0020505923,0.0037214968,0.00031011918,0.00026166305,0.0048116343],"genre_scores_gemma":[0.9914109,0.0018968057,0.0008154929,0.00076981937,0.0003337052,0.002696072,0.00012131554,0.00008625571,0.0018696417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994584,0.00056842354,0.0015730701,0.0013709408,0.00060790236,0.0012956654],"domain_scores_gemma":[0.99566257,0.0019397296,0.0007149625,0.0010127069,0.00026078877,0.00040923126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012716451,0.0006594048,0.0021180338,0.00066103565,0.00020877898,0.000024074196,0.00038665914,0.0006169717,0.0011771686],"category_scores_gemma":[0.0009980799,0.00054885587,0.0002413888,0.001627249,0.00023735358,0.00013669675,0.00027623205,0.00075384014,0.00019747594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016335122,0.054602243,0.6380989,0.00085531943,0.002697017,0.018724361,0.015047425,0.0016686547,0.012238588,0.0028268485,0.03108501,0.20582053],"study_design_scores_gemma":[0.07133682,0.056064926,0.7582866,0.0003436715,0.00093867554,0.000074287105,0.00991327,0.00040432965,0.0007549719,0.0009049237,0.10013029,0.00084722036],"about_ca_topic_score_codex":0.0023631225,"about_ca_topic_score_gemma":0.009723563,"teacher_disagreement_score":0.20497331,"about_ca_system_score_codex":0.0023339337,"about_ca_system_score_gemma":0.0012226364,"threshold_uncertainty_score":0.9997359},"labels":[],"label_agreement":null},{"id":"W4387276454","doi":"10.1016/j.ygyno.2023.09.006","title":"Budget impact analysis of molecular subtype profiling in endometrial cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Immunohistochemistry; Biopsy; Endometrial cancer; Internal medicine; Cost analysis; Oncology; Gynecology; Pathology; Cancer; Operations research; Mathematics","score_opus":0.040852919591682635,"score_gpt":0.39607788846000513,"score_spread":0.3552249688683225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387276454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436724,0.00066516345,0.000009913328,0.00049016066,0.00040033585,0.00054730236,0.00006228824,0.00006426953,0.0033933227],"genre_scores_gemma":[0.99843544,0.00047051016,0.0002555589,0.0002649473,0.00007271147,0.00017637125,0.00014745435,0.000011852379,0.00016515776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983425,0.00017443874,0.00048234174,0.00033682864,0.00023234033,0.00043152526],"domain_scores_gemma":[0.99820817,0.0011475848,0.00018848496,0.00021831863,0.00010736647,0.00013010016],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057233917,0.00015975987,0.0011336723,0.0019570524,0.000022505,0.0000036359404,0.00011684985,0.0002520346,0.0018764252],"category_scores_gemma":[0.0016797511,0.000114898394,0.0003874685,0.008963311,0.00007671959,0.000028453,0.000075993295,0.00019940644,0.000045232926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021554148,0.000746756,0.9283556,0.0000507791,0.003209779,0.0008647827,0.00011467768,0.003337638,0.025961507,0.0001349607,0.00013812764,0.03493001],"study_design_scores_gemma":[0.010228339,0.0041620065,0.97182417,0.000012250425,0.0024051797,0.0000045075544,0.000112122994,0.0008479056,0.009277036,0.0004503741,0.00052210136,0.000154005],"about_ca_topic_score_codex":0.0011525704,"about_ca_topic_score_gemma":0.0005592766,"teacher_disagreement_score":0.043468606,"about_ca_system_score_codex":0.0007897342,"about_ca_system_score_gemma":0.0004616909,"threshold_uncertainty_score":0.999036},"labels":[],"label_agreement":null},{"id":"W4387470122","doi":"10.1016/j.ygyno.2023.09.016","title":"Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia; CancerCare Manitoba; Saskatchewan Cancer Agency; University of Saskatchewan; University of Alberta; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Immunohistochemistry; Ovarian cancer; Serous carcinoma; Serous fluid; Tissue microarray; Ovarian carcinoma; Cancer research; Cancer; Internal medicine; Oncology","score_opus":0.04174035862380889,"score_gpt":0.3238223373514621,"score_spread":0.2820819787276532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387470122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930839,0.0001523101,0.0000030183041,0.0006679446,0.00023413802,0.0002956891,0.000047461966,0.00006319406,0.0054523577],"genre_scores_gemma":[0.9986309,0.000046249643,0.00006595334,0.00015880575,0.000016452559,0.000051884625,0.00036801022,0.000014865857,0.0006469081],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99850714,0.00027133955,0.0004737902,0.00030165707,0.00013518335,0.00031091482],"domain_scores_gemma":[0.9982489,0.0010922899,0.00020002444,0.00027347545,0.00011352577,0.00007182579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008257656,0.00013736916,0.0005509163,0.0001686828,0.00004126796,0.000003985037,0.000112549045,0.00026855987,0.00025072074],"category_scores_gemma":[0.0015051368,0.0001263447,0.00005994074,0.0007172263,0.00012450502,0.000043193664,0.00008198889,0.00023586824,0.000049468737],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025978152,0.00033984688,0.4161784,0.000068434536,0.00002190023,0.00036598265,0.00007919462,0.000004247134,0.57054055,0.000046567933,0.010448998,0.0016461235],"study_design_scores_gemma":[0.001618631,0.0010662178,0.9502505,0.000015369502,0.000016142498,0.000051797728,0.00012795553,0.00006883686,0.04547779,0.000047834994,0.0011581588,0.0001007664],"about_ca_topic_score_codex":0.0008450572,"about_ca_topic_score_gemma":0.00009150127,"teacher_disagreement_score":0.5340721,"about_ca_system_score_codex":0.00029200953,"about_ca_system_score_gemma":0.0003228426,"threshold_uncertainty_score":0.51521873},"labels":[],"label_agreement":null},{"id":"W4387647049","doi":"10.1016/j.ygyno.2023.09.013","title":"A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; Eisai; Seagen; Takeda Pharmaceuticals U.S.A.; Clovis Oncology; AstraZeneca; Bristol-Myers Squibb","keywords":"Paclitaxel; Medicine; Hazard ratio; Endometrial cancer; Internal medicine; Clinical endpoint; Chemotherapy; Gastroenterology; Randomized controlled trial; Urology; Confidence interval; Oncology; Cancer","score_opus":0.06679682524608217,"score_gpt":0.3854782519070304,"score_spread":0.31868142666094823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387647049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923698,0.00043268088,0.00000241368,0.00073487294,0.00057938945,0.00497911,0.00002942944,0.00006651029,0.00080585165],"genre_scores_gemma":[0.9941343,0.00088421063,0.00016190448,0.00011702217,0.000051807598,0.004401554,0.0000404249,0.000024961813,0.00018383244],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967566,0.0007267448,0.00082288857,0.0005825197,0.00045772252,0.0006534869],"domain_scores_gemma":[0.99497795,0.003990492,0.00040668185,0.00026943823,0.00016859832,0.00018683987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001282574,0.0003099542,0.0020698968,0.0009915767,0.00005303592,0.000007641423,0.00014660056,0.00018441869,0.0005341144],"category_scores_gemma":[0.0022897383,0.00018155738,0.00010754641,0.0034120402,0.00021789741,0.00009734617,0.00007328182,0.0003392376,0.00001204489],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88618207,0.013625252,0.009420065,0.00008697473,0.0007204932,0.00072938495,0.0030225033,0.00016394054,0.00008082129,0.00001940622,0.000024825797,0.08592426],"study_design_scores_gemma":[0.8263622,0.1392977,0.019002914,0.00009341236,0.00040389688,0.000008328864,0.01419026,0.00009097716,0.00003464997,0.000051459487,0.00027631715,0.00018793147],"about_ca_topic_score_codex":0.00072283356,"about_ca_topic_score_gemma":0.0061386647,"teacher_disagreement_score":0.12567243,"about_ca_system_score_codex":0.0020512578,"about_ca_system_score_gemma":0.0005674095,"threshold_uncertainty_score":0.7403695},"labels":[],"label_agreement":null},{"id":"W4387762871","doi":"10.1016/j.ygyno.2023.10.004","title":"Intraluminal tumor cells and prognostic accuracy of endometrial cancer stage criteria: A multi-institution study","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Endometrial cancer; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Gynecology; Biology","score_opus":0.07736244208173527,"score_gpt":0.4026993669627106,"score_spread":0.3253369248809753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387762871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995048,0.00028486914,0.000018112574,0.00038584947,0.0014012497,0.0022484136,0.000119894605,0.00011032714,0.0003832808],"genre_scores_gemma":[0.99769604,0.00034450015,0.00058343785,0.00021179423,0.00023344268,0.0005756375,0.000027237393,0.000012835688,0.0003150583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982416,0.0002295814,0.0004934344,0.00041428424,0.00022382305,0.0003972494],"domain_scores_gemma":[0.99744266,0.0018392127,0.00023856931,0.00017645382,0.00013121273,0.00017191231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053064356,0.00019679742,0.0007754992,0.0004022097,0.00009233511,0.000011105272,0.000103632934,0.00014065248,0.000962054],"category_scores_gemma":[0.0034423857,0.0001452779,0.000085886415,0.0010836388,0.0002167362,0.00007444891,0.00014579306,0.00020967268,0.000051883388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006843775,0.010971894,0.77183557,0.0006910374,0.0009884541,0.004202892,0.0019479416,0.000053704818,0.054637175,0.0001329631,0.0009113268,0.14678329],"study_design_scores_gemma":[0.03390641,0.021408092,0.9309419,0.00004733445,0.0008155806,0.000039323375,0.0017476493,0.00023955535,0.0052384925,0.000062084444,0.005323783,0.00022980271],"about_ca_topic_score_codex":0.0004938568,"about_ca_topic_score_gemma":0.00036683728,"teacher_disagreement_score":0.15910634,"about_ca_system_score_codex":0.0003270012,"about_ca_system_score_gemma":0.00036807382,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W4387763222","doi":"10.1016/j.ygyno.2023.09.012","title":"Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Oncology; Internal medicine; Proportional hazards model; Ovarian cancer; Pembrolizumab; Progression-free survival; Immunohistochemistry; Cancer research; Cancer; Immunotherapy; Overall survival","score_opus":0.08579269681327752,"score_gpt":0.43773957484359644,"score_spread":0.35194687803031893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387763222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975236,0.0005424876,0.0000073897795,0.00047468912,0.00061898335,0.0003644524,0.000053919215,0.000022760029,0.0003917329],"genre_scores_gemma":[0.9976383,0.0017486094,0.00014839275,0.00028906658,0.00001650211,0.00007496622,0.000021820697,0.00001112727,0.00005125642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971477,0.0003913391,0.0016207551,0.0003256447,0.00022540013,0.00028917345],"domain_scores_gemma":[0.9975754,0.0009928454,0.0008136283,0.00039954763,0.0001481384,0.00007041465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014279779,0.00015700552,0.0019606384,0.0007825989,0.000015014048,0.0000010589941,0.00020155525,0.0003579801,0.00040016396],"category_scores_gemma":[0.0007571169,0.00012560075,0.00059835427,0.0018086657,0.00034838184,0.000028471111,0.00009078244,0.00020258865,0.0000035044545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030329116,0.0007889274,0.88404876,0.00010201423,0.0015048495,0.00015512432,0.000311512,0.00008294644,0.0029738378,0.000028484483,0.00017395159,0.10679668],"study_design_scores_gemma":[0.0055541205,0.0028046407,0.9861079,0.000043925567,0.0009839034,0.0000019619813,0.00034394866,0.00057394383,0.0023619588,0.000054665972,0.0010661309,0.000102931335],"about_ca_topic_score_codex":0.00043035616,"about_ca_topic_score_gemma":0.0023234845,"teacher_disagreement_score":0.106693745,"about_ca_system_score_codex":0.00018852316,"about_ca_system_score_gemma":0.0007417728,"threshold_uncertainty_score":0.512185},"labels":[],"label_agreement":null},{"id":"W4389339828","doi":"10.1016/j.ygyno.2023.11.012","title":"Lunchbox trial: A randomized phase III trial of cisplatin and irradiation followed by carboplatin and paclitaxel versus sandwich therapy of carboplatin and paclitaxel followed by irradiation then carboplatin and paclitaxel for advanced endometrial carcinoma","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Carboplatin; Medicine; Paclitaxel; Internal medicine; Radiation therapy; Cisplatin; Confidence interval; Randomized controlled trial; Gastroenterology; Urology; Chemotherapy; Oncology","score_opus":0.03701574934282058,"score_gpt":0.3546578547871267,"score_spread":0.3176421054443061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389339828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974913,0.009878338,0.000045548346,0.0006972511,0.0014624255,0.011535521,0.00077870995,0.00009704039,0.000592187],"genre_scores_gemma":[0.99123496,0.0046370514,0.0007894159,0.0001325518,0.00030100453,0.0019357331,0.0007086821,0.00006707135,0.0001935205],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945055,0.0011378764,0.0019693275,0.0010749118,0.00056099985,0.0007513589],"domain_scores_gemma":[0.9790324,0.018497068,0.0014280599,0.00039749633,0.0002279218,0.0004170361],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030817436,0.00068231137,0.0036090813,0.0007164056,0.00023625942,0.000040223233,0.00014065331,0.0008116472,0.00006733921],"category_scores_gemma":[0.009116407,0.0005399557,0.00039536526,0.0010708732,0.000571171,0.00019497056,0.00011639192,0.00035140105,8.724787e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90174496,0.0009937516,0.0011638599,0.00015745206,0.00094180333,0.000017222455,0.0014505269,0.000002884538,0.037647426,0.0001575416,0.0008128828,0.054909714],"study_design_scores_gemma":[0.9500137,0.038821675,0.004606684,0.000037636208,0.0012226637,0.000007740767,0.0009241812,0.00093034183,0.0013981272,0.0007665235,0.000831185,0.00043955314],"about_ca_topic_score_codex":0.00073755754,"about_ca_topic_score_gemma":0.00014493636,"teacher_disagreement_score":0.05447016,"about_ca_system_score_codex":0.00031812082,"about_ca_system_score_gemma":0.00037316073,"threshold_uncertainty_score":0.9997052},"labels":[],"label_agreement":null},{"id":"W4389636481","doi":"10.1016/j.ygyno.2023.11.033","title":"Obesity is associated with improved progression-free survival in Microsatellite-Instability-High endometrial cancer treated with pembrolizumab","year":2023,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Royal College of Physicians and Surgeons of Canada; National Cancer Institute; Foundation for the National Institutes of Health","keywords":"Medicine; Pembrolizumab; Endometrial cancer; Internal medicine; Body mass index; Microsatellite instability; Proportional hazards model; Retrospective cohort study; Oncology; Cancer; Gynecology; Microsatellite","score_opus":0.029563947245311403,"score_gpt":0.32438592112858344,"score_spread":0.294821973883272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389636481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923661,0.0002914759,0.0000026487326,0.0017867646,0.000462079,0.0022003676,0.00023199625,0.00036217354,0.0022963914],"genre_scores_gemma":[0.9965575,0.0002966439,0.00024487812,0.0005371707,0.00016404368,0.00082508527,0.00041343336,0.000047683698,0.0009135755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964636,0.0004663851,0.0006053507,0.0009159448,0.0005199352,0.0010287655],"domain_scores_gemma":[0.99631673,0.0021102014,0.0003307572,0.0005599096,0.00037667787,0.00030575108],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082521094,0.00045201954,0.0015196855,0.0005661265,0.00016288902,0.000025406585,0.00030263152,0.00057376834,0.001144332],"category_scores_gemma":[0.0021436813,0.00027498393,0.00012905007,0.0047702454,0.00034605205,0.000094232404,0.00018697268,0.00056815404,0.000052538253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01990972,0.0034086695,0.9411185,0.000081959726,0.0007356123,0.0018035606,0.00024277845,0.000013403125,0.0017589377,0.000036280075,0.0002721453,0.030618433],"study_design_scores_gemma":[0.070635505,0.016808406,0.9063117,0.00015724073,0.00044954213,0.000030093297,0.00017621918,0.000056138808,0.0033850404,0.00026733606,0.0013330672,0.00038972552],"about_ca_topic_score_codex":0.0021073683,"about_ca_topic_score_gemma":0.0094557125,"teacher_disagreement_score":0.050725784,"about_ca_system_score_codex":0.0022050904,"about_ca_system_score_gemma":0.0010845107,"threshold_uncertainty_score":0.99997026},"labels":[],"label_agreement":null},{"id":"W4391096098","doi":"10.1016/j.ygyno.2023.12.027","title":"Cost-effectiveness of lenvatinib plus pembrolizumab versus chemotherapy for recurrent mismatch repair-proficient endometrial cancer after platinum-based therapy","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Internal medicine; Endometrial cancer; Chemotherapy; Cancer; Immunotherapy; Thyroid cancer","score_opus":0.11435504682769686,"score_gpt":0.4176501410211599,"score_spread":0.303295094193463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391096098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96557707,0.017439239,0.000613961,0.0011672195,0.007180996,0.005902456,0.00028737786,0.00025456926,0.0015771018],"genre_scores_gemma":[0.9889636,0.001168405,0.0016905074,0.00058766763,0.0005281852,0.0066673905,0.00016248894,0.00004957362,0.0001821488],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974876,0.0003597474,0.00059031433,0.0007059786,0.00033475558,0.00052160246],"domain_scores_gemma":[0.99181825,0.007230347,0.00017379838,0.00032174762,0.00029786932,0.00015797079],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008487931,0.0003360058,0.0011466448,0.0003176292,0.00006645904,0.000016368422,0.0001295816,0.0003992551,0.0020210685],"category_scores_gemma":[0.000838005,0.00024219968,0.0006181247,0.00091368833,0.00016699909,0.000043501528,0.000037295147,0.00027532032,0.000013627811],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37380943,0.0032309901,0.005467051,0.002006567,0.0022462842,0.0003450385,0.00046510267,0.00024300446,0.004725786,0.00043780042,0.001343151,0.6056798],"study_design_scores_gemma":[0.41471416,0.10965157,0.063879296,0.0010739117,0.0016931277,0.000042701653,0.00037048472,0.004130201,0.08689309,0.0005866258,0.31583533,0.0011295193],"about_ca_topic_score_codex":0.000085705535,"about_ca_topic_score_gemma":0.00007078626,"teacher_disagreement_score":0.6045503,"about_ca_system_score_codex":0.0020203013,"about_ca_system_score_gemma":0.0016677186,"threshold_uncertainty_score":0.99889123},"labels":[],"label_agreement":null},{"id":"W4391286454","doi":"10.1016/j.ygyno.2024.01.027","title":"Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University; Princess Margaret Cancer Centre","funders":"Queen's University; Cancer Care Ontario","keywords":"Medicine; Bevacizumab; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Gynecology; Cancer","score_opus":0.0225401340826704,"score_gpt":0.32631354091009895,"score_spread":0.30377340682742854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391286454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93553036,0.00036077757,0.000007823361,0.035915345,0.00042430064,0.0014524966,0.00005511205,0.0002939172,0.025959864],"genre_scores_gemma":[0.99184304,0.00036635157,0.00081655814,0.0019293603,0.000065402885,0.0009316117,0.00007276542,0.00005612337,0.003918763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980036,0.0001293307,0.00041282678,0.00063298206,0.00025989415,0.00056136685],"domain_scores_gemma":[0.9982967,0.001014739,0.00014550166,0.00030891073,0.00008508329,0.00014911001],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030782295,0.0003515053,0.001009208,0.00029111106,0.00007715951,0.000036407964,0.00011102764,0.00024191912,0.0018465641],"category_scores_gemma":[0.000068644,0.00020901725,0.00007965804,0.0008003788,0.00015315796,0.000068308735,0.000029484987,0.00039336397,0.000030150157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041189156,0.0026202195,0.94665045,0.00010589289,0.002147035,0.006430443,0.0007436223,0.00008128151,0.00013386963,0.005274529,0.0033019753,0.028391793],"study_design_scores_gemma":[0.014790181,0.010607059,0.95905405,0.00033942997,0.00040927698,0.000019754863,0.00011546126,0.00015270444,0.0001242502,0.0003240529,0.013791259,0.00027252088],"about_ca_topic_score_codex":0.0015377483,"about_ca_topic_score_gemma":0.06564481,"teacher_disagreement_score":0.06410706,"about_ca_system_score_codex":0.0032470075,"about_ca_system_score_gemma":0.001351322,"threshold_uncertainty_score":0.9990659},"labels":[],"label_agreement":null},{"id":"W4391589947","doi":"10.1016/j.ygyno.2024.01.021","title":"Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Nausea; Quality of life (healthcare); Placebo; Constipation; Internal medicine; Vomiting; Ovarian cancer; Cancer; Randomized controlled trial; Surgery","score_opus":0.03742922405848668,"score_gpt":0.3674416813460257,"score_spread":0.330012457287539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391589947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734125,0.0015159562,0.00017308188,0.013441345,0.00093348743,0.008432369,0.0008013233,0.00021853248,0.0010714176],"genre_scores_gemma":[0.9920906,0.00045764897,0.0009889517,0.0031359035,0.00016721121,0.00213105,0.0007958147,0.000055630724,0.00017722949],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9926032,0.0030001272,0.0022949348,0.00091126113,0.00052917394,0.0006613199],"domain_scores_gemma":[0.9838484,0.013676781,0.0012700643,0.0006519604,0.00027214424,0.00028062877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029949723,0.00046499813,0.002919504,0.00021880011,0.00013173657,0.000023120205,0.00024999442,0.00046891833,0.000834035],"category_scores_gemma":[0.0032763148,0.0002619964,0.00021059425,0.00094287086,0.00071725086,0.00014211844,0.000046947513,0.0008692087,0.00001676087],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9615347,0.0025227962,0.008779331,0.00006567969,0.0009176027,0.00009475654,0.0019491292,0.00041859486,0.00006058641,0.00023673952,0.0029514146,0.02046867],"study_design_scores_gemma":[0.94202644,0.013253417,0.040370274,0.00039146506,0.0002835093,0.0000031083764,0.00019204189,0.00028620954,0.00006285308,0.00033521483,0.002497699,0.0002977506],"about_ca_topic_score_codex":0.007968978,"about_ca_topic_score_gemma":0.00589733,"teacher_disagreement_score":0.031590942,"about_ca_system_score_codex":0.0014931103,"about_ca_system_score_gemma":0.003225202,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W4391714990","doi":"10.1016/j.ygyno.2024.02.003","title":"High grade adverse event reporting and enrolment in gynecologic oncology clinical trials","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Saskatchewan; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Odds ratio; Adverse effect; Internal medicine; Odds; Gynecologic oncology; Oncology; Logistic regression","score_opus":0.7534761201980854,"score_gpt":0.6731920710918551,"score_spread":0.08028404910623033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391714990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113693,0.001294973,0.02018782,0.020061988,0.02773448,0.0064453674,0.00012334788,0.0010907876,0.011691905],"genre_scores_gemma":[0.5085989,0.0011521127,0.48569676,0.0020087438,0.0011305213,0.0007980958,0.000008887322,0.000068158784,0.00053781254],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9575475,0.025038576,0.013727724,0.0019152029,0.00048099825,0.0012900223],"domain_scores_gemma":[0.5243251,0.47002628,0.0042771874,0.00072581746,0.00013719067,0.00050844444],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.13495357,0.00058712263,0.0052345735,0.00038527386,0.0001495617,0.00005277893,0.0005126903,0.0022623092,0.002802555],"category_scores_gemma":[0.71404684,0.0004396219,0.000757426,0.00057820755,0.00088251434,0.00011607712,0.00069746235,0.002312653,0.00019755716],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065947726,0.0041444213,0.011927143,0.00048391006,0.0006688884,0.010526241,0.0003947488,0.00004759369,0.00032660307,0.24620615,0.019028807,0.705586],"study_design_scores_gemma":[0.004339131,0.006345054,0.022800406,0.00011601504,0.000559338,0.00020510815,0.0004739724,0.0008185296,0.00007952609,0.9142018,0.049524207,0.0005368861],"about_ca_topic_score_codex":0.000046852794,"about_ca_topic_score_gemma":0.0003077959,"teacher_disagreement_score":0.70504916,"about_ca_system_score_codex":0.0014464321,"about_ca_system_score_gemma":0.001162582,"threshold_uncertainty_score":0.99998903},"labels":[],"label_agreement":null},{"id":"W4391731534","doi":"10.1016/j.ygyno.2024.02.001","title":"High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Subtyping; Concordance; Immunohistochemistry; Immunostaining; Biopsy; Pathology; Medicine; Staining; Carcinoma; Internal medicine","score_opus":0.016024859926096195,"score_gpt":0.29152196762209626,"score_spread":0.27549710769600005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391731534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961857,0.002283811,0.00004970318,0.0001232537,0.00012910266,0.0005631982,0.000021852158,0.00003902673,0.0006043244],"genre_scores_gemma":[0.9987609,0.000045124587,0.00093665125,0.000024908637,0.00007771515,0.00002462421,0.00006633232,0.000018909419,0.000044837754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801517,0.00027656168,0.00052619557,0.0005610578,0.00024090198,0.00038013206],"domain_scores_gemma":[0.99825317,0.0011584018,0.000163413,0.00018254928,0.00009478439,0.00014765566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043097805,0.00023497822,0.001028042,0.00047311408,0.000063543754,0.000018855044,0.00006886659,0.00028816043,0.000119548116],"category_scores_gemma":[0.00010045264,0.00017447076,0.000091654925,0.0013016565,0.00022586108,0.00008064855,0.000116443836,0.0003511818,0.0000015162041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023164132,0.0003373961,0.9902911,0.00019289096,0.00030037484,0.0016211557,0.00019820532,0.00012141194,0.0003738504,0.00009045308,0.0000014132872,0.00415531],"study_design_scores_gemma":[0.010979287,0.0070905467,0.9784418,0.00005098126,0.0012090914,0.000061959865,0.00015100591,0.00030607352,0.0012170138,0.00011872365,0.00018324848,0.00019029649],"about_ca_topic_score_codex":0.0007245157,"about_ca_topic_score_gemma":0.000062468906,"teacher_disagreement_score":0.011849354,"about_ca_system_score_codex":0.0004862928,"about_ca_system_score_gemma":0.00016153078,"threshold_uncertainty_score":0.7114711},"labels":[],"label_agreement":null},{"id":"W4391914065","doi":"10.1016/j.ygyno.2024.01.051","title":"The impact of body mass index on robotic surgery outcomes in endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Jewish General Hospital; Israel Cancer Research Fund","keywords":"Medicine; Endometrial cancer; Perioperative; Body mass index; Pacu; Retrospective cohort study; Mann–Whitney U test; Cancer; Laparotomy; Surgery; Blood loss; Internal medicine","score_opus":0.04905617729042589,"score_gpt":0.3953727401349736,"score_spread":0.3463165628445477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391914065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983516,0.0028343622,0.000010488672,0.0032713062,0.003299065,0.00075429043,0.000025330515,0.000065681255,0.0062234914],"genre_scores_gemma":[0.997149,0.0012857281,0.000019179144,0.00022131311,0.00023310426,0.00022626303,0.000009608852,0.000016602196,0.00083921995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998194,0.00023970348,0.00054749945,0.0003136179,0.00024346536,0.0004617533],"domain_scores_gemma":[0.9863853,0.013097851,0.00012036722,0.0002278089,0.000053353535,0.00011532238],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073403766,0.00020696486,0.0009876719,0.0005489903,0.000050917875,0.00001605021,0.00012699974,0.00025286787,0.0011476201],"category_scores_gemma":[0.0025700962,0.00010080256,0.00046844076,0.0011636924,0.000141111,0.000037171885,0.000043053464,0.00038208178,0.000060643604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021513184,0.00077817735,0.8963288,0.00005284561,0.00077841064,0.000597511,0.000031233038,0.00047466284,0.00035701456,0.00028904108,0.0016917237,0.09646923],"study_design_scores_gemma":[0.0039463104,0.004501256,0.98710054,0.000056014556,0.00014461462,0.000013137389,0.000040491195,0.0002368323,0.00017103701,0.0012840775,0.0023905276,0.00011517952],"about_ca_topic_score_codex":0.0011061348,"about_ca_topic_score_gemma":0.00033367088,"teacher_disagreement_score":0.096354045,"about_ca_system_score_codex":0.0016686277,"about_ca_system_score_gemma":0.0009675969,"threshold_uncertainty_score":0.99976546},"labels":[],"label_agreement":null},{"id":"W4391938901","doi":"10.1016/j.ygyno.2024.02.018","title":"Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; University of British Columbia; Université Laval; University Health Network; University of Toronto; McMaster University; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"Intuitive Foundation","keywords":"Trachelectomy; Medicine; Cervical cancer; Radical Hysterectomy; Retrospective cohort study; Stage (stratigraphy); Radical surgery; Surgery; Cancer; Internal medicine","score_opus":0.04332750020202683,"score_gpt":0.3367277057959261,"score_spread":0.29340020559389923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391938901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099755,0.000256359,0.00029712042,0.0008439803,0.0016221692,0.0050095175,0.000044265922,0.00020234424,0.000726711],"genre_scores_gemma":[0.9950569,0.00000828189,0.0019865497,0.00023193352,0.0003781711,0.0013141343,0.00014783553,0.000048911716,0.0008272732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703205,0.00028248547,0.00045362065,0.0011767688,0.00039015803,0.0006649171],"domain_scores_gemma":[0.9979806,0.0010186032,0.00008976757,0.00041322244,0.00020656691,0.00029125856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048437685,0.00035641572,0.0009332067,0.0002186913,0.0001469888,0.000036302175,0.0001714387,0.00027081696,0.00060324115],"category_scores_gemma":[0.0006637388,0.0002360259,0.00019094553,0.00056413363,0.0002507566,0.00010525479,0.00008266643,0.00055204995,0.000080356745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010651594,0.0120617235,0.97079754,0.00012204351,0.0010245915,0.0007886095,0.00036704564,0.000008678097,0.000022296761,0.0000378462,0.00020817442,0.0039098836],"study_design_scores_gemma":[0.060110223,0.035112135,0.8995828,0.000014535431,0.0011516261,0.000019056077,0.00012669562,0.00008024553,0.000032029224,0.000017404793,0.0035296746,0.00022355372],"about_ca_topic_score_codex":0.00014547922,"about_ca_topic_score_gemma":0.00026622013,"teacher_disagreement_score":0.07121469,"about_ca_system_score_codex":0.0009909242,"about_ca_system_score_gemma":0.0003352901,"threshold_uncertainty_score":0.9624857},"labels":[],"label_agreement":null},{"id":"W4391984374","doi":"10.1016/j.ygyno.2024.02.011","title":"Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Lawrence College; University of British Columbia; Queen's University","funders":"","keywords":"Medicine; Incidence (geometry); Ovarian cancer; Venous thromboembolism; Database; Internal medicine; Cancer; Oncology; Thrombosis","score_opus":0.022247789200535155,"score_gpt":0.2944428566406049,"score_spread":0.2721950674400697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391984374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322456,0.0007053026,0.000027078833,0.00025845575,0.0007135166,0.00090141874,0.0038097494,0.000042129486,0.000317786],"genre_scores_gemma":[0.9962162,0.0018449412,0.0003498941,0.00025366442,0.000104442304,0.000055611494,0.0011385645,0.000023839833,0.0000128402735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827164,0.0001297321,0.00030232384,0.000664921,0.00018313152,0.00044822434],"domain_scores_gemma":[0.9986499,0.00027609098,0.00014807642,0.00054310274,0.00005733079,0.00032547754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003226684,0.00022332574,0.0007552629,0.00018193321,0.00014784811,0.000026164194,0.00021876466,0.00018304327,0.00064574543],"category_scores_gemma":[0.0002306511,0.00016605748,0.000024162406,0.00016974437,0.00019089844,0.0002205999,0.00038577087,0.0002527267,0.000008428963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005625466,0.0007339623,0.9893002,0.000105819396,0.00045951118,0.00016285919,0.0009262702,0.0000020685593,0.000034311903,0.00011851611,0.0021457272,0.005954531],"study_design_scores_gemma":[0.0017414966,0.001534981,0.986014,0.00014582105,0.00096724083,0.000003035729,0.00029331917,0.00030374655,0.000010984374,0.00014218177,0.008675313,0.00016784364],"about_ca_topic_score_codex":0.29601792,"about_ca_topic_score_gemma":0.513878,"teacher_disagreement_score":0.21786007,"about_ca_system_score_codex":0.00027244937,"about_ca_system_score_gemma":0.00066246337,"threshold_uncertainty_score":0.70866996},"labels":[],"label_agreement":null},{"id":"W4392180369","doi":"10.1016/j.ygyno.2024.02.025","title":"Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"UCLH Biomedical Research Centre; Medical Research Council; National Health and Medical Research Council; University College London Hospitals NHS Foundation Trust; Department of Health and Social Care; Cancer Australia; Cancer Research UK; National Institute for Health and Care Research; University of Sydney; Australian Government; Target Ovarian Cancer","keywords":"Medicine; Baseline (sea); Ovarian cancer; Oncology; Internal medicine; Overall survival; Cancer; Progression-free survival","score_opus":0.024873493181761516,"score_gpt":0.3204660633406764,"score_spread":0.2955925701589149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392180369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491987,0.0040402594,0.000008650992,0.024254635,0.00089278043,0.0008472244,0.000068150184,0.000052779687,0.0049156593],"genre_scores_gemma":[0.9958351,0.0018487091,0.00055835344,0.0003782996,0.00016807496,0.00094968034,0.000022147393,0.000018404888,0.00022118421],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979801,0.00030589013,0.0005170003,0.000520311,0.00019870161,0.0004779574],"domain_scores_gemma":[0.99821323,0.0012811747,0.000109178385,0.00020801676,0.000061880826,0.00012650354],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008718636,0.00022180128,0.000810897,0.00033027428,0.000022179742,0.000012015494,0.00011854833,0.00022810792,0.0024106556],"category_scores_gemma":[0.00015911636,0.00015214198,0.000046967463,0.0005923103,0.00024773736,0.000055124914,0.000049128837,0.0003235023,0.000023338744],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035189902,0.0025789486,0.3453874,0.00067782856,0.0007691206,0.010198689,0.0059502767,0.00036798723,0.0016030092,0.004741709,0.0018097443,0.6223963],"study_design_scores_gemma":[0.014105671,0.014885838,0.8641989,0.001675383,0.00033450846,0.00015249435,0.0031856191,0.0007242325,0.0009481544,0.0021650712,0.097053416,0.00057069707],"about_ca_topic_score_codex":0.001747814,"about_ca_topic_score_gemma":0.0077957218,"teacher_disagreement_score":0.6218256,"about_ca_system_score_codex":0.0022313579,"about_ca_system_score_gemma":0.0017535469,"threshold_uncertainty_score":0.9985013},"labels":[],"label_agreement":null},{"id":"W4392189936","doi":"10.1016/j.ygyno.2024.02.022","title":"The role of surgeon specialty in management and survival of malignant ovarian germ cell tumors: A population-based study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Specialty; Chemotherapy; Internal medicine; Retrospective cohort study; Population; Cohort; Stage (stratigraphy); Proportional hazards model; Surgery; Oncology; Gynecology; Pathology","score_opus":0.01171939071686338,"score_gpt":0.28502543992893653,"score_spread":0.27330604921207313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392189936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950504,0.0015321181,0.0000042485217,0.00018600191,0.00017970799,0.00090989354,0.00001148954,0.000020042497,0.0021061318],"genre_scores_gemma":[0.99956584,0.00004273899,0.00015010817,0.000017264076,0.0000188043,0.0000677553,0.000016980934,0.000008263514,0.00011225637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891484,0.00018386857,0.00035500719,0.00022666919,0.0001442942,0.00017535072],"domain_scores_gemma":[0.9988966,0.0007186208,0.00011580787,0.00018536192,0.000029782279,0.000053827574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043057374,0.0001049135,0.00034771088,0.00011080152,0.000036591948,0.00000722031,0.00005658573,0.000057143883,0.00008801874],"category_scores_gemma":[0.000100119636,0.00006556529,0.00006359687,0.00018717625,0.000047075537,0.000013897425,0.00005125286,0.00007115667,0.000004300947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016925042,0.0018020064,0.975821,0.00015521575,0.000098303986,0.0007847377,0.000103336075,0.000027067936,0.00003037736,0.001091098,0.000009542622,0.019908074],"study_design_scores_gemma":[0.0016510724,0.0016425293,0.9933221,0.0000471385,0.0002417567,0.0000037666568,0.00093172636,0.00035590414,0.000042985463,0.0011148199,0.0005938233,0.000052410902],"about_ca_topic_score_codex":0.0005348689,"about_ca_topic_score_gemma":0.0011347402,"teacher_disagreement_score":0.019855663,"about_ca_system_score_codex":0.00014642373,"about_ca_system_score_gemma":0.00014131062,"threshold_uncertainty_score":0.26736748},"labels":[],"label_agreement":null},{"id":"W4392438288","doi":"10.1016/j.ygyno.2024.02.023","title":"Implementation of a surgical site infection prevention bundle in gynecologic oncology patients: An enhanced recovery after surgery initiative","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Gynecologic oncology; Laparotomy; Incidence (geometry); Surgery; Multivariate analysis; Urinary system; Surgical wound; Surgical site infection; Internal medicine","score_opus":0.02719410957219355,"score_gpt":0.3574440298484475,"score_spread":0.33024992027625394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392438288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913238,0.0003404295,0.00048716122,0.00046531047,0.0026982317,0.0014470455,0.000050709223,0.00020717416,0.0029801305],"genre_scores_gemma":[0.99523073,0.0013625778,0.00074062246,0.0005682141,0.0001915362,0.0011234963,0.0005367584,0.000044960103,0.00020110232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950066,0.0014992659,0.0015456047,0.00091600354,0.0003039691,0.0007285335],"domain_scores_gemma":[0.99425423,0.0043959417,0.00052161334,0.00033553195,0.0003089116,0.00018379069],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019102514,0.00039628407,0.0013566574,0.0011397332,0.000062693,0.000026553445,0.00009371451,0.000892184,0.0032758838],"category_scores_gemma":[0.00054519554,0.0003604165,0.00042334475,0.0010545829,0.00021578498,0.0008078035,0.00013235892,0.0006946743,0.00015427156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034193213,0.007547333,0.5657581,0.00056218513,0.0003050601,0.0012173076,0.0014538025,0.000068811045,0.0028888325,0.0000623852,0.0011159453,0.41560093],"study_design_scores_gemma":[0.0033558223,0.027098997,0.94138306,0.0002566388,0.0002545265,0.00012265293,0.00049468724,0.00008167125,0.006521222,0.0016265224,0.018314345,0.00048983836],"about_ca_topic_score_codex":0.00019705729,"about_ca_topic_score_gemma":0.0059175324,"teacher_disagreement_score":0.41511106,"about_ca_system_score_codex":0.0025229973,"about_ca_system_score_gemma":0.0016359385,"threshold_uncertainty_score":0.9998848},"labels":[],"label_agreement":null},{"id":"W4392482408","doi":"10.1016/j.ygyno.2024.01.045","title":"Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"ImmunoGen","keywords":"Medicine; Bevacizumab; Carboplatin; Conjugate; Ovarian cancer; Antibody-drug conjugate; Folate receptor; Antibody; Oncology; Drug; Pharmacology; Internal medicine; Cancer research; Cancer; Monoclonal antibody; Chemotherapy; Immunology; Cisplatin; Cancer cell","score_opus":0.011109194254551804,"score_gpt":0.31071417876062785,"score_spread":0.29960498450607603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392482408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507046,0.00046076256,0.000011083757,0.0009706086,0.0002505612,0.0026637318,0.000077496814,0.000046262892,0.00044901457],"genre_scores_gemma":[0.9984919,0.00009797952,0.0007334361,0.00013094035,0.000029062365,0.00027830398,0.00016878243,0.000034920347,0.00003469251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978576,0.00027456429,0.000585872,0.00065497146,0.00024701454,0.00037999995],"domain_scores_gemma":[0.9987253,0.0005635756,0.0002377743,0.00017491124,0.00020197008,0.00009646691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040687952,0.0003074231,0.000909577,0.0003633804,0.00005813205,0.000021713327,0.00005513215,0.00016988906,0.000092421484],"category_scores_gemma":[0.00009245308,0.00021958604,0.000031574313,0.00062833476,0.00012908451,0.0001386874,0.000048063805,0.00036998818,0.0000031793638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060483566,0.02790834,0.90965235,0.00022139322,0.00064176944,0.0015829231,0.008938928,0.00008904951,0.00036923832,0.00020338203,0.00017838586,0.04416591],"study_design_scores_gemma":[0.11244503,0.04414733,0.8375854,0.0005834542,0.00040464482,0.000015727013,0.002599346,0.0012685459,0.00034430454,0.000058561185,0.00023445296,0.00031323032],"about_ca_topic_score_codex":0.0020039743,"about_ca_topic_score_gemma":0.007663824,"teacher_disagreement_score":0.10639667,"about_ca_system_score_codex":0.00088614726,"about_ca_system_score_gemma":0.0004741586,"threshold_uncertainty_score":0.89544594},"labels":[],"label_agreement":null},{"id":"W4392791549","doi":"10.1016/j.ygyno.2024.03.002","title":"Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis; Sierra Oncology; GlaxoSmithKline","keywords":"Topotecan; Medicine; Internal medicine; Cisplatin; Interim analysis; Nausea; Paclitaxel; Chemotherapy; Oncology; Phases of clinical research; Vomiting; Surgery; Gastroenterology; Randomized controlled trial","score_opus":0.0193579640632174,"score_gpt":0.3288404467273487,"score_spread":0.3094824826641313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392791549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860083,0.0028649278,0.0000010613719,0.00067575247,0.00009984246,0.010032442,0.000084016414,0.0000061376504,0.00022750511],"genre_scores_gemma":[0.9986842,0.00032299254,0.000045296503,0.00007035639,0.00001649408,0.0008259193,0.000006197504,0.000008657451,0.000019867966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977409,0.00080653984,0.0005652236,0.00037352898,0.0003325696,0.00018123178],"domain_scores_gemma":[0.99622166,0.0030187704,0.0002788568,0.00027643036,0.0001365006,0.000067797366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060765643,0.00021696529,0.0012976325,0.00011003799,0.00006027211,0.000006470498,0.000111745816,0.00004745692,0.000009811019],"category_scores_gemma":[0.00024917102,0.000079604375,0.00008811808,0.00050646433,0.00045381606,0.00002155207,0.00009241368,0.00014853357,4.699199e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28626555,0.02852473,0.55739576,0.0007351705,0.0019492671,0.00006241558,0.060305588,0.000010670608,0.00009966424,0.00004650147,0.000016932434,0.06458773],"study_design_scores_gemma":[0.2447503,0.07658246,0.6707225,0.00019693724,0.0015007788,0.000003569855,0.005989368,0.0000146593275,0.000107999105,0.000037095357,0.000028554425,0.00006579879],"about_ca_topic_score_codex":0.00146733,"about_ca_topic_score_gemma":0.005126651,"teacher_disagreement_score":0.1133267,"about_ca_system_score_codex":0.0002547699,"about_ca_system_score_gemma":0.00017353009,"threshold_uncertainty_score":0.3246172},"labels":[],"label_agreement":null},{"id":"W4394006826","doi":"10.1016/j.ygyno.2024.03.029","title":"High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Target Ovarian Cancer; Cancer Research UK; Ovarian Cancer Canada; Nicola Murray Foundation","keywords":"Medicine; Trametinib; Dasatinib; Ovarian carcinoma; Serous fluid; Serous carcinoma; Oncology; Internal medicine; Cancer research; Ovarian cancer; Kinase; Cancer; MAPK/ERK pathway; Biology; Receptor; Genetics; Tyrosine kinase","score_opus":0.026357467618951844,"score_gpt":0.3162409133208326,"score_spread":0.28988344570188074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394006826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760851,0.001411866,0.0004222518,0.012504089,0.0012840689,0.0010895462,0.000027512624,0.0002590236,0.006916493],"genre_scores_gemma":[0.9904549,0.00017283892,0.0059036002,0.0014488546,0.00031799733,0.00053589634,0.000092776274,0.0000533318,0.0010197959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973894,0.00022626032,0.00054939254,0.0008904139,0.00028257733,0.00066196476],"domain_scores_gemma":[0.99781317,0.0013749828,0.00012221048,0.00043294881,0.00006762036,0.00018909524],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004622606,0.00037077838,0.0008842151,0.00029180959,0.0001137425,0.0000819385,0.00016582714,0.00036627028,0.0013631661],"category_scores_gemma":[0.00027007324,0.00027006026,0.00013348363,0.0006139639,0.00025592753,0.00012100574,0.000082937964,0.00054766866,0.0002260073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028577019,0.009432913,0.43865085,0.002353026,0.0031877449,0.15464436,0.007395122,0.003029583,0.0014018444,0.07335194,0.013586628,0.2901083],"study_design_scores_gemma":[0.011559727,0.013233091,0.9402819,0.00088404265,0.001199796,0.0014915562,0.0017244437,0.0010231732,0.0019754535,0.0049837744,0.020904,0.0007390011],"about_ca_topic_score_codex":0.0016716782,"about_ca_topic_score_gemma":0.0018233127,"teacher_disagreement_score":0.5016311,"about_ca_system_score_codex":0.0008339061,"about_ca_system_score_gemma":0.00077485223,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W4396633513","doi":"10.1016/j.ygyno.2024.04.014","title":"Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysis","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"University of Toronto","keywords":"Medicine; Gestational trophoblastic neoplasia; Hysterectomy; Chemotherapy; Obstetrics; Oncology; Gynecology; Gestational trophoblastic disease; Internal medicine; Gestation; Pregnancy; Surgery","score_opus":0.031032462053792703,"score_gpt":0.36642903395046306,"score_spread":0.3353965718966704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396633513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94458264,0.00045997725,0.046277594,0.0009204646,0.0019172587,0.003376239,0.0005104965,0.00024682705,0.0017085245],"genre_scores_gemma":[0.9855254,0.00013856796,0.010169618,0.00032083486,0.00020376359,0.0028389248,0.00038661543,0.000053052292,0.00036316484],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973767,0.0002975244,0.0005470235,0.0008173962,0.0003582545,0.0006031292],"domain_scores_gemma":[0.98552036,0.013394092,0.00018919237,0.00026201614,0.00039608125,0.00023825339],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057124667,0.00039822154,0.0010920871,0.0006108594,0.00020560491,0.000050815273,0.00014017968,0.00017123188,0.0008182106],"category_scores_gemma":[0.002166831,0.000327864,0.00054815836,0.0011687824,0.00029214777,0.00009263479,0.000051534415,0.0003115335,0.00026992467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11789516,0.018157573,0.14256668,0.015517753,0.15302114,0.00956077,0.0073021436,0.07479892,0.0134281805,0.020066222,0.03133922,0.39634624],"study_design_scores_gemma":[0.021663345,0.011046832,0.88041085,0.00016205701,0.013792827,0.00007336573,0.0008539191,0.052805513,0.00023794669,0.0024748214,0.015845234,0.0006332909],"about_ca_topic_score_codex":0.000025804628,"about_ca_topic_score_gemma":0.000099660196,"teacher_disagreement_score":0.73784417,"about_ca_system_score_codex":0.0010143695,"about_ca_system_score_gemma":0.0011337905,"threshold_uncertainty_score":0.9999173},"labels":[],"label_agreement":null},{"id":"W4396684179","doi":"10.1016/j.ygyno.2024.04.016","title":"Prognostic performance of the 2023 FIGO staging schema for endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Endometrial cancer; Schema (genetic algorithms); Oncology; Gynecology; Internal medicine; Obstetrics; Cancer","score_opus":0.04968334600599996,"score_gpt":0.3626271697430849,"score_spread":0.31294382373708496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396684179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288125,0.0035890064,0.00002811827,0.0034982306,0.0035068044,0.0016649567,0.00008446223,0.00006944452,0.004677718],"genre_scores_gemma":[0.99451506,0.00046589738,0.0005310065,0.00046812082,0.00054257136,0.0008341551,0.000014339666,0.000015951517,0.0026128707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987833,0.00006048486,0.00033770668,0.00029326644,0.00018763596,0.00033759556],"domain_scores_gemma":[0.9972361,0.0022954752,0.00010066302,0.00018122642,0.00011125277,0.00007530302],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003588738,0.00014365456,0.00046572063,0.00016157303,0.000085856744,0.000009744684,0.00014908191,0.00017102496,0.0011738313],"category_scores_gemma":[0.0015896388,0.00008045132,0.00021854964,0.00088734174,0.00013144968,0.000045037046,0.00008630738,0.00021546708,0.000030843057],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030005146,0.001016514,0.25654683,0.0022392482,0.0011218393,0.00008706909,0.00025409568,0.00007933927,0.009024957,0.0013548115,0.008605449,0.7166693],"study_design_scores_gemma":[0.02315658,0.018815175,0.4574559,0.0007983228,0.002596589,0.00008426021,0.0002405347,0.0022614996,0.029751139,0.0012251955,0.46310318,0.0005116185],"about_ca_topic_score_codex":0.000043186865,"about_ca_topic_score_gemma":0.000036914895,"teacher_disagreement_score":0.71615773,"about_ca_system_score_codex":0.0004681932,"about_ca_system_score_gemma":0.00066649227,"threshold_uncertainty_score":0.9997392},"labels":[],"label_agreement":null},{"id":"W4396733055","doi":"10.1016/j.ygyno.2024.04.025","title":"Management of inguinal lymph nodes in locally advanced, surgically unresectable, squamous cell carcinoma of the vulva","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Vulva; Inguinal lymph nodes; Lymph; Basal cell; Oncology; Radiology; Internal medicine; Surgery; Pathology","score_opus":0.017352021080047245,"score_gpt":0.2988825267649804,"score_spread":0.28153050568493315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396733055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9044261,0.003732505,0.000019061035,0.00060440553,0.0006535499,0.000581795,0.0000131650995,0.00002602817,0.089943394],"genre_scores_gemma":[0.9971017,0.0002473902,0.00068650057,0.00020267995,0.00004418677,0.000092053444,0.000006772851,0.000013700637,0.0016049726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983514,0.00015974924,0.0005416561,0.00033712885,0.00026520205,0.0003448725],"domain_scores_gemma":[0.9985436,0.000891899,0.00012633471,0.0002788861,0.00008376961,0.000075474236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003655696,0.000169209,0.0005876937,0.0001798175,0.000028893148,0.000004340374,0.00023150802,0.00018623742,0.00067645416],"category_scores_gemma":[0.00014940328,0.00010236174,0.0001701745,0.0009288136,0.0001840521,0.00003086647,0.00020467535,0.00020826077,0.000018739811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005531271,0.005937425,0.5751668,0.00520075,0.00034217423,0.008497836,0.00056796643,0.0007153189,0.00449935,0.008761555,0.0003260694,0.38445348],"study_design_scores_gemma":[0.012998285,0.0042325095,0.96628904,0.00022563704,0.00034411118,0.00007705338,0.00044152173,0.00018062688,0.0046206387,0.0014939669,0.008917093,0.00017952925],"about_ca_topic_score_codex":0.00021355657,"about_ca_topic_score_gemma":0.00009204182,"teacher_disagreement_score":0.39112222,"about_ca_system_score_codex":0.0005632245,"about_ca_system_score_gemma":0.0003500897,"threshold_uncertainty_score":0.74066985},"labels":[],"label_agreement":null},{"id":"W4396827157","doi":"10.1016/j.ygyno.2024.05.004","title":"Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Cervical conization; Obstetrics; Gynecology; Adenocarcinoma; Cervical cancer; Cervical intraepithelial neoplasia; Internal medicine; Cancer","score_opus":0.041081454319046654,"score_gpt":0.3393646678209666,"score_spread":0.29828321350191994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896908,0.0012885511,0.00002083513,0.0014691395,0.00045300054,0.00050373055,0.000014073494,0.000087220986,0.0064726397],"genre_scores_gemma":[0.99766797,0.000095843614,0.00019549082,0.00071400194,0.00008984636,0.00011542476,0.000052525294,0.000017414977,0.0010514662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980295,0.00021844283,0.0005894679,0.00049233367,0.00019559167,0.0004747083],"domain_scores_gemma":[0.9983163,0.0010447879,0.0000978808,0.00019622345,0.000092432354,0.00025236447],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027591473,0.00018599156,0.0008113287,0.00013758386,0.000027430635,0.000010740335,0.00011513419,0.00033107825,0.0019466513],"category_scores_gemma":[0.00045073315,0.00012437133,0.00008356821,0.0009114482,0.00026013135,0.000059999,0.00005907645,0.00025360964,0.000053106127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00466742,0.0029174474,0.93616843,0.00014779242,0.00028595363,0.0017083115,0.0026739063,0.000001733646,0.002705725,0.00022030233,0.0011720089,0.047330953],"study_design_scores_gemma":[0.0328795,0.041194513,0.87432176,0.00019762963,0.00038993458,0.00015990964,0.0040716804,0.000103434,0.005048815,0.00030845625,0.040884063,0.0004403268],"about_ca_topic_score_codex":0.000071924616,"about_ca_topic_score_gemma":0.00028554263,"teacher_disagreement_score":0.06184671,"about_ca_system_score_codex":0.0011782,"about_ca_system_score_gemma":0.00034010567,"threshold_uncertainty_score":0.9989657},"labels":[],"label_agreement":null},{"id":"W4396842244","doi":"10.1016/j.ygyno.2024.04.009","title":"Correlating the KELIM (CA125 elimination rate constant K) score and the chemo-response score as predictors of chemosensitivity in patients with advanced ovarian carcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Cohort; Serous carcinoma; Ovarian cancer; Retrospective cohort study; Progression-free survival; Confidence interval; Cancer; Overall survival; Serous fluid; Stage (stratigraphy); Oncology","score_opus":0.009540329117824433,"score_gpt":0.2532768980417366,"score_spread":0.24373656892391216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396842244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652697,0.00050861057,0.000009423785,0.00949906,0.0004025554,0.0017020836,0.000031287986,0.000034632172,0.001285353],"genre_scores_gemma":[0.9988152,0.000095809126,0.00013151251,0.00063525606,0.000037931073,0.00018546754,0.000031104137,0.000016638562,0.00005109784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830693,0.0005062117,0.00035854,0.0003802805,0.00018134256,0.00026671408],"domain_scores_gemma":[0.9955811,0.0037746013,0.00018686018,0.0002581312,0.00013584398,0.00006345513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259929,0.00020050937,0.0005069422,0.000096707576,0.000108752974,0.000018061592,0.000072138195,0.00015792775,0.00005905673],"category_scores_gemma":[0.001019485,0.00009847987,0.000062363346,0.00032827677,0.0006363451,0.00006814334,0.000076601,0.00032306754,0.000004271287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012856223,0.00066354603,0.9219494,0.00011621203,0.00024861062,0.00040559957,0.0022158239,0.0000721704,0.0002039583,0.003385709,0.00017248686,0.05771028],"study_design_scores_gemma":[0.011462503,0.0040388945,0.9814932,0.0001867883,0.00030186857,0.000046375637,0.0004673261,0.00070977455,0.0004657544,0.0002556577,0.0004727538,0.00009915365],"about_ca_topic_score_codex":0.00010602113,"about_ca_topic_score_gemma":0.00019038311,"teacher_disagreement_score":0.059543766,"about_ca_system_score_codex":0.00049531605,"about_ca_system_score_gemma":0.0005781259,"threshold_uncertainty_score":0.40158924},"labels":[],"label_agreement":null},{"id":"W4399300834","doi":"10.1016/j.ygyno.2024.05.016","title":"Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Karyopharm Therapeutics","keywords":"Medicine; Endometrial cancer; Oncology; Subgroup analysis; Internal medicine; Term (time); Cancer; Gynecology","score_opus":0.026318760374372967,"score_gpt":0.3368973699782399,"score_spread":0.3105786096038669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399300834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346834,0.0016478295,0.000012523697,0.00018670082,0.0008198191,0.003443225,0.00025351084,0.000021536674,0.0001464994],"genre_scores_gemma":[0.99794644,0.0012014669,0.00011304011,0.000038031998,0.00004541832,0.00037322927,0.00004781035,0.00001766501,0.0002168811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725515,0.0003618289,0.0010171842,0.0005910242,0.00039814072,0.00037667307],"domain_scores_gemma":[0.99633306,0.0024357697,0.00047452387,0.00042015358,0.00021954984,0.00011693726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041309767,0.0003146142,0.0018589558,0.0007163936,0.000043711374,0.0000052458067,0.00019134961,0.00015630542,0.0003574398],"category_scores_gemma":[0.0008748413,0.00015245286,0.0002897628,0.0034454938,0.00023470959,0.000052421623,0.00012050398,0.00020540912,9.632055e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03261625,0.0061471644,0.762686,0.00015533653,0.003591958,0.00006951539,0.0009062314,0.00008363262,0.000084260086,0.000018894141,0.0000063172115,0.1936344],"study_design_scores_gemma":[0.062104523,0.035594963,0.8961897,0.00017833257,0.004988748,0.0000024369035,0.0002444337,0.000034665216,0.00024288424,0.000006707346,0.00028519012,0.00012740982],"about_ca_topic_score_codex":0.00051493617,"about_ca_topic_score_gemma":0.0072742715,"teacher_disagreement_score":0.19350699,"about_ca_system_score_codex":0.0010718021,"about_ca_system_score_gemma":0.00047275552,"threshold_uncertainty_score":0.62168473},"labels":[],"label_agreement":null},{"id":"W4399316087","doi":"10.1016/j.ygyno.2024.03.009","title":"Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Regeneron Pharmaceuticals; National Institutes of Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; LEO Pharma; PharmaMar; European Society for Medical Oncology; Juno Therapeutics; Eisai; Seagen; Pfizer; Incyte; ANGLE; Mersana Therapeutics; Syndax Pharmaceuticals; Clovis Oncology; Ludwig Institute for Cancer Research; Fujirebio US; Teva Pharmaceutical Industries; Atara Biotherapeutics; Sanofi; Amgen; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Ovarian cancer; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.019324522038202896,"score_gpt":0.3192194002741925,"score_spread":0.2998948782359896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399316087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993224,0.0018286172,0.000019295869,0.004339938,0.0007256934,0.0019348592,0.00020758786,0.000055442626,0.0009563278],"genre_scores_gemma":[0.9959457,0.0016014933,0.0008352311,0.0010056233,0.00019781271,0.00019550174,0.0000846995,0.000021901453,0.00011205553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99816686,0.00029446738,0.0005425254,0.0005090268,0.00019685955,0.0002902665],"domain_scores_gemma":[0.9973919,0.001988967,0.00018764217,0.00028522604,0.000058144113,0.00008816601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056308345,0.00018744785,0.0005810347,0.00009740345,0.0000611876,0.000014091166,0.00010209727,0.000253277,0.00019270819],"category_scores_gemma":[0.0003665451,0.00012387092,0.0000393999,0.00028933506,0.0003618777,0.00007253608,0.00006573402,0.00044500685,0.000004117084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2975991,0.0015009369,0.060493626,0.00010819829,0.00057648844,0.00024567466,0.008572495,0.000103707374,0.0014687836,0.0005457718,0.0058806115,0.6229046],"study_design_scores_gemma":[0.16572161,0.004840259,0.8034177,0.00021613263,0.000113642614,0.000006158778,0.00015377124,0.000029687135,0.0001148909,0.00025046253,0.02499368,0.00014203937],"about_ca_topic_score_codex":0.00032530248,"about_ca_topic_score_gemma":0.0006872861,"teacher_disagreement_score":0.74292403,"about_ca_system_score_codex":0.00035544083,"about_ca_system_score_gemma":0.00041231886,"threshold_uncertainty_score":0.505131},"labels":[],"label_agreement":null},{"id":"W4400268735","doi":"10.1016/j.ygyno.2024.06.013","title":"Avoiding the needle: A quality improvement program introducing apixaban for extended thromboprophylaxis after major gynecologic cancer surgery","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver Coastal Health; Health Canada; University of British Columbia","funders":"","keywords":"Medicine; Gynecologic cancer; Apixaban; General surgery; Gynecologic oncology; Surgery; Intensive care medicine; Cancer; Ovarian cancer; Internal medicine; Rivaroxaban; Warfarin","score_opus":0.03932746025013476,"score_gpt":0.3826162693454713,"score_spread":0.34328880909533654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400268735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95354414,0.005541812,0.00036515098,0.024554588,0.0057595014,0.0075725927,0.000056758283,0.0007476234,0.0018578633],"genre_scores_gemma":[0.96953946,0.0013466802,0.0017155164,0.0062463977,0.0011911285,0.018864995,0.000056874895,0.000070704045,0.000968212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99570465,0.00048305723,0.0010296258,0.0012002102,0.00035949264,0.0012229384],"domain_scores_gemma":[0.9940776,0.0045389254,0.00027902107,0.0006782707,0.00022284551,0.0002032873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042741057,0.000492849,0.0014488717,0.00028113648,0.0005754547,0.00015596116,0.00030177282,0.00041907147,0.0018162667],"category_scores_gemma":[0.0020355333,0.00030929412,0.0006049819,0.0005891479,0.00033629368,0.00013932779,0.00033281604,0.0008349285,0.000099456985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033927086,0.0029406268,0.003346274,0.0014947371,0.0012462984,0.00036202424,0.0014494681,0.00003229988,0.0029104105,0.002547495,0.041368913,0.9419622],"study_design_scores_gemma":[0.0025286695,0.011085142,0.48679575,0.00033888192,0.0021811968,0.00008959097,0.004382199,0.0008766007,0.0020804957,0.0065748384,0.48194697,0.0011196665],"about_ca_topic_score_codex":0.00035894912,"about_ca_topic_score_gemma":0.0007393863,"teacher_disagreement_score":0.9408425,"about_ca_system_score_codex":0.0014779496,"about_ca_system_score_gemma":0.0007746082,"threshold_uncertainty_score":0.9999359},"labels":[],"label_agreement":null},{"id":"W4400348482","doi":"10.1016/j.ygyno.2024.06.029","title":"Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; The King's University; Queen's University; University of British Columbia; Calgary Laboratory Services; BC Cancer Agency; Saskatchewan Cancer Agency; University of Saskatchewan; University of Alberta","funders":"Alberta Cancer Foundation; Women and Children's Health Research Institute; Children's Health Research Institute","keywords":"Medicine; Endometrial cancer; Digoxin; Oncology; Gynecologic cancer; Internal medicine; Gynecology; Cancer; Ovarian cancer; Heart failure","score_opus":0.05849712729548591,"score_gpt":0.42383741801276803,"score_spread":0.36534029071728213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400348482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98006195,0.014846436,0.0031278832,0.00015934082,0.0005250337,0.0008483601,0.000074220334,0.00002779874,0.0003289632],"genre_scores_gemma":[0.9880012,0.0033485421,0.0071334303,0.0003654995,0.00041354756,0.00038226604,0.000068163754,0.00002391997,0.00026342648],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987264,0.00017902965,0.0002898004,0.0004944087,0.00007538956,0.00023496152],"domain_scores_gemma":[0.9987925,0.0006297693,0.00016833853,0.00018077533,0.00015254763,0.00007603967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005139576,0.0001590336,0.0003613701,0.00006134895,0.00006347317,0.00001596983,0.00013497974,0.0004125475,0.00004580749],"category_scores_gemma":[0.0011801544,0.00012607191,0.00012776912,0.00010540085,0.00014158258,0.0000064072856,0.0000788286,0.0001348718,0.000001215465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036204509,0.00024265845,0.0013022787,0.00011914797,0.0005047352,0.000020306976,0.00030895742,0.005529278,0.17933832,0.00018198279,0.0019091453,0.80692273],"study_design_scores_gemma":[0.036675483,0.12177094,0.009003552,0.0008625865,0.0011965724,0.00036294543,0.0008328937,0.5289623,0.16712408,0.027552944,0.10289364,0.0027620478],"about_ca_topic_score_codex":0.000027249835,"about_ca_topic_score_gemma":0.000048637736,"teacher_disagreement_score":0.8041607,"about_ca_system_score_codex":0.000046172965,"about_ca_system_score_gemma":0.00032405948,"threshold_uncertainty_score":0.51410633},"labels":[],"label_agreement":null},{"id":"W4401450016","doi":"10.1016/j.ygyno.2024.07.677","title":"Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; National Institutes of Health","keywords":"Stage (stratigraphy); Medicine; Endometrial cancer; Oncology; Adenocarcinoma; Internal medicine; Adjuvant therapy; Cancer research; Gynecology; Cancer; Biology","score_opus":0.04486383639407366,"score_gpt":0.3336582234163099,"score_spread":0.28879438702223625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401450016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98930734,0.0031398307,0.00034828912,0.0007197416,0.0017844932,0.0010531317,0.00013019111,0.00016167678,0.0033553205],"genre_scores_gemma":[0.9968361,0.00057525135,0.00057928124,0.00052545255,0.0002918954,0.00012537022,0.00019095956,0.000031085434,0.000844599],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99789554,0.00022839276,0.00059634505,0.0005003236,0.00036328295,0.0004160939],"domain_scores_gemma":[0.997673,0.0015048403,0.00017506377,0.0002759851,0.00017208293,0.00019902745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023156998,0.00025384844,0.00091184146,0.0009609452,0.000047549394,0.000022577009,0.00015311733,0.00033828156,0.0016430942],"category_scores_gemma":[0.0006158816,0.00019877224,0.00030687888,0.0020415597,0.00017511223,0.00009536433,0.00010341393,0.00033890575,0.00016012187],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032010074,0.0018382617,0.040224455,0.00088475866,0.0015170742,0.0048882994,0.0005704422,0.00000736544,0.8180615,0.004912979,0.000114022805,0.12377989],"study_design_scores_gemma":[0.022465827,0.032799985,0.6721781,0.00011876978,0.0012078233,0.0002645087,0.00019412317,0.00010986019,0.13711666,0.00091459765,0.13208237,0.00054737995],"about_ca_topic_score_codex":0.00008644099,"about_ca_topic_score_gemma":0.000003373617,"teacher_disagreement_score":0.6809448,"about_ca_system_score_codex":0.0004828061,"about_ca_system_score_gemma":0.00036046677,"threshold_uncertainty_score":0.99926955},"labels":[],"label_agreement":null},{"id":"W4401757080","doi":"10.1016/j.ygyno.2024.07.687","title":"Incidence of endometrial cancer in BRCA mutation carriers","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; McMaster University; Women's College Hospital","funders":"Canada Research Chairs; Kreftforeningen; Canadian Cancer Society; Canadian Cancer Society Research Institute; Peter Gilgan Foundation; Cleveland Clinic","keywords":"Endometrial cancer; Medicine; Germline mutation; Germline; Incidence (geometry); Mutation; BRCA mutation; Cancer; Oncology; Gynecology; Gene; Genetics; Internal medicine; Ovarian cancer; Biology","score_opus":0.01634167977427807,"score_gpt":0.33992430711782345,"score_spread":0.32358262734354537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401757080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873658,0.005730882,0.0005067482,0.00062210235,0.0022222851,0.00030278217,0.0000538743,0.000020879115,0.0031746905],"genre_scores_gemma":[0.99748176,0.0006566324,0.0009057212,0.00019427534,0.00024079927,0.00020779761,0.00003314936,0.00001360129,0.00026628017],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884784,0.00014404264,0.00032221462,0.0003626034,0.00010064768,0.00022267582],"domain_scores_gemma":[0.99939525,0.00022618343,0.00008593464,0.00017391877,0.00007941842,0.00003928627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347608,0.00011174176,0.00020842144,0.00021104654,0.000026557884,0.000009392029,0.00018032565,0.00029720896,0.00036193914],"category_scores_gemma":[0.00070633745,0.00010752146,0.00006975576,0.00046687177,0.00016917988,0.0000059196427,0.0000862474,0.00014169204,0.000012786809],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004029173,0.00020846167,0.029153887,0.00016411734,0.00028382515,0.00026853156,0.001244401,0.014861959,0.55417186,0.0013074348,0.0095594805,0.3883731],"study_design_scores_gemma":[0.005942949,0.0063636135,0.09295774,0.00012555403,0.00022219276,0.00020539114,0.00187651,0.0032666528,0.4272478,0.0052138087,0.45551983,0.0010579542],"about_ca_topic_score_codex":0.00014613123,"about_ca_topic_score_gemma":0.001997722,"teacher_disagreement_score":0.44596037,"about_ca_system_score_codex":0.000456193,"about_ca_system_score_gemma":0.0012534552,"threshold_uncertainty_score":0.43845978},"labels":[],"label_agreement":null},{"id":"W4401903200","doi":"10.1016/j.ygyno.2024.08.022","title":"Patient-reported sexual health outcomes of cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Royal Victoria Regional Health Centre; Sinai Health System; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Brachytherapy; Cervical cancer; Radiology; Chemoradiotherapy; Radiation therapy; Cancer; Internal medicine","score_opus":0.04190539241402042,"score_gpt":0.3490121972935634,"score_spread":0.307106804879543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401903200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924956,0.0013668805,0.000012627215,0.0034247155,0.00027091324,0.0009560048,0.00007978636,0.0000991484,0.0012943514],"genre_scores_gemma":[0.9961183,0.00045888702,0.00041669348,0.0024109085,0.00004624119,0.00021575381,0.0001700011,0.000022009579,0.0001411912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833614,0.0001319474,0.0005332931,0.0004364885,0.0002450751,0.00031705343],"domain_scores_gemma":[0.99864745,0.0005914072,0.000253111,0.00013630785,0.00017957679,0.00019215232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014374587,0.0002192647,0.0008203827,0.00018123964,0.00006090153,0.000009792899,0.000037771624,0.00019053198,0.0004093783],"category_scores_gemma":[0.00016239825,0.00013615604,0.00006152695,0.0004909444,0.00013582077,0.00006320155,0.00003043967,0.00018237258,0.000007727548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000754264,0.0009829263,0.8262101,0.0001337417,0.000649241,0.00011233419,0.00043655938,0.0000035588232,0.000059219692,0.00008080642,0.00039231093,0.17018496],"study_design_scores_gemma":[0.00800827,0.018011095,0.9711196,0.000041817355,0.00028969912,0.000035880876,0.00014778893,0.000054317068,0.00033017324,0.00010270459,0.0017222456,0.00013640964],"about_ca_topic_score_codex":0.0010450553,"about_ca_topic_score_gemma":0.00042061653,"teacher_disagreement_score":0.17004855,"about_ca_system_score_codex":0.00066388224,"about_ca_system_score_gemma":0.0005392796,"threshold_uncertainty_score":0.55522823},"labels":[],"label_agreement":null},{"id":"W4402446611","doi":"10.1016/j.ygyno.2024.09.006","title":"Cervical squamous cell carcinoma outcomes across continents: A retrospective study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Retrospective cohort study; Basal cell; Cervical carcinoma; Oncology; Cervical cancer; Internal medicine; Cancer","score_opus":0.03776894125392861,"score_gpt":0.39865021012008045,"score_spread":0.36088126886615185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402446611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113771,0.0007881578,0.000020547119,0.0049582105,0.0011064028,0.0014268446,0.000037291527,0.00027619526,0.08000927],"genre_scores_gemma":[0.99122715,0.000017470602,0.00008456999,0.0015478375,0.00034522766,0.00031923602,0.000019368375,0.000037069658,0.006402044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971174,0.00024460626,0.00047324962,0.00080563803,0.00048285344,0.00087628164],"domain_scores_gemma":[0.9979842,0.0009212077,0.000052336018,0.0004351583,0.0002772492,0.0003298842],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007960842,0.00028043432,0.00092458876,0.00014087054,0.00016942757,0.00006681084,0.0002605407,0.0003648106,0.011406402],"category_scores_gemma":[0.0007577908,0.0001987361,0.00025590695,0.0005074793,0.0002358708,0.00007052118,0.00037034784,0.0010264752,0.0008885038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048019757,0.0029773454,0.9581919,0.00019316873,0.000092643655,0.003951735,0.002220848,8.8319433e-7,0.00010086892,0.00018984194,0.004832714,0.026767893],"study_design_scores_gemma":[0.005028656,0.011291645,0.9525666,0.0000023050543,0.000151365,0.000066147964,0.0022304393,0.00015893368,0.0000620101,0.00034938095,0.027901368,0.00019111733],"about_ca_topic_score_codex":0.00036885584,"about_ca_topic_score_gemma":0.0011343727,"teacher_disagreement_score":0.07985009,"about_ca_system_score_codex":0.0013988488,"about_ca_system_score_gemma":0.00045086947,"threshold_uncertainty_score":0.99988943},"labels":[],"label_agreement":null},{"id":"W4402507712","doi":"10.1016/j.ygyno.2024.09.005","title":"Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Cervical cancer; Radiation therapy; Immune system; Oncology; Internal medicine; Cancer; Outcome (game theory); Chemo-radiotherapy; Immunology","score_opus":0.011624950606615959,"score_gpt":0.31005631006245643,"score_spread":0.2984313594558405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402507712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625194,0.001300732,0.0000047402273,0.00023765283,0.0000658188,0.001109317,0.00009536728,0.00007387318,0.00086054654],"genre_scores_gemma":[0.99802256,0.00018216508,0.0009845911,0.00028098098,0.00002762082,0.00038432828,0.000069451395,0.000032561155,0.000015760434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983671,0.00013636178,0.0004766995,0.00042385096,0.00025120276,0.0003448205],"domain_scores_gemma":[0.9987565,0.000601475,0.00017591471,0.00016427739,0.00016602824,0.00013577042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018622693,0.00028085793,0.00065805716,0.0003555956,0.000040791496,0.000011270786,0.0000891447,0.00028169437,0.00045011909],"category_scores_gemma":[0.00007475401,0.00017714662,0.00009779177,0.00035016725,0.00044524457,0.00010119357,0.00003120589,0.00032600813,0.000005411875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012278127,0.0010892838,0.9630642,0.00027250167,0.0006182012,0.00041988358,0.00013332638,0.000028439463,0.00016840013,0.000104278355,0.00003258205,0.021790812],"study_design_scores_gemma":[0.010163116,0.011624475,0.9769541,0.00039762547,0.00014627818,0.000017469374,0.00006147472,0.00008835854,0.00016317677,0.000041873638,0.00014258013,0.00019945778],"about_ca_topic_score_codex":0.000043563465,"about_ca_topic_score_gemma":0.00009299954,"teacher_disagreement_score":0.021591354,"about_ca_system_score_codex":0.0011056451,"about_ca_system_score_gemma":0.00070636196,"threshold_uncertainty_score":0.7223829},"labels":[],"label_agreement":null},{"id":"W4403249104","doi":"10.1016/j.ygyno.2024.07.535","title":"Association of reviewer experience in discriminating human- versus ChatGPT-written abstracts","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Association (psychology); Information retrieval; Computational biology; Natural language processing; Psychotherapist; Psychology; Biology; Computer science","score_opus":0.25728696981695093,"score_gpt":0.5122957221683564,"score_spread":0.25500875235140547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97768945,0.0009774497,0.000008798268,0.0055563636,0.00280185,0.00039047204,0.0000013638847,0.000046589594,0.01252767],"genre_scores_gemma":[0.997803,0.0004289446,0.00027583356,0.00030496257,0.00028907583,0.00011410918,0.000015969217,0.000008191673,0.0007599597],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99857414,0.000112174326,0.0006446074,0.0002429018,0.00015316778,0.00027300412],"domain_scores_gemma":[0.9980592,0.0013698442,0.00017688703,0.00013556554,0.00019858197,0.00005992891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010223972,0.000090257185,0.00032177687,0.00014569533,0.000050831186,0.000009497019,0.00007306491,0.0002595097,0.0005595321],"category_scores_gemma":[0.004578743,0.00007752106,0.000061606384,0.00028843718,0.000059911697,0.00009582765,0.000026815716,0.0003081246,0.00009535832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020526914,0.0009499211,0.16989961,0.0012568183,0.00007968078,0.00023128271,0.025134638,0.0000364313,0.007408274,0.002896207,0.008478951,0.7834229],"study_design_scores_gemma":[0.0007744907,0.0082441745,0.7216905,0.0014626026,0.00036038557,0.00003696611,0.03213869,0.0008023428,0.01982958,0.007374771,0.20670128,0.0005842598],"about_ca_topic_score_codex":0.0003983023,"about_ca_topic_score_gemma":0.0009290467,"teacher_disagreement_score":0.78283864,"about_ca_system_score_codex":0.0010465629,"about_ca_system_score_gemma":0.00029346038,"threshold_uncertainty_score":0.61264837},"labels":[],"label_agreement":null},{"id":"W4403249296","doi":"10.1016/j.ygyno.2024.07.613","title":"Outcomes of groin recurrence in vulvar cancer after primary treatment with a sentinel lymph node procedure","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Groin; Vulvar cancer; Sentinel lymph node; Lymph node; Surgery; Cancer; Vulva; Internal medicine; Breast cancer","score_opus":0.025138636306800258,"score_gpt":0.33049296630148556,"score_spread":0.3053543299946853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98167574,0.0076480564,0.0000059098234,0.0032116445,0.0003563732,0.0006851561,0.000040016184,0.0000698924,0.006307229],"genre_scores_gemma":[0.99408776,0.0014664648,0.00058280764,0.0011130455,0.00008274611,0.0011988241,0.000023748844,0.000019316629,0.0014252886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985492,0.00007595209,0.00037060402,0.0004570826,0.00018505182,0.00036208288],"domain_scores_gemma":[0.99909556,0.00046597898,0.000084831394,0.0001864231,0.000059067454,0.00010814858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012978693,0.00024595088,0.0008481669,0.00023387407,0.000019725361,0.000007104394,0.00007600762,0.00019540862,0.0008678652],"category_scores_gemma":[0.00007983008,0.00013864363,0.000114498805,0.00063235965,0.00012340493,0.000055138386,0.00004457622,0.00014773764,0.000038228478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013591616,0.0013421939,0.91943306,0.0003348309,0.00032224666,0.0016950929,0.00024448242,0.0000056708864,0.00019511378,0.000042295487,0.000069583184,0.0749563],"study_design_scores_gemma":[0.0064030145,0.002283888,0.98609424,0.00018868204,0.00035247463,0.00011732701,0.000063177395,0.000032583834,0.00017808034,0.00013207279,0.00401249,0.00014197016],"about_ca_topic_score_codex":0.0003661095,"about_ca_topic_score_gemma":0.00046073296,"teacher_disagreement_score":0.07481433,"about_ca_system_score_codex":0.0017916353,"about_ca_system_score_gemma":0.0011204609,"threshold_uncertainty_score":0.9502516},"labels":[],"label_agreement":null},{"id":"W4403249364","doi":"10.1016/j.ygyno.2024.07.475","title":"The evolving landscape of molecular profiling in early-stage endometrial cancer: An NRG Oncology cooperative group mixed-methods study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Oncology; Endometrial cancer; Internal medicine; Profiling (computer programming); Gynecologic oncology; Stage (stratigraphy); Gynecology; Cancer; Biology","score_opus":0.03596728911885335,"score_gpt":0.4180571462010987,"score_spread":0.38208985708224535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801424,0.008322432,0.00023662721,0.0006285528,0.002789609,0.0024179292,0.000030716023,0.00009958055,0.0053321663],"genre_scores_gemma":[0.99348295,0.00070935854,0.003957283,0.00020540248,0.00030034923,0.0010506236,0.000025619724,0.00003311883,0.00023530656],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950562,0.002433593,0.0008890552,0.0006974617,0.000307424,0.0006162421],"domain_scores_gemma":[0.9922936,0.0067427517,0.00021319647,0.00036410324,0.00019824001,0.0001880898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034671603,0.0003042584,0.0011674557,0.00050882634,0.00015044231,0.000041968087,0.00030186275,0.00038580727,0.0005401634],"category_scores_gemma":[0.0028712242,0.00018800661,0.00017913275,0.0018231046,0.00023531987,0.000120688186,0.00020777338,0.00073513325,0.000016274324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053836433,0.006112156,0.18586174,0.0001957508,0.0014142914,0.003885908,0.0033401093,0.00025843864,0.023602452,0.00230574,0.00015526205,0.7674845],"study_design_scores_gemma":[0.07483163,0.21932025,0.5668308,0.0002711854,0.002617279,0.00016914145,0.03320349,0.0048242677,0.02846921,0.002278448,0.065802254,0.0013820124],"about_ca_topic_score_codex":0.000861152,"about_ca_topic_score_gemma":0.002721534,"teacher_disagreement_score":0.7661025,"about_ca_system_score_codex":0.0011880673,"about_ca_system_score_gemma":0.0008640452,"threshold_uncertainty_score":0.76666874},"labels":[],"label_agreement":null},{"id":"W4403249386","doi":"10.1016/j.ygyno.2024.07.555","title":"Oncologic outcomes among patients undergoing fertility-sparing treatment of atypical hyperplasia and grade one cancer of the endometrium using progestin therapy: Results of a novel, specialized, oncofertility program","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Oncofertility; Progestin; Fertility preservation; Gynecology; Fertility; Endometrial cancer; Oncology; Endometrium; Cancer; Obstetrics; Internal medicine; Hormone; Population","score_opus":0.10908844508021874,"score_gpt":0.3792467151502728,"score_spread":0.27015827007005405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924178,0.0019175541,0.000006730952,0.0013221666,0.00060874753,0.003089362,0.000111770525,0.000057784942,0.00046809218],"genre_scores_gemma":[0.9952804,0.0009479702,0.0031743073,0.00006352205,0.000052439926,0.00040485174,0.000013753582,0.000021706683,0.00004106669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740916,0.00025863503,0.0010174713,0.0005954067,0.000327478,0.00039186314],"domain_scores_gemma":[0.9965453,0.002231146,0.000510617,0.0004076893,0.0001871134,0.00011812161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003897734,0.00031323102,0.0013429354,0.00018963093,0.00008294352,0.000012610851,0.00013671501,0.0003203193,0.00006269394],"category_scores_gemma":[0.0007795,0.00018275654,0.00030110255,0.00060633133,0.0006372459,0.000060142593,0.00012464238,0.00019133992,5.111924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020741555,0.013275095,0.8741075,0.00024969605,0.00078500225,0.000019360628,0.00052559964,0.000038494367,0.0007311222,0.00007419494,0.000014885719,0.1081049],"study_design_scores_gemma":[0.014350203,0.012512691,0.964293,0.0002710057,0.000693678,0.000008911538,0.00008737904,0.0003338553,0.0060236664,0.00010278986,0.0011964111,0.00012639121],"about_ca_topic_score_codex":0.0011156367,"about_ca_topic_score_gemma":0.001618792,"teacher_disagreement_score":0.10797851,"about_ca_system_score_codex":0.001500841,"about_ca_system_score_gemma":0.0009769244,"threshold_uncertainty_score":0.7452596},"labels":[],"label_agreement":null},{"id":"W4403249608","doi":"10.1016/j.ygyno.2024.07.456","title":"Canadian management of Serous Tubal Intraepithelial Carcinoma (Can-STIC)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; McMaster University; McGill University; University of Calgary; Memorial University of Newfoundland; University of British Columbia; Dalhousie University; St. John’s Health Sciences Centre; University of Toronto; University of Alberta; Université de Montréal; Université Laval","funders":"","keywords":"Medicine; Serous carcinoma; Gynecology; Serous fluid; General surgery; Internal medicine; Ovarian cancer; Cancer","score_opus":0.0182200598169985,"score_gpt":0.2972685235601204,"score_spread":0.2790484637431219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8743413,0.0019966913,0.000027953098,0.024306249,0.002488255,0.0010041578,0.00014396374,0.00011624669,0.095575154],"genre_scores_gemma":[0.9950612,0.00039755992,0.001586912,0.0010872476,0.00018297548,0.00017138824,0.000041805884,0.000020267273,0.001450654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986661,0.00005637468,0.00030858038,0.0003876826,0.00013453343,0.00044672846],"domain_scores_gemma":[0.9991684,0.00019096698,0.0000449133,0.00025842988,0.000054724223,0.00028256723],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019544063,0.00017558904,0.00043665472,0.00020179198,0.00005391925,0.000013147699,0.000108895896,0.00021168379,0.0018917765],"category_scores_gemma":[0.00002398411,0.00013903173,0.00012102266,0.00024898825,0.00009595452,0.00002305054,0.00005057971,0.00018343597,0.00020355568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022533558,0.0012290715,0.0983045,0.0010774824,0.001878332,0.033093944,0.00083696755,0.0000432062,0.00017384067,0.049483713,0.031151878,0.7825017],"study_design_scores_gemma":[0.0037109917,0.007272765,0.6260328,0.0001987947,0.0015613877,0.0005366229,0.0006881639,0.000295405,0.00080444425,0.002202367,0.35636804,0.00032819595],"about_ca_topic_score_codex":0.018055974,"about_ca_topic_score_gemma":0.04837334,"teacher_disagreement_score":0.7821735,"about_ca_system_score_codex":0.0021480941,"about_ca_system_score_gemma":0.0011677167,"threshold_uncertainty_score":0.99902064},"labels":[],"label_agreement":null},{"id":"W4403249789","doi":"10.1016/j.ygyno.2024.07.608","title":"Multidimensional measurements of long-term quality of life and recovery patterns of cervical cancer patients after treatment","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Term (time); Cervical cancer; Quality of life (healthcare); Cancer; Oncology; Quality (philosophy); Intensive care medicine; Internal medicine; Nursing","score_opus":0.07992084789624244,"score_gpt":0.3717524938578674,"score_spread":0.291831645961625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950896,0.0028989261,0.000009209343,0.00024618825,0.00059482845,0.00055922323,0.0002360339,0.000015714404,0.0003502582],"genre_scores_gemma":[0.9985172,0.00064880546,0.0002228313,0.00021300752,0.000057366567,0.00014578612,0.000051523093,0.000011855318,0.0001316126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982155,0.0001949489,0.0007265347,0.0003313111,0.00031938314,0.00021230821],"domain_scores_gemma":[0.99850655,0.00074009213,0.00023022063,0.00016342563,0.00020618405,0.00015351002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023744426,0.00018297897,0.0009054948,0.00014600788,0.00001586357,0.0000020191617,0.000046412202,0.00021183668,0.001724393],"category_scores_gemma":[0.00026481252,0.00012138397,0.0001921528,0.00016714695,0.00012046228,0.000040689105,0.00007568769,0.00009250007,0.0000057150023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025862774,0.0024992274,0.91469353,0.00071751553,0.0006928622,0.000027664159,0.00011657896,0.0000022363656,0.0012087997,0.000010229735,0.000015404483,0.07742967],"study_design_scores_gemma":[0.0064137904,0.0068945684,0.9818471,0.00013446777,0.00033824408,0.000001517575,0.000018175993,0.00000360429,0.0041568386,0.000032008636,0.00007155428,0.0000881243],"about_ca_topic_score_codex":0.0006666687,"about_ca_topic_score_gemma":0.0005343359,"teacher_disagreement_score":0.07734154,"about_ca_system_score_codex":0.0004719121,"about_ca_system_score_gemma":0.0003608931,"threshold_uncertainty_score":0.9991882},"labels":[],"label_agreement":null},{"id":"W4403249848","doi":"10.1016/j.ygyno.2024.07.392","title":"Outcomes of niraparib first-line maintenance among patients with BRCA wild-type advanced ovarian cancer in a real-world clinical setting","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hôpital Maisonneuve-Rosemont; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Ovarian cancer; Internal medicine; Gynecology; Cancer","score_opus":0.03439876027864869,"score_gpt":0.39291256203307656,"score_spread":0.3585138017544279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839371,0.0002969533,0.00007635544,0.0058977418,0.0019540905,0.0011445297,0.00005843168,0.00016420688,0.006470632],"genre_scores_gemma":[0.9924224,0.0009631602,0.0024734288,0.001981531,0.00014835129,0.0002665594,0.00004667584,0.000044283548,0.0016536028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714774,0.000230673,0.0011197098,0.0006740582,0.00026865196,0.0005591892],"domain_scores_gemma":[0.99705935,0.0017304309,0.00039001735,0.00039210447,0.00027527116,0.00015284937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000837955,0.00028764023,0.0011493285,0.0003163954,0.00005983131,0.00000977737,0.0001780889,0.0003263443,0.0009625812],"category_scores_gemma":[0.00062591373,0.00020728196,0.00014534913,0.00091090257,0.00045443946,0.00013281372,0.000078331555,0.0007219901,0.000023512133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012547319,0.00065674365,0.9463308,0.0001233832,0.0002226298,0.00022651276,0.00019826899,0.00043433232,0.000034109187,0.00032268692,0.0017095469,0.04848628],"study_design_scores_gemma":[0.008544556,0.003330133,0.96437716,0.00048106126,0.0001178195,0.000005104165,0.0000650326,0.0004278738,0.00005674421,0.00039243794,0.021983111,0.0002189434],"about_ca_topic_score_codex":0.0004644112,"about_ca_topic_score_gemma":0.013939405,"teacher_disagreement_score":0.04826734,"about_ca_system_score_codex":0.0010543739,"about_ca_system_score_gemma":0.0008106685,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W4403249882","doi":"10.1016/j.ygyno.2024.07.317","title":"3D organoid models for predicting drug response in platinum-sensitive, high-grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Organoid; Serous ovarian cancer; Ovarian cancer; Oncology; Serous fluid; Platinum; Drug response; Internal medicine; Epithelial ovarian cancer; Drug; Cancer; Pharmacology; Neuroscience; Biology","score_opus":0.029603607368928992,"score_gpt":0.3244030361045668,"score_spread":0.2947994287356378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960406,0.0015065983,0.00077620253,0.030590577,0.0021904097,0.0020697587,0.00022719562,0.00029974148,0.0019335098],"genre_scores_gemma":[0.98501873,0.0004048698,0.009327395,0.001952323,0.000429604,0.0015083525,0.00006115533,0.00005594187,0.0012416524],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976369,0.00029508522,0.0005192403,0.00075169187,0.0001700628,0.00062702876],"domain_scores_gemma":[0.9953691,0.00398132,0.00011082166,0.00027697973,0.00010311554,0.00015865701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009344685,0.0002939323,0.0007289506,0.00027636453,0.000116758994,0.000032800133,0.00010218657,0.00036390717,0.00040870777],"category_scores_gemma":[0.00049575156,0.00024013715,0.0001271774,0.0004067471,0.00010033068,0.00012035218,0.00007723092,0.00040074563,0.00003903021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038884368,0.011193005,0.11037993,0.0024319317,0.0050064577,0.035279647,0.029024573,0.045447957,0.017746586,0.03318596,0.07886507,0.5925545],"study_design_scores_gemma":[0.05099506,0.024138598,0.503219,0.0019742113,0.0031607694,0.0012426837,0.003812113,0.18698187,0.0140401,0.020600196,0.18768236,0.0021530318],"about_ca_topic_score_codex":0.00072748424,"about_ca_topic_score_gemma":0.0016782111,"teacher_disagreement_score":0.5904015,"about_ca_system_score_codex":0.0023899938,"about_ca_system_score_gemma":0.0013399239,"threshold_uncertainty_score":0.97925085},"labels":[],"label_agreement":null},{"id":"W4403249890","doi":"10.1016/j.ygyno.2024.07.537","title":"Time interval from biopsy of endometrial intraepithelial neoplasia to surgery and risk for concurrent endometrial carcinoma","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Endometrial cancer; Carcinoma; Endometrial biopsy; Biopsy; Gynecology; Oncology; Urology; Internal medicine; Cancer","score_opus":0.03570565787752728,"score_gpt":0.32235460501366,"score_spread":0.2866489471361327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985621,0.0025188397,0.00036358216,0.00085144106,0.0071135773,0.0016123034,0.0013573898,0.00010338263,0.00045850204],"genre_scores_gemma":[0.99520826,0.0004054812,0.001545082,0.00019125285,0.0019495295,0.00029443146,0.00017612871,0.000030954,0.00019884964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974967,0.00028042588,0.0008221609,0.0006661894,0.0002498271,0.00048467226],"domain_scores_gemma":[0.980999,0.01810698,0.0002035337,0.00021184151,0.00013071256,0.00034793463],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093189004,0.00030008645,0.001514053,0.00094211596,0.00006559127,0.000026721826,0.00013245187,0.00036290888,0.0014971808],"category_scores_gemma":[0.00793025,0.00022214631,0.00045151453,0.0010512606,0.00022638029,0.000057937083,0.00014969542,0.0002869145,0.00013490555],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013839849,0.00095980486,0.049536314,0.00023362631,0.001529057,0.0004215931,0.00048772618,0.0000026741966,0.008041517,0.00019822124,0.00549982,0.9192498],"study_design_scores_gemma":[0.10718443,0.086416155,0.42124465,0.0005116369,0.009130814,0.000548589,0.00050370325,0.001242557,0.03110698,0.0049501993,0.33540183,0.0017584498],"about_ca_topic_score_codex":0.00043275874,"about_ca_topic_score_gemma":0.000056127523,"teacher_disagreement_score":0.9174914,"about_ca_system_score_codex":0.0004578323,"about_ca_system_score_gemma":0.00051855284,"threshold_uncertainty_score":0.9994156},"labels":[],"label_agreement":null},{"id":"W4403249954","doi":"10.1016/j.ygyno.2024.07.611","title":"How long is hCG monitoring required after normalization following evacuation of a complete hydatidiform mole? A national, retrospective population study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Mole; Retrospective cohort study; Normalization (sociology); Gynecology; Population; Obstetrics; Internal medicine; Environmental health","score_opus":0.04396816887534006,"score_gpt":0.3552006262779243,"score_spread":0.31123245740258426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403249954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929855,0.00041112426,0.0011166262,0.0016147255,0.0011691375,0.0012628016,0.00005137764,0.0001268098,0.0012618836],"genre_scores_gemma":[0.99732924,0.000022088041,0.001334839,0.00010274536,0.0002513024,0.00038791407,0.00014952553,0.00002468604,0.0003976882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796563,0.00013125977,0.00047591713,0.00045170158,0.0007227962,0.00025270032],"domain_scores_gemma":[0.9986014,0.00041784358,0.00019243202,0.00015410637,0.00056016305,0.000074057665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046560302,0.00020884722,0.0004919375,0.0003448765,0.00012071883,0.000044692646,0.00007295579,0.00013174627,0.00005682717],"category_scores_gemma":[0.0014080475,0.00018582665,0.00015728928,0.00054313464,0.000062238825,0.00033214432,0.00007995282,0.00016001942,0.000047719517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005117812,0.00089034654,0.98963237,0.00027025066,0.0008776158,0.00034933048,0.0028554997,0.00014339073,0.0013434878,0.0007516514,0.0004248298,0.001949432],"study_design_scores_gemma":[0.0013625675,0.0019433146,0.98970306,0.00012380347,0.00046414998,0.000014066663,0.0013018221,0.0023058178,0.000071230636,0.0023717768,0.00018958603,0.00014879745],"about_ca_topic_score_codex":0.00005909091,"about_ca_topic_score_gemma":0.00006018882,"teacher_disagreement_score":0.0043436973,"about_ca_system_score_codex":0.0013305193,"about_ca_system_score_gemma":0.00023740211,"threshold_uncertainty_score":0.75777906},"labels":[],"label_agreement":null},{"id":"W4403250000","doi":"10.1016/j.ygyno.2024.07.593","title":"Predictors for PARP inhibitor hematologic toxicity in ovarian cancer: Are patients with chemotherapy-induced toxicity at an increased risk?","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Toxicity; Ovarian cancer; Chemotherapy; Oncology; Internal medicine; PARP inhibitor; Pharmacology; Cancer; Poly ADP ribose polymerase; Genetics","score_opus":0.02311995834596108,"score_gpt":0.31787791736721444,"score_spread":0.29475795902125335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914749,0.00030935966,0.00016230925,0.0022461072,0.0010991105,0.0031718337,0.00042158942,0.00039698707,0.00071777205],"genre_scores_gemma":[0.9925548,0.0001795281,0.0012507786,0.003230774,0.00040765374,0.0020093734,0.00019363617,0.00007560545,0.00009787459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658024,0.0004380432,0.00072843645,0.0010862921,0.00034723838,0.0008197544],"domain_scores_gemma":[0.9974868,0.0010199905,0.00041027548,0.0005007285,0.00022776733,0.00035441],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078264426,0.000480609,0.0011355876,0.00032344164,0.00021836402,0.000031534495,0.00023433362,0.0007835997,0.001153167],"category_scores_gemma":[0.0004169679,0.000364043,0.00017205921,0.0005925951,0.00024742974,0.00020072487,0.000072340816,0.0006342999,0.00002834652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005506391,0.002572545,0.96617436,0.00028727832,0.00032704015,0.00021845469,0.000674038,0.000048591002,0.012625433,0.00016140853,0.0042743157,0.0071301367],"study_design_scores_gemma":[0.018707579,0.011814434,0.9198661,0.00028957214,0.00023746918,0.000052965148,0.00022184974,0.00063474075,0.032252483,0.00073785806,0.01457476,0.0006101911],"about_ca_topic_score_codex":0.00025997573,"about_ca_topic_score_gemma":0.0032909357,"teacher_disagreement_score":0.046308268,"about_ca_system_score_codex":0.0035599647,"about_ca_system_score_gemma":0.00084094825,"threshold_uncertainty_score":0.99988115},"labels":[],"label_agreement":null},{"id":"W4403250115","doi":"10.1016/j.ygyno.2024.07.485","title":"Practice patterns in the treatment of small cell carcinoma of the cervix: Analysis of a Canadian multidisciplinary survey","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Multidisciplinary approach; Cervix; Gynecology; Carcinoma; Oncology; General surgery; Internal medicine; Cancer","score_opus":0.0803598955646283,"score_gpt":0.38781550183967584,"score_spread":0.30745560627504753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98487866,0.0020473865,0.0000021066226,0.0059656003,0.00017356111,0.0008392467,0.00025205425,0.000004740779,0.0058366586],"genre_scores_gemma":[0.99840087,0.0009651136,0.000094658666,0.00013454471,0.000020854037,0.00011547209,0.00003003498,0.000007341209,0.00023113655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977796,0.0010464168,0.0004162163,0.00024818775,0.00020473727,0.0003048044],"domain_scores_gemma":[0.99389035,0.005228004,0.0001654819,0.0004556127,0.00019578506,0.00006480019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012595518,0.00012680331,0.0006545708,0.0007527132,0.0000459977,0.000003411408,0.00025634584,0.00012565387,0.00013642487],"category_scores_gemma":[0.00076687033,0.000062644365,0.00021983817,0.002223817,0.00022797573,0.000021410126,0.000085268846,0.0001829916,0.0000024575972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015246046,0.0010700907,0.98419523,0.00019346022,0.00089759583,0.00030468102,0.009939436,0.00011616451,0.00017695395,0.000035132598,0.00030670874,0.0026120553],"study_design_scores_gemma":[0.000724713,0.0039393045,0.98495495,0.000017094628,0.0014633527,0.000007945767,0.004371772,0.00045527323,0.00038109886,0.000011496921,0.003624668,0.00004832729],"about_ca_topic_score_codex":0.423648,"about_ca_topic_score_gemma":0.89210945,"teacher_disagreement_score":0.46846148,"about_ca_system_score_codex":0.0009801926,"about_ca_system_score_gemma":0.001477134,"threshold_uncertainty_score":0.58019},"labels":[],"label_agreement":null},{"id":"W4403250146","doi":"10.1016/j.ygyno.2024.07.557","title":"Assessing the impact of brachytherapy boost in intermediate-risk, early-stage cervical cancer treatment","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Brachytherapy; Cervical cancer; Stage (stratigraphy); Oncology; Radiology; Radiation therapy; Cancer; Internal medicine","score_opus":0.054199140413671854,"score_gpt":0.4324429596663124,"score_spread":0.37824381925264056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884714,0.0038618708,0.0000121036355,0.0012570038,0.00070607115,0.0006909297,0.000060034163,0.00006218297,0.0045026815],"genre_scores_gemma":[0.9958161,0.0027094544,0.00007064574,0.00024873664,0.00026652956,0.0002940635,0.000019272014,0.000021895205,0.0005533124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982601,0.00033401162,0.0004567885,0.00037075084,0.00015787639,0.0004205159],"domain_scores_gemma":[0.9975968,0.001845071,0.00013922913,0.0002451716,0.000048191414,0.00012551453],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003822255,0.00024089248,0.00070914184,0.00021459522,0.000059576287,0.00003575765,0.00013110563,0.00025474644,0.0031507537],"category_scores_gemma":[0.00019970923,0.00011630575,0.00034331484,0.00063636224,0.00019274483,0.00010418931,0.000051762032,0.00040152858,0.000049560527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054693455,0.0010086092,0.6563579,0.000045992067,0.0005547594,0.00055052945,0.0008306943,0.000103858765,0.00046291886,0.00006199558,0.00013879008,0.33933702],"study_design_scores_gemma":[0.004138009,0.00938404,0.98102665,0.000058911777,0.00019493053,0.000021490465,0.00024245385,0.0004525278,0.0003544965,0.00034220697,0.003677032,0.00010726003],"about_ca_topic_score_codex":0.010662178,"about_ca_topic_score_gemma":0.0026081882,"teacher_disagreement_score":0.33922976,"about_ca_system_score_codex":0.0023760032,"about_ca_system_score_gemma":0.0008715538,"threshold_uncertainty_score":0.9977605},"labels":[],"label_agreement":null},{"id":"W4403250150","doi":"10.1016/j.ygyno.2024.07.560","title":"Voices of women with low-grade serous ovarian cancer: Results from a multinational survey","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ovarian Cancer Canada","funders":"","keywords":"Medicine; Multinational corporation; Serous ovarian cancer; Ovarian cancer; Serous fluid; Gynecology; General surgery; Oncology; Cancer; Internal medicine","score_opus":0.027588450933206114,"score_gpt":0.324597553348614,"score_spread":0.2970091024154079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873064,0.0012051656,0.00003284505,0.00709536,0.0006979801,0.00053491583,0.0011238916,0.00009673683,0.0019066834],"genre_scores_gemma":[0.99564064,0.0005068585,0.0019179129,0.0005943782,0.00020488698,0.00043249485,0.00032392485,0.000021042448,0.00035786518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821323,0.00020140175,0.00041761843,0.0005416893,0.00022435535,0.00040167835],"domain_scores_gemma":[0.99669474,0.0025653765,0.00016646321,0.0002520053,0.0001541814,0.00016720567],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006284304,0.00019608694,0.0006036058,0.00012342448,0.000051981602,0.000017791288,0.000111413916,0.0002192224,0.0010794582],"category_scores_gemma":[0.00034926564,0.00013357904,0.000055503602,0.00034006473,0.00015184189,0.00005792069,0.00004922679,0.00021324778,0.00004976492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009380194,0.0065920516,0.6238758,0.00042008076,0.004696655,0.0038041398,0.008071897,0.00063751166,0.0011687858,0.0017225407,0.011744539,0.32788584],"study_design_scores_gemma":[0.00641414,0.003888851,0.9636984,0.00016523732,0.00019120733,0.000025445841,0.00020616276,0.00033693833,0.00048487168,0.0003234572,0.02411696,0.00014836348],"about_ca_topic_score_codex":0.0070397584,"about_ca_topic_score_gemma":0.0089143,"teacher_disagreement_score":0.3398226,"about_ca_system_score_codex":0.0017516833,"about_ca_system_score_gemma":0.0013540875,"threshold_uncertainty_score":0.9998337},"labels":[],"label_agreement":null},{"id":"W4403250163","doi":"10.1016/j.ygyno.2024.07.476","title":"Impact of FIGO 2023 staging criteria for endometrial cancer on stage migration and survival outcomes","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Endometrial cancer; Stage (stratigraphy); Oncology; Gynecology; Internal medicine; Cancer; Obstetrics","score_opus":0.08346122517017392,"score_gpt":0.44946153232901404,"score_spread":0.36600030715884013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123454,0.0011732237,0.00010265864,0.0018194123,0.0021678586,0.0009113348,0.00045843993,0.000059009504,0.0020735422],"genre_scores_gemma":[0.9966472,0.0005296457,0.00037292117,0.000209638,0.00032556156,0.00026012195,0.00007635135,0.000016618653,0.0015619615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987917,0.000101508136,0.00033790746,0.00033029754,0.00015245409,0.00028611676],"domain_scores_gemma":[0.99630886,0.003275973,0.00009359606,0.00012460625,0.000084049985,0.00011291685],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039168954,0.00017905602,0.00071569433,0.0003290092,0.0000477568,0.000019021982,0.00005517911,0.00017594451,0.0022064012],"category_scores_gemma":[0.0011857694,0.00011301794,0.00023970648,0.0003840758,0.00007078404,0.000055472585,0.00003476298,0.00013794964,0.000010655345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007913597,0.0013767411,0.6660598,0.0007745817,0.0022982636,0.00022499544,0.00048863416,0.00007666618,0.009631704,0.0014628222,0.0033320035,0.30636021],"study_design_scores_gemma":[0.014845876,0.02449973,0.93754244,0.000070268055,0.0005593153,0.0000062007102,0.00017229794,0.000736237,0.0008164283,0.00069319666,0.019830111,0.00022791058],"about_ca_topic_score_codex":0.00077395234,"about_ca_topic_score_gemma":0.00055331184,"teacher_disagreement_score":0.3061323,"about_ca_system_score_codex":0.0006229013,"about_ca_system_score_gemma":0.0003026605,"threshold_uncertainty_score":0.99870574},"labels":[],"label_agreement":null},{"id":"W4403250365","doi":"10.1016/j.ygyno.2024.07.603","title":"In the era of the HPV vaccine, what are the current HPV subtypes contributing to high-grade cervical dysplasia, adenocarcinoma in situ, and early cervical cancer?","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Toronto","funders":"","keywords":"Medicine; Cervical cancer; Dysplasia; Oncology; Adenocarcinoma; Gynecology; Internal medicine; Cancer","score_opus":0.02801371543450604,"score_gpt":0.34911940846617434,"score_spread":0.3211056930316683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8278629,0.024540937,0.000005003333,0.14452386,0.0009849198,0.0012992703,0.000017919918,0.000022000015,0.00074315356],"genre_scores_gemma":[0.99300575,0.0019515166,0.000016180424,0.0041906796,0.0004070071,0.0003655905,0.0000043671726,0.000017216504,0.000041663738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691415,0.000723835,0.00057079893,0.0005269767,0.00044714662,0.000817123],"domain_scores_gemma":[0.9960692,0.0031345899,0.00009477729,0.00042031816,0.00013121839,0.0001499122],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015290468,0.00023443575,0.0006887952,0.00014080474,0.00015589352,0.00009196848,0.00057636946,0.00026915906,0.0011141478],"category_scores_gemma":[0.00067619456,0.000111534195,0.00012398169,0.0010616356,0.00021797417,0.00011692471,0.0005189846,0.0020313102,0.000025806848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006238568,0.00045452974,0.6319078,0.0004010861,0.00006306242,0.000362309,0.0028731956,0.000024372039,0.00013171545,0.002329651,0.0018275101,0.35900092],"study_design_scores_gemma":[0.0017420637,0.0009807365,0.9780462,0.00009420521,0.0000888902,0.000052745716,0.0015953835,0.00015264579,0.00018193081,0.001510743,0.015433751,0.000120739205],"about_ca_topic_score_codex":0.0013654062,"about_ca_topic_score_gemma":0.023589399,"teacher_disagreement_score":0.35888016,"about_ca_system_score_codex":0.0006163915,"about_ca_system_score_gemma":0.0005670127,"threshold_uncertainty_score":0.99979895},"labels":[],"label_agreement":null},{"id":"W4403250423","doi":"10.1016/j.ygyno.2024.07.213","title":"Homologous recombination status in BRCA wild-type patients as a predictor of disease volume and surgical outcome in patients with high-grade serous ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Homologous recombination; Oncology; Serous fluid; Ovarian cancer; Internal medicine; Disease; Serous ovarian cancer; Gynecology; Cancer; Genetics; Gene; Biology","score_opus":0.012608136172239277,"score_gpt":0.2913689870168873,"score_spread":0.278760850844648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944361,0.0006592968,6.274129e-7,0.002391649,0.0008137963,0.0012947351,0.00012182211,0.00004453716,0.00023747473],"genre_scores_gemma":[0.99838185,0.00043791358,0.00015747029,0.00024313851,0.000033568293,0.00030185023,0.00022161471,0.00002355493,0.00019901565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812937,0.00018434456,0.00050536846,0.00053153606,0.00023006246,0.00041930744],"domain_scores_gemma":[0.99900335,0.00033004643,0.00013214609,0.00019319728,0.00011870876,0.00022253205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017791464,0.0002206906,0.00064809906,0.0002963193,0.000029415482,0.000013087789,0.00006445202,0.00022868617,0.00046371474],"category_scores_gemma":[0.00018539152,0.00016282217,0.000044909502,0.00045511086,0.00013521478,0.00009469178,0.00006429228,0.00026820533,0.000013502856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016173229,0.0039845435,0.9724797,0.00014684285,0.00011405891,0.00082200347,0.00022876967,0.000036701967,4.448546e-7,0.0002964754,0.00024105943,0.020032078],"study_design_scores_gemma":[0.015096917,0.009656502,0.971257,0.00013220475,0.00020701443,0.000004280731,0.000023317001,0.000082907936,0.00000263991,0.00041744875,0.0029730918,0.00014667978],"about_ca_topic_score_codex":0.0016198215,"about_ca_topic_score_gemma":0.0011413067,"teacher_disagreement_score":0.019885397,"about_ca_system_score_codex":0.001471008,"about_ca_system_score_gemma":0.00064587034,"threshold_uncertainty_score":0.6639696},"labels":[],"label_agreement":null},{"id":"W4403250513","doi":"10.1016/j.ygyno.2024.07.448","title":"A surgery-based comprehensive treatment improved prognosis among patients with stage IIIC cervical squamous carcinoma: A single center retrospective study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Single Center; Retrospective cohort study; Stage (stratigraphy); Center (category theory); Oncology; Cervical carcinoma; Surgery; Internal medicine; Cervical cancer; Cancer","score_opus":0.03486107201102,"score_gpt":0.294003398708514,"score_spread":0.259142326697494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922953,0.00026815658,0.000012790409,0.0005413266,0.00074143364,0.0043466203,0.00016679522,0.0003029907,0.0013245397],"genre_scores_gemma":[0.9969426,0.0000076623155,0.00019050702,0.00047771275,0.00014797105,0.0014471106,0.00025733456,0.00005700308,0.0004721071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969921,0.0003394504,0.0005496756,0.0010139021,0.00038595643,0.0007189142],"domain_scores_gemma":[0.9974655,0.0013283187,0.00017576512,0.0003655209,0.00032932463,0.0003355819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013817291,0.00050136395,0.0013103076,0.00037397034,0.00014772771,0.000054791562,0.00010853193,0.00028323312,0.0008234733],"category_scores_gemma":[0.0001924995,0.0003082158,0.00031789043,0.00085632934,0.00023042424,0.00009523763,0.0000774776,0.00032404246,0.00006913047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027806845,0.02103304,0.9618148,0.00012099899,0.00063853286,0.001789732,0.00046610096,0.0000038093037,0.000051782663,0.000004068366,0.00012884982,0.011167585],"study_design_scores_gemma":[0.018140022,0.064534456,0.91217947,0.000034919856,0.0008164964,0.00001023854,0.00044260654,0.00013326103,0.00014391654,0.000010801372,0.0032737402,0.00028005725],"about_ca_topic_score_codex":0.001105654,"about_ca_topic_score_gemma":0.0020850855,"teacher_disagreement_score":0.049635332,"about_ca_system_score_codex":0.0040055793,"about_ca_system_score_gemma":0.0005127716,"threshold_uncertainty_score":0.999937},"labels":[],"label_agreement":null},{"id":"W4403250519","doi":"10.1016/j.ygyno.2024.07.441","title":"Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Context (archaeology); Quality of life (healthcare); Oncology; Ovarian cancer; Internal medicine; Cancer; Gynecology; Nursing","score_opus":0.055185630282282426,"score_gpt":0.34160691524997633,"score_spread":0.2864212849676939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855961,0.001268851,0.00009404246,0.0075448244,0.00032230053,0.0043632677,0.0003502941,0.00014516499,0.00031515697],"genre_scores_gemma":[0.9948831,0.001091818,0.00048750237,0.002442272,0.00006820006,0.00058944983,0.00022872476,0.000057168607,0.00015175769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958045,0.00071971613,0.0015124178,0.00093500555,0.0004070913,0.0006212847],"domain_scores_gemma":[0.99285775,0.0053171134,0.000854736,0.0005210369,0.00024200964,0.00020733813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013487113,0.0004726457,0.0016943867,0.00016196462,0.00018812114,0.000025401208,0.00019292977,0.00034985703,0.00021623836],"category_scores_gemma":[0.00071345083,0.00024420116,0.00006744596,0.00071459106,0.0007710493,0.00016317658,0.000044623594,0.0007624702,0.0000025093186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21655703,0.0010821902,0.7230048,0.00006517574,0.00082551513,0.00005607671,0.005105847,0.0003489437,0.000027046368,0.000077356606,0.00027111912,0.052578896],"study_design_scores_gemma":[0.22349192,0.013684153,0.7598332,0.0007504157,0.0000707225,0.0000037407945,0.00067078153,0.000055566696,0.000031106687,0.000020979218,0.001141596,0.0002457715],"about_ca_topic_score_codex":0.003996932,"about_ca_topic_score_gemma":0.0141309025,"teacher_disagreement_score":0.052333124,"about_ca_system_score_codex":0.00095000595,"about_ca_system_score_gemma":0.0010983917,"threshold_uncertainty_score":0.9958234},"labels":[],"label_agreement":null},{"id":"W4403250566","doi":"10.1016/j.ygyno.2024.07.088","title":"Evaluation of physical function and quality of life before and after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2–IB1 cervical cancer (GOG-278)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Radical Hysterectomy; Stage (stratigraphy); Hysterectomy; Lymphadenectomy; Biopsy; Cervical cancer; Quality of life (healthcare); Surgery; Radiology; Cancer; Internal medicine","score_opus":0.07135393619552927,"score_gpt":0.38804995572645673,"score_spread":0.31669601953092746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931827,0.0037463238,0.00006550172,0.00082196144,0.00025221164,0.0015195945,0.00013366752,0.00003361625,0.00024438414],"genre_scores_gemma":[0.99807745,0.00034720727,0.00018848122,0.00019768762,0.00037844546,0.00066958496,0.000031044554,0.000021363756,0.000088707726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977742,0.00035302364,0.00049448514,0.0005676423,0.00051034597,0.00030032295],"domain_scores_gemma":[0.9976092,0.0015584317,0.00017133827,0.00014410297,0.00028404684,0.00023287194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010343456,0.0002578996,0.0010777778,0.0001543342,0.000057664485,0.000017533894,0.00005038859,0.00031736417,0.0005135937],"category_scores_gemma":[0.0002930151,0.00014967134,0.00011034269,0.00033931356,0.0005651435,0.00008909491,0.000051884483,0.00017007353,0.0000013051477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055322982,0.0026988892,0.4735963,0.002110779,0.0019805632,0.000100393096,0.0013258576,0.000005445518,0.0037818612,0.001118692,0.000042098945,0.45791614],"study_design_scores_gemma":[0.03328583,0.019221773,0.9416514,0.000106414605,0.0012123206,0.00005249591,0.0002585085,0.0013597792,0.00036193882,0.000624299,0.0016619279,0.00020331636],"about_ca_topic_score_codex":0.00039726778,"about_ca_topic_score_gemma":0.0013454437,"teacher_disagreement_score":0.4680551,"about_ca_system_score_codex":0.00027331198,"about_ca_system_score_gemma":0.0008763682,"threshold_uncertainty_score":0.610342},"labels":[],"label_agreement":null},{"id":"W4403250594","doi":"10.1016/j.ygyno.2024.07.116","title":"Fertility outcomes among patients undergoing fertility-sparing treatment of atypical hyperplasia and grade one cancer of the endometrium using progestin therapy: Results of a novel, specialized oncofertility program","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oncofertility; Medicine; Progestin; Fertility preservation; Fertility; Gynecology; Endometrium; Endometrial cancer; Oncology; Cancer; Obstetrics; Internal medicine; Hormone; Population","score_opus":0.10941808920208522,"score_gpt":0.37811560129542526,"score_spread":0.26869751209334003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939283,0.0014288084,0.000015922931,0.0005697464,0.0006165973,0.0030257409,0.000091672184,0.00006951214,0.00025367396],"genre_scores_gemma":[0.9980001,0.00015056474,0.0015386463,0.000031970685,0.00003718006,0.00016899906,0.00001530601,0.000016249664,0.000040980194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967256,0.0005699959,0.0011953418,0.0008265495,0.00027463314,0.00040783282],"domain_scores_gemma":[0.9965463,0.001892764,0.0004849556,0.00064840924,0.00031767733,0.000109889756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009366489,0.00031681923,0.0014221306,0.00015849264,0.00010304708,0.000007127756,0.00017145362,0.00044518616,0.00004196706],"category_scores_gemma":[0.0033612214,0.00018830526,0.0003102853,0.00058789755,0.001542053,0.00007537525,0.00015906547,0.00029889596,3.734769e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013777787,0.008790357,0.9256005,0.00030254136,0.0005473652,0.000004395118,0.0006332546,0.000008271219,0.009139737,0.000017734741,0.000003233917,0.04117477],"study_design_scores_gemma":[0.0073247836,0.0058549396,0.96513784,0.00011854773,0.00034606023,0.0000043822747,0.00007442375,0.00030729882,0.020237198,0.00020148263,0.00027012793,0.00012293165],"about_ca_topic_score_codex":0.0007464733,"about_ca_topic_score_gemma":0.00076156517,"teacher_disagreement_score":0.041051835,"about_ca_system_score_codex":0.0007022048,"about_ca_system_score_gemma":0.00073716574,"threshold_uncertainty_score":0.7678865},"labels":[],"label_agreement":null},{"id":"W4403250649","doi":"10.1016/j.ygyno.2024.07.419","title":"A phase III, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of therapy among patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-OV81/NCRI/RAMP 301","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Serous fluid; Serous ovarian cancer; Ovarian cancer; Oncology; Cancer; Internal medicine","score_opus":0.06630499522620008,"score_gpt":0.39115386280972236,"score_spread":0.32484886758352227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817229,0.002630261,0.000053312004,0.0020921533,0.002041256,0.010255378,0.00011090767,0.0002507359,0.0008430903],"genre_scores_gemma":[0.9900292,0.0007304452,0.002058117,0.00085380336,0.00046164068,0.0054210094,0.0002613222,0.00008619423,0.00009825238],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946764,0.0011751018,0.0013691108,0.0011483142,0.0008028234,0.00082823914],"domain_scores_gemma":[0.99303365,0.004379905,0.0009542006,0.00059859257,0.00046780708,0.0005658209],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015252552,0.00070020126,0.0030345942,0.0003539226,0.00020310683,0.00007199656,0.0002670129,0.00041248646,0.0010215603],"category_scores_gemma":[0.001146609,0.00043401666,0.00035490326,0.0008602329,0.0008026722,0.00016680564,0.00007900724,0.0007383116,0.000013784126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8202446,0.009900764,0.031934507,0.00033688283,0.00422106,0.0003168996,0.0024729562,0.0003575388,0.00008953689,0.00014099946,0.0017125685,0.12827168],"study_design_scores_gemma":[0.93075895,0.040084094,0.017141776,0.00072242355,0.0021970957,0.000015469557,0.00020874203,0.0023869905,0.0003281198,0.00007658994,0.005595184,0.00048455896],"about_ca_topic_score_codex":0.0014068948,"about_ca_topic_score_gemma":0.0011653836,"teacher_disagreement_score":0.12778711,"about_ca_system_score_codex":0.0016767186,"about_ca_system_score_gemma":0.0037960182,"threshold_uncertainty_score":0.99989164},"labels":[],"label_agreement":null},{"id":"W4403250841","doi":"10.1016/j.ygyno.2024.07.207","title":"Upfront tumor next-generation sequencing for diagnosis of Lynch syndrome in endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Lynch syndrome; Endometrial cancer; Oncology; Gynecology; Internal medicine; Cancer; DNA mismatch repair; Colorectal cancer","score_opus":0.14029568482834542,"score_gpt":0.3679936929979476,"score_spread":0.22769800816960217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98628306,0.0048290314,0.00014419002,0.0015377061,0.004662574,0.0016546461,0.000054212418,0.00006609552,0.0007685019],"genre_scores_gemma":[0.9923812,0.0004838665,0.0033058538,0.00047818807,0.00040300965,0.002693017,0.000030081572,0.000027685954,0.00019708354],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823827,0.00011919966,0.0005837409,0.00047005573,0.00018472793,0.0004039875],"domain_scores_gemma":[0.9975982,0.001890111,0.00012319621,0.00018075721,0.000119712604,0.000088056026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000661968,0.00018725115,0.0006950117,0.00043873905,0.000036583064,0.000015311698,0.00012321482,0.0002806209,0.0014121783],"category_scores_gemma":[0.0018218814,0.00015852545,0.00015362137,0.00055731286,0.00011394895,0.000068649,0.000056513218,0.0002554498,0.000015806874],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001707184,0.0012313679,0.23178066,0.0022132741,0.00076387613,0.0024900108,0.0020238736,0.0035099313,0.31363866,0.0015028822,0.027481403,0.4116569],"study_design_scores_gemma":[0.029244622,0.07335673,0.26477072,0.001411013,0.0022829138,0.0018609599,0.0018850418,0.06848324,0.3082514,0.0052341693,0.2410994,0.002119781],"about_ca_topic_score_codex":0.00032618147,"about_ca_topic_score_gemma":0.0020817663,"teacher_disagreement_score":0.4095371,"about_ca_system_score_codex":0.002992255,"about_ca_system_score_gemma":0.0016132998,"threshold_uncertainty_score":0.9995007},"labels":[],"label_agreement":null},{"id":"W4403250854","doi":"10.1016/j.ygyno.2024.07.237","title":"Characterization of epithelial ovarian cancer based on multigene tumor testing and homologous recombination deficiency (HRD) testing (COMBO)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université Laval","funders":"","keywords":"Homologous recombination; Medicine; Ovarian cancer; Homologous chromosome; Epithelial ovarian cancer; Cancer research; Genetic testing; Oncology; Cancer; Internal medicine; Gene; Genetics; Biology","score_opus":0.055751893199495986,"score_gpt":0.3356247419975424,"score_spread":0.2798728487980464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093103,0.0001854138,0.00096648757,0.0019270001,0.0012310273,0.0007260774,0.000064821645,0.00023035378,0.0037377845],"genre_scores_gemma":[0.99043244,0.00004489908,0.007467773,0.001441973,0.0002011117,0.00024696626,0.000038442824,0.000028597187,0.00009778464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983146,0.00024029436,0.00048824403,0.00047239522,0.00017498428,0.00030945623],"domain_scores_gemma":[0.99661726,0.002600465,0.0002591749,0.00018053532,0.00025624587,0.00008631723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080860226,0.00019362931,0.00043148434,0.00030078602,0.00012841752,0.000018356412,0.000081389284,0.00020634568,0.0003572834],"category_scores_gemma":[0.0023017477,0.00017007055,0.000049296337,0.0006125551,0.00018564811,0.000074877884,0.000031728243,0.00030164747,0.000017799317],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024309725,0.0005134721,0.018791117,0.0002801488,0.00002730698,0.00020183268,0.0001979786,0.00033378825,0.7247438,0.00024998083,0.000043096883,0.25437438],"study_design_scores_gemma":[0.0058750585,0.0101154465,0.78739095,0.00080766325,0.00022552481,0.00030463992,0.00007666054,0.12040035,0.06983101,0.0017176521,0.0027911917,0.0004638617],"about_ca_topic_score_codex":0.00011657643,"about_ca_topic_score_gemma":0.000022677068,"teacher_disagreement_score":0.7685998,"about_ca_system_score_codex":0.0005846401,"about_ca_system_score_gemma":0.00072712876,"threshold_uncertainty_score":0.6935275},"labels":[],"label_agreement":null},{"id":"W4403250889","doi":"10.1016/j.ygyno.2024.07.276","title":"Serum CA-125 levels in the context of ProMisE molecular classification provide preoperative prognostic information that can direct endometrial cancer management","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endometrial cancer; Context (archaeology); Cancer; Oncology; Internal medicine; Gynecology; General surgery","score_opus":0.049055402284770414,"score_gpt":0.33718740100633887,"score_spread":0.28813199872156847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9393789,0.0019221002,0.000072441304,0.02842043,0.0010141765,0.008964642,0.00023802687,0.00007751636,0.019911742],"genre_scores_gemma":[0.99336207,0.00045856452,0.00024639646,0.0013752085,0.000050476432,0.0042931987,0.000068946734,0.0000094054085,0.00013570875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985171,0.0002759335,0.000425662,0.00027981235,0.00024169637,0.0002597847],"domain_scores_gemma":[0.9987511,0.00072525966,0.00015638581,0.00022639555,0.000091260816,0.000049587914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057230523,0.00017485983,0.00040882893,0.0002672249,0.000047544127,0.000036749618,0.00012623407,0.00014526657,0.00024817305],"category_scores_gemma":[0.00029087212,0.000107656946,0.00008887187,0.0005431838,0.000097606746,0.00013852565,0.000043246026,0.00019254444,0.000024137707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062627415,0.001939687,0.1814249,0.00131953,0.0013198353,0.0009239164,0.012005955,0.00014415728,0.00048285176,0.014767679,0.0053934287,0.77965176],"study_design_scores_gemma":[0.0069030924,0.0035950274,0.92552125,0.0003217044,0.0008671346,0.000031390744,0.004613788,0.00075035664,0.004061778,0.00028111233,0.052844357,0.00020902742],"about_ca_topic_score_codex":0.00032486554,"about_ca_topic_score_gemma":0.0009120505,"teacher_disagreement_score":0.7794428,"about_ca_system_score_codex":0.0011271236,"about_ca_system_score_gemma":0.000638356,"threshold_uncertainty_score":0.43901226},"labels":[],"label_agreement":null},{"id":"W4403250910","doi":"10.1016/j.ygyno.2024.07.130","title":"Developing ovarian cancer innovative diversion criteria (OV-Divert) to decrease the rate of diverting ileostomy among patients undergoing cytoreductive surgery for gynecologic malignancy","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ileostomy; Cytoreductive surgery; Ovarian cancer; Malignancy; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.04810546689178408,"score_gpt":0.34653049072758635,"score_spread":0.29842502383580227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191786,0.0005648329,0.00071428466,0.010092151,0.0029589487,0.002718355,0.00018569261,0.00011147297,0.0007364101],"genre_scores_gemma":[0.99162966,0.00034177923,0.0028523274,0.0032421637,0.00021089497,0.0014364625,0.00011688066,0.000036573027,0.00013328418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973108,0.00032813897,0.00072890095,0.0007794991,0.0001919205,0.00066075206],"domain_scores_gemma":[0.9921181,0.0062265685,0.000365314,0.00028116273,0.0007657389,0.00024307941],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009211665,0.00037013486,0.00088455237,0.00034807142,0.00039799107,0.00004555023,0.0002092092,0.0002852329,0.0007868612],"category_scores_gemma":[0.0041179946,0.0002496289,0.00022870496,0.0010201609,0.00023288208,0.00019382154,0.00033362856,0.00023406508,0.000025800431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010450743,0.00096135825,0.8439669,0.00066198886,0.0013363132,0.00040076015,0.0030830936,0.00006205498,0.000443164,0.0037939784,0.021591792,0.1226535],"study_design_scores_gemma":[0.002591434,0.002585476,0.9749643,0.00080579624,0.0005676599,0.000008697719,0.0013426914,0.00013774545,0.0027836196,0.0014418083,0.012394961,0.00037580525],"about_ca_topic_score_codex":0.00043142997,"about_ca_topic_score_gemma":0.00039926803,"teacher_disagreement_score":0.13099737,"about_ca_system_score_codex":0.0024322858,"about_ca_system_score_gemma":0.0026516863,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W4403250917","doi":"10.1016/j.ygyno.2024.07.067","title":"Population-based BRCA1 and BRCA2 genetic testing is cost-effective in Canada","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Genetic testing; BRCA2 Protein; Population; Oncology; Genetics; Internal medicine; Mutation; Environmental health; Biology; Gene; Germline mutation","score_opus":0.015640605760171802,"score_gpt":0.29045553425287773,"score_spread":0.27481492849270595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99369234,0.0022930906,0.00027641965,0.0010068561,0.00067465776,0.00082011346,0.000039586317,0.000021111236,0.0011758117],"genre_scores_gemma":[0.99410653,0.000040062936,0.002889474,0.002133738,0.00011671467,0.00056376867,0.00005278192,0.000019561932,0.000077364966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987257,0.00014346573,0.00024093423,0.0005111259,0.00008170968,0.00029708174],"domain_scores_gemma":[0.9991317,0.0005021405,0.00005540925,0.00018675733,0.000058807065,0.0000652164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018912133,0.00015399967,0.00019705843,0.00007987014,0.00006461947,0.00002054449,0.0001189151,0.00019845339,0.00010611096],"category_scores_gemma":[0.00044207342,0.00015249837,0.0000277913,0.00024020186,0.000057905138,0.0000031271934,0.00007431709,0.00016078654,0.0000074806685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032946842,0.000049232956,0.5087984,0.00007325409,0.00006626037,0.00017710422,0.00008847127,0.0073043015,0.008482507,0.0000353621,0.005097203,0.46979493],"study_design_scores_gemma":[0.0006149008,0.00046894586,0.9199057,0.000018957637,0.000029633398,0.00005249848,0.000105818115,0.008824393,0.0032667466,0.00034470344,0.06610581,0.00026187228],"about_ca_topic_score_codex":0.15686972,"about_ca_topic_score_gemma":0.70731235,"teacher_disagreement_score":0.5504426,"about_ca_system_score_codex":0.0016198804,"about_ca_system_score_gemma":0.003172805,"threshold_uncertainty_score":0.84874475},"labels":[],"label_agreement":null},{"id":"W4403250934","doi":"10.1016/j.ygyno.2024.07.109","title":"Final overall survival data from a randomized, open-label, phase II study of relacorilant, a selective glucocorticoid receptor modulator, in combination with nab-paclitaxel among patients with recurrent platinum-resistant ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Paclitaxel; Open label; Glucocorticoid receptor; Nab-paclitaxel; Oncology; Ovarian cancer; Internal medicine; Glucocorticoid; Cancer research; Chemotherapy; Randomized controlled trial; Cancer","score_opus":0.05512589460480387,"score_gpt":0.358533714032534,"score_spread":0.3034078194277301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403250934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852724,0.00058460777,0.000041763906,0.00065651676,0.0009258195,0.007861301,0.0007507556,0.000048645572,0.00060332735],"genre_scores_gemma":[0.9956136,0.00017204492,0.0010375516,0.00008688984,0.000065165616,0.0018138908,0.0010122522,0.000042309486,0.00015634738],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99638987,0.0007049516,0.00085406966,0.0011583575,0.00046852673,0.000424249],"domain_scores_gemma":[0.99688274,0.0015438215,0.0004964175,0.0006712418,0.0002668091,0.00013894947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008217037,0.0003924708,0.0017690426,0.00021997721,0.00010962235,0.000048585265,0.0003638901,0.00021176126,0.00052602065],"category_scores_gemma":[0.00034535516,0.0002563853,0.000040633044,0.0005542436,0.00017793367,0.00031392905,0.00037779164,0.00047432136,0.000008332486],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4045271,0.08864464,0.4661288,0.00018343246,0.004497692,0.0007147022,0.0041456944,0.00011899861,0.00013449354,0.00071535516,0.0024792675,0.027709834],"study_design_scores_gemma":[0.55083627,0.07819556,0.36447063,0.0005371227,0.001413498,0.0000023930845,0.0004188365,0.0028442994,0.000021818854,0.00019691107,0.0007598914,0.00030277096],"about_ca_topic_score_codex":0.0067790486,"about_ca_topic_score_gemma":0.018731551,"teacher_disagreement_score":0.14630918,"about_ca_system_score_codex":0.0016063853,"about_ca_system_score_gemma":0.0012676166,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W4403251129","doi":"10.1016/j.ygyno.2024.07.406","title":"Use of individualized starting dose and niraparib hematologic adverse event management costs in ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Ovarian cancer; Oncology; Internal medicine; Cancer","score_opus":0.062247400791230645,"score_gpt":0.3838646518758335,"score_spread":0.3216172510846029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98615223,0.0020439166,0.000108712244,0.004136465,0.00073436263,0.0012127904,0.000041036277,0.00010655297,0.0054639475],"genre_scores_gemma":[0.9903202,0.0018919627,0.004584041,0.002250196,0.000045852183,0.00048313953,0.000022275397,0.000019663263,0.00038267957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980487,0.00023995298,0.00066624634,0.00046119277,0.00019246533,0.00039141282],"domain_scores_gemma":[0.9987497,0.00068084436,0.00018127864,0.00022481907,0.00005262035,0.00011076166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069264695,0.00019797684,0.0006280175,0.00036306688,0.000043339485,0.0000125890365,0.00008366079,0.00025942412,0.0008335645],"category_scores_gemma":[0.00015571815,0.00016596988,0.00008619336,0.00044406552,0.0002110612,0.00011461158,0.00011839989,0.00031327058,0.000020657437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036672985,0.0030626566,0.46108165,0.0032183842,0.0019543704,0.010575049,0.0057520526,0.0008438392,0.02327794,0.06997957,0.017769063,0.39881814],"study_design_scores_gemma":[0.020985333,0.0040986976,0.7376492,0.0018269295,0.00075377093,0.00038054373,0.0024114815,0.0020851244,0.0047579478,0.008396154,0.21584323,0.0008115847],"about_ca_topic_score_codex":0.0001975304,"about_ca_topic_score_gemma":0.00039719665,"teacher_disagreement_score":0.39800656,"about_ca_system_score_codex":0.0010219862,"about_ca_system_score_gemma":0.00025982966,"threshold_uncertainty_score":0.91269463},"labels":[],"label_agreement":null},{"id":"W4403251157","doi":"10.1016/j.ygyno.2024.07.394","title":"Machine learning for prediction of concurrent endometrial carcinoma patients diagnosed with endometrial intraepithelial neoplasia","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"AI in cancer detection","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Carcinoma; Oncology; Internal medicine; Gynecology","score_opus":0.021735532683258032,"score_gpt":0.26814216648218225,"score_spread":0.24640663379892422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6064437,0.0007048474,0.36715657,0.00029599498,0.02152427,0.0023201306,0.00022060746,0.0005596935,0.0007742111],"genre_scores_gemma":[0.9938539,0.00008331635,0.0048111225,0.000040967443,0.00066504383,0.00042325284,0.000059571845,0.000019586745,0.00004323606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977163,0.00033737678,0.0005527613,0.0006436374,0.00032575743,0.00042418804],"domain_scores_gemma":[0.994283,0.0048675574,0.0003027554,0.00023170067,0.00021876587,0.000096181466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008012559,0.00022632295,0.0005023618,0.0006225983,0.00014558672,0.0000648389,0.00046595963,0.00026243896,0.00006642006],"category_scores_gemma":[0.0018848411,0.00017977117,0.00014697753,0.0011164898,0.00014281113,0.00029549442,0.00017329988,0.00040452162,0.0000145748945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090630486,0.00048089464,0.05457148,0.00013501466,0.00018395267,0.000056414192,0.00093934516,0.0009241246,0.0007283311,0.003672529,0.0008167599,0.93658483],"study_design_scores_gemma":[0.059492245,0.14905225,0.16408709,0.00012677068,0.0005302362,0.00013859793,0.00013323732,0.2858637,0.010589561,0.0031391408,0.325721,0.0011261995],"about_ca_topic_score_codex":0.000058075773,"about_ca_topic_score_gemma":0.00007065647,"teacher_disagreement_score":0.93545866,"about_ca_system_score_codex":0.00073206547,"about_ca_system_score_gemma":0.0004822025,"threshold_uncertainty_score":0.7330856},"labels":[],"label_agreement":null},{"id":"W4403251174","doi":"10.1016/j.ygyno.2024.07.025","title":"A phase II/III study of cediranib and olaparib combination compared to cediranib or olaparib alone or standard of care chemotherapy, in platinum-resistant ovarian cancer (NRG-GY005)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Olaparib; Medicine; Ovarian cancer; Oncology; Chemotherapy; Standard of care; Internal medicine; Cancer research; Cancer","score_opus":0.043202448538459996,"score_gpt":0.39464880593340146,"score_spread":0.35144635739494146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896504,0.0012618811,0.000111594876,0.0030920461,0.00077563775,0.003640203,0.0003367751,0.000119849006,0.0010115736],"genre_scores_gemma":[0.99665517,0.00031055106,0.0009940482,0.0008150483,0.0001089714,0.0006262908,0.000058304493,0.000047564612,0.00038404917],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99671143,0.00030465878,0.0012786727,0.00071959716,0.000493655,0.0004919682],"domain_scores_gemma":[0.9977003,0.00093976175,0.00036291988,0.00039643256,0.00039357797,0.00020700583],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008029622,0.00037332732,0.0017796787,0.00054785394,0.000120814526,0.000018724295,0.00020616932,0.00035255574,0.0020404875],"category_scores_gemma":[0.0002762483,0.00028307643,0.00008177155,0.0010380377,0.0002489962,0.0001084081,0.00011284339,0.00042576328,0.0000028986715],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3761105,0.03501531,0.017486855,0.0039797286,0.002424512,0.0027242221,0.1823723,0.00044885982,0.20619962,0.0017656329,0.017782768,0.1536897],"study_design_scores_gemma":[0.40405807,0.37787428,0.048915967,0.0023490102,0.0011986076,0.00018202394,0.050983768,0.0013916232,0.03220843,0.0006570678,0.07878866,0.0013925049],"about_ca_topic_score_codex":0.00081957167,"about_ca_topic_score_gemma":0.015416096,"teacher_disagreement_score":0.34285897,"about_ca_system_score_codex":0.0016096383,"about_ca_system_score_gemma":0.0015084689,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W4403251189","doi":"10.1016/j.ygyno.2024.07.048","title":"Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Vulvar cancer; Stage (stratigraphy); Sentinel lymph node; Biopsy; Sentinel node; Basal cell; Oncology; Lymph node; Cancer; Radiology; Internal medicine; Breast cancer","score_opus":0.021111525780943427,"score_gpt":0.2857658278140819,"score_spread":0.26465430203313844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909389,0.0005265784,0.000027902453,0.0025775314,0.001302166,0.00061626954,0.0013956879,0.00007730585,0.002537628],"genre_scores_gemma":[0.99582446,0.000043354306,0.0002383818,0.0010511684,0.00012265828,0.00016415665,0.000398988,0.000031750453,0.0021250872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978042,0.00016811895,0.0006168342,0.00057726743,0.0004607013,0.0003728499],"domain_scores_gemma":[0.9960364,0.0028917908,0.0003072673,0.00035835017,0.00018752481,0.00021863343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018773125,0.00028750693,0.0006236023,0.00013987845,0.000083030565,0.00003587395,0.00027053937,0.00010139692,0.0011093616],"category_scores_gemma":[0.0008103665,0.00016221727,0.00018487536,0.00036435825,0.0002901341,0.00010112716,0.00015774161,0.00022922557,0.00006165771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018642033,0.000927453,0.9946422,0.00012372891,0.00044998733,0.0006847463,0.00017396879,0.00010602759,0.0000531205,0.000051984476,0.0002788969,0.00064370007],"study_design_scores_gemma":[0.012959825,0.00038195538,0.98440915,0.00005762825,0.000901716,0.0000017098154,0.000178118,0.00038451402,0.000079001045,0.00010155689,0.00037634352,0.0001684521],"about_ca_topic_score_codex":0.003104162,"about_ca_topic_score_gemma":0.00030684585,"teacher_disagreement_score":0.011095622,"about_ca_system_score_codex":0.00067074265,"about_ca_system_score_gemma":0.0007716519,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W4403251225","doi":"10.1016/j.ygyno.2024.07.417","title":"GOG-3084: A phase II trial of ADP-A2M4CD8 TCR-T cell therapy, alone or in combination with nivolumab, among patients with recurrent ovarian cancers","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Oncology; Internal medicine; Immunotherapy; Cancer","score_opus":0.03270045354597139,"score_gpt":0.34693050096028794,"score_spread":0.31423004741431654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98807895,0.00030421652,0.000034516277,0.00097642455,0.00073889113,0.004145745,0.00002938678,0.00008828576,0.0056036036],"genre_scores_gemma":[0.9945892,0.00040481336,0.00040503038,0.00018620663,0.00011885513,0.00060096564,0.00013865529,0.000051229115,0.0035050053],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971323,0.00043750147,0.0006254839,0.0006326902,0.0005745123,0.0005975293],"domain_scores_gemma":[0.9981742,0.00077569386,0.00024536994,0.00039189757,0.00023112551,0.00018172365],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088128436,0.00030520762,0.0009095556,0.0004904831,0.00009349509,0.000020836833,0.00021419974,0.00034661693,0.004642578],"category_scores_gemma":[0.00016726802,0.00019385059,0.00009631799,0.0009791004,0.0004327827,0.00012412493,0.00008324709,0.0007061489,0.000014686381],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4389175,0.022673633,0.021521226,0.00032037936,0.0005171212,0.0010807439,0.0033122976,0.00005327437,0.0025564437,0.000117968804,0.0029047758,0.50602466],"study_design_scores_gemma":[0.50805944,0.3968053,0.039677337,0.00030733895,0.00021798797,0.00002846627,0.000625444,0.0011419787,0.0015533193,0.00014999889,0.050939295,0.00049412553],"about_ca_topic_score_codex":0.000724727,"about_ca_topic_score_gemma":0.0043953774,"teacher_disagreement_score":0.50553054,"about_ca_system_score_codex":0.0018988604,"about_ca_system_score_gemma":0.0021527314,"threshold_uncertainty_score":0.9962673},"labels":[],"label_agreement":null},{"id":"W4403251372","doi":"10.1016/j.ygyno.2024.07.021","title":"Efficacy and safety of tisotumab vedotin versus investigator's choice of chemotherapy in second-line or third-line recurrent or metastatic cervical cancer (innovaTV 301/ENGOT-cx12/GOG-3057): A global, randomized, open-label, phase III study","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cervical cancer; Chemotherapy; Cancer","score_opus":0.11259405134976598,"score_gpt":0.44635040720930785,"score_spread":0.3337563558595419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98093885,0.003296889,0.00006391609,0.0062611024,0.0015530189,0.0066923904,0.0001057037,0.00008353511,0.0010045765],"genre_scores_gemma":[0.9923032,0.0021041129,0.0018100057,0.0018317424,0.00018559299,0.00070217537,0.00005736289,0.00003997426,0.00096582156],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958973,0.0006098177,0.0017712775,0.00081247115,0.00035967596,0.00054946885],"domain_scores_gemma":[0.9945974,0.0039933035,0.0005481049,0.00044243847,0.00017445358,0.00024433667],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021318486,0.00046587113,0.0029235433,0.0003333744,0.00006323937,0.000036205704,0.00046643242,0.00021535401,0.0031744628],"category_scores_gemma":[0.0026630934,0.0003043736,0.00011280473,0.0016770046,0.0005157634,0.00014059433,0.00045594553,0.0005279561,0.000007946049],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7281766,0.013362723,0.0035394162,0.001512196,0.003414028,0.0016216694,0.001612723,0.000035300327,0.00023291273,0.0008332197,0.008491262,0.23716797],"study_design_scores_gemma":[0.9239176,0.032140452,0.011328456,0.0003334604,0.0019439904,0.000051125488,0.0009874833,0.0015833195,0.00013466958,0.00019485746,0.026998837,0.00038575404],"about_ca_topic_score_codex":0.0008237984,"about_ca_topic_score_gemma":0.00824631,"teacher_disagreement_score":0.23678221,"about_ca_system_score_codex":0.0007711925,"about_ca_system_score_gemma":0.0016158927,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W4403251483","doi":"10.1016/j.ygyno.2024.07.022","title":"Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Interim; Ovarian cancer; Oncology; Internal medicine; Gynecology; Interim analysis; Cancer; Clinical trial","score_opus":0.023837470427492412,"score_gpt":0.34583760093827504,"score_spread":0.32200013051078263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98918366,0.0017377428,0.000016974867,0.005970968,0.0008510342,0.0011834531,0.00017003455,0.00007239546,0.0008137413],"genre_scores_gemma":[0.9964926,0.0006703901,0.0011132233,0.000664541,0.00004855553,0.00032587806,0.0005910388,0.000029035044,0.00006473095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981173,0.00015765929,0.00036898267,0.0007903402,0.00015560366,0.00041007515],"domain_scores_gemma":[0.9987666,0.0005125294,0.00008614215,0.00043839574,0.00006722849,0.00012911498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029618613,0.00024402454,0.000593513,0.00022529873,0.000036091096,0.000028051452,0.00017054155,0.00022286564,0.00074318075],"category_scores_gemma":[0.00017671795,0.00016462692,0.000025838473,0.00041439,0.00011334103,0.0001848183,0.00025652442,0.00033051218,0.000018595618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011548874,0.0012498344,0.598029,0.000055644752,0.00010108745,0.0012774849,0.00030080558,0.000022004031,0.000031253934,0.00016562467,0.0004517568,0.39716062],"study_design_scores_gemma":[0.0133545315,0.004681996,0.9689965,0.0003564183,0.00011561691,0.0000081707185,0.00017113706,0.00070881995,0.000013826141,0.00013127147,0.011274664,0.00018699563],"about_ca_topic_score_codex":0.00048444158,"about_ca_topic_score_gemma":0.008140183,"teacher_disagreement_score":0.39697364,"about_ca_system_score_codex":0.0007922609,"about_ca_system_score_gemma":0.0004986417,"threshold_uncertainty_score":0.8137308},"labels":[],"label_agreement":null},{"id":"W4403251487","doi":"10.1016/j.ygyno.2024.07.113","title":"Postoperative complications in elderly patients undergoing surgery for ovarian cancer: A NSQIP analysis","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Ovarian cancer; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.033332167115089864,"score_gpt":0.3448152933717361,"score_spread":0.31148312625664626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9389378,0.0009253395,0.0010179837,0.040664703,0.00067807117,0.0013495614,0.000058338293,0.00015465739,0.016213534],"genre_scores_gemma":[0.99378014,0.0002801512,0.0008045019,0.0030985621,0.00005480837,0.0006250326,0.00019743161,0.00001459292,0.0011448037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850994,0.00019324994,0.0004272999,0.00040856903,0.00011574262,0.00034519637],"domain_scores_gemma":[0.9880526,0.011472588,0.00006307288,0.00018110401,0.000121080026,0.00010956159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047385925,0.00015562846,0.0010352227,0.000494363,0.00008870078,0.00002571837,0.000066404515,0.00022406671,0.000325756],"category_scores_gemma":[0.0010157931,0.000121964,0.0005964393,0.0009270334,0.00007726111,0.000057129564,0.000024477096,0.00017828522,0.000032899687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017119116,0.00045961843,0.9203859,0.00009599588,0.0011242571,0.00024178137,0.00045658005,0.0001421546,0.000029227376,0.010752547,0.0023908769,0.06374989],"study_design_scores_gemma":[0.001022325,0.00072864833,0.8245216,0.00003385604,0.00078821514,0.000014620606,0.00016549451,0.0006322318,0.000007911278,0.00021896823,0.17172225,0.00014389194],"about_ca_topic_score_codex":0.00015539564,"about_ca_topic_score_gemma":0.003073771,"teacher_disagreement_score":0.16933137,"about_ca_system_score_codex":0.0006205336,"about_ca_system_score_gemma":0.0008419012,"threshold_uncertainty_score":0.49735478},"labels":[],"label_agreement":null},{"id":"W4403251505","doi":"10.1016/j.ygyno.2024.07.092","title":"Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as a firstline treatment for endometrial cancer: Overall survival and additional secondary efficacy en‑dpoints by mismatch repair status in the DUO-E/GOG-3041/ENGOT-EN10 Trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Durvalumab; Olaparib; Carboplatin; Endometrial cancer; Oncology; Paclitaxel; Internal medicine; Overall survival; Urology; Cancer; Chemotherapy; Cisplatin; Nivolumab; Immunotherapy","score_opus":0.03717994450346522,"score_gpt":0.35809486382559974,"score_spread":0.3209149193221345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632712,0.005684766,0.000026412034,0.0051410124,0.0023826559,0.009273585,0.009121285,0.00032277431,0.004776322],"genre_scores_gemma":[0.9766849,0.002910097,0.0014038055,0.0012924726,0.001598317,0.00573486,0.0044985595,0.000113532566,0.0057634036],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949039,0.0009653355,0.0010555211,0.0012718334,0.00069924246,0.0011041734],"domain_scores_gemma":[0.9825635,0.016156252,0.00030297576,0.00043873274,0.00013859957,0.00039993325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012624054,0.0007191798,0.0020057494,0.00034530586,0.00029530132,0.00009200784,0.00022886068,0.00062884315,0.0058075725],"category_scores_gemma":[0.0025166736,0.00040887063,0.0004469521,0.00087199523,0.00029894945,0.00016623797,0.000075319804,0.0006911501,0.000031981708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7052261,0.010370338,0.0046858224,0.0006254989,0.0056345626,0.002415425,0.004234164,0.00003156595,0.0005327312,0.00047737596,0.15293834,0.112828076],"study_design_scores_gemma":[0.46722153,0.07605898,0.0050168606,0.00015390548,0.0017370739,0.0002587947,0.0008915877,0.00039617284,0.00011673924,0.00037509235,0.44713008,0.0006431785],"about_ca_topic_score_codex":0.0031143043,"about_ca_topic_score_gemma":0.006925156,"teacher_disagreement_score":0.29419175,"about_ca_system_score_codex":0.0035391375,"about_ca_system_score_gemma":0.0037684743,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W4403251516","doi":"10.1016/j.ygyno.2024.07.020","title":"Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Placebo; Chemoradiotherapy; Oncology; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Alternative medicine","score_opus":0.019305037816924935,"score_gpt":0.3229214523200555,"score_spread":0.30361641450313054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764234,0.0032744533,0.00021049366,0.0012349047,0.002774362,0.015451148,0.00012430818,0.00021353348,0.00029341102],"genre_scores_gemma":[0.9929711,0.00074133393,0.00011783606,0.0010955638,0.00018936722,0.004429289,0.00017990696,0.00007867905,0.00019688113],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99428695,0.0010232652,0.002094141,0.001056702,0.0008226997,0.00071621663],"domain_scores_gemma":[0.9924189,0.004725238,0.0013921063,0.00079264666,0.00044482562,0.00022627697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011598271,0.00073985907,0.0038930916,0.00022337331,0.00025163003,0.000060023493,0.00039813056,0.0004734418,0.0023334452],"category_scores_gemma":[0.0003862132,0.0003880201,0.0006394881,0.0005597039,0.0008585491,0.00015355894,0.0001097784,0.0009287104,0.000008336223],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84958935,0.0045948317,0.037546936,0.000043663393,0.008356987,0.00019994624,0.00359649,0.00028611286,0.000090506044,0.000014771318,0.0004934768,0.09518695],"study_design_scores_gemma":[0.93518615,0.012843434,0.04382448,0.00013316849,0.0031393638,0.000008644818,0.0014560346,0.0010072754,0.00015973064,0.00002474418,0.0017717716,0.00044517856],"about_ca_topic_score_codex":0.005809713,"about_ca_topic_score_gemma":0.0047101374,"teacher_disagreement_score":0.09474178,"about_ca_system_score_codex":0.0012581706,"about_ca_system_score_gemma":0.001305907,"threshold_uncertainty_score":0.9998572},"labels":[],"label_agreement":null},{"id":"W4403251522","doi":"10.1016/j.ygyno.2024.07.089","title":"Evaluation of efficacy and fertility after non-radical surgical therapy (extra fascial hysterectomy or cone biopsy with pelvic lymphadenectomy) for stage IA1 (LVSI+) and IA2–IB1 (GOG-278) cervical cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Stage (stratigraphy); Cervical cancer; Radical Hysterectomy; Hysterectomy; Lymphadenectomy; Fertility preservation; Biopsy; Fertility; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.07138324590284907,"score_gpt":0.390665598570525,"score_spread":0.31928235266767596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403251522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98572874,0.008638124,0.00004905982,0.0015626134,0.00045859444,0.0024701187,0.00012155698,0.00006896824,0.0009022224],"genre_scores_gemma":[0.9966374,0.0007114588,0.0004313365,0.0003136575,0.00030164066,0.0012608751,0.00003465706,0.000030548214,0.00027840855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972758,0.00037351545,0.0005249878,0.00077740423,0.000575166,0.00047311853],"domain_scores_gemma":[0.99687016,0.0021943466,0.000120021294,0.00021776573,0.00030652186,0.0002911778],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012061785,0.00033157898,0.0010420525,0.0001895659,0.00008607183,0.00003354348,0.0000936241,0.0004378702,0.0026651772],"category_scores_gemma":[0.00034221745,0.00019192419,0.00012365659,0.0004644981,0.00054086925,0.00008678695,0.0000665855,0.00023146781,0.000007030514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076942965,0.0038031419,0.13425057,0.0012576326,0.0021064274,0.0010542157,0.001031232,0.000007661613,0.002085119,0.00017872996,0.00017019511,0.7771121],"study_design_scores_gemma":[0.057143405,0.015903877,0.90529025,0.00016780423,0.0015718737,0.00025740205,0.00014687794,0.0014440626,0.000896413,0.00026527248,0.016563509,0.00034925225],"about_ca_topic_score_codex":0.00026703562,"about_ca_topic_score_gemma":0.00058050925,"teacher_disagreement_score":0.77676284,"about_ca_system_score_codex":0.00063888857,"about_ca_system_score_gemma":0.0013314168,"threshold_uncertainty_score":0.99824655},"labels":[],"label_agreement":null},{"id":"W4403254218","doi":"10.1016/j.ygyno.2024.07.015","title":"Overall survival and progression-free survival by PD-L1 status among endometrial cancer patients treated with pembrolizumab plus carboplatin/paclitaxel as compared to carboplatin/paclitaxel plus placebo in the NRG GY018 trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Carboplatin; Paclitaxel; Oncology; Internal medicine; Pembrolizumab; Placebo; Endometrial cancer; Progression-free survival; Overall survival; Chemotherapy; Cancer; Cisplatin; Immunotherapy; Pathology","score_opus":0.025459327438658953,"score_gpt":0.33373437308985604,"score_spread":0.30827504565119707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403254218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97759855,0.002279243,0.0000059026092,0.0016204555,0.0027950385,0.0065201153,0.00049808196,0.00018794027,0.008494699],"genre_scores_gemma":[0.99556357,0.0003973595,0.00012390372,0.00061692594,0.0005036741,0.0016251525,0.00033066212,0.00007793374,0.0007607932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99417377,0.0012264858,0.0011140282,0.0011630718,0.0010442416,0.0012783884],"domain_scores_gemma":[0.99423295,0.0041361116,0.00036252342,0.0006630069,0.0001973694,0.00040801952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001631438,0.0007030341,0.0016515079,0.0005150836,0.00025100593,0.00015724168,0.000466085,0.00063276425,0.00054035254],"category_scores_gemma":[0.001548911,0.00044289816,0.00022370288,0.0012562296,0.00061177794,0.00017711383,0.00023229285,0.0009059489,0.0000146111415],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7685038,0.0018891119,0.17700954,0.00026044788,0.0014641682,0.0010779203,0.005985174,0.00009965308,0.0009393197,0.00016349749,0.018425891,0.024181515],"study_design_scores_gemma":[0.49339157,0.040746763,0.4237768,0.00043064184,0.0007896819,0.00007305928,0.0028167877,0.00085919694,0.00015568557,0.00013101335,0.035665486,0.0011632809],"about_ca_topic_score_codex":0.0118072955,"about_ca_topic_score_gemma":0.014358208,"teacher_disagreement_score":0.27511218,"about_ca_system_score_codex":0.0030158928,"about_ca_system_score_gemma":0.0020328204,"threshold_uncertainty_score":0.9998023},"labels":[],"label_agreement":null},{"id":"W4403254231","doi":"10.1016/j.ygyno.2024.07.014","title":"Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Chemotherapy; Overall survival; Internal medicine; Primary (astronomy); Gynecology; Cancer","score_opus":0.028488554740678657,"score_gpt":0.32124280329814653,"score_spread":0.2927542485574679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403254231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845031,0.0011356908,0.000012432681,0.0015942719,0.0018653449,0.0052643893,0.00010971141,0.00016926034,0.005345819],"genre_scores_gemma":[0.9928036,0.0012683306,0.00032275336,0.0016548742,0.0007501638,0.0020752947,0.00032075465,0.0000660792,0.00073820044],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962747,0.00055055006,0.00068989175,0.00090482243,0.0007555332,0.0008244957],"domain_scores_gemma":[0.99587274,0.0030811704,0.0002572927,0.00042003684,0.00016448628,0.00020426814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00064332195,0.0005440766,0.0014055514,0.00044397858,0.00012656418,0.00006135549,0.00031314386,0.0003819737,0.001683186],"category_scores_gemma":[0.0004546646,0.0002514706,0.00019257594,0.0018910182,0.000280081,0.00019083415,0.00006634292,0.00079128286,0.000025047619],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.618688,0.004720064,0.08179525,0.0001987622,0.0010649584,0.0014388091,0.0009948931,0.00004905787,0.00004315366,0.00008113993,0.0008088933,0.290117],"study_design_scores_gemma":[0.47313666,0.07426016,0.4093456,0.00022757328,0.00075196807,0.000025024077,0.0002734269,0.000040584753,0.00007604366,0.00008174262,0.04124526,0.00053598254],"about_ca_topic_score_codex":0.0006706014,"about_ca_topic_score_gemma":0.0027834263,"teacher_disagreement_score":0.32755032,"about_ca_system_score_codex":0.0028997727,"about_ca_system_score_gemma":0.0013490373,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W4403789396","doi":"10.1016/j.ygyno.2024.10.013","title":"Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"ImmunoGen","keywords":"Medicine; Tolerability; Ovarian cancer; Oncology; Folate receptor; Internal medicine; Gynecology; Cancer; Adverse effect; Cancer cell","score_opus":0.05559084458819756,"score_gpt":0.40697704372038457,"score_spread":0.351386199132187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403789396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89391476,0.034463417,0.011411863,0.036730673,0.006202848,0.0086870985,0.0029615678,0.0007755054,0.0048522563],"genre_scores_gemma":[0.9188371,0.024065819,0.049350064,0.002027615,0.0010909062,0.0011291039,0.0011607799,0.00022449215,0.0021141453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964635,0.00063021417,0.0010045717,0.00093108224,0.00027677044,0.0006939032],"domain_scores_gemma":[0.99694616,0.0016145578,0.00018668827,0.00050698523,0.00042168205,0.00032393055],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024300506,0.00034560458,0.0012288052,0.00023721764,0.00017391251,0.0000412026,0.00024463868,0.00058038486,0.0017702497],"category_scores_gemma":[0.00072489155,0.00027465884,0.00017189114,0.0004896633,0.000513273,0.00016532927,0.000107738466,0.00076846994,0.000007136069],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009015281,0.00078460237,0.0034327966,0.0007631968,0.0002827296,0.00005358326,0.0009076644,0.000023359074,0.018577531,0.0005770151,0.0053111645,0.96027106],"study_design_scores_gemma":[0.0067992266,0.013997864,0.014937632,0.00063529314,0.00021526038,0.000052390373,0.0004045323,0.0100696385,0.003383072,0.0014168294,0.9476672,0.000421057],"about_ca_topic_score_codex":0.0005615245,"about_ca_topic_score_gemma":0.0010059106,"teacher_disagreement_score":0.95985,"about_ca_system_score_codex":0.001827066,"about_ca_system_score_gemma":0.0022265618,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W4404133569","doi":"10.1016/j.ygyno.2024.10.028","title":"Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Internal medicine; Cancer; Hormone; Gynecology","score_opus":0.027087104696916775,"score_gpt":0.33568392531615876,"score_spread":0.308596820619242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404133569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312608,0.01634055,0.00012448269,0.029418007,0.0032510993,0.0022767908,0.000040803196,0.00021431081,0.017073127],"genre_scores_gemma":[0.9945699,0.0006240428,0.00112938,0.0022083374,0.00036450633,0.0007366872,0.000029229688,0.00002820575,0.0003097305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975275,0.0003787866,0.00059993437,0.0005741732,0.00037546054,0.0005441719],"domain_scores_gemma":[0.9959623,0.0034345097,0.00009384425,0.00025165855,0.000071469025,0.0001862024],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012803574,0.00025410418,0.00061502785,0.000396301,0.00007170314,0.000035503985,0.00020856931,0.00035001378,0.0009935007],"category_scores_gemma":[0.0034123084,0.00014265656,0.0002113235,0.0017736023,0.00029401353,0.000051544546,0.000117055526,0.0006068416,0.00012646927],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01601973,0.0043671,0.09465365,0.00067007216,0.0041750325,0.040724386,0.0011446123,0.0001725951,0.04696178,0.069720834,0.0084636705,0.71292657],"study_design_scores_gemma":[0.057981312,0.04383618,0.55731803,0.00091532245,0.004028614,0.0017880602,0.0014239475,0.0038291253,0.010085256,0.050908852,0.2659864,0.0018988481],"about_ca_topic_score_codex":0.00029257726,"about_ca_topic_score_gemma":0.0006169103,"teacher_disagreement_score":0.7110277,"about_ca_system_score_codex":0.0012080007,"about_ca_system_score_gemma":0.0009864713,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W4404235280","doi":"10.1016/j.ygyno.2024.10.022","title":"Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Endometrial cancer; Oncology; Placebo; Internal medicine; Cancer; Chemotherapy; Randomized controlled trial; Pathology; Alternative medicine","score_opus":0.013766321379200216,"score_gpt":0.3232513664158988,"score_spread":0.3094850450366986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404235280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97951597,0.0019064413,0.00002381165,0.0009709061,0.0007783426,0.015906986,0.000042688316,0.00004352755,0.0008113228],"genre_scores_gemma":[0.9938003,0.00206675,0.0004620607,0.00025115607,0.00009626682,0.0030982173,0.000091361886,0.00003304731,0.00010083074],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963848,0.0007705346,0.0012526097,0.0006753118,0.00041910502,0.00049765746],"domain_scores_gemma":[0.9925217,0.006630661,0.00039929402,0.00019838192,0.00011911733,0.00013084865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001446462,0.0003937278,0.0029512474,0.0011121504,0.000033967874,0.000015610285,0.000116478586,0.00030672125,0.00053343654],"category_scores_gemma":[0.0017410248,0.00022339533,0.00013402976,0.0017884047,0.00025028287,0.00014449618,0.000046957215,0.00052933506,0.000002136928],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76997834,0.007916722,0.0044326126,0.00014018727,0.00033184257,0.00016040496,0.0004274448,0.000036846646,0.000027829246,0.000038966748,0.0000093526605,0.21649946],"study_design_scores_gemma":[0.92743224,0.044160094,0.026651567,0.00036813784,0.00033502604,0.0000046432433,0.000064968626,0.00013309225,0.000046802128,0.00009272387,0.0004869588,0.0002237699],"about_ca_topic_score_codex":0.00019684253,"about_ca_topic_score_gemma":0.0015943408,"teacher_disagreement_score":0.21627569,"about_ca_system_score_codex":0.0018295499,"about_ca_system_score_gemma":0.00095316395,"threshold_uncertainty_score":0.9109797},"labels":[],"label_agreement":null},{"id":"W4404275877","doi":"10.1016/j.ygyno.2024.11.004","title":"Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Ovarian cancer; Placebo; Adverse effect; Oncology; Internal medicine; Gynecology; Cancer; Alternative medicine; Pathology","score_opus":0.04708799353265499,"score_gpt":0.38366285423559926,"score_spread":0.3365748607029443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404275877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744472,0.0010565462,0.000052181855,0.008055292,0.003236962,0.0022597467,0.00005108272,0.000034760076,0.010806247],"genre_scores_gemma":[0.99625903,0.0011441807,0.00029329088,0.0009135494,0.00020962114,0.0009044489,0.000014468906,0.00001458028,0.00024680258],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99755985,0.00057151465,0.0008383326,0.00037623206,0.00025944092,0.00039460624],"domain_scores_gemma":[0.99794143,0.0013527278,0.0002555453,0.0003198181,0.00007854816,0.000051908155],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018356909,0.00018192042,0.0007143813,0.0002887851,0.000021742208,0.0000015031005,0.00024532012,0.00031130516,0.0010188045],"category_scores_gemma":[0.00053825416,0.00012536903,0.00015002744,0.0006242612,0.00023028097,0.000053879547,0.00005264477,0.00060965936,0.00002103259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37660012,0.024407405,0.088785216,0.0027200924,0.0012086122,0.0030453217,0.029243298,0.0020205916,0.015549779,0.038713202,0.048181824,0.36952454],"study_design_scores_gemma":[0.42429048,0.035319537,0.23789878,0.002877402,0.0004813199,0.0002620537,0.0053455336,0.0024709743,0.0035788007,0.020122154,0.26645842,0.00089454936],"about_ca_topic_score_codex":0.00029225342,"about_ca_topic_score_gemma":0.001885016,"teacher_disagreement_score":0.36863,"about_ca_system_score_codex":0.0009950906,"about_ca_system_score_gemma":0.0010614161,"threshold_uncertainty_score":0.9998944},"labels":[],"label_agreement":null},{"id":"W4404381380","doi":"10.1016/j.ygyno.2024.10.032","title":"A randomized controlled trial of an online support group addressing psychosexual distress among women treated for gynecologic cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Western University; University of Calgary; Women's Health Research Institute; Queen's University; Women's College Hospital","funders":"National Cancer Institute; Canadian Institutes of Health Research; Ovarian Cancer Canada; Clinical Trials Fund, Canadian Institutes of Health Research","keywords":"Medicine; Psychosexual development; Randomized controlled trial; Distress; Gynecology; Gynecologic cancer; Oncology; Family medicine; Obstetrics; Cancer; Clinical psychology; Internal medicine; Ovarian cancer; Psychoanalysis","score_opus":0.056446843126611065,"score_gpt":0.3871980454179118,"score_spread":0.3307512022913007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404381380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797077,0.00096835854,0.00011500526,0.0008565126,0.0054732477,0.009239278,0.00041719762,0.0003071791,0.0029155225],"genre_scores_gemma":[0.9810475,0.000341819,0.00025527066,0.0006765324,0.00093565526,0.013129331,0.0007205859,0.000056399957,0.0028368959],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99575245,0.0009191849,0.0013941476,0.0008166081,0.00030491935,0.0008127],"domain_scores_gemma":[0.99329937,0.0052014347,0.00051220384,0.00040559095,0.00025754343,0.00032384918],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00246435,0.00044751627,0.003943136,0.00032889805,0.000117748656,0.000043708096,0.00025661875,0.00072283094,0.0027598822],"category_scores_gemma":[0.0015990466,0.00030017324,0.000769005,0.00038664546,0.0006448695,0.00014006469,0.00006380309,0.00044356077,0.0000058861],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92001384,0.0025482355,0.0007003614,0.00036811893,0.0011643034,0.0002584947,0.0015688232,0.000013751394,0.0004588368,0.00020591801,0.00084742747,0.0718519],"study_design_scores_gemma":[0.96469164,0.017491458,0.0019545914,0.0000926368,0.0014747301,0.000022797272,0.0017845405,0.002084114,0.00005039951,0.00059309136,0.009426388,0.00033363397],"about_ca_topic_score_codex":0.0004835747,"about_ca_topic_score_gemma":0.00687716,"teacher_disagreement_score":0.07151827,"about_ca_system_score_codex":0.0009585744,"about_ca_system_score_gemma":0.0007889002,"threshold_uncertainty_score":0.99994504},"labels":[],"label_agreement":null},{"id":"W4405911956","doi":"10.1016/j.ygyno.2024.12.010","title":"Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Foundation; Vancouver Coastal Health Research Institute; Canada Research Chairs; Canadian Cancer Society; Michael Smith Health Research BC; VGH and UBC Hospital Foundation","keywords":"Medicine; Endometrial cancer; Context (archaeology); Cancer; Oncology; Internal medicine; Gynecology","score_opus":0.048338033816177184,"score_gpt":0.3532392348807828,"score_spread":0.3049012010646056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405911956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95439035,0.0018075128,0.00006825333,0.023219088,0.00085147156,0.007643432,0.00017396167,0.00007554015,0.011770408],"genre_scores_gemma":[0.9936367,0.00048207922,0.00024272272,0.001211163,0.000049493025,0.0041968687,0.00005459387,0.000009322184,0.00011701029],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985556,0.0002707201,0.00041506422,0.00027288613,0.00023520461,0.00025051882],"domain_scores_gemma":[0.9987309,0.0007632531,0.00015441341,0.00021695241,0.00008789343,0.00004661572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005700152,0.00017241167,0.00040515195,0.00026652537,0.000048869853,0.000039398492,0.00012429188,0.00014265126,0.00015505374],"category_scores_gemma":[0.00027764787,0.00010504159,0.00008728901,0.00047401883,0.000105376814,0.00014257107,0.00004200918,0.00018339446,0.000013948663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005952376,0.0022477787,0.108846724,0.0011056536,0.0011119371,0.0006345899,0.0132885575,0.000108688764,0.00053174625,0.013932738,0.0026681118,0.85492826],"study_design_scores_gemma":[0.00806035,0.0037337716,0.93782,0.00033306214,0.0007979889,0.00002873793,0.0045785033,0.00067493203,0.0047112536,0.00030561019,0.038752437,0.00020331147],"about_ca_topic_score_codex":0.0003333063,"about_ca_topic_score_gemma":0.000905375,"teacher_disagreement_score":0.85472494,"about_ca_system_score_codex":0.001007155,"about_ca_system_score_gemma":0.0005738653,"threshold_uncertainty_score":0.42834717},"labels":[],"label_agreement":null},{"id":"W4406725734","doi":"10.1016/j.ygyno.2024.12.020","title":"Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non–MSI-H/non–dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Endometrial cancer; Pembrolizumab; Medicine; Cancer research; Oncology; Cancer; Internal medicine; Genetics; Biology; Microsatellite; Colorectal cancer; Gene; Immunotherapy","score_opus":0.02129513662601327,"score_gpt":0.3649009953266963,"score_spread":0.343605858700683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406725734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789945,0.0034024108,0.00002018917,0.0016743091,0.0026152884,0.0048463326,0.00018261373,0.00020359815,0.008060798],"genre_scores_gemma":[0.9931038,0.0015174991,0.00087727024,0.0012709878,0.00020873992,0.0009356064,0.00010802524,0.000034149172,0.0019438916],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945428,0.0006006122,0.0016777122,0.0016408231,0.00043612617,0.0011019625],"domain_scores_gemma":[0.99534595,0.0027136374,0.00042986788,0.00086316897,0.00028272628,0.00036467164],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015803309,0.0006202933,0.0021357134,0.0010605262,0.00024272024,0.000037284066,0.00032572797,0.00060058944,0.00036255133],"category_scores_gemma":[0.003139168,0.0005003602,0.00029352,0.0027978416,0.00036022218,0.00013292421,0.00042179687,0.0008232568,0.000037922877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13810132,0.042749207,0.33403,0.0007351111,0.001350598,0.0031064858,0.0035519442,0.00028400714,0.0077032773,0.0001770701,0.0016116126,0.46659935],"study_design_scores_gemma":[0.30459878,0.040918916,0.60124904,0.0002626069,0.0010842946,0.00005000209,0.0023915765,0.00018909751,0.002995326,0.0006641303,0.04483046,0.0007657913],"about_ca_topic_score_codex":0.0022917206,"about_ca_topic_score_gemma":0.004997687,"teacher_disagreement_score":0.46583354,"about_ca_system_score_codex":0.0022020321,"about_ca_system_score_gemma":0.0011354815,"threshold_uncertainty_score":0.9997448},"labels":[],"label_agreement":null},{"id":"W4407625636","doi":"10.1016/j.ygyno.2025.02.012","title":"Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Endometrial cancer; Histology; Cancer; Oncology; Internal medicine; Pathology","score_opus":0.02489723195196432,"score_gpt":0.3146477110345341,"score_spread":0.2897504790825698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407625636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970788,0.02233819,0.000063998115,0.0011700372,0.0012825592,0.0018280542,0.0002836532,0.000057076722,0.0021884595],"genre_scores_gemma":[0.99361753,0.0026677279,0.001958959,0.0007817508,0.000059581816,0.00044990404,0.000055253036,0.000014751895,0.00039450757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759793,0.00033245492,0.0007958019,0.0006070257,0.00015421561,0.0005125629],"domain_scores_gemma":[0.99654645,0.0026301031,0.00029059724,0.0002548587,0.00013930636,0.0001386673],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044078683,0.00028112228,0.0013478489,0.0010142681,0.00006120635,0.000008261651,0.00016170407,0.00023542039,0.0012528413],"category_scores_gemma":[0.0009273546,0.00022679644,0.00012888975,0.002067313,0.00044425234,0.000046312693,0.0001245691,0.0003508692,0.000014177085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015744148,0.008534789,0.4261079,0.0011817141,0.0012755474,0.0030234812,0.0002215123,0.0000425941,0.26644266,0.0014032347,0.008620123,0.2674023],"study_design_scores_gemma":[0.06413574,0.019321144,0.56390035,0.00039545438,0.0017511671,0.00021483249,0.0005412229,0.00006262085,0.06292732,0.0022219387,0.28369194,0.0008362741],"about_ca_topic_score_codex":0.00050507835,"about_ca_topic_score_gemma":0.0004144589,"teacher_disagreement_score":0.27507183,"about_ca_system_score_codex":0.0007578033,"about_ca_system_score_gemma":0.00060635345,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W4408167542","doi":"10.1016/j.ygyno.2025.03.005","title":"Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"University of Oklahoma Health Sciences Center; Leonard M. Miller School of Medicine; EMD Serono; Seoul National University Hospital; Eisai; Daiichi Sankyo Europe; Seoul National University; National Cancer Institute; Natera; NRG Oncology; Virginia Commonwealth University; Rush University; Memorial Sloan-Kettering Cancer Center; University of Texas Southwestern Medical Center; Dana-Farber Cancer Institute; Northwestern University; GlaxoSmithKline; National Institutes of Health; Ohio State University; AstraZeneca; University of Miami; Dartmouth College; University of Oklahoma","keywords":"Medicine; Stage (stratigraphy); Cervical cancer; Hysterectomy; Radical Hysterectomy; Lymphadenectomy; Biopsy; Gynecology; Surgery; Cancer; Radiology; Internal medicine","score_opus":0.06703958441082579,"score_gpt":0.3942079374506364,"score_spread":0.3271683530398106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408167542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902675,0.0035176182,0.000053428572,0.002120632,0.00030101225,0.002537897,0.00008133152,0.000043191943,0.0010773523],"genre_scores_gemma":[0.99668354,0.00048477724,0.00051844725,0.00061460934,0.00012651885,0.0011929107,0.000027860235,0.000016205422,0.0003351301],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745953,0.0004859462,0.0005178205,0.0006548883,0.00045536715,0.00042642892],"domain_scores_gemma":[0.99683565,0.0021308193,0.00016528092,0.00023062003,0.0004219178,0.00021569515],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010998008,0.00029373515,0.0010831531,0.00018531522,0.00009939011,0.000018376833,0.00009800407,0.00042392948,0.0014777079],"category_scores_gemma":[0.0005476453,0.00016209943,0.00010110746,0.00045164218,0.00051557337,0.000059242884,0.00007738643,0.0001809283,0.0000020535458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0745807,0.003658024,0.3154009,0.00044578983,0.0011980582,0.00018243508,0.0003004256,0.00000403526,0.000602881,0.00013904084,0.000085082545,0.6034026],"study_design_scores_gemma":[0.06715497,0.008542727,0.9130446,0.00007846491,0.0011513237,0.000056264096,0.00009927161,0.00022728521,0.0007430775,0.00031728795,0.008384857,0.00019991172],"about_ca_topic_score_codex":0.00032199314,"about_ca_topic_score_gemma":0.0011323893,"teacher_disagreement_score":0.6032027,"about_ca_system_score_codex":0.00058713264,"about_ca_system_score_gemma":0.0013288374,"threshold_uncertainty_score":0.99943507},"labels":[],"label_agreement":null},{"id":"W4408253634","doi":"10.1016/j.ygyno.2025.02.023","title":"Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Leonard M. Miller School of Medicine; University of Oklahoma Health Sciences Center; Seoul National University Hospital; Seoul National University; Rush University; Memorial Sloan-Kettering Cancer Center; University of Texas Southwestern Medical Center; Northwestern University; Dana-Farber Cancer Institute; Virginia Commonwealth University; NRG Oncology; National Institutes of Health; Ohio State University; University of Miami; Dartmouth College; University of Oklahoma","keywords":"Medicine; Stage (stratigraphy); Cervical cancer; Quality of life (healthcare); Cancer; Oncology; Internal medicine; Nursing","score_opus":0.06820246507817962,"score_gpt":0.4130976780163622,"score_spread":0.3448952129381826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408253634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931519,0.00298513,0.00004238213,0.0019963982,0.00017515157,0.0010886855,0.00006180172,0.000013733415,0.00048481402],"genre_scores_gemma":[0.99807924,0.0004633601,0.00013971928,0.00058743265,0.00013346988,0.00046022682,0.000018843675,0.000006737224,0.00011098058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983782,0.0003706049,0.0004076458,0.0003466377,0.0003018242,0.00019504652],"domain_scores_gemma":[0.99793553,0.0013560584,0.00015651532,0.00012368859,0.00029309947,0.00013507938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011590453,0.00014971511,0.00079799,0.00010033587,0.00004595594,0.000004786511,0.000036011214,0.0002683459,0.0003419745],"category_scores_gemma":[0.0007064117,0.00009407887,0.000093618284,0.00018728612,0.00035148722,0.000039711354,0.000060001625,0.00013880272,3.931431e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010355368,0.0014989373,0.55182946,0.00037514308,0.00047480853,0.0000035788048,0.0002093495,0.000002230122,0.0005162642,0.0020940658,0.00003342603,0.43260735],"study_design_scores_gemma":[0.020090804,0.007105811,0.96437865,0.000024303105,0.00058798713,0.000001938156,0.00012114079,0.00036226484,0.00022874161,0.004552123,0.0024677739,0.000078447905],"about_ca_topic_score_codex":0.00022121902,"about_ca_topic_score_gemma":0.00064320525,"teacher_disagreement_score":0.4325289,"about_ca_system_score_codex":0.00017200496,"about_ca_system_score_gemma":0.0004431575,"threshold_uncertainty_score":0.38364246},"labels":[],"label_agreement":null},{"id":"W4408518362","doi":"10.1016/j.ygyno.2025.03.007","title":"Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Winship Cancer Institute; Masonic Cancer Center, University of Minnesota; Medical Center, University of Pittsburgh; Markey Cancer Center, University of Kentucky; Moores Cancer Center, UC San Diego Health; University of Alabama; National Cancer Institute; Cancer Center, University of Colorado; Emory University; University of Kentucky; University of Rochester; Chao Family Comprehensive Cancer Center; Case Comprehensive Cancer Center, Case Western Reserve University; Abramson Cancer Center; Indiana University; University of Arkansas for Medical Sciences; University of Minnesota; University of Pennsylvania; University of Wisconsin Carbone Cancer Center; Houston Methodist Hospital; Mayo Clinic; Loyola Medicine","keywords":"Medicine; Cervical cancer; Randomized controlled trial; Cisplatin; Oncology; Internal medicine; Urology; Cancer; Chemotherapy","score_opus":0.027712189824755058,"score_gpt":0.3761694282054406,"score_spread":0.34845723838068554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408518362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677398,0.000729968,0.007828549,0.011307519,0.0013432053,0.008514374,0.00036707325,0.00006525987,0.002104251],"genre_scores_gemma":[0.98586327,0.0003247243,0.008329911,0.0019040515,0.00036497842,0.002180384,0.00054545666,0.000012209643,0.0004749974],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99752057,0.00026928616,0.0011921558,0.0005461262,0.00018963063,0.00028220666],"domain_scores_gemma":[0.9943113,0.0044519445,0.0005415949,0.00022236751,0.0002942932,0.00017850891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009852984,0.00023265115,0.0018124974,0.00027155736,0.00008156169,0.000010709495,0.00010464005,0.00033579522,0.00019166239],"category_scores_gemma":[0.0051963087,0.00017698135,0.00018879646,0.0005756725,0.00014273198,0.00006355787,0.00006593234,0.00016517602,0.0000037205164],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77273405,0.001013041,0.00007770865,0.00004686159,0.00026418953,0.000009661609,0.00013292597,0.00005314465,0.0018025913,0.0004899273,0.00044921032,0.2229267],"study_design_scores_gemma":[0.9721627,0.01202169,0.0012213498,0.00006629602,0.0008773106,0.0000014963668,0.00006924361,0.00144163,0.0028484513,0.005109185,0.0040402347,0.000140414],"about_ca_topic_score_codex":0.00051346753,"about_ca_topic_score_gemma":0.00046422638,"teacher_disagreement_score":0.22278629,"about_ca_system_score_codex":0.0005615536,"about_ca_system_score_gemma":0.00080023956,"threshold_uncertainty_score":0.721709},"labels":[],"label_agreement":null},{"id":"W4408575377","doi":"10.1016/j.ygyno.2025.03.008","title":"Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario","funders":"Cancer Care Ontario","keywords":"Medicine; Observational study; Vaccination; Cervical cancer; Population; Cochrane Library; Meta-analysis; HPV infection; Systematic review; Demography; MEDLINE; Relative risk; Gynecology; Cancer; Internal medicine; Environmental health; Confidence interval; Immunology","score_opus":0.303914501453571,"score_gpt":0.5224103502438978,"score_spread":0.2184958487903268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408575377","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009342486,0.99260026,0.000054645265,0.00038645655,0.00011419791,0.005218902,0.0007244739,0.000023841227,0.0007838239],"genre_scores_gemma":[0.00472823,0.9936602,0.00020113557,0.00016147424,0.00008324413,0.00057000754,0.00048326323,0.00002052906,0.00009191691],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99507743,0.0016037144,0.0017849926,0.0006935602,0.0005081854,0.00033209426],"domain_scores_gemma":[0.98960084,0.0076720375,0.0011087299,0.000917006,0.00057946786,0.00012194519],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027737443,0.00039800582,0.004564352,0.00028339287,0.0001418794,0.000012202887,0.0005027535,0.0004917667,0.0009372136],"category_scores_gemma":[0.0068122763,0.00020976334,0.0002817179,0.000645354,0.00015506461,0.000071303104,0.000824878,0.00072734273,0.0000010869522],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038663104,0.00010082344,0.000177414,0.60806656,0.00044451733,0.0000036712806,0.000034477056,0.000009826246,2.5868083e-8,0.00006687825,0.0001895425,0.3908676],"study_design_scores_gemma":[0.002864244,0.0063475487,0.063185126,0.871595,0.036235645,0.00018248241,0.0003131978,0.013376663,7.0019803e-7,0.0006182068,0.0045428653,0.0007382971],"about_ca_topic_score_codex":0.00020764387,"about_ca_topic_score_gemma":0.00009423278,"teacher_disagreement_score":0.3901293,"about_ca_system_score_codex":0.00080650166,"about_ca_system_score_gemma":0.0011206025,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W4408780557","doi":"10.1016/j.ygyno.2025.03.022","title":"Comparative efficacy and safety of low-dose versus high-dose bevacizumab in ovarian cancer: An indirect treatment comparison","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Bevacizumab; Ovarian cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.10881160243309326,"score_gpt":0.4425460591949762,"score_spread":0.33373445676188296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408780557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009567298,0.9791642,0.000001295246,0.0004109711,0.0014437472,0.0054094866,0.00042367724,0.00005606179,0.0035232555],"genre_scores_gemma":[0.032852963,0.9634785,0.0005817847,0.00006850964,0.00014577442,0.0019095971,0.0006974876,0.00003374575,0.00023164625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955283,0.0010046954,0.0015035493,0.0011446777,0.00020616862,0.00061261136],"domain_scores_gemma":[0.9939455,0.004064312,0.00092405564,0.0006827456,0.00010511842,0.00027826475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035033515,0.0008474689,0.007603603,0.00059776474,0.000113570946,0.000016399948,0.00024006094,0.0009887277,0.0004936354],"category_scores_gemma":[0.0001646606,0.0006212147,0.00035604037,0.00069893216,0.0003014103,0.00005810628,0.00015734031,0.0005680705,0.000021684864],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032401467,0.007343355,0.0011809734,0.00424443,0.0021435823,0.00040948766,0.0006492084,0.000028156637,5.501102e-7,0.0003405616,0.00032269864,0.9800969],"study_design_scores_gemma":[0.06007533,0.030796403,0.060407933,0.0096467985,0.010176882,0.000045190973,0.00029571884,0.000021733957,0.000025006786,0.000037226502,0.8276941,0.0007776812],"about_ca_topic_score_codex":0.0012792612,"about_ca_topic_score_gemma":0.007188273,"teacher_disagreement_score":0.97931916,"about_ca_system_score_codex":0.005704416,"about_ca_system_score_gemma":0.0041775056,"threshold_uncertainty_score":0.9996239},"labels":[],"label_agreement":null},{"id":"W4408851570","doi":"10.1016/j.ygyno.2025.03.018","title":"ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Medicine; Nova (rocket); Oncology; Ovarian cancer; Term (time); Gynecology; Internal medicine; Cancer","score_opus":0.06785633356941483,"score_gpt":0.40835887318693526,"score_spread":0.3405025396175204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408851570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950563,0.0018371268,0.00017617398,0.008850152,0.004974256,0.0017020635,0.000030482031,0.000059715323,0.03180699],"genre_scores_gemma":[0.9939815,0.0035336618,0.0003477303,0.0010392793,0.0002530179,0.00026595904,0.000033416836,0.000012507379,0.0005329676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978267,0.00038814498,0.0007827211,0.0004530034,0.00016563841,0.00038379326],"domain_scores_gemma":[0.9982185,0.0009951941,0.00025827438,0.00031091823,0.00012111279,0.00009600649],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009671767,0.00020613898,0.0009613004,0.000311373,0.000055447876,0.0000060376105,0.00014225557,0.00042383763,0.0013025363],"category_scores_gemma":[0.0004067294,0.00018518053,0.00009712939,0.00048840244,0.00032017988,0.00004424897,0.00009914217,0.0004512019,0.0000074221434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0966966,0.0028980917,0.36373648,0.00033941242,0.00039107658,0.00023333963,0.0005119093,0.000022655659,0.0028646023,0.009424574,0.0030677167,0.51981354],"study_design_scores_gemma":[0.16431986,0.0059692753,0.79212105,0.00023976843,0.00016308649,0.00002312399,0.00013721365,0.00003670776,0.00095022534,0.001424454,0.034373093,0.0002421435],"about_ca_topic_score_codex":0.0001773115,"about_ca_topic_score_gemma":0.0032219077,"teacher_disagreement_score":0.5195714,"about_ca_system_score_codex":0.00095129985,"about_ca_system_score_gemma":0.0010876274,"threshold_uncertainty_score":0.9996104},"labels":[],"label_agreement":null},{"id":"W4409311003","doi":"10.1016/j.ygyno.2025.03.039","title":"The use of indocyanine green (ICG) for sentinel lymph node detection in vulvar cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Medicine; Indocyanine green; Vulvar cancer; Sentinel lymph node; Vulvar neoplasm; Lymph node; Radiology; Cancer; Pathology; Carcinoma; Internal medicine; Breast cancer","score_opus":0.05892365380486989,"score_gpt":0.35162198786727183,"score_spread":0.2926983340624019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409311003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955685,0.0007109231,0.00023355626,0.005771226,0.00088857056,0.0009547969,0.00002014885,0.000033706616,0.0018302521],"genre_scores_gemma":[0.99331844,0.00051910843,0.0003880512,0.002183687,0.00010069129,0.0006890794,0.000011073677,0.000008346526,0.0027815392],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988977,0.00010373211,0.00039462763,0.00022751531,0.00008891628,0.00028750868],"domain_scores_gemma":[0.9972984,0.0022055947,0.00014412779,0.00017750902,0.00012952172,0.00004480638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025942296,0.000118324046,0.00044721764,0.00016159247,0.000088211316,0.0000059375093,0.00009394411,0.00020391196,0.00009886428],"category_scores_gemma":[0.0010020523,0.00007373059,0.00010242816,0.0005194588,0.000106306456,0.000034586832,0.000063385414,0.00012407496,0.0000043128894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038043817,0.00080965477,0.45636058,0.00016877124,0.00032371486,0.000034240653,0.000053622003,0.00009418548,0.00575658,0.0004741583,0.0005773344,0.5315428],"study_design_scores_gemma":[0.013242081,0.0008407244,0.90404123,0.00003957333,0.00027125934,0.000006824591,0.00006716535,0.00058346696,0.0038952325,0.0010520852,0.07586879,0.000091570175],"about_ca_topic_score_codex":0.0015996291,"about_ca_topic_score_gemma":0.002570022,"teacher_disagreement_score":0.5314512,"about_ca_system_score_codex":0.0006648071,"about_ca_system_score_gemma":0.00030332417,"threshold_uncertainty_score":0.30066463},"labels":[],"label_agreement":null},{"id":"W4409322410","doi":"10.1016/j.ygyno.2025.02.020","title":"Ensuring relevance and equity in patient reported outcomes (PROs) in endometrial cancer: The SGO promote study (Patient Reported Outcomes Measurement Opportunities Through Equity)","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Equity (law); Endometrial cancer; Relevance (law); Clinical significance; Family medicine; Gynecology; Internal medicine; Cancer","score_opus":0.23648872817552277,"score_gpt":0.42255282685808015,"score_spread":0.18606409868255738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409322410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973544,0.0021198199,0.000006910352,0.006486991,0.001926829,0.0054497356,0.000012162356,0.000098250996,0.010355292],"genre_scores_gemma":[0.9944984,0.0009206867,0.00018435177,0.0019532645,0.000044337892,0.002027666,0.0000094148245,0.000021129203,0.00034079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944592,0.0007016194,0.0021077774,0.00094328995,0.00095068984,0.0008373927],"domain_scores_gemma":[0.9961029,0.0018435728,0.00086685485,0.0007061567,0.00033117368,0.00014933347],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025562015,0.00047775017,0.0018453606,0.0006009003,0.00020476797,0.000039716848,0.00025728598,0.0002979491,0.000120490484],"category_scores_gemma":[0.0104552135,0.00029707677,0.00018664102,0.0014546067,0.00023888981,0.00013162446,0.00096186437,0.0006677135,0.0000020189198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016606412,0.00427944,0.78024596,0.000111767746,0.00080477685,0.0029375385,0.0015842716,0.000039040566,0.00017269408,0.00017070676,0.00009398548,0.20789918],"study_design_scores_gemma":[0.022667995,0.007643948,0.9547788,0.00017577595,0.000619082,0.00004514064,0.0035107667,0.000013408149,0.00048787994,0.00228403,0.007437476,0.0003356843],"about_ca_topic_score_codex":0.0036217335,"about_ca_topic_score_gemma":0.010299619,"teacher_disagreement_score":0.20756349,"about_ca_system_score_codex":0.0037277513,"about_ca_system_score_gemma":0.001220585,"threshold_uncertainty_score":0.99994814},"labels":[],"label_agreement":null},{"id":"W4409742164","doi":"10.1016/j.ygyno.2025.04.583","title":"Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Sunnybrook Health Science Centre","funders":"National Institutes of Health; Wellcome Trust; Howard Hughes Medical Institute","keywords":"Medicine; Mesonephric duct; Female circumcision; Adenocarcinoma; Genital tract; Gynecology; Pathology; Internal medicine; Physiology; Cancer; Kidney","score_opus":0.1344649058981779,"score_gpt":0.42915876991963814,"score_spread":0.29469386402146025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409742164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002652083,0.988164,0.000006595397,0.0014656017,0.0025685,0.0032167654,0.00021776218,0.000051871084,0.0016568361],"genre_scores_gemma":[0.0056248354,0.98798305,0.0009277616,0.0029907618,0.00016137188,0.0013572185,0.0000653429,0.00004189989,0.00084773835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957807,0.0007217493,0.0017154792,0.0009700324,0.00026726341,0.0005447582],"domain_scores_gemma":[0.98977053,0.007796764,0.0011209879,0.0010155896,0.00012667471,0.00016944874],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008891917,0.0007016244,0.004770802,0.00018928223,0.00014484467,0.000017605116,0.00048017214,0.001713692,0.00023224235],"category_scores_gemma":[0.0007648582,0.00037373378,0.0015127667,0.0004403661,0.0006162117,0.000030983738,0.00049631007,0.0011124724,0.000024582941],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001744629,0.0031416107,0.29220542,0.0029030081,0.0009452753,0.00030836565,0.00003429445,8.285983e-8,5.2501406e-8,0.00038944295,0.00080379285,0.69925123],"study_design_scores_gemma":[0.0020392,0.0019801508,0.33831486,0.0010915551,0.008166995,0.0003314209,0.00003901522,4.6985485e-7,3.6144235e-7,0.00005885384,0.6477507,0.00022644964],"about_ca_topic_score_codex":0.000022405848,"about_ca_topic_score_gemma":0.0000548402,"teacher_disagreement_score":0.69902474,"about_ca_system_score_codex":0.00056512654,"about_ca_system_score_gemma":0.0021682088,"threshold_uncertainty_score":0.99987143},"labels":[],"label_agreement":null},{"id":"W4409889205","doi":"10.1016/j.ygyno.2025.04.580","title":"Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck; AstraZeneca","keywords":"Olaparib; Medicine; Ovarian cancer; Germline; Oncology; Internal medicine; Germline mutation; BRCA mutation; Mutation; Cancer; Poly ADP ribose polymerase; Genetics; Gene; Biology","score_opus":0.038635838531484425,"score_gpt":0.3417833927683687,"score_spread":0.3031475542368843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409889205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97373605,0.00015143435,0.0004661411,0.018393246,0.0019492834,0.0026515329,0.00030859144,0.00007643707,0.0022673092],"genre_scores_gemma":[0.9865623,0.00035593772,0.0019761333,0.008719109,0.0004659822,0.00050247903,0.0003181661,0.000027101998,0.0010727512],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971937,0.00060000777,0.0007717082,0.0007187404,0.00027895483,0.00043686776],"domain_scores_gemma":[0.9961444,0.0026433752,0.00045675828,0.00039387558,0.00027638202,0.00008520257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000731965,0.00031088688,0.00081336516,0.00012779028,0.0001694092,0.000026232432,0.00015293107,0.00038582712,0.00024449016],"category_scores_gemma":[0.00078800356,0.00019150885,0.00006859344,0.0003852798,0.00034981122,0.00010197638,0.00005449196,0.0006126023,0.0000068703653],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83758,0.0015040858,0.10044809,0.00002731529,0.00057968555,0.00021226199,0.0027519802,0.00037263334,0.00014129162,0.001034024,0.0074685807,0.047880054],"study_design_scores_gemma":[0.32644817,0.00554193,0.6509416,0.00026524212,0.0000705838,0.00000935963,0.00025082327,0.00044562327,0.000072559465,0.000845498,0.014882945,0.00022567171],"about_ca_topic_score_codex":0.001215935,"about_ca_topic_score_gemma":0.0038370697,"teacher_disagreement_score":0.55049354,"about_ca_system_score_codex":0.0009859877,"about_ca_system_score_gemma":0.0011619417,"threshold_uncertainty_score":0.7809504},"labels":[],"label_agreement":null},{"id":"W4410840565","doi":"10.1016/j.ygyno.2025.05.016","title":"Combined genomic and molecular analysis defines prognostic markers of relapse in stage IA-IC1 clear cell ovarian carcinoma","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Institute of Genetics; Cancer Research UK","keywords":"Medicine; Stage (stratigraphy); Oncology; Ovarian carcinoma; Internal medicine; Ovarian cancer; Gynecology; Cancer; Biology","score_opus":0.006279922373374964,"score_gpt":0.25855150989458375,"score_spread":0.25227158752120876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410840565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925007,0.0013260286,0.0005490628,0.00028770807,0.00011791442,0.00030518064,0.00001677308,0.000011512892,0.0048851003],"genre_scores_gemma":[0.9964593,0.00022889416,0.0021433935,0.0003968954,0.00001065857,0.000044876535,0.00006734899,0.00001104382,0.0006376092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859905,0.00022248615,0.00039836866,0.000444613,0.00006152398,0.0002739322],"domain_scores_gemma":[0.99928206,0.00012249508,0.00015876553,0.000317892,0.00006624425,0.000052530497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003571653,0.000169217,0.00043486137,0.00017262822,0.000048751135,0.0000086582095,0.00018509608,0.00034070417,0.000052967156],"category_scores_gemma":[0.00022525107,0.00016520082,0.00012267542,0.0003715745,0.00016167005,0.0000022307333,0.00019099178,0.00013378533,0.0000019931365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011165631,0.0005436803,0.51437837,0.00024682784,0.00056108943,0.00009651151,0.00011233462,0.005028997,0.47204345,0.00059653027,0.0006656165,0.0046100244],"study_design_scores_gemma":[0.005745625,0.004307902,0.93870044,0.000024823084,0.0009447749,0.00000669087,0.00070737884,0.008916486,0.034325764,0.0007815841,0.005012397,0.0005261578],"about_ca_topic_score_codex":0.00016207734,"about_ca_topic_score_gemma":0.00047184082,"teacher_disagreement_score":0.4377177,"about_ca_system_score_codex":0.00008512497,"about_ca_system_score_gemma":0.00029185574,"threshold_uncertainty_score":0.6736694},"labels":[],"label_agreement":null},{"id":"W4410945979","doi":"10.1016/j.ygyno.2025.04.578","title":"OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Daiichi Sankyo Europe; Natera; Seagen; Eisai; BeiGene; National Institutes of Health; Novocure; AstraZeneca; Pfizer; Imunon","keywords":"Medicine; Debulking; Internal medicine; Carboplatin; Clinical endpoint; Chemotherapy; Ovarian cancer; Adjuvant; Gastroenterology; Randomized controlled trial; Urology; Oncology; Phases of clinical research; Surgery; Cancer; Cisplatin","score_opus":0.0141862198773747,"score_gpt":0.3188930408041692,"score_spread":0.30470682092679446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410945979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894444,0.0033812164,0.00010937539,0.0010404444,0.0004797233,0.0052476954,0.000055313223,0.000048854556,0.00019300073],"genre_scores_gemma":[0.99509794,0.0018032028,0.00031067504,0.0011070078,0.000015944112,0.0008621582,0.000064433254,0.000029235198,0.0007093803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951283,0.0026688997,0.0009772335,0.00057677337,0.00010006378,0.0005487669],"domain_scores_gemma":[0.99421424,0.0043386263,0.0006845447,0.00047225587,0.00027065072,0.000019669991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021277873,0.0004260032,0.0015131026,0.000274339,0.00051426404,0.000013038273,0.0003970077,0.00033328618,0.0005026844],"category_scores_gemma":[0.000626592,0.00023720361,0.00010022857,0.0005232417,0.0008915648,0.00010804669,0.000108471315,0.00049634237,0.0000037307989],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5481503,0.0067065815,0.008925492,0.000009365478,0.001399641,0.000009056152,0.005546864,0.00022541678,0.03277901,0.00007265093,0.00003519449,0.39614046],"study_design_scores_gemma":[0.73707914,0.03949553,0.212481,0.000059064645,0.00020963668,0.000007564824,0.0013034978,0.000034602213,0.0054368363,0.000053713018,0.0035315913,0.00030783867],"about_ca_topic_score_codex":0.00058832054,"about_ca_topic_score_gemma":0.00045559823,"teacher_disagreement_score":0.3958326,"about_ca_system_score_codex":0.00020694768,"about_ca_system_score_gemma":0.00069841085,"threshold_uncertainty_score":0.96728826},"labels":[],"label_agreement":null},{"id":"W4411049391","doi":"10.1016/j.ygyno.2025.05.013","title":"Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Calgary; Alberta Health Services; University of British Columbia; Alberta Health; BC Cancer Agency; Foothills Medical Centre","funders":"Medical Research and Materiel Command; European Social Fund; National Center for Advancing Translational Sciences; National Cancer Institute; Cancer Research UK Cambridge Institute, University of Cambridge; Instituto de Salud Carlos III; National Health and Medical Research Council; National Institutes of Health; Peter MacCallum Foundation; National Center for Research Resources; BC Cancer Foundation; Deutsches Krebsforschungszentrum; Pomorski Uniwersytet Medyczny W Szczecinie; European Regional Development Fund; Swedish Cancer Foundation; Bundesministerium für Bildung und Forschung; Canadian Institutes of Health Research; Cancer Institute NSW; Ministry of Higher Education, Malaysia; Fred C. and Katherine B. Andersen Foundation; VGH and UBC Hospital Foundation; Ministerio de Ciencia, Innovación y Universidades; U.S. Department of Defense; Universitätsbund Erlangen-Nürnberg; Ministerio de Economía y Competitividad; University of Cambridge; University of Pittsburgh; Mayo Foundation for Medical Education and Research; Kræftens Bekæmpelse; Cancer Research UK; American Cancer Society; Minnesota Ovarian Cancer Alliance; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Ovarian Cancer Research Fund; Ovarian Cancer Australia; European Commission","keywords":"Medicine; Oncology; Internal medicine; Estrogen receptor; Ovarian cancer; Odds ratio; Proportional hazards model; Cancer; Endocrinology; Gynecology; Breast cancer","score_opus":0.015697954783322778,"score_gpt":0.32793359437747827,"score_spread":0.3122356395941555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411049391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97789705,0.0023450134,0.0009989755,0.013345161,0.0010970103,0.0016828743,0.0006258237,0.00018347603,0.0018245911],"genre_scores_gemma":[0.98749495,0.0016647343,0.0037864237,0.0034633777,0.0003547657,0.0014077312,0.00017454183,0.000037515903,0.0016159822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497294,0.0010159198,0.0010547068,0.0016098575,0.00041938626,0.00092718797],"domain_scores_gemma":[0.9958395,0.0014747164,0.00086546066,0.0007158891,0.00042174305,0.0006827248],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001581268,0.00059326034,0.002484884,0.0012013844,0.0005668451,0.0001513953,0.00020319918,0.000500058,0.0022234542],"category_scores_gemma":[0.0010069044,0.0005157989,0.00029350785,0.0030705302,0.00017081473,0.00019819863,0.0002743033,0.00054786564,0.000016169795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007080472,0.00076893496,0.9505009,0.000042930893,0.01348136,0.00024470285,0.0005116686,0.00035643918,0.0033693414,0.0002437263,0.0021304549,0.027641496],"study_design_scores_gemma":[0.0056912615,0.0013182479,0.9359797,0.000043823704,0.033782102,0.000009566748,0.0013803851,0.00075095455,0.0015932806,0.000120734505,0.018817646,0.0005122645],"about_ca_topic_score_codex":0.008982564,"about_ca_topic_score_gemma":0.012371819,"teacher_disagreement_score":0.027129231,"about_ca_system_score_codex":0.0024353757,"about_ca_system_score_gemma":0.0010135707,"threshold_uncertainty_score":0.99972934},"labels":[],"label_agreement":null},{"id":"W4411118608","doi":"10.1016/j.ygyno.2025.05.021","title":"Association of frailty with perioperative and survival outcomes in patients with gynecologic cancers: A population-based study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute; McMaster University; University of Toronto; McMaster University Medical Centre","funders":"Hamilton Health Sciences Foundation; Ontario Ministry of Health and Long-Term Care; Fondation du cancer des Cèdres; Institute for Clinical Evaluative Sciences; Government of Ontario; Hamilton Health Sciences","keywords":"Medicine; Perioperative; Association (psychology); Population; Oncology; Gynecologic cancer; Internal medicine; Surgery; Cancer; Ovarian cancer; Environmental health","score_opus":0.013553742178525743,"score_gpt":0.3064418662890615,"score_spread":0.2928881241105358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411118608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929368,0.00001683112,0.000022267126,0.0021870525,0.00021636108,0.0022051313,0.000021315773,0.000044637934,0.00234963],"genre_scores_gemma":[0.9968425,0.00000251293,0.0009391372,0.0007122085,0.000008775201,0.00025357545,0.000051740633,0.000011564115,0.001177992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808645,0.00039085167,0.00045981255,0.00043701523,0.0002983986,0.00032746783],"domain_scores_gemma":[0.9971547,0.0018664077,0.00032033474,0.0002374956,0.00035926152,0.00006176357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004512505,0.00023512468,0.0009973855,0.00025695312,0.00008231134,0.000010521324,0.000098120356,0.0002626119,0.000216146],"category_scores_gemma":[0.0017025728,0.0001558838,0.000034576526,0.00045847462,0.00009269719,0.00007687681,0.000051287145,0.00031446683,0.0000022447744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008587193,0.0021451449,0.992959,0.000044561817,0.0002770954,0.00002564194,0.0005631231,0.00035399862,0.000004355431,0.000034432887,0.000042809792,0.0026910661],"study_design_scores_gemma":[0.018448524,0.012822699,0.96680224,0.000041732437,0.00021764947,3.2530784e-7,0.0012107051,0.00010734459,0.0000091104,0.000024726181,0.0001675163,0.00014742753],"about_ca_topic_score_codex":0.0010614713,"about_ca_topic_score_gemma":0.044501603,"teacher_disagreement_score":0.04344013,"about_ca_system_score_codex":0.0022918407,"about_ca_system_score_gemma":0.00071061763,"threshold_uncertainty_score":0.97293377},"labels":[],"label_agreement":null},{"id":"W4411230311","doi":"10.1016/j.ygyno.2025.05.024","title":"Definitive intensity-modulated radiotherapy for organ preservation in vulvar cancer: A multicenter study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Vulvar cancer; Radiation therapy; Multicenter study; Radiology; Cancer; Surgery; Internal medicine; Randomized controlled trial","score_opus":0.045826639538616265,"score_gpt":0.38810432073505247,"score_spread":0.3422776811964362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411230311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889199,0.00047090856,0.00020406272,0.004414893,0.0007633636,0.0035335491,0.000015410178,0.000063035346,0.0016148417],"genre_scores_gemma":[0.99175346,0.00021574067,0.00096353993,0.004827923,0.00007605025,0.0012827051,0.000039084174,0.00001190257,0.00082962046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986847,0.00015403297,0.00037328302,0.0003849952,0.00009109331,0.0003118929],"domain_scores_gemma":[0.9984804,0.00093536364,0.000100787,0.00017234433,0.0002497526,0.00006138115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030619345,0.00016128925,0.00065702986,0.00027316605,0.00006519772,0.0000076107744,0.00010009644,0.0002080297,0.00033990864],"category_scores_gemma":[0.0009620047,0.0001238734,0.000075539225,0.0006677893,0.00005489735,0.00005285775,0.000050765724,0.00019056194,0.00000649345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007349232,0.0048553133,0.9339504,0.00006108771,0.00059857115,0.00010674512,0.0012283,0.000033262088,0.001351632,0.000094835275,0.00052626,0.049844343],"study_design_scores_gemma":[0.033668105,0.0077953315,0.9469283,0.000039813218,0.00026316362,0.0000020362932,0.00091024616,0.00053490495,0.00055910833,0.0006097996,0.008572311,0.000116884854],"about_ca_topic_score_codex":0.00075608894,"about_ca_topic_score_gemma":0.0028104025,"teacher_disagreement_score":0.04972746,"about_ca_system_score_codex":0.0013614794,"about_ca_system_score_gemma":0.0002661298,"threshold_uncertainty_score":0.505141},"labels":[],"label_agreement":null},{"id":"W4411871296","doi":"10.1016/j.ygyno.2025.06.015","title":"Oncologic and fertility outcomes of progestin therapy for atypical hyperplasia and grade 1 cancer of the endometrium: Results of a specialized oncofertility program","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital; University Health Network; CReATe Fertility Centre; Sunnybrook Health Science Centre; Sinai Health System","funders":"","keywords":"Oncofertility; Medicine; Progestin; Fertility preservation; Gynecology; Fertility; Endometrium; Oncology; Endometrial cancer; Cancer; Obstetrics; Internal medicine; Estrogen; Population; Environmental health","score_opus":0.060392996931631894,"score_gpt":0.4047583202090009,"score_spread":0.34436532327736896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411871296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743933,0.002047807,0.0000055088644,0.004700986,0.00033852184,0.003919604,0.00013984513,0.00002835953,0.0013800341],"genre_scores_gemma":[0.99593335,0.0006155401,0.00218374,0.0003373201,0.00002321263,0.0007000243,0.000008444884,0.0000065746176,0.00019180727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979554,0.0003106631,0.0008594595,0.00040791885,0.00018640471,0.00028016407],"domain_scores_gemma":[0.99482715,0.004061244,0.000453572,0.00030738462,0.0002653868,0.00008528603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007382843,0.00020359555,0.0013775534,0.00015369592,0.00006451184,0.000003296927,0.00016272608,0.00033143794,0.000051671825],"category_scores_gemma":[0.0048078564,0.00011021276,0.00021947971,0.00071553595,0.00084564986,0.000023165641,0.00014285573,0.00018561148,1.3355994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021686302,0.0036129563,0.7110303,0.00028572505,0.00037022866,0.000002874558,0.00010544895,5.9422626e-7,0.0023165455,0.0002604272,0.00010640897,0.2602222],"study_design_scores_gemma":[0.023226248,0.0085671535,0.9487061,0.000041491403,0.00033345885,0.0000041545786,0.00008215875,0.000015085987,0.011679602,0.0018700617,0.0054035243,0.00007096362],"about_ca_topic_score_codex":0.00024838824,"about_ca_topic_score_gemma":0.00036415708,"teacher_disagreement_score":0.26015124,"about_ca_system_score_codex":0.00023522749,"about_ca_system_score_gemma":0.00057535246,"threshold_uncertainty_score":0.57558006},"labels":[],"label_agreement":null},{"id":"W4411871304","doi":"10.1016/j.ygyno.2025.06.003","title":"Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Placebo; Double blind; Internal medicine; Alternative medicine; Cancer","score_opus":0.041959950357662014,"score_gpt":0.37561186101468613,"score_spread":0.3336519106570241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411871304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98066807,0.0020530075,0.00013130058,0.0025012863,0.0011939405,0.012668669,0.000059960228,0.00008546141,0.00063828065],"genre_scores_gemma":[0.9897793,0.00066026195,0.00015911771,0.0017152897,0.00009442522,0.007352917,0.00005754351,0.00003298733,0.0001481828],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944207,0.0013467438,0.0019431947,0.0008955121,0.00058718305,0.0008066679],"domain_scores_gemma":[0.98984426,0.0077382065,0.0011622004,0.0006860329,0.000327506,0.00024178733],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010212804,0.0005948406,0.004641965,0.0002789029,0.00015676774,0.000022011485,0.00034133127,0.0003760734,0.0011649407],"category_scores_gemma":[0.0015262127,0.0003085564,0.0003718571,0.0009487378,0.00043291735,0.000076294404,0.00013214893,0.0007216048,0.0000080893815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83364487,0.009392561,0.08252098,0.000032499996,0.004512007,0.00029834962,0.001478377,0.0010076328,0.000056702447,0.00006188871,0.00005409828,0.06694004],"study_design_scores_gemma":[0.9386672,0.010772935,0.0437607,0.00008679861,0.0034994201,0.0000043604437,0.0016050878,0.0005447502,0.00032271055,0.00015295156,0.00031116558,0.0002719485],"about_ca_topic_score_codex":0.007280708,"about_ca_topic_score_gemma":0.012527882,"teacher_disagreement_score":0.105022304,"about_ca_system_score_codex":0.0013342376,"about_ca_system_score_gemma":0.0014336248,"threshold_uncertainty_score":0.99993664},"labels":[],"label_agreement":null},{"id":"W4412581556","doi":"10.1016/j.ygyno.2025.06.016","title":"Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"ImmunoGen; AbbVie","keywords":"Medicine; Pembrolizumab; Ovarian cancer; Conjugate; Folate receptor; Antibody; Drug; Antibody-drug conjugate; Oncology; Internal medicine; Monoclonal antibody; Cancer research; Cancer; Pharmacology; Immunology; Immunotherapy; Cancer cell","score_opus":0.006874718684096245,"score_gpt":0.27977110662065596,"score_spread":0.27289638793655974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412581556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922928,0.0006090045,0.000030935207,0.0033003534,0.00019053648,0.0017439672,0.00005643362,0.000030999297,0.0017449586],"genre_scores_gemma":[0.9971055,0.0004051043,0.0016628599,0.0003706546,0.000014416737,0.00013007264,0.00017388668,0.00002173602,0.000115785835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790376,0.00022942794,0.0006806233,0.00056255114,0.00019735005,0.00042625994],"domain_scores_gemma":[0.9984753,0.00065018516,0.00035757245,0.00022469727,0.00020494884,0.00008727763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003991478,0.0002895909,0.00099862,0.0003316323,0.00007867598,0.000012626209,0.000089545494,0.00020762288,0.00015330658],"category_scores_gemma":[0.0001839131,0.00020939439,0.00003768411,0.00061498734,0.0001908541,0.00009234514,0.00006198866,0.0003021089,0.0000021792032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017509002,0.003957396,0.95371664,0.00019348293,0.00029694528,0.00013209501,0.00058088265,0.00011794273,0.00031663539,0.0013339807,0.00018795657,0.02165707],"study_design_scores_gemma":[0.065836385,0.006054968,0.9250446,0.0005402259,0.00020109197,0.000002270108,0.00013151883,0.00014716567,0.00020023494,0.000099547535,0.0015530126,0.00018900451],"about_ca_topic_score_codex":0.0011839339,"about_ca_topic_score_gemma":0.004109395,"teacher_disagreement_score":0.048327383,"about_ca_system_score_codex":0.0010555548,"about_ca_system_score_gemma":0.00071274396,"threshold_uncertainty_score":0.8538856},"labels":[],"label_agreement":null},{"id":"W4412827235","doi":"10.1016/j.ygyno.2025.07.011","title":"Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Race (biology); Endometrial cancer; Ethnic group; Incidence (geometry); Relative survival; Gynecology; Oncology; Demography; Cancer; Internal medicine; Cancer registry; Gender studies","score_opus":0.0220336890145757,"score_gpt":0.3241077562378447,"score_spread":0.302074067223269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412827235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829372,0.007494228,0.00004346462,0.0016151873,0.0008401827,0.0008008005,0.00007722086,0.000030173356,0.0061615156],"genre_scores_gemma":[0.9867947,0.004572156,0.00039609725,0.0007060224,0.000092539056,0.00017438558,0.000012554204,0.000010165864,0.007241354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982896,0.0002718978,0.0004039564,0.00048110064,0.00018645005,0.00036701257],"domain_scores_gemma":[0.99683607,0.0024963256,0.00013224453,0.00018344854,0.00013319074,0.00021872745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005484566,0.00019869342,0.00095717714,0.0002949225,0.00008638978,0.000008227465,0.000110725225,0.00030405424,0.0008195696],"category_scores_gemma":[0.001314617,0.00015685895,0.000057743782,0.00084746623,0.0004046721,0.00007247624,0.00017739725,0.00030298435,0.000012151127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013177481,0.0012866075,0.85364914,0.00020461602,0.0010655278,0.00027969576,0.0030889045,0.00003394512,0.008835317,0.0011650394,0.025276287,0.091937445],"study_design_scores_gemma":[0.011406858,0.0053757573,0.9244126,0.0000554143,0.00022300555,0.0000039930615,0.00035375048,0.0000052704795,0.0008016629,0.0007982108,0.056369588,0.0001938853],"about_ca_topic_score_codex":0.0015185226,"about_ca_topic_score_gemma":0.00076864,"teacher_disagreement_score":0.09174356,"about_ca_system_score_codex":0.00134495,"about_ca_system_score_gemma":0.0003143868,"threshold_uncertainty_score":0.8973713},"labels":[],"label_agreement":null},{"id":"W4412992909","doi":"10.1016/j.ygyno.2025.07.027","title":"Optimizing the screening and management of preoperative anemia prior to gynecologic oncology surgery (OPRA1): A quality improvement initiative","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Blood transfusion and management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Gynecologic oncology; Quality management; Anemia; General surgery; Oncology; Internal medicine; Operations management; Management system","score_opus":0.056188974635619726,"score_gpt":0.36353663246208556,"score_spread":0.30734765782646584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412992909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84668046,0.0006508136,0.010235652,0.05452147,0.0009849184,0.0070862356,0.000020219655,0.00017240027,0.07964782],"genre_scores_gemma":[0.95127445,0.0015340379,0.021767195,0.022557953,0.000040898623,0.0012272962,0.00002045327,0.000017979843,0.0015597442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964069,0.00088532845,0.0010626855,0.00075175375,0.00026364854,0.00062964275],"domain_scores_gemma":[0.9946938,0.0040095393,0.00036545022,0.00049679243,0.00025112848,0.00018325598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034008608,0.00034963616,0.0012227265,0.0003450848,0.0003403924,0.000021918848,0.00026853115,0.00034549288,0.00035870302],"category_scores_gemma":[0.0007413165,0.0002405237,0.00019279328,0.0006481467,0.00039538246,0.00007526931,0.0007011003,0.00046941772,0.0000148188155],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035023883,0.0040558744,0.01816535,0.0017202898,0.0023530347,0.00071512954,0.004896978,0.0002951923,0.0023662993,0.016214253,0.012951276,0.93276393],"study_design_scores_gemma":[0.013010921,0.0129852295,0.7574834,0.0004612419,0.0021279387,0.000046278867,0.03326834,0.00024372643,0.0043230737,0.0010602451,0.17425014,0.0007394182],"about_ca_topic_score_codex":0.00010075562,"about_ca_topic_score_gemma":0.0004998496,"teacher_disagreement_score":0.93202454,"about_ca_system_score_codex":0.00054589513,"about_ca_system_score_gemma":0.0004467599,"threshold_uncertainty_score":0.9808272},"labels":[],"label_agreement":null},{"id":"W4413101740","doi":"10.1016/j.ygyno.2025.07.030","title":"Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; McMaster University; Women's College Hospital","funders":"Canadian Cancer Society Research Institute; Peter Gilgan Foundation","keywords":"Ovarian cancer; Medicine; Breast cancer; Oncology; Cancer; Gynecology; Internal medicine; Family history; BRCA mutation; Obstetrics","score_opus":0.007765804059895411,"score_gpt":0.2873327297635537,"score_spread":0.27956692570365826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413101740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465824,0.001962095,0.000426998,0.0074551613,0.0010640007,0.0007323852,0.0003154126,0.00003750316,0.0033481938],"genre_scores_gemma":[0.9826008,0.0010356313,0.0010707893,0.0066253464,0.00022540023,0.0046801344,0.000017499508,0.000030742394,0.0037136625],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780107,0.00022475804,0.00037910367,0.00077999296,0.000111314665,0.0007037644],"domain_scores_gemma":[0.99904364,0.00008627117,0.0001391007,0.00047599853,0.00015222603,0.00010278809],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035324774,0.00028973605,0.0004128792,0.00016660975,0.00009018822,0.000024574507,0.0003619712,0.00051041006,0.002917184],"category_scores_gemma":[0.00008323855,0.00022106974,0.000053051106,0.0005586756,0.00022425319,0.000008222023,0.0002343509,0.0002600665,0.000015371143],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024359044,0.0020658916,0.16246141,0.000272526,0.0019312663,0.0020067373,0.0020816128,0.007141591,0.09426171,0.0005296978,0.022824058,0.68006444],"study_design_scores_gemma":[0.0053197937,0.0014504374,0.77490586,0.00007349829,0.000116577365,0.0002217016,0.0006284317,0.00010154345,0.0014506765,0.00043202387,0.21468633,0.00061310036],"about_ca_topic_score_codex":0.00027670746,"about_ca_topic_score_gemma":0.018164359,"teacher_disagreement_score":0.67945135,"about_ca_system_score_codex":0.0016622422,"about_ca_system_score_gemma":0.003967788,"threshold_uncertainty_score":0.99975157},"labels":[],"label_agreement":null},{"id":"W4413974283","doi":"10.1016/j.ygyno.2025.08.028","title":"Prognosis of HPV-independent, p53-wild-type vulvar squamous cell carcinoma: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Meta-analysis; Vulvar Carcinoma; Oncology; Vulvar neoplasm; Carcinoma; Basal cell; Vulvar cancer; Internal medicine; Dermatology; Gynecology; Vulva","score_opus":0.11931668841373722,"score_gpt":0.41850678324740453,"score_spread":0.2991900948336673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413974283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000023917476,0.9654432,0.00000555515,0.00036372934,0.00010738944,0.009210971,0.00012755825,0.000046461337,0.024692765],"genre_scores_gemma":[0.0040547675,0.9860314,0.0001554071,0.0010535367,0.000037768576,0.0027889155,0.00019158733,0.00003837678,0.005648206],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993026,0.0021274576,0.0023802386,0.0011399264,0.00062520936,0.0007011625],"domain_scores_gemma":[0.99177283,0.004590064,0.0012943039,0.0011763741,0.0008121948,0.0003542275],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002339077,0.0007623714,0.021961516,0.0009813254,0.0000988622,0.000020528405,0.00062455534,0.0011301144,0.016467595],"category_scores_gemma":[0.0031700062,0.0004643616,0.003756616,0.0028714135,0.00023949918,0.00003653447,0.0005607779,0.0011304398,0.000090130474],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020247935,0.00056824775,0.000044175667,0.9465747,0.035264492,0.00021961579,0.000018524444,1.313542e-7,4.8104e-8,0.000036677102,0.0010750074,0.016178127],"study_design_scores_gemma":[0.0005690482,0.0020311773,0.00014526352,0.001610867,0.93800044,0.0000920037,0.000023563643,0.0000015126125,8.95125e-7,0.000018834124,0.057184376,0.0003220412],"about_ca_topic_score_codex":0.000120265235,"about_ca_topic_score_gemma":0.0002559262,"teacher_disagreement_score":0.9449638,"about_ca_system_score_codex":0.0006918908,"about_ca_system_score_gemma":0.002434081,"threshold_uncertainty_score":0.99978083},"labels":[],"label_agreement":null},{"id":"W4414380597","doi":"10.1016/j.ygyno.2025.09.001","title":"Sacituzumab govitecan in Chinese patients with recurrent/metastatic cervical cancer: Results from the phase 2 EVER-132-003 basket study (NCT05119907)","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"Gilead UK and Ireland Corporate Contributions; Gilead Sciences","keywords":"Cervical cancer; Phases of clinical research; Phase (matter); Cancer; Cervical carcinoma","score_opus":0.023596234639539897,"score_gpt":0.3596982165339163,"score_spread":0.3361019818943764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414380597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859825,0.0005673407,0.000015966381,0.0045431354,0.0011947149,0.0031361436,0.00062433176,0.00007487077,0.0038610066],"genre_scores_gemma":[0.9949238,0.00009112549,0.00022268703,0.003062213,0.00013558492,0.000789608,0.0004206112,0.000020698166,0.00033372946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648076,0.0007373546,0.0008686575,0.0008634512,0.00043611723,0.0006136293],"domain_scores_gemma":[0.99528575,0.0034317751,0.0002928468,0.0006324818,0.00016164347,0.00019551483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000552446,0.00042408338,0.0011633843,0.00024170971,0.00017077712,0.000025164461,0.00037611963,0.0001981374,0.0010243191],"category_scores_gemma":[0.0018445163,0.00022345828,0.00012500075,0.0017561624,0.00019321239,0.00008097113,0.00019865582,0.00066558836,0.00004239481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020056903,0.014754234,0.79832447,0.000031683874,0.0005917052,0.00032762365,0.00067056436,0.000019246418,0.000008937168,0.000030388306,0.0015070908,0.16367714],"study_design_scores_gemma":[0.09403631,0.0140407495,0.8825378,0.000073640564,0.0005942811,0.0000019162017,0.00056391786,0.000053862157,0.000006952866,0.0007101271,0.007174766,0.00020566977],"about_ca_topic_score_codex":0.0034463408,"about_ca_topic_score_gemma":0.022549823,"teacher_disagreement_score":0.16347148,"about_ca_system_score_codex":0.0016600942,"about_ca_system_score_gemma":0.00082189665,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W4414464410","doi":"10.1016/j.ygyno.2025.09.006","title":"Real-world utility of Silva pattern in predicting outcomes in cervical adenocarcinoma from a population-based series","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Vancouver General Hospital","funders":"","keywords":"Series (stratigraphy); Adenocarcinoma; Neoplasm staging; Cervical cancer","score_opus":0.03139638171484829,"score_gpt":0.34127871080805305,"score_spread":0.3098823290932048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414464410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894486,0.00014157407,0.00001442078,0.003292151,0.00038749722,0.0006034991,0.00004975544,0.000045484107,0.006017023],"genre_scores_gemma":[0.9982837,0.000021166228,0.00040117337,0.00084271823,0.0000355002,0.00012864548,0.000112530804,0.000007345852,0.00016725184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981307,0.00028075223,0.00073990686,0.0003865491,0.0001549903,0.00030713555],"domain_scores_gemma":[0.9972048,0.0022531124,0.00015990798,0.00026025312,0.000051549257,0.00007037183],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029694408,0.00017304248,0.00097034825,0.00043879804,0.00002947687,0.0000039034057,0.00012506815,0.000261917,0.0009757091],"category_scores_gemma":[0.0009174421,0.00013662889,0.00011299001,0.0008154389,0.00007637216,0.000045485685,0.00008487717,0.0002921092,0.0000055650657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078043726,0.0010130059,0.9819528,0.00008551306,0.00005744316,0.00013008907,0.00006567306,0.00001669089,0.00003481777,0.00006318719,0.00001972231,0.01578063],"study_design_scores_gemma":[0.006924153,0.00083265355,0.98983157,0.00006571494,0.00008684895,6.501019e-7,0.00017243547,0.00045161057,0.00017764719,0.0012940819,0.000081547725,0.00008108811],"about_ca_topic_score_codex":0.025112618,"about_ca_topic_score_gemma":0.07546842,"teacher_disagreement_score":0.050355803,"about_ca_system_score_codex":0.0006712575,"about_ca_system_score_gemma":0.00033965948,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W4414649183","doi":"10.1016/j.ygyno.2025.04.243","title":"Assessing the relationship between KELIM score and response to niraparib first-line maintenance therapy in non-BRCA mutant advanced ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Maintenance therapy; Mutant; Ovarian cancer; Cancer; Overall survival","score_opus":0.08085281568655181,"score_gpt":0.4215503135163501,"score_spread":0.3406974978297983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060819,0.00068650703,0.0012910523,0.08744373,0.00056707056,0.0015717486,0.00001918973,0.000069892034,0.0022688915],"genre_scores_gemma":[0.9839448,0.0005600983,0.001411598,0.012056874,0.00014003196,0.0009535875,0.00001148304,0.000022627313,0.00089894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975573,0.0005405736,0.0006182388,0.0005776232,0.00017010055,0.000536169],"domain_scores_gemma":[0.9922685,0.006769912,0.00020935276,0.0004657243,0.00015656807,0.00012996072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018347759,0.00026024715,0.0006490421,0.00034425018,0.00033156443,0.000040016686,0.00019463668,0.00036135313,0.00016691681],"category_scores_gemma":[0.0024407867,0.00018509044,0.00007167207,0.0010279646,0.0003003537,0.00013503159,0.00009907459,0.0006834251,0.000013218747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035856925,0.00020399722,0.89877665,0.000040167342,0.000076823024,0.0001377007,0.0010022371,0.00039756473,0.0056572747,0.00069872756,0.0011581759,0.088264994],"study_design_scores_gemma":[0.007671444,0.0014709571,0.9513429,0.00032797016,0.000038419705,0.000022322889,0.00047485108,0.00009354417,0.00067077874,0.003416199,0.03429004,0.00018059998],"about_ca_topic_score_codex":0.00012733808,"about_ca_topic_score_gemma":0.0008277634,"teacher_disagreement_score":0.0880844,"about_ca_system_score_codex":0.001509556,"about_ca_system_score_gemma":0.0010248113,"threshold_uncertainty_score":0.7547769},"labels":[],"label_agreement":null},{"id":"W4414649215","doi":"10.1016/j.ygyno.2025.04.380","title":"Tranexamic acid use in advanced ovarian cancer patients undergoing cytoreductive surgery: A quality improvement study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Tranexamic acid; Ovarian cancer; Cytoreductive surgery; Quality management; Quality of life (healthcare)","score_opus":0.033937608329052904,"score_gpt":0.3470935976615319,"score_spread":0.313155989332479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940688,0.00011872083,0.000058777558,0.0012439624,0.0012113368,0.0024198357,0.000016790163,0.00006774677,0.00079404726],"genre_scores_gemma":[0.9974939,0.00016047539,0.00022691989,0.0012782974,0.000033775956,0.00056562974,0.000032411303,0.000014309642,0.00019423431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764544,0.00039371615,0.0006834355,0.0006200855,0.00018426977,0.00047307424],"domain_scores_gemma":[0.9980857,0.0012300473,0.00016435463,0.00028637765,0.00014179763,0.00009174986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006823315,0.0002366711,0.00087655697,0.00028681676,0.00010923497,0.000012707588,0.00009926573,0.00025721008,0.00016578697],"category_scores_gemma":[0.0006638352,0.00019905817,0.00011838245,0.00050954736,0.000082588944,0.00013180716,0.000064730295,0.00039525938,0.000005431678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012091113,0.007103529,0.87238663,0.00009299834,0.00020870208,0.00009433078,0.00087348605,0.000016926559,0.0040694373,0.00014668364,0.000070457245,0.11372773],"study_design_scores_gemma":[0.011769822,0.004185645,0.9800279,0.00006791247,0.00019210577,0.0000014043188,0.0018693007,0.000011628603,0.0008202812,0.00027980297,0.00060035184,0.00017385892],"about_ca_topic_score_codex":0.001552019,"about_ca_topic_score_gemma":0.024259988,"teacher_disagreement_score":0.113553874,"about_ca_system_score_codex":0.0011359529,"about_ca_system_score_gemma":0.000739956,"threshold_uncertainty_score":0.9935447},"labels":[],"label_agreement":null},{"id":"W4414649221","doi":"10.1016/j.ygyno.2025.04.271","title":"High concordance between immunohistochemistry and next generation sequencing for determining TP53 mutation status in endometrial cancer: A post hoc analysis of the ENGOT-EN5/GOG-3055/SIENDO study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Concordance; Post-hoc analysis; DNA sequencing; Immunohistochemistry; Post hoc","score_opus":0.03465561186666487,"score_gpt":0.33777516545035924,"score_spread":0.30311955358369436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637544,0.0013568129,0.0004283132,0.00014315598,0.000531517,0.0008504613,0.00023077402,0.0000053388526,0.00007817346],"genre_scores_gemma":[0.99775374,0.00041497537,0.0007746552,0.0002706075,0.00016132343,0.00035526688,0.00021580969,0.000009151591,0.000044473094],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985468,0.00014177548,0.0005192713,0.00043485247,0.00007671283,0.00028059055],"domain_scores_gemma":[0.99843377,0.0007297761,0.00034793184,0.00028112993,0.0001682492,0.00003914731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043114612,0.0001626993,0.000496583,0.00019606152,0.00013043964,0.000024171368,0.00019511383,0.00022352733,0.000009944092],"category_scores_gemma":[0.0014644915,0.00014661717,0.00011687261,0.0005233372,0.0001222058,0.0000060020443,0.00017361717,0.00011962934,1.06553706e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004353689,0.00016228018,0.150194,0.000038644157,0.00080679904,0.000006761173,0.0007625645,0.0047992705,0.7846615,0.000071417875,0.000074054755,0.057987373],"study_design_scores_gemma":[0.025163876,0.013095306,0.6532141,0.00005864451,0.005238961,0.000008533789,0.0069316155,0.007255046,0.2778821,0.00030917316,0.0097585,0.0010841122],"about_ca_topic_score_codex":0.0010451693,"about_ca_topic_score_gemma":0.004937538,"teacher_disagreement_score":0.5067794,"about_ca_system_score_codex":0.00050070864,"about_ca_system_score_gemma":0.00077426684,"threshold_uncertainty_score":0.59788746},"labels":[],"label_agreement":null},{"id":"W4414649286","doi":"10.1016/j.ygyno.2025.04.370","title":"Association between body mass index and length of hospital stay in patients undergoing minimally invasive surgery for uterine cancer: A National Surgical Quality Improvement Program study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Body mass index; Invasive surgery; Gynecologic surgical procedures; Laparoscopy; Minimally invasive procedures","score_opus":0.027082278722807225,"score_gpt":0.38091349971299676,"score_spread":0.35383122099018954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953864,0.000036748002,0.000007685305,0.0010627357,0.00040662434,0.0027553504,0.00013139224,0.00002484102,0.00018821438],"genre_scores_gemma":[0.9985358,0.000121435,0.00013684329,0.00010204227,0.00006828757,0.0008137626,0.00009018886,0.000007492816,0.00012414082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982601,0.00015364289,0.00069042895,0.00033988393,0.0002659276,0.00029003102],"domain_scores_gemma":[0.99539787,0.003643373,0.00044914978,0.00008639158,0.00036520255,0.00005804292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010417935,0.000144852,0.000739392,0.00019452604,0.000049008464,0.000009885764,0.000058695194,0.00022478426,0.000034315814],"category_scores_gemma":[0.0015659297,0.00012825243,0.00008752418,0.00020999713,0.000053710028,0.000055201876,0.000081917744,0.00017154549,2.3839326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005085676,0.002474083,0.95071286,0.00015881604,0.0004312927,0.000006253236,0.0001799607,0.0000026217497,0.000017781735,0.00002222648,0.00026658172,0.045218967],"study_design_scores_gemma":[0.0081493,0.0099319555,0.9785495,0.000028627852,0.000111206675,7.041736e-8,0.00046356482,0.000017945862,0.00004895763,0.0002079141,0.0023809653,0.000110024484],"about_ca_topic_score_codex":0.0005213141,"about_ca_topic_score_gemma":0.003620195,"teacher_disagreement_score":0.04510894,"about_ca_system_score_codex":0.0020232173,"about_ca_system_score_gemma":0.0011391196,"threshold_uncertainty_score":0.5290643},"labels":[],"label_agreement":null},{"id":"W4414649317","doi":"10.1016/j.ygyno.2025.04.261","title":"Surgery versus definitive radiotherapy in the management of early-stage small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Neuroendocrine carcinoma; Radiation therapy; Small-cell carcinoma; Carcinoma; MEDLINE","score_opus":0.14556811490329732,"score_gpt":0.3991759563635927,"score_spread":0.25360784146029536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003419527,0.9869638,0.00000174845,0.00087945664,0.00011624264,0.009424719,0.00011493823,0.00001276033,0.0021443851],"genre_scores_gemma":[0.0012958021,0.9936403,0.00016983174,0.0007564498,0.0000087357985,0.00250071,0.000023024097,0.000027484662,0.0015776373],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99105626,0.0052033104,0.0020225868,0.0006962472,0.00046240978,0.0005591768],"domain_scores_gemma":[0.982869,0.013723046,0.0017085264,0.001474946,0.00014547129,0.000078983445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013936543,0.0005773957,0.011769833,0.00071073294,0.000056959307,0.000010542509,0.00091607124,0.000049691138,0.00024688573],"category_scores_gemma":[0.0010807327,0.00027149924,0.0030904885,0.0026690098,0.00034957763,0.000029550223,0.00044429878,0.0007528401,0.0000034630832],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067316614,0.0003949548,0.00012977888,0.9556912,0.037510406,0.003900381,0.000023615792,0.0000011681885,6.803037e-8,0.00018529738,0.00013938158,0.0019564272],"study_design_scores_gemma":[0.0011186829,0.0015937709,0.00046262555,0.012665355,0.9435832,0.00035037418,0.00018220874,9.929645e-7,0.0000029428186,0.000022545111,0.03974774,0.00026954603],"about_ca_topic_score_codex":0.00008712614,"about_ca_topic_score_gemma":0.00014865161,"teacher_disagreement_score":0.9430258,"about_ca_system_score_codex":0.00024259608,"about_ca_system_score_gemma":0.00055288186,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W4414649505","doi":"10.1016/j.ygyno.2025.04.180","title":"Racial and ethnic enrollment disparities in clinical trials leading to drug approvals for gynecologic malignancies by the Food and Drug Administration","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Food and drug administration; Clinical trial; Ethnic group; Drug; Drug approval; Clinical research; Expanded access","score_opus":0.1254473756907313,"score_gpt":0.3991003611446773,"score_spread":0.273652985453946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95628816,0.008408725,0.0011307771,0.023857746,0.0015963521,0.0021802902,0.00024351252,0.00003103106,0.006263383],"genre_scores_gemma":[0.9878337,0.0017408325,0.0006010146,0.006077384,0.00015224762,0.00092671614,0.00001494046,0.000012482049,0.0026406741],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661773,0.00032955702,0.0018337865,0.0006764028,0.000025114925,0.00051739474],"domain_scores_gemma":[0.99235225,0.0065808115,0.00069539744,0.00022250751,0.00003943541,0.000109595116],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01062185,0.00023962546,0.0014322306,0.00019915789,0.00023264355,0.00010147502,0.00026686257,0.00036025277,0.00005978743],"category_scores_gemma":[0.009038992,0.00020577741,0.00015742794,0.00018252991,0.0003189627,0.00017959213,0.0001654147,0.0002966222,0.000018496894],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094046287,0.00068507,0.16307314,0.00017722987,0.0002558466,0.0000062787335,0.0019793243,0.000059990645,0.000058462192,0.49710274,0.080809385,0.25485206],"study_design_scores_gemma":[0.0063996883,0.0046020625,0.3196049,0.000041294497,0.000087310895,0.000005761393,0.0016027178,0.00035285708,0.00026182772,0.243514,0.4227912,0.0007363451],"about_ca_topic_score_codex":0.00008935165,"about_ca_topic_score_gemma":0.003385184,"teacher_disagreement_score":0.34198183,"about_ca_system_score_codex":0.0003375891,"about_ca_system_score_gemma":0.00020779921,"threshold_uncertainty_score":0.9993083},"labels":[],"label_agreement":null},{"id":"W4414649521","doi":"10.1016/j.ygyno.2025.04.213","title":"Prognostic value of circulating tumor DNA in endometrial cancer: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Endometrial cancer; Circulating tumor cell; Circulating tumor DNA; Risk stratification; Value (mathematics); Cancer; Endometrium","score_opus":0.05172379336433202,"score_gpt":0.369395244460807,"score_spread":0.317671451096475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057500485,0.9945957,0.000027005593,0.00006875866,0.00016646888,0.0043205414,0.00040833975,0.0000071716454,0.0003485194],"genre_scores_gemma":[0.0005388623,0.9949081,0.00026704933,0.00058576977,0.000052091513,0.003286767,0.00020780542,0.000023565934,0.0001299843],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99576575,0.0010738841,0.0018362054,0.0008086931,0.00013362522,0.00038183073],"domain_scores_gemma":[0.99479115,0.0028042344,0.0015560852,0.00062675384,0.00013598893,0.000085814165],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013653028,0.00050557574,0.00990843,0.0005484874,0.000043457156,0.000015884276,0.00044375425,0.000533423,0.000102899685],"category_scores_gemma":[0.008576024,0.00037956628,0.0018764494,0.0012912425,0.00012064528,0.0000022512784,0.00041149845,0.00026562382,0.0000022276909],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008055219,0.00018395016,0.000052932788,0.91885656,0.073801614,0.000057819223,0.000009928295,0.0000446341,0.0000062272065,0.0002019576,0.00016295606,0.006613342],"study_design_scores_gemma":[0.00039609743,0.0005208804,0.000012543816,0.009885931,0.94678146,0.000036996047,0.000010890121,0.000006051841,0.000004406239,0.000046282945,0.04186759,0.00043085625],"about_ca_topic_score_codex":0.00010509461,"about_ca_topic_score_gemma":0.0005605404,"teacher_disagreement_score":0.90897065,"about_ca_system_score_codex":0.00022343583,"about_ca_system_score_gemma":0.0015572404,"threshold_uncertainty_score":0.99986565},"labels":[],"label_agreement":null},{"id":"W4414649545","doi":"10.1016/j.ygyno.2025.04.052","title":"Post hoc tipping point and multiple imputation analyses to determine the impact of early censored patients in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"GlaxoSmithKline","keywords":"Post-hoc analysis; Food and drug administration; Clinical endpoint; Clinical trial; Imputation (statistics); Endometrial cancer; Disease; Tipping point (physics)","score_opus":0.3957069601206963,"score_gpt":0.5835680224617531,"score_spread":0.18786106234105682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921336,0.000019981188,0.0031695566,0.001030002,0.00050785637,0.0024112992,0.00009258543,0.000027299055,0.0006077863],"genre_scores_gemma":[0.9229116,0.000017234457,0.07615551,0.0006561102,0.00009151477,0.0001303205,0.0000049853206,0.000011657937,0.000021059715],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99411756,0.0035657997,0.0013065155,0.00039394925,0.00021917974,0.0003970096],"domain_scores_gemma":[0.85794497,0.14086714,0.00050090393,0.0003996164,0.00022043157,0.00006693781],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004609563,0.00023177773,0.0009629031,0.00020391082,0.00012216638,0.00003688218,0.0004505416,0.00031963657,0.000089181325],"category_scores_gemma":[0.21393739,0.0001221767,0.00021579696,0.000500783,0.0002524871,0.00005339208,0.00023344418,0.00038237506,0.000007046966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07641981,0.009039699,0.13465098,0.00034740233,0.0014512717,0.00013460293,0.014611026,0.0006113168,0.00592503,0.017648548,0.0060389703,0.73312134],"study_design_scores_gemma":[0.032413878,0.017133748,0.59661096,0.000052333544,0.00031542912,0.0000035203102,0.00092972995,0.0014361487,0.00020032996,0.35053754,0.000103513485,0.00026285177],"about_ca_topic_score_codex":0.00031502446,"about_ca_topic_score_gemma":0.00033723318,"teacher_disagreement_score":0.7328585,"about_ca_system_score_codex":0.00024797634,"about_ca_system_score_gemma":0.00018356019,"threshold_uncertainty_score":0.79268396},"labels":[],"label_agreement":null},{"id":"W4414649561","doi":"10.1016/j.ygyno.2025.03.082","title":"Opportunistic salpingectomy during non-gynecologic surgery: Final data from a survey of Canadian general surgeons and urologists","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; Juravinski Hospital","funders":"","keywords":"Salpingectomy; Ovarian cancer; MEDLINE; Gynecologic surgical procedures","score_opus":0.141038097856628,"score_gpt":0.3484487976556022,"score_spread":0.20741069979897422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904306,0.0003177821,0.00001426746,0.0022940703,0.00070016587,0.00055037305,0.0011026181,0.000054936405,0.004535173],"genre_scores_gemma":[0.99383795,0.000737156,0.00090477895,0.0009560633,0.000039233415,0.000061181774,0.0026121973,0.000017391842,0.00083405443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973323,0.00037520297,0.00065392844,0.0008027314,0.00012976216,0.00070609094],"domain_scores_gemma":[0.9955385,0.0027832205,0.00025644852,0.00087400497,0.00016726964,0.00038057074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009302792,0.00031312992,0.0012565827,0.00082755665,0.00018991856,0.000018336888,0.00033070243,0.0004436128,0.0006574917],"category_scores_gemma":[0.0026443547,0.00026703236,0.000082692975,0.0006934373,0.0003372453,0.00007011638,0.00050036557,0.00029300342,0.000023658904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027829738,0.00041489984,0.98345,0.000055041175,0.00040441015,0.002241001,0.000018288089,0.0000026821408,0.0003753612,0.000059921556,0.0074587893,0.0052413302],"study_design_scores_gemma":[0.0020083426,0.0006227224,0.98316365,0.000026226837,0.00030462054,0.00008538602,0.000019366558,0.00034355244,0.00006859772,0.000121658755,0.013048524,0.00018736116],"about_ca_topic_score_codex":0.2945273,"about_ca_topic_score_gemma":0.57452875,"teacher_disagreement_score":0.28000146,"about_ca_system_score_codex":0.00037660624,"about_ca_system_score_gemma":0.0026613967,"threshold_uncertainty_score":0.9999782},"labels":[],"label_agreement":null},{"id":"W4414649563","doi":"10.1016/j.ygyno.2025.03.075","title":"Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; University of Toronto","funders":"","keywords":"Vulvar cancer; Squamous cell cancer; Margin (machine learning); Resection margin; Vulvar neoplasm; Resection; Basal cell","score_opus":0.019102224407214263,"score_gpt":0.30857213861389116,"score_spread":0.2894699142066769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880234,0.0006249969,0.00006176481,0.0006039703,0.0004093784,0.00073214306,0.0004628403,0.000013950808,0.009067546],"genre_scores_gemma":[0.99851215,0.000622301,0.000092592025,0.00026432346,0.00003893151,0.00012256886,0.00010272447,0.0000060572415,0.00023835067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981685,0.00033977797,0.00041493104,0.00044923296,0.00027987015,0.0003476382],"domain_scores_gemma":[0.99754167,0.0016196056,0.0002007097,0.00025332626,0.00029890728,0.00008577705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053936645,0.00014062285,0.00036849728,0.00012969499,0.00007413509,0.000011169065,0.00017900037,0.00019873976,0.0005802061],"category_scores_gemma":[0.0007931904,0.00008690584,0.000035366957,0.00029656469,0.00044316927,0.00003742022,0.00020723812,0.00062374945,0.000003826702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007960401,0.0005355864,0.9589008,0.00003646995,0.000026785121,0.000043627577,0.00039128898,0.00009841734,0.0000143336265,0.00003313944,0.0005304198,0.03142871],"study_design_scores_gemma":[0.010267571,0.0030351575,0.98292893,0.000013577444,0.000070508875,5.7792033e-7,0.0007175914,0.00020257529,0.00021937248,0.00013057468,0.0023327912,0.00008075999],"about_ca_topic_score_codex":0.011622125,"about_ca_topic_score_gemma":0.016533384,"teacher_disagreement_score":0.03134795,"about_ca_system_score_codex":0.0006830509,"about_ca_system_score_gemma":0.00056202576,"threshold_uncertainty_score":0.9949596},"labels":[],"label_agreement":null},{"id":"W4414649622","doi":"10.1016/j.ygyno.2025.04.262","title":"Should we advocate for the continued availability of actinomycin D to remain an essential first-line treatment for low-risk gestational trophoblastic neoplasia?","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Methotrexate; Gestational trophoblastic neoplasia; Regimen; Chorioepithelioma; Chemotherapy; Gestational trophoblastic disease; Trophoblastic neoplasm; Dactinomycin","score_opus":0.045493486211836236,"score_gpt":0.3722108733287157,"score_spread":0.3267173871168795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9308208,0.00023677803,0.03934634,0.020817386,0.0010671376,0.0062763314,0.0008170067,0.00007511415,0.0005430863],"genre_scores_gemma":[0.97930765,0.00016217258,0.0148961805,0.00070022186,0.00019772701,0.0031314818,0.00015315753,0.000021120413,0.0014302621],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99794024,0.00016960679,0.0006930775,0.0005719697,0.00018715012,0.0004379708],"domain_scores_gemma":[0.9859616,0.012546047,0.0003118613,0.00037067154,0.00065632554,0.00015346333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052216585,0.0002875004,0.000789459,0.00015439371,0.0003294213,0.000011472541,0.00017784884,0.00017809152,0.00021532811],"category_scores_gemma":[0.0071995817,0.00019221235,0.00025405432,0.00024841455,0.00032214267,0.000039948398,0.000067536595,0.00012940833,0.000015100291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16291417,0.048675887,0.14661062,0.0065295384,0.012467455,0.00026833813,0.011363014,0.08175255,0.025778549,0.04167886,0.08167985,0.38028115],"study_design_scores_gemma":[0.0310235,0.04125721,0.7915667,0.00017945065,0.0047802236,0.00002236213,0.0037681442,0.015883692,0.0037032086,0.013845638,0.093409516,0.00056031585],"about_ca_topic_score_codex":0.000058180874,"about_ca_topic_score_gemma":0.0013230158,"teacher_disagreement_score":0.6449561,"about_ca_system_score_codex":0.0006194086,"about_ca_system_score_gemma":0.0011753022,"threshold_uncertainty_score":0.86190915},"labels":[],"label_agreement":null},{"id":"W4414649631","doi":"10.1016/j.ygyno.2025.04.010","title":"Waiting for gynecologic oncologists: Inefficient referral patterns and treatment delays for patients with limited english proficiency","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Interpreting and Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Referral; Limiting; Limited English proficiency; Gynecologic cancer; Gynecologic oncology; Quarter (Canadian coin)","score_opus":0.06672393381836753,"score_gpt":0.4245937595255898,"score_spread":0.35786982570722226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97349644,0.00012633034,0.0012670194,0.0036830897,0.001990064,0.008047797,0.0002362923,0.0003201408,0.010832806],"genre_scores_gemma":[0.97744215,0.00010737691,0.0042463625,0.003628125,0.00014815606,0.012848766,0.00034686987,0.000028045739,0.0012041433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604905,0.001033742,0.0010103525,0.00072192895,0.000118073396,0.0010668655],"domain_scores_gemma":[0.9836324,0.013626684,0.00065039133,0.0005417107,0.0014120282,0.00013678665],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0012325346,0.0003492096,0.00074529933,0.00023081154,0.0019385472,0.000018322247,0.00041346395,0.0007601426,0.000093295756],"category_scores_gemma":[0.0053308965,0.00024862398,0.000106762345,0.0002610422,0.00020470779,0.000063665124,0.00026296073,0.0005349527,0.0000073066526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014622414,0.0018606241,0.9002457,0.0005414882,0.00012279359,0.0000028726129,0.005890167,0.00007512071,0.0000061577025,0.014597867,0.003202676,0.071992286],"study_design_scores_gemma":[0.018985635,0.04585724,0.6178099,0.0005207741,0.00037370695,0.0000017524313,0.029001823,0.0084524015,0.000025264379,0.0016910583,0.2764295,0.0008509607],"about_ca_topic_score_codex":0.00014597368,"about_ca_topic_score_gemma":0.0016734772,"teacher_disagreement_score":0.28243583,"about_ca_system_score_codex":0.0020829649,"about_ca_system_score_gemma":0.0011280004,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W4414649692","doi":"10.1016/j.ygyno.2025.04.507","title":"Efficacy and safety of luveltamab tazevibulin in patients with recurrent platinum-resistant ovarian cancer: Results from the dose-optimization stage of the REFRαME-O1 (GOG-3086, ENGOT-79ov, and APGOT-OV9) phase II/III study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University Health Centre","funders":"","keywords":"Ovarian cancer; Stage (stratigraphy); Clinical trial; Phases of clinical research; Folate receptor; Cancer; Tumor stage","score_opus":0.016031749350944445,"score_gpt":0.306201884038879,"score_spread":0.29017013468793457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899583,0.0006262612,0.000027274124,0.004091117,0.000290336,0.0034829215,0.00077007536,0.000014179295,0.00073952216],"genre_scores_gemma":[0.99804366,0.0005387778,0.0005924818,0.0002905813,0.000029220117,0.00021159158,0.00011931807,0.000012113707,0.00016226912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767864,0.00041112024,0.0008548352,0.0005488126,0.0002472418,0.00025937735],"domain_scores_gemma":[0.99703336,0.0016322001,0.0005917183,0.00051988836,0.00015525658,0.00006758239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058307295,0.0002534429,0.0007934063,0.00009475236,0.00018841327,0.00000995761,0.00016652238,0.00017907713,0.00013180778],"category_scores_gemma":[0.0005313349,0.00013604488,0.000038309005,0.00043306552,0.000261797,0.000041911506,0.00022257373,0.00029202033,2.3288068e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07748959,0.027738946,0.62160224,0.00014874896,0.0016392835,0.00006396997,0.010276047,0.003069034,0.00013897949,0.0006036971,0.0011575195,0.25607195],"study_design_scores_gemma":[0.09254346,0.012934887,0.8873702,0.00025566595,0.0005388171,4.834927e-7,0.0008177033,0.00028445167,0.0000634814,0.000027978978,0.0050425646,0.00012028913],"about_ca_topic_score_codex":0.0015664119,"about_ca_topic_score_gemma":0.003997779,"teacher_disagreement_score":0.265768,"about_ca_system_score_codex":0.00047584766,"about_ca_system_score_gemma":0.0004985303,"threshold_uncertainty_score":0.55477494},"labels":[],"label_agreement":null},{"id":"W4414649700","doi":"10.1016/j.ygyno.2025.04.334","title":"Highlights and challenges to enhanced recovery after surgery in gynecologic oncology hysterectomies performed at a community hospital","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brandon University","funders":"","keywords":"Gynecologic oncology; Community hospital; Gynecologic surgical procedures; Hysterectomy","score_opus":0.030084501427914575,"score_gpt":0.2950062049066202,"score_spread":0.26492170347870564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94866586,0.0034201627,0.000027126964,0.018790767,0.0035367713,0.0017019096,0.00001597749,0.00022659509,0.023614855],"genre_scores_gemma":[0.97820836,0.009736227,0.0010011062,0.0063266098,0.00012037151,0.0018714758,0.000036281974,0.000040686195,0.002658896],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9943426,0.001879916,0.0012422294,0.0010377007,0.0002267888,0.001270751],"domain_scores_gemma":[0.9834249,0.014783604,0.0003466133,0.00088110793,0.00020946762,0.0003543054],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002433934,0.00063467055,0.0024623815,0.0012339979,0.00030352647,0.00002700195,0.00032401123,0.0013295619,0.0006151148],"category_scores_gemma":[0.0043914425,0.000547734,0.00030906088,0.0007080547,0.00048071484,0.00024481615,0.0009873053,0.001256899,0.00022396112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01973866,0.0107105905,0.2569644,0.0028446289,0.0011260778,0.0045876843,0.009976272,0.000046863228,0.012460573,0.00037120242,0.014402213,0.6667709],"study_design_scores_gemma":[0.0030244815,0.009863005,0.8883367,0.0003791019,0.0001648218,0.00014016712,0.0018023069,0.000009972468,0.006496135,0.0011039379,0.08796631,0.0007130536],"about_ca_topic_score_codex":0.000091656315,"about_ca_topic_score_gemma":0.009853683,"teacher_disagreement_score":0.6660578,"about_ca_system_score_codex":0.003919394,"about_ca_system_score_gemma":0.001045304,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W4414649704","doi":"10.1016/j.ygyno.2025.03.101","title":"Measuring contemporary symptoms in a diverse population of endometrial cancer patients: Development and initial validation of a brief symptom index from the PROMOTE study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Endometrial cancer; Population; Index (typography); MEDLINE; Population based study","score_opus":0.061214730080927496,"score_gpt":0.3381577629793547,"score_spread":0.2769430328984272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967573,0.0002959595,0.000009144844,0.00013052831,0.00042828944,0.0017725864,0.00002621481,0.000012251727,0.00056768797],"genre_scores_gemma":[0.9994654,0.000018803097,0.000065083004,0.00012964694,0.00004203304,0.00019896035,0.0000622451,0.0000048196753,0.0000129814935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846166,0.00029231881,0.0006255393,0.00025157217,0.00023122183,0.000137688],"domain_scores_gemma":[0.99838907,0.0010078409,0.0003049532,0.00011855165,0.0001421436,0.000037420614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042281015,0.00012490689,0.0005748571,0.00027052395,0.000049944858,0.0000047022777,0.0000855995,0.00013792116,0.00007213317],"category_scores_gemma":[0.0010882205,0.00008417258,0.000043430107,0.00062269904,0.00006891597,0.000058866055,0.00012760186,0.000134263,5.4681965e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019323393,0.001772265,0.9227352,0.000031927197,0.0002959104,0.000009540238,0.0011840116,0.0000063620805,0.00007718038,0.000012307451,0.0000076066763,0.07193534],"study_design_scores_gemma":[0.022922477,0.0021871524,0.9723052,0.00008712466,0.00015710163,2.4842933e-7,0.00043420782,0.000008077999,0.0015050326,0.00014343689,0.00018875461,0.00006121862],"about_ca_topic_score_codex":0.0049157445,"about_ca_topic_score_gemma":0.0012184015,"teacher_disagreement_score":0.07187413,"about_ca_system_score_codex":0.00049991853,"about_ca_system_score_gemma":0.00036227592,"threshold_uncertainty_score":0.7431168},"labels":[],"label_agreement":null},{"id":"W4414649724","doi":"10.1016/j.ygyno.2025.03.097","title":"(ENCORE) Long-term safety and efficacy of selinexor maintenance treatment in patients with TP53 wild-type advanced or recurrent endometrial cancer: Follow-up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Subgroup analysis; Endometrial cancer; Overall survival; MEDLINE; Stage (stratigraphy); Maintenance therapy","score_opus":0.02594590860317818,"score_gpt":0.35823256426794303,"score_spread":0.33228665566476484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99295396,0.0012154698,0.0000119805445,0.00036890674,0.00070243934,0.0043643056,0.00008321636,0.00001860866,0.00028114184],"genre_scores_gemma":[0.99546766,0.0028706368,0.000091953225,0.000059726663,0.000024330328,0.00029774036,0.00007836921,0.000012882286,0.0010967061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973697,0.00042763219,0.0007737684,0.0006052504,0.00034089325,0.0004827735],"domain_scores_gemma":[0.9969808,0.0015920075,0.0004116537,0.00051691866,0.00039319418,0.000105448285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004566802,0.00030347178,0.0015306491,0.0006938773,0.00010089781,0.0000064884953,0.00023772438,0.00016396835,0.00013433336],"category_scores_gemma":[0.00081014336,0.00014910912,0.0001882199,0.0031733487,0.00033598224,0.000059558704,0.00016970304,0.0002522204,6.887337e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04578617,0.005270264,0.8309411,0.00006309153,0.0025518746,0.00005488233,0.00090378616,0.00016638776,0.00004275033,0.0000180767,0.000022539307,0.11417908],"study_design_scores_gemma":[0.06302915,0.022761384,0.9100683,0.00011546395,0.0027821872,0.000001021709,0.00045667076,0.000059052556,0.00016616915,0.000009052799,0.00042975362,0.00012180626],"about_ca_topic_score_codex":0.00037648625,"about_ca_topic_score_gemma":0.012928956,"teacher_disagreement_score":0.11405728,"about_ca_system_score_codex":0.0016161252,"about_ca_system_score_gemma":0.0010562221,"threshold_uncertainty_score":0.7214661},"labels":[],"label_agreement":null},{"id":"W4414649750","doi":"10.1016/j.ygyno.2025.04.297","title":"Radiotherapy at the end of life in patients with gynecologic malignancies: A 12-year population-based retrospective analysis","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Radiation therapy; Palliative care; Gynecologic cancer; Gynecologic oncology; Retrospective cohort study","score_opus":0.03320615826880095,"score_gpt":0.35264121287778605,"score_spread":0.3194350546089851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993019,0.00071458647,0.0001590123,0.0015968288,0.00013855674,0.00076537306,0.00003941438,0.00002584533,0.0035413916],"genre_scores_gemma":[0.9958232,0.00013177624,0.0017967916,0.001646264,0.000017325623,0.000085357016,0.000111748595,0.000009085024,0.00037847582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982045,0.00030829717,0.0005744327,0.00036751825,0.00024500908,0.00030021832],"domain_scores_gemma":[0.9968167,0.0020284462,0.0004270335,0.00038851413,0.0002799758,0.000059329002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045197716,0.00019668166,0.0011495195,0.0004477044,0.00007114316,0.0000034572079,0.00017472757,0.00027054874,0.0012352985],"category_scores_gemma":[0.0018096099,0.00011988615,0.00023456657,0.0013116823,0.00035310382,0.000030733496,0.00004989996,0.00020125076,0.000003936221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010158792,0.0005918048,0.9948244,0.00004538169,0.0008809891,0.0000098896435,0.00028213963,0.0007226267,0.00003857476,0.00037989786,0.0003451084,0.00086329243],"study_design_scores_gemma":[0.005110485,0.0028329412,0.9890271,0.00005471129,0.00057037023,1.4656365e-7,0.00032521712,0.00013256054,0.00012320756,0.00020447353,0.0015122958,0.00010648662],"about_ca_topic_score_codex":0.00043507665,"about_ca_topic_score_gemma":0.004684713,"teacher_disagreement_score":0.0057973117,"about_ca_system_score_codex":0.0013414031,"about_ca_system_score_gemma":0.00048586866,"threshold_uncertainty_score":0.9996777},"labels":[],"label_agreement":null},{"id":"W4414649761","doi":"10.1016/j.ygyno.2025.04.300","title":"Comparative efficacy and safety of low-dose versus high-dose bevacizumab in ovarian cancer: A systematic literature review and indirect treatment comparison","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; AstraZeneca (Canada)","funders":"","keywords":"Bevacizumab; Systematic review; Ovarian cancer; Randomized controlled trial; Meta-analysis; Clinical trial","score_opus":0.034633791414051165,"score_gpt":0.37185822400243446,"score_spread":0.3372244325883833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56672966,0.415178,0.0000032011644,0.008121514,0.00059401215,0.0064964625,0.000096222946,0.000038648013,0.0027422588],"genre_scores_gemma":[0.8930014,0.104869,0.00037143962,0.00053019373,0.000021668377,0.00097527896,0.000050070597,0.000008010697,0.00017293378],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99785846,0.00046671805,0.0007834055,0.0004971987,0.00010410536,0.0002901174],"domain_scores_gemma":[0.99734783,0.00178534,0.00033891495,0.00031288993,0.0000995981,0.00011544668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031655308,0.00031491925,0.0026905772,0.00022100883,0.00007379884,0.000013765912,0.000076933764,0.0002474455,0.00009133083],"category_scores_gemma":[0.00021504502,0.00021814425,0.00007982137,0.00052426534,0.00015751686,0.00004356364,0.00007361179,0.00021806038,0.000003935803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042196922,0.03854269,0.26504582,0.41685104,0.01850456,0.0037209655,0.02371734,0.00023055615,0.00053014397,0.014610586,0.009470637,0.16657871],"study_design_scores_gemma":[0.07127259,0.013550616,0.8502612,0.054157134,0.0060246545,0.00006830276,0.00056578027,0.00010372594,0.0004085793,0.00010064564,0.003120777,0.0003659603],"about_ca_topic_score_codex":0.0001867927,"about_ca_topic_score_gemma":0.001497877,"teacher_disagreement_score":0.5852154,"about_ca_system_score_codex":0.0014135323,"about_ca_system_score_gemma":0.00048556525,"threshold_uncertainty_score":0.8895664},"labels":[],"label_agreement":null},{"id":"W4414649823","doi":"10.1016/j.ygyno.2025.04.399","title":"Real-world experience with poly (ADP-ribose) polymerase inhibitors for the treatment of ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Olaparib; Ovarian cancer; Chemotherapy; Polymerase; Poly ADP ribose polymerase; Epithelial ovarian cancer","score_opus":0.0359723972299745,"score_gpt":0.39097497735633274,"score_spread":0.3550025801263582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90751094,0.0057335496,0.0012720117,0.050757065,0.0032922768,0.004422115,0.00013252332,0.00018678118,0.026692767],"genre_scores_gemma":[0.9798983,0.0021177079,0.0017528655,0.0034177636,0.00047206218,0.0040474217,0.000017632206,0.000021794505,0.00825445],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855214,0.00009173884,0.0004301155,0.0003917654,0.00014032972,0.00039391706],"domain_scores_gemma":[0.9976719,0.0013947957,0.00024229584,0.00044468595,0.00015642423,0.000089873356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016021781,0.00022795523,0.00059943827,0.00018113852,0.00019393508,0.000007757406,0.00014809486,0.00016524622,0.00070352043],"category_scores_gemma":[0.000059105667,0.00013113671,0.00014143868,0.00051732105,0.00050706795,0.00004040334,0.0000211379,0.00011035084,0.0000040121035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015544224,0.006323082,0.2297543,0.00023163181,0.0021850828,0.00021770468,0.009014565,0.00016548306,0.04419309,0.016259523,0.029799541,0.64631176],"study_design_scores_gemma":[0.017864985,0.013412022,0.10354594,0.00013798125,0.00063563156,0.000025581907,0.0019708707,0.00015354449,0.15443777,0.0005442027,0.7069698,0.00030165268],"about_ca_topic_score_codex":0.0016671328,"about_ca_topic_score_gemma":0.002654857,"teacher_disagreement_score":0.6771703,"about_ca_system_score_codex":0.0012981689,"about_ca_system_score_gemma":0.0012104587,"threshold_uncertainty_score":0.7703055},"labels":[],"label_agreement":null},{"id":"W4414649848","doi":"10.1016/j.ygyno.2025.04.079","title":"Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Placebo; Duration (music); Interim analysis; Interim; Clinical trial; Overall survival","score_opus":0.03125459928371742,"score_gpt":0.3467446620976846,"score_spread":0.3154900628139672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980835,0.00017537223,0.00003748167,0.0021717255,0.0015468133,0.010480453,0.00022677497,0.00009160281,0.0044347374],"genre_scores_gemma":[0.9929355,0.00009269,0.0011236977,0.00081749423,0.00014483274,0.0027260368,0.001290843,0.000044567045,0.00082436315],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944188,0.0018430275,0.0015204904,0.0009045594,0.0004169949,0.00089614146],"domain_scores_gemma":[0.9902506,0.0075087664,0.0009686319,0.00061385916,0.0005061291,0.0001520544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015205505,0.00063336536,0.0017259475,0.0005660893,0.00032667106,0.00003314143,0.00033093893,0.0005673629,0.00017672691],"category_scores_gemma":[0.0020022492,0.00043813282,0.00026474075,0.0008521819,0.00028979752,0.00015462321,0.00010674626,0.0004772763,0.000007936983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77058905,0.011642762,0.17069809,0.00023742073,0.0013721869,0.00014050315,0.014430883,0.0007142041,0.0012085385,0.000147606,0.0070507755,0.021767976],"study_design_scores_gemma":[0.45897412,0.06796416,0.4514258,0.00018671337,0.0016442947,0.0000143045645,0.0029591958,0.0021229915,0.0007132208,0.00020337274,0.013198715,0.00059310003],"about_ca_topic_score_codex":0.00074589526,"about_ca_topic_score_gemma":0.0059168967,"teacher_disagreement_score":0.31161493,"about_ca_system_score_codex":0.005304113,"about_ca_system_score_gemma":0.0021847086,"threshold_uncertainty_score":0.99980706},"labels":[],"label_agreement":null},{"id":"W4414649927","doi":"10.1016/j.ygyno.2025.04.502","title":"Safety and preliminary efficacy of puxitatug samrotecan (AZD8205) in patients with endometrial cancer: A first-in-human phase I/IIa study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"","keywords":"Phase (matter); Phases of clinical research; Clinical trial; Endometrium; MEDLINE","score_opus":0.018039757716295558,"score_gpt":0.34776533870691695,"score_spread":0.3297255809906214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926395,0.0005104125,0.00000507385,0.000669269,0.0003180665,0.0034668094,0.000035298362,0.000026140033,0.0023294205],"genre_scores_gemma":[0.99895513,0.00015005138,0.00012644504,0.00019862478,0.000042631124,0.0003406649,0.000036026864,0.000012290478,0.00013814363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997872,0.00025351395,0.0007205282,0.0005199904,0.00022036978,0.00041357827],"domain_scores_gemma":[0.99753505,0.0017682409,0.0002175023,0.00026159428,0.00009804834,0.000119557066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004447393,0.00024405685,0.0011725918,0.00080654694,0.00008027316,0.000005473475,0.00014086446,0.00021292671,0.00031567388],"category_scores_gemma":[0.0009876316,0.00017771099,0.000065423075,0.0015048063,0.00018253124,0.00005059294,0.0001479938,0.00032329612,0.0000016981912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03959816,0.017679762,0.8567746,0.000095706855,0.00024469898,0.00017080967,0.0004360001,0.00003054818,0.000023314444,0.00007132125,0.00003471758,0.08484036],"study_design_scores_gemma":[0.15460257,0.04613665,0.797482,0.000087587956,0.0002623207,0.000001210357,0.00022746803,0.000007026853,0.00003485481,0.0000834732,0.0009618686,0.000112968],"about_ca_topic_score_codex":0.0014123635,"about_ca_topic_score_gemma":0.004674481,"teacher_disagreement_score":0.11500441,"about_ca_system_score_codex":0.0009875413,"about_ca_system_score_gemma":0.0003044922,"threshold_uncertainty_score":0.72468436},"labels":[],"label_agreement":null},{"id":"W4414649963","doi":"10.1016/j.ygyno.2025.04.137","title":"TroFuse-020/GOG-3101/ENGOT-cx20: A phase III, randomized, active-controlled, open-label, multicenter study comparing sacituzumab tirumotecan monotherapy versus treatment of physician's choice as second-line treatment for recurrent or metastatic cervical cancer","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multicenter study; Cervical cancer; Phases of clinical research; Clinical trial; MEDLINE","score_opus":0.1429722319449285,"score_gpt":0.4711110225805251,"score_spread":0.3281387906355966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414649963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610942,0.002379281,0.00018652857,0.0018609331,0.002012541,0.028422844,0.00028678702,0.00010053016,0.003656346],"genre_scores_gemma":[0.9705316,0.0011586803,0.0011468027,0.0011654817,0.00032049863,0.02171134,0.00015818766,0.000055424916,0.0037519832],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951891,0.00094201637,0.0015982075,0.0011146608,0.0003092375,0.0008467823],"domain_scores_gemma":[0.9896413,0.008238111,0.0008645196,0.0006274897,0.00031591588,0.00031264464],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005022657,0.00083648297,0.006064995,0.00040616698,0.00026700727,0.000047334637,0.0004179715,0.00024449822,0.0025209761],"category_scores_gemma":[0.0006580068,0.00049951655,0.0006725459,0.0006483114,0.00024572053,0.00012770615,0.0001320468,0.00022759169,0.000022583074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65611595,0.05410393,0.00022607466,0.00007864278,0.011187663,0.00009112946,0.00072332716,0.00002693127,0.0003335396,0.00010623109,0.00010927676,0.2768973],"study_design_scores_gemma":[0.83688545,0.13352937,0.0004061831,0.00007027085,0.007933762,0.0000030908375,0.0009995585,0.001897139,0.0021933021,0.00015626162,0.015604037,0.00032155172],"about_ca_topic_score_codex":0.0025336484,"about_ca_topic_score_gemma":0.013293153,"teacher_disagreement_score":0.27657577,"about_ca_system_score_codex":0.0051555997,"about_ca_system_score_gemma":0.0014077112,"threshold_uncertainty_score":0.99974567},"labels":[],"label_agreement":null},{"id":"W4414650676","doi":"10.1016/j.ygyno.2025.04.309","title":"The lived experience and patient-driven iterations to improve a novel preoperative weight loss intervention in patients with endometrial cancer and obesity","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Emissions Reduction Alberta","funders":"","keywords":"Endometrial cancer; Weight loss; Lived experience; Obesity; Intervention (counseling); Cancer","score_opus":0.01704287470629774,"score_gpt":0.3195538758851878,"score_spread":0.30251100117889007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414650676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954599,0.0003525866,0.00009155908,0.0014955715,0.00045774723,0.0016612676,0.000027583053,0.000014275131,0.00043951988],"genre_scores_gemma":[0.9973914,0.00014447438,0.00049005804,0.0007687388,0.00003035065,0.0009485617,0.000010211466,0.0000046257837,0.00021155147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893117,0.00009737371,0.00028433258,0.00034637726,0.00011188791,0.00022888138],"domain_scores_gemma":[0.9989082,0.0006349193,0.00008925202,0.00012228837,0.0001504564,0.000094862145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010182595,0.00013933824,0.00033135604,0.00016506352,0.00017595726,0.00002758833,0.000063876236,0.000104499,0.000056860677],"category_scores_gemma":[0.000651631,0.0000795786,0.000031511554,0.0004974396,0.00015982764,0.00007755271,0.00013842799,0.00015136173,0.000001758197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030863157,0.0011379368,0.8933808,0.00001913032,0.00011042433,0.000010262347,0.001552056,0.000005089083,0.00018607092,0.00023211326,0.000038931295,0.10024085],"study_design_scores_gemma":[0.016816394,0.0070317183,0.9723655,0.00005859261,0.00007903262,0.00000145439,0.00037576543,0.000038221722,0.00038220288,0.00006475975,0.0026963335,0.000090035974],"about_ca_topic_score_codex":0.00023662917,"about_ca_topic_score_gemma":0.0013392926,"teacher_disagreement_score":0.100150816,"about_ca_system_score_codex":0.00044158718,"about_ca_system_score_gemma":0.000117011594,"threshold_uncertainty_score":0.32451212},"labels":[],"label_agreement":null},{"id":"W4414867677","doi":"10.1016/j.ygyno.2025.09.015","title":"Impact of FIGO 2023 staging criteria on stage migration and survival outcomes in early-stage endometrial cancer: A retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Retrospective cohort study; Lymphovascular invasion; Stage (stratigraphy); Overall survival; Cohort; Cohort study","score_opus":0.03546744611278862,"score_gpt":0.4055535874806237,"score_spread":0.3700861413678351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414867677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914078,0.00013204805,0.0000055214787,0.00040114942,0.00093327195,0.0022225897,0.0002140182,0.000034689132,0.0046489094],"genre_scores_gemma":[0.9970539,0.0002602692,0.000048916525,0.00012611996,0.000063829204,0.00035203414,0.000023897137,0.000011177948,0.002059805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783754,0.00041037588,0.00057621626,0.00052421854,0.00028350062,0.00036813022],"domain_scores_gemma":[0.9975886,0.0016854183,0.00023207677,0.00025604825,0.00013765848,0.00010023087],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008238821,0.0002555339,0.0014410602,0.0007460206,0.00006381895,0.000016188465,0.00010349065,0.00020511923,0.0010993776],"category_scores_gemma":[0.0020959794,0.00018261437,0.00015885392,0.0011064791,0.00010114837,0.00006704871,0.0001015417,0.00032177643,0.0000050265276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030973502,0.0023071875,0.9900455,0.000034355566,0.00070046587,0.00013952683,0.00031910487,0.000018907693,0.00030277803,0.00007964136,0.000052208034,0.002902962],"study_design_scores_gemma":[0.016936732,0.015354556,0.9665966,0.000024367953,0.00020776948,4.824117e-7,0.00040414755,0.00002707106,0.00009334097,0.00009242809,0.00014414708,0.00011836489],"about_ca_topic_score_codex":0.017842436,"about_ca_topic_score_gemma":0.010260674,"teacher_disagreement_score":0.02344892,"about_ca_system_score_codex":0.0021716955,"about_ca_system_score_gemma":0.00036088462,"threshold_uncertainty_score":0.99981374},"labels":[],"label_agreement":null},{"id":"W4415009868","doi":"10.1016/j.ygyno.2025.09.012","title":"Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Intestinal and Peritoneal Adhesions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Ambulatory; Multidisciplinary approach; Triage; Prospective cohort study; Bowel obstruction","score_opus":0.01213321440406469,"score_gpt":0.32262924093335893,"score_spread":0.31049602652929426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415009868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97249776,0.000046468824,0.000008795816,0.00015042376,0.0002725767,0.0051853387,0.0000047898116,0.000109584464,0.021724287],"genre_scores_gemma":[0.98825914,0.000014940788,0.008738904,0.0000700169,0.000013052206,0.0014916116,0.000011759183,0.000015190324,0.0013853777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983507,0.00012648045,0.00045552177,0.00051605643,0.00018064867,0.00037060175],"domain_scores_gemma":[0.9991437,0.0001723537,0.00018596182,0.00024493242,0.00017832758,0.00007471712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000182873,0.0002203912,0.00059453846,0.00020971803,0.00009057773,0.0000036711942,0.00012081894,0.00016962217,0.00023286419],"category_scores_gemma":[0.00009818466,0.00014970452,0.00006045155,0.0005211938,0.00023550133,0.000045114175,0.00017621354,0.00028529426,0.000012190769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002503143,0.0092679,0.9303743,0.00014208088,0.00017684391,0.00039501893,0.00032790998,0.00009568519,0.000054106462,0.00041412108,0.000044436303,0.056204427],"study_design_scores_gemma":[0.007433303,0.02774901,0.9604933,0.00016166797,0.00016875258,0.000005389273,0.003088307,0.00006344024,0.000054821536,0.00028002678,0.00036004576,0.00014193753],"about_ca_topic_score_codex":0.000055980836,"about_ca_topic_score_gemma":0.00037997853,"teacher_disagreement_score":0.05606249,"about_ca_system_score_codex":0.0010566744,"about_ca_system_score_gemma":0.00020123295,"threshold_uncertainty_score":0.6104773},"labels":[],"label_agreement":null},{"id":"W4415716099","doi":"10.1016/j.ygyno.2025.10.022","title":"Description of first recurrence in advanced stage high grade serous ovarian cancer receiving intraperitoneal versus intravenous systemic treatment","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Sinai Health System; University of Toronto","funders":"","keywords":"Intraperitoneal chemotherapy; Serous fluid; Serous ovarian cancer; Ovarian cancer; Chemotherapy; Stage (stratigraphy)","score_opus":0.038980384936559566,"score_gpt":0.3299974935088963,"score_spread":0.2910171085723367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415716099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871409,0.0027941014,0.000058422826,0.0036269922,0.0030452204,0.0014931913,0.000056243,0.00006317085,0.0017217534],"genre_scores_gemma":[0.99006027,0.0065505574,0.0015168434,0.00016172112,0.00008107835,0.0012058422,0.0000421729,0.000015373442,0.00036614967],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980068,0.0001876362,0.0006354778,0.00056521804,0.00013384888,0.00047098676],"domain_scores_gemma":[0.9984632,0.0007024166,0.00026981765,0.00036243116,0.00010333822,0.00009876531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022554705,0.00028352268,0.00095048593,0.00026384773,0.000095467745,0.0000114238055,0.0001311561,0.00032543315,0.00029003323],"category_scores_gemma":[0.00019542177,0.00023846979,0.00012477327,0.00050833495,0.00012598626,0.00007599768,0.000052151787,0.00022895048,0.000007771287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044779247,0.0061855265,0.45738408,0.00074463367,0.000999612,0.00097343436,0.0019856882,0.0018301213,0.0021639506,0.0026383484,0.00030536752,0.5203113],"study_design_scores_gemma":[0.031907123,0.016182125,0.93050224,0.0011167815,0.00081378873,0.000058674992,0.001694926,0.0003021339,0.0027488638,0.0002663759,0.014024321,0.00038264142],"about_ca_topic_score_codex":0.0039267717,"about_ca_topic_score_gemma":0.01818954,"teacher_disagreement_score":0.5199287,"about_ca_system_score_codex":0.0056861797,"about_ca_system_score_gemma":0.0008965431,"threshold_uncertainty_score":0.99972594},"labels":[],"label_agreement":null},{"id":"W4415769740","doi":"10.1016/j.ygyno.2025.10.027","title":"Experiences of radiotherapy for treatment of Granulosa Cell Tumor of the ovary: insights from the GCT-survivor sisters","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Future Fund; State Government of Victoria; Hudson Institute","keywords":"Radiation therapy; Granulosa cell; MEDLINE; Cell; Chemotherapy","score_opus":0.0198184208580872,"score_gpt":0.3038408724828228,"score_spread":0.2840224516247356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415769740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860337,0.005312189,0.000052276093,0.0035857763,0.000910391,0.0016059141,0.000055527038,0.000009505414,0.0024347354],"genre_scores_gemma":[0.99613154,0.0006452102,0.0012327653,0.0008918057,0.00005290758,0.00078794,0.000010608342,0.0000072621765,0.0002399638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884534,0.00017413455,0.00045103353,0.00025396503,0.00011230661,0.00016324056],"domain_scores_gemma":[0.99678934,0.0022734494,0.0003762765,0.0004412463,0.00008829269,0.000031372627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098057506,0.00016015119,0.0007541079,0.0000481227,0.00007369095,0.0000025595655,0.0002027368,0.000110922956,0.00016472631],"category_scores_gemma":[0.000073182295,0.00007331071,0.0002932806,0.00020327873,0.0004018629,0.000015726513,0.000030188952,0.00003768908,5.6639846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088690445,0.03682439,0.5305436,0.0008071089,0.0070817154,0.00010630807,0.13063763,0.00018257718,0.053002384,0.0115713095,0.017979406,0.20239447],"study_design_scores_gemma":[0.02461064,0.027199835,0.47320366,0.00018432307,0.0019172444,0.000006583652,0.024104817,0.00016053408,0.2965471,0.0025921944,0.14922243,0.00025060782],"about_ca_topic_score_codex":0.0004575732,"about_ca_topic_score_gemma":0.00040233287,"teacher_disagreement_score":0.24354474,"about_ca_system_score_codex":0.0003064591,"about_ca_system_score_gemma":0.00048008063,"threshold_uncertainty_score":0.2989524},"labels":[],"label_agreement":null},{"id":"W4415978236","doi":"10.1016/j.ygyno.2025.10.031","title":"Corrigendum to “OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer” [Gynecol Oncol 2025 Jun 197 182–191]","year":2025,"lang":"en","type":"erratum","venue":"Gynecologic Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Chemotherapy; Epithelial ovarian cancer; Gene; Phases of clinical research; Randomized controlled trial","score_opus":0.024242278572047582,"score_gpt":0.35825690809539845,"score_spread":0.33401462952335087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415978236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725708,0.0013614061,0.0001205251,0.0012102228,0.0034391354,0.019606203,0.0006963924,0.000041665193,0.00095365994],"genre_scores_gemma":[0.875052,0.019582205,0.0038402723,0.010390008,0.0022815298,0.02257038,0.0053147143,0.0006175982,0.060351323],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9918038,0.0027886038,0.001606556,0.0018054376,0.0008412847,0.0011543187],"domain_scores_gemma":[0.99485344,0.0011515898,0.0013251415,0.0013108238,0.0011102668,0.00024871752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032815859,0.0010718866,0.002773457,0.000500984,0.0005245746,0.000046269102,0.0011857165,0.0010480315,0.0003662797],"category_scores_gemma":[0.001609836,0.0007037253,0.00022238203,0.0010574735,0.00064019876,0.000017906223,0.0004904412,0.0012103773,0.000003926872],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6342857,0.008518052,0.0016485051,0.00007073929,0.0019922778,0.00004818747,0.0016979048,0.0013374956,0.008966232,0.0000039610154,0.015913263,0.3255177],"study_design_scores_gemma":[0.67859894,0.24988307,0.011431301,0.00018908145,0.00045591616,0.0000047616645,0.00065963285,0.00033677835,0.0042665587,0.000023323555,0.052957773,0.0011928707],"about_ca_topic_score_codex":0.0007020527,"about_ca_topic_score_gemma":0.012871208,"teacher_disagreement_score":0.32432485,"about_ca_system_score_codex":0.0006472067,"about_ca_system_score_gemma":0.005475465,"threshold_uncertainty_score":0.9995414},"labels":[],"label_agreement":null},{"id":"W4415978426","doi":"10.1016/j.ygyno.2025.10.028","title":"Quantifying opportunities to reduce high grade serous ovarian cancer via opportunistic salpingectomy","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Center for Clinical and Translational Science, Mayo Clinic; Mayo Clinic","keywords":"Salpingectomy; Ovarian cancer; Serous fluid; Serous ovarian cancer; Fallopian tube; Reduction (mathematics)","score_opus":0.1425214410840193,"score_gpt":0.3961736908832295,"score_spread":0.2536522497992102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415978426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6452771,0.00198342,0.00149432,0.28896847,0.007858834,0.0034382984,0.0001445497,0.0006339158,0.050201103],"genre_scores_gemma":[0.96741176,0.0013174035,0.004195382,0.01900409,0.0002792548,0.0012878219,0.00008772135,0.000033705823,0.006382847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976265,0.00018595265,0.00057166535,0.00071709807,0.00020004768,0.00069875584],"domain_scores_gemma":[0.99809146,0.0006257905,0.00018428013,0.00052986847,0.00018302348,0.00038557142],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037749432,0.0003548216,0.0009561017,0.00037600793,0.00025243594,0.00003489007,0.00022172324,0.00035728505,0.0017593519],"category_scores_gemma":[0.00023458032,0.00030519467,0.00014465803,0.00038233644,0.00015992913,0.000061759456,0.00017275916,0.0003273442,0.00011738886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009913291,0.0041304687,0.112251505,0.00055016787,0.0020611547,0.0069782943,0.00067567674,0.00013955592,0.0041637854,0.050121404,0.12572704,0.6922096],"study_design_scores_gemma":[0.00571293,0.003200826,0.32283336,0.00028321688,0.0011967222,0.00016108282,0.000566905,0.00009974776,0.0014248037,0.0017490581,0.66229486,0.0004764455],"about_ca_topic_score_codex":0.0011700427,"about_ca_topic_score_gemma":0.0022065735,"teacher_disagreement_score":0.6917332,"about_ca_system_score_codex":0.0019150253,"about_ca_system_score_gemma":0.0020662865,"threshold_uncertainty_score":0.99994004},"labels":[],"label_agreement":null},{"id":"W4416625136","doi":"10.1016/j.ygyno.2025.11.009","title":"Exploring novel therapeutic targets in vulvar squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Canadian Institute for Advanced Research; BC Cancer Agency","funders":"University of British Columbia; VGH and UBC Hospital Foundation","keywords":"Clinical trial; Basal cell; Vulvar cancer; Immunotherapy; Vulvar Carcinoma; Immune system","score_opus":0.09852588944055593,"score_gpt":0.329724878850397,"score_spread":0.23119898940984104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416625136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91113293,0.0021016249,0.00014612255,0.0020188321,0.0012522846,0.00067931134,0.000005009098,0.00007673291,0.08258715],"genre_scores_gemma":[0.99379665,0.00012767377,0.0006277134,0.0034788246,0.00009177353,0.0003968224,0.000014944175,0.000012070149,0.0014535106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985576,0.000092168055,0.00036191367,0.00039352826,0.00012045568,0.00047431025],"domain_scores_gemma":[0.99861276,0.00091880636,0.0000728036,0.00023775088,0.000055136505,0.000102735845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024313077,0.00019163512,0.00058227027,0.00033962287,0.00006429307,0.0000062435215,0.00013841117,0.0002119276,0.0006582423],"category_scores_gemma":[0.00028099187,0.00014908472,0.00010476962,0.0007237759,0.00007143125,0.000060921226,0.0000924764,0.0003225949,0.00008833202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032407057,0.011424733,0.678235,0.00050058804,0.00018226607,0.0015195819,0.0011506785,0.00010628189,0.026715351,0.0045931097,0.0009228393,0.27140886],"study_design_scores_gemma":[0.01860483,0.004349526,0.9292696,0.000014323283,0.00019836774,0.00001670294,0.00055343413,0.000053621465,0.0076160417,0.0010438925,0.03807433,0.00020532435],"about_ca_topic_score_codex":0.00021188348,"about_ca_topic_score_gemma":0.000250411,"teacher_disagreement_score":0.27120352,"about_ca_system_score_codex":0.00097633485,"about_ca_system_score_gemma":0.00035389472,"threshold_uncertainty_score":0.72072923},"labels":[],"label_agreement":null},{"id":"W4416707929","doi":"10.1016/j.ygyno.2025.11.015","title":"Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Stage (stratigraphy); Radiation therapy; Multidisciplinary approach; Neuroendocrine carcinoma; Retrospective cohort study; Small-cell carcinoma; Surgical resection","score_opus":0.1427908414638958,"score_gpt":0.3998525693989923,"score_spread":0.25706172793509646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416707929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020268881,0.9865167,0.0000015538534,0.0012217078,0.00012016448,0.00959003,0.00013568124,0.000012997693,0.0021984673],"genre_scores_gemma":[0.0007885901,0.99344975,0.00018242792,0.00090925384,0.000008753033,0.0025345744,0.00003017319,0.000026527327,0.0020699783],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99113613,0.0050585642,0.0020800352,0.00070213375,0.0004655127,0.0005576087],"domain_scores_gemma":[0.98379725,0.0127174705,0.001766525,0.0014902338,0.00015123606,0.00007729567],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014834196,0.0005835404,0.01211205,0.0007159348,0.00008002189,0.000008110184,0.0009108028,0.000047830516,0.00030346858],"category_scores_gemma":[0.0012364106,0.0002707768,0.0030429205,0.0026803112,0.0003436591,0.000028063474,0.0005964924,0.00072997954,0.0000022533766],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057723715,0.000502016,0.000053788957,0.95507765,0.038302194,0.003340169,0.000024369534,0.0000014452077,8.684643e-8,0.00019553206,0.00022762665,0.0022174248],"study_design_scores_gemma":[0.0011512258,0.001719626,0.00016722873,0.012356179,0.91715527,0.0003718026,0.00022061313,0.0000013321721,0.0000033050262,0.000021992211,0.06657449,0.00025696357],"about_ca_topic_score_codex":0.00005429316,"about_ca_topic_score_gemma":0.0001601276,"teacher_disagreement_score":0.9427214,"about_ca_system_score_codex":0.00026685276,"about_ca_system_score_gemma":0.0006102204,"threshold_uncertainty_score":0.9999744},"labels":[],"label_agreement":null},{"id":"W4417209144","doi":"10.1016/j.ygyno.2025.12.003","title":"Evaluating the clinical utility and impact on healthcare utilization of serial troponin T monitoring in gynecologic cancer patients receiving immune checkpoint inhibitors – A single centre experience","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Sunnybrook Health Science Centre","funders":"","keywords":"Gynecologic cancer; Biomarker; Gynecologic oncology; Pembrolizumab; Cancer; Immunotherapy; Myocarditis; Chemotherapy","score_opus":0.11915230043243598,"score_gpt":0.4678452331041466,"score_spread":0.34869293267171064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417209144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248314,0.0013174943,0.0000027916599,0.0021618258,0.002429956,0.0012365123,0.000009021003,0.000031473854,0.00032779586],"genre_scores_gemma":[0.99857175,0.00063706446,0.00017749179,0.0003160016,0.000108767585,0.00011673435,0.000010861505,0.000009997712,0.00005135544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996702,0.0009854841,0.0012007615,0.00048347365,0.00021384448,0.0004144303],"domain_scores_gemma":[0.997248,0.0016659693,0.0005228234,0.00028759957,0.00020641182,0.000069217174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020689508,0.00022231198,0.00070537627,0.00014023992,0.00016150787,0.000013291951,0.00014776179,0.00040251776,0.00017057132],"category_scores_gemma":[0.0029915413,0.0001442195,0.00018010511,0.0005145672,0.00037199593,0.000063782325,0.00012636384,0.00045058248,8.6916543e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041695763,0.0008319998,0.7158851,0.00006226959,0.000054907017,0.000004272575,0.0011268108,0.000029234432,0.005868231,0.0000050995154,0.00002828391,0.2719342],"study_design_scores_gemma":[0.004950014,0.0070519913,0.97975576,0.00027698523,0.00004657193,0.0000015405953,0.0019497925,0.0004139671,0.0052128225,0.00006300829,0.00016839472,0.000109137145],"about_ca_topic_score_codex":0.00080514903,"about_ca_topic_score_gemma":0.0007672066,"teacher_disagreement_score":0.27182508,"about_ca_system_score_codex":0.0013666425,"about_ca_system_score_gemma":0.0007122059,"threshold_uncertainty_score":0.5881101},"labels":[],"label_agreement":null},{"id":"W4417212566","doi":"10.1016/j.ygyno.2025.11.020","title":"Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Food and drug administration; Gynecologic oncology; Clinical trial; Ovarian cancer; Clinical Practice; Drug; MEDLINE; Biomarker","score_opus":0.04627822145111066,"score_gpt":0.44785485950269105,"score_spread":0.4015766380515804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417212566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60978717,0.09689967,0.0003270864,0.27119622,0.003178865,0.009973641,0.00021361736,0.00013772403,0.008286022],"genre_scores_gemma":[0.8440734,0.071514785,0.020227473,0.05935039,0.00043627,0.0038600783,0.00013652875,0.00003848781,0.0003625862],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99463254,0.0013636755,0.0022243839,0.00092962524,0.00020235228,0.0006474393],"domain_scores_gemma":[0.9899231,0.008009304,0.0011253702,0.00042393187,0.00033722993,0.00018101792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051049115,0.00036871558,0.0019394285,0.00028244156,0.000100362304,0.000011775791,0.00022517562,0.00096863176,0.0002424203],"category_scores_gemma":[0.005218285,0.0003374915,0.00031459038,0.0008601522,0.000607468,0.00018989573,0.00014328198,0.00089582376,0.0000042039887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00773675,0.014808543,0.22940037,0.0066190693,0.0011858523,0.0003774368,0.0013194759,0.000020948728,0.0053058807,0.00550752,0.14679849,0.5809197],"study_design_scores_gemma":[0.03926078,0.024970625,0.095574565,0.0023709706,0.0011696949,0.00024733195,0.0025333536,0.00030167896,0.009128528,0.0043412247,0.819272,0.0008292632],"about_ca_topic_score_codex":0.0002369649,"about_ca_topic_score_gemma":0.0019125465,"teacher_disagreement_score":0.6724735,"about_ca_system_score_codex":0.0015004538,"about_ca_system_score_gemma":0.004445343,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W4417289048","doi":"10.1016/j.ygyno.2025.12.005","title":"MLH1 promoter hypermethylated endometrial cancer survival outcomes: A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gynecologic Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Endometrial cancer; MLH1; Risk stratification; Overall survival; Subgroup analysis; Survival analysis; Survival rate","score_opus":0.20594877651579932,"score_gpt":0.4624880136578777,"score_spread":0.2565392371420784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417289048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000060736147,0.98077893,0.00001171896,0.0011396358,0.0011136411,0.014425051,0.00036042585,0.00013066361,0.0020338865],"genre_scores_gemma":[0.000026547837,0.97664297,0.0005186774,0.0027403426,0.00006692934,0.011069736,0.00016280955,0.0000626514,0.008709333],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990906,0.0033630247,0.002866958,0.001500622,0.00057030027,0.00079309713],"domain_scores_gemma":[0.98680854,0.009387777,0.0017450968,0.0013389648,0.000405104,0.0003145457],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027908683,0.0012562905,0.036676943,0.0014425982,0.00011410471,0.000034568762,0.0006020611,0.0016335776,0.007315983],"category_scores_gemma":[0.0107343625,0.00070707616,0.0058465768,0.0036353911,0.00026446854,0.000036504345,0.0004816462,0.001199332,0.000085936044],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013744357,0.00018087465,0.000029881556,0.69904643,0.289113,0.00011380327,0.0000131896595,2.9983178e-7,1.4035305e-7,0.000007957207,0.00044570168,0.011035013],"study_design_scores_gemma":[0.0006781093,0.00080776867,0.000022238157,0.01086897,0.8425937,0.000064994085,0.0000075133225,7.2634316e-7,2.669249e-7,0.000014658878,0.1444754,0.00046563116],"about_ca_topic_score_codex":0.000079584344,"about_ca_topic_score_gemma":0.00030866923,"teacher_disagreement_score":0.68817747,"about_ca_system_score_codex":0.0016139651,"about_ca_system_score_gemma":0.002652587,"threshold_uncertainty_score":0.9996625},"labels":[],"label_agreement":null},{"id":"W7081943438","doi":"10.1016/j.ygyno.2025.04.563","title":"Tumor microenvironment in high- versus low-NRF2 high grade serous ovarian cancer and the impact on prognosis","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Geochemistry and Geologic Mapping","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tumor microenvironment; Serous ovarian cancer; Serous fluid; Ovarian cancer; Epithelial ovarian cancer; Ovarian tumor","score_opus":0.011902246076229698,"score_gpt":0.2667890472802891,"score_spread":0.25488680120405943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7081943438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391139,0.00023643563,0.00023956345,0.053841848,0.0009814537,0.000638051,0.0000058548526,0.00007161223,0.004871263],"genre_scores_gemma":[0.9955167,0.00013002285,0.0012577559,0.0021553938,0.00004439996,0.0004181424,0.0000037728425,0.0000025475981,0.00047126372],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99810195,0.00034810993,0.00031017858,0.00060250994,0.00010657078,0.0005306965],"domain_scores_gemma":[0.9978487,0.0014733239,0.00015697395,0.00042725808,0.000025497648,0.00006825108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066861836,0.00024304834,0.00046826294,0.00008865245,0.00018060938,0.000051161314,0.0007529855,0.00019564776,0.00015432709],"category_scores_gemma":[0.00029997813,0.00015012622,0.00007490375,0.00035149275,0.00031692078,0.00006855351,0.0005285934,0.00038750345,0.000015642352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006606015,0.0072311,0.20567288,0.0004256757,0.0014004305,0.002762753,0.0041664517,0.06663266,0.004491539,0.37058517,0.030300602,0.29972473],"study_design_scores_gemma":[0.016438533,0.0018646235,0.9228273,0.00006543406,0.00006612257,0.000035618174,0.00022277469,0.00681822,0.0028899747,0.03280729,0.01547049,0.0004936039],"about_ca_topic_score_codex":0.0007679248,"about_ca_topic_score_gemma":0.00023600268,"teacher_disagreement_score":0.71715444,"about_ca_system_score_codex":0.00051890773,"about_ca_system_score_gemma":0.0002037443,"threshold_uncertainty_score":0.6121969},"labels":[],"label_agreement":null},{"id":"W7081949223","doi":"10.1016/j.ygyno.2025.04.558","title":"Addition of chemotherapy and radiation for patients with stage III endometrial cancer treated with curative intent surgery: Impact on recurrence and survival in different molecular subtypes","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Geochemistry and Geologic Mapping","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; University of the Fraser Valley; University of British Columbia","funders":"","keywords":"Endometrial cancer; Chemotherapy; Radiation therapy; Overall survival; Stage (stratigraphy)","score_opus":0.01218620410880496,"score_gpt":0.2766515175778932,"score_spread":0.26446531346908825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7081949223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947499,0.000065194654,0.003409529,0.0007891185,0.00010533249,0.00060522737,0.00003491248,0.000015365084,0.00022542539],"genre_scores_gemma":[0.99930835,0.000110866946,0.00025452985,0.00008263458,0.0000074139903,0.00015992118,0.000040458017,0.000001638659,0.00003420475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990545,0.00014328124,0.00019992123,0.00032910524,0.00008161904,0.00019159666],"domain_scores_gemma":[0.9978954,0.00159543,0.00021445681,0.000116303374,0.00014355296,0.00003482997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022411898,0.00015131786,0.00040652644,0.00016120673,0.000043135347,0.000014320322,0.00010057615,0.00010204785,0.000019645859],"category_scores_gemma":[0.00033423593,0.000091642505,0.00002771979,0.0003292117,0.000099293124,0.000073283794,0.000037587026,0.00009103992,5.434427e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034316103,0.0007538219,0.86339885,0.00007474287,0.00018377035,0.00001068243,0.00037081272,0.00049464044,0.0004366137,0.0016515641,0.0001956803,0.12899719],"study_design_scores_gemma":[0.006736119,0.005189401,0.97815025,0.00008377469,0.000023645283,7.884762e-7,0.0000840093,0.002522126,0.0054771295,0.0008116473,0.00073691073,0.00018417563],"about_ca_topic_score_codex":0.00006491801,"about_ca_topic_score_gemma":0.00008644571,"teacher_disagreement_score":0.12881301,"about_ca_system_score_codex":0.00016171843,"about_ca_system_score_gemma":0.00013066127,"threshold_uncertainty_score":0.3737073},"labels":[],"label_agreement":null},{"id":"W7081987814","doi":"10.1016/j.ygyno.2025.04.561","title":"Treatment patterns and outcomes in patients with ovarian germ cell tumors","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Geochemistry and Geologic Mapping","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbotsford Veterinary Clinic; University of the Fraser Valley; University of British Columbia","funders":"","keywords":"Germ cell tumors; Germ cell; Ovary; Chemotherapy; Cell","score_opus":0.006746426245617595,"score_gpt":0.23055246304476032,"score_spread":0.22380603679914274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7081987814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96375376,0.000012625308,0.0012811105,0.004358955,0.00018892669,0.00032924954,0.000002938705,0.00006657918,0.030005831],"genre_scores_gemma":[0.994751,0.000006948773,0.002380282,0.0006712318,0.0000054868547,0.00007425412,0.000005800337,0.0000013812047,0.0021036612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987928,0.0001148621,0.0002298107,0.00044951536,0.00006837544,0.00034459215],"domain_scores_gemma":[0.9990424,0.0004322059,0.000107228196,0.00031672313,0.00004651979,0.000054956876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014373906,0.00017635875,0.00036099105,0.000099971534,0.000081521765,0.00002880598,0.0003294363,0.00014803854,0.000045652625],"category_scores_gemma":[0.00009702178,0.000119220735,0.000029300698,0.0001911057,0.000060908915,0.00007925308,0.00023781414,0.00012120347,0.0000062139866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014332363,0.0005238938,0.9798611,0.000014021521,0.000014365314,0.000079068006,0.00015632063,0.000047524652,0.0000049892587,0.0018710999,0.000039972092,0.017373312],"study_design_scores_gemma":[0.002361574,0.0011550477,0.98625094,0.000006023931,0.000008065909,0.000002784136,0.000054719763,0.0003177898,0.00011680219,0.0017355896,0.007860974,0.00012966874],"about_ca_topic_score_codex":0.00008585281,"about_ca_topic_score_gemma":0.0002064647,"teacher_disagreement_score":0.03099717,"about_ca_system_score_codex":0.00020892345,"about_ca_system_score_gemma":0.0001520441,"threshold_uncertainty_score":0.48616803},"labels":[],"label_agreement":null},{"id":"W7116108493","doi":"10.1016/j.ygyno.2025.12.008","title":"Prognostic value of perioperative circulating tumor DNA in endometrial cancer: systematic review & meta-analysis","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"University of Toronto","keywords":"Perioperative; Circulating tumor cell; Circulating tumor DNA; Adjuvant; Prospective cohort study; Endometrial cancer","score_opus":0.03901420694009129,"score_gpt":0.34849848791685145,"score_spread":0.3094842809767602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116108493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6046357,0.3773144,0.0014417324,0.0019175479,0.000867657,0.006441943,0.0002870664,0.00002765036,0.007066281],"genre_scores_gemma":[0.98757005,0.00685505,0.00095020706,0.0025020263,0.00004926043,0.0015904346,0.00009593133,0.000012451174,0.00037459328],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99738204,0.000634273,0.0010293095,0.00051364297,0.00012564647,0.00031509233],"domain_scores_gemma":[0.9976211,0.0011066252,0.00051540526,0.0004803892,0.00022111027,0.000055343276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011492122,0.00024084703,0.002291525,0.00029947588,0.00006043165,0.00001400106,0.00032473964,0.0001918813,0.00022679853],"category_scores_gemma":[0.007845582,0.00019316652,0.0007710525,0.0011023211,0.00011807465,0.0000033066785,0.00020377088,0.00014485617,0.0000051419615],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008419332,0.004654849,0.103499986,0.23748301,0.44218534,0.00038235125,0.001205299,0.044018365,0.13672376,0.02360753,0.0032424408,0.0021551324],"study_design_scores_gemma":[0.00904815,0.004624587,0.019658307,0.0053678597,0.9164183,0.00007267601,0.0008429616,0.0012234307,0.014918022,0.0010208685,0.024407823,0.0023970008],"about_ca_topic_score_codex":0.00022715579,"about_ca_topic_score_gemma":0.002899624,"teacher_disagreement_score":0.47423297,"about_ca_system_score_codex":0.00020741226,"about_ca_system_score_gemma":0.00074909086,"threshold_uncertainty_score":0.9392461},"labels":[],"label_agreement":null}]}